,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
11819,GO:0045202,1.39211590975526e-11,1,34,1258,synapse,CC,SNAP91;SYT1;CAMK2A;RAPGEF4;SRPX2;SLC17A7;ATP1A3;SH3GL2;GABRG2;SLC8A2;KCNIP2;IQSEC3;PACSIN1;SNAP25;POSTN;ANXA1;CPLX2;INA;RAB3C;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;SVOP;GABRB3;RIMS2;GRIN1;SLITRK1;DDN;SV2B;SHISA7;SLC6A17;FRRS1L
7123,GO:0030054,5.43915588316513e-10,0.999999999871951,40,1935,cell junction,CC,VIM;SNAP91;SYT1;CAMK2A;RAPGEF4;SRPX2;SLC17A7;ATP1A3;SH3GL2;GABRG2;SLC8A2;KCNIP2;IQSEC3;PLAU;PACSIN1;SNAP25;POSTN;ANXA1;CPLX2;INA;RAB3C;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;SVOP;GABRB3;CNTNAP2;RIMS2;GRIN1;SLITRK1;DDN;ANXA2;SV2B;SHISA7;SLC6A17;OPALIN;FRRS1L
3669,GO:0007268,2.82150771508014e-09,0.99999999952803,22,661,chemical synaptic transmission,BP,RASGRF1;SYT1;CAMK2A;CELF4;SLC17A7;CUX2;GABRG2;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1;SV2B;SHISA7
17969,GO:0098916,2.82150771508014e-09,0.99999999952803,22,661,anterograde trans-synaptic signaling,BP,RASGRF1;SYT1;CAMK2A;CELF4;SLC17A7;CUX2;GABRG2;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1;SV2B;SHISA7
7597,GO:0031012,3.34735923758629e-09,0.999999999511417,19,502,extracellular matrix,CC,TIMP1;SRPX2;SERPINE1;COL1A1;LOX;TGFBI;FMOD;GDF15;COL5A1;CHI3L1;POSTN;ANXA1;COL6A2;ELFN2;COL3A1;ANXA2;COL4A1;SERPINA3;SMOC1
18159,GO:0099537,3.66885896210113e-09,0.999999999377221,22,669,trans-synaptic signaling,BP,RASGRF1;SYT1;CAMK2A;CELF4;SLC17A7;CUX2;GABRG2;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1;SV2B;SHISA7
17403,GO:0097060,5.68429001185889e-09,0.999999999242897,17,373,synaptic membrane,CC,SNAP91;SYT1;SRPX2;GABRG2;IQSEC3;SNAP25;ANXA1;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1;SLITRK1;DDN;SHISA7
18158,GO:0099536,5.7483602025035e-09,0.99999999898024,22,688,synaptic signaling,BP,RASGRF1;SYT1;CAMK2A;CELF4;SLC17A7;CUX2;GABRG2;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1;SV2B;SHISA7
14332,GO:0060078,9.35163296260248e-09,0.999999999309127,11,137,regulation of postsynaptic membrane potential,BP,CELF4;SLC17A7;CUX2;GABRG2;SLC8A2;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1
15350,GO:0062023,1.88443782274342e-08,0.999999997419166,16,381,collagen-containing extracellular matrix,CC,TIMP1;SRPX2;SERPINE1;COL1A1;TGFBI;FMOD;GDF15;COL5A1;POSTN;ANXA1;COL6A2;COL3A1;ANXA2;COL4A1;SERPINA3;SMOC1
12827,GO:0048167,2.5821271997218e-08,0.999999997553608,12,183,regulation of synaptic plasticity,BP,RASGRF1;CAMK2A;SLC8A2;SNAP25;CPLX2;JPH3;KCNB1;SHANK1;SHANK2;RIMS2;GRIN1;SHISA7
17898,GO:0098815,6.61825782760381e-08,0.999999997623716,7,44,modulation of excitatory postsynaptic potential,BP,CELF4;CUX2;SLC8A2;SHANK1;SHANK2;RIMS2;GRIN1
3817,GO:0008021,7.22956556812562e-08,0.9999999933404,11,192,synaptic vesicle,CC,SNAP91;SYT1;SLC17A7;SH3GL2;SNAP25;RAB3C;SYN2;SVOP;GRIN1;SV2B;SLC6A17
3668,GO:0007267,7.94846432932221e-08,0.99999997894432,31,1587,cell-cell signaling,BP,RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;SLC17A7;PLEKHA4;COL1A1;CUX2;GABRG2;IGFBP2;SLC8A2;KCNIP2;LIF;GDF15;SNAP25;ANXA1;CPLX2;ADM;JPH3;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1;SV2B;SHISA7
18180,GO:0099565,1.03536096781552e-07,0.999999993015078,9,106,chemical synaptic transmission, postsynaptic,BP,CELF4;SLC17A7;CUX2;SLC8A2;SHANK1;SHANK2;GABRB3;RIMS2;GRIN1
18129,GO:0099503,1.79400034558681e-07,0.999999962120558,21,911,secretory vesicle,CC,LTF;SNAP91;SYT1;CHGA;TIMP1;SLC17A7;SERPINE1;SH3GL2;COL1A1;PLAU;SNAP25;CHI3L1;RAB3C;SYN2;SVOP;GRIN1;ANXA2;SV2B;PLA2G2A;SERPINA3;SLC6A17
15614,GO:0070382,1.92426187536975e-07,0.999999980362188,11,210,exocytic vesicle,CC,SNAP91;SYT1;SLC17A7;SH3GL2;SNAP25;RAB3C;SYN2;SVOP;GRIN1;SV2B;SLC6A17
3715,GO:0007399,2.06899830954694e-07,0.999999935925294,39,2236,nervous system development,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;SRPX2;SLC17A7;SH3GL2;CUX2;GABRG2;HPCAL4;KCNIP2;PACSIN1;LIF;SNAP25;POSTN;ANXA1;SRRM4;CPLX2;INA;ADM;AFF2;SHANK1;SHANK2;CSMD3;GABRB3;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;MYT1L;COL4A1;SLC6A17;OPALIN;DOK6
16474,GO:0071944,2.65799502581494e-07,0.999999909007446,56,4460,cell periphery,CC,TNFRSF12A;LTF;VIM;RASGRF1;SNAP91;SYT1;SLCO1A2;RAPGEF4;SRPX2;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;ABCC3;GABRG2;IGFBP2;SLC8A2;KCNIP2;IQSEC3;TGFBI;PLAU;PACSIN1;SNAP25;ANXA1;GNAL;COL6A2;EMP3;RAB3C;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;GABRB3;MOBP;KSR2;CNTNAP2;DPP10;RIMS2;GRIN1;CD163;SLITRK1;DDN;ANXA2;CALN1;SV2B;SHISA7;PLA2G2A;PTPRT;SLC6A17;OPALIN;FRRS1L
2799,GO:0005886,3.06200213291511e-07,0.999999894738585,55,4367,plasma membrane,CC,TNFRSF12A;LTF;VIM;RASGRF1;SNAP91;SYT1;SLCO1A2;RAPGEF4;SRPX2;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;ABCC3;GABRG2;IGFBP2;SLC8A2;KCNIP2;IQSEC3;TGFBI;PLAU;PACSIN1;SNAP25;ANXA1;GNAL;COL6A2;EMP3;RAB3C;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;GABRB3;KSR2;CNTNAP2;DPP10;RIMS2;GRIN1;CD163;SLITRK1;DDN;ANXA2;CALN1;SV2B;SHISA7;PLA2G2A;PTPRT;SLC6A17;OPALIN;FRRS1L
17882,GO:0098794,3.23024873444327e-07,0.999999935080392,19,612,postsynapse,CC,CAMK2A;SLC17A7;GABRG2;SLC8A2;IQSEC3;SNAP25;CPLX2;INA;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;GRIN1;SLITRK1;DDN;SHISA7;SLC6A17
7453,GO:0030672,3.74508555732724e-07,0.999999976015465,8,100,synaptic vesicle membrane,CC,SYT1;SLC17A7;SH3GL2;RAB3C;SYN2;SVOP;SV2B;SLC6A17
18127,GO:0099501,3.74508555732724e-07,0.999999976015465,8,100,exocytic vesicle membrane,CC,SYT1;SLC17A7;SH3GL2;RAB3C;SYN2;SVOP;SV2B;SLC6A17
3790,GO:0007611,5.76007951943324e-07,0.999999926064188,12,245,learning or memory,BP,RASGRF1;SLC17A7;CUX2;SLC8A2;SNAP25;JPH3;AFF2;SHANK1;SHANK2;CNTNAP2;GRIN1;SHISA7
19437,GO:1902495,7.06926214479569e-07,0.99999989773287,13,299,transmembrane transporter complex,CC,ATP1A3;GABRG2;KCNIP2;SNAP25;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;CNTNAP2;DPP10;GRIN1;SHISA7
14333,GO:0060079,7.10248498937459e-07,0.999999950425203,8,99,excitatory postsynaptic potential,BP,CELF4;SLC17A7;CUX2;SLC8A2;SHANK1;SHANK2;RIMS2;GRIN1
21220,GO:1990351,8.38656452731408e-07,0.999999876696581,13,307,transporter complex,CC,ATP1A3;GABRG2;KCNIP2;SNAP25;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;CNTNAP2;DPP10;GRIN1;SHISA7
13043,GO:0048666,8.71594832162019e-07,0.999999770014904,25,1073,neuron development,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;SH3GL2;CUX2;KCNIP2;PACSIN1;LIF;SNAP25;POSTN;SRRM4;ADM;SHANK1;SHANK2;CSMD3;GABRB3;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;MYT1L;DOK6
13363,GO:0050804,1.11339962336016e-06,0.999999803532138,15,430,modulation of chemical synaptic transmission,BP,RASGRF1;SYT1;CAMK2A;CELF4;CUX2;SLC8A2;SNAP25;CPLX2;JPH3;KCNB1;SHANK1;SHANK2;RIMS2;GRIN1;SHISA7
7210,GO:0030198,1.11464664280743e-06,0.99999981716857,14,361,extracellular matrix organization,BP,TIMP1;SERPINE1;COL1A1;LOX;TGFBI;FMOD;COL5A1;POSTN;COL6A2;PDPN;COL3A1;ANXA2;COL4A1;SMOC1
18109,GO:0099177,1.12674923243869e-06,0.999999800972787,15,431,regulation of trans-synaptic signaling,BP,RASGRF1;SYT1;CAMK2A;CELF4;CUX2;SLC8A2;SNAP25;CPLX2;JPH3;KCNB1;SHANK1;SHANK2;RIMS2;GRIN1;SHISA7
11006,GO:0043062,1.15792190213051e-06,0.999999809429054,14,362,extracellular structure organization,BP,TIMP1;SERPINE1;COL1A1;LOX;TGFBI;FMOD;COL5A1;POSTN;COL6A2;PDPN;COL3A1;ANXA2;COL4A1;SMOC1
2464,GO:0005201,1.1773042597215e-06,0.999999873798291,10,149,extracellular matrix structural constituent,MF,SRPX2;COL1A1;TGFBI;FMOD;COL5A1;CHI3L1;POSTN;COL6A2;COL3A1;COL4A1
13088,GO:0048731,1.46730641974444e-06,0.999999463739849,54,4260,system development,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CELF4;TIMP1;SRPX2;SLC17A7;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;HPCAL4;KCNIP2;TGFBI;PACSIN1;LIF;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;CPLX2;INA;ADM;AFF2;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;NNMT;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;SLC6A17;OPALIN;SMOC1;DOK6
1365,GO:0003008,1.66452855967799e-06,0.999999502450842,29,1606,system process,BP,VIM;RASGRF1;CHGA;CELF4;SLC17A7;ATP1A3;SH3GL2;COL1A1;CUX2;GABRG2;SLC8A2;KCNIP2;TGFBI;SNAP25;POSTN;SRRM4;GNAL;ADM;JPH3;AFF2;SHANK1;SHANK2;GABRG1;GABRB3;CNTNAP2;RIMS2;GRIN1;SHISA7;SERPINA3
10675,GO:0042391,1.69025560069121e-06,0.999999711935996,14,402,regulation of membrane potential,BP,CELF4;SLC17A7;ATP1A3;CUX2;GABRG2;SLC8A2;KCNIP2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;RIMS2;GRIN1
11929,GO:0045595,1.81359338728376e-06,0.99999944573433,30,1685,regulation of cell differentiation,BP,TNFRSF12A;LTF;VIM;SYT1;CAMK2A;SERPINE1;COL1A1;CUX2;LOX;PACSIN1;LIF;GDF15;COL5A1;SNAP25;POSTN;ANXA1;ADM;SHANK1;SHANK2;PDPN;CSMD3;COL3A1;FUT9;RIMS2;GRIN1;SLITRK1;SOCS3;PLA2G2A;OPALIN;SMOC1
13422,GO:0050890,1.98979595408702e-06,0.999999710785497,12,279,cognition,BP,RASGRF1;SLC17A7;CUX2;SLC8A2;SNAP25;JPH3;AFF2;SHANK1;SHANK2;CNTNAP2;GRIN1;SHISA7
13413,GO:0050877,2.01795953752034e-06,0.999999501391868,21,920,nervous system process,BP,RASGRF1;CELF4;SLC17A7;COL1A1;CUX2;GABRG2;SLC8A2;TGFBI;SNAP25;SRRM4;GNAL;JPH3;AFF2;SHANK1;SHANK2;GABRG1;GABRB3;CNTNAP2;RIMS2;GRIN1;SHISA7
9463,GO:0034702,2.49258099034011e-06,0.999999629560584,12,278,ion channel complex,CC,GABRG2;KCNIP2;SNAP25;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;CNTNAP2;DPP10;GRIN1;SHISA7
8442,GO:0032501,2.82718078759102e-06,0.999998954460377,67,6269,multicellular organismal process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CHGA;CELF4;TIMP1;SRPX2;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;TGFBI;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;CPLX2;INA;ADM;JPH3;AFF2;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;GABRB3;NNMT;RBFOX3;MOBP;COL3A1;KSR2;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;SHISA7;PLA2G2A;SERPINA3;SLC6A17;OPALIN;SMOC1;DOK6
17881,GO:0098793,2.97169399803803e-06,0.999999429549012,15,495,presynapse,CC,SNAP91;SYT1;SLC17A7;SH3GL2;SLC8A2;PACSIN1;SNAP25;CPLX2;RAB3C;SYN2;SVOP;RIMS2;GRIN1;SV2B;SLC6A17
18130,GO:0099504,3.19591220791373e-06,0.999999613084337,10,192,synaptic vesicle cycle,BP,SNAP91;SYT1;RAPGEF4;SLC17A7;SH3GL2;PACSIN1;SNAP25;CPLX2;SYN2;RIMS2
12941,GO:0048407,3.24465336310567e-06,0.999999954995683,4,11,platelet-derived growth factor binding,MF,COL1A1;COL5A1;COL3A1;COL4A1
17779,GO:0098590,3.43656361381597e-06,0.999999039126822,24,1133,plasma membrane region,CC,SNAP91;SYT1;SRPX2;ATP1A3;GABRG2;IGFBP2;SLC8A2;IQSEC3;PACSIN1;SNAP25;ANXA1;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;CNTNAP2;RIMS2;GRIN1;SLITRK1;DDN;ANXA2;SHISA7
12828,GO:0048168,3.63337243054337e-06,0.999999817731902,6,52,regulation of neuronal synaptic plasticity,BP,RASGRF1;CAMK2A;SLC8A2;JPH3;GRIN1;SHISA7
21733,GO:2000463,3.76213538094481e-06,0.999999880372126,5,28,positive regulation of excitatory postsynaptic potential,BP,CUX2;SHANK1;SHANK2;RIMS2;GRIN1
14330,GO:0060076,4.28649221171686e-06,0.999999778931125,6,51,excitatory synapse,CC,SYT1;SRPX2;SLC17A7;SHANK1;GRIN1;SHISA7
3792,GO:0007613,4.74319682174996e-06,0.999999568082544,8,115,memory,BP,RASGRF1;SLC17A7;CUX2;SLC8A2;JPH3;SHANK1;GRIN1;SHISA7
7211,GO:0030199,4.83249796573278e-06,0.99999974506305,6,52,collagen fibril organization,BP,COL1A1;LOX;FMOD;COL5A1;COL3A1;ANXA2
3400,GO:0006811,4.94831304069526e-06,0.999998515941952,26,1473,ion transport,BP,LTF;RASGRF1;SYT1;CAMK2A;SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;ANXA1;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;DPP10;GRIN1;ANXA2;SHISA7;PLA2G2A;SLC6A17
3789,GO:0007610,5.21767565683973e-06,0.999998886675875,16,559,behavior,BP,RASGRF1;SRPX2;SLC17A7;CUX2;GABRG2;SLC8A2;GDF15;SNAP25;JPH3;AFF2;SHANK1;SHANK2;CNTNAP2;GRIN1;SLITRK1;SHISA7
13355,GO:0050793,5.52537245993441e-06,0.999998061198655,36,2379,regulation of developmental process,BP,TNFRSF12A;LTF;VIM;SYT1;CAMK2A;CELF4;TIMP1;SRPX2;PLEKHA4;SERPINE1;COL1A1;CUX2;LOX;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;ADM;SHANK1;SHANK2;PDPN;CSMD3;COL3A1;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;PLA2G2A;OPALIN;SMOC1
13634,GO:0051239,5.60755511712023e-06,0.999997958748127,40,2873,regulation of multicellular organismal process,BP,TNFRSF12A;LTF;VIM;SYT1;CAMK2A;CHGA;CELF4;TIMP1;SRPX2;ATP1A3;PLEKHA4;SERPINE1;COL1A1;CUX2;LOX;SLC8A2;KCNIP2;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;ANXA1;ADM;SHANK1;SHANK2;PDPN;CSMD3;COL3A1;KSR2;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SHISA7;OPALIN;SMOC1
13365,GO:0050806,5.87447518084323e-06,0.999999338436118,9,166,positive regulation of synaptic transmission,BP,SYT1;CUX2;SLC8A2;SNAP25;SHANK1;SHANK2;RIMS2;GRIN1;SHISA7
18017,GO:0098984,5.93869662281186e-06,0.999998949274787,13,351,neuron to neuron synapse,CC,SYT1;CAMK2A;RAPGEF4;ATP1A3;SH3GL2;SLC8A2;IQSEC3;SYN2;SHANK1;SHANK2;GRIN1;SLITRK1;SHISA7
18585,GO:0140352,5.96211629492245e-06,0.999998272390142,24,1351,export from cell,BP,LTF;SYT1;CAMK2A;RAPGEF4;CHGA;TIMP1;SLC17A7;ATP1A3;SERPINE1;SLC8A2;KCNIP2;PLAU;LIF;SNAP25;CHI3L1;ANXA1;CPLX2;ADM;RAB3C;SYN2;KCNB1;RIMS2;ANXA2;SERPINA3
18025,GO:0099003,6.98449055884603e-06,0.999999072191436,10,212,vesicle-mediated transport in synapse,BP,SNAP91;SYT1;RAPGEF4;SLC17A7;SH3GL2;PACSIN1;SNAP25;CPLX2;SYN2;RIMS2
7946,GO:0031644,7.43180885365541e-06,0.999999276009516,8,133,regulation of nervous system process,BP,CELF4;CUX2;SLC8A2;SHANK1;SHANK2;RIMS2;GRIN1;SHISA7
7162,GO:0030133,9.09989886715085e-06,0.999998451209985,12,381,transport vesicle,CC,SNAP91;SYT1;CHGA;SLC17A7;SH3GL2;SNAP25;RAB3C;SYN2;SVOP;GRIN1;SV2B;SLC6A17
11824,GO:0045211,9.99434048407772e-06,0.999998445538105,11,269,postsynaptic membrane,CC,GABRG2;IQSEC3;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;GRIN1;SLITRK1;DDN;SHISA7
8490,GO:0032589,1.00476567933643e-05,0.999999391839187,6,58,neuron projection membrane,CC,GABRG2;KCNB1;GABRG1;CNTNAP2;DDN;SHISA7
18078,GO:0099095,1.04539362940741e-05,0.999999776320013,4,18,ligand-gated anion channel activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3
15388,GO:0065008,1.22350837587239e-05,0.999995231448963,45,3602,regulation of biological quality,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;SRPX2;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;SLC8A2;KCNIP2;PLAU;LIF;SNAP25;POSTN;ANXA1;CPLX2;ADM;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;COL3A1;KSR2;RIMS2;GRIN1;SLITRK1;ANXA2;SHISA7;PLA2G2A;SERPINA3;FRRS1L
14457,GO:0060284,1.26300304351992e-05,0.999996573755468,20,884,regulation of cell development,BP,TNFRSF12A;LTF;VIM;SYT1;CAMK2A;CUX2;PACSIN1;LIF;SNAP25;POSTN;SHANK1;SHANK2;PDPN;CSMD3;COL3A1;FUT9;RIMS2;GRIN1;SLITRK1;OPALIN
8491,GO:0032590,1.31466057881013e-05,0.99999943399226,5,42,dendrite membrane,CC,GABRG2;KCNB1;GABRG1;DDN;SHISA7
18838,GO:1900449,1.33145771764242e-05,0.999999149059295,6,62,regulation of glutamate receptor signaling pathway,BP,RASGRF1;SHANK1;SHANK2;GRIN1;SHISA7;FRRS1L
13071,GO:0048699,1.35480972020481e-05,0.999995597922062,27,1455,generation of neurons,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;SH3GL2;CUX2;KCNIP2;PACSIN1;LIF;SNAP25;POSTN;SRRM4;ADM;SHANK1;SHANK2;CSMD3;GABRB3;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;MYT1L;OPALIN;DOK6
6993,GO:0022008,1.44445862348778e-05,0.99999520343588,28,1553,neurogenesis,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;SH3GL2;CUX2;KCNIP2;PACSIN1;LIF;SNAP25;POSTN;ANXA1;SRRM4;ADM;SHANK1;SHANK2;CSMD3;GABRB3;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;MYT1L;OPALIN;DOK6
12943,GO:0048468,1.81742083868765e-05,0.999993511718119,32,1970,cell development,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CELF4;SH3GL2;CUX2;LOX;KCNIP2;PACSIN1;LIF;SNAP25;POSTN;SRRM4;ADM;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;MYT1L;OPALIN;DOK6
3640,GO:0007215,1.88765423367462e-05,0.999998299111598,7,98,glutamate receptor signaling pathway,BP,RASGRF1;KCNB1;SHANK1;SHANK2;GRIN1;SHISA7;FRRS1L
21468,GO:2000026,2.05571162437744e-05,0.999992804627482,30,1889,regulation of multicellular organismal development,BP,TNFRSF12A;LTF;VIM;SYT1;CAMK2A;CELF4;TIMP1;SRPX2;PLEKHA4;SERPINE1;COL1A1;CUX2;LOX;PACSIN1;LIF;COL5A1;SNAP25;CHI3L1;ANXA1;ADM;SHANK1;SHANK2;PDPN;CSMD3;COL3A1;FUT9;RIMS2;GRIN1;SLITRK1;OPALIN
7200,GO:0030182,2.16764426994448e-05,0.999993027981182,25,1314,neuron differentiation,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;SH3GL2;CUX2;KCNIP2;PACSIN1;LIF;SNAP25;POSTN;SRRM4;ADM;SHANK1;SHANK2;CSMD3;GABRB3;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;MYT1L;DOK6
9624,GO:0035254,2.36905859554182e-05,0.999998839573737,5,45,glutamate receptor binding,MF,RASGRF1;CAMK2A;SHANK1;SHANK2;SHISA7
7819,GO:0031410,2.47461465816746e-05,0.999991119683219,31,2189,cytoplasmic vesicle,CC,LTF;VIM;SNAP91;SYT1;CAMK2A;CHGA;TIMP1;SLC17A7;SERPINE1;SH3GL2;COL1A1;GABRG2;IGFBP2;PLAU;PACSIN1;SNAP25;CHI3L1;ANXA1;RAB3C;SYN2;PDPN;SVOP;GABRB3;CNTNAP2;GRIN1;CD163;ANXA2;SV2B;PLA2G2A;SERPINA3;SLC6A17
17715,GO:0097708,2.59391729458179e-05,0.99999066631636,31,2193,intracellular vesicle,CC,LTF;VIM;SNAP91;SYT1;CAMK2A;CHGA;TIMP1;SLC17A7;SERPINE1;SH3GL2;COL1A1;GABRG2;IGFBP2;PLAU;PACSIN1;SNAP25;CHI3L1;ANXA1;RAB3C;SYN2;PDPN;SVOP;GABRB3;CNTNAP2;GRIN1;CD163;ANXA2;SV2B;PLA2G2A;SERPINA3;SLC6A17
11931,GO:0045597,2.74574618186828e-05,0.999992367724582,19,927,positive regulation of cell differentiation,BP,TNFRSF12A;LTF;SYT1;SERPINE1;COL1A1;CUX2;PACSIN1;LIF;GDF15;ANXA1;ADM;SHANK1;SHANK2;PDPN;FUT9;RIMS2;SLITRK1;SOCS3;PLA2G2A
7779,GO:0031338,2.85706530281316e-05,0.99999915736114,4,28,regulation of vesicle fusion,BP,SYT1;ANXA1;CPLX2;ANXA2
12901,GO:0048306,2.92478789288931e-05,0.999998465496187,5,68,calcium-dependent protein binding,MF,SYT1;SNAP25;ANXA1;CPLX2;ANXA2
7081,GO:0023051,2.97788045778331e-05,0.999988144053089,41,3228,regulation of signaling,BP,TNFRSF12A;LTF;RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;TIMP1;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;IQSEC3;PLAU;LIF;GDF15;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;JPH3;KCNB1;SHANK1;SHANK2;COL3A1;RIMS2;GRIN1;ANXA2;SOCS3;SHISA7;PLA2G2A;PTPRT;FRRS1L
2641,GO:0005615,3.07650789278843e-05,0.999988542023403,33,2632,extracellular space,CC,LTF;VIM;CHI3L2;CHGA;TIMP1;SRPX2;SERPINE1;COL1A1;CUX2;LOX;IGFBP2;TGFBI;FMOD;PLAU;LIF;GDF15;COL5A1;CHI3L1;POSTN;ANXA1;GNAL;COL6A2;INA;ADM;C1R;ELFN2;COL3A1;RIMS2;ANXA2;COL4A1;PLA2G2A;SERPINA3;SMOC1
16298,GO:0071625,3.22755822283247e-05,0.999999076772994,4,18,vocalization behavior,BP,SRPX2;SHANK1;SHANK2;CNTNAP2
2796,GO:0005883,3.55859533714394e-05,0.999999619296185,3,8,neurofilament,CC,NEFM;INA;SHANK2
6642,GO:0019834,3.62472629143373e-05,0.999999958491889,2,3,phospholipase A2 inhibitor activity,MF,ANXA1;ANXA2
3675,GO:0007275,3.9196307049672e-05,0.999983452056656,54,4743,multicellular organism development,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CELF4;TIMP1;SRPX2;SLC17A7;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;HPCAL4;KCNIP2;TGFBI;PACSIN1;LIF;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;CPLX2;INA;ADM;AFF2;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;NNMT;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;SLC6A17;OPALIN;SMOC1;DOK6
3415,GO:0006836,3.96894832860263e-05,0.999994252778518,9,218,neurotransmitter transport,BP,SYT1;CAMK2A;SLC17A7;SNAP25;CPLX2;SYN2;RIMS2;SV2B;SLC6A17
2615,GO:0005581,3.97530282490883e-05,0.99999686944264,6,78,collagen trimer,CC,COL1A1;LOX;COL5A1;COL6A2;COL3A1;COL4A1
3447,GO:0006887,3.98946793203769e-05,0.99998941098105,17,850,exocytosis,BP,LTF;SYT1;RAPGEF4;CHGA;TIMP1;SERPINE1;PLAU;SNAP25;CHI3L1;ANXA1;CPLX2;RAB3C;SYN2;KCNB1;RIMS2;ANXA2;SERPINA3
729,GO:0001944,4.11275036390001e-05,0.999989544265232,16,657,vasculature development,BP,TNFRSF12A;SRPX2;SERPINE1;COL1A1;LOX;TGFBI;LIF;COL5A1;CHI3L1;ANXA1;ADM;PDPN;COL3A1;ANXA2;SOCS3;COL4A1
12564,GO:0046903,4.18992541468492e-05,0.999986516793998,23,1415,secretion,BP,LTF;SYT1;CAMK2A;RAPGEF4;CHGA;TIMP1;SLC17A7;SERPINE1;ABCC3;PLAU;LIF;SNAP25;CHI3L1;ANXA1;CPLX2;ADM;RAB3C;SYN2;KCNB1;RIMS2;ANXA2;PLA2G2A;SERPINA3
7781,GO:0031340,4.44957931845767e-05,0.999999427623925,3,11,positive regulation of vesicle fusion,BP,SYT1;ANXA1;ANXA2
3639,GO:0007214,4.60465652897226e-05,0.999998483060041,4,25,gamma-aminobutyric acid signaling pathway,BP,GABRG2;GABRG1;GABRB3;SHISA7
2462,GO:0005198,4.66738727637491e-05,0.999989188252221,14,580,structural molecule activity,MF,VIM;SRPX2;NEFM;COL1A1;TGFBI;FMOD;COL5A1;CHI3L1;POSTN;COL6A2;INA;MOBP;COL3A1;COL4A1
7444,GO:0030659,4.91930468113848e-05,0.999987286722727,16,725,cytoplasmic vesicle membrane,CC,SYT1;CAMK2A;SLC17A7;SH3GL2;GABRG2;PLAU;PACSIN1;SNAP25;ANXA1;RAB3C;SYN2;SVOP;GABRB3;CD163;SV2B;SLC6A17
7443,GO:0030658,5.18404169737647e-05,0.99999328757611,8,194,transport vesicle membrane,CC,SYT1;SLC17A7;SH3GL2;RAB3C;SYN2;SVOP;SV2B;SLC6A17
12884,GO:0048278,5.83724885862659e-05,0.999996462209436,5,65,vesicle docking,BP,SYT1;SNAP25;CPLX2;RAB3C;KCNB1
7100,GO:0030020,6.10990741185858e-05,0.999996375457173,5,40,extracellular matrix structural constituent conferring tensile strength,MF,COL1A1;COL5A1;COL6A2;COL3A1;COL4A1
21503,GO:2000097,6.25646126511426e-05,0.999999905768362,2,3,regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1;PLAU
14708,GO:0060627,6.34691638554364e-05,0.999985771487244,13,507,regulation of vesicle-mediated transport,BP,SNAP91;SYT1;RAPGEF4;SLC17A7;SERPINE1;SH3GL2;PACSIN1;ANXA1;CPLX2;RAB3C;KCNB1;RIMS2;ANXA2
14234,GO:0055085,6.52380684987201e-05,0.999978352290358,23,1399,transmembrane transport,BP,RASGRF1;SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;SVOP;GABRB3;DPP10;GRIN1;ANXA2;SV2B;SHISA7;SLC6A17
7688,GO:0031175,6.52858474931081e-05,0.999979986319724,20,947,neuron projection development,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;SH3GL2;CUX2;PACSIN1;SNAP25;POSTN;ADM;SHANK1;SHANK2;CSMD3;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
5083,GO:0012506,6.87005257553611e-05,0.999981715320628,16,745,vesicle membrane,CC,SYT1;CAMK2A;SLC17A7;SH3GL2;GABRG2;PLAU;PACSIN1;SNAP25;ANXA1;RAB3C;SYN2;SVOP;GABRB3;CD163;SV2B;SLC6A17
7720,GO:0031256,6.92160151530035e-05,0.999990689692481,8,166,leading edge membrane,CC,GABRG2;PACSIN1;KCNB1;PDPN;GABRG1;CNTNAP2;DDN;SHISA7
10970,GO:0043005,7.35153405838034e-05,0.999975414417376,23,1264,neuron projection,CC,VIM;RASGRF1;SYT1;CAMK2A;NEFM;SLC17A7;ATP1A3;SH3GL2;GABRG2;SLC8A2;PACSIN1;SNAP25;CPLX2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;CNTNAP2;GRIN1;DDN;SV2B;SHISA7
8676,GO:0032879,7.47057147604458e-05,0.999970445129416,34,2496,regulation of localization,BP,RASGRF1;SNAP91;SYT1;CAMK2A;RAPGEF4;CHGA;TIMP1;SRPX2;SLC17A7;SERPINE1;SH3GL2;COL1A1;KCNIP2;PLAU;PACSIN1;LIF;SNAP25;POSTN;ANXA1;CPLX2;RAB3C;JPH3;KCNB1;SHANK1;SHANK2;PDPN;COL3A1;FUT9;DPP10;RIMS2;GRIN1;ANXA2;SHISA7;PTPRT
7177,GO:0030154,7.82743949421065e-05,0.999966727038469,44,3636,cell differentiation,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CELF4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;KCNIP2;TGFBI;PACSIN1;LIF;GDF15;COL5A1;SNAP25;POSTN;ANXA1;SRRM4;CPLX2;INA;ADM;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;PLA2G2A;OPALIN;SMOC1;DOK6
13886,GO:0051703,7.94466434679542e-05,0.999994939229238,5,49,intraspecies interaction between organisms,BP,LTF;SHANK1;SHANK2;CNTNAP2;GRIN1
17802,GO:0098644,8.22541868649384e-05,0.999996945071465,4,20,complex of collagen trimers,CC,COL1A1;COL5A1;COL3A1;COL4A1
4721,GO:0010469,9.78108872182666e-05,0.999988387210365,7,147,regulation of signaling receptor activity,BP,RASGRF1;SERPINE1;PLAU;SHANK1;SHANK2;GRIN1;SHISA7
3588,GO:0007154,9.80435459035146e-05,0.99995669970046,56,5427,cell communication,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;TIMP1;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;FMOD;PLAU;LIF;GDF15;SNAP25;CHI3L1;POSTN;ANXA1;GNAL;CPLX2;ADM;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;COL3A1;KSR2;CNTNAP2;RIMS2;GRIN1;ANXA2;SOCS3;SV2B;COL4A1;SHISA7;PLA2G2A;PTPRT;FRRS1L
7082,GO:0023052,9.81917153928908e-05,0.999956631178787,56,5417,signaling,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;TIMP1;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;FMOD;PLAU;LIF;GDF15;SNAP25;CHI3L1;POSTN;ANXA1;GNAL;CPLX2;ADM;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;COL3A1;KSR2;CNTNAP2;RIMS2;GRIN1;ANXA2;SOCS3;SV2B;COL4A1;SHISA7;PLA2G2A;PTPRT;FRRS1L
3725,GO:0007416,0.000101444857761508,0.999985590321611,8,159,synapse assembly,BP,SRPX2;CUX2;GABRG2;SHANK1;SHANK2;GABRB3;GRIN1;SLITRK1
11739,GO:0045055,0.000102324508955935,0.999973037756477,15,749,regulated exocytosis,BP,LTF;SYT1;RAPGEF4;CHGA;TIMP1;SERPINE1;PLAU;SNAP25;CHI3L1;CPLX2;SYN2;KCNB1;RIMS2;ANXA2;SERPINA3
8720,GO:0032940,0.000103412500846484,0.999966195263043,21,1302,secretion by cell,BP,LTF;SYT1;CAMK2A;RAPGEF4;CHGA;TIMP1;SLC17A7;SERPINE1;PLAU;LIF;SNAP25;CHI3L1;ANXA1;CPLX2;ADM;RAB3C;SYN2;KCNB1;RIMS2;ANXA2;SERPINA3
6213,GO:0017156,0.000105051998572064,0.999992810269782,5,60,calcium-ion regulated exocytosis,BP,SYT1;RAPGEF4;SYN2;KCNB1;RIMS2
10528,GO:0042060,0.000105255878529948,0.999976795066178,12,455,wound healing,BP,TNFRSF12A;TIMP1;SERPINE1;COL1A1;LOX;PLAU;COL5A1;POSTN;ANXA1;PDPN;COL3A1;ANXA2
13334,GO:0050767,0.000105697279144333,0.999969565153036,17,777,regulation of neurogenesis,BP,TNFRSF12A;VIM;SYT1;CAMK2A;CUX2;PACSIN1;LIF;SNAP25;SHANK1;SHANK2;CSMD3;COL3A1;FUT9;RIMS2;GRIN1;SLITRK1;OPALIN
2402,GO:0005102,0.000106927161294485,0.999964956375177,21,1316,signaling receptor binding,MF,RASGRF1;SYT1;CAMK2A;TIMP1;SRPX2;SERPINE1;IGFBP2;TGFBI;LIF;GDF15;COL5A1;ANXA1;GNAL;ADM;SHANK1;SHANK2;PDPN;GABRG1;COL3A1;GRIN1;SHISA7
9212,GO:0034220,0.000107586955009401,0.999966704665029,19,1026,ion transmembrane transport,BP,RASGRF1;SLC17A7;ATP1A3;GABRG2;SLC8A2;KCNIP2;SNAP25;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;DPP10;GRIN1;ANXA2;SHISA7;SLC6A17
13523,GO:0051049,0.000112100305109506,0.999959760661995,25,1631,regulation of transport,BP,RASGRF1;SNAP91;SYT1;CAMK2A;RAPGEF4;CHGA;SLC17A7;SERPINE1;SH3GL2;KCNIP2;PACSIN1;LIF;SNAP25;ANXA1;CPLX2;RAB3C;JPH3;KCNB1;SHANK1;SHANK2;DPP10;RIMS2;GRIN1;ANXA2;SHISA7
2262,GO:0004857,0.00011426972290587,0.999980865822711,9,302,enzyme inhibitor activity,MF,LTF;PHACTR3;TIMP1;SERPINE1;ANXA1;ELFN2;ANXA2;SOCS3;SERPINA3
2478,GO:0005230,0.000115579596909754,0.99999188194841,5,67,extracellular ligand-gated ion channel activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3;GRIN1
13152,GO:0048869,0.000115964428929086,0.999949686331912,44,3702,cellular developmental process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CELF4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;KCNIP2;TGFBI;PACSIN1;LIF;GDF15;COL5A1;SNAP25;POSTN;ANXA1;SRRM4;CPLX2;INA;ADM;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;PLA2G2A;OPALIN;SMOC1;DOK6
13367,GO:0050808,0.000121364687148409,0.999972875701674,12,393,synapse organization,BP,SRPX2;CUX2;GABRG2;SLC8A2;INA;SHANK1;SHANK2;GABRB3;GRIN1;SLITRK1;COL4A1;SHISA7
4819,GO:0010646,0.000122779765229777,0.999947985368881,39,3188,regulation of cell communication,BP,TNFRSF12A;LTF;RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;TIMP1;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;IQSEC3;PLAU;LIF;GDF15;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;JPH3;KCNB1;SHANK1;SHANK2;COL3A1;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A;PTPRT;FRRS1L
10845,GO:0042730,0.000124440225482846,0.999997471562472,3,20,fibrinolysis,BP,SERPINE1;PLAU;ANXA2
7057,GO:0022851,0.000128111894074588,0.999997587940823,3,12,GABA-gated chloride ion channel activity,MF,GABRG2;GABRG1;GABRB3
12955,GO:0048488,0.000133781749063049,0.999990347204904,5,61,synaptic vesicle endocytosis,BP,SNAP91;SYT1;SLC17A7;SH3GL2;PACSIN1
18564,GO:0140238,0.000133781749063049,0.999990347204904,5,61,presynaptic endocytosis,BP,SNAP91;SYT1;SLC17A7;SH3GL2;PACSIN1
7948,GO:0031646,0.000135901370923502,0.999990152892349,5,62,positive regulation of nervous system process,BP,CUX2;SHANK1;SHANK2;RIMS2;GRIN1
3791,GO:0007612,0.000135988938801242,0.999982993914913,7,138,learning,BP,SLC8A2;SNAP25;JPH3;SHANK1;SHANK2;CNTNAP2;GRIN1
14017,GO:0051960,0.000136969905554675,0.99995818108182,18,878,regulation of nervous system development,BP,TNFRSF12A;VIM;SYT1;CAMK2A;SRPX2;CUX2;PACSIN1;LIF;SNAP25;SHANK1;SHANK2;CSMD3;COL3A1;FUT9;RIMS2;GRIN1;SLITRK1;OPALIN
17767,GO:0098563,0.000144737948353469,0.999993232017917,4,46,intrinsic component of synaptic vesicle membrane,CC,SYT1;SLC17A7;RAB3C;SLC6A17
3600,GO:0007166,0.000158596818381474,0.999934430560656,34,2692,cell surface receptor signaling pathway,BP,TNFRSF12A;LTF;VIM;RASGRF1;CAMK2A;CELF4;TIMP1;SLC17A7;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;FMOD;LIF;GDF15;POSTN;ANXA1;KCNB1;SHANK1;SHANK2;GABRB3;COL3A1;RIMS2;GRIN1;ANXA2;SOCS3;COL4A1;SHISA7;PTPRT;FRRS1L
5061,GO:0010975,0.000159237013770735,0.999960798243638,13,486,regulation of neuron projection development,BP,TNFRSF12A;VIM;SYT1;CUX2;PACSIN1;SNAP25;SHANK1;SHANK2;CSMD3;FUT9;RIMS2;GRIN1;SLITRK1
13142,GO:0048856,0.000161290015663267,0.999927013362215,55,5145,anatomical structure development,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CELF4;TIMP1;SRPX2;SLC17A7;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;HPCAL4;KCNIP2;TGFBI;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;CPLX2;INA;ADM;AFF2;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;NNMT;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;SLC6A17;OPALIN;SMOC1;DOK6
3460,GO:0006904,0.000170044573693657,0.999991727562497,4,44,vesicle docking involved in exocytosis,BP,SNAP25;CPLX2;RAB3C;KCNB1
8104,GO:0031982,0.000173580011155011,0.999925021621228,39,3437,vesicle,CC,LTF;VIM;SNAP91;SYT1;CAMK2A;CHGA;TIMP1;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;GABRG2;IGFBP2;TGFBI;PLAU;PACSIN1;GDF15;SNAP25;CHI3L1;ANXA1;GNAL;COL6A2;RAB3C;SYN2;C1R;PDPN;SVOP;GABRB3;CNTNAP2;RIMS2;GRIN1;CD163;ANXA2;SV2B;PLA2G2A;SERPINA3;SLC6A17
18509,GO:0140029,0.000179250810654595,0.999986051115284,5,81,exocytic process,BP,SYT1;SNAP25;CPLX2;RAB3C;KCNB1
4510,GO:0009611,0.000180128393644406,0.999955015143027,13,563,response to wounding,BP,TNFRSF12A;TIMP1;SERPINE1;COL1A1;LOX;PLAU;COL5A1;POSTN;ANXA1;ADM;PDPN;COL3A1;ANXA2
2886,GO:0006030,0.000182154053604367,0.99999922934387,2,5,chitin metabolic process,BP,CHI3L2;CHI3L1
2887,GO:0006032,0.000182154053604367,0.99999922934387,2,5,chitin catabolic process,BP,CHI3L2;CHI3L1
14405,GO:0060199,0.000183464325185975,0.999999329205759,2,4,clathrin-sculpted glutamate transport vesicle,CC,SYT1;SLC17A7
14408,GO:0060203,0.000183464325185975,0.999999329205759,2,4,clathrin-sculpted glutamate transport vesicle membrane,CC,SYT1;SLC17A7
2612,GO:0005576,0.000187897426499426,0.99991956219331,37,3370,extracellular region,CC,LTF;VIM;CHI3L2;CHGA;TIMP1;SRPX2;ATP1A3;SERPINE1;COL1A1;CUX2;LOX;IGFBP2;TGFBI;FMOD;PLAU;LIF;GDF15;COL5A1;CHI3L1;POSTN;ANXA1;GNAL;COL6A2;INA;ADM;C1R;ELFN2;COL3A1;RIMS2;GRIN1;CD163;SLITRK1;ANXA2;COL4A1;PLA2G2A;SERPINA3;SMOC1
13548,GO:0051094,0.000188328891301269,0.999935572947995,21,1271,positive regulation of developmental process,BP,TNFRSF12A;LTF;SYT1;SRPX2;SERPINE1;COL1A1;CUX2;PACSIN1;LIF;GDF15;CHI3L1;ANXA1;ADM;SHANK1;SHANK2;PDPN;FUT9;RIMS2;SLITRK1;SOCS3;PLA2G2A
12585,GO:0046942,0.000194830671060758,0.999964945042897,9,302,carboxylic acid transport,BP,SYT1;SLCO1A2;SLC17A7;ABCC3;SNAP25;ANXA1;PDPN;PLA2G2A;SLC6A17
3794,GO:0007616,0.000198363462593218,0.999990133605295,4,34,long-term memory,BP,RASGRF1;SLC17A7;SHANK1;GRIN1
14941,GO:0061041,0.000200896271710752,0.99997833277892,6,127,regulation of wound healing,BP,TNFRSF12A;SERPINE1;PLAU;ANXA1;PDPN;ANXA2
13704,GO:0051346,0.000202344680726336,0.999959268748956,10,377,negative regulation of hydrolase activity,BP,LTF;CAMK2A;PHACTR3;TIMP1;SERPINE1;SPOCD1;ANXA1;ELFN2;ANXA2;SERPINA3
5550,GO:0015849,0.000206048374578637,0.999962638568061,9,305,organic acid transport,BP,SYT1;SLCO1A2;SLC17A7;ABCC3;SNAP25;ANXA1;PDPN;PLA2G2A;SLC6A17
3844,GO:0008076,0.000218981532830548,0.999982187927487,5,83,voltage-gated potassium channel complex,CC,KCNIP2;SNAP25;KCNB1;CNTNAP2;DPP10
15048,GO:0061302,0.00023775390472061,0.999998849728759,2,5,smooth muscle cell-matrix adhesion,BP,SERPINE1;PLAU
7086,GO:0023061,0.000238550064330651,0.99994239803974,12,513,signal release,BP,SYT1;CAMK2A;RAPGEF4;CHGA;LIF;SNAP25;ANXA1;CPLX2;ADM;SYN2;KCNB1;RIMS2
10262,GO:0036465,0.000239325544676824,0.999980275374325,5,71,synaptic vesicle recycling,BP,SNAP91;SYT1;SLC17A7;SH3GL2;PACSIN1
3401,GO:0006812,0.00024137941543756,0.999922609490324,18,1031,cation transport,BP,LTF;RASGRF1;SYT1;CAMK2A;SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;JPH3;KCNB1;SHANK1;SHANK2;DPP10;GRIN1;ANXA2;SHISA7;SLC6A17
2280,GO:0004890,0.000248975641053523,0.999993725996343,3,17,GABA-A receptor activity,MF,GABRG2;GABRG1;GABRB3
19520,GO:1902711,0.000248975641053523,0.999993725996343,3,17,GABA-A receptor complex,CC,GABRG2;GABRG1;GABRB3
22137,GO:2001257,0.00024976311201575,0.999965321973278,7,167,regulation of cation channel activity,BP,RASGRF1;KCNIP2;JPH3;SHANK1;SHANK2;GRIN1;SHISA7
2617,GO:0005583,0.000280065955942717,0.999993109153001,3,12,fibrillar collagen trimer,CC,COL1A1;COL5A1;COL3A1
17801,GO:0098643,0.000280065955942717,0.999993109153001,3,12,banded collagen fibril,CC,COL1A1;COL5A1;COL3A1
20310,GO:1904315,0.000291245379309772,0.999983673536947,4,44,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,GABRG2;GABRG1;GABRB3;GRIN1
8443,GO:0032502,0.000304937686398035,0.999857443241118,57,5572,developmental process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CELF4;TIMP1;SRPX2;SLC17A7;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;KCNIP2;TGFBI;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;CPLX2;INA;ADM;AFF2;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;NNMT;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;PLA2G2A;SLC6A17;OPALIN;SMOC1;DOK6
19519,GO:1902710,0.000321836641460385,0.999991072362296,3,18,GABA receptor complex,CC,GABRG2;GABRG1;GABRB3
7936,GO:0031629,0.000321982600167226,0.999990807070196,3,23,synaptic vesicle fusion to presynaptic active zone membrane,BP,SYT1;SNAP25;CPLX2
18126,GO:0099500,0.000321982600167226,0.999990807070196,3,23,vesicle fusion to plasma membrane,BP,SYT1;SNAP25;CPLX2
10802,GO:0042629,0.000334732635913346,0.999990407954592,3,21,mast cell granule,CC,CHGA;ANXA1;CPLX2
3461,GO:0006906,0.000338550509680186,0.999969612889238,5,92,vesicle fusion,BP,SYT1;SNAP25;ANXA1;CPLX2;ANXA2
20732,GO:1905114,0.00033922306026439,0.999909403518231,13,586,cell surface receptor signaling pathway involved in cell-cell signaling,BP,CAMK2A;CELF4;SLC17A7;PLEKHA4;COL1A1;CUX2;IGFBP2;SLC8A2;SHANK1;SHANK2;GABRB3;RIMS2;GRIN1
483,GO:0001568,0.000345155423111466,0.99990264007818,14,627,blood vessel development,BP,TNFRSF12A;SRPX2;SERPINE1;COL1A1;LOX;TGFBI;COL5A1;CHI3L1;ANXA1;ADM;COL3A1;ANXA2;SOCS3;COL4A1
9464,GO:0034703,0.000361727406233186,0.999937569172467,8,209,cation channel complex,CC,KCNIP2;SNAP25;KCNB1;SHANK1;CNTNAP2;DPP10;GRIN1;SHISA7
18152,GO:0099529,0.00036358936885321,0.999978300964868,4,47,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,GABRG2;GABRG1;GABRB3;GRIN1
9466,GO:0034705,0.000371989571415778,0.999965927520685,5,91,potassium channel complex,CC,KCNIP2;SNAP25;KCNB1;CNTNAP2;DPP10
2263,GO:0004859,0.000377334398890839,0.999997248475113,2,8,phospholipase inhibitor activity,MF,ANXA1;ANXA2
18198,GO:0099601,0.000379379126172883,0.999965380785745,5,73,regulation of neurotransmitter receptor activity,BP,RASGRF1;SHANK1;SHANK2;GRIN1;SHISA7
17809,GO:0098655,0.000405340066179863,0.999878200057691,15,777,cation transmembrane transport,BP,RASGRF1;SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;JPH3;KCNB1;SHANK1;SHANK2;DPP10;GRIN1;ANXA2;SHISA7;SLC6A17
5062,GO:0010976,0.000407657074376306,0.999918958911163,9,271,positive regulation of neuron projection development,BP,TNFRSF12A;SYT1;CUX2;PACSIN1;SHANK1;SHANK2;FUT9;RIMS2;SLITRK1
17107,GO:0090174,0.000440600163645175,0.999958030853756,5,97,organelle membrane fusion,BP,SYT1;SNAP25;ANXA1;CPLX2;ANXA2
18015,GO:0098982,0.000452167446757058,0.999957139349151,5,72,GABA-ergic synapse,CC,GABRG2;IQSEC3;GABRB3;SLITRK1;SLC6A17
6107,GO:0016917,0.000453754475161859,0.999985644391462,3,20,GABA receptor activity,MF,GABRG2;GABRG1;GABRB3
3399,GO:0006810,0.000455184408180844,0.999785141102808,47,4536,transport,BP,LTF;RASGRF1;SNAP91;SYT1;CAMK2A;SLCO1A2;RAPGEF4;CHGA;TIMP1;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;GABRG2;SLC8A2;KCNIP2;PLAU;PACSIN1;LIF;SNAP25;CHI3L1;ANXA1;CPLX2;ADM;RAB3C;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;SVOP;GABRB3;DPP10;RIMS2;GRIN1;CD163;ANXA2;SV2B;SHISA7;PLA2G2A;SERPINA3;SLC6A17
11794,GO:0045163,0.000458688720714018,0.999998114363294,2,3,clustering of voltage-gated potassium channels,BP,KCNIP2;CNTNAP2
7349,GO:0030424,0.000469849515784835,0.99986324739529,14,612,axon,CC,RASGRF1;SYT1;NEFM;SLC17A7;ATP1A3;GABRG2;SLC8A2;PACSIN1;SNAP25;CPLX2;KCNB1;SHANK2;CNTNAP2;GRIN1
18899,GO:1901072,0.000476652876273796,0.999996089384053,2,8,glucosamine-containing compound catabolic process,BP,CHI3L2;CHI3L1
3837,GO:0008061,0.000477020665328762,0.999996231691236,2,7,chitin binding,MF,CHI3L2;CHI3L1
2635,GO:0005604,0.000486785876701683,0.999938461978414,6,98,basement membrane,CC,TIMP1;TGFBI;COL5A1;ANXA2;COL4A1;SMOC1
18013,GO:0098978,0.000492935458353387,0.999888942064542,10,348,glutamatergic synapse,CC,SYT1;SH3GL2;SNAP25;CPLX2;SYN2;SHANK1;GRIN1;SLITRK1;SHISA7;SLC6A17
18439,GO:0120035,0.000499951063073002,0.999853493988997,14,641,regulation of plasma membrane bounded cell projection organization,BP,TNFRSF12A;VIM;SYT1;CUX2;PACSIN1;SNAP25;SHANK1;SHANK2;PDPN;CSMD3;FUT9;RIMS2;GRIN1;SLITRK1
7717,GO:0031252,0.000521803781125376,0.999871627648208,11,399,cell leading edge,CC,TNFRSF12A;VIM;GABRG2;PACSIN1;KCNB1;PDPN;GABRG1;CNTNAP2;DDN;ANXA2;SHISA7
6644,GO:0019838,0.000522419847066328,0.99993258744247,6,124,growth factor binding,MF,SRPX2;COL1A1;IGFBP2;COL5A1;COL3A1;COL4A1
3406,GO:0006820,0.000528386711312554,0.999860295642778,12,574,anion transport,BP,SYT1;SLCO1A2;SLC17A7;ABCC3;GABRG2;SNAP25;ANXA1;PDPN;GABRG1;GABRB3;PLA2G2A;SLC6A17
11450,GO:0044057,0.000554435237477027,0.999852666145519,12,544,regulation of system process,BP,CHGA;CELF4;ATP1A3;CUX2;SLC8A2;KCNIP2;ADM;SHANK1;SHANK2;RIMS2;GRIN1;SHISA7
7785,GO:0031344,0.000566546029163816,0.999831797229936,14,650,regulation of cell projection organization,BP,TNFRSF12A;VIM;SYT1;CUX2;PACSIN1;SNAP25;SHANK1;SHANK2;PDPN;CSMD3;FUT9;RIMS2;GRIN1;SLITRK1
7083,GO:0023056,0.000584844914948369,0.999771904117097,23,1659,positive regulation of signaling,BP,TNFRSF12A;LTF;RASGRF1;SYT1;CHGA;PLEKHA4;COL1A1;CUX2;SLC8A2;LIF;GDF15;SNAP25;CHI3L1;KCNB1;SHANK1;SHANK2;COL3A1;RIMS2;GRIN1;ANXA2;SOCS3;SHISA7;PLA2G2A
18440,GO:0120036,0.000591086460843945,0.999769434355283,23,1426,plasma membrane bounded cell projection organization,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;ATP1A3;SH3GL2;CUX2;PACSIN1;SNAP25;POSTN;EMP3;ADM;SHANK1;SHANK2;PDPN;CSMD3;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
7060,GO:0022857,0.000593824465848067,0.999807229893065,16,914,transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;KCNB1;GABRG1;SVOP;GABRB3;GRIN1;ANXA2;SV2B;SLC6A17
6214,GO:0017157,0.000617371757702219,0.999899840292831,7,206,regulation of exocytosis,BP,SYT1;RAPGEF4;ANXA1;CPLX2;RAB3C;KCNB1;RIMS2
7394,GO:0030534,0.000620611957919464,0.999917122247913,6,131,adult behavior,BP,GABRG2;SHANK1;SHANK2;CNTNAP2;GRIN1;SLITRK1
14461,GO:0060291,0.000630010755295121,0.999935385391932,5,83,long-term synaptic potentiation,BP,SLC8A2;SNAP25;SHANK1;SHANK2;SHISA7
17884,GO:0098796,0.000667669621621999,0.99977303684736,17,1064,membrane protein complex,CC,ATP1A3;GABRG2;KCNIP2;SNAP25;GNAL;CPLX2;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;CNTNAP2;DPP10;GRIN1;SOCS3;SHISA7
19668,GO:1903034,0.000668480335945277,0.999909104024697,6,155,regulation of response to wounding,BP,TNFRSF12A;SERPINE1;PLAU;ANXA1;PDPN;ANXA2
10961,GO:0042995,0.000673079776861599,0.999710289062029,29,2092,cell projection,CC,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;NEFM;SLC17A7;ATP1A3;SH3GL2;GABRG2;SLC8A2;PACSIN1;SNAP25;ANXA1;CPLX2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;CNTNAP2;RIMS2;GRIN1;DDN;ANXA2;SV2B;SHISA7;SLC6A17
17822,GO:0098684,0.000715366354496511,0.999993064240516,2,7,photoreceptor ribbon synapse,CC,SH3GL2;PACSIN1
11088,GO:0043204,0.00073937753451079,0.999897555245763,6,151,perikaryon,CC,SLC8A2;CPLX2;KCNB1;RBFOX3;CNTNAP2;DDN
12547,GO:0046879,0.000756050889222273,0.999853263653938,8,282,hormone secretion,BP,RAPGEF4;CHGA;LIF;SNAP25;ANXA1;ADM;KCNB1;RIMS2
7169,GO:0030141,0.000783659100554837,0.999770357889383,13,759,secretory granule,CC,LTF;SYT1;CHGA;TIMP1;SERPINE1;COL1A1;PLAU;SNAP25;CHI3L1;ANXA2;SV2B;PLA2G2A;SERPINA3
7043,GO:0022824,0.000787105229090267,0.999941849784601,4,54,transmitter-gated ion channel activity,MF,GABRG2;GABRG1;GABRB3;GRIN1
7047,GO:0022835,0.000787105229090267,0.999941849784601,4,54,transmitter-gated channel activity,MF,GABRG2;GABRG1;GABRB3;GRIN1
7106,GO:0030030,0.000793269946858162,0.999683369229036,23,1465,cell projection organization,BP,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;ATP1A3;SH3GL2;CUX2;PACSIN1;SNAP25;POSTN;EMP3;ADM;SHANK1;SHANK2;PDPN;CSMD3;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
13630,GO:0051234,0.000802262614920744,0.999609015184154,47,4644,establishment of localization,BP,LTF;RASGRF1;SNAP91;SYT1;CAMK2A;SLCO1A2;RAPGEF4;CHGA;TIMP1;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;GABRG2;SLC8A2;KCNIP2;PLAU;PACSIN1;LIF;SNAP25;CHI3L1;ANXA1;CPLX2;ADM;RAB3C;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;SVOP;GABRB3;DPP10;RIMS2;GRIN1;CD163;ANXA2;SV2B;SHISA7;PLA2G2A;SERPINA3;SLC6A17
17998,GO:0098960,0.00081544901205653,0.999938891248334,4,60,postsynaptic neurotransmitter receptor activity,MF,GABRG2;GABRG1;GABRB3;GRIN1
3999,GO:0008328,0.000819807077554948,0.999939064966914,4,49,ionotropic glutamate receptor complex,CC,SHANK1;SHANK2;GRIN1;SHISA7
7183,GO:0030160,0.000846262823772306,0.999993300019643,2,4,synaptic receptor adaptor activity,MF,SHANK1;SHANK2
7718,GO:0031253,0.000862481135688478,0.999809069228808,9,315,cell projection membrane,CC,GABRG2;PACSIN1;KCNB1;SHANK2;PDPN;GABRG1;CNTNAP2;DDN;SHISA7
14247,GO:0055102,0.000877363431342266,0.999989518737259,2,11,lipase inhibitor activity,MF,ANXA1;ANXA2
17936,GO:0098878,0.000882206580239246,0.999932979583659,4,51,neurotransmitter receptor complex,CC,SHANK1;SHANK2;GRIN1;SHISA7
4592,GO:0009914,0.000883725431127498,0.99982422194112,8,290,hormone transport,BP,RAPGEF4;CHGA;LIF;SNAP25;ANXA1;ADM;KCNB1;RIMS2
4670,GO:0010243,0.00090902274739712,0.999692464480526,16,951,response to organonitrogen compound,BP,VIM;CAMK2A;TIMP1;ATP1A3;COL1A1;GABRG2;GDF15;ANXA1;GNAL;ADM;GABRB3;NNMT;COL3A1;GRIN1;SOCS3;COL4A1
7206,GO:0030193,0.000911366494079734,0.999929066674766,4,74,regulation of blood coagulation,BP,SERPINE1;PLAU;PDPN;ANXA2
17814,GO:0098660,0.000941019338922737,0.999705018075181,14,753,inorganic ion transmembrane transport,BP,SLC17A7;ATP1A3;GABRG2;SLC8A2;KCNIP2;SNAP25;JPH3;KCNB1;GABRG1;GABRB3;DPP10;GRIN1;ANXA2;SLC6A17
4607,GO:0009966,0.000945764912563097,0.999566582623127,33,2802,regulation of signal transduction,BP,TNFRSF12A;LTF;RASGRF1;CAMK2A;CHGA;CELF4;TIMP1;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;IQSEC3;PLAU;LIF;GDF15;CHI3L1;POSTN;ADM;JPH3;SHANK1;SHANK2;COL3A1;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A;PTPRT;FRRS1L
18680,GO:1900046,0.000948524848872458,0.999925341514285,4,75,regulation of hemostasis,BP,SERPINE1;PLAU;PDPN;ANXA2
9619,GO:0035249,0.000950304628238905,0.999892776679778,5,93,synaptic transmission, glutamatergic,BP,SYT1;SLC17A7;SHANK1;SHANK2;GRIN1
9596,GO:0035176,0.000971601860370507,0.999924480154143,4,48,social behavior,BP,SHANK1;SHANK2;CNTNAP2;GRIN1
5646,GO:0016043,0.000979598161404133,0.999512194329004,56,5635,cellular component organization,BP,TNFRSF12A;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PHACTR3;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PACSIN1;LIF;GDF15;COL5A1;SNAP25;POSTN;ANXA1;COL6A2;EMP3;CPLX2;INA;ADM;AFF2;KCNB1;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;COL4A1;SHISA7;PLA2G2A;SMOC1;DOK6
12304,GO:0046348,0.00107254553306083,0.999985614003258,2,12,amino sugar catabolic process,BP,CHI3L2;CHI3L1
3599,GO:0007165,0.00110776971586166,0.999447606349668,49,4951,signal transduction,BP,TNFRSF12A;LTF;VIM;RASGRF1;CAMK2A;RAPGEF4;CHGA;CELF4;TIMP1;SLC17A7;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;FMOD;PLAU;LIF;GDF15;CHI3L1;POSTN;ANXA1;GNAL;ADM;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;COL3A1;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;FRRS1L
13374,GO:0050818,0.00111332492559245,0.999908378564491,4,78,regulation of coagulation,BP,SERPINE1;PLAU;PDPN;ANXA2
6169,GO:0017075,0.0011188569846934,0.999950313699612,3,26,syntaxin-1 binding,MF,SYT1;SNAP25;CPLX2
2494,GO:0005254,0.00116531600786525,0.999903469209017,4,66,chloride channel activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3
6676,GO:0019897,0.00117372176862217,0.999821878773466,6,163,extrinsic component of plasma membrane,CC,SNAP91;PLEKHA4;SNAP25;ANXA1;GNAL;ANXA2
21625,GO:2000311,0.0011756106081717,0.99994706820421,3,25,regulation of AMPA receptor activity,BP,SHANK1;SHANK2;SHISA7
7275,GO:0030285,0.00119922031348746,0.999944456233117,3,33,integral component of synaptic vesicle membrane,CC,SYT1;SLC17A7;SLC6A17
7024,GO:0022603,0.00120788989711917,0.999566039482161,17,1004,regulation of anatomical structure morphogenesis,BP,TNFRSF12A;SYT1;SRPX2;PLEKHA4;SERPINE1;CUX2;LIF;GDF15;COL5A1;CHI3L1;POSTN;ANXA1;ADM;PDPN;RIMS2;GRIN1;SLITRK1
2269,GO:0004866,0.00120870323246883,0.999854765168724,5,131,endopeptidase inhibitor activity,MF,LTF;TIMP1;SERPINE1;ANXA2;SERPINA3
18441,GO:0120039,0.00121104670043216,0.999610422372269,14,650,plasma membrane bounded cell projection morphogenesis,BP,TNFRSF12A;SYT1;SH3GL2;CUX2;PACSIN1;POSTN;SHANK1;SHANK2;PDPN;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
2800,GO:0005887,0.00122581394928206,0.999522520356013,20,1385,integral component of plasma membrane,CC,SLCO1A2;ATP1A3;GABRG2;SLC8A2;KCNIP2;SNAP25;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;CNTNAP2;DPP10;GRIN1;CD163;SLITRK1;SHISA7;PTPRT;SLC6A17
13609,GO:0051179,0.00123040490678143,0.999379332139434,56,5892,localization,BP,TNFRSF12A;LTF;RASGRF1;SNAP91;SYT1;CAMK2A;SLCO1A2;RAPGEF4;CHGA;TIMP1;SRPX2;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;SLC8A2;KCNIP2;PLAU;PACSIN1;LIF;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;RAB3C;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;SVOP;GABRB3;COL3A1;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;CD163;ANXA2;SV2B;SHISA7;PLA2G2A;PTPRT;SERPINA3;SLC6A17
13144,GO:0048858,0.00125788237139608,0.999593680851831,14,654,cell projection morphogenesis,BP,TNFRSF12A;SYT1;SH3GL2;CUX2;PACSIN1;POSTN;SHANK1;SHANK2;PDPN;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
13635,GO:0051240,0.00126413889118235,0.999485479366604,22,1586,positive regulation of multicellular organismal process,BP,TNFRSF12A;LTF;SYT1;CHGA;SRPX2;SERPINE1;COL1A1;CUX2;PACSIN1;LIF;CHI3L1;ANXA1;ADM;SHANK1;SHANK2;PDPN;KSR2;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2
12886,GO:0048284,0.0012947123222584,0.999842133608013,5,126,organelle fusion,BP,SYT1;SNAP25;ANXA1;CPLX2;ANXA2
9625,GO:0035255,0.00130487674494249,0.999938666187598,3,27,ionotropic glutamate receptor binding,MF,SHANK1;SHANK2;SHISA7
4820,GO:0010647,0.00134927350161755,0.999447780591817,22,1651,positive regulation of cell communication,BP,TNFRSF12A;LTF;RASGRF1;SYT1;CHGA;PLEKHA4;COL1A1;CUX2;SLC8A2;LIF;GDF15;SNAP25;CHI3L1;KCNB1;SHANK1;SHANK2;COL3A1;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A
11985,GO:0045664,0.00135476112105465,0.999578497988323,13,631,regulation of neuron differentiation,BP,TNFRSF12A;VIM;SYT1;CUX2;PACSIN1;SNAP25;SHANK1;SHANK2;CSMD3;FUT9;RIMS2;GRIN1;SLITRK1
14724,GO:0060670,0.00139378648067042,0.999979305221175,2,10,branching involved in labyrinthine layer morphogenesis,BP,ADM;SOCS3
7028,GO:0022610,0.00139610748368617,0.999450216773115,20,1267,biological adhesion,BP,TNFRSF12A;LTF;SRPX2;SERPINE1;COL1A1;IGFBP2;TGFBI;PLAU;LIF;COL5A1;POSTN;ANXA1;COL6A2;PDPN;COL3A1;FUT9;CNTNAP2;SLITRK1;ANXA2;PTPRT
440,GO:0001505,0.00140415493192774,0.999737222264727,7,226,regulation of neurotransmitter levels,BP,SYT1;CAMK2A;SLC17A7;SNAP25;CPLX2;SYN2;RIMS2
7345,GO:0030414,0.00143285741013916,0.999820973511886,5,135,peptidase inhibitor activity,MF,LTF;TIMP1;SERPINE1;ANXA2;SERPINA3
10594,GO:0042221,0.00146874291000197,0.999279490287091,39,3796,response to chemical,BP,TNFRSF12A;LTF;VIM;SYT1;CAMK2A;CHGA;TIMP1;ATP1A3;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;KCNIP2;FMOD;PLAU;LIF;GDF15;CHI3L1;POSTN;ANXA1;GNAL;COL6A2;INA;ADM;KCNB1;SHANK1;GABRB3;NNMT;COL3A1;GRIN1;ANXA2;SOCS3;COL4A1;PTPRT;DOK6
8753,GO:0032990,0.00148241596848898,0.999512468930499,14,672,cell part morphogenesis,BP,TNFRSF12A;SYT1;SH3GL2;CUX2;PACSIN1;POSTN;SHANK1;SHANK2;PDPN;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
5140,GO:0014069,0.00151604016770524,0.999635813544709,9,324,postsynaptic density,CC,CAMK2A;SLC8A2;IQSEC3;SYN2;SHANK1;SHANK2;GRIN1;SLITRK1;SHISA7
17824,GO:0098686,0.00152537640813227,0.999923483634026,3,31,hippocampal mossy fiber to CA3 synapse,CC,SYT1;RAPGEF4;SH3GL2
14995,GO:0061135,0.00154379474605184,0.999803708171482,5,139,endopeptidase regulator activity,MF,LTF;TIMP1;SERPINE1;ANXA2;SERPINA3
13380,GO:0050829,0.00154644008497355,0.999920074916015,3,49,defense response to Gram-negative bacterium,BP,LTF;CHGA;SERPINE1
18434,GO:0120025,0.00156736225708694,0.999299911318443,27,1998,plasma membrane bounded cell projection,CC,TNFRSF12A;VIM;RASGRF1;SYT1;CAMK2A;NEFM;SLC17A7;ATP1A3;SH3GL2;GABRG2;SLC8A2;PACSIN1;SNAP25;ANXA1;CPLX2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;CNTNAP2;GRIN1;DDN;ANXA2;SV2B;SHISA7
19140,GO:1901698,0.00157859410940444,0.999435825576902,16,1005,response to nitrogen compound,BP,VIM;CAMK2A;TIMP1;ATP1A3;COL1A1;GABRG2;GDF15;ANXA1;GNAL;ADM;GABRB3;NNMT;COL3A1;GRIN1;SOCS3;COL4A1
14404,GO:0060198,0.00157920142649742,0.999974222689214,2,12,clathrin-sculpted vesicle,CC,SYT1;SLC17A7
6692,GO:0019932,0.00159124545357739,0.999614244891373,9,390,second-messenger-mediated signaling,BP,RAPGEF4;CHGA;SLC8A2;GNAL;ADM;JPH3;KSR2;RIMS2;GRIN1
5390,GO:0015318,0.00163528142710252,0.999479771955795,13,708,inorganic molecular entity transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;KCNB1;GABRG1;GABRB3;GRIN1;ANXA2
5082,GO:0012505,0.00163668238912862,0.999184081568888,41,4056,endomembrane system,CC,LTF;SNAP91;SYT1;CHGA;TIMP1;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;TGFBI;FMOD;PLAU;PACSIN1;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;COL6A2;GALNT13;RAB3C;JPH3;SYN2;SVOP;COL3A1;FUT9;CNTNAP2;GRIN1;ST8SIA3;DDN;ANXA2;CALN1;SV2B;COL4A1;PLA2G2A;SERPINA3;SLC6A17;OPALIN
15211,GO:0061669,0.00164042148311829,0.999975764807593,2,7,spontaneous neurotransmitter secretion,BP,SYT1;RIMS2
2607,GO:0005546,0.00165280917839202,0.999849107070617,4,70,phosphatidylinositol-4,5-bisphosphate binding,MF,SNAP91;SYT1;PLEKHA4;ANXA2
16084,GO:0071310,0.00166362425036473,0.999244466453266,28,2389,cellular response to organic substance,BP,TNFRSF12A;LTF;VIM;CAMK2A;TIMP1;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;FMOD;LIF;GDF15;CHI3L1;POSTN;ANXA1;GNAL;INA;KCNB1;GABRB3;COL3A1;ANXA2;SOCS3;COL4A1;PTPRT
9137,GO:0034097,0.00168223343289462,0.999415285574794,15,1051,response to cytokine,BP,TNFRSF12A;VIM;CAMK2A;TIMP1;COL1A1;LOX;LIF;CHI3L1;POSTN;ANXA1;INA;COL3A1;ANXA2;SOCS3;PTPRT
16162,GO:0071420,0.00169677596110698,0.999974497263661,2,7,cellular response to histamine,BP,GABRG2;GABRB3
8271,GO:0032279,0.00173184045118169,0.999575696764207,9,330,asymmetric synapse,CC,CAMK2A;SLC8A2;IQSEC3;SYN2;SHANK1;SHANK2;GRIN1;SLITRK1;SHISA7
14019,GO:0051962,0.0017338269406308,0.999503405924599,11,508,positive regulation of nervous system development,BP,TNFRSF12A;SYT1;SRPX2;CUX2;PACSIN1;LIF;SHANK1;SHANK2;FUT9;RIMS2;SLITRK1
4627,GO:0010033,0.00174251730240122,0.999174397666327,32,2931,response to organic substance,BP,TNFRSF12A;LTF;VIM;CAMK2A;TIMP1;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;FMOD;LIF;GDF15;CHI3L1;POSTN;ANXA1;GNAL;COL6A2;INA;ADM;KCNB1;GABRB3;NNMT;COL3A1;GRIN1;ANXA2;SOCS3;COL4A1;PTPRT
19916,GO:1903530,0.00180000336556807,0.999481469638931,11,573,regulation of secretion by cell,BP,SYT1;CAMK2A;RAPGEF4;CHGA;LIF;SNAP25;ANXA1;CPLX2;RAB3C;KCNB1;RIMS2
11987,GO:0045666,0.00181048791473923,0.999553179623086,9,353,positive regulation of neuron differentiation,BP,TNFRSF12A;SYT1;CUX2;PACSIN1;SHANK1;SHANK2;FUT9;RIMS2;SLITRK1
9009,GO:0033605,0.0018367238377883,0.999968074872425,2,11,positive regulation of catecholamine secretion,BP,SYT1;KCNB1
7208,GO:0030195,0.00183994774259221,0.999899424430297,3,44,negative regulation of blood coagulation,BP,SERPINE1;PLAU;ANXA2
16408,GO:0071840,0.00184955622897107,0.999044763842847,56,5809,cellular component organization or biogenesis,BP,TNFRSF12A;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PHACTR3;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PACSIN1;LIF;GDF15;COL5A1;SNAP25;POSTN;ANXA1;COL6A2;EMP3;CPLX2;INA;ADM;AFF2;KCNB1;SHANK1;SHANK2;PDPN;CSMD3;GABRB3;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;COL4A1;SHISA7;PLA2G2A;SMOC1;DOK6
3670,GO:0007269,0.00185930270734938,0.999691005466185,6,167,neurotransmitter secretion,BP,SYT1;CAMK2A;SNAP25;CPLX2;SYN2;RIMS2
18224,GO:0099643,0.00185930270734938,0.999691005466185,6,167,signal release from synapse,BP,SYT1;CAMK2A;SNAP25;CPLX2;SYN2;RIMS2
17908,GO:0098833,0.0018646312377273,0.999968584996517,2,9,presynaptic endocytic zone,CC,SNAP91;PACSIN1
11017,GO:0043086,0.00187497330641647,0.999423794184664,12,686,negative regulation of catalytic activity,BP,LTF;CAMK2A;PHACTR3;TIMP1;SERPINE1;SPOCD1;ANXA1;ELFN2;ANXA2;SOCS3;PTPRT;SERPINA3
17829,GO:0098693,0.00193586459338306,0.999742200901987,5,110,regulation of synaptic vesicle cycle,BP,SYT1;RAPGEF4;SLC17A7;CPLX2;RIMS2
18681,GO:1900047,0.00194267673704881,0.999891651840598,3,45,negative regulation of hemostasis,BP,SERPINE1;PLAU;ANXA2
8734,GO:0032964,0.00194928658830402,0.999891781884473,3,40,collagen biosynthetic process,BP,VIM;COL1A1;COL5A1
17885,GO:0098797,0.00196877479023276,0.99942656713842,11,538,plasma membrane protein complex,CC,ATP1A3;KCNIP2;SNAP25;GNAL;KCNB1;SHANK1;SHANK2;CNTNAP2;DPP10;GRIN1;SHISA7
13340,GO:0050773,0.00197117157789693,0.99966943260587,6,147,regulation of dendrite development,BP,CUX2;PACSIN1;SHANK1;SHANK2;CSMD3;GRIN1
2493,GO:0005253,0.00200671415357759,0.999806184951041,4,77,anion channel activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3
2466,GO:0005215,0.00203674526613411,0.99925300112321,16,1034,transporter activity,MF,SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;KCNB1;GABRG1;SVOP;GABRB3;GRIN1;ANXA2;SV2B;SLC6A17
17625,GO:0097484,0.00204181883659859,0.999886069047182,3,33,dendrite extension,BP,SYT1;SH3GL2;RIMS2
5719,GO:0016192,0.00210448243616111,0.999076265461927,24,1878,vesicle-mediated transport,BP,LTF;SNAP91;SYT1;RAPGEF4;CHGA;TIMP1;SLC17A7;SERPINE1;SH3GL2;CUX2;PLAU;PACSIN1;SNAP25;CHI3L1;ANXA1;CPLX2;ADM;RAB3C;SYN2;KCNB1;RIMS2;CD163;ANXA2;SERPINA3
7937,GO:0031630,0.0021069636171375,0.999960725295365,2,11,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,SYT1;CPLX2
7940,GO:0031638,0.00211531746919276,0.999878203557323,3,47,zymogen activation,BP,SERPINE1;PLAU;C1R
13375,GO:0050819,0.00211698979411443,0.999878073398242,3,47,negative regulation of coagulation,BP,SERPINE1;PLAU;ANXA2
7704,GO:0031226,0.00215151385751792,0.999119143325973,20,1458,intrinsic component of plasma membrane,CC,SLCO1A2;ATP1A3;GABRG2;SLC8A2;KCNIP2;SNAP25;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;CNTNAP2;DPP10;GRIN1;CD163;SLITRK1;SHISA7;PTPRT;SLC6A17
18186,GO:0099572,0.00217652332302201,0.999448141486846,9,347,postsynaptic specialization,CC,CAMK2A;SLC8A2;IQSEC3;SYN2;SHANK1;SHANK2;GRIN1;SLITRK1;SHISA7
20206,GO:1904062,0.00218493135936153,0.999497930573836,8,320,regulation of cation transmembrane transport,BP,RASGRF1;KCNIP2;JPH3;SHANK1;SHANK2;DPP10;GRIN1;SHISA7
2467,GO:0005216,0.00220339258616477,0.999439908041846,9,371,ion channel activity,MF,SLC17A7;GABRG2;KCNIP2;SNAP25;KCNB1;GABRG1;GABRB3;GRIN1;ANXA2
16107,GO:0071345,0.00224988002045787,0.999223631006224,14,973,cellular response to cytokine stimulus,BP,TNFRSF12A;VIM;CAMK2A;TIMP1;COL1A1;LOX;LIF;CHI3L1;POSTN;ANXA1;INA;ANXA2;SOCS3;PTPRT
784,GO:0002020,0.00226699218477716,0.999686200037555,5,122,protease binding,MF,TIMP1;SERPINE1;COL1A1;COL3A1;ANXA2
4529,GO:0009653,0.00227403208528792,0.998911759575467,31,2472,anatomical structure morphogenesis,BP,TNFRSF12A;LTF;SYT1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;TGFBI;PACSIN1;LIF;GDF15;COL5A1;CHI3L1;POSTN;ANXA1;ADM;SHANK1;SHANK2;PDPN;COL3A1;CNTNAP2;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;DOK6
10775,GO:0042583,0.00227669579211163,0.999956603139463,2,10,chromaffin granule,CC,SYT1;CHGA
3456,GO:0006898,0.002302654772703,0.999529229737777,7,248,receptor-mediated endocytosis,BP,SNAP91;SERPINE1;SH3GL2;SNAP25;ADM;CD163;ANXA2
7048,GO:0022836,0.00245183815895067,0.999426220200566,8,310,gated channel activity,MF,SLC17A7;GABRG2;KCNIP2;SNAP25;KCNB1;GABRG1;GABRB3;GRIN1
9507,GO:0034776,0.00247402023648826,0.999950797782014,2,10,response to histamine,BP,GABRG2;GABRB3
13336,GO:0050769,0.00248846822098851,0.999301660062897,10,450,positive regulation of neurogenesis,BP,TNFRSF12A;SYT1;CUX2;PACSIN1;LIF;SHANK1;SHANK2;FUT9;RIMS2;SLITRK1
4105,GO:0008503,0.00254048311545114,0.999948787187108,2,10,benzodiazepine receptor activity,MF,GABRG2;GABRG1
14926,GO:0061025,0.00254456571171485,0.999637091809241,5,143,membrane fusion,BP,SYT1;SNAP25;ANXA1;CPLX2;ANXA2
5634,GO:0016020,0.00255620310078082,0.998673054137998,65,7600,membrane,CC,TNFRSF12A;LTF;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;SLCO1A2;RAPGEF4;SRPX2;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;ABCC3;CUX2;GABRG2;IGFBP2;SLC8A2;KCNIP2;IQSEC3;TGFBI;PLAU;PACSIN1;SNAP25;ANXA1;GNAL;COL6A2;EMP3;GALNT13;CPLX2;RAB3C;JPH3;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;SVOP;GABRB3;ELFN2;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;DDN;ANXA2;CALN1;SOCS3;SV2B;SHISA7;PLA2G2A;PTPRT;SLC6A17;OPALIN;FRRS1L
8364,GO:0032412,0.00257950518600165,0.999461963461279,7,244,regulation of ion transmembrane transporter activity,BP,RASGRF1;KCNIP2;JPH3;SHANK1;SHANK2;GRIN1;SHISA7
13427,GO:0050896,0.00262519725231507,0.998631232551489,64,7419,response to stimulus,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;TIMP1;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;GNAL;COL6A2;CPLX2;INA;ADM;JPH3;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;NNMT;COL3A1;KSR2;CNTNAP2;RIMS2;GRIN1;CD163;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;DOK6;FRRS1L
7787,GO:0031346,0.00267306978282799,0.999300862318232,9,361,positive regulation of cell projection organization,BP,TNFRSF12A;SYT1;CUX2;PACSIN1;SHANK1;SHANK2;FUT9;RIMS2;SLITRK1
14754,GO:0060707,0.00271089049236007,0.999941044365875,2,13,trophoblast giant cell differentiation,BP,LIF;SOCS3
7691,GO:0031201,0.00273631461467105,0.999827485650018,3,47,SNARE complex,CC,SNAP25;CPLX2;SYN2
3726,GO:0007417,0.00282787495526988,0.998927673169365,16,965,central nervous system development,BP,VIM;SYT1;SLC17A7;SH3GL2;HPCAL4;LIF;INA;AFF2;SHANK1;SHANK2;COL3A1;CNTNAP2;GRIN1;COL4A1;SLC6A17;OPALIN
5267,GO:0015075,0.00285003696937603,0.999032492555924,13,761,ion transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;KCNB1;GABRG1;GABRB3;GRIN1;ANXA2
9468,GO:0034707,0.00287655591852945,0.999816371486206,3,42,chloride channel complex,CC,GABRG2;GABRG1;GABRB3
7133,GO:0030073,0.00293524211034464,0.99946422333841,6,195,insulin secretion,BP,RAPGEF4;CHGA;SNAP25;ANXA1;KCNB1;RIMS2
13121,GO:0048812,0.00294099107834325,0.998999106182252,13,636,neuron projection morphogenesis,BP,TNFRSF12A;SYT1;SH3GL2;CUX2;PACSIN1;POSTN;SHANK1;SHANK2;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
7066,GO:0022898,0.00295088741471613,0.999369176917008,7,253,regulation of transmembrane transporter activity,BP,RASGRF1;KCNIP2;JPH3;SHANK1;SHANK2;GRIN1;SHISA7
14925,GO:0061024,0.00297753589061328,0.998983842268227,13,778,membrane organization,BP,SNAP91;SYT1;CAMK2A;SH3GL2;KCNIP2;PACSIN1;COL5A1;SNAP25;ANXA1;CPLX2;CNTNAP2;ANXA2;SHISA7
13230,GO:0050433,0.00298314640335182,0.999805745291383,3,49,regulation of catecholamine secretion,BP,SYT1;CHGA;KCNB1
6848,GO:0021700,0.00299823569329018,0.999357184894935,7,254,developmental maturation,BP,LTF;SLC17A7;KCNIP2;SRRM4;SHANK1;CNTNAP2;GRIN1
12966,GO:0048514,0.00305336238661633,0.999058230480131,11,548,blood vessel morphogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;LOX;TGFBI;CHI3L1;ANXA1;ADM;COL3A1;ANXA2;COL4A1
7138,GO:0030100,0.00305745391849649,0.999437307209685,6,195,regulation of endocytosis,BP,SNAP91;SLC17A7;SERPINE1;SH3GL2;PACSIN1;ANXA2
5290,GO:0015125,0.00305855394203565,0.999928557766335,2,14,bile acid transmembrane transporter activity,MF,SLCO1A2;ABCC3
10522,GO:0042048,0.00306164758608795,0.999933550249169,2,9,olfactory behavior,BP,SHANK1;GRIN1
2795,GO:0005882,0.00307367952871559,0.999665296765082,4,83,intermediate filament,CC,VIM;NEFM;INA;SHANK2
9022,GO:0033628,0.00308087071249156,0.99979783097221,3,45,regulation of cell adhesion mediated by integrin,BP,SERPINE1;PLAU;LIF
7941,GO:0031639,0.00308629183639582,0.999925977920244,2,17,plasminogen activation,BP,SERPINE1;PLAU
15874,GO:0070887,0.00311780781274362,0.998472673957121,31,2911,cellular response to chemical stimulus,BP,TNFRSF12A;LTF;VIM;SYT1;CAMK2A;CHGA;TIMP1;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;FMOD;LIF;GDF15;CHI3L1;POSTN;ANXA1;GNAL;INA;KCNB1;GABRB3;COL3A1;GRIN1;ANXA2;SOCS3;COL4A1;PTPRT
5475,GO:0015711,0.00313792244636835,0.999157558501515,9,447,organic anion transport,BP,SYT1;SLCO1A2;SLC17A7;ABCC3;SNAP25;ANXA1;PDPN;PLA2G2A;SLC6A17
5372,GO:0015276,0.00313900316740238,0.999531148657533,5,127,ligand-gated ion channel activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3;GRIN1
7046,GO:0022834,0.00313900316740238,0.999531148657533,5,127,ligand-gated channel activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3;GRIN1
5367,GO:0015267,0.00317287586360927,0.999147514035596,9,404,channel activity,MF,SLC17A7;GABRG2;KCNIP2;SNAP25;KCNB1;GABRG1;GABRB3;GRIN1;ANXA2
7040,GO:0022803,0.00317287586360927,0.999147514035596,9,404,passive transmembrane transporter activity,MF,SLC17A7;GABRG2;KCNIP2;SNAP25;KCNB1;GABRG1;GABRB3;GRIN1;ANXA2
3589,GO:0007155,0.00320426380413085,0.998668785425202,19,1261,cell adhesion,BP,TNFRSF12A;SRPX2;SERPINE1;COL1A1;IGFBP2;TGFBI;PLAU;LIF;COL5A1;POSTN;ANXA1;COL6A2;PDPN;COL3A1;FUT9;CNTNAP2;SLITRK1;ANXA2;PTPRT
13520,GO:0051046,0.00324161113883062,0.998991323628825,11,622,regulation of secretion,BP,SYT1;CAMK2A;RAPGEF4;CHGA;LIF;SNAP25;ANXA1;CPLX2;RAB3C;KCNB1;RIMS2
13573,GO:0051130,0.00324315355293656,0.998715672843803,17,1118,positive regulation of cellular component organization,BP,TNFRSF12A;SYT1;SRPX2;SERPINE1;SH3GL2;CUX2;PACSIN1;LIF;GDF15;ANXA1;SHANK1;SHANK2;PDPN;FUT9;RIMS2;SLITRK1;ANXA2
3431,GO:0006865,0.00325377962596836,0.999508889629963,5,141,amino acid transport,BP,SYT1;SLC17A7;SNAP25;PDPN;SLC6A17
4511,GO:0009612,0.00328263560882303,0.999386984113103,6,198,response to mechanical stimulus,BP,COL1A1;IGFBP2;CHI3L1;POSTN;COL3A1;CNTNAP2
4538,GO:0009719,0.00333189517740196,0.998580517805435,20,1466,response to endogenous stimulus,BP,VIM;CAMK2A;TIMP1;ATP1A3;SH3GL2;COL1A1;LOX;GABRG2;IGFBP2;FMOD;GDF15;POSTN;ANXA1;GNAL;ADM;GABRB3;COL3A1;ANXA2;SOCS3;COL4A1
17799,GO:0098641,0.00336067858683754,0.999915339997504,2,18,cadherin binding involved in cell-cell adhesion,MF,ANXA1;ANXA2
7421,GO:0030594,0.00337089196582188,0.999622434620708,4,91,neurotransmitter receptor activity,MF,GABRG2;GABRG1;GABRB3;GRIN1
21383,GO:1990814,0.00338972886313997,1,1,1,DNA/DNA annealing activity,MF,ANXA1
7982,GO:0031700,0.00341591854799488,1,1,1,adrenomedullin receptor binding,MF,ADM
5180,GO:0014812,0.00345178638925017,0.999612668185852,4,77,muscle cell migration,BP,SERPINE1;PLAU;POSTN;ANXA1
3864,GO:0008112,0.0035076547563127,1,1,1,nicotinamide N-methyltransferase activity,MF,NNMT
7483,GO:0030760,0.0035076547563127,1,1,1,pyridine N-methyltransferase activity,MF,NNMT
15807,GO:0070741,0.00351346734124979,0.999759515465727,3,41,response to interleukin-6,BP,CHI3L1;SOCS3;PTPRT
11532,GO:0044306,0.00354354845523845,0.999454567229943,5,139,neuron projection terminus,CC,SYT1;SLC8A2;PACSIN1;CPLX2;GRIN1
11444,GO:0044033,0.00355738203717923,1,1,1,multi-organism metabolic process,BP,ANXA2
11445,GO:0044035,0.00355738203717923,1,1,1,multi-organism catabolic process,BP,ANXA2
11472,GO:0044115,0.00355738203717923,1,1,1,development of symbiont involved in interaction with host,BP,ANXA2
11474,GO:0044145,0.00355738203717923,1,1,1,modulation of development of symbiont involved in interaction with host,BP,ANXA2
11475,GO:0044147,0.00355738203717923,1,1,1,negative regulation of development of symbiont involved in interaction with host,BP,ANXA2
11645,GO:0044730,0.00355738203717923,1,1,1,bone sialoprotein binding,MF,ANXA2
14066,GO:0052214,0.00355738203717923,1,1,1,metabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
14067,GO:0052227,0.00355738203717923,1,1,1,catabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
14068,GO:0052229,0.00355738203717923,1,1,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
14074,GO:0052360,0.00355738203717923,1,1,1,catabolism by host of symbiont macromolecule,BP,ANXA2
14075,GO:0052361,0.00355738203717923,1,1,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
14076,GO:0052362,0.00355738203717923,1,1,1,catabolism by host of symbiont protein,BP,ANXA2
14077,GO:0052363,0.00355738203717923,1,1,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
14078,GO:0052364,0.00355738203717923,1,1,1,catabolism by host of substance in symbiont,BP,ANXA2
14083,GO:0052416,0.00355738203717923,1,1,1,metabolism by host of symbiont macromolecule,BP,ANXA2
14084,GO:0052417,0.00355738203717923,1,1,1,metabolism by host of symbiont protein,BP,ANXA2
14085,GO:0052418,0.00355738203717923,1,1,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
14086,GO:0052419,0.00355738203717923,1,1,1,metabolism by host of substance in symbiont,BP,ANXA2
20964,GO:1905597,0.00355738203717923,1,1,1,positive regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
20966,GO:1905599,0.00355738203717923,1,1,1,positive regulation of low-density lipoprotein receptor activity,BP,ANXA2
8361,GO:0032409,0.00355790985426827,0.999212864990812,7,264,regulation of transporter activity,BP,RASGRF1;KCNIP2;JPH3;SHANK1;SHANK2;GRIN1;SHISA7
18657,GO:1900006,0.0035683696225653,0.999596927200276,4,71,positive regulation of dendrite development,BP,CUX2;PACSIN1;SHANK1;SHANK2
13229,GO:0050432,0.0036559379417486,0.999743706520567,3,51,catecholamine secretion,BP,SYT1;CHGA;KCNB1
6595,GO:0019730,0.00365636781172473,0.999740163969258,3,78,antimicrobial humoral response,BP,LTF;CHGA;PLA2G2A
5551,GO:0015850,0.00372476867759984,0.999285193125507,6,222,organic hydroxy compound transport,BP,SYT1;SLCO1A2;CHGA;ABCC3;KCNB1;ANXA2
17617,GO:0097470,0.00374852834498919,0.999906187923057,2,11,ribbon synapse,CC,SH3GL2;PACSIN1
19431,GO:1902476,0.0037946646841542,0.999561505567176,4,85,chloride transmembrane transport,BP,SLC17A7;GABRG2;GABRG1;GABRB3
2605,GO:0005544,0.00381155693095475,0.99972972253203,3,47,calcium-dependent phospholipid binding,MF,SYT1;ANXA1;ANXA2
2585,GO:0005513,0.00394010636287702,0.999896230883443,2,13,detection of calcium ion,BP,SYT1;KCNIP2
16956,GO:0086030,0.00398512013283647,1,1,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,CHGA
16160,GO:0071417,0.00405099373121893,0.998702004633894,11,591,cellular response to organonitrogen compound,BP,VIM;CAMK2A;ATP1A3;COL1A1;GABRG2;GDF15;GNAL;GABRB3;COL3A1;SOCS3;COL4A1
17897,GO:0098814,0.00417246979913031,0.999888127812948,2,12,spontaneous synaptic transmission,BP,SYT1;RIMS2
10258,GO:0036458,0.00418381279591811,1,1,1,hepatocyte growth factor binding,MF,SRPX2
5119,GO:0014047,0.00423006027887981,0.999689953043106,3,43,glutamate secretion,BP,SYT1;SLC17A7;SNAP25
6693,GO:0019933,0.00423348812191778,0.999319302747758,5,155,cAMP-mediated signaling,BP,RAPGEF4;CHGA;GNAL;ADM;RIMS2
17823,GO:0098685,0.00424935572457083,0.999493852744492,4,81,Schaffer collateral - CA1 synapse,CC,SH3GL2;INA;SYN2;SHANK1
14994,GO:0061134,0.00426247645569301,0.999312376915151,5,172,peptidase regulator activity,MF,LTF;TIMP1;SERPINE1;ANXA2;SERPINA3
5805,GO:0016358,0.00432718302051585,0.999009314667139,7,237,dendrite development,BP,CAMK2A;CUX2;PACSIN1;SHANK1;SHANK2;CSMD3;GRIN1
6677,GO:0019898,0.00436149243424162,0.998997878598528,7,281,extrinsic component of membrane,CC,SNAP91;PLEKHA4;SNAP25;ANXA1;GNAL;ANXA2;SOCS3
8881,GO:0033214,0.00444452204967678,1,1,1,siderophore-dependent iron import into cell,BP,LTF
10835,GO:0042710,0.00444452204967678,1,1,1,biofilm formation,BP,LTF
11437,GO:0044010,0.00444452204967678,1,1,1,single-species biofilm formation,BP,LTF
11587,GO:0044407,0.00444452204967678,1,1,1,single-species biofilm formation in or on host organism,BP,LTF
17790,GO:0098630,0.00444452204967678,1,1,1,aggregation of unicellular organisms,BP,LTF
18753,GO:1900159,0.00444452204967678,1,1,1,positive regulation of bone mineralization involved in bone maturation,BP,LTF
18767,GO:1900190,0.00444452204967678,1,1,1,regulation of single-species biofilm formation,BP,LTF
18768,GO:1900191,0.00444452204967678,1,1,1,negative regulation of single-species biofilm formation,BP,LTF
18791,GO:1900228,0.00444452204967678,1,1,1,regulation of single-species biofilm formation in or on host organism,BP,LTF
18792,GO:1900229,0.00444452204967678,1,1,1,negative regulation of single-species biofilm formation in or on host organism,BP,LTF
21622,GO:2000308,0.00444452204967678,1,1,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
13382,GO:0050832,0.00444915362096976,0.999866587154035,2,27,defense response to fungus,BP,LTF;CHGA
5283,GO:0015108,0.00446932570603943,0.999458470683779,4,90,chloride transmembrane transporter activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3
12038,GO:0045766,0.00448685230502365,0.999268799654224,5,153,positive regulation of angiogenesis,BP,SRPX2;SERPINE1;CHI3L1;ANXA1;ADM
8752,GO:0032989,0.00453985742548778,0.998306061794087,14,756,cellular component morphogenesis,BP,TNFRSF12A;SYT1;SH3GL2;CUX2;PACSIN1;POSTN;SHANK1;SHANK2;PDPN;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
17206,GO:0090303,0.00456547545214886,0.999653561720441,3,51,positive regulation of wound healing,BP,SERPINE1;ANXA1;PDPN
16721,GO:0072359,0.00461705557961597,0.998156116559148,16,993,circulatory system development,BP,TNFRSF12A;SRPX2;SERPINE1;COL1A1;LOX;TGFBI;LIF;COL5A1;CHI3L1;ANXA1;ADM;PDPN;COL3A1;ANXA2;SOCS3;COL4A1
11130,GO:0043269,0.00473999322796088,0.99844811796699,11,632,regulation of ion transport,BP,RASGRF1;SYT1;CAMK2A;KCNIP2;JPH3;KCNB1;SHANK1;SHANK2;DPP10;GRIN1;SHISA7
12556,GO:0046888,0.00480797071439901,0.999627277430545,3,55,negative regulation of hormone secretion,BP,CHGA;LIF;KCNB1
13567,GO:0051124,0.00482179484470427,0.999864976271042,2,10,synaptic growth at neuromuscular junction,BP,SHANK1;SHANK2
11032,GO:0043116,0.00489247472264471,0.999853367927466,2,15,negative regulation of vascular permeability,BP,SH3GL2;ADM
7087,GO:0030001,0.00494433648528134,0.998206309561053,13,814,metal ion transport,BP,LTF;CAMK2A;SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;JPH3;KCNB1;DPP10;GRIN1;ANXA2;SLC6A17
19142,GO:1901700,0.00497027934204222,0.99784457626418,19,1515,response to oxygen-containing compound,BP,LTF;VIM;CAMK2A;TIMP1;ATP1A3;SERPINE1;COL1A1;IGFBP2;GDF15;POSTN;ANXA1;GNAL;COL6A2;ADM;KCNB1;COL3A1;GRIN1;SOCS3;COL4A1
20318,GO:1904328,0.00502166071328014,1,1,1,regulation of myofibroblast contraction,BP,PDPN
21360,GO:1990764,0.00502166071328014,1,1,1,myofibroblast contraction,BP,PDPN
708,GO:0001917,0.00502876038356918,0.999605609261293,3,49,photoreceptor inner segment,CC,ATP1A3;SNAP25;SHANK2
18048,GO:0099050,0.00503939799246337,1,1,1,vesicle scission,BP,SH3GL2
13235,GO:0050459,0.00510912313516581,1,1,1,ethanolamine-phosphate phospho-lyase activity,MF,ETNPPL
12872,GO:0048259,0.00516340175294011,0.999347859507587,4,93,regulation of receptor-mediated endocytosis,BP,SNAP91;SERPINE1;SH3GL2;ANXA2
14758,GO:0060713,0.0051708992498202,0.999837497931673,2,18,labyrinthine layer morphogenesis,BP,ADM;SOCS3
2481,GO:0005237,0.00524674143864077,0.999838332168853,2,14,inhibitory extracellular ligand-gated ion channel activity,MF,GABRG2;GABRG1
11761,GO:0045104,0.00547964878628874,0.999560912275049,3,40,intermediate filament cytoskeleton organization,BP,VIM;NEFM;INA
3842,GO:0008068,0.00550412914281504,1,1,1,extracellularly glutamate-gated chloride channel activity,MF,SLC17A7
5391,GO:0015319,0.00550412914281504,1,1,1,sodium:inorganic phosphate symporter activity,MF,SLC17A7
17586,GO:0097401,0.00550412914281504,1,1,1,synaptic vesicle lumen acidification,BP,SLC17A7
10674,GO:0042383,0.00554464417437174,0.99905264243518,5,132,sarcolemma,CC,SLC8A2;ANXA1;COL6A2;KCNB1;ANXA2
3455,GO:0006897,0.00554630624691547,0.998253742952425,10,531,endocytosis,BP,SNAP91;SYT1;SLC17A7;SERPINE1;SH3GL2;PACSIN1;SNAP25;ADM;CD163;ANXA2
10348,GO:0038063,0.00574398456234485,0.999820932447879,2,11,collagen-activated tyrosine kinase receptor signaling pathway,BP,COL1A1;COL4A1
11760,GO:0045103,0.00576288329466066,0.999529179943077,3,41,intermediate filament-based process,BP,VIM;NEFM;INA
12551,GO:0046883,0.00577540898217186,0.998786043072932,6,239,regulation of hormone secretion,BP,RAPGEF4;CHGA;LIF;SNAP25;ANXA1;KCNB1
13001,GO:0048583,0.00579248695386314,0.996913539998339,37,3708,regulation of response to stimulus,BP,TNFRSF12A;LTF;RASGRF1;CAMK2A;CHGA;CELF4;TIMP1;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;IQSEC3;PLAU;LIF;GDF15;CHI3L1;POSTN;ANXA1;ADM;JPH3;C1R;SHANK1;SHANK2;PDPN;COL3A1;RIMS2;GRIN1;ANXA2;SOCS3;SHISA7;PLA2G2A;PTPRT;FRRS1L
9738,GO:0035490,0.00585383259293519,1,1,1,regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
9739,GO:0035491,0.00585383259293519,1,1,1,positive regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
18990,GO:1901331,0.00585383259293519,1,1,1,positive regulation of odontoblast differentiation,BP,SERPINE1
19598,GO:1902913,0.00585383259293519,1,1,1,positive regulation of neuroepithelial cell differentiation,BP,SERPINE1
9505,GO:0034774,0.00587733839483733,0.998757113165679,6,299,secretory granule lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;ANXA2;SERPINA3
9499,GO:0034765,0.00592884832516322,0.998244998947267,9,446,regulation of ion transmembrane transport,BP,RASGRF1;KCNIP2;JPH3;KCNB1;SHANK1;SHANK2;DPP10;GRIN1;SHISA7
4860,GO:0010720,0.00594931623736831,0.998108014904451,10,517,positive regulation of cell development,BP,TNFRSF12A;SYT1;CUX2;PACSIN1;LIF;SHANK1;SHANK2;FUT9;RIMS2;SLITRK1
3407,GO:0006821,0.00604401725897183,0.999200613770533,4,99,chloride transport,BP,SLC17A7;GABRG2;GABRG1;GABRB3
7132,GO:0030072,0.00606049587850201,0.998713706093299,6,233,peptide hormone secretion,BP,RAPGEF4;CHGA;SNAP25;ANXA1;KCNB1;RIMS2
11084,GO:0043200,0.00610835239665227,0.9991885861436,4,105,response to amino acid,BP,COL1A1;COL3A1;GRIN1;COL4A1
11792,GO:0045161,0.00613318470152471,0.999799456040644,2,12,neuronal ion channel clustering,BP,KCNIP2;CNTNAP2
13240,GO:0050482,0.0061405591514463,0.999785601730922,2,22,arachidonic acid secretion,BP,ANXA1;PLA2G2A
20146,GO:1903963,0.0061405591514463,0.999785601730922,2,22,arachidonate transport,BP,ANXA1;PLA2G2A
2270,GO:0004867,0.00617741536281366,0.999473354702345,3,64,serine-type endopeptidase inhibitor activity,MF,SERPINE1;ANXA2;SERPINA3
14409,GO:0060205,0.00619663331310473,0.998674979108834,6,302,cytoplasmic vesicle lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;ANXA2;SERPINA3
3940,GO:0008236,0.00619678693368756,0.99916922977331,4,137,serine-type peptidase activity,MF,LTF;PLAU;C1R;DPP10
3809,GO:0007635,0.00620398721050743,0.999789843028196,2,15,chemosensory behavior,BP,SHANK1;GRIN1
10753,GO:0042551,0.00624835810805482,0.999471584247163,3,46,neuron maturation,BP,KCNIP2;SRRM4;CNTNAP2
6206,GO:0017146,0.00627299489468429,0.999795330376595,2,11,NMDA selective glutamate receptor complex,CC,SHANK1;GRIN1
7648,GO:0031093,0.00629025646274926,0.999460760542411,3,62,platelet alpha granule lumen,CC,TIMP1;SERPINE1;SERPINA3
19141,GO:1901699,0.0066034147717314,0.997737883280534,11,634,cellular response to nitrogen compound,BP,VIM;CAMK2A;ATP1A3;COL1A1;GABRG2;GDF15;GNAL;GABRB3;COL3A1;SOCS3;COL4A1
14242,GO:0055093,0.00660662379070112,0.99976326034145,2,19,response to hyperoxia,BP,COL1A1;PDPN
17542,GO:0097320,0.0066362517224789,0.999762806166932,2,18,plasma membrane tubulation,BP,SH3GL2;PACSIN1
18144,GO:0099520,0.00667630359603458,1,1,1,ion antiporter activity involved in regulation of presynaptic membrane potential,MF,ATP1A3
6695,GO:0019935,0.00672805985300523,0.998790136121848,5,176,cyclic-nucleotide-mediated signaling,BP,RAPGEF4;CHGA;GNAL;ADM;RIMS2
8492,GO:0032591,0.00673179100847882,0.999762134170178,2,15,dendritic spine membrane,CC,DDN;SHISA7
6222,GO:0017171,0.00673948700013042,0.999074307910702,4,140,serine hydrolase activity,MF,LTF;PLAU;C1R;DPP10
8105,GO:0031983,0.00674685244007054,0.998531413667955,6,304,vesicle lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;ANXA2;SERPINA3
5042,GO:0010951,0.00675407485877395,0.998782755372984,5,193,negative regulation of endopeptidase activity,BP,LTF;TIMP1;SERPINE1;ANXA2;SERPINA3
13999,GO:0051937,0.0067600691782423,0.99940408199526,3,66,catecholamine transport,BP,SYT1;CHGA;KCNB1
21319,GO:1990665,0.00676619504512037,0.999988630962375,1,2,AnxA2-p11 complex,CC,ANXA2
5651,GO:0016050,0.00683227183788081,0.998292197860562,7,313,vesicle organization,BP,SNAP91;SYT1;SLC17A7;SNAP25;ANXA1;CPLX2;ANXA2
454,GO:0001525,0.00693823058558884,0.99789435531413,9,460,angiogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;TGFBI;CHI3L1;ANXA1;ADM;ANXA2;COL4A1
15113,GO:0061448,0.00699195814079199,0.998470812844075,6,236,connective tissue development,BP,TIMP1;COL1A1;LOX;TGFBI;COL5A1;CHI3L1
14912,GO:0060999,0.00704538702586652,0.999380356793806,3,42,positive regulation of dendritic spine development,BP,CUX2;SHANK1;SHANK2
19112,GO:1901652,0.00707454448343916,0.997845885476684,9,474,response to peptide,BP,VIM;CAMK2A;TIMP1;ATP1A3;COL1A1;GDF15;ANXA1;ADM;SOCS3
10076,GO:0036035,0.00711956556856178,0.999739181241288,2,16,osteoclast development,BP,LTF;ANXA2
18524,GO:0140056,0.00714173291888383,0.998698031687329,5,169,organelle localization by membrane tethering,BP,SYT1;SNAP25;CPLX2;RAB3C;KCNB1
10000,GO:0035906,0.00738102867238504,1,1,1,descending aorta development,BP,LOX
19131,GO:1901676,0.00740387491045366,1,1,1,positive regulation of histone H3-K27 acetylation,BP,LIF
18546,GO:0140115,0.0074043180383044,0.999328603417789,3,57,export across plasma membrane,BP,ATP1A3;SLC8A2;KCNIP2
12299,GO:0046337,0.00741979913709084,0.999714323985749,2,22,phosphatidylethanolamine metabolic process,BP,ETNPPL;PLA2G2A
13385,GO:0050840,0.00746571804754197,0.999322782505714,3,53,extracellular matrix binding,MF,TGFBI;ANXA2;SMOC1
18898,GO:1901071,0.00754818168177717,0.999706788634282,2,22,glucosamine-containing compound metabolic process,BP,CHI3L2;CHI3L1
20176,GO:1904018,0.00764663899678192,0.998582383405465,5,173,positive regulation of vasculature development,BP,SRPX2;SERPINE1;CHI3L1;ANXA1;ADM
19605,GO:1902936,0.00766772491438625,0.998913189244441,4,105,phosphatidylinositol bisphosphate binding,MF,SNAP91;SYT1;PLEKHA4;ANXA2
11765,GO:0045109,0.00770528760913288,0.999702464210149,2,18,intermediate filament organization,BP,VIM;NEFM
20598,GO:1904862,0.00775813910911536,0.999702854550855,2,16,inhibitory synapse assembly,BP,GABRG2;GABRB3
17029,GO:0090050,0.00781142886252035,0.999694739911749,2,19,positive regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
12148,GO:0045956,0.00783666372686706,0.999694727828388,2,18,positive regulation of calcium ion-dependent exocytosis,BP,SYT1;KCNB1
13571,GO:0051128,0.00787826021164184,0.996039170485709,26,2212,regulation of cellular component organization,BP,TNFRSF12A;VIM;SNAP91;SYT1;SRPX2;SLC17A7;SERPINE1;SH3GL2;CUX2;PACSIN1;LIF;GDF15;COL5A1;SNAP25;ANXA1;CPLX2;SHANK1;SHANK2;PDPN;CSMD3;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SHISA7
2883,GO:0006026,0.00792501026245577,0.999262593176243,3,59,aminoglycan catabolic process,BP,CHI3L2;FMOD;CHI3L1
14334,GO:0060080,0.00798246124567451,0.999689709420025,2,16,inhibitory postsynaptic potential,BP,GABRB3;RIMS2
16215,GO:0071495,0.00802838725549829,0.996504321540949,17,1237,cellular response to endogenous stimulus,BP,VIM;CAMK2A;ATP1A3;SH3GL2;COL1A1;LOX;GABRG2;IGFBP2;FMOD;GDF15;POSTN;ANXA1;GNAL;GABRB3;COL3A1;SOCS3;COL4A1
72,GO:0000149,0.00804426423879397,0.998843106479973,4,109,SNARE binding,MF,SNAP91;SYT1;SNAP25;CPLX2
19670,GO:1903036,0.00809491267166047,0.999240131416468,3,61,positive regulation of response to wounding,BP,SERPINE1;ANXA1;PDPN
14020,GO:0051963,0.00812355993151909,0.998832034105883,4,95,regulation of synapse assembly,BP,SRPX2;CUX2;GRIN1;SLITRK1
6370,GO:0018964,0.00814517373905308,1,1,1,propylene metabolic process,BP,GRIN1
12576,GO:0046928,0.00815529202171282,0.998824736682262,4,100,regulation of neurotransmitter secretion,BP,SYT1;CAMK2A;CPLX2;RIMS2
8522,GO:0032637,0.00818245190068023,0.999225135039472,3,72,interleukin-8 production,BP,SERPINE1;CHI3L1;ANXA1
9252,GO:0034330,0.00821370018848103,0.996958030873521,12,650,cell junction organization,BP,SRPX2;CUX2;GABRG2;SLC8A2;INA;SHANK1;SHANK2;GABRB3;GRIN1;SLITRK1;COL4A1;SHISA7
13369,GO:0050811,0.00826654229736601,0.999670743816393,2,17,GABA receptor binding,MF,GABRG1;SHISA7
17815,GO:0098661,0.00828145183498303,0.998799723018788,4,106,inorganic anion transmembrane transport,BP,SLC17A7;GABRG2;GABRG1;GABRB3
20623,GO:1904893,0.0083226893661443,0.999662429360545,2,20,negative regulation of receptor signaling pathway via STAT,BP,SOCS3;PTPRT
13362,GO:0050803,0.00835442601696721,0.998104723991723,6,220,regulation of synapse structure or activity,BP,SRPX2;SLC17A7;CUX2;GRIN1;SLITRK1;SHISA7
10271,GO:0036477,0.00838507644221253,0.996752087440649,13,810,somatodendritic compartment,CC,CAMK2A;ATP1A3;SH3GL2;SLC8A2;SNAP25;CPLX2;KCNB1;SHANK1;SHANK2;RBFOX3;CNTNAP2;GRIN1;DDN
4718,GO:0010466,0.00839683700769367,0.99840452502244,5,200,negative regulation of peptidase activity,BP,LTF;TIMP1;SERPINE1;ANXA2;SERPINA3
18337,GO:0106027,0.00841994105577047,0.998779607463189,4,87,neuron projection organization,BP,ATP1A3;CUX2;SHANK1;SHANK2
18905,GO:1901079,0.00842897823684326,0.999982341600989,1,2,positive regulation of relaxation of muscle,BP,CHGA
19203,GO:1901899,0.00842897823684326,0.999982341600989,1,2,positive regulation of relaxation of cardiac muscle,BP,CHGA
15298,GO:0061851,0.00844335259329106,0.999982281192695,1,2,leading edge of lamellipodium,CC,PDPN
14753,GO:0060706,0.00849370826353367,0.999648122672803,2,23,cell differentiation involved in embryonic placenta development,BP,LIF;SOCS3
7012,GO:0022406,0.00855555943553405,0.998369563868139,5,178,membrane docking,BP,SYT1;SNAP25;CPLX2;RAB3C;KCNB1
17816,GO:0098662,0.00855729048330446,0.996959763243825,11,673,inorganic cation transmembrane transport,BP,SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;JPH3;KCNB1;DPP10;GRIN1;ANXA2;SLC6A17
13005,GO:0048589,0.00861650362740526,0.996937831391584,11,603,developmental growth,BP,TNFRSF12A;SYT1;SH3GL2;GDF15;POSTN;ANXA1;ADM;SHANK1;SHANK2;RIMS2;SLITRK1
16254,GO:0071560,0.00863194498698491,0.998027166629695,6,229,cellular response to transforming growth factor beta stimulus,BP,COL1A1;LOX;FMOD;GDF15;POSTN;COL3A1
12831,GO:0048172,0.00870688759594377,0.999645935282516,2,16,regulation of short-term neuronal synaptic plasticity,BP,SLC8A2;SHISA7
14945,GO:0061045,0.00878836427642456,0.999148325939737,3,65,negative regulation of wound healing,BP,SERPINE1;PLAU;ANXA2
8314,GO:0032355,0.00879385397079367,0.99869845768556,4,128,response to estradiol,BP,COL1A1;IGFBP2;POSTN;ANXA1
18615,GO:0150034,0.00880799318177045,0.997691809222449,7,293,distal axon,CC,RASGRF1;SLC8A2;PACSIN1;SNAP25;CPLX2;SHANK2;GRIN1
10350,GO:0038065,0.00885508844028816,0.99964226011065,2,14,collagen-activated signaling pathway,BP,COL1A1;COL4A1
4930,GO:0010817,0.00893114794218765,0.997396325021122,8,448,regulation of hormone levels,BP,RAPGEF4;CHGA;LIF;SNAP25;ANXA1;ADM;KCNB1;RIMS2
20958,GO:1905581,0.00895711777823652,0.999980054054594,1,2,positive regulation of low-density lipoprotein particle clearance,BP,ANXA2
20969,GO:1905602,0.00895711777823652,0.999980054054594,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
21504,GO:2000098,0.0090843359606021,0.99997948211823,1,2,negative regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
14723,GO:0060669,0.00913675598471806,0.999608117020647,2,22,embryonic placenta morphogenesis,BP,ADM;SOCS3
16453,GO:0071911,0.00921465927808259,1,1,1,synchronous neurotransmitter secretion,BP,SYT1
17857,GO:0098746,0.00921465927808259,1,1,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
19763,GO:1903235,0.00921465927808259,1,1,1,positive regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
17777,GO:0098588,0.00928573273731976,0.99549244516845,22,1941,bounding membrane of organelle,CC,SYT1;CAMK2A;SLC17A7;SH3GL2;CUX2;PLAU;SNAP25;ANXA1;GALNT13;RAB3C;JPH3;SYN2;SHANK2;SVOP;FUT9;ST8SIA3;CD163;ANXA2;CALN1;SV2B;PLA2G2A;SLC6A17
10562,GO:0042137,0.00930308904020099,0.999978479675503,1,2,sequestering of neurotransmitter,BP,SLC17A7
7207,GO:0030194,0.00937257655630202,0.999589054819137,2,25,positive regulation of blood coagulation,BP,SERPINE1;PDPN
18682,GO:1900048,0.00937257655630202,0.999589054819137,2,25,positive regulation of hemostasis,BP,SERPINE1;PDPN
19653,GO:1903010,0.0094016985486367,0.999593735091052,2,20,regulation of bone development,BP,LTF;LOX
397,GO:0001101,0.00976470275823043,0.998511918503805,4,121,response to acid chemical,BP,COL1A1;COL3A1;GRIN1;COL4A1
21371,GO:1990778,0.00978520952317243,0.997381432483915,7,320,protein localization to cell periphery,BP,PACSIN1;SNAP25;RAB3C;KCNB1;DPP10;GRIN1;ANXA2
17932,GO:0098874,0.00979753084374034,1,1,1,spike train,BP,SLC8A2
18203,GO:0099608,0.00979753084374034,1,1,1,regulation of action potential firing pattern,BP,SLC8A2
19917,GO:1903531,0.00986833679827856,0.998488064931437,4,138,negative regulation of secretion by cell,BP,CHGA;LIF;ANXA1;KCNB1
16780,GO:0072535,0.0102490057185242,0.999973868344214,1,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
21621,GO:2000307,0.0102490057185242,0.999973868344214,1,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
18858,GO:1900738,0.0103530207311533,0.999964465861362,1,3,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,CHGA
7942,GO:0031640,0.0103537777432278,0.999511542984433,2,38,killing of cells of other organism,BP,LTF;CHGA
20962,GO:1905595,0.0103672101521035,0.999973260493377,1,2,regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
21321,GO:1990667,0.0103672101521035,0.999973260493377,1,2,PCSK9-AnxA2 complex,CC,ANXA2
18724,GO:1900120,0.0105105659824693,0.999512140728641,2,24,regulation of receptor binding,BP,LOX;ANXA2
1109,GO:0002538,0.0105708463450857,0.999972196842361,1,2,arachidonic acid metabolite production involved in inflammatory response,BP,SERPINE1
1110,GO:0002540,0.0105708463450857,0.999972196842361,1,2,leukotriene production involved in inflammatory response,BP,SERPINE1
2620,GO:0005586,0.0106015223008128,1,1,1,collagen type III trimer,CC,COL3A1
16253,GO:0071559,0.010603125436729,0.997467257576605,6,235,response to transforming growth factor beta,BP,COL1A1;LOX;FMOD;GDF15;POSTN;COL3A1
16083,GO:0071307,0.0106140162539824,0.999971968673962,1,2,cellular response to vitamin K,BP,POSTN
13376,GO:0050820,0.0108590326869384,0.99948470099498,2,26,positive regulation of coagulation,BP,SERPINE1;PDPN
11147,GO:0043299,0.0109525786195131,0.996688465158297,8,506,leukocyte degranulation,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;CPLX2;ANXA2;SERPINA3
2430,GO:0005146,0.0109537633569509,0.999970140263007,1,2,leukemia inhibitory factor receptor binding,MF,LIF
3757,GO:0007528,0.0109693002267849,0.998858477748153,3,49,neuromuscular junction development,BP,SHANK1;SHANK2;COL4A1
13312,GO:0050709,0.0109778418231155,0.998841450680692,3,75,negative regulation of protein secretion,BP,CHGA;ANXA1;KCNB1
6673,GO:0019888,0.0109808354398871,0.998840629480675,3,76,protein phosphatase regulator activity,MF,PPP2R2C;PHACTR3;ELFN2
5548,GO:0015844,0.0110787793094003,0.998825713592378,3,78,monoamine transport,BP,SYT1;CHGA;KCNB1
21672,GO:2000369,0.0111008189213596,0.999481699972269,2,18,regulation of clathrin-dependent endocytosis,BP,SNAP91;SH3GL2
5478,GO:0015721,0.0111507523034114,0.999466220476331,2,24,bile acid and bile salt transport,BP,SLCO1A2;ABCC3
3495,GO:0006959,0.0112930970620392,0.998194044906217,4,179,humoral immune response,BP,LTF;CHGA;C1R;PLA2G2A
14022,GO:0051965,0.0113184124212013,0.998801103435328,3,58,positive regulation of synapse assembly,BP,SRPX2;CUX2;SLITRK1
11767,GO:0045111,0.0113899208555097,0.998186317344396,4,116,intermediate filament cytoskeleton,CC,VIM;NEFM;INA;SHANK2
10184,GO:0036296,0.0113908107750203,0.999445816191412,2,26,response to increased oxygen levels,BP,COL1A1;PDPN
19490,GO:1902618,0.0114192311024963,1,1,1,cellular response to fluoride,BP,COL1A1
8634,GO:0032804,0.0114975800486838,0.999967092685631,1,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
18342,GO:0106040,0.0115367966150349,1,1,1,regulation of GABA-A receptor activity,BP,SHISA7
4506,GO:0009605,0.011558331867649,0.99405208281787,25,2383,response to external stimulus,BP,LTF;VIM;CAMK2A;CHGA;SERPINE1;COL1A1;LOX;IGFBP2;PLAU;GDF15;CHI3L1;POSTN;ANXA1;ADM;KCNB1;C1R;SHANK1;PDPN;COL3A1;CNTNAP2;GRIN1;ANXA2;SOCS3;PLA2G2A;DOK6
20971,GO:1905604,0.0115867665998467,0.999966578664068,1,2,negative regulation of blood-brain barrier permeability,BP,SH3GL2
429,GO:0001300,0.0116237384940099,0.999966364403806,1,2,chronological cell aging,BP,SERPINE1
6059,GO:0016838,0.0116720848543003,0.999954807358796,1,3,carbon-oxygen lyase activity, acting on phosphates,MF,ETNPPL
13822,GO:0051588,0.0116947600561356,0.998124009318203,4,114,regulation of neurotransmitter transport,BP,SYT1;CAMK2A;CPLX2;RIMS2
11081,GO:0043197,0.0117320050184992,0.997586807635744,5,169,dendritic spine,CC,CAMK2A;SLC8A2;SHANK1;SHANK2;GRIN1
11365,GO:0043679,0.0117647636652357,0.99810705264032,4,122,axon terminus,CC,SLC8A2;PACSIN1;CPLX2;GRIN1
9021,GO:0033627,0.0120418503340373,0.998690369129094,3,65,cell adhesion mediated by integrin,BP,SERPINE1;PLAU;LIF
12542,GO:0046873,0.0120435747523764,0.996304062167068,8,391,metal ion transmembrane transporter activity,MF,SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;KCNB1;GRIN1;ANXA2
14555,GO:0060400,0.0121211151411962,0.999963415031082,1,2,negative regulation of growth hormone receptor signaling pathway,BP,GDF15
4925,GO:0010812,0.0121399574831329,0.99868125986913,3,57,negative regulation of cell-substrate adhesion,BP,SERPINE1;COL1A1;POSTN
17738,GO:0097753,0.0121642109977892,0.999963153608232,1,2,membrane bending,BP,SH3GL2
16043,GO:0071230,0.012182692785631,0.998669979241934,3,64,cellular response to amino acid stimulus,BP,COL1A1;COL3A1;COL4A1
14909,GO:0060996,0.012185177000884,0.9980290393025,4,96,dendritic spine development,BP,CAMK2A;CUX2;SHANK1;SHANK2
8292,GO:0032309,0.0121917945909386,0.999379403645634,2,31,icosanoid secretion,BP,ANXA1;PLA2G2A
18751,GO:1900157,0.0122556020115379,0.999962596124367,1,2,regulation of bone mineralization involved in bone maturation,BP,LTF
9051,GO:0033693,0.012278616530177,0.999962455072249,1,2,neurofilament bundle assembly,BP,NEFM
13671,GO:0051291,0.0122788943366696,0.999387753440486,2,21,protein heterooligomerization,BP,SYT1;GRIN1
177,GO:0000381,0.012306517697602,0.998647973066311,3,70,regulation of alternative mRNA splicing, via spliceosome,BP,CELF4;SRRM4;RBFOX3
8334,GO:0032379,0.0123254843180183,0.999949591086292,1,3,positive regulation of intracellular lipid transport,BP,ANXA2
8337,GO:0032382,0.0123254843180183,0.999949591086292,1,3,positive regulation of intracellular sterol transport,BP,ANXA2
8340,GO:0032385,0.0123254843180183,0.999949591086292,1,3,positive regulation of intracellular cholesterol transport,BP,ANXA2
936,GO:0002274,0.0123256832547091,0.995889447612018,9,616,myeloid leukocyte activation,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;CPLX2;ANXA2;PLA2G2A;SERPINA3
937,GO:0002275,0.0123272551852658,0.996193735222401,8,517,myeloid cell activation involved in immune response,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;CPLX2;ANXA2;SERPINA3
12037,GO:0045765,0.0123982688910912,0.996932408424775,6,269,regulation of angiogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;CHI3L1;ANXA1;ADM
18106,GO:0099173,0.012527612234339,0.997382525587218,5,163,postsynapse organization,BP,CUX2;INA;SHANK1;SHANK2;SHISA7
20096,GO:1903861,0.012557785631688,0.999366445196594,2,21,positive regulation of dendrite extension,BP,SYT1;RIMS2
11535,GO:0044309,0.012583359895656,0.997366084313469,5,171,neuron spine,CC,CAMK2A;SLC8A2;SHANK1;SHANK2;GRIN1
21262,GO:1990443,0.0126567030321897,0.999960099596405,1,2,peptidyl-threonine autophosphorylation,BP,CAMK2A
8057,GO:0031877,0.0126956004978409,1,1,1,somatostatin receptor binding,MF,SHANK1
13426,GO:0050894,0.0126956004978409,1,1,1,determination of affect,BP,SHANK1
16388,GO:0071805,0.0127053706724748,0.99732919330359,5,196,potassium ion transmembrane transport,BP,ATP1A3;KCNIP2;SNAP25;KCNB1;DPP10
8094,GO:0031960,0.0127563379673497,0.997891627168424,4,148,response to corticosteroid,BP,COL1A1;IGFBP2;ANXA1;ADM
10985,GO:0043025,0.0127929648918317,0.995713050516967,9,499,neuronal cell body,CC,ATP1A3;SH3GL2;SLC8A2;CPLX2;KCNB1;SHANK2;RBFOX3;CNTNAP2;DDN
4514,GO:0009620,0.0128634686898693,0.999319688295818,2,39,response to fungus,BP,LTF;CHGA
2739,GO:0005788,0.0128901035766404,0.996783128898956,6,274,endoplasmic reticulum lumen,CC,TIMP1;COL1A1;COL5A1;COL6A2;COL3A1;COL4A1
18115,GO:0099184,0.0129273103944642,0.999958369427029,1,2,structural constituent of postsynaptic intermediate filament cytoskeleton,MF,INA
18116,GO:0099185,0.0129273103944642,0.999958369427029,1,2,postsynaptic intermediate filament cytoskeleton organization,BP,INA
11238,GO:0043449,0.0129350596437611,0.999958319336633,1,2,cellular alkene metabolic process,BP,GRIN1
17427,GO:0097107,0.0129881913480806,0.9993416600569,2,18,postsynaptic density assembly,BP,SHANK1;SHANK2
18735,GO:1900138,0.0130119335438594,0.999957820789107,1,2,negative regulation of phospholipase A2 activity,BP,ANXA1
15714,GO:0070554,0.0130603540179508,0.999957505238051,1,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,CPLX2
1263,GO:0002792,0.0131496417545414,0.998514112292749,3,81,negative regulation of peptide secretion,BP,CHGA;ANXA1;KCNB1
7702,GO:0031224,0.013193008817758,0.992492104276892,38,4199,intrinsic component of membrane,CC,TNFRSF12A;SYT1;SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;EMP3;GALNT13;RAB3C;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;SVOP;GABRB3;ELFN2;FUT9;CNTNAP2;DPP10;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;CALN1;SV2B;SHISA7;PTPRT;SLC6A17;OPALIN;FRRS1L
1050,GO:0002444,0.0132279158809697,0.995863871067737,8,523,myeloid leukocyte mediated immunity,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;CPLX2;ANXA2;SERPINA3
3778,GO:0007596,0.0133322514686076,0.996646481567732,6,290,blood coagulation,BP,SERPINE1;COL1A1;PLAU;PDPN;COL3A1;ANXA2
5240,GO:0014910,0.0134737983163697,0.998478030879841,3,58,regulation of smooth muscle cell migration,BP,SERPINE1;PLAU;POSTN
18009,GO:0098973,0.0134778165561916,0.999939693349781,1,3,structural constituent of postsynaptic actin cytoskeleton,MF,INA
10476,GO:0040007,0.0135832135025654,0.994398919011504,13,883,growth,BP,TNFRSF12A;SYT1;SH3GL2;IGFBP2;GDF15;POSTN;ANXA1;ADM;SHANK1;SHANK2;RIMS2;SLITRK1;SOCS3
603,GO:0001775,0.0136288582615874,0.994009032651645,15,1277,cell activation,BP,LTF;CHGA;TIMP1;COL1A1;IGFBP2;PLAU;SNAP25;CHI3L1;ANXA1;CPLX2;PDPN;COL3A1;ANXA2;PLA2G2A;SERPINA3
21167,GO:1990138,0.0136979275666657,0.997073112944077,5,166,neuron projection extension,BP,TNFRSF12A;SYT1;SH3GL2;POSTN;RIMS2
786,GO:0002023,0.0137382295583848,0.999937332995469,1,3,reduction of food intake in response to dietary excess,BP,GDF15
327,GO:0000902,0.0137838491226097,0.993938939570465,15,979,cell morphogenesis,BP,TNFRSF12A;SYT1;SH3GL2;CUX2;PACSIN1;POSTN;ANXA1;SHANK1;SHANK2;PDPN;CNTNAP2;RIMS2;GRIN1;SLITRK1;DOK6
13373,GO:0050817,0.0138562509333905,0.99648509854339,6,292,coagulation,BP,SERPINE1;COL1A1;PLAU;PDPN;COL3A1;ANXA2
10852,GO:0042742,0.0138836146654735,0.997643039473242,4,170,defense response to bacterium,BP,LTF;CHGA;SERPINE1;PLA2G2A
14082,GO:0052405,0.0138880777212432,0.999927976637607,1,4,negative regulation by host of symbiont molecular function,BP,ANXA2
2588,GO:0005518,0.0138971336403717,0.998405742889301,3,66,collagen binding,MF,LOX;TGFBI;COL6A2
5669,GO:0016079,0.0139710964487947,0.997637719218656,4,117,synaptic vesicle exocytosis,BP,SYT1;SNAP25;CPLX2;RIMS2
5635,GO:0016021,0.0140376357194979,0.992005841913903,37,4061,integral component of membrane,CC,TNFRSF12A;SYT1;SLCO1A2;SLC17A7;ATP1A3;ABCC3;GABRG2;SLC8A2;KCNIP2;SNAP25;EMP3;GALNT13;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;SVOP;GABRB3;ELFN2;FUT9;CNTNAP2;DPP10;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;CALN1;SV2B;SHISA7;PTPRT;SLC6A17;OPALIN;FRRS1L
3781,GO:0007599,0.0140801626504028,0.996415458810187,6,295,hemostasis,BP,SERPINE1;COL1A1;PLAU;PDPN;COL3A1;ANXA2
20094,GO:1903859,0.0141167683770891,0.999237685420138,2,23,regulation of dendrite extension,BP,SYT1;RIMS2
14009,GO:0051952,0.0143019255097721,0.998331960342636,3,83,regulation of amine transport,BP,SYT1;CHGA;KCNB1
2480,GO:0005234,0.0144241704995296,0.999948130813611,1,2,extracellularly glutamate-gated ion channel activity,MF,SLC17A7
5281,GO:0015103,0.0146450411113987,0.997485054431302,4,128,inorganic anion transmembrane transporter activity,MF,SLC17A7;GABRG2;GABRG1;GABRB3
16042,GO:0071229,0.0146891355714014,0.998277737471708,3,69,cellular response to acid chemical,BP,COL1A1;COL3A1;COL4A1
9496,GO:0034762,0.0147471367245898,0.994939367565603,9,519,regulation of transmembrane transport,BP,RASGRF1;KCNIP2;JPH3;KCNB1;SHANK1;SHANK2;DPP10;GRIN1;SHISA7
5477,GO:0015718,0.0147507329251116,0.997455879065261,4,147,monocarboxylic acid transport,BP,SLCO1A2;ABCC3;ANXA1;PLA2G2A
7314,GO:0030334,0.0148297696216127,0.994042897322996,12,792,regulation of cell migration,BP,CAMK2A;TIMP1;SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT
13522,GO:0051048,0.0149017236532843,0.997419883520365,4,156,negative regulation of secretion,BP,CHGA;LIF;ANXA1;KCNB1
7025,GO:0022604,0.0149359463524388,0.994867208631441,9,470,regulation of cell morphogenesis,BP,TNFRSF12A;SYT1;CUX2;POSTN;ANXA1;PDPN;RIMS2;GRIN1;SLITRK1
2584,GO:0005509,0.0149471028609502,0.994536836872802,10,563,calcium ion binding,MF,SYT1;HPCAL4;KCNIP2;ANXA1;C1R;GRIN1;ANXA2;CALN1;PLA2G2A;SMOC1
5456,GO:0015672,0.0149967610326306,0.995207811850554,8,467,monovalent inorganic cation transport,BP,SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;KCNB1;DPP10;SLC6A17
3920,GO:0008201,0.0150200331559871,0.997397794016749,4,139,heparin binding,MF,LTF;COL5A1;POSTN;SMOC1
10773,GO:0042581,0.0150468295838326,0.997387770364812,4,154,specific granule,CC,LTF;PLAU;SNAP25;CHI3L1
16082,GO:0071306,0.0151443050839481,0.999942801299985,1,2,cellular response to vitamin E,BP,COL1A1
8639,GO:0032809,0.0152646881972131,0.999130550042826,2,28,neuronal cell body membrane,CC,ATP1A3;KCNB1
5378,GO:0015291,0.0153005112468923,0.996629655945785,5,205,secondary active transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ATP1A3;SLC8A2;SLC6A17
14488,GO:0060322,0.0153020030261321,0.993828362988605,12,743,head development,BP,SYT1;SLC17A7;COL1A1;INA;AFF2;SHANK1;SHANK2;COL3A1;CNTNAP2;GRIN1;COL4A1;SLC6A17
5270,GO:0015079,0.0154073211083271,0.997309061159282,4,144,potassium ion transmembrane transporter activity,MF,ATP1A3;KCNIP2;SNAP25;KCNB1
21554,GO:2000184,0.0154522265433307,0.999940442300811,1,2,positive regulation of progesterone biosynthetic process,BP,ADM
3490,GO:0006954,0.0155653538727489,0.994603655290965,9,642,inflammatory response,BP,TIMP1;SERPINE1;CHI3L1;ANXA1;ADM;CD163;SOCS3;PLA2G2A;SERPINA3
11471,GO:0044111,0.0157282248252539,0.999938287030215,1,2,development involved in symbiotic interaction,BP,ANXA2
5421,GO:0015432,0.0157426514871972,0.999938173310425,1,2,ATPase-coupled bile acid transmembrane transporter activity,MF,ABCC3
8911,GO:0033283,0.0157426514871972,0.999938173310425,1,2,ATPase-coupled organic acid transmembrane transporter activity,MF,ABCC3
8912,GO:0033284,0.0157426514871972,0.999938173310425,1,2,ATPase-coupled carboxylic acid transmembrane transporter activity,MF,ABCC3
8913,GO:0033285,0.0157426514871972,0.999938173310425,1,2,ATPase-coupled monocarboxylic acid transmembrane transporter activity,MF,ABCC3
19669,GO:1903035,0.0157705412911341,0.998094878647365,3,79,negative regulation of response to wounding,BP,SERPINE1;PLAU;ANXA2
17833,GO:0098698,0.0158800001906035,0.999093770708628,2,21,postsynaptic specialization assembly,BP,SHANK1;SHANK2
17950,GO:0098894,0.0159117021291374,0.999936832886078,1,2,extrinsic component of presynaptic endocytic zone membrane,CC,SNAP91
6597,GO:0019732,0.0160072864430844,0.999904232965805,1,4,antifungal humoral response,BP,LTF
15402,GO:0070032,0.0162054541548024,0.999901838845682,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,SNAP25
5239,GO:0014909,0.0162454657278435,0.998026812169797,3,64,smooth muscle cell migration,BP,SERPINE1;PLAU;POSTN
3489,GO:0006953,0.0163435850033294,0.99902314878434,2,36,acute-phase response,BP,CD163;SERPINA3
4015,GO:0008355,0.0164888772448577,0.99993214715332,1,2,olfactory learning,BP,GRIN1
21285,GO:1990523,0.0165293729260299,0.999909167695481,1,3,bone regeneration,BP,POSTN
5516,GO:0015800,0.0165329283347824,0.997974369674962,3,69,acidic amino acid transport,BP,SYT1;SLC17A7;SNAP25
6273,GO:0018149,0.0166212898934171,0.999011943549519,2,27,peptide cross-linking,BP,ANXA1;COL3A1
10909,GO:0042835,0.016632374447936,0.999930955946623,1,2,BRE binding,MF,CELF4
17373,GO:0097013,0.0166700540957803,0.999896109178319,1,4,phagocytic vesicle lumen,CC,LTF
7646,GO:0031091,0.016689294482278,0.997937995033729,3,84,platelet alpha granule,CC,TIMP1;SERPINE1;SERPINA3
18856,GO:1900736,0.0167028714675441,0.99989569827018,1,4,regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,CHGA
8835,GO:0033141,0.0167168357663231,0.999930249924331,1,2,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
20042,GO:1903766,0.0167510519369132,0.999906705618096,1,3,positive regulation of potassium ion export across plasma membrane,BP,KCNIP2
16346,GO:0071695,0.0170310776346805,0.996146480359331,5,204,anatomical structure maturation,BP,LTF;KCNIP2;SRRM4;CNTNAP2;GRIN1
13364,GO:0050805,0.0170804918437037,0.997880038966219,3,71,negative regulation of synaptic transmission,BP,CELF4;KCNB1;SHANK2
5544,GO:0015837,0.0170807384153211,0.997867650945835,3,91,amine transport,BP,SYT1;CHGA;KCNB1
18855,GO:1900673,0.017084599178201,0.99990293855705,1,3,olefin metabolic process,BP,GRIN1
14406,GO:0060200,0.0170900182085199,0.999902876734607,1,3,clathrin-sculpted acetylcholine transport vesicle,CC,SYT1
14407,GO:0060201,0.0170900182085199,0.999902876734607,1,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,SYT1
15403,GO:0070033,0.0170965291439271,0.999902802429044,1,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,CPLX2
5198,GO:0014839,0.0171430882369479,0.999890107313056,1,4,myoblast migration involved in skeletal muscle regeneration,BP,ANXA1
789,GO:0002026,0.0172037475276791,0.9989634112235,2,25,regulation of the force of heart contraction,BP,CHGA;ADM
6684,GO:0019905,0.0172272221879111,0.997852674261382,3,74,syntaxin binding,MF,SYT1;SNAP25;CPLX2
2489,GO:0005249,0.0172616896397927,0.997842043235486,3,81,voltage-gated potassium channel activity,MF,KCNIP2;SNAP25;KCNB1
10122,GO:0036121,0.0173064255734843,0.999925220548471,1,2,double-stranded DNA helicase activity,MF,ANXA1
14904,GO:0060988,0.017323470799975,0.999900194579566,1,3,lipid tube assembly,BP,SH3GL2
16077,GO:0071295,0.017419191767078,0.998934365203773,2,29,cellular response to vitamin,BP,COL1A1;POSTN
176,GO:0000380,0.0174884132139902,0.997803013463069,3,81,alternative mRNA splicing, via spliceosome,BP,CELF4;SRRM4;RBFOX3
10210,GO:0036335,0.0175122587764928,0.999897998650072,1,3,intestinal stem cell homeostasis,BP,PLA2G2A
7917,GO:0031589,0.0175858997443538,0.994722425886272,7,330,cell-substrate adhesion,BP,TNFRSF12A;SERPINE1;COL1A1;PLAU;POSTN;PDPN;COL3A1
1000,GO:0002366,0.0176395368009199,0.993754576770899,9,650,leukocyte activation involved in immune response,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;ANXA1;CPLX2;ANXA2;SERPINA3
7059,GO:0022853,0.0176760509292808,0.995963392546339,5,202,active ion transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ATP1A3;ABCC3;SLC8A2
18989,GO:1901329,0.0177440414091313,0.999895269676877,1,3,regulation of odontoblast differentiation,BP,SERPINE1
8939,GO:0033366,0.0178147994291232,0.999881292855206,1,4,protein localization to secretory granule,BP,CHGA
16361,GO:0071715,0.0179015037245386,0.998878806661981,2,35,icosanoid transport,BP,ANXA1;PLA2G2A
19075,GO:1901571,0.0179015037245386,0.998878806661981,2,35,fatty acid derivative transport,BP,ANXA1;PLA2G2A
14833,GO:0060838,0.017979418044902,0.999892461219045,1,3,lymphatic endothelial cell fate commitment,BP,PDPN
15312,GO:0061891,0.0180896985706436,0.999891132489227,1,3,calcium ion sensor activity,MF,SYT1
8733,GO:0032963,0.01819153482325,0.997674861671684,3,91,collagen metabolic process,BP,VIM;COL1A1;COL5A1
3986,GO:0008306,0.0182603658975251,0.997675399012718,3,72,associative learning,BP,SNAP25;SHANK1;GRIN1
13114,GO:0048791,0.0183182146681649,0.99886531780619,2,23,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT1;RIMS2
14505,GO:0060341,0.0183450631075425,0.992124669565306,13,939,regulation of cellular localization,BP,SYT1;CAMK2A;RAPGEF4;SLC17A7;LIF;CPLX2;JPH3;KCNB1;DPP10;RIMS2;GRIN1;ANXA2;SHISA7
3402,GO:0006813,0.0183835224206254,0.995756247740931,5,218,potassium ion transport,BP,ATP1A3;KCNIP2;SNAP25;KCNB1;DPP10
14910,GO:0060997,0.0185348991589398,0.997640906432478,3,59,dendritic spine morphogenesis,BP,CUX2;SHANK1;SHANK2
20882,GO:1905429,0.0187235752664749,0.999883335575891,1,3,response to glycine,BP,GRIN1
12985,GO:0048545,0.0188033937046755,0.994895193953354,6,316,response to steroid hormone,BP,ATP1A3;COL1A1;LOX;IGFBP2;ANXA1;ADM
1116,GO:0002548,0.0188330640306399,0.998775854569725,2,46,monocyte chemotaxis,BP,SERPINE1;ANXA1
930,GO:0002263,0.0188392369455074,0.993255109619566,9,653,cell activation involved in immune response,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;ANXA1;CPLX2;ANXA2;SERPINA3
11526,GO:0044298,0.0189454090612097,0.998784262219457,2,31,cell body membrane,CC,ATP1A3;KCNB1
11252,GO:0043484,0.0191809256070977,0.996423985420348,4,145,regulation of RNA splicing,BP,CELF4;SRRM4;AFF2;RBFOX3
19153,GO:1901731,0.0192646720205927,0.999876464698287,1,3,positive regulation of platelet aggregation,BP,PDPN
4847,GO:0010701,0.0193139683067627,0.999875828874776,1,3,positive regulation of norepinephrine secretion,BP,KCNB1
9611,GO:0035239,0.0193260876424138,0.991943114796765,12,782,tube morphogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;LOX;TGFBI;CHI3L1;ANXA1;ADM;PDPN;COL3A1;ANXA2;COL4A1
8482,GO:0032571,0.0193386974653105,0.999860024613685,1,4,response to vitamin K,BP,POSTN
21242,GO:1990410,0.0193721079435346,0.999859538536747,1,4,adrenomedullin receptor signaling pathway,BP,ADM
9251,GO:0034329,0.0196581125254508,0.993410193679617,8,392,cell junction assembly,BP,SRPX2;CUX2;GABRG2;SHANK1;SHANK2;GABRB3;GRIN1;SLITRK1
7053,GO:0022843,0.0197148430930264,0.996299989679617,4,131,voltage-gated cation channel activity,MF,KCNIP2;SNAP25;KCNB1;GRIN1
17697,GO:0097647,0.0197221866957873,0.999844739247199,1,5,amylin receptor signaling pathway,BP,ADM
4110,GO:0008509,0.0197386874702595,0.994583625075468,6,312,anion transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ABCC3;GABRG2;GABRG1;GABRB3
4445,GO:0009306,0.0198717277099872,0.993879109604015,7,404,protein secretion,BP,RAPGEF4;CHGA;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
9804,GO:0035592,0.0198717277099872,0.993879109604015,7,404,establishment of protein localization to extracellular region,BP,RAPGEF4;CHGA;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
6788,GO:0021586,0.0198878325574345,0.999868306000683,1,3,pons maturation,BP,GRIN1
4608,GO:0009967,0.0199440273461655,0.990379230667255,17,1479,positive regulation of signal transduction,BP,TNFRSF12A;LTF;RASGRF1;CHGA;PLEKHA4;COL1A1;CUX2;LIF;GDF15;CHI3L1;SHANK1;SHANK2;COL3A1;RIMS2;GRIN1;SOCS3;PLA2G2A
3972,GO:0008289,0.0199982678812093,0.992339414858256,10,685,lipid binding,MF,LTF;SNAP91;SYT1;ATP1A3;PLEKHA4;SH3GL2;PACSIN1;ANXA1;ANXA2;PLA2G2A
2750,GO:0005802,0.0200311203162687,0.995274170618931,5,218,trans-Golgi network,CC,TGFBI;SNAP25;POSTN;FUT9;CALN1
11419,GO:0043974,0.0200682068813407,0.999899307062473,1,2,histone H3-K27 acetylation,BP,LIF
19129,GO:1901674,0.0200682068813407,0.999899307062473,1,2,regulation of histone H3-K27 acetylation,BP,LIF
14023,GO:0051966,0.0200861436879288,0.99735079699981,3,71,regulation of synaptic transmission, glutamatergic,BP,SYT1;SHANK1;SHANK2
11546,GO:0044325,0.0201298163852546,0.996199392269681,4,129,ion channel binding,MF,KCNIP2;KCNB1;DPP10;RIMS2
11540,GO:0044319,0.0201726490401919,0.998671643510514,2,27,wound healing, spreading of cells,BP,COL5A1;PDPN
17287,GO:0090505,0.0201726490401919,0.998671643510514,2,27,epiboly involved in wound healing,BP,COL5A1;PDPN
14011,GO:0051954,0.020185516050707,0.998654634087176,2,34,positive regulation of amine transport,BP,SYT1;KCNB1
2888,GO:0006040,0.0203563995399942,0.998633779432201,2,36,amino sugar metabolic process,BP,CHI3L2;CHI3L1
693,GO:0001892,0.0203786450175055,0.997288769301766,3,81,embryonic placenta development,BP,LIF;ADM;SOCS3
21900,GO:2000707,0.0203865921416016,0.99989606973173,1,2,positive regulation of dense core granule biogenesis,BP,CHGA
18054,GO:0099060,0.0203898239203078,0.997294519637684,3,72,integral component of postsynaptic specialization membrane,CC,GRIN1;SLITRK1;SHISA7
4923,GO:0010810,0.020399641645177,0.995170581187947,5,197,regulation of cell-substrate adhesion,BP,SERPINE1;COL1A1;PLAU;POSTN;PDPN
12469,GO:0046676,0.02040308759931,0.998634248808233,2,33,negative regulation of insulin secretion,BP,CHGA;KCNB1
18996,GO:1901342,0.0204094077261073,0.994359216687465,6,302,regulation of vasculature development,BP,TNFRSF12A;SRPX2;SERPINE1;CHI3L1;ANXA1;ADM
21861,GO:2000645,0.0204559535376064,0.999860638460692,1,3,negative regulation of receptor catabolic process,BP,ANXA2
7322,GO:0030348,0.0206601026031612,0.99985782971728,1,3,syntaxin-3 binding,MF,SYT1
10892,GO:0042802,0.0207912359215325,0.989721543079552,18,1711,identical protein binding,MF,VIM;SYT1;CAMK2A;SRPX2;SH3GL2;COL1A1;TGFBI;PACSIN1;GDF15;ANXA1;SRRM4;SYN2;C1R;SHANK1;GABRB3;ST8SIA3;ANXA2;PTPRT
5070,GO:0010986,0.0210083301275159,0.999834693510682,1,4,positive regulation of lipoprotein particle clearance,BP,ANXA2
3612,GO:0007181,0.0210242067552469,0.999852750038869,1,3,transforming growth factor beta receptor complex assembly,BP,FMOD
14092,GO:0052548,0.0212132108536982,0.994079136033275,6,349,regulation of endopeptidase activity,BP,LTF;TIMP1;SERPINE1;GRIN1;ANXA2;SERPINA3
21532,GO:2000145,0.0212489136603912,0.991017659749236,12,843,regulation of cell motility,BP,CAMK2A;TIMP1;SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT
12575,GO:0046923,0.0213146971445001,0.999818534780116,1,5,ER retention sequence binding,MF,KCNIP2
13356,GO:0050794,0.0216631866947313,0.987422459159216,73,9292,regulation of cellular process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PPP2R2C;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;SLC17A7;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;SPOCD1;ANXA1;SRRM4;GNAL;CPLX2;ADM;RAB3C;JPH3;AFF2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;GABRB3;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;DPP10;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;OPALIN;SMOC1;FRRS1L
2618,GO:0005584,0.0217546664783757,0.999881569784602,1,2,collagen type I trimer,CC,COL1A1
21616,GO:2000300,0.021861539692976,0.997016972001738,3,77,regulation of synaptic vesicle exocytosis,BP,SYT1;CPLX2;RIMS2
8181,GO:0032102,0.0219045566512308,0.993844241975405,6,333,negative regulation of response to external stimulus,BP,LTF;SERPINE1;PLAU;GRIN1;ANXA2;SOCS3
13002,GO:0048584,0.0219559578617195,0.988546296827559,21,2035,positive regulation of response to stimulus,BP,TNFRSF12A;LTF;RASGRF1;CHGA;PLEKHA4;SERPINE1;COL1A1;CUX2;LIF;GDF15;CHI3L1;ANXA1;C1R;SHANK1;SHANK2;PDPN;COL3A1;RIMS2;GRIN1;SOCS3;PLA2G2A
3616,GO:0007186,0.0219969804266031,0.991439489013039,10,774,G protein-coupled receptor signaling pathway,BP,CAMK2A;RAPGEF4;CHGA;GABRG2;ANXA1;GNAL;ADM;GABRG1;GABRB3;SHISA7
7178,GO:0030155,0.0220165698716988,0.991437183417509,10,660,regulation of cell adhesion,BP,SERPINE1;COL1A1;IGFBP2;TGFBI;PLAU;LIF;POSTN;ANXA1;PDPN;FUT9
17990,GO:0098948,0.0220368819038162,0.996985896956908,3,75,intrinsic component of postsynaptic specialization membrane,CC,GRIN1;SLITRK1;SHISA7
21524,GO:2000124,0.0221027004097887,0.999837175325045,1,3,regulation of endocannabinoid signaling pathway,BP,CAMK2A
6440,GO:0019208,0.0221068363284027,0.996960226463843,3,90,phosphatase regulator activity,MF,PPP2R2C;PHACTR3;ELFN2
2267,GO:0004864,0.0222239129916854,0.998433903283702,2,38,protein phosphatase inhibitor activity,MF,PHACTR3;ELFN2
16344,GO:0071692,0.022348336797534,0.992950407069035,7,411,protein localization to extracellular region,BP,RAPGEF4;CHGA;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
14506,GO:0060342,0.0224596448870844,0.999810947673061,1,4,photoreceptor inner segment membrane,CC,ATP1A3
7610,GO:0031045,0.0224746544164334,0.998432682957345,2,27,dense core granule,CC,SYT1;CHGA
20622,GO:1904892,0.0225843839251004,0.996866649599467,3,94,regulation of receptor signaling pathway via STAT,BP,LIF;SOCS3;PTPRT
11956,GO:0045629,0.0226282293147232,0.999808085091492,1,4,negative regulation of T-helper 2 cell differentiation,BP,ANXA1
20597,GO:1904861,0.0226764981405044,0.99841458093652,2,26,excitatory synapse assembly,BP,SHANK1;SHANK2
10553,GO:0042119,0.02271169766386,0.992805704636609,7,474,neutrophil activation,BP,LTF;PLAU;SNAP25;CHI3L1;ANXA2;PLA2G2A;SERPINA3
19936,GO:1903561,0.0227182590263882,0.988456662391215,19,1845,extracellular vesicle,CC,LTF;VIM;TIMP1;ATP1A3;SERPINE1;CUX2;IGFBP2;TGFBI;PLAU;GDF15;CHI3L1;ANXA1;GNAL;COL6A2;C1R;RIMS2;ANXA2;PLA2G2A;SERPINA3
1868,GO:0004252,0.0228350305677461,0.996805187253198,3,120,serine-type endopeptidase activity,MF,LTF;PLAU;C1R
11102,GO:0043230,0.0228488450148548,0.9883828653496,19,1847,extracellular organelle,CC,LTF;VIM;TIMP1;ATP1A3;SERPINE1;CUX2;IGFBP2;TGFBI;PLAU;GDF15;CHI3L1;ANXA1;GNAL;COL6A2;C1R;RIMS2;ANXA2;PLA2G2A;SERPINA3
7711,GO:0031234,0.0229301529277002,0.996800339214676,3,94,extrinsic component of cytoplasmic side of plasma membrane,CC,PLEKHA4;SNAP25;GNAL
15408,GO:0070050,0.0229403511515297,0.998368194952791,2,32,neuron cellular homeostasis,BP,SLC17A7;SLC8A2
18213,GO:0099629,0.0230418768791918,0.999867052395932,1,2,postsynaptic specialization of symmetric synapse,CC,IQSEC3
21064,GO:1905863,0.0231108608536182,0.999866250411624,1,2,invadopodium organization,BP,PDPN
436,GO:0001501,0.0231281855692342,0.992000138955441,8,469,skeletal system development,BP,LTF;TIMP1;COL1A1;LOX;TGFBI;CHI3L1;COL3A1;ANXA2
11525,GO:0044297,0.0231684537254735,0.991413285408635,9,566,cell body,CC,ATP1A3;SH3GL2;SLC8A2;CPLX2;KCNB1;SHANK2;RBFOX3;CNTNAP2;DDN
8833,GO:0033139,0.0237181019495833,0.999789054644645,1,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
10165,GO:0036230,0.0237364154458199,0.992412923905437,7,479,granulocyte activation,BP,LTF;PLAU;SNAP25;CHI3L1;ANXA2;PLA2G2A;SERPINA3
17286,GO:0090504,0.0237931912965058,0.998286107563917,2,28,epiboly,BP,COL5A1;PDPN
19529,GO:1902732,0.0239095842717575,0.99977141813645,1,5,positive regulation of chondrocyte proliferation,BP,LTF
12945,GO:0048471,0.0239614435005141,0.990551650488951,10,674,perinuclear region of cytoplasm,CC,CHGA;SH3GL2;PACSIN1;SNAP25;CHI3L1;RAB3C;MOBP;ANXA2;CALN1;PLA2G2A
11234,GO:0043434,0.0240423331442664,0.992304622432557,7,396,response to peptide hormone,BP,CAMK2A;TIMP1;COL1A1;GDF15;ANXA1;ADM;SOCS3
19795,GO:1903305,0.024050436242901,0.995195631923487,4,154,regulation of regulated secretory pathway,BP,SYT1;CPLX2;KCNB1;RIMS2
8261,GO:0032269,0.024152493720407,0.989595930153733,12,925,negative regulation of cellular protein metabolic process,BP,LTF;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;LIF;ELFN2;ANXA2;SOCS3;PTPRT;SERPINA3
3491,GO:0006955,0.0243524249060649,0.987968307611116,17,1706,immune response,BP,LTF;VIM;CAMK2A;CHGA;COL1A1;PLAU;LIF;SNAP25;CHI3L1;ANXA1;CPLX2;C1R;COL3A1;ANXA2;SOCS3;PLA2G2A;SERPINA3
1009,GO:0002376,0.0245067704913186,0.986595441134527,24,2560,immune system process,BP,LTF;VIM;CAMK2A;CHGA;SERPINE1;SH3GL2;COL1A1;LOX;IGFBP2;PLAU;LIF;SNAP25;CHI3L1;ANXA1;CPLX2;RAB3C;C1R;PDPN;COL3A1;FUT9;ANXA2;SOCS3;PLA2G2A;SERPINA3
4539,GO:0009725,0.0246266068718514,0.989777368465724,11,809,response to hormone,BP,CAMK2A;TIMP1;ATP1A3;COL1A1;LOX;IGFBP2;GDF15;ANXA1;ADM;ANXA2;SOCS3
8781,GO:0033031,0.0246665606930487,0.999771753730956,1,4,positive regulation of neutrophil apoptotic process,BP,ANXA1
3728,GO:0007420,0.024847279624492,0.989678644617175,11,701,brain development,BP,SYT1;SLC17A7;INA;AFF2;SHANK1;SHANK2;COL3A1;CNTNAP2;GRIN1;COL4A1;SLC6A17
5268,GO:0015077,0.0249804246843501,0.992770675475827,6,320,monovalent inorganic cation transmembrane transporter activity,MF,SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;KCNB1
14462,GO:0060292,0.0252667963679775,0.998110705286176,2,31,long-term synaptic depression,BP,KCNB1;SHANK2
16561,GO:0072108,0.0254133085978357,0.999757647297519,1,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
13425,GO:0050893,0.0254315157215338,0.999757298016634,1,4,sensory processing,BP,SHANK1
15429,GO:0070081,0.0256240136650678,0.999737276949762,1,5,clathrin-sculpted monoamine transport vesicle,CC,SYT1
15430,GO:0070083,0.0256240136650678,0.999737276949762,1,5,clathrin-sculpted monoamine transport vesicle membrane,CC,SYT1
6444,GO:0019212,0.0256750380817878,0.998040540458792,2,41,phosphatase inhibitor activity,MF,PHACTR3;ELFN2
3766,GO:0007565,0.0256860310059863,0.994759230413341,4,168,female pregnancy,BP,TIMP1;IGFBP2;LIF;ADM
5141,GO:0014070,0.0257363273862705,0.989242885825355,11,833,response to organic cyclic compound,BP,ATP1A3;COL1A1;LOX;GABRG2;IGFBP2;POSTN;ANXA1;GNAL;ADM;GABRB3;GRIN1
2463,GO:0005200,0.0258688861475184,0.996228962621709,3,85,structural constituent of cytoskeleton,MF,VIM;NEFM;INA
13892,GO:0051716,0.0259333888232893,0.984025774598561,52,6196,cellular response to stimulus,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;RAPGEF4;CHGA;CELF4;TIMP1;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;FMOD;PLAU;LIF;GDF15;CHI3L1;POSTN;ANXA1;GNAL;INA;ADM;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;GABRB3;COL3A1;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;FRRS1L
3601,GO:0007167,0.0259457403768381,0.988318650406368,13,965,enzyme linked receptor protein signaling pathway,BP,VIM;SH3GL2;COL1A1;LOX;IGFBP2;FMOD;LIF;GDF15;COL3A1;GRIN1;SOCS3;COL4A1;PTPRT
12066,GO:0045823,0.0260294632768429,0.998004665872447,2,38,positive regulation of heart contraction,BP,CHGA;ADM
14575,GO:0060426,0.0261512215471104,0.999726295434504,1,5,lung vasculature development,BP,LIF
7041,GO:0022804,0.0262167032620437,0.992331925248391,6,306,active transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ATP1A3;ABCC3;SLC8A2;SLC6A17
1049,GO:0002443,0.0262947475185968,0.990026217684733,9,721,leukocyte mediated immunity,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;CPLX2;C1R;ANXA2;SERPINA3
18003,GO:0098967,0.0263951256085149,0.999721138121503,1,5,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,SNAP25
5469,GO:0015698,0.0264465121359096,0.994562554710523,4,153,inorganic anion transport,BP,SLC17A7;GABRG2;GABRG1;GABRB3
12965,GO:0048513,0.026497917080642,0.98456472300889,31,3112,animal organ development,BP,LTF;VIM;SYT1;CELF4;TIMP1;SLC17A7;PLEKHA4;SERPINE1;COL1A1;LOX;TGFBI;LIF;COL5A1;CHI3L1;ANXA1;INA;ADM;AFF2;SHANK1;SHANK2;PDPN;GABRB3;NNMT;COL3A1;CNTNAP2;GRIN1;ANXA2;SOCS3;COL4A1;SLC6A17;SMOC1
17185,GO:0090278,0.0266221566183286,0.997932449673701,2,39,negative regulation of peptide hormone secretion,BP,CHGA;KCNB1
14025,GO:0051968,0.0267282264789176,0.997940482104842,2,31,positive regulation of synaptic transmission, glutamatergic,BP,SHANK1;SHANK2
13366,GO:0050807,0.0268163705539779,0.993184301789628,5,209,regulation of synapse organization,BP,SRPX2;CUX2;GRIN1;SLITRK1;SHISA7
14944,GO:0061044,0.0270294192273719,0.999725653221543,1,4,negative regulation of vascular wound healing,BP,SERPINE1
14988,GO:0061110,0.0271191830894803,0.999754315081282,1,3,dense core granule biogenesis,BP,CHGA
21898,GO:2000705,0.0271191830894803,0.999754315081282,1,3,regulation of dense core granule biogenesis,BP,CHGA
19995,GO:1903672,0.0273869654234732,0.997845081799096,2,37,positive regulation of sprouting angiogenesis,BP,SRPX2;ANXA1
16441,GO:0071895,0.0274340313646888,0.999698625331048,1,5,odontoblast differentiation,BP,SERPINE1
19095,GO:1901618,0.0277776256370975,0.997789010851386,2,41,organic hydroxy compound transmembrane transporter activity,MF,SLCO1A2;ABCC3
4613,GO:0009986,0.0279423653090286,0.988697960079483,10,730,cell surface,CC,TNFRSF12A;LTF;SRPX2;PLAU;ANXA1;CNTNAP2;GRIN1;CD163;ANXA2;PTPRT
7652,GO:0031099,0.0280723748899006,0.994112229180995,4,174,regeneration,BP,POSTN;ANXA1;ADM;NNMT
13352,GO:0050789,0.028091447340077,0.983538740435229,75,9758,regulation of biological process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PPP2R2C;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;SPOCD1;ANXA1;SRRM4;GNAL;CPLX2;ADM;RAB3C;JPH3;AFF2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;GABRB3;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;DPP10;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;OPALIN;SMOC1;FRRS1L
17028,GO:0090049,0.0281979504043055,0.997748879671208,2,36,regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
2490,GO:0005250,0.0283985671733945,0.999696977717787,1,4,A-type (transient outward) potassium channel activity,MF,KCNIP2
17859,GO:0098751,0.028548008280539,0.997717808224394,2,32,bone cell development,BP,LTF;ANXA2
10481,GO:0040012,0.0286445442669345,0.987351778516394,12,880,regulation of locomotion,BP,CAMK2A;TIMP1;SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT
4894,GO:0010757,0.0286713410658127,0.999670659632947,1,5,negative regulation of plasminogen activation,BP,SERPINE1
11571,GO:0044362,0.0287099112038911,0.999656120266634,1,6,negative regulation of molecular function in other organism,BP,ANXA2
14064,GO:0052204,0.0287099112038911,0.999656120266634,1,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,ANXA2
11106,GO:0043235,0.0287345871354585,0.990464088942916,7,372,receptor complex,CC,GABRG2;SHANK1;SHANK2;GABRG1;GABRB3;GRIN1;SHISA7
21583,GO:2000242,0.0287371880571296,0.997659875191138,2,47,negative regulation of reproductive process,BP,TIMP1;LIF
3849,GO:0008083,0.0287920133995409,0.995596762083799,3,127,growth factor activity,MF,TIMP1;LIF;GDF15
11954,GO:0045627,0.0288792785550597,0.999652027401412,1,6,positive regulation of T-helper 1 cell differentiation,BP,ANXA1
21879,GO:2000671,0.0288854607421633,0.999665692673106,1,5,regulation of motor neuron apoptotic process,BP,KCNB1
14091,GO:0052547,0.0289491871156267,0.991325111880867,6,374,regulation of peptidase activity,BP,LTF;TIMP1;SERPINE1;GRIN1;ANXA2;SERPINA3
17696,GO:0097646,0.0291179960300237,0.999646217053398,1,6,calcitonin family receptor signaling pathway,BP,ADM
11151,GO:0043303,0.0291283861660558,0.997617763394875,2,43,mast cell degranulation,BP,CHGA;CPLX2
3814,GO:0008016,0.0291495618299935,0.992420792273744,5,230,regulation of heart contraction,BP,CHGA;ATP1A3;SLC8A2;KCNIP2;ADM
5023,GO:0010923,0.0293234288454873,0.995509267900952,3,91,negative regulation of phosphatase activity,BP,PHACTR3;SPOCD1;ELFN2
1261,GO:0002790,0.0293417477811298,0.990208990612382,7,440,peptide secretion,BP,RAPGEF4;CHGA;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
10736,GO:0042493,0.0293597878302358,0.991175734556289,6,361,response to drug,BP,COL1A1;ABCC3;LOX;IGFBP2;ANXA1;NNMT
14088,GO:0052428,0.0295967115482681,0.999634418492251,1,6,modulation by host of symbiont molecular function,BP,ANXA2
7938,GO:0031632,0.0297904859943349,0.999666345749829,1,4,positive regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,SYT1
18128,GO:0099502,0.0297904859943349,0.999666345749829,1,4,calcium-dependent activation of synaptic vesicle fusion,BP,SYT1
21553,GO:2000182,0.0298696384658205,0.999664558958883,1,4,regulation of progesterone biosynthetic process,BP,ADM
17558,GO:0097350,0.0299554395478287,0.999640308318665,1,5,neutrophil clearance,BP,ANXA1
941,GO:0002279,0.0303328259474263,0.997462765016219,2,44,mast cell activation involved in immune response,BP,CHGA;CPLX2
14565,GO:0060414,0.0303370025958027,0.999692098858339,1,3,aorta smooth muscle tissue morphogenesis,BP,COL3A1
12787,GO:0048024,0.0303803496857375,0.995271242738863,3,105,regulation of mRNA splicing, via spliceosome,BP,CELF4;SRRM4;RBFOX3
5021,GO:0010921,0.0303920341805118,0.993476270960268,4,158,regulation of phosphatase activity,BP,PPP2R2C;PHACTR3;SPOCD1;ELFN2
21201,GO:1990254,0.0304284442882104,0.999628786901611,1,5,keratin filament binding,MF,VIM
13358,GO:0050796,0.0304873806920895,0.993445309030134,4,166,regulation of insulin secretion,BP,RAPGEF4;CHGA;SNAP25;KCNB1
921,GO:0002248,0.0305038444896138,0.999611523712055,1,6,connective tissue replacement involved in inflammatory response wound healing,BP,TIMP1
5479,GO:0015722,0.0307579973661635,0.999644173474474,1,4,canalicular bile acid transport,BP,ABCC3
3619,GO:0007189,0.0307838278928764,0.995182546448261,3,107,adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,CHGA;GNAL;ADM
9648,GO:0035295,0.0307995364841668,0.985795176515651,13,961,tube development,BP,TNFRSF12A;SRPX2;SERPINE1;LOX;TGFBI;LIF;CHI3L1;ANXA1;ADM;PDPN;COL3A1;ANXA2;COL4A1
11463,GO:0044092,0.0308287288377313,0.986232231262472,12,988,negative regulation of molecular function,BP,LTF;CAMK2A;PHACTR3;TIMP1;SERPINE1;SPOCD1;ANXA1;ELFN2;ANXA2;SOCS3;PTPRT;SERPINA3
20967,GO:1905600,0.0309406005641442,0.999639907719856,1,4,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
7805,GO:0031394,0.0310309933021588,0.999597895798111,1,6,positive regulation of prostaglandin biosynthetic process,BP,ANXA1
20714,GO:1905060,0.031085680900265,0.999676602980697,1,3,calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,SLC8A2
13414,GO:0050878,0.0312090426510094,0.989452261898775,7,435,regulation of body fluid levels,BP,SERPINE1;COL1A1;PLAU;ADM;PDPN;COL3A1;ANXA2
19143,GO:1901701,0.0312686639478617,0.985541636120311,13,1080,cellular response to oxygen-containing compound,BP,LTF;VIM;CAMK2A;ATP1A3;SERPINE1;COL1A1;GDF15;ANXA1;GNAL;KCNB1;COL3A1;SOCS3;COL4A1
2165,GO:0004720,0.0312941619150207,0.999607223303188,1,5,protein-lysine 6-oxidase activity,MF,LOX
6251,GO:0018057,0.0312941619150207,0.999607223303188,1,5,peptidyl-lysine oxidation,BP,LOX
1054,GO:0002448,0.031517364418589,0.997306855414269,2,45,mast cell mediated immunity,BP,CHGA;CPLX2
16001,GO:0071109,0.0316331456243328,0.999748317277128,1,2,superior temporal gyrus development,BP,CNTNAP2
19859,GO:1903416,0.031862269925981,0.999592737491359,1,5,response to glycoside,BP,ATP1A3
14756,GO:0060711,0.0320378761324104,0.997242367377918,2,43,labyrinthine layer development,BP,ADM;SOCS3
13381,GO:0050830,0.032108394791598,0.997206162553662,2,60,defense response to Gram-positive bacterium,BP,CHGA;PLA2G2A
19759,GO:1903225,0.032203425746663,0.99965274986999,1,3,negative regulation of endodermal cell differentiation,BP,COL5A1
14911,GO:0060998,0.0322461761426934,0.994903024707166,3,73,regulation of dendritic spine development,BP,CUX2;SHANK1;SHANK2
9713,GO:0035418,0.032314667629893,0.994874020337352,3,82,protein localization to synapse,BP,SNAP25;SHANK1;GRIN1
13872,GO:0051673,0.0324621677384849,0.999537895044909,1,8,membrane disruption in other organism,BP,LTF
10744,GO:0042531,0.0324682414666163,0.997175117912584,2,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,LIF;SOCS3
21893,GO:2000698,0.0326551622444022,0.999572075601178,1,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,LIF
7962,GO:0031670,0.0327454061110409,0.997152914105428,2,41,cellular response to nutrient,BP,COL1A1;POSTN
16400,GO:0071825,0.0327939323672085,0.997139395479538,2,44,protein-lipid complex subunit organization,BP,SH3GL2;PLA2G2A
4743,GO:0010519,0.033187244225275,0.999557919547474,1,5,negative regulation of phospholipase activity,BP,ANXA1
17600,GO:0097435,0.0333151594454957,0.986133408325862,10,656,supramolecular fiber organization,BP,VIM;NEFM;COL1A1;LOX;FMOD;PACSIN1;COL5A1;SHANK1;COL3A1;ANXA2
18058,GO:0099068,0.0333464652596325,0.997106350679156,2,31,postsynapse assembly,BP,SHANK1;SHANK2
3488,GO:0006952,0.0334526275919496,0.983929156310797,14,1367,defense response,BP,LTF;VIM;CAMK2A;CHGA;TIMP1;SERPINE1;CHI3L1;ANXA1;ADM;C1R;CD163;SOCS3;PLA2G2A;SERPINA3
5856,GO:0016477,0.0334732982035833,0.983156232265259,16,1323,cell migration,BP,TNFRSF12A;CAMK2A;CHGA;TIMP1;SRPX2;SERPINE1;COL1A1;LOX;PLAU;COL5A1;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT
3414,GO:0006835,0.0335017979703378,0.99459711060245,3,93,dicarboxylic acid transport,BP,SYT1;SLC17A7;SNAP25
2498,GO:0005267,0.0336543720251543,0.994545951894562,3,111,potassium channel activity,MF,KCNIP2;SNAP25;KCNB1
18082,GO:0099106,0.0336868276314832,0.994538658543908,3,111,ion channel regulator activity,MF,HPCAL4;KCNIP2;DPP10
920,GO:0002246,0.0338862630042733,0.999506363043809,1,7,wound healing involved in inflammatory response,BP,TIMP1
16116,GO:0071354,0.0338996892171676,0.997008735485321,2,37,cellular response to interleukin-6,BP,SOCS3;PTPRT
2604,GO:0005543,0.0340774167182837,0.988273288734625,7,411,phospholipid binding,MF,SNAP91;SYT1;PLEKHA4;PACSIN1;ANXA1;ANXA2;PLA2G2A
11766,GO:0045110,0.0341447089597509,0.999531857757393,1,5,intermediate filament bundle assembly,BP,NEFM
17432,GO:0097112,0.0341927324135237,0.999559615079775,1,4,gamma-aminobutyric acid receptor clustering,BP,SHISA7
15656,GO:0070459,0.0342327402394999,0.99949614805346,1,7,prolactin secretion,BP,ANXA1
3596,GO:0007162,0.0344669663141567,0.990625749625757,5,254,negative regulation of cell adhesion,BP,SERPINE1;COL1A1;TGFBI;POSTN;ANXA1
9999,GO:0035905,0.0345504924979715,0.999520584085047,1,5,ascending aorta development,BP,LOX
7064,GO:0022890,0.0345805166634379,0.987086473816852,8,503,inorganic cation transmembrane transporter activity,MF,SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;KCNB1;GRIN1;ANXA2
21347,GO:1990743,0.0346184765401677,0.999548497151998,1,4,protein sialylation,BP,ST8SIA3
17735,GO:0097749,0.0347479753578141,0.999545087503164,1,4,membrane tubulation,BP,SH3GL2
530,GO:0001661,0.0349117631969725,0.999510432584471,1,5,conditioned taste aversion,BP,GRIN1
3336,GO:0006701,0.0349600727409801,0.999509066935095,1,5,progesterone biosynthetic process,BP,ADM
9556,GO:0035063,0.0351448506312307,0.999585857815636,1,3,nuclear speck organization,BP,AFF2
17404,GO:0097061,0.0351463841256443,0.994245552363713,3,79,dendritic spine organization,BP,CUX2;SHANK1;SHANK2
13004,GO:0048588,0.0351909940509423,0.990390464515247,5,218,developmental cell growth,BP,TNFRSF12A;SYT1;SH3GL2;POSTN;RIMS2
17593,GO:0097418,0.035271048625529,0.999500229845489,1,5,neurofibrillary tangle,CC,NEFM
19224,GO:1901981,0.0355116681052274,0.991998055641386,4,162,phosphatidylinositol phosphate binding,MF,SNAP91;SYT1;PLEKHA4;ANXA2
13122,GO:0048813,0.0355153773399882,0.992013020507833,4,140,dendrite morphogenesis,BP,CUX2;SHANK1;SHANK2;GRIN1
13852,GO:0051641,0.0355731420281621,0.978833265987367,30,3175,cellular localization,BP,LTF;SNAP91;SYT1;CAMK2A;RAPGEF4;CHGA;TIMP1;SLC17A7;SERPINE1;SH3GL2;COL1A1;SLC8A2;KCNIP2;PLAU;PACSIN1;LIF;SNAP25;CHI3L1;CPLX2;RAB3C;JPH3;SYN2;KCNB1;CNTNAP2;DPP10;RIMS2;GRIN1;ANXA2;SHISA7;SERPINA3
19922,GO:1903539,0.0356533556976788,0.996754462392178,2,41,protein localization to postsynaptic membrane,BP,SNAP25;GRIN1
19758,GO:1903224,0.0357958656402891,0.99951701788353,1,4,regulation of endodermal cell differentiation,BP,COL5A1
13639,GO:0051248,0.035919580565427,0.983588180989871,12,971,negative regulation of protein metabolic process,BP,LTF;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;LIF;ELFN2;ANXA2;SOCS3;PTPRT;SERPINA3
18922,GO:1901164,0.0359621819639606,0.999458871190293,1,6,negative regulation of trophoblast cell migration,BP,TIMP1
3767,GO:0007566,0.0360708701036297,0.99668281274986,2,46,embryo implantation,BP,TIMP1;LIF
3617,GO:0007187,0.0361461742444364,0.991787762670816,4,206,G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,CHGA;ANXA1;GNAL;ADM
2836,GO:0005954,0.0361625340370732,0.999474452788425,1,5,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK2A
19915,GO:1903527,0.0361813520438767,0.999506477221241,1,4,positive regulation of membrane tubulation,BP,SH3GL2
11364,GO:0043666,0.0361844036603305,0.993972625146131,3,107,regulation of phosphoprotein phosphatase activity,BP,PPP2R2C;PHACTR3;ELFN2
12089,GO:0045861,0.0362292496469928,0.990006064853443,5,283,negative regulation of proteolysis,BP,LTF;TIMP1;SERPINE1;ANXA2;SERPINA3
13141,GO:0048854,0.036251572524384,0.996699323949846,2,33,brain morphogenesis,BP,SHANK1;SHANK2
14553,GO:0060398,0.0364570990254669,0.9994657909018,1,5,regulation of growth hormone receptor signaling pathway,BP,GDF15
9653,GO:0035305,0.0365112834821179,0.993906230690316,3,98,negative regulation of dephosphorylation,BP,PHACTR3;SPOCD1;ELFN2
11031,GO:0043114,0.0365620867969602,0.996617859757915,2,44,regulation of vascular permeability,BP,SH3GL2;ADM
10849,GO:0042734,0.0365835892555519,0.991685197872014,4,154,presynaptic membrane,CC,SNAP91;SYT1;SNAP25;RIMS2
2414,GO:0005125,0.0366618857768009,0.993827412427937,3,162,cytokine activity,MF,TIMP1;LIF;GDF15
7930,GO:0031623,0.0367929545037982,0.993832401927034,3,106,receptor internalization,BP,SH3GL2;SNAP25;ADM
2517,GO:0005315,0.0370395647730663,0.999448451476751,1,5,inorganic phosphate transmembrane transporter activity,MF,SLC17A7
14309,GO:0060052,0.0372633684706334,0.999418699633389,1,6,neurofilament cytoskeleton organization,BP,INA
21624,GO:2000310,0.0373722376978154,0.996536099853296,2,34,regulation of NMDA receptor activity,BP,RASGRF1;GRIN1
17480,GO:0097187,0.0375750755969362,0.999408859519369,1,6,dentinogenesis,BP,SERPINE1
3821,GO:0008028,0.0376338094749754,0.996445741669769,2,52,monocarboxylic acid transmembrane transporter activity,MF,SLCO1A2;ABCC3
2560,GO:0005436,0.0376547847140837,0.999389555161772,1,7,sodium:phosphate symporter activity,MF,SLC17A7
22101,GO:2001205,0.0376962206815285,0.99946393483136,1,4,negative regulation of osteoclast development,BP,LTF
6215,GO:0017158,0.0377193037970507,0.996460115500036,2,41,regulation of calcium ion-dependent exocytosis,BP,SYT1;KCNB1
13618,GO:0051216,0.0378149420145831,0.991301986901109,4,175,cartilage development,BP,TIMP1;COL1A1;TGFBI;CHI3L1
11768,GO:0045112,0.0378635507937742,0.999423441812752,1,5,integrin biosynthetic process,BP,COL5A1
7350,GO:0030425,0.0378850420210969,0.984683985182125,9,579,dendrite,CC,CAMK2A;SH3GL2;SLC8A2;CPLX2;KCNB1;SHANK1;SHANK2;CNTNAP2;GRIN1
736,GO:0001953,0.037961400734189,0.996447082148395,2,35,negative regulation of cell-matrix adhesion,BP,SERPINE1;POSTN
19575,GO:1902866,0.0380199975974254,0.999377566535934,1,7,regulation of retina development in camera-type eye,BP,CELF4
14834,GO:0060839,0.0381249991491271,0.999374097809307,1,7,endothelial cell fate commitment,BP,PDPN
19489,GO:1902617,0.0381672193397968,0.999414082792442,1,5,response to fluoride,BP,COL1A1
19655,GO:1903012,0.0381795024278448,0.999359365785655,1,8,positive regulation of bone development,BP,LTF
9007,GO:0033603,0.0382507133209563,0.999387242776337,1,6,positive regulation of dopamine secretion,BP,SYT1
15416,GO:0070062,0.0382752286190781,0.979669757107658,18,1827,extracellular exosome,CC,LTF;VIM;TIMP1;SERPINE1;CUX2;IGFBP2;TGFBI;PLAU;GDF15;CHI3L1;ANXA1;GNAL;COL6A2;C1R;RIMS2;ANXA2;PLA2G2A;SERPINA3
17606,GO:0097447,0.0382971917221752,0.984486741362355,9,581,dendritic tree,CC,CAMK2A;SH3GL2;SLC8A2;CPLX2;KCNB1;SHANK1;SHANK2;CNTNAP2;GRIN1
9794,GO:0035580,0.0384841676835413,0.996308989988238,2,59,specific granule lumen,CC,LTF;CHI3L1
7448,GO:0030665,0.0385709360572754,0.993410526271419,3,110,clathrin-coated vesicle membrane,CC,SYT1;SLC17A7;SH3GL2
8880,GO:0033212,0.0386325046799489,0.999357194407132,1,7,iron import into cell,BP,LTF
17426,GO:0097106,0.0388874114737058,0.996327214801935,2,32,postsynaptic density organization,BP,SHANK1;SHANK2
19197,GO:1901890,0.0390950801900266,0.99330551926055,3,93,positive regulation of cell junction assembly,BP,SRPX2;CUX2;SLITRK1
12594,GO:0046959,0.039352080548741,0.999415386906023,1,4,habituation,BP,SHANK1
11637,GO:0044706,0.0394951712798126,0.990780332186773,4,194,multi-multicellular organism process,BP,TIMP1;IGFBP2;LIF;ADM
13986,GO:0051918,0.0396437998758221,0.999322829268016,1,7,negative regulation of fibrinolysis,BP,SERPINE1
9105,GO:0033993,0.0397650969286093,0.982930680724272,10,815,response to lipid,BP,LTF;VIM;ATP1A3;SERPINE1;COL1A1;LOX;IGFBP2;POSTN;ANXA1;ADM
11029,GO:0043112,0.0398476476355627,0.990679093109396,4,181,receptor metabolic process,BP,SH3GL2;SNAP25;ADM;ANXA2
17711,GO:0097696,0.0401496702821924,0.993028687629821,3,114,receptor signaling pathway via STAT,BP,LIF;SOCS3;PTPRT
15033,GO:0061200,0.0401515151142809,0.999290933622658,1,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,SYT1
15034,GO:0061202,0.0401515151142809,0.999290933622658,1,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,SYT1
13035,GO:0048646,0.0402274410228912,0.980717024800166,13,998,anatomical structure formation involved in morphogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;COL1A1;TGFBI;GDF15;COL5A1;CHI3L1;ANXA1;ADM;PDPN;ANXA2;COL4A1
18666,GO:1900024,0.0402536761685236,0.996066171221902,2,48,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;PDPN
10742,GO:0042501,0.0403717805221155,0.9992975287381,1,7,serine phosphorylation of STAT protein,BP,LIF
14607,GO:0060462,0.0404840942335116,0.999312979066567,1,6,lung lobe development,BP,LIF
14608,GO:0060463,0.0404840942335116,0.999312979066567,1,6,lung lobe morphogenesis,BP,LIF
15389,GO:0065009,0.0405776668381705,0.976214744644691,26,2700,regulation of molecular function,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;TIMP1;SERPINE1;LOX;SLC8A2;KCNIP2;PLAU;LIF;GDF15;CHI3L1;SPOCD1;ANXA1;JPH3;SHANK1;SHANK2;ELFN2;GRIN1;ANXA2;SOCS3;SHISA7;PTPRT;SERPINA3
4906,GO:0010769,0.0410089911257695,0.986695648672611,6,295,regulation of cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;POSTN;PDPN;GRIN1;SLITRK1
18069,GO:0099084,0.0411093938400295,0.995987277150528,2,34,postsynaptic specialization organization,BP,SHANK1;SHANK2
17834,GO:0098700,0.0412014725614789,0.999253059162176,1,8,neurotransmitter loading into synaptic vesicle,BP,SLC17A7
7165,GO:0030136,0.0413421337083991,0.990216824405301,4,181,clathrin-coated vesicle,CC,SNAP91;SYT1;SLC17A7;SH3GL2
19762,GO:1903233,0.0413511549734757,0.9993539225147,1,4,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
9915,GO:0035749,0.0416450058481926,0.999272671084808,1,6,myelin sheath adaxonal region,CC,ANXA2
6452,GO:0019221,0.041683008184084,0.983833795294491,8,677,cytokine-mediated signaling pathway,BP,TNFRSF12A;VIM;CAMK2A;TIMP1;LIF;ANXA1;ANXA2;SOCS3
18499,GO:0120252,0.041714564460301,0.99922218522336,1,9,hydrocarbon metabolic process,BP,GRIN1
8633,GO:0032803,0.0420563022181951,0.999258110127829,1,6,regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
11915,GO:0045576,0.0421116119086672,0.995766148433479,2,55,mast cell activation,BP,CHGA;CPLX2
5718,GO:0016191,0.042122598741639,0.999285175033474,1,5,synaptic vesicle uncoating,BP,SH3GL2
17827,GO:0098690,0.0421718055117484,0.999232944452982,1,7,glycinergic synapse,CC,IQSEC3
8596,GO:0032762,0.0422842952032917,0.999228812497651,1,7,mast cell cytokine production,BP,CHGA
2601,GO:0005539,0.042362304868112,0.989892673845781,4,190,glycosaminoglycan binding,MF,LTF;COL5A1;POSTN;SMOC1
20040,GO:1903764,0.0423752389081645,0.999225463715947,1,7,regulation of potassium ion export across plasma membrane,BP,KCNIP2
16462,GO:0071926,0.0424400902341382,0.999244390639351,1,6,endocannabinoid signaling pathway,BP,CAMK2A
14665,GO:0060560,0.0424854153261909,0.987795591726773,5,225,developmental growth involved in morphogenesis,BP,TNFRSF12A;SYT1;SH3GL2;POSTN;RIMS2
13657,GO:0051270,0.0426495496210325,0.979999902107117,12,920,regulation of cellular component movement,BP,CAMK2A;TIMP1;SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT
19201,GO:1901897,0.0426757809898542,0.999235901890976,1,6,regulation of relaxation of cardiac muscle,BP,CHGA
8452,GO:0032515,0.0429477297190538,0.995639934515453,2,53,negative regulation of phosphoprotein phosphatase activity,BP,PHACTR3;ELFN2
3476,GO:0006931,0.0429542780842312,0.999302371465533,1,4,substrate-dependent cell migration, cell attachment to substrate,BP,TNFRSF12A
13623,GO:0051224,0.043126435705837,0.992287860500982,3,126,negative regulation of protein transport,BP,CHGA;ANXA1;KCNB1
7182,GO:0030159,0.0435920337598634,0.995574123367042,2,41,signaling receptor complex adaptor activity,MF,SHANK1;SHANK2
7164,GO:0030135,0.0441621364921038,0.987156494991929,5,277,coated vesicle,CC,SNAP91;SYT1;SLC17A7;SH3GL2;PACSIN1
7305,GO:0030324,0.0441834668167172,0.98933102328661,4,169,lung development,BP,LOX;LIF;CHI3L1;PDPN
11570,GO:0044359,0.0441847575640007,0.99913997446064,1,8,modulation of molecular function in other organism,BP,ANXA2
14065,GO:0052205,0.0441847575640007,0.99913997446064,1,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,ANXA2
9897,GO:0035725,0.0442476213435377,0.989316987843288,4,161,sodium ion transmembrane transport,BP,SLC17A7;ATP1A3;SLC8A2;SLC6A17
17183,GO:0090276,0.0444017387326049,0.989246754115886,4,191,regulation of peptide hormone secretion,BP,RAPGEF4;CHGA;SNAP25;KCNB1
21196,GO:1990239,0.0444374427564109,0.999170924212243,1,6,steroid hormone binding,MF,ATP1A3
10743,GO:0042509,0.044437996416767,0.995395186269348,2,57,regulation of tyrosine phosphorylation of STAT protein,BP,LIF;SOCS3
1547,GO:0003339,0.0444604748612295,0.999129113862087,1,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
3782,GO:0007600,0.0445181885786055,0.983767530691381,7,485,sensory perception,BP,COL1A1;TGFBI;SRRM4;GNAL;SHANK1;GABRB3;GRIN1
10043,GO:0035989,0.0446103507309988,0.999164401151126,1,6,tendon development,BP,COL5A1
15381,GO:0062237,0.044611154211486,0.995398635650607,2,45,protein localization to postsynapse,BP,SNAP25;GRIN1
1347,GO:0002931,0.044672929540668,0.995373904299488,2,50,response to ischemia,BP,CAMK2A;SLC8A2
913,GO:0002227,0.0447403831254575,0.999076609279688,1,12,innate immune response in mucosa,BP,LTF
17890,GO:0098802,0.04512221120512,0.989024122920682,4,179,plasma membrane signaling receptor complex,CC,SHANK1;SHANK2;GRIN1;SHISA7
6787,GO:0021578,0.0452367796197958,0.999140550743125,1,6,hindbrain maturation,BP,GRIN1
11635,GO:0044691,0.0457063650382066,0.999157108581775,1,5,tooth eruption,BP,COL1A1
12873,GO:0048260,0.0457297606468308,0.995212441872581,2,47,positive regulation of receptor-mediated endocytosis,BP,SERPINE1;ANXA2
17909,GO:0098835,0.045796546283919,0.999094115802121,1,7,presynaptic endocytic zone membrane,CC,SNAP91
4770,GO:0010572,0.0458605599185156,0.999091558461879,1,7,positive regulation of platelet activation,BP,PDPN
16698,GO:0072318,0.045929503071309,0.999113778198989,1,6,clathrin coat disassembly,BP,SH3GL2
6687,GO:0019911,0.0460462129485622,0.999038978751469,1,10,structural constituent of myelin sheath,MF,MOBP
16828,GO:0072659,0.0461357392031931,0.986428615075831,5,263,protein localization to plasma membrane,BP,PACSIN1;RAB3C;KCNB1;DPP10;ANXA2
1127,GO:0002576,0.0461407844484745,0.991533497103412,3,119,platelet degranulation,BP,TIMP1;SERPINE1;SERPINA3
17393,GO:0097049,0.0462864884523244,0.999055435201497,1,8,motor neuron apoptotic process,BP,KCNB1
16234,GO:0071532,0.0463496789620869,0.999132981465895,1,5,ankyrin repeat binding,MF,SHANK1
16826,GO:0072657,0.0463624871510503,0.981644875594271,8,613,protein localization to membrane,BP,PACSIN1;SNAP25;RAB3C;KCNB1;DPP10;GRIN1;ANXA2;SHISA7
8332,GO:0032377,0.0463821616886258,0.999070583673009,1,7,regulation of intracellular lipid transport,BP,ANXA2
8335,GO:0032380,0.0463821616886258,0.999070583673009,1,7,regulation of intracellular sterol transport,BP,ANXA2
8338,GO:0032383,0.0463821616886258,0.999070583673009,1,7,regulation of intracellular cholesterol transport,BP,ANXA2
13723,GO:0051384,0.0464294479577668,0.991447238251744,3,132,response to glucocorticoid,BP,IGFBP2;ANXA1;ADM
740,GO:0001957,0.0464476531945021,0.999093479093165,1,6,intramembranous ossification,BP,COL1A1
10096,GO:0036072,0.0464476531945021,0.999093479093165,1,6,direct ossification,BP,COL1A1
8784,GO:0033034,0.0465145257166936,0.999065222227812,1,7,positive regulation of myeloid cell apoptotic process,BP,ANXA1
21786,GO:2000542,0.0465472317509789,0.999089551162613,1,6,negative regulation of gastrulation,BP,COL5A1
7803,GO:0031392,0.0466133274359501,0.999026935014023,1,9,regulation of prostaglandin biosynthetic process,BP,ANXA1
9173,GO:0034145,0.0466810379777414,0.999024080470387,1,9,positive regulation of toll-like receptor 4 signaling pathway,BP,LTF
17912,GO:0098839,0.0466889643152239,0.991433635256071,3,90,postsynaptic density membrane,CC,GRIN1;SLITRK1;SHISA7
20651,GO:1904950,0.0467816827989242,0.991358370454762,3,130,negative regulation of establishment of protein localization,BP,CHGA;ANXA1;KCNB1
13946,GO:0051851,0.0468244715789134,0.995016709005763,2,53,modulation by host of symbiont process,BP,LTF;ANXA2
3522,GO:0007009,0.046833469888224,0.991376849023688,3,102,plasma membrane organization,BP,SH3GL2;PACSIN1;COL5A1
7304,GO:0030323,0.0469861007523272,0.988427226464819,4,173,respiratory tube development,BP,LOX;LIF;CHI3L1;PDPN
5071,GO:0010988,0.0471818266634269,0.998990553378164,1,10,regulation of low-density lipoprotein particle clearance,BP,ANXA2
17055,GO:0090091,0.0473178203242571,0.999058862235777,1,6,positive regulation of extracellular matrix disassembly,BP,PDPN
11566,GO:0044352,0.0475370996105423,0.999050034599298,1,6,pinosome,CC,ANXA2
11567,GO:0044354,0.0475370996105423,0.999050034599298,1,6,macropinosome,CC,ANXA2
12699,GO:0047498,0.047557789773876,0.998986733810541,1,9,calcium-dependent phospholipase A2 activity,MF,PLA2G2A
22149,GO:2001280,0.0475653716690141,0.999002018462248,1,8,positive regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
3997,GO:0008324,0.0479579678543018,0.980895425165249,8,547,cation transmembrane transporter activity,MF,SLC17A7;ATP1A3;SLC8A2;KCNIP2;SNAP25;KCNB1;GRIN1;ANXA2
4892,GO:0010755,0.0479838757717316,0.998955621620499,1,10,regulation of plasminogen activation,BP,SERPINE1
2744,GO:0005794,0.048042551707788,0.974653526519653,16,1454,Golgi apparatus,CC,SYT1;ATP1A3;SH3GL2;COL1A1;CUX2;TGFBI;FMOD;GDF15;SNAP25;POSTN;GALNT13;FUT9;CNTNAP2;ST8SIA3;CALN1;OPALIN
18843,GO:1900454,0.0481350474307019,0.999025749215536,1,6,positive regulation of long-term synaptic depression,BP,KCNB1
594,GO:0001765,0.0481384711951949,0.998948818940396,1,10,membrane raft assembly,BP,ANXA2
3818,GO:0008022,0.0481968018773206,0.988024045564073,4,184,protein C-terminus binding,MF,SYT1;SH3GL2;HPCAL4;SHANK1
11527,GO:0044300,0.0482824490108859,0.998992105083076,1,7,cerebellar mossy fiber,CC,SLC17A7
3663,GO:0007260,0.0482944620683937,0.994758148014422,2,59,tyrosine phosphorylation of STAT protein,BP,LIF;SOCS3
14304,GO:0060047,0.0486282964390804,0.98549062519516,5,260,heart contraction,BP,CHGA;ATP1A3;SLC8A2;KCNIP2;ADM
13433,GO:0050905,0.0487481747756212,0.990885669002246,3,99,neuromuscular process,BP,JPH3;SHANK1;GRIN1
9116,GO:0034040,0.0488246229709547,0.999036920748761,1,5,ATPase-coupled lipid transmembrane transporter activity,MF,ABCC3
19654,GO:1903011,0.0489219187648661,0.998993314387985,1,6,negative regulation of bone development,BP,LTF
19910,GO:1903522,0.0490190496427267,0.985337403677334,5,270,regulation of blood circulation,BP,CHGA;ATP1A3;SLC8A2;KCNIP2;ADM
12074,GO:0045835,0.0492787382879001,0.998911349093574,1,9,negative regulation of meiotic nuclear division,BP,LIF
12593,GO:0046958,0.0494270366269064,0.998972207896679,1,6,nonassociative learning,BP,SHANK1
614,GO:0001786,0.0498584347167625,0.994508083732536,2,53,phosphatidylserine binding,MF,SYT1;ANXA2
4858,GO:0010718,0.049896804656857,0.994524197924293,2,46,positive regulation of epithelial to mesenchymal transition,BP,COL1A1;PDPN
16699,GO:0072319,0.049905840332453,0.998922492554861,1,7,vesicle uncoating,BP,SH3GL2
7957,GO:0031665,0.050628067065031,0.998836168403232,1,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
16118,GO:0071356,0.0507190451773562,0.987152248243055,4,253,cellular response to tumor necrosis factor,BP,TNFRSF12A;COL1A1;CHI3L1;POSTN
5426,GO:0015459,0.0507890472642211,0.994354459869924,2,51,potassium channel regulator activity,MF,KCNIP2;DPP10
11290,GO:0043536,0.0508156402585091,0.994353058035267,2,50,positive regulation of blood vessel endothelial cell migration,BP,SRPX2;ANXA1
19913,GO:1903525,0.0508516060337966,0.998911477740669,1,6,regulation of membrane tubulation,BP,SH3GL2
6808,GO:0021626,0.0508624220005421,0.998880362956611,1,7,central nervous system maturation,BP,GRIN1
20970,GO:1905603,0.0509804063609258,0.998875109601058,1,7,regulation of blood-brain barrier permeability,BP,SH3GL2
2622,GO:0005588,0.0509885234575067,0.99901354901417,1,4,collagen type V trimer,CC,COL5A1
16039,GO:0071225,0.0511102186506635,0.998828092914381,1,9,cellular response to muramyl dipeptide,BP,VIM
16332,GO:0071674,0.0512001084640699,0.994238358992448,2,71,mononuclear cell migration,BP,SERPINE1;ANXA1
14943,GO:0061043,0.0513759170153444,0.998815754823756,1,9,regulation of vascular wound healing,BP,SERPINE1
19797,GO:1903307,0.0514082142652157,0.994241346892998,2,53,positive regulation of regulated secretory pathway,BP,SYT1;KCNB1
6174,GO:0017083,0.0518454186896019,0.998868056939692,1,6,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity,MF,FUT9
569,GO:0001726,0.0519299547926402,0.98679542219967,4,171,ruffle,CC,TNFRSF12A;PACSIN1;PDPN;ANXA2
18726,GO:1900122,0.0523626360750315,0.998769358059932,1,9,positive regulation of receptor binding,BP,ANXA2
7167,GO:0030139,0.0524111972017505,0.984021445989985,5,296,endocytic vesicle,CC,LTF;VIM;CAMK2A;SH3GL2;CD163
13985,GO:0051917,0.0524990042000076,0.998747661955735,1,10,regulation of fibrinolysis,BP,SERPINE1
11952,GO:0045625,0.0526159926418819,0.998742017784876,1,10,regulation of T-helper 1 cell differentiation,BP,ANXA1
9656,GO:0035308,0.0528996279684254,0.993966320385196,2,58,negative regulation of protein dephosphorylation,BP,PHACTR3;ELFN2
9146,GO:0034112,0.0529274395250388,0.998786602923703,1,7,positive regulation of homotypic cell-cell adhesion,BP,PDPN
17792,GO:0098632,0.0530860446500705,0.993953768958821,2,51,cell-cell adhesion mediator activity,MF,ANXA1;ANXA2
13695,GO:0051336,0.0531281150199789,0.973446765877567,13,1136,regulation of hydrolase activity,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;TIMP1;SERPINE1;SPOCD1;ANXA1;ELFN2;GRIN1;ANXA2;SERPINA3
10596,GO:0042246,0.0531693802403533,0.993906716171529,2,63,tissue regeneration,BP,POSTN;ANXA1
3963,GO:0008277,0.0532815270846499,0.989636693328823,3,130,regulation of G protein-coupled receptor signaling pathway,BP,CAMK2A;CHGA;ADM
7709,GO:0031232,0.0533455648247469,0.998741878531097,1,8,extrinsic component of external side of plasma membrane,CC,ANXA1
22108,GO:2001222,0.0537268507461426,0.993899509620982,2,38,regulation of neuron migration,BP,CAMK2A;COL3A1
13995,GO:0051932,0.0538294137916262,0.993845073697596,2,45,synaptic transmission, GABAergic,BP,GABRG2;GABRG1
19407,GO:1902414,0.053943315448272,0.989498147001747,3,100,protein localization to cell junction,BP,SNAP25;SHANK1;GRIN1
17810,GO:0098656,0.0539929844172944,0.983411151688011,5,280,anion transmembrane transport,BP,SLC17A7;GABRG2;PDPN;GABRG1;GABRB3
5585,GO:0015909,0.0540918387753995,0.993744255289486,2,62,long-chain fatty acid transport,BP,ANXA1;PLA2G2A
14279,GO:0060020,0.0541315485960296,0.998704130920485,1,8,Bergmann glial cell differentiation,BP,VIM
14511,GO:0060348,0.0541803981950951,0.986021500722859,4,185,bone development,BP,LTF;COL1A1;LOX;ANXA2
7509,GO:0030858,0.054340803648729,0.993727269369577,2,52,positive regulation of epithelial cell differentiation,BP,SERPINE1;LIF
10724,GO:0042476,0.0543541831196932,0.989359367370886,3,117,odontogenesis,BP,SERPINE1;COL1A1;ADM
4142,GO:0008559,0.0543555973411567,0.998754519118332,1,6,ATPase-coupled xenobiotic transmembrane transporter activity,MF,ABCC3
18370,GO:0106104,0.0544623970894395,0.998798830537585,1,5,regulation of glutamate receptor clustering,BP,SHISA7
20520,GO:1904717,0.0544623970894395,0.998798830537585,1,5,regulation of AMPA glutamate receptor clustering,BP,SHISA7
12554,GO:0046886,0.0545247501631288,0.99868503316207,1,8,positive regulation of hormone biosynthetic process,BP,ADM
14274,GO:0060013,0.0547590465505385,0.998700216841682,1,7,righting reflex,BP,SHANK1
8547,GO:0032677,0.0548473105666765,0.993599349165445,2,66,regulation of interleukin-8 production,BP,SERPINE1;ANXA1
18022,GO:0098993,0.0549048858876187,0.998594441703342,1,13,anchored component of synaptic vesicle membrane,CC,RAB3C
3611,GO:0007179,0.0550375518733756,0.985731641587328,4,181,transforming growth factor beta receptor signaling pathway,BP,LOX;FMOD;GDF15;COL3A1
9651,GO:0035303,0.0552014872083782,0.985666414237529,4,192,regulation of dephosphorylation,BP,PPP2R2C;PHACTR3;SPOCD1;ELFN2
3621,GO:0007191,0.0552955413180461,0.998595388257955,1,11,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNAL
1372,GO:0003015,0.0556670841787219,0.982757168849092,5,270,heart process,BP,CHGA;ATP1A3;SLC8A2;KCNIP2;ADM
5533,GO:0015820,0.055825954032126,0.9986208157688,1,8,leucine transport,BP,SLC6A17
17415,GO:0097084,0.0560786656745189,0.998586449779529,1,9,vascular associated smooth muscle cell development,BP,ADM
9652,GO:0035304,0.056249179523363,0.988821297692032,3,129,regulation of protein dephosphorylation,BP,PPP2R2C;PHACTR3;ELFN2
7315,GO:0030335,0.0563532784753365,0.978370219537848,7,471,positive regulation of cell migration,BP,SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN
6764,GO:0021548,0.0563700944493552,0.998571557763559,1,9,pons development,BP,GRIN1
3603,GO:0007169,0.0564034133208747,0.975440332791869,9,668,transmembrane receptor protein tyrosine kinase signaling pathway,BP,SH3GL2;COL1A1;LOX;IGFBP2;GDF15;GRIN1;SOCS3;COL4A1;PTPRT
2484,GO:0005244,0.0564090820447894,0.985258373413856,4,182,voltage-gated ion channel activity,MF,KCNIP2;SNAP25;KCNB1;GRIN1
7045,GO:0022832,0.0564090820447894,0.985258373413856,4,182,voltage-gated channel activity,MF,KCNIP2;SNAP25;KCNB1;GRIN1
16811,GO:0072583,0.0566594823445006,0.993340365263732,2,44,clathrin-dependent endocytosis,BP,SNAP91;SH3GL2
21502,GO:2000096,0.0569192116101904,0.998543281109015,1,9,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,PLEKHA4
7761,GO:0031313,0.05698525269389,0.998539861253967,1,9,extrinsic component of endosome membrane,CC,ANXA1
10776,GO:0042584,0.0570694459364092,0.998586915405408,1,7,chromaffin granule membrane,CC,SYT1
17489,GO:0097197,0.0570699814979071,0.998517485619741,1,10,tetraspanin-enriched microdomain,CC,PDPN
10480,GO:0040011,0.057079617339639,0.968140067192164,18,1638,locomotion,BP,TNFRSF12A;CAMK2A;CHGA;TIMP1;SRPX2;SERPINE1;COL1A1;LOX;PLAU;COL5A1;POSTN;ANXA1;JPH3;PDPN;COL3A1;FUT9;PTPRT;DOK6
17945,GO:0098888,0.0572357403106687,0.998617406887218,1,6,extrinsic component of presynaptic membrane,CC,SNAP91
5748,GO:0016247,0.0572449256372036,0.988533299422345,3,138,channel regulator activity,MF,HPCAL4;KCNIP2;DPP10
803,GO:0002042,0.0572922337621583,0.993190522909567,2,52,cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
18903,GO:1901077,0.0574304162268575,0.998498491724622,1,10,regulation of relaxation of muscle,BP,CHGA
1117,GO:0002551,0.057478986415791,0.998495922763093,1,10,mast cell chemotaxis,BP,CHGA
21132,GO:1990034,0.0575075158031497,0.998564886314931,1,7,calcium ion export across plasma membrane,BP,SLC8A2
18051,GO:0099055,0.057547835091819,0.988476839768389,3,115,integral component of postsynaptic membrane,CC,GRIN1;SLITRK1;SHISA7
11160,GO:0043312,0.0576244175455408,0.979648027512521,6,461,neutrophil degranulation,BP,LTF;PLAU;SNAP25;CHI3L1;ANXA2;SERPINA3
7959,GO:0031667,0.0580109135214226,0.97948799930824,6,421,response to nutrient levels,BP,COL1A1;IGFBP2;GDF15;POSTN;ADM;KCNB1
9831,GO:0035630,0.0582251138298918,0.998498305656816,1,8,bone mineralization involved in bone maturation,BP,LTF
8779,GO:0033029,0.0582970561526166,0.998524742562041,1,7,regulation of neutrophil apoptotic process,BP,ANXA1
1277,GO:0002829,0.0583386247211905,0.998434714496987,1,11,negative regulation of type 2 immune response,BP,ANXA1
17309,GO:0090594,0.0585689903544247,0.998398368333197,1,13,inflammatory response to wounding,BP,TIMP1
945,GO:0002283,0.0586755778843427,0.979183989868217,6,464,neutrophil activation involved in immune response,BP,LTF;PLAU;SNAP25;CHI3L1;ANXA2;SERPINA3
17071,GO:0090118,0.0586764264061778,0.998546070876498,1,6,receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
13420,GO:0050885,0.0587778580068235,0.992939536424177,2,46,neuromuscular process controlling balance,BP,JPH3;SHANK1
13859,GO:0051649,0.0588000757340367,0.964727328933715,24,2552,establishment of localization in cell,BP,LTF;SNAP91;SYT1;CAMK2A;RAPGEF4;CHGA;TIMP1;SLC17A7;SERPINE1;SH3GL2;SLC8A2;KCNIP2;PLAU;PACSIN1;SNAP25;CHI3L1;CPLX2;JPH3;SYN2;KCNB1;RIMS2;GRIN1;ANXA2;SERPINA3
11955,GO:0045628,0.0588842317536003,0.998404966170813,1,11,regulation of T-helper 2 cell differentiation,BP,ANXA1
13519,GO:0051045,0.0589190445960304,0.998461876459202,1,8,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP1
14597,GO:0060452,0.0589653483677899,0.998400518967825,1,11,positive regulation of cardiac muscle contraction,BP,CHGA
518,GO:0001649,0.0589702331434631,0.984348093204239,4,203,osteoblast differentiation,BP,LTF;COL1A1;LOX;SMOC1
5715,GO:0016185,0.0590182213991931,0.998456633495511,1,8,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,SNAP91
11669,GO:0044793,0.0590182368141582,0.998432578878007,1,9,negative regulation by host of viral process,BP,LTF
19912,GO:1903524,0.0590458315955525,0.992827472000414,2,64,positive regulation of blood circulation,BP,CHGA;ADM
6303,GO:0018242,0.059489283170795,0.998431606218964,1,8,protein O-linked glycosylation via serine,BP,GALNT13
5132,GO:0014061,0.0595046305616149,0.998357471078368,1,12,regulation of norepinephrine secretion,BP,KCNB1
2465,GO:0005212,0.0596052515821582,0.998315113463877,1,16,structural constituent of eye lens,MF,VIM
4503,GO:0009593,0.0599344909392277,0.992633561767253,2,76,detection of chemical stimulus,BP,SYT1;KCNIP2
8872,GO:0033197,0.0600403188885014,0.998340985746596,1,11,response to vitamin E,BP,COL1A1
13636,GO:0051241,0.0600432301688099,0.970270350739701,12,1081,negative regulation of multicellular organismal process,BP,LTF;VIM;CELF4;TIMP1;SERPINE1;PLAU;GDF15;COL5A1;ANXA1;ADM;COL3A1;ANXA2
13311,GO:0050708,0.0604705743942186,0.980815544283924,5,307,regulation of protein secretion,BP,RAPGEF4;CHGA;SNAP25;ANXA1;KCNB1
6592,GO:0019722,0.060503224083371,0.983808165313871,4,201,calcium-mediated signaling,BP,SLC8A2;JPH3;KSR2;GRIN1
874,GO:0002151,0.0605195710509685,0.998513002859101,1,5,G-quadruplex RNA binding,MF,AFF2
12332,GO:0046427,0.0605392421654852,0.992543539379684,2,64,positive regulation of receptor signaling pathway via JAK-STAT,BP,LIF;SOCS3
2553,GO:0005391,0.0606939387504133,0.998304243254821,1,11,sodium:potassium-exchanging ATPase activity,MF,ATP1A3
4141,GO:0008556,0.0606939387504133,0.998304243254821,1,11,potassium transmembrane transporter activity, phosphorylative mechanism,MF,ATP1A3
16108,GO:0071346,0.0609932417983625,0.987448654578105,3,157,cellular response to interferon-gamma,BP,VIM;CAMK2A;SOCS3
12510,GO:0046790,0.0611606913793954,0.998374381586253,1,7,virion binding,MF,ANXA2
609,GO:0001781,0.0613793676881892,0.99832911347999,1,8,neutrophil apoptotic process,BP,ANXA1
7055,GO:0022849,0.0614530156562161,0.998466174369321,1,5,glutamate-gated calcium ion channel activity,MF,GRIN1
18018,GO:0098985,0.061625001945876,0.998394335162149,1,6,asymmetric, glutamatergic, excitatory synapse,CC,SHISA7
11586,GO:0044406,0.0616719074132734,0.998248498494176,1,11,adhesion of symbiont to host,BP,LTF
12586,GO:0046943,0.0617096609561927,0.987261450477068,3,137,carboxylic acid transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ABCC3
6304,GO:0018243,0.0617403567027923,0.998282831192876,1,9,protein O-linked glycosylation via threonine,BP,GALNT13
12572,GO:0046920,0.0618997744078817,0.998300310111394,1,8,alpha-(1->3)-fucosyltransferase activity,MF,FUT9
1640,GO:0003828,0.0620415821413911,0.998372275089868,1,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,ST8SIA3
9971,GO:0035860,0.0621921872088993,0.998284015025865,1,8,glial cell-derived neurotrophic factor receptor signaling pathway,BP,GDF15
794,GO:0002031,0.0623511913928445,0.998171630639477,1,14,G protein-coupled receptor internalization,BP,ADM
7638,GO:0031083,0.0624468660353732,0.998165949140186,1,14,BLOC-1 complex,CC,SNAP25
2802,GO:0005890,0.0625635879716873,0.998182139639167,1,12,sodium:potassium-exchanging ATPase complex,CC,ATP1A3
2529,GO:0005342,0.0625867452471295,0.987005497345649,3,138,organic acid transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ABCC3
17602,GO:0097441,0.0626171495231026,0.998295037784128,1,7,basal dendrite,CC,SH3GL2
1052,GO:0002446,0.0626416349579696,0.977413714466959,6,473,neutrophil mediated immunity,BP,LTF;PLAU;SNAP25;CHI3L1;ANXA2;SERPINA3
3813,GO:0008015,0.0626822750130356,0.975357760515294,7,495,blood circulation,BP,CHGA;ATP1A3;SH3GL2;SLC8A2;KCNIP2;POSTN;ADM
3425,GO:0006855,0.0627362724002309,0.998253483113578,1,8,drug transmembrane transport,BP,ABCC3
20624,GO:1904894,0.0627637812338074,0.992107838301444,2,66,positive regulation of receptor signaling pathway via STAT,BP,LIF;SOCS3
10798,GO:0042625,0.0628707332505048,0.992116950115777,2,56,ATPase-coupled ion transmembrane transporter activity,MF,ATP1A3;ABCC3
22148,GO:2001279,0.0628844255410135,0.998178102208167,1,11,regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
15442,GO:0070097,0.0629447107917446,0.998276926138919,1,7,delta-catenin binding,MF,PTPRT
17716,GO:0097709,0.0630045537154879,0.99821090568997,1,9,connective tissue replacement,BP,TIMP1
10409,GO:0038171,0.0633879172882773,0.998188795677253,1,9,cannabinoid signaling pathway,BP,CAMK2A
14433,GO:0060249,0.0634319553241249,0.977076866654768,6,405,anatomical structure homeostasis,BP,LTF;SLC17A7;SH3GL2;LOX;SLC8A2;SERPINA3
8112,GO:0031995,0.0634772261982896,0.998211459798807,1,8,insulin-like growth factor II binding,MF,IGFBP2
6985,GO:0021987,0.0635845525429001,0.986759111135844,3,108,cerebral cortex development,BP,COL3A1;CNTNAP2;GRIN1
17983,GO:0098936,0.0637675084437873,0.986684606284617,3,120,intrinsic component of postsynaptic membrane,CC,GRIN1;SLITRK1;SHISA7
523,GO:0001654,0.0638406878014136,0.97691181656625,6,354,eye development,BP,VIM;CELF4;SLC17A7;COL5A1;COL4A1;SMOC1
21534,GO:2000147,0.0640029779504941,0.974721973130629,7,490,positive regulation of cell motility,BP,SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN
19135,GO:1901681,0.0641491634605005,0.982484569695138,4,223,sulfur compound binding,MF,LTF;COL5A1;POSTN;SMOC1
7645,GO:0031090,0.0642032236278284,0.960213342926024,27,3179,organelle membrane,CC,SYT1;CAMK2A;SLC17A7;ATP1A3;SH3GL2;CUX2;GABRG2;PLAU;PACSIN1;SNAP25;ANXA1;GALNT13;RAB3C;JPH3;SYN2;SHANK2;SVOP;GABRB3;FUT9;ST8SIA3;CD163;DDN;ANXA2;CALN1;SV2B;PLA2G2A;SLC6A17
18055,GO:0099061,0.0649416060462688,0.991738872216518,2,49,integral component of postsynaptic density membrane,CC,GRIN1;SLITRK1
13296,GO:0050684,0.0650379988133161,0.98627940980542,3,143,regulation of mRNA processing,BP,CELF4;SRRM4;RBFOX3
9400,GO:0034612,0.0650586525208874,0.982125779684647,4,273,response to tumor necrosis factor,BP,TNFRSF12A;COL1A1;CHI3L1;POSTN
18622,GO:0150063,0.0660929505032232,0.975888613384506,6,358,visual system development,BP,VIM;CELF4;SLC17A7;COL5A1;COL4A1;SMOC1
15114,GO:0061450,0.0664385834339299,0.997946946828344,1,12,trophoblast cell migration,BP,TIMP1
18921,GO:1901163,0.0664385834339299,0.997946946828344,1,12,regulation of trophoblast cell migration,BP,TIMP1
17014,GO:0090026,0.0666826974410749,0.99789484374757,1,15,positive regulation of monocyte chemotaxis,BP,SERPINE1
17656,GO:0097531,0.0667042545240961,0.997947030022214,1,11,mast cell migration,BP,CHGA
3793,GO:0007614,0.0668549957283893,0.99793762107739,1,11,short-term memory,BP,CUX2
15050,GO:0061304,0.0670523017187789,0.998094811897547,1,6,retinal blood vessel morphogenesis,BP,COL4A1
14492,GO:0060326,0.0671091964881058,0.981380256436467,4,260,cell chemotaxis,BP,CHGA;SERPINE1;LOX;ANXA1
17703,GO:0097677,0.0673674107148481,0.998022760467033,1,7,STAT family protein binding,MF,PTPRT
9272,GO:0034356,0.0674851232333754,0.997898050869188,1,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NNMT
6480,GO:0019317,0.0675278854595174,0.997972657480844,1,8,fucose catabolic process,BP,FUT9
10655,GO:0042354,0.0675278854595174,0.997972657480844,1,8,L-fucose metabolic process,BP,FUT9
10656,GO:0042355,0.0675278854595174,0.997972657480844,1,8,L-fucose catabolic process,BP,FUT9
17892,GO:0098805,0.067550755888353,0.962659310918957,16,1589,whole membrane,CC,SYT1;CAMK2A;SLC17A7;SH3GL2;PLAU;SNAP25;ANXA1;RAB3C;SYN2;PDPN;SVOP;CD163;ANXA2;SV2B;PLA2G2A;SLC6A17
8380,GO:0032429,0.0676247248247618,0.997935159730484,1,9,regulation of phospholipase A2 activity,BP,ANXA1
14329,GO:0060075,0.0676516821937753,0.997933491318967,1,9,regulation of resting membrane potential,BP,ATP1A3
9048,GO:0033690,0.0678977579713022,0.997871929496401,1,11,positive regulation of osteoblast proliferation,BP,LTF
8767,GO:0033010,0.0679022444223651,0.997949811938981,1,8,paranodal junction,CC,CNTNAP2
5068,GO:0010984,0.0679261317145655,0.997814579192208,1,15,regulation of lipoprotein particle clearance,BP,ANXA2
14654,GO:0060541,0.0679500049627633,0.981116339133902,4,195,respiratory system development,BP,LOX;LIF;CHI3L1;PDPN
17624,GO:0097479,0.067984037448107,0.991100049507689,2,55,synaptic vesicle localization,BP,SNAP91;SYN2
11079,GO:0043195,0.0682311073694206,0.991062769412397,2,52,terminal bouton,CC,CPLX2;GRIN1
19195,GO:1901888,0.0684190968069908,0.980950912749303,4,187,regulation of cell junction assembly,BP,SRPX2;CUX2;GRIN1;SLITRK1
12162,GO:0045989,0.068567045037975,0.997796545424457,1,13,positive regulation of striated muscle contraction,BP,CHGA
16023,GO:0071205,0.0685833041512124,0.998083814245452,1,5,protein localization to juxtaparanode region of axon,BP,CNTNAP2
9008,GO:0033604,0.0687392022536411,0.997818149662201,1,11,negative regulation of catecholamine secretion,BP,CHGA
12133,GO:0045936,0.0687771420566439,0.972384796190198,7,517,negative regulation of phosphate metabolic process,BP,PHACTR3;SH3GL2;LIF;SPOCD1;ELFN2;SOCS3;PTPRT
12860,GO:0048243,0.0689761375365202,0.997769826846608,1,13,norepinephrine secretion,BP,KCNB1
4764,GO:0010563,0.069113347836656,0.972218875563729,7,518,negative regulation of phosphorus metabolic process,BP,PHACTR3;SH3GL2;LIF;SPOCD1;ELFN2;SOCS3;PTPRT
10142,GO:0036149,0.0691435701226897,0.997792059866207,1,11,phosphatidylinositol acyl-chain remodeling,BP,PLA2G2A
6275,GO:0018158,0.0693083634720265,0.99773490159713,1,14,protein oxidation,BP,LOX
4139,GO:0008554,0.0693234046831194,0.997762317116621,1,12,sodium transmembrane transporter activity, phosphorylative mechanism,MF,ATP1A3
13160,GO:0048880,0.0693550082569103,0.974390020246696,6,363,sensory system development,BP,VIM;CELF4;SLC17A7;COL5A1;COL4A1;SMOC1
6295,GO:0018210,0.0693613935063201,0.985021175048616,3,116,peptidyl-threonine modification,BP,CAMK2A;CHI3L1;GALNT13
7296,GO:0030314,0.0694928984007376,0.997894218170129,1,7,junctional membrane complex,CC,JPH3
13146,GO:0048861,0.0696189949924487,0.997886461487209,1,7,leukemia inhibitory factor signaling pathway,BP,LIF
19132,GO:1901678,0.0696511869372611,0.997725376692532,1,13,iron coordination entity transport,BP,LTF
2559,GO:0005432,0.0696909068495557,0.997805275190544,1,9,calcium:sodium antiporter activity,MF,SLC8A2
18090,GO:0099146,0.0697868560795984,0.990742934903504,2,52,intrinsic component of postsynaptic density membrane,CC,GRIN1;SLITRK1
19156,GO:1901741,0.0698663396692204,0.997686258363636,1,15,positive regulation of myoblast fusion,BP,GDF15
15828,GO:0070820,0.0698945876839128,0.984803606279303,3,155,tertiary granule,CC,LTF;PLAU;SNAP25
14831,GO:0060836,0.0703230235402502,0.997842884451497,1,7,lymphatic endothelial cell differentiation,BP,PDPN
13885,GO:0051702,0.0703438292856889,0.990554754215183,2,73,interaction with symbiont,BP,LTF;ANXA2
11997,GO:0045685,0.0704830235116945,0.990538818240721,2,68,regulation of glial cell differentiation,BP,LIF;OPALIN
8370,GO:0032418,0.0705238358910361,0.990530270714488,2,68,lysosome localization,BP,CHGA;CPLX2
13153,GO:0048870,0.0705543405517272,0.960768491165506,16,1462,cell motility,BP,TNFRSF12A;CAMK2A;CHGA;TIMP1;SRPX2;SERPINE1;COL1A1;LOX;PLAU;COL5A1;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT
13873,GO:0051674,0.0705543405517272,0.960768491165506,16,1462,localization of cell,BP,TNFRSF12A;CAMK2A;CHGA;TIMP1;SRPX2;SERPINE1;COL1A1;LOX;PLAU;COL5A1;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT
17453,GO:0097151,0.0705642849499125,0.997827845936042,1,7,positive regulation of inhibitory postsynaptic potential,BP,RIMS2
17904,GO:0098828,0.0705642849499125,0.997827845936042,1,7,modulation of inhibitory postsynaptic potential,BP,RIMS2
7700,GO:0031214,0.0706937507081028,0.984579022255877,3,138,biomineral tissue development,BP,LTF;COL1A1;LOX
18417,GO:0110148,0.0706937507081028,0.984579022255877,3,138,biomineralization,BP,LTF;COL1A1;LOX
11747,GO:0045064,0.0707290768672746,0.997639817710017,1,14,T-helper 2 cell differentiation,BP,ANXA1
12107,GO:0045906,0.0708467435683768,0.997810171187704,1,7,negative regulation of vasoconstriction,BP,ADM
4671,GO:0010248,0.0710879475956412,0.997615481971801,1,14,establishment or maintenance of transmembrane electrochemical gradient,BP,ATP1A3
3434,GO:0006869,0.0711316713625341,0.97637525496452,5,316,lipid transport,BP,SLCO1A2;ABCC3;ANXA1;ANXA2;PLA2G2A
5529,GO:0015816,0.0714913083895044,0.997637435299799,1,11,glycine transport,BP,SLC6A17
5927,GO:0016595,0.071778254673202,0.997641451397941,1,10,glutamate binding,MF,GRIN1
10745,GO:0042532,0.0718026472592417,0.997616526269371,1,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
17791,GO:0098631,0.0718130438087437,0.990285317638364,2,60,cell adhesion mediator activity,MF,ANXA1;ANXA2
17811,GO:0098657,0.0719197832523113,0.979614366501209,4,217,import into cell,BP,LTF;ATP1A3;SLC8A2;SNAP25
14401,GO:0060192,0.0719208488333431,0.997589091123213,1,12,negative regulation of lipase activity,BP,ANXA1
10652,GO:0042340,0.0720917300975138,0.997597027135213,1,11,keratan sulfate catabolic process,BP,FMOD
18575,GO:0140299,0.0721312670116335,0.997617867544907,1,10,small molecule sensor activity,MF,SYT1
10711,GO:0042448,0.0721865736208296,0.997540184638142,1,14,progesterone metabolic process,BP,ADM
735,GO:0001952,0.0723325272105661,0.984113982535469,3,114,regulation of cell-matrix adhesion,BP,SERPINE1;PLAU;POSTN
12557,GO:0046889,0.0724409527171834,0.990114331712353,2,72,positive regulation of lipid biosynthetic process,BP,ANXA1;ADM
2728,GO:0005775,0.0725560385007741,0.983977296262572,3,160,vacuolar lumen,CC,FMOD;ANXA2;SERPINA3
5537,GO:0015824,0.0728021297194698,0.997602008407412,1,9,proline transport,BP,SLC6A17
7653,GO:0031100,0.0729340596412876,0.990014571551625,2,70,animal organ regeneration,BP,ADM;NNMT
10486,GO:0040017,0.0730226787238267,0.970281944081891,7,504,positive regulation of locomotion,BP,SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN
18117,GO:0099186,0.0730621624038996,0.997584600229404,1,9,structural constituent of postsynapse,MF,INA
13659,GO:0051272,0.0730854206289242,0.970250289426946,7,505,positive regulation of cellular component movement,BP,SRPX2;SERPINE1;COL1A1;PLAU;POSTN;ANXA1;PDPN
16639,GO:0072216,0.0733567236436859,0.997490481332189,1,12,positive regulation of metanephros development,BP,LIF
11096,GO:0043220,0.073416216254066,0.997506643546276,1,11,Schmidt-Lanterman incisure,CC,ANXA2
17757,GO:0098542,0.0736535848943351,0.966206491751653,9,882,defense response to other organism,BP,LTF;VIM;CAMK2A;CHGA;SERPINE1;ANXA1;C1R;SOCS3;PLA2G2A
3933,GO:0008217,0.073748272488897,0.983607297546281,3,158,regulation of blood pressure,BP,CHGA;POSTN;ADM
9260,GO:0034341,0.0740628151519118,0.98349274249899,3,174,response to interferon-gamma,BP,VIM;CAMK2A;SOCS3
9792,GO:0035578,0.0741110847358527,0.989726150873601,2,85,azurophil granule lumen,CC,ANXA2;SERPINA3
11461,GO:0044090,0.074143793620623,0.997481109558203,1,10,positive regulation of vacuole organization,BP,ANXA2
18667,GO:1900025,0.0742813504747561,0.997425905728087,1,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN
2496,GO:0005261,0.0742860902640074,0.975041077751154,5,283,cation channel activity,MF,KCNIP2;SNAP25;KCNB1;GRIN1;ANXA2
18297,GO:0102567,0.074317805892378,0.997390682449891,1,14,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,PLA2G2A
18298,GO:0102568,0.074317805892378,0.997390682449891,1,14,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,PLA2G2A
1017,GO:0002385,0.0744089897717717,0.997332531039173,1,19,mucosal immune response,BP,LTF
17955,GO:0098900,0.0744425064650441,0.989777794422839,2,49,regulation of action potential,BP,SLC8A2;KCNB1
16661,GO:0072257,0.0745306569473594,0.99757289419363,1,7,metanephric nephron tubule epithelial cell differentiation,BP,LIF
16691,GO:0072307,0.0745306569473594,0.99757289419363,1,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,LIF
16936,GO:0086008,0.0746064401519186,0.997370086515992,1,14,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNIP2
18216,GO:0099634,0.0746648562905204,0.983383100324843,3,116,postsynaptic specialization membrane,CC,GRIN1;SLITRK1;SHISA7
792,GO:0002029,0.0747800676050882,0.997322666066839,1,17,desensitization of G protein-coupled receptor signaling pathway,BP,ADM
7007,GO:0022401,0.0747800676050882,0.997322666066839,1,17,negative adaptation of signaling pathway,BP,ADM
7085,GO:0023058,0.0747800676050882,0.997322666066839,1,17,adaptation of signaling pathway,BP,ADM
14394,GO:0060179,0.0748057286633012,0.997504889024662,1,8,male mating behavior,BP,GRIN1
3667,GO:0007266,0.0748366018428474,0.983308335797107,3,127,Rho protein signal transduction,BP,RASGRF1;PDPN;COL3A1
8147,GO:0032050,0.0749020935767128,0.997498360160502,1,8,clathrin heavy chain binding,MF,SNAP91
5522,GO:0015807,0.0749702972911343,0.989595097923068,2,64,L-amino acid transport,BP,SLC17A7;SLC6A17
18059,GO:0099072,0.0750409618237985,0.989579770753459,2,64,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,SNAP25;FRRS1L
10404,GO:0038166,0.0751877605504788,0.997383067728848,1,11,angiotensin-activated signaling pathway,BP,CAMK2A
13756,GO:0051447,0.0752269444172395,0.997325527487074,1,14,negative regulation of meiotic cell cycle,BP,LIF
15792,GO:0070700,0.0752351237116418,0.997358410036505,1,12,BMP receptor binding,MF,GDF15
1545,GO:0003337,0.0752872927496773,0.997336640955955,1,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
13081,GO:0048711,0.0755406327538553,0.997336599967162,1,12,positive regulation of astrocyte differentiation,BP,LIF
22107,GO:2001214,0.0755798281238202,0.997333795158504,1,12,positive regulation of vasculogenesis,BP,ADM
17654,GO:0097529,0.0756119765683498,0.982998584042577,3,180,myeloid leukocyte migration,BP,CHGA;SERPINE1;ANXA1
19466,GO:1902563,0.0760091945727301,0.997302970333554,1,12,regulation of neutrophil activation,BP,PLA2G2A
4616,GO:0009991,0.0762880291658409,0.971109619920538,6,452,response to extracellular stimulus,BP,COL1A1;IGFBP2;GDF15;POSTN;ADM;KCNB1
1370,GO:0003013,0.0763666627194902,0.968597397537838,7,516,circulatory system process,BP,CHGA;ATP1A3;SH3GL2;SLC8A2;KCNIP2;POSTN;ADM
19154,GO:1901739,0.0765096976697535,0.997195559821209,1,17,regulation of myoblast fusion,BP,GDF15
1262,GO:0002791,0.0766185588279265,0.974000559979132,5,332,regulation of peptide secretion,BP,RAPGEF4;CHGA;SNAP25;ANXA1;KCNB1
749,GO:0001967,0.0769421332657335,0.997257655993826,1,11,suckling behavior,BP,GRIN1
691,GO:0001890,0.0773603450675992,0.982484676122957,3,142,placenta development,BP,LIF;ADM;SOCS3
22100,GO:2001204,0.0773790267835163,0.997253021594233,1,10,regulation of osteoclast development,BP,LTF
13003,GO:0048585,0.0774624223083295,0.957124142927226,15,1498,negative regulation of response to stimulus,BP,LTF;CELF4;SERPINE1;SH3GL2;IGFBP2;PLAU;LIF;GDF15;ANXA1;ADM;COL3A1;GRIN1;ANXA2;SOCS3;PTPRT
15574,GO:0070307,0.0774865184344542,0.997195517077999,1,12,lens fiber cell development,BP,VIM
15602,GO:0070365,0.0776706020367615,0.997162761970915,1,13,hepatocyte differentiation,BP,ANXA1
22109,GO:2001223,0.0778459610053249,0.997252762980219,1,9,negative regulation of neuron migration,BP,COL3A1
4516,GO:0009628,0.0783519087425203,0.959472384708041,12,1125,response to abiotic stimulus,BP,CAMK2A;COL1A1;IGFBP2;PLAU;CHI3L1;POSTN;ANXA1;ADM;PDPN;COL3A1;CNTNAP2;GRIN1
15470,GO:0070142,0.0784127887250874,0.997150195126861,1,11,synaptic vesicle budding,BP,SNAP91
21860,GO:2000644,0.0784166660506369,0.997177708682807,1,10,regulation of receptor catabolic process,BP,ANXA2
16950,GO:0086023,0.0784692388777086,0.997305284588791,1,7,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,CHGA
1395,GO:0003073,0.0786004612633099,0.988753437519932,2,78,regulation of systemic arterial blood pressure,BP,POSTN;ADM
17879,GO:0098791,0.0789211839467494,0.972994856341653,5,325,Golgi apparatus subcompartment,CC,TGFBI;SNAP25;POSTN;FUT9;CALN1
5582,GO:0015893,0.0791959127563687,0.997120459642256,1,10,drug transport,BP,ABCC3
4832,GO:0010663,0.0792493865716081,0.997064463648698,1,12,positive regulation of striated muscle cell apoptotic process,BP,CAMK2A
4835,GO:0010666,0.0792493865716081,0.997064463648698,1,12,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
4579,GO:0009888,0.0793169202487456,0.953767531525293,18,1738,tissue development,BP,LTF;VIM;TIMP1;PLEKHA4;SERPINE1;COL1A1;LOX;TGFBI;LIF;COL5A1;CHI3L1;POSTN;ANXA1;ADM;PDPN;COL3A1;SOCS3;COL4A1
5403,GO:0015368,0.079442434356948,0.997102224965425,1,10,calcium:cation antiporter activity,MF,SLC8A2
10484,GO:0040015,0.0796219353539812,0.997060247597458,1,11,negative regulation of multicellular organism growth,BP,GDF15
8156,GO:0032060,0.0796422930946446,0.997058720865057,1,11,bleb assembly,BP,EMP3
7449,GO:0030666,0.0797490447321884,0.98170239320876,3,152,endocytic vesicle membrane,CC,CAMK2A;SH3GL2;CD163
20708,GO:1905049,0.0798377900696804,0.997208914858351,1,7,negative regulation of metallopeptidase activity,BP,TIMP1
3772,GO:0007584,0.0803487088307501,0.98150263252872,3,156,response to nutrient,BP,COL1A1;IGFBP2;POSTN
18912,GO:1901136,0.0805830166699537,0.98140918547588,3,171,carbohydrate derivative catabolic process,BP,CHI3L2;FMOD;CHI3L1
11856,GO:0045294,0.080694485061516,0.997008696732731,1,10,alpha-catenin binding,MF,PTPRT
15133,GO:0061515,0.0807210670341869,0.988312600589457,2,66,myeloid cell development,BP,LTF;ANXA2
2621,GO:0005587,0.0807863656324771,0.997218638641469,1,6,collagen type IV trimer,CC,COL4A1
5952,GO:0016641,0.0808935083238074,0.996885275377261,1,15,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOX
5397,GO:0015347,0.0810052233845688,0.996930864698346,1,12,sodium-independent organic anion transmembrane transporter activity,MF,SLCO1A2
5519,GO:0015803,0.0810528449147202,0.996927198537089,1,12,branched-chain amino acid transport,BP,SLC6A17
9289,GO:0034374,0.0810670851662909,0.996905167222221,1,13,low-density lipoprotein particle remodeling,BP,PLA2G2A
7034,GO:0022617,0.0814447156189107,0.988137413769788,2,69,extracellular matrix disassembly,BP,TIMP1;PDPN
10141,GO:0036148,0.0814538727591734,0.996875100519472,1,13,phosphatidylglycerol acyl-chain remodeling,BP,PLA2G2A
9837,GO:0035637,0.0815759644929526,0.975909120936484,4,195,multicellular organismal signaling,BP,ATP1A3;SLC8A2;KCNIP2;CNTNAP2
16796,GO:0072562,0.0817925139213196,0.987998670717883,2,92,blood microparticle,CC,C1R;SERPINA3
3292,GO:0006646,0.0820369463854324,0.996811121912865,1,14,phosphatidylethanolamine biosynthetic process,BP,ETNPPL
13851,GO:0051640,0.082234372110452,0.963370736787071,8,612,organelle localization,BP,SNAP91;SYT1;CHGA;SNAP25;CPLX2;RAB3C;SYN2;KCNB1
10143,GO:0036150,0.0823103380568069,0.996789496842229,1,14,phosphatidylserine acyl-chain remodeling,BP,PLA2G2A
8311,GO:0032352,0.0823183405584858,0.996807359472682,1,13,positive regulation of hormone metabolic process,BP,ADM
15387,GO:0065007,0.0824112328396333,0.947063151486228,76,10303,biological regulation,BP,TNFRSF12A;LTF;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PPP2R2C;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;SPOCD1;ANXA1;SRRM4;GNAL;CPLX2;ADM;RAB3C;JPH3;AFF2;SYN2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;CSMD3;GABRB3;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;DPP10;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;OPALIN;SMOC1;FRRS1L
1275,GO:0002827,0.082430320330712,0.996737455392736,1,17,positive regulation of T-helper 1 type immune response,BP,ANXA1
21691,GO:2000392,0.0825387610724368,0.996837329355012,1,11,regulation of lamellipodium morphogenesis,BP,PDPN
14497,GO:0060333,0.0826482741525945,0.987816365177112,2,85,interferon-gamma-mediated signaling pathway,BP,CAMK2A;SOCS3
8610,GO:0032780,0.0828535228080893,0.996703342083608,1,17,negative regulation of ATPase activity,BP,LTF
21822,GO:2000586,0.0830631909159719,0.99691344221089,1,8,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LOX
12412,GO:0046579,0.0832112541947427,0.987747025133867,2,65,positive regulation of Ras protein signal transduction,BP,RASGRF1;COL3A1
6643,GO:0019835,0.0833064544375307,0.996645303784153,1,19,cytolysis,BP,PLA2G2A
8296,GO:0032328,0.0833082656268031,0.99675097672555,1,12,alanine transport,BP,SLC6A17
5369,GO:0015271,0.0833298756206941,0.996749263747716,1,12,outward rectifier potassium channel activity,MF,KCNIP2
11972,GO:0045651,0.0833406256520158,0.996707324215534,1,14,positive regulation of macrophage differentiation,BP,LIF
12944,GO:0048469,0.0836481790909833,0.980422832737747,3,154,cell maturation,BP,KCNIP2;SRRM4;CNTNAP2
21482,GO:2000052,0.0836970045161929,0.996697773554385,1,13,positive regulation of non-canonical Wnt signaling pathway,BP,PLEKHA4
9023,GO:0033629,0.0839597629220681,0.996757559822117,1,10,negative regulation of cell adhesion mediated by integrin,BP,SERPINE1
11094,GO:0043218,0.0839802525667186,0.996655770189268,1,14,compact myelin,CC,ANXA2
19993,GO:1903670,0.0840395114455535,0.987551408657285,2,66,regulation of sprouting angiogenesis,BP,SRPX2;ANXA1
13758,GO:0051451,0.0845526133811873,0.996628803395007,1,13,myoblast migration,BP,ANXA1
4513,GO:0009617,0.0846059192372213,0.967088172442853,6,498,response to bacterium,BP,LTF;VIM;CHGA;SERPINE1;ADM;PLA2G2A
21245,GO:1990416,0.0847985931468084,0.996691355380644,1,10,cellular response to brain-derived neurotrophic factor stimulus,BP,SH3GL2
17680,GO:0097617,0.0848082265024901,0.996608055729709,1,13,annealing activity,MF,ANXA1
779,GO:0002011,0.0848914460823146,0.987424054118733,2,52,morphogenesis of an epithelial sheet,BP,COL5A1;PDPN
12867,GO:0048251,0.0849344576075096,0.996680567239456,1,10,elastic fiber assembly,BP,LOX
17256,GO:0090394,0.0849597361011387,0.996645913948881,1,11,negative regulation of excitatory postsynaptic potential,BP,CELF4
10543,GO:0042102,0.0852183651629481,0.987206263141346,2,90,positive regulation of T cell proliferation,BP,IGFBP2;ANXA1
17800,GO:0098642,0.085256319896418,0.996810151964484,1,7,network-forming collagen trimer,CC,COL4A1
17803,GO:0098645,0.085256319896418,0.996810151964484,1,7,collagen network,CC,COL4A1
488,GO:0001574,0.0852737042758234,0.996570104832062,1,13,ganglioside biosynthetic process,BP,ST8SIA3
12972,GO:0048522,0.0853124857816401,0.942515972709012,41,4959,positive regulation of cellular process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CHGA;CELF4;TIMP1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;IGFBP2;SLC8A2;KCNIP2;PLAU;PACSIN1;LIF;GDF15;SNAP25;CHI3L1;POSTN;ANXA1;ADM;KCNB1;SHANK1;SHANK2;PDPN;COL3A1;FUT9;DPP10;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;SHISA7;PLA2G2A
16036,GO:0071222,0.0853131667349979,0.979838469919236,3,180,cellular response to lipopolysaccharide,BP,LTF;VIM;SERPINE1
17433,GO:0097113,0.085937645947334,0.996641197603467,1,9,AMPA glutamate receptor clustering,BP,SHISA7
17707,GO:0097688,0.085937645947334,0.996641197603467,1,9,glutamate receptor clustering,BP,SHISA7
13547,GO:0051093,0.0859838889585206,0.957637146597877,10,859,negative regulation of developmental process,BP,LTF;VIM;TIMP1;SERPINE1;GDF15;COL5A1;POSTN;ANXA1;COL3A1;ANXA2
17430,GO:0097110,0.0860965992411165,0.987097348779251,2,60,scaffold protein binding,MF,VIM;SHANK1
16335,GO:0071677,0.0861153501269782,0.996401792476295,1,20,positive regulation of mononuclear cell migration,BP,SERPINE1
5795,GO:0016328,0.08617430271734,0.98706497434133,2,63,lateral plasma membrane,CC,ANXA1;KCNB1
4049,GO:0008417,0.0861941309904709,0.996518090726903,1,12,fucosyltransferase activity,MF,FUT9
17740,GO:0097756,0.0864864023609659,0.986949340885654,2,74,negative regulation of blood vessel diameter,BP,CHGA;ADM
21207,GO:1990264,0.0869008596873093,0.996616421896724,1,8,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,PTPRT
5926,GO:0016594,0.0869091428571659,0.996414414306003,1,14,glycine binding,MF,GRIN1
10145,GO:0036152,0.087246030086037,0.99633844707089,1,17,phosphatidylethanolamine acyl-chain remodeling,BP,PLA2G2A
19120,GO:1901660,0.0875240862466865,0.996471467701449,1,10,calcium ion export,BP,SLC8A2
6883,GO:0021794,0.0875608321418305,0.996404890936266,1,12,thalamus development,BP,CNTNAP2
2458,GO:0005178,0.0875785055969376,0.979143769791873,3,133,integrin binding,MF,TGFBI;COL5A1;COL3A1
21287,GO:1990535,0.0876343174139608,0.996504902990491,1,9,neuron projection maintenance,BP,ATP1A3
6451,GO:0019220,0.0877187567213542,0.949672164044347,16,1608,regulation of phosphate metabolic process,BP,LTF;PPP2R2C;PHACTR3;SRPX2;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;SPOCD1;ELFN2;ANXA2;SOCS3;PLA2G2A;PTPRT
11118,GO:0043252,0.0877825670247189,0.996361795019775,1,13,sodium-independent organic anion transport,BP,SLCO1A2
14509,GO:0060346,0.0879527222309614,0.996436219996652,1,10,bone trabecula formation,BP,COL1A1
924,GO:0002251,0.087957558027616,0.996226152464619,1,22,organ or tissue specific immune response,BP,LTF
13606,GO:0051174,0.0879923024996013,0.949492298707845,16,1609,regulation of phosphorus metabolic process,BP,LTF;PPP2R2C;PHACTR3;SRPX2;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;SPOCD1;ELFN2;ANXA2;SOCS3;PLA2G2A;PTPRT
12781,GO:0048018,0.0882608493384574,0.973126440372069,4,334,receptor ligand activity,MF,TIMP1;LIF;GDF15;ADM
13384,GO:0050839,0.0882981640616242,0.962454696351994,7,500,cell adhesion molecule binding,MF,TGFBI;COL5A1;POSTN;ANXA1;COL3A1;ANXA2;PTPRT
3403,GO:0006814,0.0883885127452017,0.973154178714884,4,218,sodium ion transport,BP,SLC17A7;ATP1A3;SLC8A2;SLC6A17
15829,GO:0070821,0.0884340677417389,0.986499632395586,2,70,tertiary granule membrane,CC,PLAU;SNAP25
2336,GO:0004972,0.0884822032289669,0.996489920829412,1,8,NMDA glutamate receptor activity,MF,GRIN1
17368,GO:0097006,0.0888466407157485,0.986376580841969,2,77,regulation of plasma lipoprotein particle levels,BP,ANXA2;PLA2G2A
7865,GO:0031489,0.0891258089009198,0.996190739424151,1,16,myosin V binding,MF,RAB3C
16586,GO:0072148,0.0892683919321912,0.996213674244728,1,14,epithelial cell fate commitment,BP,PDPN
19764,GO:1903236,0.0892941807120851,0.996233219035161,1,13,regulation of leukocyte tethering or rolling,BP,FUT9
18010,GO:0098974,0.0893092444426953,0.996287394227049,1,11,postsynaptic actin cytoskeleton organization,BP,INA
16124,GO:0071363,0.0894258754065959,0.959441150430556,8,624,cellular response to growth factor stimulus,BP,SH3GL2;COL1A1;LOX;FMOD;GDF15;POSTN;ANXA1;COL3A1
7189,GO:0030168,0.0894468012197959,0.978483926731559,3,148,platelet activation,BP,COL1A1;PDPN;COL3A1
12979,GO:0048535,0.0894723786386105,0.996160549894788,1,16,lymph node development,BP,PDPN
17669,GO:0097553,0.0895134302135413,0.978496270405771,3,129,calcium ion transmembrane import into cytosol,BP,SLC8A2;JPH3;GRIN1
712,GO:0001921,0.0898341016053602,0.996186733967226,1,13,positive regulation of receptor recycling,BP,ANXA2
13111,GO:0048788,0.0899531803294719,0.99667335970835,1,5,cytoskeleton of presynaptic active zone,CC,RIMS2
18184,GO:0099569,0.0899531803294719,0.99667335970835,1,5,presynaptic cytoskeleton,CC,RIMS2
4589,GO:0009898,0.0899741318861509,0.978291699982772,3,156,cytoplasmic side of plasma membrane,CC,PLEKHA4;SNAP25;GNAL
7267,GO:0030276,0.0899781392678082,0.986153189833995,2,64,clathrin binding,MF,SNAP91;SYT1
7242,GO:0030234,0.0904347392172713,0.95500931997024,10,914,enzyme regulator activity,MF,LTF;PPP2R2C;PHACTR3;TIMP1;SERPINE1;ANXA1;ELFN2;ANXA2;SOCS3;SERPINA3
5584,GO:0015908,0.0906216373155041,0.985934715963135,2,81,fatty acid transport,BP,ANXA1;PLA2G2A
8571,GO:0032717,0.0906760736125302,0.996039729680763,1,17,negative regulation of interleukin-8 production,BP,ANXA1
4997,GO:0010893,0.0907842781098259,0.996062209275565,1,15,positive regulation of steroid biosynthetic process,BP,ADM
3912,GO:0008191,0.0914380537771623,0.995986987095592,1,16,metalloendopeptidase inhibitor activity,MF,TIMP1
11131,GO:0043270,0.091593097444955,0.971810102732115,4,252,positive regulation of ion transport,BP,SYT1;CAMK2A;KCNIP2;GRIN1
7268,GO:0030277,0.0916186410220926,0.995988213202659,1,15,maintenance of gastrointestinal epithelium,BP,SERPINA3
2098,GO:0004623,0.0916193462819084,0.995941838485028,1,18,phospholipase A2 activity,MF,PLA2G2A
1103,GO:0002526,0.0916890145649243,0.985640604355077,2,94,acute inflammatory response,BP,CD163;SERPINA3
11861,GO:0045321,0.0916926677902682,0.952672135982961,11,1137,leukocyte activation,BP,LTF;CHGA;IGFBP2;PLAU;SNAP25;CHI3L1;ANXA1;CPLX2;ANXA2;PLA2G2A;SERPINA3
12582,GO:0046935,0.0917973114417331,0.996015220595821,1,13,1-phosphatidylinositol-3-kinase regulator activity,MF,SOCS3
17935,GO:0098877,0.0918210688956013,0.995970153237359,1,15,neurotransmitter receptor transport to plasma membrane,BP,SNAP25
18005,GO:0098969,0.0918210688956013,0.995970153237359,1,15,neurotransmitter receptor transport to postsynaptic membrane,BP,SNAP25
18011,GO:0098976,0.0919946643918198,0.9961417400592,1,9,excitatory chemical synaptic transmission,BP,GRIN1
17682,GO:0097623,0.0921848281089684,0.995920008006749,1,16,potassium ion export across plasma membrane,BP,KCNIP2
22042,GO:2001044,0.0923131244262475,0.995926078474864,1,15,regulation of integrin-mediated signaling pathway,BP,TIMP1
7400,GO:0030546,0.0931669157843169,0.971104690568502,4,339,signaling receptor activator activity,MF,TIMP1;LIF;GDF15;ADM
20118,GO:1903909,0.093287929386403,0.995942914273854,1,11,regulation of receptor clustering,BP,SHISA7
6142,GO:0017022,0.0936028346214791,0.985252846991785,2,67,myosin binding,MF,RAB3C;MOBP
15045,GO:0061299,0.0936171560127206,0.995913699537404,1,11,retina vasculature morphogenesis in camera-type eye,BP,COL4A1
9998,GO:0035904,0.0936867257600648,0.985297658182938,2,55,aorta development,BP,LOX;COL3A1
11328,GO:0043589,0.0937076404981689,0.995945382300337,1,10,skin morphogenesis,BP,COL1A1
11607,GO:0044548,0.0938578941028832,0.995806937075947,1,14,S100 protein binding,MF,ANXA2
4821,GO:0010648,0.0940145425455265,0.948579732593836,13,1281,negative regulation of cell communication,BP,LTF;CHGA;CELF4;SERPINE1;SH3GL2;IGFBP2;LIF;GDF15;ADM;KCNB1;SHANK2;SOCS3;PTPRT
10628,GO:0042297,0.0940325705076381,0.996105624250028,1,7,vocal learning,BP,CNTNAP2
17784,GO:0098596,0.0940325705076381,0.996105624250028,1,7,imitative learning,BP,CNTNAP2
5671,GO:0016081,0.094157225327887,0.995865539719343,1,11,synaptic vesicle docking,BP,SNAP25
15840,GO:0070839,0.0941798038946328,0.995863519938723,1,11,divalent metal ion export,BP,SLC8A2
1186,GO:0002685,0.0942952744039535,0.976755481847568,3,190,regulation of leukocyte migration,BP,SERPINE1;ANXA1;FUT9
16033,GO:0071219,0.0943068397473074,0.976753538109015,3,188,cellular response to molecule of bacterial origin,BP,LTF;VIM;SERPINE1
17807,GO:0098651,0.0945690892810574,0.995980493451989,1,8,basement membrane collagen trimer,CC,COL4A1
11492,GO:0044224,0.0947936150172433,0.995849074725062,1,10,juxtaparanode region of axon,CC,CNTNAP2
5049,GO:0010959,0.0948066312757097,0.965767805510241,5,356,regulation of metal ion transport,BP,CAMK2A;KCNIP2;JPH3;DPP10;GRIN1
19662,GO:1903025,0.0948100882938558,0.995773054943029,1,12,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,LIF
8070,GO:0031915,0.0949277432020406,0.995796323270991,1,11,positive regulation of synaptic plasticity,BP,CPLX2
19923,GO:1903540,0.0950107816693549,0.995661343150372,1,16,establishment of protein localization to postsynaptic membrane,BP,SNAP25
7084,GO:0023057,0.0950185974390136,0.947939471143969,13,1284,negative regulation of signaling,BP,LTF;CHGA;CELF4;SERPINE1;SH3GL2;IGFBP2;LIF;GDF15;ADM;KCNB1;SHANK2;SOCS3;PTPRT
7637,GO:0031082,0.0954086667548702,0.995579663117517,1,19,BLOC complex,CC,SNAP25
16710,GO:0072341,0.0954178669248977,0.984744467783902,2,82,modified amino acid binding,MF,SYT1;ANXA2
3806,GO:0007631,0.095438945947431,0.98473030551073,2,85,feeding behavior,BP,GDF15;GRIN1
8106,GO:0031984,0.0955287206813076,0.965435320236066,5,347,organelle subcompartment,CC,TGFBI;SNAP25;POSTN;FUT9;CALN1
18118,GO:0099188,0.0956769637402861,0.995693948476778,1,12,postsynaptic cytoskeleton organization,BP,INA
16172,GO:0071437,0.0958332337320143,0.995625251708566,1,14,invadopodium,CC,PDPN
7422,GO:0030595,0.0958394606891279,0.97620623991611,3,197,leukocyte chemotaxis,BP,CHGA;SERPINE1;ANXA1
10230,GO:0036376,0.095848466440925,0.995602098322661,1,15,sodium ion export across plasma membrane,BP,ATP1A3
16610,GO:0072182,0.0959164260679904,0.995706635209793,1,11,regulation of nephron tubule epithelial cell differentiation,BP,LIF
17001,GO:0086103,0.0961780554499895,0.995682737140088,1,11,G protein-coupled receptor signaling pathway involved in heart process,BP,CHGA
2880,GO:0006022,0.096183407348721,0.976130174945077,3,160,aminoglycan metabolic process,BP,CHI3L2;FMOD;CHI3L1
11951,GO:0045624,0.0962375051316902,0.995501114513324,1,19,positive regulation of T-helper cell differentiation,BP,ANXA1
8437,GO:0032496,0.0963045196146753,0.969816569179699,4,295,response to lipopolysaccharide,BP,LTF;VIM;SERPINE1;ADM
11392,GO:0043901,0.0964933859768355,0.9954767199096,1,19,negative regulation of multi-organism process,BP,TIMP1
2870,GO:0006004,0.0966109669791281,0.995552621384571,1,14,fucose metabolic process,BP,FUT9
3786,GO:0007605,0.096730316554392,0.975971969906279,3,140,sensory perception of sound,BP,COL1A1;SRRM4;GABRB3
17258,GO:0090399,0.0971001415925647,0.995532371234047,1,13,replicative senescence,BP,SERPINE1
8272,GO:0032280,0.0974440888987139,0.995566120326674,1,11,symmetric synapse,CC,IQSEC3
3655,GO:0007250,0.0975700194366716,0.995402592303465,1,17,activation of NF-kappaB-inducing kinase activity,BP,CHI3L1
4881,GO:0010744,0.0975773500716135,0.995419272442738,1,16,positive regulation of macrophage derived foam cell differentiation,BP,PLA2G2A
78,GO:0000159,0.0976339556912678,0.995396452658177,1,17,protein phosphatase type 2A complex,CC,PPP2R2C
8632,GO:0032802,0.0977561492523295,0.99544454612724,1,14,low-density lipoprotein particle receptor catabolic process,BP,ANXA2
2521,GO:0005326,0.0978755001021077,0.995373219358945,1,17,neurotransmitter transmembrane transporter activity,MF,SLC17A7
6446,GO:0019215,0.0978960040954661,0.995431255197154,1,14,intermediate filament binding,MF,VIM
442,GO:0001508,0.097909930182491,0.975581181518668,3,128,action potential,BP,SLC8A2;KCNIP2;KCNB1
12010,GO:0045723,0.0979825287771808,0.995347327920046,1,18,positive regulation of fatty acid biosynthetic process,BP,ANXA1
7091,GO:0030007,0.0981651664495951,0.995405619119256,1,14,cellular potassium ion homeostasis,BP,ATP1A3
778,GO:0002009,0.0985743260717473,0.956975554710517,7,518,morphogenesis of an epithelium,BP,PLEKHA4;LIF;COL5A1;ADM;PDPN;SOCS3;COL4A1
13429,GO:0050900,0.0985962635519368,0.963963581468095,5,401,leukocyte migration,BP,CHGA;SERPINE1;COL1A1;ANXA1;FUT9
3610,GO:0007178,0.098607720351582,0.964004433647059,5,320,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,VIM;LOX;FMOD;GDF15;COL3A1
1375,GO:0003018,0.0988744741602565,0.975158496758738,3,172,vascular process in circulatory system,BP,CHGA;SH3GL2;ADM
3594,GO:0007160,0.098914575259102,0.968792139833802,4,210,cell-matrix adhesion,BP,SERPINE1;PLAU;POSTN;COL3A1
5716,GO:0016188,0.0990722668045468,0.995376773882243,1,12,synaptic vesicle maturation,BP,SLC17A7
11950,GO:0045623,0.0992578248817867,0.995277471719306,1,15,negative regulation of T-helper cell differentiation,BP,ANXA1
15670,GO:0070482,0.0995472119905035,0.963531610354137,5,364,response to oxygen levels,BP,COL1A1;PLAU;POSTN;ADM;PDPN
14942,GO:0061042,0.099652161771249,0.995200462542807,1,17,vascular wound healing,BP,SERPINE1
14550,GO:0060395,0.0996589277551505,0.983701359005652,2,72,SMAD protein signal transduction,BP,VIM;GDF15
10093,GO:0036065,0.100165203852273,0.995189051236848,1,15,fucosylation,BP,FUT9
5950,GO:0016638,0.100326077678956,0.995103130594979,1,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,LOX
21501,GO:2000095,0.100362540686932,0.995169708739094,1,15,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,PLEKHA4
4095,GO:0008483,0.100439560661441,0.995122846575792,1,17,transaminase activity,MF,ETNPPL
5792,GO:0016323,0.100533174780311,0.968083089641858,4,227,basolateral plasma membrane,CC,SLC8A2;ANXA1;PDPN;ANXA2
13086,GO:0048729,0.100664765975019,0.953155301198662,8,612,tissue morphogenesis,BP,PLEKHA4;LIF;COL5A1;ADM;PDPN;COL3A1;SOCS3;COL4A1
17013,GO:0090025,0.100824831787237,0.995028094572873,1,21,regulation of monocyte chemotaxis,BP,SERPINE1
14368,GO:0060143,0.101023181864816,0.995008138046988,1,21,positive regulation of syncytium formation by plasma membrane fusion,BP,GDF15
21618,GO:2000302,0.101374789399978,0.995155012747268,1,12,positive regulation of synaptic vesicle exocytosis,BP,SYT1
17293,GO:0090533,0.101407777379109,0.995009833294481,1,18,cation-transporting ATPase complex,CC,ATP1A3
8904,GO:0033273,0.101492104934083,0.983185075424933,2,83,response to vitamin,BP,COL1A1;POSTN
17786,GO:0098598,0.101653857154081,0.995270708423955,1,9,learned vocalization behavior or vocal learning,BP,CNTNAP2
4981,GO:0010876,0.102442458857891,0.962155432910435,5,357,lipid localization,BP,SLCO1A2;ABCC3;ANXA1;ANXA2;PLA2G2A
2723,GO:0005769,0.102748222453287,0.962018366337022,5,342,early endosome,CC,LTF;SH3GL2;ANXA1;CNTNAP2;ANXA2
7316,GO:0030336,0.102794704218803,0.96710182055225,4,238,negative regulation of cell migration,BP,TIMP1;SERPINE1;COL3A1;PTPRT
16340,GO:0071682,0.102844482827811,0.994835447284545,1,20,endocytic vesicle lumen,CC,LTF
7291,GO:0030307,0.102862597113685,0.973761395859982,3,148,positive regulation of cell growth,BP,TNFRSF12A;SYT1;RIMS2
22105,GO:2001212,0.103216246564398,0.994863428479984,1,16,regulation of vasculogenesis,BP,ADM
5271,GO:0015081,0.103662572476931,0.973493626686226,3,137,sodium ion transmembrane transporter activity,MF,SLC17A7;ATP1A3;SLC8A2
16413,GO:0071855,0.103682029933263,0.994687780028193,1,26,neuropeptide receptor binding,MF,SHANK1
7446,GO:0030662,0.104120872194788,0.973265925120887,3,170,coated vesicle membrane,CC,SYT1;SLC17A7;SH3GL2
13078,GO:0048708,0.104276457221666,0.982478453747021,2,76,astrocyte differentiation,BP,VIM;LIF
20026,GO:1903729,0.10428393961587,0.994776968015179,1,15,regulation of plasma membrane organization,BP,SH3GL2
5384,GO:0015297,0.104682355983685,0.982370787021026,2,76,antiporter activity,MF,ATP1A3;SLC8A2
2515,GO:0005313,0.105050190347317,0.994724477943738,1,14,L-glutamate transmembrane transporter activity,MF,SLC17A7
2587,GO:0005516,0.105090214773135,0.966177164872456,4,189,calmodulin binding,MF,SYT1;CAMK2A;SLC8A2;GRIN1
10042,GO:0035988,0.105168523902191,0.994663267776957,1,16,chondrocyte proliferation,BP,LTF
18104,GO:0099171,0.105277108720641,0.994674962978525,1,15,presynaptic modulation of chemical synaptic transmission,BP,SYT1
4767,GO:0010566,0.10540429903269,0.994618536389974,1,17,regulation of ketone biosynthetic process,BP,ADM
326,GO:0000900,0.105689905638919,0.99463226382085,1,15,translation repressor activity, mRNA regulatory element binding,MF,CELF4
7969,GO:0031683,0.105888933799812,0.994533451700813,1,19,G-protein beta/gamma-subunit complex binding,MF,GNAL
8489,GO:0032588,0.106135280044765,0.981949687339935,2,85,trans-Golgi network membrane,CC,FUT9;CALN1
9171,GO:0034143,0.106268341402746,0.994509802917766,1,18,regulation of toll-like receptor 4 signaling pathway,BP,LTF
6596,GO:0019731,0.106269173585907,0.994398541057349,1,28,antibacterial humoral response,BP,LTF
1183,GO:0002682,0.106394071282015,0.941991812930882,12,1313,regulation of immune system process,BP,LTF;SERPINE1;COL1A1;LOX;IGFBP2;LIF;ANXA1;C1R;COL3A1;FUT9;SOCS3;PLA2G2A
10544,GO:0042104,0.106742738963324,0.994428243861442,1,20,positive regulation of activated T cell proliferation,BP,IGFBP2
3666,GO:0007265,0.107108446190579,0.959924940169192,5,327,Ras protein signal transduction,BP,RASGRF1;IQSEC3;PDPN;COL3A1;KSR2
14557,GO:0060402,0.107190224368951,0.972179591022158,3,146,calcium ion transport into cytosol,BP,SLC8A2;JPH3;GRIN1
14367,GO:0060142,0.107446193238547,0.994315688837925,1,23,regulation of syncytium formation by plasma membrane fusion,BP,GDF15
13525,GO:0051051,0.107694036075728,0.959595477889449,5,399,negative regulation of transport,BP,CHGA;PACSIN1;LIF;ANXA1;KCNB1
19101,GO:1901626,0.10771070880637,0.994479828586337,1,13,regulation of postsynaptic membrane organization,BP,SHISA7
6014,GO:0016769,0.107745512897597,0.994336059054295,1,19,transferase activity, transferring nitrogenous groups,MF,ETNPPL
13531,GO:0051057,0.107807014108426,0.98155153188148,2,72,positive regulation of small GTPase mediated signal transduction,BP,RASGRF1;COL3A1
1542,GO:0003333,0.107958091373141,0.981480214428989,2,79,amino acid transmembrane transport,BP,SLC17A7;PDPN
9803,GO:0035591,0.108025507830877,0.981518212999068,2,67,signaling adaptor activity,MF,SHANK1;SHANK2
18021,GO:0098992,0.108435881147511,0.994441157067532,1,12,neuronal dense core vesicle,CC,CHGA
16677,GO:0072283,0.10849124477121,0.994337801119388,1,15,metanephric renal vesicle morphogenesis,BP,LIF
15849,GO:0070848,0.108537463293064,0.94863176314755,8,651,response to growth factor,BP,SH3GL2;COL1A1;LOX;FMOD;GDF15;POSTN;ANXA1;COL3A1
18205,GO:0099612,0.108656631170751,0.994515996689837,1,10,protein localization to axon,BP,CNTNAP2
9951,GO:0035809,0.109207350580871,0.994162488810219,1,20,regulation of urine volume,BP,ADM
12494,GO:0046716,0.109421402542702,0.994154743941154,1,19,muscle cell cellular homeostasis,BP,LOX
12331,GO:0046426,0.109521355262176,0.994143835933006,1,19,negative regulation of receptor signaling pathway via JAK-STAT,BP,SOCS3
11970,GO:0045649,0.109692530178524,0.994109412506656,1,20,regulation of macrophage differentiation,BP,LIF
12788,GO:0048025,0.109704493336097,0.994080952714718,1,22,negative regulation of mRNA splicing, via spliceosome,BP,CELF4
19284,GO:1902106,0.10981220203614,0.980939447634819,2,89,negative regulation of leukocyte differentiation,BP,LTF;ANXA1
18501,GO:0120254,0.109901608616446,0.980878626300072,2,102,olefinic compound metabolic process,BP,ADM;GRIN1
14424,GO:0060231,0.110085497494302,0.994066240245044,1,20,mesenchymal to epithelial transition,BP,LIF
3618,GO:0007188,0.110182973243026,0.970993834878841,3,189,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,BP,CHGA;GNAL;ADM
18841,GO:1900452,0.110394282827253,0.994161932652666,1,14,regulation of long-term synaptic depression,BP,KCNB1
9024,GO:0033630,0.110741297725462,0.993993826548953,1,20,positive regulation of cell adhesion mediated by integrin,BP,LIF
917,GO:0002237,0.11110569318922,0.963407781939778,4,308,response to molecule of bacterial origin,BP,LTF;VIM;SERPINE1;ADM
15065,GO:0061337,0.111147299368622,0.970715027730824,3,141,cardiac conduction,BP,ATP1A3;SLC8A2;KCNIP2
4855,GO:0010715,0.111178806977838,0.994076846381956,1,14,regulation of extracellular matrix disassembly,BP,PDPN
15546,GO:0070262,0.111321567068372,0.993929371042276,1,20,peptidyl-serine dephosphorylation,BP,PPP2R2C
3730,GO:0007423,0.111361568418518,0.949947048904139,7,528,sensory organ development,BP,VIM;CELF4;SLC17A7;COL5A1;GABRB3;COL4A1;SMOC1
17088,GO:0090148,0.111625878258541,0.993998574873476,1,15,membrane fission,BP,SH3GL2
12330,GO:0046425,0.111970770053625,0.980337779683911,2,91,regulation of receptor signaling pathway via JAK-STAT,BP,LIF;SOCS3
18226,GO:0099699,0.112157705980625,0.970314264958786,3,150,integral component of synaptic membrane,CC,GRIN1;SLITRK1;SHISA7
21533,GO:2000146,0.112173513636114,0.962983085142875,4,250,negative regulation of cell motility,BP,TIMP1;SERPINE1;COL3A1;PTPRT
2118,GO:0004653,0.112441992141533,0.993838773000284,1,18,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT13
456,GO:0001530,0.112469978701278,0.993737985655931,1,25,lipopolysaccharide binding,MF,LTF
5568,GO:0015874,0.112654667375738,0.993764935028531,1,21,norepinephrine transport,BP,KCNB1
7399,GO:0030545,0.112657736412901,0.962683943833789,4,363,receptor regulator activity,MF,TIMP1;LIF;GDF15;ADM
2606,GO:0005545,0.112666644354671,0.993913715856986,1,14,1-phosphatidylinositol binding,MF,SNAP91
11315,GO:0043567,0.112794306198231,0.993799261366203,1,18,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2
925,GO:0002252,0.112817920924827,0.941407150996239,10,1064,immune effector process,BP,LTF;CHGA;PLAU;SNAP25;CHI3L1;ANXA1;CPLX2;C1R;ANXA2;SERPINA3
5145,GO:0014701,0.113219204970563,0.994105881282566,1,9,junctional sarcoplasmic reticulum membrane,CC,JPH3
5860,GO:0016485,0.113297679404656,0.969819614730669,3,187,protein processing,BP,SERPINE1;PLAU;C1R
3335,GO:0006700,0.113847234529496,0.993644639717224,1,20,C21-steroid hormone biosynthetic process,BP,ADM
13670,GO:0051290,0.114327501253758,0.993697935246777,1,15,protein heterotetramerization,BP,GRIN1
12789,GO:0048026,0.114347139484565,0.993572023307519,1,21,positive regulation of mRNA splicing, via spliceosome,BP,CELF4
17785,GO:0098597,0.114352457962674,0.994075185487894,1,8,observational learning,BP,CNTNAP2
10576,GO:0042165,0.114379787459387,0.993583732449418,1,20,neurotransmitter binding,MF,GRIN1
15788,GO:0070696,0.114563348964546,0.99356266850068,1,20,transmembrane receptor protein serine/threonine kinase binding,MF,GDF15
9049,GO:0033691,0.114923832801515,0.993538452196859,1,19,sialic acid binding,MF,ST8SIA3
10951,GO:0042981,0.115026873673496,0.934921179547566,13,1375,regulation of apoptotic process,BP,TNFRSF12A;LTF;CAMK2A;TIMP1;SERPINE1;LOX;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
16588,GO:0072160,0.115394925350024,0.99364495093382,1,13,nephron tubule epithelial cell differentiation,BP,LIF
14298,GO:0060041,0.115516082019091,0.96905775087621,3,141,retina development in camera-type eye,BP,CELF4;SLC17A7;COL4A1
10144,GO:0036151,0.115516879858347,0.993422565961489,1,22,phosphatidylcholine acyl-chain remodeling,BP,PLA2G2A
14331,GO:0060077,0.115535064954543,0.993509048391507,1,17,inhibitory synapse,CC,IQSEC3
608,GO:0001780,0.115538883919204,0.993532993252374,1,16,neutrophil homeostasis,BP,ANXA1
20072,GO:1903818,0.11566853708254,0.993545850386729,1,15,positive regulation of voltage-gated potassium channel activity,BP,KCNIP2
5317,GO:0015172,0.115812474721437,0.993501639008356,1,16,acidic amino acid transmembrane transporter activity,MF,SLC17A7
12137,GO:0045940,0.116032338627257,0.993362427715527,1,22,positive regulation of steroid metabolic process,BP,ADM
5036,GO:0010941,0.116279963968227,0.932734686963864,14,1511,regulation of cell death,BP,TNFRSF12A;LTF;CAMK2A;CHGA;TIMP1;SERPINE1;LOX;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
15102,GO:0061430,0.116492850449415,0.993520642754909,1,13,bone trabecula morphogenesis,BP,COL1A1
20707,GO:1905048,0.116565329500189,0.993443088307937,1,15,regulation of metallopeptidase activity,BP,TIMP1
5272,GO:0015085,0.116584801797127,0.968696242952482,3,124,calcium ion transmembrane transporter activity,MF,SLC8A2;GRIN1;ANXA2
14266,GO:0060004,0.116716001375349,0.993350533079499,1,18,reflex,BP,SHANK1
447,GO:0001516,0.116918970363834,0.993221324507905,1,25,prostaglandin biosynthetic process,BP,ANXA1
12344,GO:0046457,0.116918970363834,0.993221324507905,1,25,prostanoid biosynthetic process,BP,ANXA1
1273,GO:0002825,0.116982324353318,0.993225126052069,1,24,regulation of T-helper 1 type immune response,BP,ANXA1
20050,GO:1903779,0.117073798927902,0.979012024259851,2,67,regulation of cardiac conduction,BP,ATP1A3;SLC8A2
4854,GO:0010714,0.11732370686608,0.99322529416764,1,21,positive regulation of collagen metabolic process,BP,VIM
8737,GO:0032967,0.11732370686608,0.99322529416764,1,21,positive regulation of collagen biosynthetic process,BP,VIM
17766,GO:0098562,0.117400872723306,0.968259853068345,3,178,cytoplasmic side of membrane,CC,PLEKHA4;SNAP25;GNAL
11746,GO:0045063,0.117556011736623,0.993232220045672,1,19,T-helper 1 cell differentiation,BP,ANXA1
3443,GO:0006883,0.118068291980901,0.99321462789558,1,17,cellular sodium ion homeostasis,BP,ATP1A3
9534,GO:0035014,0.118259583778584,0.993192117850423,1,17,phosphatidylinositol 3-kinase regulator activity,MF,SOCS3
8436,GO:0032495,0.118738411857905,0.993112715035069,1,18,response to muramyl dipeptide,BP,VIM
14257,GO:0055119,0.118853928118316,0.993147734976965,1,16,relaxation of cardiac muscle,BP,CHGA
14362,GO:0060134,0.118937569057772,0.993167160237189,1,15,prepulse inhibition,BP,GRIN1
12120,GO:0045921,0.118982367796088,0.978377154138953,2,85,positive regulation of exocytosis,BP,SYT1;KCNB1
21891,GO:2000696,0.119027257100914,0.993127270561753,1,16,regulation of epithelial cell differentiation involved in kidney development,BP,LIF
7701,GO:0031223,0.119267705924529,0.993246231735497,1,12,auditory behavior,BP,CNTNAP2
3472,GO:0006925,0.1201753643521,0.992920112678965,1,19,inflammatory cell apoptotic process,BP,ANXA1
3769,GO:0007568,0.120331102890561,0.959268441620134,4,283,aging,BP,TIMP1;SERPINE1;IGFBP2;ADM
11327,GO:0043588,0.120647018063528,0.959149847864844,4,257,skin development,BP,COL1A1;COL5A1;ANXA1;COL3A1
9940,GO:0035791,0.120797418596147,0.9929812162639,1,14,platelet-derived growth factor receptor-beta signaling pathway,BP,LOX
19113,GO:1901653,0.121214408654435,0.952903452046426,5,356,cellular response to peptide,BP,VIM;CAMK2A;ATP1A3;GDF15;SOCS3
14000,GO:0051938,0.121582440865389,0.992887497232343,1,14,L-glutamate import,BP,SLC17A7
9566,GO:0035091,0.121633691847795,0.958715177267999,4,242,phosphatidylinositol binding,MF,SNAP91;SYT1;PLEKHA4;ANXA2
16837,GO:0072673,0.121718565951344,0.992778347770821,1,17,lamellipodium morphogenesis,BP,PDPN
20911,GO:1905475,0.121843360643753,0.96652002721771,3,183,regulation of protein localization to membrane,BP,KCNB1;DPP10;SHISA7
10723,GO:0042475,0.121925568423725,0.977550152328028,2,79,odontogenesis of dentin-containing tooth,BP,SERPINE1;ADM
14660,GO:0060548,0.12206750191126,0.937944959820861,9,889,negative regulation of cell death,BP,LTF;CHGA;TIMP1;SERPINE1;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
18146,GO:0099523,0.12214910437462,0.992819441704466,1,14,presynaptic cytosol,CC,SH3GL2
464,GO:0001540,0.1221656185348,0.977500139536127,2,75,amyloid-beta binding,MF,ATP1A3;GRIN1
2391,GO:0005085,0.122300978342472,0.958456967278879,4,209,guanyl-nucleotide exchange factor activity,MF,MCF2L2;RASGRF1;RAPGEF4;IQSEC3
9793,GO:0035579,0.122413977094185,0.977368833987099,2,88,specific granule membrane,CC,PLAU;SNAP25
19010,GO:1901379,0.122499170968922,0.977377771387026,2,80,regulation of potassium ion transmembrane transport,BP,KCNIP2;DPP10
12968,GO:0048518,0.1226029952589,0.914038627303033,43,5420,positive regulation of biological process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SYT1;CAMK2A;CHGA;CELF4;TIMP1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;IGFBP2;SLC8A2;KCNIP2;PLAU;PACSIN1;LIF;GDF15;SNAP25;CHI3L1;POSTN;ANXA1;ADM;KCNB1;C1R;SHANK1;SHANK2;PDPN;COL3A1;KSR2;FUT9;DPP10;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;SHISA7;PLA2G2A
13942,GO:0051817,0.122762974408214,0.977266468823504,2,88,modulation of process of other organism involved in symbiotic interaction,BP,LTF;ANXA2
13463,GO:0050954,0.122770678740428,0.966198399487798,3,159,sensory perception of mechanical stimulus,BP,COL1A1;SRRM4;GABRB3
9539,GO:0035023,0.122881900712955,0.977280226193087,2,77,regulation of Rho protein signal transduction,BP,RASGRF1;COL3A1
12553,GO:0046885,0.122890845620109,0.992610697462889,1,18,regulation of hormone biosynthetic process,BP,ADM
13109,GO:0048786,0.123733816792966,0.977045912648004,2,74,presynaptic active zone,CC,SLC17A7;RIMS2
2697,GO:0005737,0.124520808428751,0.914905033094109,72,10035,cytoplasm,CC,LTF;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PPP2R2C;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;GABRG2;IGFBP2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;COL6A2;GALNT13;CPLX2;INA;ADM;RAB3C;SPHKAP;JPH3;SYN2;SHANK1;SHANK2;PDPN;ETNPPL;SVOP;GABRB3;NNMT;RBFOX3;MOBP;COL3A1;KSR2;FUT9;CNTNAP2;RIMS2;GRIN1;ST8SIA3;CD163;DDN;ANXA2;CALN1;SOCS3;SV2B;COL4A1;PLA2G2A;SERPINA3;SLC6A17;OPALIN;DOK6
6594,GO:0019725,0.12479730870052,0.936263335105179,9,871,cellular homeostasis,BP,LTF;SLC17A7;ATP1A3;LOX;SLC8A2;ADM;JPH3;KCNB1;GRIN1
18122,GO:0099243,0.124891889380604,0.992527869749488,1,13,extrinsic component of synaptic membrane,CC,SNAP91
11010,GO:0043067,0.124965403867076,0.928285960314592,13,1393,regulation of programmed cell death,BP,TNFRSF12A;LTF;CAMK2A;TIMP1;SERPINE1;LOX;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
12369,GO:0046488,0.125182883392092,0.96523065243383,3,165,phosphatidylinositol metabolic process,BP,PLEKHA4;SOCS3;PLA2G2A
11014,GO:0043083,0.125492614202554,0.992341049046035,1,16,synaptic cleft,CC,GRIN1
7101,GO:0030021,0.125696440306104,0.99231553616757,1,16,extracellular matrix structural constituent conferring compression resistance,MF,FMOD
16809,GO:0072578,0.125834439204789,0.992411822801968,1,13,neurotransmitter-gated ion channel clustering,BP,SHISA7
731,GO:0001946,0.125836674981505,0.992330756588042,1,15,lymphangiogenesis,BP,PDPN
8821,GO:0033119,0.126033002088757,0.992083734762061,1,26,negative regulation of RNA splicing,BP,CELF4
12880,GO:0048268,0.126139569958146,0.992259916031536,1,16,clathrin coat assembly,BP,SNAP91
3925,GO:0008209,0.126408052608686,0.992090842576799,1,22,androgen metabolic process,BP,ADM
7956,GO:0031664,0.12640919460316,0.992075025778306,1,23,regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
16537,GO:0072077,0.126595087545431,0.992147221848898,1,18,renal vesicle morphogenesis,BP,LIF
7412,GO:0030575,0.126812107662417,0.992208409629614,1,15,nuclear body organization,BP,AFF2
16031,GO:0071216,0.12741281607105,0.964268619517482,3,209,cellular response to biotic stimulus,BP,LTF;VIM;SERPINE1
11187,GO:0043372,0.127458197806107,0.991899268152995,1,26,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
7298,GO:0030316,0.127480768115353,0.975877655179171,2,85,osteoclast differentiation,BP,LTF;ANXA2
14010,GO:0051953,0.127540339166381,0.991914429271755,1,24,negative regulation of amine transport,BP,CHGA
11186,GO:0043371,0.12756938181471,0.991999225459534,1,19,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
7909,GO:0031579,0.127597026141752,0.991921697289183,1,23,membrane raft organization,BP,ANXA2
11289,GO:0043535,0.127616656038766,0.975841260287794,2,84,regulation of blood vessel endothelial cell migration,BP,SRPX2;ANXA1
4838,GO:0010669,0.128172653152723,0.991880598568296,1,21,epithelial structure maintenance,BP,SERPINA3
18799,GO:1900242,0.128213374633834,0.991966783022846,1,17,regulation of synaptic vesicle endocytosis,BP,SLC17A7
8180,GO:0032101,0.128850970644008,0.933736013833597,9,910,regulation of response to external stimulus,BP,LTF;SERPINE1;PLAU;ANXA1;PDPN;GRIN1;ANXA2;SOCS3;PLA2G2A
1126,GO:0002573,0.128884643024976,0.963707020828376,3,187,myeloid leukocyte differentiation,BP,LTF;LIF;ANXA2
16941,GO:0086013,0.129021232833517,0.991752147947362,1,22,membrane repolarization during cardiac muscle cell action potential,BP,KCNIP2
487,GO:0001573,0.129510316711516,0.991705948194289,1,21,ganglioside metabolic process,BP,ST8SIA3
11753,GO:0045087,0.129512646533228,0.939526022230121,7,719,innate immune response,BP,LTF;VIM;CAMK2A;CHGA;ANXA1;C1R;SOCS3
18121,GO:0099240,0.129648325409966,0.963445079127529,3,162,intrinsic component of synaptic membrane,CC,GRIN1;SLITRK1;SHISA7
9371,GO:0034505,0.129682271735314,0.99174963283424,1,18,tooth mineralization,BP,COL1A1
13517,GO:0051043,0.12974345408743,0.991675309072848,1,21,regulation of membrane protein ectodomain proteolysis,BP,TIMP1
16543,GO:0072087,0.129922175880103,0.991693789890569,1,19,renal vesicle development,BP,LIF
13316,GO:0050727,0.130271584342178,0.954618846651337,4,315,regulation of inflammatory response,BP,SERPINE1;ANXA1;SOCS3;PLA2G2A
14494,GO:0060330,0.130478635768639,0.991543316058976,1,23,regulation of response to interferon-gamma,BP,SOCS3
14498,GO:0060334,0.130478635768639,0.991543316058976,1,23,regulation of interferon-gamma-mediated signaling pathway,BP,SOCS3
4480,GO:0009435,0.130578627224928,0.991500600183096,1,25,NAD biosynthetic process,BP,NNMT
4857,GO:0010717,0.130737359148484,0.974882675184555,2,87,regulation of epithelial to mesenchymal transition,BP,COL1A1;PDPN
19685,GO:1903055,0.130828525067572,0.991599381962517,1,18,positive regulation of extracellular matrix organization,BP,PDPN
14512,GO:0060349,0.131416618284746,0.974674966449611,2,87,bone morphogenesis,BP,LTF;COL1A1
13542,GO:0051087,0.131459063977449,0.974622755090088,2,97,chaperone binding,MF,ATP1A3;PDPN
3300,GO:0006658,0.131479370015956,0.991366759647348,1,26,phosphatidylserine metabolic process,BP,PLA2G2A
698,GO:0001906,0.132051126746231,0.974357889229439,2,128,cell killing,BP,LTF;CHGA
8111,GO:0031994,0.132298063105698,0.991590644861464,1,13,insulin-like growth factor I binding,MF,IGFBP2
9958,GO:0035821,0.133384878956167,0.974032852636541,2,96,modulation of process of other organism,BP,LTF;ANXA2
9536,GO:0035020,0.133511628540111,0.991271043111312,1,17,regulation of Rac protein signal transduction,BP,RASGRF1
21386,GO:1990823,0.13351480482004,0.974003992419063,2,93,response to leukemia inhibitory factor,BP,INA;SOCS3
21390,GO:1990830,0.13351480482004,0.974003992419063,2,93,cellular response to leukemia inhibitory factor,BP,INA;SOCS3
4907,GO:0010770,0.133730945146738,0.961815828227934,3,148,positive regulation of cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;SLITRK1
14556,GO:0060401,0.134000098058002,0.961668395990292,3,163,cytosolic calcium ion transport,BP,SLC8A2;JPH3;GRIN1
9156,GO:0034123,0.134053816802575,0.991045042364786,1,24,positive regulation of toll-like receptor signaling pathway,BP,LTF
1276,GO:0002828,0.134577729770129,0.990919615182316,1,28,regulation of type 2 immune response,BP,ANXA1
9283,GO:0034368,0.134919110737108,0.990926031461976,1,24,protein-lipid complex remodeling,BP,PLA2G2A
9284,GO:0034369,0.134919110737108,0.990926031461976,1,24,plasma lipoprotein particle remodeling,BP,PLA2G2A
710,GO:0001919,0.136082051664879,0.990799586248368,1,22,regulation of receptor recycling,BP,ANXA2
17228,GO:0090330,0.136310252041147,0.990809811223176,1,20,regulation of platelet aggregation,BP,PDPN
4668,GO:0010226,0.136455451363767,0.990729423615353,1,23,response to lithium ion,BP,IGFBP2
7166,GO:0030137,0.137087871162702,0.990594228244709,1,26,COPI-coated vesicle,CC,PACSIN1
11857,GO:0045295,0.137154676585058,0.991004393649634,1,12,gamma-catenin binding,MF,PTPRT
13326,GO:0050750,0.13725347287179,0.990730736393824,1,18,low-density lipoprotein particle receptor binding,MF,SYT1
13387,GO:0050848,0.137307392624657,0.972831880373324,2,90,regulation of calcium-mediated signaling,BP,SLC8A2;JPH3
17753,GO:0098533,0.137395097483201,0.990597883248583,1,23,ATPase dependent transmembrane transport complex,CC,ATP1A3
16638,GO:0072215,0.137402359508601,0.990657979384053,1,20,regulation of metanephros development,BP,LIF
9011,GO:0033612,0.137409726259734,0.990578856062823,1,24,receptor serine/threonine kinase binding,MF,GDF15
19481,GO:1902600,0.137432231887996,0.972707292481024,2,115,proton transmembrane transport,BP,SLC17A7;ATP1A3
10529,GO:0042063,0.137478986423721,0.951209638092083,4,282,gliogenesis,BP,VIM;LIF;ANXA1;OPALIN
20349,GO:1904385,0.137832851310605,0.990554901121118,1,22,cellular response to angiotensin,BP,CAMK2A
4021,GO:0008373,0.137923767290886,0.990585027284065,1,20,sialyltransferase activity,MF,ST8SIA3
17640,GO:0097503,0.137923767290886,0.990585027284065,1,20,sialylation,BP,ST8SIA3
10863,GO:0042755,0.138674371682561,0.990384042496807,1,25,eating behavior,BP,GDF15
9658,GO:0035313,0.138686783437538,0.990637039113613,1,15,wound healing, spreading of epidermal cells,BP,COL5A1
9282,GO:0034367,0.139770547775637,0.990227274139016,1,25,protein-containing complex remodeling,BP,PLA2G2A
17419,GO:0097091,0.140066954060054,0.990403868616757,1,16,synaptic vesicle clustering,BP,SYN2
13500,GO:0051020,0.140108154914066,0.933367672505023,7,508,GTPase binding,MF,MCF2L2;RASGRF1;RAPGEF4;IQSEC3;MOBP;RIMS2;ANXA2
3810,GO:0007638,0.140522453473185,0.990427308846776,1,14,mechanosensory behavior,BP,CNTNAP2
3437,GO:0006875,0.140808970457639,0.937264649708111,6,523,cellular metal ion homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;GRIN1
17835,GO:0098703,0.140941031475142,0.990156988271158,1,20,calcium ion import across plasma membrane,BP,SLC8A2
2479,GO:0005231,0.141117172565692,0.989990531123234,1,28,excitatory extracellular ligand-gated ion channel activity,MF,SLC17A7
6759,GO:0021543,0.141397422665056,0.958600988579739,3,158,pallium development,BP,COL3A1;CNTNAP2;GRIN1
17813,GO:0098659,0.141609697830915,0.971463231501769,2,90,inorganic cation import across plasma membrane,BP,ATP1A3;SLC8A2
18194,GO:0099587,0.141609697830915,0.971463231501769,2,90,inorganic ion import across plasma membrane,BP,ATP1A3;SLC8A2
12483,GO:0046697,0.141635235963607,0.989974110254836,1,24,decidualization,BP,LIF
12027,GO:0045745,0.141867908133367,0.989940233856135,1,24,positive regulation of G protein-coupled receptor signaling pathway,BP,CHGA
532,GO:0001664,0.142053776657321,0.958196116709646,3,231,G protein-coupled receptor binding,MF,GNAL;ADM;SHANK1
7481,GO:0030742,0.142107721124519,0.989923406935844,1,23,GTP-dependent protein binding,MF,RAB3C
13033,GO:0048644,0.142398415758041,0.971299071355379,2,74,muscle organ morphogenesis,BP,LIF;COL3A1
4746,GO:0010522,0.142565137047544,0.971146650196957,2,92,regulation of calcium ion transport into cytosol,BP,JPH3;GRIN1
21511,GO:2000108,0.142621296445664,0.989813310635281,1,25,positive regulation of leukocyte apoptotic process,BP,ANXA1
11009,GO:0043066,0.142829092626177,0.927999901972991,8,797,negative regulation of apoptotic process,BP,LTF;TIMP1;SERPINE1;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
3795,GO:0007617,0.143017742730494,0.989832357968553,1,21,mating behavior,BP,GRIN1
328,GO:0000904,0.14302676859769,0.924832067993499,9,710,cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;POSTN;SHANK1;SHANK2;PDPN;GRIN1;SLITRK1;DOK6
3631,GO:0007204,0.143199761486442,0.948419645074506,4,290,positive regulation of cytosolic calcium ion concentration,BP,SLC8A2;ADM;JPH3;GRIN1
6493,GO:0019359,0.143361252314974,0.989660694511326,1,28,nicotinamide nucleotide biosynthetic process,BP,NNMT
6495,GO:0019363,0.143361252314974,0.989660694511326,1,28,pyridine nucleotide biosynthetic process,BP,NNMT
4830,GO:0010661,0.143446974627324,0.989708731409753,1,24,positive regulation of muscle cell apoptotic process,BP,CAMK2A
16939,GO:0086011,0.143948189474693,0.989617535422733,1,25,membrane repolarization during action potential,BP,KCNIP2
6202,GO:0017137,0.144908267563573,0.95711745527583,3,156,Rab GTPase binding,MF,MOBP;RIMS2;ANXA2
15292,GO:0061844,0.145013595681205,0.98927890246687,1,44,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,LTF
7947,GO:0031645,0.145317644427833,0.989449856532597,1,23,negative regulation of nervous system process,BP,CELF4
18000,GO:0098962,0.145734141773188,0.989549426638696,1,17,regulation of postsynaptic neurotransmitter receptor activity,BP,SHISA7
16147,GO:0071396,0.145874228431046,0.934365951820552,6,526,cellular response to lipid,BP,LTF;VIM;ATP1A3;SERPINE1;COL1A1;ANXA1
4782,GO:0010595,0.145874690586684,0.970066299909739,2,93,positive regulation of endothelial cell migration,BP,SRPX2;ANXA1
19503,GO:1902656,0.146502268637051,0.989316297983286,1,21,calcium ion import into cytosol,BP,SLC8A2
785,GO:0002021,0.146734246161842,0.989258328283818,1,22,response to dietary excess,BP,GDF15
13028,GO:0048639,0.146950373449032,0.95623272637648,3,160,positive regulation of developmental growth,BP,TNFRSF12A;SYT1;RIMS2
14551,GO:0060396,0.147222778081261,0.989261854474012,1,19,growth hormone receptor signaling pathway,BP,GDF15
18181,GO:0099566,0.147316151700303,0.989510033312694,1,13,regulation of postsynaptic cytosolic calcium ion concentration,BP,SLC8A2
4944,GO:0010831,0.147663190282998,0.989026877886996,1,27,positive regulation of myotube differentiation,BP,GDF15
4114,GO:0008514,0.147700862927212,0.955820904218093,3,203,organic anion transmembrane transporter activity,MF,SLCO1A2;SLC17A7;ABCC3
18940,GO:1901214,0.14831309609828,0.945888733193554,4,296,regulation of neuron death,BP,CHGA;KCNB1;GABRB3;GRIN1
6858,GO:0021756,0.148332197292222,0.989126596974123,1,18,striatum development,BP,CNTNAP2
17408,GO:0097066,0.148346144994309,0.98899251694545,1,23,response to thyroid hormone,BP,ANXA2
3404,GO:0006816,0.148390138581621,0.938611599821701,5,381,calcium ion transport,BP,CAMK2A;SLC8A2;JPH3;GRIN1;ANXA2
3164,GO:0006491,0.148471463930077,0.989105569177443,1,18,N-glycan processing,BP,ST8SIA3
17855,GO:0098743,0.148698562044347,0.98903911371825,1,19,cell aggregation,BP,LTF
3405,GO:0006817,0.148934205797431,0.988882582840436,1,24,phosphate ion transport,BP,SLC17A7
13284,GO:0050671,0.148938558689434,0.968952015826181,2,123,positive regulation of lymphocyte proliferation,BP,IGFBP2;ANXA1
4596,GO:0009931,0.14913893705872,0.988892914198595,1,22,calcium-dependent protein serine/threonine kinase activity,MF,CAMK2A
9046,GO:0033688,0.149266991848357,0.988851420594676,1,23,regulation of osteoblast proliferation,BP,LTF
8629,GO:0032799,0.149433009510239,0.988847782984543,1,22,low-density lipoprotein receptor particle metabolic process,BP,ANXA2
18941,GO:1901215,0.149843337372217,0.954909091460856,3,194,negative regulation of neuron death,BP,CHGA;GABRB3;GRIN1
12451,GO:0046639,0.150368217107275,0.988681435674943,1,23,negative regulation of alpha-beta T cell differentiation,BP,ANXA1
8725,GO:0032946,0.15050987937947,0.968424515086956,2,124,positive regulation of mononuclear cell proliferation,BP,IGFBP2;ANXA1
3326,GO:0006688,0.150555426972164,0.988613285913871,1,25,glycosphingolipid biosynthetic process,BP,ST8SIA3
3924,GO:0008207,0.151128746588808,0.988448326406298,1,30,C21-steroid hormone metabolic process,BP,ADM
16133,GO:0071378,0.151437699249701,0.988589292331979,1,20,cellular response to growth hormone stimulus,BP,GDF15
8455,GO:0032526,0.151770759831053,0.96807573712382,2,101,response to retinoic acid,BP,COL1A1;IGFBP2
11281,GO:0043523,0.151866511862718,0.954018592187072,3,199,regulation of neuron apoptotic process,BP,KCNB1;GABRB3;GRIN1
5205,GO:0014850,0.151878548018256,0.988493493090825,1,21,response to muscle activity,BP,POSTN
3494,GO:0006958,0.151958273654523,0.988359806537722,1,27,complement activation, classical pathway,BP,C1R
8321,GO:0032366,0.15216331645192,0.988449008392107,1,21,intracellular sterol transport,BP,ANXA2
8322,GO:0032367,0.15216331645192,0.988449008392107,1,21,intracellular cholesterol transport,BP,ANXA2
10489,GO:0040020,0.152224747458417,0.988302534648685,1,28,regulation of meiotic nuclear division,BP,LIF
7750,GO:0031300,0.152430439444327,0.943766548312254,4,368,intrinsic component of organelle membrane,CC,SYT1;SLC17A7;RAB3C;SLC6A17
11320,GO:0043576,0.152673431016372,0.988344048768296,1,22,regulation of respiratory gaseous exchange,BP,GRIN1
11666,GO:0044788,0.152698274511798,0.988277033675386,1,25,modulation by host of viral process,BP,LTF
7250,GO:0030246,0.15286256326624,0.953537592485055,3,228,carbohydrate binding,MF,CHI3L2;CHI3L1;GALNT13
16649,GO:0072234,0.153113744176236,0.988358237360323,1,19,metanephric nephron tubule development,BP,LIF
8273,GO:0032281,0.153122795607465,0.9881919109297,1,26,AMPA glutamate receptor complex,CC,SHISA7
7454,GO:0030673,0.153296481194224,0.988493555262896,1,15,axolemma,CC,CNTNAP2
4966,GO:0010857,0.153331890117227,0.988217186155727,1,23,calcium-dependent protein kinase activity,MF,CAMK2A
16762,GO:0072509,0.153421389474529,0.953456341483051,3,149,divalent inorganic cation transmembrane transporter activity,MF,SLC8A2;GRIN1;ANXA2
1244,GO:0002761,0.153546828261942,0.967464436447128,2,104,regulation of myeloid leukocyte differentiation,BP,LTF;LIF
21766,GO:2000516,0.15378721065744,0.988001568223234,1,32,positive regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
11012,GO:0043069,0.154025750043904,0.920965895096156,8,811,negative regulation of programmed cell death,BP,LTF;TIMP1;SERPINE1;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
5242,GO:0014912,0.154334255031003,0.988106883236093,1,21,negative regulation of smooth muscle cell migration,BP,SERPINE1
11127,GO:0043266,0.154544788213607,0.967163791922185,2,95,regulation of potassium ion transport,BP,KCNIP2;DPP10
21765,GO:2000515,0.154615291221197,0.987936687534367,1,27,negative regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
19798,GO:1903311,0.15475809454801,0.942635170262541,4,316,regulation of mRNA metabolic process,BP,VIM;CELF4;SRRM4;RBFOX3
5672,GO:0016082,0.154883371212836,0.988047866665281,1,20,synaptic vesicle priming,BP,SNAP25
10482,GO:0040013,0.155212886259921,0.942444857035544,4,280,negative regulation of locomotion,BP,TIMP1;SERPINE1;COL3A1;PTPRT
9991,GO:0035886,0.155668156742107,0.987802414763925,1,25,vascular associated smooth muscle cell differentiation,BP,ADM
8782,GO:0033032,0.156051503583822,0.987740423009272,1,25,regulation of myeloid cell apoptotic process,BP,ANXA1
7887,GO:0031527,0.156523997460352,0.987853000089759,1,18,filopodium membrane,CC,PDPN
4714,GO:0010460,0.156773667998666,0.987623186987967,1,25,positive regulation of heart rate,BP,ADM
14312,GO:0060055,0.156981723054816,0.987570496719032,1,26,angiogenesis involved in wound healing,BP,SERPINE1
692,GO:0001891,0.157625372169422,0.987484159576569,1,25,phagocytic cup,CC,ANXA1
3294,GO:0006650,0.158232279128471,0.940878314957415,4,307,glycerophospholipid metabolic process,BP,PLEKHA4;ETNPPL;SOCS3;PLA2G2A
12058,GO:0045807,0.158285191496449,0.965882427635001,2,95,positive regulation of endocytosis,BP,SERPINE1;ANXA2
18502,GO:0120255,0.15834533599459,0.987312703144992,1,28,olefinic compound biosynthetic process,BP,ADM
13992,GO:0051928,0.158660275533552,0.965697551312364,2,108,positive regulation of calcium ion transport,BP,CAMK2A;GRIN1
16627,GO:0072202,0.158754238351491,0.987342110458092,1,23,cell differentiation involved in metanephros development,BP,LIF
8488,GO:0032587,0.15899087239554,0.965669568256714,2,89,ruffle membrane,CC,PACSIN1;PDPN
6272,GO:0018146,0.159501211436122,0.987155632705602,1,26,keratan sulfate biosynthetic process,BP,FMOD
13298,GO:0050686,0.159774196434387,0.987031736853059,1,31,negative regulation of mRNA processing,BP,CELF4
8260,GO:0032268,0.16039751737041,0.894467903118933,20,2347,regulation of cellular protein metabolic process,BP,LTF;VIM;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ELFN2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
6494,GO:0019362,0.160960304535627,0.986832381741018,1,31,pyridine nucleotide metabolic process,BP,NNMT
12373,GO:0046496,0.160960304535627,0.986832381741018,1,31,nicotinamide nucleotide metabolic process,BP,NNMT
8735,GO:0032965,0.161062223377417,0.986815176260539,1,31,regulation of collagen biosynthetic process,BP,VIM
17217,GO:0090314,0.161500628265743,0.986754930245199,1,30,positive regulation of protein targeting to membrane,BP,KCNB1
17971,GO:0098918,0.162082451048324,0.987091180412136,1,15,structural constituent of synapse,MF,INA
5045,GO:0010955,0.162092724764227,0.986702784264545,1,27,negative regulation of protein processing,BP,SERPINE1
19803,GO:1903318,0.162092724764227,0.986702784264545,1,27,negative regulation of protein maturation,BP,SERPINE1
10538,GO:0042092,0.162437122636834,0.986533706641353,1,35,type 2 immune response,BP,ANXA1
3662,GO:0007259,0.162550211733234,0.964332358124697,2,110,receptor signaling pathway via JAK-STAT,BP,LIF;SOCS3
16655,GO:0072243,0.162583016669032,0.986789683301032,1,20,metanephric nephron epithelium development,BP,LIF
13658,GO:0051271,0.162590857321573,0.938668924796168,4,283,negative regulation of cellular component movement,BP,TIMP1;SERPINE1;COL3A1;PTPRT
12357,GO:0046471,0.1626005455691,0.986583184293243,1,29,phosphatidylglycerol metabolic process,BP,PLA2G2A
14997,GO:0061138,0.16268434556764,0.949260004264872,3,175,morphogenesis of a branching epithelium,BP,ADM;SOCS3;COL4A1
7961,GO:0031669,0.162900680796559,0.949105861557819,3,201,cellular response to nutrient levels,BP,COL1A1;POSTN;KCNB1
8588,GO:0032743,0.163032448097004,0.986561965148383,1,26,positive regulation of interleukin-2 production,BP,ANXA1
7888,GO:0031528,0.163106289836101,0.986591694837056,1,24,microvillus membrane,CC,PDPN
5142,GO:0014072,0.163314257508289,0.986446159294091,1,30,response to isoquinoline alkaloid,BP,GRIN1
11137,GO:0043278,0.163314257508289,0.986446159294091,1,30,response to morphine,BP,GRIN1
3457,GO:0006900,0.163482620166696,0.9640193530831,2,106,vesicle budding from membrane,BP,SNAP91;ANXA2
14482,GO:0060314,0.16381611166941,0.98644875636993,1,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH3
16430,GO:0071880,0.163928522429811,0.986475924312036,1,23,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,CHGA
21369,GO:1990776,0.163979893554878,0.986420768521439,1,25,response to angiotensin,BP,CAMK2A
12165,GO:0045992,0.164101197937208,0.986400019602785,1,25,negative regulation of embryonic development,BP,COL5A1
15063,GO:0061326,0.164181251802307,0.963861034858493,2,88,renal tubule development,BP,LIF;COL4A1
15447,GO:0070102,0.164252099688601,0.986447203345063,1,22,interleukin-6-mediated signaling pathway,BP,SOCS3
16772,GO:0072525,0.164286597396149,0.986264674290318,1,31,pyridine-containing compound biosynthetic process,BP,NNMT
16155,GO:0071407,0.164608646222046,0.923378427131757,6,521,cellular response to organic cyclic compound,BP,ATP1A3;COL1A1;GABRG2;ANXA1;GNAL;GABRB3
12119,GO:0045920,0.16467149880383,0.98621260867865,1,30,negative regulation of exocytosis,BP,ANXA1
7272,GO:0030282,0.164829714179741,0.963542589285898,2,106,bone mineralization,BP,LTF;LOX
20674,GO:1904994,0.165169630040237,0.986195719682052,1,26,regulation of leukocyte adhesion to vascular endothelial cell,BP,FUT9
5528,GO:0015813,0.165347550544191,0.986233034891688,1,23,L-glutamate transmembrane transport,BP,SLC17A7
14507,GO:0060343,0.165456588657572,0.986189667994825,1,24,trabecula formation,BP,COL1A1
2763,GO:0005834,0.166371359152699,0.985888523796937,1,32,heterotrimeric G-protein complex,CC,GNAL
20850,GO:1905360,0.166371359152699,0.985888523796937,1,32,GTPase complex,CC,GNAL
16598,GO:0072170,0.16653401234094,0.986055384415128,1,22,metanephric tubule development,BP,LIF
6700,GO:0019956,0.166588739173475,0.985850418260952,1,32,chemokine binding,MF,PDPN
4813,GO:0010640,0.167249879097057,0.985931237382835,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,LOX
21659,GO:2000352,0.167422348391969,0.985803986950739,1,26,negative regulation of endothelial cell apoptotic process,BP,SERPINE1
13097,GO:0048745,0.168170626877848,0.985770695651653,1,22,smooth muscle tissue development,BP,COL3A1
3147,GO:0006470,0.168583486677426,0.935530712638479,4,300,protein dephosphorylation,BP,PPP2R2C;PHACTR3;ELFN2;PTPRT
15044,GO:0061298,0.168588240238901,0.985840150256347,1,18,retina vasculature development in camera-type eye,BP,COL4A1
13080,GO:0048710,0.168720125496775,0.985575655581698,1,26,regulation of astrocyte differentiation,BP,LIF
9541,GO:0035025,0.168834867642989,0.98551654414511,1,28,positive regulation of Rho protein signal transduction,BP,COL3A1
15386,GO:0065005,0.168987108096404,0.985508269240011,1,27,protein-lipid complex assembly,BP,SH3GL2
14916,GO:0061003,0.16922610487336,0.98565009515354,1,20,positive regulation of dendritic spine morphogenesis,BP,CUX2
5430,GO:0015491,0.169282730419679,0.985521625397118,1,24,cation:cation antiporter activity,MF,SLC8A2
11403,GO:0043931,0.169336022897612,0.985808968423864,1,16,ossification involved in bone maturation,BP,LTF
15770,GO:0070665,0.169366404889026,0.961826432254251,2,133,positive regulation of leukocyte proliferation,BP,IGFBP2;ANXA1
13297,GO:0050685,0.169537891514847,0.985342385309155,1,31,positive regulation of mRNA processing,BP,CELF4
18197,GO:0099590,0.169729681812324,0.98537633866317,1,27,neurotransmitter receptor internalization,BP,SNAP25
17040,GO:0090075,0.169777640086909,0.985367796126774,1,27,relaxation of muscle,BP,CHGA
8124,GO:0032011,0.169903174343816,0.985568851938233,1,19,ARF protein signal transduction,BP,IQSEC3
8125,GO:0032012,0.169903174343816,0.985568851938233,1,19,regulation of ARF protein signal transduction,BP,IQSEC3
21480,GO:2000050,0.171146589279101,0.985216416201817,1,23,regulation of non-canonical Wnt signaling pathway,BP,PLEKHA4
11531,GO:0044305,0.171390834345822,0.985172748351712,1,23,calyx of Held,CC,CPLX2
9045,GO:0033687,0.171825570975342,0.984981159649689,1,28,osteoblast proliferation,BP,LTF
13339,GO:0050772,0.172205869587699,0.961023128125424,2,82,positive regulation of axonogenesis,BP,TNFRSF12A;SLITRK1
7406,GO:0030552,0.172294986429581,0.985010498201483,1,23,cAMP binding,MF,RAPGEF4
8778,GO:0033028,0.172306052640953,0.984876052433957,1,29,myeloid cell apoptotic process,BP,ANXA1
9559,GO:0035066,0.172772385560726,0.984791276226184,1,29,positive regulation of histone acetylation,BP,LIF
13344,GO:0050777,0.173061157294317,0.960482186468148,2,132,negative regulation of immune response,BP,ANXA1;COL3A1
19861,GO:1903421,0.173287767943937,0.984804263340667,1,24,regulation of synaptic vesicle recycling,BP,SLC17A7
741,GO:0001958,0.173403572575166,0.98471420205353,1,27,endochondral ossification,BP,COL1A1
10097,GO:0036075,0.173403572575166,0.98471420205353,1,27,replacement ossification,BP,COL1A1
9336,GO:0034446,0.17379188479393,0.960339377749326,2,99,substrate adhesion-dependent cell spreading,BP,POSTN;PDPN
7722,GO:0031258,0.174147560312579,0.984704847114154,1,22,lamellipodium membrane,CC,PDPN
2573,GO:0005484,0.174168738049778,0.984459691929079,1,34,SNAP receptor activity,MF,SNAP25
739,GO:0001956,0.174262434748994,0.984654173249006,1,23,positive regulation of neurotransmitter secretion,BP,SYT1
2491,GO:0005251,0.174267158286244,0.984517827824683,1,29,delayed rectifier potassium channel activity,MF,KCNB1
8328,GO:0032373,0.174439155645099,0.984546220666386,1,26,positive regulation of sterol transport,BP,ANXA2
8331,GO:0032376,0.174439155645099,0.984546220666386,1,26,positive regulation of cholesterol transport,BP,ANXA2
11949,GO:0045622,0.174682740373915,0.984407697081806,1,31,regulation of T-helper cell differentiation,BP,ANXA1
13888,GO:0051707,0.175074144548455,0.900517713159618,10,1183,response to other organism,BP,LTF;VIM;CAMK2A;CHGA;SERPINE1;ANXA1;ADM;C1R;SOCS3;PLA2G2A
3892,GO:0008157,0.175215048090862,0.984361814192558,1,28,protein phosphatase 1 binding,MF,PHACTR3
16426,GO:0071875,0.175232969325284,0.984400330642664,1,26,adrenergic receptor signaling pathway,BP,CHGA
16900,GO:0080025,0.175591340706138,0.984357752699032,1,25,phosphatidylinositol-3,5-bisphosphate binding,MF,PLEKHA4
11089,GO:0043207,0.17593580236951,0.899923043873317,10,1185,response to external biotic stimulus,BP,LTF;VIM;CAMK2A;CHGA;SERPINE1;ANXA1;ADM;C1R;SOCS3;PLA2G2A
7329,GO:0030371,0.176539688901815,0.984182357659908,1,25,translation repressor activity,MF,CELF4
14514,GO:0060351,0.176603002648252,0.984085291699997,1,29,cartilage development involved in endochondral bone morphogenesis,BP,COL1A1
2392,GO:0005086,0.176626925197596,0.984361791454061,1,19,ARF guanyl-nucleotide exchange factor activity,MF,IQSEC3
4852,GO:0010712,0.177020174531698,0.983915594475546,1,35,regulation of collagen metabolic process,BP,VIM
13042,GO:0048665,0.177245223589688,0.983914923984367,1,32,neuron fate specification,BP,MYT1L
2334,GO:0004970,0.177555446134705,0.984191015328808,1,19,ionotropic glutamate receptor activity,MF,GRIN1
2355,GO:0005001,0.177752222278549,0.984251934548249,1,17,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRT
6432,GO:0019198,0.177752222278549,0.984251934548249,1,17,transmembrane receptor protein phosphatase activity,MF,PTPRT
13318,GO:0050729,0.177791949536652,0.958741937051034,2,128,positive regulation of inflammatory response,BP,SERPINE1;PLA2G2A
6760,GO:0021544,0.178004726194086,0.983935537553769,1,24,subpallium development,BP,CNTNAP2
13430,GO:0050901,0.178340544688116,0.983759402439111,1,29,leukocyte tethering or rolling,BP,FUT9
11992,GO:0045671,0.178596690210797,0.983773978459814,1,26,negative regulation of osteoclast differentiation,BP,LTF
5808,GO:0016363,0.178723397135368,0.958482173469059,2,105,nuclear matrix,CC,VIM;PHACTR3
18882,GO:1901018,0.178900090718361,0.983767712811863,1,24,positive regulation of potassium ion transmembrane transporter activity,BP,KCNIP2
5096,GO:0014013,0.179209587178382,0.958264920598685,2,113,regulation of gliogenesis,BP,LIF;OPALIN
8309,GO:0032350,0.179294071979393,0.98354361588873,1,31,regulation of hormone metabolic process,BP,ADM
17907,GO:0098831,0.179415318408527,0.984070618450541,1,15,presynaptic active zone cytoplasmic component,CC,RIMS2
6410,GO:0019098,0.179507280822829,0.983558254147372,1,28,reproductive behavior,BP,GRIN1
17216,GO:0090313,0.179604398680625,0.983439084928807,1,34,regulation of protein targeting to membrane,BP,KCNB1
13353,GO:0050790,0.179658095814358,0.882050588012859,18,2100,regulation of catalytic activity,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;TIMP1;SERPINE1;SLC8A2;GDF15;CHI3L1;SPOCD1;ANXA1;ELFN2;GRIN1;ANXA2;SOCS3;PTPRT;SERPINA3
10189,GO:0036303,0.179773445167582,0.983736796938041,1,20,lymph vessel morphogenesis,BP,PDPN
12829,GO:0048169,0.179849947722413,0.983561909280489,1,25,regulation of long-term neuronal synaptic plasticity,BP,GRIN1
14328,GO:0060074,0.179950391216604,0.983569654490855,1,24,synapse maturation,BP,SHANK1
15584,GO:0070325,0.180339061983571,0.983592110479468,1,21,lipoprotein particle receptor binding,MF,SYT1
16632,GO:0072207,0.180433587100914,0.983478103838666,1,24,metanephric epithelium development,BP,LIF
10924,GO:0042910,0.18059615446119,0.983372355577439,1,27,xenobiotic transmembrane transporter activity,MF,ABCC3
9144,GO:0034110,0.18082068280197,0.983329492610353,1,27,regulation of homotypic cell-cell adhesion,BP,PDPN
11962,GO:0045637,0.180908448075117,0.940717093512219,3,210,regulation of myeloid cell differentiation,BP,LTF;LOX;LIF
9297,GO:0034383,0.181225395863442,0.983191790037767,1,30,low-density lipoprotein particle clearance,BP,ANXA2
2828,GO:0005942,0.181400078708731,0.983266959530472,1,25,phosphatidylinositol 3-kinase complex,CC,SOCS3
9839,GO:0035640,0.181728202495836,0.983261152023262,1,23,exploration behavior,BP,JPH3
3086,GO:0006376,0.182210885549428,0.982984142254263,1,31,mRNA splice site selection,BP,CELF4
4917,GO:0010800,0.182250772909636,0.983013039040603,1,29,positive regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
10651,GO:0042339,0.182270426674961,0.982972617112794,1,31,keratan sulfate metabolic process,BP,FMOD
2140,GO:0004683,0.182502494508022,0.982984705877801,1,28,calmodulin-dependent protein kinase activity,MF,CAMK2A
15739,GO:0070588,0.182552429180493,0.928106598098598,4,284,calcium ion transmembrane transport,BP,SLC8A2;JPH3;GRIN1;ANXA2
6009,GO:0016757,0.182845480606652,0.939750635267428,3,232,transferase activity, transferring glycosyl groups,MF,GALNT13;FUT9;ST8SIA3
2590,GO:0005520,0.18293778008799,0.983029338537553,1,23,insulin-like growth factor binding,MF,IGFBP2
15932,GO:0070977,0.183292873056473,0.983162465756907,1,18,bone maturation,BP,LTF
10750,GO:0042542,0.183532488357983,0.956571098890824,2,129,response to hydrogen peroxide,BP,COL1A1;ANXA1
16670,GO:0072273,0.184601879057777,0.982648812441811,1,25,metanephric nephron morphogenesis,BP,LIF
4880,GO:0010743,0.184758270860405,0.982568156628847,1,27,regulation of macrophage derived foam cell differentiation,BP,PLA2G2A
1192,GO:0002691,0.184763811015002,0.982504405529606,1,30,regulation of cellular extravasation,BP,FUT9
12359,GO:0046474,0.18505753850205,0.938716236261384,3,215,glycerophospholipid biosynthetic process,BP,PLEKHA4;ETNPPL;PLA2G2A
7810,GO:0031400,0.185111103783312,0.91085414432126,6,556,negative regulation of protein modification process,BP,PHACTR3;SH3GL2;LIF;ELFN2;SOCS3;PTPRT
16978,GO:0086064,0.185230759339812,0.982585186088044,1,23,cell communication by electrical coupling involved in cardiac conduction,BP,ATP1A3
9649,GO:0035296,0.185321562725866,0.955896299012386,2,126,regulation of tube diameter,BP,CHGA;ADM
17733,GO:0097746,0.185321562725866,0.955896299012386,2,126,regulation of blood vessel diameter,BP,CHGA;ADM
12343,GO:0046456,0.185420541950503,0.982213055650048,1,42,icosanoid biosynthetic process,BP,ANXA1
12170,GO:0046006,0.18583528308639,0.982211875705597,1,35,regulation of activated T cell proliferation,BP,IGFBP2
13772,GO:0051480,0.18619675599188,0.926071949587401,4,323,regulation of cytosolic calcium ion concentration,BP,SLC8A2;ADM;JPH3;GRIN1
11212,GO:0043403,0.186410446552146,0.982111968696335,1,34,skeletal muscle tissue regeneration,BP,ANXA1
20009,GO:1903707,0.186475753689293,0.955452200901065,2,126,negative regulation of hemopoiesis,BP,LTF;ANXA1
10587,GO:0042181,0.186504813726636,0.982065037163673,1,36,ketone biosynthetic process,BP,ADM
9590,GO:0035150,0.18655793399251,0.955417058862991,2,127,regulation of tube size,BP,CHGA;ADM
14966,GO:0061082,0.18665546964949,0.982130847134107,1,30,myeloid leukocyte cytokine production,BP,CHGA
10799,GO:0042626,0.18713330176994,0.955342326742332,2,95,ATPase-coupled transmembrane transporter activity,MF,ATP1A3;ABCC3
13650,GO:0051259,0.187384031706915,0.937587738023859,3,216,protein complex oligomerization,BP,SYT1;KCNB1;GRIN1
9170,GO:0034142,0.187831603533753,0.981843484336594,1,33,toll-like receptor 4 signaling pathway,BP,LTF
7351,GO:0030426,0.18790973760569,0.937431418555685,3,175,growth cone,CC,RASGRF1;SNAP25;SHANK2
18486,GO:0120178,0.187963477640637,0.981747274330474,1,38,steroid hormone biosynthetic process,BP,ADM
3652,GO:0007229,0.188000422142564,0.954972629459526,2,101,integrin-mediated signaling pathway,BP,TIMP1;COL3A1
14226,GO:0055075,0.188141510971797,0.981899386010684,1,27,potassium ion homeostasis,BP,ATP1A3
12440,GO:0046627,0.189452242516685,0.9815707631754,1,30,negative regulation of insulin receptor signaling pathway,BP,SOCS3
19258,GO:1902042,0.189699645886938,0.981408376520394,1,37,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1
13824,GO:0051590,0.189748265962094,0.981577025881652,1,27,positive regulation of neurotransmitter transport,BP,SYT1
13990,GO:0051924,0.189812972068151,0.936388615481688,3,224,regulation of calcium ion transport,BP,CAMK2A;JPH3;GRIN1
4834,GO:0010665,0.189885368781538,0.981429067028557,1,33,regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
18812,GO:1900273,0.190076634161705,0.981661621386722,1,22,positive regulation of long-term synaptic potentiation,BP,SHISA7
12411,GO:0046578,0.190474671732131,0.93615774577075,3,183,regulation of Ras protein signal transduction,BP,RASGRF1;IQSEC3;COL3A1
20913,GO:1905477,0.190973352161783,0.953726852066366,2,120,positive regulation of protein localization to membrane,BP,KCNB1;DPP10
5077,GO:0010996,0.192421404454687,0.981088314381796,1,25,response to auditory stimulus,BP,CNTNAP2
13123,GO:0048814,0.192467449844263,0.953301271506978,2,90,regulation of dendrite morphogenesis,BP,CUX2;GRIN1
592,GO:0001763,0.192685172703096,0.935056437944537,3,189,morphogenesis of a branching structure,BP,ADM;SOCS3;COL4A1
15839,GO:0070838,0.192761079792156,0.913234382944089,5,422,divalent metal ion transport,BP,CAMK2A;SLC8A2;JPH3;GRIN1;ANXA2
17116,GO:0090184,0.19331490835997,0.980693753265791,1,35,positive regulation of kidney development,BP,LIF
13837,GO:0051604,0.19350498022808,0.934531444294359,3,249,protein maturation,BP,SERPINE1;PLAU;C1R
4620,GO:0010001,0.193937091832568,0.934374027914551,3,217,glial cell differentiation,BP,VIM;LIF;OPALIN
11988,GO:0045667,0.193965719584365,0.952588516120168,2,111,regulation of osteoblast differentiation,BP,LTF;SMOC1
12448,GO:0046636,0.194153884561203,0.980504474088638,1,36,negative regulation of alpha-beta T cell activation,BP,ANXA1
11288,GO:0043534,0.194682635668342,0.952314441601401,2,109,blood vessel endothelial cell migration,BP,SRPX2;ANXA1
5417,GO:0015399,0.194866739155675,0.952290186229222,2,100,primary active transmembrane transporter activity,MF,ATP1A3;ABCC3
5118,GO:0014046,0.195096438021214,0.980338104367999,1,34,dopamine secretion,BP,SYT1
5130,GO:0014059,0.195096438021214,0.980338104367999,1,34,regulation of dopamine secretion,BP,SYT1
3473,GO:0006928,0.195456057905285,0.86996380876328,18,1898,movement of cell or subcellular component,BP,TNFRSF12A;VIM;CAMK2A;CHGA;TIMP1;SRPX2;SERPINE1;COL1A1;LOX;PLAU;COL5A1;POSTN;ANXA1;PDPN;COL3A1;FUT9;PTPRT;DOK6
14835,GO:0060840,0.195544046696501,0.952110313052339,2,87,artery development,BP,LOX;COL3A1
17788,GO:0098609,0.195566397668793,0.893709512322494,8,747,cell-cell adhesion,BP,SRPX2;IGFBP2;ANXA1;PDPN;FUT9;SLITRK1;ANXA2;PTPRT
3665,GO:0007264,0.195576378865028,0.904333946892647,6,486,small GTPase mediated signal transduction,BP,RASGRF1;RAPGEF4;IQSEC3;PDPN;COL3A1;KSR2
12122,GO:0045923,0.195702266079493,0.980264992144349,1,31,positive regulation of fatty acid metabolic process,BP,ANXA1
16771,GO:0072524,0.1960962886172,0.980082704942349,1,37,pyridine-containing compound metabolic process,BP,NNMT
757,GO:0001975,0.196127970833606,0.980156444766122,1,32,response to amphetamine,BP,GRIN1
2519,GO:0005319,0.197568919876312,0.951136131538462,2,115,lipid transporter activity,MF,SLCO1A2;ABCC3
4507,GO:0009607,0.19766544973817,0.884692147750098,10,1212,response to biotic stimulus,BP,LTF;VIM;CAMK2A;CHGA;SERPINE1;ANXA1;ADM;C1R;SOCS3;PLA2G2A
18145,GO:0099522,0.198122516850322,0.979904771967255,1,25,region of cytosol,CC,SH3GL2
3330,GO:0006692,0.198352347392031,0.979529963544304,1,43,prostanoid metabolic process,BP,ANXA1
3331,GO:0006693,0.198352347392031,0.979529963544304,1,43,prostaglandin metabolic process,BP,ANXA1
11172,GO:0043325,0.198568654244596,0.979843107471062,1,24,phosphatidylinositol-3,4-bisphosphate binding,MF,PLEKHA4
458,GO:0001533,0.199062063486242,0.979621804324013,1,28,cornified envelope,CC,ANXA1
695,GO:0001894,0.19910836106223,0.931787471634374,3,223,tissue homeostasis,BP,LTF;SH3GL2;SERPINA3
11293,GO:0043539,0.199584041707846,0.979339090584414,1,37,protein serine/threonine kinase activator activity,MF,LTF
4831,GO:0010662,0.199922861463703,0.979296620703302,1,35,regulation of striated muscle cell apoptotic process,BP,CAMK2A
18693,GO:1900077,0.200041807874683,0.979324060659027,1,32,negative regulation of cellular response to insulin stimulus,BP,SOCS3
20523,GO:1904724,0.200517124356387,0.978982602676749,1,52,tertiary granule lumen,CC,LTF
18066,GO:0099081,0.200995012363341,0.885914258833104,9,807,supramolecular polymer,CC,VIM;NEFM;COL1A1;COL5A1;ANXA1;INA;SHANK2;COL3A1;COL4A1
1058,GO:0002455,0.201148872439288,0.978947874753106,1,41,humoral immune response mediated by circulating immunoglobulin,BP,C1R
802,GO:0002040,0.201507894324194,0.94956755329194,2,111,sprouting angiogenesis,BP,SRPX2;ANXA1
16763,GO:0072511,0.201756139874794,0.907802204832732,5,428,divalent inorganic cation transport,BP,CAMK2A;SLC8A2;JPH3;GRIN1;ANXA2
484,GO:0001569,0.201993054110793,0.978902157184726,1,32,branching involved in blood vessel morphogenesis,BP,COL4A1
17760,GO:0098552,0.202545092421005,0.9072712263797,5,493,side of membrane,CC,PLEKHA4;SNAP25;ANXA1;GNAL;CD163
21928,GO:2000758,0.202726768645299,0.978742317308456,1,32,positive regulation of peptidyl-lysine acetylation,BP,LIF
2734,GO:0005783,0.203199906158644,0.877688554404467,11,1255,endoplasmic reticulum,CC,TIMP1;ATP1A3;COL1A1;COL5A1;CHI3L1;COL6A2;JPH3;COL3A1;GRIN1;COL4A1;PLA2G2A
12073,GO:0045834,0.203209685600106,0.948796428144566,2,129,positive regulation of lipid metabolic process,BP,ANXA1;ADM
15948,GO:0070997,0.2032252151039,0.916569407282663,4,333,neuron death,BP,CHGA;KCNB1;GABRB3;GRIN1
10556,GO:0042129,0.203254456330148,0.948710243476812,2,150,regulation of T cell proliferation,BP,IGFBP2;ANXA1
2720,GO:0005766,0.20394035494575,0.948443743565578,2,145,primary lysosome,CC,ANXA2;SERPINA3
10774,GO:0042582,0.20394035494575,0.948443743565578,2,145,azurophil granule,CC,ANXA2;SERPINA3
4755,GO:0010543,0.204015075580846,0.978440560705343,1,33,regulation of platelet activation,BP,PDPN
20836,GO:1905332,0.204816319211152,0.978263854549961,1,33,positive regulation of morphogenesis of an epithelium,BP,LIF
4861,GO:0010721,0.20511918738544,0.915529216645491,4,305,negative regulation of cell development,BP,LTF;VIM;POSTN;COL3A1
10536,GO:0042088,0.205338329427164,0.978024932350184,1,41,T-helper 1 type immune response,BP,ANXA1
3159,GO:0006486,0.205387647468205,0.928614111279342,3,223,protein glycosylation,BP,GALNT13;FUT9;ST8SIA3
11221,GO:0043413,0.205387647468205,0.928614111279342,3,223,macromolecule glycosylation,BP,GALNT13;FUT9;ST8SIA3
5785,GO:0016311,0.205441076054071,0.905545635188133,5,435,dephosphorylation,BP,PPP2R2C;PHACTR3;SPOCD1;ELFN2;PTPRT
4828,GO:0010659,0.205449940296977,0.978087379128411,1,35,cardiac muscle cell apoptotic process,BP,CAMK2A
15348,GO:0062013,0.205887959362007,0.947725630347099,2,122,positive regulation of small molecule metabolic process,BP,ANXA1;ADM
10783,GO:0042592,0.20604949249618,0.866439472956992,15,1727,homeostatic process,BP,LTF;SLC17A7;ATP1A3;SH3GL2;LOX;SLC8A2;ANXA1;ADM;JPH3;KCNB1;KSR2;GRIN1;SLITRK1;PLA2G2A;SERPINA3
13117,GO:0048799,0.20672275432151,0.978161211355805,1,22,animal organ maturation,BP,LTF
683,GO:0001881,0.206951792545543,0.9778305361865,1,31,receptor recycling,BP,ANXA2
14218,GO:0055065,0.207029394563367,0.896942447583828,6,584,metal ion homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;GRIN1
18108,GO:0099175,0.207408941618288,0.947213871705433,2,100,regulation of postsynapse organization,BP,CUX2;SHISA7
13733,GO:0051402,0.207485579915617,0.927532288766141,3,228,neuron apoptotic process,BP,KCNB1;GABRB3;GRIN1
9894,GO:0035722,0.207518144659525,0.977500802036352,1,44,interleukin-12-mediated signaling pathway,BP,ANXA2
13337,GO:0050770,0.208176905392775,0.927296455924308,3,181,regulation of axonogenesis,BP,TNFRSF12A;GRIN1;SLITRK1
10051,GO:0036002,0.208225122238619,0.977449129464468,1,36,pre-mRNA binding,MF,CELF4
7352,GO:0030427,0.208264085022339,0.927248612424485,3,182,site of polarized growth,CC,RASGRF1;SNAP25;SHANK2
15379,GO:0062208,0.208272632778326,0.977473485262126,1,34,positive regulation of pattern recognition receptor signaling pathway,BP,LTF
12973,GO:0048523,0.209043262425661,0.847009483906354,34,4362,negative regulation of cellular process,BP,LTF;VIM;PHACTR3;CHGA;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;IGFBP2;TGFBI;PACSIN1;LIF;GDF15;COL5A1;POSTN;SPOCD1;ANXA1;ADM;JPH3;KCNB1;SHANK1;SHANK2;PDPN;GABRB3;ELFN2;COL3A1;GRIN1;ANXA2;SOCS3;MYT1L;PTPRT;SERPINA3
3474,GO:0006929,0.209391306884301,0.977417080451024,1,26,substrate-dependent cell migration,BP,TNFRSF12A
11920,GO:0045581,0.209422845657183,0.977146184318646,1,38,negative regulation of T cell differentiation,BP,ANXA1
5385,GO:0015298,0.209870075138525,0.977222408795582,1,29,solute:cation antiporter activity,MF,SLC8A2
5380,GO:0015293,0.209934964924542,0.946046995591217,2,122,symporter activity,MF,SLC17A7;SLC6A17
14727,GO:0060674,0.20999655870396,0.977168662971185,1,30,placenta blood vessel development,BP,SOCS3
4722,GO:0010470,0.210127044628351,0.977093514443925,1,32,regulation of gastrulation,BP,COL5A1
7237,GO:0030225,0.210225699785236,0.976921057377951,1,41,macrophage differentiation,BP,LIF
694,GO:0001893,0.210239197784643,0.977009403598238,1,35,maternal placenta development,BP,LIF
11561,GO:0044344,0.210263582956959,0.945909712072013,2,122,cellular response to fibroblast growth factor stimulus,BP,COL1A1;POSTN
13359,GO:0050798,0.210418962611359,0.976904195237467,1,39,activated T cell proliferation,BP,IGFBP2
19911,GO:1903523,0.210557569988594,0.977041270788851,1,30,negative regulation of blood circulation,BP,ADM
3934,GO:0008219,0.21129994222792,0.860645146434307,16,1961,cell death,BP,TNFRSF12A;LTF;CAMK2A;CHGA;TIMP1;SERPINE1;LOX;CHI3L1;ANXA1;EMP3;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
3637,GO:0007212,0.211314793035725,0.976713597474812,1,38,dopamine receptor signaling pathway,BP,GNAL
7089,GO:0030003,0.211609796290344,0.893964911370264,6,596,cellular cation homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;GRIN1
14541,GO:0060384,0.211814001786359,0.976868565501277,1,26,innervation,BP,GABRB3
4879,GO:0010742,0.211974423626227,0.976693893412509,1,31,macrophage derived foam cell differentiation,BP,PLA2G2A
17042,GO:0090077,0.211974423626227,0.976693893412509,1,31,foam cell differentiation,BP,PLA2G2A
11868,GO:0045335,0.212954834011911,0.944734454075572,2,133,phagocytic vesicle,CC,LTF;VIM
7358,GO:0030449,0.213013340250301,0.976278256089207,1,41,regulation of complement activation,BP,C1R
7960,GO:0031668,0.21323213742363,0.92456132073905,3,231,cellular response to extracellular stimulus,BP,COL1A1;POSTN;KCNB1
4654,GO:0010165,0.213366896412118,0.976373294470984,1,31,response to X-ray,BP,ANXA1
16333,GO:0071675,0.213571969734906,0.97611077910131,1,44,regulation of mononuclear cell migration,BP,SERPINE1
12130,GO:0045933,0.213832158931429,0.976101408039613,1,40,positive regulation of muscle contraction,BP,CHGA
7191,GO:0030170,0.214127765600978,0.975980890356135,1,44,pyridoxal phosphate binding,MF,ETNPPL
15555,GO:0070279,0.214127765600978,0.975980890356135,1,44,vitamin B6 binding,MF,ETNPPL
8822,GO:0033120,0.21494208327912,0.975923441112924,1,35,positive regulation of RNA splicing,BP,CELF4
4578,GO:0009887,0.214993406727397,0.872286846965569,10,988,animal organ morphogenesis,BP,LTF;PLEKHA4;SERPINE1;COL1A1;LIF;COL5A1;ADM;SHANK1;SHANK2;COL3A1
10584,GO:0042177,0.215192723680526,0.943846983886598,2,119,negative regulation of protein catabolic process,BP,TIMP1;ANXA2
4161,GO:0008610,0.215228957595978,0.891578615370906,6,639,lipid biosynthetic process,BP,PLEKHA4;ANXA1;ADM;ETNPPL;ST8SIA3;PLA2G2A
4827,GO:0010658,0.215296481164278,0.97580507914653,1,37,striated muscle cell apoptotic process,BP,CAMK2A
3753,GO:0007520,0.215584472172801,0.975792313471632,1,34,myoblast fusion,BP,GDF15
18701,GO:1900087,0.215593655566645,0.97575257728092,1,36,positive regulation of G1/S transition of mitotic cell cycle,BP,ANXA1
15609,GO:0070372,0.216568205147069,0.922784565484461,3,250,regulation of ERK1 and ERK2 cascade,BP,LIF;CHI3L1;PLA2G2A
2486,GO:0005246,0.216772632540241,0.975382674492598,1,42,calcium channel regulator activity,MF,HPCAL4
9609,GO:0035235,0.217522807677,0.975583736241686,1,25,ionotropic glutamate receptor signaling pathway,BP,GRIN1
9834,GO:0035633,0.218091286461726,0.975221727558944,1,33,maintenance of blood-brain barrier,BP,SH3GL2
3796,GO:0007618,0.218112165498808,0.97515732327928,1,36,mating,BP,GRIN1
10923,GO:0042908,0.218750197533042,0.975043961700722,1,34,xenobiotic transport,BP,ABCC3
7015,GO:0022409,0.218897901666672,0.921551254917086,3,255,positive regulation of cell-cell adhesion,BP,IGFBP2;ANXA1;PDPN
730,GO:0001945,0.219326610441073,0.975121958527246,1,26,lymph vessel development,BP,PDPN
5520,GO:0015804,0.219389989669526,0.97483441932817,1,37,neutral amino acid transport,BP,SLC6A17
6863,GO:0021762,0.219598944844906,0.974751253979339,1,39,substantia nigra development,BP,INA
13044,GO:0048667,0.219884033215117,0.88222432075589,7,573,cell morphogenesis involved in neuron differentiation,BP,TNFRSF12A;CUX2;SHANK1;SHANK2;GRIN1;SLITRK1;DOK6
16358,GO:0071711,0.220075481806574,0.974848573001301,1,29,basement membrane organization,BP,COL4A1
18207,GO:0099622,0.220281333204351,0.974677551086817,1,34,cardiac muscle cell membrane repolarization,BP,KCNIP2
15573,GO:0070306,0.220281917507871,0.974721557865959,1,32,lens fiber cell differentiation,BP,VIM
1546,GO:0003338,0.220562547144563,0.974678474284469,1,31,metanephros morphogenesis,BP,LIF
10632,GO:0042304,0.220576593172201,0.974500377877049,1,40,regulation of fatty acid biosynthetic process,BP,ANXA1
7184,GO:0030162,0.220975253371261,0.887800396358601,6,632,regulation of proteolysis,BP,LTF;TIMP1;SERPINE1;GRIN1;ANXA2;SERPINA3
14567,GO:0060416,0.221037258047977,0.974540027541016,1,32,response to growth hormone,BP,GDF15
6261,GO:0018107,0.221476413289118,0.941219274982761,2,107,peptidyl-threonine phosphorylation,BP,CAMK2A;CHI3L1
12026,GO:0045744,0.22163556930519,0.974188651205102,1,44,negative regulation of G protein-coupled receptor signaling pathway,BP,ADM
16111,GO:0071349,0.221746550642701,0.974137615965793,1,46,cellular response to interleukin-12,BP,ANXA2
15432,GO:0070085,0.222121330450171,0.91988282665593,3,235,glycosylation,BP,GALNT13;FUT9;ST8SIA3
8668,GO:0032870,0.222182646546841,0.887043389650128,6,561,cellular response to hormone stimulus,BP,CAMK2A;ATP1A3;IGFBP2;GDF15;ANXA1;SOCS3
5451,GO:0015662,0.222621694428063,0.974156934655475,1,32,ion transmembrane transporter activity, phosphorylative mechanism,MF,ATP1A3
20973,GO:1905606,0.223201592729034,0.973992592765924,1,33,regulation of presynapse assembly,BP,SLITRK1
7513,GO:0030863,0.223547444970205,0.940353374625902,2,102,cortical cytoskeleton,CC,MOBP;RIMS2
7451,GO:0030669,0.223549215645343,0.973826802736022,1,37,clathrin-coated endocytic vesicle membrane,CC,SH3GL2
13083,GO:0048713,0.223774958536774,0.973737171855756,1,39,regulation of oligodendrocyte differentiation,BP,OPALIN
3435,GO:0006873,0.224313389659397,0.885601770963882,6,606,cellular ion homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;GRIN1
11259,GO:0043491,0.224546301658589,0.918608296859981,3,227,protein kinase B signaling,BP,LOX;GDF15;CHI3L1
12057,GO:0045806,0.224835103764022,0.973444994909697,1,41,negative regulation of endocytosis,BP,PACSIN1
7760,GO:0031312,0.225006059841753,0.973402740851419,1,41,extrinsic component of organelle membrane,CC,ANXA1
5793,GO:0016324,0.225118050799697,0.903865729383933,4,320,apical plasma membrane,CC,IGFBP2;ANXA1;SHANK2;PDPN
15776,GO:0070671,0.225488880803305,0.973204964850264,1,47,response to interleukin-12,BP,ANXA2
18350,GO:0106056,0.225756609787357,0.973389731222331,1,32,regulation of calcineurin-mediated signaling,BP,SLC8A2
16375,GO:0071774,0.225926547034012,0.93917287583887,2,127,response to fibroblast growth factor,BP,COL1A1;POSTN
13637,GO:0051246,0.225950474377169,0.843362100408529,20,2473,regulation of protein metabolic process,BP,LTF;VIM;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ELFN2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
12450,GO:0046638,0.226045544298885,0.97311637521806,1,43,positive regulation of alpha-beta T cell differentiation,BP,ANXA1
8242,GO:0032232,0.226325394086436,0.97336243712301,1,28,negative regulation of actin filament bundle assembly,BP,SHANK1
746,GO:0001964,0.227378372073897,0.973136163751742,1,27,startle response,BP,GRIN1
13027,GO:0048638,0.227834536399976,0.902259670466199,4,312,regulation of developmental growth,BP,TNFRSF12A;SYT1;GDF15;RIMS2
7506,GO:0030855,0.228228784948131,0.883012484030823,6,572,epithelial cell differentiation,BP,VIM;SERPINE1;LIF;ANXA1;PDPN;COL4A1
11060,GO:0043168,0.228278532412037,0.839239156819891,22,2551,anion binding,MF,LTF;SNAP91;SYT1;CAMK2A;RAPGEF4;ATP1A3;PLEKHA4;ABCC3;PACSIN1;COL5A1;POSTN;ANXA1;GNAL;RAB3C;SYN2;ETNPPL;KSR2;GRIN1;ST8SIA3;ANXA2;PLA2G2A;SMOC1
21582,GO:2000241,0.228719527486589,0.937886119856642,2,140,regulation of reproductive process,BP,TIMP1;LIF
13524,GO:0051050,0.228830086848323,0.870556196881766,8,843,positive regulation of transport,BP,SYT1;CAMK2A;SERPINE1;KCNIP2;ANXA1;KCNB1;GRIN1;ANXA2
18107,GO:0099174,0.228980323942211,0.972540274210726,1,34,regulation of presynapse organization,BP,SLITRK1
3391,GO:0006796,0.229047208255783,0.837596895016526,23,2904,phosphate-containing compound metabolic process,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;SRPX2;PLEKHA4;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;SPOCD1;ETNPPL;NNMT;ELFN2;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT
4024,GO:0008376,0.229270785159366,0.972321656516298,1,42,acetylgalactosaminyltransferase activity,MF,GALNT13
11720,GO:0045017,0.22938532832599,0.915974791615699,3,243,glycerolipid biosynthetic process,BP,PLEKHA4;ETNPPL;PLA2G2A
2271,GO:0004869,0.229866698319884,0.972142538020357,1,44,cysteine-type endopeptidase inhibitor activity,MF,LTF
20190,GO:1904036,0.230104060513507,0.972176181372357,1,38,negative regulation of epithelial cell apoptotic process,BP,SERPINE1
4817,GO:0010644,0.230482635989814,0.972264644325868,1,30,cell communication by electrical coupling,BP,ATP1A3
6138,GO:0017016,0.230731547434075,0.889743108491818,5,383,Ras GTPase binding,MF,RASGRF1;RAPGEF4;MOBP;RIMS2;ANXA2
19934,GO:1903556,0.230968668621981,0.971823878863036,1,47,negative regulation of tumor necrosis factor superfamily cytokine production,BP,LTF
18176,GO:0099560,0.231117681371425,0.972167236403887,1,28,synaptic membrane adhesion,BP,SLITRK1
10975,GO:0043010,0.231179386140653,0.900261643233626,4,308,camera-type eye development,BP,VIM;CELF4;SLC17A7;COL4A1
14232,GO:0055082,0.231520410864708,0.874111054709116,7,735,cellular chemical homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;KCNB1;GRIN1
2514,GO:0005310,0.231620433616678,0.971829465385646,1,36,dicarboxylic acid transmembrane transporter activity,MF,SLC17A7
5650,GO:0016049,0.231670404999358,0.889068812512229,5,448,cell growth,BP,TNFRSF12A;SYT1;SH3GL2;POSTN;RIMS2
11999,GO:0045687,0.231830386284509,0.971670494753984,1,42,positive regulation of glial cell differentiation,BP,LIF
11185,GO:0043370,0.231875050547894,0.971659058437489,1,42,regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
7405,GO:0030551,0.233009079988068,0.971542163560307,1,33,cyclic nucleotide binding,MF,RAPGEF4
14491,GO:0060325,0.233116113990895,0.971596247070696,1,30,face morphogenesis,BP,COL1A1
10002,GO:0035909,0.233639769578123,0.97146229669286,1,30,aorta morphogenesis,BP,COL3A1
16402,GO:0071827,0.235164461167927,0.970825701261992,1,41,plasma lipoprotein particle organization,BP,PLA2G2A
11947,GO:0045620,0.235335642794497,0.970721827959615,1,45,negative regulation of lymphocyte differentiation,BP,ANXA1
19283,GO:1902105,0.235685273183199,0.912515851092541,3,258,regulation of leukocyte differentiation,BP,LTF;LIF;ANXA1
3283,GO:0006636,0.236172716728964,0.970420630493949,1,52,unsaturated fatty acid biosynthetic process,BP,ANXA1
439,GO:0001504,0.236622188126107,0.97044514821145,1,41,neurotransmitter uptake,BP,SNAP25
19285,GO:1902107,0.2366470258559,0.934308728481312,2,145,positive regulation of leukocyte differentiation,BP,LIF;ANXA1
12772,GO:0048009,0.236672638041594,0.970679672259529,1,30,insulin-like growth factor receptor signaling pathway,BP,IGFBP2
3841,GO:0008066,0.237353909432455,0.970605577691752,1,27,glutamate receptor activity,MF,GRIN1
8631,GO:0032801,0.238300208734865,0.970144693724544,1,34,receptor catabolic process,BP,ANXA2
9311,GO:0034399,0.238388316549251,0.933592747207339,2,127,nuclear periphery,CC,VIM;PHACTR3
4629,GO:0010035,0.238605626667776,0.884535858924996,5,507,response to inorganic substance,BP,SYT1;COL1A1;IGFBP2;KCNIP2;ANXA1
14229,GO:0055078,0.239440795389978,0.969669491117972,1,43,sodium ion homeostasis,BP,ATP1A3
13546,GO:0051092,0.239472226206195,0.933001582898076,2,150,positive regulation of NF-kappaB transcription factor activity,BP,LTF;CAMK2A
4185,GO:0008654,0.240811588825203,0.909700599008693,3,251,phospholipid biosynthetic process,BP,PLEKHA4;ETNPPL;PLA2G2A
16635,GO:0072210,0.241713244949986,0.969215497131246,1,35,metanephric nephron development,BP,LIF
3175,GO:0006509,0.241721546139775,0.969110131629197,1,40,membrane protein ectodomain proteolysis,BP,TIMP1
161,GO:0000323,0.242288574418089,0.873460443211345,6,648,lytic vacuole,CC,CHGA;FMOD;ANXA1;CPLX2;ANXA2;SERPINA3
2718,GO:0005764,0.242288574418089,0.873460443211345,6,648,lysosome,CC,CHGA;FMOD;ANXA1;CPLX2;ANXA2;SERPINA3
3390,GO:0006793,0.242590927908966,0.826489931710521,23,2929,phosphorus metabolic process,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;SRPX2;PLEKHA4;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;SPOCD1;ETNPPL;NNMT;ELFN2;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT
10616,GO:0042277,0.243511111094638,0.908169478751821,3,266,peptide binding,MF,ATP1A3;KCNIP2;GRIN1
5932,GO:0016601,0.243804271497666,0.968607922733187,1,37,Rac protein signal transduction,BP,RASGRF1
8593,GO:0032757,0.243929158146129,0.968379586519203,1,49,positive regulation of interleukin-8 production,BP,SERPINE1
4027,GO:0008380,0.244620232081471,0.89192932966805,4,421,RNA splicing,BP,CELF4;SRRM4;AFF2;RBFOX3
20701,GO:1905039,0.244758143826087,0.930635080201097,2,132,carboxylic acid transmembrane transport,BP,SLC17A7;PDPN
17171,GO:0090263,0.245416572295693,0.930297265044824,2,139,positive regulation of canonical Wnt signaling pathway,BP,PLEKHA4;COL1A1
14577,GO:0060429,0.245439571507089,0.849721666531981,10,1063,epithelium development,BP,VIM;PLEKHA4;SERPINE1;LIF;COL5A1;ANXA1;ADM;PDPN;SOCS3;COL4A1
4474,GO:0009409,0.245471485145636,0.968042759107636,1,43,response to cold,BP,ADM
7370,GO:0030501,0.24549033828926,0.9681498864104,1,37,positive regulation of bone mineralization,BP,LTF
6447,GO:0019216,0.24601760575152,0.891121007246678,4,369,regulation of lipid metabolic process,BP,ANXA1;ADM;SOCS3;SERPINA3
11282,GO:0043524,0.246535760321187,0.929774887133838,2,139,negative regulation of neuron apoptotic process,BP,GABRB3;GRIN1
3478,GO:0006935,0.246672845052924,0.870493167758506,6,584,chemotaxis,BP,CHGA;SERPINE1;LOX;PLAU;ANXA1;DOK6
8320,GO:0032365,0.246707975682203,0.967816823368169,1,37,intracellular lipid transport,BP,ANXA2
20075,GO:1903825,0.246735715566485,0.929708304951523,2,133,organic acid transmembrane transport,BP,SLC17A7;PDPN
4969,GO:0010862,0.246912152430843,0.967631290163939,1,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,GDF15
7455,GO:0030674,0.24795767771728,0.905740118204534,3,234,protein-macromolecule adaptor activity,MF,SNAP25;SHANK1;SHANK2
2383,GO:0005048,0.248139559037667,0.967342575577384,1,41,signal sequence binding,MF,KCNIP2
15255,GO:0061756,0.248695995005422,0.967170606327429,1,42,leukocyte adhesion to vascular endothelial cell,BP,FUT9
720,GO:0001934,0.249090284371125,0.855937276510427,8,883,positive regulation of protein phosphorylation,BP,LTF;SLC8A2;LIF;GDF15;CHI3L1;ANXA2;SOCS3;PLA2G2A
19227,GO:1901985,0.249252831991756,0.967033602261017,1,41,positive regulation of protein acetylation,BP,LIF
7728,GO:0031267,0.249445113740829,0.877538229773484,5,394,small GTPase binding,MF,RASGRF1;RAPGEF4;MOBP;RIMS2;ANXA2
14489,GO:0060323,0.249802618143387,0.96700933918192,1,35,head morphogenesis,BP,COL1A1
10649,GO:0042330,0.249994761905632,0.868200938298821,6,586,taxis,BP,CHGA;SERPINE1;LOX;PLAU;ANXA1;DOK6
7809,GO:0031399,0.250165461949173,0.834176998126952,14,1659,regulation of protein modification process,BP,LTF;PPP2R2C;PHACTR3;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ELFN2;ANXA2;SOCS3;PLA2G2A;PTPRT
7105,GO:0030029,0.250223154987029,0.855172631040295,8,741,actin filament-based process,BP,VIM;PHACTR3;IQSEC3;PACSIN1;ANXA1;INA;SHANK1;PDPN
7137,GO:0030099,0.250226852834778,0.888503663625881,4,370,myeloid cell differentiation,BP,LTF;LOX;LIF;ANXA2
15608,GO:0070371,0.250973238373852,0.903965051906739,3,267,ERK1 and ERK2 cascade,BP,LIF;CHI3L1;PLA2G2A
11515,GO:0044273,0.25111191848766,0.966390085371716,1,49,sulfur compound catabolic process,BP,FMOD
5567,GO:0015872,0.251203544772539,0.966377513072126,1,48,dopamine transport,BP,SYT1
11459,GO:0044088,0.251231815913526,0.966428556621597,1,44,regulation of vacuole organization,BP,ANXA2
12367,GO:0046486,0.252256233672068,0.887228809143645,4,375,glycerolipid metabolic process,BP,PLEKHA4;ETNPPL;SOCS3;PLA2G2A
7507,GO:0030856,0.252277210791349,0.927101223926458,2,132,regulation of epithelial cell differentiation,BP,SERPINE1;LIF
4916,GO:0010799,0.252742253894926,0.966018934650962,1,43,regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
14351,GO:0060119,0.252980119105579,0.966070767445874,1,37,inner ear receptor cell development,BP,GABRB3
3492,GO:0006956,0.253451052247207,0.965678855395626,1,53,complement activation,BP,C1R
19554,GO:1902808,0.253856840882932,0.965685784539157,1,44,positive regulation of cell cycle G1/S phase transition,BP,ANXA1
13754,GO:0051445,0.253997600150499,0.96562961717385,1,45,regulation of meiotic cell cycle,BP,LIF
8541,GO:0032663,0.254047441608653,0.965585289636732,1,47,regulation of interleukin-2 production,BP,ANXA1
3468,GO:0006915,0.25440806498853,0.830798691061277,14,1743,apoptotic process,BP,TNFRSF12A;LTF;CAMK2A;TIMP1;SERPINE1;LOX;CHI3L1;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
19683,GO:1903053,0.254818200708279,0.965526566919884,1,38,regulation of extracellular matrix organization,BP,PDPN
7013,GO:0022407,0.254950941824475,0.885520064737097,4,389,regulation of cell-cell adhesion,BP,IGFBP2;ANXA1;PDPN;FUT9
11091,GO:0043209,0.255680315059042,0.965148213529248,1,45,myelin sheath,CC,ANXA2
656,GO:0001837,0.255872635794643,0.925360331677226,2,137,epithelial to mesenchymal transition,BP,COL1A1;PDPN
2583,GO:0005507,0.256437215477395,0.964833402198247,1,52,copper ion binding,MF,LOX
15484,GO:0070169,0.256875960833396,0.964874514554871,1,41,positive regulation of biomineral tissue development,BP,LTF
18420,GO:0110151,0.256875960833396,0.964874514554871,1,41,positive regulation of biomineralization,BP,LTF
12956,GO:0048489,0.257483218199149,0.964680243372355,1,42,synaptic vesicle transport,BP,SNAP91
7602,GO:0031018,0.257533407608798,0.964647600199144,1,43,endocrine pancreas development,BP,ANXA1
8329,GO:0032374,0.257727811213891,0.964591321505899,1,43,regulation of cholesterol transport,BP,ANXA2
4943,GO:0010830,0.258983505093559,0.964161095844827,1,47,regulation of myotube differentiation,BP,GDF15
5086,GO:0014002,0.259054242712369,0.96426378457372,1,40,astrocyte development,BP,VIM
9295,GO:0034381,0.259060715141172,0.964138563689833,1,47,plasma lipoprotein particle clearance,BP,ANXA2
8326,GO:0032371,0.260532797972169,0.963756047304035,1,44,regulation of sterol transport,BP,ANXA2
3971,GO:0008287,0.261288786573604,0.963500533022761,1,46,protein serine/threonine phosphatase complex,CC,PPP2R2C
19786,GO:1903293,0.261288786573604,0.963500533022761,1,46,phosphatase complex,CC,PPP2R2C
13321,GO:0050732,0.261490060418715,0.963425586106437,1,47,negative regulation of peptidyl-tyrosine phosphorylation,BP,SOCS3
10527,GO:0042059,0.262371827152224,0.963196983792375,1,45,negative regulation of epidermal growth factor receptor signaling pathway,BP,SH3GL2
2380,GO:0005044,0.262679292428821,0.963141097944539,1,43,scavenger receptor activity,MF,CD163
7121,GO:0030049,0.262767868594317,0.963296087288681,1,35,muscle filament sliding,BP,VIM
8906,GO:0033275,0.262767868594317,0.963296087288681,1,35,actin-myosin filament sliding,BP,VIM
22118,GO:2001236,0.262950994148771,0.921867256256699,2,151,regulation of extrinsic apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1
15538,GO:0070252,0.262987030446539,0.922066832994222,2,111,actin-mediated cell contraction,BP,VIM;PDPN
11204,GO:0043394,0.263248470138238,0.963213496844527,1,33,proteoglycan binding,MF,COL5A1
1245,GO:0002762,0.263530568096787,0.962870391637351,1,44,negative regulation of myeloid leukocyte differentiation,BP,LTF
11752,GO:0045071,0.263669517190439,0.96270915215045,1,52,negative regulation of viral genome replication,BP,LTF
10477,GO:0040008,0.26372566739731,0.858595423141512,6,610,regulation of growth,BP,TNFRSF12A;SYT1;IGFBP2;GDF15;RIMS2;SOCS3
16357,GO:0071709,0.265018141897616,0.962575549135421,1,37,membrane assembly,BP,ANXA2
19286,GO:1902108,0.265466575677886,0.962101452067602,1,58,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,CAMK2A
756,GO:0001974,0.265575625933204,0.962384285302177,1,38,blood vessel remodeling,BP,LIF
12126,GO:0045927,0.265642223860733,0.89558284858585,3,231,positive regulation of growth,BP,TNFRSF12A;SYT1;RIMS2
718,GO:0001932,0.266464475111708,0.829905004462774,11,1283,regulation of protein phosphorylation,BP,LTF;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ANXA2;SOCS3;PLA2G2A;PTPRT
19532,GO:1902743,0.266524668216651,0.962011850211075,1,42,regulation of lamellipodium organization,BP,PDPN
554,GO:0001701,0.267088539420783,0.877839077142684,4,355,in utero embryonic development,BP,CELF4;LIF;ADM;SOCS3
13342,GO:0050775,0.267107108635775,0.96194955222106,1,37,positive regulation of dendrite morphogenesis,BP,CUX2
18200,GO:0099604,0.267831828327159,0.962191152992207,1,25,ligand-gated calcium channel activity,MF,GRIN1
19671,GO:1903037,0.268508035254401,0.893771664675377,3,291,regulation of leukocyte cell-cell adhesion,BP,IGFBP2;ANXA1;FUT9
4766,GO:0010565,0.268580131438563,0.919039038575814,2,164,regulation of cellular ketone metabolic process,BP,ANXA1;ADM
4807,GO:0010634,0.268726021498086,0.919094385414054,2,134,positive regulation of epithelial cell migration,BP,SRPX2;ANXA1
4748,GO:0010524,0.268954979580715,0.961126192997553,1,51,positive regulation of calcium ion transport into cytosol,BP,GRIN1
1339,GO:0002920,0.269005473855398,0.961037153822184,1,57,regulation of humoral immune response,BP,C1R
21658,GO:2000351,0.269172438516658,0.961135874736712,1,46,regulation of endothelial cell apoptotic process,BP,SERPINE1
8515,GO:0032623,0.270241823900612,0.960718414897552,1,52,interleukin-2 production,BP,ANXA1
6672,GO:0019887,0.270476559673296,0.918082310891565,2,167,protein kinase regulator activity,MF,LTF;SOCS3
7955,GO:0031663,0.270512404314694,0.960609529513457,1,54,lipopolysaccharide-mediated signaling pathway,BP,LTF
3296,GO:0006654,0.27057580108399,0.960801992006418,1,41,phosphatidic acid biosynthetic process,BP,PLA2G2A
3145,GO:0006468,0.270760597365573,0.815388444530102,15,1764,protein phosphorylation,BP,LTF;RASGRF1;CAMK2A;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT
10540,GO:0042098,0.2707871568021,0.917891813614827,2,178,T cell proliferation,BP,IGFBP2;ANXA1
6483,GO:0019320,0.27081089448703,0.96057113163846,1,50,hexose catabolic process,BP,FUT9
719,GO:0001933,0.271033568931451,0.875257555612888,4,380,negative regulation of protein phosphorylation,BP,SH3GL2;LIF;SOCS3;PTPRT
6194,GO:0017124,0.271046042265495,0.917976192857163,2,127,SH3 domain binding,MF,SHANK1;SHANK2
3291,GO:0006644,0.271257073694648,0.875095240740378,4,394,phospholipid metabolic process,BP,PLEKHA4;ETNPPL;SOCS3;PLA2G2A
4449,GO:0009311,0.271617942477826,0.960322238208939,1,50,oligosaccharide metabolic process,BP,ST8SIA3
4609,GO:0009968,0.27169085245158,0.829607536043459,10,1168,negative regulation of signal transduction,BP,LTF;CELF4;SERPINE1;SH3GL2;IGFBP2;LIF;GDF15;ADM;SOCS3;PTPRT
1246,GO:0002763,0.271908916738679,0.960247163126268,1,49,positive regulation of myeloid leukocyte differentiation,BP,LIF
19866,GO:1903428,0.272208696988634,0.960220679760256,1,45,positive regulation of reactive oxygen species biosynthetic process,BP,GRIN1
13826,GO:0051592,0.27247872162544,0.917203173660917,2,137,response to calcium ion,BP,SYT1;KCNIP2
3647,GO:0007223,0.272663697287964,0.960230030124238,1,38,Wnt signaling pathway, calcium modulating pathway,BP,CAMK2A
19012,GO:1901381,0.2734255757993,0.960020723967851,1,37,positive regulation of potassium ion transmembrane transport,BP,KCNIP2
16937,GO:0086009,0.273731754254683,0.959806934509236,1,42,membrane repolarization,BP,KCNIP2
11019,GO:0043090,0.273795835112069,0.959787017465934,1,42,amino acid import,BP,SLC17A7
16125,GO:0071364,0.273929097192073,0.95976707702919,1,41,cellular response to epidermal growth factor stimulus,BP,COL1A1
5144,GO:0014075,0.274222140349778,0.959577595498592,1,46,response to amine,BP,GRIN1
438,GO:0001503,0.274650671780007,0.872925204910957,4,366,ossification,BP,LTF;COL1A1;LOX;SMOC1
21764,GO:2000514,0.275650011022416,0.958997538446598,1,55,regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
2497,GO:0005262,0.276247492350014,0.91549178346901,2,108,calcium channel activity,MF,GRIN1;ANXA2
17115,GO:0090183,0.276561968841847,0.958793732288693,1,49,regulation of kidney development,BP,LIF
22120,GO:2001238,0.276782670105827,0.958708657268792,1,50,positive regulation of extrinsic apoptotic signaling pathway,BP,TNFRSF12A
13595,GO:0051155,0.277065238586943,0.958604501741315,1,51,positive regulation of striated muscle cell differentiation,BP,GDF15
9784,GO:0035567,0.277566533522223,0.914580803259934,2,147,non-canonical Wnt signaling pathway,BP,CAMK2A;PLEKHA4
17720,GO:0097720,0.277832072050717,0.958521357010778,1,42,calcineurin-mediated signaling,BP,SLC8A2
8677,GO:0032880,0.278276574611613,0.83423453145726,8,869,regulation of protein localization,BP,RAPGEF4;CHGA;LIF;SNAP25;ANXA1;KCNB1;DPP10;SHISA7
15715,GO:0070555,0.278304091600811,0.914087947246858,2,178,response to interleukin-1,BP,CHI3L1;ANXA1
12358,GO:0046473,0.278319168537369,0.958345976434229,1,43,phosphatidic acid metabolic process,BP,PLA2G2A
15611,GO:0070374,0.278935575905841,0.913791024000459,2,170,positive regulation of ERK1 and ERK2 cascade,BP,CHI3L1;PLA2G2A
6682,GO:0019903,0.28067637812336,0.913008754656544,2,143,protein phosphatase binding,MF,PHACTR3;PTPRT
20478,GO:1904646,0.280984908791087,0.957614980980901,1,38,cellular response to amyloid-beta,BP,ATP1A3
12819,GO:0048146,0.28101929628616,0.95740774845756,1,47,positive regulation of fibroblast proliferation,BP,ANXA2
18926,GO:1901185,0.281029555769052,0.957370653915173,1,49,negative regulation of ERBB signaling pathway,BP,SH3GL2
13108,GO:0048771,0.28169248056022,0.912462470028899,2,148,tissue remodeling,BP,TIMP1;LIF
18218,GO:0099637,0.28182653886376,0.957166027895664,1,46,neurotransmitter receptor transport,BP,SNAP25
21884,GO:2000677,0.282391121392101,0.956983850899999,1,46,regulation of transcription regulatory region DNA binding,BP,LIF
2394,GO:0005088,0.28243307284336,0.912291671571379,2,113,Ras guanyl-nucleotide exchange factor activity,MF,RASGRF1;RAPGEF4
11462,GO:0044091,0.282678271774026,0.956972579750302,1,42,membrane biogenesis,BP,ANXA2
17739,GO:0097755,0.282757366073797,0.956752344428859,1,53,positive regulation of blood vessel diameter,BP,ADM
5241,GO:0014911,0.283010870513965,0.957021894360591,1,36,positive regulation of smooth muscle cell migration,BP,POSTN
6010,GO:0016758,0.284063302665496,0.911155840951841,2,168,transferase activity, transferring hexosyl groups,MF,GALNT13;FUT9
12046,GO:0045785,0.284102540845155,0.866670248304782,4,396,positive regulation of cell adhesion,BP,IGFBP2;LIF;ANXA1;PDPN
612,GO:0001784,0.284658633909835,0.9563304866009,1,42,phosphotyrosine residue binding,MF,SOCS3
11136,GO:0043277,0.28491757648926,0.956127065200889,1,48,apoptotic cell clearance,BP,ANXA1
12447,GO:0046635,0.285057216030162,0.955925997793428,1,59,positive regulation of alpha-beta T cell activation,BP,ANXA1
272,GO:0000768,0.286192572992417,0.955765376796959,1,45,syncytium formation by plasma membrane fusion,BP,GDF15
18569,GO:0140253,0.286192572992417,0.955765376796959,1,45,cell-cell fusion,BP,GDF15
5929,GO:0016597,0.287241687176875,0.955269867928708,1,54,amino acid binding,MF,GRIN1
727,GO:0001941,0.287979171229788,0.95529050595148,1,40,postsynaptic membrane organization,BP,SHISA7
117,GO:0000245,0.288404527795601,0.954844592473857,1,57,spliceosomal complex assembly,BP,CELF4
2459,GO:0005179,0.28875443034445,0.954578245172714,1,72,hormone activity,MF,ADM
1622,GO:0003729,0.289530341837193,0.881129665336257,3,274,mRNA binding,MF,CELF4;SRRM4;RBFOX3
20008,GO:1903706,0.290398535872774,0.862435445797133,4,428,regulation of hemopoiesis,BP,LTF;LOX;LIF;ANXA1
3486,GO:0006949,0.290602934408291,0.954284770444554,1,46,syncytium formation,BP,GDF15
6057,GO:0016835,0.290833783907695,0.953905882608223,1,69,carbon-oxygen lyase activity,MF,ETNPPL
13406,GO:0050867,0.29094139114041,0.880192884678554,3,310,positive regulation of cell activation,BP,IGFBP2;ANXA1;PDPN
8772,GO:0033017,0.291035224440351,0.954392242289694,1,36,sarcoplasmic reticulum membrane,CC,JPH3
10645,GO:0042325,0.291169680341913,0.806862174287011,12,1436,regulation of phosphorylation,BP,LTF;SRPX2;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ANXA2;SOCS3;PLA2G2A;PTPRT
10709,GO:0042446,0.291771044852666,0.953744192521581,1,55,hormone biosynthetic process,BP,ADM
16927,GO:0085029,0.292070561137063,0.953879629882523,1,42,extracellular matrix assembly,BP,LOX
9558,GO:0035065,0.29295782415122,0.953357548004204,1,54,regulation of histone acetylation,BP,LIF
15747,GO:0070613,0.293095221272767,0.953311025505996,1,54,regulation of protein processing,BP,SERPINE1
6457,GO:0019229,0.293362999203483,0.953250450892977,1,52,regulation of vasoconstriction,BP,ADM
12969,GO:0048519,0.293837823745602,0.774102032688441,36,4863,negative regulation of biological process,BP,LTF;VIM;PHACTR3;CHGA;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;IGFBP2;TGFBI;PLAU;PACSIN1;LIF;GDF15;COL5A1;POSTN;SPOCD1;ANXA1;ADM;JPH3;AFF2;KCNB1;SHANK1;SHANK2;PDPN;GABRB3;ELFN2;COL3A1;GRIN1;ANXA2;SOCS3;MYT1L;PTPRT;SERPINA3
14230,GO:0055080,0.293896867948763,0.836821782696209,6,661,cation homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;GRIN1
4781,GO:0010594,0.29562909403229,0.905157314861607,2,147,regulation of endothelial cell migration,BP,SRPX2;ANXA1
21297,GO:1990573,0.295734583269973,0.952550903030379,1,46,potassium ion import across plasma membrane,BP,ATP1A3
11930,GO:0045596,0.29583350954812,0.835415355568924,6,631,negative regulation of cell differentiation,BP,LTF;VIM;COL5A1;POSTN;ANXA1;COL3A1
11867,GO:0045334,0.296020477506738,0.952314310402618,1,54,clathrin-coated endocytic vesicle,CC,SH3GL2
12312,GO:0046365,0.296601265220676,0.95204708299289,1,59,monosaccharide catabolic process,BP,FUT9
3968,GO:0008284,0.296852524287674,0.826569891948216,7,815,positive regulation of cell population proliferation,BP,LTF;TIMP1;IGFBP2;LIF;ANXA1;ADM;ANXA2
3487,GO:0006950,0.297327465280125,0.778295082710745,25,3430,response to stress,BP,TNFRSF12A;LTF;VIM;RASGRF1;CAMK2A;CHGA;TIMP1;SERPINE1;COL1A1;LOX;SLC8A2;PLAU;COL5A1;CHI3L1;POSTN;ANXA1;ADM;C1R;PDPN;COL3A1;CD163;ANXA2;SOCS3;PLA2G2A;SERPINA3
13971,GO:0051897,0.297731879133426,0.904016817523522,2,150,positive regulation of protein kinase B signaling,BP,GDF15;CHI3L1
15850,GO:0070849,0.298058327933388,0.95177486634276,1,45,response to epidermal growth factor,BP,COL1A1
12888,GO:0048286,0.298257705781203,0.951827867724758,1,40,lung alveolus development,BP,LIF
7751,GO:0031301,0.298317127747865,0.875557771912029,3,339,integral component of organelle membrane,CC,SYT1;SLC17A7;SLC6A17
14548,GO:0060393,0.298658038487864,0.951362629131551,1,57,regulation of pathway-restricted SMAD protein phosphorylation,BP,GDF15
16138,GO:0071385,0.299815404659691,0.950988601597941,1,55,cellular response to glucocorticoid stimulus,BP,ANXA1
2264,GO:0004860,0.299869206932282,0.950915351956035,1,59,protein kinase inhibitor activity,MF,SOCS3
13320,GO:0050731,0.300205314685699,0.902626444953878,2,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,LIF;SOCS3
5321,GO:0015179,0.300224693511183,0.950909218365042,1,51,L-amino acid transmembrane transporter activity,MF,SLC17A7
14668,GO:0060563,0.300784678777065,0.950731399812659,1,50,neuroepithelial cell differentiation,BP,SERPINE1
9965,GO:0035850,0.300845426418908,0.950855258911817,1,43,epithelial cell differentiation involved in kidney development,BP,LIF
10041,GO:0035987,0.301717120499805,0.95052757627605,1,44,endodermal cell differentiation,BP,COL5A1
17870,GO:0098771,0.302230478987272,0.830651795023527,6,669,inorganic ion homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;GRIN1
17062,GO:0090102,0.303229716006074,0.949892363109013,1,49,cochlea development,BP,GABRB3
5760,GO:0016266,0.303260693499935,0.949920751727027,1,47,O-glycan processing,BP,GALNT13
19802,GO:1903317,0.303471460931679,0.949691589848957,1,56,regulation of protein maturation,BP,SERPINE1
10539,GO:0042093,0.304144099918947,0.949483643113303,1,54,T-helper cell differentiation,BP,ANXA1
14574,GO:0060425,0.304256151099518,0.949511408771412,1,50,lung morphogenesis,BP,LIF
12383,GO:0046513,0.305113772615634,0.949030204035707,1,62,ceramide biosynthetic process,BP,ST8SIA3
13585,GO:0051145,0.3052053960846,0.949106982855594,1,54,smooth muscle cell differentiation,BP,ADM
14827,GO:0060828,0.306023689859392,0.870807552834011,3,273,regulation of canonical Wnt signaling pathway,BP,PLEKHA4;COL1A1;IGFBP2
19257,GO:1902041,0.306037048431078,0.948765829997425,1,57,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1
953,GO:0002294,0.306649181448748,0.948576451536378,1,55,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ANXA1
17853,GO:0098739,0.307125750625463,0.898934644721048,2,146,import across plasma membrane,BP,ATP1A3;SLC8A2
4420,GO:0009247,0.307399304632277,0.948200429847298,1,63,glycolipid biosynthetic process,BP,ST8SIA3
3895,GO:0008168,0.307610739040461,0.898517503015142,2,181,methyltransferase activity,MF,NNMT;METTL7B
7450,GO:0030667,0.307786891289199,0.869668602987813,3,280,secretory granule membrane,CC,SYT1;PLAU;SNAP25
11973,GO:0045652,0.307987566373738,0.948145233043583,1,52,regulation of megakaryocyte differentiation,BP,LOX
173,GO:0000377,0.30808352458641,0.86938194021996,3,334,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,CELF4;SRRM4;RBFOX3
186,GO:0000398,0.30808352458641,0.86938194021996,3,334,mRNA splicing, via spliceosome,BP,CELF4;SRRM4;RBFOX3
3436,GO:0006874,0.308109076153395,0.850408493033076,4,410,cellular calcium ion homeostasis,BP,SLC8A2;ADM;JPH3;GRIN1
8259,GO:0032266,0.308489782012907,0.948178958033913,1,42,phosphatidylinositol-3-phosphate binding,MF,PLEKHA4
4134,GO:0008542,0.308518895202308,0.948142569807045,1,43,visual learning,BP,GRIN1
16137,GO:0071384,0.30863839430211,0.947817875334691,1,58,cellular response to corticosteroid stimulus,BP,ANXA1
9778,GO:0035556,0.308790952272806,0.774484963798665,20,2507,intracellular signal transduction,BP,LTF;RASGRF1;RAPGEF4;CHGA;LOX;SLC8A2;IQSEC3;LIF;GDF15;CHI3L1;GNAL;ADM;JPH3;PDPN;COL3A1;KSR2;RIMS2;GRIN1;SOCS3;PLA2G2A
13143,GO:0048857,0.308807836888075,0.947785564867997,1,56,neural nucleus development,BP,INA
12558,GO:0046890,0.309275602005784,0.897616482351411,2,176,regulation of lipid biosynthetic process,BP,ANXA1;ADM
11129,GO:0043268,0.309382399531332,0.947807208375326,1,44,positive regulation of potassium ion transport,BP,KCNIP2
948,GO:0002287,0.310162237116998,0.94729537857177,1,56,alpha-beta T cell activation involved in immune response,BP,ANXA1
952,GO:0002293,0.310162237116998,0.94729537857177,1,56,alpha-beta T cell differentiation involved in immune response,BP,ANXA1
12449,GO:0046637,0.310196263421779,0.947253910775854,1,58,regulation of alpha-beta T cell differentiation,BP,ANXA1
18137,GO:0099512,0.310313650848907,0.809555835883404,8,800,supramolecular fiber,CC,VIM;NEFM;COL1A1;COL5A1;ANXA1;INA;SHANK2;COL3A1
7816,GO:0031406,0.31079990670262,0.896733421607794,2,187,carboxylic acid binding,MF,GRIN1;ST8SIA3
4018,GO:0008360,0.311434047463623,0.89656564927734,2,144,regulation of cell shape,BP,ANXA1;PDPN
14513,GO:0060350,0.311557701493088,0.946835823053098,1,53,endochondral bone morphogenesis,BP,COL1A1
9632,GO:0035264,0.31158080109331,0.896513086726142,2,139,multicellular organism growth,BP,GDF15;SLITRK1
172,GO:0000375,0.311881894902484,0.866940961911153,3,337,RNA splicing, via transesterification reactions,BP,CELF4;SRRM4;RBFOX3
18810,GO:1900271,0.31215279543021,0.946779348190147,1,45,regulation of long-term synaptic potentiation,BP,SHISA7
11305,GO:0043551,0.312297444828691,0.946601221608258,1,51,regulation of phosphatidylinositol 3-kinase activity,BP,SOCS3
7501,GO:0030850,0.312355049398265,0.946660233763947,1,47,prostate gland development,BP,ANXA1
5081,GO:0012501,0.314324490930242,0.781817892904546,14,1831,programmed cell death,BP,TNFRSF12A;LTF;CAMK2A;TIMP1;SERPINE1;LOX;CHI3L1;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
6641,GO:0019829,0.314784193184188,0.945669781650797,1,52,ATPase-coupled cation transmembrane transporter activity,MF,ATP1A3
11412,GO:0043966,0.315805344425702,0.945224839495834,1,56,histone H3 acetylation,BP,LIF
13925,GO:0051784,0.315916707951282,0.945183519656285,1,56,negative regulation of nuclear division,BP,LIF
840,GO:0002090,0.316126296406882,0.945173160173542,1,52,regulation of receptor internalization,BP,SH3GL2
13283,GO:0050670,0.316684268209205,0.893401276263102,2,200,regulation of lymphocyte proliferation,BP,IGFBP2;ANXA1
12563,GO:0046902,0.316772066587087,0.944699778053155,1,69,regulation of mitochondrial membrane permeability,BP,CAMK2A
10009,GO:0035924,0.317409595487412,0.944695879693357,1,52,cellular response to vascular endothelial growth factor stimulus,BP,ANXA1
14490,GO:0060324,0.317464120970787,0.944799819091656,1,46,face development,BP,COL1A1
6442,GO:0019210,0.318120055567662,0.944276444684033,1,62,kinase inhibitor activity,MF,SOCS3
8723,GO:0032944,0.318351555745693,0.89245692911345,2,201,regulation of mononuclear cell proliferation,BP,IGFBP2;ANXA1
9015,GO:0033619,0.318784145423295,0.944082720421879,1,58,membrane protein proteolysis,BP,TIMP1
14544,GO:0060389,0.319589090948166,0.943751224538066,1,60,pathway-restricted SMAD protein phosphorylation,BP,GDF15
2767,GO:0005844,0.319672831559308,0.943655350254419,1,65,polysome,CC,VIM
10646,GO:0042326,0.319725114694262,0.842309210642984,4,414,negative regulation of phosphorylation,BP,SH3GL2;LIF;SOCS3;PTPRT
13012,GO:0048608,0.319899027122007,0.842214295301129,4,394,reproductive structure development,BP,LIF;ANXA1;ADM;SOCS3
16808,GO:0072577,0.320422729420303,0.943565925643763,1,52,endothelial cell apoptotic process,BP,SERPINE1
3593,GO:0007159,0.320447225829019,0.861407572553923,3,321,leukocyte cell-cell adhesion,BP,IGFBP2;ANXA1;FUT9
20834,GO:1905330,0.320598918179698,0.891282908974011,2,172,regulation of morphogenesis of an epithelium,BP,PLEKHA4;LIF
8325,GO:0032370,0.320863605019882,0.94326984523718,1,60,positive regulation of lipid transport,BP,ANXA2
1105,GO:0002532,0.321217846725251,0.943095432492931,1,63,production of molecular mediator involved in inflammatory response,BP,SERPINE1
6753,GO:0021537,0.321491711619351,0.860904043138583,3,242,telencephalon development,BP,COL3A1;CNTNAP2;GRIN1
20477,GO:1904645,0.321936897261078,0.943097340102115,1,47,response to amyloid-beta,BP,ATP1A3
11391,GO:0043900,0.322020884175277,0.942816798834042,1,61,regulation of multi-organism process,BP,TIMP1
4829,GO:0010660,0.322106132874168,0.94279828226571,1,60,regulation of muscle cell apoptotic process,BP,CAMK2A
3325,GO:0006687,0.322117560211005,0.942766551442621,1,62,glycosphingolipid metabolic process,BP,ST8SIA3
3440,GO:0006879,0.322349400409224,0.942691759008365,1,61,cellular iron ion homeostasis,BP,LTF
19706,GO:1903115,0.322374209907998,0.943090683659407,1,41,regulation of actin filament-based movement,BP,PDPN
2884,GO:0006027,0.322525527093411,0.942733195585976,1,54,glycosaminoglycan catabolic process,BP,FMOD
11243,GO:0043462,0.323047394415246,0.942259901542473,1,76,regulation of ATPase activity,BP,LTF
18228,GO:0099738,0.324217975755861,0.942390560515084,1,41,cell cortex region,CC,RIMS2
19430,GO:1902475,0.324247604138587,0.942041736372534,1,56,L-alpha-amino acid transmembrane transport,BP,SLC17A7
13409,GO:0050870,0.325014019753265,0.888669546586843,2,197,positive regulation of T cell activation,BP,IGFBP2;ANXA1
3099,GO:0006397,0.325161896419764,0.838398087054883,4,475,mRNA processing,BP,CELF4;SRRM4;AFF2;RBFOX3
7886,GO:0031526,0.32556983744026,0.941645378786278,1,50,brush border membrane,CC,SHANK2
15115,GO:0061458,0.325595054393592,0.838183336530005,4,398,reproductive system development,BP,LIF;ANXA1;ADM;SOCS3
15090,GO:0061383,0.325923319581302,0.941576028644635,1,47,trabecula morphogenesis,BP,COL1A1
21151,GO:1990090,0.326031131864124,0.941511414138305,1,48,cellular response to nerve growth factor stimulus,BP,SH3GL2
14225,GO:0055074,0.326895270721152,0.837227970706132,4,421,calcium ion homeostasis,BP,SLC8A2;ADM;JPH3;GRIN1
12040,GO:0045773,0.327163425799587,0.94126187740516,1,41,positive regulation of axon extension,BP,TNFRSF12A
11991,GO:0045670,0.328497768066564,0.940417281314811,1,55,regulation of osteoclast differentiation,BP,LTF
10647,GO:0042327,0.33022512394126,0.79366553733675,8,952,positive regulation of phosphorylation,BP,LTF;SLC8A2;LIF;GDF15;CHI3L1;ANXA2;SOCS3;PLA2G2A
696,GO:0001895,0.331228042724907,0.939267476353888,1,60,retina homeostasis,BP,LTF
13040,GO:0048663,0.331918837182638,0.938966073831268,1,62,neuron fate commitment,BP,MYT1L
12356,GO:0046470,0.332381004857889,0.938651749971151,1,73,phosphatidylcholine metabolic process,BP,PLA2G2A
4656,GO:0010171,0.332453082387704,0.939010028741294,1,48,body morphogenesis,BP,COL1A1
21926,GO:2000756,0.332539514604457,0.938749820234075,1,60,regulation of peptidyl-lysine acetylation,BP,LIF
5999,GO:0016741,0.333440693377171,0.883793803090124,2,192,transferase activity, transferring one-carbon groups,MF,NNMT;METTL7B
11068,GO:0043177,0.33400875563559,0.883440409515506,2,198,organic acid binding,MF,GRIN1;ST8SIA3
12535,GO:0046854,0.334177205252711,0.938304861384563,1,49,phosphatidylinositol phosphorylation,BP,SOCS3
4548,GO:0009749,0.334428569051053,0.883300016288416,2,170,response to glucose,BP,COL6A2;KCNB1
11860,GO:0045309,0.334483228166726,0.938098757717612,1,53,protein phosphorylated amino acid binding,MF,SOCS3
7654,GO:0031102,0.334577248433321,0.938061346388138,1,53,neuron projection regeneration,BP,ADM
16216,GO:0071496,0.334916935665601,0.851848413914907,3,302,cellular response to external stimulus,BP,COL1A1;POSTN;KCNB1
20010,GO:1903708,0.335763360391331,0.882449852600173,2,186,positive regulation of hemopoiesis,BP,LIF;ANXA1
558,GO:0001706,0.336221217758318,0.937425213709767,1,52,endoderm formation,BP,COL5A1
14349,GO:0060113,0.336395700050224,0.937398065322079,1,50,inner ear receptor cell differentiation,BP,GABRB3
2726,GO:0005773,0.337536653171328,0.803736445209636,6,734,vacuole,CC,CHGA;FMOD;ANXA1;CPLX2;ANXA2;SERPINA3
4826,GO:0010657,0.338684046998392,0.936246006866496,1,63,muscle cell apoptotic process,BP,CAMK2A
15693,GO:0070527,0.33872586103934,0.936306033886058,1,58,platelet aggregation,BP,PDPN
21150,GO:1990089,0.338946030401976,0.936350248873364,1,51,response to nerve growth factor,BP,SH3GL2
6667,GO:0019882,0.339410029603052,0.88019122667186,2,217,antigen processing and presentation,BP,SH3GL2;RAB3C
17440,GO:0097120,0.339656766669752,0.936000942173791,1,54,receptor localization to synapse,BP,SNAP25
3807,GO:0007632,0.34160308009609,0.93531680857289,1,49,visual behavior,BP,GRIN1
951,GO:0002292,0.34170400268762,0.935015997834191,1,63,T cell differentiation involved in immune response,BP,ANXA1
7198,GO:0030177,0.342111873009855,0.878742368767091,2,171,positive regulation of Wnt signaling pathway,BP,PLEKHA4;COL1A1
11774,GO:0045123,0.343333558124725,0.934361412383308,1,62,cellular extravasation,BP,FUT9
8883,GO:0033218,0.344405336581057,0.845363255010144,3,330,amide binding,MF,ATP1A3;KCNIP2;GRIN1
6439,GO:0019207,0.344778086001564,0.877054448063452,2,193,kinase regulator activity,MF,LTF;SOCS3
3783,GO:0007601,0.34493251907655,0.877011369202966,2,180,visual perception,BP,COL1A1;TGFBI
11348,GO:0043627,0.345220056521147,0.933474093014898,1,70,response to estrogen,BP,IGFBP2
11304,GO:0043550,0.345589445599246,0.933476366423891,1,59,regulation of lipid kinase activity,BP,SOCS3
4547,GO:0009746,0.34567365576607,0.876586090936919,2,175,response to hexose,BP,COL6A2;KCNB1
3410,GO:0006826,0.34640386970393,0.932981337675003,1,70,iron ion transport,BP,LTF
11801,GO:0045177,0.346518782867475,0.823108164016907,4,383,apical part of cell,CC,IGFBP2;ANXA1;SHANK2;PDPN
3773,GO:0007585,0.346568339262781,0.933036684888139,1,61,respiratory gaseous exchange by respiratory system,BP,GRIN1
16758,GO:0072503,0.346698228807774,0.822894123798108,4,440,cellular divalent inorganic cation homeostasis,BP,SLC8A2;ADM;JPH3;GRIN1
19697,GO:1903078,0.346919508042941,0.932976575872181,1,56,positive regulation of protein localization to plasma membrane,BP,DPP10
21407,GO:1990868,0.346992085138854,0.932630483462363,1,80,response to chemokine,BP,LOX
21408,GO:1990869,0.346992085138854,0.932630483462363,1,80,cellular response to chemokine,BP,LOX
20113,GO:1903901,0.347957663638282,0.932319446629626,1,71,negative regulation of viral life cycle,BP,LTF
19821,GO:1903350,0.348630202588475,0.932036940215422,1,71,response to dopamine,BP,GNAL
19822,GO:1903351,0.348630202588475,0.932036940215422,1,71,cellular response to dopamine,BP,GNAL
14918,GO:0061005,0.348658429120314,0.932331484658064,1,52,cell differentiation involved in kidney development,BP,LIF
18880,GO:1901016,0.34887868005885,0.932157254603164,1,56,regulation of potassium ion transmembrane transporter activity,BP,KCNIP2
15768,GO:0070663,0.349537404969853,0.874099005643449,2,216,regulation of leukocyte proliferation,BP,IGFBP2;ANXA1
12439,GO:0046626,0.350946453647026,0.931231448673244,1,59,regulation of insulin receptor signaling pathway,BP,SOCS3
11990,GO:0045669,0.351874885608641,0.930855681294175,1,58,positive regulation of osteoblast differentiation,BP,LTF
13498,GO:0051018,0.352184780272615,0.930969335768709,1,47,protein kinase A binding,MF,SPHKAP
69,GO:0000139,0.352326059683074,0.792133821946689,6,708,Golgi membrane,CC,SH3GL2;CUX2;GALNT13;FUT9;ST8SIA3;CALN1
19074,GO:1901570,0.35317887132266,0.930002131491005,1,81,fatty acid derivative biosynthetic process,BP,ANXA1
13462,GO:0050953,0.354053482060144,0.871450681893318,2,183,sensory perception of light stimulus,BP,COL1A1;TGFBI
18050,GO:0099054,0.355624846169566,0.929475919708346,1,48,presynapse assembly,BP,SLITRK1
3825,GO:0008038,0.356177691953764,0.929186764926826,1,50,neuron recognition,BP,CNTNAP2
14914,GO:0061001,0.356409351077824,0.929225447189347,1,45,regulation of dendritic spine morphogenesis,BP,CUX2
3787,GO:0007606,0.357555860702721,0.928077517407766,1,85,sensory perception of chemical stimulus,BP,GNAL
148,GO:0000302,0.357617823069615,0.86915252998095,2,210,response to reactive oxygen species,BP,COL1A1;ANXA1
9154,GO:0034121,0.358220952463173,0.928014982698875,1,65,regulation of toll-like receptor signaling pathway,BP,LTF
9240,GO:0034284,0.358251963229428,0.868870619896478,2,180,response to monosaccharide,BP,COL6A2;KCNB1
1858,GO:0004175,0.359670330040494,0.834766173188425,3,338,endopeptidase activity,MF,LTF;PLAU;C1R
14363,GO:0060135,0.361063400713386,0.92682047206285,1,62,maternal process involved in female pregnancy,BP,LIF
14343,GO:0060090,0.362286284762397,0.833043541487195,3,282,molecular adaptor activity,MF,SNAP25;SHANK1;SHANK2
3395,GO:0006805,0.363163229030837,0.925605401093115,1,86,xenobiotic metabolic process,BP,GRIN1
3888,GO:0008150,0.363531079463756,0.784612710663994,95,14293,biological_process,BP,TNFRSF12A;LTF;VIM;RASGRF1;CHI3L2;SNAP91;SYT1;CAMK2A;PPP2R2C;SLCO1A2;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;SPOCD1;ANXA1;SRRM4;GNAL;COL6A2;EMP3;GALNT13;CPLX2;INA;ADM;RAB3C;JPH3;AFF2;SYN2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;ETNPPL;CSMD3;SVOP;GABRB3;NNMT;ELFN2;RBFOX3;MOBP;COL3A1;METTL7B;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;ANXA2;SOCS3;SV2B;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SLC6A17;OPALIN;SMOC1;DOK6;FRRS1L
15610,GO:0070373,0.36369125165582,0.925569820877081,1,68,negative regulation of ERK1 and ERK2 cascade,BP,LIF
5405,GO:0015370,0.365366017194014,0.924952965948547,1,60,solute:sodium symporter activity,MF,SLC17A7
18105,GO:0099172,0.365510806047819,0.925080703514074,1,51,presynapse organization,BP,SLITRK1
1191,GO:0002690,0.366085259460235,0.924302314152669,1,86,positive regulation of leukocyte chemotaxis,BP,SERPINE1
4741,GO:0010517,0.367228129957359,0.924036482301234,1,65,regulation of phospholipase activity,BP,ANXA1
10733,GO:0042490,0.367607232058458,0.924008918648215,1,57,mechanoreceptor differentiation,BP,GABRB3
10760,GO:0042562,0.368414208656577,0.923391410642965,1,73,hormone binding,MF,ATP1A3
17303,GO:0090559,0.369174594914869,0.922989483708652,1,78,regulation of membrane permeability,BP,CAMK2A
16079,GO:0071300,0.369513426063688,0.923039608222221,1,63,cellular response to retinoic acid,BP,COL1A1
10637,GO:0042310,0.370051987207027,0.922689717770277,1,70,vasoconstriction,BP,ADM
13622,GO:0051223,0.370198323703685,0.789666622978135,5,574,regulation of protein transport,BP,RAPGEF4;CHGA;SNAP25;ANXA1;KCNB1
7269,GO:0030278,0.37072016593749,0.861021699162395,2,181,regulation of ossification,BP,LTF;SMOC1
16130,GO:0071375,0.371456057373815,0.826488267491018,3,295,cellular response to peptide hormone stimulus,BP,CAMK2A;GDF15;SOCS3
11182,GO:0043367,0.372362044037335,0.921637947878458,1,70,CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
2816,GO:0005912,0.373021693079626,0.859681616972177,2,156,adherens junction,CC,ANXA1;ANXA2
6294,GO:0018209,0.373259483232302,0.825202877988537,3,291,peptidyl-serine modification,BP,CAMK2A;LIF;GALNT13
10586,GO:0042180,0.373524104701436,0.859078680805339,2,221,cellular ketone metabolic process,BP,ANXA1;ADM
16979,GO:0086065,0.374549394926135,0.920948352162334,1,53,cell communication involved in cardiac conduction,BP,ATP1A3
16448,GO:0071902,0.374747978446442,0.824070950601676,3,317,positive regulation of protein serine/threonine kinase activity,BP,LTF;SLC8A2;GDF15
11008,GO:0043065,0.375240166040371,0.78564898687082,5,602,positive regulation of apoptotic process,BP,TNFRSF12A;CAMK2A;ANXA1;ADM;GRIN1
10483,GO:0040014,0.37538998598079,0.920355823422188,1,63,regulation of multicellular organism growth,BP,GDF15
5098,GO:0014015,0.37568603037879,0.920109802791956,1,70,positive regulation of gliogenesis,BP,LIF
5187,GO:0014823,0.376193951944292,0.919967289449357,1,64,response to activity,BP,POSTN
14324,GO:0060070,0.376344933769325,0.822928197518169,3,312,canonical Wnt signaling pathway,BP,PLEKHA4;COL1A1;IGFBP2
3328,GO:0006690,0.376858739221806,0.919321756246112,1,93,icosanoid metabolic process,BP,ANXA1
8534,GO:0032652,0.377644258989919,0.919055919034269,1,82,regulation of interleukin-1 production,BP,ANXA1
12771,GO:0048008,0.37770983476742,0.919465737161736,1,54,platelet-derived growth factor receptor signaling pathway,BP,LOX
19673,GO:1903039,0.378485927681504,0.855889771979454,2,216,positive regulation of leukocyte cell-cell adhesion,BP,IGFBP2;ANXA1
7369,GO:0030500,0.378707204876349,0.918766316735215,1,66,regulation of bone mineralization,BP,LTF
593,GO:0001764,0.378863665072274,0.855947260196522,2,151,neuron migration,BP,CAMK2A;COL3A1
534,GO:0001666,0.378893967440252,0.821042851851677,3,330,response to hypoxia,BP,PLAU;POSTN;ADM
20342,GO:1904377,0.379673004530027,0.918365474741931,1,63,positive regulation of protein localization to cell periphery,BP,DPP10
11030,GO:0043113,0.379760466137823,0.918487125997621,1,55,receptor clustering,BP,SHISA7
16193,GO:0071466,0.379765252732526,0.917978719617173,1,91,cellular response to xenobiotic stimulus,BP,GRIN1
21509,GO:2000106,0.379836463831969,0.918085780461462,1,77,regulation of leukocyte apoptotic process,BP,ANXA1
16761,GO:0072507,0.380097429691806,0.797738212080558,4,457,divalent inorganic cation homeostasis,BP,SLC8A2;ADM;JPH3;GRIN1
1272,GO:0002824,0.380862902152058,0.917488322605263,1,88,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1
4303,GO:0009101,0.381068436426151,0.819509091348976,3,307,glycoprotein biosynthetic process,BP,GALNT13;FUT9;ST8SIA3
14387,GO:0060170,0.381308472638002,0.917546583397313,1,66,ciliary membrane,CC,SHANK2
6752,GO:0021536,0.381501336069616,0.917408943201427,1,69,diencephalon development,BP,CNTNAP2
18947,GO:1901224,0.381767286320812,0.917188601905024,1,76,positive regulation of NIK/NF-kappaB signaling,BP,CHI3L1
4631,GO:0010038,0.381898582921383,0.818844289426752,3,335,response to metal ion,BP,SYT1;IGFBP2;KCNIP2
19225,GO:1901983,0.382282951889669,0.917010808792861,1,71,regulation of protein acetylation,BP,LIF
5316,GO:0015171,0.384268393263144,0.916083195166563,1,70,amino acid transmembrane transporter activity,MF,SLC17A7
7120,GO:0030048,0.384437550112974,0.852390039385415,2,140,actin filament-based movement,BP,VIM;PDPN
11011,GO:0043068,0.384668167139271,0.778106551660474,5,608,positive regulation of programmed cell death,BP,TNFRSF12A;CAMK2A;ANXA1;ADM;GRIN1
13887,GO:0051704,0.385866550438127,0.755384176854462,7,894,multi-organism process,BP,CELF4;TIMP1;IGFBP2;LIF;ADM;GRIN1;ANXA2
22139,GO:2001259,0.387448772908646,0.914607954529265,1,67,positive regulation of cation channel activity,BP,KCNIP2
18692,GO:1900076,0.387669610259799,0.9144856324946,1,68,regulation of cellular response to insulin stimulus,BP,SOCS3
11963,GO:0045638,0.388060662641468,0.914209763955378,1,74,negative regulation of myeloid cell differentiation,BP,LTF
4763,GO:0010562,0.388956154202949,0.744969782443236,8,1010,positive regulation of phosphorus metabolic process,BP,LTF;SLC8A2;LIF;GDF15;CHI3L1;ANXA2;SOCS3;PLA2G2A
12134,GO:0045937,0.388956154202949,0.744969782443236,8,1010,positive regulation of phosphate metabolic process,BP,LTF;SLC8A2;LIF;GDF15;CHI3L1;ANXA2;SOCS3;PLA2G2A
16059,GO:0071260,0.389345475731557,0.913549743522995,1,77,cellular response to mechanical stimulus,BP,COL1A1
7022,GO:0022600,0.389499978900622,0.913427448205742,1,81,digestive system process,BP,SERPINA3
12087,GO:0045859,0.390159966733728,0.761436499431389,6,726,regulation of protein kinase activity,BP,LTF;SLC8A2;GDF15;CHI3L1;SOCS3;PTPRT
13404,GO:0050865,0.390318246843498,0.789729714843052,4,513,regulation of cell activation,BP,IGFBP2;ANXA1;PDPN;PLA2G2A
1098,GO:0002521,0.390434611674988,0.78967905182054,4,477,leukocyte differentiation,BP,LTF;LIF;ANXA1;ANXA2
3629,GO:0007200,0.390815199244024,0.912678186203733,1,92,phospholipase C-activating G protein-coupled receptor signaling pathway,BP,CHGA
14185,GO:0055001,0.390953265141402,0.847941301670011,2,160,muscle cell development,BP,LOX;ADM
3937,GO:0008233,0.391462003445789,0.788849534348823,4,498,peptidase activity,MF,LTF;PLAU;C1R;DPP10
20189,GO:1904035,0.391704520629286,0.912441199102293,1,74,regulation of epithelial cell apoptotic process,BP,SERPINE1
16136,GO:0071383,0.391996789204002,0.84708822208615,2,190,cellular response to steroid hormone stimulus,BP,ATP1A3;ANXA1
19799,GO:1903312,0.392509390222372,0.912034128498396,1,75,negative regulation of mRNA metabolic process,BP,CELF4
19919,GO:1903533,0.392933349088199,0.911787821035955,1,78,regulation of protein targeting,BP,KCNB1
13360,GO:0050801,0.394307424368233,0.757983727090148,6,733,ion homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;GRIN1
2722,GO:0005768,0.394441462433641,0.748151122178497,7,888,endosome,CC,LTF;SH3GL2;PACSIN1;ANXA1;RAB3C;CNTNAP2;ANXA2
1280,GO:0002832,0.394599403034507,0.910909716479545,1,83,negative regulation of response to biotic stimulus,BP,LTF
14223,GO:0055072,0.394845914327446,0.910872207223567,1,76,iron ion homeostasis,BP,LTF
7282,GO:0030295,0.394901171162185,0.910844932260959,1,76,protein kinase activator activity,MF,LTF
4475,GO:0009410,0.395911374877927,0.910136352674644,1,96,response to xenobiotic stimulus,BP,GRIN1
11858,GO:0045296,0.39592204957054,0.808538142681126,3,308,cadherin binding,MF,ANXA1;ANXA2;PTPRT
8982,GO:0033559,0.397842262437618,0.909158578501328,1,98,unsaturated fatty acid metabolic process,BP,ANXA1
7231,GO:0030219,0.39855717349757,0.909132419364985,1,69,megakaryocyte differentiation,BP,LOX
13098,GO:0048747,0.399065586916518,0.90921788951315,1,53,muscle fiber development,BP,LOX
638,GO:0001818,0.399543295053559,0.841849790329742,2,232,negative regulation of cytokine production,BP,LTF;ANXA1
1269,GO:0002821,0.399607598794786,0.908316674020305,1,93,positive regulation of adaptive immune response,BP,ANXA1
15508,GO:0070201,0.400071488103546,0.76560270346188,5,598,regulation of establishment of protein localization,BP,RAPGEF4;CHGA;SNAP25;ANXA1;KCNB1
19234,GO:1901992,0.400141253988578,0.908196760156284,1,79,positive regulation of mitotic cell cycle phase transition,BP,ANXA1
2827,GO:0005938,0.400328321001145,0.805326507869613,3,273,cell cortex,CC,MOBP;RIMS2;ANXA2
18413,GO:0110110,0.400650821239568,0.907966193860191,1,77,positive regulation of animal organ morphogenesis,BP,LIF
21519,GO:2000117,0.401480250460641,0.907441765053335,1,86,negative regulation of cysteine-type endopeptidase activity,BP,LTF
1062,GO:0002460,0.402309451669491,0.839958675773607,2,234,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1;C1R
12975,GO:0048525,0.402364026324509,0.907005545827461,1,85,negative regulation of viral process,BP,LTF
17051,GO:0090087,0.402607299574331,0.763516401263501,5,601,regulation of peptide transport,BP,RAPGEF4;CHGA;SNAP25;ANXA1;KCNB1
21518,GO:2000116,0.402650515555172,0.839763553098727,2,222,regulation of cysteine-type endopeptidase activity,BP,LTF;GRIN1
1621,GO:0003727,0.403170292444576,0.90664258545016,1,81,single-stranded RNA binding,MF,ANXA1
11203,GO:0043393,0.403549901997433,0.839255495262,2,194,regulation of protein binding,BP,LOX;ANXA2
12446,GO:0046634,0.403831484048429,0.906218663611421,1,89,regulation of alpha-beta T cell activation,BP,ANXA1
536,GO:0001669,0.405024332905007,0.905641467676501,1,86,acrosomal vesicle,CC,SV2B
11219,GO:0043410,0.405112126452767,0.77806089100922,4,479,positive regulation of MAPK cascade,BP,LIF;GDF15;CHI3L1;PLA2G2A
3314,GO:0006672,0.405125895477683,0.905558310419195,1,89,ceramide metabolic process,BP,ST8SIA3
13589,GO:0051149,0.406195429506117,0.905111921471636,1,80,positive regulation of muscle cell differentiation,BP,GDF15
12524,GO:0046834,0.406712537098198,0.905117990294395,1,63,lipid phosphorylation,BP,SOCS3
10181,GO:0036293,0.406802230551764,0.800254609200896,3,341,response to decreased oxygen levels,BP,PLAU;POSTN;ADM
11921,GO:0045582,0.406972386688613,0.904665299124745,1,84,positive regulation of T cell differentiation,BP,ANXA1
17262,GO:0090407,0.40846496319608,0.775330102647095,4,516,organophosphate biosynthetic process,BP,PLEKHA4;ETNPPL;NNMT;PLA2G2A
3622,GO:0007193,0.408983772079086,0.903676330116216,1,80,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,BP,GNAL
9050,GO:0033692,0.409188381989336,0.903824823886032,1,64,cellular polysaccharide biosynthetic process,BP,FUT9
7600,GO:0031016,0.409394026769149,0.903561632536563,1,73,pancreas development,BP,ANXA1
11296,GO:0043542,0.409500437852653,0.835164253109845,2,192,endothelial cell migration,BP,SRPX2;ANXA1
7545,GO:0030901,0.409861652065056,0.90322165879775,1,80,midbrain development,BP,INA
18765,GO:1900182,0.409944465676171,0.903218464165559,1,77,positive regulation of protein localization to nucleus,BP,LIF
12613,GO:0046982,0.410712470010927,0.834217579863739,2,218,protein heterodimerization activity,MF,SYT1;KCNB1
19828,GO:1903363,0.410736880828693,0.902806986958795,1,77,negative regulation of cellular protein catabolic process,BP,ANXA2
584,GO:0001750,0.410861769242334,0.902865558071436,1,69,photoreceptor outer segment,CC,SHANK2
19864,GO:1903426,0.411983931199824,0.902130191162822,1,79,regulation of reactive oxygen species biosynthetic process,BP,GRIN1
6681,GO:0019902,0.412162160680986,0.833332536415315,2,188,phosphatase binding,MF,PHACTR3;PTPRT
12818,GO:0048145,0.412507708739779,0.901897761666221,1,76,regulation of fibroblast proliferation,BP,ANXA2
13552,GO:0051098,0.413259401325381,0.795312016608394,3,340,regulation of binding,BP,LOX;LIF;ANXA2
13154,GO:0048871,0.413270857218137,0.771524886005537,4,459,multicellular organismal homeostasis,BP,LTF;SH3GL2;KSR2;SERPINA3
17483,GO:0097191,0.413649693553776,0.832179613512019,2,215,extrinsic apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1
636,GO:0001816,0.413955577146035,0.754049784230686,5,673,cytokine production,BP,LTF;CHGA;SERPINE1;CHI3L1;ANXA1
947,GO:0002286,0.41494329381725,0.900514582868449,1,84,T cell activation involved in immune response,BP,ANXA1
5784,GO:0016310,0.415704472102091,0.687535472606673,16,2136,phosphorylation,BP,LTF;RASGRF1;CAMK2A;SRPX2;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT
12458,GO:0046651,0.415897971776052,0.830501979882125,2,246,lymphocyte proliferation,BP,IGFBP2;ANXA1
7287,GO:0030301,0.415998916893218,0.900076861098247,1,75,cholesterol transport,BP,ANXA2
12817,GO:0048144,0.416873166589546,0.899584805908177,1,77,fibroblast proliferation,BP,ANXA2
9884,GO:0035710,0.417445943817025,0.899154562633722,1,87,CD4-positive, alpha-beta T cell activation,BP,ANXA1
8508,GO:0032612,0.417812704878946,0.898906494020853,1,92,interleukin-1 production,BP,ANXA1
10327,GO:0038024,0.418147157043373,0.899053751313457,1,68,cargo receptor activity,MF,CD163
20079,GO:1903829,0.41836424159951,0.791405083372658,3,322,positive regulation of cellular protein localization,BP,LIF;KCNB1;DPP10
3897,GO:0008170,0.419085572144174,0.898352778740093,1,81,N-methyltransferase activity,MF,NNMT
8722,GO:0032943,0.4196386739461,0.827855380321694,2,248,mononuclear cell proliferation,BP,IGFBP2;ANXA1
6441,GO:0019209,0.419912582779675,0.897897443381343,1,82,kinase activator activity,MF,LTF
4545,GO:0009743,0.420016119193424,0.827735369363013,2,205,response to carbohydrate,BP,COL6A2;KCNB1
1184,GO:0002683,0.420236103849764,0.789820680616594,3,389,negative regulation of immune system process,BP,LTF;ANXA1;COL3A1
7112,GO:0030036,0.420398635197832,0.735977403835316,6,650,actin cytoskeleton organization,BP,PHACTR3;IQSEC3;PACSIN1;ANXA1;INA;SHANK1
2746,GO:0005796,0.420536306581855,0.897645535662006,1,76,Golgi lumen,CC,FMOD
19454,GO:1902533,0.42084234245643,0.725432736104777,7,926,positive regulation of intracellular signal transduction,BP,LTF;RASGRF1;LIF;GDF15;CHI3L1;COL3A1;PLA2G2A
13368,GO:0050810,0.42115581014563,0.897205059603875,1,84,regulation of steroid biosynthetic process,BP,ADM
4170,GO:0008625,0.421464986557638,0.897050992110885,1,83,extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1
10526,GO:0042058,0.421577401453363,0.897003111119989,1,82,regulation of epidermal growth factor receptor signaling pathway,BP,SH3GL2
21115,GO:1905954,0.421628608448243,0.896975527859707,1,82,positive regulation of lipid localization,BP,ANXA2
16294,GO:0071621,0.421945584379276,0.896590120822852,1,103,granulocyte chemotaxis,BP,ANXA1
1619,GO:0003725,0.422218805731664,0.896755699780369,1,75,double-stranded RNA binding,MF,VIM
1001,GO:0002367,0.422884721295095,0.896152846235531,1,95,cytokine production involved in immune response,BP,CHGA
13135,GO:0048844,0.423135287633748,0.896550419197143,1,60,artery morphogenesis,BP,COL3A1
2095,GO:0004620,0.423265860229858,0.896078472727494,1,83,phospholipase activity,MF,PLA2G2A
1577,GO:0003407,0.423441033022025,0.896233812824148,1,67,neural retina development,BP,SLC17A7
9490,GO:0034754,0.423807652867186,0.895581191784936,1,103,cellular hormone metabolic process,BP,ADM
604,GO:0001776,0.424099458503996,0.895639234582961,1,82,leukocyte homeostasis,BP,ANXA1
2751,GO:0005811,0.424794061369528,0.895188971038482,1,88,lipid droplet,CC,ANXA2
4008,GO:0008344,0.426072571947918,0.894696911451543,1,73,adult locomotory behavior,BP,GRIN1
8832,GO:0033138,0.427048020239774,0.893980725273949,1,86,positive regulation of peptidyl-serine phosphorylation,BP,LIF
4435,GO:0009266,0.427073411921187,0.822667819880208,2,212,response to temperature stimulus,BP,CAMK2A;ADM
13319,GO:0050730,0.428811691683025,0.821380853713097,2,221,regulation of peptidyl-tyrosine phosphorylation,BP,LIF;SOCS3
13970,GO:0051896,0.428814306120308,0.821450996531195,2,203,regulation of protein kinase B signaling,BP,GDF15;CHI3L1
17675,GO:0097581,0.430029680640771,0.892475374710728,1,76,lamellipodium organization,BP,PDPN
15482,GO:0070167,0.430131585903601,0.892374244205317,1,79,regulation of biomineral tissue development,BP,LTF
18418,GO:0110149,0.430131585903601,0.892374244205317,1,79,regulation of biomineralization,BP,LTF
3146,GO:0006469,0.43015173091774,0.820434886950928,2,215,negative regulation of protein kinase activity,BP,SOCS3;PTPRT
14400,GO:0060191,0.430653649531675,0.892017531187776,1,84,regulation of lipase activity,BP,ANXA1
16419,GO:0071868,0.430908778113297,0.891851140834182,1,86,cellular response to monoamine stimulus,BP,GNAL
16421,GO:0071870,0.430908778113297,0.891851140834182,1,86,cellular response to catecholamine stimulus,BP,GNAL
18672,GO:1900034,0.431058544612819,0.891921488434797,1,75,regulation of cellular response to heat,BP,CAMK2A
16544,GO:0072088,0.431759532989429,0.891618371387826,1,70,nephron epithelium morphogenesis,BP,LIF
15568,GO:0070301,0.432864444872455,0.890750390567574,1,87,cellular response to hydrogen peroxide,BP,ANXA1
11708,GO:0044877,0.433204111512459,0.699468996201132,9,1116,protein-containing complex binding,MF,VIM;LOX;TGFBI;COL5A1;GNAL;COL6A2;SHANK1;COL3A1;GRIN1
6827,GO:0021675,0.434064155283285,0.890263382852519,1,74,nerve development,BP,GABRB3
838,GO:0002088,0.434194160419084,0.890261119720807,1,70,lens development in camera-type eye,BP,VIM
11521,GO:0044291,0.434861681285346,0.889925673857467,1,68,cell-cell contact zone,CC,OPALIN
19800,GO:1903313,0.435719567920977,0.88927077037603,1,78,positive regulation of mRNA metabolic process,BP,CELF4
13661,GO:0051279,0.436157637924847,0.889104893185001,1,73,regulation of release of sequestered calcium ion into cytosol,BP,JPH3
21680,GO:2000379,0.436573157453808,0.888655313395464,1,88,positive regulation of reactive oxygen species metabolic process,BP,GRIN1
6454,GO:0019226,0.437427424414822,0.888481545748904,1,68,transmission of nerve impulse,BP,CNTNAP2
9143,GO:0034109,0.437682498375791,0.88819378323283,1,76,homotypic cell-cell adhesion,BP,PDPN
11750,GO:0045069,0.441636178084855,0.885748462391119,1,90,regulation of viral genome replication,BP,LTF
20023,GO:1903725,0.441913202232207,0.88566429111034,1,84,regulation of phospholipid metabolic process,BP,SOCS3
3776,GO:0007589,0.442051342390094,0.885626610467355,1,81,body fluid secretion,BP,ANXA2
16418,GO:0071867,0.442135476118819,0.885473430264198,1,89,response to monoamine,BP,GNAL
16420,GO:0071869,0.442135476118819,0.885473430264198,1,89,response to catecholamine,BP,GNAL
16510,GO:0072028,0.44234835287682,0.885602010015909,1,72,nephron morphogenesis,BP,LIF
524,GO:0001655,0.442925769333727,0.771995584298004,3,306,urogenital system development,BP,LIF;ANXA1;COL4A1
1189,GO:0002688,0.443002113764427,0.884779152194322,1,109,regulation of leukocyte chemotaxis,BP,SERPINE1
6448,GO:0019217,0.443426273881522,0.884835385362268,1,81,regulation of fatty acid metabolic process,BP,ANXA1
19231,GO:1901989,0.443529590024829,0.884646825033146,1,91,positive regulation of cell cycle phase transition,BP,ANXA1
131,GO:0000271,0.443619597683325,0.884889330497413,1,71,polysaccharide biosynthetic process,BP,FUT9
5658,GO:0016064,0.444017526143595,0.884252022267218,1,102,immunoglobulin mediated immune response,BP,C1R
3804,GO:0007626,0.444134950727254,0.810316024794712,2,184,locomotory behavior,BP,SNAP25;GRIN1
5738,GO:0016234,0.445175883554979,0.883918287229204,1,75,inclusion body,CC,NEFM
7173,GO:0030148,0.445752638294968,0.883325105701289,1,94,sphingolipid biosynthetic process,BP,ST8SIA3
11086,GO:0043202,0.446133137771465,0.883161141547791,1,89,lysosomal lumen,CC,FMOD
15064,GO:0061333,0.446194395508291,0.883380706282531,1,72,renal tubule morphogenesis,BP,COL4A1
13407,GO:0050868,0.446608060220226,0.882746646960878,1,102,negative regulation of T cell activation,BP,ANXA1
3774,GO:0007586,0.446933555191122,0.882566008249408,1,101,digestion,BP,SERPINA3
3479,GO:0006936,0.447059615184211,0.768586765838422,3,329,muscle contraction,BP,VIM;CHGA;KCNIP2
3519,GO:0007006,0.447526495625625,0.88214921013334,1,109,mitochondrial membrane organization,BP,CAMK2A
8549,GO:0032680,0.447778785496701,0.882121681435425,1,96,regulation of tumor necrosis factor production,BP,LTF
15378,GO:0062207,0.448201818350286,0.882032168025929,1,83,regulation of pattern recognition receptor signaling pathway,BP,LTF
9416,GO:0034637,0.44835044362577,0.882020139201841,1,78,cellular carbohydrate biosynthetic process,BP,FUT9
2814,GO:0005905,0.449247340212651,0.881657541984186,1,69,clathrin-coated pit,CC,SNAP91
8343,GO:0032388,0.449761812298257,0.805967574033935,2,212,positive regulation of intracellular transport,BP,KCNB1;ANXA2
14255,GO:0055117,0.450281142202008,0.880954628096264,1,74,regulation of cardiac muscle contraction,BP,CHGA
6593,GO:0019724,0.450307605026464,0.880548554823656,1,105,B cell mediated immunity,BP,C1R
18883,GO:1901019,0.450548569325697,0.880667945461656,1,82,regulation of calcium ion transmembrane transporter activity,BP,JPH3
12088,GO:0045860,0.450703989201864,0.740395860412627,4,491,positive regulation of protein kinase activity,BP,LTF;SLC8A2;GDF15;CHI3L1
2575,GO:0005496,0.450756702527709,0.880426928647015,1,91,steroid binding,MF,ATP1A3
5037,GO:0010942,0.450839692029117,0.722551617576966,5,659,positive regulation of cell death,BP,TNFRSF12A;CAMK2A;ANXA1;ADM;GRIN1
3737,GO:0007492,0.451083147727135,0.880464378545909,1,75,endoderm development,BP,COL5A1
12776,GO:0048013,0.451142245304334,0.880248795487994,1,87,ephrin receptor signaling pathway,BP,GRIN1
11964,GO:0045639,0.451512686923265,0.880016936348357,1,88,positive regulation of myeloid cell differentiation,BP,LIF
13653,GO:0051262,0.451605970574948,0.88002912160825,1,83,protein tetramerization,BP,GRIN1
5889,GO:0016529,0.451844798140928,0.880216810681842,1,65,sarcoplasmic reticulum,CC,JPH3
6671,GO:0019886,0.45258316065291,0.879310936062834,1,94,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,SH3GL2
19933,GO:1903555,0.452939560797728,0.879056215801119,1,98,regulation of tumor necrosis factor superfamily cytokine production,BP,LTF
16435,GO:0071887,0.453359084782754,0.878796363076072,1,99,leukocyte apoptotic process,BP,ANXA1
14113,GO:0052689,0.454311753532842,0.878127764824081,1,110,carboxylic ester hydrolase activity,MF,PLA2G2A
3306,GO:0006664,0.454432504174723,0.878117074757597,1,103,glycolipid metabolic process,BP,ST8SIA3
1083,GO:0002495,0.456098275731231,0.877190071808701,1,96,antigen processing and presentation of peptide antigen via MHC class II,BP,SH3GL2
8171,GO:0032092,0.456307061800682,0.877273855312443,1,80,positive regulation of protein binding,BP,ANXA2
19899,GO:1903509,0.456888962890725,0.87663423613695,1,104,liposaccharide metabolic process,BP,ST8SIA3
12571,GO:0046916,0.457450066818522,0.87632489581769,1,101,cellular transition metal ion homeostasis,BP,LTF
13104,GO:0048762,0.457805759241543,0.799865864379544,2,211,mesenchymal cell differentiation,BP,COL1A1;PDPN
10718,GO:0042470,0.457981064136769,0.876004440272303,1,101,melanosome,CC,ANXA2
13107,GO:0048770,0.457981064136769,0.876004440272303,1,101,pigment granule,CC,ANXA2
15685,GO:0070509,0.458285202391407,0.876186416309367,1,74,calcium ion import,BP,SLC8A2
560,GO:0001708,0.458574613718677,0.875768231162158,1,90,cell fate specification,BP,MYT1L
6459,GO:0019233,0.458607155486518,0.875761211085193,1,89,sensory perception of pain,BP,GRIN1
10974,GO:0043009,0.458756749584497,0.715655154847303,5,601,chordate embryonic development,BP,CELF4;COL1A1;LIF;ADM;SOCS3
13838,GO:0051606,0.459491859319373,0.79844098834181,2,246,detection of stimulus,BP,SYT1;KCNIP2
12043,GO:0045778,0.459899262955187,0.875061310375841,1,83,positive regulation of ossification,BP,LTF
1597,GO:0003678,0.460441754592245,0.874900667852871,1,73,DNA helicase activity,MF,ANXA1
13593,GO:0051153,0.460659105472505,0.874504051886881,1,90,regulation of striated muscle cell differentiation,BP,GDF15
18925,GO:1901184,0.460709351863036,0.874499303018914,1,88,regulation of ERBB signaling pathway,BP,SH3GL2
13076,GO:0048705,0.460712128829421,0.797640029292953,2,210,skeletal system morphogenesis,BP,LTF;COL1A1
7145,GO:0030111,0.460821273472323,0.757228980051024,3,348,regulation of Wnt signaling pathway,BP,PLEKHA4;COL1A1;IGFBP2
16066,GO:0071277,0.460904092044396,0.874497123985536,1,80,cellular response to calcium ion,BP,SYT1
8524,GO:0032640,0.460957906484633,0.874198350911752,1,101,tumor necrosis factor production,BP,LTF
15766,GO:0070661,0.461986665675716,0.796448492308213,2,270,leukocyte proliferation,BP,IGFBP2;ANXA1
16929,GO:0086001,0.462018894056909,0.874067537550393,1,67,cardiac muscle cell action potential,BP,KCNIP2
11948,GO:0045621,0.462081984693401,0.873554089014079,1,97,positive regulation of lymphocyte differentiation,BP,ANXA1
1087,GO:0002504,0.462177869306684,0.873495461916975,1,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,SH3GL2
18138,GO:0099513,0.462193672136651,0.712638668453239,5,581,polymeric cytoskeletal fiber,CC,VIM;NEFM;ANXA1;INA;SHANK2
8323,GO:0032368,0.463175814705251,0.872930071730542,1,93,regulation of lipid transport,BP,ANXA2
9036,GO:0033673,0.463177107856382,0.795652373798576,2,231,negative regulation of kinase activity,BP,SOCS3;PTPRT
17043,GO:0090079,0.463593327309,0.872596036009257,1,100,translation regulator activity, nucleic acid binding,MF,CELF4
7621,GO:0031058,0.46408419616175,0.872463068787336,1,86,positive regulation of histone modification,BP,LIF
21469,GO:2000027,0.464557653860826,0.794561097104844,2,237,regulation of animal organ morphogenesis,BP,PLEKHA4;LIF
4177,GO:0008637,0.465796794718136,0.871109866157691,1,114,apoptotic mitochondrial changes,BP,CAMK2A
7922,GO:0031594,0.465956957602167,0.871506205742244,1,74,neuromuscular junction,CC,POSTN
7811,GO:0031401,0.465963394556985,0.676596737788312,8,1088,positive regulation of protein modification process,BP,LTF;SLC8A2;LIF;GDF15;CHI3L1;ANXA2;SOCS3;PLA2G2A
16355,GO:0071706,0.465996730792844,0.87108392285575,1,103,tumor necrosis factor superfamily cytokine production,BP,LTF
5381,GO:0015294,0.466285344769017,0.871150007093759,1,83,solute:cation symporter activity,MF,SLC17A7
4805,GO:0010632,0.46663555366756,0.793077998121552,2,205,regulation of epithelial cell migration,BP,SRPX2;ANXA1
13642,GO:0051251,0.466880673245431,0.792679997584781,2,260,positive regulation of lymphocyte activation,BP,IGFBP2;ANXA1
5593,GO:0015918,0.467370064306623,0.870419903971474,1,87,sterol transport,BP,ANXA2
14566,GO:0060415,0.467772924876145,0.870508124188801,1,68,muscle tissue morphogenesis,BP,COL3A1
485,GO:0001570,0.470002104707497,0.868920862709388,1,78,vasculogenesis,BP,ADM
11530,GO:0044304,0.470709543168224,0.868726929147817,1,66,main axon,CC,CNTNAP2
11636,GO:0044703,0.47071125550147,0.691404315734349,6,828,multi-organism reproductive process,BP,CELF4;TIMP1;IGFBP2;LIF;ADM;GRIN1
1694,GO:0003924,0.470979353490091,0.789408687005617,2,283,GTPase activity,MF,GNAL;RAB3C
5656,GO:0016055,0.4712567453069,0.722644863454324,4,485,Wnt signaling pathway,BP,CAMK2A;PLEKHA4;COL1A1;IGFBP2
17934,GO:0098876,0.471491200997121,0.867905536016275,1,83,vesicle-mediated transport to the plasma membrane,BP,SNAP25
10825,GO:0042692,0.471719805678173,0.748142425526327,3,327,muscle cell differentiation,BP,LOX;GDF15;ADM
17655,GO:0097530,0.472002042308403,0.867194194548261,1,119,granulocyte migration,BP,ANXA1
18653,GO:0198738,0.474311341489132,0.719960329108928,4,487,cell-cell signaling by wnt,BP,CAMK2A;PLEKHA4;COL1A1;IGFBP2
13619,GO:0051219,0.474626672202359,0.865926890108558,1,83,phosphoprotein binding,MF,SOCS3
3165,GO:0006493,0.47475411512078,0.865830535165274,1,84,protein O-linked glycosylation,BP,GALNT13
2847,GO:0005975,0.476568705257726,0.717900861605092,4,543,carbohydrate metabolic process,BP,CHI3L2;CHI3L1;FUT9;ST8SIA3
12444,GO:0046632,0.477041693007937,0.864200162920561,1,97,alpha-beta T cell differentiation,BP,ANXA1
2812,GO:0005902,0.477869060882652,0.863845512516531,1,84,microvillus,CC,PDPN
6678,GO:0019899,0.477993143852644,0.629240421243081,16,2096,enzyme binding,MF,MCF2L2;RASGRF1;SNAP91;PHACTR3;RAPGEF4;TIMP1;SERPINE1;SH3GL2;COL1A1;IQSEC3;MOBP;COL3A1;CNTNAP2;RIMS2;ANXA2;PTPRT
22119,GO:2001237,0.478020723443136,0.863561782100372,1,98,negative regulation of extrinsic apoptotic signaling pathway,BP,SERPINE1
18945,GO:1901222,0.478281617973323,0.863372012818249,1,100,regulation of NIK/NF-kappaB signaling,BP,CHI3L1
7514,GO:0030864,0.479537687135278,0.862894137839947,1,77,cortical actin cytoskeleton,CC,MOBP
13825,GO:0051591,0.479687227177718,0.86263299963964,1,87,response to cAMP,BP,COL1A1
19695,GO:1903076,0.479861295685207,0.86241390685345,1,95,regulation of protein localization to plasma membrane,BP,DPP10
1199,GO:0002698,0.481870060026917,0.860974079603933,1,108,negative regulation of immune effector process,BP,ANXA1
7027,GO:0022607,0.482154152822824,0.618351055545097,19,2601,cellular component assembly,BP,SNAP91;SYT1;CELF4;SRPX2;NEFM;SH3GL2;CUX2;LOX;GABRG2;FMOD;SNAP25;EMP3;KCNB1;SHANK1;SHANK2;GABRB3;GRIN1;SLITRK1;ANXA2
40,GO:0000082,0.482413706130375,0.780438046571061,2,244,G1/S transition of mitotic cell cycle,BP,CAMK2A;ANXA1
14957,GO:0061061,0.48301873824312,0.693948282104384,5,593,muscle structure development,BP,LOX;LIF;GDF15;ADM;COL3A1
4561,GO:0009792,0.483645532184402,0.693352528397728,5,618,embryo development ending in birth or egg hatching,BP,CELF4;COL1A1;LIF;ADM;SOCS3
1608,GO:0003697,0.484539106191914,0.859275071048721,1,104,single-stranded DNA binding,MF,ANXA1
4302,GO:0009100,0.485546530385001,0.736226926152459,3,369,glycoprotein metabolic process,BP,GALNT13;FUT9;ST8SIA3
5777,GO:0016298,0.486513805455305,0.857990475579191,1,103,lipase activity,MF,PLA2G2A
13155,GO:0048872,0.486571981369584,0.777097993039157,2,240,homeostasis of number of cells,BP,ANXA1;PLA2G2A
18065,GO:0099080,0.488247011508768,0.648694183640617,9,1099,supramolecular complex,CC,VIM;NEFM;COL1A1;COL5A1;ANXA1;INA;SHANK2;COL3A1;COL4A1
81,GO:0000165,0.488454681794891,0.675137708094628,6,820,MAPK cascade,BP,RASGRF1;LIF;GDF15;CHI3L1;GRIN1;PLA2G2A
16914,GO:0080134,0.489047484293358,0.647862842489836,9,1297,regulation of response to stress,BP,TNFRSF12A;CAMK2A;SERPINE1;PLAU;ANXA1;PDPN;ANXA2;SOCS3;PLA2G2A
525,GO:0001656,0.489166349000705,0.856507137811117,1,83,metanephros development,BP,LIF
4614,GO:0009987,0.489459511961706,0.64496267761033,91,13730,cellular process,BP,TNFRSF12A;LTF;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PPP2R2C;SLCO1A2;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;SPOCD1;ANXA1;SRRM4;GNAL;COL6A2;EMP3;GALNT13;CPLX2;INA;ADM;RAB3C;JPH3;AFF2;SYN2;KCNB1;SHANK1;SHANK2;PDPN;GABRG1;ETNPPL;CSMD3;SVOP;GABRB3;NNMT;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;ANXA2;SOCS3;SV2B;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SLC6A17;OPALIN;SMOC1;DOK6;FRRS1L
2815,GO:0005911,0.489486836205711,0.706532523737089,4,449,cell-cell junction,CC,ANXA1;CNTNAP2;ANXA2;OPALIN
9401,GO:0034613,0.492090866650767,0.625139255191232,13,1825,cellular protein localization,BP,CHGA;COL1A1;PACSIN1;LIF;SNAP25;RAB3C;KCNB1;CNTNAP2;DPP10;RIMS2;GRIN1;ANXA2;SHISA7
3484,GO:0006942,0.492354264754067,0.854354378277739,1,85,regulation of striated muscle contraction,BP,CHGA
19672,GO:1903038,0.492702293295359,0.853782992725609,1,113,negative regulation of leukocyte cell-cell adhesion,BP,ANXA1
18481,GO:0120162,0.493640291307419,0.853417181308344,1,90,positive regulation of cold-induced thermogenesis,BP,KSR2
13079,GO:0048709,0.494622798419947,0.852626888363253,1,100,oligodendrocyte differentiation,BP,OPALIN
13530,GO:0051056,0.494777238003722,0.72834747996542,3,308,regulation of small GTPase mediated signal transduction,BP,RASGRF1;IQSEC3;COL3A1
12978,GO:0048534,0.495197768210481,0.668849427078103,6,855,hematopoietic or lymphoid organ development,BP,LTF;LOX;LIF;ANXA1;PDPN;ANXA2
7772,GO:0031330,0.496270318047255,0.769212209863914,2,229,negative regulation of cellular catabolic process,BP,TIMP1;ANXA2
11138,GO:0043279,0.496554307977253,0.851346526514196,1,98,response to alkaloid,BP,GRIN1
15799,GO:0070727,0.497145281421388,0.620271271138143,13,1834,cellular macromolecule localization,BP,CHGA;COL1A1;PACSIN1;LIF;SNAP25;RAB3C;KCNB1;CNTNAP2;DPP10;RIMS2;GRIN1;ANXA2;SHISA7
13343,GO:0050776,0.497505296810409,0.680514357720854,5,788,regulation of immune response,BP,COL1A1;ANXA1;C1R;COL3A1;SOCS3
19856,GO:1903409,0.497854623320679,0.850464346258984,1,98,reactive oxygen species biosynthetic process,BP,GRIN1
14325,GO:0060071,0.498016451591708,0.850284528449509,1,104,Wnt signaling pathway, planar cell polarity pathway,BP,PLEKHA4
5235,GO:0014902,0.498631632327257,0.850000809786439,1,93,myotube differentiation,BP,GDF15
5888,GO:0016528,0.500164131296676,0.849285167062839,1,74,sarcoplasm,CC,JPH3
12695,GO:0047485,0.500215402251871,0.848794932990663,1,103,protein N-terminus binding,MF,KCNIP2
11460,GO:0044089,0.500388606117655,0.696604131546716,4,494,positive regulation of cellular component biogenesis,BP,CHGA;SRPX2;CUX2;SLITRK1
7069,GO:0023014,0.501507409134138,0.662960583552129,6,828,signal transduction by protein phosphorylation,BP,RASGRF1;LIF;GDF15;CHI3L1;GRIN1;PLA2G2A
11457,GO:0044085,0.502139618711164,0.597055392283544,20,2823,cellular component biogenesis,BP,SNAP91;SYT1;CHGA;CELF4;SRPX2;NEFM;SH3GL2;CUX2;LOX;GABRG2;FMOD;SNAP25;EMP3;KCNB1;SHANK1;SHANK2;GABRB3;GRIN1;SLITRK1;ANXA2
8262,GO:0032270,0.502165769393879,0.629237496609124,10,1437,positive regulation of cellular protein metabolic process,BP,LTF;VIM;SLC8A2;LIF;GDF15;CHI3L1;GRIN1;ANXA2;SOCS3;PLA2G2A
3915,GO:0008194,0.502710179353739,0.84697708664908,1,113,UDP-glycosyltransferase activity,MF,GALNT13
6647,GO:0019842,0.502972268066759,0.846742312651753,1,119,vitamin binding,MF,ETNPPL
11892,GO:0045471,0.503847379726702,0.846210450381929,1,111,response to ethanol,BP,GRIN1
3770,GO:0007569,0.504672287648124,0.845759222880177,1,100,cell aging,BP,SERPINE1
8063,GO:0031902,0.504898011027228,0.845359415788375,1,125,late endosome membrane,CC,ANXA2
17108,GO:0090175,0.505030406780703,0.845441875426727,1,106,regulation of establishment of planar polarity,BP,PLEKHA4
6449,GO:0019218,0.506023978755817,0.844719255193886,1,109,regulation of steroid metabolic process,BP,ADM
12297,GO:0046332,0.506154139013318,0.845054681255476,1,79,SMAD binding,MF,COL3A1
4153,GO:0008593,0.506640804607323,0.844441397700862,1,96,regulation of Notch signaling pathway,BP,POSTN
11509,GO:0044264,0.50707925981025,0.844220748288928,1,90,cellular polysaccharide metabolic process,BP,FUT9
17090,GO:0090150,0.508794426639818,0.758487812849982,2,314,establishment of protein localization to membrane,BP,SNAP25;KCNB1
13871,GO:0051668,0.508820000171671,0.842973279818831,1,92,localization within membrane,BP,SHISA7
13545,GO:0051091,0.509602715931798,0.757989816572386,2,249,positive regulation of DNA-binding transcription factor activity,BP,LTF;CAMK2A
16540,GO:0072080,0.510177297671416,0.842113619804727,1,86,nephron tubule development,BP,LIF
13706,GO:0051348,0.510554982198286,0.757147882101356,2,259,negative regulation of transferase activity,BP,SOCS3;PTPRT
790,GO:0002027,0.511038001012428,0.841398123277334,1,93,regulation of heart rate,BP,ADM
1188,GO:0002687,0.511087052593458,0.840997550684087,1,128,positive regulation of leukocyte migration,BP,SERPINE1
22,GO:0000041,0.511098955767043,0.84108967188375,1,116,transition metal ion transport,BP,LTF
17728,GO:0097733,0.511119421990083,0.841340640507737,1,93,photoreceptor cell cilium,CC,SHANK2
7090,GO:0030004,0.511354311307364,0.841010374932804,1,106,cellular monovalent inorganic cation homeostasis,BP,ATP1A3
3279,GO:0006629,0.511696934751322,0.633498811947568,8,1221,lipid metabolic process,BP,PLEKHA4;ANXA1;ADM;ETNPPL;ST8SIA3;SOCS3;PLA2G2A;SERPINA3
2582,GO:0005506,0.512183121875358,0.840260673227917,1,123,iron ion binding,MF,LTF
13858,GO:0051648,0.512225634601433,0.755911585082525,2,214,vesicle localization,BP,SNAP91;SYN2
2279,GO:0004888,0.512743156106028,0.666342289143285,5,734,transmembrane signaling receptor activity,MF,GABRG2;GABRG1;GABRB3;GRIN1;PTPRT
7788,GO:0031347,0.512750702697458,0.685127483118596,4,596,regulation of defense response,BP,SERPINE1;ANXA1;SOCS3;PLA2G2A
20177,GO:1904019,0.514222615810134,0.839083873223832,1,97,epithelial cell apoptotic process,BP,SERPINE1
14280,GO:0060021,0.514421681786754,0.83909139644773,1,87,roof of mouth development,BP,GABRB3
11688,GO:0044843,0.514603888349688,0.753702867783418,2,258,cell cycle G1/S phase transition,BP,CAMK2A;ANXA1
478,GO:0001558,0.515367535213844,0.709824819813506,3,383,regulation of cell growth,BP,TNFRSF12A;SYT1;RIMS2
11795,GO:0045165,0.516922127497836,0.751767196164653,2,244,cell fate commitment,BP,PDPN;MYT1L
662,GO:0001843,0.517730625767863,0.83668965874568,1,89,neural tube closure,BP,ADM
14906,GO:0060993,0.517911556199067,0.836575774838928,1,88,kidney morphogenesis,BP,LIF
17854,GO:0098742,0.518852216770753,0.75030817254383,2,201,cell-cell adhesion via plasma-membrane adhesion molecules,BP,SLITRK1;PTPRT
5661,GO:0016071,0.518935565448874,0.660456014856732,5,789,mRNA metabolic process,BP,VIM;CELF4;SRRM4;AFF2;RBFOX3
2813,GO:0005903,0.519205245617198,0.835579574819212,1,92,brush border,CC,SHANK2
14701,GO:0060606,0.51924805680451,0.835579635977266,1,90,tube closure,BP,ADM
20802,GO:1905269,0.519298138932978,0.835427040414592,1,98,positive regulation of chromatin organization,BP,LIF
1371,GO:0003014,0.519495571400424,0.835162950592857,1,108,renal system process,BP,ADM
16352,GO:0071702,0.519832750741081,0.586032376099674,17,2510,organic substance transport,BP,SNAP91;SYT1;SLCO1A2;RAPGEF4;CHGA;SLC17A7;COL1A1;ABCC3;SNAP25;ANXA1;RAB3C;KCNB1;PDPN;RIMS2;ANXA2;PLA2G2A;SLC6A17
818,GO:0002065,0.521559770994245,0.833698361026209,1,105,columnar/cuboidal epithelial cell differentiation,BP,SERPINE1
2170,GO:0004725,0.521754160085788,0.833701043720264,1,94,protein tyrosine phosphatase activity,MF,PTPRT
17056,GO:0090092,0.521969768549056,0.747474193573598,2,229,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LOX;GDF15
2730,GO:0005777,0.522189783005322,0.83303358892641,1,126,peroxisome,CC,VIM
10772,GO:0042579,0.522189783005322,0.83303358892641,1,126,microbody,CC,VIM
4452,GO:0009314,0.522951181845587,0.702881443550565,3,404,response to radiation,BP,ANXA1;COL3A1;GRIN1
13317,GO:0050728,0.523054523220738,0.832426558221159,1,123,negative regulation of inflammatory response,BP,SOCS3
3812,GO:0008013,0.523359783229385,0.832732285792267,1,82,beta-catenin binding,MF,PTPRT
8785,GO:0033036,0.523792518631239,0.575767326623605,20,2853,macromolecule localization,BP,SNAP91;SLCO1A2;RAPGEF4;CHGA;COL1A1;ABCC3;PACSIN1;LIF;SNAP25;ANXA1;RAB3C;KCNB1;SHANK1;CNTNAP2;DPP10;RIMS2;GRIN1;ANXA2;SHISA7;PLA2G2A
11303,GO:0043549,0.52593002039548,0.639722131685433,6,824,regulation of kinase activity,BP,LTF;SLC8A2;GDF15;CHI3L1;SOCS3;PTPRT
5887,GO:0016525,0.52597632898734,0.830524838051605,1,100,negative regulation of angiogenesis,BP,SERPINE1
8754,GO:0032991,0.526008965721553,0.560235524368019,31,4582,protein-containing complex,CC,LTF;VIM;CAMK2A;PPP2R2C;CELF4;ATP1A3;COL1A1;LOX;GABRG2;KCNIP2;COL5A1;SNAP25;ANXA1;GNAL;COL6A2;CPLX2;JPH3;SYN2;KCNB1;SHANK1;SHANK2;GABRG1;GABRB3;COL3A1;CNTNAP2;DPP10;GRIN1;ANXA2;SOCS3;COL4A1;SHISA7
3750,GO:0007517,0.527122067338559,0.699152895467214,3,356,muscle organ development,BP,LOX;LIF;COL3A1
9667,GO:0035335,0.527496207494728,0.829457138886857,1,96,peptidyl-tyrosine dephosphorylation,BP,PTPRT
8366,GO:0032414,0.527645387617132,0.829318600324115,1,98,positive regulation of ion transmembrane transporter activity,BP,KCNIP2
4560,GO:0009791,0.528120576933002,0.82933524806015,1,77,post-embryonic development,BP,GABRG2
1270,GO:0002822,0.528521199445875,0.828313385587029,1,133,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1
20077,GO:1903827,0.528717221882514,0.670263149124541,4,527,regulation of cellular protein localization,BP,LIF;KCNB1;DPP10;SHISA7
19072,GO:1901568,0.528948643023565,0.827938761132199,1,141,fatty acid derivative metabolic process,BP,ANXA1
14227,GO:0055076,0.530487765044613,0.826955531134245,1,120,transition metal ion homeostasis,BP,LTF
815,GO:0002062,0.530599478957666,0.827135853736252,1,97,chondrocyte differentiation,BP,TGFBI
4908,GO:0010771,0.531381830746614,0.82658008157055,1,95,negative regulation of cell morphogenesis involved in differentiation,BP,POSTN
6402,GO:0019079,0.53206429341388,0.825823183400145,1,115,viral genome replication,BP,LTF
17568,GO:0097367,0.534138654595476,0.577330621443862,15,2013,carbohydrate derivative binding,MF,LTF;CHI3L2;CAMK2A;RAPGEF4;ATP1A3;ABCC3;COL5A1;CHI3L1;POSTN;GNAL;RAB3C;SYN2;KSR2;ST8SIA3;SMOC1
21552,GO:2000181,0.534713306844854,0.823977500473032,1,102,negative regulation of blood vessel morphogenesis,BP,SERPINE1
19900,GO:1903510,0.53684833066091,0.822284803546745,1,108,mucopolysaccharide metabolic process,BP,FMOD
13555,GO:0051101,0.537930963318516,0.821382954193039,1,115,regulation of DNA binding,BP,LIF
17871,GO:0098772,0.538006661959678,0.558231872977795,22,3282,molecular function regulator,MF,LTF;MCF2L2;RASGRF1;PPP2R2C;PHACTR3;RAPGEF4;TIMP1;SERPINE1;CUX2;HPCAL4;KCNIP2;IQSEC3;LIF;GDF15;ANXA1;ADM;ELFN2;DPP10;ANXA2;SOCS3;MYT1L;SERPINA3
535,GO:0001667,0.538420405055442,0.68861276021591,3,374,ameboidal-type cell migration,BP,TIMP1;SRPX2;ANXA1
11888,GO:0045446,0.538611905875048,0.821069915932203,1,98,endothelial cell differentiation,BP,PDPN
8877,GO:0033209,0.538693156743991,0.820492752037678,1,155,tumor necrosis factor-mediated signaling pathway,BP,TNFRSF12A
13402,GO:0050863,0.539173209527541,0.732062528302496,2,302,regulation of T cell activation,BP,IGFBP2;ANXA1
5101,GO:0014020,0.539721823586247,0.820250030638943,1,96,primary neural tube formation,BP,ADM
11504,GO:0044255,0.541075126563153,0.624932902052818,6,936,cellular lipid metabolic process,BP,PLEKHA4;ANXA1;ETNPPL;ST8SIA3;SOCS3;PLA2G2A
12014,GO:0045727,0.541183046604783,0.81880232202008,1,124,positive regulation of translation,BP,VIM
7892,GO:0031532,0.541422285650291,0.818832878742791,1,104,actin cytoskeleton reorganization,BP,ANXA1
17321,GO:0090630,0.541931565856806,0.818566873546578,1,95,activation of GTPase activity,BP,RASGRF1
2848,GO:0005976,0.542243051427822,0.818253424204335,1,100,polysaccharide metabolic process,BP,FUT9
1197,GO:0002696,0.542433887109391,0.729142342098861,2,298,positive regulation of leukocyte activation,BP,IGFBP2;ANXA1
2586,GO:0005515,0.542631042293656,0.550691275941581,76,11691,protein binding,MF,TNFRSF12A;LTF;VIM;MCF2L2;RASGRF1;SNAP91;SYT1;CAMK2A;PPP2R2C;PHACTR3;RAPGEF4;TIMP1;SRPX2;NEFM;ATP1A3;SERPINE1;SH3GL2;COL1A1;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;EMP3;CPLX2;ADM;RAB3C;SPHKAP;JPH3;SYN2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;SVOP;GABRB3;MOBP;COL3A1;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;DDN;ANXA2;CALN1;SOCS3;SV2B;COL4A1;SHISA7;PTPRT;SERPINA3;SLC6A17;SMOC1;DOK6
2882,GO:0006024,0.544012790016349,0.816817393402454,1,105,glycosaminoglycan biosynthetic process,BP,FMOD
6862,GO:0021761,0.544133786413425,0.816790136819713,1,100,limbic system development,BP,CNTNAP2
17060,GO:0090100,0.544968959576983,0.816113768316445,1,102,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,GDF15
13641,GO:0051250,0.545369620483261,0.815457658353627,1,136,negative regulation of lymphocyte activation,BP,ANXA1
8363,GO:0032411,0.545384365935638,0.815738436931467,1,106,positive regulation of transporter activity,BP,KCNIP2
6699,GO:0019955,0.547346527185567,0.81402131575886,1,123,cytokine binding,MF,PDPN
18077,GO:0099094,0.547352639505391,0.814309888903031,1,98,ligand-gated cation channel activity,MF,GRIN1
9370,GO:0034504,0.547582920860137,0.724627143768289,2,252,protein localization to nucleus,BP,COL1A1;LIF
12354,GO:0046467,0.548485752391879,0.813048169932858,1,132,membrane lipid biosynthetic process,BP,ST8SIA3
8448,GO:0032508,0.548943493719639,0.812991077906978,1,103,DNA duplex unwinding,BP,ANXA1
7004,GO:0022037,0.549547656480172,0.812528955163554,1,102,metencephalon development,BP,GRIN1
15476,GO:0070161,0.549574938653631,0.616666703256094,6,776,anchoring junction,CC,VIM;PLAU;ANXA1;CNTNAP2;ANXA2;OPALIN
18913,GO:1901137,0.54965197057056,0.65011486783355,4,589,carbohydrate derivative biosynthetic process,BP,FMOD;GALNT13;FUT9;ST8SIA3
13029,GO:0048640,0.551085396318834,0.81128762094988,1,104,negative regulation of developmental growth,BP,GDF15
8830,GO:0033135,0.551097063225862,0.811125358029181,1,117,regulation of peptidyl-serine phosphorylation,BP,LIF
8241,GO:0032231,0.551150738428438,0.811350750633893,1,96,regulation of actin filament bundle assembly,BP,SHANK1
1097,GO:0002520,0.551159852098015,0.615015158673793,6,900,immune system development,BP,LTF;LOX;LIF;ANXA1;PDPN;ANXA2
3606,GO:0007173,0.55141726037429,0.810937878868243,1,111,epidermal growth factor receptor signaling pathway,BP,SH3GL2
20340,GO:1904375,0.551829227495208,0.810566217998803,1,115,regulation of protein localization to cell periphery,BP,DPP10
578,GO:0001736,0.552965803209802,0.809620716451844,1,119,establishment of planar polarity,BP,PLEKHA4
3598,GO:0007164,0.552965803209802,0.809620716451844,1,119,establishment of tissue polarity,BP,PLEKHA4
18763,GO:1900180,0.555737290200072,0.807426267757449,1,117,regulation of protein localization to nucleus,BP,LIF
9637,GO:0035270,0.556248813788599,0.806994622045032,1,119,endocrine system development,BP,ANXA1
7383,GO:0030516,0.557604767384321,0.806230134786841,1,94,regulation of axon extension,BP,TNFRSF12A
6878,GO:0021782,0.557606594914725,0.805966754140737,1,113,glial cell development,BP,VIM
2797,GO:0005884,0.557849306412352,0.805806312313811,1,110,actin filament,CC,ANXA1
2881,GO:0006023,0.557988049737822,0.805682343252146,1,111,aminoglycan biosynthetic process,BP,FMOD
7703,GO:0031225,0.558405405236859,0.805071549703964,1,140,anchored component of membrane,CC,RAB3C
13448,GO:0050921,0.558411478085915,0.805121753052749,1,133,positive regulation of chemotaxis,BP,SERPINE1
3721,GO:0007409,0.558629913795988,0.641514328929449,4,461,axonogenesis,BP,TNFRSF12A;GRIN1;SLITRK1;DOK6
17726,GO:0097731,0.559330016833415,0.804573603228409,1,113,9+0 non-motile cilium,CC,SHANK2
8666,GO:0032868,0.559483283426301,0.713643918159715,2,260,response to insulin,BP,ADM;SOCS3
3281,GO:0006633,0.560025990734961,0.803742631344324,1,142,fatty acid biosynthetic process,BP,ANXA1
4588,GO:0009897,0.561408609403243,0.711722278601217,2,299,external side of plasma membrane,CC,ANXA1;CD163
1195,GO:0002694,0.561904166890773,0.666017710981678,3,477,regulation of leukocyte activation,BP,IGFBP2;ANXA1;PLA2G2A
16496,GO:0072009,0.562569359156728,0.802108020205397,1,100,nephron epithelium development,BP,LIF
12443,GO:0046631,0.562627169359381,0.801683316525264,1,134,alpha-beta T cell activation,BP,ANXA1
11805,GO:0045182,0.563036003774253,0.801409744801573,1,127,translation regulator activity,MF,CELF4
16100,GO:0071333,0.563588686366409,0.801046233173216,1,118,cellular response to glucose stimulus,BP,KCNB1
4205,GO:0008757,0.565445447867844,0.799375999287798,1,133,S-adenosylmethionine-dependent methyltransferase activity,MF,NNMT
1267,GO:0002819,0.565889229487632,0.798895239953045,1,148,regulation of adaptive immune response,BP,ANXA1
2823,GO:0005925,0.566489622658955,0.661672729632764,3,403,focal adhesion,CC,VIM;PLAU;ANXA1
19918,GO:1903532,0.567101325983882,0.706425893450813,2,282,positive regulation of secretion by cell,BP,SYT1;KCNB1
16098,GO:0071331,0.567661039739817,0.797665861910934,1,120,cellular response to hexose stimulus,BP,KCNB1
7196,GO:0030175,0.56882058961564,0.797002363951048,1,97,filopodium,CC,PDPN
2595,GO:0005525,0.568826135761077,0.704672136294726,2,326,GTP binding,MF,GNAL;RAB3C
8346,GO:0032392,0.569586350979668,0.796167172727972,1,111,DNA geometric change,BP,ANXA1
18997,GO:1901343,0.570322764061055,0.79551643448935,1,114,negative regulation of vasculature development,BP,SERPINE1
16096,GO:0071326,0.570444190877666,0.795337550237,1,121,cellular response to monosaccharide stimulus,BP,KCNB1
13638,GO:0051247,0.571257341266796,0.56083652961587,10,1511,positive regulation of protein metabolic process,BP,LTF;VIM;SLC8A2;LIF;GDF15;CHI3L1;GRIN1;ANXA2;SOCS3;PLA2G2A
13864,GO:0051656,0.571330255562758,0.656922375160908,3,402,establishment of organelle localization,BP,SNAP91;CHGA;CPLX2
3513,GO:0006997,0.572022416562259,0.794069783029197,1,116,nucleus organization,BP,AFF2
660,GO:0001841,0.572059886399521,0.794190896747591,1,104,neural tube formation,BP,ADM
20112,GO:1903900,0.572839012187171,0.793180376869196,1,137,regulation of viral life cycle,BP,LTF
9037,GO:0033674,0.572850459550428,0.627249245227955,4,560,positive regulation of kinase activity,BP,LTF;SLC8A2;GDF15;CHI3L1
14619,GO:0060485,0.574375368981081,0.699576050824496,2,263,mesenchyme development,BP,COL1A1;PDPN
8468,GO:0032550,0.574714183479208,0.699051923306039,2,330,purine ribonucleoside binding,MF,GNAL;RAB3C
11590,GO:0044419,0.575003181417025,0.551605845558663,11,1801,interspecies interaction between organisms,BP,LTF;VIM;CAMK2A;CHGA;SERPINE1;ANXA1;ADM;C1R;ANXA2;SOCS3;PLA2G2A
9398,GO:0034605,0.575266370398505,0.791345635646646,1,115,cellular response to heat,BP,CAMK2A
3303,GO:0006661,0.575825637506324,0.790883349252816,1,114,phosphatidylinositol biosynthetic process,BP,PLEKHA4
3856,GO:0008094,0.576274863519194,0.790677531113258,1,101,DNA-dependent ATPase activity,MF,ANXA1
12998,GO:0048568,0.576903940613535,0.651375322210163,3,418,embryonic organ development,BP,LIF;ADM;SOCS3
13077,GO:0048706,0.576975481766307,0.789816709811863,1,122,embryonic skeletal system development,BP,COL1A1
7124,GO:0030055,0.577306076546357,0.650993054869531,3,409,cell-substrate junction,CC,VIM;PLAU;ANXA1
21113,GO:1905952,0.577842495218578,0.789037050705286,1,126,regulation of lipid localization,BP,ANXA2
685,GO:0001883,0.578641229448029,0.695268184490938,2,333,purine nucleoside binding,MF,GNAL;RAB3C
556,GO:0001704,0.579077428828468,0.788136694287342,1,112,formation of primary germ layer,BP,COL5A1
3967,GO:0008283,0.580150717702378,0.546352092201111,11,1698,cell population proliferation,BP,LTF;RASGRF1;TIMP1;IGFBP2;TGFBI;PLAU;LIF;ANXA1;ADM;PDPN;ANXA2
8467,GO:0032549,0.581897561894454,0.692115404738533,2,333,ribonucleoside binding,MF,GNAL;RAB3C
11919,GO:0045580,0.582061160321532,0.78532285472029,1,136,regulation of T cell differentiation,BP,ANXA1
911,GO:0002224,0.582400328066917,0.785038349656498,1,135,toll-like receptor signaling pathway,BP,LTF
1431,GO:0003158,0.582718266384295,0.784967530175422,1,115,endothelium development,BP,PDPN
3307,GO:0006665,0.585622544422667,0.782158225817247,1,145,sphingolipid metabolic process,BP,ST8SIA3
13616,GO:0051209,0.585931576507818,0.782280565162963,1,107,release of sequestered calcium ion into cytosol,BP,JPH3
3236,GO:0006575,0.586897865860929,0.78092730996188,1,162,cellular modified amino acid metabolic process,BP,PLA2G2A
7020,GO:0022414,0.588101289538193,0.557321211644442,8,1224,reproductive process,BP,CELF4;TIMP1;IGFBP2;LIF;ANXA1;ADM;GRIN1;SOCS3
13665,GO:0051283,0.588186897178461,0.780293490208336,1,108,negative regulation of sequestering of calcium ion,BP,JPH3
6052,GO:0016829,0.58866116272616,0.779343278811494,1,168,lyase activity,MF,ETNPPL
13652,GO:0051261,0.589747510237752,0.778949198031424,1,106,protein depolymerization,BP,SH3GL2
2,GO:0000003,0.589879807621391,0.555480997297167,8,1227,reproduction,BP,CELF4;TIMP1;IGFBP2;LIF;ANXA1;ADM;GRIN1;SOCS3
684,GO:0001882,0.589980449053542,0.68419185078804,2,339,nucleoside binding,MF,GNAL;RAB3C
13664,GO:0051282,0.590873276629474,0.777913236358206,1,109,regulation of sequestering of calcium ion,BP,JPH3
13159,GO:0048878,0.590874547585581,0.563532269568437,7,1052,chemical homeostasis,BP,LTF;ATP1A3;SLC8A2;ADM;JPH3;KCNB1;GRIN1
13586,GO:0051146,0.590940632571946,0.683524657305149,2,250,striated muscle cell differentiation,BP,LOX;GDF15
3824,GO:0008037,0.591244036498442,0.77733448964551,1,131,cell recognition,BP,CNTNAP2
16109,GO:0071347,0.591532438974861,0.776873158642932,1,157,cellular response to interleukin-1,BP,CHI3L1
16094,GO:0071322,0.591819345298515,0.776843717659718,1,129,cellular response to carbohydrate stimulus,BP,KCNB1
7790,GO:0031349,0.591963427902368,0.682274648679819,2,322,positive regulation of defense response,BP,SERPINE1;PLA2G2A
12472,GO:0046683,0.592333908370101,0.776406786165324,1,127,response to organophosphorus,BP,COL1A1
22050,GO:2001056,0.593332095507297,0.775390778444078,1,141,positive regulation of cysteine-type endopeptidase activity,BP,GRIN1
7544,GO:0030900,0.593391581858525,0.634891712126646,3,369,forebrain development,BP,COL3A1;CNTNAP2;GRIN1
1369,GO:0003012,0.593776102571955,0.634407590129439,3,410,muscle system process,BP,VIM;CHGA;KCNIP2
6556,GO:0019538,0.59649205952322,0.4874385003001,33,5028,protein metabolic process,BP,LTF;VIM;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;LOX;IGFBP2;SLC8A2;TGFBI;PLAU;LIF;GDF15;CHI3L1;ANXA1;GALNT13;C1R;ELFN2;COL3A1;KSR2;FUT9;DPP10;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
13615,GO:0051208,0.599528656416194,0.770126994075788,1,112,sequestering of calcium ion,BP,JPH3
10346,GO:0038061,0.601365790565667,0.768043579426598,1,155,NIK/NF-kappaB signaling,BP,CHI3L1
15093,GO:0061387,0.601484212669829,0.768421169135691,1,107,regulation of extent of cell growth,BP,TNFRSF12A
4673,GO:0010256,0.601532276259556,0.626443134034202,3,415,endomembrane system organization,BP,SH3GL2;PACSIN1;COL5A1
6375,GO:0019001,0.603337109614066,0.670847030387574,2,343,guanyl nucleotide binding,MF,GNAL;RAB3C
8478,GO:0032561,0.603337109614066,0.670847030387574,2,343,guanyl ribonucleotide binding,MF,GNAL;RAB3C
12168,GO:0045995,0.603444285700982,0.766522200144044,1,115,regulation of embryonic development,BP,COL5A1
1073,GO:0002478,0.603900678945958,0.765652813225945,1,166,antigen processing and presentation of exogenous peptide antigen,BP,SH3GL2
13521,GO:0051047,0.604122424536845,0.670151784267242,2,305,positive regulation of secretion,BP,SYT1;KCNB1
4804,GO:0010631,0.60497757498879,0.669421034607941,2,265,epithelial cell migration,BP,SRPX2;ANXA1
742,GO:0001959,0.605496425210002,0.764332548208354,1,145,regulation of cytokine-mediated signaling pathway,BP,SOCS3
17078,GO:0090132,0.605846866659201,0.668535261370656,2,266,epithelium migration,BP,SRPX2;ANXA1
4664,GO:0010212,0.606472427026153,0.763528119831951,1,134,response to ionizing radiation,BP,ANXA1
6137,GO:0017015,0.606938431590049,0.763307534447118,1,115,regulation of transforming growth factor beta receptor signaling pathway,BP,LOX
4811,GO:0010638,0.608496558082973,0.590644032183908,4,587,positive regulation of organelle organization,BP,SYT1;LIF;ANXA1;ANXA2
5723,GO:0016202,0.608794845455227,0.761467734686216,1,125,regulation of striated muscle tissue development,BP,LOX
18507,GO:0140013,0.608939448052214,0.761169109181404,1,142,meiotic nuclear division,BP,LIF
11511,GO:0044267,0.609435951882993,0.476193116205498,30,4589,cellular protein metabolic process,BP,LTF;VIM;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;LOX;IGFBP2;SLC8A2;TGFBI;LIF;GDF15;CHI3L1;ANXA1;GALNT13;ELFN2;COL3A1;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
427,GO:0001227,0.609666826786245,0.664484150061893,2,314,DNA-binding transcription repressor activity, RNA polymerase II-specific,MF,CUX2;MYT1L
12995,GO:0048565,0.60979682210575,0.760568920691381,1,122,digestive tract development,BP,COL3A1
20087,GO:1903844,0.610179511789581,0.760272374664247,1,117,regulation of cellular response to transforming growth factor beta stimulus,BP,LOX
8254,GO:0032259,0.610297375177144,0.663861797567148,2,306,methylation,BP,NNMT;METTL7B
12614,GO:0046983,0.611209277746785,0.56805436497257,5,825,protein dimerization activity,MF,SYT1;CAMK2A;GDF15;KCNB1;PTPRT
420,GO:0001217,0.611735907161173,0.662360802393235,2,315,DNA-binding transcription repressor activity,MF,CUX2;MYT1L
17076,GO:0090130,0.611746865217823,0.662492423042109,2,271,tissue migration,BP,SRPX2;ANXA1
9402,GO:0034614,0.611825121602838,0.758393676145195,1,152,cellular response to reactive oxygen species,BP,ANXA1
3266,GO:0006612,0.611953179395735,0.758041479016342,1,191,protein targeting to membrane,BP,KCNB1
15152,GO:0061564,0.612541855327796,0.58650074705311,4,502,axon development,BP,TNFRSF12A;GRIN1;SLITRK1;DOK6
657,GO:0001838,0.612971855447962,0.757608674274208,1,121,embryonic epithelial tube formation,BP,ADM
97,GO:0000187,0.613505235307195,0.75690322287677,1,141,activation of MAPK activity,BP,GDF15
1196,GO:0002695,0.613545879186482,0.756698735475881,1,163,negative regulation of leukocyte activation,BP,ANXA1
3858,GO:0008104,0.613819717163028,0.490410121209437,17,2541,protein localization,BP,SNAP91;RAPGEF4;CHGA;COL1A1;PACSIN1;LIF;SNAP25;ANXA1;RAB3C;KCNB1;SHANK1;CNTNAP2;DPP10;RIMS2;GRIN1;ANXA2;SHISA7
14219,GO:0055067,0.614423289096447,0.756011538628798,1,144,monovalent inorganic cation homeostasis,BP,ATP1A3
13024,GO:0048634,0.614778794831814,0.755826916724183,1,128,regulation of muscle organ development,BP,LOX
20208,GO:1904064,0.614788920871471,0.755756354147088,1,134,positive regulation of cation transmembrane transport,BP,KCNIP2
6259,GO:0018105,0.615676356561382,0.658439550583854,2,272,peptidyl-serine phosphorylation,BP,CAMK2A;LIF
1185,GO:0002684,0.616015161958575,0.562934745836928,5,869,positive regulation of immune system process,BP,SERPINE1;IGFBP2;LIF;ANXA1;C1R
7228,GO:0030216,0.616024218267725,0.754530810985679,1,140,keratinocyte differentiation,BP,ANXA1
1198,GO:0002697,0.617534301024815,0.656289936672412,2,348,regulation of immune effector process,BP,ANXA1;C1R
923,GO:0002250,0.617891619639341,0.655892039525614,2,360,adaptive immune response,BP,ANXA1;C1R
13335,GO:0050768,0.618608931272551,0.655413586366562,2,268,negative regulation of neurogenesis,BP,VIM;COL3A1
11368,GO:0043687,0.618766395093648,0.655042996750278,2,334,post-translational protein modification,BP,TIMP1;SOCS3
15384,GO:0065003,0.619048062351806,0.517388666630183,9,1437,protein-containing complex assembly,BP,SNAP91;SYT1;CELF4;SH3GL2;FMOD;SNAP25;KCNB1;SHANK1;GRIN1
9231,GO:0034250,0.619459194328414,0.751172979785671,1,150,positive regulation of cellular amide metabolic process,BP,VIM
6669,GO:0019884,0.619602135775275,0.75087952734729,1,173,antigen processing and presentation of exogenous antigen,BP,SH3GL2
19185,GO:1901861,0.62014576668455,0.750717561701857,1,128,regulation of muscle tissue development,BP,LOX
22117,GO:2001235,0.620238085760504,0.750312479702294,1,166,positive regulation of apoptotic signaling pathway,BP,TNFRSF12A
13696,GO:0051338,0.620962077792874,0.54317817235891,6,927,regulation of transferase activity,BP,LTF;SLC8A2;GDF15;CHI3L1;SOCS3;PTPRT
17725,GO:0097730,0.621402264907457,0.749438500861931,1,135,non-motile cilium,CC,SHANK2
18911,GO:1901135,0.621509171842601,0.542559164652072,6,991,carbohydrate derivative metabolic process,BP,CHI3L2;FMOD;CHI3L1;GALNT13;FUT9;ST8SIA3
543,GO:0001678,0.621590066753561,0.749257687611372,1,135,cellular glucose homeostasis,BP,KCNB1
19727,GO:1903169,0.621596783265547,0.749222600972064,1,138,regulation of calcium ion transmembrane transport,BP,JPH3
690,GO:0001889,0.621718679234377,0.749124124003061,1,136,liver development,BP,ANXA1
4586,GO:0009895,0.622791140262378,0.650998476231425,2,281,negative regulation of catabolic process,BP,TIMP1;ANXA2
10555,GO:0042127,0.623897222835112,0.512219724740186,9,1452,regulation of cell population proliferation,BP,LTF;TIMP1;IGFBP2;PLAU;LIF;ANXA1;ADM;PDPN;ANXA2
6208,GO:0017148,0.623964740626482,0.747035815915077,1,128,negative regulation of translation,BP,CELF4
946,GO:0002285,0.62487950023101,0.745942683093484,1,150,lymphocyte activation involved in immune response,BP,ANXA1
16446,GO:0071900,0.626432266990239,0.600153016003168,3,476,regulation of protein serine/threonine kinase activity,BP,LTF;SLC8A2;GDF15
2611,GO:0005575,0.627569776740334,0.600268782379322,97,14892,cellular_component,CC,TNFRSF12A;LTF;VIM;RASGRF1;CHI3L2;SNAP91;SYT1;CAMK2A;PPP2R2C;SLCO1A2;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;EMP3;GALNT13;CPLX2;INA;ADM;RAB3C;SPHKAP;JPH3;AFF2;SYN2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;ETNPPL;CSMD3;SVOP;GABRB3;NNMT;ELFN2;RBFOX3;MOBP;COL3A1;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;DDN;ANXA2;CALN1;SOCS3;SV2B;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SLC6A17;OPALIN;SMOC1;DOK6;FRRS1L
10383,GO:0038127,0.627775087867517,0.743280935758124,1,132,ERBB signaling pathway,BP,SH3GL2
14792,GO:0060759,0.629122954932532,0.741761993012163,1,154,regulation of response to cytokine stimulus,BP,SOCS3
1594,GO:0003674,0.629882443611175,0.550616848905664,95,14660,molecular_function,MF,TNFRSF12A;LTF;VIM;MCF2L2;RASGRF1;CHI3L2;SNAP91;SYT1;CAMK2A;PPP2R2C;SLCO1A2;PHACTR3;RAPGEF4;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;EMP3;GALNT13;CPLX2;INA;ADM;RAB3C;SPHKAP;JPH3;AFF2;SYN2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;ETNPPL;SVOP;GABRB3;NNMT;ELFN2;RBFOX3;MOBP;COL3A1;METTL7B;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;DDN;ANXA2;CALN1;SOCS3;SV2B;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SLC6A17;SMOC1;DOK6;FRRS1L
579,GO:0001738,0.630243801628116,0.740776008660853,1,140,morphogenesis of a polarized epithelium,BP,PLEKHA4
4786,GO:0010605,0.630363192491768,0.472924596478979,17,2635,negative regulation of macromolecule metabolic process,BP,LTF;VIM;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;CUX2;LIF;ANXA1;AFF2;ELFN2;ANXA2;SOCS3;MYT1L;PTPRT;SERPINA3
7135,GO:0030097,0.631039828615858,0.546860537995394,5,816,hemopoiesis,BP,LTF;LOX;LIF;ANXA1;ANXA2
21476,GO:2000045,0.631929566570154,0.739055830606229,1,146,regulation of G1/S transition of mitotic cell cycle,BP,ANXA1
7882,GO:0031514,0.632080977627856,0.738880528414754,1,149,motile cilium,CC,ANXA1
14919,GO:0061008,0.632223364904698,0.738827675293481,1,139,hepaticobiliary system development,BP,ANXA1
16603,GO:0072175,0.633124610287329,0.738035199346941,1,129,epithelial tube formation,BP,ADM
8202,GO:0032147,0.633473267225726,0.639613819922681,2,303,activation of protein kinase activity,BP,GDF15;CHI3L1
18372,GO:0106106,0.634060605642442,0.73704041653889,1,135,cold-induced thermogenesis,BP,KSR2
18480,GO:0120161,0.634060605642442,0.73704041653889,1,135,regulation of cold-induced thermogenesis,BP,KSR2
13587,GO:0051147,0.634098391494865,0.736926530653593,1,143,regulation of muscle cell differentiation,BP,GDF15
3332,GO:0006694,0.634183616362469,0.736683762465466,1,163,steroid biosynthetic process,BP,ADM
14259,GO:0055123,0.634738698116192,0.736405731603488,1,131,digestive system development,BP,COL3A1
12767,GO:0048002,0.635843507303683,0.734917250286583,1,180,antigen processing and presentation of peptide antigen,BP,SH3GL2
3970,GO:0008286,0.636473075970571,0.734628331907806,1,135,insulin receptor signaling pathway,BP,SOCS3
5041,GO:0010950,0.637147601885883,0.733736441563305,1,160,positive regulation of endopeptidase activity,BP,GRIN1
929,GO:0002262,0.637806142602045,0.733184926890306,1,146,myeloid cell homeostasis,BP,ANXA1
1279,GO:0002831,0.641371003853645,0.630974224811634,2,350,regulation of response to biotic stimulus,BP,LTF;SOCS3
10708,GO:0042445,0.642349329345622,0.728349421466098,1,178,hormone metabolic process,BP,ADM
13604,GO:0051172,0.642559472647585,0.468425977871794,14,2143,negative regulation of nitrogen compound metabolic process,BP,LTF;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;CUX2;LIF;ELFN2;ANXA2;SOCS3;MYT1L;PTPRT;SERPINA3
7014,GO:0022408,0.642672234780072,0.728131358154529,1,161,negative regulation of cell-cell adhesion,BP,ANXA1
16490,GO:0072001,0.644229774786319,0.628104838150828,2,271,renal system development,BP,LIF;COL4A1
11773,GO:0045121,0.644522840527116,0.627652237006498,2,309,membrane raft,CC,PDPN;ANXA2
11217,GO:0043408,0.644735703486006,0.551591384053289,4,644,regulation of MAPK cascade,BP,LIF;GDF15;CHI3L1;PLA2G2A
21678,GO:2000377,0.645037285391553,0.725694479870336,1,163,regulation of reactive oxygen species metabolic process,BP,GRIN1
14305,GO:0060048,0.64645264497157,0.724567764543196,1,127,cardiac muscle contraction,BP,CHGA
7215,GO:0030203,0.647123748728325,0.723662569038564,1,148,glycosaminoglycan metabolic process,BP,FMOD
7619,GO:0031056,0.647550479468042,0.723314745206238,1,138,regulation of histone modification,BP,LIF
17923,GO:0098857,0.647774019502501,0.62408731906327,2,310,membrane microdomain,CC,PDPN;ANXA2
3747,GO:0007507,0.647954033718774,0.54817730575082,4,529,heart development,BP,LOX;COL5A1;ADM;COL3A1
9501,GO:0034767,0.649214352308089,0.721505098693904,1,147,positive regulation of ion transmembrane transport,BP,KCNIP2
8062,GO:0031901,0.649392965700546,0.721328372184557,1,146,early endosome membrane,CC,ANXA1
19678,GO:1903046,0.649576760818134,0.721053119989219,1,156,meiotic cell cycle process,BP,LIF
18423,GO:0110165,0.651237554931882,0.548427662758114,96,14761,cellular anatomical entity,CC,TNFRSF12A;LTF;VIM;RASGRF1;CHI3L2;SNAP91;SYT1;CAMK2A;PPP2R2C;SLCO1A2;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;SLC8A2;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;EMP3;GALNT13;CPLX2;INA;ADM;RAB3C;SPHKAP;JPH3;AFF2;SYN2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;ETNPPL;CSMD3;SVOP;GABRB3;NNMT;ELFN2;RBFOX3;MOBP;COL3A1;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;DDN;ANXA2;CALN1;SOCS3;SV2B;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SLC6A17;OPALIN;SMOC1;DOK6;FRRS1L
7035,GO:0022618,0.651968835261422,0.718403595291169,1,178,ribonucleoprotein complex assembly,BP,CELF4
11946,GO:0045619,0.652425686520753,0.7180172025856,1,164,regulation of lymphocyte differentiation,BP,ANXA1
13052,GO:0048675,0.653479215799897,0.71735724719353,1,119,axon extension,BP,TNFRSF12A
4473,GO:0009408,0.654179383940277,0.716266979223983,1,152,response to heat,BP,CAMK2A
7766,GO:0031324,0.655310263252943,0.451507509585495,15,2317,negative regulation of cellular metabolic process,BP,LTF;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;CUX2;LIF;SPOCD1;ELFN2;ANXA2;SOCS3;MYT1L;PTPRT;SERPINA3
11458,GO:0044087,0.655587420593022,0.505500759029008,6,884,regulation of cellular component biogenesis,BP,CHGA;SRPX2;CUX2;SHANK1;GRIN1;SLITRK1
17925,GO:0098862,0.657034378584272,0.713398551967663,1,136,cluster of actin-based cell projections,CC,SHANK2
5910,GO:0016573,0.657475418649627,0.712804651356121,1,149,histone acetylation,BP,LIF
13705,GO:0051347,0.658436519982871,0.536358134369969,4,637,positive regulation of transferase activity,BP,LTF;SLC8A2;GDF15;CHI3L1
5143,GO:0014074,0.658574390797831,0.71170930744197,1,141,response to purine-containing compound,BP,COL1A1
11218,GO:0043409,0.658955387535637,0.711177182048542,1,155,negative regulation of MAPK cascade,BP,LIF
11256,GO:0043488,0.659062991836217,0.710971310629605,1,167,regulation of mRNA stability,BP,VIM
7546,GO:0030902,0.65929886618668,0.710936192985407,1,141,hindbrain development,BP,GRIN1
22115,GO:2001233,0.659351073871243,0.611055209754885,2,376,regulation of apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1
16533,GO:0072073,0.660077859723256,0.710198407715059,1,132,kidney epithelium development,BP,LIF
14018,GO:0051961,0.660481269427362,0.610016133400439,2,291,negative regulation of nervous system development,BP,VIM;COL3A1
1363,GO:0003006,0.6606111061662,0.514299805114938,5,811,developmental process involved in reproduction,BP,CELF4;LIF;ANXA1;ADM;SOCS3
12128,GO:0045931,0.66083345434483,0.709227314028521,1,148,positive regulation of mitotic cell cycle,BP,ANXA1
6330,GO:0018393,0.66260152226552,0.707290531643924,1,152,internal peptidyl-lysine acetylation,BP,LIF
13405,GO:0050866,0.662681634492934,0.706983447097956,1,183,negative regulation of cell activation,BP,ANXA1
21401,GO:1990845,0.663156066430505,0.706764666509208,1,144,adaptive thermogenesis,BP,KSR2
19552,GO:1902806,0.663753439301677,0.70599692899827,1,158,regulation of cell cycle G1/S phase transition,BP,ANXA1
3480,GO:0006937,0.664175055424757,0.705616595457647,1,149,regulation of muscle contraction,BP,CHGA
13631,GO:0051235,0.666186493645987,0.603541210877253,2,296,maintenance of location,BP,SLC17A7;JPH3
3590,GO:0007156,0.666231394990755,0.703964746352891,1,104,homophilic cell adhesion via plasma membrane adhesion molecules,BP,PTPRT
3151,GO:0006475,0.667435704772543,0.702026294793143,1,154,internal protein amino acid acetylation,BP,LIF
16401,GO:0071826,0.667500987405557,0.701736893368033,1,185,ribonucleoprotein complex subunit organization,BP,CELF4
4583,GO:0009892,0.667879872555449,0.430271999542557,18,2850,negative regulation of metabolic process,BP,LTF;VIM;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;CUX2;LIF;SPOCD1;ANXA1;AFF2;ELFN2;ANXA2;SOCS3;MYT1L;PTPRT;SERPINA3
9230,GO:0034249,0.668975663866928,0.700421110714804,1,145,negative regulation of cellular amide metabolic process,BP,CELF4
19592,GO:1902904,0.66905350194007,0.700416788795066,1,137,negative regulation of supramolecular fiber organization,BP,SHANK1
17778,GO:0098589,0.66934775905809,0.599853020058887,2,321,membrane region,CC,PDPN;ANXA2
2700,GO:0005741,0.66996656705409,0.699127894374737,1,170,mitochondrial outer membrane,CC,PLA2G2A
16493,GO:0072006,0.670291287525507,0.699112235539527,1,132,nephron development,BP,LIF
11037,GO:0043123,0.67047122791318,0.698512352858907,1,179,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF
3538,GO:0007033,0.670732202769643,0.698350729322115,1,161,vacuole organization,BP,ANXA2
13553,GO:0051099,0.671505019060872,0.697482114596294,1,163,positive regulation of binding,BP,ANXA2
17033,GO:0090066,0.671644549451381,0.549978912347739,3,472,regulation of anatomical structure size,BP,TNFRSF12A;CHGA;ADM
1046,GO:0002440,0.671849789217841,0.696947250954146,1,186,production of molecular mediator of immune response,BP,CHGA
2415,GO:0005126,0.672911073011893,0.695715398460819,1,196,cytokine receptor binding,MF,LIF
5043,GO:0010952,0.67356030290138,0.695092602297387,1,179,positive regulation of peptidase activity,BP,GRIN1
3290,GO:0006643,0.674368401134337,0.694127292713685,1,190,membrane lipid metabolic process,BP,ST8SIA3
13651,GO:0051260,0.675450424800166,0.693067737854167,1,167,protein homooligomerization,BP,KCNB1
17054,GO:0090090,0.675839326172726,0.692611337811728,1,170,negative regulation of canonical Wnt signaling pathway,BP,IGFBP2
7376,GO:0030509,0.676812020612814,0.69181238226882,1,137,BMP signaling pathway,BP,GDF15
11255,GO:0043487,0.677290987104836,0.690949694306907,1,175,regulation of RNA stability,BP,VIM
1200,GO:0002699,0.677718694749042,0.690359555589238,1,193,positive regulation of immune effector process,BP,ANXA1
2748,GO:0005798,0.677787186154296,0.690440886548334,1,168,Golgi-associated vesicle,CC,PACSIN1
3116,GO:0006417,0.678552811340379,0.589165850718777,2,340,regulation of translation,BP,VIM;CELF4
9589,GO:0035148,0.679562556550104,0.68863420496011,1,145,tube formation,BP,ADM
5796,GO:0016331,0.679831917593446,0.688320027549418,1,146,morphogenesis of embryonic epithelium,BP,ADM
5063,GO:0010977,0.680168618097393,0.687958852609163,1,144,negative regulation of neuron projection development,BP,VIM
7789,GO:0031348,0.680222055793354,0.687568308394956,1,187,negative regulation of defense response,BP,SOCS3
3143,GO:0006464,0.68238582164888,0.404588490812552,24,3675,cellular protein modification process,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;TIMP1;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;GALNT13;ELFN2;COL3A1;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
10158,GO:0036211,0.68238582164888,0.404588490812552,24,3675,protein modification process,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;TIMP1;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;GALNT13;ELFN2;COL3A1;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
11514,GO:0044272,0.683792802147325,0.683587456322353,1,174,sulfur compound biosynthetic process,BP,FMOD
13497,GO:0051017,0.684492311613653,0.682997535738755,1,148,actin filament bundle assembly,BP,SHANK1
15160,GO:0061572,0.684492311613653,0.682997535738755,1,148,actin filament bundle organization,BP,SHANK1
6331,GO:0018394,0.685391739035863,0.68186004668654,1,160,peptidyl-lysine acetylation,BP,LIF
7017,GO:0022411,0.68566894279189,0.533603591879215,3,523,cellular component disassembly,BP,TIMP1;SH3GL2;PDPN
11405,GO:0043933,0.686987950307014,0.436779437633997,10,1694,protein-containing complex subunit organization,BP,SNAP91;SYT1;CELF4;SH3GL2;FMOD;SNAP25;KCNB1;SHANK1;GRIN1;PLA2G2A
8341,GO:0032386,0.688121079507262,0.57792644642581,2,334,regulation of intracellular transport,BP,KCNB1;ANXA2
6262,GO:0018108,0.688319971204107,0.57770435906279,2,329,peptidyl-tyrosine phosphorylation,BP,LIF;SOCS3
16443,GO:0071897,0.689710266048513,0.676757418337145,1,175,DNA biosynthetic process,BP,LOX
909,GO:0002221,0.689957825205955,0.676462654203079,1,176,pattern recognition receptor signaling pathway,BP,LTF
3174,GO:0006508,0.691381256565091,0.437871475669097,9,1537,proteolysis,BP,LTF;TIMP1;SERPINE1;PLAU;C1R;DPP10;GRIN1;ANXA2;SERPINA3
13780,GO:0051494,0.692283157291816,0.67399686414993,1,146,negative regulation of cytoskeleton organization,BP,SHANK1
6297,GO:0018212,0.692287245365659,0.572965674890701,2,332,peptidyl-tyrosine modification,BP,LIF;SOCS3
639,GO:0001819,0.693179542394753,0.571765569369403,2,386,positive regulation of cytokine production,BP,SERPINE1;ANXA1
13101,GO:0048754,0.694002033695614,0.67199042516273,1,145,branching morphogenesis of an epithelial tube,BP,COL4A1
13354,GO:0050792,0.695293974043669,0.670107114047346,1,192,regulation of viral process,BP,LTF
12541,GO:0046872,0.695601034602655,0.388921821294481,25,3712,metal ion binding,MF,LTF;SYT1;CAMK2A;TIMP1;ATP1A3;COL1A1;LOX;HPCAL4;SLC8A2;KCNIP2;COL5A1;POSTN;ANXA1;GNAL;GALNT13;C1R;COL3A1;KSR2;RIMS2;GRIN1;ANXA2;CALN1;MYT1L;PLA2G2A;SMOC1
528,GO:0001659,0.696326374506179,0.669084794730725,1,163,temperature homeostasis,BP,KSR2
16354,GO:0071705,0.697419420885498,0.411522998160684,13,2159,nitrogen compound transport,BP,SNAP91;SYT1;RAPGEF4;CHGA;SLC17A7;COL1A1;SNAP25;ANXA1;RAB3C;KCNB1;PDPN;RIMS2;SLC6A17
22133,GO:2001252,0.700786890392773,0.663731095405796,1,168,positive regulation of chromosome organization,BP,LIF
16373,GO:0071772,0.701052297061725,0.663577367015575,1,149,response to BMP,BP,GDF15
16374,GO:0071773,0.701052297061725,0.663577367015575,1,149,cellular response to BMP stimulus,BP,GDF15
9407,GO:0034622,0.701415422605622,0.467321345931048,5,912,cellular protein-containing complex assembly,BP,SNAP91;CELF4;SH3GL2;FMOD;SNAP25
13640,GO:0051249,0.701571442746595,0.561587420960643,2,402,regulation of lymphocyte activation,BP,IGFBP2;ANXA1
6639,GO:0019827,0.701583848417966,0.662882923147698,1,155,stem cell population maintenance,BP,LIF
7367,GO:0030496,0.702291548864923,0.661938944756228,1,166,midbody,CC,ANXA2
13924,GO:0051783,0.706218125581765,0.657132107353019,1,173,regulation of nuclear division,BP,LIF
6574,GO:0019637,0.706754109424417,0.461003407348154,5,913,organophosphate metabolic process,BP,PLEKHA4;ETNPPL;NNMT;SOCS3;PLA2G2A
17846,GO:0098727,0.707198357792878,0.656066598850291,1,157,maintenance of cell number,BP,LIF
13006,GO:0048592,0.708403647136799,0.654719860260899,1,144,eye morphogenesis,BP,COL5A1
14210,GO:0055037,0.709853681434597,0.652691069835355,1,172,recycling endosome,CC,LTF
16703,GO:0072330,0.710413410407957,0.651759623205665,1,212,monocarboxylic acid biosynthetic process,BP,ANXA1
14186,GO:0055002,0.710774161945433,0.651786848614713,1,146,striated muscle cell development,BP,LOX
16052,GO:0071248,0.710850078527728,0.651427578008458,1,177,cellular response to metal ion,BP,SYT1
19068,GO:1901564,0.711401982444288,0.363332436109742,36,5851,organonitrogen compound metabolic process,BP,LTF;VIM;RASGRF1;CHI3L2;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;LOX;IGFBP2;SLC8A2;TGFBI;FMOD;PLAU;LIF;GDF15;CHI3L1;ANXA1;GALNT13;C1R;NNMT;ELFN2;COL3A1;KSR2;FUT9;DPP10;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
14667,GO:0060562,0.713495586555525,0.547102254744411,2,314,epithelial tube morphogenesis,BP,ADM;COL4A1
1941,GO:0004386,0.714061749365406,0.647655601786237,1,152,helicase activity,MF,ANXA1
13572,GO:0051129,0.715980914976169,0.469104622571989,4,662,negative regulation of cellular component organization,BP,VIM;PACSIN1;LIF;SHANK1
11394,GO:0043903,0.716664992139316,0.644029008127622,1,204,regulation of symbiotic process,BP,LTF
2166,GO:0004721,0.717192807630044,0.643610173725114,1,167,phosphoprotein phosphatase activity,MF,PTPRT
3483,GO:0006941,0.717565274333591,0.64318381105169,1,162,striated muscle contraction,BP,CHGA
2574,GO:0005488,0.717728588016235,0.391986253509571,87,13523,binding,MF,TNFRSF12A;LTF;VIM;MCF2L2;RASGRF1;CHI3L2;SNAP91;SYT1;CAMK2A;PPP2R2C;PHACTR3;RAPGEF4;CELF4;TIMP1;SRPX2;NEFM;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;ABCC3;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;SLC8A2;KCNIP2;IQSEC3;TGFBI;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;EMP3;GALNT13;CPLX2;ADM;RAB3C;SPHKAP;JPH3;AFF2;SYN2;KCNB1;C1R;SHANK1;SHANK2;PDPN;GABRG1;ETNPPL;SVOP;GABRB3;RBFOX3;MOBP;COL3A1;KSR2;FUT9;CNTNAP2;DPP10;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;DDN;ANXA2;CALN1;SOCS3;SV2B;MYT1L;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;SLC6A17;SMOC1;DOK6
17219,GO:0090316,0.71814293079831,0.642332514415799,1,178,positive regulation of intracellular protein transport,BP,KCNB1
4357,GO:0009165,0.718740112919207,0.641357674927107,1,216,nucleotide biosynthetic process,BP,NNMT
6950,GO:0021915,0.718921086722587,0.641539461658765,1,155,neural tube development,BP,ADM
1055,GO:0002449,0.718968706498571,0.641031990623739,1,224,lymphocyte mediated immunity,BP,C1R
5652,GO:0016051,0.720549784517343,0.639211715570968,1,190,carbohydrate biosynthetic process,BP,FUT9
14922,GO:0061013,0.721448199169441,0.638077544429104,1,189,regulation of mRNA catabolic process,BP,VIM
10785,GO:0042594,0.721758161449329,0.637722674533822,1,183,response to starvation,BP,ADM
18970,GO:1901293,0.721928178731945,0.637302976684437,1,219,nucleoside phosphate biosynthetic process,BP,NNMT
5653,GO:0016052,0.722063702885647,0.637361503221659,1,179,carbohydrate catabolic process,BP,FUT9
3504,GO:0006979,0.722064168771777,0.536085941945857,2,407,response to oxidative stress,BP,COL1A1;ANXA1
10893,GO:0042803,0.723352586834916,0.487885100159379,3,578,protein homodimerization activity,MF,CAMK2A;GDF15;PTPRT
19452,GO:1902531,0.724964338083369,0.393211626592386,10,1643,regulation of intracellular signal transduction,BP,LTF;RASGRF1;SLC8A2;IQSEC3;LIF;GDF15;CHI3L1;JPH3;COL3A1;PLA2G2A
3417,GO:0006839,0.725241251005004,0.63302415629358,1,228,mitochondrial transport,BP,CAMK2A
10326,GO:0038023,0.72580711151272,0.438106239509468,5,905,signaling receptor activity,MF,GABRG2;GABRG1;GABRB3;GRIN1;PTPRT
14342,GO:0060089,0.72580711151272,0.438106239509468,5,905,molecular transducer activity,MF,GABRG2;GABRG1;GABRB3;GRIN1;PTPRT
22116,GO:2001234,0.726311098401605,0.631722654035773,1,212,negative regulation of apoptotic signaling pathway,BP,SERPINE1
3644,GO:0007219,0.727216023023646,0.630746628871181,1,180,Notch signaling pathway,BP,POSTN
3707,GO:0007369,0.728222161267101,0.629535955169175,1,168,gastrulation,BP,COL5A1
11061,GO:0043169,0.728533064046102,0.352294654151776,25,3786,cation binding,MF,LTF;SYT1;CAMK2A;TIMP1;ATP1A3;COL1A1;LOX;HPCAL4;SLC8A2;KCNIP2;COL5A1;POSTN;ANXA1;GNAL;GALNT13;C1R;COL3A1;KSR2;RIMS2;GRIN1;ANXA2;CALN1;MYT1L;PLA2G2A;SMOC1
7786,GO:0031345,0.729537911572371,0.627796403783952,1,172,negative regulation of cell projection organization,BP,VIM
6683,GO:0019904,0.730448090444585,0.451329343652268,4,661,protein domain specific binding,MF,VIM;HPCAL4;SHANK1;SHANK2
4591,GO:0009913,0.733528817450675,0.622442851632798,1,191,epidermal cell differentiation,BP,ANXA1
6291,GO:0018205,0.733783410693525,0.521139129422236,2,359,peptidyl-lysine modification,BP,LOX;LIF
3149,GO:0006473,0.734837519332576,0.620750593781442,1,186,protein acetylation,BP,LIF
8099,GO:0031968,0.736411833604024,0.618621598157359,1,193,organelle outer membrane,CC,PLA2G2A
15347,GO:0062012,0.738216299462739,0.515273634615227,2,393,regulation of small molecule metabolic process,BP,ANXA1;ADM
637,GO:0001817,0.73860912769124,0.468551751385534,3,611,regulation of cytokine production,BP,LTF;SERPINE1;ANXA1
13447,GO:0050920,0.738813788220571,0.615370219891585,1,202,regulation of chemotaxis,BP,SERPINE1
19359,GO:1902275,0.739183419129874,0.615078473695301,1,172,regulation of chromatin organization,BP,LIF
10583,GO:0042176,0.739662669238691,0.513427777388215,2,369,regulation of protein catabolic process,BP,TIMP1;ANXA2
13130,GO:0048839,0.739683099620993,0.614364000480548,1,178,inner ear development,BP,GABRB3
11345,GO:0043624,0.740730085189893,0.612753655719792,1,211,cellular protein complex disassembly,BP,SH3GL2
3677,GO:0007281,0.743059363231693,0.609663878297694,1,202,germ cell development,BP,CELF4
6662,GO:0019867,0.743450365536239,0.609176768359528,1,195,outer membrane,CC,PLA2G2A
7199,GO:0030178,0.745885355525693,0.605815020978554,1,204,negative regulation of Wnt signaling pathway,BP,IGFBP2
18538,GO:0140097,0.746658758740026,0.604819327221585,1,194,catalytic activity, acting on DNA,MF,ANXA1
3854,GO:0008092,0.748363771664007,0.39681360623269,6,908,cytoskeletal protein binding,MF,PHACTR3;NEFM;PACSIN1;RAB3C;MOBP;ANXA2
9498,GO:0034764,0.752266871714255,0.597139666594533,1,187,positive regulation of transmembrane transport,BP,KCNIP2
4559,GO:0009790,0.753453891585407,0.390454882002891,6,979,embryo development,BP,CELF4;COL1A1;LIF;COL5A1;ADM;SOCS3
13692,GO:0051321,0.754620558235586,0.593746350495951,1,205,meiotic cell cycle,BP,LIF
16047,GO:0071241,0.755779614232593,0.592145894318017,1,201,cellular response to inorganic substance,BP,SYT1
10548,GO:0042110,0.756076232035032,0.491341877091337,2,431,T cell activation,BP,IGFBP2;ANXA1
4812,GO:0010639,0.756277309213096,0.491201176079592,2,367,negative regulation of organelle organization,BP,LIF;SHANK1
11220,GO:0043412,0.756812442806258,0.321253299536451,24,3857,macromolecule modification,BP,LTF;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;TIMP1;SH3GL2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;GALNT13;ELFN2;COL3A1;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
9229,GO:0034248,0.758990474652038,0.487437982681315,2,393,regulation of cellular amide metabolic process,BP,VIM;CELF4
13544,GO:0051090,0.759450424333872,0.486789226620189,2,402,regulation of DNA-binding transcription factor activity,BP,LTF;CAMK2A
4019,GO:0008361,0.760508069205499,0.585667864265796,1,172,regulation of cell size,BP,TNFRSF12A
13091,GO:0048736,0.761025011614287,0.584956994509626,1,169,appendage development,BP,SMOC1
14389,GO:0060173,0.761025011614287,0.584956994509626,1,169,limb development,BP,SMOC1
3098,GO:0006396,0.765707912178542,0.406234495077084,4,859,RNA processing,BP,CELF4;SRRM4;AFF2;RBFOX3
17538,GO:0097305,0.768813993643049,0.57345029592451,1,209,response to alcohol,BP,GRIN1
8182,GO:0032103,0.77137274167584,0.47015381734232,2,451,positive regulation of response to external stimulus,BP,SERPINE1;PLA2G2A
11036,GO:0043122,0.776058499142232,0.562640076941796,1,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF
8966,GO:0033500,0.776492098690958,0.562071424372649,1,218,carbohydrate homeostasis,BP,KCNB1
10784,GO:0042593,0.776492098690958,0.562071424372649,1,218,glucose homeostasis,BP,KCNB1
16820,GO:0072593,0.778316841303657,0.559248043818533,1,237,reactive oxygen species metabolic process,BP,GRIN1
3969,GO:0008285,0.780832503345496,0.412431899582825,3,625,negative regulation of cell population proliferation,BP,LIF;ADM;PDPN
11322,GO:0043583,0.781041342456202,0.555306655121503,1,205,ear development,BP,GABRB3
3801,GO:0007623,0.783245194415478,0.551960221459542,1,205,circadian rhythm,BP,SERPINE1
6481,GO:0019318,0.785354179129248,0.54862213850666,1,226,hexose metabolic process,BP,FUT9
8667,GO:0032869,0.787157823154428,0.545945482234119,1,208,cellular response to insulin stimulus,BP,SOCS3
14651,GO:0060537,0.787357897926793,0.447476800026449,2,361,muscle tissue development,BP,LOX;COL3A1
8739,GO:0032970,0.787920017119283,0.44664320242396,2,367,regulation of actin filament-based process,BP,SHANK1;PDPN
13861,GO:0051651,0.789670153972836,0.542124888990778,1,197,maintenance of location in cell,BP,JPH3
7229,GO:0030217,0.791444994444318,0.539159645266313,1,233,T cell differentiation,BP,ANXA1
13860,GO:0051650,0.792186911413758,0.538199061973346,1,197,establishment of vesicle localization,BP,SNAP91
7256,GO:0030258,0.792919157712212,0.536855529939189,1,232,lipid modification,BP,SOCS3
12125,GO:0045926,0.79298600660311,0.536755344783824,1,231,negative regulation of growth,BP,GDF15
13010,GO:0048598,0.794654187694113,0.393209213032267,3,554,embryonic morphogenesis,BP,COL5A1;ADM;SOCS3
7104,GO:0030027,0.795575776928937,0.532919310337347,1,189,lamellipodium,CC,PDPN
3523,GO:0007010,0.798309662827055,0.315742748892773,8,1262,cytoskeleton organization,BP,VIM;PHACTR3;NEFM;IQSEC3;PACSIN1;ANXA1;INA;SHANK1
11297,GO:0043543,0.799308267311367,0.526740170702149,1,229,protein acylation,BP,LIF
2724,GO:0005770,0.800670048803677,0.524464392168873,1,249,late endosome,CC,ANXA2
15221,GO:0061695,0.800757368931245,0.52439501854035,1,233,transferase complex, transferring phosphorus-containing groups,CC,SOCS3
17166,GO:0090257,0.801303543348989,0.523619621570066,1,213,regulation of muscle system process,BP,CHGA
10261,GO:0036464,0.803138630371874,0.520620830986174,1,219,cytoplasmic ribonucleoprotein granule,CC,INA
17924,GO:0098858,0.804704989963995,0.518201383568568,1,198,actin-based cell projection,CC,PDPN
817,GO:0002064,0.804903886943293,0.517870765637097,1,199,epithelial cell development,BP,VIM
11333,GO:0043604,0.80656088879547,0.376006792794783,3,739,amide biosynthetic process,BP,VIM;CELF4;ST8SIA3
11754,GO:0045088,0.806865821823378,0.514345850062722,1,263,regulation of innate immune response,BP,SOCS3
6186,GO:0017111,0.807744032428991,0.349426483344452,4,720,nucleoside-triphosphatase activity,MF,ABCC3;ANXA1;GNAL;RAB3C
2698,GO:0005739,0.807749975813679,0.32022874293695,6,1424,mitochondrion,CC,CAMK2A;ANXA1;SPHKAP;ETNPPL;MOBP;PLA2G2A
11986,GO:0045665,0.80867448768302,0.511614411771893,1,211,negative regulation of neuron differentiation,BP,VIM
3463,GO:0006909,0.810544696635439,0.508331687907066,1,249,phagocytosis,BP,ANXA1
2862,GO:0005996,0.812701256348609,0.50472773423918,1,252,monosaccharide metabolic process,BP,FUT9
19827,GO:1903362,0.813345238500438,0.503688833908366,1,243,regulation of cellular protein catabolic process,BP,ANXA2
3654,GO:0007249,0.813873166578829,0.502703612700892,1,268,I-kappaB kinase/NF-kappaB signaling,BP,LTF
6281,GO:0018193,0.814131618596012,0.311730114243743,6,1135,peptidyl-amino acid modification,BP,CAMK2A;LOX;LIF;CHI3L1;GALNT13;SOCS3
13147,GO:0048863,0.817336310953921,0.496940189851081,1,248,stem cell differentiation,BP,LIF
3525,GO:0007015,0.817406017489033,0.402152498332461,2,395,actin filament organization,BP,PACSIN1;SHANK1
9927,GO:0035770,0.817687062018496,0.496432678320007,1,229,ribonucleoprotein granule,CC,INA
4622,GO:0010008,0.821020290633986,0.396362304938137,2,469,endosome membrane,CC,ANXA1;ANXA2
3921,GO:0008202,0.8216751914143,0.489426212335734,1,274,steroid metabolic process,BP,ADM
6031,GO:0016791,0.82207454498039,0.488884070880181,1,238,phosphatase activity,MF,PTPRT
11215,GO:0043406,0.825438618442397,0.483028258255109,1,244,positive regulation of MAP kinase activity,BP,GDF15
9519,GO:0034976,0.828037209559777,0.478369395426331,1,272,response to endoplasmic reticulum stress,BP,RASGRF1
5645,GO:0016042,0.831420140606145,0.472332574267598,1,289,lipid catabolic process,BP,PLA2G2A
11464,GO:0044093,0.831749874647317,0.266061379936201,9,1652,positive regulation of molecular function,BP,LTF;RASGRF1;CAMK2A;SLC8A2;KCNIP2;GDF15;CHI3L1;GRIN1;ANXA2
9395,GO:0034599,0.832108821033173,0.4711433005514,1,278,cellular response to oxidative stress,BP,ANXA1
5852,GO:0016462,0.83444288365325,0.311110219554952,4,763,pyrophosphatase activity,MF,ABCC3;ANXA1;GNAL;RAB3C
8848,GO:0033157,0.835507916651479,0.465155039638332,1,251,regulation of intracellular protein transport,BP,KCNB1
2642,GO:0005622,0.836121501947501,0.233421840893331,79,12466,intracellular,CC,LTF;VIM;RASGRF1;SNAP91;SYT1;CAMK2A;PPP2R2C;PHACTR3;RAPGEF4;CHGA;CELF4;TIMP1;SRPX2;NEFM;SLC17A7;ATP1A3;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;HPCAL4;KCNIP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;LIF;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;GALNT13;CPLX2;INA;ADM;RAB3C;SPHKAP;JPH3;AFF2;SYN2;SHANK1;SHANK2;PDPN;ETNPPL;SVOP;GABRB3;NNMT;RBFOX3;MOBP;COL3A1;KSR2;FUT9;CNTNAP2;RIMS2;GRIN1;ST8SIA3;CD163;DDN;ANXA2;CALN1;SOCS3;SV2B;MYT1L;COL4A1;PLA2G2A;SERPINA3;SLC6A17;OPALIN;DOK6
8097,GO:0031966,0.836873594511921,0.370783753190351,2,620,mitochondrial membrane,CC,ANXA1;PLA2G2A
6047,GO:0016817,0.837375643675523,0.306790124286978,4,766,hydrolase activity, acting on acid anhydrides,MF,ABCC3;ANXA1;GNAL;RAB3C
6048,GO:0016818,0.837375643675523,0.306790124286978,4,766,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ABCC3;ANXA1;GNAL;RAB3C
12503,GO:0046777,0.840104250928031,0.456907582971788,1,229,protein autophosphorylation,BP,CAMK2A
19070,GO:1901566,0.843856572983307,0.262098203215932,7,1556,organonitrogen compound biosynthetic process,BP,VIM;CELF4;FMOD;GALNT13;NNMT;FUT9;ST8SIA3
13013,GO:0048609,0.845424695095913,0.317596816466034,3,687,multicellular organismal reproductive process,BP,CELF4;LIF;GRIN1
11508,GO:0044262,0.846375080169306,0.44519721085448,1,251,cellular carbohydrate metabolic process,BP,FUT9
15995,GO:0071103,0.846416818938407,0.445119090980537,1,251,DNA conformation change,BP,ANXA1
17035,GO:0090068,0.847142837170697,0.443709660126552,1,263,positive regulation of cell cycle process,BP,ANXA1
12323,GO:0046394,0.847440657718396,0.442982232582363,1,315,carboxylic acid biosynthetic process,BP,ANXA1
5654,GO:0016053,0.848217437080723,0.441518246987533,1,316,organic acid biosynthetic process,BP,ANXA1
8444,GO:0032504,0.848906159961926,0.312120788296282,3,695,multicellular organism reproduction,BP,CELF4;LIF;GRIN1
18397,GO:0110053,0.850810758668131,0.436830374593517,1,251,regulation of actin filament organization,BP,SHANK1
7018,GO:0022412,0.851096592941627,0.436175868920157,1,280,cellular process involved in reproduction in multicellular organism,BP,CELF4
3112,GO:0006412,0.85270774575982,0.344411439609275,2,586,translation,BP,VIM;CELF4
1617,GO:0003723,0.855310993096925,0.246089519963144,7,1507,RNA binding,MF,VIM;CELF4;ANXA1;SRRM4;AFF2;RBFOX3;ANXA2
13345,GO:0050778,0.855410827698989,0.339814001093538,2,566,positive regulation of immune response,BP,ANXA1;C1R
17310,GO:0090596,0.856882406476414,0.425177673698491,1,247,sensory organ morphogenesis,BP,COL5A1
5039,GO:0010948,0.857128036154257,0.424490191102367,1,306,negative regulation of cell cycle process,BP,LIF
2135,GO:0004674,0.857165982771405,0.337023437827941,2,406,protein serine/threonine kinase activity,MF,CAMK2A;KSR2
2699,GO:0005740,0.857546932254735,0.33606139751146,2,659,mitochondrial envelope,CC,ANXA1;PLA2G2A
8938,GO:0033365,0.858122500104008,0.275471988268101,4,903,protein localization to organelle,BP,CHGA;COL1A1;LIF;SNAP25
1364,GO:0003007,0.8593958328136,0.420312194356634,1,238,heart morphogenesis,BP,COL5A1
3389,GO:0006790,0.861627035042432,0.41560061939857,1,331,sulfur compound metabolic process,BP,FMOD
17193,GO:0090287,0.862793011634067,0.413532277253591,1,255,regulation of cellular response to growth factor stimulus,BP,LOX
4479,GO:0009416,0.863741734504517,0.411527074545638,1,287,response to light stimulus,BP,GRIN1
7875,GO:0031503,0.864025611705077,0.411012716058286,1,272,protein-containing complex localization,BP,SNAP25
8749,GO:0032984,0.867022535155364,0.404889752128218,1,306,protein-containing complex disassembly,BP,SH3GL2
3280,GO:0006631,0.867288851688894,0.404259609474065,1,342,fatty acid metabolic process,BP,ANXA1
10998,GO:0043043,0.867746109577063,0.31827439442636,2,606,peptide biosynthetic process,BP,VIM;CELF4
17482,GO:0097190,0.868241898299848,0.317437934025328,2,560,apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1
18183,GO:0099568,0.868652663336287,0.401866044130284,1,233,cytoplasmic region,CC,RIMS2
11656,GO:0044772,0.871674370693909,0.311334061729872,2,541,mitotic cell cycle phase transition,BP,CAMK2A;ANXA1
16029,GO:0071214,0.872136440361703,0.394473135117054,1,305,cellular response to abiotic stimulus,BP,COL1A1
18323,GO:0104004,0.872136440361703,0.394473135117054,1,305,cellular response to environmental stimulus,BP,COL1A1
1632,GO:0003779,0.872437975502238,0.310160229590897,2,405,actin binding,MF,PHACTR3;MOBP
6091,GO:0016887,0.87358626333219,0.30812759046268,2,388,ATPase activity,MF,ABCC3;ANXA1
5254,GO:0015031,0.873677254990164,0.208867133789396,9,1814,protein transport,BP,SNAP91;RAPGEF4;CHGA;COL1A1;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
6391,GO:0019058,0.874575148591385,0.38942036568907,1,309,viral life cycle,BP,LTF
3815,GO:0008017,0.875474558792764,0.387776229360539,1,245,microtubule binding,MF,NEFM
3104,GO:0006402,0.876070835063983,0.386209559249078,1,347,mRNA catabolic process,BP,VIM
4136,GO:0008544,0.879680310547181,0.378754261781579,1,294,epidermis development,BP,ANXA1
8790,GO:0033043,0.880218494857996,0.2176415768039,6,1196,regulation of organelle organization,BP,SYT1;LIF;ANXA1;CPLX2;SHANK1;ANXA2
642,GO:0001822,0.880896471305692,0.376282134760183,1,262,kidney development,BP,LIF
4270,GO:0009057,0.880949295411634,0.216513382430228,6,1303,macromolecule catabolic process,BP,VIM;CHI3L2;TIMP1;FMOD;CHI3L1;ANXA2
21418,GO:1990904,0.881874609104976,0.292684788213612,2,641,ribonucleoprotein complex,CC,VIM;CELF4
4789,GO:0010608,0.882283931005297,0.292011657330387,2,547,posttranscriptional regulation of gene expression,BP,VIM;CELF4
12963,GO:0048511,0.88291111660155,0.371885322442284,1,287,rhythmic process,BP,SERPINE1
15377,GO:0062197,0.883141743909082,0.371273358751704,1,328,cellular response to chemical stress,BP,ANXA1
12090,GO:0045862,0.886207457150022,0.364629994194665,1,334,positive regulation of proteolysis,BP,GRIN1
5543,GO:0015833,0.887274396094686,0.189547475171031,9,1851,peptide transport,BP,SNAP91;RAPGEF4;CHGA;COL1A1;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
5441,GO:0015629,0.889190445793252,0.279205499291035,2,464,actin cytoskeleton,CC,ANXA1;MOBP
2713,GO:0005759,0.889212092653396,0.357872521180535,1,431,mitochondrial matrix,CC,ETNPPL
11214,GO:0043405,0.889507785669048,0.357453723834942,1,313,regulation of MAP kinase activity,BP,GDF15
7136,GO:0030098,0.889823945644731,0.356724481174193,1,325,lymphocyte differentiation,BP,ANXA1
11654,GO:0044770,0.890781057490578,0.276069415805236,2,572,cell cycle phase transition,BP,CAMK2A;ANXA1
11520,GO:0044283,0.89317307998731,0.271459051225101,2,636,small molecule biosynthetic process,BP,ANXA1;ADM
13621,GO:0051222,0.89693721377272,0.340763419927119,1,330,positive regulation of protein transport,BP,KCNB1
12569,GO:0046914,0.897059218461008,0.2130840169467,4,939,transition metal ion binding,MF,LTF;TIMP1;LOX;MYT1L
10918,GO:0042886,0.897588169568864,0.174600623122222,9,1882,amide transport,BP,SNAP91;RAPGEF4;CHGA;COL1A1;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
11059,GO:0043167,0.898023699484773,0.144278793838921,34,5549,ion binding,MF,LTF;SNAP91;SYT1;CAMK2A;RAPGEF4;TIMP1;ATP1A3;PLEKHA4;COL1A1;ABCC3;LOX;HPCAL4;SLC8A2;KCNIP2;PACSIN1;COL5A1;POSTN;ANXA1;GNAL;GALNT13;RAB3C;SYN2;C1R;ETNPPL;COL3A1;KSR2;RIMS2;GRIN1;ST8SIA3;ANXA2;CALN1;MYT1L;PLA2G2A;SMOC1
3103,GO:0006401,0.901007213385325,0.331307164871609,1,382,RNA catabolic process,BP,VIM
2825,GO:0005929,0.902398816799224,0.253632687757532,2,542,cilium,CC,ANXA1;SHANK2
7030,GO:0022613,0.904110018628355,0.324029999702614,1,404,ribonucleoprotein complex biogenesis,BP,CELF4
11519,GO:0044282,0.904383990772096,0.32337331704261,1,412,small molecule catabolic process,BP,FUT9
20652,GO:1904951,0.905889453874781,0.319940593588807,1,346,positive regulation of establishment of protein localization,BP,KCNB1
19069,GO:1901565,0.906486322109338,0.185418828548132,5,1201,organonitrogen compound catabolic process,BP,CHI3L2;TIMP1;FMOD;CHI3L1;ANXA2
2719,GO:0005765,0.906512283193038,0.31846315273803,1,346,lysosomal membrane,CC,ANXA2
17920,GO:0098852,0.906512283193038,0.31846315273803,1,346,lytic vacuole membrane,CC,ANXA2
12457,GO:0046649,0.906760282822227,0.244905346598913,2,620,lymphocyte activation,BP,IGFBP2;ANXA1
8791,GO:0033044,0.906850089399616,0.317723883709147,1,319,regulation of chromosome organization,BP,LIF
10771,GO:0042578,0.907916025098705,0.315171338969721,1,323,phosphoric ester hydrolase activity,MF,PTPRT
11807,GO:0045184,0.908125735401399,0.159046164671461,9,1898,establishment of protein localization,BP,SNAP91;RAPGEF4;CHGA;COL1A1;SNAP25;ANXA1;RAB3C;KCNB1;RIMS2
3261,GO:0006605,0.910828029394466,0.307983591857025,1,415,protein targeting,BP,KCNB1
11016,GO:0043085,0.911625850448969,0.168823401405728,6,1326,positive regulation of catalytic activity,BP,LTF;RASGRF1;SLC8A2;GDF15;CHI3L1;GRIN1
3722,GO:0007411,0.914975237155989,0.298162390206555,1,271,axon guidance,BP,DOK6
17626,GO:0097485,0.915413757084318,0.297073460940486,1,272,neuron projection guidance,BP,DOK6
5639,GO:0016032,0.916485436634987,0.196223586305202,3,855,viral process,BP,LTF;VIM;ANXA2
926,GO:0002253,0.91660289803541,0.293814058100756,1,402,activation of immune response,BP,C1R
12048,GO:0045787,0.918070928816011,0.290233091693303,1,352,positive regulation of cell cycle,BP,ANXA1
4803,GO:0010629,0.919016131532645,0.142634847117165,9,1945,negative regulation of gene expression,BP,LTF;VIM;CELF4;SERPINE1;SH3GL2;CUX2;ANXA1;AFF2;MYT1L
4584,GO:0009893,0.919733757802183,0.124806294432501,18,3394,positive regulation of metabolic process,BP,LTF;VIM;CELF4;SERPINE1;COL1A1;CUX2;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;ADM;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A
8727,GO:0032956,0.92077849073668,0.283448557203668,1,326,regulation of actin cytoskeleton organization,BP,SHANK1
5937,GO:0016607,0.921258206664585,0.282130584942803,1,372,nuclear speck,CC,AFF2
7765,GO:0031323,0.92147288680265,0.114704268036672,31,5500,regulation of cellular metabolic process,BP,LTF;VIM;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SRPX2;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;SLC8A2;LIF;GDF15;CHI3L1;SPOCD1;ANXA1;SRRM4;ADM;AFF2;ELFN2;RBFOX3;GRIN1;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
6028,GO:0016787,0.924729319580146,0.130910873978965,10,2132,hydrolase activity,MF,LTF;ABCC3;PLAU;ANXA1;GNAL;RAB3C;C1R;DPP10;PLA2G2A;PTPRT
7771,GO:0031329,0.925940764481374,0.178223951642214,3,803,regulation of cellular catabolic process,BP,VIM;TIMP1;ANXA2
19591,GO:1902903,0.926210189105097,0.269411142941762,1,336,regulation of supramolecular fiber organization,BP,SHANK1
12840,GO:0048193,0.927145286768056,0.266938831944798,1,345,Golgi vesicle transport,BP,CUX2
19232,GO:1901990,0.927903621157654,0.264851228970602,1,394,regulation of mitotic cell cycle phase transition,BP,ANXA1
2727,GO:0005774,0.929334570405693,0.261060351882056,1,393,vacuolar membrane,CC,ANXA2
11332,GO:0043603,0.93022130575794,0.16981148262054,3,982,cellular amide metabolic process,BP,VIM;CELF4;ST8SIA3
3181,GO:0006518,0.930684293201976,0.194829631070091,2,728,peptide metabolic process,BP,VIM;CELF4
11585,GO:0044403,0.93163777814649,0.167046766179296,3,900,symbiotic process,BP,LTF;VIM;ANXA2
134,GO:0000280,0.932246480284759,0.253277192359053,1,377,nuclear division,BP,LIF
4785,GO:0010604,0.93308484939024,0.108071349402193,16,3138,positive regulation of macromolecule metabolic process,BP,LTF;VIM;CELF4;SERPINE1;COL1A1;CUX2;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A
6029,GO:0016788,0.933255384204047,0.189214849288414,2,646,hydrolase activity, acting on ester bonds,MF,PLA2G2A;PTPRT
5443,GO:0015631,0.933419628191807,0.250173630381525,1,336,tubulin binding,MF,NEFM
8461,GO:0032535,0.934745408155464,0.246516866016948,1,353,regulation of cellular component size,BP,TNFRSF12A
2133,GO:0004672,0.935209165668317,0.184960147067089,2,528,protein kinase activity,MF,CAMK2A;KSR2
5148,GO:0014706,0.938029768856651,0.23744409638884,1,343,striated muscle tissue development,BP,LOX
19229,GO:1901987,0.938198173495611,0.236848589324187,1,418,regulation of cell cycle phase transition,BP,ANXA1
7767,GO:0031325,0.939433949917289,0.0999637489142591,15,3000,positive regulation of cellular metabolic process,BP,LTF;VIM;CELF4;SERPINE1;COL1A1;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;ADM;GRIN1;ANXA2;SOCS3;PLA2G2A
16906,GO:0080090,0.941264766563153,0.0886477743207112,29,5300,regulation of primary metabolic process,BP,LTF;VIM;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;SRRM4;ADM;AFF2;ELFN2;RBFOX3;GRIN1;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
6698,GO:0019953,0.942928652042836,0.167316455462629,2,677,sexual reproduction,BP,CELF4;GRIN1
3512,GO:0006996,0.943154918458632,0.0908419207680983,19,3534,organelle organization,BP,VIM;SNAP91;SYT1;CAMK2A;PHACTR3;CHGA;NEFM;SLC17A7;IQSEC3;PACSIN1;LIF;SNAP25;ANXA1;CPLX2;INA;AFF2;SHANK1;SHANK2;ANXA2
3518,GO:0007005,0.943555217322586,0.221544816952245,1,482,mitochondrion organization,BP,CAMK2A
6680,GO:0019901,0.943982909192871,0.164904889713604,2,620,protein kinase binding,MF,SNAP91;SH3GL2
4313,GO:0009117,0.944370731798489,0.219209439050493,1,456,nucleotide metabolic process,BP,NNMT
18537,GO:0140096,0.944849551902901,0.102108049176436,9,1923,catalytic activity, acting on a protein,MF,LTF;CAMK2A;LOX;PLAU;GALNT13;C1R;KSR2;DPP10;PTPRT
2740,GO:0005789,0.945766367735875,0.138362319030545,3,963,endoplasmic reticulum membrane,CC,JPH3;DDN;PLA2G2A
3367,GO:0006753,0.945941417910162,0.214616510701641,1,463,nucleoside phosphate metabolic process,BP,NNMT
11301,GO:0043547,0.948164769824429,0.208176589332345,1,365,positive regulation of GTPase activity,BP,RASGRF1
4802,GO:0010628,0.949522606894683,0.0944793338161578,9,2037,positive regulation of gene expression,BP,VIM;CELF4;SERPINE1;COL1A1;CUX2;LIF;ANXA1;RIMS2;GRIN1
10106,GO:0036094,0.94979580483965,0.0898832530388004,11,2277,small molecule binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;GNAL;RAB3C;SYN2;ETNPPL;KSR2;GRIN1;ST8SIA3
12887,GO:0048285,0.950450364632208,0.201239495260703,1,419,organelle fission,BP,LIF
11062,GO:0043170,0.951807500113121,0.0718695471876333,47,8271,macromolecule metabolic process,BP,LTF;VIM;RASGRF1;CHI3L2;CAMK2A;PPP2R2C;PHACTR3;CHGA;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;TGFBI;FMOD;PLAU;LIF;GDF15;COL5A1;SNAP25;CHI3L1;SPOCD1;ANXA1;SRRM4;GALNT13;ADM;AFF2;C1R;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;DPP10;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
10582,GO:0042175,0.953627531467517,0.121665299526193,3,983,nuclear outer membrane-endoplasmic reticulum membrane network,CC,JPH3;DDN;PLA2G2A
9430,GO:0034655,0.954560551042832,0.188537979546308,1,513,nucleobase-containing compound catabolic process,BP,VIM
13089,GO:0048732,0.955237834478512,0.186527874709617,1,412,gland development,BP,ANXA1
4765,GO:0010564,0.955288341944221,0.13781353270858,2,694,regulation of cell cycle process,BP,LIF;ANXA1
19076,GO:1901575,0.956005619910668,0.0861967684799708,8,1993,organic substance catabolic process,BP,VIM;CHI3L2;TIMP1;FMOD;CHI3L1;FUT9;ANXA2;PLA2G2A
8472,GO:0032555,0.957503453399581,0.0836412937406497,8,1712,purine ribonucleotide binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;GNAL;RAB3C;SYN2;KSR2
6170,GO:0017076,0.959417513886215,0.0803285681811737,8,1726,purine nucleotide binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;GNAL;RAB3C;SYN2;KSR2
6453,GO:0019222,0.959609081469227,0.0621833142249386,33,6103,regulation of metabolic process,BP,LTF;VIM;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SRPX2;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;SLC8A2;LIF;GDF15;CHI3L1;SPOCD1;ANXA1;SRRM4;ADM;AFF2;ELFN2;RBFOX3;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
8470,GO:0032553,0.959656379862708,0.0799136122399579,8,1727,ribonucleotide binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;GNAL;RAB3C;SYN2;KSR2
11099,GO:0043227,0.961856707436824,0.0593906140668132,64,10968,membrane-bounded organelle,CC,LTF;VIM;SNAP91;SYT1;CAMK2A;PHACTR3;CHGA;CELF4;TIMP1;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;GALNT13;CPLX2;RAB3C;SPHKAP;JPH3;AFF2;SYN2;C1R;SHANK2;PDPN;ETNPPL;SVOP;GABRB3;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;ST8SIA3;CD163;DDN;ANXA2;CALN1;SV2B;MYT1L;COL4A1;PLA2G2A;SERPINA3;SLC6A17;OPALIN
13703,GO:0051345,0.962183658427854,0.120457081756538,2,697,positive regulation of hydrolase activity,BP,RASGRF1;GRIN1
13603,GO:0051171,0.962918478906011,0.0587018854658782,27,5140,regulation of nitrogen compound metabolic process,BP,LTF;VIM;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;SLC8A2;LIF;GDF15;CHI3L1;SRRM4;AFF2;ELFN2;RBFOX3;GRIN1;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
5907,GO:0016570,0.963397840952618,0.160173572349836,1,426,histone modification,BP,LIF
19453,GO:1902532,0.963708841678803,0.159093385522147,1,468,negative regulation of intracellular signal transduction,BP,LIF
6016,GO:0016773,0.963988643251874,0.115822790336177,2,624,phosphotransferase activity, alcohol group as acceptor,MF,CAMK2A;KSR2
12484,GO:0046700,0.963990845549592,0.158085316705255,1,552,heterocycle catabolic process,BP,VIM
11512,GO:0044270,0.964130643637191,0.157616048258819,1,553,cellular nitrogen compound catabolic process,BP,VIM
7770,GO:0031328,0.964713998445846,0.0736363150609445,7,1767,positive regulation of cellular biosynthetic process,BP,VIM;SERPINE1;COL1A1;LIF;ANXA1;ADM;GRIN1
14235,GO:0055086,0.965781829664803,0.152049167444393,1,536,nucleobase-containing small molecule metabolic process,BP,NNMT
13605,GO:0051173,0.965851705788226,0.0615048218478571,13,2840,positive regulation of nitrogen compound metabolic process,BP,LTF;VIM;CELF4;SERPINE1;COL1A1;SLC8A2;LIF;GDF15;CHI3L1;GRIN1;ANXA2;SOCS3;PLA2G2A
5906,GO:0016569,0.965940402986361,0.151591919431078,1,436,covalent chromatin modification,BP,LIF
2778,GO:0005856,0.966878442966212,0.0651673482438252,9,1955,cytoskeleton,CC,VIM;NEFM;PACSIN1;SNAP25;ANXA1;INA;SHANK2;MOBP;RIMS2
6528,GO:0019439,0.967080414040956,0.147584175297063,1,569,aromatic compound catabolic process,BP,VIM
4585,GO:0009894,0.967658615955506,0.0902152245217803,3,946,regulation of catabolic process,BP,VIM;TIMP1;ANXA2
6679,GO:0019900,0.967772138667591,0.10581810093204,2,702,kinase binding,MF,SNAP91;SH3GL2
4582,GO:0009891,0.968413984854453,0.0668263954450059,7,1794,positive regulation of biosynthetic process,BP,VIM;SERPINE1;COL1A1;LIF;ANXA1;ADM;GRIN1
16821,GO:0072594,0.968514984271588,0.142629739171598,1,542,establishment of protein localization to organelle,BP,SNAP25
3956,GO:0008270,0.96860638561336,0.103578284204975,2,717,zinc ion binding,MF,TIMP1;MYT1L
3830,GO:0008047,0.970476390946487,0.135771623556349,1,474,enzyme activator activity,MF,LTF
19002,GO:1901361,0.971099568525011,0.133471380250972,1,596,organic cyclic compound catabolic process,BP,VIM
5864,GO:0016491,0.971286336300306,0.132779539713254,1,646,oxidoreductase activity,MF,LOX
8617,GO:0032787,0.971673798521785,0.131419695006205,1,581,monocarboxylic acid metabolic process,BP,ANXA1
5779,GO:0016301,0.972678278018029,0.0924813225076744,2,680,kinase activity,MF,CAMK2A;KSR2
11018,GO:0043087,0.972839074692976,0.127302798511675,1,437,regulation of GTPase activity,BP,RASGRF1
5998,GO:0016740,0.973595844967425,0.0549805144865743,8,1986,transferase activity,MF,CAMK2A;GALNT13;ETNPPL;NNMT;METTL7B;KSR2;FUT9;ST8SIA3
9838,GO:0035639,0.975623236452394,0.0532155868170422,7,1654,purine ribonucleoside triphosphate binding,MF,CAMK2A;ATP1A3;ABCC3;GNAL;RAB3C;SYN2;KSR2
8476,GO:0032559,0.97567168626032,0.0556582889017869,6,1413,adenyl ribonucleotide binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;SYN2;KSR2
12047,GO:0045786,0.975804424628305,0.116244583260229,1,563,negative regulation of cell cycle,BP,LIF
14438,GO:0060255,0.976300001373114,0.0385751527690855,29,5629,regulation of macromolecule metabolic process,BP,LTF;VIM;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;SLC8A2;LIF;GDF15;CHI3L1;ANXA1;SRRM4;AFF2;ELFN2;RBFOX3;RIMS2;GRIN1;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
7408,GO:0030554,0.976672639736672,0.0536452232209082,6,1425,adenyl nucleotide binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;SYN2;KSR2
3676,GO:0007276,0.977565706953365,0.109559555451392,1,554,gamete generation,BP,CELF4
11098,GO:0043226,0.977627252752317,0.0374136535882983,70,11824,organelle,CC,LTF;VIM;SNAP91;SYT1;CAMK2A;PHACTR3;CHGA;CELF4;TIMP1;NEFM;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;SLC8A2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;GNAL;COL6A2;GALNT13;CPLX2;INA;RAB3C;SPHKAP;JPH3;AFF2;SYN2;C1R;SHANK1;SHANK2;PDPN;ETNPPL;SVOP;GABRB3;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;DDN;ANXA2;CALN1;SV2B;MYT1L;COL4A1;SHISA7;PLA2G2A;SERPINA3;SLC6A17;OPALIN
19679,GO:1903047,0.978165737383036,0.0768621661654787,2,820,mitotic cell cycle process,BP,CAMK2A;ANXA1
18435,GO:0120031,0.980620493549379,0.0976324876262768,1,512,plasma membrane bounded cell projection assembly,BP,EMP3
82,GO:0000166,0.981642417433532,0.0398010204213229,8,1945,nucleotide binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;GNAL;RAB3C;SYN2;KSR2
18967,GO:1901265,0.981680657004598,0.0397270198332496,8,1946,nucleoside phosphate binding,MF,CAMK2A;RAPGEF4;ATP1A3;ABCC3;GNAL;RAB3C;SYN2;KSR2
11518,GO:0044281,0.981768816386606,0.0458717817121934,5,1726,small molecule metabolic process,BP,FMOD;ANXA1;ADM;NNMT;FUT9
15897,GO:0070925,0.982057835249953,0.0653151611820479,2,785,organelle assembly,BP,SHANK1;SHANK2
13779,GO:0051493,0.982280901053285,0.0909324759645534,1,511,regulation of cytoskeleton organization,BP,SHANK1
7107,GO:0030031,0.982305464460564,0.0908236698025282,1,527,cell projection assembly,BP,EMP3
11236,GO:0043436,0.984091524316061,0.0590420532339814,2,1005,oxoacid metabolic process,BP,FMOD;ANXA1
3699,GO:0007346,0.984123277351343,0.0832688413022563,1,599,regulation of mitotic cell cycle,BP,ANXA1
7185,GO:0030163,0.984234619905451,0.0586182985300332,2,861,protein catabolic process,BP,TIMP1;ANXA2
60,GO:0000122,0.984991384242225,0.0562532712887315,2,862,negative regulation of transcription by RNA polymerase II,BP,CUX2;MYT1L
2918,GO:0006082,0.98530698210826,0.0552388133580569,2,1019,organic acid metabolic process,BP,FMOD;ANXA1
12139,GO:0045944,0.986089686415458,0.0441030635556448,3,1097,positive regulation of transcription by RNA polymerase II,BP,SERPINE1;LIF;GRIN1
6015,GO:0016772,0.986320443700577,0.0520516060320765,2,808,transferase activity, transferring phosphorus-containing groups,MF,CAMK2A;KSR2
13645,GO:0051254,0.987344367219885,0.0333022208053228,5,1547,positive regulation of RNA metabolic process,BP,CELF4;SERPINE1;COL1A1;LIF;GRIN1
11101,GO:0043229,0.988248997006927,0.0200531894014077,63,10994,intracellular organelle,CC,LTF;VIM;SNAP91;SYT1;CAMK2A;PHACTR3;CHGA;CELF4;TIMP1;NEFM;SLC17A7;ATP1A3;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;GABRG2;IGFBP2;IQSEC3;TGFBI;FMOD;PLAU;PACSIN1;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;COL6A2;GALNT13;CPLX2;INA;RAB3C;SPHKAP;JPH3;AFF2;SYN2;SHANK2;PDPN;ETNPPL;SVOP;GABRB3;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;RIMS2;GRIN1;ST8SIA3;CD163;ANXA2;CALN1;SV2B;MYT1L;COL4A1;PLA2G2A;SERPINA3;SLC6A17;OPALIN
2594,GO:0005524,0.988440304077106,0.030754538916675,5,1358,ATP binding,MF,CAMK2A;ATP1A3;ABCC3;SYN2;KSR2
8098,GO:0031967,0.988878057085177,0.0436876724873722,2,1067,organelle envelope,CC,ANXA1;PLA2G2A
8102,GO:0031975,0.988878057085177,0.0436876724873722,2,1067,envelope,CC,ANXA1;PLA2G2A
12100,GO:0045893,0.990418009235309,0.0283688723077689,4,1389,positive regulation of transcription, DNA-templated,BP,SERPINE1;COL1A1;LIF;GRIN1
133,GO:0000278,0.99049458894231,0.0382521422425184,2,956,mitotic cell cycle,BP,CAMK2A;ANXA1
4719,GO:0010467,0.991363764627211,0.0156637454892693,23,5091,gene expression,BP,LTF;VIM;CAMK2A;CHGA;CELF4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;SLC8A2;PLAU;LIF;CHI3L1;SPOCD1;ANXA1;SRRM4;AFF2;C1R;RBFOX3;RIMS2;GRIN1;MYT1L
16915,GO:0080135,0.991953875133926,0.0479414580891804,1,687,regulation of cellular response to stress,BP,CAMK2A
19436,GO:1902494,0.992102028233261,0.0270297723651534,3,1272,catalytic complex,CC,PPP2R2C;GNAL;SOCS3
4269,GO:0009056,0.992533176099755,0.0177290882372985,8,2415,catabolic process,BP,VIM;CHI3L2;TIMP1;FMOD;CHI3L1;FUT9;ANXA2;PLA2G2A
4758,GO:0010557,0.993017622527588,0.0196598682060872,5,1685,positive regulation of macromolecule biosynthetic process,BP,VIM;SERPINE1;COL1A1;LIF;GRIN1
7008,GO:0022402,0.993112496369026,0.0239923180277605,3,1239,cell cycle process,BP,CAMK2A;LIF;ANXA1
2760,GO:0005829,0.993277745656227,0.0126157759404172,21,4688,cytosol,CC,VIM;RASGRF1;CAMK2A;PPP2R2C;RAPGEF4;SH3GL2;IQSEC3;PACSIN1;LIF;SNAP25;ANXA1;CPLX2;RAB3C;SHANK1;SHANK2;PDPN;NNMT;KSR2;ANXA2;SOCS3;DOK6
21194,GO:1990234,0.993318591163308,0.0411185946180874,1,717,transferase complex,CC,SOCS3
19898,GO:1903508,0.993472161534008,0.020229869976606,4,1461,positive regulation of nucleic acid-templated transcription,BP,SERPINE1;COL1A1;LIF;GRIN1
19510,GO:1902680,0.993499186909855,0.0201558000446929,4,1462,positive regulation of RNA biosynthetic process,BP,SERPINE1;COL1A1;LIF;GRIN1
16353,GO:0071704,0.993563153185291,0.0111333165170307,50,9498,organic substance metabolic process,BP,LTF;VIM;RASGRF1;CHI3L2;CAMK2A;PPP2R2C;PHACTR3;CHGA;CELF4;TIMP1;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;TGFBI;FMOD;PLAU;LIF;GDF15;COL5A1;SNAP25;CHI3L1;SPOCD1;ANXA1;SRRM4;GALNT13;ADM;AFF2;C1R;ETNPPL;NNMT;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;DPP10;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
12132,GO:0045935,0.993635119366535,0.0181027421315821,5,1689,positive regulation of nucleobase-containing compound metabolic process,BP,CELF4;SERPINE1;COL1A1;LIF;GRIN1
3057,GO:0006325,0.99385665189309,0.0383638255220434,1,656,chromatin organization,BP,LIF
11505,GO:0044257,0.993902756457672,0.0381130439647833,1,726,cellular protein catabolic process,BP,ANXA2
14254,GO:0055114,0.993977244006438,0.0377069742911303,1,881,oxidation-reduction process,BP,LOX
364,GO:0000978,0.994482428970198,0.0240167266456988,2,1015,RNA polymerase II cis-regulatory region sequence-specific DNA binding,MF,CUX2;MYT1L
13644,GO:0051253,0.994640584216844,0.0192646353248956,3,1273,negative regulation of RNA metabolic process,BP,CELF4;CUX2;MYT1L
5935,GO:0016604,0.994941277747561,0.0326224443012671,1,733,nuclear body,CC,AFF2
3446,GO:0006886,0.99507951056419,0.021754098008304,2,1096,intracellular protein transport,BP,KCNB1;RIMS2
11510,GO:0044265,0.995215468645953,0.021234095091722,2,1094,cellular macromolecule catabolic process,BP,VIM;ANXA2
367,GO:0000987,0.995267032552319,0.0210390790854219,2,1038,cis-regulatory region sequence-specific DNA binding,MF,CUX2;MYT1L
5905,GO:0016567,0.995324951741799,0.0305355587283651,1,770,protein ubiquitination,BP,SOCS3
4720,GO:0010468,0.995375924343732,0.00919438217337471,18,4265,regulation of gene expression,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;SLC8A2;LIF;ANXA1;SRRM4;AFF2;RBFOX3;RIMS2;GRIN1;MYT1L
11507,GO:0044260,0.995435385441686,0.00814689584900228,36,7240,cellular macromolecule metabolic process,BP,LTF;VIM;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;TGFBI;LIF;GDF15;SNAP25;CHI3L1;SPOCD1;ANXA1;GALNT13;ADM;ELFN2;COL3A1;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
13643,GO:0051252,0.99567765677428,0.00934108677719273,13,3341,regulation of RNA metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LIF;SRRM4;AFF2;RBFOX3;GRIN1;MYT1L
6603,GO:0019752,0.996118153927652,0.0261094343268559,1,924,carboxylic acid metabolic process,BP,ANXA1
13899,GO:0051726,0.996257725755893,0.0171636505421626,2,1098,regulation of cell cycle,BP,LIF;ANXA1
3012,GO:0006259,0.996291573174226,0.0251309390244385,1,823,DNA metabolic process,BP,LOX
3889,GO:0008152,0.996368124256547,0.00653205136996481,52,9980,metabolic process,BP,LTF;VIM;RASGRF1;CHI3L2;CAMK2A;PPP2R2C;PHACTR3;CHGA;CELF4;TIMP1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;TGFBI;FMOD;PLAU;LIF;GDF15;COL5A1;SNAP25;CHI3L1;SPOCD1;ANXA1;SRRM4;GALNT13;ADM;AFF2;C1R;ETNPPL;NNMT;ELFN2;RBFOX3;COL3A1;METTL7B;KSR2;FUT9;DPP10;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
21516,GO:2000113,0.996467199633952,0.0133485839911413,3,1328,negative regulation of cellular macromolecule biosynthetic process,BP,CELF4;CUX2;MYT1L
13660,GO:0051276,0.996560811380404,0.0159510245865339,2,1047,chromosome organization,BP,LIF;ANXA1
19077,GO:1901576,0.996663079317868,0.00646012391596882,23,5395,organic substance biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;PLEKHA4;SERPINE1;COL1A1;CUX2;LOX;FMOD;LIF;COL5A1;SPOCD1;ANXA1;GALNT13;ADM;ETNPPL;NNMT;FUT9;GRIN1;ST8SIA3;MYT1L;PLA2G2A
289,GO:0000790,0.99668286168162,0.015453756473998,2,1142,nuclear chromatin,CC,CUX2;MYT1L
12131,GO:0045934,0.996942206314222,0.011747885236213,3,1360,negative regulation of nucleobase-containing compound metabolic process,BP,CELF4;CUX2;MYT1L
8393,GO:0032446,0.997254347208518,0.0194852557697882,1,844,protein modification by small protein conjugation,BP,SOCS3
3396,GO:0006807,0.99740054616242,0.00475314389740417,43,8631,nitrogen compound metabolic process,BP,LTF;VIM;RASGRF1;CHI3L2;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;TGFBI;FMOD;PLAU;LIF;GDF15;CHI3L1;SPOCD1;ANXA1;SRRM4;GALNT13;AFF2;C1R;NNMT;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;DPP10;GRIN1;ST8SIA3;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
4759,GO:0010558,0.997401179526955,0.0101704660830763,3,1377,negative regulation of macromolecule biosynthetic process,BP,CELF4;CUX2;MYT1L
4271,GO:0009058,0.997447356894387,0.00502805610525474,23,5463,biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;PLEKHA4;SERPINE1;COL1A1;CUX2;LOX;FMOD;LIF;COL5A1;SPOCD1;ANXA1;GALNT13;ADM;ETNPPL;NNMT;FUT9;GRIN1;ST8SIA3;MYT1L;PLA2G2A
11503,GO:0044249,0.997621031829856,0.00474707256315853,22,5302,cellular biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;PLEKHA4;SERPINE1;COL1A1;CUX2;LOX;FMOD;LIF;SPOCD1;ANXA1;GALNT13;ADM;ETNPPL;NNMT;FUT9;GRIN1;ST8SIA3;MYT1L;PLA2G2A
12099,GO:0045892,0.997760609435692,0.0109636798492667,2,1150,negative regulation of transcription, DNA-templated,BP,CUX2;MYT1L
11497,GO:0044238,0.99797313574308,0.00375862443701023,45,9012,primary metabolic process,BP,LTF;VIM;RASGRF1;CHI3L2;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;TGFBI;PLAU;LIF;GDF15;CHI3L1;SPOCD1;ANXA1;SRRM4;GALNT13;ADM;AFF2;C1R;ETNPPL;NNMT;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;DPP10;GRIN1;ST8SIA3;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
7769,GO:0031327,0.998002739120229,0.00804694399147353,3,1426,negative regulation of cellular biosynthetic process,BP,CELF4;CUX2;MYT1L
19897,GO:1903507,0.998234270395594,0.00889725240865916,2,1186,negative regulation of nucleic acid-templated transcription,BP,CUX2;MYT1L
19509,GO:1902679,0.998246361068625,0.00884356146258132,2,1188,negative regulation of RNA biosynthetic process,BP,CUX2;MYT1L
4581,GO:0009890,0.998264989320865,0.00709732305394061,3,1454,negative regulation of biosynthetic process,BP,CELF4;CUX2;MYT1L
6450,GO:0019219,0.998451549588949,0.00360924923043608,13,3567,regulation of nucleobase-containing compound metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LIF;SRRM4;AFF2;RBFOX3;GRIN1;MYT1L
4272,GO:0009059,0.99862021154868,0.00301810382190844,17,4441,macromolecule biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;FMOD;LIF;COL5A1;SPOCD1;GALNT13;FUT9;GRIN1;ST8SIA3;MYT1L
1596,GO:0003677,0.998714515740093,0.00396711137803185,6,2178,DNA binding,MF,LTF;CUX2;ANXA1;RBFOX3;MYT1L;SERPINA3
285,GO:0000785,0.998766115047723,0.00648292470198738,2,1284,chromatin,CC,CUX2;MYT1L
363,GO:0000977,0.998799529741582,0.00632761778977794,2,1257,RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,CUX2;MYT1L
8101,GO:0031974,0.998839838779719,0.00242050877368248,22,5447,membrane-enclosed lumen,CC,LTF;VIM;CAMK2A;PHACTR3;CELF4;TIMP1;SERPINE1;COL1A1;CUX2;IQSEC3;FMOD;COL5A1;CHI3L1;ANXA1;COL6A2;AFF2;ETNPPL;COL3A1;ANXA2;MYT1L;COL4A1;SERPINA3
11105,GO:0043233,0.998839838779719,0.00242050877368248,22,5447,organelle lumen,CC,LTF;VIM;CAMK2A;PHACTR3;CELF4;TIMP1;SERPINE1;COL1A1;CUX2;IQSEC3;FMOD;COL5A1;CHI3L1;ANXA1;COL6A2;AFF2;ETNPPL;COL3A1;ANXA2;MYT1L;COL4A1;SERPINA3
15398,GO:0070013,0.998839838779719,0.00242050877368248,22,5447,intracellular organelle lumen,CC,LTF;VIM;CAMK2A;PHACTR3;CELF4;TIMP1;SERPINE1;COL1A1;CUX2;IQSEC3;FMOD;COL5A1;CHI3L1;ANXA1;COL6A2;AFF2;ETNPPL;COL3A1;ANXA2;MYT1L;COL4A1;SERPINA3
1637,GO:0003824,0.998963394897525,0.00224826376276845,19,4902,catalytic activity,MF,LTF;CAMK2A;ABCC3;LOX;PLAU;ANXA1;GNAL;GALNT13;RAB3C;C1R;ETNPPL;NNMT;METTL7B;KSR2;FUT9;DPP10;ST8SIA3;PLA2G2A;PTPRT
8978,GO:0033554,0.999110959302133,0.0033836498916033,4,1882,cellular response to stress,BP,RASGRF1;CAMK2A;ANXA1;ADM
111,GO:0000228,0.999144567634228,0.0046831355543721,2,1344,nuclear chromosome,CC,CUX2;MYT1L
366,GO:0000981,0.999159740790249,0.00460933670270632,2,1324,DNA-binding transcription factor activity, RNA polymerase II-specific,MF,CUX2;MYT1L
12566,GO:0046907,0.99924228821855,0.00337403468232938,3,1593,intracellular transport,BP,KCNB1;RIMS2;ANXA2
15761,GO:0070647,0.999297551800416,0.00601217118056563,1,1006,protein modification by small protein conjugation or removal,BP,SOCS3
362,GO:0000976,0.999366467506028,0.00358325561774123,2,1345,transcription regulatory region sequence-specific DNA binding,MF,CUX2;MYT1L
384,GO:0001067,0.999372817095819,0.00355115348514754,2,1346,regulatory region nucleic acid binding,MF,CUX2;MYT1L
1609,GO:0003700,0.999418623202299,0.00331820608266428,2,1382,DNA-binding transcription factor activity,MF,CUX2;MYT1L
3547,GO:0007049,0.99946972275927,0.00244386604195448,3,1658,cell cycle,BP,CAMK2A;LIF;ANXA1
5660,GO:0016070,0.999478920300963,0.00127776032777891,14,4103,RNA metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LIF;SPOCD1;SRRM4;AFF2;RBFOX3;GRIN1;MYT1L
1595,GO:0003676,0.999550525899671,0.00119997689943162,11,3512,nucleic acid binding,MF,LTF;VIM;CELF4;CUX2;ANXA1;SRRM4;AFF2;RBFOX3;ANXA2;MYT1L;SERPINA3
9422,GO:0034645,0.999580283437985,0.00102249034721112,15,4326,cellular macromolecule biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;GALNT13;FUT9;GRIN1;ST8SIA3;MYT1L
7768,GO:0031326,0.999590779510861,0.0010683563283799,12,3679,regulation of cellular biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LIF;ANXA1;ADM;GRIN1;MYT1L
21395,GO:1990837,0.999636469811659,0.00217785426864966,2,1439,sequence-specific double-stranded DNA binding,MF,CUX2;MYT1L
11502,GO:0044248,0.999653639817857,0.00143259389429283,4,2099,cellular catabolic process,BP,VIM;TIMP1;FMOD;ANXA2
11496,GO:0044237,0.999668825314688,0.000678645646177387,44,9298,cellular metabolic process,BP,LTF;VIM;RASGRF1;CAMK2A;PPP2R2C;PHACTR3;CELF4;TIMP1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;COL1A1;CUX2;LOX;IGFBP2;SLC8A2;TGFBI;FMOD;LIF;GDF15;SNAP25;CHI3L1;SPOCD1;ANXA1;SRRM4;GALNT13;ADM;AFF2;ETNPPL;NNMT;ELFN2;RBFOX3;COL3A1;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;MYT1L;PLA2G2A;PTPRT;SERPINA3
11513,GO:0044271,0.999714271276916,0.000726948468861403,14,4289,cellular nitrogen compound biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;NNMT;GRIN1;ST8SIA3;MYT1L
4580,GO:0009889,0.999724534595226,0.000737357223088464,12,3754,regulation of biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LIF;ANXA1;ADM;GRIN1;MYT1L
19003,GO:1901362,0.99973607087468,0.00070833336313516,12,3838,organic cyclic compound biosynthetic process,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;ADM;NNMT;GRIN1;MYT1L
1604,GO:0003690,0.999768606508229,0.00144937810948095,2,1508,double-stranded DNA binding,MF,CUX2;MYT1L
9429,GO:0034654,0.999776853532061,0.000623175948369791,11,3647,nucleobase-containing compound biosynthetic process,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;NNMT;GRIN1;MYT1L
3068,GO:0006351,0.999786628318081,0.000642585703932068,9,3198,transcription, DNA-templated,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LIF;SPOCD1;GRIN1;MYT1L
19004,GO:1901363,0.999801389651833,0.00046804181776178,20,5231,heterocyclic compound binding,MF,LTF;VIM;CAMK2A;RAPGEF4;CELF4;ATP1A3;ABCC3;CUX2;ANXA1;SRRM4;GNAL;RAB3C;AFF2;SYN2;ETNPPL;RBFOX3;KSR2;ANXA2;MYT1L;SERPINA3
3074,GO:0006357,0.99982319754983,0.000692970052239638,5,2311,regulation of transcription by RNA polymerase II,BP,SERPINE1;CUX2;LIF;GRIN1;MYT1L
6269,GO:0018130,0.999827512921018,0.000489457421439612,11,3704,heterocycle biosynthetic process,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;NNMT;GRIN1;MYT1L
17701,GO:0097659,0.999831140857514,0.000516347041433507,9,3242,nucleic acid-templated transcription,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LIF;SPOCD1;GRIN1;MYT1L
11314,GO:0043565,0.999833341638081,0.00107701197330846,2,1541,sequence-specific DNA binding,MF,CUX2;MYT1L
17207,GO:0090304,0.99983791833415,0.00041752171753997,15,4529,nucleic acid metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;SRRM4;AFF2;RBFOX3;GRIN1;MYT1L
6527,GO:0019438,0.999840387194136,0.000455085009767818,11,3714,aromatic compound biosynthetic process,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;NNMT;GRIN1;MYT1L
8606,GO:0032774,0.999840407398079,0.000489790022574017,9,3255,RNA biosynthetic process,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LIF;SPOCD1;GRIN1;MYT1L
3072,GO:0006355,0.999853826161459,0.000472566425393454,8,3038,regulation of transcription, DNA-templated,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LIF;GRIN1;MYT1L
17461,GO:0097159,0.999857243828345,0.000342404392468401,20,5302,organic cyclic compound binding,MF,LTF;VIM;CAMK2A;RAPGEF4;CELF4;ATP1A3;ABCC3;CUX2;ANXA1;SRRM4;GNAL;RAB3C;AFF2;SYN2;ETNPPL;RBFOX3;KSR2;ANXA2;MYT1L;SERPINA3
21515,GO:2000112,0.999861406345776,0.000412507601274476,10,3462,regulation of cellular macromolecule biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LIF;GRIN1;MYT1L
19896,GO:1903506,0.99989186832786,0.000356519086850073,8,3092,regulation of nucleic acid-templated transcription,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LIF;GRIN1;MYT1L
22068,GO:2001141,0.999894133089629,0.000349528277715349,8,3097,regulation of RNA biosynthetic process,BP,LTF;CAMK2A;SERPINE1;COL1A1;CUX2;LIF;GRIN1;MYT1L
3081,GO:0006366,0.999913948460119,0.000355584069279721,5,2442,transcription by RNA polymerase II,BP,SERPINE1;CUX2;LIF;GRIN1;MYT1L
4757,GO:0010556,0.999916886701067,0.000255208501564222,10,3554,regulation of macromolecule biosynthetic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LIF;GRIN1;MYT1L
11103,GO:0043231,0.999931811957597,0.000151121862517337,44,9529,intracellular membrane-bounded organelle,CC,LTF;VIM;SYT1;CAMK2A;PHACTR3;CHGA;CELF4;TIMP1;ATP1A3;SH3GL2;COL1A1;CUX2;LOX;IQSEC3;TGFBI;FMOD;GDF15;COL5A1;SNAP25;CHI3L1;POSTN;ANXA1;SRRM4;COL6A2;GALNT13;CPLX2;SPHKAP;JPH3;AFF2;ETNPPL;RBFOX3;MOBP;COL3A1;FUT9;CNTNAP2;GRIN1;ST8SIA3;ANXA2;CALN1;MYT1L;COL4A1;PLA2G2A;SERPINA3;OPALIN
2953,GO:0006139,0.999944092458612,0.000149697839322143,16,4966,nucleobase-containing compound metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;SRRM4;AFF2;NNMT;RBFOX3;GRIN1;MYT1L
2684,GO:0005694,0.999950444273866,0.0003567228750284,2,1735,chromosome,CC,CUX2;MYT1L
18544,GO:0140110,0.999971104923284,0.000217504591578681,2,1809,transcription regulator activity,MF,CUX2;MYT1L
12365,GO:0046483,0.999972944789017,7.51871574847151e-05,16,5114,heterocycle metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;SRRM4;AFF2;NNMT;RBFOX3;GRIN1;MYT1L
19001,GO:1901360,0.999975667852332,6.6744981224028e-05,17,5341,organic cyclic compound metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;SRRM4;ADM;AFF2;NNMT;RBFOX3;GRIN1;MYT1L
3350,GO:0006725,0.999978838578373,5.95329244293331e-05,16,5156,cellular aromatic compound metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;SRRM4;AFF2;NNMT;RBFOX3;GRIN1;MYT1L
9419,GO:0034641,0.999992899258295,2.06568790080772e-05,17,5606,cellular nitrogen compound metabolic process,BP,LTF;VIM;CAMK2A;CELF4;SERPINE1;COL1A1;CUX2;LOX;LIF;SPOCD1;SRRM4;AFF2;NNMT;RBFOX3;GRIN1;ST8SIA3;MYT1L
11104,GO:0043232,0.999998755093984,4.43652246468025e-06,12,4543,intracellular non-membrane-bounded organelle,CC,VIM;NEFM;CUX2;PACSIN1;SNAP25;ANXA1;INA;SHANK2;MOBP;RIMS2;ANXA2;MYT1L
11100,GO:0043228,0.999998834936581,4.16456315897737e-06,12,4552,non-membrane-bounded organelle,CC,VIM;NEFM;CUX2;PACSIN1;SNAP25;ANXA1;INA;SHANK2;MOBP;RIMS2;ANXA2;MYT1L
2653,GO:0005654,0.999999858840663,7.72464733060296e-07,6,3641,nucleoplasm,CC,CAMK2A;PHACTR3;CELF4;IQSEC3;ANXA1;AFF2
8103,GO:0031981,0.999999902200144,4.45363220152459e-07,9,4451,nuclear lumen,CC,VIM;CAMK2A;PHACTR3;CELF4;CUX2;IQSEC3;ANXA1;AFF2;MYT1L
2643,GO:0005634,0.999999997186144,1.11792670182433e-08,17,6572,nucleus,CC,LTF;VIM;CAMK2A;PHACTR3;CELF4;CUX2;LOX;IQSEC3;GDF15;ANXA1;SRRM4;CPLX2;AFF2;RBFOX3;ANXA2;MYT1L;SERPINA3
16722,GO:0072376,0.999999999999989,0.876670400735569,0,22,protein activation cascade,BP,
16723,GO:0072378,0.999999999999989,0.876670400735569,0,22,blood coagulation, fibrin clot formation,BP,
4322,GO:0009129,0.99999999999999,0.931029793297918,0,15,pyrimidine nucleoside monophosphate metabolic process,BP,
7660,GO:0031111,0.999999999999991,0.727180922717598,0,37,negative regulation of microtubule polymerization or depolymerization,BP,
13856,GO:0051646,0.999999999999992,0.711274905012353,0,43,mitochondrion localization,BP,
4376,GO:0009187,0.999999999999992,0.72930566859467,0,35,cyclic nucleotide metabolic process,BP,
11582,GO:0044390,0.999999999999992,0.768246689974479,0,36,ubiquitin-like protein conjugating enzyme binding,MF,
3030,GO:0006284,0.999999999999994,0.776890461157971,0,40,base-excision repair,BP,
585,GO:0001754,0.999999999999995,0.724350824813793,0,41,eye photoreceptor cell differentiation,BP,
9659,GO:0035315,0.999999999999998,0.742772768452286,0,38,hair cell differentiation,BP,
10967,GO:0043001,0.999999999999998,0.746319124433317,0,38,Golgi to plasma membrane protein transport,BP,
6972,GO:0021955,0.999999999999999,0.715586590714209,0,35,central nervous system neuron axonogenesis,BP,
17220,GO:0090317,0.999999999999999,0.773287871403029,0,41,negative regulation of intracellular protein transport,BP,
8175,GO:0032096,0.999999999999999,0.937635962124322,0,12,negative regulation of response to food,BP,
8178,GO:0032099,0.999999999999999,0.937635962124322,0,12,negative regulation of appetite,BP,
6187,GO:0017112,1,0.752233496722982,0,32,Rab guanyl-nucleotide exchange factor activity,MF,
41,GO:0000083,1,0.816025769924602,0,34,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15578,GO:0070316,1,0.734743057639281,0,40,regulation of G0 to G1 transition,BP,
1,GO:0000002,1,0.861456208345786,0,23,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.991138119494829,0,2,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.98982655545591,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.934598538483596,0,10,single strand break repair,BP,
6,GO:0000014,1,0.941079454561415,0,9,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.983276580308383,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000017,1,0.986304679224616,0,2,alpha-glucoside transport,BP,
9,GO:0000018,1,0.549199216091443,0,83,regulation of DNA recombination,BP,
10,GO:0000019,1,0.970790727479728,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.948801762259349,0,8,mitotic spindle elongation,BP,
12,GO:0000023,1,0.972248202658214,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.974321461403505,0,4,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.874452245853821,0,25,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.917175203699893,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.828228128783235,0,28,mannosyltransferase activity,MF,
17,GO:0000032,1,0.996318235555698,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.987600212521369,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.991281016882377,0,2,acyl binding,MF,
20,GO:0000036,1,0.996871328163206,0,1,acyl carrier activity,MF,
21,GO:0000038,1,0.835328562592615,0,32,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.540850152323129,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.986085166569851,0,3,peptidyltransferase activity,MF,
25,GO:0000049,1,0.734630927747409,0,54,tRNA binding,MF,
26,GO:0000050,1,0.948456678061616,0,11,urea cycle,BP,
27,GO:0000052,1,0.93591110655045,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.996265080058039,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.93200307930848,0,14,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.965904864897253,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.962611849838366,0,8,ribosomal small subunit export from nucleus,BP,
32,GO:0000062,1,0.910535442333504,0,20,fatty-acyl-CoA binding,MF,
33,GO:0000064,1,0.957142840126875,0,5,L-ornithine transmembrane transporter activity,MF,
34,GO:0000070,1,0.339269816941302,0,150,mitotic sister chromatid segregation,BP,
35,GO:0000075,1,0.250347031442862,0,204,cell cycle checkpoint,BP,
36,GO:0000076,1,0.913944787412731,0,16,DNA replication checkpoint,BP,
37,GO:0000077,1,0.385846857006698,0,138,DNA damage checkpoint,BP,
38,GO:0000079,1,0.573930059053232,0,94,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
39,GO:0000080,1,0.983659524878209,0,2,mitotic G1 phase,BP,
42,GO:0000086,1,0.209656903391515,0,239,G2/M transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.995768401140782,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.797454530127003,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.90333523609327,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.932585954902474,0,14,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.950946085111346,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.95929870277162,0,6,sulfur amino acid transport,BP,
49,GO:0000103,1,0.984778136134811,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.98397300109008,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.989119909425266,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.929365019107193,0,12,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.977582489232044,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.993218002781279,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000112,1,0.994907044021789,0,1,nucleotide-excision repair factor 3 complex,CC,
56,GO:0000117,1,0.983690378738113,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000118,1,0.509431282316287,0,75,histone deacetylase complex,CC,
58,GO:0000120,1,0.988676557735361,0,3,RNA polymerase I transcription regulator complex,CC,
59,GO:0000121,1,0.994203344040641,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.60307572318359,0,75,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.941542271791249,0,8,SAGA complex,CC,
63,GO:0000125,1,0.965130326376987,0,3,PCAF complex,CC,
64,GO:0000126,1,0.969196519121271,0,3,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.959285364696156,0,6,transcription factor TFIIIC complex,CC,
66,GO:0000132,1,0.809157419609262,0,30,establishment of mitotic spindle orientation,BP,
67,GO:0000137,1,0.889415652594591,0,17,Golgi cis cisterna,CC,
68,GO:0000138,1,0.955676183561852,0,9,Golgi trans cisterna,CC,
70,GO:0000145,1,0.89901956145275,0,15,exocyst,CC,
71,GO:0000146,1,0.716796690437091,0,26,microfilament motor activity,MF,
73,GO:0000150,1,0.991465059468678,0,2,recombinase activity,MF,
74,GO:0000151,1,0.155310785116859,0,268,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.769141480760665,0,40,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.93648261985355,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.866802412644529,0,31,rRNA modification,BP,
79,GO:0000160,1,0.993026807914862,0,1,phosphorelay signal transduction system,BP,
80,GO:0000164,1,0.913175260812191,0,14,protein phosphatase type 1 complex,CC,
83,GO:0000170,1,0.996612746461703,0,1,sphingosine hydroxylase activity,MF,
84,GO:0000171,1,0.983223585498765,0,3,ribonuclease MRP activity,MF,
85,GO:0000172,1,0.961795891776774,0,8,ribonuclease MRP complex,CC,
86,GO:0000173,1,0.996431616628595,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
87,GO:0000175,1,0.795431083467606,0,35,3'-5'-exoribonuclease activity,MF,
88,GO:0000176,1,0.936254255586343,0,15,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.925194406032101,0,14,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.879963911056828,0,23,exosome (RNase complex),CC,
91,GO:0000179,1,0.982877825216412,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
92,GO:0000182,1,0.942898648439376,0,6,rDNA binding,MF,
93,GO:0000183,1,0.9148613090731,0,11,rDNA heterochromatin assembly,BP,
94,GO:0000184,1,0.577545465594689,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
95,GO:0000185,1,0.932818236894998,0,12,activation of MAPKKK activity,BP,
96,GO:0000186,1,0.668850618855631,0,49,activation of MAPKK activity,BP,
98,GO:0000188,1,0.876062127987241,0,24,inactivation of MAPK activity,BP,
99,GO:0000209,1,0.112691633349045,0,319,protein polyubiquitination,BP,
100,GO:0000210,1,0.993484732409896,0,1,NAD+ diphosphatase activity,MF,
101,GO:0000212,1,0.907811590982133,0,10,meiotic spindle organization,BP,
102,GO:0000213,1,0.991632754012883,0,2,tRNA-intron endonuclease activity,MF,
103,GO:0000214,1,0.984185635527875,0,4,tRNA-intron endonuclease complex,CC,
104,GO:0000215,1,0.99170208888324,0,2,tRNA 2'-phosphotransferase activity,MF,
105,GO:0000217,1,0.794095772181086,0,33,DNA secondary structure binding,MF,
106,GO:0000220,1,0.969412282913301,0,4,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
107,GO:0000221,1,0.979261697488273,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
108,GO:0000224,1,0.995290406985066,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
109,GO:0000225,1,0.996741253594688,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
110,GO:0000226,1,0.014140274606087,0,534,microtubule cytoskeleton organization,BP,
112,GO:0000229,1,0.996761238140268,0,1,cytoplasmic chromosome,CC,
113,GO:0000235,1,0.922937470427716,0,11,astral microtubule,CC,
114,GO:0000242,1,0.829817149061865,0,20,pericentriolar material,CC,
115,GO:0000243,1,0.978901690323493,0,5,commitment complex,CC,
116,GO:0000244,1,0.92239484893146,0,13,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000246,1,0.99183051038241,0,1,delta24(24-1) sterol reductase activity,MF,
119,GO:0000247,1,0.99674041724777,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000248,1,0.986499910056994,0,2,C-5 sterol desaturase activity,MF,
121,GO:0000250,1,0.991894383511468,0,1,lanosterol synthase activity,MF,
122,GO:0000252,1,0.996473390007712,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000253,1,0.990008095540733,0,3,3-keto sterol reductase activity,MF,
124,GO:0000254,1,0.986473045849931,0,3,C-4 methylsterol oxidase activity,MF,
125,GO:0000255,1,0.996583423867145,0,1,allantoin metabolic process,BP,
126,GO:0000256,1,0.996583423867145,0,1,allantoin catabolic process,BP,
127,GO:0000257,1,0.996636152300077,0,1,nitrilase activity,MF,
128,GO:0000266,1,0.750398338208983,0,37,mitochondrial fission,BP,
129,GO:0000268,1,0.973110669281798,0,5,peroxisome targeting sequence binding,MF,
130,GO:0000270,1,0.993621973910818,0,2,peptidoglycan metabolic process,BP,
132,GO:0000272,1,0.824061238032498,0,24,polysaccharide catabolic process,BP,
135,GO:0000281,1,0.598122960782289,0,70,mitotic cytokinesis,BP,
136,GO:0000285,1,0.988548091018321,0,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
137,GO:0000287,1,0.246696695894951,0,200,magnesium ion binding,MF,
138,GO:0000288,1,0.608869437977969,0,68,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
139,GO:0000289,1,0.780794150064188,0,28,nuclear-transcribed mRNA poly(A) tail shortening,BP,
140,GO:0000290,1,0.946872232671697,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.818494033020636,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000293,1,0.976820460209886,0,4,ferric-chelate reductase activity,MF,
143,GO:0000294,1,0.984765281712809,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
144,GO:0000295,1,0.863148061852203,0,28,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000296,1,0.988124984661182,0,2,spermine transport,BP,
146,GO:0000298,1,0.979209716404853,0,4,endopolyphosphatase activity,MF,
147,GO:0000301,1,0.989254845334611,0,2,retrograde transport, vesicle recycling within Golgi,BP,
149,GO:0000303,1,0.871157430931664,0,26,response to superoxide,BP,
150,GO:0000304,1,0.995972914617277,0,1,response to singlet oxygen,BP,
151,GO:0000305,1,0.867752539918549,0,27,response to oxygen radical,BP,
152,GO:0000306,1,0.97136320390415,0,4,extrinsic component of vacuolar membrane,CC,
153,GO:0000307,1,0.775022702816178,0,42,cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000308,1,0.983098568983878,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000309,1,0.978620449388382,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
156,GO:0000313,1,0.730958687588566,0,84,organellar ribosome,CC,
157,GO:0000314,1,0.909955287986935,0,27,organellar small ribosomal subunit,CC,
158,GO:0000315,1,0.809730784815024,0,55,organellar large ribosomal subunit,CC,
159,GO:0000320,1,0.983713042528599,0,2,re-entry into mitotic cell cycle,BP,
160,GO:0000322,1,0.992486028547056,0,2,storage vacuole,CC,
162,GO:0000333,1,0.992411688368383,0,1,telomerase catalytic core complex,CC,
163,GO:0000334,1,0.996678074209217,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
164,GO:0000338,1,0.958741608975798,0,10,protein deneddylation,BP,
165,GO:0000339,1,0.892802772003,0,17,RNA cap binding,MF,
166,GO:0000340,1,0.928500891843269,0,10,RNA 7-methylguanosine cap binding,MF,
167,GO:0000346,1,0.934605912897651,0,13,transcription export complex,CC,
168,GO:0000347,1,0.97037932451211,0,6,THO complex,CC,
169,GO:0000349,1,0.99068022281776,0,2,generation of catalytic spliceosome for first transesterification step,BP,
170,GO:0000350,1,0.992721123274869,0,2,generation of catalytic spliceosome for second transesterification step,BP,
171,GO:0000354,1,0.980235553255811,0,2,cis assembly of pre-catalytic spliceosome,BP,
174,GO:0000378,1,0.994890876864838,0,1,RNA exon ligation,BP,
175,GO:0000379,1,0.987797049747466,0,3,tRNA-type intron splice site recognition and cleavage,BP,
178,GO:0000386,1,0.993317486823431,0,1,second spliceosomal transesterification activity,MF,
179,GO:0000387,1,0.82219692410908,0,39,spliceosomal snRNP assembly,BP,
180,GO:0000388,1,0.986237919978601,0,1,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),BP,
181,GO:0000389,1,0.966153380894719,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.986673529118225,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.969931694816678,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.93529957915879,0,15,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.970166397751676,0,6,mRNA 5'-splice site recognition,BP,
187,GO:0000400,1,0.885976957391386,0,17,four-way junction DNA binding,MF,
188,GO:0000403,1,0.958801293304015,0,5,Y-form DNA binding,MF,
189,GO:0000404,1,0.993218002781279,0,1,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.938474814768911,0,8,bubble DNA binding,MF,
191,GO:0000406,1,0.988161857424721,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.805875083192132,0,30,phagophore assembly site,CC,
193,GO:0000408,1,0.97918160650965,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.986853485365181,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.986853485365181,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000413,1,0.836926943422049,0,34,protein peptidyl-prolyl isomerization,BP,
197,GO:0000414,1,0.937749192739925,0,6,regulation of histone H3-K36 methylation,BP,
198,GO:0000415,1,0.987835063001304,0,1,negative regulation of histone H3-K36 methylation,BP,
199,GO:0000416,1,0.976796029350797,0,3,positive regulation of histone H3-K36 methylation,BP,
200,GO:0000417,1,0.992355916765143,0,1,HIR complex,CC,
201,GO:0000421,1,0.813989691512514,0,35,autophagosome membrane,CC,
202,GO:0000422,1,0.568447401075801,0,75,autophagy of mitochondrion,BP,
203,GO:0000423,1,0.812778964306206,0,23,mitophagy,BP,
204,GO:0000428,1,0.555962871697501,0,97,DNA-directed RNA polymerase complex,CC,
205,GO:0000429,1,0.975311465992306,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
206,GO:0000430,1,0.988305761349393,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000431,1,0.986853485365181,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000432,1,0.988305761349393,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000435,1,0.986853485365181,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000436,1,0.975311465992306,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
211,GO:0000438,1,0.989062260948612,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
212,GO:0000439,1,0.946252361211931,0,11,transcription factor TFIIH core complex,CC,
213,GO:0000444,1,0.964610123897391,0,4,MIS12/MIND type complex,CC,
214,GO:0000445,1,0.97037932451211,0,6,THO complex part of transcription export complex,CC,
215,GO:0000447,1,0.945361772181372,0,10,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
216,GO:0000448,1,0.987201892377649,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000451,1,0.993311276206321,0,1,rRNA 2'-O-methylation,BP,
218,GO:0000453,1,0.993311276206321,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
219,GO:0000454,1,0.989987351611566,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
220,GO:0000455,1,0.974765349100642,0,6,enzyme-directed rRNA pseudouridine synthesis,BP,
221,GO:0000459,1,0.960780077014857,0,9,exonucleolytic trimming involved in rRNA processing,BP,
222,GO:0000460,1,0.806257491233122,0,34,maturation of 5.8S rRNA,BP,
223,GO:0000461,1,0.996895710840824,0,1,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000462,1,0.813706727013045,0,35,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000463,1,0.913993731352596,0,13,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000466,1,0.865354908200595,0,24,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000467,1,0.960780077014857,0,9,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000469,1,0.854190125513402,0,27,cleavage involved in rRNA processing,BP,
229,GO:0000470,1,0.857063760386533,0,25,maturation of LSU-rRNA,BP,
230,GO:0000472,1,0.963901072508654,0,5,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000478,1,0.899769347841637,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
232,GO:0000479,1,0.899769347841637,0,15,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000480,1,0.948955520590739,0,8,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000481,1,0.99322422714344,0,1,maturation of 5S rRNA,BP,
235,GO:0000491,1,0.959755003827311,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
236,GO:0000492,1,0.968396785742076,0,6,box C/D snoRNP assembly,BP,
237,GO:0000493,1,0.991079055961674,0,2,box H/ACA snoRNP assembly,BP,
238,GO:0000494,1,0.99251557403184,0,2,box C/D snoRNA 3'-end processing,BP,
239,GO:0000495,1,0.989609908917226,0,2,box H/ACA snoRNA 3'-end processing,BP,
240,GO:0000502,1,0.757923463842405,0,59,proteasome complex,CC,
241,GO:0000506,1,0.967079221468086,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
242,GO:0000578,1,0.777682555208429,0,35,embryonic axis specification,BP,
243,GO:0000700,1,0.982384392536673,0,4,mismatch base pair DNA N-glycosylase activity,MF,
244,GO:0000701,1,0.992910999566958,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.985764484713359,0,4,oxidized base lesion DNA N-glycosylase activity,MF,
246,GO:0000703,1,0.993283147731499,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
247,GO:0000706,1,0.981138055687846,0,3,meiotic DNA double-strand break processing,BP,
248,GO:0000707,1,0.991722910518924,0,2,meiotic DNA recombinase assembly,BP,
249,GO:0000710,1,0.972172553689074,0,4,meiotic mismatch repair,BP,
250,GO:0000711,1,0.996603076131207,0,1,meiotic DNA repair synthesis,BP,
251,GO:0000712,1,0.904924527852478,0,14,resolution of meiotic recombination intermediates,BP,
252,GO:0000715,1,0.890494162844099,0,23,nucleotide-excision repair, DNA damage recognition,BP,
253,GO:0000717,1,0.882974671336688,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
254,GO:0000718,1,0.996363308056365,0,1,nucleotide-excision repair, DNA damage removal,BP,
255,GO:0000720,1,0.976681342552767,0,4,pyrimidine dimer repair by nucleotide-excision repair,BP,
256,GO:0000721,1,0.995305280149271,0,1,(R,R)-butanediol dehydrogenase activity,MF,
257,GO:0000722,1,0.888624484060094,0,13,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.369769785513966,0,139,telomere maintenance,BP,
259,GO:0000724,1,0.402173505843414,0,124,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.400099988550318,0,125,recombinational repair,BP,
261,GO:0000726,1,0.577587399483116,0,74,non-recombinational repair,BP,
262,GO:0000727,1,0.936165829770689,0,12,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.8523470834227,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.973388881565455,0,6,DNA recombinase assembly,BP,
265,GO:0000731,1,0.733438705480252,0,47,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.991251849792857,0,1,strand displacement,BP,
267,GO:0000733,1,0.947682911555011,0,8,DNA strand renaturation,BP,
268,GO:0000735,1,0.991133852266399,0,1,removal of nonhomologous ends,BP,
269,GO:0000737,1,0.838299662163514,0,30,DNA catabolic process, endonucleolytic,BP,
270,GO:0000738,1,0.962544651778142,0,8,DNA catabolic process, exonucleolytic,BP,
271,GO:0000741,1,0.996344421464864,0,1,karyogamy,BP,
273,GO:0000773,1,0.996799244009751,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
274,GO:0000774,1,0.946725653388283,0,10,adenyl-nucleotide exchange factor activity,MF,
275,GO:0000775,1,0.281091831985093,0,180,chromosome, centromeric region,CC,
276,GO:0000776,1,0.419243646931913,0,126,kinetochore,CC,
277,GO:0000777,1,0.541901560843619,0,95,condensed chromosome kinetochore,CC,
278,GO:0000778,1,0.924176125458557,0,17,condensed nuclear chromosome kinetochore,CC,
279,GO:0000779,1,0.489714824238486,0,109,condensed chromosome, centromeric region,CC,
280,GO:0000780,1,0.854889448300519,0,28,condensed nuclear chromosome, centromeric region,CC,
281,GO:0000781,1,0.389034466858262,0,130,chromosome, telomeric region,CC,
282,GO:0000782,1,0.942621836702609,0,11,telomere cap complex,CC,
283,GO:0000783,1,0.942621836702609,0,11,nuclear telomere cap complex,CC,
284,GO:0000784,1,0.497896223169149,0,97,nuclear chromosome, telomeric region,CC,
286,GO:0000786,1,0.929425319211372,0,10,nucleosome,CC,
287,GO:0000788,1,0.978439379264561,0,3,nuclear nucleosome,CC,
288,GO:0000789,1,0.996761238140268,0,1,cytoplasmic chromatin,CC,
290,GO:0000791,1,0.810274977201362,0,32,euchromatin,CC,
291,GO:0000792,1,0.608852008527425,0,68,heterochromatin,CC,
292,GO:0000793,1,0.265456290357142,0,188,condensed chromosome,CC,
293,GO:0000794,1,0.55045228703005,0,84,condensed nuclear chromosome,CC,
294,GO:0000795,1,0.8150376299786,0,32,synaptonemal complex,CC,
295,GO:0000796,1,0.931885657906297,0,8,condensin complex,CC,
296,GO:0000797,1,0.969592090916185,0,3,condensin core heterodimer,CC,
297,GO:0000798,1,0.969266673830603,0,5,nuclear cohesin complex,CC,
298,GO:0000799,1,0.961907734656283,0,4,nuclear condensin complex,CC,
299,GO:0000800,1,0.900688539451952,0,13,lateral element,CC,
300,GO:0000801,1,0.969953249691747,0,6,central element,CC,
301,GO:0000803,1,0.838132287669061,0,23,sex chromosome,CC,
302,GO:0000805,1,0.941444191943306,0,6,X chromosome,CC,
303,GO:0000806,1,0.985935808007346,0,2,Y chromosome,CC,
304,GO:0000808,1,0.954019889791689,0,9,origin recognition complex,CC,
305,GO:0000811,1,0.983457687425999,0,3,GINS complex,CC,
306,GO:0000812,1,0.902253311766998,0,12,Swr1 complex,CC,
307,GO:0000813,1,0.951621426730978,0,10,ESCRT I complex,CC,
308,GO:0000814,1,0.985089768256359,0,3,ESCRT II complex,CC,
309,GO:0000815,1,0.956933891975276,0,10,ESCRT III complex,CC,
310,GO:0000818,1,0.987906812853443,0,3,nuclear MIS12/MIND complex,CC,
311,GO:0000819,1,0.285467652009244,0,175,sister chromatid segregation,BP,
312,GO:0000820,1,0.941714071594204,0,7,regulation of glutamine family amino acid metabolic process,BP,
313,GO:0000821,1,0.975485680931758,0,3,regulation of arginine metabolic process,BP,
314,GO:0000822,1,0.962465368886588,0,3,inositol hexakisphosphate binding,MF,
315,GO:0000823,1,0.996298331802648,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
316,GO:0000824,1,0.996298331802648,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
317,GO:0000825,1,0.990279395857818,0,2,inositol tetrakisphosphate 6-kinase activity,MF,
318,GO:0000827,1,0.966192436645805,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
319,GO:0000828,1,0.942128669228324,0,8,inositol hexakisphosphate kinase activity,MF,
320,GO:0000829,1,0.979146608111783,0,2,inositol heptakisphosphate kinase activity,MF,
321,GO:0000831,1,0.994907044021789,0,1,inositol hexakisphosphate 6-kinase activity,MF,
322,GO:0000832,1,0.962958011102612,0,5,inositol hexakisphosphate 5-kinase activity,MF,
323,GO:0000835,1,0.955495024157613,0,8,ER ubiquitin ligase complex,CC,
324,GO:0000836,1,0.955495024157613,0,8,Hrd1p ubiquitin ligase complex,CC,
325,GO:0000839,1,0.960390812832161,0,7,Hrd1p ubiquitin ligase ERAD-L complex,CC,
329,GO:0000910,1,0.336858799597323,0,144,cytokinesis,BP,
330,GO:0000912,1,0.956570113022906,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
331,GO:0000915,1,0.956570113022906,0,6,actomyosin contractile ring assembly,BP,
332,GO:0000916,1,0.995834197106905,0,1,actomyosin contractile ring contraction,BP,
333,GO:0000917,1,0.996241409002472,0,1,division septum assembly,BP,
334,GO:0000921,1,0.990840231113178,0,1,septin ring assembly,BP,
335,GO:0000922,1,0.343736798779179,0,150,spindle pole,CC,
336,GO:0000923,1,0.969761325900653,0,4,equatorial microtubule organizing center,CC,
337,GO:0000930,1,0.860869780541228,0,19,gamma-tubulin complex,CC,
338,GO:0000931,1,0.9435054003885,0,7,gamma-tubulin large complex,CC,
339,GO:0000932,1,0.555489434295823,0,81,P-body,CC,
340,GO:0000938,1,0.969778565822134,0,4,GARP complex,CC,
341,GO:0000939,1,0.980206003490004,0,5,condensed chromosome inner kinetochore,CC,
342,GO:0000940,1,0.919906028039249,0,13,condensed chromosome outer kinetochore,CC,
343,GO:0000941,1,0.992101469142982,0,2,condensed nuclear chromosome inner kinetochore,CC,
344,GO:0000942,1,0.981181580826845,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.322020307277334,0,196,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.949783982495379,0,6,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.97916907830977,0,3,mitochondrial mRNA catabolic process,BP,
348,GO:0000959,1,0.767948413811331,0,42,mitochondrial RNA metabolic process,BP,
349,GO:0000960,1,0.957017619935571,0,5,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.982275903335524,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.974290489836168,0,3,positive regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000963,1,0.919544795164253,0,16,mitochondrial RNA processing,BP,
353,GO:0000964,1,0.98299617322905,0,3,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.974243818499716,0,5,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.887049436639126,0,22,RNA 5'-end processing,BP,
356,GO:0000967,1,0.963901072508654,0,5,rRNA 5'-end processing,BP,
357,GO:0000968,1,0.994890876864838,0,1,tRNA exon ligation,BP,
358,GO:0000971,1,0.994890876864838,0,1,tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate,BP,
359,GO:0000972,1,0.966896375585097,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000973,1,0.990574909315164,0,2,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
361,GO:0000974,1,0.933821781357165,0,13,Prp19 complex,CC,
365,GO:0000979,1,0.88987936180079,0,20,RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000992,1,0.951686652873916,0,6,RNA polymerase III cis-regulatory region sequence-specific DNA binding,MF,
369,GO:0000993,1,0.780291484432433,0,37,RNA polymerase II complex binding,MF,
370,GO:0000994,1,0.996314289137698,0,1,RNA polymerase III core binding,MF,
371,GO:0000995,1,0.973836227414564,0,5,RNA polymerase III general transcription initiation factor activity,MF,
372,GO:0001002,1,0.967500334816149,0,3,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
373,GO:0001003,1,0.967500334816149,0,3,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
374,GO:0001006,1,0.951686652873916,0,6,RNA polymerase III type 3 promoter sequence-specific DNA binding,MF,
375,GO:0001010,1,0.994592483981713,0,1,RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity,MF,
376,GO:0001016,1,0.948694551742687,0,7,RNA polymerase III transcription regulatory region sequence-specific DNA binding,MF,
377,GO:0001018,1,0.983263491402737,0,3,mitochondrial promoter sequence-specific DNA binding,MF,
378,GO:0001025,1,0.951316718314212,0,3,RNA polymerase III general transcription initiation factor binding,MF,
379,GO:0001042,1,0.956710173845077,0,5,RNA polymerase I core binding,MF,
380,GO:0001046,1,0.774594265785218,0,41,core promoter sequence-specific DNA binding,MF,
381,GO:0001054,1,0.984056691977895,0,2,RNA polymerase I activity,MF,
382,GO:0001055,1,0.977151150549784,0,4,RNA polymerase II activity,MF,
383,GO:0001056,1,0.996716498344604,0,1,RNA polymerase III activity,MF,
385,GO:0001069,1,0.981171618435718,0,2,regulatory region RNA binding,MF,
386,GO:0001079,1,0.995877903634853,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
387,GO:0001080,1,0.995877903634853,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
388,GO:0001085,1,0.681982148727853,0,53,RNA polymerase II transcription factor binding,MF,
389,GO:0001091,1,0.873730383587829,0,19,RNA polymerase II general transcription initiation factor binding,MF,
390,GO:0001093,1,0.968764172701651,0,3,TFIIB-class transcription factor binding,MF,
391,GO:0001094,1,0.936838837388705,0,10,TFIID-class transcription factor complex binding,MF,
392,GO:0001096,1,0.988385438992116,0,2,TFIIF-class transcription factor complex binding,MF,
393,GO:0001097,1,0.982736305479369,0,2,TFIIH-class transcription factor complex binding,MF,
394,GO:0001098,1,0.688267263702885,0,56,basal transcription machinery binding,MF,
395,GO:0001099,1,0.688267263702885,0,56,basal RNA polymerase II transcription machinery binding,MF,
396,GO:0001100,1,0.994890876864838,0,1,negative regulation of exit from mitosis,BP,
398,GO:0001102,1,0.72866718176211,0,44,RNA polymerase II activating transcription factor binding,MF,
399,GO:0001103,1,0.79077870420571,0,35,RNA polymerase II repressing transcription factor binding,MF,
400,GO:0001112,1,0.994400032367371,0,1,DNA-templated transcription open complex formation,BP,
401,GO:0001113,1,0.994400032367371,0,1,transcription open complex formation at RNA polymerase II promoter,BP,
402,GO:0001120,1,0.994400032367371,0,1,protein-DNA complex remodeling,BP,
403,GO:0001139,1,0.992548516558088,0,2,RNA polymerase II complex recruiting activity,MF,
404,GO:0001147,1,0.973444932170159,0,2,transcription termination site sequence-specific DNA binding,MF,
405,GO:0001156,1,0.951316718314212,0,3,TFIIIC-class transcription factor complex binding,MF,
406,GO:0001161,1,0.927020027306234,0,14,intronic transcription regulatory region sequence-specific DNA binding,MF,
407,GO:0001162,1,0.937194162273546,0,12,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
408,GO:0001163,1,0.940249346056346,0,8,RNA polymerase I transcription regulatory region sequence-specific DNA binding,MF,
409,GO:0001164,1,0.940249346056346,0,8,RNA polymerase I core promoter sequence-specific DNA binding,MF,
410,GO:0001165,1,0.991236951940712,0,1,RNA polymerase I cis-regulatory region sequence-specific DNA binding,MF,
411,GO:0001172,1,0.979915192916939,0,2,transcription, RNA-templated,BP,
412,GO:0001173,1,0.992548516558088,0,2,DNA-templated transcriptional start site selection,BP,
413,GO:0001174,1,0.992548516558088,0,2,transcriptional start site selection at RNA polymerase II promoter,BP,
414,GO:0001179,1,0.996228569180991,0,1,RNA polymerase I general transcription initiation factor binding,MF,
415,GO:0001181,1,0.962926386125042,0,4,RNA polymerase I general transcription initiation factor activity,MF,
416,GO:0001188,1,0.936701075371191,0,9,RNA polymerase I preinitiation complex assembly,BP,
417,GO:0001192,1,0.996832399252931,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
418,GO:0001193,1,0.996832399252931,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
419,GO:0001216,1,0.0340370294055744,0,475,DNA-binding transcription activator activity,MF,
421,GO:0001221,1,0.660626279074415,0,49,transcription cofactor binding,MF,
422,GO:0001222,1,0.899207594499084,0,14,transcription corepressor binding,MF,
423,GO:0001223,1,0.767211036583275,0,28,transcription coactivator binding,MF,
424,GO:0001224,1,0.919177220522381,0,8,RNA polymerase II transcription cofactor binding,MF,
425,GO:0001225,1,0.927858341214743,0,6,RNA polymerase II transcription coactivator binding,MF,
426,GO:0001226,1,0.990650884156532,0,2,RNA polymerase II transcription corepressor binding,MF,
428,GO:0001228,1,0.0345639261233517,0,472,DNA-binding transcription activator activity, RNA polymerase II-specific,MF,
430,GO:0001302,1,0.960681011678238,0,6,replicative cell aging,BP,
431,GO:0001306,1,0.99678965917787,0,1,age-dependent response to oxidative stress,BP,
432,GO:0001315,1,0.99678965917787,0,1,age-dependent response to reactive oxygen species,BP,
433,GO:0001325,1,0.908098356603238,0,14,formation of extrachromosomal circular DNA,BP,
434,GO:0001401,1,0.943304766026429,0,11,SAM complex,CC,
435,GO:0001405,1,0.975370803568645,0,5,PAM complex, Tim23 associated import motor,CC,
437,GO:0001502,1,0.858440243892926,0,17,cartilage condensation,BP,
441,GO:0001507,1,0.989678284712688,0,2,acetylcholine catabolic process in synaptic cleft,BP,
443,GO:0001510,1,0.674068986733714,0,69,RNA methylation,BP,
444,GO:0001512,1,0.996746211301798,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
445,GO:0001514,1,0.944071579170005,0,8,selenocysteine incorporation,BP,
446,GO:0001515,1,0.984856824327216,0,4,opioid peptide activity,MF,
448,GO:0001517,1,0.95352083369243,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
449,GO:0001518,1,0.795730627857285,0,17,voltage-gated sodium channel complex,CC,
450,GO:0001519,1,0.992986227776736,0,1,peptide amidation,BP,
451,GO:0001520,1,0.979289180900086,0,3,outer dense fiber,CC,
452,GO:0001522,1,0.922618274157697,0,18,pseudouridine synthesis,BP,
453,GO:0001523,1,0.589476921193097,0,82,retinoid metabolic process,BP,
455,GO:0001527,1,0.906035609663819,0,10,microfibril,CC,
457,GO:0001532,1,0.993936837294832,0,1,interleukin-21 receptor activity,MF,
459,GO:0001534,1,0.982094874172577,0,4,radial spoke,CC,
460,GO:0001535,1,0.994884577363256,0,1,radial spoke head,CC,
461,GO:0001536,1,0.994890876864838,0,1,radial spoke stalk,CC,
462,GO:0001537,1,0.972961392779525,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
463,GO:0001539,1,0.483983863849376,0,96,cilium or flagellum-dependent cell motility,BP,
465,GO:0001541,1,0.725576859333125,0,50,ovarian follicle development,BP,
466,GO:0001542,1,0.914509297606512,0,9,ovulation from ovarian follicle,BP,
467,GO:0001543,1,0.985687175654892,0,1,ovarian follicle rupture,BP,
468,GO:0001544,1,0.981994510480436,0,2,initiation of primordial ovarian follicle growth,BP,
469,GO:0001545,1,0.992309519094027,0,1,primary ovarian follicle growth,BP,
470,GO:0001546,1,0.9881576270748,0,3,preantral ovarian follicle growth,BP,
471,GO:0001547,1,0.940275191028333,0,8,antral ovarian follicle growth,BP,
472,GO:0001550,1,0.976822002634892,0,3,ovarian cumulus expansion,BP,
473,GO:0001552,1,0.996139216548151,0,1,ovarian follicle atresia,BP,
474,GO:0001553,1,0.929738036544858,0,9,luteinization,BP,
475,GO:0001554,1,0.944183437432895,0,7,luteolysis,BP,
476,GO:0001555,1,0.985635570539,0,3,oocyte growth,BP,
477,GO:0001556,1,0.87193405212545,0,21,oocyte maturation,BP,
479,GO:0001560,1,0.96681485878528,0,3,regulation of cell growth by extracellular stimulus,BP,
480,GO:0001561,1,0.957113371992935,0,9,fatty acid alpha-oxidation,BP,
481,GO:0001562,1,0.863325124515516,0,25,response to protozoan,BP,
482,GO:0001567,1,0.996631457948612,0,1,cholesterol 25-hydroxylase activity,MF,
486,GO:0001572,1,0.990781423347301,0,1,lactosylceramide biosynthetic process,BP,
489,GO:0001575,1,0.995957405259747,0,1,globoside metabolic process,BP,
490,GO:0001576,1,0.995957405259747,0,1,globoside biosynthetic process,BP,
491,GO:0001578,1,0.50544146158694,0,86,microtubule bundle formation,BP,
492,GO:0001579,1,0.987933657062542,0,2,medium-chain fatty acid transport,BP,
493,GO:0001580,1,0.925272442336784,0,20,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
494,GO:0001581,1,0.99434202641678,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
495,GO:0001582,1,0.995255489379337,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
496,GO:0001587,1,0.990908969246756,0,1,Gq/11-coupled serotonin receptor activity,MF,
497,GO:0001588,1,0.989315074264752,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
498,GO:0001591,1,0.988251873093018,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
499,GO:0001595,1,0.989144315514077,0,3,angiotensin receptor activity,MF,
500,GO:0001596,1,0.995625296401021,0,1,angiotensin type I receptor activity,MF,
501,GO:0001601,1,0.984453286592536,0,3,peptide YY receptor activity,MF,
502,GO:0001602,1,0.991182246854971,0,2,pancreatic polypeptide receptor activity,MF,
503,GO:0001604,1,0.993301609123407,0,2,urotensin II receptor activity,MF,
504,GO:0001605,1,0.983989664163563,0,3,adrenomedullin receptor activity,MF,
505,GO:0001607,1,0.989943735924561,0,2,neuromedin U receptor activity,MF,
506,GO:0001609,1,0.982883941355984,0,4,G protein-coupled adenosine receptor activity,MF,
507,GO:0001614,1,0.915061762341272,0,20,purinergic nucleotide receptor activity,MF,
508,GO:0001618,1,0.640483811199394,0,65,virus receptor activity,MF,
509,GO:0001621,1,0.987209076042011,0,3,G protein-coupled ADP receptor activity,MF,
510,GO:0001626,1,0.99391471508194,0,1,nociceptin receptor activity,MF,
511,GO:0001631,1,0.991837485262607,0,2,cysteinyl leukotriene receptor activity,MF,
512,GO:0001632,1,0.990020063187792,0,2,leukotriene B4 receptor activity,MF,
513,GO:0001635,1,0.975684399054653,0,4,calcitonin gene-related peptide receptor activity,MF,
514,GO:0001637,1,0.888794553731285,0,25,G protein-coupled chemoattractant receptor activity,MF,
515,GO:0001640,1,0.937565692009808,0,7,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,MF,
516,GO:0001641,1,0.987046908146394,0,2,group II metabotropic glutamate receptor activity,MF,
517,GO:0001642,1,0.966538760917888,0,4,group III metabotropic glutamate receptor activity,MF,
519,GO:0001650,1,0.438915091560582,0,121,fibrillar center,CC,
520,GO:0001651,1,0.996734910369831,0,1,dense fibrillar component,CC,
521,GO:0001652,1,0.970255255007079,0,6,granular component,CC,
522,GO:0001653,1,0.517678900093793,0,132,peptide receptor activity,MF,
526,GO:0001657,1,0.492424908943401,0,93,ureteric bud development,BP,
527,GO:0001658,1,0.654811251095265,0,54,branching involved in ureteric bud morphogenesis,BP,
529,GO:0001660,1,0.943544527549206,0,9,fever generation,BP,
531,GO:0001662,1,0.773639985814379,0,39,behavioral fear response,BP,
533,GO:0001665,1,0.975250044580566,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
537,GO:0001671,1,0.890050404162005,0,24,ATPase activator activity,MF,
538,GO:0001672,1,0.811028822032236,0,23,regulation of chromatin assembly or disassembly,BP,
539,GO:0001673,1,0.934527039466919,0,10,male germ cell nucleus,CC,
540,GO:0001674,1,0.991325040229251,0,2,female germ cell nucleus,CC,
541,GO:0001675,1,0.923281407231065,0,10,acrosome assembly,BP,
542,GO:0001676,1,0.579252703380225,0,98,long-chain fatty acid metabolic process,BP,
544,GO:0001680,1,0.995699287977245,0,1,tRNA 3'-terminal CCA addition,BP,
545,GO:0001681,1,0.994756261266842,0,1,sialate O-acetylesterase activity,MF,
546,GO:0001682,1,0.946206162569736,0,12,tRNA 5'-leader removal,BP,
547,GO:0001691,1,0.98755896532316,0,2,pseudophosphatase activity,MF,
548,GO:0001692,1,0.972553065831286,0,5,histamine metabolic process,BP,
549,GO:0001694,1,0.995495011965105,0,1,histamine biosynthetic process,BP,
550,GO:0001695,1,0.996824453654078,0,1,histamine catabolic process,BP,
551,GO:0001696,1,0.913837114404102,0,16,gastric acid secretion,BP,
552,GO:0001697,1,0.994797503619085,0,1,histamine-induced gastric acid secretion,BP,
553,GO:0001698,1,0.994797503619085,0,1,gastrin-induced gastric acid secretion,BP,
555,GO:0001702,1,0.800400739597233,0,24,gastrulation with mouth forming second,BP,
557,GO:0001705,1,0.981500595506654,0,3,ectoderm formation,BP,
559,GO:0001707,1,0.637579860505814,0,63,mesoderm formation,BP,
561,GO:0001709,1,0.768835796871557,0,39,cell fate determination,BP,
562,GO:0001710,1,0.919927620921942,0,16,mesodermal cell fate commitment,BP,
563,GO:0001711,1,0.923841482485529,0,14,endodermal cell fate commitment,BP,
564,GO:0001712,1,0.981500595506654,0,3,ectodermal cell fate commitment,BP,
565,GO:0001714,1,0.971837733100108,0,7,endodermal cell fate specification,BP,
566,GO:0001715,1,0.99274163979786,0,1,ectodermal cell fate specification,BP,
567,GO:0001716,1,0.996000370462797,0,1,L-amino-acid oxidase activity,MF,
568,GO:0001725,1,0.591782291515053,0,62,stress fiber,CC,
570,GO:0001727,1,0.957289415046237,0,6,lipid kinase activity,MF,
571,GO:0001729,1,0.986132839198993,0,2,ceramide kinase activity,MF,
572,GO:0001730,1,0.977371849952325,0,3,2'-5'-oligoadenylate synthetase activity,MF,
573,GO:0001731,1,0.92711255423988,0,10,formation of translation preinitiation complex,BP,
574,GO:0001732,1,0.929238960770856,0,15,formation of cytoplasmic translation initiation complex,BP,
575,GO:0001733,1,0.982130340359506,0,4,galactosylceramide sulfotransferase activity,MF,
576,GO:0001734,1,0.991027571230058,0,2,mRNA (N6-adenosine)-methyltransferase activity,MF,
577,GO:0001735,1,0.985015854865441,0,2,prenylcysteine oxidase activity,MF,
580,GO:0001739,1,0.977128178885909,0,4,sex chromatin,CC,
581,GO:0001740,1,0.978624516051589,0,2,Barr body,CC,
582,GO:0001741,1,0.934058178622274,0,11,XY body,CC,
583,GO:0001743,1,0.981334487789533,0,2,optic placode formation,BP,
586,GO:0001755,1,0.645562772685755,0,55,neural crest cell migration,BP,
587,GO:0001756,1,0.609418727386077,0,61,somitogenesis,BP,
588,GO:0001757,1,0.97214118515216,0,5,somite specification,BP,
589,GO:0001758,1,0.965765359304891,0,8,retinal dehydrogenase activity,MF,
590,GO:0001759,1,0.866932602360971,0,23,organ induction,BP,
591,GO:0001760,1,0.996695800687134,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
595,GO:0001766,1,0.976743292593468,0,4,membrane raft polarization,BP,
596,GO:0001767,1,0.906834561201897,0,12,establishment of lymphocyte polarity,BP,
597,GO:0001768,1,0.91923656623206,0,11,establishment of T cell polarity,BP,
598,GO:0001770,1,0.986519620473538,0,1,establishment of natural killer cell polarity,BP,
599,GO:0001771,1,0.914629665551062,0,14,immunological synapse formation,BP,
600,GO:0001772,1,0.781530300277862,0,38,immunological synapse,CC,
601,GO:0001773,1,0.858059443332044,0,27,myeloid dendritic cell activation,BP,
602,GO:0001774,1,0.748613646809684,0,42,microglial cell activation,BP,
605,GO:0001777,1,0.98761346601743,0,3,T cell homeostatic proliferation,BP,
606,GO:0001778,1,0.898920220994159,0,12,plasma membrane repair,BP,
607,GO:0001779,1,0.871112895627394,0,20,natural killer cell differentiation,BP,
610,GO:0001782,1,0.815782120335759,0,28,B cell homeostasis,BP,
611,GO:0001783,1,0.858590442011394,0,24,B cell apoptotic process,BP,
613,GO:0001785,1,0.989497590344194,0,2,prostaglandin J receptor activity,MF,
615,GO:0001787,1,0.954433849544649,0,9,natural killer cell proliferation,BP,
616,GO:0001788,1,0.992888413209454,0,2,antibody-dependent cellular cytotoxicity,BP,
617,GO:0001791,1,0.990269041651773,0,2,IgM binding,MF,
618,GO:0001792,1,0.991852799152899,0,1,polymeric immunoglobulin receptor activity,MF,
619,GO:0001794,1,0.980052253343581,0,4,type IIa hypersensitivity,BP,
620,GO:0001796,1,0.980052253343581,0,4,regulation of type IIa hypersensitivity,BP,
621,GO:0001797,1,0.996468965415065,0,1,negative regulation of type IIa hypersensitivity,BP,
622,GO:0001798,1,0.983525694401706,0,3,positive regulation of type IIa hypersensitivity,BP,
623,GO:0001802,1,0.992039278071032,0,2,type III hypersensitivity,BP,
624,GO:0001803,1,0.992039278071032,0,2,regulation of type III hypersensitivity,BP,
625,GO:0001805,1,0.992039278071032,0,2,positive regulation of type III hypersensitivity,BP,
626,GO:0001806,1,0.98257629279671,0,4,type IV hypersensitivity,BP,
627,GO:0001807,1,0.988178594767682,0,3,regulation of type IV hypersensitivity,BP,
628,GO:0001808,1,0.996017390618282,0,1,negative regulation of type IV hypersensitivity,BP,
629,GO:0001809,1,0.996620088484601,0,1,positive regulation of type IV hypersensitivity,BP,
630,GO:0001810,1,0.98853607225426,0,3,regulation of type I hypersensitivity,BP,
631,GO:0001811,1,0.996468965415065,0,1,negative regulation of type I hypersensitivity,BP,
632,GO:0001812,1,0.992039278071032,0,2,positive regulation of type I hypersensitivity,BP,
633,GO:0001813,1,0.992888413209454,0,2,regulation of antibody-dependent cellular cytotoxicity,BP,
634,GO:0001814,1,0.996468965415065,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
635,GO:0001815,1,0.99640688748682,0,1,positive regulation of antibody-dependent cellular cytotoxicity,BP,
640,GO:0001820,1,0.93891909147942,0,11,serotonin secretion,BP,
641,GO:0001821,1,0.956914078236435,0,10,histamine secretion,BP,
643,GO:0001823,1,0.474580728709053,0,97,mesonephros development,BP,
644,GO:0001824,1,0.551612342056554,0,92,blastocyst development,BP,
645,GO:0001825,1,0.806890063606959,0,34,blastocyst formation,BP,
646,GO:0001826,1,0.956221817915745,0,5,inner cell mass cell differentiation,BP,
647,GO:0001827,1,0.990897175595521,0,1,inner cell mass cell fate commitment,BP,
648,GO:0001828,1,0.986532016735677,0,2,inner cell mass cellular morphogenesis,BP,
649,GO:0001829,1,0.926007113823613,0,12,trophectodermal cell differentiation,BP,
650,GO:0001831,1,0.983074979346237,0,2,trophectodermal cellular morphogenesis,BP,
651,GO:0001832,1,0.855415946911481,0,19,blastocyst growth,BP,
652,GO:0001833,1,0.909089592622126,0,13,inner cell mass cell proliferation,BP,
653,GO:0001834,1,0.965151968070538,0,3,trophectodermal cell proliferation,BP,
654,GO:0001835,1,0.850403525699969,0,26,blastocyst hatching,BP,
655,GO:0001836,1,0.749655940846339,0,57,release of cytochrome c from mitochondria,BP,
658,GO:0001839,1,0.959875170464106,0,6,neural plate morphogenesis,BP,
659,GO:0001840,1,0.928286928959406,0,9,neural plate development,BP,
661,GO:0001842,1,0.954724146628035,0,7,neural fold formation,BP,
663,GO:0001844,1,0.849842180693363,0,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
664,GO:0001845,1,0.917208746750249,0,14,phagolysosome assembly,BP,
665,GO:0001846,1,0.899938430108379,0,13,opsonin binding,MF,
666,GO:0001847,1,0.969858259375696,0,4,opsonin receptor activity,MF,
667,GO:0001848,1,0.874248013658549,0,17,complement binding,MF,
668,GO:0001849,1,0.952158809835076,0,6,complement component C1q complex binding,MF,
669,GO:0001850,1,0.996263518456062,0,1,complement component C3a binding,MF,
670,GO:0001851,1,0.961225206692198,0,5,complement component C3b binding,MF,
671,GO:0001855,1,0.979145630535854,0,2,complement component C4b binding,MF,
672,GO:0001856,1,0.995607242035168,0,1,complement component C5a binding,MF,
673,GO:0001861,1,0.982599387937213,0,1,complement component C4b receptor activity,MF,
674,GO:0001865,1,0.930886714153559,0,10,NK T cell differentiation,BP,
675,GO:0001866,1,0.969514990535838,0,6,NK T cell proliferation,BP,
676,GO:0001867,1,0.958480777017179,0,9,complement activation, lectin pathway,BP,
677,GO:0001868,1,0.987270834016319,0,2,regulation of complement activation, lectin pathway,BP,
678,GO:0001869,1,0.987270834016319,0,2,negative regulation of complement activation, lectin pathway,BP,
679,GO:0001872,1,0.991638010046182,0,2,(1->3)-beta-D-glucan binding,MF,
680,GO:0001875,1,0.967329308503975,0,5,lipopolysaccharide immune receptor activity,MF,
681,GO:0001878,1,0.982754425347648,0,4,response to yeast,BP,
682,GO:0001880,1,0.976083936427746,0,3,Mullerian duct regression,BP,
686,GO:0001885,1,0.620485817366267,0,61,endothelial cell development,BP,
687,GO:0001886,1,0.895723618519198,0,12,endothelial cell morphogenesis,BP,
688,GO:0001887,1,0.977798252858404,0,4,selenium compound metabolic process,BP,
689,GO:0001888,1,0.982972772932684,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
697,GO:0001905,1,0.969111016927602,0,3,activation of membrane attack complex,BP,
699,GO:0001907,1,0.984082806793767,0,3,killing by symbiont of host cells,BP,
700,GO:0001909,1,0.623270863310503,0,92,leukocyte mediated cytotoxicity,BP,
701,GO:0001910,1,0.722284204100539,0,65,regulation of leukocyte mediated cytotoxicity,BP,
702,GO:0001911,1,0.916499884470662,0,19,negative regulation of leukocyte mediated cytotoxicity,BP,
703,GO:0001912,1,0.795006259048279,0,44,positive regulation of leukocyte mediated cytotoxicity,BP,
704,GO:0001913,1,0.833981495250301,0,37,T cell mediated cytotoxicity,BP,
705,GO:0001914,1,0.872391464898345,0,29,regulation of T cell mediated cytotoxicity,BP,
706,GO:0001915,1,0.962575948222098,0,7,negative regulation of T cell mediated cytotoxicity,BP,
707,GO:0001916,1,0.900901908754863,0,22,positive regulation of T cell mediated cytotoxicity,BP,
709,GO:0001918,1,0.994852977708029,0,1,farnesylated protein binding,MF,
711,GO:0001920,1,0.977789891778899,0,4,negative regulation of receptor recycling,BP,
713,GO:0001922,1,0.973398992193963,0,3,B-1 B cell homeostasis,BP,
714,GO:0001923,1,0.969713294124662,0,5,B-1 B cell differentiation,BP,
715,GO:0001927,1,0.995725428858656,0,1,exocyst assembly,BP,
716,GO:0001928,1,0.995725428858656,0,1,regulation of exocyst assembly,BP,
717,GO:0001931,1,0.91882680036155,0,13,uropod,CC,
721,GO:0001935,1,0.376312924211642,0,134,endothelial cell proliferation,BP,
722,GO:0001936,1,0.412010767401997,0,119,regulation of endothelial cell proliferation,BP,
723,GO:0001937,1,0.76257745477792,0,36,negative regulation of endothelial cell proliferation,BP,
724,GO:0001938,1,0.521942326703175,0,86,positive regulation of endothelial cell proliferation,BP,
725,GO:0001939,1,0.938797143247248,0,7,female pronucleus,CC,
726,GO:0001940,1,0.95161535012874,0,5,male pronucleus,CC,
728,GO:0001942,1,0.542012574950483,0,80,hair follicle development,BP,
732,GO:0001947,1,0.647082111963102,0,60,heart looping,BP,
733,GO:0001949,1,0.995469875416489,0,1,sebaceous gland cell differentiation,BP,
734,GO:0001951,1,0.982203512005441,0,3,intestinal D-glucose absorption,BP,
737,GO:0001954,1,0.65089910311725,0,53,positive regulation of cell-matrix adhesion,BP,
738,GO:0001955,1,0.941601879240074,0,8,blood vessel maturation,BP,
743,GO:0001960,1,0.728358549845273,0,50,negative regulation of cytokine-mediated signaling pathway,BP,
744,GO:0001961,1,0.742998709967063,0,47,positive regulation of cytokine-mediated signaling pathway,BP,
745,GO:0001963,1,0.872984172065149,0,26,synaptic transmission, dopaminergic,BP,
747,GO:0001965,1,0.848142269589837,0,24,G-protein alpha-subunit binding,MF,
748,GO:0001966,1,0.980219964990473,0,2,thigmotaxis,BP,
750,GO:0001968,1,0.82635251045074,0,25,fibronectin binding,MF,
751,GO:0001969,1,0.969111016927602,0,3,regulation of activation of membrane attack complex,BP,
752,GO:0001970,1,0.983387474896837,0,2,positive regulation of activation of membrane attack complex,BP,
753,GO:0001971,1,0.985484775700309,0,1,negative regulation of activation of membrane attack complex,BP,
754,GO:0001972,1,0.910954890665553,0,14,retinoic acid binding,MF,
755,GO:0001973,1,0.940116377337864,0,11,G protein-coupled adenosine receptor signaling pathway,BP,
758,GO:0001976,1,0.93495260700597,0,10,nervous system process involved in regulation of systemic arterial blood pressure,BP,
759,GO:0001977,1,0.934279686291239,0,12,renal system process involved in regulation of blood volume,BP,
760,GO:0001978,1,0.995832126484585,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
761,GO:0001979,1,0.996388574651171,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
762,GO:0001980,1,0.996839340062039,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
763,GO:0001983,1,0.995832126484585,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
764,GO:0001985,1,0.995832126484585,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
765,GO:0001990,1,0.845754344347925,0,31,regulation of systemic arterial blood pressure by hormone,BP,
766,GO:0001991,1,0.923869756916424,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
767,GO:0001992,1,0.976028819560935,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
768,GO:0001993,1,0.950122619038378,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
769,GO:0001994,1,0.99140747246464,0,2,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
770,GO:0001996,1,0.962880638472899,0,6,positive regulation of heart rate by epinephrine-norepinephrine,BP,
771,GO:0001997,1,0.990586174177342,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
772,GO:0001998,1,0.9961644315838,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
773,GO:0001999,1,0.972847628515514,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
774,GO:0002001,1,0.972847628515514,0,5,renin secretion into blood stream,BP,
775,GO:0002002,1,0.949668665722169,0,9,regulation of angiotensin levels in blood,BP,
776,GO:0002003,1,0.949668665722169,0,9,angiotensin maturation,BP,
777,GO:0002007,1,0.996388574651171,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
780,GO:0002016,1,0.971686120259208,0,6,regulation of blood volume by renin-angiotensin,BP,
781,GO:0002017,1,0.996207935943619,0,1,regulation of blood volume by renal aldosterone,BP,
782,GO:0002018,1,0.990867950370049,0,2,renin-angiotensin regulation of aldosterone production,BP,
783,GO:0002019,1,0.985895234019796,0,3,regulation of renal output by angiotensin,BP,
787,GO:0002024,1,0.934753479615938,0,9,diet induced thermogenesis,BP,
788,GO:0002025,1,0.985937658076247,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
791,GO:0002028,1,0.528946719323132,0,85,regulation of sodium ion transport,BP,
793,GO:0002030,1,0.99464314001561,0,1,inhibitory G protein-coupled receptor phosphorylation,BP,
795,GO:0002032,1,0.99221891331899,0,2,desensitization of G protein-coupled receptor signaling pathway by arrestin,BP,
796,GO:0002034,1,0.982834350766139,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
797,GO:0002035,1,0.988671861748243,0,2,brain renin-angiotensin system,BP,
798,GO:0002036,1,0.951253233081687,0,6,regulation of L-glutamate import across plasma membrane,BP,
799,GO:0002037,1,0.995911421694241,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
800,GO:0002038,1,0.977147296788351,0,3,positive regulation of L-glutamate import across plasma membrane,BP,
801,GO:0002039,1,0.614667873114518,0,63,p53 binding,MF,
804,GO:0002043,1,0.871386906721426,0,19,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
805,GO:0002046,1,0.992850271766401,0,2,opsin binding,MF,
806,GO:0002051,1,0.956526010820401,0,4,osteoblast fate commitment,BP,
807,GO:0002052,1,0.839970812125935,0,23,positive regulation of neuroblast proliferation,BP,
808,GO:0002053,1,0.839729841399008,0,25,positive regulation of mesenchymal cell proliferation,BP,
809,GO:0002054,1,0.977495314751787,0,5,nucleobase binding,MF,
810,GO:0002055,1,0.996859833881271,0,1,adenine binding,MF,
811,GO:0002058,1,0.990147960378247,0,2,uracil binding,MF,
812,GO:0002059,1,0.995907428906688,0,1,thymine binding,MF,
813,GO:0002060,1,0.987222720150841,0,3,purine nucleobase binding,MF,
814,GO:0002061,1,0.990147960378247,0,2,pyrimidine nucleobase binding,MF,
816,GO:0002063,1,0.793442682291781,0,28,chondrocyte development,BP,
819,GO:0002066,1,0.662205778192854,0,56,columnar/cuboidal epithelial cell development,BP,
820,GO:0002067,1,0.731976714379295,0,45,glandular epithelial cell differentiation,BP,
821,GO:0002068,1,0.826943652756086,0,25,glandular epithelial cell development,BP,
822,GO:0002069,1,0.972638132496624,0,6,columnar/cuboidal epithelial cell maturation,BP,
823,GO:0002070,1,0.903867981213545,0,15,epithelial cell maturation,BP,
824,GO:0002071,1,0.990990701571002,0,2,glandular epithelial cell maturation,BP,
825,GO:0002072,1,0.921754661492749,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
826,GO:0002074,1,0.961040109140482,0,4,extraocular skeletal muscle development,BP,
827,GO:0002076,1,0.868168691721819,0,19,osteoblast development,BP,
828,GO:0002077,1,0.996633224740096,0,1,acrosome matrix dispersal,BP,
829,GO:0002079,1,0.975735960644177,0,3,inner acrosomal membrane,CC,
830,GO:0002080,1,0.903904254299701,0,18,acrosomal membrane,CC,
831,GO:0002081,1,0.977750852479164,0,3,outer acrosomal membrane,CC,
832,GO:0002082,1,0.876098105086752,0,26,regulation of oxidative phosphorylation,BP,
833,GO:0002083,1,0.996439673106619,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
834,GO:0002084,1,0.955185969027224,0,9,protein depalmitoylation,BP,
835,GO:0002085,1,0.966059154473967,0,5,inhibition of neuroepithelial cell differentiation,BP,
836,GO:0002086,1,0.990132575986701,0,2,diaphragm contraction,BP,
837,GO:0002087,1,0.91724467309866,0,12,regulation of respiratory gaseous exchange by nervous system process,BP,
839,GO:0002089,1,0.847513156107183,0,18,lens morphogenesis in camera-type eye,BP,
841,GO:0002091,1,0.924036220844905,0,13,negative regulation of receptor internalization,BP,
842,GO:0002092,1,0.839968320862976,0,23,positive regulation of receptor internalization,BP,
843,GO:0002093,1,0.917796402814996,0,12,auditory receptor cell morphogenesis,BP,
844,GO:0002094,1,0.990332655021575,0,2,polyprenyltransferase activity,MF,
845,GO:0002095,1,0.98915638455126,0,2,caveolar macromolecular signaling complex,CC,
846,GO:0002096,1,0.984699011789565,0,2,polkadots,CC,
847,GO:0002097,1,0.907326018277752,0,19,tRNA wobble base modification,BP,
848,GO:0002098,1,0.92914468893463,0,15,tRNA wobble uridine modification,BP,
849,GO:0002100,1,0.98459149293044,0,2,tRNA wobble adenosine to inosine editing,BP,
850,GO:0002101,1,0.991818225517046,0,2,tRNA wobble cytosine modification,BP,
851,GO:0002102,1,0.793881654588834,0,29,podosome,CC,
852,GO:0002112,1,0.995107740824499,0,1,interleukin-33 receptor binding,MF,
853,GO:0002113,1,0.995684650811585,0,1,interleukin-33 binding,MF,
854,GO:0002114,1,0.988535012442972,0,2,interleukin-33 receptor activity,MF,
855,GO:0002115,1,0.885899736315591,0,18,store-operated calcium entry,BP,
856,GO:0002116,1,0.874332442970524,0,11,semaphorin receptor complex,CC,
857,GO:0002118,1,0.967191742645872,0,6,aggressive behavior,BP,
858,GO:0002121,1,0.987780220098278,0,2,inter-male aggressive behavior,BP,
859,GO:0002125,1,0.988394709878007,0,2,maternal aggressive behavior,BP,
860,GO:0002127,1,0.996591902128887,0,1,tRNA wobble base cytosine methylation,BP,
861,GO:0002128,1,0.99611822932062,0,1,tRNA nucleoside ribose methylation,BP,
862,GO:0002133,1,0.965470107535703,0,2,polycystin complex,CC,
863,GO:0002134,1,0.984563147640257,0,2,UTP binding,MF,
864,GO:0002135,1,0.995278800867257,0,1,CTP binding,MF,
865,GO:0002138,1,0.961801514787636,0,8,retinoic acid biosynthetic process,BP,
866,GO:0002139,1,0.946505453000647,0,5,stereocilia coupling link,CC,
867,GO:0002140,1,0.985995144371306,0,1,stereocilia tip link,CC,
868,GO:0002141,1,0.959954924572116,0,4,stereocilia ankle link,CC,
869,GO:0002142,1,0.959954924572116,0,4,stereocilia ankle link complex,CC,
870,GO:0002143,1,0.98395474729621,0,4,tRNA wobble position uridine thiolation,BP,
871,GO:0002144,1,0.995937833717985,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
872,GO:0002148,1,0.994026971364893,0,1,hypochlorous acid metabolic process,BP,
873,GO:0002149,1,0.994026971364893,0,1,hypochlorous acid biosynthetic process,BP,
875,GO:0002152,1,0.993615124228356,0,1,bile acid conjugation,BP,
876,GO:0002153,1,0.992563376773694,0,2,steroid receptor RNA activator RNA binding,MF,
877,GO:0002154,1,0.949609305211767,0,5,thyroid hormone mediated signaling pathway,BP,
878,GO:0002155,1,0.978303311173848,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
879,GO:0002158,1,0.966730748558256,0,6,osteoclast proliferation,BP,
880,GO:0002159,1,0.964167307859165,0,4,desmosome assembly,BP,
881,GO:0002161,1,0.9535196718914,0,8,aminoacyl-tRNA editing activity,MF,
882,GO:0002162,1,0.905628725266332,0,9,dystroglycan binding,MF,
883,GO:0002169,1,0.988390804671299,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
884,GO:0002174,1,0.994583065162764,0,1,mammary stem cell proliferation,BP,
885,GO:0002175,1,0.954618576851171,0,5,protein localization to paranode region of axon,BP,
886,GO:0002176,1,0.976186878386897,0,6,male germ cell proliferation,BP,
887,GO:0002177,1,0.952720863971922,0,8,manchette,CC,
888,GO:0002178,1,0.940538730448342,0,11,palmitoyltransferase complex,CC,
889,GO:0002181,1,0.611128618793351,0,96,cytoplasmic translation,BP,
890,GO:0002182,1,0.94410327619797,0,9,cytoplasmic translational elongation,BP,
891,GO:0002183,1,0.826218413440894,0,33,cytoplasmic translational initiation,BP,
892,GO:0002184,1,0.974422420358221,0,3,cytoplasmic translational termination,BP,
893,GO:0002188,1,0.966469339117925,0,3,translation reinitiation,BP,
894,GO:0002189,1,0.983023038846317,0,4,ribose phosphate diphosphokinase complex,CC,
895,GO:0002190,1,0.980502135566638,0,5,cap-independent translational initiation,BP,
896,GO:0002191,1,0.982356537507198,0,3,cap-dependent translational initiation,BP,
897,GO:0002192,1,0.993285302449125,0,2,IRES-dependent translational initiation of linear mRNA,BP,
898,GO:0002193,1,0.967545285516709,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
899,GO:0002194,1,0.994328439527581,0,1,hepatocyte cell migration,BP,
900,GO:0002196,1,0.996187491161553,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
901,GO:0002199,1,0.974886908527458,0,6,zona pellucida receptor complex,CC,
902,GO:0002200,1,0.625854622820428,0,64,somatic diversification of immune receptors,BP,
903,GO:0002204,1,0.757871840133272,0,43,somatic recombination of immunoglobulin genes involved in immune response,BP,
904,GO:0002208,1,0.757871840133272,0,43,somatic diversification of immunoglobulins involved in immune response,BP,
905,GO:0002209,1,0.760863134290094,0,40,behavioral defense response,BP,
906,GO:0002215,1,0.993482673451939,0,1,defense response to nematode,BP,
907,GO:0002218,1,0.452103584748275,0,124,activation of innate immune response,BP,
908,GO:0002220,1,0.540853422315157,0,100,innate immune response activating cell surface receptor signaling pathway,BP,
910,GO:0002223,1,0.546854423075972,0,97,stimulatory C-type lectin receptor signaling pathway,BP,
912,GO:0002225,1,0.992765314648126,0,2,positive regulation of antimicrobial peptide production,BP,
914,GO:0002228,1,0.740236355771198,0,56,natural killer cell mediated immunity,BP,
915,GO:0002230,1,0.85953612359776,0,23,positive regulation of defense response to virus by host,BP,
916,GO:0002232,1,0.974998691331013,0,6,leukocyte chemotaxis involved in inflammatory response,BP,
918,GO:0002238,1,0.976074084177313,0,4,response to molecule of fungal origin,BP,
919,GO:0002244,1,0.353220823081351,0,163,hematopoietic progenitor cell differentiation,BP,
922,GO:0002249,1,0.97353369436886,0,5,lymphocyte anergy,BP,
927,GO:0002254,1,0.98761479958311,0,3,kinin cascade,BP,
928,GO:0002260,1,0.679227341003632,0,59,lymphocyte homeostasis,BP,
931,GO:0002265,1,0.952028024393143,0,4,astrocyte activation involved in immune response,BP,
932,GO:0002266,1,0.987079453881058,0,3,follicular dendritic cell activation,BP,
933,GO:0002268,1,0.990577549333236,0,2,follicular dendritic cell differentiation,BP,
934,GO:0002269,1,0.748613646809684,0,42,leukocyte activation involved in inflammatory response,BP,
935,GO:0002270,1,0.996077722109172,0,1,plasmacytoid dendritic cell activation,BP,
938,GO:0002276,1,0.986184918929118,0,2,basophil activation involved in immune response,BP,
939,GO:0002277,1,0.981250750140166,0,3,myeloid dendritic cell activation involved in immune response,BP,
940,GO:0002278,1,0.982644390676801,0,4,eosinophil activation involved in immune response,BP,
942,GO:0002280,1,0.978390116903392,0,2,monocyte activation involved in immune response,BP,
943,GO:0002281,1,0.916405920659438,0,14,macrophage activation involved in immune response,BP,
944,GO:0002282,1,0.984505742678524,0,4,microglial cell activation involved in immune response,BP,
949,GO:0002290,1,0.994717530295309,0,1,gamma-delta T cell activation involved in immune response,BP,
950,GO:0002291,1,0.948925997972014,0,10,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
954,GO:0002295,1,0.908138026194092,0,14,T-helper cell lineage commitment,BP,
955,GO:0002296,1,0.963314962022139,0,3,T-helper 1 cell lineage commitment,BP,
956,GO:0002298,1,0.996413039573279,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
957,GO:0002299,1,0.996503522295109,0,1,alpha-beta intraepithelial T cell differentiation,BP,
958,GO:0002300,1,0.996503522295109,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
959,GO:0002302,1,0.994951711571553,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
960,GO:0002304,1,0.996503522295109,0,1,gamma-delta intraepithelial T cell differentiation,BP,
961,GO:0002305,1,0.996503522295109,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
962,GO:0002309,1,0.979644898955064,0,4,T cell proliferation involved in immune response,BP,
963,GO:0002312,1,0.640923086600151,0,68,B cell activation involved in immune response,BP,
964,GO:0002313,1,0.882926522716559,0,19,mature B cell differentiation involved in immune response,BP,
965,GO:0002314,1,0.976458987132515,0,5,germinal center B cell differentiation,BP,
966,GO:0002315,1,0.921514602712603,0,9,marginal zone B cell differentiation,BP,
967,GO:0002316,1,0.988372474091301,0,2,follicular B cell differentiation,BP,
968,GO:0002317,1,0.98953170166378,0,3,plasma cell differentiation,BP,
969,GO:0002318,1,0.967537086895715,0,5,myeloid progenitor cell differentiation,BP,
970,GO:0002320,1,0.849555606885588,0,20,lymphoid progenitor cell differentiation,BP,
971,GO:0002322,1,0.958319443747726,0,6,B cell proliferation involved in immune response,BP,
972,GO:0002323,1,0.951365515568401,0,9,natural killer cell activation involved in immune response,BP,
973,GO:0002325,1,0.993253187356942,0,2,natural killer cell differentiation involved in immune response,BP,
974,GO:0002326,1,0.950434054402097,0,5,B cell lineage commitment,BP,
975,GO:0002327,1,0.903678615572008,0,9,immature B cell differentiation,BP,
976,GO:0002328,1,0.891270489157153,0,11,pro-B cell differentiation,BP,
977,GO:0002329,1,0.948175914890953,0,4,pre-B cell differentiation,BP,
978,GO:0002331,1,0.967371439826836,0,2,pre-B cell allelic exclusion,BP,
979,GO:0002332,1,0.98920666255267,0,1,transitional stage B cell differentiation,BP,
980,GO:0002333,1,0.98920666255267,0,1,transitional one stage B cell differentiation,BP,
981,GO:0002335,1,0.848787220832966,0,25,mature B cell differentiation,BP,
982,GO:0002336,1,0.993872389007951,0,1,B-1 B cell lineage commitment,BP,
983,GO:0002337,1,0.98901226564018,0,2,B-1a B cell differentiation,BP,
984,GO:0002339,1,0.98785591411355,0,3,B cell selection,BP,
985,GO:0002343,1,0.995143849625378,0,1,peripheral B cell selection,BP,
986,GO:0002344,1,0.995143849625378,0,1,B cell affinity maturation,BP,
987,GO:0002347,1,0.902603849518648,0,21,response to tumor cell,BP,
988,GO:0002349,1,0.969861255057816,0,7,histamine production involved in inflammatory response,BP,
989,GO:0002351,1,0.982046821790093,0,3,serotonin production involved in inflammatory response,BP,
990,GO:0002352,1,0.99267685694229,0,2,B cell negative selection,BP,
991,GO:0002353,1,0.98761479958311,0,3,plasma kallikrein-kinin cascade,BP,
992,GO:0002355,1,0.995473027856283,0,1,detection of tumor cell,BP,
993,GO:0002357,1,0.985185293146742,0,3,defense response to tumor cell,BP,
994,GO:0002358,1,0.996846220865447,0,1,B cell homeostatic proliferation,BP,
995,GO:0002360,1,0.836888538545502,0,24,T cell lineage commitment,BP,
996,GO:0002361,1,0.975063044423555,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
997,GO:0002362,1,0.987792090554077,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
998,GO:0002363,1,0.882566398905887,0,19,alpha-beta T cell lineage commitment,BP,
999,GO:0002364,1,0.99214620290163,0,1,NK T cell lineage commitment,BP,
1002,GO:0002368,1,0.990805064719765,0,2,B cell cytokine production,BP,
1003,GO:0002369,1,0.810546489647921,0,39,T cell cytokine production,BP,
1004,GO:0002370,1,0.966064241330626,0,8,natural killer cell cytokine production,BP,
1005,GO:0002371,1,0.896275560632903,0,13,dendritic cell cytokine production,BP,
1006,GO:0002372,1,0.945949629510639,0,6,myeloid dendritic cell cytokine production,BP,
1007,GO:0002373,1,0.996815376007367,0,1,plasmacytoid dendritic cell cytokine production,BP,
1008,GO:0002374,1,0.971760001023767,0,4,cytokine secretion involved in immune response,BP,
1010,GO:0002377,1,0.54814902446034,0,100,immunoglobulin production,BP,
1011,GO:0002378,1,0.973387211055925,0,4,immunoglobulin biosynthetic process,BP,
1012,GO:0002379,1,0.996430763181575,0,1,immunoglobulin biosynthetic process involved in immune response,BP,
1013,GO:0002380,1,0.991410205764241,0,1,immunoglobulin secretion involved in immune response,BP,
1014,GO:0002381,1,0.728588894827361,0,51,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1015,GO:0002383,1,0.996430763181575,0,1,immune response in brain or nervous system,BP,
1016,GO:0002384,1,0.988903542147107,0,2,hepatic immune response,BP,
1018,GO:0002386,1,0.98804309168583,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1019,GO:0002396,1,0.973042579245217,0,7,MHC protein complex assembly,BP,
1020,GO:0002397,1,0.992456980687471,0,2,MHC class I protein complex assembly,BP,
1021,GO:0002398,1,0.993453831522747,0,1,MHC class Ib protein complex assembly,BP,
1022,GO:0002399,1,0.986900786050355,0,4,MHC class II protein complex assembly,BP,
1023,GO:0002407,1,0.877445602748263,0,23,dendritic cell chemotaxis,BP,
1024,GO:0002408,1,0.979167833329803,0,4,myeloid dendritic cell chemotaxis,BP,
1025,GO:0002413,1,0.996519718586635,0,1,tolerance induction to tumor cell,BP,
1026,GO:0002414,1,0.984416028419155,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1027,GO:0002415,1,0.98804309168583,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1028,GO:0002416,1,0.996329485399528,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1029,GO:0002418,1,0.917779136839503,0,17,immune response to tumor cell,BP,
1030,GO:0002419,1,0.988490656422384,0,3,T cell mediated cytotoxicity directed against tumor cell target,BP,
1031,GO:0002420,1,0.965792506923374,0,6,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1032,GO:0002423,1,0.962415563472807,0,7,natural killer cell mediated immune response to tumor cell,BP,
1033,GO:0002424,1,0.969926854240337,0,6,T cell mediated immune response to tumor cell,BP,
1034,GO:0002426,1,0.996711635262835,0,1,immunoglobulin production in mucosal tissue,BP,
1035,GO:0002428,1,0.975674460045883,0,6,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1036,GO:0002429,1,0.126998291757652,0,335,immune response-activating cell surface receptor signaling pathway,BP,
1037,GO:0002430,1,0.936772764182362,0,10,complement receptor mediated signaling pathway,BP,
1038,GO:0002431,1,0.581013598445152,0,81,Fc receptor mediated stimulatory signaling pathway,BP,
1039,GO:0002432,1,0.99157641114913,0,1,granuloma formation,BP,
1040,GO:0002433,1,0.599957710242831,0,75,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1041,GO:0002434,1,0.98287518222828,0,4,immune complex clearance,BP,
1042,GO:0002436,1,0.988062399489242,0,3,immune complex clearance by monocytes and macrophages,BP,
1043,GO:0002437,1,0.766628496984366,0,49,inflammatory response to antigenic stimulus,BP,
1044,GO:0002438,1,0.898015484696553,0,22,acute inflammatory response to antigenic stimulus,BP,
1045,GO:0002439,1,0.985226470307768,0,4,chronic inflammatory response to antigenic stimulus,BP,
1047,GO:0002441,1,0.969861255057816,0,7,histamine secretion involved in inflammatory response,BP,
1048,GO:0002442,1,0.982046821790093,0,3,serotonin secretion involved in inflammatory response,BP,
1051,GO:0002445,1,0.980052253343581,0,4,type II hypersensitivity,BP,
1053,GO:0002447,1,0.982644390676801,0,4,eosinophil mediated immunity,BP,
1056,GO:0002450,1,0.996468965415065,0,1,B cell antigen processing and presentation,BP,
1057,GO:0002451,1,0.996488443237661,0,1,peripheral B cell tolerance induction,BP,
1059,GO:0002456,1,0.604155903944068,0,93,T cell mediated immunity,BP,
1060,GO:0002457,1,0.977446913788626,0,5,T cell antigen processing and presentation,BP,
1061,GO:0002458,1,0.991553486207542,0,2,peripheral T cell tolerance induction,BP,
1063,GO:0002461,1,0.980329873410057,0,5,tolerance induction dependent upon immune response,BP,
1064,GO:0002465,1,0.984632113578242,0,4,peripheral tolerance induction,BP,
1065,GO:0002467,1,0.897483400691405,0,15,germinal center formation,BP,
1066,GO:0002468,1,0.934022096490642,0,12,dendritic cell antigen processing and presentation,BP,
1067,GO:0002470,1,0.996732759558118,0,1,plasmacytoid dendritic cell antigen processing and presentation,BP,
1068,GO:0002472,1,0.991883220809669,0,1,macrophage antigen processing and presentation,BP,
1069,GO:0002474,1,0.625953385350433,0,93,antigen processing and presentation of peptide antigen via MHC class I,BP,
1070,GO:0002475,1,0.940453601452424,0,12,antigen processing and presentation via MHC class Ib,BP,
1071,GO:0002476,1,0.978805642377464,0,5,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1072,GO:0002477,1,0.989921887669369,0,3,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1074,GO:0002479,1,0.740339145274105,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1075,GO:0002480,1,0.968012529695118,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1076,GO:0002481,1,0.996801704832381,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1077,GO:0002483,1,0.915265207368047,0,16,antigen processing and presentation of endogenous peptide antigen,BP,
1078,GO:0002484,1,0.97605657878299,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,BP,
1079,GO:0002485,1,0.996511488008149,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,BP,
1080,GO:0002486,1,0.97605657878299,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent,BP,
1081,GO:0002488,1,0.992366237350058,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1082,GO:0002489,1,0.992366237350058,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1084,GO:0002501,1,0.979455591063425,0,6,peptide antigen assembly with MHC protein complex,BP,
1085,GO:0002502,1,0.992456980687471,0,2,peptide antigen assembly with MHC class I protein complex,BP,
1086,GO:0002503,1,0.986900786050355,0,4,peptide antigen assembly with MHC class II protein complex,BP,
1088,GO:0002507,1,0.876395534518975,0,24,tolerance induction,BP,
1089,GO:0002508,1,0.991068654557991,0,2,central tolerance induction,BP,
1090,GO:0002509,1,0.99592401230561,0,1,central tolerance induction to self antigen,BP,
1091,GO:0002510,1,0.995124970104541,0,1,central B cell tolerance induction,BP,
1092,GO:0002513,1,0.972441095628673,0,5,tolerance induction to self antigen,BP,
1093,GO:0002514,1,0.982782764386387,0,3,B cell tolerance induction,BP,
1094,GO:0002517,1,0.938740527494114,0,12,T cell tolerance induction,BP,
1095,GO:0002518,1,0.996720374049634,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1096,GO:0002519,1,0.988494974891572,0,3,natural killer cell tolerance induction,BP,
1099,GO:0002522,1,0.991377798519428,0,2,leukocyte migration involved in immune response,BP,
1100,GO:0002523,1,0.925731956349652,0,16,leukocyte migration involved in inflammatory response,BP,
1101,GO:0002524,1,0.954316629944257,0,10,hypersensitivity,BP,
1102,GO:0002525,1,0.986615935027502,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1104,GO:0002528,1,0.96978859332638,0,4,regulation of vascular permeability involved in acute inflammatory response,BP,
1106,GO:0002534,1,0.752225725465467,0,43,cytokine production involved in inflammatory response,BP,
1107,GO:0002536,1,0.975446969348967,0,6,respiratory burst involved in inflammatory response,BP,
1108,GO:0002537,1,0.975002636375482,0,2,nitric oxide production involved in inflammatory response,BP,
1111,GO:0002541,1,0.987364565794435,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1112,GO:0002542,1,0.991742444656076,0,2,Factor XII activation,BP,
1113,GO:0002543,1,0.986468249612794,0,2,activation of blood coagulation via clotting cascade,BP,
1114,GO:0002544,1,0.91429126258133,0,17,chronic inflammatory response,BP,
1115,GO:0002545,1,0.996205742500756,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1118,GO:0002553,1,0.969861255057816,0,7,histamine secretion by mast cell,BP,
1119,GO:0002554,1,0.982046821790093,0,3,serotonin secretion by platelet,BP,
1120,GO:0002560,1,0.992035818229649,0,1,basophil mediated immunity,BP,
1121,GO:0002561,1,0.992035818229649,0,1,basophil degranulation,BP,
1122,GO:0002562,1,0.668547677723838,0,56,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1123,GO:0002566,1,0.905643809521957,0,14,somatic diversification of immune receptors via somatic mutation,BP,
1124,GO:0002568,1,0.943027287015296,0,5,somatic diversification of T cell receptor genes,BP,
1125,GO:0002572,1,0.986849416774676,0,2,pro-T cell differentiation,BP,
1128,GO:0002577,1,0.901098708847473,0,20,regulation of antigen processing and presentation,BP,
1129,GO:0002578,1,0.951679557865711,0,9,negative regulation of antigen processing and presentation,BP,
1130,GO:0002579,1,0.956204248776261,0,9,positive regulation of antigen processing and presentation,BP,
1131,GO:0002580,1,0.972899336525382,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1132,GO:0002581,1,0.979150270008315,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1133,GO:0002582,1,0.993617305896146,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1134,GO:0002583,1,0.976374693081028,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1135,GO:0002584,1,0.982647732824168,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1136,GO:0002585,1,0.993617305896146,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1137,GO:0002586,1,0.983831813089415,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1138,GO:0002587,1,0.990152278399709,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1139,GO:0002588,1,0.993617305896146,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1140,GO:0002589,1,0.992421566424925,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1141,GO:0002590,1,0.992421566424925,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1142,GO:0002604,1,0.937085774932201,0,11,regulation of dendritic cell antigen processing and presentation,BP,
1143,GO:0002605,1,0.973758333881578,0,4,negative regulation of dendritic cell antigen processing and presentation,BP,
1144,GO:0002606,1,0.962348987534242,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1145,GO:0002616,1,0.991883220809669,0,1,regulation of macrophage antigen processing and presentation,BP,
1146,GO:0002617,1,0.991883220809669,0,1,negative regulation of macrophage antigen processing and presentation,BP,
1147,GO:0002622,1,0.996468965415065,0,1,regulation of B cell antigen processing and presentation,BP,
1148,GO:0002625,1,0.992403949456856,0,2,regulation of T cell antigen processing and presentation,BP,
1149,GO:0002626,1,0.996133418816741,0,1,negative regulation of T cell antigen processing and presentation,BP,
1150,GO:0002634,1,0.934185789115363,0,9,regulation of germinal center formation,BP,
1151,GO:0002635,1,0.975038880820734,0,2,negative regulation of germinal center formation,BP,
1152,GO:0002636,1,0.990102602994022,0,3,positive regulation of germinal center formation,BP,
1153,GO:0002637,1,0.722472405573326,0,56,regulation of immunoglobulin production,BP,
1154,GO:0002638,1,0.923074490155072,0,12,negative regulation of immunoglobulin production,BP,
1155,GO:0002639,1,0.822189671677306,0,35,positive regulation of immunoglobulin production,BP,
1156,GO:0002640,1,0.994890876864838,0,1,regulation of immunoglobulin biosynthetic process,BP,
1157,GO:0002642,1,0.994890876864838,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1158,GO:0002643,1,0.9110533514456,0,16,regulation of tolerance induction,BP,
1159,GO:0002644,1,0.995928630498755,0,1,negative regulation of tolerance induction,BP,
1160,GO:0002645,1,0.948069662122858,0,9,positive regulation of tolerance induction,BP,
1161,GO:0002646,1,0.995124970104541,0,1,regulation of central tolerance induction,BP,
1162,GO:0002648,1,0.995124970104541,0,1,positive regulation of central tolerance induction,BP,
1163,GO:0002649,1,0.99107847423784,0,1,regulation of tolerance induction to self antigen,BP,
1164,GO:0002651,1,0.99107847423784,0,1,positive regulation of tolerance induction to self antigen,BP,
1165,GO:0002652,1,0.987811860565303,0,3,regulation of tolerance induction dependent upon immune response,BP,
1166,GO:0002654,1,0.992146604332539,0,2,positive regulation of tolerance induction dependent upon immune response,BP,
1167,GO:0002658,1,0.992146604332539,0,2,regulation of peripheral tolerance induction,BP,
1168,GO:0002660,1,0.992146604332539,0,2,positive regulation of peripheral tolerance induction,BP,
1169,GO:0002661,1,0.986246505011949,0,2,regulation of B cell tolerance induction,BP,
1170,GO:0002663,1,0.986246505011949,0,2,positive regulation of B cell tolerance induction,BP,
1171,GO:0002664,1,0.947213117357329,0,10,regulation of T cell tolerance induction,BP,
1172,GO:0002666,1,0.971141367011815,0,6,positive regulation of T cell tolerance induction,BP,
1173,GO:0002667,1,0.97353369436886,0,5,regulation of T cell anergy,BP,
1174,GO:0002669,1,0.992164083120729,0,2,positive regulation of T cell anergy,BP,
1175,GO:0002673,1,0.795589752791433,0,42,regulation of acute inflammatory response,BP,
1176,GO:0002674,1,0.942442064404972,0,9,negative regulation of acute inflammatory response,BP,
1177,GO:0002675,1,0.867103509089254,0,28,positive regulation of acute inflammatory response,BP,
1178,GO:0002676,1,0.961448758982893,0,8,regulation of chronic inflammatory response,BP,
1179,GO:0002677,1,0.975305325711183,0,4,negative regulation of chronic inflammatory response,BP,
1180,GO:0002678,1,0.985796122568025,0,4,positive regulation of chronic inflammatory response,BP,
1181,GO:0002679,1,0.945715332012687,0,10,respiratory burst involved in defense response,BP,
1182,GO:0002681,1,0.943027287015296,0,5,somatic recombination of T cell receptor gene segments,BP,
1187,GO:0002686,1,0.777530533125576,0,42,negative regulation of leukocyte migration,BP,
1190,GO:0002689,1,0.912513937525379,0,16,negative regulation of leukocyte chemotaxis,BP,
1193,GO:0002692,1,0.939719377885261,0,9,negative regulation of cellular extravasation,BP,
1194,GO:0002693,1,0.894563171349955,0,18,positive regulation of cellular extravasation,BP,
1201,GO:0002700,1,0.476239983206506,0,125,regulation of production of molecular mediator of immune response,BP,
1202,GO:0002701,1,0.825351226579335,0,32,negative regulation of production of molecular mediator of immune response,BP,
1203,GO:0002702,1,0.604262747654832,0,87,positive regulation of production of molecular mediator of immune response,BP,
1204,GO:0002703,1,0.343190915893793,0,186,regulation of leukocyte mediated immunity,BP,
1205,GO:0002704,1,0.776905135838938,0,48,negative regulation of leukocyte mediated immunity,BP,
1206,GO:0002705,1,0.50339678727696,0,119,positive regulation of leukocyte mediated immunity,BP,
1207,GO:0002706,1,0.487210027478974,0,131,regulation of lymphocyte mediated immunity,BP,
1208,GO:0002707,1,0.827684874965996,0,38,negative regulation of lymphocyte mediated immunity,BP,
1209,GO:0002708,1,0.61288508477721,0,88,positive regulation of lymphocyte mediated immunity,BP,
1210,GO:0002709,1,0.716911493959536,0,65,regulation of T cell mediated immunity,BP,
1211,GO:0002710,1,0.925166239949723,0,17,negative regulation of T cell mediated immunity,BP,
1212,GO:0002711,1,0.79083763297032,0,44,positive regulation of T cell mediated immunity,BP,
1213,GO:0002712,1,0.762273231428687,0,45,regulation of B cell mediated immunity,BP,
1214,GO:0002713,1,0.937165938696299,0,11,negative regulation of B cell mediated immunity,BP,
1215,GO:0002714,1,0.836885193635879,0,30,positive regulation of B cell mediated immunity,BP,
1216,GO:0002715,1,0.820515010022993,0,38,regulation of natural killer cell mediated immunity,BP,
1217,GO:0002716,1,0.929672331540132,0,16,negative regulation of natural killer cell mediated immunity,BP,
1218,GO:0002717,1,0.878862465483191,0,24,positive regulation of natural killer cell mediated immunity,BP,
1219,GO:0002718,1,0.638261734948608,0,77,regulation of cytokine production involved in immune response,BP,
1220,GO:0002719,1,0.890532004480291,0,21,negative regulation of cytokine production involved in immune response,BP,
1221,GO:0002720,1,0.73230416278128,0,53,positive regulation of cytokine production involved in immune response,BP,
1222,GO:0002721,1,0.995143849625378,0,1,regulation of B cell cytokine production,BP,
1223,GO:0002724,1,0.851880601812507,0,30,regulation of T cell cytokine production,BP,
1224,GO:0002725,1,0.971594596405773,0,7,negative regulation of T cell cytokine production,BP,
1225,GO:0002726,1,0.893821432130669,0,20,positive regulation of T cell cytokine production,BP,
1226,GO:0002727,1,0.966064241330626,0,8,regulation of natural killer cell cytokine production,BP,
1227,GO:0002728,1,0.988184827722682,0,2,negative regulation of natural killer cell cytokine production,BP,
1228,GO:0002729,1,0.974370779966037,0,7,positive regulation of natural killer cell cytokine production,BP,
1229,GO:0002730,1,0.905274124613132,0,12,regulation of dendritic cell cytokine production,BP,
1230,GO:0002731,1,0.986407957671546,0,2,negative regulation of dendritic cell cytokine production,BP,
1231,GO:0002732,1,0.933038289517153,0,8,positive regulation of dendritic cell cytokine production,BP,
1232,GO:0002733,1,0.945949629510639,0,6,regulation of myeloid dendritic cell cytokine production,BP,
1233,GO:0002735,1,0.945949629510639,0,6,positive regulation of myeloid dendritic cell cytokine production,BP,
1234,GO:0002736,1,0.996815376007367,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1235,GO:0002737,1,0.996815376007367,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1236,GO:0002752,1,0.992705394853609,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1237,GO:0002753,1,0.663856140242687,0,59,cytoplasmic pattern recognition receptor signaling pathway,BP,
1238,GO:0002755,1,0.795048140191885,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1239,GO:0002756,1,0.827714436242195,0,32,MyD88-independent toll-like receptor signaling pathway,BP,
1240,GO:0002757,1,0.126998291757652,0,335,immune response-activating signal transduction,BP,
1241,GO:0002758,1,0.538602847739702,0,101,innate immune response-activating signal transduction,BP,
1242,GO:0002759,1,0.982232979151607,0,4,regulation of antimicrobial humoral response,BP,
1243,GO:0002760,1,0.992765314648126,0,2,positive regulation of antimicrobial humoral response,BP,
1247,GO:0002764,1,0.101994088472075,0,369,immune response-regulating signaling pathway,BP,
1248,GO:0002765,1,0.965697190849306,0,8,immune response-inhibiting signal transduction,BP,
1249,GO:0002767,1,0.972786660486198,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1250,GO:0002768,1,0.103122223818537,0,366,immune response-regulating cell surface receptor signaling pathway,BP,
1251,GO:0002769,1,0.992358139850924,0,2,natural killer cell inhibitory signaling pathway,BP,
1252,GO:0002774,1,0.983734315589406,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1253,GO:0002775,1,0.98279488609494,0,4,antimicrobial peptide production,BP,
1254,GO:0002777,1,0.996819730889267,0,1,antimicrobial peptide biosynthetic process,BP,
1255,GO:0002778,1,0.98279488609494,0,4,antibacterial peptide production,BP,
1256,GO:0002780,1,0.996819730889267,0,1,antibacterial peptide biosynthetic process,BP,
1257,GO:0002784,1,0.985930857180233,0,3,regulation of antimicrobial peptide production,BP,
1258,GO:0002785,1,0.993116236374285,0,1,negative regulation of antimicrobial peptide production,BP,
1259,GO:0002786,1,0.985930857180233,0,3,regulation of antibacterial peptide production,BP,
1260,GO:0002787,1,0.993116236374285,0,1,negative regulation of antibacterial peptide production,BP,
1264,GO:0002793,1,0.330695041939254,0,169,positive regulation of peptide secretion,BP,
1265,GO:0002803,1,0.992765314648126,0,2,positive regulation of antibacterial peptide production,BP,
1266,GO:0002812,1,0.996819730889267,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1268,GO:0002820,1,0.784443075113179,0,43,negative regulation of adaptive immune response,BP,
1271,GO:0002823,1,0.801458736139966,0,38,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1274,GO:0002826,1,0.962306940402303,0,7,negative regulation of T-helper 1 type immune response,BP,
1278,GO:0002830,1,0.922669952411449,0,16,positive regulation of type 2 immune response,BP,
1281,GO:0002833,1,0.258964881525215,0,213,positive regulation of response to biotic stimulus,BP,
1282,GO:0002834,1,0.933469475322371,0,13,regulation of response to tumor cell,BP,
1283,GO:0002835,1,0.989176980223424,0,2,negative regulation of response to tumor cell,BP,
1284,GO:0002836,1,0.949753194810146,0,10,positive regulation of response to tumor cell,BP,
1285,GO:0002837,1,0.933469475322371,0,13,regulation of immune response to tumor cell,BP,
1286,GO:0002838,1,0.989176980223424,0,2,negative regulation of immune response to tumor cell,BP,
1287,GO:0002839,1,0.949753194810146,0,10,positive regulation of immune response to tumor cell,BP,
1288,GO:0002840,1,0.973323223758532,0,5,regulation of T cell mediated immune response to tumor cell,BP,
1289,GO:0002842,1,0.979575973459936,0,4,positive regulation of T cell mediated immune response to tumor cell,BP,
1290,GO:0002843,1,0.996519718586635,0,1,regulation of tolerance induction to tumor cell,BP,
1291,GO:0002845,1,0.996519718586635,0,1,positive regulation of tolerance induction to tumor cell,BP,
1292,GO:0002849,1,0.995611766244669,0,1,regulation of peripheral T cell tolerance induction,BP,
1293,GO:0002851,1,0.995611766244669,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1294,GO:0002852,1,0.991951371171927,0,2,regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1295,GO:0002854,1,0.991951371171927,0,2,positive regulation of T cell mediated cytotoxicity directed against tumor cell target,BP,
1296,GO:0002855,1,0.962415563472807,0,7,regulation of natural killer cell mediated immune response to tumor cell,BP,
1297,GO:0002856,1,0.989176980223424,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1298,GO:0002857,1,0.972948682520568,0,5,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1299,GO:0002858,1,0.965792506923374,0,6,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1300,GO:0002859,1,0.989176980223424,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1301,GO:0002860,1,0.976362211303004,0,4,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1302,GO:0002861,1,0.892502039883485,0,25,regulation of inflammatory response to antigenic stimulus,BP,
1303,GO:0002862,1,0.957666731156911,0,11,negative regulation of inflammatory response to antigenic stimulus,BP,
1304,GO:0002863,1,0.940766837284438,0,12,positive regulation of inflammatory response to antigenic stimulus,BP,
1305,GO:0002864,1,0.932426239297403,0,14,regulation of acute inflammatory response to antigenic stimulus,BP,
1306,GO:0002865,1,0.982973627599365,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1307,GO:0002866,1,0.957524177459117,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1308,GO:0002870,1,0.97353369436886,0,5,T cell anergy,BP,
1309,GO:0002874,1,0.989505714091989,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1310,GO:0002875,1,0.996449717705429,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1311,GO:0002876,1,0.993031503709362,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1312,GO:0002877,1,0.986615935027502,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1313,GO:0002878,1,0.994129353515148,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1314,GO:0002879,1,0.992442656901829,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1315,GO:0002880,1,0.996205742500756,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1316,GO:0002882,1,0.996205742500756,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1317,GO:0002883,1,0.959759400386507,0,9,regulation of hypersensitivity,BP,
1318,GO:0002884,1,0.992500277997506,0,2,negative regulation of hypersensitivity,BP,
1319,GO:0002885,1,0.971391548320285,0,6,positive regulation of hypersensitivity,BP,
1320,GO:0002886,1,0.721462508530573,0,55,regulation of myeloid leukocyte mediated immunity,BP,
1321,GO:0002887,1,0.944937235977474,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1322,GO:0002888,1,0.822419114609712,0,32,positive regulation of myeloid leukocyte mediated immunity,BP,
1323,GO:0002889,1,0.762273231428687,0,45,regulation of immunoglobulin mediated immune response,BP,
1324,GO:0002890,1,0.937165938696299,0,11,negative regulation of immunoglobulin mediated immune response,BP,
1325,GO:0002891,1,0.836885193635879,0,30,positive regulation of immunoglobulin mediated immune response,BP,
1326,GO:0002892,1,0.980052253343581,0,4,regulation of type II hypersensitivity,BP,
1327,GO:0002893,1,0.996468965415065,0,1,negative regulation of type II hypersensitivity,BP,
1328,GO:0002894,1,0.983525694401706,0,3,positive regulation of type II hypersensitivity,BP,
1329,GO:0002895,1,0.995124970104541,0,1,regulation of central B cell tolerance induction,BP,
1330,GO:0002897,1,0.995124970104541,0,1,positive regulation of central B cell tolerance induction,BP,
1331,GO:0002901,1,0.9844245406399,0,4,mature B cell apoptotic process,BP,
1332,GO:0002902,1,0.894831916269694,0,18,regulation of B cell apoptotic process,BP,
1333,GO:0002903,1,0.936431312813014,0,11,negative regulation of B cell apoptotic process,BP,
1334,GO:0002904,1,0.980834915168188,0,3,positive regulation of B cell apoptotic process,BP,
1335,GO:0002905,1,0.9844245406399,0,4,regulation of mature B cell apoptotic process,BP,
1336,GO:0002906,1,0.9844245406399,0,4,negative regulation of mature B cell apoptotic process,BP,
1337,GO:0002911,1,0.97353369436886,0,5,regulation of lymphocyte anergy,BP,
1338,GO:0002913,1,0.992164083120729,0,2,positive regulation of lymphocyte anergy,BP,
1340,GO:0002921,1,0.921435119428016,0,12,negative regulation of humoral immune response,BP,
1341,GO:0002922,1,0.936021531760834,0,14,positive regulation of humoral immune response,BP,
1342,GO:0002923,1,0.939547976576124,0,11,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1343,GO:0002924,1,0.96219114915676,0,6,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1344,GO:0002925,1,0.976476047447146,0,5,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1345,GO:0002926,1,0.994016986456071,0,1,tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,BP,
1346,GO:0002930,1,0.986269359008465,0,2,trabecular meshwork development,BP,
1348,GO:0002933,1,0.984208684675745,0,4,lipid hydroxylation,BP,
1349,GO:0002934,1,0.920148541552897,0,9,desmosome organization,BP,
1350,GO:0002939,1,0.984829553798278,0,2,tRNA N1-guanine methylation,BP,
1351,GO:0002940,1,0.990736514574347,0,2,tRNA N2-guanine methylation,BP,
1352,GO:0002941,1,0.996418272104253,0,1,synoviocyte proliferation,BP,
1353,GO:0002943,1,0.983285350782958,0,4,tRNA dihydrouridine synthesis,BP,
1354,GO:0002944,1,0.980166963911442,0,2,cyclin K-CDK12 complex,CC,
1355,GO:0002945,1,0.982641341313326,0,2,cyclin K-CDK13 complex,CC,
1356,GO:0002946,1,0.992069194842441,0,2,tRNA C5-cytosine methylation,BP,
1357,GO:0002947,1,0.981267930815127,0,4,tumor necrosis factor receptor superfamily complex,CC,
1358,GO:0002949,1,0.989041869113384,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1359,GO:0002950,1,0.977874482419559,0,3,ceramide phosphoethanolamine synthase activity,MF,
1360,GO:0002951,1,0.990938671180735,0,2,leukotriene-C(4) hydrolase,MF,
1361,GO:0002953,1,0.996460434227222,0,1,5'-deoxynucleotidase activity,MF,
1362,GO:0003002,1,0.096262438637854,0,331,regionalization,BP,
1366,GO:0003009,1,0.763680120504429,0,40,skeletal muscle contraction,BP,
1367,GO:0003010,1,0.96275447980925,0,5,voluntary skeletal muscle contraction,BP,
1368,GO:0003011,1,0.980579958511008,0,3,involuntary skeletal muscle contraction,BP,
1373,GO:0003016,1,0.809034848671733,0,31,respiratory system process,BP,
1374,GO:0003017,1,0.960890390078039,0,2,lymph circulation,BP,
1376,GO:0003025,1,0.970976602762157,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1377,GO:0003026,1,0.994890876864838,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1378,GO:0003027,1,0.996388574651171,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1379,GO:0003029,1,0.996388574651171,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1380,GO:0003032,1,0.989853880844781,0,2,detection of oxygen,BP,
1381,GO:0003044,1,0.800977220105451,0,41,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1382,GO:0003050,1,0.990508290284945,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1383,GO:0003051,1,0.988671861748243,0,2,angiotensin-mediated drinking behavior,BP,
1384,GO:0003056,1,0.939019211640159,0,7,regulation of vascular associated smooth muscle contraction,BP,
1385,GO:0003057,1,0.977933764361473,0,5,regulation of the force of heart contraction by chemical signal,BP,
1386,GO:0003058,1,0.996702139098049,0,1,hormonal regulation of the force of heart contraction,BP,
1387,GO:0003062,1,0.954104990408273,0,6,regulation of heart rate by chemical signal,BP,
1388,GO:0003064,1,0.990354476079499,0,2,regulation of heart rate by hormone,BP,
1389,GO:0003065,1,0.996302346819352,0,1,positive regulation of heart rate by epinephrine,BP,
1390,GO:0003068,1,0.99678965917787,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1391,GO:0003069,1,0.99678965917787,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1392,GO:0003070,1,0.99678965917787,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1393,GO:0003071,1,0.90454701974961,0,19,renal system process involved in regulation of systemic arterial blood pressure,BP,
1394,GO:0003072,1,0.982834350766139,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1396,GO:0003081,1,0.901961479339711,0,20,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1397,GO:0003083,1,0.996867862427499,0,1,negative regulation of renal output by angiotensin,BP,
1398,GO:0003084,1,0.947745626191254,0,11,positive regulation of systemic arterial blood pressure,BP,
1399,GO:0003085,1,0.906819316577705,0,17,negative regulation of systemic arterial blood pressure,BP,
1400,GO:0003091,1,0.770640423204728,0,31,renal water homeostasis,BP,
1401,GO:0003093,1,0.941268786887812,0,10,regulation of glomerular filtration,BP,
1402,GO:0003094,1,0.883401715012292,0,18,glomerular filtration,BP,
1403,GO:0003095,1,0.996357687542497,0,1,pressure natriuresis,BP,
1404,GO:0003096,1,0.963061149480088,0,6,renal sodium ion transport,BP,
1405,GO:0003097,1,0.975185382050105,0,5,renal water transport,BP,
1406,GO:0003099,1,0.987319048927938,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1407,GO:0003100,1,0.969953386985687,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1408,GO:0003104,1,0.979102689137781,0,4,positive regulation of glomerular filtration,BP,
1409,GO:0003105,1,0.98215592388648,0,3,negative regulation of glomerular filtration,BP,
1410,GO:0003106,1,0.996867862427499,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1411,GO:0003127,1,0.973529673894712,0,2,detection of nodal flow,BP,
1412,GO:0003128,1,0.880489258664491,0,16,heart field specification,BP,
1413,GO:0003129,1,0.939881611879145,0,9,heart induction,BP,
1414,GO:0003130,1,0.990504426605749,0,2,BMP signaling pathway involved in heart induction,BP,
1415,GO:0003131,1,0.994782870291466,0,1,mesodermal-endodermal cell signaling,BP,
1416,GO:0003133,1,0.990504426605749,0,2,endodermal-mesodermal cell signaling,BP,
1417,GO:0003134,1,0.990504426605749,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1418,GO:0003137,1,0.966911646759619,0,4,Notch signaling pathway involved in heart induction,BP,
1419,GO:0003138,1,0.973176988379565,0,3,primary heart field specification,BP,
1420,GO:0003139,1,0.916404641544293,0,11,secondary heart field specification,BP,
1421,GO:0003140,1,0.952281300715572,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1422,GO:0003142,1,0.995595143021993,0,1,cardiogenic plate morphogenesis,BP,
1423,GO:0003143,1,0.601716044839468,0,66,embryonic heart tube morphogenesis,BP,
1424,GO:0003147,1,0.996781921628756,0,1,neural crest cell migration involved in heart formation,BP,
1425,GO:0003148,1,0.796259933805423,0,27,outflow tract septum morphogenesis,BP,
1426,GO:0003149,1,0.941585659510198,0,9,membranous septum morphogenesis,BP,
1427,GO:0003150,1,0.960959980488031,0,5,muscular septum morphogenesis,BP,
1428,GO:0003151,1,0.552761397626903,0,76,outflow tract morphogenesis,BP,
1429,GO:0003156,1,0.795680474721039,0,36,regulation of animal organ formation,BP,
1430,GO:0003157,1,0.920195687988164,0,11,endocardium development,BP,
1432,GO:0003159,1,0.899899257774035,0,18,morphogenesis of an endothelium,BP,
1433,GO:0003160,1,0.961556381912285,0,6,endocardium morphogenesis,BP,
1434,GO:0003161,1,0.912143233659609,0,12,cardiac conduction system development,BP,
1435,GO:0003162,1,0.968114968529647,0,3,atrioventricular node development,BP,
1436,GO:0003163,1,0.977318761184714,0,3,sinoatrial node development,BP,
1437,GO:0003164,1,0.966448652656865,0,5,His-Purkinje system development,BP,
1438,GO:0003165,1,0.985363810085637,0,2,Purkinje myocyte development,BP,
1439,GO:0003166,1,0.977041776988347,0,4,bundle of His development,BP,
1440,GO:0003167,1,0.990902089112779,0,1,atrioventricular bundle cell differentiation,BP,
1441,GO:0003168,1,0.996162159258601,0,1,Purkinje myocyte differentiation,BP,
1442,GO:0003169,1,0.976140992066656,0,2,coronary vein morphogenesis,BP,
1443,GO:0003170,1,0.597526883133062,0,58,heart valve development,BP,
1444,GO:0003171,1,0.800491077113756,0,24,atrioventricular valve development,BP,
1445,GO:0003172,1,0.987968171442445,0,1,sinoatrial valve development,BP,
1446,GO:0003174,1,0.905032088323858,0,10,mitral valve development,BP,
1447,GO:0003175,1,0.948919139745278,0,6,tricuspid valve development,BP,
1448,GO:0003176,1,0.779836634580562,0,32,aortic valve development,BP,
1449,GO:0003177,1,0.834437075218351,0,20,pulmonary valve development,BP,
1450,GO:0003178,1,0.982607875776869,0,1,coronary sinus valve development,BP,
1451,GO:0003179,1,0.640336970125565,0,49,heart valve morphogenesis,BP,
1452,GO:0003180,1,0.80986989352329,0,28,aortic valve morphogenesis,BP,
1453,GO:0003181,1,0.803329996551496,0,23,atrioventricular valve morphogenesis,BP,
1454,GO:0003182,1,0.982607875776869,0,1,coronary sinus valve morphogenesis,BP,
1455,GO:0003183,1,0.905032088323858,0,10,mitral valve morphogenesis,BP,
1456,GO:0003184,1,0.866550981682484,0,16,pulmonary valve morphogenesis,BP,
1457,GO:0003185,1,0.987968171442445,0,1,sinoatrial valve morphogenesis,BP,
1458,GO:0003186,1,0.952278715925658,0,5,tricuspid valve morphogenesis,BP,
1459,GO:0003188,1,0.906755433651289,0,12,heart valve formation,BP,
1460,GO:0003190,1,0.923277627569976,0,8,atrioventricular valve formation,BP,
1461,GO:0003192,1,0.957358231579133,0,3,mitral valve formation,BP,
1462,GO:0003193,1,0.996473790744259,0,1,pulmonary valve formation,BP,
1463,GO:0003195,1,0.989074785311381,0,2,tricuspid valve formation,BP,
1464,GO:0003197,1,0.701459008768132,0,45,endocardial cushion development,BP,
1465,GO:0003198,1,0.886379898952015,0,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1466,GO:0003199,1,0.988060425641437,0,3,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1467,GO:0003203,1,0.762262470620164,0,35,endocardial cushion morphogenesis,BP,
1468,GO:0003205,1,0.248645602240852,0,162,cardiac chamber development,BP,
1469,GO:0003206,1,0.38030388418808,0,120,cardiac chamber morphogenesis,BP,
1470,GO:0003207,1,0.916294393658848,0,11,cardiac chamber formation,BP,
1471,GO:0003208,1,0.567481609507001,0,68,cardiac ventricle morphogenesis,BP,
1472,GO:0003209,1,0.79725200153883,0,26,cardiac atrium morphogenesis,BP,
1473,GO:0003210,1,0.996739578012618,0,1,cardiac atrium formation,BP,
1474,GO:0003211,1,0.925366438818309,0,9,cardiac ventricle formation,BP,
1475,GO:0003213,1,0.971631729741899,0,2,cardiac right atrium morphogenesis,BP,
1476,GO:0003214,1,0.890381073982367,0,13,cardiac left ventricle morphogenesis,BP,
1477,GO:0003215,1,0.868581025420099,0,18,cardiac right ventricle morphogenesis,BP,
1478,GO:0003218,1,0.993151563060952,0,1,cardiac left ventricle formation,BP,
1479,GO:0003219,1,0.974725137402681,0,3,cardiac right ventricle formation,BP,
1480,GO:0003220,1,0.955692353049046,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1481,GO:0003221,1,0.968561803540829,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1482,GO:0003222,1,0.861453532896099,0,16,ventricular trabecula myocardium morphogenesis,BP,
1483,GO:0003223,1,0.899019169041753,0,8,ventricular compact myocardium morphogenesis,BP,
1484,GO:0003226,1,0.980684592448341,0,1,right ventricular compact myocardium morphogenesis,BP,
1485,GO:0003228,1,0.964928921217185,0,6,atrial cardiac muscle tissue development,BP,
1486,GO:0003229,1,0.627381996750152,0,52,ventricular cardiac muscle tissue development,BP,
1487,GO:0003230,1,0.74608059934888,0,32,cardiac atrium development,BP,
1488,GO:0003231,1,0.350772513697845,0,120,cardiac ventricle development,BP,
1489,GO:0003235,1,0.996739578012618,0,1,sinus venosus development,BP,
1490,GO:0003236,1,0.996739578012618,0,1,sinus venosus morphogenesis,BP,
1491,GO:0003241,1,0.970423642152345,0,4,growth involved in heart morphogenesis,BP,
1492,GO:0003245,1,0.990833099825043,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1493,GO:0003247,1,0.996442198035923,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1494,GO:0003249,1,0.945278775655358,0,3,cell proliferation involved in heart valve morphogenesis,BP,
1495,GO:0003250,1,0.945278775655358,0,3,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1496,GO:0003251,1,0.983543904499243,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1497,GO:0003252,1,0.961100943887419,0,2,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003253,1,0.963809384797778,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1499,GO:0003254,1,0.72804061026885,0,42,regulation of membrane depolarization,BP,
1500,GO:0003256,1,0.944119314183214,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1501,GO:0003257,1,0.971220551169184,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1502,GO:0003259,1,0.996739578012618,0,1,cardioblast anterior-lateral migration,BP,
1503,GO:0003260,1,0.996739578012618,0,1,cardioblast migration,BP,
1504,GO:0003263,1,0.936432954728866,0,10,cardioblast proliferation,BP,
1505,GO:0003264,1,0.936432954728866,0,10,regulation of cardioblast proliferation,BP,
1506,GO:0003266,1,0.941141942088159,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1507,GO:0003270,1,0.982607875776869,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1508,GO:0003271,1,0.995503608654208,0,1,smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1509,GO:0003272,1,0.828251266855115,0,24,endocardial cushion formation,BP,
1510,GO:0003273,1,0.953684399412445,0,4,cell migration involved in endocardial cushion formation,BP,
1511,GO:0003274,1,0.971155084831441,0,4,endocardial cushion fusion,BP,
1512,GO:0003275,1,0.980154678070441,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1513,GO:0003278,1,0.972062092481877,0,5,apoptotic process involved in heart morphogenesis,BP,
1514,GO:0003279,1,0.382605498398101,0,106,cardiac septum development,BP,
1515,GO:0003281,1,0.525981800545565,0,69,ventricular septum development,BP,
1516,GO:0003283,1,0.827488810674103,0,20,atrial septum development,BP,
1517,GO:0003284,1,0.969251364133406,0,4,septum primum development,BP,
1518,GO:0003285,1,0.989833136346623,0,2,septum secundum development,BP,
1519,GO:0003289,1,0.969251364133406,0,4,atrial septum primum morphogenesis,BP,
1520,GO:0003290,1,0.993646837814256,0,1,atrial septum secundum morphogenesis,BP,
1521,GO:0003292,1,0.985253131196003,0,2,cardiac septum cell differentiation,BP,
1522,GO:0003298,1,0.817177279252084,0,26,physiological muscle hypertrophy,BP,
1523,GO:0003299,1,0.834005498938505,0,21,muscle hypertrophy in response to stress,BP,
1524,GO:0003300,1,0.485854964872563,0,78,cardiac muscle hypertrophy,BP,
1525,GO:0003301,1,0.817177279252084,0,26,physiological cardiac muscle hypertrophy,BP,
1526,GO:0003306,1,0.934780031734886,0,10,Wnt signaling pathway involved in heart development,BP,
1527,GO:0003307,1,0.950533940564759,0,8,regulation of Wnt signaling pathway involved in heart development,BP,
1528,GO:0003308,1,0.95475961928717,0,7,negative regulation of Wnt signaling pathway involved in heart development,BP,
1529,GO:0003309,1,0.840693248322895,0,24,type B pancreatic cell differentiation,BP,
1530,GO:0003310,1,0.963376337892184,0,6,pancreatic A cell differentiation,BP,
1531,GO:0003312,1,0.991139534433085,0,2,pancreatic PP cell differentiation,BP,
1532,GO:0003318,1,0.996739578012618,0,1,cell migration to the midline involved in heart development,BP,
1533,GO:0003321,1,0.958600954949609,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1534,GO:0003322,1,0.986875319544628,0,1,pancreatic A cell development,BP,
1535,GO:0003323,1,0.866046853517718,0,20,type B pancreatic cell development,BP,
1536,GO:0003326,1,0.991139534433085,0,2,pancreatic A cell fate commitment,BP,
1537,GO:0003327,1,0.995978055021198,0,1,type B pancreatic cell fate commitment,BP,
1538,GO:0003329,1,0.991139534433085,0,2,pancreatic PP cell fate commitment,BP,
1539,GO:0003330,1,0.952318477247005,0,7,regulation of extracellular matrix constituent secretion,BP,
1540,GO:0003331,1,0.990137005149255,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1541,GO:0003332,1,0.966749375682321,0,4,negative regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003334,1,0.918043228560525,0,9,keratinocyte development,BP,
1544,GO:0003335,1,0.991443591438834,0,2,corneocyte development,BP,
1548,GO:0003340,1,0.983832185806269,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1549,GO:0003341,1,0.421339389381104,0,121,cilium movement,BP,
1550,GO:0003342,1,0.99060839455216,0,2,proepicardium development,BP,
1551,GO:0003343,1,0.99060839455216,0,2,septum transversum development,BP,
1552,GO:0003344,1,0.911620238574533,0,9,pericardium morphogenesis,BP,
1553,GO:0003345,1,0.992688598789605,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1554,GO:0003348,1,0.949207391265306,0,6,cardiac endothelial cell differentiation,BP,
1555,GO:0003350,1,0.98626573010808,0,2,pulmonary myocardium development,BP,
1556,GO:0003351,1,0.796665021385112,0,27,epithelial cilium movement involved in extracellular fluid movement,BP,
1557,GO:0003352,1,0.866873985937264,0,25,regulation of cilium movement,BP,
1558,GO:0003353,1,0.956815778843042,0,10,positive regulation of cilium movement,BP,
1559,GO:0003354,1,0.996154746580108,0,1,negative regulation of cilium movement,BP,
1560,GO:0003356,1,0.92053793765789,0,11,regulation of cilium beat frequency,BP,
1561,GO:0003357,1,0.957189013935033,0,6,noradrenergic neuron differentiation,BP,
1562,GO:0003358,1,0.990213446395411,0,2,noradrenergic neuron development,BP,
1563,GO:0003359,1,0.995394952611099,0,1,noradrenergic neuron fate commitment,BP,
1564,GO:0003360,1,0.943591721777965,0,6,brainstem development,BP,
1565,GO:0003365,1,0.961256534190572,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1566,GO:0003366,1,0.983274297093685,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1567,GO:0003373,1,0.937029258191466,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1568,GO:0003374,1,0.937029258191466,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1569,GO:0003376,1,0.94612213875975,0,10,sphingosine-1-phosphate receptor signaling pathway,BP,
1570,GO:0003382,1,0.741352970525005,0,32,epithelial cell morphogenesis,BP,
1571,GO:0003383,1,0.951957822200351,0,4,apical constriction,BP,
1572,GO:0003400,1,0.974101094811901,0,4,regulation of COPII vesicle coating,BP,
1573,GO:0003401,1,0.797075954365449,0,28,axis elongation,BP,
1574,GO:0003402,1,0.95019912547011,0,6,planar cell polarity pathway involved in axis elongation,BP,
1575,GO:0003404,1,0.989218492284067,0,2,optic vesicle morphogenesis,BP,
1576,GO:0003406,1,0.963988603382673,0,5,retinal pigment epithelium development,BP,
1578,GO:0003408,1,0.968039308996132,0,3,optic cup formation involved in camera-type eye development,BP,
1579,GO:0003409,1,0.993868351749194,0,1,optic cup structural organization,BP,
1580,GO:0003413,1,0.902454905419924,0,14,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1581,GO:0003414,1,0.99277493391596,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1582,GO:0003415,1,0.965353034778872,0,5,chondrocyte hypertrophy,BP,
1583,GO:0003416,1,0.8321984719355,0,27,endochondral bone growth,BP,
1584,GO:0003417,1,0.891777752286552,0,19,growth plate cartilage development,BP,
1585,GO:0003418,1,0.941076355497344,0,9,growth plate cartilage chondrocyte differentiation,BP,
1586,GO:0003419,1,0.983558394963826,0,4,growth plate cartilage chondrocyte proliferation,BP,
1587,GO:0003420,1,0.989866992071889,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003421,1,0.992681321135424,0,1,growth plate cartilage axis specification,BP,
1589,GO:0003422,1,0.98550860838438,0,2,growth plate cartilage morphogenesis,BP,
1590,GO:0003429,1,0.99277493391596,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1591,GO:0003430,1,0.978582611789233,0,3,growth plate cartilage chondrocyte growth,BP,
1592,GO:0003431,1,0.963956477999725,0,5,growth plate cartilage chondrocyte development,BP,
1593,GO:0003433,1,0.94334604386124,0,8,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003680,1,0.95498218667046,0,7,minor groove of adenine-thymine-rich DNA binding,MF,
1599,GO:0003681,1,0.994271947123789,0,1,bent DNA binding,MF,
1600,GO:0003682,1,0.0161419286670989,0,529,chromatin binding,MF,
1601,GO:0003684,1,0.640431231825679,0,63,damaged DNA binding,MF,
1602,GO:0003688,1,0.87151051912036,0,23,DNA replication origin binding,MF,
1603,GO:0003689,1,0.955769005394902,0,9,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.950007176904252,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.995829362628576,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.97166830098356,0,4,satellite DNA binding,MF,
1610,GO:0003707,1,0.805601171350587,0,25,steroid hormone receptor activity,MF,
1611,GO:0003711,1,0.985528918900579,0,2,transcription elongation regulator activity,MF,
1612,GO:0003712,1,0.0337332634440014,0,464,transcription coregulator activity,MF,
1613,GO:0003713,1,0.154930946541635,0,253,transcription coactivator activity,MF,
1614,GO:0003714,1,0.262838462465011,0,181,transcription corepressor activity,MF,
1615,GO:0003720,1,0.954090409763126,0,6,telomerase activity,MF,
1616,GO:0003721,1,0.992411688368383,0,1,telomerase RNA reverse transcriptase activity,MF,
1618,GO:0003724,1,0.602226810553005,0,72,RNA helicase activity,MF,
1620,GO:0003726,1,0.967395631330987,0,4,double-stranded RNA adenosine deaminase activity,MF,
1623,GO:0003730,1,0.541187593454054,0,86,mRNA 3'-UTR binding,MF,
1624,GO:0003735,1,0.582028012843527,0,153,structural constituent of ribosome,MF,
1625,GO:0003743,1,0.753138029651014,0,49,translation initiation factor activity,MF,
1626,GO:0003746,1,0.905790007490861,0,17,translation elongation factor activity,MF,
1627,GO:0003747,1,0.959981872812965,0,6,translation release factor activity,MF,
1628,GO:0003755,1,0.870162190954241,0,30,peptidyl-prolyl cis-trans isomerase activity,MF,
1629,GO:0003756,1,0.909242974568795,0,16,protein disulfide isomerase activity,MF,
1630,GO:0003774,1,0.245497887806338,0,124,motor activity,MF,
1631,GO:0003777,1,0.421312558561918,0,74,microtubule motor activity,MF,
1633,GO:0003785,1,0.861704471751087,0,24,actin monomer binding,MF,
1634,GO:0003796,1,0.993348823944364,0,2,lysozyme activity,MF,
1635,GO:0003810,1,0.962735718127932,0,7,protein-glutamine gamma-glutamyltransferase activity,MF,
1636,GO:0003823,1,0.768635037110379,0,52,antigen binding,MF,
1638,GO:0003826,1,0.991458647421007,0,2,alpha-ketoacid dehydrogenase activity,MF,
1639,GO:0003827,1,0.994611286164918,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1641,GO:0003829,1,0.98296235344739,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003830,1,0.990380241034033,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003831,1,0.971845901547134,0,5,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1644,GO:0003834,1,0.989646160058766,0,2,beta-carotene 15,15'-monooxygenase activity,MF,
1645,GO:0003835,1,0.979028864936051,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1646,GO:0003836,1,0.974951777175938,0,3,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1647,GO:0003837,1,0.995980619695328,0,1,beta-ureidopropionase activity,MF,
1648,GO:0003839,1,0.990011336336505,0,3,gamma-glutamylcyclotransferase activity,MF,
1649,GO:0003841,1,0.894601019439507,0,14,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1650,GO:0003842,1,0.993968953500063,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1651,GO:0003844,1,0.994248477082807,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1652,GO:0003845,1,0.992828763129062,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1653,GO:0003846,1,0.988469323204644,0,2,2-acylglycerol O-acyltransferase activity,MF,
1654,GO:0003847,1,0.970484817819009,0,7,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1655,GO:0003851,1,0.99464594393384,0,1,2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity,MF,
1656,GO:0003854,1,0.987243620929708,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.964685029441888,0,8,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.988316898707568,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.996152457272457,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.991458647421007,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.990823992165876,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.990584166653363,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.99641566052401,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.991657842753145,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.983389729457766,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.971574169929113,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.996816752933256,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.98991582605139,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.984733058752411,0,2,AMP deaminase activity,MF,
1670,GO:0003878,1,0.991690080629105,0,1,ATP citrate synthase activity,MF,
1671,GO:0003880,1,0.987495296789046,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1672,GO:0003881,1,0.996214491728388,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1673,GO:0003882,1,0.995431817170293,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1674,GO:0003883,1,0.987460446748115,0,2,CTP synthase activity,MF,
1675,GO:0003884,1,0.992942933145261,0,2,D-amino-acid oxidase activity,MF,
1676,GO:0003886,1,0.974213734181369,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1677,GO:0003887,1,0.836050197926713,0,23,DNA-directed DNA polymerase activity,MF,
1678,GO:0003896,1,0.987195416639734,0,3,DNA primase activity,MF,
1679,GO:0003899,1,0.820427260104583,0,37,DNA-directed 5'-3' RNA polymerase activity,MF,
1680,GO:0003905,1,0.996767636191414,0,1,alkylbase DNA N-glycosylase activity,MF,
1681,GO:0003906,1,0.946865653038511,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1682,GO:0003908,1,0.996689832431374,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1683,GO:0003909,1,0.980373895347,0,3,DNA ligase activity,MF,
1684,GO:0003910,1,0.980373895347,0,3,DNA ligase (ATP) activity,MF,
1685,GO:0003912,1,0.996016763282003,0,1,DNA nucleotidylexotransferase activity,MF,
1686,GO:0003916,1,0.955375494761393,0,6,DNA topoisomerase activity,MF,
1687,GO:0003917,1,0.975723409466779,0,4,DNA topoisomerase type I (single strand cut, ATP-independent) activity,MF,
1688,GO:0003918,1,0.97915088282969,0,2,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity,MF,
1689,GO:0003919,1,0.996102280169004,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.99275530522785,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.995409423158449,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.995409423158449,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.981920336285249,0,3,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.996124675943206,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.996124675943206,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.995945686882425,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.991740888996352,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.995305280149271,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.995816187204086,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.988511811013923,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.987762244587429,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.995798032171201,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.971024968441872,0,5,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.994430816996473,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.995957405259747,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.862987469059072,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.881589194276324,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.995442960961871,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1710,GO:0003953,1,0.898281725630931,0,16,NAD+ nucleosidase activity,MF,
1711,GO:0003954,1,0.874333615178542,0,38,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.985742356409766,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.989627858110153,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.991056744478635,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1715,GO:0003958,1,0.954573190171815,0,6,NADPH-hemoprotein reductase activity,MF,
1716,GO:0003960,1,0.984929400662222,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003963,1,0.994890876864838,0,1,RNA-3'-phosphate cyclase activity,MF,
1718,GO:0003964,1,0.954090409763126,0,6,RNA-directed DNA polymerase activity,MF,
1719,GO:0003968,1,0.979915192916939,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1720,GO:0003972,1,0.994890876864838,0,1,RNA ligase (ATP) activity,MF,
1721,GO:0003973,1,0.981263648946833,0,3,(S)-2-hydroxy-acid oxidase activity,MF,
1722,GO:0003974,1,0.996462883021595,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1723,GO:0003975,1,0.99588330378555,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1724,GO:0003976,1,0.98189388999536,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003977,1,0.989377498053141,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1726,GO:0003978,1,0.996462883021595,0,1,UDP-glucose 4-epimerase activity,MF,
1727,GO:0003979,1,0.994078766715654,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1728,GO:0003980,1,0.97069687329084,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1729,GO:0003983,1,0.995884651613967,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1730,GO:0003984,1,0.995653649421474,0,1,acetolactate synthase activity,MF,
1731,GO:0003985,1,0.983014227043059,0,4,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.982240126473096,0,5,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.980424724656974,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.971924756341407,0,7,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.982657129529842,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.990685639674056,0,2,acetylcholinesterase activity,MF,
1737,GO:0003993,1,0.977674017560043,0,6,acid phosphatase activity,MF,
1738,GO:0003994,1,0.976242312533794,0,3,aconitate hydratase activity,MF,
1739,GO:0003995,1,0.936986033521799,0,11,acyl-CoA dehydrogenase activity,MF,
1740,GO:0003996,1,0.928464905731634,0,13,acyl-CoA ligase activity,MF,
1741,GO:0003997,1,0.963082047813885,0,6,acyl-CoA oxidase activity,MF,
1742,GO:0003998,1,0.993596439891043,0,2,acylphosphatase activity,MF,
1743,GO:0003999,1,0.996859833881271,0,1,adenine phosphoribosyltransferase activity,MF,
1744,GO:0004000,1,0.935073201592969,0,10,adenosine deaminase activity,MF,
1745,GO:0004001,1,0.996001003871741,0,1,adenosine kinase activity,MF,
1746,GO:0004013,1,0.995675829553584,0,1,adenosylhomocysteinase activity,MF,
1747,GO:0004014,1,0.993941860303577,0,1,adenosylmethionine decarboxylase activity,MF,
1748,GO:0004016,1,0.892384347297116,0,10,adenylate cyclase activity,MF,
1749,GO:0004017,1,0.949263474640303,0,9,adenylate kinase activity,MF,
1750,GO:0004018,1,0.99656258692143,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1751,GO:0004020,1,0.988030783400239,0,2,adenylylsulfate kinase activity,MF,
1752,GO:0004021,1,0.988809489177916,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1753,GO:0004022,1,0.978862433171759,0,5,alcohol dehydrogenase (NAD+) activity,MF,
1754,GO:0004024,1,0.986303602316538,0,3,alcohol dehydrogenase activity, zinc-dependent,MF,
1755,GO:0004027,1,0.996708346551797,0,1,alcohol sulfotransferase activity,MF,
1756,GO:0004028,1,0.978117234922693,0,4,3-chloroallyl aldehyde dehydrogenase activity,MF,
1757,GO:0004029,1,0.918141282366377,0,14,aldehyde dehydrogenase (NAD+) activity,MF,
1758,GO:0004030,1,0.914550254353739,0,15,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1759,GO:0004031,1,0.985895435497158,0,2,aldehyde oxidase activity,MF,
1760,GO:0004032,1,0.962551133683784,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1761,GO:0004033,1,0.905478900969104,0,25,aldo-keto reductase (NADP) activity,MF,
1762,GO:0004034,1,0.995378806480956,0,1,aldose 1-epimerase activity,MF,
1763,GO:0004035,1,0.989944877173835,0,2,alkaline phosphatase activity,MF,
1764,GO:0004037,1,0.996583423867145,0,1,allantoicase activity,MF,
1765,GO:0004040,1,0.992583290267981,0,2,amidase activity,MF,
1766,GO:0004042,1,0.995978055021198,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1767,GO:0004043,1,0.993329904932893,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1768,GO:0004044,1,0.992945637586108,0,1,amidophosphoribosyltransferase activity,MF,
1769,GO:0004045,1,0.988627412862254,0,3,aminoacyl-tRNA hydrolase activity,MF,
1770,GO:0004046,1,0.985624669854786,0,4,aminoacylase activity,MF,
1771,GO:0004047,1,0.992537873090291,0,2,aminomethyltransferase activity,MF,
1772,GO:0004051,1,0.995255489379337,0,1,arachidonate 5-lipoxygenase activity,MF,
1773,GO:0004052,1,0.986001209530717,0,3,arachidonate 12(S)-lipoxygenase activity,MF,
1774,GO:0004053,1,0.992688132673555,0,2,arginase activity,MF,
1775,GO:0004055,1,0.996265080058039,0,1,argininosuccinate synthase activity,MF,
1776,GO:0004056,1,0.996077722109172,0,1,argininosuccinate lyase activity,MF,
1777,GO:0004057,1,0.995786788202415,0,1,arginyltransferase activity,MF,
1778,GO:0004058,1,0.996044143436566,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1779,GO:0004059,1,0.996570081355208,0,1,aralkylamine N-acetyltransferase activity,MF,
1780,GO:0004060,1,0.989320557578306,0,3,arylamine N-acetyltransferase activity,MF,
1781,GO:0004061,1,0.99639083166836,0,1,arylformamidase activity,MF,
1782,GO:0004062,1,0.983162439236108,0,5,aryl sulfotransferase activity,MF,
1783,GO:0004063,1,0.993073558237482,0,2,aryldialkylphosphatase activity,MF,
1784,GO:0004064,1,0.977705952422621,0,6,arylesterase activity,MF,
1785,GO:0004065,1,0.918895919820031,0,12,arylsulfatase activity,MF,
1786,GO:0004066,1,0.99104201511006,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1787,GO:0004067,1,0.991794020504297,0,2,asparaginase activity,MF,
1788,GO:0004068,1,0.995003072987144,0,1,aspartate 1-decarboxylase activity,MF,
1789,GO:0004069,1,0.991352183790309,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1790,GO:0004070,1,0.986421967847451,0,1,aspartate carbamoyltransferase activity,MF,
1791,GO:0004074,1,0.993616490549402,0,2,biliverdin reductase (NAD(P)+) activity,MF,
1792,GO:0004075,1,0.995275478738233,0,1,biotin carboxylase activity,MF,
1793,GO:0004077,1,0.988496772383391,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1794,GO:0004078,1,0.988496772383391,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1795,GO:0004079,1,0.988496772383391,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1796,GO:0004080,1,0.988496772383391,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1797,GO:0004081,1,0.996800786663507,0,1,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1798,GO:0004082,1,0.985833784560178,0,4,bisphosphoglycerate mutase activity,MF,
1799,GO:0004084,1,0.980934409095038,0,2,branched-chain-amino-acid transaminase activity,MF,
1800,GO:0004085,1,0.987352385456587,0,2,butyryl-CoA dehydrogenase activity,MF,
1801,GO:0004087,1,0.988987312397286,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1802,GO:0004088,1,0.975557338234828,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1803,GO:0004089,1,0.934297797589963,0,14,carbonate dehydratase activity,MF,
1804,GO:0004090,1,0.98349627817071,0,5,carbonyl reductase (NADPH) activity,MF,
1805,GO:0004092,1,0.994792934358987,0,1,carnitine O-acetyltransferase activity,MF,
1806,GO:0004095,1,0.976894690264778,0,4,carnitine O-palmitoyltransferase activity,MF,
1807,GO:0004096,1,0.983092959846662,0,4,catalase activity,MF,
1808,GO:0004098,1,0.996181346019262,0,1,cerebroside-sulfatase activity,MF,
1809,GO:0004102,1,0.995404606085471,0,1,choline O-acetyltransferase activity,MF,
1810,GO:0004103,1,0.991485533615363,0,2,choline kinase activity,MF,
1811,GO:0004104,1,0.985754836222411,0,3,cholinesterase activity,MF,
1812,GO:0004105,1,0.986001530038711,0,2,choline-phosphate cytidylyltransferase activity,MF,
1813,GO:0004108,1,0.994495870857179,0,1,citrate (Si)-synthase activity,MF,
1814,GO:0004109,1,0.990368755362824,0,2,coproporphyrinogen oxidase activity,MF,
1815,GO:0004111,1,0.969033408653344,0,6,creatine kinase activity,MF,
1816,GO:0004112,1,0.819757549868482,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1817,GO:0004113,1,0.989998632677009,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1818,GO:0004114,1,0.832314954822307,0,21,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1819,GO:0004115,1,0.899520622331778,0,12,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1820,GO:0004117,1,0.98469190276325,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1821,GO:0004118,1,0.961702077388101,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004119,1,0.980578979329288,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004122,1,0.995183075943713,0,1,cystathionine beta-synthase activity,MF,
1824,GO:0004123,1,0.996346806019679,0,1,cystathionine gamma-lyase activity,MF,
1825,GO:0004126,1,0.959267045663034,0,10,cytidine deaminase activity,MF,
1826,GO:0004127,1,0.979351422968285,0,4,cytidylate kinase activity,MF,
1827,GO:0004128,1,0.967839274728103,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1828,GO:0004129,1,0.9240318034323,0,21,cytochrome-c oxidase activity,MF,
1829,GO:0004132,1,0.996031754515466,0,1,dCMP deaminase activity,MF,
1830,GO:0004133,1,0.986306424654686,0,1,glycogen debranching enzyme activity,MF,
1831,GO:0004134,1,0.986306424654686,0,1,4-alpha-glucanotransferase activity,MF,
1832,GO:0004135,1,0.986306424654686,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1833,GO:0004136,1,0.991986846858326,0,2,deoxyadenosine kinase activity,MF,
1834,GO:0004137,1,0.985547325768434,0,2,deoxycytidine kinase activity,MF,
1835,GO:0004138,1,0.991986846858326,0,2,deoxyguanosine kinase activity,MF,
1836,GO:0004139,1,0.996363308056365,0,1,deoxyribose-phosphate aldolase activity,MF,
1837,GO:0004140,1,0.991700204556423,0,2,dephospho-CoA kinase activity,MF,
1838,GO:0004142,1,0.983653657599457,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1839,GO:0004143,1,0.91283327366833,0,10,diacylglycerol kinase activity,MF,
1840,GO:0004144,1,0.988469323204644,0,2,diacylglycerol O-acyltransferase activity,MF,
1841,GO:0004145,1,0.984378527618955,0,3,diamine N-acetyltransferase activity,MF,
1842,GO:0004146,1,0.992594048614084,0,1,dihydrofolate reductase activity,MF,
1843,GO:0004148,1,0.993282280062323,0,1,dihydrolipoyl dehydrogenase activity,MF,
1844,GO:0004149,1,0.994739690112676,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1845,GO:0004151,1,0.986421967847451,0,1,dihydroorotase activity,MF,
1846,GO:0004152,1,0.995983180678702,0,1,dihydroorotate dehydrogenase activity,MF,
1847,GO:0004155,1,0.996431190033839,0,1,6,7-dihydropteridine reductase activity,MF,
1848,GO:0004157,1,0.995907428906688,0,1,dihydropyrimidinase activity,MF,
1849,GO:0004161,1,0.991390266117537,0,2,dimethylallyltranstransferase activity,MF,
1850,GO:0004163,1,0.996292277288225,0,1,diphosphomevalonate decarboxylase activity,MF,
1851,GO:0004164,1,0.996300341446394,0,1,diphthine synthase activity,MF,
1852,GO:0004165,1,0.982489743386171,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1853,GO:0004167,1,0.989384635154915,0,3,dopachrome isomerase activity,MF,
1854,GO:0004168,1,0.995809221611913,0,1,dolichol kinase activity,MF,
1855,GO:0004169,1,0.931007948292554,0,9,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1856,GO:0004170,1,0.996215580774424,0,1,dUTP diphosphatase activity,MF,
1857,GO:0004174,1,0.989592287335449,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1859,GO:0004176,1,0.971092679724481,0,5,ATP-dependent peptidase activity,MF,
1860,GO:0004177,1,0.768816186599273,0,43,aminopeptidase activity,MF,
1861,GO:0004180,1,0.807164313324169,0,37,carboxypeptidase activity,MF,
1862,GO:0004181,1,0.857314311224707,0,25,metallocarboxypeptidase activity,MF,
1863,GO:0004185,1,0.96921316545083,0,5,serine-type carboxypeptidase activity,MF,
1864,GO:0004190,1,0.907594126923346,0,18,aspartic-type endopeptidase activity,MF,
1865,GO:0004197,1,0.520577883337439,0,87,cysteine-type endopeptidase activity,MF,
1866,GO:0004198,1,0.937631541418636,0,11,calcium-dependent cysteine-type endopeptidase activity,MF,
1867,GO:0004222,1,0.496590176517532,0,92,metalloendopeptidase activity,MF,
1869,GO:0004298,1,0.942113667138449,0,18,threonine-type endopeptidase activity,MF,
1870,GO:0004300,1,0.955806548481036,0,10,enoyl-CoA hydratase activity,MF,
1871,GO:0004301,1,0.976761932652588,0,6,epoxide hydrolase activity,MF,
1872,GO:0004303,1,0.959065198276261,0,11,estradiol 17-beta-dehydrogenase activity,MF,
1873,GO:0004304,1,0.996310325520138,0,1,estrone sulfotransferase activity,MF,
1874,GO:0004305,1,0.979207075713862,0,4,ethanolamine kinase activity,MF,
1875,GO:0004306,1,0.996231793101294,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1876,GO:0004307,1,0.992540065586716,0,2,ethanolaminephosphotransferase activity,MF,
1877,GO:0004308,1,0.986566604142633,0,3,exo-alpha-sialidase activity,MF,
1878,GO:0004309,1,0.959170659915843,0,4,exopolyphosphatase activity,MF,
1879,GO:0004310,1,0.995932580157358,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1880,GO:0004311,1,0.985280410590907,0,3,farnesyltranstransferase activity,MF,
1881,GO:0004312,1,0.939152877397809,0,10,fatty acid synthase activity,MF,
1882,GO:0004313,1,0.98403052900273,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1883,GO:0004314,1,0.980222221373661,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1884,GO:0004315,1,0.980767216109676,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1885,GO:0004316,1,0.98403052900273,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1886,GO:0004317,1,0.98403052900273,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1887,GO:0004320,1,0.980422343982843,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1888,GO:0004321,1,0.982331885294858,0,4,fatty-acyl-CoA synthase activity,MF,
1889,GO:0004322,1,0.951910867446098,0,6,ferroxidase activity,MF,
1890,GO:0004324,1,0.996188048293622,0,1,ferredoxin-NADP+ reductase activity,MF,
1891,GO:0004325,1,0.986191090868325,0,1,ferrochelatase activity,MF,
1892,GO:0004326,1,0.995367462028409,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1893,GO:0004329,1,0.98677918291178,0,2,formate-tetrahydrofolate ligase activity,MF,
1894,GO:0004331,1,0.971574169929113,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1895,GO:0004332,1,0.988459600158994,0,3,fructose-bisphosphate aldolase activity,MF,
1896,GO:0004333,1,0.996300341446394,0,1,fumarate hydratase activity,MF,
1897,GO:0004334,1,0.996578795406472,0,1,fumarylacetoacetase activity,MF,
1898,GO:0004335,1,0.990787608896491,0,2,galactokinase activity,MF,
1899,GO:0004336,1,0.991053052485728,0,2,galactosylceramidase activity,MF,
1900,GO:0004337,1,0.991390266117537,0,2,geranyltranstransferase activity,MF,
1901,GO:0004339,1,0.987552180723627,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1902,GO:0004340,1,0.962430080048406,0,5,glucokinase activity,MF,
1903,GO:0004341,1,0.996154746580108,0,1,gluconolactonase activity,MF,
1904,GO:0004342,1,0.991852276216149,0,2,glucosamine-6-phosphate deaminase activity,MF,
1905,GO:0004343,1,0.992573288256797,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1906,GO:0004344,1,0.982965478178739,0,1,glucose dehydrogenase activity,MF,
1907,GO:0004345,1,0.978643096879938,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1908,GO:0004346,1,0.985210455307856,0,3,glucose-6-phosphatase activity,MF,
1909,GO:0004347,1,0.995958702741933,0,1,glucose-6-phosphate isomerase activity,MF,
1910,GO:0004348,1,0.985187970489709,0,3,glucosylceramidase activity,MF,
1911,GO:0004349,1,0.993519709717117,0,1,glutamate 5-kinase activity,MF,
1912,GO:0004350,1,0.993519709717117,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1913,GO:0004351,1,0.990710087723568,0,2,glutamate decarboxylase activity,MF,
1914,GO:0004352,1,0.989144021087264,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1915,GO:0004353,1,0.989144021087264,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1916,GO:0004356,1,0.991678996243949,0,1,glutamate-ammonia ligase activity,MF,
1917,GO:0004357,1,0.987345713161486,0,2,glutamate-cysteine ligase activity,MF,
1918,GO:0004359,1,0.982376103821297,0,3,glutaminase activity,MF,
1919,GO:0004360,1,0.978256346077414,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1920,GO:0004361,1,0.996377189990659,0,1,glutaryl-CoA dehydrogenase activity,MF,
1921,GO:0004362,1,0.995708031135128,0,1,glutathione-disulfide reductase activity,MF,
1922,GO:0004363,1,0.996177981246907,0,1,glutathione synthase activity,MF,
1923,GO:0004364,1,0.927079877334145,0,20,glutathione transferase activity,MF,
1924,GO:0004365,1,0.996664269302455,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1925,GO:0004366,1,0.98263145838392,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1926,GO:0004367,1,0.994693441098482,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1927,GO:0004368,1,0.983416006431856,0,2,glycerol-3-phosphate dehydrogenase (quinone) activity,MF,
1928,GO:0004370,1,0.974101814469426,0,2,glycerol kinase activity,MF,
1929,GO:0004372,1,0.991188185081593,0,2,glycine hydroxymethyltransferase activity,MF,
1930,GO:0004373,1,0.987799733126833,0,2,glycogen (starch) synthase activity,MF,
1931,GO:0004375,1,0.992783258733263,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1932,GO:0004376,1,0.973361672286551,0,5,glycolipid mannosyltransferase activity,MF,
1933,GO:0004377,1,0.99529537084545,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1934,GO:0004378,1,0.994639399754126,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1935,GO:0004379,1,0.981133110354137,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1936,GO:0004380,1,0.996488443237661,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1937,GO:0004381,1,0.996488443237661,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1938,GO:0004382,1,0.989529511560533,0,2,guanosine-diphosphatase activity,MF,
1939,GO:0004383,1,0.97356615379557,0,4,guanylate cyclase activity,MF,
1940,GO:0004385,1,0.921325507047677,0,9,guanylate kinase activity,MF,
1942,GO:0004392,1,0.99287403045981,0,2,heme oxygenase (decyclizing) activity,MF,
1943,GO:0004394,1,0.992078693768814,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1944,GO:0004395,1,0.996689329953739,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1945,GO:0004396,1,0.962430080048406,0,5,hexokinase activity,MF,
1946,GO:0004397,1,0.994159995566144,0,1,histidine ammonia-lyase activity,MF,
1947,GO:0004398,1,0.995495011965105,0,1,histidine decarboxylase activity,MF,
1948,GO:0004402,1,0.680964496712346,0,48,histone acetyltransferase activity,MF,
1949,GO:0004407,1,0.833116663316039,0,25,histone deacetylase activity,MF,
1950,GO:0004408,1,0.995681713630481,0,1,holocytochrome-c synthase activity,MF,
1951,GO:0004411,1,0.996154174627011,0,1,homogentisate 1,2-dioxygenase activity,MF,
1952,GO:0004415,1,0.978600695730639,0,5,hyalurononglucosaminidase activity,MF,
1953,GO:0004416,1,0.991000954236584,0,2,hydroxyacylglutathione hydrolase activity,MF,
1954,GO:0004418,1,0.996570081355208,0,1,hydroxymethylbilane synthase activity,MF,
1955,GO:0004419,1,0.991884755918266,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1956,GO:0004420,1,0.99137827023303,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1957,GO:0004421,1,0.989023990762747,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1958,GO:0004422,1,0.996604021233342,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1959,GO:0004423,1,0.988878404844315,0,1,iduronate-2-sulfatase activity,MF,
1960,GO:0004427,1,0.989624718312124,0,3,inorganic diphosphatase activity,MF,
1961,GO:0004430,1,0.969725673123336,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1962,GO:0004435,1,0.821823631053949,0,24,phosphatidylinositol phospholipase C activity,MF,
1963,GO:0004438,1,0.857201575407771,0,17,phosphatidylinositol-3-phosphatase activity,MF,
1964,GO:0004439,1,0.927047142082073,0,9,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1965,GO:0004441,1,0.995954157559585,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1966,GO:0004445,1,0.959565679476537,0,6,inositol-polyphosphate 5-phosphatase activity,MF,
1967,GO:0004446,1,0.994748901495519,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1968,GO:0004447,1,0.994539588658084,0,1,iodide peroxidase activity,MF,
1969,GO:0004448,1,0.980195434075436,0,5,isocitrate dehydrogenase activity,MF,
1970,GO:0004449,1,0.988114732555682,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1971,GO:0004450,1,0.991986404638506,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1972,GO:0004452,1,0.995898081151283,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1973,GO:0004454,1,0.995484038098491,0,1,ketohexokinase activity,MF,
1974,GO:0004457,1,0.981091450380295,0,5,lactate dehydrogenase activity,MF,
1975,GO:0004458,1,0.996023026087141,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1976,GO:0004459,1,0.985009400208006,0,4,L-lactate dehydrogenase activity,MF,
1977,GO:0004461,1,0.984883833747356,0,3,lactose synthase activity,MF,
1978,GO:0004462,1,0.996013623086257,0,1,lactoylglutathione lyase activity,MF,
1979,GO:0004463,1,0.995976771301393,0,1,leukotriene-A4 hydrolase activity,MF,
1980,GO:0004464,1,0.984153801472756,0,5,leukotriene-C4 synthase activity,MF,
1981,GO:0004465,1,0.977116353820293,0,4,lipoprotein lipase activity,MF,
1982,GO:0004466,1,0.979753112456385,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1983,GO:0004467,1,0.924688172647023,0,13,long-chain fatty acid-CoA ligase activity,MF,
1984,GO:0004468,1,0.963378038664601,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1985,GO:0004470,1,0.977663888293876,0,4,malic enzyme activity,MF,
1986,GO:0004471,1,0.980914975103104,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1987,GO:0004473,1,0.980914975103104,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1988,GO:0004474,1,0.988951615016751,0,1,malate synthase activity,MF,
1989,GO:0004475,1,0.996469368901463,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1990,GO:0004476,1,0.996318235555698,0,1,mannose-6-phosphate isomerase activity,MF,
1991,GO:0004477,1,0.984920511788859,0,3,methenyltetrahydrofolate cyclohydrolase activity,MF,
1992,GO:0004478,1,0.988482257895467,0,2,methionine adenosyltransferase activity,MF,
1993,GO:0004479,1,0.994926741713297,0,1,methionyl-tRNA formyltransferase activity,MF,
1994,GO:0004482,1,0.988135863387112,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1995,GO:0004483,1,0.989807596705769,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1996,GO:0004484,1,0.991460171793269,0,1,mRNA guanylyltransferase activity,MF,
1997,GO:0004485,1,0.988390804671299,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1998,GO:0004486,1,0.984920511788859,0,3,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1999,GO:0004487,1,0.984920511788859,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2000,GO:0004488,1,0.984920511788859,0,3,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2001,GO:0004489,1,0.986402093948128,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2002,GO:0004490,1,0.996480565152294,0,1,methylglutaconyl-CoA hydratase activity,MF,
2003,GO:0004491,1,0.995828671124588,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2004,GO:0004493,1,0.996833352720764,0,1,methylmalonyl-CoA epimerase activity,MF,
2005,GO:0004496,1,0.995977413276461,0,1,mevalonate kinase activity,MF,
2006,GO:0004497,1,0.63990573381689,0,78,monooxygenase activity,MF,
2007,GO:0004498,1,0.995367462028409,0,1,calcidiol 1-monooxygenase activity,MF,
2008,GO:0004499,1,0.973448070825167,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2009,GO:0004500,1,0.989296059771533,0,2,dopamine beta-monooxygenase activity,MF,
2010,GO:0004502,1,0.990378304276012,0,1,kynurenine 3-monooxygenase activity,MF,
2011,GO:0004503,1,0.994691584553626,0,1,monophenol monooxygenase activity,MF,
2012,GO:0004504,1,0.992986227776736,0,1,peptidylglycine monooxygenase activity,MF,
2013,GO:0004505,1,0.987429452679694,0,3,phenylalanine 4-monooxygenase activity,MF,
2014,GO:0004506,1,0.994474879033118,0,1,squalene monooxygenase activity,MF,
2015,GO:0004509,1,0.996034860613632,0,1,steroid 21-monooxygenase activity,MF,
2016,GO:0004510,1,0.991852867772992,0,2,tryptophan 5-monooxygenase activity,MF,
2017,GO:0004511,1,0.996179103846318,0,1,tyrosine 3-monooxygenase activity,MF,
2018,GO:0004512,1,0.995718194201822,0,1,inositol-3-phosphate synthase activity,MF,
2019,GO:0004513,1,0.995649191738072,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2020,GO:0004514,1,0.98273559728423,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2021,GO:0004515,1,0.968055601546178,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2022,GO:0004516,1,0.994890876864838,0,1,nicotinate phosphoribosyltransferase activity,MF,
2023,GO:0004517,1,0.973988540145112,0,3,nitric-oxide synthase activity,MF,
2024,GO:0004518,1,0.295305880596509,0,189,nuclease activity,MF,
2025,GO:0004519,1,0.502542567796766,0,112,endonuclease activity,MF,
2026,GO:0004520,1,0.792307947826933,0,37,endodeoxyribonuclease activity,MF,
2027,GO:0004521,1,0.688886878418061,0,59,endoribonuclease activity,MF,
2028,GO:0004522,1,0.990222372431339,0,3,ribonuclease A activity,MF,
2029,GO:0004523,1,0.976285229888243,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2030,GO:0004525,1,0.964183522584255,0,4,ribonuclease III activity,MF,
2031,GO:0004526,1,0.95446995466897,0,10,ribonuclease P activity,MF,
2032,GO:0004527,1,0.589999414409988,0,78,exonuclease activity,MF,
2033,GO:0004528,1,0.962111097390843,0,6,phosphodiesterase I activity,MF,
2034,GO:0004529,1,0.886312818455,0,22,exodeoxyribonuclease activity,MF,
2035,GO:0004530,1,0.963643161429091,0,5,deoxyribonuclease I activity,MF,
2036,GO:0004531,1,0.992820015111555,0,2,deoxyribonuclease II activity,MF,
2037,GO:0004532,1,0.760915487796029,0,39,exoribonuclease activity,MF,
2038,GO:0004534,1,0.958612635162832,0,3,5'-3' exoribonuclease activity,MF,
2039,GO:0004535,1,0.900679019623589,0,13,poly(A)-specific ribonuclease activity,MF,
2040,GO:0004536,1,0.712803553404887,0,56,deoxyribonuclease activity,MF,
2041,GO:0004540,1,0.509512353433268,0,105,ribonuclease activity,MF,
2042,GO:0004549,1,0.939661470403119,0,13,tRNA-specific ribonuclease activity,MF,
2043,GO:0004550,1,0.929201383092467,0,17,nucleoside diphosphate kinase activity,MF,
2044,GO:0004551,1,0.916759330903865,0,16,nucleotide diphosphatase activity,MF,
2045,GO:0004553,1,0.651521110381949,0,70,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2046,GO:0004556,1,0.992293599957951,0,2,alpha-amylase activity,MF,
2047,GO:0004557,1,0.989612988136025,0,2,alpha-galactosidase activity,MF,
2048,GO:0004558,1,0.972248202658214,0,3,alpha-1,4-glucosidase activity,MF,
2049,GO:0004559,1,0.89262574526049,0,14,alpha-mannosidase activity,MF,
2050,GO:0004560,1,0.991884048571243,0,2,alpha-L-fucosidase activity,MF,
2051,GO:0004561,1,0.994869250143251,0,1,alpha-N-acetylglucosaminidase activity,MF,
2052,GO:0004563,1,0.984987775490433,0,3,beta-N-acetylhexosaminidase activity,MF,
2053,GO:0004565,1,0.970879037590909,0,6,beta-galactosidase activity,MF,
2054,GO:0004566,1,0.982493431486319,0,3,beta-glucuronidase activity,MF,
2055,GO:0004567,1,0.993825897365371,0,1,beta-mannosidase activity,MF,
2056,GO:0004568,1,0.985715365937881,0,3,chitinase activity,MF,
2057,GO:0004569,1,0.991260791890362,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2058,GO:0004571,1,0.943898797371684,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2059,GO:0004572,1,0.978258664640206,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2060,GO:0004573,1,0.994959713615781,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2061,GO:0004576,1,0.974900517231133,0,6,oligosaccharyl transferase activity,MF,
2062,GO:0004577,1,0.994369141416316,0,1,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2063,GO:0004578,1,0.992548386943247,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2064,GO:0004579,1,0.978095847235721,0,5,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2065,GO:0004581,1,0.996733837250522,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2066,GO:0004582,1,0.990220791829669,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2067,GO:0004583,1,0.990106009118811,0,2,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2068,GO:0004585,1,0.996431190033839,0,1,ornithine carbamoyltransferase activity,MF,
2069,GO:0004586,1,0.987863332954613,0,2,ornithine decarboxylase activity,MF,
2070,GO:0004587,1,0.996090351479374,0,1,ornithine-oxo-acid transaminase activity,MF,
2071,GO:0004588,1,0.995088716568703,0,1,orotate phosphoribosyltransferase activity,MF,
2072,GO:0004590,1,0.995088716568703,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2073,GO:0004591,1,0.975264552487931,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2074,GO:0004594,1,0.985153071969479,0,3,pantothenate kinase activity,MF,
2075,GO:0004595,1,0.995666979213845,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2076,GO:0004596,1,0.939665049228928,0,10,peptide alpha-N-acetyltransferase activity,MF,
2077,GO:0004597,1,0.993187907411743,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2078,GO:0004598,1,0.992986227776736,0,1,peptidylamidoglycolate lyase activity,MF,
2079,GO:0004601,1,0.804654939962156,0,45,peroxidase activity,MF,
2080,GO:0004602,1,0.940576107885259,0,17,glutathione peroxidase activity,MF,
2081,GO:0004603,1,0.99674041724777,0,1,phenylethanolamine N-methyltransferase activity,MF,
2082,GO:0004605,1,0.981317395706333,0,3,phosphatidate cytidylyltransferase activity,MF,
2083,GO:0004607,1,0.996641368288431,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2084,GO:0004608,1,0.996799244009751,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2085,GO:0004609,1,0.990966984217418,0,2,phosphatidylserine decarboxylase activity,MF,
2086,GO:0004610,1,0.996069243493824,0,1,phosphoacetylglucosamine mutase activity,MF,
2087,GO:0004611,1,0.991169016876542,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2088,GO:0004613,1,0.991169016876542,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2089,GO:0004614,1,0.985506688777491,0,3,phosphoglucomutase activity,MF,
2090,GO:0004615,1,0.992320286829559,0,2,phosphomannomutase activity,MF,
2091,GO:0004616,1,0.996135740875937,0,1,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2092,GO:0004617,1,0.996043526239926,0,1,phosphoglycerate dehydrogenase activity,MF,
2093,GO:0004618,1,0.995469875416489,0,1,phosphoglycerate kinase activity,MF,
2094,GO:0004619,1,0.985833784560178,0,4,phosphoglycerate mutase activity,MF,
2096,GO:0004621,1,0.99567950861844,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2097,GO:0004622,1,0.888037868997791,0,22,lysophospholipase activity,MF,
2099,GO:0004629,1,0.813708326897436,0,26,phospholipase C activity,MF,
2100,GO:0004630,1,0.971023383656422,0,5,phospholipase D activity,MF,
2101,GO:0004631,1,0.99667282960388,0,1,phosphomevalonate kinase activity,MF,
2102,GO:0004632,1,0.996690584665961,0,1,phosphopantothenate--cysteine ligase activity,MF,
2103,GO:0004633,1,0.995781145853149,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2104,GO:0004634,1,0.983276580308383,0,4,phosphopyruvate hydratase activity,MF,
2105,GO:0004637,1,0.993572082836495,0,1,phosphoribosylamine-glycine ligase activity,MF,
2106,GO:0004638,1,0.99378130158399,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2107,GO:0004639,1,0.99378130158399,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2108,GO:0004641,1,0.993572082836495,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2109,GO:0004642,1,0.989643312273554,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2110,GO:0004643,1,0.995945686882425,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2111,GO:0004644,1,0.993572082836495,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2112,GO:0004645,1,0.962873852098128,0,6,1,4-alpha-oligoglucan phosphorylase activity,MF,
2113,GO:0004647,1,0.9884669587876,0,3,phosphoserine phosphatase activity,MF,
2114,GO:0004648,1,0.995916069763166,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2115,GO:0004649,1,0.991883220809669,0,1,poly(ADP-ribose) glycohydrolase activity,MF,
2116,GO:0004651,1,0.987929110133272,0,2,polynucleotide 5'-phosphatase activity,MF,
2117,GO:0004652,1,0.955693028937466,0,6,polynucleotide adenylyltransferase activity,MF,
2119,GO:0004654,1,0.991205193332263,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2120,GO:0004655,1,0.994092674639147,0,1,porphobilinogen synthase activity,MF,
2121,GO:0004656,1,0.97741697460535,0,5,procollagen-proline 4-dioxygenase activity,MF,
2122,GO:0004657,1,0.995781145853149,0,1,proline dehydrogenase activity,MF,
2123,GO:0004658,1,0.991685259312787,0,2,propionyl-CoA carboxylase activity,MF,
2124,GO:0004659,1,0.90268534707585,0,17,prenyltransferase activity,MF,
2125,GO:0004660,1,0.991278461913513,0,2,protein farnesyltransferase activity,MF,
2126,GO:0004661,1,0.976294009412255,0,5,protein geranylgeranyltransferase activity,MF,
2127,GO:0004662,1,0.991449188755883,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2128,GO:0004663,1,0.981239803528132,0,4,Rab geranylgeranyltransferase activity,MF,
2129,GO:0004666,1,0.981836871099315,0,2,prostaglandin-endoperoxide synthase activity,MF,
2130,GO:0004667,1,0.989649847210049,0,3,prostaglandin-D synthase activity,MF,
2131,GO:0004668,1,0.974400133486073,0,4,protein-arginine deiminase activity,MF,
2132,GO:0004671,1,0.990789258543549,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2134,GO:0004673,1,0.996861194148444,0,1,protein histidine kinase activity,MF,
2136,GO:0004675,1,0.841549461489993,0,17,transmembrane receptor protein serine/threonine kinase activity,MF,
2137,GO:0004676,1,0.986592052058446,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2138,GO:0004677,1,0.956017078541067,0,2,DNA-dependent protein kinase activity,MF,
2139,GO:0004679,1,0.936817223573182,0,8,AMP-activated protein kinase activity,MF,
2141,GO:0004686,1,0.985921596517854,0,1,elongation factor-2 kinase activity,MF,
2142,GO:0004687,1,0.955071239520851,0,4,myosin light chain kinase activity,MF,
2143,GO:0004689,1,0.957204959209973,0,5,phosphorylase kinase activity,MF,
2144,GO:0004690,1,0.926687124513922,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2145,GO:0004691,1,0.939255172958604,0,6,cAMP-dependent protein kinase activity,MF,
2146,GO:0004692,1,0.986627449309205,0,2,cGMP-dependent protein kinase activity,MF,
2147,GO:0004693,1,0.83804823593162,0,28,cyclin-dependent protein serine/threonine kinase activity,MF,
2148,GO:0004694,1,0.967334084397047,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2149,GO:0004697,1,0.884292034776279,0,15,protein kinase C activity,MF,
2150,GO:0004698,1,0.884292034776279,0,15,calcium-dependent protein kinase C activity,MF,
2151,GO:0004699,1,0.98431777166281,0,2,calcium-independent protein kinase C activity,MF,
2152,GO:0004703,1,0.978033685874436,0,5,G protein-coupled receptor kinase activity,MF,
2153,GO:0004704,1,0.966258879798867,0,5,NF-kappaB-inducing kinase activity,MF,
2154,GO:0004705,1,0.980943732086209,0,3,JUN kinase activity,MF,
2155,GO:0004706,1,0.948115362333598,0,8,JUN kinase kinase kinase activity,MF,
2156,GO:0004707,1,0.891377559523273,0,19,MAP kinase activity,MF,
2157,GO:0004708,1,0.89936105558931,0,17,MAP kinase kinase activity,MF,
2158,GO:0004709,1,0.848758990029793,0,21,MAP kinase kinase kinase activity,MF,
2159,GO:0004711,1,0.944679877688333,0,6,ribosomal protein S6 kinase activity,MF,
2160,GO:0004712,1,0.738682510390234,0,44,protein serine/threonine/tyrosine kinase activity,MF,
2161,GO:0004713,1,0.32780630717793,0,133,protein tyrosine kinase activity,MF,
2162,GO:0004714,1,0.578855859587171,0,61,transmembrane receptor protein tyrosine kinase activity,MF,
2163,GO:0004715,1,0.738630055892849,0,45,non-membrane spanning protein tyrosine kinase activity,MF,
2164,GO:0004719,1,0.981199962967434,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2167,GO:0004722,1,0.602004071334739,0,70,protein serine/threonine phosphatase activity,MF,
2168,GO:0004723,1,0.944741171466179,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2169,GO:0004724,1,0.927408409211631,0,11,magnesium-dependent protein serine/threonine phosphatase activity,MF,
2171,GO:0004726,1,0.945884999455351,0,9,non-membrane spanning protein tyrosine phosphatase activity,MF,
2172,GO:0004727,1,0.992689104767825,0,2,prenylated protein tyrosine phosphatase activity,MF,
2173,GO:0004729,1,0.99634585301425,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2174,GO:0004731,1,0.981069911234485,0,3,purine-nucleoside phosphorylase activity,MF,
2175,GO:0004733,1,0.993532043076939,0,1,pyridoxamine-phosphate oxidase activity,MF,
2176,GO:0004735,1,0.987532324614964,0,3,pyrroline-5-carboxylate reductase activity,MF,
2177,GO:0004736,1,0.992380692004869,0,1,pyruvate carboxylase activity,MF,
2178,GO:0004738,1,0.970624397296884,0,5,pyruvate dehydrogenase activity,MF,
2179,GO:0004739,1,0.990242874829471,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2180,GO:0004740,1,0.966517847157889,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2181,GO:0004741,1,0.984793057711522,0,2,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2182,GO:0004742,1,0.991703185747767,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2183,GO:0004743,1,0.989307721937314,0,2,pyruvate kinase activity,MF,
2184,GO:0004744,1,0.995157531975832,0,1,retinal isomerase activity,MF,
2185,GO:0004745,1,0.94136923677634,0,14,retinol dehydrogenase activity,MF,
2186,GO:0004747,1,0.996721278084209,0,1,ribokinase activity,MF,
2187,GO:0004748,1,0.978553777052999,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2188,GO:0004749,1,0.983023038846317,0,4,ribose phosphate diphosphokinase activity,MF,
2189,GO:0004750,1,0.9956655013377,0,1,ribulose-phosphate 3-epimerase activity,MF,
2190,GO:0004751,1,0.996254099340822,0,1,ribose-5-phosphate isomerase activity,MF,
2191,GO:0004753,1,0.988735973416558,0,1,saccharopine dehydrogenase activity,MF,
2192,GO:0004756,1,0.990924821637235,0,2,selenide, water dikinase activity,MF,
2193,GO:0004757,1,0.996578130566547,0,1,sepiapterin reductase activity,MF,
2194,GO:0004758,1,0.965427460888856,0,5,serine C-palmitoyltransferase activity,MF,
2195,GO:0004760,1,0.9964709803441,0,1,serine-pyruvate transaminase activity,MF,
2196,GO:0004766,1,0.996684261567024,0,1,spermidine synthase activity,MF,
2197,GO:0004767,1,0.969557052722861,0,5,sphingomyelin phosphodiesterase activity,MF,
2198,GO:0004768,1,0.979025747053472,0,3,stearoyl-CoA 9-desaturase activity,MF,
2199,GO:0004769,1,0.993443423695066,0,2,steroid delta-isomerase activity,MF,
2200,GO:0004771,1,0.94760110129488,0,9,sterol esterase activity,MF,
2201,GO:0004772,1,0.993661144114025,0,1,sterol O-acyltransferase activity,MF,
2202,GO:0004773,1,0.987821213012257,0,1,steryl-sulfatase activity,MF,
2203,GO:0004774,1,0.988053251455694,0,3,succinate-CoA ligase activity,MF,
2204,GO:0004775,1,0.988053251455694,0,3,succinate-CoA ligase (ADP-forming) activity,MF,
2205,GO:0004776,1,0.988053251455694,0,3,succinate-CoA ligase (GDP-forming) activity,MF,
2206,GO:0004777,1,0.990125428856343,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2207,GO:0004778,1,0.993201163620248,0,2,succinyl-CoA hydrolase activity,MF,
2208,GO:0004779,1,0.988030783400239,0,2,sulfate adenylyltransferase activity,MF,
2209,GO:0004781,1,0.988030783400239,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2210,GO:0004782,1,0.995003072987144,0,1,sulfinoalanine decarboxylase activity,MF,
2211,GO:0004784,1,0.982410078187564,0,5,superoxide dismutase activity,MF,
2212,GO:0004788,1,0.995573849824925,0,1,thiamine diphosphokinase activity,MF,
2213,GO:0004790,1,0.995258827654657,0,1,thioether S-methyltransferase activity,MF,
2214,GO:0004791,1,0.971469777352152,0,6,thioredoxin-disulfide reductase activity,MF,
2215,GO:0004792,1,0.988787275659684,0,3,thiosulfate sulfurtransferase activity,MF,
2216,GO:0004793,1,0.991188185081593,0,2,threonine aldolase activity,MF,
2217,GO:0004794,1,0.993094990966666,0,2,L-threonine ammonia-lyase activity,MF,
2218,GO:0004796,1,0.991091791128546,0,2,thromboxane-A synthase activity,MF,
2219,GO:0004797,1,0.986832702915083,0,2,thymidine kinase activity,MF,
2220,GO:0004798,1,0.991251928816876,0,2,thymidylate kinase activity,MF,
2221,GO:0004799,1,0.996485303877563,0,1,thymidylate synthase activity,MF,
2222,GO:0004800,1,0.983808430689671,0,2,thyroxine 5'-deiodinase activity,MF,
2223,GO:0004801,1,0.996699716820156,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2224,GO:0004802,1,0.991065989431672,0,2,transketolase activity,MF,
2225,GO:0004803,1,0.98596537802872,0,2,transposase activity,MF,
2226,GO:0004806,1,0.880242360560948,0,23,triglyceride lipase activity,MF,
2227,GO:0004807,1,0.996576130586228,0,1,triose-phosphate isomerase activity,MF,
2228,GO:0004809,1,0.98689267027549,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2229,GO:0004810,1,0.995699287977245,0,1,tRNA adenylyltransferase activity,MF,
2230,GO:0004812,1,0.892476108889597,0,22,aminoacyl-tRNA ligase activity,MF,
2231,GO:0004813,1,0.987038850122027,0,2,alanine-tRNA ligase activity,MF,
2232,GO:0004814,1,0.992002756970686,0,2,arginine-tRNA ligase activity,MF,
2233,GO:0004815,1,0.993748794652577,0,1,aspartate-tRNA ligase activity,MF,
2234,GO:0004816,1,0.9956970975926,0,1,asparagine-tRNA ligase activity,MF,
2235,GO:0004817,1,0.996216668794837,0,1,cysteine-tRNA ligase activity,MF,
2236,GO:0004818,1,0.992591972216921,0,1,glutamate-tRNA ligase activity,MF,
2237,GO:0004821,1,0.995357710732009,0,1,histidine-tRNA ligase activity,MF,
2238,GO:0004822,1,0.99333818130966,0,1,isoleucine-tRNA ligase activity,MF,
2239,GO:0004823,1,0.99197264500631,0,1,leucine-tRNA ligase activity,MF,
2240,GO:0004825,1,0.994417361950566,0,1,methionine-tRNA ligase activity,MF,
2241,GO:0004826,1,0.98342388078621,0,4,phenylalanine-tRNA ligase activity,MF,
2242,GO:0004827,1,0.995601198783344,0,1,proline-tRNA ligase activity,MF,
2243,GO:0004828,1,0.995977413276461,0,1,serine-tRNA ligase activity,MF,
2244,GO:0004829,1,0.995536995734659,0,1,threonine-tRNA ligase activity,MF,
2245,GO:0004830,1,0.994799330390074,0,1,tryptophan-tRNA ligase activity,MF,
2246,GO:0004831,1,0.995864341580592,0,1,tyrosine-tRNA ligase activity,MF,
2247,GO:0004832,1,0.993193097521698,0,1,valine-tRNA ligase activity,MF,
2248,GO:0004833,1,0.992896102798329,0,2,tryptophan 2,3-dioxygenase activity,MF,
2249,GO:0004835,1,0.990113885607682,0,1,tubulin-tyrosine ligase activity,MF,
2250,GO:0004838,1,0.994899864244307,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2251,GO:0004839,1,0.976517759678043,0,3,ubiquitin activating enzyme activity,MF,
2252,GO:0004842,1,0.0607467243019098,0,382,ubiquitin-protein transferase activity,MF,
2253,GO:0004843,1,0.501393540932466,0,80,thiol-dependent ubiquitin-specific protease activity,MF,
2254,GO:0004844,1,0.983137551182562,0,4,uracil DNA N-glycosylase activity,MF,
2255,GO:0004849,1,0.983684063325914,0,4,uridine kinase activity,MF,
2256,GO:0004850,1,0.991790336331877,0,2,uridine phosphorylase activity,MF,
2257,GO:0004852,1,0.996639637265096,0,1,uroporphyrinogen-III synthase activity,MF,
2258,GO:0004853,1,0.996621904402646,0,1,uroporphyrinogen decarboxylase activity,MF,
2259,GO:0004854,1,0.979602582281667,0,2,xanthine dehydrogenase activity,MF,
2260,GO:0004855,1,0.988998589550453,0,1,xanthine oxidase activity,MF,
2261,GO:0004856,1,0.993053853719577,0,1,xylulokinase activity,MF,
2265,GO:0004861,1,0.941755131104919,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2266,GO:0004862,1,0.960781618371283,0,8,cAMP-dependent protein kinase inhibitor activity,MF,
2268,GO:0004865,1,0.956322089707348,0,10,protein serine/threonine phosphatase inhibitor activity,MF,
2272,GO:0004873,1,0.993156918260917,0,2,asialoglycoprotein receptor activity,MF,
2273,GO:0004875,1,0.940840133867074,0,9,complement receptor activity,MF,
2274,GO:0004876,1,0.996126428951869,0,1,complement component C3a receptor activity,MF,
2275,GO:0004877,1,0.982599387937213,0,1,complement component C3b receptor activity,MF,
2276,GO:0004878,1,0.990520338127412,0,2,complement component C5a receptor activity,MF,
2277,GO:0004879,1,0.671692056237698,0,49,nuclear receptor activity,MF,
2278,GO:0004883,1,0.987385054372477,0,1,glucocorticoid receptor activity,MF,
2281,GO:0004896,1,0.591559517796814,0,87,cytokine receptor activity,MF,
2282,GO:0004897,1,0.929645337556609,0,7,ciliary neurotrophic factor receptor activity,MF,
2283,GO:0004900,1,0.996239279388746,0,1,erythropoietin receptor activity,MF,
2284,GO:0004903,1,0.991681011276179,0,1,growth hormone receptor activity,MF,
2285,GO:0004904,1,0.971773752175546,0,5,interferon receptor activity,MF,
2286,GO:0004905,1,0.984989057693799,0,2,type I interferon receptor activity,MF,
2287,GO:0004906,1,0.991708067052043,0,2,interferon-gamma receptor activity,MF,
2288,GO:0004908,1,0.960361088125696,0,7,interleukin-1 receptor activity,MF,
2289,GO:0004909,1,0.986737363832256,0,2,interleukin-1, type I, activating receptor activity,MF,
2290,GO:0004910,1,0.991091795006767,0,2,interleukin-1, type II, blocking receptor activity,MF,
2291,GO:0004911,1,0.982972040724107,0,3,interleukin-2 receptor activity,MF,
2292,GO:0004912,1,0.990710986513408,0,1,interleukin-3 receptor activity,MF,
2293,GO:0004913,1,0.992066599468023,0,2,interleukin-4 receptor activity,MF,
2294,GO:0004914,1,0.986789675242692,0,2,interleukin-5 receptor activity,MF,
2295,GO:0004915,1,0.986272093820697,0,2,interleukin-6 receptor activity,MF,
2296,GO:0004917,1,0.992821929655149,0,2,interleukin-7 receptor activity,MF,
2297,GO:0004918,1,0.990307725036389,0,2,interleukin-8 receptor activity,MF,
2298,GO:0004920,1,0.989173427548217,0,2,interleukin-10 receptor activity,MF,
2299,GO:0004921,1,0.982696711158895,0,3,interleukin-11 receptor activity,MF,
2300,GO:0004923,1,0.940691377549718,0,5,leukemia inhibitory factor receptor activity,MF,
2301,GO:0004924,1,0.940691377549718,0,5,oncostatin-M receptor activity,MF,
2302,GO:0004925,1,0.978562628376245,0,1,prolactin receptor activity,MF,
2303,GO:0004930,1,0.15620647400855,0,348,G protein-coupled receptor activity,MF,
2304,GO:0004931,1,0.96928563756562,0,7,extracellularly ATP-gated cation channel activity,MF,
2305,GO:0004935,1,0.961981667875621,0,8,adrenergic receptor activity,MF,
2306,GO:0004936,1,0.975705734417744,0,5,alpha-adrenergic receptor activity,MF,
2307,GO:0004937,1,0.986704555773689,0,3,alpha1-adrenergic receptor activity,MF,
2308,GO:0004938,1,0.988854460570124,0,2,alpha2-adrenergic receptor activity,MF,
2309,GO:0004939,1,0.985937658076247,0,3,beta-adrenergic receptor activity,MF,
2310,GO:0004940,1,0.994732311715085,0,1,beta1-adrenergic receptor activity,MF,
2311,GO:0004941,1,0.996023651076096,0,1,beta2-adrenergic receptor activity,MF,
2312,GO:0004945,1,0.989144315514077,0,3,angiotensin type II receptor activity,MF,
2313,GO:0004946,1,0.996607781753855,0,1,bombesin receptor activity,MF,
2314,GO:0004947,1,0.988729432602608,0,2,bradykinin receptor activity,MF,
2315,GO:0004948,1,0.983699408826862,0,2,calcitonin receptor activity,MF,
2316,GO:0004949,1,0.978133117684629,0,3,cannabinoid receptor activity,MF,
2317,GO:0004950,1,0.888794553731285,0,25,chemokine receptor activity,MF,
2318,GO:0004951,1,0.992336824435793,0,2,cholecystokinin receptor activity,MF,
2319,GO:0004952,1,0.977691230443164,0,5,dopamine neurotransmitter receptor activity,MF,
2320,GO:0004953,1,0.927979629140795,0,15,icosanoid receptor activity,MF,
2321,GO:0004954,1,0.945058672633246,0,11,prostanoid receptor activity,MF,
2322,GO:0004955,1,0.949133762456866,0,10,prostaglandin receptor activity,MF,
2323,GO:0004956,1,0.989497590344194,0,2,prostaglandin D receptor activity,MF,
2324,GO:0004957,1,0.976836091097837,0,5,prostaglandin E receptor activity,MF,
2325,GO:0004958,1,0.984613089606102,0,2,prostaglandin F receptor activity,MF,
2326,GO:0004960,1,0.995708758401878,0,1,thromboxane receptor activity,MF,
2327,GO:0004961,1,0.995708758401878,0,1,thromboxane A2 receptor activity,MF,
2328,GO:0004962,1,0.98468839191325,0,2,endothelin receptor activity,MF,
2329,GO:0004965,1,0.972851644278321,0,3,G protein-coupled GABA receptor activity,MF,
2330,GO:0004966,1,0.985217570398524,0,4,galanin receptor activity,MF,
2331,GO:0004967,1,0.99064458361535,0,2,glucagon receptor activity,MF,
2332,GO:0004968,1,0.991919769513068,0,1,gonadotropin-releasing hormone receptor activity,MF,
2333,GO:0004969,1,0.972486429698364,0,5,histamine receptor activity,MF,
2335,GO:0004971,1,0.960185563599408,0,4,AMPA glutamate receptor activity,MF,
2337,GO:0004974,1,0.981938200237228,0,4,leukotriene receptor activity,MF,
2338,GO:0004977,1,0.983996802802277,0,4,melanocortin receptor activity,MF,
2339,GO:0004979,1,0.996224256177234,0,1,beta-endorphin receptor activity,MF,
2340,GO:0004980,1,0.990892244513727,0,2,melanocyte-stimulating hormone receptor activity,MF,
2341,GO:0004982,1,0.988161438956397,0,3,N-formyl peptide receptor activity,MF,
2342,GO:0004983,1,0.962015166914769,0,8,neuropeptide Y receptor activity,MF,
2343,GO:0004984,1,0.940981793600197,0,16,olfactory receptor activity,MF,
2344,GO:0004985,1,0.95958495041946,0,9,opioid receptor activity,MF,
2345,GO:0004990,1,0.991695120367462,0,1,oxytocin receptor activity,MF,
2346,GO:0004991,1,0.990904718923187,0,2,parathyroid hormone receptor activity,MF,
2347,GO:0004992,1,0.977859558886925,0,3,platelet activating factor receptor activity,MF,
2348,GO:0004993,1,0.89752580343295,0,22,G protein-coupled serotonin receptor activity,MF,
2349,GO:0004994,1,0.979425588712903,0,4,somatostatin receptor activity,MF,
2350,GO:0004995,1,0.98585390208481,0,3,tachykinin receptor activity,MF,
2351,GO:0004996,1,0.989414830352707,0,2,thyroid-stimulating hormone receptor activity,MF,
2352,GO:0004998,1,0.984804488289664,0,2,transferrin receptor activity,MF,
2353,GO:0004999,1,0.983875412874088,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2354,GO:0005000,1,0.966361563676238,0,6,vasopressin receptor activity,MF,
2356,GO:0005003,1,0.864077293932559,0,19,ephrin receptor activity,MF,
2357,GO:0005004,1,0.937374990594936,0,7,GPI-linked ephrin receptor activity,MF,
2358,GO:0005005,1,0.872968277366229,0,17,transmembrane-ephrin receptor activity,MF,
2359,GO:0005006,1,0.990236542998943,0,2,epidermal growth factor-activated receptor activity,MF,
2360,GO:0005007,1,0.962454900880807,0,5,fibroblast growth factor-activated receptor activity,MF,
2361,GO:0005008,1,0.98729890394661,0,1,hepatocyte growth factor-activated receptor activity,MF,
2362,GO:0005009,1,0.955201401383334,0,3,insulin-activated receptor activity,MF,
2363,GO:0005010,1,0.952379154442384,0,3,insulin-like growth factor-activated receptor activity,MF,
2364,GO:0005011,1,0.9833286291857,0,2,macrophage colony-stimulating factor receptor activity,MF,
2365,GO:0005017,1,0.973226378389656,0,3,platelet-derived growth factor-activated receptor activity,MF,
2366,GO:0005018,1,0.987432761075086,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2367,GO:0005019,1,0.985614613049207,0,2,platelet-derived growth factor beta-receptor activity,MF,
2368,GO:0005020,1,0.990069666968894,0,1,stem cell factor receptor activity,MF,
2369,GO:0005021,1,0.936327682537646,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2370,GO:0005024,1,0.889237398108115,0,12,transforming growth factor beta-activated receptor activity,MF,
2371,GO:0005025,1,0.957687329028931,0,5,transforming growth factor beta receptor activity, type I,MF,
2372,GO:0005026,1,0.99107847423784,0,1,transforming growth factor beta receptor activity, type II,MF,
2373,GO:0005030,1,0.96337454373701,0,4,neurotrophin receptor activity,MF,
2374,GO:0005031,1,0.954130347998379,0,10,tumor necrosis factor-activated receptor activity,MF,
2375,GO:0005034,1,0.969614651041783,0,4,osmosensor activity,MF,
2376,GO:0005035,1,0.944603476390189,0,12,death receptor activity,MF,
2377,GO:0005041,1,0.876090808975049,0,12,low-density lipoprotein particle receptor activity,MF,
2378,GO:0005042,1,0.93970032557452,0,6,netrin receptor activity,MF,
2379,GO:0005043,1,0.99313701909526,0,1,netrin receptor activity involved in chemorepulsion,MF,
2381,GO:0005046,1,0.988173568606547,0,3,KDEL sequence binding,MF,
2382,GO:0005047,1,0.984549702210517,0,3,signal recognition particle binding,MF,
2384,GO:0005049,1,0.909946241695613,0,10,nuclear export signal receptor activity,MF,
2385,GO:0005052,1,0.987430013531593,0,2,peroxisome matrix targeting signal-1 binding,MF,
2386,GO:0005053,1,0.996558451979698,0,1,peroxisome matrix targeting signal-2 binding,MF,
2387,GO:0005055,1,0.992216992629295,0,2,laminin receptor activity,MF,
2388,GO:0005068,1,0.907833163791248,0,13,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2389,GO:0005078,1,0.892500887917926,0,11,MAP-kinase scaffold activity,MF,
2390,GO:0005080,1,0.703061681324491,0,48,protein kinase C binding,MF,
2393,GO:0005087,1,0.982964308521098,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2395,GO:0005089,1,0.552476404070664,0,59,Rho guanyl-nucleotide exchange factor activity,MF,
2396,GO:0005090,1,0.995852060737781,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2397,GO:0005092,1,0.897467710205358,0,16,GDP-dissociation inhibitor activity,MF,
2398,GO:0005093,1,0.990987961336259,0,2,Rab GDP-dissociation inhibitor activity,MF,
2399,GO:0005094,1,0.989789013751167,0,3,Rho GDP-dissociation inhibitor activity,MF,
2400,GO:0005095,1,0.902773899357519,0,14,GTPase inhibitor activity,MF,
2401,GO:0005096,1,0.118572682502914,0,252,GTPase activator activity,MF,
2403,GO:0005104,1,0.882390247648463,0,19,fibroblast growth factor receptor binding,MF,
2404,GO:0005105,1,0.985806380125593,0,4,type 1 fibroblast growth factor receptor binding,MF,
2405,GO:0005109,1,0.802265575978369,0,34,frizzled binding,MF,
2406,GO:0005111,1,0.979629474754704,0,5,type 2 fibroblast growth factor receptor binding,MF,
2407,GO:0005112,1,0.799753716456201,0,22,Notch binding,MF,
2408,GO:0005113,1,0.952461863153043,0,8,patched binding,MF,
2409,GO:0005114,1,0.94244188301934,0,8,type II transforming growth factor beta receptor binding,MF,
2410,GO:0005115,1,0.988831518817606,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2411,GO:0005119,1,0.971461707622593,0,3,smoothened binding,MF,
2412,GO:0005123,1,0.899746566711203,0,19,death receptor binding,MF,
2413,GO:0005124,1,0.984310529903825,0,4,scavenger receptor binding,MF,
2416,GO:0005127,1,0.930169566373531,0,8,ciliary neurotrophic factor receptor binding,MF,
2417,GO:0005128,1,0.990607503152174,0,2,erythropoietin receptor binding,MF,
2418,GO:0005130,1,0.996536553126788,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2419,GO:0005131,1,0.968169300463492,0,4,growth hormone receptor binding,MF,
2420,GO:0005134,1,0.985738905661608,0,3,interleukin-2 receptor binding,MF,
2421,GO:0005135,1,0.993930807341583,0,1,interleukin-3 receptor binding,MF,
2422,GO:0005136,1,0.990573926058258,0,2,interleukin-4 receptor binding,MF,
2423,GO:0005137,1,0.995853428771886,0,1,interleukin-5 receptor binding,MF,
2424,GO:0005138,1,0.959749549956855,0,7,interleukin-6 receptor binding,MF,
2425,GO:0005139,1,0.991325092130755,0,2,interleukin-7 receptor binding,MF,
2426,GO:0005141,1,0.996449717705429,0,1,interleukin-10 receptor binding,MF,
2427,GO:0005142,1,0.995582994103754,0,1,interleukin-11 receptor binding,MF,
2428,GO:0005143,1,0.976645886050812,0,4,interleukin-12 receptor binding,MF,
2429,GO:0005144,1,0.996681697515034,0,1,interleukin-13 receptor binding,MF,
2431,GO:0005147,1,0.996229644853621,0,1,oncostatin-M receptor binding,MF,
2432,GO:0005148,1,0.996724641556705,0,1,prolactin receptor binding,MF,
2433,GO:0005149,1,0.933174808982535,0,11,interleukin-1 receptor binding,MF,
2434,GO:0005150,1,0.989582036036053,0,2,interleukin-1, type I receptor binding,MF,
2435,GO:0005151,1,0.986104411358488,0,2,interleukin-1, type II receptor binding,MF,
2436,GO:0005152,1,0.983338840580458,0,2,interleukin-1 receptor antagonist activity,MF,
2437,GO:0005153,1,0.988854383854096,0,2,interleukin-8 receptor binding,MF,
2438,GO:0005154,1,0.781664874006327,0,30,epidermal growth factor receptor binding,MF,
2439,GO:0005157,1,0.988362943252748,0,3,macrophage colony-stimulating factor receptor binding,MF,
2440,GO:0005158,1,0.782012524654098,0,22,insulin receptor binding,MF,
2441,GO:0005159,1,0.899907863558463,0,13,insulin-like growth factor receptor binding,MF,
2442,GO:0005160,1,0.848438446534849,0,24,transforming growth factor beta receptor binding,MF,
2443,GO:0005161,1,0.89080656145008,0,14,platelet-derived growth factor receptor binding,MF,
2444,GO:0005163,1,0.982772849742259,0,4,nerve growth factor receptor binding,MF,
2445,GO:0005164,1,0.876816310962262,0,29,tumor necrosis factor receptor binding,MF,
2446,GO:0005165,1,0.923831715536361,0,11,neurotrophin receptor binding,MF,
2447,GO:0005166,1,0.995104287464315,0,1,neurotrophin p75 receptor binding,MF,
2448,GO:0005167,1,0.944663218821936,0,6,neurotrophin TRK receptor binding,MF,
2449,GO:0005168,1,0.944663218821936,0,6,neurotrophin TRKA receptor binding,MF,
2450,GO:0005169,1,0.989782425696876,0,1,neurotrophin TRKB receptor binding,MF,
2451,GO:0005170,1,0.989782425696876,0,1,neurotrophin TRKC receptor binding,MF,
2452,GO:0005171,1,0.99208687571926,0,2,hepatocyte growth factor receptor binding,MF,
2453,GO:0005172,1,0.908695876796551,0,13,vascular endothelial growth factor receptor binding,MF,
2454,GO:0005173,1,0.95807302085218,0,4,stem cell factor receptor binding,MF,
2455,GO:0005174,1,0.991965817190298,0,2,CD40 receptor binding,MF,
2456,GO:0005175,1,0.996870342491923,0,1,CD27 receptor binding,MF,
2457,GO:0005176,1,0.983937360230006,0,3,ErbB-2 class receptor binding,MF,
2460,GO:0005183,1,0.993283781756578,0,2,gonadotropin hormone-releasing hormone activity,MF,
2461,GO:0005184,1,0.926103052148971,0,22,neuropeptide hormone activity,MF,
2468,GO:0005217,1,0.744573133821995,0,26,intracellular ligand-gated ion channel activity,MF,
2469,GO:0005219,1,0.916827970506197,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2470,GO:0005220,1,0.942636907806323,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2471,GO:0005221,1,0.937130453839342,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2472,GO:0005222,1,0.941918648084439,0,8,intracellular cAMP-activated cation channel activity,MF,
2473,GO:0005223,1,0.966202575469401,0,6,intracellular cGMP-activated cation channel activity,MF,
2474,GO:0005225,1,0.924994573475947,0,9,volume-sensitive anion channel activity,MF,
2475,GO:0005227,1,0.869968639660927,0,22,calcium activated cation channel activity,MF,
2476,GO:0005228,1,0.979585148719741,0,2,intracellular sodium activated potassium channel activity,MF,
2477,GO:0005229,1,0.894961901020962,0,16,intracellular calcium activated chloride channel activity,MF,
2482,GO:0005242,1,0.877620749099803,0,21,inward rectifier potassium channel activity,MF,
2483,GO:0005243,1,0.926931996984528,0,14,gap junction channel activity,MF,
2485,GO:0005245,1,0.66937918132828,0,42,voltage-gated calcium channel activity,MF,
2487,GO:0005247,1,0.924884115650313,0,9,voltage-gated chloride channel activity,MF,
2488,GO:0005248,1,0.751116215775769,0,23,voltage-gated sodium channel activity,MF,
2492,GO:0005252,1,0.992475836045063,0,1,open rectifier potassium channel activity,MF,
2495,GO:0005260,1,0.988245416847562,0,1,intracellularly ATP-gated chloride channel activity,MF,
2499,GO:0005272,1,0.646401348797346,0,43,sodium channel activity,MF,
2500,GO:0005275,1,0.985914558179467,0,3,amine transmembrane transporter activity,MF,
2501,GO:0005277,1,0.991742696778015,0,2,acetylcholine transmembrane transporter activity,MF,
2502,GO:0005280,1,0.984228131478399,0,2,amino acid:proton symporter activity,MF,
2503,GO:0005283,1,0.882689850445821,0,15,amino acid:sodium symporter activity,MF,
2504,GO:0005287,1,0.995563146359098,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2505,GO:0005289,1,0.995563146359098,0,1,high-affinity arginine transmembrane transporter activity,MF,
2506,GO:0005290,1,0.967644754537385,0,5,L-histidine transmembrane transporter activity,MF,
2507,GO:0005292,1,0.995563146359098,0,1,high-affinity lysine transmembrane transporter activity,MF,
2508,GO:0005294,1,0.982046951199635,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2509,GO:0005295,1,0.964145991512281,0,4,neutral amino acid:sodium symporter activity,MF,
2510,GO:0005298,1,0.974551819074362,0,3,proline:sodium symporter activity,MF,
2511,GO:0005302,1,0.994159995566144,0,1,L-tyrosine transmembrane transporter activity,MF,
2512,GO:0005308,1,0.980469577939026,0,3,creatine transmembrane transporter activity,MF,
2513,GO:0005309,1,0.993373333927774,0,1,creatine:sodium symporter activity,MF,
2516,GO:0005314,1,0.961187838620484,0,4,high-affinity glutamate transmembrane transporter activity,MF,
2518,GO:0005316,1,0.993894574777475,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2520,GO:0005324,1,0.917888650617972,0,17,long-chain fatty acid transporter activity,MF,
2522,GO:0005328,1,0.993748794652577,0,1,neurotransmitter:sodium symporter activity,MF,
2523,GO:0005330,1,0.972031239113109,0,4,dopamine:sodium symporter activity,MF,
2524,GO:0005332,1,0.977410543478474,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2525,GO:0005334,1,0.982623108388497,0,3,norepinephrine:sodium symporter activity,MF,
2526,GO:0005335,1,0.982344058215749,0,3,serotonin:sodium symporter activity,MF,
2527,GO:0005337,1,0.973460063891481,0,6,nucleoside transmembrane transporter activity,MF,
2528,GO:0005338,1,0.933309678927086,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2530,GO:0005343,1,0.816869300787411,0,26,organic acid:sodium symporter activity,MF,
2531,GO:0005344,1,0.94916627503377,0,13,oxygen carrier activity,MF,
2532,GO:0005345,1,0.974678966895709,0,5,purine nucleobase transmembrane transporter activity,MF,
2533,GO:0005346,1,0.863148061852203,0,28,purine ribonucleotide transmembrane transporter activity,MF,
2534,GO:0005347,1,0.880477021465385,0,24,ATP transmembrane transporter activity,MF,
2535,GO:0005350,1,0.986273454655044,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2536,GO:0005351,1,0.96132062377036,0,7,carbohydrate:proton symporter activity,MF,
2537,GO:0005353,1,0.980690008543129,0,4,fructose transmembrane transporter activity,MF,
2538,GO:0005354,1,0.990575403541497,0,1,galactose transmembrane transporter activity,MF,
2539,GO:0005355,1,0.88950363683276,0,19,glucose transmembrane transporter activity,MF,
2540,GO:0005362,1,0.989693722655087,0,2,low-affinity glucose:sodium symporter activity,MF,
2541,GO:0005365,1,0.956760310457424,0,3,myo-inositol transmembrane transporter activity,MF,
2542,GO:0005366,1,0.986675449790949,0,1,myo-inositol:proton symporter activity,MF,
2543,GO:0005367,1,0.969684862973102,0,2,myo-inositol:sodium symporter activity,MF,
2544,GO:0005368,1,0.97256769220061,0,3,taurine transmembrane transporter activity,MF,
2545,GO:0005369,1,0.987577930484385,0,1,taurine:sodium symporter activity,MF,
2546,GO:0005371,1,0.9964709803441,0,1,tricarboxylate secondary active transmembrane transporter activity,MF,
2547,GO:0005372,1,0.937364408492913,0,12,water transmembrane transporter activity,MF,
2548,GO:0005375,1,0.952043741635073,0,5,copper ion transmembrane transporter activity,MF,
2549,GO:0005381,1,0.942935049009194,0,10,iron ion transmembrane transporter activity,MF,
2550,GO:0005384,1,0.941968776092523,0,9,manganese ion transmembrane transporter activity,MF,
2551,GO:0005385,1,0.907449943978282,0,18,zinc ion transmembrane transporter activity,MF,
2552,GO:0005388,1,0.901522630556586,0,9,calcium transmembrane transporter activity, phosphorylative mechanism,MF,
2554,GO:0005402,1,0.895011430522276,0,16,carbohydrate:cation symporter activity,MF,
2555,GO:0005412,1,0.947754240833922,0,7,glucose:sodium symporter activity,MF,
2556,GO:0005415,1,0.991808912258776,0,2,nucleoside:sodium symporter activity,MF,
2557,GO:0005416,1,0.868750958391141,0,17,amino acid:cation symporter activity,MF,
2558,GO:0005427,1,0.993023686816491,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2561,GO:0005451,1,0.911858326033874,0,12,monovalent cation:proton antiporter activity,MF,
2562,GO:0005452,1,0.900900725383242,0,12,inorganic anion exchanger activity,MF,
2563,GO:0005456,1,0.996278001386186,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2564,GO:0005457,1,0.994048910858054,0,1,GDP-fucose transmembrane transporter activity,MF,
2565,GO:0005459,1,0.985323726568939,0,4,UDP-galactose transmembrane transporter activity,MF,
2566,GO:0005460,1,0.99672530921576,0,1,UDP-glucose transmembrane transporter activity,MF,
2567,GO:0005461,1,0.979805191106273,0,3,UDP-glucuronic acid transmembrane transporter activity,MF,
2568,GO:0005462,1,0.963088773335378,0,5,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2569,GO:0005463,1,0.979805191106273,0,3,UDP-N-acetylgalactosamine transmembrane transporter activity,MF,
2570,GO:0005464,1,0.987015598412905,0,1,UDP-xylose transmembrane transporter activity,MF,
2571,GO:0005477,1,0.993379533502681,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2572,GO:0005483,1,0.98203764557136,0,3,soluble NSF attachment protein activity,MF,
2576,GO:0005497,1,0.983989496066267,0,4,androgen binding,MF,
2577,GO:0005499,1,0.969500193758577,0,5,vitamin D binding,MF,
2578,GO:0005501,1,0.871348145561847,0,25,retinoid binding,MF,
2579,GO:0005502,1,0.977965197917085,0,4,11-cis retinal binding,MF,
2580,GO:0005503,1,0.987161861434446,0,2,all-trans retinal binding,MF,
2581,GO:0005504,1,0.858440425901955,0,32,fatty acid binding,MF,
2589,GO:0005519,1,0.99246962332468,0,1,cytoskeletal regulatory protein binding,MF,
2591,GO:0005521,1,0.878930082966682,0,16,lamin binding,MF,
2592,GO:0005522,1,0.879211737238853,0,11,profilin binding,MF,
2593,GO:0005523,1,0.911803289044368,0,15,tropomyosin binding,MF,
2596,GO:0005527,1,0.952686702302341,0,10,macrolide binding,MF,
2597,GO:0005528,1,0.959805251917071,0,8,FK506 binding,MF,
2598,GO:0005534,1,0.981564570883088,0,4,galactose binding,MF,
2599,GO:0005536,1,0.932346061821892,0,11,glucose binding,MF,
2600,GO:0005537,1,0.918372887015609,0,15,mannose binding,MF,
2602,GO:0005540,1,0.858082934588164,0,20,hyaluronic acid binding,MF,
2603,GO:0005542,1,0.952622108300266,0,10,folic acid binding,MF,
2608,GO:0005547,1,0.724409234610029,0,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2609,GO:0005548,1,0.743318384825195,0,41,phospholipid transporter activity,MF,
2610,GO:0005549,1,0.968021098611328,0,10,odorant binding,MF,
2613,GO:0005577,1,0.954516536473429,0,6,fibrinogen complex,CC,
2614,GO:0005579,1,0.970348956258196,0,4,membrane attack complex,CC,
2616,GO:0005582,1,0.989828255656942,0,1,collagen type XV trimer,CC,
2619,GO:0005585,1,0.990364749756741,0,1,collagen type II trimer,CC,
2623,GO:0005589,1,0.972179160441286,0,3,collagen type VI trimer,CC,
2624,GO:0005590,1,0.9826775225133,0,1,collagen type VII trimer,CC,
2625,GO:0005591,1,0.995141279653256,0,1,collagen type VIII trimer,CC,
2626,GO:0005592,1,0.974543267975175,0,2,collagen type XI trimer,CC,
2627,GO:0005593,1,0.943391465164146,0,6,FACIT collagen trimer,CC,
2628,GO:0005594,1,0.983726037455684,0,3,collagen type IX trimer,CC,
2629,GO:0005595,1,0.981660689913458,0,1,collagen type XII trimer,CC,
2630,GO:0005596,1,0.987609211689067,0,1,collagen type XIV trimer,CC,
2631,GO:0005597,1,0.989183086983565,0,1,collagen type XVI trimer,CC,
2632,GO:0005598,1,0.995141279653256,0,1,short-chain collagen trimer,CC,
2633,GO:0005600,1,0.994345904806534,0,1,collagen type XIII trimer,CC,
2634,GO:0005602,1,0.993558209383747,0,2,complement component C1 complex,CC,
2636,GO:0005606,1,0.956630091470631,0,3,laminin-1 complex,CC,
2637,GO:0005607,1,0.979127144210265,0,2,laminin-2 complex,CC,
2638,GO:0005608,1,0.971224046666001,0,2,laminin-3 complex,CC,
2639,GO:0005610,1,0.9567343981075,0,3,laminin-5 complex,CC,
2640,GO:0005614,1,0.894721844742008,0,13,interstitial matrix,CC,
2644,GO:0005635,1,0.0432925622538022,0,432,nuclear envelope,CC,
2645,GO:0005637,1,0.693272666863016,0,53,nuclear inner membrane,CC,
2646,GO:0005638,1,0.973423418106994,0,5,lamin filament,CC,
2647,GO:0005639,1,0.922542019250899,0,14,integral component of nuclear inner membrane,CC,
2648,GO:0005640,1,0.792568179692224,0,25,nuclear outer membrane,CC,
2649,GO:0005641,1,0.928155765576719,0,9,nuclear envelope lumen,CC,
2650,GO:0005642,1,0.943629923769702,0,6,annulate lamellae,CC,
2651,GO:0005643,1,0.552098912430614,0,75,nuclear pore,CC,
2652,GO:0005652,1,0.932166312847117,0,11,nuclear lamina,CC,
2654,GO:0005655,1,0.975566088475114,0,5,nucleolar ribonuclease P complex,CC,
2655,GO:0005656,1,0.987608765942062,0,3,nuclear pre-replicative complex,CC,
2656,GO:0005657,1,0.660609841551182,0,65,replication fork,CC,
2657,GO:0005658,1,0.971677607785573,0,5,alpha DNA polymerase:primase complex,CC,
2658,GO:0005662,1,0.920165044186139,0,14,DNA replication factor A complex,CC,
2659,GO:0005663,1,0.97582643990482,0,5,DNA replication factor C complex,CC,
2660,GO:0005664,1,0.954019889791689,0,9,nuclear origin of replication recognition complex,CC,
2661,GO:0005665,1,0.933591662705303,0,15,RNA polymerase II, core complex,CC,
2662,GO:0005666,1,0.916658027731962,0,18,RNA polymerase III complex,CC,
2663,GO:0005667,1,0.0687880572260842,0,381,transcription regulator complex,CC,
2664,GO:0005668,1,0.992354711284131,0,2,RNA polymerase transcription factor SL1 complex,CC,
2665,GO:0005669,1,0.833550775909795,0,32,transcription factor TFIID complex,CC,
2666,GO:0005671,1,0.912430883358302,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2667,GO:0005672,1,0.982494312131094,0,5,transcription factor TFIIA complex,CC,
2668,GO:0005673,1,0.990940521480126,0,2,transcription factor TFIIE complex,CC,
2669,GO:0005674,1,0.991851675124791,0,2,transcription factor TFIIF complex,CC,
2670,GO:0005675,1,0.93965032534644,0,12,transcription factor TFIIH holo complex,CC,
2671,GO:0005677,1,0.948631057437356,0,7,chromatin silencing complex,CC,
2672,GO:0005680,1,0.892041053359731,0,21,anaphase-promoting complex,CC,
2673,GO:0005681,1,0.3774981141774,0,178,spliceosomal complex,CC,
2674,GO:0005682,1,0.918572396940325,0,16,U5 snRNP,CC,
2675,GO:0005683,1,0.975981407830189,0,7,U7 snRNP,CC,
2676,GO:0005684,1,0.631178998598761,0,87,U2-type spliceosomal complex,CC,
2677,GO:0005685,1,0.92270357405004,0,18,U1 snRNP,CC,
2678,GO:0005686,1,0.924159730891919,0,19,U2 snRNP,CC,
2679,GO:0005687,1,0.964693563447472,0,10,U4 snRNP,CC,
2680,GO:0005688,1,0.969970105134086,0,8,U6 snRNP,CC,
2681,GO:0005689,1,0.883404447382147,0,27,U12-type spliceosomal complex,CC,
2682,GO:0005690,1,0.995818967433284,0,1,U4atac snRNP,CC,
2683,GO:0005691,1,0.991640736763234,0,1,U6atac snRNP,CC,
2685,GO:0005697,1,0.868126606391586,0,20,telomerase holoenzyme complex,CC,
2686,GO:0005712,1,0.980602156097319,0,2,chiasma,CC,
2687,GO:0005713,1,0.995402998961019,0,1,recombination nodule,CC,
2688,GO:0005715,1,0.995402998961019,0,1,late recombination nodule,CC,
2689,GO:0005719,1,0.843805762773671,0,25,nuclear euchromatin,CC,
2690,GO:0005720,1,0.811764710024759,0,27,nuclear heterochromatin,CC,
2691,GO:0005721,1,0.860534210747021,0,18,pericentric heterochromatin,CC,
2692,GO:0005726,1,0.957223734763233,0,5,perichromatin fibrils,CC,
2693,GO:0005730,1,0.00333329493324057,0,849,nucleolus,CC,
2694,GO:0005731,1,0.996371666164808,0,1,nucleolus organizer region,CC,
2695,GO:0005732,1,0.910611140573555,0,22,small nucleolar ribonucleoprotein complex,CC,
2696,GO:0005736,1,0.94897267896038,0,10,RNA polymerase I complex,CC,
2701,GO:0005742,1,0.972620592982692,0,7,mitochondrial outer membrane translocase complex,CC,
2702,GO:0005743,1,0.156624530736676,0,407,mitochondrial inner membrane,CC,
2703,GO:0005744,1,0.948355807213497,0,12,TIM23 mitochondrial import inner membrane translocase complex,CC,
2704,GO:0005745,1,0.989550820027009,0,2,m-AAA complex,CC,
2705,GO:0005746,1,0.764055104107763,0,71,mitochondrial respirasome,CC,
2706,GO:0005747,1,0.865193603089621,0,41,mitochondrial respiratory chain complex I,CC,
2707,GO:0005749,1,0.98397300109008,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2708,GO:0005750,1,0.960165678163681,0,10,mitochondrial respiratory chain complex III,CC,
2709,GO:0005751,1,0.965323448247632,0,11,mitochondrial respiratory chain complex IV,CC,
2710,GO:0005753,1,0.995813403539853,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2711,GO:0005757,1,0.984050668560771,0,4,mitochondrial permeability transition pore complex,CC,
2712,GO:0005758,1,0.722789788933996,0,71,mitochondrial intermembrane space,CC,
2714,GO:0005760,1,0.979644025013419,0,3,gamma DNA polymerase complex,CC,
2715,GO:0005761,1,0.730958687588566,0,84,mitochondrial ribosome,CC,
2716,GO:0005762,1,0.809730784815024,0,55,mitochondrial large ribosomal subunit,CC,
2717,GO:0005763,1,0.909955287986935,0,27,mitochondrial small ribosomal subunit,CC,
2721,GO:0005767,1,0.923826620189688,0,15,secondary lysosome,CC,
2725,GO:0005771,1,0.732270356558627,0,54,multivesicular body,CC,
2729,GO:0005776,1,0.550615063708006,0,90,autophagosome,CC,
2731,GO:0005778,1,0.690284430139399,0,58,peroxisomal membrane,CC,
2732,GO:0005779,1,0.924290331961455,0,15,integral component of peroxisomal membrane,CC,
2733,GO:0005782,1,0.774343922299053,0,51,peroxisomal matrix,CC,
2735,GO:0005784,1,0.978377497338864,0,5,Sec61 translocon complex,CC,
2736,GO:0005785,1,0.973557503042388,0,6,signal recognition particle receptor complex,CC,
2737,GO:0005786,1,0.974077366413093,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2738,GO:0005787,1,0.976673645848136,0,5,signal peptidase complex,CC,
2741,GO:0005790,1,0.735182743447598,0,32,smooth endoplasmic reticulum,CC,
2742,GO:0005791,1,0.639041936747756,0,78,rough endoplasmic reticulum,CC,
2743,GO:0005793,1,0.44099900297628,0,119,endoplasmic reticulum-Golgi intermediate compartment,CC,
2745,GO:0005795,1,0.404961533723006,0,131,Golgi stack,CC,
2747,GO:0005797,1,0.948391721919316,0,10,Golgi medial cisterna,CC,
2749,GO:0005801,1,0.670460385783256,0,56,cis-Golgi network,CC,
2752,GO:0005813,1,0.0187021533984665,0,550,centrosome,CC,
2753,GO:0005814,1,0.370649646873181,0,126,centriole,CC,
2754,GO:0005815,1,0.00527520420702209,0,716,microtubule organizing center,CC,
2755,GO:0005818,1,0.922937470427716,0,11,aster,CC,
2756,GO:0005819,1,0.0876860698961427,0,334,spindle,CC,
2757,GO:0005826,1,0.968602994083185,0,4,actomyosin contractile ring,CC,
2758,GO:0005827,1,0.963003156316308,0,5,polar microtubule,CC,
2759,GO:0005828,1,0.927509838788182,0,7,kinetochore microtubule,CC,
2761,GO:0005832,1,0.961344009437682,0,9,chaperonin-containing T-complex,CC,
2762,GO:0005833,1,0.963871139631165,0,11,hemoglobin complex,CC,
2764,GO:0005838,1,0.920964694862619,0,21,proteasome regulatory particle,CC,
2765,GO:0005839,1,0.942903001200797,0,17,proteasome core complex,CC,
2766,GO:0005840,1,0.39550327294563,0,216,ribosome,CC,
2768,GO:0005845,1,0.930912418376687,0,10,mRNA cap binding complex,CC,
2769,GO:0005846,1,0.980625782171708,0,3,nuclear cap binding complex,CC,
2770,GO:0005847,1,0.893215599983231,0,17,mRNA cleavage and polyadenylation specificity factor complex,CC,
2771,GO:0005848,1,0.995669932551463,0,1,mRNA cleavage stimulating factor complex,CC,
2772,GO:0005849,1,0.87155924458494,0,21,mRNA cleavage factor complex,CC,
2773,GO:0005850,1,0.973717342169243,0,4,eukaryotic translation initiation factor 2 complex,CC,
2774,GO:0005851,1,0.972395038673542,0,6,eukaryotic translation initiation factor 2B complex,CC,
2775,GO:0005852,1,0.923725826828787,0,16,eukaryotic translation initiation factor 3 complex,CC,
2776,GO:0005853,1,0.98321027275644,0,4,eukaryotic translation elongation factor 1 complex,CC,
2777,GO:0005854,1,0.984470191525906,0,3,nascent polypeptide-associated complex,CC,
2779,GO:0005858,1,0.774230047328812,0,18,axonemal dynein complex,CC,
2780,GO:0005859,1,0.905779055491851,0,12,muscle myosin complex,CC,
2781,GO:0005861,1,0.966421530131399,0,8,troponin complex,CC,
2782,GO:0005862,1,0.979617300963717,0,4,muscle thin filament tropomyosin,CC,
2783,GO:0005863,1,0.974182135061583,0,3,striated muscle myosin thick filament,CC,
2784,GO:0005865,1,0.888626906614118,0,21,striated muscle thin filament,CC,
2785,GO:0005868,1,0.864688834372821,0,18,cytoplasmic dynein complex,CC,
2786,GO:0005869,1,0.947360767161855,0,12,dynactin complex,CC,
2787,GO:0005871,1,0.655015695071178,0,48,kinesin complex,CC,
2788,GO:0005873,1,0.979131622228143,0,2,plus-end kinesin complex,CC,
2789,GO:0005874,1,0.0381786972144709,0,397,microtubule,CC,
2790,GO:0005875,1,0.271463238491169,0,144,microtubule associated complex,CC,
2791,GO:0005876,1,0.63902866630335,0,62,spindle microtubule,CC,
2792,GO:0005879,1,0.950196466414465,0,6,axonemal microtubule,CC,
2793,GO:0005880,1,0.989700120889558,0,2,nuclear microtubule,CC,
2794,GO:0005881,1,0.599594930694968,0,69,cytoplasmic microtubule,CC,
2798,GO:0005885,1,0.956876743199254,0,11,Arp2/3 protein complex,CC,
2801,GO:0005889,1,0.993292638285859,0,1,potassium:proton exchanging ATPase complex,CC,
2803,GO:0005891,1,0.678838503300999,0,40,voltage-gated calcium channel complex,CC,
2804,GO:0005892,1,0.914175498189951,0,15,acetylcholine-gated channel complex,CC,
2805,GO:0005893,1,0.986403277609875,0,2,interleukin-2 receptor complex,CC,
2806,GO:0005895,1,0.995853428771886,0,1,interleukin-5 receptor complex,CC,
2807,GO:0005896,1,0.983045395220022,0,3,interleukin-6 receptor complex,CC,
2808,GO:0005898,1,0.992401352976824,0,1,interleukin-13 receptor complex,CC,
2809,GO:0005899,1,0.939547964303408,0,4,insulin receptor complex,CC,
2810,GO:0005900,1,0.98727676386521,0,2,oncostatin-M receptor complex,CC,
2811,GO:0005901,1,0.542681020720394,0,75,caveola,CC,
2817,GO:0005914,1,0.993783331241489,0,1,spot adherens junction,CC,
2818,GO:0005915,1,0.944637454087614,0,7,zonula adherens,CC,
2819,GO:0005916,1,0.921341509979541,0,10,fascia adherens,CC,
2820,GO:0005921,1,0.876456815499942,0,23,gap junction,CC,
2821,GO:0005922,1,0.926931996984528,0,14,connexin complex,CC,
2822,GO:0005923,1,0.408115750280883,0,110,bicellular tight junction,CC,
2824,GO:0005927,1,0.982906871335444,0,3,muscle tendon junction,CC,
2826,GO:0005930,1,0.399540464666496,0,104,axoneme,CC,
2829,GO:0005943,1,0.971841517031546,0,3,phosphatidylinositol 3-kinase complex, class IA,CC,
2830,GO:0005944,1,0.974373579863086,0,3,phosphatidylinositol 3-kinase complex, class IB,CC,
2831,GO:0005945,1,0.983389729457766,0,3,6-phosphofructokinase complex,CC,
2832,GO:0005947,1,0.964527718193456,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2833,GO:0005948,1,0.995653649421474,0,1,acetolactate synthase complex,CC,
2834,GO:0005952,1,0.950123113406603,0,8,cAMP-dependent protein kinase complex,CC,
2835,GO:0005953,1,0.991449188755883,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2837,GO:0005955,1,0.957403310578269,0,5,calcineurin complex,CC,
2838,GO:0005956,1,0.988184672434557,0,3,protein kinase CK2 complex,CC,
2839,GO:0005958,1,0.964905716686242,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2840,GO:0005960,1,0.989352727570896,0,2,glycine cleavage complex,CC,
2841,GO:0005964,1,0.957204959209973,0,5,phosphorylase kinase complex,CC,
2842,GO:0005965,1,0.991278461913513,0,2,protein farnesyltransferase complex,CC,
2843,GO:0005967,1,0.969216101615485,0,5,mitochondrial pyruvate dehydrogenase complex,CC,
2844,GO:0005968,1,0.971496114675349,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2845,GO:0005969,1,0.984851523888453,0,1,serine-pyruvate aminotransferase complex,CC,
2846,GO:0005971,1,0.987854456246501,0,2,ribonucleoside-diphosphate reductase complex,CC,
2849,GO:0005977,1,0.598729323753462,0,64,glycogen metabolic process,BP,
2850,GO:0005978,1,0.700878060305153,0,41,glycogen biosynthetic process,BP,
2851,GO:0005979,1,0.778751627632834,0,26,regulation of glycogen biosynthetic process,BP,
2852,GO:0005980,1,0.841898195936329,0,21,glycogen catabolic process,BP,
2853,GO:0005981,1,0.963234027248381,0,5,regulation of glycogen catabolic process,BP,
2854,GO:0005982,1,0.987552180723627,0,1,starch metabolic process,BP,
2855,GO:0005983,1,0.987552180723627,0,1,starch catabolic process,BP,
2856,GO:0005984,1,0.942335895792098,0,9,disaccharide metabolic process,BP,
2857,GO:0005985,1,0.989787962545094,0,2,sucrose metabolic process,BP,
2858,GO:0005986,1,0.996519718586635,0,1,sucrose biosynthetic process,BP,
2859,GO:0005988,1,0.98207550247311,0,3,lactose metabolic process,BP,
2860,GO:0005989,1,0.98207550247311,0,3,lactose biosynthetic process,BP,
2861,GO:0005991,1,0.994543378900449,0,1,trehalose metabolic process,BP,
2863,GO:0005997,1,0.982633740785933,0,4,xylulose metabolic process,BP,
2864,GO:0005998,1,0.993053853719577,0,1,xylulose catabolic process,BP,
2865,GO:0005999,1,0.992642962591794,0,2,xylulose biosynthetic process,BP,
2866,GO:0006000,1,0.935508027488215,0,13,fructose metabolic process,BP,
2867,GO:0006001,1,0.981017515924691,0,4,fructose catabolic process,BP,
2868,GO:0006002,1,0.921758572817872,0,11,fructose 6-phosphate metabolic process,BP,
2869,GO:0006003,1,0.971574169929113,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2871,GO:0006006,1,0.273002563074302,0,189,glucose metabolic process,BP,
2872,GO:0006007,1,0.818091309757692,0,32,glucose catabolic process,BP,
2873,GO:0006011,1,0.959441973676071,0,5,UDP-glucose metabolic process,BP,
2874,GO:0006012,1,0.922088402111379,0,13,galactose metabolic process,BP,
2875,GO:0006013,1,0.940916846248219,0,9,mannose metabolic process,BP,
2876,GO:0006014,1,0.989727512608346,0,3,D-ribose metabolic process,BP,
2877,GO:0006015,1,0.977929507382852,0,5,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2878,GO:0006020,1,0.917422109748396,0,10,inositol metabolic process,BP,
2879,GO:0006021,1,0.985995065911186,0,3,inositol biosynthetic process,BP,
2885,GO:0006029,1,0.501135733088741,0,88,proteoglycan metabolic process,BP,
2889,GO:0006041,1,0.980615095546093,0,4,glucosamine metabolic process,BP,
2890,GO:0006043,1,0.991852276216149,0,2,glucosamine catabolic process,BP,
2891,GO:0006044,1,0.899126672807419,0,16,N-acetylglucosamine metabolic process,BP,
2892,GO:0006045,1,0.982769272933706,0,2,N-acetylglucosamine biosynthetic process,BP,
2893,GO:0006046,1,0.988138154445242,0,3,N-acetylglucosamine catabolic process,BP,
2894,GO:0006047,1,0.916818204022496,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2895,GO:0006048,1,0.938981603815354,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2896,GO:0006049,1,0.994611286164918,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2897,GO:0006050,1,0.993068821438724,0,2,mannosamine metabolic process,BP,
2898,GO:0006051,1,0.993068821438724,0,2,N-acetylmannosamine metabolic process,BP,
2899,GO:0006054,1,0.937253982409808,0,11,N-acetylneuraminate metabolic process,BP,
2900,GO:0006055,1,0.996702139098049,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2901,GO:0006056,1,0.996318235555698,0,1,mannoprotein metabolic process,BP,
2902,GO:0006057,1,0.996318235555698,0,1,mannoprotein biosynthetic process,BP,
2903,GO:0006059,1,0.988597362801645,0,3,hexitol metabolic process,BP,
2904,GO:0006060,1,0.99193376976849,0,2,sorbitol metabolic process,BP,
2905,GO:0006061,1,0.996612746461703,0,1,sorbitol biosynthetic process,BP,
2906,GO:0006062,1,0.995305280149271,0,1,sorbitol catabolic process,BP,
2907,GO:0006063,1,0.959524326094641,0,8,uronic acid metabolic process,BP,
2908,GO:0006064,1,0.97849578384914,0,5,glucuronate catabolic process,BP,
2909,GO:0006065,1,0.977770634546768,0,3,UDP-glucuronate biosynthetic process,BP,
2910,GO:0006066,1,0.121308363996287,0,330,alcohol metabolic process,BP,
2911,GO:0006067,1,0.93060309535761,0,16,ethanol metabolic process,BP,
2912,GO:0006068,1,0.960869461681423,0,10,ethanol catabolic process,BP,
2913,GO:0006069,1,0.958779424039731,0,8,ethanol oxidation,BP,
2914,GO:0006071,1,0.892735701798182,0,16,glycerol metabolic process,BP,
2915,GO:0006072,1,0.934332348876926,0,7,glycerol-3-phosphate metabolic process,BP,
2916,GO:0006073,1,0.591238442266318,0,65,cellular glucan metabolic process,BP,
2917,GO:0006081,1,0.734803363148863,0,58,cellular aldehyde metabolic process,BP,
2919,GO:0006083,1,0.985969738170278,0,2,acetate metabolic process,BP,
2920,GO:0006084,1,0.788457608427183,0,36,acetyl-CoA metabolic process,BP,
2921,GO:0006085,1,0.867431132499786,0,21,acetyl-CoA biosynthetic process,BP,
2922,GO:0006086,1,0.89755526563417,0,15,acetyl-CoA biosynthetic process from pyruvate,BP,
2923,GO:0006089,1,0.930228375394868,0,12,lactate metabolic process,BP,
2924,GO:0006090,1,0.368432017505181,0,139,pyruvate metabolic process,BP,
2925,GO:0006091,1,0.0664988709200061,0,451,generation of precursor metabolites and energy,BP,
2926,GO:0006094,1,0.624615296789467,0,76,gluconeogenesis,BP,
2927,GO:0006096,1,0.454500599845407,0,104,glycolytic process,BP,
2928,GO:0006097,1,0.991986404638506,0,2,glyoxylate cycle,BP,
2929,GO:0006098,1,0.929728441621793,0,14,pentose-phosphate shunt,BP,
2930,GO:0006099,1,0.838027081836174,0,33,tricarboxylic acid cycle,BP,
2931,GO:0006101,1,0.962797455023345,0,5,citrate metabolic process,BP,
2932,GO:0006102,1,0.975214639710567,0,6,isocitrate metabolic process,BP,
2933,GO:0006103,1,0.922103785136625,0,15,2-oxoglutarate metabolic process,BP,
2934,GO:0006104,1,0.974668312390615,0,5,succinyl-CoA metabolic process,BP,
2935,GO:0006105,1,0.974073570403367,0,5,succinate metabolic process,BP,
2936,GO:0006106,1,0.987684199937835,0,3,fumarate metabolic process,BP,
2937,GO:0006107,1,0.9642708275441,0,8,oxaloacetate metabolic process,BP,
2938,GO:0006108,1,0.966536887019197,0,7,malate metabolic process,BP,
2939,GO:0006109,1,0.248322402041677,0,180,regulation of carbohydrate metabolic process,BP,
2940,GO:0006110,1,0.558289554298122,0,71,regulation of glycolytic process,BP,
2941,GO:0006111,1,0.75309436053591,0,37,regulation of gluconeogenesis,BP,
2942,GO:0006112,1,0.559758472669352,0,75,energy reserve metabolic process,BP,
2943,GO:0006113,1,0.98764869320882,0,2,fermentation,BP,
2944,GO:0006114,1,0.971283101710567,0,6,glycerol biosynthetic process,BP,
2945,GO:0006116,1,0.978955609046184,0,3,NADH oxidation,BP,
2946,GO:0006117,1,0.995222801563837,0,1,acetaldehyde metabolic process,BP,
2947,GO:0006119,1,0.629343064001537,0,106,oxidative phosphorylation,BP,
2948,GO:0006120,1,0.844422229646436,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
2949,GO:0006121,1,0.983947274327015,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2950,GO:0006122,1,0.939337461092405,0,12,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2951,GO:0006123,1,0.931949055245998,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2952,GO:0006127,1,0.983416006431856,0,2,glycerophosphate shuttle,BP,
2954,GO:0006140,1,0.454739697392472,0,105,regulation of nucleotide metabolic process,BP,
2955,GO:0006144,1,0.904390863079077,0,18,purine nucleobase metabolic process,BP,
2956,GO:0006145,1,0.963789646968422,0,4,purine nucleobase catabolic process,BP,
2957,GO:0006147,1,0.989584362975858,0,1,guanine catabolic process,BP,
2958,GO:0006148,1,0.995490313344996,0,1,inosine catabolic process,BP,
2959,GO:0006152,1,0.970927617330035,0,6,purine nucleoside catabolic process,BP,
2960,GO:0006154,1,0.991774687230019,0,2,adenosine catabolic process,BP,
2961,GO:0006157,1,0.996521202535912,0,1,deoxyadenosine catabolic process,BP,
2962,GO:0006163,1,0.0864574461699565,0,375,purine nucleotide metabolic process,BP,
2963,GO:0006164,1,0.394830437672569,0,155,purine nucleotide biosynthetic process,BP,
2964,GO:0006165,1,0.422076767200439,0,121,nucleoside diphosphate phosphorylation,BP,
2965,GO:0006166,1,0.976402997568566,0,5,purine ribonucleoside salvage,BP,
2966,GO:0006167,1,0.986294277963602,0,4,AMP biosynthetic process,BP,
2967,GO:0006168,1,0.993474412079687,0,2,adenine salvage,BP,
2968,GO:0006170,1,0.991986846858326,0,2,dAMP biosynthetic process,BP,
2969,GO:0006171,1,0.892384347297116,0,10,cAMP biosynthetic process,BP,
2970,GO:0006172,1,0.974916948426746,0,5,ADP biosynthetic process,BP,
2971,GO:0006173,1,0.993260519273692,0,1,dADP biosynthetic process,BP,
2972,GO:0006174,1,0.994890876864838,0,1,dADP phosphorylation,BP,
2973,GO:0006175,1,0.996001003871741,0,1,dATP biosynthetic process,BP,
2974,GO:0006177,1,0.983834945764362,0,4,GMP biosynthetic process,BP,
2975,GO:0006178,1,0.996604021233342,0,1,guanine salvage,BP,
2976,GO:0006182,1,0.964441431994392,0,7,cGMP biosynthetic process,BP,
2977,GO:0006183,1,0.9643693231877,0,10,GTP biosynthetic process,BP,
2978,GO:0006185,1,0.996800171460964,0,1,dGDP biosynthetic process,BP,
2979,GO:0006186,1,0.994890876864838,0,1,dGDP phosphorylation,BP,
2980,GO:0006188,1,0.94508298810358,0,9,IMP biosynthetic process,BP,
2981,GO:0006189,1,0.96301288305201,0,6,'de novo' IMP biosynthetic process,BP,
2982,GO:0006193,1,0.996762191458164,0,1,ITP catabolic process,BP,
2983,GO:0006195,1,0.7605217142971,0,42,purine nucleotide catabolic process,BP,
2984,GO:0006196,1,0.984086744619706,0,2,AMP catabolic process,BP,
2985,GO:0006198,1,0.915994025105791,0,9,cAMP catabolic process,BP,
2986,GO:0006203,1,0.987033394143245,0,3,dGTP catabolic process,BP,
2987,GO:0006206,1,0.899813726201533,0,16,pyrimidine nucleobase metabolic process,BP,
2988,GO:0006207,1,0.945934786558354,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2989,GO:0006208,1,0.986017318350403,0,3,pyrimidine nucleobase catabolic process,BP,
2990,GO:0006210,1,0.986017318350403,0,3,thymine catabolic process,BP,
2991,GO:0006211,1,0.945419683205745,0,3,5-methylcytosine catabolic process,BP,
2992,GO:0006212,1,0.990147960378247,0,2,uracil catabolic process,BP,
2993,GO:0006213,1,0.861968298341216,0,32,pyrimidine nucleoside metabolic process,BP,
2994,GO:0006214,1,0.994217100594094,0,1,thymidine catabolic process,BP,
2995,GO:0006216,1,0.959267045663034,0,10,cytidine catabolic process,BP,
2996,GO:0006218,1,0.991790336331877,0,2,uridine catabolic process,BP,
2997,GO:0006220,1,0.822068426464942,0,44,pyrimidine nucleotide metabolic process,BP,
2998,GO:0006221,1,0.876659531253516,0,29,pyrimidine nucleotide biosynthetic process,BP,
2999,GO:0006222,1,0.949280860997233,0,10,UMP biosynthetic process,BP,
3000,GO:0006225,1,0.994732311715085,0,1,UDP biosynthetic process,BP,
3001,GO:0006226,1,0.99226220254426,0,2,dUMP biosynthetic process,BP,
3002,GO:0006227,1,0.991251928816876,0,2,dUDP biosynthetic process,BP,
3003,GO:0006228,1,0.959195764045999,0,9,UTP biosynthetic process,BP,
3004,GO:0006231,1,0.987983778297835,0,3,dTMP biosynthetic process,BP,
3005,GO:0006233,1,0.991251928816876,0,2,dTDP biosynthetic process,BP,
3006,GO:0006235,1,0.984469653614238,0,4,dTTP biosynthetic process,BP,
3007,GO:0006241,1,0.949537321198212,0,13,CTP biosynthetic process,BP,
3008,GO:0006244,1,0.948997295436748,0,13,pyrimidine nucleotide catabolic process,BP,
3009,GO:0006253,1,0.996756211178004,0,1,dCTP catabolic process,BP,
3010,GO:0006256,1,0.994590601159284,0,1,UDP catabolic process,BP,
3011,GO:0006258,1,0.992493534951366,0,2,UDP-glucose catabolic process,BP,
3013,GO:0006260,1,0.173637182354586,0,257,DNA replication,BP,
3014,GO:0006261,1,0.39891908163785,0,143,DNA-dependent DNA replication,BP,
3015,GO:0006264,1,0.928199065813214,0,12,mitochondrial DNA replication,BP,
3016,GO:0006265,1,0.941198644373108,0,9,DNA topological change,BP,
3017,GO:0006266,1,0.919022753679071,0,16,DNA ligation,BP,
3018,GO:0006267,1,0.954881290425402,0,8,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3019,GO:0006268,1,0.908442464838519,0,15,DNA unwinding involved in DNA replication,BP,
3020,GO:0006269,1,0.970717919664515,0,5,DNA replication, synthesis of RNA primer,BP,
3021,GO:0006270,1,0.808335934992719,0,38,DNA replication initiation,BP,
3022,GO:0006271,1,0.891384575237167,0,19,DNA strand elongation involved in DNA replication,BP,
3023,GO:0006272,1,0.967257849933636,0,4,leading strand elongation,BP,
3024,GO:0006273,1,0.969355625201774,0,4,lagging strand elongation,BP,
3025,GO:0006275,1,0.482662277708241,0,104,regulation of DNA replication,BP,
3026,GO:0006278,1,0.623282294182616,0,67,RNA-dependent DNA biosynthetic process,BP,
3027,GO:0006281,1,0.0353829181558598,0,488,DNA repair,BP,
3028,GO:0006282,1,0.450244076206866,0,112,regulation of DNA repair,BP,
3029,GO:0006283,1,0.671922773934266,0,73,transcription-coupled nucleotide-excision repair,BP,
3031,GO:0006285,1,0.960631240679499,0,10,base-excision repair, AP site formation,BP,
3032,GO:0006286,1,0.993254597724336,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3033,GO:0006287,1,0.95930391163438,0,6,base-excision repair, gap-filling,BP,
3034,GO:0006288,1,0.986352020172899,0,3,base-excision repair, DNA ligation,BP,
3035,GO:0006289,1,0.538269349727913,0,106,nucleotide-excision repair,BP,
3036,GO:0006290,1,0.933908880099356,0,9,pyrimidine dimer repair,BP,
3037,GO:0006293,1,0.875688448913223,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3038,GO:0006294,1,0.8537887518237,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3039,GO:0006295,1,0.875688448913223,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3040,GO:0006296,1,0.811709977577903,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3041,GO:0006297,1,0.880727143579325,0,23,nucleotide-excision repair, DNA gap filling,BP,
3042,GO:0006298,1,0.817789029889527,0,32,mismatch repair,BP,
3043,GO:0006301,1,0.731528304787663,0,49,postreplication repair,BP,
3044,GO:0006302,1,0.20833697187623,0,218,double-strand break repair,BP,
3045,GO:0006303,1,0.598605643338358,0,67,double-strand break repair via nonhomologous end joining,BP,
3046,GO:0006304,1,0.500321943817347,0,104,DNA modification,BP,
3047,GO:0006305,1,0.647936310151696,0,60,DNA alkylation,BP,
3048,GO:0006306,1,0.647936310151696,0,60,DNA methylation,BP,
3049,GO:0006307,1,0.948773420278639,0,10,DNA dealkylation involved in DNA repair,BP,
3050,GO:0006308,1,0.790861113259672,0,39,DNA catabolic process,BP,
3051,GO:0006309,1,0.861727542265572,0,24,apoptotic DNA fragmentation,BP,
3052,GO:0006310,1,0.176767814801541,0,249,DNA recombination,BP,
3053,GO:0006311,1,0.982612903379845,0,3,meiotic gene conversion,BP,
3054,GO:0006312,1,0.846099880523883,0,21,mitotic recombination,BP,
3055,GO:0006313,1,0.98596537802872,0,2,transposition, DNA-mediated,BP,
3056,GO:0006323,1,0.351694504714815,0,141,DNA packaging,BP,
3058,GO:0006333,1,0.394071277165294,0,131,chromatin assembly or disassembly,BP,
3059,GO:0006334,1,0.680781530100613,0,62,nucleosome assembly,BP,
3060,GO:0006335,1,0.950832281394146,0,8,DNA replication-dependent nucleosome assembly,BP,
3061,GO:0006336,1,0.814184272720851,0,34,DNA replication-independent nucleosome assembly,BP,
3062,GO:0006337,1,0.892883303262357,0,15,nucleosome disassembly,BP,
3063,GO:0006338,1,0.25171604040697,0,173,chromatin remodeling,BP,
3064,GO:0006342,1,0.770675448984225,0,34,chromatin silencing,BP,
3065,GO:0006346,1,0.877933045742524,0,17,DNA methylation-dependent heterochromatin assembly,BP,
3066,GO:0006348,1,0.936307866320219,0,10,chromatin silencing at telomere,BP,
3067,GO:0006349,1,0.872377931574676,0,17,regulation of gene expression by genetic imprinting,BP,
3069,GO:0006352,1,0.211316968302399,0,220,DNA-templated transcription, initiation,BP,
3070,GO:0006353,1,0.663828688690668,0,71,DNA-templated transcription, termination,BP,
3071,GO:0006354,1,0.523023519404914,0,104,DNA-templated transcription, elongation,BP,
3073,GO:0006356,1,0.825921580765584,0,27,regulation of transcription by RNA polymerase I,BP,
3075,GO:0006359,1,0.856672286931671,0,23,regulation of transcription by RNA polymerase III,BP,
3076,GO:0006360,1,0.684442937164459,0,56,transcription by RNA polymerase I,BP,
3077,GO:0006361,1,0.82600553314346,0,32,transcription initiation from RNA polymerase I promoter,BP,
3078,GO:0006362,1,0.858948393180805,0,27,transcription elongation from RNA polymerase I promoter,BP,
3079,GO:0006363,1,0.866688477500159,0,27,termination of RNA polymerase I transcription,BP,
3080,GO:0006364,1,0.317460197201312,0,205,rRNA processing,BP,
3082,GO:0006367,1,0.285689049817046,0,180,transcription initiation from RNA polymerase II promoter,BP,
3083,GO:0006368,1,0.611226100534341,0,78,transcription elongation from RNA polymerase II promoter,BP,
3084,GO:0006369,1,0.808038268646384,0,35,termination of RNA polymerase II transcription,BP,
3085,GO:0006370,1,0.84532794183288,0,31,7-methylguanosine mRNA capping,BP,
3087,GO:0006378,1,0.74792117093706,0,42,mRNA polyadenylation,BP,
3088,GO:0006379,1,0.877131634134493,0,20,mRNA cleavage,BP,
3089,GO:0006382,1,0.937844224917765,0,8,adenosine to inosine editing,BP,
3090,GO:0006383,1,0.746882108856417,0,46,transcription by RNA polymerase III,BP,
3091,GO:0006384,1,0.932882783200668,0,8,transcription initiation from RNA polymerase III promoter,BP,
3092,GO:0006386,1,0.996849465134937,0,1,termination of RNA polymerase III transcription,BP,
3093,GO:0006388,1,0.942486868702505,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3094,GO:0006390,1,0.90893982041958,0,14,mitochondrial transcription,BP,
3095,GO:0006391,1,0.985326078937727,0,3,transcription initiation from mitochondrial promoter,BP,
3096,GO:0006392,1,0.994890876864838,0,1,transcription elongation from mitochondrial promoter,BP,
3097,GO:0006393,1,0.989807596705769,0,2,termination of mitochondrial transcription,BP,
3100,GO:0006398,1,0.969290572070783,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3101,GO:0006399,1,0.440684376282407,0,157,tRNA metabolic process,BP,
3102,GO:0006400,1,0.643656212378324,0,81,tRNA modification,BP,
3105,GO:0006403,1,0.220227926187821,0,219,RNA localization,BP,
3106,GO:0006404,1,0.975182655388156,0,3,RNA import into nucleus,BP,
3107,GO:0006405,1,0.401762226262643,0,133,RNA export from nucleus,BP,
3108,GO:0006406,1,0.481189670104648,0,105,mRNA export from nucleus,BP,
3109,GO:0006407,1,0.980483493061401,0,2,rRNA export from nucleus,BP,
3110,GO:0006408,1,0.992311996018136,0,2,snRNA export from nucleus,BP,
3111,GO:0006409,1,0.781393116364339,0,31,tRNA export from nucleus,BP,
3113,GO:0006413,1,0.390668713445959,0,186,translational initiation,BP,
3114,GO:0006414,1,0.555564676313703,0,125,translational elongation,BP,
3115,GO:0006415,1,0.647520649165604,0,101,translational termination,BP,
3117,GO:0006418,1,0.880750781344971,0,26,tRNA aminoacylation for protein translation,BP,
3118,GO:0006419,1,0.987038850122027,0,2,alanyl-tRNA aminoacylation,BP,
3119,GO:0006420,1,0.992002756970686,0,2,arginyl-tRNA aminoacylation,BP,
3120,GO:0006421,1,0.989472522523062,0,2,asparaginyl-tRNA aminoacylation,BP,
3121,GO:0006423,1,0.996216668794837,0,1,cysteinyl-tRNA aminoacylation,BP,
3122,GO:0006424,1,0.992591972216921,0,1,glutamyl-tRNA aminoacylation,BP,
3123,GO:0006427,1,0.995357710732009,0,1,histidyl-tRNA aminoacylation,BP,
3124,GO:0006428,1,0.99333818130966,0,1,isoleucyl-tRNA aminoacylation,BP,
3125,GO:0006429,1,0.99197264500631,0,1,leucyl-tRNA aminoacylation,BP,
3126,GO:0006431,1,0.994417361950566,0,1,methionyl-tRNA aminoacylation,BP,
3127,GO:0006432,1,0.988266134911893,0,3,phenylalanyl-tRNA aminoacylation,BP,
3128,GO:0006433,1,0.995601198783344,0,1,prolyl-tRNA aminoacylation,BP,
3129,GO:0006434,1,0.995977413276461,0,1,seryl-tRNA aminoacylation,BP,
3130,GO:0006435,1,0.995536995734659,0,1,threonyl-tRNA aminoacylation,BP,
3131,GO:0006436,1,0.994799330390074,0,1,tryptophanyl-tRNA aminoacylation,BP,
3132,GO:0006437,1,0.995864341580592,0,1,tyrosyl-tRNA aminoacylation,BP,
3133,GO:0006438,1,0.993193097521698,0,1,valyl-tRNA aminoacylation,BP,
3134,GO:0006446,1,0.6101543848784,0,76,regulation of translational initiation,BP,
3135,GO:0006447,1,0.977455893408402,0,3,regulation of translational initiation by iron,BP,
3136,GO:0006448,1,0.891871082145253,0,18,regulation of translational elongation,BP,
3137,GO:0006449,1,0.930533049883619,0,10,regulation of translational termination,BP,
3138,GO:0006450,1,0.93125398646116,0,14,regulation of translational fidelity,BP,
3139,GO:0006451,1,0.944071579170005,0,8,translational readthrough,BP,
3140,GO:0006457,1,0.334244426258893,0,201,protein folding,BP,
3141,GO:0006458,1,0.826194281016017,0,36,'de novo' protein folding,BP,
3142,GO:0006463,1,0.992956046057208,0,1,steroid hormone receptor complex assembly,BP,
3144,GO:0006465,1,0.944966650150721,0,11,signal peptide processing,BP,
3148,GO:0006471,1,0.827943926476889,0,29,protein ADP-ribosylation,BP,
3150,GO:0006474,1,0.882557455971098,0,16,N-terminal protein amino acid acetylation,BP,
3152,GO:0006476,1,0.481420070373986,0,92,protein deacetylation,BP,
3153,GO:0006477,1,0.954401356510601,0,7,protein sulfation,BP,
3154,GO:0006478,1,0.992152453171458,0,2,peptidyl-tyrosine sulfation,BP,
3155,GO:0006479,1,0.308579039970061,0,154,protein methylation,BP,
3156,GO:0006480,1,0.991722635944497,0,2,N-terminal protein amino acid methylation,BP,
3157,GO:0006481,1,0.987495296789046,0,2,C-terminal protein methylation,BP,
3158,GO:0006482,1,0.758077736780534,0,29,protein demethylation,BP,
3160,GO:0006487,1,0.651830607054279,0,71,protein N-linked glycosylation,BP,
3161,GO:0006488,1,0.881442664342705,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3162,GO:0006489,1,0.964214986133718,0,7,dolichyl diphosphate biosynthetic process,BP,
3163,GO:0006490,1,0.87729057232053,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3166,GO:0006497,1,0.580886403495624,0,89,protein lipidation,BP,
3167,GO:0006498,1,0.953992691833711,0,6,N-terminal protein lipidation,BP,
3168,GO:0006499,1,0.961506412537665,0,4,N-terminal protein myristoylation,BP,
3169,GO:0006500,1,0.992188528208418,0,2,N-terminal protein palmitoylation,BP,
3170,GO:0006501,1,0.960259610818572,0,6,C-terminal protein lipidation,BP,
3171,GO:0006505,1,0.84773903424142,0,31,GPI anchor metabolic process,BP,
3172,GO:0006506,1,0.851423524809189,0,30,GPI anchor biosynthetic process,BP,
3173,GO:0006507,1,0.99567950861844,0,1,GPI anchor release,BP,
3176,GO:0006511,1,0.0169160895338895,0,580,ubiquitin-dependent protein catabolic process,BP,
3177,GO:0006513,1,0.607528533215126,0,64,protein monoubiquitination,BP,
3178,GO:0006515,1,0.810681442139095,0,28,protein quality control for misfolded or incompletely synthesized proteins,BP,
3179,GO:0006516,1,0.885003746848264,0,20,glycoprotein catabolic process,BP,
3180,GO:0006517,1,0.814979476133413,0,26,protein deglycosylation,BP,
3182,GO:0006520,1,0.206361451567799,0,294,cellular amino acid metabolic process,BP,
3183,GO:0006521,1,0.765938687848727,0,58,regulation of cellular amino acid metabolic process,BP,
3184,GO:0006522,1,0.981843424406226,0,4,alanine metabolic process,BP,
3185,GO:0006524,1,0.981843424406226,0,4,alanine catabolic process,BP,
3186,GO:0006525,1,0.899665990269686,0,19,arginine metabolic process,BP,
3187,GO:0006526,1,0.98107620409421,0,5,arginine biosynthetic process,BP,
3188,GO:0006527,1,0.933597364316002,0,10,arginine catabolic process,BP,
3189,GO:0006528,1,0.979784543111975,0,5,asparagine metabolic process,BP,
3190,GO:0006529,1,0.99104201511006,0,2,asparagine biosynthetic process,BP,
3191,GO:0006530,1,0.995542397726162,0,1,asparagine catabolic process,BP,
3192,GO:0006531,1,0.980827219751249,0,5,aspartate metabolic process,BP,
3193,GO:0006532,1,0.991352183790309,0,2,aspartate biosynthetic process,BP,
3194,GO:0006533,1,0.984504842321396,0,4,aspartate catabolic process,BP,
3195,GO:0006534,1,0.939337885388922,0,11,cysteine metabolic process,BP,
3196,GO:0006535,1,0.995183075943713,0,1,cysteine biosynthetic process from serine,BP,
3197,GO:0006536,1,0.832650906408709,0,31,glutamate metabolic process,BP,
3198,GO:0006537,1,0.96874581285199,0,5,glutamate biosynthetic process,BP,
3199,GO:0006538,1,0.959713706929971,0,8,glutamate catabolic process,BP,
3200,GO:0006539,1,0.996183584154226,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3201,GO:0006540,1,0.990710087723568,0,2,glutamate decarboxylation to succinate,BP,
3202,GO:0006541,1,0.861723200514954,0,21,glutamine metabolic process,BP,
3203,GO:0006542,1,0.991678996243949,0,1,glutamine biosynthetic process,BP,
3204,GO:0006543,1,0.979911237790319,0,3,glutamine catabolic process,BP,
3205,GO:0006544,1,0.94705361145647,0,12,glycine metabolic process,BP,
3206,GO:0006545,1,0.987689952120186,0,3,glycine biosynthetic process,BP,
3207,GO:0006546,1,0.985374448360338,0,3,glycine catabolic process,BP,
3208,GO:0006547,1,0.954804530966238,0,9,histidine metabolic process,BP,
3209,GO:0006548,1,0.965310895226039,0,7,histidine catabolic process,BP,
3210,GO:0006549,1,0.981225737932909,0,5,isoleucine metabolic process,BP,
3211,GO:0006550,1,0.992362533703358,0,2,isoleucine catabolic process,BP,
3212,GO:0006551,1,0.949809888403453,0,8,leucine metabolic process,BP,
3213,GO:0006552,1,0.968276546501968,0,6,leucine catabolic process,BP,
3214,GO:0006553,1,0.927842241137613,0,13,lysine metabolic process,BP,
3215,GO:0006554,1,0.932769541178765,0,12,lysine catabolic process,BP,
3216,GO:0006555,1,0.903172216427329,0,16,methionine metabolic process,BP,
3217,GO:0006556,1,0.979459579540596,0,4,S-adenosylmethionine biosynthetic process,BP,
3218,GO:0006557,1,0.993941860303577,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3219,GO:0006558,1,0.961187842314145,0,10,L-phenylalanine metabolic process,BP,
3220,GO:0006559,1,0.961187842314145,0,10,L-phenylalanine catabolic process,BP,
3221,GO:0006560,1,0.963887357831736,0,8,proline metabolic process,BP,
3222,GO:0006561,1,0.977295413585508,0,5,proline biosynthetic process,BP,
3223,GO:0006562,1,0.986283584874565,0,3,proline catabolic process,BP,
3224,GO:0006563,1,0.95885215228946,0,10,L-serine metabolic process,BP,
3225,GO:0006564,1,0.971361765087013,0,7,L-serine biosynthetic process,BP,
3226,GO:0006565,1,0.982929348821571,0,4,L-serine catabolic process,BP,
3227,GO:0006566,1,0.985689345070244,0,4,threonine metabolic process,BP,
3228,GO:0006567,1,0.989605102019769,0,3,threonine catabolic process,BP,
3229,GO:0006568,1,0.94696641908056,0,10,tryptophan metabolic process,BP,
3230,GO:0006569,1,0.965857681052591,0,8,tryptophan catabolic process,BP,
3231,GO:0006570,1,0.964607733776243,0,9,tyrosine metabolic process,BP,
3232,GO:0006571,1,0.99503295042009,0,1,tyrosine biosynthetic process,BP,
3233,GO:0006572,1,0.980845471748261,0,5,tyrosine catabolic process,BP,
3234,GO:0006573,1,0.96101306020075,0,7,valine metabolic process,BP,
3235,GO:0006574,1,0.983972711775445,0,4,valine catabolic process,BP,
3237,GO:0006576,1,0.764358894890253,0,52,cellular biogenic amine metabolic process,BP,
3238,GO:0006577,1,0.91427819726699,0,17,amino-acid betaine metabolic process,BP,
3239,GO:0006578,1,0.963903784318756,0,7,amino-acid betaine biosynthetic process,BP,
3240,GO:0006579,1,0.98506767758452,0,3,amino-acid betaine catabolic process,BP,
3241,GO:0006580,1,0.989633058070354,0,2,ethanolamine metabolic process,BP,
3242,GO:0006581,1,0.989678284712688,0,2,acetylcholine catabolic process,BP,
3243,GO:0006582,1,0.840170891637609,0,21,melanin metabolic process,BP,
3244,GO:0006583,1,0.995589833995237,0,1,melanin biosynthetic process from tyrosine,BP,
3245,GO:0006584,1,0.741731984345464,0,49,catecholamine metabolic process,BP,
3246,GO:0006585,1,0.996179103846318,0,1,dopamine biosynthetic process from tyrosine,BP,
3247,GO:0006586,1,0.9323183681222,0,14,indolalkylamine metabolic process,BP,
3248,GO:0006589,1,0.989296059771533,0,2,octopamine biosynthetic process,BP,
3249,GO:0006590,1,0.863704945336405,0,19,thyroid hormone generation,BP,
3250,GO:0006591,1,0.958740686627585,0,9,ornithine metabolic process,BP,
3251,GO:0006592,1,0.993519709717117,0,1,ornithine biosynthetic process,BP,
3252,GO:0006593,1,0.996431190033839,0,1,ornithine catabolic process,BP,
3253,GO:0006595,1,0.93502231087059,0,16,polyamine metabolic process,BP,
3254,GO:0006596,1,0.945800476317469,0,13,polyamine biosynthetic process,BP,
3255,GO:0006597,1,0.990357914498936,0,2,spermine biosynthetic process,BP,
3256,GO:0006598,1,0.98600454448933,0,4,polyamine catabolic process,BP,
3257,GO:0006599,1,0.982399670306247,0,5,phosphagen metabolic process,BP,
3258,GO:0006600,1,0.968096211170757,0,8,creatine metabolic process,BP,
3259,GO:0006601,1,0.992017153733996,0,2,creatine biosynthetic process,BP,
3260,GO:0006603,1,0.982399670306247,0,5,phosphocreatine metabolic process,BP,
3262,GO:0006606,1,0.342113847557647,0,135,protein import into nucleus,BP,
3263,GO:0006607,1,0.853931194614772,0,16,NLS-bearing protein import into nucleus,BP,
3264,GO:0006610,1,0.969201410659031,0,4,ribosomal protein import into nucleus,BP,
3265,GO:0006611,1,0.296916233579912,0,176,protein export from nucleus,BP,
3267,GO:0006613,1,0.677848470662926,0,98,cotranslational protein targeting to membrane,BP,
3268,GO:0006614,1,0.704600081300801,0,94,SRP-dependent cotranslational protein targeting to membrane,BP,
3269,GO:0006616,1,0.955745871839046,0,8,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3270,GO:0006617,1,0.992588884792196,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3271,GO:0006620,1,0.930452605114567,0,11,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3272,GO:0006621,1,0.953120600145839,0,9,protein retention in ER lumen,BP,
3273,GO:0006622,1,0.840277919309925,0,20,protein targeting to lysosome,BP,
3274,GO:0006623,1,0.713907732226226,0,37,protein targeting to vacuole,BP,
3275,GO:0006624,1,0.992823803961303,0,2,vacuolar protein processing,BP,
3276,GO:0006625,1,0.691007368302155,0,68,protein targeting to peroxisome,BP,
3277,GO:0006626,1,0.596722794042302,0,92,protein targeting to mitochondrion,BP,
3278,GO:0006627,1,0.95755297766681,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3282,GO:0006635,1,0.646514895210462,0,71,fatty acid beta-oxidation,BP,
3284,GO:0006637,1,0.583609938129829,0,93,acyl-CoA metabolic process,BP,
3285,GO:0006638,1,0.486208168368867,0,106,neutral lipid metabolic process,BP,
3286,GO:0006639,1,0.486208168368867,0,106,acylglycerol metabolic process,BP,
3287,GO:0006640,1,0.983119817456536,0,3,monoacylglycerol biosynthetic process,BP,
3288,GO:0006641,1,0.585995998639074,0,82,triglyceride metabolic process,BP,
3289,GO:0006642,1,0.953694081552937,0,4,triglyceride mobilization,BP,
3293,GO:0006649,1,0.980286231313091,0,2,phospholipid transfer to membrane,BP,
3295,GO:0006651,1,0.953098067234813,0,7,diacylglycerol biosynthetic process,BP,
3297,GO:0006655,1,0.943104276662092,0,10,phosphatidylglycerol biosynthetic process,BP,
3298,GO:0006656,1,0.817825531139109,0,37,phosphatidylcholine biosynthetic process,BP,
3299,GO:0006657,1,0.961621211346118,0,7,CDP-choline pathway,BP,
3301,GO:0006659,1,0.980052874830991,0,4,phosphatidylserine biosynthetic process,BP,
3302,GO:0006660,1,0.987774237705271,0,3,phosphatidylserine catabolic process,BP,
3304,GO:0006662,1,0.879584388004269,0,19,glycerol ether metabolic process,BP,
3305,GO:0006663,1,0.972527420887371,0,5,platelet activating factor biosynthetic process,BP,
3308,GO:0006666,1,0.99003509446927,0,1,3-keto-sphinganine metabolic process,BP,
3309,GO:0006667,1,0.979185610320525,0,3,sphinganine metabolic process,BP,
3310,GO:0006668,1,0.988425637503063,0,2,sphinganine-1-phosphate metabolic process,BP,
3311,GO:0006669,1,0.994530105079586,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3312,GO:0006670,1,0.909162439568725,0,15,sphingosine metabolic process,BP,
3313,GO:0006671,1,0.991622631109925,0,1,phytosphingosine metabolic process,BP,
3315,GO:0006677,1,0.912480616378468,0,18,glycosylceramide metabolic process,BP,
3316,GO:0006678,1,0.957648569006944,0,8,glucosylceramide metabolic process,BP,
3317,GO:0006679,1,0.982220578792917,0,3,glucosylceramide biosynthetic process,BP,
3318,GO:0006680,1,0.980115537775343,0,4,glucosylceramide catabolic process,BP,
3319,GO:0006681,1,0.958354671158063,0,9,galactosylceramide metabolic process,BP,
3320,GO:0006682,1,0.972095704221585,0,6,galactosylceramide biosynthetic process,BP,
3321,GO:0006683,1,0.985868507924837,0,3,galactosylceramide catabolic process,BP,
3322,GO:0006684,1,0.923744355447388,0,12,sphingomyelin metabolic process,BP,
3323,GO:0006685,1,0.964564302253023,0,6,sphingomyelin catabolic process,BP,
3324,GO:0006686,1,0.957695370352658,0,6,sphingomyelin biosynthetic process,BP,
3327,GO:0006689,1,0.971754051866136,0,6,ganglioside catabolic process,BP,
3329,GO:0006691,1,0.891954534955622,0,23,leukotriene metabolic process,BP,
3333,GO:0006695,1,0.646356357083369,0,63,cholesterol biosynthetic process,BP,
3334,GO:0006699,1,0.833236057587541,0,33,bile acid biosynthetic process,BP,
3337,GO:0006702,1,0.957123069001017,0,7,androgen biosynthetic process,BP,
3338,GO:0006703,1,0.954228019329975,0,11,estrogen biosynthetic process,BP,
3339,GO:0006704,1,0.908061967806715,0,14,glucocorticoid biosynthetic process,BP,
3340,GO:0006705,1,0.94132839569377,0,9,mineralocorticoid biosynthetic process,BP,
3341,GO:0006706,1,0.901743369347873,0,22,steroid catabolic process,BP,
3342,GO:0006707,1,0.961808096172055,0,9,cholesterol catabolic process,BP,
3343,GO:0006710,1,0.976649973647184,0,5,androgen catabolic process,BP,
3344,GO:0006711,1,0.996310325520138,0,1,estrogen catabolic process,BP,
3345,GO:0006713,1,0.996303347902985,0,1,glucocorticoid catabolic process,BP,
3346,GO:0006714,1,0.993193699032343,0,2,sesquiterpenoid metabolic process,BP,
3347,GO:0006720,1,0.505335447123225,0,114,isoprenoid metabolic process,BP,
3348,GO:0006721,1,0.550386574283817,0,96,terpenoid metabolic process,BP,
3349,GO:0006722,1,0.987432526898731,0,2,triterpenoid metabolic process,BP,
3351,GO:0006726,1,0.99056989974232,0,2,eye pigment biosynthetic process,BP,
3352,GO:0006729,1,0.97124018211104,0,7,tetrahydrobiopterin biosynthetic process,BP,
3353,GO:0006730,1,0.809794226149434,0,38,one-carbon metabolic process,BP,
3354,GO:0006734,1,0.801291047107958,0,37,NADH metabolic process,BP,
3355,GO:0006735,1,0.852124185754144,0,26,NADH regeneration,BP,
3356,GO:0006738,1,0.995490313344996,0,1,nicotinamide riboside catabolic process,BP,
3357,GO:0006739,1,0.847089945881314,0,31,NADP metabolic process,BP,
3358,GO:0006740,1,0.917363724249237,0,16,NADPH regeneration,BP,
3359,GO:0006741,1,0.985317989086295,0,3,NADP biosynthetic process,BP,
3360,GO:0006742,1,0.986243685842132,0,3,NADP catabolic process,BP,
3361,GO:0006743,1,0.923908776744864,0,17,ubiquinone metabolic process,BP,
3362,GO:0006744,1,0.937594594802198,0,15,ubiquinone biosynthetic process,BP,
3363,GO:0006747,1,0.996102280169004,0,1,FAD biosynthetic process,BP,
3364,GO:0006749,1,0.82005965741037,0,42,glutathione metabolic process,BP,
3365,GO:0006750,1,0.915928326964876,0,15,glutathione biosynthetic process,BP,
3366,GO:0006751,1,0.975894538544894,0,6,glutathione catabolic process,BP,
3368,GO:0006754,1,0.860370845913653,0,29,ATP biosynthetic process,BP,
3369,GO:0006756,1,0.994890876864838,0,1,AMP phosphorylation,BP,
3370,GO:0006757,1,0.45216015600316,0,105,ATP generation from ADP,BP,
3371,GO:0006760,1,0.860228144276245,0,26,folic acid-containing compound metabolic process,BP,
3372,GO:0006766,1,0.490054185007893,0,117,vitamin metabolic process,BP,
3373,GO:0006767,1,0.610652934631529,0,78,water-soluble vitamin metabolic process,BP,
3374,GO:0006768,1,0.948627902406951,0,9,biotin metabolic process,BP,
3375,GO:0006771,1,0.958820859426495,0,7,riboflavin metabolic process,BP,
3376,GO:0006772,1,0.987042987404958,0,3,thiamine metabolic process,BP,
3377,GO:0006775,1,0.793716503646646,0,38,fat-soluble vitamin metabolic process,BP,
3378,GO:0006776,1,0.961828152318269,0,7,vitamin A metabolic process,BP,
3379,GO:0006777,1,0.966933966056222,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3380,GO:0006778,1,0.817404190230906,0,34,porphyrin-containing compound metabolic process,BP,
3381,GO:0006779,1,0.847364408767842,0,26,porphyrin-containing compound biosynthetic process,BP,
3382,GO:0006780,1,0.992504132693676,0,2,uroporphyrinogen III biosynthetic process,BP,
3383,GO:0006781,1,0.995850691831409,0,1,succinyl-CoA pathway,BP,
3384,GO:0006782,1,0.955583646391547,0,9,protoporphyrinogen IX biosynthetic process,BP,
3385,GO:0006783,1,0.872929062368595,0,22,heme biosynthetic process,BP,
3386,GO:0006784,1,0.981091943343443,0,2,heme A biosynthetic process,BP,
3387,GO:0006787,1,0.986535555165494,0,4,porphyrin-containing compound catabolic process,BP,
3388,GO:0006788,1,0.99287403045981,0,2,heme oxidation,BP,
3392,GO:0006797,1,0.954131866654735,0,5,polyphosphate metabolic process,BP,
3393,GO:0006798,1,0.959170659915843,0,4,polyphosphate catabolic process,BP,
3394,GO:0006801,1,0.692489868183639,0,63,superoxide metabolic process,BP,
3397,GO:0006808,1,0.98553186006836,0,3,regulation of nitrogen utilization,BP,
3398,GO:0006809,1,0.638555963280311,0,64,nitric oxide biosynthetic process,BP,
3408,GO:0006824,1,0.968134953166872,0,6,cobalt ion transport,BP,
3409,GO:0006825,1,0.871574030111459,0,18,copper ion transport,BP,
3411,GO:0006828,1,0.900329506499512,0,15,manganese ion transport,BP,
3412,GO:0006829,1,0.863039165310901,0,24,zinc ion transport,BP,
3413,GO:0006833,1,0.904532738328821,0,18,water transport,BP,
3416,GO:0006837,1,0.878569870496451,0,21,serotonin transport,BP,
3418,GO:0006842,1,0.975145142321467,0,4,tricarboxylic acid transport,BP,
3419,GO:0006843,1,0.9964709803441,0,1,mitochondrial citrate transmembrane transport,BP,
3420,GO:0006844,1,0.977487974741407,0,5,acyl carnitine transport,BP,
3421,GO:0006848,1,0.979605696540701,0,4,pyruvate transport,BP,
3422,GO:0006850,1,0.989807596705769,0,2,mitochondrial pyruvate transmembrane transport,BP,
3423,GO:0006851,1,0.878195617553954,0,23,mitochondrial calcium ion transmembrane transport,BP,
3424,GO:0006853,1,0.925544385298628,0,9,carnitine shuttle,BP,
3426,GO:0006857,1,0.923870619739825,0,10,oligopeptide transport,BP,
3427,GO:0006858,1,0.785610133940642,0,30,extracellular transport,BP,
3428,GO:0006862,1,0.826072795077241,0,36,nucleotide transport,BP,
3429,GO:0006863,1,0.966808480698851,0,7,purine nucleobase transport,BP,
3430,GO:0006864,1,0.987692384182257,0,2,pyrimidine nucleotide transport,BP,
3432,GO:0006867,1,0.986413944831214,0,3,asparagine transport,BP,
3433,GO:0006868,1,0.940757417301993,0,9,glutamine transport,BP,
3438,GO:0006876,1,0.986757786461612,0,2,cellular cadmium ion homeostasis,BP,
3439,GO:0006878,1,0.912293589893435,0,14,cellular copper ion homeostasis,BP,
3441,GO:0006880,1,0.989641751599587,0,3,intracellular sequestering of iron ion,BP,
3442,GO:0006882,1,0.845713429741067,0,31,cellular zinc ion homeostasis,BP,
3444,GO:0006884,1,0.810083372588537,0,27,cell volume homeostasis,BP,
3445,GO:0006885,1,0.54193688073453,0,96,regulation of pH,BP,
3448,GO:0006888,1,0.258409004732036,0,188,endoplasmic reticulum to Golgi vesicle-mediated transport,BP,
3449,GO:0006890,1,0.581032600034622,0,81,retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum,BP,
3450,GO:0006891,1,0.815742880505548,0,32,intra-Golgi vesicle-mediated transport,BP,
3451,GO:0006892,1,0.445748515051819,0,98,post-Golgi vesicle-mediated transport,BP,
3452,GO:0006893,1,0.64037021525541,0,56,Golgi to plasma membrane transport,BP,
3453,GO:0006895,1,0.857950764727612,0,15,Golgi to endosome transport,BP,
3454,GO:0006896,1,0.897375297387009,0,17,Golgi to vacuole transport,BP,
3458,GO:0006901,1,0.622306982586037,0,68,vesicle coating,BP,
3459,GO:0006903,1,0.52397229440459,0,90,vesicle targeting,BP,
3462,GO:0006907,1,0.872515435563463,0,22,pinocytosis,BP,
3464,GO:0006910,1,0.91841723030795,0,14,phagocytosis, recognition,BP,
3465,GO:0006911,1,0.713824295244065,0,51,phagocytosis, engulfment,BP,
3466,GO:0006913,1,0.0903770592112786,0,332,nucleocytoplasmic transport,BP,
3467,GO:0006914,1,0.0307315723382426,0,500,autophagy,BP,
3469,GO:0006919,1,0.60667810244691,0,83,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3470,GO:0006921,1,0.806808166591533,0,34,cellular component disassembly involved in execution phase of apoptosis,BP,
3471,GO:0006924,1,0.956224633512885,0,8,activation-induced cell death of T cells,BP,
3475,GO:0006930,1,0.929626951185883,0,9,substrate-dependent cell migration, cell extension,BP,
3477,GO:0006933,1,0.982624430332595,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3481,GO:0006939,1,0.506373603439704,0,98,smooth muscle contraction,BP,
3482,GO:0006940,1,0.698155755773019,0,55,regulation of smooth muscle contraction,BP,
3485,GO:0006948,1,0.994252392499678,0,1,induction by virus of host cell-cell fusion,BP,
3493,GO:0006957,1,0.927179025065258,0,11,complement activation, alternative pathway,BP,
3496,GO:0006968,1,0.779116561763696,0,48,cellular defense response,BP,
3497,GO:0006970,1,0.561474224089707,0,81,response to osmotic stress,BP,
3498,GO:0006971,1,0.913634405173973,0,10,hypotonic response,BP,
3499,GO:0006972,1,0.857736231792264,0,25,hyperosmotic response,BP,
3500,GO:0006974,1,0.00490121128319622,0,771,cellular response to DNA damage stimulus,BP,
3501,GO:0006975,1,0.944108182806847,0,8,DNA damage induced protein phosphorylation,BP,
3502,GO:0006977,1,0.705012809033192,0,54,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3503,GO:0006978,1,0.873587038849649,0,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3505,GO:0006982,1,0.993165043450787,0,2,response to lipid hydroperoxide,BP,
3506,GO:0006983,1,0.919511050036392,0,11,ER overload response,BP,
3507,GO:0006984,1,0.734352821351044,0,48,ER-nucleus signaling pathway,BP,
3508,GO:0006986,1,0.361259898696095,0,171,response to unfolded protein,BP,
3509,GO:0006990,1,0.976184000258848,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3510,GO:0006991,1,0.903181657143948,0,15,response to sterol depletion,BP,
3511,GO:0006995,1,0.952177816248799,0,11,cellular response to nitrogen starvation,BP,
3514,GO:0006998,1,0.737416666412815,0,50,nuclear envelope organization,BP,
3515,GO:0006999,1,0.893398919341359,0,14,nuclear pore organization,BP,
3516,GO:0007000,1,0.955365171288113,0,7,nucleolus organization,BP,
3517,GO:0007004,1,0.638657995992425,0,65,telomere maintenance via telomerase,BP,
3520,GO:0007007,1,0.864456291291546,0,29,inner mitochondrial membrane organization,BP,
3521,GO:0007008,1,0.970760788516787,0,6,outer mitochondrial membrane organization,BP,
3524,GO:0007014,1,0.99301744437563,0,1,actin ubiquitination,BP,
3526,GO:0007017,1,0.00224112210723586,0,764,microtubule-based process,BP,
3527,GO:0007018,1,0.0745812546060193,0,321,microtubule-based movement,BP,
3528,GO:0007019,1,0.685574931078429,0,43,microtubule depolymerization,BP,
3529,GO:0007020,1,0.7851096548748,0,28,microtubule nucleation,BP,
3530,GO:0007021,1,0.959738427161344,0,9,tubulin complex assembly,BP,
3531,GO:0007023,1,0.973678131673246,0,5,post-chaperonin tubulin folding pathway,BP,
3532,GO:0007026,1,0.786886741208396,0,25,negative regulation of microtubule depolymerization,BP,
3533,GO:0007028,1,0.907315519994528,0,10,cytoplasm organization,BP,
3534,GO:0007029,1,0.641930236397562,0,62,endoplasmic reticulum organization,BP,
3535,GO:0007030,1,0.335701274063928,0,135,Golgi organization,BP,
3536,GO:0007031,1,0.625259147289384,0,81,peroxisome organization,BP,
3537,GO:0007032,1,0.623512304732588,0,71,endosome organization,BP,
3539,GO:0007034,1,0.337151955058964,0,141,vacuolar transport,BP,
3540,GO:0007035,1,0.862994099577567,0,23,vacuolar acidification,BP,
3541,GO:0007039,1,0.847044344237753,0,19,protein catabolic process in the vacuole,BP,
3542,GO:0007040,1,0.645621963270419,0,62,lysosome organization,BP,
3543,GO:0007041,1,0.439310460373875,0,102,lysosomal transport,BP,
3544,GO:0007042,1,0.964395436816192,0,9,lysosomal lumen acidification,BP,
3545,GO:0007043,1,0.371647673714483,0,132,cell-cell junction assembly,BP,
3546,GO:0007044,1,0.392428995125337,0,97,cell-substrate junction assembly,BP,
3548,GO:0007050,1,0.231246724020553,0,219,cell cycle arrest,BP,
3549,GO:0007051,1,0.274365339351075,0,168,spindle organization,BP,
3550,GO:0007052,1,0.439711170814194,0,109,mitotic spindle organization,BP,
3551,GO:0007056,1,0.991622407727754,0,2,spindle assembly involved in female meiosis,BP,
3552,GO:0007057,1,0.991622407727754,0,2,spindle assembly involved in female meiosis I,BP,
3553,GO:0007059,1,0.129111761475448,0,290,chromosome segregation,BP,
3554,GO:0007060,1,0.979601949339672,0,4,male meiosis chromosome segregation,BP,
3555,GO:0007062,1,0.695685389486899,0,47,sister chromatid cohesion,BP,
3556,GO:0007063,1,0.8528915733295,0,18,regulation of sister chromatid cohesion,BP,
3557,GO:0007064,1,0.825536669644896,0,21,mitotic sister chromatid cohesion,BP,
3558,GO:0007066,1,0.996815928534647,0,1,female meiosis sister chromatid cohesion,BP,
3559,GO:0007072,1,0.996371666164808,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3560,GO:0007076,1,0.840953864834159,0,15,mitotic chromosome condensation,BP,
3561,GO:0007077,1,0.921233571012384,0,12,mitotic nuclear envelope disassembly,BP,
3562,GO:0007079,1,0.965581265838267,0,4,mitotic chromosome movement towards spindle pole,BP,
3563,GO:0007080,1,0.773375283803094,0,47,mitotic metaphase plate congression,BP,
3564,GO:0007084,1,0.954665721049338,0,10,mitotic nuclear envelope reassembly,BP,
3565,GO:0007088,1,0.335210376063637,0,153,regulation of mitotic nuclear division,BP,
3566,GO:0007089,1,0.971311231725333,0,4,traversing start control point of mitotic cell cycle,BP,
3567,GO:0007091,1,0.671950460715905,0,57,metaphase/anaphase transition of mitotic cell cycle,BP,
3568,GO:0007093,1,0.353385407159914,0,157,mitotic cell cycle checkpoint,BP,
3569,GO:0007094,1,0.791685372176502,0,34,mitotic spindle assembly checkpoint,BP,
3570,GO:0007095,1,0.858772294844526,0,20,mitotic G2 DNA damage checkpoint,BP,
3571,GO:0007096,1,0.915386899945589,0,15,regulation of exit from mitosis,BP,
3572,GO:0007097,1,0.753165707400741,0,23,nuclear migration,BP,
3573,GO:0007098,1,0.392967370135266,0,120,centrosome cycle,BP,
3574,GO:0007099,1,0.759215956073611,0,34,centriole replication,BP,
3575,GO:0007100,1,0.909867146040699,0,14,mitotic centrosome separation,BP,
3576,GO:0007113,1,0.988342312516253,0,3,endomitotic cell cycle,BP,
3577,GO:0007127,1,0.546400322888173,0,93,meiosis I,BP,
3578,GO:0007129,1,0.802891226823879,0,36,homologous chromosome pairing at meiosis,BP,
3579,GO:0007130,1,0.910391257948303,0,16,synaptonemal complex assembly,BP,
3580,GO:0007131,1,0.726595329094375,0,47,reciprocal meiotic recombination,BP,
3581,GO:0007135,1,0.949047093484934,0,10,meiosis II,BP,
3582,GO:0007140,1,0.762767105604155,0,37,male meiotic nuclear division,BP,
3583,GO:0007141,1,0.892371854056961,0,18,male meiosis I,BP,
3584,GO:0007143,1,0.8306815082997,0,26,female meiotic nuclear division,BP,
3585,GO:0007144,1,0.958445185180056,0,7,female meiosis I,BP,
3586,GO:0007146,1,0.994890876864838,0,1,meiotic recombination nodule assembly,BP,
3587,GO:0007147,1,0.993193097521698,0,1,female meiosis II,BP,
3591,GO:0007157,1,0.725048594431371,0,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3592,GO:0007158,1,0.858061608545248,0,17,neuron cell-cell adhesion,BP,
3595,GO:0007161,1,0.947526178754836,0,4,calcium-independent cell-matrix adhesion,BP,
3597,GO:0007163,1,0.185441725159282,0,210,establishment or maintenance of cell polarity,BP,
3602,GO:0007168,1,0.961395807837507,0,8,receptor guanylyl cyclase signaling pathway,BP,
3604,GO:0007171,1,0.903214027037261,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3605,GO:0007172,1,0.95169151160735,0,8,signal complex assembly,BP,
3607,GO:0007174,1,0.99170635034373,0,2,epidermal growth factor catabolic process,BP,
3608,GO:0007175,1,0.903323507135176,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3609,GO:0007176,1,0.825932304793987,0,29,regulation of epidermal growth factor-activated receptor activity,BP,
3613,GO:0007182,1,0.941853218544519,0,6,common-partner SMAD protein phosphorylation,BP,
3614,GO:0007183,1,0.896283725201083,0,13,SMAD protein complex assembly,BP,
3615,GO:0007185,1,0.925805170523206,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3620,GO:0007190,1,0.793203417402889,0,34,activation of adenylate cyclase activity,BP,
3623,GO:0007194,1,0.879886134397089,0,19,negative regulation of adenylate cyclase activity,BP,
3624,GO:0007195,1,0.960914239033776,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3625,GO:0007196,1,0.937565692009808,0,7,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,BP,
3626,GO:0007197,1,0.967776822859915,0,7,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,BP,
3627,GO:0007198,1,0.970736269590497,0,7,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3628,GO:0007199,1,0.995221960103272,0,1,G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3630,GO:0007202,1,0.833501389124946,0,32,activation of phospholipase C activity,BP,
3632,GO:0007205,1,0.833410630384063,0,24,protein kinase C-activating G protein-coupled receptor signaling pathway,BP,
3633,GO:0007206,1,0.977181800441642,0,2,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway,BP,
3634,GO:0007207,1,0.986113350615559,0,3,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway,BP,
3635,GO:0007208,1,0.9850479254498,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3636,GO:0007210,1,0.890373981365944,0,24,serotonin receptor signaling pathway,BP,
3638,GO:0007213,1,0.909140876403895,0,17,G protein-coupled acetylcholine receptor signaling pathway,BP,
3641,GO:0007216,1,0.873924311425975,0,15,G protein-coupled glutamate receptor signaling pathway,BP,
3642,GO:0007217,1,0.971837454755521,0,7,tachykinin receptor signaling pathway,BP,
3643,GO:0007218,1,0.63495856862404,0,91,neuropeptide signaling pathway,BP,
3645,GO:0007220,1,0.940042443235099,0,10,Notch receptor processing,BP,
3646,GO:0007221,1,0.818435290977393,0,18,positive regulation of transcription of Notch receptor target,BP,
3648,GO:0007224,1,0.355766278756651,0,134,smoothened signaling pathway,BP,
3649,GO:0007225,1,0.990920767052528,0,1,patched ligand maturation,BP,
3650,GO:0007227,1,0.972787434729707,0,4,signal transduction downstream of smoothened,BP,
3651,GO:0007228,1,0.980112648749121,0,3,positive regulation of hh target transcription factor activity,BP,
3653,GO:0007231,1,0.967754513963863,0,4,osmosensory signaling pathway,BP,
3656,GO:0007252,1,0.882573161008676,0,18,I-kappaB phosphorylation,BP,
3657,GO:0007253,1,0.965222353300844,0,8,cytoplasmic sequestering of NF-kappaB,BP,
3658,GO:0007254,1,0.231398480923555,0,199,JNK cascade,BP,
3659,GO:0007256,1,0.911176914366891,0,11,activation of JNKK activity,BP,
3660,GO:0007257,1,0.768246360712265,0,36,activation of JUN kinase activity,BP,
3661,GO:0007258,1,0.97540392375512,0,4,JUN phosphorylation,BP,
3664,GO:0007263,1,0.852013203166007,0,25,nitric oxide mediated signal transduction,BP,
3671,GO:0007270,1,0.912520309605898,0,8,neuron-neuron synaptic transmission,BP,
3672,GO:0007271,1,0.856024482840752,0,26,synaptic transmission, cholinergic,BP,
3673,GO:0007272,1,0.347197761283791,0,134,ensheathment of neurons,BP,
3674,GO:0007274,1,0.860842213502703,0,22,neuromuscular synaptic transmission,BP,
3678,GO:0007283,1,0.0631030933232415,0,412,spermatogenesis,BP,
3679,GO:0007284,1,0.983623859868966,0,2,spermatogonial cell division,BP,
3680,GO:0007286,1,0.492301089284216,0,107,spermatid development,BP,
3681,GO:0007288,1,0.913416526976739,0,14,sperm axoneme assembly,BP,
3682,GO:0007289,1,0.88588617499713,0,14,spermatid nucleus differentiation,BP,
3683,GO:0007290,1,0.990862801058762,0,1,spermatid nucleus elongation,BP,
3684,GO:0007291,1,0.996803524545926,0,1,sperm individualization,BP,
3685,GO:0007292,1,0.444000542157504,0,117,female gamete generation,BP,
3686,GO:0007296,1,0.955651426003277,0,4,vitellogenesis,BP,
3687,GO:0007308,1,0.984213171120046,0,3,oocyte construction,BP,
3688,GO:0007309,1,0.984213171120046,0,3,oocyte axis specification,BP,
3689,GO:0007314,1,0.984213171120046,0,3,oocyte anterior/posterior axis specification,BP,
3690,GO:0007315,1,0.984213171120046,0,3,pole plasm assembly,BP,
3691,GO:0007320,1,0.946730112263567,0,9,insemination,BP,
3692,GO:0007338,1,0.505357485505771,0,114,single fertilization,BP,
3693,GO:0007339,1,0.864119327990675,0,29,binding of sperm to zona pellucida,BP,
3694,GO:0007340,1,0.808896300581828,0,31,acrosome reaction,BP,
3695,GO:0007341,1,0.974862533905905,0,6,penetration of zona pellucida,BP,
3696,GO:0007342,1,0.968238557891443,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3697,GO:0007343,1,0.982766964801083,0,2,egg activation,BP,
3698,GO:0007344,1,0.996344421464864,0,1,pronuclear fusion,BP,
3700,GO:0007349,1,0.996803524545926,0,1,cellularization,BP,
3701,GO:0007350,1,0.881474868758288,0,18,blastoderm segmentation,BP,
3702,GO:0007351,1,0.910637720531966,0,14,tripartite regional subdivision,BP,
3703,GO:0007352,1,0.972462346422508,0,3,zygotic specification of dorsal/ventral axis,BP,
3704,GO:0007354,1,0.97642497164958,0,5,zygotic determination of anterior/posterior axis, embryo,BP,
3705,GO:0007356,1,0.982454067597273,0,4,thorax and anterior abdomen determination,BP,
3706,GO:0007368,1,0.420498128352823,0,116,determination of left/right symmetry,BP,
3708,GO:0007371,1,0.992960209320914,0,1,ventral midline determination,BP,
3709,GO:0007379,1,0.923220698277733,0,15,segment specification,BP,
3710,GO:0007386,1,0.963554389360211,0,5,compartment pattern specification,BP,
3711,GO:0007387,1,0.994993369954705,0,1,anterior compartment pattern formation,BP,
3712,GO:0007388,1,0.994993369954705,0,1,posterior compartment specification,BP,
3713,GO:0007389,1,0.046950702184243,0,425,pattern specification process,BP,
3714,GO:0007398,1,0.874415897479304,0,19,ectoderm development,BP,
3716,GO:0007400,1,0.995394952611099,0,1,neuroblast fate determination,BP,
3717,GO:0007402,1,0.992511850622512,0,2,ganglion mother cell fate determination,BP,
3718,GO:0007403,1,0.993614100415638,0,1,glial cell fate determination,BP,
3719,GO:0007405,1,0.625558239108834,0,58,neuroblast proliferation,BP,
3720,GO:0007406,1,0.949572623611506,0,6,negative regulation of neuroblast proliferation,BP,
3723,GO:0007412,1,0.9818377629713,0,3,axon target recognition,BP,
3724,GO:0007413,1,0.806788765762744,0,23,axonal fasciculation,BP,
3727,GO:0007418,1,0.970354124878197,0,4,ventral midline development,BP,
3729,GO:0007422,1,0.544911051560707,0,74,peripheral nervous system development,BP,
3731,GO:0007431,1,0.730929377494191,0,39,salivary gland development,BP,
3732,GO:0007435,1,0.753474317254993,0,35,salivary gland morphogenesis,BP,
3733,GO:0007439,1,0.989811059031193,0,2,ectodermal digestive tract development,BP,
3734,GO:0007440,1,0.89810842040312,0,10,foregut morphogenesis,BP,
3735,GO:0007442,1,0.941586351938453,0,7,hindgut morphogenesis,BP,
3736,GO:0007468,1,0.987138772505477,0,3,regulation of rhodopsin gene expression,BP,
3738,GO:0007493,1,0.989093935217518,0,2,endodermal cell fate determination,BP,
3739,GO:0007494,1,0.919580365972149,0,13,midgut development,BP,
3740,GO:0007495,1,0.994100614828953,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3741,GO:0007497,1,0.982534696706857,0,2,posterior midgut development,BP,
3742,GO:0007498,1,0.455646832224679,0,114,mesoderm development,BP,
3743,GO:0007499,1,0.991132862537944,0,1,ectoderm and mesoderm interaction,BP,
3744,GO:0007500,1,0.99092157397215,0,2,mesodermal cell fate determination,BP,
3745,GO:0007501,1,0.93683828721449,0,12,mesodermal cell fate specification,BP,
3746,GO:0007506,1,0.987526873810838,0,2,gonadal mesoderm development,BP,
3748,GO:0007509,1,0.987491524981713,0,1,mesoderm migration involved in gastrulation,BP,
3749,GO:0007512,1,0.904569591692506,0,12,adult heart development,BP,
3751,GO:0007518,1,0.99186486379775,0,2,myoblast fate determination,BP,
3752,GO:0007519,1,0.358393526945341,0,144,skeletal muscle tissue development,BP,
3754,GO:0007521,1,0.981751203324718,0,2,muscle cell fate determination,BP,
3755,GO:0007522,1,0.988573298257396,0,1,visceral muscle development,BP,
3756,GO:0007525,1,0.955521541962797,0,2,somatic muscle development,BP,
3758,GO:0007529,1,0.984759777974549,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3759,GO:0007530,1,0.858882626205511,0,22,sex determination,BP,
3760,GO:0007531,1,0.981051855925942,0,1,mating type determination,BP,
3761,GO:0007533,1,0.981051855925942,0,1,mating type switching,BP,
3762,GO:0007538,1,0.982258494772777,0,2,primary sex determination,BP,
3763,GO:0007542,1,0.982258494772777,0,2,primary sex determination, germ-line,BP,
3764,GO:0007548,1,0.172429292003115,0,240,sex differentiation,BP,
3765,GO:0007549,1,0.869297220092156,0,14,dosage compensation,BP,
3768,GO:0007567,1,0.902250225727821,0,16,parturition,BP,
3771,GO:0007571,1,0.99678965917787,0,1,age-dependent general metabolic decline,BP,
3775,GO:0007588,1,0.723882850167748,0,52,excretion,BP,
3777,GO:0007595,1,0.700137937172725,0,42,lactation,BP,
3779,GO:0007597,1,0.921711303159166,0,14,blood coagulation, intrinsic pathway,BP,
3780,GO:0007598,1,0.981807523633652,0,4,blood coagulation, extrinsic pathway,BP,
3784,GO:0007602,1,0.78007901922832,0,45,phototransduction,BP,
3785,GO:0007603,1,0.851266315288861,0,27,phototransduction, visible light,BP,
3788,GO:0007608,1,0.813979275426244,0,37,sensory perception of smell,BP,
3797,GO:0007619,1,0.97763176818008,0,3,courtship behavior,BP,
3798,GO:0007620,1,0.905299445525281,0,16,copulation,BP,
3799,GO:0007621,1,0.974557211504144,0,3,negative regulation of female receptivity,BP,
3800,GO:0007622,1,0.732224177471648,0,46,rhythmic behavior,BP,
3802,GO:0007624,1,0.986908049303568,0,2,ultradian rhythm,BP,
3803,GO:0007625,1,0.906196742170236,0,16,grooming behavior,BP,
3805,GO:0007628,1,0.794952586131072,0,27,adult walking behavior,BP,
3808,GO:0007634,1,0.990992509142793,0,2,optokinetic behavior,BP,
3811,GO:0008009,1,0.879545175605393,0,34,chemokine activity,MF,
3816,GO:0008020,1,0.957331546879765,0,10,G protein-coupled photoreceptor activity,MF,
3819,GO:0008023,1,0.70182805686262,0,47,transcription elongation factor complex,CC,
3820,GO:0008024,1,0.937361957967295,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3822,GO:0008033,1,0.539965380133973,0,118,tRNA processing,BP,
3823,GO:0008035,1,0.942526586753976,0,10,high-density lipoprotein particle binding,MF,
3826,GO:0008039,1,0.994437536735561,0,1,synaptic target recognition,BP,
3827,GO:0008043,1,0.993552252054026,0,2,intracellular ferritin complex,CC,
3828,GO:0008045,1,0.796128343239134,0,30,motor neuron axon guidance,BP,
3829,GO:0008046,1,0.920960565939645,0,9,axon guidance receptor activity,MF,
3831,GO:0008048,1,0.988668543087354,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3832,GO:0008049,1,0.996176857639559,0,1,male courtship behavior,BP,
3833,GO:0008050,1,0.981384445276178,0,2,female courtship behavior,BP,
3834,GO:0008052,1,0.996798933617564,0,1,sensory organ boundary specification,BP,
3835,GO:0008053,1,0.857267041570077,0,24,mitochondrial fusion,BP,
3836,GO:0008057,1,0.985875000781476,0,1,eye pigment granule organization,BP,
3838,GO:0008063,1,0.957824905107422,0,7,Toll signaling pathway,BP,
3839,GO:0008064,1,0.301983521400804,0,170,regulation of actin polymerization or depolymerization,BP,
3840,GO:0008065,1,0.982283399740999,0,3,establishment of blood-nerve barrier,BP,
3843,GO:0008073,1,0.989780168509741,0,3,ornithine decarboxylase inhibitor activity,MF,
3845,GO:0008078,1,0.981104022155166,0,3,mesodermal cell migration,BP,
3846,GO:0008079,1,0.959981872812965,0,6,translation termination factor activity,MF,
3847,GO:0008080,1,0.586505120992594,0,74,N-acetyltransferase activity,MF,
3848,GO:0008081,1,0.539339485110571,0,82,phosphoric diester hydrolase activity,MF,
3850,GO:0008088,1,0.564582137003794,0,68,axo-dendritic transport,BP,
3851,GO:0008089,1,0.696516274199227,0,46,anterograde axonal transport,BP,
3852,GO:0008090,1,0.804247119065241,0,19,retrograde axonal transport,BP,
3853,GO:0008091,1,0.879105806461722,0,9,spectrin,CC,
3855,GO:0008093,1,0.83094549676697,0,21,cytoskeletal anchor activity,MF,
3857,GO:0008097,1,0.954762549433056,0,10,5S rRNA binding,MF,
3859,GO:0008106,1,0.926959354473656,0,20,alcohol dehydrogenase (NADP+) activity,MF,
3860,GO:0008107,1,0.991925865516053,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3861,GO:0008108,1,0.99665103403508,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3862,GO:0008109,1,0.985026818795771,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3863,GO:0008111,1,0.996099902205554,0,1,alpha-methylacyl-CoA racemase activity,MF,
3865,GO:0008113,1,0.993224635702461,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3866,GO:0008115,1,0.995488745648731,0,1,sarcosine oxidase activity,MF,
3867,GO:0008116,1,0.989266117755474,0,1,prostaglandin-I synthase activity,MF,
3868,GO:0008117,1,0.981395945126919,0,2,sphinganine-1-phosphate aldolase activity,MF,
3869,GO:0008118,1,0.995773365534119,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3870,GO:0008119,1,0.993970958296155,0,1,thiopurine S-methyltransferase activity,MF,
3871,GO:0008120,1,0.996446385820686,0,1,ceramide glucosyltransferase activity,MF,
3872,GO:0008121,1,0.980170261788847,0,6,ubiquinol-cytochrome-c reductase activity,MF,
3873,GO:0008124,1,0.99235892705595,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3874,GO:0008126,1,0.966501242932447,0,5,acetylesterase activity,MF,
3875,GO:0008127,1,0.996672300693468,0,1,quercetin 2,3-dioxygenase activity,MF,
3876,GO:0008131,1,0.969852621560359,0,5,primary amine oxidase activity,MF,
3877,GO:0008134,1,0.0120891981251251,0,611,transcription factor binding,MF,
3878,GO:0008135,1,0.614319351678708,0,78,translation factor activity, RNA binding,MF,
3879,GO:0008137,1,0.874333615178542,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3880,GO:0008138,1,0.783095088368762,0,39,protein tyrosine/serine/threonine phosphatase activity,MF,
3881,GO:0008139,1,0.832918668263333,0,21,nuclear localization sequence binding,MF,
3882,GO:0008140,1,0.945437773096428,0,9,cAMP response element binding protein binding,MF,
3883,GO:0008142,1,0.945364425790933,0,7,oxysterol binding,MF,
3884,GO:0008143,1,0.846793412864955,0,23,poly(A) binding,MF,
3885,GO:0008144,1,0.56316641835614,0,91,drug binding,MF,
3886,GO:0008146,1,0.739820242083912,0,47,sulfotransferase activity,MF,
3887,GO:0008147,1,0.993767766218038,0,2,structural constituent of bone,MF,
3890,GO:0008154,1,0.242440805632184,0,199,actin polymerization or depolymerization,BP,
3891,GO:0008156,1,0.815593061105565,0,29,negative regulation of DNA replication,BP,
3893,GO:0008158,1,0.974506539823269,0,3,hedgehog receptor activity,MF,
3894,GO:0008160,1,0.995159239399523,0,1,protein tyrosine phosphatase activator activity,MF,
3896,GO:0008169,1,0.975545343672591,0,5,C-methyltransferase activity,MF,
3898,GO:0008171,1,0.913672965177452,0,17,O-methyltransferase activity,MF,
3899,GO:0008172,1,0.958483789567333,0,6,S-methyltransferase activity,MF,
3900,GO:0008173,1,0.719890821149769,0,59,RNA methyltransferase activity,MF,
3901,GO:0008174,1,0.931767015760663,0,11,mRNA methyltransferase activity,MF,
3902,GO:0008175,1,0.828659467029221,0,32,tRNA methyltransferase activity,MF,
3903,GO:0008176,1,0.992991134291699,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3904,GO:0008177,1,0.992275458341866,0,2,succinate dehydrogenase (ubiquinone) activity,MF,
3905,GO:0008179,1,0.897851836761034,0,13,adenylate cyclase binding,MF,
3906,GO:0008180,1,0.819110724663084,0,32,COP9 signalosome,CC,
3907,GO:0008184,1,0.980537927783794,0,3,glycogen phosphorylase activity,MF,
3908,GO:0008186,1,0.960420723332306,0,5,RNA-dependent ATPase activity,MF,
3909,GO:0008187,1,0.821276238050802,0,29,poly-pyrimidine tract binding,MF,
3910,GO:0008188,1,0.818302431650238,0,40,neuropeptide receptor activity,MF,
3911,GO:0008190,1,0.928124396249049,0,10,eukaryotic initiation factor 4E binding,MF,
3913,GO:0008192,1,0.988157443761998,0,2,RNA guanylyltransferase activity,MF,
3914,GO:0008193,1,0.996669110166492,0,1,tRNA guanylyltransferase activity,MF,
3916,GO:0008195,1,0.969749120478931,0,3,phosphatidate phosphatase activity,MF,
3917,GO:0008198,1,0.857420504914162,0,23,ferrous iron binding,MF,
3918,GO:0008199,1,0.961770349680381,0,7,ferric iron binding,MF,
3919,GO:0008200,1,0.77951593369413,0,35,ion channel inhibitor activity,MF,
3922,GO:0008203,1,0.436081447025053,0,127,cholesterol metabolic process,BP,
3923,GO:0008206,1,0.775672099836921,0,44,bile acid metabolic process,BP,
3926,GO:0008210,1,0.880711561402132,0,24,estrogen metabolic process,BP,
3927,GO:0008211,1,0.87816422968071,0,21,glucocorticoid metabolic process,BP,
3928,GO:0008212,1,0.94132839569377,0,9,mineralocorticoid metabolic process,BP,
3929,GO:0008213,1,0.308579039970061,0,154,protein alkylation,BP,
3930,GO:0008214,1,0.758077736780534,0,29,protein dealkylation,BP,
3931,GO:0008215,1,0.979675541543242,0,5,spermine metabolic process,BP,
3932,GO:0008216,1,0.968583505295351,0,8,spermidine metabolic process,BP,
3935,GO:0008227,1,0.858667094451656,0,31,G protein-coupled amine receptor activity,MF,
3936,GO:0008228,1,0.946791588206443,0,8,opsonization,BP,
3938,GO:0008234,1,0.461402576769599,0,107,cysteine-type peptidase activity,MF,
3939,GO:0008235,1,0.693466148311847,0,58,metalloexopeptidase activity,MF,
3941,GO:0008237,1,0.312981690560224,0,167,metallopeptidase activity,MF,
3942,GO:0008238,1,0.593152293518048,0,86,exopeptidase activity,MF,
3943,GO:0008239,1,0.956565259618028,0,8,dipeptidyl-peptidase activity,MF,
3944,GO:0008240,1,0.978223561970497,0,3,tripeptidyl-peptidase activity,MF,
3945,GO:0008241,1,0.987201223242612,0,2,peptidyl-dipeptidase activity,MF,
3946,GO:0008242,1,0.475977073698144,0,88,omega peptidase activity,MF,
3947,GO:0008250,1,0.946019338420185,0,13,oligosaccharyltransferase complex,CC,
3948,GO:0008251,1,0.947677248154617,0,7,tRNA-specific adenosine deaminase activity,MF,
3949,GO:0008252,1,0.931035702863015,0,12,nucleotidase activity,MF,
3950,GO:0008253,1,0.935329270948859,0,11,5'-nucleotidase activity,MF,
3951,GO:0008260,1,0.989616034035811,0,2,3-oxoacid CoA-transferase activity,MF,
3952,GO:0008263,1,0.98939898984301,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3953,GO:0008265,1,0.994949931748947,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3954,GO:0008266,1,0.842038963071854,0,26,poly(U) RNA binding,MF,
3955,GO:0008269,1,0.995796629651648,0,1,JAK pathway signal transduction adaptor activity,MF,
3957,GO:0008271,1,0.928693727495571,0,10,secondary active sulfate transmembrane transporter activity,MF,
3958,GO:0008272,1,0.906509323445109,0,15,sulfate transport,BP,
3959,GO:0008273,1,0.969253940801522,0,4,calcium, potassium:sodium antiporter activity,MF,
3960,GO:0008274,1,0.9435054003885,0,7,gamma-tubulin ring complex,CC,
3961,GO:0008275,1,0.965629395943029,0,4,gamma-tubulin small complex,CC,
3962,GO:0008276,1,0.592543872866949,0,75,protein methyltransferase activity,MF,
3964,GO:0008278,1,0.923654061249048,0,9,cohesin complex,CC,
3965,GO:0008281,1,0.981494393443769,0,2,sulfonylurea receptor activity,MF,
3966,GO:0008282,1,0.975909575585433,0,3,inward rectifying potassium channel,CC,
3973,GO:0008290,1,0.96205177679203,0,7,F-actin capping protein complex,CC,
3974,GO:0008291,1,0.980307917998036,0,4,acetylcholine metabolic process,BP,
3975,GO:0008292,1,0.990532885958926,0,2,acetylcholine biosynthetic process,BP,
3976,GO:0008294,1,0.969806948797753,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3977,GO:0008295,1,0.982934508738176,0,4,spermidine biosynthetic process,BP,
3978,GO:0008296,1,0.943967340498474,0,11,3'-5'-exodeoxyribonuclease activity,MF,
3979,GO:0008297,1,0.948395775281181,0,9,single-stranded DNA exodeoxyribonuclease activity,MF,
3980,GO:0008298,1,0.941903465474095,0,12,intracellular mRNA localization,BP,
3981,GO:0008299,1,0.873908877732211,0,26,isoprenoid biosynthetic process,BP,
3982,GO:0008300,1,0.959158823854038,0,9,isoprenoid catabolic process,BP,
3983,GO:0008301,1,0.905066951184904,0,17,DNA binding, bending,MF,
3984,GO:0008303,1,0.974090278387228,0,5,caspase complex,CC,
3985,GO:0008305,1,0.767642730581641,0,31,integrin complex,CC,
3987,GO:0008307,1,0.671955173118715,0,40,structural constituent of muscle,MF,
3988,GO:0008308,1,0.904537530350585,0,15,voltage-gated anion channel activity,MF,
3989,GO:0008309,1,0.982579796087293,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3990,GO:0008310,1,0.966869319342248,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3991,GO:0008311,1,0.992665216499416,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3992,GO:0008312,1,0.969995509426107,0,7,7S RNA binding,MF,
3993,GO:0008315,1,0.982463462020401,0,3,G2/MI transition of meiotic cell cycle,BP,
3994,GO:0008318,1,0.953118093945419,0,7,protein prenyltransferase activity,MF,
3995,GO:0008320,1,0.905881042710971,0,17,protein transmembrane transporter activity,MF,
3996,GO:0008321,1,0.973522321419186,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
3998,GO:0008327,1,0.853754375746765,0,21,methyl-CpG binding,MF,
4000,GO:0008330,1,0.948803885473029,0,10,protein tyrosine/threonine phosphatase activity,MF,
4001,GO:0008331,1,0.878326830856163,0,10,high voltage-gated calcium channel activity,MF,
4002,GO:0008332,1,0.952616981454764,0,3,low voltage-gated calcium channel activity,MF,
4003,GO:0008333,1,0.691346797023839,0,48,endosome to lysosome transport,BP,
4004,GO:0008334,1,0.853960429721273,0,22,histone mRNA metabolic process,BP,
4005,GO:0008336,1,0.996196927933804,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4006,GO:0008340,1,0.872614830614147,0,15,determination of adult lifespan,BP,
4007,GO:0008343,1,0.946415919512808,0,10,adult feeding behavior,BP,
4009,GO:0008347,1,0.691334365387771,0,48,glial cell migration,BP,
4010,GO:0008348,1,0.993116236374285,0,1,negative regulation of antimicrobial humoral response,BP,
4011,GO:0008349,1,0.973412005599159,0,4,MAP kinase kinase kinase kinase activity,MF,
4012,GO:0008352,1,0.995081780073566,0,1,katanin complex,CC,
4013,GO:0008353,1,0.903124734160019,0,12,RNA polymerase II CTD heptapeptide repeat kinase activity,MF,
4014,GO:0008354,1,0.956379803013351,0,6,germ cell migration,BP,
4016,GO:0008356,1,0.868477266993029,0,19,asymmetric cell division,BP,
4017,GO:0008358,1,0.984213171120046,0,3,maternal determination of anterior/posterior axis, embryo,BP,
4020,GO:0008366,1,0.347197761283791,0,134,axon ensheathment,BP,
4022,GO:0008374,1,0.785465925711356,0,36,O-acyltransferase activity,MF,
4023,GO:0008375,1,0.777297264129363,0,43,acetylglucosaminyltransferase activity,MF,
4025,GO:0008378,1,0.875036750422652,0,25,galactosyltransferase activity,MF,
4026,GO:0008379,1,0.983835452511613,0,5,thioredoxin peroxidase activity,MF,
4028,GO:0008381,1,0.898206130202011,0,17,mechanosensitive ion channel activity,MF,
4029,GO:0008384,1,0.985993244024768,0,2,IkappaB kinase activity,MF,
4030,GO:0008385,1,0.950357878974929,0,7,IkappaB kinase complex,CC,
4031,GO:0008386,1,0.996103467690149,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4032,GO:0008387,1,0.99569490537338,0,1,steroid 7-alpha-hydroxylase activity,MF,
4033,GO:0008389,1,0.996325100300731,0,1,coumarin 7-hydroxylase activity,MF,
4034,GO:0008391,1,0.953496121867475,0,11,arachidonic acid monooxygenase activity,MF,
4035,GO:0008392,1,0.969185482701791,0,8,arachidonic acid epoxygenase activity,MF,
4036,GO:0008395,1,0.89041498590277,0,24,steroid hydroxylase activity,MF,
4037,GO:0008396,1,0.991232410454124,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4038,GO:0008397,1,0.992538015186998,0,1,sterol 12-alpha-hydroxylase activity,MF,
4039,GO:0008398,1,0.994316778224343,0,1,sterol 14-demethylase activity,MF,
4040,GO:0008401,1,0.971681455771485,0,6,retinoic acid 4-hydroxylase activity,MF,
4041,GO:0008403,1,0.994123413353288,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4042,GO:0008404,1,0.996229644853621,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4043,GO:0008405,1,0.996229644853621,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4044,GO:0008406,1,0.251468976392236,0,191,gonad development,BP,
4045,GO:0008408,1,0.709520256301705,0,53,3'-5' exonuclease activity,MF,
4046,GO:0008409,1,0.878860913263555,0,17,5'-3' exonuclease activity,MF,
4047,GO:0008410,1,0.973374259990012,0,6,CoA-transferase activity,MF,
4048,GO:0008413,1,0.992921027654906,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4050,GO:0008418,1,0.996756992198529,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4051,GO:0008419,1,0.995097373273033,0,1,RNA lariat debranching enzyme activity,MF,
4052,GO:0008420,1,0.953854875407085,0,7,RNA polymerase II CTD heptapeptide repeat phosphatase activity,MF,
4053,GO:0008422,1,0.971741560983456,0,5,beta-glucosidase activity,MF,
4054,GO:0008424,1,0.993890543430555,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4055,GO:0008425,1,0.993242241771513,0,2,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4056,GO:0008426,1,0.986504713434167,0,3,protein kinase C inhibitor activity,MF,
4057,GO:0008427,1,0.989076851646041,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4058,GO:0008428,1,0.982608507245398,0,3,ribonuclease inhibitor activity,MF,
4059,GO:0008429,1,0.926289140226627,0,11,phosphatidylethanolamine binding,MF,
4060,GO:0008430,1,0.968904751463194,0,5,selenium binding,MF,
4061,GO:0008431,1,0.989521385716677,0,2,vitamin E binding,MF,
4062,GO:0008432,1,0.933980379212584,0,9,JUN kinase binding,MF,
4063,GO:0008437,1,0.996063158541748,0,1,thyrotropin-releasing hormone activity,MF,
4064,GO:0008440,1,0.97475506624493,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4065,GO:0008441,1,0.99541263095158,0,1,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4066,GO:0008442,1,0.996094537566221,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4067,GO:0008443,1,0.955431443058545,0,7,phosphofructokinase activity,MF,
4068,GO:0008444,1,0.995816187204086,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4069,GO:0008445,1,0.99645797635803,0,1,D-aspartate oxidase activity,MF,
4070,GO:0008446,1,0.996408650453324,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4071,GO:0008448,1,0.996255675077856,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4072,GO:0008449,1,0.966576281259826,0,4,N-acetylglucosamine-6-sulfatase activity,MF,
4073,GO:0008452,1,0.994890876864838,0,1,RNA ligase activity,MF,
4074,GO:0008453,1,0.9964709803441,0,1,alanine-glyoxylate transaminase activity,MF,
4075,GO:0008454,1,0.979723375567066,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4076,GO:0008455,1,0.995003072987144,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4077,GO:0008456,1,0.992987268436278,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4078,GO:0008457,1,0.983745752959739,0,3,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4079,GO:0008458,1,0.988790984545103,0,2,carnitine O-octanoyltransferase activity,MF,
4080,GO:0008459,1,0.982451500664883,0,2,chondroitin 6-sulfotransferase activity,MF,
4081,GO:0008460,1,0.996176857639559,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4082,GO:0008465,1,0.996702621226445,0,1,glycerate dehydrogenase activity,MF,
4083,GO:0008466,1,0.990067078012985,0,2,glycogenin glucosyltransferase activity,MF,
4084,GO:0008467,1,0.972916824946429,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4085,GO:0008469,1,0.969012585775772,0,7,histone-arginine N-methyltransferase activity,MF,
4086,GO:0008470,1,0.991156624454728,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4087,GO:0008474,1,0.943525043059792,0,12,palmitoyl-(protein) hydrolase activity,MF,
4088,GO:0008475,1,0.981361206781466,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4089,GO:0008476,1,0.992152453171458,0,2,protein-tyrosine sulfotransferase activity,MF,
4090,GO:0008478,1,0.985989759916566,0,1,pyridoxal kinase activity,MF,
4091,GO:0008479,1,0.99665103403508,0,1,queuine tRNA-ribosyltransferase activity,MF,
4092,GO:0008480,1,0.993847138847661,0,1,sarcosine dehydrogenase activity,MF,
4093,GO:0008481,1,0.990774807994975,0,2,sphinganine kinase activity,MF,
4094,GO:0008482,1,0.995613272744234,0,1,sulfite oxidase activity,MF,
4096,GO:0008484,1,0.89511987844086,0,15,sulfuric ester hydrolase activity,MF,
4097,GO:0008486,1,0.979209716404853,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4098,GO:0008488,1,0.994128363698972,0,1,gamma-glutamyl carboxylase activity,MF,
4099,GO:0008489,1,0.976560533068541,0,3,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4100,GO:0008493,1,0.996225875486232,0,1,tetracycline transmembrane transporter activity,MF,
4101,GO:0008494,1,0.928196045974315,0,12,translation activator activity,MF,
4102,GO:0008495,1,0.994461493013875,0,1,protoheme IX farnesyltransferase activity,MF,
4103,GO:0008499,1,0.963100850516607,0,7,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4104,GO:0008502,1,0.982585091956169,0,4,melatonin receptor activity,MF,
4106,GO:0008504,1,0.945326281712365,0,9,monoamine transmembrane transporter activity,MF,
4107,GO:0008506,1,0.978844298507358,0,4,sucrose:proton symporter activity,MF,
4108,GO:0008507,1,0.99328642367277,0,1,sodium:iodide symporter activity,MF,
4109,GO:0008508,1,0.985410922203338,0,4,bile acid:sodium symporter activity,MF,
4111,GO:0008510,1,0.93736781711846,0,6,sodium:bicarbonate symporter activity,MF,
4112,GO:0008511,1,0.977974146772685,0,2,sodium:potassium:chloride symporter activity,MF,
4113,GO:0008513,1,0.992067532233237,0,2,secondary active organic cation transmembrane transporter activity,MF,
4115,GO:0008515,1,0.978844298507358,0,4,sucrose transmembrane transporter activity,MF,
4116,GO:0008517,1,0.970298708696173,0,4,folic acid transmembrane transporter activity,MF,
4117,GO:0008518,1,0.994763612701618,0,1,folate:anion antiporter activity,MF,
4118,GO:0008519,1,0.937932888731178,0,8,ammonium transmembrane transporter activity,MF,
4119,GO:0008520,1,0.982383295646187,0,2,L-ascorbate:sodium symporter activity,MF,
4120,GO:0008521,1,0.995083515122915,0,1,acetyl-CoA transmembrane transporter activity,MF,
4121,GO:0008523,1,0.993861283997531,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4122,GO:0008525,1,0.908222888926357,0,11,phosphatidylcholine transporter activity,MF,
4123,GO:0008526,1,0.942689948429525,0,9,phosphatidylinositol transfer activity,MF,
4124,GO:0008527,1,0.954987859953803,0,12,taste receptor activity,MF,
4125,GO:0008528,1,0.524652563956771,0,130,G protein-coupled peptide receptor activity,MF,
4126,GO:0008531,1,0.995003072987144,0,1,riboflavin kinase activity,MF,
4127,GO:0008532,1,0.954818323624195,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4128,GO:0008534,1,0.989229373246073,0,3,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4129,GO:0008535,1,0.883691804828338,0,24,respiratory chain complex IV assembly,BP,
4130,GO:0008536,1,0.707190452490756,0,38,Ran GTPase binding,MF,
4131,GO:0008537,1,0.987733673249002,0,3,proteasome activator complex,CC,
4132,GO:0008540,1,0.951382441950395,0,12,proteasome regulatory particle, base subcomplex,CC,
4133,GO:0008541,1,0.97477178274031,0,7,proteasome regulatory particle, lid subcomplex,CC,
4135,GO:0008543,1,0.491329947269978,0,98,fibroblast growth factor receptor signaling pathway,BP,
4137,GO:0008545,1,0.986705799268996,0,2,JUN kinase kinase activity,MF,
4138,GO:0008553,1,0.904309021413071,0,16,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4140,GO:0008555,1,0.98970043089499,0,1,ATPase-coupled chloride transmembrane transporter activity,MF,
4143,GO:0008568,1,0.942154646335141,0,8,microtubule-severing ATPase activity,MF,
4144,GO:0008569,1,0.706807072823616,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4145,GO:0008574,1,0.838004118905765,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4146,GO:0008579,1,0.989876046120474,0,1,JUN kinase phosphatase activity,MF,
4147,GO:0008582,1,0.959628513655742,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4148,GO:0008584,1,0.411515092180913,0,120,male gonad development,BP,
4149,GO:0008585,1,0.521959076394162,0,89,female gonad development,BP,
4150,GO:0008589,1,0.516324351939623,0,81,regulation of smoothened signaling pathway,BP,
4151,GO:0008591,1,0.9962892356662,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4152,GO:0008592,1,0.97129560218858,0,4,regulation of Toll signaling pathway,BP,
4154,GO:0008594,1,0.976424116892036,0,4,photoreceptor cell morphogenesis,BP,
4155,GO:0008595,1,0.910637720531966,0,14,anterior/posterior axis specification, embryo,BP,
4156,GO:0008597,1,0.985799751958166,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4157,GO:0008603,1,0.954161525306751,0,10,cAMP-dependent protein kinase regulator activity,MF,
4158,GO:0008607,1,0.984765089193478,0,3,phosphorylase kinase regulator activity,MF,
4159,GO:0008608,1,0.827342479513192,0,30,attachment of spindle microtubules to kinetochore,BP,
4160,GO:0008609,1,0.98546430468773,0,1,alkylglycerone-phosphate synthase activity,MF,
4162,GO:0008611,1,0.925690690159388,0,10,ether lipid biosynthetic process,BP,
4163,GO:0008612,1,0.98648841101957,0,3,peptidyl-lysine modification to peptidyl-hypusine,BP,
4164,GO:0008613,1,0.996866805152442,0,1,diuretic hormone activity,MF,
4165,GO:0008614,1,0.989474264256638,0,2,pyridoxine metabolic process,BP,
4166,GO:0008615,1,0.989474264256638,0,2,pyridoxine biosynthetic process,BP,
4167,GO:0008617,1,0.996793561287034,0,1,guanosine metabolic process,BP,
4168,GO:0008622,1,0.969760529219009,0,5,epsilon DNA polymerase complex,CC,
4169,GO:0008623,1,0.979757348039099,0,3,CHRAC,CC,
4171,GO:0008626,1,0.974588020076421,0,5,granzyme-mediated apoptotic signaling pathway,BP,
4172,GO:0008627,1,0.943805260552988,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4173,GO:0008628,1,0.988494116350311,0,3,hormone-mediated apoptotic signaling pathway,BP,
4174,GO:0008630,1,0.530202400674276,0,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
4175,GO:0008631,1,0.795403948761444,0,40,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4176,GO:0008635,1,0.956809820783192,0,7,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4178,GO:0008641,1,0.939527402069269,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4179,GO:0008643,1,0.40283455156069,0,130,carbohydrate transport,BP,
4180,GO:0008645,1,0.49755144843584,0,94,hexose transmembrane transport,BP,
4181,GO:0008649,1,0.923481164951225,0,17,rRNA methyltransferase activity,MF,
4182,GO:0008650,1,0.993311276206321,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4183,GO:0008652,1,0.625811107443657,0,77,cellular amino acid biosynthetic process,BP,
4184,GO:0008653,1,0.995524613400313,0,1,lipopolysaccharide metabolic process,BP,
4186,GO:0008655,1,0.956679677503291,0,10,pyrimidine-containing compound salvage,BP,
4187,GO:0008656,1,0.902206330270518,0,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4188,GO:0008659,1,0.98403052900273,0,1,(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity,MF,
4189,GO:0008663,1,0.994890876864838,0,1,2',3'-cyclic-nucleotide 2'-phosphodiesterase activity,MF,
4190,GO:0008670,1,0.993190340373502,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4191,GO:0008682,1,0.995211849749443,0,1,2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity,MF,
4192,GO:0008689,1,0.996689329953739,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4193,GO:0008693,1,0.98403052900273,0,1,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity,MF,
4194,GO:0008700,1,0.994890876864838,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4195,GO:0008705,1,0.98050431534504,0,1,methionine synthase activity,MF,
4196,GO:0008709,1,0.996811869309223,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4197,GO:0008720,1,0.996023026087141,0,1,D-lactate dehydrogenase activity,MF,
4198,GO:0008721,1,0.995385273459009,0,1,D-serine ammonia-lyase activity,MF,
4199,GO:0008725,1,0.996767636191414,0,1,DNA-3-methyladenine glycosylase activity,MF,
4200,GO:0008732,1,0.991188185081593,0,2,L-allo-threonine aldolase activity,MF,
4201,GO:0008745,1,0.996812011353675,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4202,GO:0008746,1,0.987854099301573,0,2,NAD(P)+ transhydrogenase activity,MF,
4203,GO:0008747,1,0.99650542861175,0,1,N-acetylneuraminate lyase activity,MF,
4204,GO:0008753,1,0.993558743818404,0,1,NADPH dehydrogenase (quinone) activity,MF,
4206,GO:0008761,1,0.989845454192184,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4207,GO:0008768,1,0.993635649553778,0,2,UDP-sugar diphosphatase activity,MF,
4208,GO:0008775,1,0.996266639298026,0,1,acetate CoA-transferase activity,MF,
4209,GO:0008781,1,0.993062294912838,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4210,GO:0008783,1,0.995810616444748,0,1,agmatinase activity,MF,
4211,GO:0008785,1,0.996500843217237,0,1,alkyl hydroperoxide reductase activity,MF,
4212,GO:0008792,1,0.994890876864838,0,1,arginine decarboxylase activity,MF,
4213,GO:0008794,1,0.996822899952107,0,1,arsenate reductase (glutaredoxin) activity,MF,
4214,GO:0008796,1,0.996800786663507,0,1,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4215,GO:0008798,1,0.984618554171257,0,2,beta-aspartyl-peptidase activity,MF,
4216,GO:0008800,1,0.99639083166836,0,1,beta-lactamase activity,MF,
4217,GO:0008802,1,0.993329904932893,0,1,betaine-aldehyde dehydrogenase activity,MF,
4218,GO:0008803,1,0.996800786663507,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4219,GO:0008808,1,0.992836338383579,0,1,cardiolipin synthase activity,MF,
4220,GO:0008812,1,0.993161949499453,0,1,choline dehydrogenase activity,MF,
4221,GO:0008817,1,0.992135963707126,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4222,GO:0008821,1,0.970070430861286,0,5,crossover junction endodeoxyribonuclease activity,MF,
4223,GO:0008823,1,0.971572260296097,0,3,cupric reductase activity,MF,
4224,GO:0008828,1,0.996863987862682,0,1,dATP pyrophosphohydrolase activity,MF,
4225,GO:0008832,1,0.994070812197178,0,1,dGTPase activity,MF,
4226,GO:0008843,1,0.995644726868416,0,1,endochitinase activity,MF,
4227,GO:0008852,1,0.994774624144413,0,1,exodeoxyribonuclease I activity,MF,
4228,GO:0008853,1,0.980373793111505,0,4,exodeoxyribonuclease III activity,MF,
4229,GO:0008859,1,0.996810584207557,0,1,exoribonuclease II activity,MF,
4230,GO:0008865,1,0.962430080048406,0,5,fructokinase activity,MF,
4231,GO:0008887,1,0.993994992792531,0,1,glycerate kinase activity,MF,
4232,GO:0008889,1,0.987175542928497,0,2,glycerophosphodiester phosphodiesterase activity,MF,
4233,GO:0008890,1,0.996486090199684,0,1,glycine C-acetyltransferase activity,MF,
4234,GO:0008891,1,0.996342508918834,0,1,glycolate oxidase activity,MF,
4235,GO:0008892,1,0.989584362975858,0,1,guanine deaminase activity,MF,
4236,GO:0008893,1,0.996783291939296,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4237,GO:0008894,1,0.994948151349082,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4238,GO:0008897,1,0.994721228717135,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4239,GO:0008900,1,0.983246128705528,0,3,potassium:proton exchanging ATPase activity,MF,
4240,GO:0008903,1,0.996758932570798,0,1,hydroxypyruvate isomerase activity,MF,
4241,GO:0008905,1,0.996469368901463,0,1,mannose-phosphate guanylyltransferase activity,MF,
4242,GO:0008929,1,0.996576130586228,0,1,methylglyoxal synthase activity,MF,
4243,GO:0008934,1,0.984469514448657,0,3,inositol monophosphate 1-phosphatase activity,MF,
4244,GO:0008937,1,0.996188048293622,0,1,ferredoxin-NAD(P) reductase activity,MF,
4245,GO:0008940,1,0.991875105213165,0,1,nitrate reductase activity,MF,
4246,GO:0008941,1,0.995338132508373,0,1,nitric oxide dioxygenase activity,MF,
4247,GO:0008946,1,0.992444782635476,0,1,oligonucleotidase activity,MF,
4248,GO:0008948,1,0.977388891055614,0,4,oxaloacetate decarboxylase activity,MF,
4249,GO:0008955,1,0.992517278739248,0,1,peptidoglycan glycosyltransferase activity,MF,
4250,GO:0008962,1,0.995209318468699,0,1,phosphatidylglycerophosphatase activity,MF,
4251,GO:0008963,1,0.99588330378555,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4252,GO:0008967,1,0.990269575803078,0,2,phosphoglycolate phosphatase activity,MF,
4253,GO:0008970,1,0.964659543601805,0,7,phospholipase A1 activity,MF,
4254,GO:0008973,1,0.993976970920884,0,1,phosphopentomutase activity,MF,
4255,GO:0008988,1,0.981552818458374,0,4,rRNA (adenine-N6-)-methyltransferase activity,MF,
4256,GO:0008995,1,0.99520171579299,0,1,ribonuclease E activity,MF,
4257,GO:0009000,1,0.995407818184713,0,1,selenocysteine lyase activity,MF,
4258,GO:0009007,1,0.983927248968935,0,2,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4259,GO:0009008,1,0.955377076644449,0,6,DNA-methyltransferase activity,MF,
4260,GO:0009013,1,0.990125428856343,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4261,GO:0009019,1,0.97479024641518,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4262,GO:0009020,1,0.99611822932062,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4263,GO:0009032,1,0.996422603960133,0,1,thymidine phosphorylase activity,MF,
4264,GO:0009041,1,0.986029863971242,0,3,uridylate kinase activity,MF,
4265,GO:0009048,1,0.869297220092156,0,14,dosage compensation by inactivation of X chromosome,BP,
4266,GO:0009051,1,0.97172720572665,0,4,pentose-phosphate shunt, oxidative branch,BP,
4267,GO:0009052,1,0.977503761877425,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4268,GO:0009055,1,0.648649056457352,0,96,electron transfer activity,MF,
4273,GO:0009060,1,0.684855089863699,0,75,aerobic respiration,BP,
4274,GO:0009062,1,0.524182225120246,0,108,fatty acid catabolic process,BP,
4275,GO:0009063,1,0.53612232842651,0,115,cellular amino acid catabolic process,BP,
4276,GO:0009064,1,0.657960906674251,0,69,glutamine family amino acid metabolic process,BP,
4277,GO:0009065,1,0.862019354038581,0,25,glutamine family amino acid catabolic process,BP,
4278,GO:0009066,1,0.78319673030196,0,45,aspartate family amino acid metabolic process,BP,
4279,GO:0009067,1,0.875682095823606,0,20,aspartate family amino acid biosynthetic process,BP,
4280,GO:0009068,1,0.898949677137197,0,21,aspartate family amino acid catabolic process,BP,
4281,GO:0009069,1,0.844936334621131,0,33,serine family amino acid metabolic process,BP,
4282,GO:0009070,1,0.936362731919719,0,15,serine family amino acid biosynthetic process,BP,
4283,GO:0009071,1,0.949644168285713,0,12,serine family amino acid catabolic process,BP,
4284,GO:0009072,1,0.849163015865509,0,35,aromatic amino acid family metabolic process,BP,
4285,GO:0009073,1,0.981072892693915,0,4,aromatic amino acid family biosynthetic process,BP,
4286,GO:0009074,1,0.896130341703292,0,25,aromatic amino acid family catabolic process,BP,
4287,GO:0009078,1,0.981843424406226,0,4,pyruvate family amino acid metabolic process,BP,
4288,GO:0009080,1,0.981843424406226,0,4,pyruvate family amino acid catabolic process,BP,
4289,GO:0009081,1,0.859726453877882,0,25,branched-chain amino acid metabolic process,BP,
4290,GO:0009082,1,0.9699245985646,0,5,branched-chain amino acid biosynthetic process,BP,
4291,GO:0009083,1,0.869497256663252,0,22,branched-chain amino acid catabolic process,BP,
4292,GO:0009084,1,0.921083805118502,0,16,glutamine family amino acid biosynthetic process,BP,
4293,GO:0009085,1,0.98351607299788,0,2,lysine biosynthetic process,BP,
4294,GO:0009086,1,0.918355201374432,0,12,methionine biosynthetic process,BP,
4295,GO:0009087,1,0.99365297032258,0,1,methionine catabolic process,BP,
4296,GO:0009092,1,0.984933168552039,0,4,homoserine metabolic process,BP,
4297,GO:0009093,1,0.983225372405601,0,4,cysteine catabolic process,BP,
4298,GO:0009095,1,0.99503295042009,0,1,aromatic amino acid family biosynthetic process, prephenate pathway,BP,
4299,GO:0009097,1,0.988778352216189,0,3,isoleucine biosynthetic process,BP,
4300,GO:0009098,1,0.980934409095038,0,2,leucine biosynthetic process,BP,
4301,GO:0009099,1,0.976670104790784,0,3,valine biosynthetic process,BP,
4304,GO:0009104,1,0.995524613400313,0,1,lipopolysaccharide catabolic process,BP,
4305,GO:0009106,1,0.989716126275255,0,2,lipoate metabolic process,BP,
4306,GO:0009107,1,0.99640996993186,0,1,lipoate biosynthetic process,BP,
4307,GO:0009110,1,0.903249188541419,0,19,vitamin biosynthetic process,BP,
4308,GO:0009111,1,0.949030817043144,0,11,vitamin catabolic process,BP,
4309,GO:0009112,1,0.818439274912667,0,33,nucleobase metabolic process,BP,
4310,GO:0009113,1,0.953704656409636,0,10,purine nucleobase biosynthetic process,BP,
4311,GO:0009115,1,0.979602582281667,0,2,xanthine catabolic process,BP,
4312,GO:0009116,1,0.597348298946056,0,94,nucleoside metabolic process,BP,
4314,GO:0009119,1,0.689142593760499,0,65,ribonucleoside metabolic process,BP,
4315,GO:0009120,1,0.967871704298522,0,7,deoxyribonucleoside metabolic process,BP,
4316,GO:0009123,1,0.684070025315431,0,67,nucleoside monophosphate metabolic process,BP,
4317,GO:0009124,1,0.823491981836838,0,39,nucleoside monophosphate biosynthetic process,BP,
4318,GO:0009125,1,0.969149732417696,0,6,nucleoside monophosphate catabolic process,BP,
4319,GO:0009126,1,0.797907323270741,0,37,purine nucleoside monophosphate metabolic process,BP,
4320,GO:0009127,1,0.909502724948674,0,19,purine nucleoside monophosphate biosynthetic process,BP,
4321,GO:0009128,1,0.977565371658584,0,4,purine nucleoside monophosphate catabolic process,BP,
4323,GO:0009130,1,0.934316604790066,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4324,GO:0009131,1,0.996484516566367,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4325,GO:0009132,1,0.365331806418896,0,142,nucleoside diphosphate metabolic process,BP,
4326,GO:0009133,1,0.954237641316926,0,10,nucleoside diphosphate biosynthetic process,BP,
4327,GO:0009134,1,0.967547360280937,0,6,nucleoside diphosphate catabolic process,BP,
4328,GO:0009135,1,0.393421269066138,0,124,purine nucleoside diphosphate metabolic process,BP,
4329,GO:0009136,1,0.971796586702805,0,6,purine nucleoside diphosphate biosynthetic process,BP,
4330,GO:0009137,1,0.981080828342829,0,3,purine nucleoside diphosphate catabolic process,BP,
4331,GO:0009138,1,0.980695285314824,0,4,pyrimidine nucleoside diphosphate metabolic process,BP,
4332,GO:0009139,1,0.986029863971242,0,3,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4333,GO:0009140,1,0.994590601159284,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4334,GO:0009141,1,0.63924889885693,0,82,nucleoside triphosphate metabolic process,BP,
4335,GO:0009142,1,0.759318114692152,0,56,nucleoside triphosphate biosynthetic process,BP,
4336,GO:0009143,1,0.934298648565784,0,12,nucleoside triphosphate catabolic process,BP,
4337,GO:0009144,1,0.725093531456446,0,60,purine nucleoside triphosphate metabolic process,BP,
4338,GO:0009145,1,0.826345728688138,0,40,purine nucleoside triphosphate biosynthetic process,BP,
4339,GO:0009146,1,0.969112842690871,0,6,purine nucleoside triphosphate catabolic process,BP,
4340,GO:0009147,1,0.911130394272598,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4341,GO:0009148,1,0.922082044462497,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4342,GO:0009149,1,0.992983944800869,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4343,GO:0009150,1,0.104293867571206,0,339,purine ribonucleotide metabolic process,BP,
4344,GO:0009151,1,0.946217624083937,0,11,purine deoxyribonucleotide metabolic process,BP,
4345,GO:0009152,1,0.435428096313036,0,136,purine ribonucleotide biosynthetic process,BP,
4346,GO:0009153,1,0.978219258667187,0,5,purine deoxyribonucleotide biosynthetic process,BP,
4347,GO:0009154,1,0.818055286685971,0,29,purine ribonucleotide catabolic process,BP,
4348,GO:0009155,1,0.972261727573014,0,5,purine deoxyribonucleotide catabolic process,BP,
4349,GO:0009156,1,0.858308647555956,0,30,ribonucleoside monophosphate biosynthetic process,BP,
4350,GO:0009157,1,0.963497191822575,0,8,deoxyribonucleoside monophosphate biosynthetic process,BP,
4351,GO:0009158,1,0.980744270453135,0,3,ribonucleoside monophosphate catabolic process,BP,
4352,GO:0009159,1,0.991393174981777,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4353,GO:0009161,1,0.75539241940943,0,47,ribonucleoside monophosphate metabolic process,BP,
4354,GO:0009162,1,0.952143573643152,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4355,GO:0009163,1,0.851887304379068,0,35,nucleoside biosynthetic process,BP,
4356,GO:0009164,1,0.883947707080228,0,28,nucleoside catabolic process,BP,
4358,GO:0009166,1,0.681795392671833,0,64,nucleotide catabolic process,BP,
4359,GO:0009167,1,0.806987673235236,0,34,purine ribonucleoside monophosphate metabolic process,BP,
4360,GO:0009168,1,0.91685600567104,0,17,purine ribonucleoside monophosphate biosynthetic process,BP,
4361,GO:0009169,1,0.980744270453135,0,3,purine ribonucleoside monophosphate catabolic process,BP,
4362,GO:0009170,1,0.988812402700057,0,3,purine deoxyribonucleoside monophosphate metabolic process,BP,
4363,GO:0009171,1,0.991986846858326,0,2,purine deoxyribonucleoside monophosphate biosynthetic process,BP,
4364,GO:0009173,1,0.949280860997233,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4365,GO:0009174,1,0.949280860997233,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4366,GO:0009176,1,0.98078373435173,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4367,GO:0009177,1,0.984244380378185,0,4,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4368,GO:0009178,1,0.996484516566367,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4369,GO:0009179,1,0.393421269066138,0,124,purine ribonucleoside diphosphate metabolic process,BP,
4370,GO:0009180,1,0.971796586702805,0,6,purine ribonucleoside diphosphate biosynthetic process,BP,
4371,GO:0009181,1,0.981080828342829,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4372,GO:0009182,1,0.985023085700847,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4373,GO:0009183,1,0.990082040641479,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4374,GO:0009185,1,0.387902933593963,0,127,ribonucleoside diphosphate metabolic process,BP,
4375,GO:0009186,1,0.976404735617097,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4377,GO:0009188,1,0.966676001495993,0,7,ribonucleoside diphosphate biosynthetic process,BP,
4378,GO:0009189,1,0.981419870687023,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4379,GO:0009190,1,0.854543946997638,0,18,cyclic nucleotide biosynthetic process,BP,
4380,GO:0009191,1,0.972568691776553,0,5,ribonucleoside diphosphate catabolic process,BP,
4381,GO:0009193,1,0.989351124063173,0,2,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4382,GO:0009194,1,0.994732311715085,0,1,pyrimidine ribonucleoside diphosphate biosynthetic process,BP,
4383,GO:0009195,1,0.994590601159284,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4384,GO:0009196,1,0.991251928816876,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4385,GO:0009197,1,0.991251928816876,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4386,GO:0009199,1,0.725889729794529,0,58,ribonucleoside triphosphate metabolic process,BP,
4387,GO:0009200,1,0.923951543215668,0,17,deoxyribonucleoside triphosphate metabolic process,BP,
4388,GO:0009201,1,0.799106944860639,0,45,ribonucleoside triphosphate biosynthetic process,BP,
4389,GO:0009202,1,0.975521500802379,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4390,GO:0009203,1,0.996762191458164,0,1,ribonucleoside triphosphate catabolic process,BP,
4391,GO:0009204,1,0.962311359856574,0,8,deoxyribonucleoside triphosphate catabolic process,BP,
4392,GO:0009205,1,0.753679469693014,0,52,purine ribonucleoside triphosphate metabolic process,BP,
4393,GO:0009206,1,0.829669783432939,0,39,purine ribonucleoside triphosphate biosynthetic process,BP,
4394,GO:0009207,1,0.996762191458164,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4395,GO:0009208,1,0.932059029048942,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4396,GO:0009209,1,0.93663783795849,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4397,GO:0009211,1,0.977561477504717,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4398,GO:0009212,1,0.984469653614238,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4399,GO:0009213,1,0.992983944800869,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4400,GO:0009214,1,0.880802401025205,0,14,cyclic nucleotide catabolic process,BP,
4401,GO:0009215,1,0.957258977844752,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4402,GO:0009216,1,0.990912108122261,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4403,GO:0009217,1,0.972261727573014,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4404,GO:0009218,1,0.896031329229202,0,23,pyrimidine ribonucleotide metabolic process,BP,
4405,GO:0009219,1,0.931317086472287,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4406,GO:0009220,1,0.905337090899866,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4407,GO:0009221,1,0.972374867750479,0,7,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4408,GO:0009222,1,0.994590601159284,0,1,pyrimidine ribonucleotide catabolic process,BP,
4409,GO:0009223,1,0.954161156375199,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4410,GO:0009225,1,0.813189344928607,0,35,nucleotide-sugar metabolic process,BP,
4411,GO:0009226,1,0.894607170645524,0,21,nucleotide-sugar biosynthetic process,BP,
4412,GO:0009227,1,0.987144868184203,0,3,nucleotide-sugar catabolic process,BP,
4413,GO:0009229,1,0.995573849824925,0,1,thiamine diphosphate biosynthetic process,BP,
4414,GO:0009231,1,0.995003072987144,0,1,riboflavin biosynthetic process,BP,
4415,GO:0009233,1,0.97824329873774,0,4,menaquinone metabolic process,BP,
4416,GO:0009234,1,0.993151563060952,0,1,menaquinone biosynthetic process,BP,
4417,GO:0009235,1,0.8752910376181,0,18,cobalamin metabolic process,BP,
4418,GO:0009237,1,0.994605650497108,0,1,siderophore metabolic process,BP,
4419,GO:0009240,1,0.984925522604704,0,4,isopentenyl diphosphate biosynthetic process,BP,
4421,GO:0009249,1,0.97690121127405,0,7,protein lipoylation,BP,
4422,GO:0009250,1,0.700878060305153,0,41,glucan biosynthetic process,BP,
4423,GO:0009251,1,0.831400499964794,0,22,glucan catabolic process,BP,
4424,GO:0009253,1,0.993621973910818,0,2,peptidoglycan catabolic process,BP,
4425,GO:0009256,1,0.96275526913735,0,5,10-formyltetrahydrofolate metabolic process,BP,
4426,GO:0009257,1,0.98677918291178,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4427,GO:0009258,1,0.97999589728372,0,2,10-formyltetrahydrofolate catabolic process,BP,
4428,GO:0009259,1,0.0962337841722165,0,354,ribonucleotide metabolic process,BP,
4429,GO:0009260,1,0.40588035587227,0,149,ribonucleotide biosynthetic process,BP,
4430,GO:0009261,1,0.813621223416487,0,30,ribonucleotide catabolic process,BP,
4431,GO:0009262,1,0.859131401570933,0,33,deoxyribonucleotide metabolic process,BP,
4432,GO:0009263,1,0.930780384071823,0,15,deoxyribonucleotide biosynthetic process,BP,
4433,GO:0009264,1,0.924305859086698,0,18,deoxyribonucleotide catabolic process,BP,
4434,GO:0009265,1,0.951189931958597,0,12,2'-deoxyribonucleotide biosynthetic process,BP,
4436,GO:0009267,1,0.363419936266374,0,147,cellular response to starvation,BP,
4437,GO:0009268,1,0.82519021177479,0,36,response to pH,BP,
4438,GO:0009295,1,0.782368641959759,0,40,nucleoid,CC,
4439,GO:0009298,1,0.985175498885195,0,4,GDP-mannose biosynthetic process,BP,
4440,GO:0009299,1,0.871403817240355,0,17,mRNA transcription,BP,
4441,GO:0009301,1,0.661569407164176,0,70,snRNA transcription,BP,
4442,GO:0009303,1,0.842278473248709,0,27,rRNA transcription,BP,
4443,GO:0009304,1,0.949742430069403,0,8,tRNA transcription,BP,
4444,GO:0009305,1,0.988496772383391,0,1,protein biotinylation,BP,
4446,GO:0009308,1,0.520545781868569,0,128,amine metabolic process,BP,
4447,GO:0009309,1,0.914037574655261,0,21,amine biosynthetic process,BP,
4448,GO:0009310,1,0.897983895465212,0,20,amine catabolic process,BP,
4450,GO:0009312,1,0.920449686080069,0,16,oligosaccharide biosynthetic process,BP,
4451,GO:0009313,1,0.941853229690225,0,11,oligosaccharide catabolic process,BP,
4453,GO:0009328,1,0.991988601564373,0,2,phenylalanine-tRNA ligase complex,CC,
4454,GO:0009330,1,0.989041838048128,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex,CC,
4455,GO:0009331,1,0.976141875702469,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4456,GO:0009353,1,0.996657711308508,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4457,GO:0009360,1,0.995013637657979,0,1,DNA polymerase III complex,CC,
4458,GO:0009361,1,0.996575462103879,0,1,succinate-CoA ligase complex (ADP-forming),CC,
4459,GO:0009368,1,0.992331319078973,0,2,endopeptidase Clp complex,CC,
4460,GO:0009374,1,0.954977946862525,0,5,biotin binding,MF,
4461,GO:0009378,1,0.94677459001047,0,6,four-way junction helicase activity,MF,
4462,GO:0009383,1,0.982183898129221,0,3,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4463,GO:0009384,1,0.989845454192184,0,1,N-acylmannosamine kinase activity,MF,
4464,GO:0009386,1,0.992151027819729,0,2,translational attenuation,BP,
4465,GO:0009394,1,0.881193849510551,0,29,2'-deoxyribonucleotide metabolic process,BP,
4466,GO:0009395,1,0.787928915226513,0,41,phospholipid catabolic process,BP,
4467,GO:0009396,1,0.957947325609155,0,8,folic acid-containing compound biosynthetic process,BP,
4468,GO:0009397,1,0.976888659791669,0,3,folic acid-containing compound catabolic process,BP,
4469,GO:0009398,1,0.995003072987144,0,1,FMN biosynthetic process,BP,
4470,GO:0009404,1,0.926045366649949,0,13,toxin metabolic process,BP,
4471,GO:0009405,1,0.978349466617682,0,2,pathogenesis,BP,
4472,GO:0009407,1,0.991661789485292,0,2,toxin catabolic process,BP,
4476,GO:0009411,1,0.4157224051432,0,131,response to UV,BP,
4477,GO:0009414,1,0.957341536728303,0,8,response to water deprivation,BP,
4478,GO:0009415,1,0.908671432154785,0,14,response to water,BP,
4481,GO:0009436,1,0.99137970723194,0,2,glyoxylate catabolic process,BP,
4482,GO:0009437,1,0.936456196307915,0,13,carnitine metabolic process,BP,
4483,GO:0009438,1,0.980538338373849,0,5,methylglyoxal metabolic process,BP,
4484,GO:0009439,1,0.993330048451773,0,2,cyanate metabolic process,BP,
4485,GO:0009440,1,0.993330048451773,0,2,cyanate catabolic process,BP,
4486,GO:0009441,1,0.979477605654782,0,3,glycolate metabolic process,BP,
4487,GO:0009443,1,0.985989759916566,0,1,pyridoxal 5'-phosphate salvage,BP,
4488,GO:0009444,1,0.989827300380563,0,1,pyruvate oxidation,BP,
4489,GO:0009445,1,0.968895941730226,0,7,putrescine metabolic process,BP,
4490,GO:0009446,1,0.975164450957064,0,5,putrescine biosynthetic process,BP,
4491,GO:0009447,1,0.989987256053083,0,3,putrescine catabolic process,BP,
4492,GO:0009448,1,0.965907821909456,0,5,gamma-aminobutyric acid metabolic process,BP,
4493,GO:0009449,1,0.979419116749354,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4494,GO:0009450,1,0.980801653881412,0,2,gamma-aminobutyric acid catabolic process,BP,
4495,GO:0009451,1,0.455559011048701,0,144,RNA modification,BP,
4496,GO:0009452,1,0.839444564015537,0,32,7-methylguanosine RNA capping,BP,
4497,GO:0009566,1,0.423674657728572,0,141,fertilization,BP,
4498,GO:0009581,1,0.428832935195287,0,117,detection of external stimulus,BP,
4499,GO:0009582,1,0.420906092631595,0,120,detection of abiotic stimulus,BP,
4500,GO:0009583,1,0.689716636026651,0,60,detection of light stimulus,BP,
4501,GO:0009584,1,0.728363375042564,0,50,detection of visible light,BP,
4502,GO:0009590,1,0.996004799435319,0,1,detection of gravity,BP,
4504,GO:0009595,1,0.806358555636841,0,32,detection of biotic stimulus,BP,
4505,GO:0009597,1,0.971188389712354,0,5,detection of virus,BP,
4508,GO:0009608,1,0.978739702574321,0,4,response to symbiont,BP,
4509,GO:0009609,1,0.978739702574321,0,4,response to symbiotic bacterium,BP,
4512,GO:0009615,1,0.165276113332348,0,290,response to virus,BP,
4515,GO:0009624,1,0.991915216247916,0,2,response to nematode,BP,
4517,GO:0009629,1,0.954435641421683,0,10,response to gravity,BP,
4518,GO:0009631,1,0.984247516377285,0,2,cold acclimation,BP,
4519,GO:0009635,1,0.9698271301856,0,7,response to herbicide,BP,
4520,GO:0009636,1,0.288674883605428,0,217,response to toxic substance,BP,
4521,GO:0009637,1,0.986122978262566,0,2,response to blue light,BP,
4522,GO:0009642,1,0.940842573856641,0,9,response to light intensity,BP,
4523,GO:0009644,1,0.985904500992774,0,2,response to high light intensity,BP,
4524,GO:0009645,1,0.993492966633309,0,1,response to low light intensity stimulus,BP,
4525,GO:0009648,1,0.828924657765198,0,30,photoperiodism,BP,
4526,GO:0009649,1,0.82389852780951,0,31,entrainment of circadian clock,BP,
4527,GO:0009650,1,0.932328536270025,0,13,UV protection,BP,
4528,GO:0009651,1,0.866714233637918,0,24,response to salt stress,BP,
4530,GO:0009669,1,0.978844298507358,0,4,sucrose:cation symporter activity,MF,
4531,GO:0009673,1,0.993120393425834,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4532,GO:0009674,1,0.977974146772685,0,2,potassium:sodium symporter activity,MF,
4533,GO:0009678,1,0.842432154402458,0,29,pyrophosphate hydrolysis-driven proton transmembrane transporter activity,MF,
4534,GO:0009692,1,0.995171173429256,0,1,ethylene metabolic process,BP,
4535,GO:0009698,1,0.977064404931606,0,6,phenylpropanoid metabolic process,BP,
4536,GO:0009712,1,0.741731984345464,0,49,catechol-containing compound metabolic process,BP,
4537,GO:0009713,1,0.905817758075596,0,19,catechol-containing compound biosynthetic process,BP,
4540,GO:0009726,1,0.970053984375519,0,3,detection of endogenous stimulus,BP,
4541,GO:0009730,1,0.982842687178758,0,4,detection of carbohydrate stimulus,BP,
4542,GO:0009732,1,0.982842687178758,0,4,detection of hexose stimulus,BP,
4543,GO:0009737,1,0.991699152780688,0,1,response to abscisic acid,BP,
4544,GO:0009738,1,0.991699152780688,0,1,abscisic acid-activated signaling pathway,BP,
4546,GO:0009744,1,0.971443342265852,0,4,response to sucrose,BP,
4549,GO:0009750,1,0.953610743999398,0,8,response to fructose,BP,
4550,GO:0009753,1,0.986676254002955,0,4,response to jasmonic acid,BP,
4551,GO:0009755,1,0.285462642374787,0,169,hormone-mediated signaling pathway,BP,
4552,GO:0009756,1,0.956144119819556,0,8,carbohydrate mediated signaling,BP,
4553,GO:0009757,1,0.966104088548816,0,6,hexose mediated signaling,BP,
4554,GO:0009758,1,0.983542179762854,0,1,carbohydrate utilization,BP,
4555,GO:0009785,1,0.986122978262566,0,2,blue light signaling pathway,BP,
4556,GO:0009786,1,0.955352371324193,0,5,regulation of asymmetric cell division,BP,
4557,GO:0009787,1,0.991699152780688,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4558,GO:0009789,1,0.991699152780688,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4562,GO:0009794,1,0.978192799141459,0,4,regulation of mitotic cell cycle, embryonic,BP,
4563,GO:0009798,1,0.559533962278802,0,80,axis specification,BP,
4564,GO:0009799,1,0.400389081412476,0,125,specification of symmetry,BP,
4565,GO:0009804,1,0.977064404931606,0,6,coumarin metabolic process,BP,
4566,GO:0009810,1,0.995796629651648,0,1,stilbene metabolic process,BP,
4567,GO:0009812,1,0.968719582295414,0,6,flavonoid metabolic process,BP,
4568,GO:0009820,1,0.980676131213421,0,5,alkaloid metabolic process,BP,
4569,GO:0009822,1,0.992873268788283,0,2,alkaloid catabolic process,BP,
4570,GO:0009826,1,0.983779481508308,0,2,unidimensional cell growth,BP,
4571,GO:0009838,1,0.979537331071581,0,5,abscission,BP,
4572,GO:0009841,1,0.995575375805659,0,1,mitochondrial endopeptidase Clp complex,CC,
4573,GO:0009855,1,0.401885895007352,0,124,determination of bilateral symmetry,BP,
4574,GO:0009880,1,0.619203307066619,0,63,embryonic pattern specification,BP,
4575,GO:0009881,1,0.944040874110154,0,12,photoreceptor activity,MF,
4576,GO:0009882,1,0.986122978262566,0,2,blue light photoreceptor activity,MF,
4577,GO:0009886,1,0.894222455590946,0,12,post-embryonic animal morphogenesis,BP,
4587,GO:0009896,1,0.0422525841361257,0,417,positive regulation of catabolic process,BP,
4590,GO:0009912,1,0.962094674507375,0,4,auditory receptor cell fate commitment,BP,
4593,GO:0009918,1,0.99509131520587,0,1,sterol delta7 reductase activity,MF,
4594,GO:0009922,1,0.964837379943381,0,6,fatty acid elongase activity,MF,
4595,GO:0009925,1,0.64918505851327,0,50,basal plasma membrane,CC,
4597,GO:0009946,1,0.988207659792414,0,3,proximal/distal axis specification,BP,
4598,GO:0009948,1,0.745149203743833,0,45,anterior/posterior axis specification,BP,
4599,GO:0009949,1,0.996493899157185,0,1,polarity specification of anterior/posterior axis,BP,
4600,GO:0009950,1,0.923895967980749,0,11,dorsal/ventral axis specification,BP,
4601,GO:0009952,1,0.244031989576443,0,199,anterior/posterior pattern specification,BP,
4602,GO:0009953,1,0.568737168236446,0,87,dorsal/ventral pattern formation,BP,
4603,GO:0009954,1,0.812475202664664,0,33,proximal/distal pattern formation,BP,
4604,GO:0009955,1,0.995802234615765,0,1,adaxial/abaxial pattern specification,BP,
4605,GO:0009956,1,0.992607547079092,0,1,radial pattern formation,BP,
4606,GO:0009957,1,0.97329235348468,0,3,epidermal cell fate specification,BP,
4610,GO:0009972,1,0.959267045663034,0,10,cytidine deamination,BP,
4611,GO:0009975,1,0.861346680272773,0,16,cyclase activity,MF,
4612,GO:0009982,1,0.939708738552265,0,13,pseudouridine synthase activity,MF,
4615,GO:0009988,1,0.730406375435545,0,60,cell-cell recognition,BP,
4617,GO:0009992,1,0.973902055407168,0,5,cellular water homeostasis,BP,
4618,GO:0009994,1,0.748209274526907,0,44,oocyte differentiation,BP,
4619,GO:0009996,1,0.981971121957649,0,4,negative regulation of cell fate specification,BP,
4621,GO:0010002,1,0.880226202391804,0,17,cardioblast differentiation,BP,
4623,GO:0010009,1,0.9807518592664,0,4,cytoplasmic side of endosome membrane,CC,
4624,GO:0010021,1,0.994161969635545,0,1,amylopectin biosynthetic process,BP,
4625,GO:0010025,1,0.985868013585868,0,2,wax biosynthetic process,BP,
4626,GO:0010032,1,0.939912512791054,0,7,meiotic chromosome condensation,BP,
4628,GO:0010034,1,0.99338159976465,0,1,response to acetate,BP,
4630,GO:0010037,1,0.994278782330307,0,1,response to carbon dioxide,BP,
4632,GO:0010039,1,0.808663220122937,0,32,response to iron ion,BP,
4633,GO:0010040,1,0.979669338289892,0,4,response to iron(II) ion,BP,
4634,GO:0010041,1,0.967903129552879,0,5,response to iron(III) ion,BP,
4635,GO:0010042,1,0.869730070136224,0,19,response to manganese ion,BP,
4636,GO:0010043,1,0.780273721519548,0,47,response to zinc ion,BP,
4637,GO:0010044,1,0.980073923734682,0,4,response to aluminum ion,BP,
4638,GO:0010045,1,0.985647892841487,0,1,response to nickel cation,BP,
4639,GO:0010046,1,0.983912782221474,0,4,response to mycotoxin,BP,
4640,GO:0010070,1,0.995488745648731,0,1,zygote asymmetric cell division,BP,
4641,GO:0010085,1,0.99596388352694,0,1,polarity specification of proximal/distal axis,BP,
4642,GO:0010092,1,0.776670535260259,0,35,specification of animal organ identity,BP,
4643,GO:0010106,1,0.996133418816741,0,1,cellular response to iron ion starvation,BP,
4644,GO:0010121,1,0.996090351479374,0,1,arginine catabolic process to proline via ornithine,BP,
4645,GO:0010124,1,0.993002719555948,0,2,phenylacetate catabolic process,BP,
4646,GO:0010133,1,0.989775289807838,0,2,proline catabolic process to glutamate,BP,
4647,GO:0010138,1,0.980774437232525,0,5,pyrimidine ribonucleotide salvage,BP,
4648,GO:0010142,1,0.989023990762747,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4649,GO:0010155,1,0.910826335839694,0,20,regulation of proton transport,BP,
4650,GO:0010157,1,0.980497734737946,0,2,response to chlorate,BP,
4651,GO:0010159,1,0.981283843285762,0,3,specification of animal organ position,BP,
4652,GO:0010160,1,0.996798933617564,0,1,formation of animal organ boundary,BP,
4653,GO:0010164,1,0.996460434227222,0,1,response to cesium ion,BP,
4655,GO:0010166,1,0.985868013585868,0,2,wax metabolic process,BP,
4657,GO:0010172,1,0.89741946854542,0,11,embryonic body morphogenesis,BP,
4658,GO:0010181,1,0.920033098398518,0,14,FMN binding,MF,
4659,GO:0010182,1,0.966104088548816,0,6,sugar mediated signaling pathway,BP,
4660,GO:0010185,1,0.995107740824499,0,1,regulation of cellular defense response,BP,
4661,GO:0010186,1,0.995107740824499,0,1,positive regulation of cellular defense response,BP,
4662,GO:0010189,1,0.996408210104187,0,1,vitamin E biosynthetic process,BP,
4663,GO:0010193,1,0.988061106559468,0,3,response to ozone,BP,
4665,GO:0010216,1,0.941941893002133,0,6,maintenance of DNA methylation,BP,
4666,GO:0010224,1,0.914711786691167,0,16,response to UV-B,BP,
4667,GO:0010225,1,0.883987051145254,0,16,response to UV-C,BP,
4669,GO:0010232,1,0.93357264912701,0,12,vascular transport,BP,
4672,GO:0010255,1,0.966104088548816,0,6,glucose mediated signaling pathway,BP,
4674,GO:0010257,1,0.810499887670144,0,56,NADH dehydrogenase complex assembly,BP,
4675,GO:0010259,1,0.779544981612628,0,31,multicellular organism aging,BP,
4676,GO:0010260,1,0.990668150659676,0,2,animal organ senescence,BP,
4677,GO:0010265,1,0.958712690248869,0,6,SCF complex assembly,BP,
4678,GO:0010266,1,0.977112666619058,0,3,response to vitamin B1,BP,
4679,GO:0010269,1,0.953258497175758,0,6,response to selenium ion,BP,
4680,GO:0010272,1,0.995216065271688,0,1,response to silver ion,BP,
4681,GO:0010273,1,0.953779984916475,0,11,detoxification of copper ion,BP,
4682,GO:0010286,1,0.980054899060106,0,5,heat acclimation,BP,
4683,GO:0010288,1,0.867329186246364,0,21,response to lead ion,BP,
4684,GO:0010309,1,0.996411287058708,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4685,GO:0010310,1,0.914306746465544,0,18,regulation of hydrogen peroxide metabolic process,BP,
4686,GO:0010314,1,0.855524346128003,0,15,phosphatidylinositol-5-phosphate binding,MF,
4687,GO:0010324,1,0.639341218478844,0,68,membrane invagination,BP,
4688,GO:0010332,1,0.665681163778616,0,52,response to gamma radiation,BP,
4689,GO:0010335,1,0.991414200042418,0,1,response to non-ionic osmotic stress,BP,
4690,GO:0010340,1,0.968928033771829,0,5,carboxyl-O-methyltransferase activity,MF,
4691,GO:0010348,1,0.994890876864838,0,1,lithium:proton antiporter activity,MF,
4692,GO:0010359,1,0.928992503920712,0,9,regulation of anion channel activity,BP,
4693,GO:0010360,1,0.980896118127402,0,3,negative regulation of anion channel activity,BP,
4694,GO:0010369,1,0.894394696164519,0,15,chromocenter,CC,
4695,GO:0010370,1,0.988848063303099,0,2,perinucleolar chromocenter,CC,
4696,GO:0010385,1,0.953382161397876,0,5,double-stranded methylated DNA binding,MF,
4697,GO:0010387,1,0.982964253089459,0,4,COP9 signalosome assembly,BP,
4698,GO:0010389,1,0.296502752910253,0,187,regulation of G2/M transition of mitotic cell cycle,BP,
4699,GO:0010390,1,0.816487552728803,0,27,histone monoubiquitination,BP,
4700,GO:0010420,1,0.996689329953739,0,1,3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity,MF,
4701,GO:0010421,1,0.936426829319573,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4702,GO:0010428,1,0.988709769081721,0,1,methyl-CpNpG binding,MF,
4703,GO:0010430,1,0.976518878240205,0,4,fatty acid omega-oxidation,BP,
4704,GO:0010436,1,0.989646160058766,0,2,carotenoid dioxygenase activity,MF,
4705,GO:0010446,1,0.988399117578077,0,2,response to alkaline pH,BP,
4706,GO:0010447,1,0.892302373791632,0,21,response to acidic pH,BP,
4707,GO:0010452,1,0.869149699139726,0,14,histone H3-K36 methylation,BP,
4708,GO:0010453,1,0.849167354940345,0,27,regulation of cell fate commitment,BP,
4709,GO:0010454,1,0.952902876675416,0,11,negative regulation of cell fate commitment,BP,
4710,GO:0010455,1,0.968901061242028,0,6,positive regulation of cell fate commitment,BP,
4711,GO:0010457,1,0.883536123454621,0,12,centriole-centriole cohesion,BP,
4712,GO:0010458,1,0.846987072782569,0,26,exit from mitosis,BP,
4713,GO:0010459,1,0.951782684963373,0,10,negative regulation of heart rate,BP,
4715,GO:0010463,1,0.725052829634214,0,43,mesenchymal cell proliferation,BP,
4716,GO:0010464,1,0.793359552238495,0,33,regulation of mesenchymal cell proliferation,BP,
4717,GO:0010465,1,0.981795597738889,0,2,nerve growth factor receptor activity,MF,
4723,GO:0010477,1,0.993974967007127,0,1,response to sulfur dioxide,BP,
4724,GO:0010481,1,0.987828022341323,0,2,epidermal cell division,BP,
4725,GO:0010482,1,0.987828022341323,0,2,regulation of epidermal cell division,BP,
4726,GO:0010484,1,0.923472679556725,0,8,H3 histone acetyltransferase activity,MF,
4727,GO:0010485,1,0.886867901237338,0,17,H4 histone acetyltransferase activity,MF,
4728,GO:0010494,1,0.571037942197054,0,71,cytoplasmic stress granule,CC,
4729,GO:0010496,1,0.97259793188081,0,5,intercellular transport,BP,
4730,GO:0010498,1,0.0528767820703976,0,453,proteasomal protein catabolic process,BP,
4731,GO:0010499,1,0.922014350631915,0,19,proteasomal ubiquitin-independent protein catabolic process,BP,
4732,GO:0010501,1,0.949614260020536,0,8,RNA secondary structure unwinding,BP,
4733,GO:0010506,1,0.0936762651403001,0,325,regulation of autophagy,BP,
4734,GO:0010507,1,0.547448420836323,0,78,negative regulation of autophagy,BP,
4735,GO:0010508,1,0.381280431939595,0,119,positive regulation of autophagy,BP,
4736,GO:0010509,1,0.989398477699186,0,1,polyamine homeostasis,BP,
4737,GO:0010510,1,0.934269936199484,0,8,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4738,GO:0010511,1,0.955471847340092,0,8,regulation of phosphatidylinositol biosynthetic process,BP,
4739,GO:0010512,1,0.989603017988495,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4740,GO:0010513,1,0.965513786247704,0,6,positive regulation of phosphatidylinositol biosynthetic process,BP,
4742,GO:0010518,1,0.67927529647164,0,57,positive regulation of phospholipase activity,BP,
4744,GO:0010520,1,0.975272802549848,0,4,regulation of reciprocal meiotic recombination,BP,
4745,GO:0010521,1,0.979134917690042,0,4,telomerase inhibitor activity,MF,
4747,GO:0010523,1,0.908752036782847,0,16,negative regulation of calcium ion transport into cytosol,BP,
4749,GO:0010525,1,0.99326881043117,0,1,regulation of transposition, RNA-mediated,BP,
4750,GO:0010526,1,0.99326881043117,0,1,negative regulation of transposition, RNA-mediated,BP,
4751,GO:0010528,1,0.893546299299327,0,19,regulation of transposition,BP,
4752,GO:0010529,1,0.893546299299327,0,19,negative regulation of transposition,BP,
4753,GO:0010533,1,0.977268167703436,0,5,regulation of activation of Janus kinase activity,BP,
4754,GO:0010536,1,0.984232438650403,0,3,positive regulation of activation of Janus kinase activity,BP,
4756,GO:0010544,1,0.884432006297203,0,18,negative regulation of platelet activation,BP,
4760,GO:0010559,1,0.758334573575103,0,40,regulation of glycoprotein biosynthetic process,BP,
4761,GO:0010560,1,0.844508186856003,0,22,positive regulation of glycoprotein biosynthetic process,BP,
4762,GO:0010561,1,0.932290925582784,0,12,negative regulation of glycoprotein biosynthetic process,BP,
4768,GO:0010569,1,0.733158302568928,0,39,regulation of double-strand break repair via homologous recombination,BP,
4769,GO:0010571,1,0.932292762840291,0,7,positive regulation of nuclear cell cycle DNA replication,BP,
4771,GO:0010573,1,0.793232017413359,0,32,vascular endothelial growth factor production,BP,
4772,GO:0010574,1,0.81148658198126,0,29,regulation of vascular endothelial growth factor production,BP,
4773,GO:0010575,1,0.821183504283365,0,26,positive regulation of vascular endothelial growth factor production,BP,
4774,GO:0010578,1,0.995248804803298,0,1,regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway,BP,
4775,GO:0010585,1,0.996155318283885,0,1,glutamine secretion,BP,
4776,GO:0010586,1,0.833722314763631,0,25,miRNA metabolic process,BP,
4777,GO:0010587,1,0.957599790296209,0,6,miRNA catabolic process,BP,
4778,GO:0010591,1,0.799616059453519,0,31,regulation of lamellipodium assembly,BP,
4779,GO:0010592,1,0.846319242357767,0,22,positive regulation of lamellipodium assembly,BP,
4780,GO:0010593,1,0.978495748359265,0,2,negative regulation of lamellipodium assembly,BP,
4783,GO:0010596,1,0.704263800926203,0,46,negative regulation of endothelial cell migration,BP,
4784,GO:0010603,1,0.914949799591983,0,9,regulation of cytoplasmic mRNA processing body assembly,BP,
4787,GO:0010606,1,0.933594082273759,0,6,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4788,GO:0010607,1,0.996115877732885,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4790,GO:0010609,1,0.990547421218914,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4791,GO:0010610,1,0.969204023831187,0,3,regulation of mRNA stability involved in response to stress,BP,
4792,GO:0010611,1,0.65506921673529,0,53,regulation of cardiac muscle hypertrophy,BP,
4793,GO:0010612,1,0.931225704493668,0,8,regulation of cardiac muscle adaptation,BP,
4794,GO:0010613,1,0.795886567524529,0,27,positive regulation of cardiac muscle hypertrophy,BP,
4795,GO:0010614,1,0.826450761698792,0,25,negative regulation of cardiac muscle hypertrophy,BP,
4796,GO:0010615,1,0.984732939504158,0,2,positive regulation of cardiac muscle adaptation,BP,
4797,GO:0010616,1,0.945671319864217,0,6,negative regulation of cardiac muscle adaptation,BP,
4798,GO:0010621,1,0.988208346465745,0,3,negative regulation of transcription by transcription factor localization,BP,
4799,GO:0010623,1,0.909043585950046,0,13,programmed cell death involved in cell development,BP,
4800,GO:0010624,1,0.949669000024706,0,6,regulation of Schwann cell proliferation,BP,
4801,GO:0010626,1,0.949669000024706,0,6,negative regulation of Schwann cell proliferation,BP,
4806,GO:0010633,1,0.633645026190753,0,61,negative regulation of epithelial cell migration,BP,
4808,GO:0010635,1,0.911765039637142,0,12,regulation of mitochondrial fusion,BP,
4809,GO:0010636,1,0.979025737170122,0,3,positive regulation of mitochondrial fusion,BP,
4810,GO:0010637,1,0.93600584338253,0,8,negative regulation of mitochondrial fusion,BP,
4814,GO:0010641,1,0.960399952833235,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4815,GO:0010642,1,0.908567551600706,0,12,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4816,GO:0010643,1,0.98869220699956,0,2,cell communication by chemical coupling,BP,
4818,GO:0010645,1,0.994217100594094,0,1,regulation of cell communication by chemical coupling,BP,
4822,GO:0010649,1,0.90287869064443,0,13,regulation of cell communication by electrical coupling,BP,
4823,GO:0010650,1,0.97309995887402,0,2,positive regulation of cell communication by electrical coupling,BP,
4824,GO:0010652,1,0.994217100594094,0,1,positive regulation of cell communication by chemical coupling,BP,
4825,GO:0010656,1,0.793968884133724,0,35,negative regulation of muscle cell apoptotic process,BP,
4833,GO:0010664,1,0.861537827460017,0,24,negative regulation of striated muscle cell apoptotic process,BP,
4836,GO:0010667,1,0.879934559252038,0,21,negative regulation of cardiac muscle cell apoptotic process,BP,
4837,GO:0010668,1,0.950549118177327,0,7,ectodermal cell differentiation,BP,
4839,GO:0010675,1,0.382769256900171,0,124,regulation of cellular carbohydrate metabolic process,BP,
4840,GO:0010676,1,0.671569940013771,0,49,positive regulation of cellular carbohydrate metabolic process,BP,
4841,GO:0010677,1,0.76493925560688,0,36,negative regulation of cellular carbohydrate metabolic process,BP,
4842,GO:0010692,1,0.91066645595569,0,9,regulation of alkaline phosphatase activity,BP,
4843,GO:0010693,1,0.977964289338519,0,3,negative regulation of alkaline phosphatase activity,BP,
4844,GO:0010694,1,0.931200566248966,0,6,positive regulation of alkaline phosphatase activity,BP,
4845,GO:0010698,1,0.98701024130095,0,3,acetyltransferase activator activity,MF,
4846,GO:0010700,1,0.976548564233907,0,5,negative regulation of norepinephrine secretion,BP,
4848,GO:0010705,1,0.98617725677942,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4849,GO:0010706,1,0.981818204628901,0,2,ganglioside biosynthetic process via lactosylceramide,BP,
4850,GO:0010710,1,0.984675004748758,0,3,regulation of collagen catabolic process,BP,
4851,GO:0010711,1,0.996853530369236,0,1,negative regulation of collagen catabolic process,BP,
4853,GO:0010713,1,0.947515907236637,0,11,negative regulation of collagen metabolic process,BP,
4856,GO:0010716,1,0.980228657105192,0,4,negative regulation of extracellular matrix disassembly,BP,
4859,GO:0010719,1,0.823915512333518,0,33,negative regulation of epithelial to mesenchymal transition,BP,
4862,GO:0010722,1,0.986382226240667,0,1,regulation of ferrochelatase activity,BP,
4863,GO:0010723,1,0.988193402781188,0,1,positive regulation of transcription from RNA polymerase II promoter in response to iron,BP,
4864,GO:0010724,1,0.976570600191642,0,4,regulation of definitive erythrocyte differentiation,BP,
4865,GO:0010725,1,0.990303592077614,0,2,regulation of primitive erythrocyte differentiation,BP,
4866,GO:0010726,1,0.977612018915596,0,4,positive regulation of hydrogen peroxide metabolic process,BP,
4867,GO:0010727,1,0.956856433017835,0,8,negative regulation of hydrogen peroxide metabolic process,BP,
4868,GO:0010728,1,0.966783574952709,0,6,regulation of hydrogen peroxide biosynthetic process,BP,
4869,GO:0010729,1,0.99225687471674,0,2,positive regulation of hydrogen peroxide biosynthetic process,BP,
4870,GO:0010730,1,0.974329892278195,0,4,negative regulation of hydrogen peroxide biosynthetic process,BP,
4871,GO:0010731,1,0.992503350265587,0,2,protein glutathionylation,BP,
4872,GO:0010732,1,0.992503350265587,0,2,regulation of protein glutathionylation,BP,
4873,GO:0010734,1,0.992503350265587,0,2,negative regulation of protein glutathionylation,BP,
4874,GO:0010735,1,0.980631138429692,0,3,positive regulation of transcription via serum response element binding,BP,
4875,GO:0010736,1,0.991771831380816,0,1,serum response element binding,MF,
4876,GO:0010737,1,0.754529481937588,0,30,protein kinase A signaling,BP,
4877,GO:0010738,1,0.847654293160905,0,20,regulation of protein kinase A signaling,BP,
4878,GO:0010739,1,0.957013037681503,0,7,positive regulation of protein kinase A signaling,BP,
4882,GO:0010745,1,0.903486517385673,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4883,GO:0010746,1,0.954748679724978,0,5,regulation of long-chain fatty acid import across plasma membrane,BP,
4884,GO:0010747,1,0.993730483236499,0,1,positive regulation of long-chain fatty acid import across plasma membrane,BP,
4885,GO:0010748,1,0.960774673562873,0,4,negative regulation of long-chain fatty acid import across plasma membrane,BP,
4886,GO:0010749,1,0.932865406849791,0,8,regulation of nitric oxide mediated signal transduction,BP,
4887,GO:0010750,1,0.981375666066819,0,3,positive regulation of nitric oxide mediated signal transduction,BP,
4888,GO:0010751,1,0.969496097640642,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4889,GO:0010752,1,0.909530068295448,0,13,regulation of cGMP-mediated signaling,BP,
4890,GO:0010753,1,0.972067977993982,0,6,positive regulation of cGMP-mediated signaling,BP,
4891,GO:0010754,1,0.94350965871296,0,6,negative regulation of cGMP-mediated signaling,BP,
4893,GO:0010756,1,0.980123144062087,0,5,positive regulation of plasminogen activation,BP,
4895,GO:0010758,1,0.859819394876774,0,25,regulation of macrophage chemotaxis,BP,
4896,GO:0010759,1,0.908834025695534,0,16,positive regulation of macrophage chemotaxis,BP,
4897,GO:0010760,1,0.965592334545595,0,6,negative regulation of macrophage chemotaxis,BP,
4898,GO:0010761,1,0.719466785571833,0,43,fibroblast migration,BP,
4899,GO:0010762,1,0.796666543755784,0,32,regulation of fibroblast migration,BP,
4900,GO:0010763,1,0.894859100578423,0,14,positive regulation of fibroblast migration,BP,
4901,GO:0010764,1,0.965510069703668,0,6,negative regulation of fibroblast migration,BP,
4902,GO:0010765,1,0.766159745287667,0,33,positive regulation of sodium ion transport,BP,
4903,GO:0010766,1,0.843113958689561,0,18,negative regulation of sodium ion transport,BP,
4904,GO:0010767,1,0.982886075614207,0,2,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4905,GO:0010768,1,0.987786139432387,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4909,GO:0010780,1,0.988424060925948,0,1,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination,BP,
4910,GO:0010789,1,0.994890876864838,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4911,GO:0010792,1,0.973086379314401,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4912,GO:0010793,1,0.947807478987178,0,6,regulation of mRNA export from nucleus,BP,
4913,GO:0010795,1,0.989658089199207,0,2,regulation of ubiquinone biosynthetic process,BP,
4914,GO:0010796,1,0.988582309108263,0,3,regulation of multivesicular body size,BP,
4915,GO:0010797,1,0.996714424413818,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4918,GO:0010801,1,0.899688477056594,0,17,negative regulation of peptidyl-threonine phosphorylation,BP,
4919,GO:0010803,1,0.740388246689331,0,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4920,GO:0010804,1,0.9290894263064,0,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4921,GO:0010807,1,0.953982126134186,0,7,regulation of synaptic vesicle priming,BP,
4922,GO:0010808,1,0.987778757906567,0,1,positive regulation of synaptic vesicle priming,BP,
4924,GO:0010811,1,0.419396212431009,0,115,positive regulation of cell-substrate adhesion,BP,
4926,GO:0010813,1,0.986773314393736,0,2,neuropeptide catabolic process,BP,
4927,GO:0010814,1,0.99017356154548,0,1,substance P catabolic process,BP,
4928,GO:0010815,1,0.972424509618141,0,4,bradykinin catabolic process,BP,
4929,GO:0010816,1,0.99017356154548,0,1,calcitonin catabolic process,BP,
4931,GO:0010818,1,0.860176439075449,0,25,T cell chemotaxis,BP,
4932,GO:0010819,1,0.911555282862831,0,15,regulation of T cell chemotaxis,BP,
4933,GO:0010820,1,0.914545602837909,0,14,positive regulation of T cell chemotaxis,BP,
4934,GO:0010821,1,0.293929132016686,0,182,regulation of mitochondrion organization,BP,
4935,GO:0010822,1,0.45347164320604,0,115,positive regulation of mitochondrion organization,BP,
4936,GO:0010823,1,0.688246906429185,0,56,negative regulation of mitochondrion organization,BP,
4937,GO:0010824,1,0.722002636738308,0,43,regulation of centrosome duplication,BP,
4938,GO:0010825,1,0.941388492852168,0,8,positive regulation of centrosome duplication,BP,
4939,GO:0010826,1,0.908623604066962,0,13,negative regulation of centrosome duplication,BP,
4940,GO:0010827,1,0.609242117846964,0,64,regulation of glucose transmembrane transport,BP,
4941,GO:0010828,1,0.724476908820041,0,36,positive regulation of glucose transmembrane transport,BP,
4942,GO:0010829,1,0.912750666821663,0,16,negative regulation of glucose transmembrane transport,BP,
4945,GO:0010832,1,0.90203737419976,0,14,negative regulation of myotube differentiation,BP,
4946,GO:0010833,1,0.593395241862991,0,76,telomere maintenance via telomere lengthening,BP,
4947,GO:0010835,1,0.970578825843185,0,5,regulation of protein ADP-ribosylation,BP,
4948,GO:0010836,1,0.988384883159388,0,3,negative regulation of protein ADP-ribosylation,BP,
4949,GO:0010837,1,0.780083896035242,0,29,regulation of keratinocyte proliferation,BP,
4950,GO:0010838,1,0.914754606324807,0,11,positive regulation of keratinocyte proliferation,BP,
4951,GO:0010839,1,0.896420900354883,0,11,negative regulation of keratinocyte proliferation,BP,
4952,GO:0010840,1,0.983618242626192,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4953,GO:0010841,1,0.987295455586611,0,2,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4954,GO:0010842,1,0.792354581251299,0,22,retina layer formation,BP,
4955,GO:0010844,1,0.993058013975563,0,1,recombination hotspot binding,MF,
4956,GO:0010845,1,0.975272802549848,0,4,positive regulation of reciprocal meiotic recombination,BP,
4957,GO:0010847,1,0.848191399048162,0,18,regulation of chromatin assembly,BP,
4958,GO:0010848,1,0.985627826311581,0,2,regulation of chromatin disassembly,BP,
4959,GO:0010849,1,0.995813403539853,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4960,GO:0010851,1,0.976531249362119,0,5,cyclase regulator activity,MF,
4961,GO:0010852,1,0.995674356513494,0,1,cyclase inhibitor activity,MF,
4962,GO:0010853,1,0.988668543087354,0,3,cyclase activator activity,MF,
4963,GO:0010854,1,0.992016443645652,0,1,adenylate cyclase regulator activity,MF,
4964,GO:0010855,1,0.992016443645652,0,1,adenylate cyclase inhibitor activity,MF,
4965,GO:0010856,1,0.974665259757239,0,5,adenylate cyclase activator activity,MF,
4967,GO:0010858,1,0.989076851646041,0,3,calcium-dependent protein kinase regulator activity,MF,
4968,GO:0010859,1,0.991652813351218,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4970,GO:0010863,1,0.73873290854766,0,44,positive regulation of phospholipase C activity,BP,
4971,GO:0010866,1,0.904936060844683,0,17,regulation of triglyceride biosynthetic process,BP,
4972,GO:0010867,1,0.931767085281548,0,13,positive regulation of triglyceride biosynthetic process,BP,
4973,GO:0010868,1,0.984014851749533,0,2,negative regulation of triglyceride biosynthetic process,BP,
4974,GO:0010869,1,0.85623334857138,0,20,regulation of receptor biosynthetic process,BP,
4975,GO:0010870,1,0.929089326242263,0,12,positive regulation of receptor biosynthetic process,BP,
4976,GO:0010871,1,0.950884292346575,0,5,negative regulation of receptor biosynthetic process,BP,
4977,GO:0010872,1,0.95192996775769,0,9,regulation of cholesterol esterification,BP,
4978,GO:0010873,1,0.977227204418394,0,6,positive regulation of cholesterol esterification,BP,
4979,GO:0010874,1,0.810106125569067,0,27,regulation of cholesterol efflux,BP,
4980,GO:0010875,1,0.855776127843838,0,19,positive regulation of cholesterol efflux,BP,
4982,GO:0010877,1,0.992459753211671,0,2,lipid transport involved in lipid storage,BP,
4983,GO:0010878,1,0.864843288453728,0,18,cholesterol storage,BP,
4984,GO:0010879,1,0.995715294575166,0,1,cholesterol transport involved in cholesterol storage,BP,
4985,GO:0010880,1,0.782792574287425,0,27,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4986,GO:0010881,1,0.844676319053321,0,20,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4987,GO:0010882,1,0.804707465053775,0,25,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4988,GO:0010883,1,0.710797596372516,0,47,regulation of lipid storage,BP,
4989,GO:0010884,1,0.848725754272199,0,23,positive regulation of lipid storage,BP,
4990,GO:0010885,1,0.874118439247325,0,16,regulation of cholesterol storage,BP,
4991,GO:0010886,1,0.939053389145775,0,7,positive regulation of cholesterol storage,BP,
4992,GO:0010887,1,0.930892515345394,0,9,negative regulation of cholesterol storage,BP,
4993,GO:0010888,1,0.86008102413794,0,20,negative regulation of lipid storage,BP,
4994,GO:0010889,1,0.91174923957643,0,14,regulation of sequestering of triglyceride,BP,
4995,GO:0010890,1,0.959173007817068,0,9,positive regulation of sequestering of triglyceride,BP,
4996,GO:0010891,1,0.950577744876513,0,5,negative regulation of sequestering of triglyceride,BP,
4998,GO:0010894,1,0.892673111239983,0,22,negative regulation of steroid biosynthetic process,BP,
4999,GO:0010896,1,0.933819797791512,0,10,regulation of triglyceride catabolic process,BP,
5000,GO:0010897,1,0.961196548159026,0,4,negative regulation of triglyceride catabolic process,BP,
5001,GO:0010898,1,0.971529161616468,0,6,positive regulation of triglyceride catabolic process,BP,
5002,GO:0010899,1,0.981924654100677,0,3,regulation of phosphatidylcholine catabolic process,BP,
5003,GO:0010900,1,0.996891968001471,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5004,GO:0010901,1,0.99369936566237,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5005,GO:0010902,1,0.996863016756573,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5006,GO:0010903,1,0.996826493587376,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5007,GO:0010904,1,0.995828671124588,0,1,regulation of UDP-glucose catabolic process,BP,
5008,GO:0010905,1,0.995828671124588,0,1,negative regulation of UDP-glucose catabolic process,BP,
5009,GO:0010906,1,0.453078220459159,0,100,regulation of glucose metabolic process,BP,
5010,GO:0010907,1,0.749620802787349,0,33,positive regulation of glucose metabolic process,BP,
5011,GO:0010908,1,0.981080084398794,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5012,GO:0010909,1,0.981080084398794,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5013,GO:0010911,1,0.939685774336991,0,8,regulation of isomerase activity,BP,
5014,GO:0010912,1,0.939685774336991,0,8,positive regulation of isomerase activity,BP,
5015,GO:0010915,1,0.990280949476913,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5016,GO:0010916,1,0.990280949476913,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5017,GO:0010917,1,0.942345693068407,0,12,negative regulation of mitochondrial membrane potential,BP,
5018,GO:0010918,1,0.941155974184098,0,10,positive regulation of mitochondrial membrane potential,BP,
5019,GO:0010919,1,0.931875266510898,0,12,regulation of inositol phosphate biosynthetic process,BP,
5020,GO:0010920,1,0.99473415708652,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5022,GO:0010922,1,0.777334771593794,0,30,positive regulation of phosphatase activity,BP,
5024,GO:0010924,1,0.99473415708652,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5025,GO:0010925,1,0.99473415708652,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5026,GO:0010927,1,0.398248113231441,0,100,cellular component assembly involved in morphogenesis,BP,
5027,GO:0010931,1,0.98445978082638,0,1,macrophage tolerance induction,BP,
5028,GO:0010932,1,0.98445978082638,0,1,regulation of macrophage tolerance induction,BP,
5029,GO:0010933,1,0.98445978082638,0,1,positive regulation of macrophage tolerance induction,BP,
5030,GO:0010934,1,0.900706890082453,0,16,macrophage cytokine production,BP,
5031,GO:0010935,1,0.911542554801283,0,14,regulation of macrophage cytokine production,BP,
5032,GO:0010936,1,0.961675900800517,0,5,negative regulation of macrophage cytokine production,BP,
5033,GO:0010938,1,0.99313701909526,0,1,cytoplasmic microtubule depolymerization,BP,
5034,GO:0010939,1,0.859111797257946,0,26,regulation of necrotic cell death,BP,
5035,GO:0010940,1,0.955866817277554,0,9,positive regulation of necrotic cell death,BP,
5038,GO:0010944,1,0.937166679390982,0,9,negative regulation of transcription by competitive promoter binding,BP,
5040,GO:0010949,1,0.995062653977197,0,1,negative regulation of intestinal phytosterol absorption,BP,
5044,GO:0010954,1,0.884889604161203,0,19,positive regulation of protein processing,BP,
5046,GO:0010956,1,0.982689361135269,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5047,GO:0010957,1,0.975181920771245,0,5,negative regulation of vitamin D biosynthetic process,BP,
5048,GO:0010958,1,0.922231199674739,0,12,regulation of amino acid import across plasma membrane,BP,
5050,GO:0010960,1,0.896602622965525,0,11,magnesium ion homeostasis,BP,
5051,GO:0010961,1,0.958269888924883,0,5,cellular magnesium ion homeostasis,BP,
5052,GO:0010962,1,0.778751627632834,0,26,regulation of glucan biosynthetic process,BP,
5053,GO:0010963,1,0.991820889890481,0,2,regulation of L-arginine import,BP,
5054,GO:0010965,1,0.669834915425654,0,58,regulation of mitotic sister chromatid separation,BP,
5055,GO:0010966,1,0.95523678222021,0,6,regulation of phosphate transport,BP,
5056,GO:0010967,1,0.99639083166836,0,1,regulation of polyamine biosynthetic process,BP,
5057,GO:0010968,1,0.952036795436678,0,7,regulation of microtubule nucleation,BP,
5058,GO:0010970,1,0.296974691444878,0,151,transport along microtubule,BP,
5059,GO:0010971,1,0.849206349680637,0,26,positive regulation of G2/M transition of mitotic cell cycle,BP,
5060,GO:0010972,1,0.639425387168454,0,85,negative regulation of G2/M transition of mitotic cell cycle,BP,
5064,GO:0010979,1,0.986385710467682,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5065,GO:0010980,1,0.986385710467682,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5066,GO:0010982,1,0.987840957148018,0,2,regulation of high-density lipoprotein particle clearance,BP,
5067,GO:0010983,1,0.987840957148018,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5069,GO:0010985,1,0.967506215487515,0,7,negative regulation of lipoprotein particle clearance,BP,
5072,GO:0010989,1,0.977003973069323,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5073,GO:0010990,1,0.955378494877862,0,6,regulation of SMAD protein complex assembly,BP,
5074,GO:0010991,1,0.962678399689615,0,5,negative regulation of SMAD protein complex assembly,BP,
5075,GO:0010992,1,0.943602771538184,0,9,ubiquitin recycling,BP,
5076,GO:0010994,1,0.969073207680103,0,6,free ubiquitin chain polymerization,BP,
5078,GO:0010997,1,0.960039352902619,0,7,anaphase-promoting complex binding,MF,
5079,GO:0010998,1,0.929794092714971,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5080,GO:0010999,1,0.99146517290305,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5084,GO:0012507,1,0.697920208540861,0,57,ER to Golgi transport vesicle membrane,CC,
5085,GO:0012510,1,0.91594600456872,0,13,trans-Golgi network transport vesicle membrane,CC,
5087,GO:0014003,1,0.756092190092038,0,44,oligodendrocyte development,BP,
5088,GO:0014004,1,0.972233717423174,0,5,microglia differentiation,BP,
5089,GO:0014005,1,0.976329002946155,0,4,microglia development,BP,
5090,GO:0014006,1,0.995806429378298,0,1,regulation of microglia differentiation,BP,
5091,GO:0014008,1,0.995806429378298,0,1,positive regulation of microglia differentiation,BP,
5092,GO:0014009,1,0.72472216863535,0,45,glial cell proliferation,BP,
5093,GO:0014010,1,0.93885090436531,0,7,Schwann cell proliferation,BP,
5094,GO:0014011,1,0.994890876864838,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5095,GO:0014012,1,0.950069148329931,0,6,peripheral nervous system axon regeneration,BP,
5097,GO:0014014,1,0.777941928352346,0,38,negative regulation of gliogenesis,BP,
5099,GO:0014016,1,0.986222769907103,0,3,neuroblast differentiation,BP,
5100,GO:0014017,1,0.995394952611099,0,1,neuroblast fate commitment,BP,
5102,GO:0014022,1,0.978897225767634,0,3,neural plate elongation,BP,
5103,GO:0014028,1,0.978365626182196,0,3,notochord formation,BP,
5104,GO:0014029,1,0.922382232105639,0,11,neural crest formation,BP,
5105,GO:0014031,1,0.529714892631675,0,83,mesenchymal cell development,BP,
5106,GO:0014032,1,0.55014674864992,0,79,neural crest cell development,BP,
5107,GO:0014033,1,0.508690466081213,0,87,neural crest cell differentiation,BP,
5108,GO:0014034,1,0.980900894590846,0,3,neural crest cell fate commitment,BP,
5109,GO:0014036,1,0.989332710554924,0,2,neural crest cell fate specification,BP,
5110,GO:0014037,1,0.711859105291111,0,38,Schwann cell differentiation,BP,
5111,GO:0014038,1,0.967630402421246,0,4,regulation of Schwann cell differentiation,BP,
5112,GO:0014040,1,0.971181671196169,0,3,positive regulation of Schwann cell differentiation,BP,
5113,GO:0014041,1,0.911750935790272,0,10,regulation of neuron maturation,BP,
5114,GO:0014042,1,0.949084965461152,0,5,positive regulation of neuron maturation,BP,
5115,GO:0014043,1,0.980759751183116,0,3,negative regulation of neuron maturation,BP,
5116,GO:0014044,1,0.75501849446507,0,30,Schwann cell development,BP,
5117,GO:0014045,1,0.973754121363668,0,5,establishment of endothelial blood-brain barrier,BP,
5120,GO:0014048,1,0.913915112310144,0,14,regulation of glutamate secretion,BP,
5121,GO:0014049,1,0.937939410629274,0,9,positive regulation of glutamate secretion,BP,
5122,GO:0014050,1,0.974402291888982,0,5,negative regulation of glutamate secretion,BP,
5123,GO:0014051,1,0.915227216686124,0,10,gamma-aminobutyric acid secretion,BP,
5124,GO:0014052,1,0.953616687561503,0,7,regulation of gamma-aminobutyric acid secretion,BP,
5125,GO:0014053,1,0.987349089690513,0,2,negative regulation of gamma-aminobutyric acid secretion,BP,
5126,GO:0014054,1,0.974050721049203,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5127,GO:0014055,1,0.985862454053897,0,3,acetylcholine secretion, neurotransmission,BP,
5128,GO:0014056,1,0.985862454053897,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5129,GO:0014057,1,0.990757209330988,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5131,GO:0014060,1,0.978991137263033,0,5,regulation of epinephrine secretion,BP,
5133,GO:0014062,1,0.95609162065893,0,8,regulation of serotonin secretion,BP,
5134,GO:0014063,1,0.970883779324505,0,5,negative regulation of serotonin secretion,BP,
5135,GO:0014064,1,0.991326445411605,0,1,positive regulation of serotonin secretion,BP,
5136,GO:0014065,1,0.347931627425791,0,137,phosphatidylinositol 3-kinase signaling,BP,
5137,GO:0014066,1,0.429404194895359,0,111,regulation of phosphatidylinositol 3-kinase signaling,BP,
5138,GO:0014067,1,0.922298432825489,0,12,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5139,GO:0014068,1,0.530418125557763,0,80,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5146,GO:0014704,1,0.651004687708338,0,50,intercalated disc,CC,
5147,GO:0014705,1,0.991921801369169,0,1,C zone,CC,
5149,GO:0014707,1,0.99156181730094,0,2,branchiomeric skeletal muscle development,BP,
5150,GO:0014717,1,0.990621206966457,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5151,GO:0014718,1,0.990621206966457,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5152,GO:0014719,1,0.957921129203317,0,6,skeletal muscle satellite cell activation,BP,
5153,GO:0014721,1,0.96275447980925,0,5,twitch skeletal muscle contraction,BP,
5154,GO:0014722,1,0.970618355579111,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5155,GO:0014724,1,0.981878131693009,0,2,regulation of twitch skeletal muscle contraction,BP,
5156,GO:0014728,1,0.988407292630268,0,1,regulation of the force of skeletal muscle contraction,BP,
5157,GO:0014731,1,0.891669338850584,0,8,spectrin-associated cytoskeleton,CC,
5158,GO:0014732,1,0.968295552174882,0,6,skeletal muscle atrophy,BP,
5159,GO:0014733,1,0.901221226183342,0,11,regulation of skeletal muscle adaptation,BP,
5160,GO:0014734,1,0.967951850791945,0,3,skeletal muscle hypertrophy,BP,
5161,GO:0014735,1,0.966326229751694,0,3,regulation of muscle atrophy,BP,
5162,GO:0014736,1,0.983542179762854,0,1,negative regulation of muscle atrophy,BP,
5163,GO:0014737,1,0.982498842980284,0,2,positive regulation of muscle atrophy,BP,
5164,GO:0014738,1,0.986932153547815,0,3,regulation of muscle hyperplasia,BP,
5165,GO:0014739,1,0.996874812213371,0,1,positive regulation of muscle hyperplasia,BP,
5166,GO:0014740,1,0.990026483261919,0,2,negative regulation of muscle hyperplasia,BP,
5167,GO:0014741,1,0.812335456229785,0,27,negative regulation of muscle hypertrophy,BP,
5168,GO:0014742,1,0.795886567524529,0,27,positive regulation of muscle hypertrophy,BP,
5169,GO:0014743,1,0.643855238186337,0,55,regulation of muscle hypertrophy,BP,
5170,GO:0014744,1,0.948592954850652,0,6,positive regulation of muscle adaptation,BP,
5171,GO:0014745,1,0.909836208995811,0,10,negative regulation of muscle adaptation,BP,
5172,GO:0014802,1,0.962179122934824,0,4,terminal cisterna,CC,
5173,GO:0014804,1,0.996114700468957,0,1,terminal cisterna lumen,CC,
5174,GO:0014805,1,0.985417216669669,0,4,smooth muscle adaptation,BP,
5175,GO:0014806,1,0.99193751493069,0,2,smooth muscle hyperplasia,BP,
5176,GO:0014807,1,0.959051905294827,0,6,regulation of somitogenesis,BP,
5177,GO:0014808,1,0.754039009016265,0,30,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5178,GO:0014809,1,0.975780469945639,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5179,GO:0014810,1,0.996851814620387,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5181,GO:0014813,1,0.995719642781064,0,1,skeletal muscle satellite cell commitment,BP,
5182,GO:0014816,1,0.926056419733843,0,9,skeletal muscle satellite cell differentiation,BP,
5183,GO:0014819,1,0.913916368844331,0,12,regulation of skeletal muscle contraction,BP,
5184,GO:0014820,1,0.939031341151808,0,11,tonic smooth muscle contraction,BP,
5185,GO:0014821,1,0.908115132361691,0,19,phasic smooth muscle contraction,BP,
5186,GO:0014822,1,0.99525715885182,0,1,detection of wounding,BP,
5188,GO:0014824,1,0.955729379124169,0,9,artery smooth muscle contraction,BP,
5189,GO:0014825,1,0.996845389599986,0,1,stomach fundus smooth muscle contraction,BP,
5190,GO:0014826,1,0.979827524372992,0,4,vein smooth muscle contraction,BP,
5191,GO:0014827,1,0.969417951277986,0,6,intestine smooth muscle contraction,BP,
5192,GO:0014828,1,0.990069666968894,0,1,distal stomach smooth muscle contraction,BP,
5193,GO:0014829,1,0.848927251175732,0,23,vascular associated smooth muscle contraction,BP,
5194,GO:0014831,1,0.935907140746311,0,11,gastro-intestinal system smooth muscle contraction,BP,
5195,GO:0014832,1,0.946090696879424,0,7,urinary bladder smooth muscle contraction,BP,
5196,GO:0014834,1,0.970753138079725,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5197,GO:0014835,1,0.995708031135128,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
5199,GO:0014841,1,0.900003135284221,0,14,skeletal muscle satellite cell proliferation,BP,
5200,GO:0014842,1,0.913329986139582,0,13,regulation of skeletal muscle satellite cell proliferation,BP,
5201,GO:0014843,1,0.987101373156459,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5202,GO:0014846,1,0.981194351089582,0,2,esophagus smooth muscle contraction,BP,
5203,GO:0014847,1,0.996845389599986,0,1,proximal stomach smooth muscle contraction,BP,
5204,GO:0014848,1,0.946090696879424,0,7,urinary tract smooth muscle contraction,BP,
5206,GO:0014852,1,0.994711053157964,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5207,GO:0014853,1,0.994711053157964,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5208,GO:0014854,1,0.895542533393553,0,13,response to inactivity,BP,
5209,GO:0014855,1,0.619509309380309,0,64,striated muscle cell proliferation,BP,
5210,GO:0014856,1,0.896844305341378,0,15,skeletal muscle cell proliferation,BP,
5211,GO:0014857,1,0.910124852416672,0,14,regulation of skeletal muscle cell proliferation,BP,
5212,GO:0014858,1,0.976986115979514,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5213,GO:0014859,1,0.974983516356631,0,4,negative regulation of skeletal muscle cell proliferation,BP,
5214,GO:0014861,1,0.989692810991723,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5215,GO:0014862,1,0.988407292630268,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5216,GO:0014866,1,0.901148067260886,0,8,skeletal myofibril assembly,BP,
5217,GO:0014870,1,0.907123493534812,0,10,response to muscle inactivity,BP,
5218,GO:0014873,1,0.991590301617391,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5219,GO:0014874,1,0.893157104533439,0,12,response to stimulus involved in regulation of muscle adaptation,BP,
5220,GO:0014877,1,0.911786213382417,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5221,GO:0014878,1,0.980698756907892,0,3,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5222,GO:0014883,1,0.947026158500531,0,6,transition between fast and slow fiber,BP,
5223,GO:0014886,1,0.993942864691503,0,1,transition between slow and fast fiber,BP,
5224,GO:0014887,1,0.834005498938505,0,21,cardiac muscle adaptation,BP,
5225,GO:0014888,1,0.73620732743505,0,41,striated muscle adaptation,BP,
5226,GO:0014889,1,0.929881613770278,0,10,muscle atrophy,BP,
5227,GO:0014891,1,0.963404881321395,0,7,striated muscle atrophy,BP,
5228,GO:0014894,1,0.911786213382417,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5229,GO:0014895,1,0.996867862427499,0,1,smooth muscle hypertrophy,BP,
5230,GO:0014896,1,0.474097100785841,0,82,muscle hypertrophy,BP,
5231,GO:0014897,1,0.478099587794993,0,80,striated muscle hypertrophy,BP,
5232,GO:0014898,1,0.834005498938505,0,21,cardiac muscle hypertrophy in response to stress,BP,
5233,GO:0014900,1,0.983489518124911,0,4,muscle hyperplasia,BP,
5234,GO:0014901,1,0.984452207290402,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5236,GO:0014904,1,0.812734314919085,0,29,myotube cell development,BP,
5237,GO:0014905,1,0.981564757494366,0,3,myoblast fusion involved in skeletal muscle regeneration,BP,
5238,GO:0014908,1,0.960173492593627,0,6,myotube differentiation involved in skeletal muscle regeneration,BP,
5243,GO:0014916,1,0.954867029726207,0,4,regulation of lung blood pressure,BP,
5244,GO:0015002,1,0.9240318034323,0,21,heme-copper terminal oxidase activity,MF,
5245,GO:0015012,1,0.808688814541464,0,26,heparan sulfate proteoglycan biosynthetic process,BP,
5246,GO:0015014,1,0.932959705999673,0,8,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5247,GO:0015015,1,0.953136494419792,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5248,GO:0015016,1,0.960205439397256,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5249,GO:0015018,1,0.986086790090493,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5250,GO:0015019,1,0.989989042780178,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5251,GO:0015020,1,0.919147908343477,0,14,glucuronosyltransferase activity,MF,
5252,GO:0015026,1,0.729100936030555,0,42,coreceptor activity,MF,
5253,GO:0015030,1,0.724177172594546,0,55,Cajal body,CC,
5255,GO:0015035,1,0.91604943826808,0,18,protein disulfide oxidoreductase activity,MF,
5256,GO:0015036,1,0.846541076033896,0,36,disulfide oxidoreductase activity,MF,
5257,GO:0015037,1,0.949505823927114,0,13,peptide disulfide oxidoreductase activity,MF,
5258,GO:0015038,1,0.982692829318402,0,5,glutathione disulfide oxidoreductase activity,MF,
5259,GO:0015039,1,0.996188048293622,0,1,NADPH-adrenodoxin reductase activity,MF,
5260,GO:0015052,1,0.995116363296497,0,1,beta3-adrenergic receptor activity,MF,
5261,GO:0015054,1,0.995918058430407,0,1,gastrin receptor activity,MF,
5262,GO:0015056,1,0.991653916453966,0,2,corticotrophin-releasing factor receptor activity,MF,
5263,GO:0015057,1,0.971814970810799,0,5,thrombin-activated receptor activity,MF,
5264,GO:0015067,1,0.995206785714547,0,1,amidinotransferase activity,MF,
5265,GO:0015068,1,0.995206785714547,0,1,glycine amidinotransferase activity,MF,
5266,GO:0015074,1,0.928977557366702,0,10,DNA integration,BP,
5269,GO:0015078,1,0.579195209931084,0,90,proton transmembrane transporter activity,MF,
5273,GO:0015086,1,0.970140726744425,0,4,cadmium ion transmembrane transporter activity,MF,
5274,GO:0015087,1,0.979369416906346,0,3,cobalt ion transmembrane transporter activity,MF,
5275,GO:0015093,1,0.970336632609245,0,4,ferrous iron transmembrane transporter activity,MF,
5276,GO:0015094,1,0.992068479353006,0,1,lead ion transmembrane transporter activity,MF,
5277,GO:0015095,1,0.899428870498693,0,15,magnesium ion transmembrane transporter activity,MF,
5278,GO:0015098,1,0.996187491161553,0,1,molybdate ion transmembrane transporter activity,MF,
5279,GO:0015099,1,0.992068479353006,0,1,nickel cation transmembrane transporter activity,MF,
5280,GO:0015101,1,0.877589354515936,0,23,organic cation transmembrane transporter activity,MF,
5282,GO:0015106,1,0.844236914844059,0,19,bicarbonate transmembrane transporter activity,MF,
5284,GO:0015111,1,0.975989494758795,0,3,iodide transmembrane transporter activity,MF,
5285,GO:0015112,1,0.995095643171785,0,1,nitrate transmembrane transporter activity,MF,
5286,GO:0015114,1,0.945280969530193,0,6,phosphate ion transmembrane transporter activity,MF,
5287,GO:0015116,1,0.912159196093296,0,14,sulfate transmembrane transporter activity,MF,
5288,GO:0015117,1,0.982208989643871,0,4,thiosulfate transmembrane transporter activity,MF,
5289,GO:0015119,1,0.982338698440941,0,3,hexose phosphate transmembrane transporter activity,MF,
5291,GO:0015126,1,0.990818656500853,0,1,canalicular bile acid transmembrane transporter activity,MF,
5292,GO:0015127,1,0.990273865801745,0,1,bilirubin transmembrane transporter activity,MF,
5293,GO:0015129,1,0.966208030620477,0,5,lactate transmembrane transporter activity,MF,
5294,GO:0015130,1,0.992132892685177,0,1,mevalonate transmembrane transporter activity,MF,
5295,GO:0015131,1,0.982208989643871,0,4,oxaloacetate transmembrane transporter activity,MF,
5296,GO:0015132,1,0.991952296627882,0,1,prostaglandin transmembrane transporter activity,MF,
5297,GO:0015136,1,0.990245288082032,0,2,sialic acid transmembrane transporter activity,MF,
5298,GO:0015137,1,0.975145142321467,0,4,citrate transmembrane transporter activity,MF,
5299,GO:0015139,1,0.983409444781781,0,3,alpha-ketoglutarate transmembrane transporter activity,MF,
5300,GO:0015140,1,0.982208989643871,0,4,malate transmembrane transporter activity,MF,
5301,GO:0015141,1,0.968822506250998,0,6,succinate transmembrane transporter activity,MF,
5302,GO:0015142,1,0.975145142321467,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5303,GO:0015143,1,0.984213912791727,0,3,urate transmembrane transporter activity,MF,
5304,GO:0015144,1,0.819761719640263,0,34,carbohydrate transmembrane transporter activity,MF,
5305,GO:0015145,1,0.873815328657063,0,21,monosaccharide transmembrane transporter activity,MF,
5306,GO:0015146,1,0.969684862973102,0,2,pentose transmembrane transporter activity,MF,
5307,GO:0015149,1,0.88950363683276,0,19,hexose transmembrane transporter activity,MF,
5308,GO:0015150,1,0.969684862973102,0,2,fucose transmembrane transporter activity,MF,
5309,GO:0015151,1,0.986304679224616,0,2,alpha-glucoside transmembrane transporter activity,MF,
5310,GO:0015152,1,0.995933894904007,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5311,GO:0015154,1,0.978844298507358,0,4,disaccharide transmembrane transporter activity,MF,
5312,GO:0015157,1,0.978844298507358,0,4,oligosaccharide transmembrane transporter activity,MF,
5313,GO:0015165,1,0.943055707799782,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5314,GO:0015166,1,0.929121552214434,0,10,polyol transmembrane transporter activity,MF,
5315,GO:0015168,1,0.975443254706433,0,6,glycerol transmembrane transporter activity,MF,
5318,GO:0015173,1,0.940137993624648,0,10,aromatic amino acid transmembrane transporter activity,MF,
5319,GO:0015174,1,0.911735496118368,0,14,basic amino acid transmembrane transporter activity,MF,
5320,GO:0015175,1,0.815181098931813,0,30,neutral amino acid transmembrane transporter activity,MF,
5322,GO:0015180,1,0.956072285294591,0,7,L-alanine transmembrane transporter activity,MF,
5323,GO:0015181,1,0.948619102203562,0,7,arginine transmembrane transporter activity,MF,
5324,GO:0015182,1,0.986413944831214,0,3,L-asparagine transmembrane transporter activity,MF,
5325,GO:0015183,1,0.950615305420447,0,9,L-aspartate transmembrane transporter activity,MF,
5326,GO:0015184,1,0.980204990660018,0,3,L-cystine transmembrane transporter activity,MF,
5327,GO:0015185,1,0.956881650398492,0,7,gamma-aminobutyric acid transmembrane transporter activity,MF,
5328,GO:0015186,1,0.946804974169911,0,8,L-glutamine transmembrane transporter activity,MF,
5329,GO:0015187,1,0.958714391727974,0,7,glycine transmembrane transporter activity,MF,
5330,GO:0015188,1,0.989692810991723,0,1,L-isoleucine transmembrane transporter activity,MF,
5331,GO:0015189,1,0.963485568438839,0,4,L-lysine transmembrane transporter activity,MF,
5332,GO:0015190,1,0.970626624650757,0,5,L-leucine transmembrane transporter activity,MF,
5333,GO:0015191,1,0.994871055428955,0,1,L-methionine transmembrane transporter activity,MF,
5334,GO:0015193,1,0.959443200591245,0,5,L-proline transmembrane transporter activity,MF,
5335,GO:0015194,1,0.960775467921711,0,7,L-serine transmembrane transporter activity,MF,
5336,GO:0015195,1,0.99180115601632,0,1,L-threonine transmembrane transporter activity,MF,
5337,GO:0015196,1,0.986757027503365,0,2,L-tryptophan transmembrane transporter activity,MF,
5338,GO:0015199,1,0.989692810991723,0,1,amino-acid betaine transmembrane transporter activity,MF,
5339,GO:0015204,1,0.968393677764165,0,6,urea transmembrane transporter activity,MF,
5340,GO:0015205,1,0.957503969977639,0,7,nucleobase transmembrane transporter activity,MF,
5341,GO:0015207,1,0.988245762882787,0,2,adenine transmembrane transporter activity,MF,
5342,GO:0015211,1,0.990956552439018,0,2,purine nucleoside transmembrane transporter activity,MF,
5343,GO:0015212,1,0.996016763282003,0,1,cytidine transmembrane transporter activity,MF,
5344,GO:0015213,1,0.982838803537047,0,4,uridine transmembrane transporter activity,MF,
5345,GO:0015214,1,0.982838803537047,0,4,pyrimidine nucleoside transmembrane transporter activity,MF,
5346,GO:0015215,1,0.847841718123276,0,31,nucleotide transmembrane transporter activity,MF,
5347,GO:0015216,1,0.855547426058163,0,29,purine nucleotide transmembrane transporter activity,MF,
5348,GO:0015217,1,0.989939310949597,0,2,ADP transmembrane transporter activity,MF,
5349,GO:0015218,1,0.987692384182257,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5350,GO:0015220,1,0.975589493055129,0,4,choline transmembrane transporter activity,MF,
5351,GO:0015225,1,0.978885495191164,0,3,biotin transmembrane transporter activity,MF,
5352,GO:0015226,1,0.98588996175365,0,3,carnitine transmembrane transporter activity,MF,
5353,GO:0015227,1,0.981845076379952,0,4,acyl carnitine transmembrane transporter activity,MF,
5354,GO:0015228,1,0.989939310949597,0,2,coenzyme A transmembrane transporter activity,MF,
5355,GO:0015229,1,0.982383295646187,0,2,L-ascorbic acid transmembrane transporter activity,MF,
5356,GO:0015230,1,0.990152506168976,0,2,FAD transmembrane transporter activity,MF,
5357,GO:0015232,1,0.946222784464163,0,9,heme transmembrane transporter activity,MF,
5358,GO:0015233,1,0.993861283997531,0,1,pantothenate transmembrane transporter activity,MF,
5359,GO:0015234,1,0.982624782176886,0,3,thiamine transmembrane transporter activity,MF,
5360,GO:0015245,1,0.964492320409481,0,7,fatty acid transmembrane transporter activity,MF,
5361,GO:0015247,1,0.962672568859844,0,4,aminophospholipid flippase activity,MF,
5362,GO:0015248,1,0.800980603954708,0,30,sterol transporter activity,MF,
5363,GO:0015250,1,0.953710045021589,0,10,water channel activity,MF,
5364,GO:0015252,1,0.982673897042335,0,4,proton channel activity,MF,
5365,GO:0015254,1,0.98042520501568,0,5,glycerol channel activity,MF,
5366,GO:0015265,1,0.986683330206359,0,2,urea channel activity,MF,
5368,GO:0015269,1,0.950444707714723,0,10,calcium-activated potassium channel activity,MF,
5370,GO:0015272,1,0.958733394125396,0,6,ATP-activated inward rectifier potassium channel activity,MF,
5371,GO:0015275,1,0.979411686997098,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5373,GO:0015277,1,0.956317331363373,0,5,kainate selective glutamate receptor activity,MF,
5374,GO:0015278,1,0.804115553336316,0,16,calcium-release channel activity,MF,
5375,GO:0015279,1,0.923793359430438,0,9,store-operated calcium channel activity,MF,
5376,GO:0015280,1,0.934782533100351,0,10,ligand-gated sodium channel activity,MF,
5377,GO:0015288,1,0.980994706412771,0,5,porin activity,MF,
5379,GO:0015292,1,0.994890876864838,0,1,uniporter activity,MF,
5382,GO:0015295,1,0.900045165613919,0,16,solute:proton symporter activity,MF,
5383,GO:0015296,1,0.850165072532142,0,20,anion:cation symporter activity,MF,
5386,GO:0015299,1,0.861017253098281,0,18,solute:proton antiporter activity,MF,
5387,GO:0015301,1,0.828020224525259,0,25,anion:anion antiporter activity,MF,
5388,GO:0015315,1,0.982338698440941,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5389,GO:0015317,1,0.996403348980523,0,1,phosphate:proton symporter activity,MF,
5392,GO:0015322,1,0.993023686816491,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5393,GO:0015327,1,0.982046951199635,0,1,cystine:glutamate antiporter activity,MF,
5394,GO:0015328,1,0.982046951199635,0,1,cystine secondary active transmembrane transporter activity,MF,
5395,GO:0015333,1,0.989479953529399,0,1,peptide:proton symporter activity,MF,
5396,GO:0015343,1,0.994890876864838,0,1,siderophore transmembrane transporter activity,MF,
5398,GO:0015349,1,0.960164775831781,0,6,thyroid hormone transmembrane transporter activity,MF,
5399,GO:0015350,1,0.982449882728074,0,2,methotrexate transmembrane transporter activity,MF,
5400,GO:0015355,1,0.94589362534862,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5401,GO:0015362,1,0.992292011083162,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5402,GO:0015367,1,0.996312309476783,0,1,oxoglutarate:malate antiporter activity,MF,
5404,GO:0015369,1,0.989525486457437,0,1,calcium:proton antiporter activity,MF,
5406,GO:0015373,1,0.914645218075961,0,12,anion:sodium symporter activity,MF,
5407,GO:0015375,1,0.988764984382043,0,2,glycine:sodium symporter activity,MF,
5408,GO:0015377,1,0.873581490288479,0,16,cation:chloride symporter activity,MF,
5409,GO:0015378,1,0.925786849019722,0,10,sodium:chloride symporter activity,MF,
5410,GO:0015379,1,0.922855271887154,0,8,potassium:chloride symporter activity,MF,
5411,GO:0015382,1,0.994652482138736,0,1,sodium:sulfate symporter activity,MF,
5412,GO:0015385,1,0.92151862387344,0,11,sodium:proton antiporter activity,MF,
5413,GO:0015386,1,0.926254591508128,0,10,potassium:proton antiporter activity,MF,
5414,GO:0015389,1,0.991808912258776,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5415,GO:0015390,1,0.995775489971659,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5416,GO:0015391,1,0.991808912258776,0,2,nucleobase:cation symporter activity,MF,
5418,GO:0015410,1,0.979918168181156,0,3,manganese transmembrane transporter activity, phosphorylative mechanism,MF,
5419,GO:0015420,1,0.980237826658604,0,3,ATPase-coupled vitamin B12 transmembrane transporter activity,MF,
5420,GO:0015431,1,0.987767687173493,0,1,ATPase-coupled glutathione S-conjugate transmembrane transporter activity,MF,
5422,GO:0015433,1,0.97400479788286,0,4,ATPase-coupled peptide antigen transmembrane transporter activity,MF,
5423,GO:0015439,1,0.994488243633323,0,1,ATPase-coupled heme transmembrane transporter activity,MF,
5424,GO:0015440,1,0.97400479788286,0,4,ATPase-coupled peptide transmembrane transporter activity,MF,
5425,GO:0015450,1,0.978873507930134,0,5,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5427,GO:0015464,1,0.905796797209737,0,18,acetylcholine receptor activity,MF,
5428,GO:0015467,1,0.979284033930698,0,4,G-protein activated inward rectifier potassium channel activity,MF,
5429,GO:0015485,1,0.758232208675601,0,42,cholesterol binding,MF,
5431,GO:0015495,1,0.995233725535343,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5432,GO:0015499,1,0.99509131520587,0,1,formate transmembrane transporter activity,MF,
5433,GO:0015501,1,0.961187838620484,0,4,glutamate:sodium symporter activity,MF,
5434,GO:0015526,1,0.982338698440941,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5435,GO:0015538,1,0.993831969239055,0,1,sialic acid:proton symporter activity,MF,
5436,GO:0015556,1,0.92096270428162,0,15,C4-dicarboxylate transmembrane transporter activity,MF,
5437,GO:0015562,1,0.905922373025453,0,13,efflux transmembrane transporter activity,MF,
5438,GO:0015605,1,0.825291099257383,0,36,organophosphate ester transmembrane transporter activity,MF,
5439,GO:0015607,1,0.993112079077958,0,1,ATPase-coupled fatty-acyl-CoA transmembrane transporter activity,MF,
5440,GO:0015616,1,0.947408485263911,0,5,DNA translocase activity,MF,
5442,GO:0015630,1,0.000157825229262653,0,1135,microtubule cytoskeleton,CC,
5444,GO:0015633,1,0.995949601204813,0,1,ATPase-coupled zinc transmembrane transporter activity,MF,
5445,GO:0015636,1,0.991644366289443,0,2,short-chain fatty acid transmembrane transporter activity,MF,
5446,GO:0015643,1,0.94899349433448,0,10,toxic substance binding,MF,
5447,GO:0015645,1,0.90055098434187,0,19,fatty acid ligase activity,MF,
5448,GO:0015651,1,0.944111162562136,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5449,GO:0015658,1,0.954077767870543,0,7,branched-chain amino acid transmembrane transporter activity,MF,
5450,GO:0015660,1,0.99509131520587,0,1,formate efflux transmembrane transporter activity,MF,
5452,GO:0015665,1,0.987838783787134,0,3,alcohol transmembrane transporter activity,MF,
5453,GO:0015669,1,0.928710268943565,0,18,gas transport,BP,
5454,GO:0015670,1,0.982813445413108,0,4,carbon dioxide transport,BP,
5455,GO:0015671,1,0.944960026803874,0,14,oxygen transport,BP,
5457,GO:0015675,1,0.992068479353006,0,1,nickel cation transport,BP,
5458,GO:0015677,1,0.935812321711553,0,6,copper ion import,BP,
5459,GO:0015679,1,0.990859856299393,0,1,plasma membrane copper ion transport,BP,
5460,GO:0015680,1,0.984711341504876,0,2,protein maturation by copper ion transfer,BP,
5461,GO:0015689,1,0.996187491161553,0,1,molybdate ion transport,BP,
5462,GO:0015691,1,0.966308399255347,0,5,cadmium ion transport,BP,
5463,GO:0015692,1,0.992068479353006,0,1,lead ion transport,BP,
5464,GO:0015693,1,0.890148520094921,0,16,magnesium ion transport,BP,
5465,GO:0015694,1,0.990273865801745,0,1,mercury ion transport,BP,
5466,GO:0015695,1,0.748057108532725,0,48,organic cation transport,BP,
5467,GO:0015696,1,0.937932888731178,0,8,ammonium transport,BP,
5468,GO:0015697,1,0.927313452707377,0,13,quaternary ammonium group transport,BP,
5470,GO:0015701,1,0.765396615437994,0,40,bicarbonate transport,BP,
5471,GO:0015705,1,0.944588978234252,0,5,iodide transport,BP,
5472,GO:0015706,1,0.995095643171785,0,1,nitrate transport,BP,
5473,GO:0015707,1,0.992712515527383,0,1,nitrite transport,BP,
5474,GO:0015709,1,0.982208989643871,0,4,thiosulfate transport,BP,
5476,GO:0015712,1,0.969726589525888,0,6,hexose phosphate transport,BP,
5480,GO:0015723,1,0.990273865801745,0,1,bilirubin transport,BP,
5481,GO:0015724,1,0.99509131520587,0,1,formate transport,BP,
5482,GO:0015727,1,0.958270822253617,0,6,lactate transport,BP,
5483,GO:0015728,1,0.992132892685177,0,1,mevalonate transport,BP,
5484,GO:0015729,1,0.982208989643871,0,4,oxaloacetate transport,BP,
5485,GO:0015732,1,0.924451945515443,0,13,prostaglandin transport,BP,
5486,GO:0015734,1,0.944529798671897,0,6,taurine transport,BP,
5487,GO:0015739,1,0.98297369450874,0,4,sialic acid transport,BP,
5488,GO:0015740,1,0.837034961901886,0,24,C4-dicarboxylate transport,BP,
5489,GO:0015742,1,0.979400409057939,0,4,alpha-ketoglutarate transport,BP,
5490,GO:0015743,1,0.982208989643871,0,4,malate transport,BP,
5491,GO:0015744,1,0.968822506250998,0,6,succinate transport,BP,
5492,GO:0015746,1,0.975145142321467,0,4,citrate transport,BP,
5493,GO:0015747,1,0.979533682586889,0,4,urate transport,BP,
5494,GO:0015748,1,0.448856185492967,0,117,organophosphate ester transport,BP,
5495,GO:0015749,1,0.488725450316724,0,96,monosaccharide transmembrane transport,BP,
5496,GO:0015750,1,0.969684862973102,0,2,pentose transmembrane transport,BP,
5497,GO:0015755,1,0.980690008543129,0,4,fructose transmembrane transport,BP,
5498,GO:0015756,1,0.969684862973102,0,2,fucose transmembrane transport,BP,
5499,GO:0015757,1,0.982596751124997,0,2,galactose transmembrane transport,BP,
5500,GO:0015760,1,0.969726589525888,0,6,glucose-6-phosphate transport,BP,
5501,GO:0015766,1,0.978844298507358,0,4,disaccharide transport,BP,
5502,GO:0015770,1,0.978844298507358,0,4,sucrose transport,BP,
5503,GO:0015772,1,0.978844298507358,0,4,oligosaccharide transport,BP,
5504,GO:0015774,1,0.989902831807601,0,1,polysaccharide transport,BP,
5505,GO:0015780,1,0.933414151442798,0,12,nucleotide-sugar transmembrane transport,BP,
5506,GO:0015782,1,0.996278001386186,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5507,GO:0015783,1,0.994048910858054,0,1,GDP-fucose transmembrane transport,BP,
5508,GO:0015786,1,0.99244725452495,0,2,UDP-glucose transmembrane transport,BP,
5509,GO:0015787,1,0.979805191106273,0,3,UDP-glucuronic acid transmembrane transport,BP,
5510,GO:0015789,1,0.979805191106273,0,3,UDP-N-acetylgalactosamine transmembrane transport,BP,
5511,GO:0015790,1,0.987015598412905,0,1,UDP-xylose transmembrane transport,BP,
5512,GO:0015791,1,0.90569411991758,0,12,polyol transport,BP,
5513,GO:0015793,1,0.975443254706433,0,6,glycerol transport,BP,
5514,GO:0015797,1,0.99509131520587,0,1,mannitol transport,BP,
5515,GO:0015798,1,0.93309550514407,0,5,myo-inositol transport,BP,
5517,GO:0015801,1,0.923382560445656,0,13,aromatic amino acid transport,BP,
5518,GO:0015802,1,0.902408739617899,0,16,basic amino acid transport,BP,
5521,GO:0015805,1,0.995768401140782,0,1,S-adenosyl-L-methionine transport,BP,
5523,GO:0015808,1,0.952312509032114,0,8,L-alanine transport,BP,
5524,GO:0015809,1,0.930425954265416,0,11,arginine transport,BP,
5525,GO:0015810,1,0.939506602707605,0,9,aspartate transmembrane transport,BP,
5526,GO:0015811,1,0.980204990660018,0,3,L-cystine transport,BP,
5527,GO:0015812,1,0.883335808413795,0,16,gamma-aminobutyric acid transport,BP,
5530,GO:0015817,1,0.990285378763495,0,2,histidine transport,BP,
5531,GO:0015818,1,0.989692810991723,0,1,isoleucine transport,BP,
5532,GO:0015819,1,0.986054403654254,0,1,lysine transport,BP,
5534,GO:0015821,1,0.994871055428955,0,1,methionine transport,BP,
5535,GO:0015822,1,0.941405208364445,0,7,ornithine transport,BP,
5536,GO:0015823,1,0.987068075205843,0,2,phenylalanine transport,BP,
5538,GO:0015825,1,0.960775467921711,0,7,L-serine transport,BP,
5539,GO:0015826,1,0.99180115601632,0,1,threonine transport,BP,
5540,GO:0015827,1,0.969328741363891,0,5,tryptophan transport,BP,
5541,GO:0015828,1,0.994159995566144,0,1,tyrosine transport,BP,
5542,GO:0015829,1,0.993102724289294,0,1,valine transport,BP,
5545,GO:0015838,1,0.962644965052785,0,6,amino-acid betaine transport,BP,
5546,GO:0015840,1,0.965327158069723,0,7,urea transport,BP,
5547,GO:0015842,1,0.983247642554388,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5549,GO:0015846,1,0.965092805989691,0,7,polyamine transport,BP,
5552,GO:0015851,1,0.949770800376195,0,9,nucleobase transport,BP,
5553,GO:0015853,1,0.980266827663415,0,4,adenine transport,BP,
5554,GO:0015854,1,0.99531845419145,0,1,guanine transport,BP,
5555,GO:0015855,1,0.98165553191145,0,4,pyrimidine nucleobase transport,BP,
5556,GO:0015858,1,0.964718650582466,0,8,nucleoside transport,BP,
5557,GO:0015860,1,0.986769865830796,0,3,purine nucleoside transmembrane transport,BP,
5558,GO:0015861,1,0.996016763282003,0,1,cytidine transport,BP,
5559,GO:0015862,1,0.982838803537047,0,4,uridine transport,BP,
5560,GO:0015864,1,0.982838803537047,0,4,pyrimidine nucleoside transport,BP,
5561,GO:0015865,1,0.842781255321936,0,32,purine nucleotide transport,BP,
5562,GO:0015866,1,0.981595653601803,0,3,ADP transport,BP,
5563,GO:0015867,1,0.870434667933501,0,26,ATP transport,BP,
5564,GO:0015868,1,0.850269607962427,0,31,purine ribonucleotide transport,BP,
5565,GO:0015870,1,0.981036970558034,0,4,acetylcholine transport,BP,
5566,GO:0015871,1,0.95406770294746,0,6,choline transport,BP,
5569,GO:0015876,1,0.995083515122915,0,1,acetyl-CoA transport,BP,
5570,GO:0015878,1,0.978885495191164,0,3,biotin transport,BP,
5571,GO:0015879,1,0.981874168427373,0,4,carnitine transport,BP,
5572,GO:0015880,1,0.989939310949597,0,2,coenzyme A transport,BP,
5573,GO:0015881,1,0.980469577939026,0,3,creatine transmembrane transport,BP,
5574,GO:0015882,1,0.982383295646187,0,2,L-ascorbic acid transmembrane transport,BP,
5575,GO:0015883,1,0.990152506168976,0,2,FAD transport,BP,
5576,GO:0015884,1,0.934640071157805,0,8,folic acid transport,BP,
5577,GO:0015886,1,0.946222784464163,0,9,heme transport,BP,
5578,GO:0015887,1,0.993861283997531,0,1,pantothenate transmembrane transport,BP,
5579,GO:0015888,1,0.977378428337099,0,4,thiamine transport,BP,
5580,GO:0015889,1,0.948477438703906,0,7,cobalamin transport,BP,
5581,GO:0015891,1,0.987623125459383,0,3,siderophore transport,BP,
5583,GO:0015904,1,0.996225875486232,0,1,tetracycline transmembrane transport,BP,
5586,GO:0015910,1,0.973053134240748,0,4,long-chain fatty acid import into peroxisome,BP,
5587,GO:0015911,1,0.937663788357941,0,8,long-chain fatty acid import across plasma membrane,BP,
5588,GO:0015912,1,0.991644366289443,0,2,short-chain fatty acid transport,BP,
5589,GO:0015913,1,0.99564770424597,0,1,short-chain fatty acid import,BP,
5590,GO:0015914,1,0.560556459140662,0,75,phospholipid transport,BP,
5591,GO:0015916,1,0.988229121611841,0,2,fatty-acyl-CoA transport,BP,
5592,GO:0015917,1,0.960513683527421,0,4,aminophospholipid transport,BP,
5594,GO:0015919,1,0.88112244903807,0,20,peroxisomal membrane transport,BP,
5595,GO:0015920,1,0.991318368128981,0,2,lipopolysaccharide transport,BP,
5596,GO:0015922,1,0.99645797635803,0,1,aspartate oxidase activity,MF,
5597,GO:0015923,1,0.887108340868183,0,15,mannosidase activity,MF,
5598,GO:0015924,1,0.923365477108573,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5599,GO:0015925,1,0.960791534702305,0,8,galactosidase activity,MF,
5600,GO:0015926,1,0.920273618725143,0,11,glucosidase activity,MF,
5601,GO:0015928,1,0.991884048571243,0,2,fucosidase activity,MF,
5602,GO:0015929,1,0.948228237137247,0,11,hexosaminidase activity,MF,
5603,GO:0015931,1,0.198009713415398,0,242,nucleobase-containing compound transport,BP,
5604,GO:0015932,1,0.75703719971938,0,51,nucleobase-containing compound transmembrane transporter activity,MF,
5605,GO:0015934,1,0.669853891568159,0,110,large ribosomal subunit,CC,
5606,GO:0015935,1,0.757342425496167,0,70,small ribosomal subunit,CC,
5607,GO:0015936,1,0.926271934991329,0,15,coenzyme A metabolic process,BP,
5608,GO:0015937,1,0.957565695586385,0,10,coenzyme A biosynthetic process,BP,
5609,GO:0015938,1,0.996793561287034,0,1,coenzyme A catabolic process,BP,
5610,GO:0015939,1,0.967261481811238,0,7,pantothenate metabolic process,BP,
5611,GO:0015942,1,0.970376860605853,0,6,formate metabolic process,BP,
5612,GO:0015949,1,0.878187869433574,0,27,nucleobase-containing small molecule interconversion,BP,
5613,GO:0015959,1,0.969239621165246,0,6,diadenosine polyphosphate metabolic process,BP,
5614,GO:0015960,1,0.993030969248542,0,1,diadenosine polyphosphate biosynthetic process,BP,
5615,GO:0015961,1,0.976043342562086,0,5,diadenosine polyphosphate catabolic process,BP,
5616,GO:0015962,1,0.996767079597239,0,1,diadenosine triphosphate metabolic process,BP,
5617,GO:0015964,1,0.996767079597239,0,1,diadenosine triphosphate catabolic process,BP,
5618,GO:0015965,1,0.993030969248542,0,1,diadenosine tetraphosphate metabolic process,BP,
5619,GO:0015966,1,0.993030969248542,0,1,diadenosine tetraphosphate biosynthetic process,BP,
5620,GO:0015980,1,0.248762823843459,0,239,energy derivation by oxidation of organic compounds,BP,
5621,GO:0015985,1,0.980630943938238,0,5,energy coupled proton transport, down electrochemical gradient,BP,
5622,GO:0015986,1,0.980630943938238,0,5,ATP synthesis coupled proton transport,BP,
5623,GO:0015988,1,0.996850648765156,0,1,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5624,GO:0015990,1,0.996850648765156,0,1,electron transport coupled proton transport,BP,
5625,GO:0016004,1,0.939372262186099,0,10,phospholipase activator activity,MF,
5626,GO:0016005,1,0.985747102336522,0,2,phospholipase A2 activator activity,MF,
5627,GO:0016010,1,0.856983670706874,0,19,dystrophin-associated glycoprotein complex,CC,
5628,GO:0016011,1,0.94920877772896,0,7,dystroglycan complex,CC,
5629,GO:0016012,1,0.95968428563195,0,6,sarcoglycan complex,CC,
5630,GO:0016013,1,0.974171299391494,0,4,syntrophin complex,CC,
5631,GO:0016015,1,0.97399479324335,0,6,morphogen activity,MF,
5632,GO:0016018,1,0.935659725221129,0,13,cyclosporin A binding,MF,
5633,GO:0016019,1,0.993305262461336,0,2,peptidoglycan immune receptor activity,MF,
5636,GO:0016024,1,0.912466223022786,0,11,CDP-diacylglycerol biosynthetic process,BP,
5637,GO:0016028,1,0.993172334102114,0,1,rhabdomere,CC,
5638,GO:0016031,1,0.993701962387395,0,1,tRNA import into mitochondrion,BP,
5640,GO:0016034,1,0.99665103403508,0,1,maleylacetoacetate isomerase activity,MF,
5641,GO:0016035,1,0.967318367231944,0,4,zeta DNA polymerase complex,CC,
5642,GO:0016036,1,0.979961428210138,0,2,cellular response to phosphate starvation,BP,
5643,GO:0016037,1,0.994894473500679,0,1,light absorption,BP,
5644,GO:0016038,1,0.994894473500679,0,1,absorption of visible light,BP,
5647,GO:0016045,1,0.901926040613514,0,14,detection of bacterium,BP,
5648,GO:0016046,1,0.984711786818078,0,2,detection of fungus,BP,
5649,GO:0016048,1,0.864111030170112,0,22,detection of temperature stimulus,BP,
5655,GO:0016054,1,0.230330422505352,0,262,organic acid catabolic process,BP,
5657,GO:0016056,1,0.870017641304067,0,24,rhodopsin mediated signaling pathway,BP,
5659,GO:0016068,1,0.98853607225426,0,3,type I hypersensitivity,BP,
5662,GO:0016072,1,0.292007873315265,0,214,rRNA metabolic process,BP,
5663,GO:0016073,1,0.835085801174205,0,33,snRNA metabolic process,BP,
5664,GO:0016074,1,0.938948920413321,0,13,snoRNA metabolic process,BP,
5665,GO:0016075,1,0.884574518160627,0,19,rRNA catabolic process,BP,
5666,GO:0016076,1,0.985797662535711,0,3,snRNA catabolic process,BP,
5667,GO:0016077,1,0.983392398260556,0,2,snoRNA catabolic process,BP,
5668,GO:0016078,1,0.925658445909259,0,11,tRNA catabolic process,BP,
5670,GO:0016080,1,0.969270754864263,0,3,synaptic vesicle targeting,BP,
5673,GO:0016093,1,0.962722947327989,0,8,polyprenol metabolic process,BP,
5674,GO:0016094,1,0.979889944297248,0,3,polyprenol biosynthetic process,BP,
5675,GO:0016095,1,0.98831034322991,0,3,polyprenol catabolic process,BP,
5676,GO:0016098,1,0.992911695877057,0,2,monoterpenoid metabolic process,BP,
5677,GO:0016101,1,0.572979382924741,0,88,diterpenoid metabolic process,BP,
5678,GO:0016102,1,0.956885639307186,0,9,diterpenoid biosynthetic process,BP,
5679,GO:0016103,1,0.980662707441359,0,4,diterpenoid catabolic process,BP,
5680,GO:0016104,1,0.991894383511468,0,1,triterpenoid biosynthetic process,BP,
5681,GO:0016107,1,0.993193699032343,0,2,sesquiterpenoid catabolic process,BP,
5682,GO:0016108,1,0.984853331620624,0,3,tetraterpenoid metabolic process,BP,
5683,GO:0016109,1,0.995157531975832,0,1,tetraterpenoid biosynthetic process,BP,
5684,GO:0016114,1,0.926106243382732,0,15,terpenoid biosynthetic process,BP,
5685,GO:0016115,1,0.973986717652525,0,6,terpenoid catabolic process,BP,
5686,GO:0016116,1,0.984853331620624,0,3,carotenoid metabolic process,BP,
5687,GO:0016117,1,0.995157531975832,0,1,carotenoid biosynthetic process,BP,
5688,GO:0016119,1,0.989646160058766,0,2,carotene metabolic process,BP,
5689,GO:0016121,1,0.989646160058766,0,2,carotene catabolic process,BP,
5690,GO:0016122,1,0.98991142344486,0,2,xanthophyll metabolic process,BP,
5691,GO:0016123,1,0.995157531975832,0,1,xanthophyll biosynthetic process,BP,
5692,GO:0016125,1,0.401723662539076,0,141,sterol metabolic process,BP,
5693,GO:0016126,1,0.632692519942891,0,68,sterol biosynthetic process,BP,
5694,GO:0016127,1,0.961808096172055,0,9,sterol catabolic process,BP,
5695,GO:0016128,1,0.99509131520587,0,1,phytosteroid metabolic process,BP,
5696,GO:0016129,1,0.99509131520587,0,1,phytosteroid biosynthetic process,BP,
5697,GO:0016131,1,0.99509131520587,0,1,brassinosteroid metabolic process,BP,
5698,GO:0016132,1,0.99509131520587,0,1,brassinosteroid biosynthetic process,BP,
5699,GO:0016137,1,0.922906265419289,0,19,glycoside metabolic process,BP,
5700,GO:0016139,1,0.958134250409533,0,9,glycoside catabolic process,BP,
5701,GO:0016149,1,0.993066333935651,0,1,translation release factor activity, codon specific,MF,
5702,GO:0016151,1,0.996340592013151,0,1,nickel cation binding,MF,
5703,GO:0016153,1,0.993727429533908,0,1,urocanate hydratase activity,MF,
5704,GO:0016154,1,0.996422603960133,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5705,GO:0016155,1,0.97999589728372,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5706,GO:0016160,1,0.979940758240902,0,3,amylase activity,MF,
5707,GO:0016165,1,0.98581019962101,0,3,linoleate 13S-lipoxygenase activity,MF,
5708,GO:0016167,1,0.973539402962128,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5709,GO:0016170,1,0.990357974321932,0,1,interleukin-15 receptor binding,MF,
5710,GO:0016174,1,0.93391852650379,0,9,NAD(P)H oxidase H2O2-forming activity,MF,
5711,GO:0016175,1,0.938983141507281,0,10,superoxide-generating NAD(P)H oxidase activity,MF,
5712,GO:0016176,1,0.942652243706086,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5713,GO:0016180,1,0.875106660715373,0,23,snRNA processing,BP,
5714,GO:0016182,1,0.983240890936194,0,2,synaptic vesicle budding from endosome,BP,
5717,GO:0016189,1,0.97232061980154,0,3,synaptic vesicle to endosome fusion,BP,
5720,GO:0016197,1,0.195515205901466,0,215,endosomal transport,BP,
5721,GO:0016198,1,0.946046853702,0,7,axon choice point recognition,BP,
5722,GO:0016199,1,0.955375285157198,0,5,axon midline choice point recognition,BP,
5724,GO:0016203,1,0.989088882827696,0,1,muscle attachment,BP,
5725,GO:0016206,1,0.990088332151663,0,2,catechol O-methyltransferase activity,MF,
5726,GO:0016208,1,0.936657147137697,0,12,AMP binding,MF,
5727,GO:0016209,1,0.708928877724361,0,72,antioxidant activity,MF,
5728,GO:0016211,1,0.991678996243949,0,1,ammonia ligase activity,MF,
5729,GO:0016212,1,0.991222709709928,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5730,GO:0016213,1,0.985773174004927,0,2,linoleoyl-CoA desaturase activity,MF,
5731,GO:0016215,1,0.970767267556856,0,4,acyl-CoA desaturase activity,MF,
5732,GO:0016222,1,0.989974483147716,0,2,procollagen-proline 4-dioxygenase complex,CC,
5733,GO:0016226,1,0.905654600325904,0,20,iron-sulfur cluster assembly,BP,
5734,GO:0016229,1,0.89932754208264,0,28,steroid dehydrogenase activity,MF,
5735,GO:0016230,1,0.989974375130312,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5736,GO:0016232,1,0.994805719880305,0,1,HNK-1 sulfotransferase activity,MF,
5737,GO:0016233,1,0.746573048490305,0,38,telomere capping,BP,
5739,GO:0016235,1,0.762102123788751,0,38,aggresome,CC,
5740,GO:0016236,1,0.140494266369298,0,289,macroautophagy,BP,
5741,GO:0016237,1,0.941361128284661,0,5,lysosomal microautophagy,BP,
5742,GO:0016239,1,0.589682348369771,0,61,positive regulation of macroautophagy,BP,
5743,GO:0016240,1,0.970787622383262,0,4,autophagosome membrane docking,BP,
5744,GO:0016241,1,0.302365123597612,0,165,regulation of macroautophagy,BP,
5745,GO:0016242,1,0.776198928005812,0,31,negative regulation of macroautophagy,BP,
5746,GO:0016243,1,0.99241375583027,0,1,regulation of autophagosome size,BP,
5747,GO:0016246,1,0.892296982564412,0,16,RNA interference,BP,
5749,GO:0016248,1,0.773844688131694,0,36,channel inhibitor activity,MF,
5750,GO:0016250,1,0.994890876864838,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5751,GO:0016251,1,0.828747490410847,0,36,RNA polymerase II general transcription initiation factor activity,MF,
5752,GO:0016254,1,0.925111193352293,0,16,preassembly of GPI anchor in ER membrane,BP,
5753,GO:0016255,1,0.954226596418093,0,6,attachment of GPI anchor to protein,BP,
5754,GO:0016256,1,0.989220812704682,0,1,N-glycan processing to lysosome,BP,
5755,GO:0016259,1,0.980205101973289,0,3,selenocysteine metabolic process,BP,
5756,GO:0016260,1,0.990924821637235,0,2,selenocysteine biosynthetic process,BP,
5757,GO:0016262,1,0.980717048798833,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5758,GO:0016263,1,0.992443954689969,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5759,GO:0016264,1,0.929401859432095,0,12,gap junction assembly,BP,
5761,GO:0016267,1,0.992443954689969,0,2,O-glycan processing, core 1,BP,
5762,GO:0016272,1,0.977244604143484,0,7,prefoldin complex,CC,
5763,GO:0016273,1,0.949944843253075,0,11,arginine N-methyltransferase activity,MF,
5764,GO:0016274,1,0.949944843253075,0,11,protein-arginine N-methyltransferase activity,MF,
5765,GO:0016277,1,0.995505949277943,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5766,GO:0016278,1,0.681394706821124,0,48,lysine N-methyltransferase activity,MF,
5767,GO:0016279,1,0.684907220689052,0,47,protein-lysine N-methyltransferase activity,MF,
5768,GO:0016281,1,0.916900296129796,0,13,eukaryotic translation initiation factor 4F complex,CC,
5769,GO:0016282,1,0.929950780068494,0,16,eukaryotic 43S preinitiation complex,CC,
5770,GO:0016286,1,0.982368696279753,0,4,small conductance calcium-activated potassium channel activity,MF,
5771,GO:0016287,1,0.995031197712301,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5772,GO:0016289,1,0.915346240139692,0,20,CoA hydrolase activity,MF,
5773,GO:0016290,1,0.949381687849343,0,12,palmitoyl-CoA hydrolase activity,MF,
5774,GO:0016295,1,0.980422343982843,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5775,GO:0016296,1,0.980422343982843,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5776,GO:0016297,1,0.980422343982843,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5778,GO:0016300,1,0.98142280361869,0,3,tRNA (uracil) methyltransferase activity,MF,
5780,GO:0016303,1,0.895549798002571,0,10,1-phosphatidylinositol-3-kinase activity,MF,
5781,GO:0016307,1,0.884035454976494,0,14,phosphatidylinositol phosphate kinase activity,MF,
5782,GO:0016308,1,0.957083461191529,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5783,GO:0016309,1,0.98702585994567,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5786,GO:0016312,1,0.990009029674479,0,2,inositol bisphosphate phosphatase activity,MF,
5787,GO:0016314,1,0.970374661292271,0,4,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5788,GO:0016316,1,0.979553559273557,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5789,GO:0016320,1,0.981332353123016,0,2,endoplasmic reticulum membrane fusion,BP,
5790,GO:0016321,1,0.968681981902223,0,6,female meiosis chromosome segregation,BP,
5791,GO:0016322,1,0.923338279713279,0,12,neuron remodeling,BP,
5794,GO:0016327,1,0.911654304758515,0,16,apicolateral plasma membrane,CC,
5797,GO:0016332,1,0.992608585555178,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5798,GO:0016333,1,0.994574578198833,0,1,morphogenesis of follicular epithelium,BP,
5799,GO:0016334,1,0.994574578198833,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5800,GO:0016338,1,0.91977774869852,0,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5801,GO:0016339,1,0.805963337010094,0,29,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5802,GO:0016340,1,0.975418475461259,0,2,calcium-dependent cell-matrix adhesion,BP,
5803,GO:0016342,1,0.774117739889319,0,31,catenin complex,CC,
5804,GO:0016344,1,0.975457074179136,0,3,meiotic chromosome movement towards spindle pole,BP,
5806,GO:0016361,1,0.955158798194295,0,5,activin receptor activity, type I,MF,
5807,GO:0016362,1,0.957789867995813,0,2,activin receptor activity, type II,MF,
5809,GO:0016401,1,0.973244825335667,0,4,palmitoyl-CoA oxidase activity,MF,
5810,GO:0016402,1,0.994740611832603,0,1,pristanoyl-CoA oxidase activity,MF,
5811,GO:0016403,1,0.989098423116672,0,2,dimethylargininase activity,MF,
5812,GO:0016404,1,0.986413050227535,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5813,GO:0016405,1,0.877422946269373,0,23,CoA-ligase activity,MF,
5814,GO:0016406,1,0.96594211461658,0,6,carnitine O-acyltransferase activity,MF,
5815,GO:0016407,1,0.518383069229755,0,93,acetyltransferase activity,MF,
5816,GO:0016408,1,0.918483207441915,0,17,C-acyltransferase activity,MF,
5817,GO:0016409,1,0.779626313602668,0,39,palmitoyltransferase activity,MF,
5818,GO:0016410,1,0.545556859671523,0,87,N-acyltransferase activity,MF,
5819,GO:0016411,1,0.879825121619254,0,17,acylglycerol O-acyltransferase activity,MF,
5820,GO:0016413,1,0.957024186422897,0,7,O-acetyltransferase activity,MF,
5821,GO:0016414,1,0.988790984545103,0,2,O-octanoyltransferase activity,MF,
5822,GO:0016415,1,0.985636678620376,0,3,octanoyltransferase activity,MF,
5823,GO:0016416,1,0.967755223973792,0,5,O-palmitoyltransferase activity,MF,
5824,GO:0016417,1,0.812353956522118,0,32,S-acyltransferase activity,MF,
5825,GO:0016418,1,0.975864904900243,0,2,S-acetyltransferase activity,MF,
5826,GO:0016419,1,0.980222221373661,0,2,S-malonyltransferase activity,MF,
5827,GO:0016420,1,0.980222221373661,0,2,malonyltransferase activity,MF,
5828,GO:0016421,1,0.96316927207137,0,5,CoA carboxylase activity,MF,
5829,GO:0016422,1,0.98710193289912,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5830,GO:0016423,1,0.931203684763116,0,13,tRNA (guanine) methyltransferase activity,MF,
5831,GO:0016426,1,0.980907837653835,0,4,tRNA (adenine) methyltransferase activity,MF,
5832,GO:0016427,1,0.941443406723083,0,9,tRNA (cytosine) methyltransferase activity,MF,
5833,GO:0016428,1,0.97293087835974,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5834,GO:0016429,1,0.980907837653835,0,4,tRNA (adenine-N1-)-methyltransferase activity,MF,
5835,GO:0016432,1,0.985563060220995,0,2,tRNA-uridine aminocarboxypropyltransferase activity,MF,
5836,GO:0016433,1,0.966059571140212,0,8,rRNA (adenine) methyltransferase activity,MF,
5837,GO:0016434,1,0.977164898732946,0,4,rRNA (cytosine) methyltransferase activity,MF,
5838,GO:0016435,1,0.9902138669786,0,2,rRNA (guanine) methyltransferase activity,MF,
5839,GO:0016436,1,0.987740730989104,0,2,rRNA (uridine) methyltransferase activity,MF,
5840,GO:0016441,1,0.390505021278338,0,121,posttranscriptional gene silencing,BP,
5841,GO:0016442,1,0.873608999465178,0,14,RISC complex,CC,
5842,GO:0016444,1,0.668547677723838,0,56,somatic cell DNA recombination,BP,
5843,GO:0016445,1,0.684470391620321,0,55,somatic diversification of immunoglobulins,BP,
5844,GO:0016446,1,0.917099883993711,0,13,somatic hypermutation of immunoglobulin genes,BP,
5845,GO:0016447,1,0.721965444322863,0,48,somatic recombination of immunoglobulin gene segments,BP,
5846,GO:0016453,1,0.979559410327235,0,5,C-acetyltransferase activity,MF,
5847,GO:0016454,1,0.965427460888856,0,5,C-palmitoyltransferase activity,MF,
5848,GO:0016458,1,0.241971681470862,0,183,gene silencing,BP,
5849,GO:0016459,1,0.582107268667053,0,51,myosin complex,CC,
5850,GO:0016460,1,0.855496841373166,0,17,myosin II complex,CC,
5851,GO:0016461,1,0.894090430202201,0,10,unconventional myosin complex,CC,
5853,GO:0016469,1,0.872544215957578,0,28,proton-transporting two-sector ATPase complex,CC,
5854,GO:0016471,1,0.918423887789471,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5855,GO:0016476,1,0.984034953139342,0,2,regulation of embryonic cell shape,BP,
5857,GO:0016479,1,0.973284910803805,0,3,negative regulation of transcription by RNA polymerase I,BP,
5858,GO:0016480,1,0.988209596264089,0,3,negative regulation of transcription by RNA polymerase III,BP,
5859,GO:0016482,1,0.292260743317613,0,149,cytosolic transport,BP,
5861,GO:0016486,1,0.850617061290108,0,26,peptide hormone processing,BP,
5862,GO:0016487,1,0.993193699032343,0,2,farnesol metabolic process,BP,
5863,GO:0016488,1,0.993193699032343,0,2,farnesol catabolic process,BP,
5865,GO:0016492,1,0.988652430564139,0,2,G protein-coupled neurotensin receptor activity,MF,
5866,GO:0016493,1,0.905555573388207,0,22,C-C chemokine receptor activity,MF,
5867,GO:0016494,1,0.965462190241801,0,8,C-X-C chemokine receptor activity,MF,
5868,GO:0016495,1,0.994110532640637,0,1,C-X3-C chemokine receptor activity,MF,
5869,GO:0016496,1,0.993962937356046,0,1,substance P receptor activity,MF,
5870,GO:0016497,1,0.995487177208541,0,1,substance K receptor activity,MF,
5871,GO:0016499,1,0.992353617884438,0,2,orexin receptor activity,MF,
5872,GO:0016500,1,0.902548770435349,0,12,protein-hormone receptor activity,MF,
5873,GO:0016501,1,0.995965176434651,0,1,prostacyclin receptor activity,MF,
5874,GO:0016502,1,0.915061762341272,0,20,nucleotide receptor activity,MF,
5875,GO:0016503,1,0.996666966851124,0,1,pheromone receptor activity,MF,
5876,GO:0016504,1,0.795892811052312,0,37,peptidase activator activity,MF,
5877,GO:0016505,1,0.88574815548078,0,18,peptidase activator activity involved in apoptotic process,MF,
5878,GO:0016507,1,0.994363337712221,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5879,GO:0016508,1,0.982105500359042,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5880,GO:0016509,1,0.987012139514773,0,2,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5881,GO:0016513,1,0.974823646680886,0,3,core-binding factor complex,CC,
5882,GO:0016514,1,0.879529124461879,0,17,SWI/SNF complex,CC,
5883,GO:0016517,1,0.996085552851057,0,1,interleukin-12 receptor activity,MF,
5884,GO:0016519,1,0.99602864251893,0,1,gastric inhibitory peptide receptor activity,MF,
5885,GO:0016520,1,0.987876454563607,0,2,growth hormone-releasing hormone receptor activity,MF,
5886,GO:0016521,1,0.994129353515148,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5890,GO:0016530,1,0.956542085886149,0,6,metallochaperone activity,MF,
5891,GO:0016531,1,0.974791748437498,0,4,copper chaperone activity,MF,
5892,GO:0016532,1,0.980880282070058,0,2,superoxide dismutase copper chaperone activity,MF,
5893,GO:0016533,1,0.984942758344386,0,3,protein kinase 5 complex,CC,
5894,GO:0016538,1,0.783959147628111,0,46,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5895,GO:0016539,1,0.992491022236586,0,2,intein-mediated protein splicing,BP,
5896,GO:0016540,1,0.896800084263549,0,20,protein autoprocessing,BP,
5897,GO:0016553,1,0.899889837017509,0,17,base conversion or substitution editing,BP,
5898,GO:0016554,1,0.959555632677501,0,9,cytidine to uridine editing,BP,
5899,GO:0016556,1,0.888609987039621,0,20,mRNA modification,BP,
5900,GO:0016557,1,0.987909230954665,0,3,peroxisome membrane biogenesis,BP,
5901,GO:0016558,1,0.925075019627993,0,13,protein import into peroxisome matrix,BP,
5902,GO:0016559,1,0.957301947906412,0,9,peroxisome fission,BP,
5903,GO:0016560,1,0.975153971855729,0,4,protein import into peroxisome matrix, docking,BP,
5904,GO:0016561,1,0.98962471587536,0,2,protein import into peroxisome matrix, translocation,BP,
5908,GO:0016571,1,0.364514987742904,0,124,histone methylation,BP,
5909,GO:0016572,1,0.786638003209327,0,36,histone phosphorylation,BP,
5911,GO:0016574,1,0.700868359975238,0,45,histone ubiquitination,BP,
5912,GO:0016575,1,0.567641841092009,0,75,histone deacetylation,BP,
5913,GO:0016576,1,0.959621160917618,0,6,histone dephosphorylation,BP,
5914,GO:0016577,1,0.76464543298827,0,27,histone demethylation,BP,
5915,GO:0016578,1,0.847406578335244,0,22,histone deubiquitination,BP,
5916,GO:0016579,1,0.177611827677841,0,239,protein deubiquitination,BP,
5917,GO:0016580,1,0.902084724118147,0,12,Sin3 complex,CC,
5918,GO:0016581,1,0.870206512192857,0,15,NuRD complex,CC,
5919,GO:0016584,1,0.965129444341488,0,5,nucleosome positioning,BP,
5920,GO:0016586,1,0.985687175654892,0,1,RSC-type complex,CC,
5921,GO:0016589,1,0.940194215516653,0,6,NURF complex,CC,
5922,GO:0016590,1,0.988549957894725,0,1,ACF complex,CC,
5923,GO:0016591,1,0.63412465855312,0,75,RNA polymerase II, holoenzyme,CC,
5924,GO:0016592,1,0.741835760141121,0,40,mediator complex,CC,
5925,GO:0016593,1,0.939485912018825,0,8,Cdc73/Paf1 complex,CC,
5928,GO:0016596,1,0.994890876864838,0,1,thienylcyclohexylpiperidine binding,MF,
5930,GO:0016598,1,0.992059647956347,0,2,protein arginylation,BP,
5931,GO:0016600,1,0.935241388106774,0,8,flotillin complex,CC,
5933,GO:0016602,1,0.974617700458999,0,4,CCAAT-binding factor complex,CC,
5934,GO:0016603,1,0.992257530166712,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5936,GO:0016605,1,0.484234038801411,0,97,PML body,CC,
5938,GO:0016608,1,0.993766261652998,0,2,growth hormone-releasing hormone activity,MF,
5939,GO:0016614,1,0.587074056150989,0,111,oxidoreductase activity, acting on CH-OH group of donors,MF,
5940,GO:0016615,1,0.966287668512437,0,7,malate dehydrogenase activity,MF,
5941,GO:0016616,1,0.62078493784281,0,102,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5942,GO:0016618,1,0.996702621226445,0,1,hydroxypyruvate reductase activity,MF,
5943,GO:0016620,1,0.834295892538344,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5944,GO:0016623,1,0.985895435497158,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5945,GO:0016624,1,0.957494753225091,0,7,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5946,GO:0016627,1,0.744582088322583,0,55,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5947,GO:0016628,1,0.885809051942793,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5948,GO:0016634,1,0.950315905030001,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5949,GO:0016635,1,0.988289357346372,0,3,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5951,GO:0016639,1,0.989144021087264,0,2,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5953,GO:0016642,1,0.992783258733263,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5954,GO:0016645,1,0.869853696485313,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5955,GO:0016646,1,0.907911035789024,0,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5956,GO:0016647,1,0.983953647279909,0,4,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5957,GO:0016649,1,0.989592287335449,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5958,GO:0016651,1,0.638375169213659,0,96,oxidoreductase activity, acting on NAD(P)H,MF,
5959,GO:0016652,1,0.987854099301573,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5960,GO:0016653,1,0.915702558602522,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5961,GO:0016655,1,0.824340614930655,0,53,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5962,GO:0016657,1,0.99275530522785,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5963,GO:0016661,1,0.983884706470082,0,3,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5964,GO:0016662,1,0.995183075943713,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5965,GO:0016667,1,0.769100590934386,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5966,GO:0016668,1,0.949261183535365,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5967,GO:0016670,1,0.946472911655988,0,9,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5968,GO:0016671,1,0.965205832697832,0,7,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5969,GO:0016672,1,0.993414747014903,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5970,GO:0016675,1,0.919720680358268,0,22,oxidoreductase activity, acting on a heme group of donors,MF,
5971,GO:0016676,1,0.9240318034323,0,21,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5972,GO:0016679,1,0.975436239831776,0,7,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5973,GO:0016681,1,0.980170261788847,0,6,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5974,GO:0016684,1,0.78966440835149,0,49,oxidoreductase activity, acting on peroxide as acceptor,MF,
5975,GO:0016701,1,0.894411097430371,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5976,GO:0016702,1,0.894411097430371,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5977,GO:0016705,1,0.432163109814109,0,134,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
5978,GO:0016706,1,0.73350209329276,0,43,2-oxoglutarate-dependent dioxygenase activity,MF,
5979,GO:0016708,1,0.995338132508373,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5980,GO:0016709,1,0.807945168862798,0,37,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
5981,GO:0016711,1,0.995171173429256,0,1,flavonoid 3'-monooxygenase activity,MF,
5982,GO:0016712,1,0.902214873297179,0,21,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5983,GO:0016713,1,0.983455806390853,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
5984,GO:0016714,1,0.97065491352856,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5985,GO:0016715,1,0.97482985362889,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5986,GO:0016716,1,0.994691584553626,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
5987,GO:0016717,1,0.965806029369754,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5988,GO:0016721,1,0.982410078187564,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
5989,GO:0016722,1,0.889183753510506,0,16,oxidoreductase activity, oxidizing metal ions,MF,
5990,GO:0016723,1,0.938282402095762,0,9,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
5991,GO:0016724,1,0.951910867446098,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
5992,GO:0016725,1,0.950734596622647,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
5993,GO:0016726,1,0.979602582281667,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5994,GO:0016727,1,0.988998589550453,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5995,GO:0016728,1,0.978553777052999,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5996,GO:0016730,1,0.996188048293622,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5997,GO:0016731,1,0.996188048293622,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6000,GO:0016742,1,0.952672256938112,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6001,GO:0016743,1,0.982901134387938,0,2,carboxyl- or carbamoyltransferase activity,MF,
6002,GO:0016744,1,0.983501065739163,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6003,GO:0016746,1,0.24671787631255,0,217,transferase activity, transferring acyl groups,MF,
6004,GO:0016747,1,0.286652414536339,0,192,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6005,GO:0016748,1,0.986440978226283,0,3,succinyltransferase activity,MF,
6006,GO:0016749,1,0.991657842753145,0,2,N-succinyltransferase activity,MF,
6007,GO:0016751,1,0.994739690112676,0,1,S-succinyltransferase activity,MF,
6008,GO:0016755,1,0.938009199194334,0,13,transferase activity, transferring amino-acyl groups,MF,
6011,GO:0016763,1,0.763309066702878,0,42,transferase activity, transferring pentosyl groups,MF,
6012,GO:0016765,1,0.773813612643078,0,51,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6013,GO:0016768,1,0.99639442913921,0,1,spermine synthase activity,MF,
6017,GO:0016774,1,0.989018649283039,0,2,phosphotransferase activity, carboxyl group as acceptor,MF,
6018,GO:0016775,1,0.965990841448775,0,7,phosphotransferase activity, nitrogenous group as acceptor,MF,
6019,GO:0016776,1,0.783381085987034,0,39,phosphotransferase activity, phosphate group as acceptor,MF,
6020,GO:0016778,1,0.978671285447005,0,5,diphosphotransferase activity,MF,
6021,GO:0016779,1,0.505181095672056,0,110,nucleotidyltransferase activity,MF,
6022,GO:0016780,1,0.898607170702054,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6023,GO:0016781,1,0.990924821637235,0,2,phosphotransferase activity, paired acceptors,MF,
6024,GO:0016782,1,0.685837332248432,0,65,transferase activity, transferring sulfur-containing groups,MF,
6025,GO:0016783,1,0.962272922777573,0,10,sulfurtransferase activity,MF,
6026,GO:0016784,1,0.996566348061452,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6027,GO:0016785,1,0.989183086983565,0,1,transferase activity, transferring selenium-containing groups,MF,
6030,GO:0016790,1,0.836261265989303,0,37,thiolester hydrolase activity,MF,
6032,GO:0016793,1,0.994070812197178,0,1,triphosphoric monoester hydrolase activity,MF,
6033,GO:0016794,1,0.996783291939296,0,1,diphosphoric monoester hydrolase activity,MF,
6034,GO:0016796,1,0.685722595013776,0,57,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6035,GO:0016798,1,0.533177450183691,0,107,hydrolase activity, acting on glycosyl bonds,MF,
6036,GO:0016799,1,0.821919713238846,0,34,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6037,GO:0016801,1,0.953455774266304,0,11,hydrolase activity, acting on ether bonds,MF,
6038,GO:0016802,1,0.995675829553584,0,1,trialkylsulfonium hydrolase activity,MF,
6039,GO:0016803,1,0.957598389339581,0,10,ether hydrolase activity,MF,
6040,GO:0016805,1,0.921216845662396,0,15,dipeptidase activity,MF,
6041,GO:0016810,1,0.547555890015953,0,108,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6042,GO:0016811,1,0.709921490404267,0,62,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6043,GO:0016812,1,0.960933682735921,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6044,GO:0016813,1,0.949458833214692,0,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6045,GO:0016814,1,0.846273741450354,0,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6046,GO:0016815,1,0.996636152300077,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6049,GO:0016822,1,0.989578940872267,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6050,GO:0016823,1,0.989578940872267,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6051,GO:0016826,1,0.994890876864838,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6053,GO:0016830,1,0.796876657087024,0,45,carbon-carbon lyase activity,MF,
6054,GO:0016831,1,0.854891162845733,0,31,carboxy-lyase activity,MF,
6055,GO:0016832,1,0.95312262060414,0,9,aldehyde-lyase activity,MF,
6056,GO:0016833,1,0.966461777875799,0,6,oxo-acid-lyase activity,MF,
6058,GO:0016836,1,0.765695925283818,0,54,hydro-lyase activity,MF,
6060,GO:0016840,1,0.945594995254874,0,13,carbon-nitrogen lyase activity,MF,
6061,GO:0016841,1,0.978990331010398,0,5,ammonia-lyase activity,MF,
6062,GO:0016842,1,0.970856818862329,0,7,amidine-lyase activity,MF,
6063,GO:0016843,1,0.994890876864838,0,1,amine-lyase activity,MF,
6064,GO:0016844,1,0.994890876864838,0,1,strictosidine synthase activity,MF,
6065,GO:0016846,1,0.964803550516074,0,10,carbon-sulfur lyase activity,MF,
6066,GO:0016849,1,0.855950285556673,0,17,phosphorus-oxygen lyase activity,MF,
6067,GO:0016853,1,0.487011558505152,0,137,isomerase activity,MF,
6068,GO:0016854,1,0.918697673072192,0,14,racemase and epimerase activity,MF,
6069,GO:0016855,1,0.995385273459009,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6070,GO:0016857,1,0.936010755786664,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6071,GO:0016859,1,0.859786110036834,0,33,cis-trans isomerase activity,MF,
6072,GO:0016860,1,0.806994247404781,0,44,intramolecular oxidoreductase activity,MF,
6073,GO:0016861,1,0.968396441590214,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6074,GO:0016862,1,0.989844093838438,0,3,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6075,GO:0016863,1,0.955471134994071,0,11,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6076,GO:0016864,1,0.909242974568795,0,16,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6077,GO:0016866,1,0.878723945969098,0,25,intramolecular transferase activity,MF,
6078,GO:0016868,1,0.948653833974875,0,10,intramolecular transferase activity, phosphotransferases,MF,
6079,GO:0016872,1,0.995718194201822,0,1,intramolecular lyase activity,MF,
6080,GO:0016874,1,0.481514082378063,0,118,ligase activity,MF,
6081,GO:0016875,1,0.892476108889597,0,22,ligase activity, forming carbon-oxygen bonds,MF,
6082,GO:0016877,1,0.808977031906666,0,37,ligase activity, forming carbon-sulfur bonds,MF,
6083,GO:0016878,1,0.861127217356689,0,27,acid-thiol ligase activity,MF,
6084,GO:0016879,1,0.751177050911843,0,43,ligase activity, forming carbon-nitrogen bonds,MF,
6085,GO:0016880,1,0.986611963771884,0,2,acid-ammonia (or amide) ligase activity,MF,
6086,GO:0016881,1,0.897737052914309,0,18,acid-amino acid ligase activity,MF,
6087,GO:0016882,1,0.990422233265525,0,2,cyclo-ligase activity,MF,
6088,GO:0016884,1,0.932922323978247,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6089,GO:0016885,1,0.955827847199449,0,6,ligase activity, forming carbon-carbon bonds,MF,
6090,GO:0016886,1,0.970379556822678,0,5,ligase activity, forming phosphoric ester bonds,MF,
6092,GO:0016888,1,0.89927000366322,0,16,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6093,GO:0016889,1,0.958765839267409,0,8,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6094,GO:0016890,1,0.988130119897826,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6095,GO:0016891,1,0.854000718594418,0,28,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6096,GO:0016892,1,0.978692464997452,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6097,GO:0016893,1,0.794864078877811,0,40,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6098,GO:0016894,1,0.938328361121703,0,14,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6099,GO:0016895,1,0.886312818455,0,22,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6100,GO:0016896,1,0.767403715829724,0,37,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6101,GO:0016898,1,0.996023026087141,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6102,GO:0016899,1,0.974302355283959,0,4,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6103,GO:0016900,1,0.993570614299539,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6104,GO:0016901,1,0.983416006431856,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6105,GO:0016903,1,0.795256640062413,0,39,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6106,GO:0016907,1,0.971445817811933,0,6,G protein-coupled acetylcholine receptor activity,MF,
6108,GO:0016918,1,0.944963212990421,0,13,retinal binding,MF,
6109,GO:0016920,1,0.986534100231104,0,1,pyroglutamyl-peptidase activity,MF,
6110,GO:0016922,1,0.472503262976522,0,96,nuclear receptor binding,MF,
6111,GO:0016925,1,0.5886895887602,0,74,protein sumoylation,BP,
6112,GO:0016926,1,0.940507395430597,0,7,protein desumoylation,BP,
6113,GO:0016929,1,0.940507395430597,0,7,SUMO-specific protease activity,MF,
6114,GO:0016933,1,0.97788531309781,0,4,extracellularly glycine-gated ion channel activity,MF,
6115,GO:0016934,1,0.97788531309781,0,4,extracellularly glycine-gated chloride channel activity,MF,
6116,GO:0016935,1,0.987626730727211,0,2,glycine-gated chloride channel complex,CC,
6117,GO:0016936,1,0.972210950602943,0,8,galactoside binding,MF,
6118,GO:0016938,1,0.994551900251594,0,1,kinesin I complex,CC,
6119,GO:0016939,1,0.971076594136202,0,3,kinesin II complex,CC,
6120,GO:0016941,1,0.980814309982379,0,3,natriuretic peptide receptor activity,MF,
6121,GO:0016942,1,0.962747919401926,0,5,insulin-like growth factor binding protein complex,CC,
6122,GO:0016964,1,0.973780452882526,0,1,alpha-2 macroglobulin receptor activity,MF,
6123,GO:0016971,1,0.981501303316748,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6124,GO:0016972,1,0.97257292770771,0,4,thiol oxidase activity,MF,
6125,GO:0016973,1,0.906657686887031,0,18,poly(A)+ mRNA export from nucleus,BP,
6126,GO:0016979,1,0.996606531778115,0,1,lipoate-protein ligase activity,MF,
6127,GO:0016992,1,0.99640996993186,0,1,lipoate synthase activity,MF,
6128,GO:0016997,1,0.986566604142633,0,3,alpha-sialidase activity,MF,
6129,GO:0016998,1,0.996799862930833,0,1,cell wall macromolecule catabolic process,BP,
6130,GO:0016999,1,0.986699451490364,0,2,antibiotic metabolic process,BP,
6131,GO:0017002,1,0.897529209405385,0,9,activin-activated receptor activity,MF,
6132,GO:0017003,1,0.995681713630481,0,1,protein-heme linkage,BP,
6133,GO:0017004,1,0.833310517874404,0,35,cytochrome complex assembly,BP,
6134,GO:0017005,1,0.993161949499453,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6135,GO:0017006,1,0.995681713630481,0,1,protein-tetrapyrrole linkage,BP,
6136,GO:0017014,1,0.897092706586575,0,14,protein nitrosylation,BP,
6139,GO:0017017,1,0.944468811091397,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6140,GO:0017018,1,0.956750676223817,0,4,myosin phosphatase activity,MF,
6141,GO:0017020,1,0.97871316157534,0,3,myosin phosphatase regulator activity,MF,
6143,GO:0017024,1,0.996826997948656,0,1,myosin I binding,MF,
6144,GO:0017025,1,0.853242592088354,0,26,TBP-class protein binding,MF,
6145,GO:0017034,1,0.948382563409263,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6146,GO:0017038,1,0.266591777094587,0,182,protein import,BP,
6147,GO:0017040,1,0.974294452565893,0,5,N-acylsphingosine amidohydrolase activity,MF,
6148,GO:0017041,1,0.99660212903607,0,1,galactosylgalactosylglucosylceramidase activity,MF,
6149,GO:0017042,1,0.996402017712202,0,1,glycosylceramidase activity,MF,
6150,GO:0017045,1,0.996684261567024,0,1,corticotropin-releasing hormone activity,MF,
6151,GO:0017046,1,0.74923644648606,0,44,peptide hormone binding,MF,
6152,GO:0017048,1,0.266511712191794,0,151,Rho GTPase binding,MF,
6153,GO:0017049,1,0.871546665982046,0,20,GTP-Rho binding,MF,
6154,GO:0017050,1,0.985407348361577,0,3,D-erythro-sphingosine kinase activity,MF,
6155,GO:0017053,1,0.54216647431755,0,73,transcription repressor complex,CC,
6156,GO:0017054,1,0.990876850266725,0,2,negative cofactor 2 complex,CC,
6157,GO:0017055,1,0.989126863151195,0,2,negative regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
6158,GO:0017056,1,0.840804264596771,0,23,structural constituent of nuclear pore,MF,
6159,GO:0017057,1,0.979806345291077,0,2,6-phosphogluconolactonase activity,MF,
6160,GO:0017059,1,0.954359087597342,0,8,serine C-palmitoyltransferase complex,CC,
6161,GO:0017060,1,0.991894462176387,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6162,GO:0017061,1,0.985514922495946,0,2,S-methyl-5-thioadenosine phosphorylase activity,MF,
6163,GO:0017062,1,0.94680254801495,0,10,respiratory chain complex III assembly,BP,
6164,GO:0017064,1,0.988322228270375,0,3,fatty acid amide hydrolase activity,MF,
6165,GO:0017065,1,0.996497766762073,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6166,GO:0017069,1,0.797107373291929,0,42,snRNA binding,MF,
6167,GO:0017070,1,0.929793735096428,0,14,U6 snRNA binding,MF,
6168,GO:0017071,1,0.993138058060691,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6171,GO:0017077,1,0.992065408534361,0,2,oxidative phosphorylation uncoupler activity,MF,
6172,GO:0017080,1,0.790896571252222,0,37,sodium channel regulator activity,MF,
6173,GO:0017081,1,0.889127898663678,0,15,chloride channel regulator activity,MF,
6175,GO:0017085,1,0.92263857742565,0,11,response to insecticide,BP,
6176,GO:0017089,1,0.991689521821463,0,2,glycolipid transfer activity,MF,
6177,GO:0017090,1,0.994579294348266,0,1,meprin A complex,CC,
6178,GO:0017091,1,0.847963393924769,0,26,AU-rich element binding,MF,
6179,GO:0017095,1,0.969481551939924,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6180,GO:0017098,1,0.995278800867257,0,1,sulfonylurea receptor binding,MF,
6181,GO:0017099,1,0.984318522820815,0,3,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6182,GO:0017101,1,0.988805920143243,0,3,aminoacyl-tRNA synthetase multienzyme complex,CC,
6183,GO:0017108,1,0.949979526570185,0,8,5'-flap endonuclease activity,MF,
6184,GO:0017109,1,0.987345713161486,0,2,glutamate-cysteine ligase complex,CC,
6185,GO:0017110,1,0.953655479421267,0,10,nucleoside-diphosphatase activity,MF,
6188,GO:0017113,1,0.994217100594094,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6189,GO:0017116,1,0.89723108106824,0,18,single-stranded DNA helicase activity,MF,
6190,GO:0017118,1,0.996606531778115,0,1,lipoyltransferase activity,MF,
6191,GO:0017119,1,0.923340853232077,0,13,Golgi transport complex,CC,
6192,GO:0017121,1,0.906577175098244,0,15,plasma membrane phospholipid scrambling,BP,
6193,GO:0017122,1,0.989497023436696,0,1,protein N-acetylglucosaminyltransferase complex,CC,
6195,GO:0017125,1,0.990913884493545,0,1,deoxycytidyl transferase activity,MF,
6196,GO:0017126,1,0.986594582919358,0,2,nucleologenesis,BP,
6197,GO:0017128,1,0.948620735456107,0,8,phospholipid scramblase activity,MF,
6198,GO:0017129,1,0.989329268380744,0,2,triglyceride binding,MF,
6199,GO:0017130,1,0.987001921477036,0,1,poly(C) RNA binding,MF,
6200,GO:0017134,1,0.846108224530066,0,21,fibroblast growth factor binding,MF,
6201,GO:0017136,1,0.900478862695323,0,15,NAD-dependent histone deacetylase activity,MF,
6203,GO:0017143,1,0.990260031206384,0,2,insecticide metabolic process,BP,
6204,GO:0017144,1,0.825200218940006,0,33,drug metabolic process,BP,
6205,GO:0017145,1,0.719130235636977,0,41,stem cell division,BP,
6207,GO:0017147,1,0.816502545723818,0,30,Wnt-protein binding,MF,
6209,GO:0017150,1,0.983285350782958,0,4,tRNA dihydrouridine synthase activity,MF,
6210,GO:0017151,1,0.945116478590319,0,8,DEAD/H-box RNA helicase binding,MF,
6211,GO:0017153,1,0.948085045917888,0,6,sodium:dicarboxylate symporter activity,MF,
6212,GO:0017154,1,0.863212679265816,0,12,semaphorin receptor activity,MF,
6216,GO:0017159,1,0.985263569650657,0,3,pantetheine hydrolase activity,MF,
6217,GO:0017160,1,0.882774609722094,0,15,Ral GTPase binding,MF,
6218,GO:0017162,1,0.929746742428399,0,9,aryl hydrocarbon receptor binding,MF,
6219,GO:0017166,1,0.891682769297478,0,11,vinculin binding,MF,
6220,GO:0017168,1,0.992355916765143,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6221,GO:0017169,1,0.968230942424747,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6223,GO:0017172,1,0.996463697272659,0,1,cysteine dioxygenase activity,MF,
6224,GO:0017174,1,0.996774196730149,0,1,glycine N-methyltransferase activity,MF,
6225,GO:0017176,1,0.975446247630804,0,6,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6226,GO:0017177,1,0.988361973975734,0,2,glucosidase II complex,CC,
6227,GO:0017178,1,0.994890876864838,0,1,diphthine-ammonia ligase activity,MF,
6228,GO:0017182,1,0.965115365263969,0,7,peptidyl-diphthamide metabolic process,BP,
6229,GO:0017183,1,0.965115365263969,0,7,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6230,GO:0017185,1,0.955110433110373,0,8,peptidyl-lysine hydroxylation,BP,
6231,GO:0017186,1,0.992257530166712,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6232,GO:0017187,1,0.987736352446205,0,3,peptidyl-glutamic acid carboxylation,BP,
6233,GO:0017188,1,0.988773425972207,0,1,aspartate N-acetyltransferase activity,MF,
6234,GO:0017196,1,0.953520535405055,0,7,N-terminal peptidyl-methionine acetylation,BP,
6235,GO:0017198,1,0.993380246549876,0,2,N-terminal peptidyl-serine acetylation,BP,
6236,GO:0018002,1,0.993380246549876,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6237,GO:0018008,1,0.981133110354137,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6238,GO:0018009,1,0.995895402346735,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6239,GO:0018011,1,0.994890876864838,0,1,N-terminal peptidyl-alanine methylation,BP,
6240,GO:0018012,1,0.994890876864838,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6241,GO:0018013,1,0.994890876864838,0,1,N-terminal peptidyl-glycine methylation,BP,
6242,GO:0018016,1,0.994890876864838,0,1,N-terminal peptidyl-proline dimethylation,BP,
6243,GO:0018021,1,0.990768678513707,0,2,peptidyl-histidine methylation,BP,
6244,GO:0018022,1,0.4149398943248,0,106,peptidyl-lysine methylation,BP,
6245,GO:0018023,1,0.708579323933645,0,41,peptidyl-lysine trimethylation,BP,
6246,GO:0018024,1,0.713094170783899,0,39,histone-lysine N-methyltransferase activity,MF,
6247,GO:0018025,1,0.994890876864838,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6248,GO:0018026,1,0.947325571587949,0,7,peptidyl-lysine monomethylation,BP,
6249,GO:0018027,1,0.852346612568264,0,20,peptidyl-lysine dimethylation,BP,
6250,GO:0018032,1,0.992986227776736,0,1,protein amidation,BP,
6252,GO:0018063,1,0.995681713630481,0,1,cytochrome c-heme linkage,BP,
6253,GO:0018064,1,0.990768678513707,0,2,protein-histidine N-methyltransferase activity,MF,
6254,GO:0018076,1,0.94717918196202,0,4,N-terminal peptidyl-lysine acetylation,BP,
6255,GO:0018094,1,0.989493448840022,0,2,protein polyglycylation,BP,
6256,GO:0018095,1,0.938028050868131,0,11,protein polyglutamylation,BP,
6257,GO:0018101,1,0.974400133486073,0,4,protein citrullination,BP,
6258,GO:0018103,1,0.957085440286567,0,5,protein C-linked glycosylation,BP,
6260,GO:0018106,1,0.996861194148444,0,1,peptidyl-histidine phosphorylation,BP,
6263,GO:0018114,1,0.995385273459009,0,1,threonine racemase activity,MF,
6264,GO:0018117,1,0.996432894868642,0,1,protein adenylylation,BP,
6265,GO:0018119,1,0.897092706586575,0,14,peptidyl-cysteine S-nitrosylation,BP,
6266,GO:0018120,1,0.993161573694566,0,2,peptidyl-arginine ADP-ribosylation,BP,
6267,GO:0018125,1,0.986442389016143,0,3,peptidyl-cysteine methylation,BP,
6268,GO:0018126,1,0.85930631653898,0,25,protein hydroxylation,BP,
6270,GO:0018142,1,0.994890876864838,0,1,protein-DNA covalent cross-linking,BP,
6271,GO:0018143,1,0.994890876864838,0,1,nucleic acid-protein covalent cross-linking,BP,
6274,GO:0018153,1,0.990566034472053,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6276,GO:0018160,1,0.996570081355208,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6277,GO:0018166,1,0.990113885607682,0,1,C-terminal protein-tyrosinylation,BP,
6278,GO:0018171,1,0.980884498328462,0,4,peptidyl-cysteine oxidation,BP,
6279,GO:0018175,1,0.996432894868642,0,1,protein nucleotidylation,BP,
6280,GO:0018192,1,0.995427030370975,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6282,GO:0018194,1,0.994890876864838,0,1,peptidyl-alanine modification,BP,
6283,GO:0018195,1,0.893257629115225,0,23,peptidyl-arginine modification,BP,
6284,GO:0018196,1,0.840169962315552,0,30,peptidyl-asparagine modification,BP,
6285,GO:0018197,1,0.972682313253597,0,3,peptidyl-aspartic acid modification,BP,
6286,GO:0018198,1,0.744687957979663,0,47,peptidyl-cysteine modification,BP,
6287,GO:0018199,1,0.982895880182535,0,4,peptidyl-glutamine modification,BP,
6288,GO:0018200,1,0.8673931936936,0,26,peptidyl-glutamic acid modification,BP,
6289,GO:0018201,1,0.972874519489887,0,4,peptidyl-glycine modification,BP,
6290,GO:0018202,1,0.940652600092161,0,11,peptidyl-histidine modification,BP,
6292,GO:0018206,1,0.931571540810938,0,12,peptidyl-methionine modification,BP,
6293,GO:0018208,1,0.766597416144292,0,49,peptidyl-proline modification,BP,
6296,GO:0018211,1,0.957085440286567,0,5,peptidyl-tryptophan modification,BP,
6298,GO:0018214,1,0.987736352446205,0,3,protein carboxylation,BP,
6299,GO:0018216,1,0.933682985206533,0,14,peptidyl-arginine methylation,BP,
6300,GO:0018217,1,0.99241375583027,0,1,peptidyl-aspartic acid phosphorylation,BP,
6301,GO:0018230,1,0.868630361569841,0,23,peptidyl-L-cysteine S-palmitoylation,BP,
6302,GO:0018231,1,0.868630361569841,0,23,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6305,GO:0018262,1,0.987273584588016,0,3,isopeptide cross-linking,BP,
6306,GO:0018271,1,0.988496772383391,0,1,biotin-protein ligase activity,MF,
6307,GO:0018272,1,0.996346806019679,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6308,GO:0018276,1,0.996676509305464,0,1,isopeptide cross-linking via N6-glycyl-L-lysine,BP,
6309,GO:0018277,1,0.995569267249844,0,1,protein deamination,BP,
6310,GO:0018279,1,0.85138996482645,0,29,protein N-linked glycosylation via asparagine,BP,
6311,GO:0018282,1,0.981987006240157,0,2,metal incorporation into metallo-sulfur cluster,BP,
6312,GO:0018283,1,0.981987006240157,0,2,iron incorporation into metallo-sulfur cluster,BP,
6313,GO:0018293,1,0.996718100815846,0,1,protein-FAD linkage,BP,
6314,GO:0018298,1,0.962103085154743,0,8,protein-chromophore linkage,BP,
6315,GO:0018307,1,0.99225819450465,0,2,enzyme active site formation,BP,
6316,GO:0018312,1,0.988659068094403,0,2,peptidyl-serine ADP-ribosylation,BP,
6317,GO:0018315,1,0.991875105213165,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6318,GO:0018317,1,0.957085440286567,0,5,protein C-linked glycosylation via tryptophan,BP,
6319,GO:0018322,1,0.990113885607682,0,1,protein tyrosinylation,BP,
6320,GO:0018323,1,0.996816752933256,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6321,GO:0018335,1,0.974283891070571,0,4,protein succinylation,BP,
6322,GO:0018342,1,0.931119692940331,0,10,protein prenylation,BP,
6323,GO:0018343,1,0.986175882684892,0,3,protein farnesylation,BP,
6324,GO:0018344,1,0.958702579699419,0,7,protein geranylgeranylation,BP,
6325,GO:0018345,1,0.811430168682953,0,35,protein palmitoylation,BP,
6326,GO:0018350,1,0.995527713529486,0,1,protein esterification,BP,
6327,GO:0018352,1,0.991921416873399,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6328,GO:0018364,1,0.96243722609412,0,5,peptidyl-glutamine methylation,BP,
6329,GO:0018377,1,0.961506412537665,0,4,protein myristoylation,BP,
6332,GO:0018395,1,0.993207627082606,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6333,GO:0018400,1,0.987320888956442,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6334,GO:0018401,1,0.952430117093716,0,9,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6335,GO:0018406,1,0.957085440286567,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6336,GO:0018410,1,0.917690928740929,0,13,C-terminal protein amino acid modification,BP,
6337,GO:0018423,1,0.996675724132414,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6338,GO:0018424,1,0.992419958973094,0,1,peptidyl-glutamic acid poly-ADP-ribosylation,BP,
6339,GO:0018444,1,0.974422420358221,0,3,translation release factor complex,CC,
6340,GO:0018455,1,0.97561458184925,0,6,alcohol dehydrogenase [NAD(P)+] activity,MF,
6341,GO:0018467,1,0.995109466568892,0,1,formaldehyde dehydrogenase activity,MF,
6342,GO:0018477,1,0.994802069545257,0,1,benzaldehyde dehydrogenase (NADP+) activity,MF,
6343,GO:0018478,1,0.995828671124588,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6344,GO:0018479,1,0.987106182135756,0,3,benzaldehyde dehydrogenase (NAD+) activity,MF,
6345,GO:0018549,1,0.996378106887364,0,1,methanethiol oxidase activity,MF,
6346,GO:0018585,1,0.995859574117069,0,1,fluorene oxygenase activity,MF,
6347,GO:0018601,1,0.996413914265722,0,1,4-nitrophenol 2-monooxygenase activity,MF,
6348,GO:0018636,1,0.989920922764206,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6349,GO:0018685,1,0.996357687542497,0,1,alkane 1-monooxygenase activity,MF,
6350,GO:0018729,1,0.996231793101294,0,1,propionate CoA-transferase activity,MF,
6351,GO:0018733,1,0.99672397222197,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6352,GO:0018738,1,0.996722628517053,0,1,S-formylglutathione hydrolase activity,MF,
6353,GO:0018773,1,0.996406004432841,0,1,acetylpyruvate hydrolase activity,MF,
6354,GO:0018812,1,0.979718048345423,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6355,GO:0018858,1,0.990532581428998,0,2,benzoate-CoA ligase activity,MF,
6356,GO:0018871,1,0.99602614868032,0,1,1-aminocyclopropane-1-carboxylate metabolic process,BP,
6357,GO:0018872,1,0.98621211548595,0,2,arsonoacetate metabolic process,BP,
6358,GO:0018874,1,0.995995930088627,0,1,benzoate metabolic process,BP,
6359,GO:0018879,1,0.990945068482126,0,2,biphenyl metabolic process,BP,
6360,GO:0018885,1,0.996413914265722,0,1,carbon tetrachloride metabolic process,BP,
6361,GO:0018894,1,0.990260031206384,0,2,dibenzo-p-dioxin metabolic process,BP,
6362,GO:0018904,1,0.861467290874521,0,24,ether metabolic process,BP,
6363,GO:0018910,1,0.996413914265722,0,1,benzene metabolic process,BP,
6364,GO:0018916,1,0.982371310090154,0,4,nitrobenzene metabolic process,BP,
6365,GO:0018917,1,0.995859574117069,0,1,fluorene metabolic process,BP,
6366,GO:0018931,1,0.996612746461703,0,1,naphthalene metabolic process,BP,
6367,GO:0018958,1,0.512070229912749,0,98,phenol-containing compound metabolic process,BP,
6368,GO:0018960,1,0.996413914265722,0,1,4-nitrophenol metabolic process,BP,
6369,GO:0018963,1,0.991263037049744,0,2,phthalate metabolic process,BP,
6371,GO:0018969,1,0.994656215564022,0,1,thiocyanate metabolic process,BP,
6372,GO:0018992,1,0.982258494772777,0,2,germ-line sex determination,BP,
6373,GO:0018993,1,0.989037829666647,0,2,somatic sex determination,BP,
6374,GO:0018995,1,0.655152135133063,0,60,host cellular component,CC,
6376,GO:0019002,1,0.978649895794075,0,3,GMP binding,MF,
6377,GO:0019003,1,0.679258363349673,0,72,GDP binding,MF,
6378,GO:0019005,1,0.698197796860676,0,59,SCF ubiquitin ligase complex,CC,
6379,GO:0019008,1,0.988713101344229,0,2,molybdopterin synthase complex,CC,
6380,GO:0019034,1,0.975718933699605,0,3,viral replication complex,CC,
6381,GO:0019035,1,0.97915088282969,0,2,viral integration complex,CC,
6382,GO:0019042,1,0.930541994389128,0,11,viral latency,BP,
6383,GO:0019043,1,0.957365379789829,0,9,establishment of viral latency,BP,
6384,GO:0019045,1,0.971994107643292,0,2,latent virus replication,BP,
6385,GO:0019046,1,0.971994107643292,0,2,release from viral latency,BP,
6386,GO:0019048,1,0.806167289497217,0,27,modulation by virus of host process,BP,
6387,GO:0019049,1,0.985064876305212,0,2,mitigation of host defenses by virus,BP,
6388,GO:0019050,1,0.987140394006605,0,3,suppression by virus of host apoptotic process,BP,
6389,GO:0019054,1,0.885207402726006,0,18,modulation by virus of host cellular process,BP,
6390,GO:0019056,1,0.994699007718779,0,1,modulation by virus of host transcription,BP,
6392,GO:0019060,1,0.993113491085501,0,2,intracellular transport of viral protein in host cell,BP,
6393,GO:0019061,1,0.995700747213611,0,1,uncoating of virus,BP,
6394,GO:0019062,1,0.956046590774023,0,7,virion attachment to host cell,BP,
6395,GO:0019064,1,0.971140403830513,0,6,fusion of virus membrane with host plasma membrane,BP,
6396,GO:0019065,1,0.942322463770947,0,7,receptor-mediated endocytosis of virus by host cell,BP,
6397,GO:0019068,1,0.804913091765687,0,40,virion assembly,BP,
6398,GO:0019072,1,0.980560041904164,0,2,viral genome packaging,BP,
6399,GO:0019074,1,0.980560041904164,0,2,viral RNA genome packaging,BP,
6400,GO:0019075,1,0.989807596705769,0,2,virus maturation,BP,
6401,GO:0019076,1,0.81693118541948,0,32,viral release from host cell,BP,
6403,GO:0019080,1,0.367100018427406,0,187,viral gene expression,BP,
6404,GO:0019081,1,0.910008482606013,0,14,viral translation,BP,
6405,GO:0019082,1,0.98014489107327,0,3,viral protein processing,BP,
6406,GO:0019083,1,0.408327155454671,0,171,viral transcription,BP,
6407,GO:0019085,1,0.985219507286313,0,2,early viral transcription,BP,
6408,GO:0019086,1,0.978106805033869,0,4,late viral transcription,BP,
6409,GO:0019087,1,0.978926790317105,0,2,transformation of host cell by virus,BP,
6411,GO:0019100,1,0.982258494772777,0,2,male germ-line sex determination,BP,
6412,GO:0019101,1,0.994628167328831,0,1,female somatic sex determination,BP,
6413,GO:0019102,1,0.994379772030534,0,1,male somatic sex determination,BP,
6414,GO:0019103,1,0.964008728143596,0,6,pyrimidine nucleotide binding,MF,
6415,GO:0019104,1,0.949819024144362,0,13,DNA N-glycosylase activity,MF,
6416,GO:0019107,1,0.970064654677026,0,5,myristoyltransferase activity,MF,
6417,GO:0019115,1,0.983248214703429,0,4,benzaldehyde dehydrogenase [NAD(P)+] activity,MF,
6418,GO:0019118,1,0.996636152300077,0,1,phenanthrene-epoxide hydrolase activity,MF,
6419,GO:0019119,1,0.996636152300077,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6420,GO:0019135,1,0.989728484436015,0,2,deoxyhypusine monooxygenase activity,MF,
6421,GO:0019136,1,0.978924015285584,0,4,deoxynucleoside kinase activity,MF,
6422,GO:0019144,1,0.99325227379831,0,2,ADP-sugar diphosphatase activity,MF,
6423,GO:0019145,1,0.995343036483078,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6424,GO:0019150,1,0.995995294820018,0,1,D-ribulokinase activity,MF,
6425,GO:0019153,1,0.996474991457117,0,1,protein-disulfide reductase (glutathione) activity,MF,
6426,GO:0019158,1,0.962430080048406,0,5,mannokinase activity,MF,
6427,GO:0019166,1,0.988291140427425,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6428,GO:0019171,1,0.98403052900273,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6429,GO:0019184,1,0.904891725372157,0,17,nonribosomal peptide biosynthetic process,BP,
6430,GO:0019185,1,0.980553641502583,0,3,snRNA-activating protein complex,CC,
6431,GO:0019187,1,0.992548386943247,0,1,beta-1,4-mannosyltransferase activity,MF,
6433,GO:0019199,1,0.486675909994465,0,78,transmembrane receptor protein kinase activity,MF,
6434,GO:0019200,1,0.877354483690593,0,21,carbohydrate kinase activity,MF,
6435,GO:0019202,1,0.988443365709117,0,2,amino acid kinase activity,MF,
6436,GO:0019203,1,0.953868125870146,0,8,carbohydrate phosphatase activity,MF,
6437,GO:0019205,1,0.77805239746683,0,42,nucleobase-containing compound kinase activity,MF,
6438,GO:0019206,1,0.959096285747388,0,9,nucleoside kinase activity,MF,
6443,GO:0019211,1,0.909238812776233,0,15,phosphatase activator activity,MF,
6445,GO:0019213,1,0.76212343968748,0,39,deacetylase activity,MF,
6455,GO:0019227,1,0.932776693209265,0,8,neuronal action potential propagation,BP,
6456,GO:0019228,1,0.712319759406506,0,34,neuronal action potential,BP,
6458,GO:0019230,1,0.961219104539276,0,5,proprioception,BP,
6460,GO:0019236,1,0.982561157892139,0,4,response to pheromone,BP,
6461,GO:0019237,1,0.958953740604987,0,6,centromeric DNA binding,MF,
6462,GO:0019238,1,0.977124586257283,0,5,cyclohydrolase activity,MF,
6463,GO:0019239,1,0.863464162096014,0,26,deaminase activity,MF,
6464,GO:0019240,1,0.949781383842438,0,5,citrulline biosynthetic process,BP,
6465,GO:0019242,1,0.996576130586228,0,1,methylglyoxal biosynthetic process,BP,
6466,GO:0019243,1,0.991000954236584,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6467,GO:0019244,1,0.996692830719892,0,1,lactate biosynthetic process from pyruvate,BP,
6468,GO:0019249,1,0.981457892288469,0,3,lactate biosynthetic process,BP,
6469,GO:0019254,1,0.985389115635625,0,3,carnitine metabolic process, CoA-linked,BP,
6470,GO:0019255,1,0.99196990978222,0,2,glucose 1-phosphate metabolic process,BP,
6471,GO:0019262,1,0.977858541748994,0,6,N-acetylneuraminate catabolic process,BP,
6472,GO:0019264,1,0.991188185081593,0,2,glycine biosynthetic process from serine,BP,
6473,GO:0019265,1,0.9964709803441,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6474,GO:0019276,1,0.987264756999931,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6475,GO:0019284,1,0.987053925558101,0,3,L-methionine salvage from S-adenosylmethionine,BP,
6476,GO:0019285,1,0.986537011940777,0,2,glycine betaine biosynthetic process from choline,BP,
6477,GO:0019287,1,0.988982699858576,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6478,GO:0019290,1,0.994605650497108,0,1,siderophore biosynthetic process,BP,
6479,GO:0019303,1,0.993449119806275,0,2,D-ribose catabolic process,BP,
6482,GO:0019319,1,0.613982319197017,0,79,hexose biosynthetic process,BP,
6484,GO:0019321,1,0.943674367515669,0,14,pentose metabolic process,BP,
6485,GO:0019322,1,0.984459036261036,0,4,pentose biosynthetic process,BP,
6486,GO:0019323,1,0.97909671414148,0,5,pentose catabolic process,BP,
6487,GO:0019336,1,0.937959837047736,0,11,phenol-containing compound catabolic process,BP,
6488,GO:0019341,1,0.995171173429256,0,1,dibenzo-p-dioxin catabolic process,BP,
6489,GO:0019343,1,0.991547303252723,0,2,cysteine biosynthetic process via cystathionine,BP,
6490,GO:0019344,1,0.987149856711085,0,3,cysteine biosynthetic process,BP,
6491,GO:0019346,1,0.984933168552039,0,4,transsulfuration,BP,
6492,GO:0019348,1,0.97530124784828,0,5,dolichol metabolic process,BP,
6496,GO:0019364,1,0.973104203600838,0,4,pyridine nucleotide catabolic process,BP,
6497,GO:0019365,1,0.994890876864838,0,1,pyridine nucleotide salvage,BP,
6498,GO:0019367,1,0.964837379943381,0,6,fatty acid elongation, saturated fatty acid,BP,
6499,GO:0019368,1,0.964837379943381,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6500,GO:0019369,1,0.790086195504574,0,46,arachidonic acid metabolic process,BP,
6501,GO:0019370,1,0.947112940702944,0,12,leukotriene biosynthetic process,BP,
6502,GO:0019371,1,0.944040191305103,0,11,cyclooxygenase pathway,BP,
6503,GO:0019372,1,0.930817543073834,0,16,lipoxygenase pathway,BP,
6504,GO:0019373,1,0.950967920098001,0,11,epoxygenase P450 pathway,BP,
6505,GO:0019374,1,0.958354671158063,0,9,galactolipid metabolic process,BP,
6506,GO:0019375,1,0.972095704221585,0,6,galactolipid biosynthetic process,BP,
6507,GO:0019376,1,0.985868507924837,0,3,galactolipid catabolic process,BP,
6508,GO:0019377,1,0.928750512451803,0,15,glycolipid catabolic process,BP,
6509,GO:0019388,1,0.954689936830864,0,8,galactose catabolic process,BP,
6510,GO:0019389,1,0.990795214717867,0,2,glucuronoside metabolic process,BP,
6511,GO:0019391,1,0.990795214717867,0,2,glucuronoside catabolic process,BP,
6512,GO:0019395,1,0.540740827631027,0,102,fatty acid oxidation,BP,
6513,GO:0019400,1,0.882544646296814,0,19,alditol metabolic process,BP,
6514,GO:0019401,1,0.967992158567212,0,7,alditol biosynthetic process,BP,
6515,GO:0019402,1,0.996636735253791,0,1,galactitol metabolic process,BP,
6516,GO:0019405,1,0.955249295809161,0,5,alditol catabolic process,BP,
6517,GO:0019406,1,0.996612746461703,0,1,hexitol biosynthetic process,BP,
6518,GO:0019407,1,0.995305280149271,0,1,hexitol catabolic process,BP,
6519,GO:0019408,1,0.985933207883841,0,2,dolichol biosynthetic process,BP,
6520,GO:0019413,1,0.985969738170278,0,2,acetate biosynthetic process,BP,
6521,GO:0019417,1,0.986021006072165,0,2,sulfur oxidation,BP,
6522,GO:0019418,1,0.985576838220196,0,4,sulfide oxidation,BP,
6523,GO:0019427,1,0.985969738170278,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6524,GO:0019430,1,0.8896827311039,0,23,removal of superoxide radicals,BP,
6525,GO:0019432,1,0.814105444692347,0,31,triglyceride biosynthetic process,BP,
6526,GO:0019433,1,0.826177163291545,0,29,triglyceride catabolic process,BP,
6529,GO:0019441,1,0.985906841744139,0,4,tryptophan catabolic process to kynurenine,BP,
6530,GO:0019442,1,0.992958535493554,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6531,GO:0019448,1,0.983225372405601,0,4,L-cysteine catabolic process,BP,
6532,GO:0019449,1,0.995003072987144,0,1,L-cysteine catabolic process to hypotaurine,BP,
6533,GO:0019452,1,0.995003072987144,0,1,L-cysteine catabolic process to taurine,BP,
6534,GO:0019464,1,0.985374448360338,0,3,glycine decarboxylation via glycine cleavage system,BP,
6535,GO:0019470,1,0.98021725179993,0,4,4-hydroxyproline catabolic process,BP,
6536,GO:0019471,1,0.98021725179993,0,4,4-hydroxyproline metabolic process,BP,
6537,GO:0019474,1,0.974957462087632,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6538,GO:0019477,1,0.974957462087632,0,4,L-lysine catabolic process,BP,
6539,GO:0019478,1,0.992942933145261,0,2,D-amino acid catabolic process,BP,
6540,GO:0019482,1,0.97957883109543,0,4,beta-alanine metabolic process,BP,
6541,GO:0019483,1,0.990220732103402,0,2,beta-alanine biosynthetic process,BP,
6542,GO:0019493,1,0.996090351479374,0,1,arginine catabolic process to proline,BP,
6543,GO:0019509,1,0.974241435763497,0,5,L-methionine salvage from methylthioadenosine,BP,
6544,GO:0019510,1,0.995675829553584,0,1,S-adenosylhomocysteine catabolic process,BP,
6545,GO:0019511,1,0.920818636354294,0,14,peptidyl-proline hydroxylation,BP,
6546,GO:0019516,1,0.996692830719892,0,1,lactate oxidation,BP,
6547,GO:0019518,1,0.989605102019769,0,3,L-threonine catabolic process to glycine,BP,
6548,GO:0019519,1,0.995305280149271,0,1,pentitol metabolic process,BP,
6549,GO:0019520,1,0.991046163562001,0,2,aldonic acid metabolic process,BP,
6550,GO:0019521,1,0.991046163562001,0,2,D-gluconate metabolic process,BP,
6551,GO:0019527,1,0.995305280149271,0,1,pentitol catabolic process,BP,
6552,GO:0019530,1,0.955649217648948,0,7,taurine metabolic process,BP,
6553,GO:0019531,1,0.938709497266308,0,8,oxalate transmembrane transporter activity,MF,
6554,GO:0019532,1,0.935394676255758,0,9,oxalate transport,BP,
6555,GO:0019534,1,0.947210179577277,0,7,toxin transmembrane transporter activity,MF,
6557,GO:0019541,1,0.977261429548751,0,4,propionate metabolic process,BP,
6558,GO:0019542,1,0.985969738170278,0,2,propionate biosynthetic process,BP,
6559,GO:0019543,1,0.991169016876542,0,2,propionate catabolic process,BP,
6560,GO:0019544,1,0.996090351479374,0,1,arginine catabolic process to glutamate,BP,
6561,GO:0019547,1,0.992688132673555,0,2,arginine catabolic process to ornithine,BP,
6562,GO:0019550,1,0.991352183790309,0,2,glutamate catabolic process to aspartate,BP,
6563,GO:0019551,1,0.991352183790309,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6564,GO:0019556,1,0.980112043616179,0,4,histidine catabolic process to glutamate and formamide,BP,
6565,GO:0019557,1,0.980112043616179,0,4,histidine catabolic process to glutamate and formate,BP,
6566,GO:0019563,1,0.959756932668702,0,4,glycerol catabolic process,BP,
6567,GO:0019566,1,0.989807596705769,0,2,arabinose metabolic process,BP,
6568,GO:0019585,1,0.959524326094641,0,8,glucuronate metabolic process,BP,
6569,GO:0019605,1,0.992173302609055,0,2,butyrate metabolic process,BP,
6570,GO:0019606,1,0.996419140551554,0,1,2-oxobutyrate catabolic process,BP,
6571,GO:0019614,1,0.956678703112889,0,8,catechol-containing compound catabolic process,BP,
6572,GO:0019626,1,0.961496908783733,0,8,short-chain fatty acid catabolic process,BP,
6573,GO:0019627,1,0.944544976795658,0,12,urea metabolic process,BP,
6575,GO:0019640,1,0.97849578384914,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6576,GO:0019646,1,0.931949055245998,0,16,aerobic electron transport chain,BP,
6577,GO:0019659,1,0.98764869320882,0,2,glucose catabolic process to lactate,BP,
6578,GO:0019660,1,0.98764869320882,0,2,glycolytic fermentation,BP,
6579,GO:0019661,1,0.98764869320882,0,2,glucose catabolic process to lactate via pyruvate,BP,
6580,GO:0019673,1,0.978495204864024,0,6,GDP-mannose metabolic process,BP,
6581,GO:0019674,1,0.756106877146969,0,46,NAD metabolic process,BP,
6582,GO:0019676,1,0.987590858583722,0,2,ammonia assimilation cycle,BP,
6583,GO:0019677,1,0.977078026360955,0,3,NAD catabolic process,BP,
6584,GO:0019682,1,0.970463702590343,0,7,glyceraldehyde-3-phosphate metabolic process,BP,
6585,GO:0019692,1,0.872690145795946,0,31,deoxyribose phosphate metabolic process,BP,
6586,GO:0019693,1,0.0922762768601118,0,364,ribose phosphate metabolic process,BP,
6587,GO:0019694,1,0.955649217648948,0,7,alkanesulfonate metabolic process,BP,
6588,GO:0019695,1,0.9456384163764,0,9,choline metabolic process,BP,
6589,GO:0019706,1,0.840149141546644,0,28,protein-cysteine S-palmitoyltransferase activity,MF,
6590,GO:0019707,1,0.840149141546644,0,28,protein-cysteine S-acyltransferase activity,MF,
6591,GO:0019720,1,0.966933966056222,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6598,GO:0019740,1,0.977330055009628,0,4,nitrogen utilization,BP,
6599,GO:0019742,1,0.995502047302218,0,1,pentacyclic triterpenoid metabolic process,BP,
6600,GO:0019747,1,0.981605429962078,0,4,regulation of isoprenoid metabolic process,BP,
6601,GO:0019748,1,0.724858610027647,0,51,secondary metabolic process,BP,
6602,GO:0019751,1,0.461231519925322,0,111,polyol metabolic process,BP,
6604,GO:0019755,1,0.948730689886942,0,11,one-carbon compound transport,BP,
6605,GO:0019763,1,0.978640224786137,0,5,immunoglobulin receptor activity,MF,
6606,GO:0019767,1,0.996880430931322,0,1,IgE receptor activity,MF,
6607,GO:0019770,1,0.996468965415065,0,1,IgG receptor activity,MF,
6608,GO:0019772,1,0.996468965415065,0,1,low-affinity IgG receptor activity,MF,
6609,GO:0019773,1,0.977448587851825,0,7,proteasome core complex, alpha-subunit complex,CC,
6610,GO:0019774,1,0.971402687128408,0,9,proteasome core complex, beta-subunit complex,CC,
6611,GO:0019776,1,0.996698254122377,0,1,Atg8 ligase activity,MF,
6612,GO:0019777,1,0.992291132382303,0,2,Atg12 transferase activity,MF,
6613,GO:0019778,1,0.990471382129943,0,1,Atg12 activating enzyme activity,MF,
6614,GO:0019779,1,0.990471382129943,0,1,Atg8 activating enzyme activity,MF,
6615,GO:0019780,1,0.987647873834641,0,1,FAT10 activating enzyme activity,MF,
6616,GO:0019781,1,0.992210215033729,0,2,NEDD8 activating enzyme activity,MF,
6617,GO:0019782,1,0.993807668122088,0,1,ISG15 activating enzyme activity,MF,
6618,GO:0019783,1,0.892935262282813,0,17,ubiquitin-like protein-specific protease activity,MF,
6619,GO:0019784,1,0.970396852655575,0,7,NEDD8-specific protease activity,MF,
6620,GO:0019785,1,0.992267312998464,0,1,ISG15-specific protease activity,MF,
6621,GO:0019787,1,0.0534799355940307,0,402,ubiquitin-like protein transferase activity,MF,
6622,GO:0019788,1,0.968854808306648,0,6,NEDD8 transferase activity,MF,
6623,GO:0019789,1,0.882420132145191,0,17,SUMO transferase activity,MF,
6624,GO:0019797,1,0.984750030119825,0,3,procollagen-proline 3-dioxygenase activity,MF,
6625,GO:0019798,1,0.962508008344542,0,8,procollagen-proline dioxygenase activity,MF,
6626,GO:0019799,1,0.994890876864838,0,1,tubulin N-acetyltransferase activity,MF,
6627,GO:0019800,1,0.968808885435871,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6628,GO:0019805,1,0.980439284419257,0,4,quinolinate biosynthetic process,BP,
6629,GO:0019806,1,0.986980955798428,0,1,bromide peroxidase activity,MF,
6630,GO:0019807,1,0.996623712519156,0,1,aspartoacylase activity,MF,
6631,GO:0019808,1,0.987553866959466,0,3,polyamine binding,MF,
6632,GO:0019809,1,0.993573462070175,0,2,spermidine binding,MF,
6633,GO:0019810,1,0.993941860303577,0,1,putrescine binding,MF,
6634,GO:0019811,1,0.991326445411605,0,1,cocaine binding,MF,
6635,GO:0019814,1,0.972522963498658,0,6,immunoglobulin complex,CC,
6636,GO:0019815,1,0.980617386542865,0,4,B cell receptor complex,CC,
6637,GO:0019825,1,0.871841996989929,0,29,oxygen binding,MF,
6638,GO:0019826,1,0.97459344766721,0,3,oxygen sensor activity,MF,
6640,GO:0019828,1,0.961198229761291,0,6,aspartic-type endopeptidase inhibitor activity,MF,
6645,GO:0019840,1,0.86695103016999,0,26,isoprenoid binding,MF,
6646,GO:0019841,1,0.95094266554793,0,11,retinol binding,MF,
6648,GO:0019843,1,0.770240392328662,0,57,rRNA binding,MF,
6649,GO:0019852,1,0.940051953650034,0,11,L-ascorbic acid metabolic process,BP,
6650,GO:0019853,1,0.99273416567712,0,2,L-ascorbic acid biosynthetic process,BP,
6651,GO:0019855,1,0.949464630199611,0,9,calcium channel inhibitor activity,MF,
6652,GO:0019856,1,0.934066638950099,0,8,pyrimidine nucleobase biosynthetic process,BP,
6653,GO:0019857,1,0.945419683205745,0,3,5-methylcytosine metabolic process,BP,
6654,GO:0019858,1,0.989863273513173,0,2,cytosine metabolic process,BP,
6655,GO:0019859,1,0.986017318350403,0,3,thymine metabolic process,BP,
6656,GO:0019860,1,0.986667545918632,0,3,uracil metabolic process,BP,
6657,GO:0019862,1,0.996498537343066,0,1,IgA binding,MF,
6658,GO:0019863,1,0.986749484039654,0,4,IgE binding,MF,
6659,GO:0019864,1,0.966365051497635,0,9,IgG binding,MF,
6660,GO:0019865,1,0.916890440657816,0,18,immunoglobulin binding,MF,
6661,GO:0019866,1,0.107831993762721,0,460,organelle inner membrane,CC,
6663,GO:0019869,1,0.914990218442591,0,10,chloride channel inhibitor activity,MF,
6664,GO:0019870,1,0.913609240251528,0,9,potassium channel inhibitor activity,MF,
6665,GO:0019871,1,0.937504195715389,0,8,sodium channel inhibitor activity,MF,
6666,GO:0019878,1,0.98351607299788,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6668,GO:0019883,1,0.888873361160386,0,22,antigen processing and presentation of endogenous antigen,BP,
6670,GO:0019885,1,0.915265207368047,0,16,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6674,GO:0019894,1,0.729030561367968,0,40,kinesin binding,MF,
6675,GO:0019896,1,0.907099370639893,0,13,axonal transport of mitochondrion,BP,
6685,GO:0019907,1,0.989823552505352,0,3,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6686,GO:0019908,1,0.924646282061039,0,12,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6688,GO:0019912,1,0.995804332958166,0,1,cyclin-dependent protein kinase activating kinase activity,MF,
6689,GO:0019915,1,0.597232776610858,0,73,lipid storage,BP,
6690,GO:0019918,1,0.98087495544361,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6691,GO:0019919,1,0.977838280930807,0,5,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6694,GO:0019934,1,0.847059355332977,0,25,cGMP-mediated signaling,BP,
6696,GO:0019941,1,0.0162917339160565,0,586,modification-dependent protein catabolic process,BP,
6697,GO:0019948,1,0.990489171091112,0,2,SUMO activating enzyme activity,MF,
6701,GO:0019957,1,0.901306398236433,0,23,C-C chemokine binding,MF,
6702,GO:0019958,1,0.96643160368155,0,6,C-X-C chemokine binding,MF,
6703,GO:0019959,1,0.981436603189019,0,3,interleukin-8 binding,MF,
6704,GO:0019960,1,0.953623970815518,0,5,C-X3-C chemokine binding,MF,
6705,GO:0019961,1,0.981944576731639,0,2,interferon binding,MF,
6706,GO:0019962,1,0.988343983862615,0,1,type I interferon binding,MF,
6707,GO:0019964,1,0.993525877168439,0,1,interferon-gamma binding,MF,
6708,GO:0019966,1,0.953817560800915,0,7,interleukin-1 binding,MF,
6709,GO:0019969,1,0.993002877489062,0,1,interleukin-10 binding,MF,
6710,GO:0019970,1,0.982696711158895,0,3,interleukin-11 binding,MF,
6711,GO:0019972,1,0.996590607678115,0,1,interleukin-12 binding,MF,
6712,GO:0019975,1,0.996590607678115,0,1,interleukin-17 binding,MF,
6713,GO:0019976,1,0.982972040724107,0,3,interleukin-2 binding,MF,
6714,GO:0019981,1,0.986272093820697,0,2,interleukin-6 binding,MF,
6715,GO:0019985,1,0.778201219432141,0,39,translesion synthesis,BP,
6716,GO:0019988,1,0.994926741713297,0,1,charged-tRNA amino acid modification,BP,
6717,GO:0019992,1,0.894936944581256,0,12,diacylglycerol binding,MF,
6718,GO:0020003,1,0.986758442415486,0,3,symbiont-containing vacuole,CC,
6719,GO:0020005,1,0.991826220710292,0,2,symbiont-containing vacuole membrane,CC,
6720,GO:0020016,1,0.978220634734329,0,3,ciliary pocket,CC,
6721,GO:0020018,1,0.978220634734329,0,3,ciliary pocket membrane,CC,
6722,GO:0020027,1,0.930664306570783,0,15,hemoglobin metabolic process,BP,
6723,GO:0020037,1,0.53082774055599,0,108,heme binding,MF,
6724,GO:0021501,1,0.995961294964222,0,1,prechordal plate formation,BP,
6725,GO:0021502,1,0.980738762854823,0,3,neural fold elevation formation,BP,
6726,GO:0021503,1,0.984102731003783,0,1,neural fold bending,BP,
6727,GO:0021508,1,0.987094068748852,0,1,floor plate formation,BP,
6728,GO:0021509,1,0.996080135909399,0,1,roof plate formation,BP,
6729,GO:0021510,1,0.457932642918113,0,103,spinal cord development,BP,
6730,GO:0021511,1,0.840334260726919,0,24,spinal cord patterning,BP,
6731,GO:0021512,1,0.991897428640714,0,1,spinal cord anterior/posterior patterning,BP,
6732,GO:0021513,1,0.865562240165143,0,22,spinal cord dorsal/ventral patterning,BP,
6733,GO:0021514,1,0.887610853720174,0,17,ventral spinal cord interneuron differentiation,BP,
6734,GO:0021515,1,0.682555680409215,0,53,cell differentiation in spinal cord,BP,
6735,GO:0021516,1,0.896358038809863,0,19,dorsal spinal cord development,BP,
6736,GO:0021517,1,0.714910250891046,0,47,ventral spinal cord development,BP,
6737,GO:0021519,1,0.996681697515034,0,1,spinal cord association neuron specification,BP,
6738,GO:0021520,1,0.920937360504893,0,12,spinal cord motor neuron cell fate specification,BP,
6739,GO:0021521,1,0.921968823504032,0,11,ventral spinal cord interneuron specification,BP,
6740,GO:0021522,1,0.781579354058349,0,34,spinal cord motor neuron differentiation,BP,
6741,GO:0021523,1,0.971390148272664,0,5,somatic motor neuron differentiation,BP,
6742,GO:0021524,1,0.987808300016929,0,3,visceral motor neuron differentiation,BP,
6743,GO:0021526,1,0.991772232340555,0,2,medial motor column neuron differentiation,BP,
6744,GO:0021527,1,0.934245857657546,0,11,spinal cord association neuron differentiation,BP,
6745,GO:0021528,1,0.994890876864838,0,1,commissural neuron differentiation in spinal cord,BP,
6746,GO:0021529,1,0.962762500113866,0,5,spinal cord oligodendrocyte cell differentiation,BP,
6747,GO:0021530,1,0.98680793150261,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6748,GO:0021532,1,0.764170106932058,0,38,neural tube patterning,BP,
6749,GO:0021533,1,0.838777018752446,0,20,cell differentiation in hindbrain,BP,
6750,GO:0021534,1,0.894732134071493,0,15,cell proliferation in hindbrain,BP,
6751,GO:0021535,1,0.882929988345554,0,14,cell migration in hindbrain,BP,
6754,GO:0021538,1,0.973317554193208,0,3,epithalamus development,BP,
6755,GO:0021539,1,0.996486875533312,0,1,subthalamus development,BP,
6756,GO:0021540,1,0.94727462873375,0,6,corpus callosum morphogenesis,BP,
6757,GO:0021541,1,0.9919614515911,0,1,ammon gyrus development,BP,
6758,GO:0021542,1,0.897374522792093,0,16,dentate gyrus development,BP,
6761,GO:0021545,1,0.717574767246825,0,46,cranial nerve development,BP,
6762,GO:0021546,1,0.971492983081755,0,6,rhombomere development,BP,
6763,GO:0021547,1,0.995961294964222,0,1,midbrain-hindbrain boundary initiation,BP,
6765,GO:0021549,1,0.474938647908261,0,94,cerebellum development,BP,
6766,GO:0021550,1,0.995394952611099,0,1,medulla oblongata development,BP,
6767,GO:0021551,1,0.978360155618196,0,1,central nervous system morphogenesis,BP,
6768,GO:0021553,1,0.966166821732494,0,3,olfactory nerve development,BP,
6769,GO:0021554,1,0.902369641266702,0,13,optic nerve development,BP,
6770,GO:0021555,1,0.983198488461792,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6771,GO:0021557,1,0.986896324080888,0,3,oculomotor nerve development,BP,
6772,GO:0021558,1,0.992985389767853,0,2,trochlear nerve development,BP,
6773,GO:0021559,1,0.930991329025089,0,11,trigeminal nerve development,BP,
6774,GO:0021560,1,0.989236836542113,0,2,abducens nerve development,BP,
6775,GO:0021561,1,0.927565468700567,0,10,facial nerve development,BP,
6776,GO:0021562,1,0.940361027700725,0,8,vestibulocochlear nerve development,BP,
6777,GO:0021563,1,0.957218767915537,0,5,glossopharyngeal nerve development,BP,
6778,GO:0021564,1,0.970440098821533,0,3,vagus nerve development,BP,
6779,GO:0021566,1,0.990531619929249,0,1,hypoglossal nerve development,BP,
6780,GO:0021568,1,0.992984817538055,0,2,rhombomere 2 development,BP,
6781,GO:0021569,1,0.987570279821622,0,3,rhombomere 3 development,BP,
6782,GO:0021570,1,0.996475790685778,0,1,rhombomere 4 development,BP,
6783,GO:0021571,1,0.988519418721042,0,2,rhombomere 5 development,BP,
6784,GO:0021572,1,0.993760991840095,0,1,rhombomere 6 development,BP,
6785,GO:0021575,1,0.71815614397594,0,39,hindbrain morphogenesis,BP,
6786,GO:0021577,1,0.987726048415804,0,2,hindbrain structural organization,BP,
6789,GO:0021587,1,0.731321950396926,0,36,cerebellum morphogenesis,BP,
6790,GO:0021589,1,0.987726048415804,0,2,cerebellum structural organization,BP,
6791,GO:0021590,1,0.9741418109449,0,3,cerebellum maturation,BP,
6792,GO:0021591,1,0.736373932719855,0,32,ventricular system development,BP,
6793,GO:0021592,1,0.975541192839727,0,2,fourth ventricle development,BP,
6794,GO:0021593,1,0.991063308670833,0,2,rhombomere morphogenesis,BP,
6795,GO:0021594,1,0.994725848872886,0,1,rhombomere formation,BP,
6796,GO:0021595,1,0.994725848872886,0,1,rhombomere structural organization,BP,
6797,GO:0021598,1,0.989236836542113,0,2,abducens nerve morphogenesis,BP,
6798,GO:0021599,1,0.989236836542113,0,2,abducens nerve formation,BP,
6799,GO:0021602,1,0.824309091174396,0,27,cranial nerve morphogenesis,BP,
6800,GO:0021603,1,0.953034264340092,0,8,cranial nerve formation,BP,
6801,GO:0021604,1,0.929937330002287,0,10,cranial nerve structural organization,BP,
6802,GO:0021610,1,0.927565468700567,0,10,facial nerve morphogenesis,BP,
6803,GO:0021612,1,0.941105265634054,0,8,facial nerve structural organization,BP,
6804,GO:0021615,1,0.97670896539103,0,4,glossopharyngeal nerve morphogenesis,BP,
6805,GO:0021618,1,0.990531619929249,0,1,hypoglossal nerve morphogenesis,BP,
6806,GO:0021622,1,0.990281988210375,0,2,oculomotor nerve morphogenesis,BP,
6807,GO:0021623,1,0.990281988210375,0,2,oculomotor nerve formation,BP,
6809,GO:0021631,1,0.944651558332849,0,6,optic nerve morphogenesis,BP,
6810,GO:0021633,1,0.98814032801074,0,2,optic nerve structural organization,BP,
6811,GO:0021634,1,0.992193352021718,0,1,optic nerve formation,BP,
6812,GO:0021636,1,0.959334128597938,0,5,trigeminal nerve morphogenesis,BP,
6813,GO:0021637,1,0.959334128597938,0,5,trigeminal nerve structural organization,BP,
6814,GO:0021639,1,0.996391732622302,0,1,trochlear nerve morphogenesis,BP,
6815,GO:0021642,1,0.996391732622302,0,1,trochlear nerve formation,BP,
6816,GO:0021644,1,0.990196768415061,0,2,vagus nerve morphogenesis,BP,
6817,GO:0021648,1,0.958385090871416,0,6,vestibulocochlear nerve morphogenesis,BP,
6818,GO:0021649,1,0.985120966502447,0,2,vestibulocochlear nerve structural organization,BP,
6819,GO:0021650,1,0.972864322668897,0,4,vestibulocochlear nerve formation,BP,
6820,GO:0021658,1,0.991063308670833,0,2,rhombomere 3 morphogenesis,BP,
6821,GO:0021659,1,0.994725848872886,0,1,rhombomere 3 structural organization,BP,
6822,GO:0021660,1,0.994725848872886,0,1,rhombomere 3 formation,BP,
6823,GO:0021664,1,0.994725848872886,0,1,rhombomere 5 morphogenesis,BP,
6824,GO:0021665,1,0.994725848872886,0,1,rhombomere 5 structural organization,BP,
6825,GO:0021666,1,0.994725848872886,0,1,rhombomere 5 formation,BP,
6826,GO:0021670,1,0.882254838415334,0,12,lateral ventricle development,BP,
6828,GO:0021678,1,0.963425660297662,0,5,third ventricle development,BP,
6829,GO:0021679,1,0.988228238941642,0,2,cerebellar molecular layer development,BP,
6830,GO:0021680,1,0.797228619433496,0,24,cerebellar Purkinje cell layer development,BP,
6831,GO:0021681,1,0.9056142927793,0,13,cerebellar granular layer development,BP,
6832,GO:0021682,1,0.989088882827696,0,1,nerve maturation,BP,
6833,GO:0021683,1,0.93008742134169,0,9,cerebellar granular layer morphogenesis,BP,
6834,GO:0021684,1,0.947222596477214,0,7,cerebellar granular layer formation,BP,
6835,GO:0021685,1,0.986140698124978,0,1,cerebellar granular layer structural organization,BP,
6836,GO:0021686,1,0.996437984702379,0,1,cerebellar granular layer maturation,BP,
6837,GO:0021687,1,0.988228238941642,0,2,cerebellar molecular layer morphogenesis,BP,
6838,GO:0021688,1,0.99384208392007,0,1,cerebellar molecular layer formation,BP,
6839,GO:0021691,1,0.977624913571424,0,2,cerebellar Purkinje cell layer maturation,BP,
6840,GO:0021692,1,0.863627843698001,0,14,cerebellar Purkinje cell layer morphogenesis,BP,
6841,GO:0021693,1,0.98006728279382,0,2,cerebellar Purkinje cell layer structural organization,BP,
6842,GO:0021694,1,0.894578869078325,0,11,cerebellar Purkinje cell layer formation,BP,
6843,GO:0021695,1,0.690741207302476,0,45,cerebellar cortex development,BP,
6844,GO:0021696,1,0.769803897406614,0,30,cerebellar cortex morphogenesis,BP,
6845,GO:0021697,1,0.825249193253381,0,22,cerebellar cortex formation,BP,
6846,GO:0021698,1,0.98006728279382,0,2,cerebellar cortex structural organization,BP,
6847,GO:0021699,1,0.9741418109449,0,3,cerebellar cortex maturation,BP,
6849,GO:0021702,1,0.894578869078325,0,11,cerebellar Purkinje cell differentiation,BP,
6850,GO:0021703,1,0.996391732622302,0,1,locus ceruleus development,BP,
6851,GO:0021707,1,0.947222596477214,0,7,cerebellar granule cell differentiation,BP,
6852,GO:0021718,1,0.98816187191926,0,2,superior olivary nucleus development,BP,
6853,GO:0021722,1,0.98816187191926,0,2,superior olivary nucleus maturation,BP,
6854,GO:0021730,1,0.978840855286158,0,2,trigeminal sensory nucleus development,BP,
6855,GO:0021740,1,0.978840855286158,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6856,GO:0021747,1,0.974167483076006,0,3,cochlear nucleus development,BP,
6857,GO:0021750,1,0.995394952611099,0,1,vestibular nucleus development,BP,
6859,GO:0021757,1,0.993161949499453,0,1,caudate nucleus development,BP,
6860,GO:0021758,1,0.993161949499453,0,1,putamen development,BP,
6861,GO:0021759,1,0.974946500431326,0,4,globus pallidus development,BP,
6864,GO:0021764,1,0.943998099960898,0,5,amygdala development,BP,
6865,GO:0021766,1,0.553430411330067,0,75,hippocampus development,BP,
6866,GO:0021767,1,0.982859673894937,0,1,mammillary body development,BP,
6867,GO:0021768,1,0.993460014495044,0,1,nucleus accumbens development,BP,
6868,GO:0021769,1,0.972865648066751,0,4,orbitofrontal cortex development,BP,
6869,GO:0021771,1,0.989056888308957,0,1,lateral geniculate nucleus development,BP,
6870,GO:0021772,1,0.765917796145467,0,31,olfactory bulb development,BP,
6871,GO:0021773,1,0.95775115849057,0,4,striatal medium spiny neuron differentiation,BP,
6872,GO:0021775,1,0.962670856617183,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6873,GO:0021776,1,0.962670856617183,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6874,GO:0021778,1,0.957537209337927,0,5,oligodendrocyte cell fate specification,BP,
6875,GO:0021779,1,0.957537209337927,0,5,oligodendrocyte cell fate commitment,BP,
6876,GO:0021780,1,0.957537209337927,0,5,glial cell fate specification,BP,
6877,GO:0021781,1,0.909944564165986,0,13,glial cell fate commitment,BP,
6879,GO:0021783,1,0.893999706669085,0,15,preganglionic parasympathetic fiber development,BP,
6880,GO:0021784,1,0.990541978464112,0,2,postganglionic parasympathetic fiber development,BP,
6881,GO:0021785,1,0.933989354945026,0,6,branchiomotor neuron axon guidance,BP,
6882,GO:0021793,1,0.99365297032258,0,1,chemorepulsion of branchiomotor axon,BP,
6884,GO:0021795,1,0.736306701915349,0,38,cerebral cortex cell migration,BP,
6885,GO:0021796,1,0.959267652738713,0,6,cerebral cortex regionalization,BP,
6886,GO:0021797,1,0.987370132210744,0,3,forebrain anterior/posterior pattern specification,BP,
6887,GO:0021798,1,0.947642108629719,0,7,forebrain dorsal/ventral pattern formation,BP,
6888,GO:0021799,1,0.79880017643134,0,27,cerebral cortex radially oriented cell migration,BP,
6889,GO:0021800,1,0.934530821464554,0,6,cerebral cortex tangential migration,BP,
6890,GO:0021801,1,0.840239284130403,0,20,cerebral cortex radial glia guided migration,BP,
6891,GO:0021806,1,0.996558797831878,0,1,initiation of movement involved in cerebral cortex radial glia guided migration,BP,
6892,GO:0021808,1,0.996558797831878,0,1,cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration,BP,
6893,GO:0021812,1,0.984013754831489,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6894,GO:0021813,1,0.995200024513429,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6895,GO:0021814,1,0.952157618366133,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6896,GO:0021815,1,0.963702044552716,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6897,GO:0021817,1,0.963702044552716,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6898,GO:0021819,1,0.915155832739305,0,10,layer formation in cerebral cortex,BP,
6899,GO:0021823,1,0.976493899975193,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6900,GO:0021825,1,0.976493899975193,0,2,substrate-dependent cerebral cortex tangential migration,BP,
6901,GO:0021826,1,0.942672593980303,0,9,substrate-independent telencephalic tangential migration,BP,
6902,GO:0021827,1,0.976493899975193,0,2,postnatal olfactory bulb interneuron migration,BP,
6903,GO:0021828,1,0.974435551502788,0,3,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6904,GO:0021830,1,0.942672593980303,0,9,interneuron migration from the subpallium to the cortex,BP,
6905,GO:0021831,1,0.994702716281486,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6906,GO:0021836,1,0.976493899975193,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6907,GO:0021840,1,0.988634424095905,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6908,GO:0021842,1,0.988634424095905,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6909,GO:0021843,1,0.942672593980303,0,9,substrate-independent telencephalic tangential interneuron migration,BP,
6910,GO:0021846,1,0.772493484004059,0,27,cell proliferation in forebrain,BP,
6911,GO:0021847,1,0.977174049846498,0,3,ventricular zone neuroblast division,BP,
6912,GO:0021849,1,0.972860369789248,0,3,neuroblast division in subventricular zone,BP,
6913,GO:0021852,1,0.976085208432083,0,3,pyramidal neuron migration,BP,
6914,GO:0021853,1,0.959501829740658,0,6,cerebral cortex GABAergic interneuron migration,BP,
6915,GO:0021854,1,0.89329203308328,0,18,hypothalamus development,BP,
6916,GO:0021855,1,0.974435551502788,0,3,hypothalamus cell migration,BP,
6917,GO:0021856,1,0.974435551502788,0,3,hypothalamic tangential migration using cell-axon interactions,BP,
6918,GO:0021859,1,0.908280745190236,0,10,pyramidal neuron differentiation,BP,
6919,GO:0021860,1,0.921054663328618,0,9,pyramidal neuron development,BP,
6920,GO:0021861,1,0.960060231301505,0,7,forebrain radial glial cell differentiation,BP,
6921,GO:0021869,1,0.955760585644215,0,6,forebrain ventricular zone progenitor cell division,BP,
6922,GO:0021870,1,0.988358874619975,0,1,Cajal-Retzius cell differentiation,BP,
6923,GO:0021871,1,0.869272218510921,0,21,forebrain regionalization,BP,
6924,GO:0021872,1,0.62749312313152,0,60,forebrain generation of neurons,BP,
6925,GO:0021873,1,0.951332402081346,0,5,forebrain neuroblast division,BP,
6926,GO:0021877,1,0.930521663143243,0,10,forebrain neuron fate commitment,BP,
6927,GO:0021879,1,0.676967313510824,0,51,forebrain neuron differentiation,BP,
6928,GO:0021882,1,0.99137811797935,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6929,GO:0021884,1,0.806714025461795,0,26,forebrain neuron development,BP,
6930,GO:0021885,1,0.657605757063677,0,53,forebrain cell migration,BP,
6931,GO:0021886,1,0.971323467632228,0,4,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6932,GO:0021888,1,0.971323467632228,0,4,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6933,GO:0021889,1,0.898264652786587,0,12,olfactory bulb interneuron differentiation,BP,
6934,GO:0021891,1,0.936920255298503,0,7,olfactory bulb interneuron development,BP,
6935,GO:0021892,1,0.939758593920951,0,11,cerebral cortex GABAergic interneuron differentiation,BP,
6936,GO:0021893,1,0.99137811797935,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6937,GO:0021894,1,0.956408115834608,0,7,cerebral cortex GABAergic interneuron development,BP,
6938,GO:0021895,1,0.830135234238458,0,25,cerebral cortex neuron differentiation,BP,
6939,GO:0021896,1,0.967554428722378,0,2,forebrain astrocyte differentiation,BP,
6940,GO:0021897,1,0.967554428722378,0,2,forebrain astrocyte development,BP,
6941,GO:0021898,1,0.99137811797935,0,2,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6942,GO:0021902,1,0.94264577987647,0,7,commitment of neuronal cell to specific neuron type in forebrain,BP,
6943,GO:0021903,1,0.932215888683802,0,10,rostrocaudal neural tube patterning,BP,
6944,GO:0021904,1,0.850819787879017,0,23,dorsal/ventral neural tube patterning,BP,
6945,GO:0021905,1,0.986875319544628,0,1,forebrain-midbrain boundary formation,BP,
6946,GO:0021910,1,0.938307114339409,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6947,GO:0021912,1,0.98051793248465,0,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
6948,GO:0021913,1,0.976824513486297,0,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
6949,GO:0021914,1,0.981612629520648,0,3,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6951,GO:0021917,1,0.986875319544628,0,1,somatic motor neuron fate commitment,BP,
6952,GO:0021918,1,0.986875319544628,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6953,GO:0021919,1,0.993377467108855,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6954,GO:0021920,1,0.996681697515034,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6955,GO:0021924,1,0.898684050230568,0,14,cell proliferation in external granule layer,BP,
6956,GO:0021930,1,0.898684050230568,0,14,cerebellar granule cell precursor proliferation,BP,
6957,GO:0021932,1,0.924424603505626,0,10,hindbrain radial glia guided cell migration,BP,
6958,GO:0021933,1,0.996437984702379,0,1,radial glia guided migration of cerebellar granule cell,BP,
6959,GO:0021934,1,0.968513078066676,0,2,hindbrain tangential cell migration,BP,
6960,GO:0021935,1,0.968513078066676,0,2,cerebellar granule cell precursor tangential migration,BP,
6961,GO:0021936,1,0.941358573468879,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6962,GO:0021937,1,0.96643648436607,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6963,GO:0021938,1,0.970354124878197,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6964,GO:0021940,1,0.952995433147088,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6965,GO:0021941,1,0.987795017803633,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6966,GO:0021942,1,0.967866911796648,0,4,radial glia guided migration of Purkinje cell,BP,
6967,GO:0021943,1,0.964526204629311,0,4,formation of radial glial scaffolds,BP,
6968,GO:0021944,1,0.993801587217129,0,1,neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration,BP,
6969,GO:0021952,1,0.762037224637454,0,26,central nervous system projection neuron axonogenesis,BP,
6970,GO:0021953,1,0.227445156881096,0,187,central nervous system neuron differentiation,BP,
6971,GO:0021954,1,0.505470574433749,0,81,central nervous system neuron development,BP,
6973,GO:0021956,1,0.996071670761121,0,1,central nervous system interneuron axonogenesis,BP,
6974,GO:0021957,1,0.929471470866595,0,7,corticospinal tract morphogenesis,BP,
6975,GO:0021960,1,0.956966303296386,0,5,anterior commissure morphogenesis,BP,
6976,GO:0021965,1,0.959245174515122,0,3,spinal cord ventral commissure morphogenesis,BP,
6977,GO:0021966,1,0.987173792730047,0,2,corticospinal neuron axon guidance,BP,
6978,GO:0021972,1,0.990459734623842,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6979,GO:0021978,1,0.935052652943041,0,12,telencephalon regionalization,BP,
6980,GO:0021979,1,0.951987249106046,0,7,hypothalamus cell differentiation,BP,
6981,GO:0021983,1,0.784588143847299,0,40,pituitary gland development,BP,
6982,GO:0021984,1,0.950402747997187,0,11,adenohypophysis development,BP,
6983,GO:0021985,1,0.987350297035694,0,2,neurohypophysis development,BP,
6984,GO:0021986,1,0.973317554193208,0,3,habenula development,BP,
6986,GO:0021988,1,0.753146719404173,0,33,olfactory lobe development,BP,
6987,GO:0021989,1,0.989517894699812,0,1,olfactory cortex development,BP,
6988,GO:0021993,1,0.989883697475773,0,1,initiation of neural tube closure,BP,
6989,GO:0021997,1,0.973321742897423,0,2,neural plate axis specification,BP,
6990,GO:0021998,1,0.993207627082606,0,1,neural plate mediolateral regionalization,BP,
6991,GO:0021999,1,0.96188343413911,0,5,neural plate anterior/posterior regionalization,BP,
6992,GO:0022007,1,0.978897225767634,0,3,convergent extension involved in neural plate elongation,BP,
6994,GO:0022009,1,0.976990847822434,0,4,central nervous system vasculogenesis,BP,
6995,GO:0022010,1,0.865824531064377,0,21,central nervous system myelination,BP,
6996,GO:0022011,1,0.776441391793795,0,27,myelination in peripheral nervous system,BP,
6997,GO:0022012,1,0.98450707858778,0,1,subpallium cell proliferation in forebrain,BP,
6998,GO:0022013,1,0.983904599470171,0,1,pallium cell proliferation in forebrain,BP,
6999,GO:0022018,1,0.98450707858778,0,1,lateral ganglionic eminence cell proliferation,BP,
7000,GO:0022027,1,0.921450437849565,0,5,interkinetic nuclear migration,BP,
7001,GO:0022028,1,0.946655001486732,0,5,tangential migration from the subventricular zone to the olfactory bulb,BP,
7002,GO:0022029,1,0.672164315549336,0,50,telencephalon cell migration,BP,
7003,GO:0022030,1,0.840239284130403,0,20,telencephalon glial cell migration,BP,
7005,GO:0022038,1,0.845170531495641,0,20,corpus callosum development,BP,
7006,GO:0022400,1,0.875098769257193,0,23,regulation of rhodopsin mediated signaling pathway,BP,
7009,GO:0022403,1,0.983659524878209,0,2,cell cycle phase,BP,
7010,GO:0022404,1,0.532915425944574,0,82,molting cycle process,BP,
7011,GO:0022405,1,0.532915425944574,0,82,hair cycle process,BP,
7016,GO:0022410,1,0.881580826982757,0,23,circadian sleep/wake cycle process,BP,
7019,GO:0022413,1,0.981051855925942,0,1,reproductive process in single-celled organism,BP,
7021,GO:0022417,1,0.973204863630441,0,7,protein maturation by protein folding,BP,
7023,GO:0022602,1,0.723440849637081,0,43,ovulation cycle process,BP,
7026,GO:0022605,1,0.965251410986718,0,6,mammalian oogenesis stage,BP,
7029,GO:0022612,1,0.39450384594271,0,117,gland morphogenesis,BP,
7031,GO:0022614,1,0.962981864857911,0,5,membrane to membrane docking,BP,
7032,GO:0022615,1,0.984047307846636,0,4,protein to membrane docking,BP,
7033,GO:0022616,1,0.843760861927121,0,25,DNA strand elongation,BP,
7036,GO:0022624,1,0.909658555765451,0,24,proteasome accessory complex,CC,
7037,GO:0022625,1,0.830515650380477,0,54,cytosolic large ribosomal subunit,CC,
7038,GO:0022626,1,0.660819412819667,0,103,cytosolic ribosome,CC,
7039,GO:0022627,1,0.829735313774038,0,44,cytosolic small ribosomal subunit,CC,
7042,GO:0022821,1,0.89775444599084,0,14,potassium ion antiporter activity,MF,
7044,GO:0022829,1,0.895400279859549,0,22,wide pore channel activity,MF,
7049,GO:0022839,1,0.771832051049733,0,39,ion gated channel activity,MF,
7050,GO:0022840,1,0.912089529626774,0,16,leak channel activity,MF,
7051,GO:0022841,1,0.929086994600661,0,14,potassium ion leak channel activity,MF,
7052,GO:0022842,1,0.912089529626774,0,16,narrow pore channel activity,MF,
7054,GO:0022848,1,0.926754393954421,0,14,acetylcholine-gated cation-selective channel activity,MF,
7056,GO:0022850,1,0.992040227687856,0,2,serotonin-gated cation-selective channel activity,MF,
7058,GO:0022852,1,0.987092340340555,0,2,glycine-gated chloride ion channel activity,MF,
7061,GO:0022858,1,0.940477078558798,0,9,alanine transmembrane transporter activity,MF,
7062,GO:0022884,1,0.890469094761729,0,19,macromolecule transmembrane transporter activity,MF,
7063,GO:0022889,1,0.950723282458698,0,9,serine transmembrane transporter activity,MF,
7065,GO:0022894,1,0.995748440757121,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7067,GO:0022900,1,0.491569358535548,0,158,electron transport chain,BP,
7068,GO:0022904,1,0.657253402315104,0,98,respiratory electron transport chain,BP,
7070,GO:0023016,1,0.966477335197537,0,3,signal transduction by trans-phosphorylation,BP,
7071,GO:0023019,1,0.882287941453511,0,19,signal transduction involved in regulation of gene expression,BP,
7072,GO:0023021,1,0.986047883925745,0,3,termination of signal transduction,BP,
7073,GO:0023023,1,0.900066946118658,0,24,MHC protein complex binding,MF,
7074,GO:0023024,1,0.975116668479501,0,6,MHC class I protein complex binding,MF,
7075,GO:0023025,1,0.983478634264136,0,3,MHC class Ib protein complex binding,MF,
7076,GO:0023026,1,0.93300905013521,0,16,MHC class II protein complex binding,MF,
7077,GO:0023029,1,0.963574944206259,0,7,MHC class Ib protein binding,MF,
7078,GO:0023030,1,0.994078766715654,0,1,MHC class Ib protein binding, via antigen binding groove,MF,
7079,GO:0023035,1,0.921888194586024,0,15,CD40 signaling pathway,BP,
7080,GO:0023041,1,0.959230451231754,0,6,neuronal signal transduction,BP,
7088,GO:0030002,1,0.915745461028443,0,10,cellular anion homeostasis,BP,
7092,GO:0030008,1,0.929645991669138,0,14,TRAPP complex,CC,
7093,GO:0030010,1,0.323084604646521,0,136,establishment of cell polarity,BP,
7094,GO:0030011,1,0.855758501670656,0,18,maintenance of cell polarity,BP,
7095,GO:0030014,1,0.89086338862236,0,15,CCR4-NOT complex,CC,
7096,GO:0030015,1,0.967203867141921,0,5,CCR4-NOT core complex,CC,
7097,GO:0030016,1,0.153437980803276,0,213,myofibril,CC,
7098,GO:0030017,1,0.182631427853975,0,194,sarcomere,CC,
7099,GO:0030018,1,0.301559763236743,0,122,Z disc,CC,
7102,GO:0030023,1,0.906032100222294,0,9,extracellular matrix constituent conferring elasticity,MF,
7103,GO:0030026,1,0.994001994752578,0,1,cellular manganese ion homeostasis,BP,
7108,GO:0030032,1,0.64371480156103,0,59,lamellipodium assembly,BP,
7109,GO:0030033,1,0.870244589903562,0,17,microvillus assembly,BP,
7110,GO:0030034,1,0.993383665894168,0,1,microvillar actin bundle assembly,BP,
7111,GO:0030035,1,0.966222365310413,0,4,microspike assembly,BP,
7113,GO:0030037,1,0.990473323739117,0,1,actin filament reorganization involved in cell cycle,BP,
7114,GO:0030038,1,0.448278032150196,0,99,contractile actin filament bundle assembly,BP,
7115,GO:0030041,1,0.297582279863975,0,173,actin filament polymerization,BP,
7116,GO:0030042,1,0.648553527022712,0,52,actin filament depolymerization,BP,
7117,GO:0030043,1,0.982019146692977,0,4,actin filament fragmentation,BP,
7118,GO:0030046,1,0.952321981861713,0,7,parallel actin filament bundle assembly,BP,
7119,GO:0030047,1,0.974404488234296,0,4,actin modification,BP,
7122,GO:0030050,1,0.811011704425284,0,18,vesicle transport along actin filament,BP,
7125,GO:0030056,1,0.91411676198003,0,5,hemidesmosome,CC,
7126,GO:0030057,1,0.816531429312942,0,22,desmosome,CC,
7127,GO:0030060,1,0.985090958131051,0,4,L-malate dehydrogenase activity,MF,
7128,GO:0030061,1,0.958730014551403,0,7,mitochondrial crista,CC,
7129,GO:0030062,1,0.960262918106054,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7130,GO:0030070,1,0.986419233910432,0,2,insulin processing,BP,
7131,GO:0030071,1,0.683762749768862,0,55,regulation of mitotic metaphase/anaphase transition,BP,
7134,GO:0030091,1,0.969729699705334,0,7,protein repair,BP,
7139,GO:0030101,1,0.716450588762505,0,59,natural killer cell activation,BP,
7140,GO:0030103,1,0.991053651054203,0,2,vasopressin secretion,BP,
7141,GO:0030104,1,0.609930114406594,0,66,water homeostasis,BP,
7142,GO:0030107,1,0.994717530295309,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7143,GO:0030108,1,0.996566348061452,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7144,GO:0030109,1,0.990918846827402,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7146,GO:0030116,1,0.986886756877004,0,4,glial cell-derived neurotrophic factor receptor binding,MF,
7147,GO:0030117,1,0.542070619957208,0,89,membrane coat,CC,
7148,GO:0030118,1,0.725685076152582,0,43,clathrin coat,CC,
7149,GO:0030119,1,0.772422162557833,0,37,AP-type membrane coat adaptor complex,CC,
7150,GO:0030120,1,0.700290775907041,0,52,vesicle coat,CC,
7151,GO:0030121,1,0.966592011369586,0,5,AP-1 adaptor complex,CC,
7152,GO:0030122,1,0.926570282751946,0,10,AP-2 adaptor complex,CC,
7153,GO:0030123,1,0.932633829457517,0,9,AP-3 adaptor complex,CC,
7154,GO:0030124,1,0.975563554732299,0,4,AP-4 adaptor complex,CC,
7155,GO:0030125,1,0.829176311941564,0,26,clathrin vesicle coat,CC,
7156,GO:0030126,1,0.936454577409318,0,12,COPI vesicle coat,CC,
7157,GO:0030127,1,0.895262310577621,0,15,COPII vesicle coat,CC,
7158,GO:0030128,1,0.918293927204806,0,11,clathrin coat of endocytic vesicle,CC,
7159,GO:0030130,1,0.922384734368612,0,11,clathrin coat of trans-Golgi network vesicle,CC,
7160,GO:0030131,1,0.856582207970004,0,22,clathrin adaptor complex,CC,
7161,GO:0030132,1,0.888818545872584,0,15,clathrin coat of coated pit,CC,
7163,GO:0030134,1,0.566744222333126,0,88,COPII-coated ER to Golgi transport vesicle,CC,
7168,GO:0030140,1,0.797807633010756,0,29,trans-Golgi network transport vesicle,CC,
7170,GO:0030142,1,0.981803664070194,0,1,COPI-coated Golgi to ER transport vesicle,CC,
7171,GO:0030144,1,0.987593559701551,0,2,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7172,GO:0030145,1,0.669537136389663,0,60,manganese ion binding,MF,
7174,GO:0030149,1,0.852282797048956,0,29,sphingolipid catabolic process,BP,
7175,GO:0030150,1,0.927704514355029,0,17,protein import into mitochondrial matrix,BP,
7176,GO:0030151,1,0.990585136724116,0,2,molybdenum ion binding,MF,
7179,GO:0030156,1,0.99686000552733,0,1,benzodiazepine receptor binding,MF,
7180,GO:0030157,1,0.933727236511821,0,11,pancreatic juice secretion,BP,
7181,GO:0030158,1,0.976006022615204,0,2,protein xylosyltransferase activity,MF,
7186,GO:0030165,1,0.522437590806272,0,79,PDZ domain binding,MF,
7187,GO:0030166,1,0.587299914408947,0,64,proteoglycan biosynthetic process,BP,
7188,GO:0030167,1,0.97499173000742,0,4,proteoglycan catabolic process,BP,
7190,GO:0030169,1,0.896469014021486,0,14,low-density lipoprotein particle binding,MF,
7192,GO:0030171,1,0.996363774680385,0,1,voltage-gated proton channel activity,MF,
7193,GO:0030172,1,0.990340088955723,0,3,troponin C binding,MF,
7194,GO:0030173,1,0.706735302239577,0,58,integral component of Golgi membrane,CC,
7195,GO:0030174,1,0.963948810755709,0,7,regulation of DNA-dependent DNA replication initiation,BP,
7197,GO:0030176,1,0.445998507882908,0,146,integral component of endoplasmic reticulum membrane,CC,
7201,GO:0030183,1,0.449496070043615,0,111,B cell differentiation,BP,
7202,GO:0030184,1,0.994919586867286,0,1,nitric oxide transmembrane transporter activity,MF,
7203,GO:0030185,1,0.987791072424834,0,3,nitric oxide transport,BP,
7204,GO:0030186,1,0.996570081355208,0,1,melatonin metabolic process,BP,
7205,GO:0030187,1,0.996570081355208,0,1,melatonin biosynthetic process,BP,
7209,GO:0030197,1,0.986507899843009,0,2,extracellular matrix constituent, lubricant activity,MF,
7212,GO:0030200,1,0.984367123843717,0,3,heparan sulfate proteoglycan catabolic process,BP,
7213,GO:0030201,1,0.776375868598281,0,32,heparan sulfate proteoglycan metabolic process,BP,
7214,GO:0030202,1,0.921061715906348,0,10,heparin metabolic process,BP,
7216,GO:0030204,1,0.747151116361846,0,38,chondroitin sulfate metabolic process,BP,
7217,GO:0030205,1,0.897748274393726,0,13,dermatan sulfate metabolic process,BP,
7218,GO:0030206,1,0.810503256095392,0,26,chondroitin sulfate biosynthetic process,BP,
7219,GO:0030207,1,0.903035452777579,0,14,chondroitin sulfate catabolic process,BP,
7220,GO:0030208,1,0.901523989934231,0,12,dermatan sulfate biosynthetic process,BP,
7221,GO:0030209,1,0.995816187204086,0,1,dermatan sulfate catabolic process,BP,
7222,GO:0030210,1,0.924934486158397,0,9,heparin biosynthetic process,BP,
7223,GO:0030211,1,0.995816187204086,0,1,heparin catabolic process,BP,
7224,GO:0030212,1,0.803129742836785,0,35,hyaluronan metabolic process,BP,
7225,GO:0030213,1,0.909541477444142,0,14,hyaluronan biosynthetic process,BP,
7226,GO:0030214,1,0.922141262802681,0,14,hyaluronan catabolic process,BP,
7227,GO:0030215,1,0.810691218733888,0,23,semaphorin receptor binding,MF,
7230,GO:0030218,1,0.450011751742142,0,113,erythrocyte differentiation,BP,
7232,GO:0030220,1,0.842265385450073,0,20,platelet formation,BP,
7233,GO:0030221,1,0.987019412732502,0,2,basophil differentiation,BP,
7234,GO:0030222,1,0.983566148725379,0,3,eosinophil differentiation,BP,
7235,GO:0030223,1,0.94470389874954,0,8,neutrophil differentiation,BP,
7236,GO:0030224,1,0.786983611644137,0,34,monocyte differentiation,BP,
7238,GO:0030226,1,0.942524890220064,0,3,apolipoprotein receptor activity,MF,
7239,GO:0030228,1,0.863011189907942,0,15,lipoprotein particle receptor activity,MF,
7240,GO:0030229,1,0.970313582485187,0,4,very-low-density lipoprotein particle receptor activity,MF,
7241,GO:0030233,1,0.996437138962998,0,1,deoxynucleotide transmembrane transporter activity,MF,
7243,GO:0030235,1,0.946678980808624,0,7,nitric-oxide synthase regulator activity,MF,
7244,GO:0030237,1,0.987292593383801,0,2,female sex determination,BP,
7245,GO:0030238,1,0.906105255119445,0,14,male sex determination,BP,
7246,GO:0030239,1,0.555923835255391,0,63,myofibril assembly,BP,
7247,GO:0030240,1,0.916792407163318,0,6,skeletal muscle thin filament assembly,BP,
7248,GO:0030241,1,0.926576022255263,0,3,skeletal muscle myosin thick filament assembly,BP,
7249,GO:0030242,1,0.960105221030714,0,5,autophagy of peroxisome,BP,
7251,GO:0030247,1,0.869798064409476,0,23,polysaccharide binding,MF,
7252,GO:0030249,1,0.98439142718854,0,4,guanylate cyclase regulator activity,MF,
7253,GO:0030250,1,0.988668543087354,0,3,guanylate cyclase activator activity,MF,
7254,GO:0030251,1,0.995674356513494,0,1,guanylate cyclase inhibitor activity,MF,
7255,GO:0030252,1,0.900560651355122,0,14,growth hormone secretion,BP,
7257,GO:0030259,1,0.949568554084003,0,10,lipid glycosylation,BP,
7258,GO:0030261,1,0.781076336408383,0,27,chromosome condensation,BP,
7259,GO:0030262,1,0.813688366955912,0,32,apoptotic nuclear changes,BP,
7260,GO:0030263,1,0.9694393994952,0,4,apoptotic chromosome condensation,BP,
7261,GO:0030264,1,0.994890876864838,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7262,GO:0030267,1,0.996702621226445,0,1,glyoxylate reductase (NADP) activity,MF,
7263,GO:0030272,1,0.99682997727444,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7264,GO:0030273,1,0.995482467429674,0,1,melanin-concentrating hormone receptor activity,MF,
7265,GO:0030274,1,0.957458367992351,0,6,LIM domain binding,MF,
7266,GO:0030275,1,0.905262015103197,0,14,LRR domain binding,MF,
7270,GO:0030279,1,0.62322919131881,0,64,negative regulation of ossification,BP,
7271,GO:0030280,1,0.955564625245494,0,5,structural constituent of skin epidermis,MF,
7273,GO:0030283,1,0.979881651460135,0,6,testosterone dehydrogenase [NAD(P)] activity,MF,
7274,GO:0030284,1,0.966020340009295,0,5,estrogen receptor activity,MF,
7276,GO:0030286,1,0.592116695065953,0,47,dynein complex,CC,
7277,GO:0030289,1,0.985806386974429,0,3,protein phosphatase 4 complex,CC,
7278,GO:0030290,1,0.993296780819711,0,1,sphingolipid activator protein activity,MF,
7279,GO:0030291,1,0.855777588226803,0,28,protein serine/threonine kinase inhibitor activity,MF,
7280,GO:0030292,1,0.984744917225283,0,2,protein tyrosine kinase inhibitor activity,MF,
7281,GO:0030294,1,0.995795928072529,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7283,GO:0030296,1,0.886594002876006,0,15,protein tyrosine kinase activator activity,MF,
7284,GO:0030297,1,0.949531420727418,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7285,GO:0030299,1,0.943960324761319,0,10,intestinal cholesterol absorption,BP,
7286,GO:0030300,1,0.981292095525437,0,4,regulation of intestinal cholesterol absorption,BP,
7288,GO:0030302,1,0.996437138962998,0,1,deoxynucleotide transport,BP,
7289,GO:0030305,1,0.988232712883245,0,2,heparanase activity,MF,
7290,GO:0030306,1,0.930471484807948,0,7,ADP-ribosylation factor binding,MF,
7292,GO:0030308,1,0.312327916963873,0,175,negative regulation of cell growth,BP,
7293,GO:0030309,1,0.94034182630459,0,11,poly-N-acetyllactosamine metabolic process,BP,
7294,GO:0030311,1,0.946177268056074,0,10,poly-N-acetyllactosamine biosynthetic process,BP,
7295,GO:0030312,1,0.988500812706035,0,3,external encapsulating structure,CC,
7297,GO:0030315,1,0.609163660441749,0,54,T-tubule,CC,
7299,GO:0030317,1,0.598167220107258,0,73,flagellated sperm motility,BP,
7300,GO:0030318,1,0.799150666915282,0,24,melanocyte differentiation,BP,
7301,GO:0030320,1,0.915745461028443,0,10,cellular monovalent inorganic anion homeostasis,BP,
7302,GO:0030321,1,0.970005498818678,0,5,transepithelial chloride transport,BP,
7303,GO:0030322,1,0.925647685219713,0,15,stabilization of membrane potential,BP,
7306,GO:0030325,1,0.824224084223634,0,23,adrenal gland development,BP,
7307,GO:0030326,1,0.367135061775247,0,120,embryonic limb morphogenesis,BP,
7308,GO:0030327,1,0.979256655555267,0,3,prenylated protein catabolic process,BP,
7309,GO:0030328,1,0.985015854865441,0,2,prenylcysteine catabolic process,BP,
7310,GO:0030329,1,0.985015854865441,0,2,prenylcysteine metabolic process,BP,
7311,GO:0030330,1,0.487717306998225,0,102,DNA damage response, signal transduction by p53 class mediator,BP,
7312,GO:0030331,1,0.735146221049337,0,38,estrogen receptor binding,MF,
7313,GO:0030332,1,0.820393178813115,0,29,cyclin binding,MF,
7317,GO:0030337,1,0.988065952517844,0,3,DNA polymerase processivity factor activity,MF,
7318,GO:0030342,1,0.994123413353288,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7319,GO:0030343,1,0.992145540012824,0,2,vitamin D3 25-hydroxylase activity,MF,
7320,GO:0030345,1,0.994307049706133,0,1,structural constituent of tooth enamel,MF,
7321,GO:0030346,1,0.946450282385691,0,7,protein phosphatase 2B binding,MF,
7323,GO:0030350,1,0.981228299951039,0,2,iron-responsive element binding,MF,
7324,GO:0030351,1,0.994748901495519,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7325,GO:0030354,1,0.99685720332644,0,1,melanin-concentrating hormone activity,MF,
7326,GO:0030366,1,0.996599593689586,0,1,molybdopterin synthase activity,MF,
7327,GO:0030368,1,0.946125411014688,0,8,interleukin-17 receptor activity,MF,
7328,GO:0030369,1,0.984833798088809,0,2,ICAM-3 receptor activity,MF,
7330,GO:0030374,1,0.638640159340891,0,54,nuclear receptor transcription coactivator activity,MF,
7331,GO:0030375,1,0.959327408758686,0,4,thyroid hormone receptor coactivator activity,MF,
7332,GO:0030377,1,0.996589959106216,0,1,urokinase plasminogen activator receptor activity,MF,
7333,GO:0030378,1,0.995385273459009,0,1,serine racemase activity,MF,
7334,GO:0030379,1,0.986626485792933,0,1,neurotensin receptor activity, non-G protein-coupled,MF,
7335,GO:0030382,1,0.98028223266894,0,1,sperm mitochondrion organization,BP,
7336,GO:0030387,1,0.996593192993099,0,1,fructosamine-3-kinase activity,MF,
7337,GO:0030388,1,0.968655192085266,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7338,GO:0030389,1,0.993472505369287,0,2,fructosamine metabolic process,BP,
7339,GO:0030393,1,0.996593192993099,0,1,fructoselysine metabolic process,BP,
7340,GO:0030395,1,0.993246513252639,0,2,lactose binding,MF,
7341,GO:0030397,1,0.89609845301503,0,16,membrane disassembly,BP,
7342,GO:0030407,1,0.99618693377639,0,1,formimidoyltransferase activity,MF,
7343,GO:0030409,1,0.99618693377639,0,1,glutamate formimidoyltransferase activity,MF,
7344,GO:0030412,1,0.99618693377639,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7346,GO:0030421,1,0.996826493587376,0,1,defecation,BP,
7347,GO:0030422,1,0.937757849688793,0,10,production of siRNA involved in RNA interference,BP,
7348,GO:0030423,1,0.965476979938082,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7353,GO:0030429,1,0.996558105895603,0,1,kynureninase activity,MF,
7354,GO:0030430,1,0.967785435136569,0,6,host cell cytoplasm,CC,
7355,GO:0030431,1,0.820982515084229,0,30,sleep,BP,
7356,GO:0030432,1,0.956077357063499,0,9,peristalsis,BP,
7357,GO:0030433,1,0.642062985967352,0,71,ubiquitin-dependent ERAD pathway,BP,
7359,GO:0030450,1,0.974498977806545,0,3,regulation of complement activation, classical pathway,BP,
7360,GO:0030451,1,0.975111691550678,0,3,regulation of complement activation, alternative pathway,BP,
7361,GO:0030473,1,0.947182894053165,0,5,nuclear migration along microtubule,BP,
7362,GO:0030478,1,0.970857373823216,0,4,actin cap,CC,
7363,GO:0030485,1,0.984285518672018,0,3,smooth muscle contractile fiber,CC,
7364,GO:0030488,1,0.805188137589341,0,37,tRNA methylation,BP,
7365,GO:0030490,1,0.768267190132994,0,46,maturation of SSU-rRNA,BP,
7366,GO:0030492,1,0.968636374811594,0,8,hemoglobin binding,MF,
7368,GO:0030497,1,0.935679267780573,0,12,fatty acid elongation,BP,
7371,GO:0030502,1,0.910792924310855,0,13,negative regulation of bone mineralization,BP,
7372,GO:0030504,1,0.984522852642917,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7373,GO:0030505,1,0.970596684104379,0,2,inorganic diphosphate transport,BP,
7374,GO:0030506,1,0.79124679633293,0,18,ankyrin binding,MF,
7375,GO:0030507,1,0.774128932577671,0,27,spectrin binding,MF,
7377,GO:0030510,1,0.495800187224159,0,83,regulation of BMP signaling pathway,BP,
7378,GO:0030511,1,0.786051924566058,0,29,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7379,GO:0030512,1,0.538301814749471,0,77,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7380,GO:0030513,1,0.755022346299733,0,31,positive regulation of BMP signaling pathway,BP,
7381,GO:0030514,1,0.683035116348764,0,46,negative regulation of BMP signaling pathway,BP,
7382,GO:0030515,1,0.823276977230226,0,30,snoRNA binding,MF,
7384,GO:0030517,1,0.709919722013663,0,42,negative regulation of axon extension,BP,
7385,GO:0030518,1,0.448730213149061,0,106,intracellular steroid hormone receptor signaling pathway,BP,
7386,GO:0030519,1,0.992540089353925,0,1,snoRNP binding,MF,
7387,GO:0030520,1,0.6955648722379,0,52,intracellular estrogen receptor signaling pathway,BP,
7388,GO:0030521,1,0.743466826138527,0,38,androgen receptor signaling pathway,BP,
7389,GO:0030522,1,0.175179516790866,0,240,intracellular receptor signaling pathway,BP,
7390,GO:0030523,1,0.991703185747767,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7391,GO:0030526,1,0.990710986513408,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7392,GO:0030527,1,0.996097520350714,0,1,structural constituent of chromatin,MF,
7393,GO:0030532,1,0.729640618408665,0,61,small nuclear ribonucleoprotein complex,CC,
7395,GO:0030538,1,0.983945076769885,0,3,embryonic genitalia morphogenesis,BP,
7396,GO:0030539,1,0.869266429845394,0,21,male genitalia development,BP,
7397,GO:0030540,1,0.865793025771649,0,16,female genitalia development,BP,
7398,GO:0030544,1,0.778676704557528,0,39,Hsp70 protein binding,MF,
7401,GO:0030547,1,0.886222449591651,0,23,receptor inhibitor activity,MF,
7402,GO:0030548,1,0.961159831638698,0,9,acetylcholine receptor regulator activity,MF,
7403,GO:0030549,1,0.996742710266944,0,1,acetylcholine receptor activator activity,MF,
7404,GO:0030550,1,0.971124823537331,0,6,acetylcholine receptor inhibitor activity,MF,
7407,GO:0030553,1,0.906543489288794,0,12,cGMP binding,MF,
7409,GO:0030572,1,0.992836338383579,0,1,phosphatidyltransferase activity,MF,
7410,GO:0030573,1,0.996083749376374,0,1,bile acid catabolic process,BP,
7411,GO:0030574,1,0.785617306056517,0,39,collagen catabolic process,BP,
7413,GO:0030576,1,0.979837607697938,0,4,Cajal body organization,BP,
7414,GO:0030578,1,0.938419021565374,0,6,PML body organization,BP,
7415,GO:0030579,1,0.96436596426982,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7416,GO:0030580,1,0.993242241771513,0,2,quinone cofactor methyltransferase activity,MF,
7417,GO:0030581,1,0.993113491085501,0,2,symbiont intracellular protein transport in host,BP,
7418,GO:0030586,1,0.993884494377349,0,1,[methionine synthase] reductase activity,MF,
7419,GO:0030592,1,0.984280350868304,0,3,DNA ADP-ribosylation,BP,
7420,GO:0030593,1,0.648631636027599,0,84,neutrophil chemotaxis,BP,
7423,GO:0030611,1,0.996822899952107,0,1,arsenate reductase activity,MF,
7424,GO:0030613,1,0.990258359415888,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7425,GO:0030614,1,0.990258359415888,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7426,GO:0030619,1,0.957688479411318,0,7,U1 snRNA binding,MF,
7427,GO:0030620,1,0.975000057105429,0,4,U2 snRNA binding,MF,
7428,GO:0030621,1,0.967312733832038,0,5,U4 snRNA binding,MF,
7429,GO:0030622,1,0.985467268466494,0,2,U4atac snRNA binding,MF,
7430,GO:0030623,1,0.978341146587925,0,2,U5 snRNA binding,MF,
7431,GO:0030624,1,0.991640736763234,0,1,U6atac snRNA binding,MF,
7432,GO:0030626,1,0.988997840320558,0,2,U12 snRNA binding,MF,
7433,GO:0030627,1,0.996723077165414,0,1,pre-mRNA 5'-splice site binding,MF,
7434,GO:0030628,1,0.977920566321424,0,5,pre-mRNA 3'-splice site binding,MF,
7435,GO:0030629,1,0.991773681351629,0,2,U6 snRNA 3'-end binding,MF,
7436,GO:0030638,1,0.966944050393003,0,9,polyketide metabolic process,BP,
7437,GO:0030641,1,0.570586497150314,0,87,regulation of cellular pH,BP,
7438,GO:0030643,1,0.954875890000378,0,5,cellular phosphate ion homeostasis,BP,
7439,GO:0030644,1,0.959038900950062,0,5,cellular chloride ion homeostasis,BP,
7440,GO:0030647,1,0.966944050393003,0,9,aminoglycoside antibiotic metabolic process,BP,
7441,GO:0030653,1,0.990273865801745,0,1,beta-lactam antibiotic metabolic process,BP,
7442,GO:0030656,1,0.936538379719455,0,12,regulation of vitamin metabolic process,BP,
7445,GO:0030660,1,0.518359387378391,0,103,Golgi-associated vesicle membrane,CC,
7447,GO:0030663,1,0.918442117869122,0,17,COPI-coated vesicle membrane,CC,
7452,GO:0030670,1,0.647752614715734,0,71,phagocytic vesicle membrane,CC,
7456,GO:0030676,1,0.836445372987226,0,19,Rac guanyl-nucleotide exchange factor activity,MF,
7457,GO:0030677,1,0.946562186318659,0,12,ribonuclease P complex,CC,
7458,GO:0030678,1,0.991718871826852,0,2,mitochondrial ribonuclease P complex,CC,
7459,GO:0030681,1,0.95446995466897,0,10,multimeric ribonuclease P complex,CC,
7460,GO:0030682,1,0.971274201551379,0,3,mitigation of host defenses by symbiont,BP,
7461,GO:0030683,1,0.985064876305212,0,2,mitigation of host immune response by virus,BP,
7462,GO:0030684,1,0.636985387847936,0,70,preribosome,CC,
7463,GO:0030686,1,0.847119266829213,0,25,90S preribosome,CC,
7464,GO:0030687,1,0.869842468564926,0,22,preribosome, large subunit precursor,CC,
7465,GO:0030688,1,0.909503620059958,0,15,preribosome, small subunit precursor,CC,
7466,GO:0030689,1,0.98590754521263,0,3,Noc complex,CC,
7467,GO:0030690,1,0.994811191363366,0,1,Noc1p-Noc2p complex,CC,
7468,GO:0030691,1,0.994811191363366,0,1,Noc2p-Noc3p complex,CC,
7469,GO:0030692,1,0.991050378137609,0,2,Noc4p-Nop14p complex,CC,
7470,GO:0030695,1,0.0943619405133375,0,284,GTPase regulator activity,MF,
7471,GO:0030696,1,0.994145179036613,0,1,tRNA (m5U54) methyltransferase activity,MF,
7472,GO:0030697,1,0.994145179036613,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7473,GO:0030704,1,0.995983180678702,0,1,vitelline membrane formation,BP,
7474,GO:0030705,1,0.201408852084287,0,186,cytoskeleton-dependent intracellular transport,BP,
7475,GO:0030718,1,0.989298856034996,0,2,germ-line stem cell population maintenance,BP,
7476,GO:0030719,1,0.988669169193162,0,2,P granule organization,BP,
7477,GO:0030728,1,0.860237909139447,0,21,ovulation,BP,
7478,GO:0030729,1,0.993799559754691,0,1,acetoacetate-CoA ligase activity,MF,
7479,GO:0030730,1,0.892525301042548,0,17,sequestering of triglyceride,BP,
7480,GO:0030731,1,0.99679516022262,0,1,guanidinoacetate N-methyltransferase activity,MF,
7482,GO:0030748,1,0.995258827654657,0,1,amine N-methyltransferase activity,MF,
7484,GO:0030791,1,0.995401391120684,0,1,arsenite methyltransferase activity,MF,
7485,GO:0030792,1,0.98621211548595,0,2,methylarsonite methyltransferase activity,MF,
7486,GO:0030808,1,0.804626593768453,0,34,regulation of nucleotide biosynthetic process,BP,
7487,GO:0030809,1,0.967012944316679,0,6,negative regulation of nucleotide biosynthetic process,BP,
7488,GO:0030810,1,0.90294996605211,0,17,positive regulation of nucleotide biosynthetic process,BP,
7489,GO:0030832,1,0.289801881068611,0,171,regulation of actin filament length,BP,
7490,GO:0030833,1,0.336387174022632,0,155,regulation of actin filament polymerization,BP,
7491,GO:0030834,1,0.67321672123937,0,48,regulation of actin filament depolymerization,BP,
7492,GO:0030835,1,0.720714993828204,0,38,negative regulation of actin filament depolymerization,BP,
7493,GO:0030836,1,0.934037323333219,0,10,positive regulation of actin filament depolymerization,BP,
7494,GO:0030837,1,0.64447417477488,0,57,negative regulation of actin filament polymerization,BP,
7495,GO:0030838,1,0.572658358570782,0,88,positive regulation of actin filament polymerization,BP,
7496,GO:0030842,1,0.989362518301575,0,1,regulation of intermediate filament depolymerization,BP,
7497,GO:0030844,1,0.989362518301575,0,1,positive regulation of intermediate filament depolymerization,BP,
7498,GO:0030845,1,0.99473415708652,0,1,phospholipase C-inhibiting G protein-coupled receptor signaling pathway,BP,
7499,GO:0030846,1,0.969783006687837,0,3,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7500,GO:0030849,1,0.986535152310605,0,2,autosome,CC,
7502,GO:0030851,1,0.829718907561075,0,30,granulocyte differentiation,BP,
7503,GO:0030852,1,0.923045089701316,0,13,regulation of granulocyte differentiation,BP,
7504,GO:0030853,1,0.953484287939196,0,7,negative regulation of granulocyte differentiation,BP,
7505,GO:0030854,1,0.961502983419958,0,7,positive regulation of granulocyte differentiation,BP,
7508,GO:0030857,1,0.753409678559372,0,41,negative regulation of epithelial cell differentiation,BP,
7510,GO:0030859,1,0.838929553725592,0,22,polarized epithelial cell differentiation,BP,
7511,GO:0030860,1,0.98477382953229,0,2,regulation of polarized epithelial cell differentiation,BP,
7512,GO:0030862,1,0.98936724836986,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7515,GO:0030865,1,0.64695982763677,0,59,cortical cytoskeleton organization,BP,
7516,GO:0030866,1,0.729039815579521,0,38,cortical actin cytoskeleton organization,BP,
7517,GO:0030867,1,0.86970467649219,0,27,rough endoplasmic reticulum membrane,CC,
7518,GO:0030868,1,0.972161713405944,0,5,smooth endoplasmic reticulum membrane,CC,
7519,GO:0030870,1,0.962331292363722,0,5,Mre11 complex,CC,
7520,GO:0030874,1,0.996371666164808,0,1,nucleolar chromatin,CC,
7521,GO:0030877,1,0.899483917530909,0,12,beta-catenin destruction complex,CC,
7522,GO:0030878,1,0.884427094558509,0,21,thyroid gland development,BP,
7523,GO:0030879,1,0.351418300433458,0,129,mammary gland development,BP,
7524,GO:0030880,1,0.543953838242902,0,99,RNA polymerase complex,CC,
7525,GO:0030881,1,0.971959968098128,0,7,beta-2-microglobulin binding,MF,
7526,GO:0030882,1,0.975213594298094,0,5,lipid antigen binding,MF,
7527,GO:0030883,1,0.980342665716165,0,4,endogenous lipid antigen binding,MF,
7528,GO:0030884,1,0.980342665716165,0,4,exogenous lipid antigen binding,MF,
7529,GO:0030885,1,0.978362247111989,0,6,regulation of myeloid dendritic cell activation,BP,
7530,GO:0030886,1,0.988748872719482,0,3,negative regulation of myeloid dendritic cell activation,BP,
7531,GO:0030887,1,0.992688783517175,0,2,positive regulation of myeloid dendritic cell activation,BP,
7532,GO:0030888,1,0.69638867186491,0,57,regulation of B cell proliferation,BP,
7533,GO:0030889,1,0.894349811353982,0,17,negative regulation of B cell proliferation,BP,
7534,GO:0030890,1,0.80072368983563,0,36,positive regulation of B cell proliferation,BP,
7535,GO:0030891,1,0.983358362345426,0,3,VCB complex,CC,
7536,GO:0030892,1,0.984946933067063,0,3,mitotic cohesin complex,CC,
7537,GO:0030893,1,0.944046081737026,0,7,meiotic cohesin complex,CC,
7538,GO:0030894,1,0.870021016512668,0,25,replisome,CC,
7539,GO:0030895,1,0.991221598058903,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7540,GO:0030896,1,0.979342258242423,0,4,checkpoint clamp complex,CC,
7541,GO:0030897,1,0.89938242761157,0,12,HOPS complex,CC,
7542,GO:0030898,1,0.750938518027317,0,23,actin-dependent ATPase activity,MF,
7543,GO:0030899,1,0.981037012368822,0,3,calcium-dependent ATPase activity,MF,
7547,GO:0030903,1,0.873549146950928,0,18,notochord development,BP,
7548,GO:0030904,1,0.864650129144935,0,20,retromer complex,CC,
7549,GO:0030905,1,0.971311019415129,0,4,retromer, tubulation complex,CC,
7550,GO:0030906,1,0.979054107963467,0,4,retromer, cargo-selective complex,CC,
7551,GO:0030908,1,0.992491022236586,0,2,protein splicing,BP,
7552,GO:0030910,1,0.97765460139325,0,3,olfactory placode formation,BP,
7553,GO:0030911,1,0.940060584560424,0,8,TPR domain binding,MF,
7554,GO:0030913,1,0.93520464213604,0,7,paranodal junction assembly,BP,
7555,GO:0030914,1,0.927800564797346,0,11,STAGA complex,CC,
7556,GO:0030915,1,0.965680487116855,0,6,Smc5-Smc6 complex,CC,
7557,GO:0030916,1,0.95218787468512,0,8,otic vesicle formation,BP,
7558,GO:0030917,1,0.952593150382133,0,7,midbrain-hindbrain boundary development,BP,
7559,GO:0030920,1,0.993380246549876,0,2,peptidyl-serine acetylation,BP,
7560,GO:0030934,1,0.952695718011032,0,3,anchoring collagen complex,CC,
7561,GO:0030935,1,0.995141279653256,0,1,sheet-forming collagen trimer,CC,
7562,GO:0030936,1,0.994345904806534,0,1,transmembrane collagen trimer,CC,
7563,GO:0030942,1,0.987857224346732,0,3,endoplasmic reticulum signal peptide binding,MF,
7564,GO:0030943,1,0.985234410880671,0,3,mitochondrion targeting sequence binding,MF,
7565,GO:0030947,1,0.825735340077916,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7566,GO:0030948,1,0.931111002348223,0,11,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7567,GO:0030949,1,0.918060424896237,0,13,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7568,GO:0030950,1,0.963208058020799,0,5,establishment or maintenance of actin cytoskeleton polarity,BP,
7569,GO:0030951,1,0.971361100009559,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7570,GO:0030952,1,0.935612652112469,0,9,establishment or maintenance of cytoskeleton polarity,BP,
7571,GO:0030953,1,0.909807626739685,0,10,astral microtubule organization,BP,
7572,GO:0030954,1,0.990071588518964,0,1,astral microtubule nucleation,BP,
7573,GO:0030955,1,0.914140183014471,0,12,potassium ion binding,MF,
7574,GO:0030956,1,0.984037995549562,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7575,GO:0030957,1,0.943057457964881,0,10,Tat protein binding,MF,
7576,GO:0030961,1,0.994890876864838,0,1,peptidyl-arginine hydroxylation,BP,
7577,GO:0030964,1,0.865193603089621,0,41,NADH dehydrogenase complex,CC,
7578,GO:0030968,1,0.486086291205334,0,116,endoplasmic reticulum unfolded protein response,BP,
7579,GO:0030970,1,0.849760120410062,0,26,retrograde protein transport, ER to cytosol,BP,
7580,GO:0030971,1,0.626013562630032,0,67,receptor tyrosine kinase binding,MF,
7581,GO:0030974,1,0.991560415731157,0,2,thiamine pyrophosphate transmembrane transport,BP,
7582,GO:0030975,1,0.995573849824925,0,1,thiamine binding,MF,
7583,GO:0030976,1,0.958516458751272,0,7,thiamine pyrophosphate binding,MF,
7584,GO:0030977,1,0.996280053509221,0,1,taurine binding,MF,
7585,GO:0030981,1,0.966793998570493,0,3,cortical microtubule cytoskeleton,CC,
7586,GO:0030983,1,0.920280212079678,0,13,mismatched DNA binding,MF,
7587,GO:0030984,1,0.991644001045785,0,2,kininogen binding,MF,
7588,GO:0030990,1,0.841270864243935,0,27,intraciliary transport particle,CC,
7589,GO:0030991,1,0.939541405502106,0,7,intraciliary transport particle A,CC,
7590,GO:0030992,1,0.898513181816202,0,19,intraciliary transport particle B,CC,
7591,GO:0030997,1,0.973980223222576,0,3,regulation of centriole-centriole cohesion,BP,
7592,GO:0031000,1,0.824946843284835,0,17,response to caffeine,BP,
7593,GO:0031004,1,0.977122248157065,0,3,potassium ion-transporting ATPase complex,CC,
7594,GO:0031005,1,0.925001566062476,0,10,filamin binding,MF,
7595,GO:0031010,1,0.90219367278916,0,11,ISWI-type complex,CC,
7596,GO:0031011,1,0.92846072781706,0,15,Ino80 complex,CC,
7598,GO:0031013,1,0.981026887850362,0,5,troponin I binding,MF,
7599,GO:0031014,1,0.987420379576169,0,4,troponin T binding,MF,
7601,GO:0031017,1,0.956691356880231,0,6,exocrine pancreas development,BP,
7603,GO:0031021,1,0.994890876864838,0,1,interphase microtubule organizing center,CC,
7604,GO:0031022,1,0.970509996931405,0,2,nuclear migration along microfilament,BP,
7605,GO:0031023,1,0.355191102893497,0,131,microtubule organizing center organization,BP,
7606,GO:0031032,1,0.19312030602186,0,188,actomyosin structure organization,BP,
7607,GO:0031033,1,0.916396048366786,0,5,myosin filament organization,BP,
7608,GO:0031034,1,0.920141760198698,0,4,myosin filament assembly,BP,
7609,GO:0031038,1,0.995932580157358,0,1,myosin II filament organization,BP,
7611,GO:0031047,1,0.344078102964341,0,140,gene silencing by RNA,BP,
7612,GO:0031048,1,0.972510099496165,0,3,heterochromatin assembly by small RNA,BP,
7613,GO:0031049,1,0.985336321842916,0,2,programmed DNA elimination,BP,
7614,GO:0031050,1,0.698787658453035,0,49,dsRNA processing,BP,
7615,GO:0031052,1,0.985336321842916,0,2,chromosome breakage,BP,
7616,GO:0031053,1,0.904148154693162,0,13,primary miRNA processing,BP,
7617,GO:0031054,1,0.918674424931162,0,12,pre-miRNA processing,BP,
7618,GO:0031055,1,0.867910658137385,0,28,chromatin remodeling at centromere,BP,
7620,GO:0031057,1,0.740344521072027,0,40,negative regulation of histone modification,BP,
7622,GO:0031060,1,0.618416905192092,0,59,regulation of histone methylation,BP,
7623,GO:0031061,1,0.870021512431666,0,18,negative regulation of histone methylation,BP,
7624,GO:0031062,1,0.752938843080603,0,36,positive regulation of histone methylation,BP,
7625,GO:0031063,1,0.817507936259088,0,27,regulation of histone deacetylation,BP,
7626,GO:0031064,1,0.952069912247961,0,6,negative regulation of histone deacetylation,BP,
7627,GO:0031065,1,0.875285763027435,0,17,positive regulation of histone deacetylation,BP,
7628,GO:0031069,1,0.838419508546838,0,25,hair follicle morphogenesis,BP,
7629,GO:0031071,1,0.995544710009777,0,1,cysteine desulfurase activity,MF,
7630,GO:0031072,1,0.469232431867503,0,115,heat shock protein binding,MF,
7631,GO:0031073,1,0.995669932551463,0,1,cholesterol 26-hydroxylase activity,MF,
7632,GO:0031074,1,0.978288051075492,0,3,nucleocytoplasmic transport complex,CC,
7633,GO:0031076,1,0.703089836395241,0,39,embryonic camera-type eye development,BP,
7634,GO:0031077,1,0.951236772727591,0,7,post-embryonic camera-type eye development,BP,
7635,GO:0031078,1,0.921989113549806,0,10,histone deacetylase activity (H3-K14 specific),MF,
7636,GO:0031080,1,0.928533055670367,0,10,nuclear pore outer ring,CC,
7639,GO:0031084,1,0.977690552953816,0,3,BLOC-2 complex,CC,
7640,GO:0031085,1,0.986884751812123,0,2,BLOC-3 complex,CC,
7641,GO:0031086,1,0.966321504130401,0,6,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7642,GO:0031087,1,0.971740455993875,0,5,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7643,GO:0031088,1,0.95334331266654,0,6,platelet dense granule membrane,CC,
7644,GO:0031089,1,0.94959934541455,0,11,platelet dense granule lumen,CC,
7647,GO:0031092,1,0.879193085285772,0,16,platelet alpha granule membrane,CC,
7649,GO:0031094,1,0.892444811211116,0,10,platelet dense tubular network,CC,
7650,GO:0031095,1,0.902835591372887,0,8,platelet dense tubular network membrane,CC,
7651,GO:0031098,1,0.148647517665992,0,271,stress-activated protein kinase signaling cascade,BP,
7655,GO:0031103,1,0.693547186414181,0,46,axon regeneration,BP,
7656,GO:0031104,1,0.988778218307654,0,2,dendrite regeneration,BP,
7657,GO:0031106,1,0.986686074613744,0,2,septin ring organization,BP,
7658,GO:0031109,1,0.432582622670779,0,109,microtubule polymerization or depolymerization,BP,
7659,GO:0031110,1,0.530969103871584,0,79,regulation of microtubule polymerization or depolymerization,BP,
7661,GO:0031112,1,0.750288705853322,0,33,positive regulation of microtubule polymerization or depolymerization,BP,
7662,GO:0031113,1,0.673496842870037,0,49,regulation of microtubule polymerization,BP,
7663,GO:0031114,1,0.755124041683079,0,29,regulation of microtubule depolymerization,BP,
7664,GO:0031115,1,0.921398594728783,0,13,negative regulation of microtubule polymerization,BP,
7666,GO:0031117,1,0.976385536521643,0,4,positive regulation of microtubule depolymerization,BP,
7667,GO:0031118,1,0.961960446952175,0,10,rRNA pseudouridine synthesis,BP,
7668,GO:0031119,1,0.975869922511847,0,5,tRNA pseudouridine synthesis,BP,
7669,GO:0031120,1,0.988996797749574,0,3,snRNA pseudouridine synthesis,BP,
7670,GO:0031122,1,0.581073900594874,0,60,cytoplasmic microtubule organization,BP,
7671,GO:0031123,1,0.455136252289726,0,131,RNA 3'-end processing,BP,
7672,GO:0031124,1,0.55615171128547,0,94,mRNA 3'-end processing,BP,
7673,GO:0031125,1,0.957796340151035,0,10,rRNA 3'-end processing,BP,
7674,GO:0031126,1,0.960237061918356,0,10,snoRNA 3'-end processing,BP,
7675,GO:0031127,1,0.991925865516053,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7676,GO:0031128,1,0.784699330106778,0,34,developmental induction,BP,
7677,GO:0031129,1,0.990046615402367,0,1,inductive cell-cell signaling,BP,
7678,GO:0031133,1,0.967766065654016,0,4,regulation of axon diameter,BP,
7679,GO:0031134,1,0.982077670469484,0,3,sister chromatid biorientation,BP,
7680,GO:0031143,1,0.909820857171705,0,15,pseudopodium,CC,
7681,GO:0031145,1,0.709007646483928,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7682,GO:0031146,1,0.631750731765415,0,87,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7683,GO:0031151,1,0.985860670556141,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7684,GO:0031161,1,0.994177749646323,0,1,phosphatidylinositol catabolic process,BP,
7685,GO:0031163,1,0.905654600325904,0,20,metallo-sulfur cluster assembly,BP,
7686,GO:0031166,1,0.96576716866409,0,5,integral component of vacuolar membrane,CC,
7687,GO:0031167,1,0.915625347958054,0,19,rRNA methylation,BP,
7689,GO:0031177,1,0.98403052900273,0,1,phosphopantetheine binding,MF,
7690,GO:0031179,1,0.988582464231479,0,2,peptide modification,BP,
7692,GO:0031204,1,0.95108239437124,0,7,posttranslational protein targeting to membrane, translocation,BP,
7693,GO:0031205,1,0.984496273092856,0,2,endoplasmic reticulum Sec complex,CC,
7694,GO:0031207,1,0.987574251326115,0,1,Sec62/Sec63 complex,CC,
7695,GO:0031208,1,0.977342551932293,0,3,POZ domain binding,MF,
7696,GO:0031209,1,0.934462272588735,0,9,SCAR complex,CC,
7697,GO:0031210,1,0.834414684502606,0,23,phosphatidylcholine binding,MF,
7698,GO:0031211,1,0.954359087597342,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7699,GO:0031213,1,0.982913735090586,0,2,RSF complex,CC,
7705,GO:0031227,1,0.42655830121661,0,153,intrinsic component of endoplasmic reticulum membrane,CC,
7706,GO:0031228,1,0.692069388497779,0,62,intrinsic component of Golgi membrane,CC,
7707,GO:0031229,1,0.922542019250899,0,14,intrinsic component of nuclear inner membrane,CC,
7708,GO:0031231,1,0.924290331961455,0,15,intrinsic component of peroxisomal membrane,CC,
7710,GO:0031233,1,0.885018878711311,0,20,intrinsic component of external side of plasma membrane,CC,
7712,GO:0031235,1,0.947333992088468,0,6,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7713,GO:0031247,1,0.990934419287641,0,2,actin rod assembly,BP,
7714,GO:0031248,1,0.557225170438462,0,85,protein acetyltransferase complex,CC,
7715,GO:0031249,1,0.99547617734118,0,1,denatured protein binding,MF,
7716,GO:0031251,1,0.979110742696555,0,2,PAN complex,CC,
7719,GO:0031254,1,0.91882680036155,0,13,cell trailing edge,CC,
7721,GO:0031257,1,0.994890876864838,0,1,cell trailing edge membrane,CC,
7723,GO:0031259,1,0.994890876864838,0,1,uropod membrane,CC,
7724,GO:0031261,1,0.974674129278004,0,5,DNA replication preinitiation complex,CC,
7725,GO:0031262,1,0.985585147234251,0,4,Ndc80 complex,CC,
7726,GO:0031264,1,0.952092705035835,0,9,death-inducing signaling complex,CC,
7727,GO:0031265,1,0.967047869063239,0,6,CD95 death-inducing signaling complex,CC,
7729,GO:0031268,1,0.921982526791742,0,13,pseudopodium organization,BP,
7730,GO:0031269,1,0.921982526791742,0,13,pseudopodium assembly,BP,
7731,GO:0031271,1,0.994890876864838,0,1,lateral pseudopodium assembly,BP,
7732,GO:0031272,1,0.921982526791742,0,13,regulation of pseudopodium assembly,BP,
7733,GO:0031274,1,0.926720856707105,0,12,positive regulation of pseudopodium assembly,BP,
7734,GO:0031275,1,0.994890876864838,0,1,regulation of lateral pseudopodium assembly,BP,
7735,GO:0031279,1,0.733670030576361,0,43,regulation of cyclase activity,BP,
7736,GO:0031280,1,0.866009522861579,0,22,negative regulation of cyclase activity,BP,
7737,GO:0031281,1,0.857367573443591,0,18,positive regulation of cyclase activity,BP,
7738,GO:0031282,1,0.944177902496626,0,10,regulation of guanylate cyclase activity,BP,
7739,GO:0031283,1,0.984249105231089,0,3,negative regulation of guanylate cyclase activity,BP,
7740,GO:0031284,1,0.959293877299585,0,7,positive regulation of guanylate cyclase activity,BP,
7741,GO:0031289,1,0.994371075172331,0,1,actin phosphorylation,BP,
7742,GO:0031290,1,0.84355650588164,0,19,retinal ganglion cell axon guidance,BP,
7743,GO:0031291,1,0.978723144749307,0,4,Ran protein signal transduction,BP,
7744,GO:0031293,1,0.890127000492662,0,18,membrane protein intracellular domain proteolysis,BP,
7745,GO:0031294,1,0.7387092594823,0,55,lymphocyte costimulation,BP,
7746,GO:0031295,1,0.741142745084261,0,54,T cell costimulation,BP,
7747,GO:0031296,1,0.990306510102758,0,3,B cell costimulation,BP,
7748,GO:0031297,1,0.79272270216536,0,31,replication fork processing,BP,
7749,GO:0031298,1,0.948867947661829,0,8,replication fork protection complex,CC,
7752,GO:0031302,1,0.980080321881335,0,3,intrinsic component of endosome membrane,CC,
7753,GO:0031304,1,0.815444826649244,0,43,intrinsic component of mitochondrial inner membrane,CC,
7754,GO:0031305,1,0.815444826649244,0,43,integral component of mitochondrial inner membrane,CC,
7755,GO:0031306,1,0.878025761570061,0,22,intrinsic component of mitochondrial outer membrane,CC,
7756,GO:0031307,1,0.88585244700121,0,21,integral component of mitochondrial outer membrane,CC,
7757,GO:0031308,1,0.994890876864838,0,1,intrinsic component of nuclear outer membrane,CC,
7758,GO:0031309,1,0.994890876864838,0,1,integral component of nuclear outer membrane,CC,
7759,GO:0031310,1,0.96576716866409,0,5,intrinsic component of vacuolar membrane,CC,
7762,GO:0031314,1,0.949940760226143,0,10,extrinsic component of mitochondrial inner membrane,CC,
7763,GO:0031315,1,0.981471753065583,0,2,extrinsic component of mitochondrial outer membrane,CC,
7764,GO:0031320,1,0.995305280149271,0,1,hexitol dehydrogenase activity,MF,
7773,GO:0031331,1,0.0637972911481779,0,362,positive regulation of cellular catabolic process,BP,
7774,GO:0031332,1,0.873608999465178,0,14,RNAi effector complex,CC,
7775,GO:0031333,1,0.39613878326954,0,129,negative regulation of protein-containing complex assembly,BP,
7776,GO:0031334,1,0.201586528594091,0,230,positive regulation of protein-containing complex assembly,BP,
7777,GO:0031335,1,0.973283628047629,0,3,regulation of sulfur amino acid metabolic process,BP,
7778,GO:0031337,1,0.995708758401878,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7780,GO:0031339,1,0.955164646506965,0,6,negative regulation of vesicle fusion,BP,
7782,GO:0031341,1,0.669076086390809,0,78,regulation of cell killing,BP,
7783,GO:0031342,1,0.909139486038161,0,21,negative regulation of cell killing,BP,
7784,GO:0031343,1,0.761648600852972,0,52,positive regulation of cell killing,BP,
7791,GO:0031362,1,0.901750679320814,0,16,anchored component of external side of plasma membrane,CC,
7792,GO:0031365,1,0.818280879386944,0,28,N-terminal protein amino acid modification,BP,
7793,GO:0031369,1,0.829704098445073,0,30,translation initiation factor binding,MF,
7794,GO:0031370,1,0.990910935258865,0,1,eukaryotic initiation factor 4G binding,MF,
7795,GO:0031371,1,0.960468964318304,0,8,ubiquitin conjugating enzyme complex,CC,
7796,GO:0031372,1,0.991822039924292,0,2,UBC13-MMS2 complex,CC,
7797,GO:0031379,1,0.978524527999371,0,2,RNA-directed RNA polymerase complex,CC,
7798,GO:0031380,1,0.986007709882963,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7799,GO:0031386,1,0.958234624355983,0,12,protein tag,MF,
7800,GO:0031389,1,0.994654349096504,0,1,Rad17 RFC-like complex,CC,
7801,GO:0031390,1,0.962777218836255,0,8,Ctf18 RFC-like complex,CC,
7802,GO:0031391,1,0.975438448835915,0,3,Elg1 RFC-like complex,CC,
7804,GO:0031393,1,0.987011437316826,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7806,GO:0031396,1,0.277454308322336,0,191,regulation of protein ubiquitination,BP,
7807,GO:0031397,1,0.623669979800065,0,72,negative regulation of protein ubiquitination,BP,
7808,GO:0031398,1,0.479322337206296,0,109,positive regulation of protein ubiquitination,BP,
7812,GO:0031402,1,0.92876777223622,0,8,sodium ion binding,MF,
7813,GO:0031403,1,0.979744878397255,0,2,lithium ion binding,MF,
7814,GO:0031404,1,0.900612062395355,0,13,chloride ion binding,MF,
7815,GO:0031405,1,0.980121128446897,0,1,lipoic acid binding,MF,
7817,GO:0031407,1,0.984982322183557,0,3,oxylipin metabolic process,BP,
7818,GO:0031408,1,0.989370970213929,0,2,oxylipin biosynthetic process,BP,
7820,GO:0031414,1,0.924340671157134,0,10,N-terminal protein acetyltransferase complex,CC,
7821,GO:0031415,1,0.972553837929156,0,5,NatA complex,CC,
7822,GO:0031416,1,0.985642444912628,0,2,NatB complex,CC,
7823,GO:0031417,1,0.964289495228143,0,3,NatC complex,CC,
7824,GO:0031418,1,0.896720583870827,0,20,L-ascorbic acid binding,MF,
7825,GO:0031419,1,0.932447023736575,0,8,cobalamin binding,MF,
7826,GO:0031420,1,0.874149689540976,0,17,alkali metal ion binding,MF,
7827,GO:0031422,1,0.993488849844404,0,1,RecQ family helicase-topoisomerase III complex,CC,
7828,GO:0031424,1,0.641564652466025,0,74,keratinization,BP,
7829,GO:0031427,1,0.974645707945903,0,4,response to methotrexate,BP,
7830,GO:0031428,1,0.978101789220815,0,5,box C/D snoRNP complex,CC,
7831,GO:0031429,1,0.978424983264267,0,5,box H/ACA snoRNP complex,CC,
7832,GO:0031430,1,0.803583660977936,0,24,M band,CC,
7833,GO:0031431,1,0.987454263598165,0,2,Dbf4-dependent protein kinase complex,CC,
7834,GO:0031432,1,0.896609585056166,0,14,titin binding,MF,
7835,GO:0031433,1,0.919125721634499,0,6,telethonin binding,MF,
7836,GO:0031434,1,0.917115956586742,0,13,mitogen-activated protein kinase kinase binding,MF,
7837,GO:0031435,1,0.888375809512514,0,17,mitogen-activated protein kinase kinase kinase binding,MF,
7838,GO:0031436,1,0.978588293011313,0,3,BRCA1-BARD1 complex,CC,
7839,GO:0031437,1,0.991592479526111,0,1,regulation of mRNA cleavage,BP,
7840,GO:0031439,1,0.991592479526111,0,1,positive regulation of mRNA cleavage,BP,
7841,GO:0031440,1,0.832190418675708,0,27,regulation of mRNA 3'-end processing,BP,
7842,GO:0031441,1,0.943824092032489,0,9,negative regulation of mRNA 3'-end processing,BP,
7843,GO:0031442,1,0.928058202613463,0,11,positive regulation of mRNA 3'-end processing,BP,
7844,GO:0031443,1,0.980376972435852,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7845,GO:0031444,1,0.982028306214609,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7846,GO:0031445,1,0.863311736224645,0,16,regulation of heterochromatin assembly,BP,
7847,GO:0031446,1,0.993395027214379,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7848,GO:0031448,1,0.993395027214379,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7849,GO:0031449,1,0.988407292630268,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7850,GO:0031452,1,0.95581891062066,0,4,negative regulation of heterochromatin assembly,BP,
7851,GO:0031453,1,0.908902963952512,0,11,positive regulation of heterochromatin assembly,BP,
7852,GO:0031455,1,0.986537011940777,0,2,glycine betaine metabolic process,BP,
7853,GO:0031456,1,0.986537011940777,0,2,glycine betaine biosynthetic process,BP,
7854,GO:0031460,1,0.990630939556817,0,1,glycine betaine transport,BP,
7855,GO:0031461,1,0.363751244301048,0,152,cullin-RING ubiquitin ligase complex,CC,
7856,GO:0031462,1,0.908168614667557,0,13,Cul2-RING ubiquitin ligase complex,CC,
7857,GO:0031463,1,0.770216859957946,0,36,Cul3-RING ubiquitin ligase complex,CC,
7858,GO:0031464,1,0.937344480313332,0,11,Cul4A-RING E3 ubiquitin ligase complex,CC,
7859,GO:0031465,1,0.966697493095047,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7860,GO:0031466,1,0.970385541793884,0,5,Cul5-RING ubiquitin ligase complex,CC,
7861,GO:0031467,1,0.973036020771244,0,4,Cul7-RING ubiquitin ligase complex,CC,
7862,GO:0031468,1,0.910336362174288,0,18,nuclear envelope reassembly,BP,
7863,GO:0031475,1,0.996534385885857,0,1,myosin V complex,CC,
7864,GO:0031477,1,0.985995144371306,0,1,myosin VII complex,CC,
7866,GO:0031490,1,0.501096360272252,0,86,chromatin DNA binding,MF,
7867,GO:0031491,1,0.693827727038521,0,51,nucleosome binding,MF,
7868,GO:0031492,1,0.852036045545825,0,24,nucleosomal DNA binding,MF,
7869,GO:0031493,1,0.973893166520613,0,5,nucleosomal histone binding,MF,
7870,GO:0031494,1,0.981051855925942,0,1,regulation of mating type switching,BP,
7871,GO:0031497,1,0.477085765396421,0,108,chromatin assembly,BP,
7872,GO:0031498,1,0.880036196962076,0,17,chromatin disassembly,BP,
7873,GO:0031499,1,0.994702716281486,0,1,TRAMP complex,CC,
7874,GO:0031501,1,0.977722194157457,0,5,mannosyltransferase complex,CC,
7876,GO:0031506,1,0.996318235555698,0,1,cell wall glycoprotein biosynthetic process,BP,
7877,GO:0031507,1,0.731800105437098,0,39,heterochromatin assembly,BP,
7878,GO:0031508,1,0.990994336083943,0,2,pericentric heterochromatin assembly,BP,
7879,GO:0031509,1,0.996442198035923,0,1,subtelomeric heterochromatin assembly,BP,
7880,GO:0031510,1,0.990489171091112,0,2,SUMO activating enzyme complex,CC,
7881,GO:0031511,1,0.996450548134146,0,1,Mis6-Sim4 complex,CC,
7883,GO:0031515,1,0.98594586921057,0,3,tRNA (m1A) methyltransferase complex,CC,
7884,GO:0031519,1,0.72028835779335,0,43,PcG protein complex,CC,
7885,GO:0031523,1,0.975896825365651,0,3,Myb complex,CC,
7889,GO:0031529,1,0.734207790052842,0,50,ruffle organization,BP,
7890,GO:0031530,1,0.993283781756578,0,2,gonadotropin-releasing hormone receptor binding,MF,
7891,GO:0031531,1,0.996657711308508,0,1,thyrotropin-releasing hormone receptor binding,MF,
7893,GO:0031533,1,0.988135863387112,0,1,mRNA cap methyltransferase complex,CC,
7894,GO:0031536,1,0.98871284368267,0,3,positive regulation of exit from mitosis,BP,
7895,GO:0031543,1,0.935629562293956,0,12,peptidyl-proline dioxygenase activity,MF,
7896,GO:0031544,1,0.979244101783974,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7897,GO:0031545,1,0.955470156893085,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7898,GO:0031547,1,0.932542427038189,0,7,brain-derived neurotrophic factor receptor signaling pathway,BP,
7899,GO:0031548,1,0.976401983875705,0,3,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7900,GO:0031549,1,0.989669958853132,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7901,GO:0031550,1,0.986594916624127,0,2,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7902,GO:0031554,1,0.964111991046659,0,4,regulation of DNA-templated transcription, termination,BP,
7903,GO:0031559,1,0.991894383511468,0,1,oxidosqualene cyclase activity,MF,
7904,GO:0031570,1,0.360611807059849,0,148,DNA integrity checkpoint,BP,
7905,GO:0031571,1,0.65676247767775,0,61,mitotic G1 DNA damage checkpoint,BP,
7906,GO:0031572,1,0.805795101176504,0,29,G2 DNA damage checkpoint,BP,
7907,GO:0031573,1,0.925472563743546,0,14,intra-S DNA damage checkpoint,BP,
7908,GO:0031577,1,0.791685372176502,0,34,spindle checkpoint,BP,
7910,GO:0031580,1,0.964213706564262,0,6,membrane raft distribution,BP,
7911,GO:0031581,1,0.861458964561904,0,12,hemidesmosome assembly,BP,
7912,GO:0031583,1,0.995946339837785,0,1,phospholipase D-activating G protein-coupled receptor signaling pathway,BP,
7913,GO:0031584,1,0.971228625131385,0,5,activation of phospholipase D activity,BP,
7914,GO:0031585,1,0.93465483983711,0,5,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7915,GO:0031587,1,0.955794176060766,0,4,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7916,GO:0031588,1,0.949176276122153,0,8,nucleotide-activated protein kinase complex,CC,
7918,GO:0031590,1,0.983401922155711,0,3,wybutosine metabolic process,BP,
7919,GO:0031591,1,0.983401922155711,0,3,wybutosine biosynthetic process,BP,
7920,GO:0031592,1,0.984990903457773,0,1,centrosomal corona,CC,
7921,GO:0031593,1,0.765664996021316,0,40,polyubiquitin modification-dependent protein binding,MF,
7923,GO:0031595,1,0.98647345798812,0,3,nuclear proteasome complex,CC,
7924,GO:0031597,1,0.95887737187853,0,8,cytosolic proteasome complex,CC,
7925,GO:0031616,1,0.928689591828597,0,13,spindle pole centrosome,CC,
7926,GO:0031617,1,0.985585147234251,0,4,NMS complex,CC,
7927,GO:0031618,1,0.915351228384139,0,9,nuclear pericentric heterochromatin,CC,
7928,GO:0031620,1,0.956191603413093,0,7,regulation of fever generation,BP,
7929,GO:0031622,1,0.964060587966401,0,6,positive regulation of fever generation,BP,
7931,GO:0031624,1,0.790354806412568,0,30,ubiquitin conjugating enzyme binding,MF,
7932,GO:0031625,1,0.153333462752741,0,283,ubiquitin protein ligase binding,MF,
7933,GO:0031626,1,0.990033174626836,0,1,beta-endorphin binding,MF,
7934,GO:0031627,1,0.987844435933289,0,2,telomeric loop formation,BP,
7935,GO:0031628,1,0.952122297715177,0,8,opioid receptor binding,MF,
7939,GO:0031635,1,0.986766092041428,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7943,GO:0031641,1,0.723124782691415,0,44,regulation of myelination,BP,
7944,GO:0031642,1,0.941408819783248,0,8,negative regulation of myelination,BP,
7945,GO:0031643,1,0.877593282929569,0,18,positive regulation of myelination,BP,
7949,GO:0031647,1,0.154510509342591,0,270,regulation of protein stability,BP,
7950,GO:0031648,1,0.702596234064776,0,48,protein destabilization,BP,
7951,GO:0031649,1,0.904264742403338,0,16,heat generation,BP,
7952,GO:0031650,1,0.924928037072289,0,12,regulation of heat generation,BP,
7953,GO:0031651,1,0.992086867989554,0,1,negative regulation of heat generation,BP,
7954,GO:0031652,1,0.939985088225253,0,10,positive regulation of heat generation,BP,
7958,GO:0031666,1,0.940472835806738,0,9,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7963,GO:0031672,1,0.712596205791892,0,35,A band,CC,
7964,GO:0031673,1,0.969995324907233,0,1,H zone,CC,
7965,GO:0031674,1,0.282625456421251,0,133,I band,CC,
7966,GO:0031680,1,0.94877889717933,0,10,G-protein beta/gamma-subunit complex,CC,
7967,GO:0031681,1,0.911166103672876,0,18,G-protein beta-subunit binding,MF,
7968,GO:0031682,1,0.951599569083567,0,6,G-protein gamma-subunit binding,MF,
7970,GO:0031685,1,0.978292620602212,0,4,adenosine receptor binding,MF,
7971,GO:0031686,1,0.994264129784068,0,1,A1 adenosine receptor binding,MF,
7972,GO:0031687,1,0.991585124408769,0,2,A2A adenosine receptor binding,MF,
7973,GO:0031690,1,0.873280945257777,0,19,adrenergic receptor binding,MF,
7974,GO:0031691,1,0.99200042462731,0,2,alpha-1A adrenergic receptor binding,MF,
7975,GO:0031692,1,0.984758277152353,0,3,alpha-1B adrenergic receptor binding,MF,
7976,GO:0031694,1,0.983134351438032,0,4,alpha-2A adrenergic receptor binding,MF,
7977,GO:0031695,1,0.995418237666838,0,1,alpha-2B adrenergic receptor binding,MF,
7978,GO:0031696,1,0.988151387945741,0,2,alpha-2C adrenergic receptor binding,MF,
7979,GO:0031697,1,0.957051339303177,0,5,beta-1 adrenergic receptor binding,MF,
7980,GO:0031698,1,0.953181244888519,0,5,beta-2 adrenergic receptor binding,MF,
7981,GO:0031699,1,0.992086867989554,0,1,beta-3 adrenergic receptor binding,MF,
7983,GO:0031701,1,0.944615878530485,0,8,angiotensin receptor binding,MF,
7984,GO:0031702,1,0.948597979023475,0,7,type 1 angiotensin receptor binding,MF,
7985,GO:0031703,1,0.995221960103272,0,1,type 2 angiotensin receptor binding,MF,
7986,GO:0031704,1,0.994030963168051,0,1,apelin receptor binding,MF,
7987,GO:0031705,1,0.984717035727448,0,4,bombesin receptor binding,MF,
7988,GO:0031707,1,0.995946339837785,0,1,endothelin A receptor binding,MF,
7989,GO:0031708,1,0.987889046736415,0,3,endothelin B receptor binding,MF,
7990,GO:0031710,1,0.996789494597526,0,1,neuromedin B receptor binding,MF,
7991,GO:0031711,1,0.98939407767499,0,2,bradykinin receptor binding,MF,
7992,GO:0031714,1,0.990162004403675,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7993,GO:0031715,1,0.990162004403675,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7994,GO:0031716,1,0.996787006640385,0,1,calcitonin receptor binding,MF,
7995,GO:0031717,1,0.996437984702379,0,1,cannabinoid receptor binding,MF,
7996,GO:0031718,1,0.996437984702379,0,1,type 1 cannabinoid receptor binding,MF,
7997,GO:0031720,1,0.972242448416602,0,9,haptoglobin binding,MF,
7998,GO:0031721,1,0.987551173506186,0,4,hemoglobin alpha binding,MF,
7999,GO:0031724,1,0.996720374049634,0,1,CXCR5 chemokine receptor binding,MF,
8000,GO:0031726,1,0.996847859079003,0,1,CCR1 chemokine receptor binding,MF,
8001,GO:0031727,1,0.986002623697072,0,4,CCR2 chemokine receptor binding,MF,
8002,GO:0031728,1,0.993786178627213,0,2,CCR3 chemokine receptor binding,MF,
8003,GO:0031729,1,0.996877787783787,0,1,CCR4 chemokine receptor binding,MF,
8004,GO:0031730,1,0.970357076369853,0,4,CCR5 chemokine receptor binding,MF,
8005,GO:0031731,1,0.993741587921828,0,2,CCR6 chemokine receptor binding,MF,
8006,GO:0031732,1,0.993710397745503,0,2,CCR7 chemokine receptor binding,MF,
8007,GO:0031735,1,0.990447537538481,0,3,CCR10 chemokine receptor binding,MF,
8008,GO:0031737,1,0.993932817609136,0,1,CX3C chemokine receptor binding,MF,
8009,GO:0031739,1,0.995918058430407,0,1,cholecystokinin receptor binding,MF,
8010,GO:0031741,1,0.995918058430407,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8011,GO:0031748,1,0.953255970507676,0,9,D1 dopamine receptor binding,MF,
8012,GO:0031749,1,0.96908697258178,0,5,D2 dopamine receptor binding,MF,
8013,GO:0031750,1,0.984146139324945,0,3,D3 dopamine receptor binding,MF,
8014,GO:0031751,1,0.989277157093927,0,2,D4 dopamine receptor binding,MF,
8015,GO:0031752,1,0.976187111681631,0,3,D5 dopamine receptor binding,MF,
8016,GO:0031753,1,0.994849355556277,0,1,endothelial differentiation G protein-coupled receptor binding,MF,
8017,GO:0031755,1,0.994849355556277,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8018,GO:0031762,1,0.99200042462731,0,2,follicle-stimulating hormone receptor binding,MF,
8019,GO:0031763,1,0.996852582048611,0,1,galanin receptor binding,MF,
8020,GO:0031764,1,0.996852582048611,0,1,type 1 galanin receptor binding,MF,
8021,GO:0031765,1,0.996852582048611,0,1,type 2 galanin receptor binding,MF,
8022,GO:0031766,1,0.996852582048611,0,1,type 3 galanin receptor binding,MF,
8023,GO:0031768,1,0.996863987862682,0,1,ghrelin receptor binding,MF,
8024,GO:0031770,1,0.996892626853042,0,1,growth hormone-releasing hormone receptor binding,MF,
8025,GO:0031773,1,0.996864307981542,0,1,kisspeptin receptor binding,MF,
8026,GO:0031775,1,0.984466785592737,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8027,GO:0031776,1,0.99685720332644,0,1,melanin-concentrating hormone receptor binding,MF,
8028,GO:0031777,1,0.99685720332644,0,1,type 1 melanin-concentrating hormone receptor binding,MF,
8029,GO:0031779,1,0.986279579589525,0,4,melanocortin receptor binding,MF,
8030,GO:0031780,1,0.992653175427745,0,2,corticotropin hormone receptor binding,MF,
8031,GO:0031781,1,0.986279579589525,0,4,type 3 melanocortin receptor binding,MF,
8032,GO:0031782,1,0.986279579589525,0,4,type 4 melanocortin receptor binding,MF,
8033,GO:0031783,1,0.992653175427745,0,2,type 5 melanocortin receptor binding,MF,
8034,GO:0031798,1,0.985513268266278,0,1,type 1 metabotropic glutamate receptor binding,MF,
8035,GO:0031799,1,0.991944154911192,0,2,type 2 metabotropic glutamate receptor binding,MF,
8036,GO:0031800,1,0.987702241805442,0,3,type 3 metabotropic glutamate receptor binding,MF,
8037,GO:0031802,1,0.968515698332007,0,5,type 5 metabotropic glutamate receptor binding,MF,
8038,GO:0031811,1,0.99263663121297,0,1,G protein-coupled nucleotide receptor binding,MF,
8039,GO:0031812,1,0.99263663121297,0,1,P2Y1 nucleotide receptor binding,MF,
8040,GO:0031821,1,0.950566505382639,0,9,G protein-coupled serotonin receptor binding,MF,
8041,GO:0031826,1,0.979939545979205,0,5,type 2A serotonin receptor binding,MF,
8042,GO:0031834,1,0.993634392496338,0,2,neurokinin receptor binding,MF,
8043,GO:0031835,1,0.993634392496338,0,2,substance P receptor binding,MF,
8044,GO:0031838,1,0.968981402449668,0,10,haptoglobin-hemoglobin complex,CC,
8045,GO:0031839,1,0.996845389599986,0,1,type 1 neuromedin U receptor binding,MF,
8046,GO:0031840,1,0.996845389599986,0,1,type 2 neuromedin U receptor binding,MF,
8047,GO:0031848,1,0.937445365685152,0,10,protection from non-homologous end joining at telomere,BP,
8048,GO:0031849,1,0.980542078455101,0,4,olfactory receptor binding,MF,
8049,GO:0031852,1,0.966856588453536,0,4,mu-type opioid receptor binding,MF,
8050,GO:0031858,1,0.994129353515148,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8051,GO:0031859,1,0.996180225437282,0,1,platelet activating factor receptor binding,MF,
8052,GO:0031860,1,0.973340994440422,0,3,telomeric 3' overhang formation,BP,
8053,GO:0031862,1,0.981224867572826,0,2,prostanoid receptor binding,MF,
8054,GO:0031867,1,0.99276036666101,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8055,GO:0031870,1,0.988381217013115,0,1,thromboxane A2 receptor binding,MF,
8056,GO:0031871,1,0.979218297173216,0,3,proteinase activated receptor binding,MF,
8058,GO:0031883,1,0.995941764382147,0,1,taste receptor binding,MF,
8059,GO:0031893,1,0.987950543744369,0,2,vasopressin receptor binding,MF,
8060,GO:0031894,1,0.992113450756079,0,1,V1A vasopressin receptor binding,MF,
8061,GO:0031896,1,0.995804332958166,0,1,V2 vasopressin receptor binding,MF,
8064,GO:0031903,1,0.690284430139399,0,58,microbody membrane,CC,
8065,GO:0031904,1,0.820087756173398,0,28,endosome lumen,CC,
8066,GO:0031905,1,0.984285060075979,0,3,early endosome lumen,CC,
8067,GO:0031906,1,0.979997991985838,0,6,late endosome lumen,CC,
8068,GO:0031907,1,0.774343922299053,0,51,microbody lumen,CC,
8069,GO:0031914,1,0.960233620334519,0,5,negative regulation of synaptic plasticity,BP,
8071,GO:0031929,1,0.448046054934434,0,107,TOR signaling,BP,
8072,GO:0031930,1,0.996574792709373,0,1,mitochondria-nucleus signaling pathway,BP,
8073,GO:0031931,1,0.914693535743288,0,8,TORC1 complex,CC,
8074,GO:0031932,1,0.895715796397072,0,12,TORC2 complex,CC,
8075,GO:0031935,1,0.930952467099126,0,9,regulation of chromatin silencing,BP,
8076,GO:0031936,1,0.96592076652975,0,4,negative regulation of chromatin silencing,BP,
8077,GO:0031937,1,0.974981633851995,0,3,positive regulation of chromatin silencing,BP,
8078,GO:0031938,1,0.992615606554646,0,2,regulation of chromatin silencing at telomere,BP,
8079,GO:0031940,1,0.996442198035923,0,1,positive regulation of chromatin silencing at telomere,BP,
8080,GO:0031941,1,0.794202319430755,0,31,filamentous actin,CC,
8081,GO:0031943,1,0.933043164038901,0,10,regulation of glucocorticoid metabolic process,BP,
8082,GO:0031944,1,0.9713391183348,0,5,negative regulation of glucocorticoid metabolic process,BP,
8083,GO:0031945,1,0.992625203655,0,1,positive regulation of glucocorticoid metabolic process,BP,
8084,GO:0031946,1,0.939307984756228,0,8,regulation of glucocorticoid biosynthetic process,BP,
8085,GO:0031947,1,0.9713391183348,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8086,GO:0031948,1,0.992625203655,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8087,GO:0031952,1,0.716636891189694,0,45,regulation of protein autophosphorylation,BP,
8088,GO:0031953,1,0.922664621580677,0,12,negative regulation of protein autophosphorylation,BP,
8089,GO:0031954,1,0.827503754645179,0,25,positive regulation of protein autophosphorylation,BP,
8090,GO:0031956,1,0.941387017563478,0,10,medium-chain fatty acid-CoA ligase activity,MF,
8091,GO:0031957,1,0.951118031738734,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8092,GO:0031958,1,0.89363559764779,0,14,corticosteroid receptor signaling pathway,BP,
8093,GO:0031959,1,0.98983972059644,0,1,mineralocorticoid receptor signaling pathway,BP,
8095,GO:0031962,1,0.98869760626895,0,1,mineralocorticoid receptor binding,MF,
8096,GO:0031965,1,0.131372642836511,0,276,nuclear membrane,CC,
8100,GO:0031970,1,0.670698720731196,0,80,organelle envelope lumen,CC,
8107,GO:0031985,1,0.515257128659214,0,101,Golgi cisterna,CC,
8108,GO:0031987,1,0.924057704669931,0,10,locomotion involved in locomotory behavior,BP,
8109,GO:0031989,1,0.996607781753855,0,1,bombesin receptor signaling pathway,BP,
8110,GO:0031990,1,0.97759560565191,0,2,mRNA export from nucleus in response to heat stress,BP,
8113,GO:0031996,1,0.93953687482961,0,11,thioesterase binding,MF,
8114,GO:0031997,1,0.984394809429271,0,3,N-terminal myristoylation domain binding,MF,
8115,GO:0031998,1,0.836724205928377,0,19,regulation of fatty acid beta-oxidation,BP,
8116,GO:0031999,1,0.95816396633737,0,5,negative regulation of fatty acid beta-oxidation,BP,
8117,GO:0032000,1,0.909557220692635,0,10,positive regulation of fatty acid beta-oxidation,BP,
8118,GO:0032002,1,0.991054218644145,0,2,interleukin-28 receptor complex,CC,
8119,GO:0032006,1,0.536569601776418,0,86,regulation of TOR signaling,BP,
8120,GO:0032007,1,0.766866229326317,0,36,negative regulation of TOR signaling,BP,
8121,GO:0032008,1,0.770780229654426,0,38,positive regulation of TOR signaling,BP,
8122,GO:0032009,1,0.90541560766254,0,13,early phagosome,CC,
8123,GO:0032010,1,0.974666674839138,0,6,phagolysosome,CC,
8126,GO:0032014,1,0.980612907734692,0,2,positive regulation of ARF protein signal transduction,BP,
8127,GO:0032020,1,0.973987318318062,0,6,ISG15-protein conjugation,BP,
8128,GO:0032021,1,0.979718048345423,0,4,NELF complex,CC,
8129,GO:0032023,1,0.99569490537338,0,1,trypsinogen activation,BP,
8130,GO:0032024,1,0.652055444016857,0,67,positive regulation of insulin secretion,BP,
8131,GO:0032025,1,0.949338562567489,0,9,response to cobalt ion,BP,
8132,GO:0032026,1,0.850996211138676,0,17,response to magnesium ion,BP,
8133,GO:0032027,1,0.955966445368004,0,7,myosin light chain binding,MF,
8134,GO:0032028,1,0.984315535304634,0,2,myosin head/neck binding,MF,
8135,GO:0032029,1,0.978575259393654,0,1,myosin tail binding,MF,
8136,GO:0032034,1,0.98833467883365,0,1,myosin II head/neck binding,MF,
8137,GO:0032036,1,0.927944898763535,0,11,myosin heavy chain binding,MF,
8138,GO:0032038,1,0.982064957400028,0,3,myosin II heavy chain binding,MF,
8139,GO:0032039,1,0.876548548600304,0,15,integrator complex,CC,
8140,GO:0032040,1,0.804173351975077,0,33,small-subunit processome,CC,
8141,GO:0032041,1,0.921989113549806,0,10,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8142,GO:0032042,1,0.916293147222389,0,14,mitochondrial DNA metabolic process,BP,
8143,GO:0032044,1,0.989568585904448,0,2,DSIF complex,CC,
8144,GO:0032045,1,0.894456424577665,0,14,guanyl-nucleotide exchange factor complex,CC,
8145,GO:0032048,1,0.912510250263794,0,17,cardiolipin metabolic process,BP,
8146,GO:0032049,1,0.959555026142827,0,8,cardiolipin biosynthetic process,BP,
8148,GO:0032051,1,0.948835948932521,0,5,clathrin light chain binding,MF,
8149,GO:0032052,1,0.962460927195711,0,9,bile acid binding,MF,
8150,GO:0032053,1,0.964162583315473,0,4,ciliary basal body organization,BP,
8151,GO:0032055,1,0.959522056469186,0,6,negative regulation of translation in response to stress,BP,
8152,GO:0032056,1,0.940174176757706,0,8,positive regulation of translation in response to stress,BP,
8153,GO:0032057,1,0.969270426995549,0,4,negative regulation of translational initiation in response to stress,BP,
8154,GO:0032058,1,0.967528663565644,0,4,positive regulation of translational initiation in response to stress,BP,
8155,GO:0032059,1,0.9367703758893,0,9,bleb,CC,
8157,GO:0032069,1,0.88898385789241,0,22,regulation of nuclease activity,BP,
8158,GO:0032070,1,0.951485948763126,0,10,regulation of deoxyribonuclease activity,BP,
8159,GO:0032071,1,0.959494430745251,0,8,regulation of endodeoxyribonuclease activity,BP,
8160,GO:0032072,1,0.993618195372727,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8161,GO:0032074,1,0.964119939777087,0,7,negative regulation of nuclease activity,BP,
8162,GO:0032075,1,0.963167666093132,0,8,positive regulation of nuclease activity,BP,
8163,GO:0032076,1,0.991831441898201,0,2,negative regulation of deoxyribonuclease activity,BP,
8164,GO:0032077,1,0.975827654502705,0,5,positive regulation of deoxyribonuclease activity,BP,
8165,GO:0032078,1,0.996826746048192,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8166,GO:0032079,1,0.979107069816506,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8167,GO:0032088,1,0.608707858022056,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8168,GO:0032089,1,0.984664299966101,0,2,NACHT domain binding,MF,
8169,GO:0032090,1,0.990243802903576,0,2,Pyrin domain binding,MF,
8170,GO:0032091,1,0.530911874750007,0,95,negative regulation of protein binding,BP,
8172,GO:0032093,1,0.994890876864838,0,1,SAM domain binding,MF,
8173,GO:0032094,1,0.819507172258038,0,33,response to food,BP,
8174,GO:0032095,1,0.904825471297235,0,18,regulation of response to food,BP,
8176,GO:0032097,1,0.990005036242905,0,3,positive regulation of response to food,BP,
8177,GO:0032098,1,0.900827565375673,0,20,regulation of appetite,BP,
8179,GO:0032100,1,0.990005036242905,0,3,positive regulation of appetite,BP,
8183,GO:0032104,1,0.864419356451472,0,24,regulation of response to extracellular stimulus,BP,
8184,GO:0032105,1,0.924733072418183,0,14,negative regulation of response to extracellular stimulus,BP,
8185,GO:0032106,1,0.981378274061038,0,5,positive regulation of response to extracellular stimulus,BP,
8186,GO:0032107,1,0.864419356451472,0,24,regulation of response to nutrient levels,BP,
8187,GO:0032108,1,0.924733072418183,0,14,negative regulation of response to nutrient levels,BP,
8188,GO:0032109,1,0.981378274061038,0,5,positive regulation of response to nutrient levels,BP,
8189,GO:0032116,1,0.976197452148476,0,2,SMC loading complex,CC,
8190,GO:0032119,1,0.953511009730049,0,7,sequestering of zinc ion,BP,
8191,GO:0032127,1,0.935220983591787,0,6,dense core granule membrane,CC,
8192,GO:0032129,1,0.989216660857588,0,2,histone deacetylase activity (H3-K9 specific),MF,
8193,GO:0032133,1,0.972426912599754,0,6,chromosome passenger complex,CC,
8194,GO:0032135,1,0.96226893934076,0,6,DNA insertion or deletion binding,MF,
8195,GO:0032137,1,0.981432264787514,0,3,guanine/thymine mispair binding,MF,
8196,GO:0032138,1,0.972097866359885,0,4,single base insertion or deletion binding,MF,
8197,GO:0032139,1,0.982043063440855,0,3,dinucleotide insertion or deletion binding,MF,
8198,GO:0032142,1,0.977222444974428,0,3,single guanine insertion binding,MF,
8199,GO:0032143,1,0.985965388597764,0,2,single thymine insertion binding,MF,
8200,GO:0032144,1,0.990584166653363,0,1,4-aminobutyrate transaminase complex,CC,
8201,GO:0032145,1,0.990584166653363,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8203,GO:0032148,1,0.803212158914716,0,29,activation of protein kinase B activity,BP,
8204,GO:0032153,1,0.664611664570566,0,56,cell division site,CC,
8205,GO:0032154,1,0.697565483730742,0,49,cleavage furrow,CC,
8206,GO:0032156,1,0.99196246899165,0,1,septin cytoskeleton,CC,
8207,GO:0032181,1,0.985343155340999,0,2,dinucleotide repeat insertion binding,MF,
8208,GO:0032182,1,0.539684767477695,0,89,ubiquitin-like protein binding,MF,
8209,GO:0032183,1,0.872464462071562,0,15,SUMO binding,MF,
8210,GO:0032184,1,0.954919501751269,0,5,SUMO polymer binding,MF,
8211,GO:0032185,1,0.977427474073893,0,4,septin cytoskeleton organization,BP,
8212,GO:0032190,1,0.988896698368358,0,3,acrosin binding,MF,
8213,GO:0032194,1,0.993151563060952,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8214,GO:0032196,1,0.877843230015306,0,22,transposition,BP,
8215,GO:0032197,1,0.989723359193061,0,2,transposition, RNA-mediated,BP,
8216,GO:0032200,1,0.364489691344278,0,140,telomere organization,BP,
8217,GO:0032201,1,0.856479021824892,0,27,telomere maintenance via semi-conservative replication,BP,
8218,GO:0032202,1,0.977149127425728,0,5,telomere assembly,BP,
8219,GO:0032203,1,0.996232329517488,0,1,telomere formation via telomerase,BP,
8220,GO:0032204,1,0.563087589792075,0,76,regulation of telomere maintenance,BP,
8221,GO:0032205,1,0.755358016674963,0,33,negative regulation of telomere maintenance,BP,
8222,GO:0032206,1,0.719217251801152,0,49,positive regulation of telomere maintenance,BP,
8223,GO:0032207,1,0.994652482138736,0,1,regulation of telomere maintenance via recombination,BP,
8224,GO:0032208,1,0.994652482138736,0,1,negative regulation of telomere maintenance via recombination,BP,
8225,GO:0032210,1,0.696871996775066,0,51,regulation of telomere maintenance via telomerase,BP,
8226,GO:0032211,1,0.871821834379264,0,18,negative regulation of telomere maintenance via telomerase,BP,
8227,GO:0032212,1,0.803627896725048,0,34,positive regulation of telomere maintenance via telomerase,BP,
8228,GO:0032213,1,0.989267037860324,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8229,GO:0032214,1,0.989267037860324,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8230,GO:0032217,1,0.973207558500776,0,5,riboflavin transmembrane transporter activity,MF,
8231,GO:0032218,1,0.973207558500776,0,5,riboflavin transport,BP,
8232,GO:0032222,1,0.960252211970246,0,6,regulation of synaptic transmission, cholinergic,BP,
8233,GO:0032223,1,0.995221118478006,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8234,GO:0032224,1,0.969656370633815,0,4,positive regulation of synaptic transmission, cholinergic,BP,
8235,GO:0032225,1,0.913963135331139,0,16,regulation of synaptic transmission, dopaminergic,BP,
8236,GO:0032226,1,0.965314613858867,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8237,GO:0032227,1,0.977047516099105,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8238,GO:0032228,1,0.757920573046452,0,33,regulation of synaptic transmission, GABAergic,BP,
8239,GO:0032229,1,0.961094201541305,0,7,negative regulation of synaptic transmission, GABAergic,BP,
8240,GO:0032230,1,0.90624220373612,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8243,GO:0032233,1,0.632977381751219,0,60,positive regulation of actin filament bundle assembly,BP,
8244,GO:0032237,1,0.969508461326366,0,4,activation of store-operated calcium channel activity,BP,
8245,GO:0032238,1,0.990956552439018,0,2,adenosine transport,BP,
8246,GO:0032239,1,0.851973150639975,0,19,regulation of nucleobase-containing compound transport,BP,
8247,GO:0032240,1,0.967513337905518,0,3,negative regulation of nucleobase-containing compound transport,BP,
8248,GO:0032241,1,0.935983505375126,0,9,positive regulation of nucleobase-containing compound transport,BP,
8249,GO:0032242,1,0.991022676355227,0,2,regulation of nucleoside transport,BP,
8250,GO:0032243,1,0.996241409002472,0,1,negative regulation of nucleoside transport,BP,
8251,GO:0032244,1,0.994761775626439,0,1,positive regulation of nucleoside transport,BP,
8252,GO:0032252,1,0.838052680320122,0,15,secretory granule localization,BP,
8253,GO:0032253,1,0.880714233509205,0,11,dense core granule localization,BP,
8255,GO:0032261,1,0.971002410430373,0,6,purine nucleotide salvage,BP,
8256,GO:0032262,1,0.980774437232525,0,5,pyrimidine nucleotide salvage,BP,
8257,GO:0032263,1,0.996604021233342,0,1,GMP salvage,BP,
8258,GO:0032264,1,0.981388411280706,0,3,IMP salvage,BP,
8263,GO:0032271,1,0.216591838067269,0,210,regulation of protein polymerization,BP,
8264,GO:0032272,1,0.591541628360729,0,71,negative regulation of protein polymerization,BP,
8265,GO:0032273,1,0.420619263290806,0,123,positive regulation of protein polymerization,BP,
8266,GO:0032274,1,0.918200262100795,0,13,gonadotropin secretion,BP,
8267,GO:0032275,1,0.936117056762683,0,9,luteinizing hormone secretion,BP,
8268,GO:0032276,1,0.94299507780272,0,10,regulation of gonadotropin secretion,BP,
8269,GO:0032277,1,0.973207265117289,0,6,negative regulation of gonadotropin secretion,BP,
8270,GO:0032278,1,0.955955912735256,0,7,positive regulation of gonadotropin secretion,BP,
8274,GO:0032286,1,0.974712270402272,0,4,central nervous system myelin maintenance,BP,
8275,GO:0032287,1,0.913425251395554,0,8,peripheral nervous system myelin maintenance,BP,
8276,GO:0032288,1,0.830840633341179,0,21,myelin assembly,BP,
8277,GO:0032289,1,0.9692861862502,0,4,central nervous system myelin formation,BP,
8278,GO:0032290,1,0.976006537894754,0,2,peripheral nervous system myelin formation,BP,
8279,GO:0032291,1,0.865824531064377,0,21,axon ensheathment in central nervous system,BP,
8280,GO:0032292,1,0.776441391793795,0,27,peripheral nervous system axon ensheathment,BP,
8281,GO:0032296,1,0.964183522584255,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8282,GO:0032298,1,0.995747724855238,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8283,GO:0032299,1,0.988150743264383,0,3,ribonuclease H2 complex,CC,
8284,GO:0032300,1,0.947177032132142,0,7,mismatch repair complex,CC,
8285,GO:0032301,1,0.985965388597764,0,2,MutSalpha complex,CC,
8286,GO:0032302,1,0.985343155340999,0,2,MutSbeta complex,CC,
8287,GO:0032303,1,0.935668808018259,0,12,regulation of icosanoid secretion,BP,
8288,GO:0032304,1,0.990345394588493,0,1,negative regulation of icosanoid secretion,BP,
8289,GO:0032305,1,0.944783585385276,0,11,positive regulation of icosanoid secretion,BP,
8290,GO:0032306,1,0.970398499499968,0,7,regulation of prostaglandin secretion,BP,
8291,GO:0032308,1,0.970398499499968,0,7,positive regulation of prostaglandin secretion,BP,
8293,GO:0032310,1,0.948274672467676,0,10,prostaglandin secretion,BP,
8294,GO:0032311,1,0.993005344920069,0,2,angiogenin-PRI complex,CC,
8295,GO:0032324,1,0.966933966056222,0,6,molybdopterin cofactor biosynthetic process,BP,
8297,GO:0032329,1,0.956178152557955,0,8,serine transport,BP,
8298,GO:0032330,1,0.710255365357257,0,45,regulation of chondrocyte differentiation,BP,
8299,GO:0032331,1,0.876539361472193,0,19,negative regulation of chondrocyte differentiation,BP,
8300,GO:0032332,1,0.859339916316588,0,20,positive regulation of chondrocyte differentiation,BP,
8301,GO:0032341,1,0.945077878268725,0,8,aldosterone metabolic process,BP,
8302,GO:0032342,1,0.945077878268725,0,8,aldosterone biosynthetic process,BP,
8303,GO:0032344,1,0.959760448674988,0,7,regulation of aldosterone metabolic process,BP,
8304,GO:0032345,1,0.978257912298077,0,4,negative regulation of aldosterone metabolic process,BP,
8305,GO:0032346,1,0.986923447804192,0,2,positive regulation of aldosterone metabolic process,BP,
8306,GO:0032347,1,0.959760448674988,0,7,regulation of aldosterone biosynthetic process,BP,
8307,GO:0032348,1,0.978257912298077,0,4,negative regulation of aldosterone biosynthetic process,BP,
8308,GO:0032349,1,0.986923447804192,0,2,positive regulation of aldosterone biosynthetic process,BP,
8310,GO:0032351,1,0.955756934821215,0,8,negative regulation of hormone metabolic process,BP,
8312,GO:0032353,1,0.964173614387335,0,6,negative regulation of hormone biosynthetic process,BP,
8313,GO:0032354,1,0.886162115206072,0,14,response to follicle-stimulating hormone,BP,
8315,GO:0032356,1,0.938113089763653,0,10,oxidized DNA binding,MF,
8316,GO:0032357,1,0.941954157047474,0,9,oxidized purine DNA binding,MF,
8317,GO:0032358,1,0.996839785721365,0,1,oxidized pyrimidine DNA binding,MF,
8318,GO:0032361,1,0.996066812388145,0,1,pyridoxal phosphate catabolic process,BP,
8319,GO:0032364,1,0.952929843093586,0,7,oxygen homeostasis,BP,
8324,GO:0032369,1,0.851376600623276,0,20,negative regulation of lipid transport,BP,
8327,GO:0032372,1,0.939269196957598,0,9,negative regulation of sterol transport,BP,
8330,GO:0032375,1,0.939269196957598,0,9,negative regulation of cholesterol transport,BP,
8333,GO:0032378,1,0.977819802737988,0,2,negative regulation of intracellular lipid transport,BP,
8336,GO:0032381,1,0.977819802737988,0,2,negative regulation of intracellular sterol transport,BP,
8339,GO:0032384,1,0.977819802737988,0,2,negative regulation of intracellular cholesterol transport,BP,
8342,GO:0032387,1,0.695747167060642,0,54,negative regulation of intracellular transport,BP,
8344,GO:0032389,1,0.990184040519376,0,2,MutLalpha complex,CC,
8345,GO:0032391,1,0.758309181956325,0,33,photoreceptor connecting cilium,CC,
8347,GO:0032393,1,0.972282939746676,0,7,MHC class I receptor activity,MF,
8348,GO:0032394,1,0.984292686585552,0,4,MHC class Ib receptor activity,MF,
8349,GO:0032395,1,0.967158422786762,0,9,MHC class II receptor activity,MF,
8350,GO:0032396,1,0.985559015877857,0,3,inhibitory MHC class I receptor activity,MF,
8351,GO:0032397,1,0.993082896354631,0,2,activating MHC class I receptor activity,MF,
8352,GO:0032398,1,0.993098330242119,0,2,MHC class Ib protein complex,CC,
8353,GO:0032400,1,0.862386865907648,0,25,melanosome localization,BP,
8354,GO:0032401,1,0.870860362166606,0,23,establishment of melanosome localization,BP,
8355,GO:0032402,1,0.883353080970865,0,22,melanosome transport,BP,
8356,GO:0032404,1,0.929450502480088,0,11,mismatch repair complex binding,MF,
8357,GO:0032405,1,0.953205465950402,0,6,MutLalpha complex binding,MF,
8358,GO:0032406,1,0.988468400750634,0,2,MutLbeta complex binding,MF,
8359,GO:0032407,1,0.956432979386951,0,7,MutSalpha complex binding,MF,
8360,GO:0032408,1,0.988468400750634,0,2,MutSbeta complex binding,MF,
8362,GO:0032410,1,0.618849635817488,0,73,negative regulation of transporter activity,BP,
8365,GO:0032413,1,0.649141729386436,0,66,negative regulation of ion transmembrane transporter activity,BP,
8367,GO:0032415,1,0.973758907836995,0,6,regulation of sodium:proton antiporter activity,BP,
8368,GO:0032416,1,0.992557073777539,0,2,negative regulation of sodium:proton antiporter activity,BP,
8369,GO:0032417,1,0.981062278001766,0,4,positive regulation of sodium:proton antiporter activity,BP,
8371,GO:0032419,1,0.995761291282718,0,1,extrinsic component of lysosome membrane,CC,
8372,GO:0032420,1,0.699475719098949,0,46,stereocilium,CC,
8373,GO:0032421,1,0.68428973701923,0,50,stereocilium bundle,CC,
8374,GO:0032422,1,0.970010291200226,0,4,purine-rich negative regulatory element binding,MF,
8375,GO:0032423,1,0.975012394103772,0,4,regulation of mismatch repair,BP,
8376,GO:0032425,1,0.982936124205419,0,3,positive regulation of mismatch repair,BP,
8377,GO:0032426,1,0.900236542637188,0,16,stereocilium tip,CC,
8378,GO:0032427,1,0.987216109159068,0,2,GBD domain binding,MF,
8379,GO:0032428,1,0.993296780819711,0,1,beta-N-acetylgalactosaminidase activity,MF,
8381,GO:0032430,1,0.97442008988873,0,5,positive regulation of phospholipase A2 activity,BP,
8382,GO:0032431,1,0.988091948377951,0,3,activation of phospholipase A2 activity,BP,
8383,GO:0032432,1,0.579137484734699,0,66,actin filament bundle,CC,
8384,GO:0032433,1,0.85726528876852,0,16,filopodium tip,CC,
8385,GO:0032434,1,0.445262898289395,0,124,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8386,GO:0032435,1,0.800278760329108,0,33,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8387,GO:0032436,1,0.591586138694501,0,82,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8388,GO:0032437,1,0.933268211169249,0,9,cuticular plate,CC,
8389,GO:0032438,1,0.824776266450477,0,27,melanosome organization,BP,
8390,GO:0032440,1,0.996696292937644,0,1,2-alkenal reductase [NAD(P)+] activity,MF,
8391,GO:0032444,1,0.960569796838831,0,3,activin responsive factor complex,CC,
8392,GO:0032445,1,0.995632785523235,0,1,fructose import,BP,
8394,GO:0032447,1,0.984357510487932,0,4,protein urmylation,BP,
8395,GO:0032448,1,0.996488443237661,0,1,DNA hairpin binding,MF,
8396,GO:0032449,1,0.969227420666996,0,4,CBM complex,CC,
8397,GO:0032450,1,0.972248202658214,0,3,maltose alpha-glucosidase activity,MF,
8398,GO:0032451,1,0.737314346187328,0,34,demethylase activity,MF,
8399,GO:0032452,1,0.77208017706002,0,25,histone demethylase activity,MF,
8400,GO:0032453,1,0.933596874969722,0,6,histone demethylase activity (H3-K4 specific),MF,
8401,GO:0032454,1,0.89136884344179,0,12,histone demethylase activity (H3-K9 specific),MF,
8402,GO:0032455,1,0.97661425683651,0,4,nerve growth factor processing,BP,
8403,GO:0032456,1,0.70467030636566,0,45,endocytic recycling,BP,
8404,GO:0032458,1,0.992683400397524,0,1,slow endocytic recycling,BP,
8405,GO:0032459,1,0.989956523828425,0,2,regulation of protein oligomerization,BP,
8406,GO:0032460,1,0.993880460326495,0,1,negative regulation of protein oligomerization,BP,
8407,GO:0032461,1,0.996052145380911,0,1,positive regulation of protein oligomerization,BP,
8408,GO:0032462,1,0.993880460326495,0,1,regulation of protein homooligomerization,BP,
8409,GO:0032463,1,0.993880460326495,0,1,negative regulation of protein homooligomerization,BP,
8410,GO:0032465,1,0.537138375450286,0,79,regulation of cytokinesis,BP,
8411,GO:0032466,1,0.957857822599539,0,7,negative regulation of cytokinesis,BP,
8412,GO:0032467,1,0.791800133720396,0,31,positive regulation of cytokinesis,BP,
8413,GO:0032468,1,0.989597235899891,0,2,Golgi calcium ion homeostasis,BP,
8414,GO:0032469,1,0.843834656570159,0,23,endoplasmic reticulum calcium ion homeostasis,BP,
8415,GO:0032470,1,0.977963396531428,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8416,GO:0032471,1,0.956036547306545,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8417,GO:0032472,1,0.989597235899891,0,2,Golgi calcium ion transport,BP,
8418,GO:0032473,1,0.978749525120149,0,2,cytoplasmic side of mitochondrial outer membrane,CC,
8419,GO:0032474,1,0.969665134993675,0,4,otolith morphogenesis,BP,
8420,GO:0032475,1,0.995106014456125,0,1,otolith formation,BP,
8421,GO:0032479,1,0.455513468729079,0,114,regulation of type I interferon production,BP,
8422,GO:0032480,1,0.748243885906087,0,41,negative regulation of type I interferon production,BP,
8423,GO:0032481,1,0.618329966852578,0,69,positive regulation of type I interferon production,BP,
8424,GO:0032482,1,0.868435100387194,0,21,Rab protein signal transduction,BP,
8425,GO:0032483,1,0.930030572087953,0,7,regulation of Rab protein signal transduction,BP,
8426,GO:0032484,1,0.970902492503547,0,3,Ral protein signal transduction,BP,
8427,GO:0032485,1,0.970902492503547,0,3,regulation of Ral protein signal transduction,BP,
8428,GO:0032486,1,0.875363740787632,0,14,Rap protein signal transduction,BP,
8429,GO:0032487,1,0.95101209748977,0,4,regulation of Rap protein signal transduction,BP,
8430,GO:0032488,1,0.923350827883566,0,12,Cdc42 protein signal transduction,BP,
8431,GO:0032489,1,0.956325616004984,0,6,regulation of Cdc42 protein signal transduction,BP,
8432,GO:0032490,1,0.911949054652695,0,12,detection of molecule of bacterial origin,BP,
8433,GO:0032491,1,0.995474602968351,0,1,detection of molecule of fungal origin,BP,
8434,GO:0032493,1,0.943337931001603,0,8,response to bacterial lipoprotein,BP,
8435,GO:0032494,1,0.936833640374977,0,11,response to peptidoglycan,BP,
8438,GO:0032497,1,0.978052689437157,0,4,detection of lipopolysaccharide,BP,
8439,GO:0032498,1,0.991424188017513,0,1,detection of muramyl dipeptide,BP,
8440,GO:0032499,1,0.988231719288969,0,2,detection of peptidoglycan,BP,
8441,GO:0032500,1,0.991424188017513,0,1,muramyl dipeptide binding,MF,
8445,GO:0032505,1,0.981051855925942,0,1,reproduction of a single-celled organism,BP,
8446,GO:0032506,1,0.790634231700451,0,39,cytokinetic process,BP,
8447,GO:0032507,1,0.627937835978414,0,63,maintenance of protein location in cell,BP,
8449,GO:0032509,1,0.827415691648584,0,33,endosome transport via multivesicular body sorting pathway,BP,
8450,GO:0032510,1,0.944628514615318,0,7,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8451,GO:0032511,1,0.92742743033189,0,16,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8453,GO:0032516,1,0.866760171858647,0,18,positive regulation of phosphoprotein phosphatase activity,BP,
8454,GO:0032525,1,0.932872546877221,0,11,somite rostral/caudal axis specification,BP,
8456,GO:0032527,1,0.723977821053369,0,45,protein exit from endoplasmic reticulum,BP,
8457,GO:0032528,1,0.827102092717238,0,24,microvillus organization,BP,
8458,GO:0032530,1,0.917845126588748,0,12,regulation of microvillus organization,BP,
8459,GO:0032532,1,0.965879598968056,0,6,regulation of microvillus length,BP,
8460,GO:0032534,1,0.950285498675672,0,6,regulation of microvillus assembly,BP,
8462,GO:0032536,1,0.927821208210971,0,11,regulation of cell projection size,BP,
8463,GO:0032541,1,0.97281531583586,0,5,cortical endoplasmic reticulum,CC,
8464,GO:0032542,1,0.988769166423394,0,2,sulfiredoxin activity,MF,
8465,GO:0032543,1,0.572375954557733,0,129,mitochondrial translation,BP,
8466,GO:0032545,1,0.988764322359233,0,2,CURI complex,CC,
8469,GO:0032552,1,0.976821930823553,0,5,deoxyribonucleotide binding,MF,
8471,GO:0032554,1,0.980001492588987,0,4,purine deoxyribonucleotide binding,MF,
8473,GO:0032556,1,0.996756211178004,0,1,pyrimidine deoxyribonucleotide binding,MF,
8474,GO:0032557,1,0.980510697324403,0,3,pyrimidine ribonucleotide binding,MF,
8475,GO:0032558,1,0.985847600163099,0,3,adenyl deoxyribonucleotide binding,MF,
8477,GO:0032560,1,0.994070812197178,0,1,guanyl deoxyribonucleotide binding,MF,
8479,GO:0032564,1,0.989379306882458,0,2,dATP binding,MF,
8480,GO:0032567,1,0.994070812197178,0,1,dGTP binding,MF,
8481,GO:0032570,1,0.76123483585448,0,42,response to progesterone,BP,
8483,GO:0032574,1,0.985817426886672,0,2,5'-3' RNA helicase activity,MF,
8484,GO:0032580,1,0.609236144051936,0,77,Golgi cisterna membrane,CC,
8485,GO:0032581,1,0.996245125832489,0,1,ER-dependent peroxisome organization,BP,
8486,GO:0032584,1,0.959460322368526,0,7,growth cone membrane,CC,
8487,GO:0032585,1,0.931923599004202,0,11,multivesicular body membrane,CC,
8493,GO:0032592,1,0.687133764137291,0,72,integral component of mitochondrial membrane,CC,
8494,GO:0032593,1,0.908282676225923,0,10,insulin-responsive compartment,CC,
8495,GO:0032594,1,0.964308396300955,0,7,protein transport within lipid bilayer,BP,
8496,GO:0032596,1,0.975619085020921,0,4,protein transport into membrane raft,BP,
8497,GO:0032601,1,0.976522977042114,0,3,connective tissue growth factor production,BP,
8498,GO:0032602,1,0.697387142770697,0,66,chemokine production,BP,
8499,GO:0032603,1,0.99325191687276,0,2,fractalkine production,BP,
8500,GO:0032604,1,0.933003066545895,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8501,GO:0032605,1,0.994070812197178,0,1,hepatocyte growth factor production,BP,
8502,GO:0032606,1,0.451561792766203,0,116,type I interferon production,BP,
8503,GO:0032607,1,0.814352112773728,0,27,interferon-alpha production,BP,
8504,GO:0032608,1,0.71944185514617,0,48,interferon-beta production,BP,
8505,GO:0032609,1,0.58239904775243,0,99,interferon-gamma production,BP,
8506,GO:0032610,1,0.970843177839114,0,4,interleukin-1 alpha production,BP,
8507,GO:0032611,1,0.622997587536753,0,81,interleukin-1 beta production,BP,
8509,GO:0032613,1,0.761969359089114,0,51,interleukin-10 production,BP,
8510,GO:0032615,1,0.727933391375344,0,52,interleukin-12 production,BP,
8511,GO:0032616,1,0.913626059659467,0,16,interleukin-13 production,BP,
8512,GO:0032618,1,0.99272747665787,0,2,interleukin-15 production,BP,
8513,GO:0032620,1,0.877532025442945,0,26,interleukin-17 production,BP,
8514,GO:0032621,1,0.947401982831752,0,8,interleukin-18 production,BP,
8516,GO:0032625,1,0.990079316603862,0,2,interleukin-21 production,BP,
8517,GO:0032627,1,0.973619903474147,0,4,interleukin-23 production,BP,
8518,GO:0032632,1,0.988375324806563,0,2,interleukin-3 production,BP,
8519,GO:0032633,1,0.846145832382856,0,31,interleukin-4 production,BP,
8520,GO:0032634,1,0.920789280445932,0,13,interleukin-5 production,BP,
8521,GO:0032635,1,0.468231564354629,0,126,interleukin-6 production,BP,
8523,GO:0032639,1,0.99640688748682,0,1,TRAIL production,BP,
8525,GO:0032642,1,0.716467829108836,0,59,regulation of chemokine production,BP,
8526,GO:0032643,1,0.976522977042114,0,3,regulation of connective tissue growth factor production,BP,
8527,GO:0032645,1,0.936413382606373,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8528,GO:0032646,1,0.994070812197178,0,1,regulation of hepatocyte growth factor production,BP,
8529,GO:0032647,1,0.82008141221379,0,25,regulation of interferon-alpha production,BP,
8530,GO:0032648,1,0.724226505555838,0,47,regulation of interferon-beta production,BP,
8531,GO:0032649,1,0.620673871916383,0,89,regulation of interferon-gamma production,BP,
8532,GO:0032650,1,0.973883737451814,0,3,regulation of interleukin-1 alpha production,BP,
8533,GO:0032651,1,0.66386457933018,0,72,regulation of interleukin-1 beta production,BP,
8535,GO:0032653,1,0.772444964344013,0,48,regulation of interleukin-10 production,BP,
8536,GO:0032655,1,0.736427566331382,0,50,regulation of interleukin-12 production,BP,
8537,GO:0032656,1,0.921658493847806,0,14,regulation of interleukin-13 production,BP,
8538,GO:0032658,1,0.996308337271904,0,1,regulation of interleukin-15 production,BP,
8539,GO:0032660,1,0.898469150867602,0,21,regulation of interleukin-17 production,BP,
8540,GO:0032661,1,0.962500836495932,0,6,regulation of interleukin-18 production,BP,
8542,GO:0032667,1,0.973619903474147,0,4,regulation of interleukin-23 production,BP,
8543,GO:0032672,1,0.995631289282231,0,1,regulation of interleukin-3 production,BP,
8544,GO:0032673,1,0.855958019904265,0,29,regulation of interleukin-4 production,BP,
8545,GO:0032674,1,0.920789280445932,0,13,regulation of interleukin-5 production,BP,
8546,GO:0032675,1,0.501230478142396,0,116,regulation of interleukin-6 production,BP,
8548,GO:0032679,1,0.99640688748682,0,1,regulation of TRAIL production,BP,
8550,GO:0032682,1,0.929143672687029,0,14,negative regulation of chemokine production,BP,
8551,GO:0032683,1,0.991946194959028,0,1,negative regulation of connective tissue growth factor production,BP,
8552,GO:0032685,1,0.993938846711865,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8553,GO:0032686,1,0.994070812197178,0,1,negative regulation of hepatocyte growth factor production,BP,
8554,GO:0032687,1,0.964024074734888,0,5,negative regulation of interferon-alpha production,BP,
8555,GO:0032688,1,0.919943502647104,0,13,negative regulation of interferon-beta production,BP,
8556,GO:0032689,1,0.861904101168566,0,31,negative regulation of interferon-gamma production,BP,
8557,GO:0032690,1,0.993932817609136,0,1,negative regulation of interleukin-1 alpha production,BP,
8558,GO:0032691,1,0.890005937020567,0,22,negative regulation of interleukin-1 beta production,BP,
8559,GO:0032692,1,0.868103842350998,0,27,negative regulation of interleukin-1 production,BP,
8560,GO:0032693,1,0.931959135929101,0,14,negative regulation of interleukin-10 production,BP,
8561,GO:0032695,1,0.900897436493292,0,16,negative regulation of interleukin-12 production,BP,
8562,GO:0032696,1,0.983506451251676,0,3,negative regulation of interleukin-13 production,BP,
8563,GO:0032700,1,0.956475733716789,0,8,negative regulation of interleukin-17 production,BP,
8564,GO:0032701,1,0.990409868438135,0,2,negative regulation of interleukin-18 production,BP,
8565,GO:0032703,1,0.882819970567946,0,22,negative regulation of interleukin-2 production,BP,
8566,GO:0032707,1,0.984794832864786,0,2,negative regulation of interleukin-23 production,BP,
8567,GO:0032712,1,0.995631289282231,0,1,negative regulation of interleukin-3 production,BP,
8568,GO:0032713,1,0.968928295451965,0,6,negative regulation of interleukin-4 production,BP,
8569,GO:0032714,1,0.982354458511921,0,3,negative regulation of interleukin-5 production,BP,
8570,GO:0032715,1,0.81034830774306,0,36,negative regulation of interleukin-6 production,BP,
8572,GO:0032720,1,0.775178207841062,0,45,negative regulation of tumor necrosis factor production,BP,
8573,GO:0032722,1,0.795157095955786,0,39,positive regulation of chemokine production,BP,
8574,GO:0032723,1,0.984452804035499,0,2,positive regulation of connective tissue growth factor production,BP,
8575,GO:0032725,1,0.942127156516179,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8576,GO:0032727,1,0.850736000725352,0,20,positive regulation of interferon-alpha production,BP,
8577,GO:0032728,1,0.807723993735944,0,30,positive regulation of interferon-beta production,BP,
8578,GO:0032729,1,0.723248846321079,0,57,positive regulation of interferon-gamma production,BP,
8579,GO:0032730,1,0.979829749942284,0,2,positive regulation of interleukin-1 alpha production,BP,
8580,GO:0032731,1,0.760832974775891,0,46,positive regulation of interleukin-1 beta production,BP,
8581,GO:0032732,1,0.729430173942784,0,51,positive regulation of interleukin-1 production,BP,
8582,GO:0032733,1,0.834607574911934,0,34,positive regulation of interleukin-10 production,BP,
8583,GO:0032735,1,0.840344997320174,0,31,positive regulation of interleukin-12 production,BP,
8584,GO:0032736,1,0.93712497726376,0,11,positive regulation of interleukin-13 production,BP,
8585,GO:0032738,1,0.996308337271904,0,1,positive regulation of interleukin-15 production,BP,
8586,GO:0032740,1,0.93938003636596,0,13,positive regulation of interleukin-17 production,BP,
8587,GO:0032741,1,0.97769776381043,0,3,positive regulation of interleukin-18 production,BP,
8589,GO:0032747,1,0.988654259106858,0,2,positive regulation of interleukin-23 production,BP,
8590,GO:0032753,1,0.882434193831605,0,23,positive regulation of interleukin-4 production,BP,
8591,GO:0032754,1,0.941066494012658,0,9,positive regulation of interleukin-5 production,BP,
8592,GO:0032755,1,0.628754207292404,0,77,positive regulation of interleukin-6 production,BP,
8594,GO:0032759,1,0.99640688748682,0,1,positive regulation of TRAIL production,BP,
8595,GO:0032760,1,0.736355107926142,0,46,positive regulation of tumor necrosis factor production,BP,
8597,GO:0032763,1,0.971196201105386,0,5,regulation of mast cell cytokine production,BP,
8598,GO:0032764,1,0.989926987560999,0,2,negative regulation of mast cell cytokine production,BP,
8599,GO:0032765,1,0.981080517580434,0,3,positive regulation of mast cell cytokine production,BP,
8600,GO:0032767,1,0.97404130547723,0,3,copper-dependent protein binding,MF,
8601,GO:0032768,1,0.732937678563066,0,52,regulation of monooxygenase activity,BP,
8602,GO:0032769,1,0.932488644271464,0,11,negative regulation of monooxygenase activity,BP,
8603,GO:0032770,1,0.860106408111893,0,26,positive regulation of monooxygenase activity,BP,
8604,GO:0032771,1,0.991836587427737,0,1,regulation of monophenol monooxygenase activity,BP,
8605,GO:0032773,1,0.991836587427737,0,1,positive regulation of monophenol monooxygenase activity,BP,
8607,GO:0032775,1,0.983927248968935,0,2,DNA methylation on adenine,BP,
8608,GO:0032776,1,0.974213734181369,0,3,DNA methylation on cytosine,BP,
8609,GO:0032777,1,0.980060175045738,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8611,GO:0032781,1,0.770621485975092,0,53,positive regulation of ATPase activity,BP,
8612,GO:0032782,1,0.957699836723484,0,7,bile acid secretion,BP,
8613,GO:0032783,1,0.939027699896987,0,5,super elongation complex,CC,
8614,GO:0032784,1,0.738912529385559,0,45,regulation of DNA-templated transcription, elongation,BP,
8615,GO:0032785,1,0.911161492438197,0,15,negative regulation of DNA-templated transcription, elongation,BP,
8616,GO:0032786,1,0.837915668367053,0,25,positive regulation of DNA-templated transcription, elongation,BP,
8618,GO:0032788,1,0.996450548134146,0,1,saturated monocarboxylic acid metabolic process,BP,
8619,GO:0032789,1,0.996450548134146,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8620,GO:0032790,1,0.94938280691458,0,8,ribosome disassembly,BP,
8621,GO:0032791,1,0.996342508918834,0,1,lead ion binding,MF,
8622,GO:0032792,1,0.968971297978352,0,5,negative regulation of CREB transcription factor activity,BP,
8623,GO:0032793,1,0.856568838826908,0,18,positive regulation of CREB transcription factor activity,BP,
8624,GO:0032794,1,0.880958209121766,0,14,GTPase activating protein binding,MF,
8625,GO:0032795,1,0.984310216586199,0,3,heterotrimeric G-protein binding,MF,
8626,GO:0032796,1,0.982217176185024,0,2,uropod organization,BP,
8627,GO:0032797,1,0.940848543933387,0,11,SMN complex,CC,
8628,GO:0032798,1,0.989807596705769,0,2,Swi5-Sfr1 complex,CC,
8630,GO:0032800,1,0.840481365038925,0,24,receptor biosynthetic process,BP,
8635,GO:0032805,1,0.974622192016424,0,3,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8636,GO:0032806,1,0.880756974687434,0,20,carboxy-terminal domain protein kinase complex,CC,
8637,GO:0032807,1,0.984749867648304,0,3,DNA ligase IV complex,CC,
8638,GO:0032808,1,0.944439092878372,0,7,lacrimal gland development,BP,
8640,GO:0032810,1,0.987023537323548,0,2,sterol response element binding,MF,
8641,GO:0032811,1,0.985575309600207,0,3,negative regulation of epinephrine secretion,BP,
8642,GO:0032812,1,0.993320434367045,0,2,positive regulation of epinephrine secretion,BP,
8643,GO:0032813,1,0.798970286192127,0,45,tumor necrosis factor receptor superfamily binding,MF,
8644,GO:0032814,1,0.851192449438662,0,30,regulation of natural killer cell activation,BP,
8645,GO:0032815,1,0.968594419626758,0,8,negative regulation of natural killer cell activation,BP,
8646,GO:0032816,1,0.901982692945784,0,18,positive regulation of natural killer cell activation,BP,
8647,GO:0032817,1,0.96200198948898,0,8,regulation of natural killer cell proliferation,BP,
8648,GO:0032819,1,0.973592413351192,0,6,positive regulation of natural killer cell proliferation,BP,
8649,GO:0032823,1,0.930782653465672,0,11,regulation of natural killer cell differentiation,BP,
8650,GO:0032824,1,0.996812011353675,0,1,negative regulation of natural killer cell differentiation,BP,
8651,GO:0032825,1,0.946022688065756,0,8,positive regulation of natural killer cell differentiation,BP,
8652,GO:0032826,1,0.993253187356942,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8653,GO:0032827,1,0.996812011353675,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8654,GO:0032829,1,0.992040388804734,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8655,GO:0032831,1,0.992040388804734,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8656,GO:0032832,1,0.996413039573279,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8657,GO:0032834,1,0.996413039573279,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8658,GO:0032835,1,0.612091125788994,0,56,glomerulus development,BP,
8659,GO:0032836,1,0.901759176422409,0,10,glomerular basement membrane development,BP,
8660,GO:0032838,1,0.196707631455876,0,191,plasma membrane bounded cell projection cytoplasm,CC,
8661,GO:0032839,1,0.772510477230358,0,34,dendrite cytoplasm,CC,
8662,GO:0032841,1,0.993218002781279,0,1,calcitonin binding,MF,
8663,GO:0032847,1,0.965373990333755,0,6,regulation of cellular pH reduction,BP,
8664,GO:0032848,1,0.992742680100308,0,1,negative regulation of cellular pH reduction,BP,
8665,GO:0032849,1,0.976544456044814,0,4,positive regulation of cellular pH reduction,BP,
8669,GO:0032872,1,0.217777704403797,0,211,regulation of stress-activated MAPK cascade,BP,
8670,GO:0032873,1,0.742149255286757,0,42,negative regulation of stress-activated MAPK cascade,BP,
8671,GO:0032874,1,0.334755936204207,0,153,positive regulation of stress-activated MAPK cascade,BP,
8672,GO:0032875,1,0.972192517459288,0,4,regulation of DNA endoreduplication,BP,
8673,GO:0032876,1,0.99584795140391,0,1,negative regulation of DNA endoreduplication,BP,
8674,GO:0032877,1,0.982078712737731,0,2,positive regulation of DNA endoreduplication,BP,
8675,GO:0032878,1,0.828044308405301,0,21,regulation of establishment or maintenance of cell polarity,BP,
8678,GO:0032881,1,0.71561590853764,0,38,regulation of polysaccharide metabolic process,BP,
8679,GO:0032885,1,0.729017674103718,0,34,regulation of polysaccharide biosynthetic process,BP,
8680,GO:0032886,1,0.174240269434875,0,223,regulation of microtubule-based process,BP,
8681,GO:0032887,1,0.986317247929674,0,1,regulation of spindle elongation,BP,
8682,GO:0032888,1,0.986317247929674,0,1,regulation of mitotic spindle elongation,BP,
8683,GO:0032889,1,0.978664456667195,0,5,regulation of vacuole fusion, non-autophagic,BP,
8684,GO:0032890,1,0.701605629330542,0,54,regulation of organic acid transport,BP,
8685,GO:0032891,1,0.879454424177268,0,20,negative regulation of organic acid transport,BP,
8686,GO:0032892,1,0.81839593117742,0,31,positive regulation of organic acid transport,BP,
8687,GO:0032896,1,0.989527384581555,0,1,palmitoyl-CoA 9-desaturase activity,MF,
8688,GO:0032897,1,0.86238111292749,0,23,negative regulation of viral transcription,BP,
8689,GO:0032898,1,0.973575262193429,0,4,neurotrophin production,BP,
8690,GO:0032899,1,0.987456235192099,0,2,regulation of neurotrophin production,BP,
8691,GO:0032900,1,0.994761775626439,0,1,negative regulation of neurotrophin production,BP,
8692,GO:0032901,1,0.992656374436386,0,1,positive regulation of neurotrophin production,BP,
8693,GO:0032902,1,0.985944457155956,0,2,nerve growth factor production,BP,
8694,GO:0032905,1,0.931176281083573,0,12,transforming growth factor beta1 production,BP,
8695,GO:0032906,1,0.93399073343481,0,8,transforming growth factor beta2 production,BP,
8696,GO:0032907,1,0.962904920477121,0,3,transforming growth factor beta3 production,BP,
8697,GO:0032908,1,0.935961384399703,0,11,regulation of transforming growth factor beta1 production,BP,
8698,GO:0032909,1,0.93399073343481,0,8,regulation of transforming growth factor beta2 production,BP,
8699,GO:0032910,1,0.962904920477121,0,3,regulation of transforming growth factor beta3 production,BP,
8700,GO:0032911,1,0.9681503559405,0,5,negative regulation of transforming growth factor beta1 production,BP,
8701,GO:0032912,1,0.985359679494212,0,2,negative regulation of transforming growth factor beta2 production,BP,
8702,GO:0032914,1,0.959056668970403,0,7,positive regulation of transforming growth factor beta1 production,BP,
8703,GO:0032915,1,0.99209137117106,0,2,positive regulation of transforming growth factor beta2 production,BP,
8704,GO:0032916,1,0.970772002706614,0,2,positive regulation of transforming growth factor beta3 production,BP,
8705,GO:0032917,1,0.993573462070175,0,2,polyamine acetylation,BP,
8706,GO:0032918,1,0.993573462070175,0,2,spermidine acetylation,BP,
8707,GO:0032919,1,0.996807977639106,0,1,spermine acetylation,BP,
8708,GO:0032920,1,0.996807977639106,0,1,putrescine acetylation,BP,
8709,GO:0032922,1,0.584610970607018,0,61,circadian regulation of gene expression,BP,
8710,GO:0032924,1,0.74728413906303,0,39,activin receptor signaling pathway,BP,
8711,GO:0032925,1,0.844047947600529,0,24,regulation of activin receptor signaling pathway,BP,
8712,GO:0032926,1,0.934224782630369,0,10,negative regulation of activin receptor signaling pathway,BP,
8713,GO:0032927,1,0.926460402066337,0,8,positive regulation of activin receptor signaling pathway,BP,
8714,GO:0032928,1,0.900077060833473,0,20,regulation of superoxide anion generation,BP,
8715,GO:0032929,1,0.993223023269902,0,2,negative regulation of superoxide anion generation,BP,
8716,GO:0032930,1,0.906224575159776,0,18,positive regulation of superoxide anion generation,BP,
8717,GO:0032933,1,0.917155374895803,0,13,SREBP signaling pathway,BP,
8718,GO:0032934,1,0.705726114138846,0,51,sterol binding,MF,
8719,GO:0032937,1,0.982081356160925,0,3,SREBP-SCAP-Insig complex,CC,
8721,GO:0032941,1,0.826421449673731,0,31,secretion by tissue,BP,
8724,GO:0032945,1,0.659745511137395,0,72,negative regulation of mononuclear cell proliferation,BP,
8726,GO:0032954,1,0.974510723024524,0,3,regulation of cytokinetic process,BP,
8728,GO:0032957,1,0.93340036720365,0,10,inositol trisphosphate metabolic process,BP,
8729,GO:0032958,1,0.84912118841851,0,24,inositol phosphate biosynthetic process,BP,
8730,GO:0032959,1,0.953808026460796,0,7,inositol trisphosphate biosynthetic process,BP,
8731,GO:0032960,1,0.969251744241555,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8732,GO:0032962,1,0.977356625114654,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8736,GO:0032966,1,0.950508174998566,0,10,negative regulation of collagen biosynthetic process,BP,
8738,GO:0032968,1,0.906460667159447,0,11,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8740,GO:0032971,1,0.983703768098379,0,3,regulation of muscle filament sliding,BP,
8741,GO:0032972,1,0.996866652374676,0,1,regulation of muscle filament sliding speed,BP,
8742,GO:0032976,1,0.996846220865447,0,1,release of matrix enzymes from mitochondria,BP,
8743,GO:0032977,1,0.987757507915959,0,2,membrane insertase activity,MF,
8744,GO:0032978,1,0.984303786969758,0,3,protein insertion into membrane from inner side,BP,
8745,GO:0032979,1,0.984303786969758,0,3,protein insertion into mitochondrial inner membrane from matrix,BP,
8746,GO:0032981,1,0.810499887670144,0,56,mitochondrial respiratory chain complex I assembly,BP,
8747,GO:0032982,1,0.811657842348027,0,20,myosin filament,CC,
8748,GO:0032983,1,0.962346226269503,0,4,kainate selective glutamate receptor complex,CC,
8750,GO:0032986,1,0.886149076142087,0,17,protein-DNA complex disassembly,BP,
8751,GO:0032988,1,0.955829703632075,0,7,ribonucleoprotein complex disassembly,BP,
8755,GO:0032993,1,0.516615815561411,0,103,protein-DNA complex,CC,
8756,GO:0032994,1,0.832023470695406,0,33,protein-lipid complex,CC,
8757,GO:0032996,1,0.996222093494714,0,1,Bcl3-Bcl10 complex,CC,
8758,GO:0032997,1,0.993270636274973,0,2,Fc receptor complex,CC,
8759,GO:0032998,1,0.993270636274973,0,2,Fc-epsilon receptor I complex,CC,
8760,GO:0033002,1,0.28376973483624,0,183,muscle cell proliferation,BP,
8761,GO:0033003,1,0.806379007891455,0,39,regulation of mast cell activation,BP,
8762,GO:0033004,1,0.941581941976403,0,12,negative regulation of mast cell activation,BP,
8763,GO:0033005,1,0.905721081898636,0,18,positive regulation of mast cell activation,BP,
8764,GO:0033006,1,0.848764404228525,0,30,regulation of mast cell activation involved in immune response,BP,
8765,GO:0033007,1,0.964143748385241,0,8,negative regulation of mast cell activation involved in immune response,BP,
8766,GO:0033008,1,0.927039006439433,0,14,positive regulation of mast cell activation involved in immune response,BP,
8768,GO:0033011,1,0.987890057178924,0,3,perinuclear theca,CC,
8769,GO:0033013,1,0.715274134380371,0,52,tetrapyrrole metabolic process,BP,
8770,GO:0033014,1,0.847364408767842,0,26,tetrapyrrole biosynthetic process,BP,
8771,GO:0033015,1,0.986535555165494,0,4,tetrapyrrole catabolic process,BP,
8773,GO:0033018,1,0.952521007499239,0,9,sarcoplasmic reticulum lumen,CC,
8774,GO:0033023,1,0.979995940661254,0,3,mast cell homeostasis,BP,
8775,GO:0033024,1,0.979995940661254,0,3,mast cell apoptotic process,BP,
8776,GO:0033025,1,0.979995940661254,0,3,regulation of mast cell apoptotic process,BP,
8777,GO:0033026,1,0.986579447324637,0,2,negative regulation of mast cell apoptotic process,BP,
8780,GO:0033030,1,0.983181491915407,0,2,negative regulation of neutrophil apoptotic process,BP,
8783,GO:0033033,1,0.925533578684665,0,13,negative regulation of myeloid cell apoptotic process,BP,
8786,GO:0033037,1,0.979008616660634,0,2,polysaccharide localization,BP,
8787,GO:0033038,1,0.973977932768195,0,8,bitter taste receptor activity,MF,
8788,GO:0033040,1,0.99434202641678,0,1,sour taste receptor activity,MF,
8789,GO:0033041,1,0.995255489379337,0,1,sweet taste receptor activity,MF,
8792,GO:0033045,1,0.570373274890788,0,76,regulation of sister chromatid segregation,BP,
8793,GO:0033046,1,0.738756377144011,0,41,negative regulation of sister chromatid segregation,BP,
8794,GO:0033047,1,0.603797609771445,0,66,regulation of mitotic sister chromatid segregation,BP,
8795,GO:0033048,1,0.748266937984205,0,40,negative regulation of mitotic sister chromatid segregation,BP,
8796,GO:0033058,1,0.96165936660485,0,3,directional locomotion,BP,
8797,GO:0033059,1,0.696326092760572,0,52,cellular pigmentation,BP,
8798,GO:0033061,1,0.966379832874471,0,7,DNA recombinase mediator complex,CC,
8799,GO:0033063,1,0.981066690190581,0,4,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8800,GO:0033065,1,0.9920074123209,0,2,Rad51C-XRCC3 complex,CC,
8801,GO:0033076,1,0.988750522584541,0,3,isoquinoline alkaloid metabolic process,BP,
8802,GO:0033077,1,0.603269460348131,0,72,T cell differentiation in thymus,BP,
8803,GO:0033078,1,0.983472749976129,0,3,extrathymic T cell differentiation,BP,
8804,GO:0033079,1,0.95173130093029,0,10,immature T cell proliferation,BP,
8805,GO:0033080,1,0.959799028886018,0,8,immature T cell proliferation in thymus,BP,
8806,GO:0033081,1,0.858151882475108,0,25,regulation of T cell differentiation in thymus,BP,
8807,GO:0033082,1,0.987046385863514,0,2,regulation of extrathymic T cell differentiation,BP,
8808,GO:0033083,1,0.958805261376876,0,9,regulation of immature T cell proliferation,BP,
8809,GO:0033084,1,0.966932349371399,0,7,regulation of immature T cell proliferation in thymus,BP,
8810,GO:0033085,1,0.967881033866706,0,7,negative regulation of T cell differentiation in thymus,BP,
8811,GO:0033087,1,0.979741014952266,0,4,negative regulation of immature T cell proliferation,BP,
8812,GO:0033088,1,0.983303938903432,0,3,negative regulation of immature T cell proliferation in thymus,BP,
8813,GO:0033089,1,0.925744507189099,0,13,positive regulation of T cell differentiation in thymus,BP,
8814,GO:0033091,1,0.978635676393901,0,5,positive regulation of immature T cell proliferation,BP,
8815,GO:0033092,1,0.983353214388122,0,4,positive regulation of immature T cell proliferation in thymus,BP,
8816,GO:0033093,1,0.956607805299942,0,5,Weibel-Palade body,CC,
8817,GO:0033100,1,0.995876551390518,0,1,NuA3 histone acetyltransferase complex,CC,
8818,GO:0033106,1,0.980134970047447,0,5,cis-Golgi network membrane,CC,
8819,GO:0033108,1,0.688818896319171,0,90,mitochondrial respiratory chain complex assembly,BP,
8820,GO:0033116,1,0.644437559473754,0,68,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8823,GO:0033127,1,0.927158738505309,0,12,regulation of histone phosphorylation,BP,
8824,GO:0033128,1,0.991573400317239,0,2,negative regulation of histone phosphorylation,BP,
8825,GO:0033129,1,0.945132135946304,0,8,positive regulation of histone phosphorylation,BP,
8826,GO:0033130,1,0.924391231286415,0,11,acetylcholine receptor binding,MF,
8827,GO:0033131,1,0.940673272589306,0,9,regulation of glucokinase activity,BP,
8828,GO:0033132,1,0.981041485671057,0,4,negative regulation of glucokinase activity,BP,
8829,GO:0033133,1,0.958859391795059,0,5,positive regulation of glucokinase activity,BP,
8831,GO:0033137,1,0.851229956389969,0,25,negative regulation of peptidyl-serine phosphorylation,BP,
8834,GO:0033140,1,0.99288090331084,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8836,GO:0033142,1,0.968593524261726,0,3,progesterone receptor binding,MF,
8837,GO:0033143,1,0.608430587070175,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8838,GO:0033144,1,0.784023671103472,0,33,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8839,GO:0033145,1,0.928259028190921,0,11,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8840,GO:0033146,1,0.780312664641354,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8841,GO:0033147,1,0.916754153166752,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8842,GO:0033148,1,0.938312456925143,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8843,GO:0033149,1,0.976822848772538,0,3,FFAT motif binding,MF,
8844,GO:0033150,1,0.992214719162207,0,2,cytoskeletal calyx,CC,
8845,GO:0033151,1,0.883493253464459,0,13,V(D)J recombination,BP,
8846,GO:0033152,1,0.953881567080862,0,5,immunoglobulin V(D)J recombination,BP,
8847,GO:0033153,1,0.943027287015296,0,5,T cell receptor V(D)J recombination,BP,
8849,GO:0033162,1,0.943738389879405,0,13,melanosome membrane,CC,
8850,GO:0033165,1,0.956733618115402,0,5,interphotoreceptor matrix,CC,
8851,GO:0033167,1,0.981019644985119,0,1,ARC complex,CC,
8852,GO:0033168,1,0.981019644985119,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8853,GO:0033169,1,0.887119948168862,0,13,histone H3-K9 demethylation,BP,
8854,GO:0033170,1,0.955769005394902,0,9,protein-DNA loading ATPase activity,MF,
8855,GO:0033173,1,0.738934785526688,0,39,calcineurin-NFAT signaling cascade,BP,
8856,GO:0033176,1,0.882613586894129,0,25,proton-transporting V-type ATPase complex,CC,
8857,GO:0033177,1,0.947766457207662,0,10,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8858,GO:0033178,1,0.94472580991667,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8859,GO:0033179,1,0.947766457207662,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8860,GO:0033180,1,0.951616822068036,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8861,GO:0033181,1,0.984846135185945,0,4,plasma membrane proton-transporting V-type ATPase complex,CC,
8862,GO:0033182,1,0.915469977745465,0,12,regulation of histone ubiquitination,BP,
8863,GO:0033183,1,0.958858672241074,0,4,negative regulation of histone ubiquitination,BP,
8864,GO:0033184,1,0.966334064014363,0,5,positive regulation of histone ubiquitination,BP,
8865,GO:0033185,1,0.990220791829669,0,3,dolichol-phosphate-mannose synthase complex,CC,
8866,GO:0033186,1,0.974625698975741,0,3,CAF-1 complex,CC,
8867,GO:0033188,1,0.977874482419559,0,3,sphingomyelin synthase activity,MF,
8868,GO:0033189,1,0.894381101869105,0,17,response to vitamin A,BP,
8869,GO:0033192,1,0.956707674741928,0,5,calmodulin-dependent protein phosphatase activity,MF,
8870,GO:0033193,1,0.990422875038549,0,1,Lsd1/2 complex,CC,
8871,GO:0033194,1,0.900057251296488,0,16,response to hydroperoxide,BP,
8873,GO:0033198,1,0.803221925845012,0,34,response to ATP,BP,
8874,GO:0033202,1,0.92846072781706,0,15,DNA helicase complex,CC,
8875,GO:0033204,1,0.95446995466897,0,10,ribonuclease P RNA binding,MF,
8876,GO:0033206,1,0.959512911586369,0,5,meiotic cytokinesis,BP,
8878,GO:0033210,1,0.941614305092432,0,11,leptin-mediated signaling pathway,BP,
8879,GO:0033211,1,0.954535677602956,0,7,adiponectin-activated signaling pathway,BP,
8882,GO:0033215,1,0.995196639998825,0,1,reductive iron assimilation,BP,
8884,GO:0033220,1,0.967294169006533,0,5,ATPase-coupled amide-transporter activity,MF,
8885,GO:0033227,1,0.985015369616049,0,3,dsRNA transport,BP,
8886,GO:0033229,1,0.992987268436278,0,1,cysteine transmembrane transporter activity,MF,
8887,GO:0033233,1,0.860433423778295,0,24,regulation of protein sumoylation,BP,
8888,GO:0033234,1,0.942883589487569,0,10,negative regulation of protein sumoylation,BP,
8889,GO:0033235,1,0.926297561705721,0,13,positive regulation of protein sumoylation,BP,
8890,GO:0033238,1,0.692133533979737,0,75,regulation of cellular amine metabolic process,BP,
8891,GO:0033239,1,0.955694836913818,0,5,negative regulation of cellular amine metabolic process,BP,
8892,GO:0033240,1,0.956437093180433,0,9,positive regulation of cellular amine metabolic process,BP,
8893,GO:0033241,1,0.98344653483578,0,1,regulation of cellular amine catabolic process,BP,
8894,GO:0033242,1,0.98344653483578,0,1,negative regulation of cellular amine catabolic process,BP,
8895,GO:0033256,1,0.979423775127358,0,4,I-kappaB/NF-kappaB complex,CC,
8896,GO:0033257,1,0.990577549333236,0,2,Bcl3/NF-kappaB2 complex,CC,
8897,GO:0033260,1,0.69025985263053,0,58,nuclear DNA replication,BP,
8898,GO:0033262,1,0.890656823662623,0,16,regulation of nuclear cell cycle DNA replication,BP,
8899,GO:0033263,1,0.96808249151878,0,5,CORVET complex,CC,
8900,GO:0033265,1,0.990488716810354,0,2,choline binding,MF,
8901,GO:0033268,1,0.85041371898418,0,15,node of Ranvier,CC,
8902,GO:0033269,1,0.976027528605595,0,4,internode region of axon,CC,
8903,GO:0033270,1,0.885174874897249,0,12,paranode region of axon,CC,
8905,GO:0033274,1,0.986402093948128,0,1,response to vitamin B2,BP,
8907,GO:0033276,1,0.914729588409981,0,13,transcription factor TFTC complex,CC,
8908,GO:0033277,1,0.983759770425471,0,2,abortive mitotic cell cycle,BP,
8909,GO:0033278,1,0.964119683206203,0,5,cell proliferation in midbrain,BP,
8910,GO:0033280,1,0.809241549443835,0,31,response to vitamin D,BP,
8914,GO:0033290,1,0.936697387183855,0,14,eukaryotic 48S preinitiation complex,CC,
8915,GO:0033291,1,0.996896819794802,0,1,eukaryotic 80S initiation complex,CC,
8916,GO:0033292,1,0.919095728733236,0,9,T-tubule organization,BP,
8917,GO:0033293,1,0.719218143065357,0,59,monocarboxylic acid binding,MF,
8918,GO:0033299,1,0.968521166448672,0,6,secretion of lysosomal enzymes,BP,
8919,GO:0033300,1,0.961967509367872,0,7,dehydroascorbic acid transmembrane transporter activity,MF,
8920,GO:0033301,1,0.993003918033406,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8921,GO:0033306,1,0.989144947372498,0,2,phytol metabolic process,BP,
8922,GO:0033313,1,0.972259726422459,0,5,meiotic cell cycle checkpoint,BP,
8923,GO:0033314,1,0.949816234929412,0,9,mitotic DNA replication checkpoint,BP,
8924,GO:0033316,1,0.994400996008306,0,1,meiotic spindle assembly checkpoint,BP,
8925,GO:0033319,1,0.995952206202863,0,1,UDP-D-xylose metabolic process,BP,
8926,GO:0033320,1,0.995952206202863,0,1,UDP-D-xylose biosynthetic process,BP,
8927,GO:0033326,1,0.966355132522448,0,3,cerebrospinal fluid secretion,BP,
8928,GO:0033327,1,0.924763293468618,0,11,Leydig cell differentiation,BP,
8929,GO:0033328,1,0.987369205324129,0,2,peroxisome membrane targeting sequence binding,MF,
8930,GO:0033341,1,0.980467454515847,0,2,regulation of collagen binding,BP,
8931,GO:0033342,1,0.995311872664628,0,1,negative regulation of collagen binding,BP,
8932,GO:0033343,1,0.985086356758412,0,1,positive regulation of collagen binding,BP,
8933,GO:0033344,1,0.738147136172124,0,39,cholesterol efflux,BP,
8934,GO:0033345,1,0.995542397726162,0,1,asparagine catabolic process via L-aspartate,BP,
8935,GO:0033353,1,0.959904135130586,0,7,S-adenosylmethionine cycle,BP,
8936,GO:0033363,1,0.792332076791793,0,29,secretory granule organization,BP,
8937,GO:0033364,1,0.97267587108317,0,2,mast cell secretory granule organization,BP,
8940,GO:0033367,1,0.996697275092226,0,1,protein localization to mast cell secretory granule,BP,
8941,GO:0033368,1,0.996697275092226,0,1,protease localization to mast cell secretory granule,BP,
8942,GO:0033370,1,0.996697275092226,0,1,maintenance of protein location in mast cell secretory granule,BP,
8943,GO:0033371,1,0.996697275092226,0,1,T cell secretory granule organization,BP,
8944,GO:0033373,1,0.996697275092226,0,1,maintenance of protease location in mast cell secretory granule,BP,
8945,GO:0033374,1,0.996697275092226,0,1,protein localization to T cell secretory granule,BP,
8946,GO:0033375,1,0.996697275092226,0,1,protease localization to T cell secretory granule,BP,
8947,GO:0033377,1,0.996697275092226,0,1,maintenance of protein location in T cell secretory granule,BP,
8948,GO:0033379,1,0.996697275092226,0,1,maintenance of protease location in T cell secretory granule,BP,
8949,GO:0033380,1,0.996697275092226,0,1,granzyme B localization to T cell secretory granule,BP,
8950,GO:0033382,1,0.996697275092226,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8951,GO:0033383,1,0.991390266117537,0,2,geranyl diphosphate metabolic process,BP,
8952,GO:0033384,1,0.991390266117537,0,2,geranyl diphosphate biosynthetic process,BP,
8953,GO:0033385,1,0.994814836333021,0,1,geranylgeranyl diphosphate metabolic process,BP,
8954,GO:0033386,1,0.994814836333021,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8955,GO:0033387,1,0.98281560210375,0,3,putrescine biosynthetic process from ornithine,BP,
8956,GO:0033388,1,0.995810616444748,0,1,putrescine biosynthetic process from arginine,BP,
8957,GO:0033389,1,0.995810616444748,0,1,putrescine biosynthetic process from arginine, using agmatinase,BP,
8958,GO:0033391,1,0.907392451500627,0,12,chromatoid body,CC,
8959,GO:0033396,1,0.995980619695328,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8960,GO:0033477,1,0.996076513763949,0,1,S-methylmethionine metabolic process,BP,
8961,GO:0033483,1,0.936835874875457,0,10,gas homeostasis,BP,
8962,GO:0033484,1,0.983119141914088,0,3,nitric oxide homeostasis,BP,
8963,GO:0033489,1,0.978717130497695,0,4,cholesterol biosynthetic process via desmosterol,BP,
8964,GO:0033490,1,0.978717130497695,0,4,cholesterol biosynthetic process via lathosterol,BP,
8965,GO:0033499,1,0.988535901041213,0,3,galactose catabolic process via UDP-galactose,BP,
8967,GO:0033503,1,0.976080935130521,0,4,HULC complex,CC,
8968,GO:0033504,1,0.952365698909478,0,6,floor plate development,BP,
8969,GO:0033505,1,0.983109525412878,0,2,floor plate morphogenesis,BP,
8970,GO:0033512,1,0.97937659889517,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8971,GO:0033514,1,0.995488745648731,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
8972,GO:0033522,1,0.817601962844467,0,25,histone H2A ubiquitination,BP,
8973,GO:0033523,1,0.91951081412347,0,12,histone H2B ubiquitination,BP,
8974,GO:0033539,1,0.953261190874872,0,10,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8975,GO:0033540,1,0.925354435604965,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8976,GO:0033549,1,0.93707790849435,0,12,MAP kinase phosphatase activity,MF,
8977,GO:0033553,1,0.967697145647047,0,4,rDNA heterochromatin,CC,
8979,GO:0033555,1,0.595471865665027,0,74,multicellular organismal response to stress,BP,
8980,GO:0033557,1,0.989807596705769,0,2,Slx1-Slx4 complex,CC,
8981,GO:0033558,1,0.828248981251019,0,26,protein deacetylase activity,MF,
8983,GO:0033561,1,0.850885951296425,0,24,regulation of water loss via skin,BP,
8984,GO:0033563,1,0.963215671600601,0,3,dorsal/ventral axon guidance,BP,
8985,GO:0033564,1,0.943179214990916,0,6,anterior/posterior axon guidance,BP,
8986,GO:0033565,1,0.978331729911201,0,3,ESCRT-0 complex,CC,
8987,GO:0033566,1,0.990396194695071,0,2,gamma-tubulin complex localization,BP,
8988,GO:0033567,1,0.985850686064676,0,2,DNA replication, Okazaki fragment processing,BP,
8989,GO:0033572,1,0.812892838134728,0,35,transferrin transport,BP,
8990,GO:0033574,1,0.78993859362528,0,39,response to testosterone,BP,
8991,GO:0033577,1,0.99124616312683,0,2,protein glycosylation in endoplasmic reticulum,BP,
8992,GO:0033578,1,0.96684014739703,0,5,protein glycosylation in Golgi,BP,
8993,GO:0033588,1,0.972344530920341,0,6,Elongator holoenzyme complex,CC,
8994,GO:0033590,1,0.98701138289972,0,3,response to cobalamin,BP,
8995,GO:0033591,1,0.965795017904516,0,5,response to L-ascorbic acid,BP,
8996,GO:0033592,1,0.964371210081545,0,5,RNA strand annealing activity,MF,
8997,GO:0033593,1,0.979173923850631,0,1,BRCA2-MAGE-D1 complex,CC,
8998,GO:0033594,1,0.982222821824151,0,4,response to hydroxyisoflavone,BP,
8999,GO:0033595,1,0.989993707431079,0,2,response to genistein,BP,
9000,GO:0033596,1,0.973247740484263,0,2,TSC1-TSC2 complex,CC,
9001,GO:0033597,1,0.99587181159592,0,1,mitotic checkpoint complex,CC,
9002,GO:0033598,1,0.810688478341219,0,26,mammary gland epithelial cell proliferation,BP,
9003,GO:0033599,1,0.881066603563014,0,16,regulation of mammary gland epithelial cell proliferation,BP,
9004,GO:0033600,1,0.956620845703355,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9005,GO:0033601,1,0.940302504520388,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9006,GO:0033602,1,0.964950689423693,0,4,negative regulation of dopamine secretion,BP,
9010,GO:0033609,1,0.994890876864838,0,1,oxalate metabolic process,BP,
9012,GO:0033613,1,0.573639945820275,0,74,activating transcription factor binding,MF,
9013,GO:0033615,1,0.984760913809775,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9014,GO:0033617,1,0.905370959948868,0,21,mitochondrial cytochrome c oxidase assembly,BP,
9016,GO:0033622,1,0.848419081388375,0,24,integrin activation,BP,
9017,GO:0033623,1,0.91247657020203,0,15,regulation of integrin activation,BP,
9018,GO:0033624,1,0.973120045017297,0,3,negative regulation of integrin activation,BP,
9019,GO:0033625,1,0.955400841115717,0,9,positive regulation of integrin activation,BP,
9020,GO:0033626,1,0.989606252093711,0,2,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9025,GO:0033631,1,0.891770984317411,0,15,cell-cell adhesion mediated by integrin,BP,
9026,GO:0033632,1,0.931355345773211,0,10,regulation of cell-cell adhesion mediated by integrin,BP,
9027,GO:0033633,1,0.971798425035646,0,2,negative regulation of cell-cell adhesion mediated by integrin,BP,
9028,GO:0033634,1,0.973537300040257,0,5,positive regulation of cell-cell adhesion mediated by integrin,BP,
9029,GO:0033643,1,0.912225796840357,0,13,host cell part,CC,
9030,GO:0033646,1,0.920574476310375,0,12,host intracellular part,CC,
9031,GO:0033647,1,0.941664955333753,0,8,host intracellular organelle,CC,
9032,GO:0033648,1,0.941664955333753,0,8,host intracellular membrane-bounded organelle,CC,
9033,GO:0033650,1,0.996338670751475,0,1,host cell mitochondrion,CC,
9034,GO:0033655,1,0.967785435136569,0,6,host cell cytoplasm part,CC,
9035,GO:0033668,1,0.979366379059727,0,4,negative regulation by symbiont of host apoptotic process,BP,
9038,GO:0033677,1,0.98131336455402,0,3,DNA/RNA helicase activity,MF,
9039,GO:0033678,1,0.995076571230536,0,1,5'-3' DNA/RNA helicase activity,MF,
9040,GO:0033679,1,0.991157614917294,0,1,3'-5' DNA/RNA helicase activity,MF,
9041,GO:0033683,1,0.804454264084116,0,39,nucleotide-excision repair, DNA incision,BP,
9042,GO:0033684,1,0.961390741808531,0,6,regulation of luteinizing hormone secretion,BP,
9043,GO:0033685,1,0.99218625239134,0,2,negative regulation of luteinizing hormone secretion,BP,
9044,GO:0033686,1,0.968964366662543,0,4,positive regulation of luteinizing hormone secretion,BP,
9047,GO:0033689,1,0.928009853614123,0,9,negative regulation of osteoblast proliferation,BP,
9052,GO:0033695,1,0.996155318283885,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9053,GO:0033699,1,0.996043526239926,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9054,GO:0033700,1,0.934998108467008,0,8,phospholipid efflux,BP,
9055,GO:0033721,1,0.994802069545257,0,1,aldehyde dehydrogenase (NADP+) activity,MF,
9056,GO:0033735,1,0.996813142364761,0,1,aspartate dehydrogenase activity,MF,
9057,GO:0033737,1,0.995343036483078,0,1,1-pyrroline dehydrogenase activity,MF,
9058,GO:0033743,1,0.979816293260096,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9059,GO:0033744,1,0.996560523616724,0,1,L-methionine:thioredoxin-disulfide S-oxidoreductase activity,MF,
9060,GO:0033745,1,0.983107596681138,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9061,GO:0033746,1,0.993207627082606,0,1,histone demethylase activity (H3-R2 specific),MF,
9062,GO:0033749,1,0.993207627082606,0,1,histone demethylase activity (H4-R3 specific),MF,
9063,GO:0033750,1,0.93200307930848,0,14,ribosome localization,BP,
9064,GO:0033754,1,0.996495449141605,0,1,indoleamine 2,3-dioxygenase activity,MF,
9065,GO:0033762,1,0.78390494998955,0,32,response to glucagon,BP,
9066,GO:0033764,1,0.911679044914951,0,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9067,GO:0033765,1,0.990823992165876,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9068,GO:0033781,1,0.995961294964222,0,1,cholesterol 24-hydroxylase activity,MF,
9069,GO:0033783,1,0.995518404075719,0,1,25-hydroxycholesterol 7alpha-hydroxylase activity,MF,
9070,GO:0033787,1,0.994748901495519,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9071,GO:0033791,1,0.995637269487643,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9072,GO:0033798,1,0.983808430689671,0,2,thyroxine 5-deiodinase activity,MF,
9073,GO:0033814,1,0.996601496531062,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9074,GO:0033819,1,0.996810296987815,0,1,lipoyl(octanoyl) transferase activity,MF,
9075,GO:0033823,1,0.994480609352846,0,1,procollagen glucosyltransferase activity,MF,
9076,GO:0033829,1,0.988129459894651,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9077,GO:0033842,1,0.987127950476233,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9078,GO:0033857,1,0.979146608111783,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9079,GO:0033858,1,0.994131332893969,0,1,N-acetylgalactosamine kinase activity,MF,
9080,GO:0033860,1,0.953414348907376,0,10,regulation of NAD(P)H oxidase activity,BP,
9081,GO:0033861,1,0.992253306319824,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9082,GO:0033862,1,0.9892474024303,0,2,UMP kinase activity,MF,
9083,GO:0033864,1,0.966786905596372,0,7,positive regulation of NAD(P)H oxidase activity,BP,
9084,GO:0033865,1,0.494569856706401,0,124,nucleoside bisphosphate metabolic process,BP,
9085,GO:0033866,1,0.669964840995649,0,63,nucleoside bisphosphate biosynthetic process,BP,
9086,GO:0033867,1,0.99643629219795,0,1,Fas-activated serine/threonine kinase activity,MF,
9087,GO:0033869,1,0.978325524023587,0,5,nucleoside bisphosphate catabolic process,BP,
9088,GO:0033871,1,0.996132256305386,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9089,GO:0033872,1,0.991365540633209,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9090,GO:0033875,1,0.494569856706401,0,124,ribonucleoside bisphosphate metabolic process,BP,
9091,GO:0033878,1,0.97619596532665,0,2,hormone-sensitive lipase activity,MF,
9092,GO:0033882,1,0.990374893735534,0,2,choloyl-CoA hydrolase activity,MF,
9093,GO:0033883,1,0.992833303548861,0,2,pyridoxal phosphatase activity,MF,
9094,GO:0033885,1,0.995796629651648,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9095,GO:0033897,1,0.996697275092226,0,1,ribonuclease T2 activity,MF,
9096,GO:0033906,1,0.991951213331503,0,2,hyaluronoglucuronidase activity,MF,
9097,GO:0033919,1,0.99261897132761,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9098,GO:0033925,1,0.991414200042418,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9099,GO:0033961,1,0.996342987464129,0,1,cis-stilbene-oxide hydrolase activity,MF,
9100,GO:0033962,1,0.825118892049696,0,19,P-body assembly,BP,
9101,GO:0033967,1,0.99251557403184,0,2,box C/D snoRNA metabolic process,BP,
9102,GO:0033979,1,0.982226738899085,0,3,box H/ACA snoRNA metabolic process,BP,
9103,GO:0033981,1,0.996874163561311,0,1,D-dopachrome decarboxylase activity,MF,
9104,GO:0033989,1,0.995029444403381,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9106,GO:0034014,1,0.99567950861844,0,1,response to triglyceride,BP,
9107,GO:0034030,1,0.669964840995649,0,63,ribonucleoside bisphosphate biosynthetic process,BP,
9108,GO:0034031,1,0.978325524023587,0,5,ribonucleoside bisphosphate catabolic process,BP,
9109,GO:0034032,1,0.494569856706401,0,124,purine nucleoside bisphosphate metabolic process,BP,
9110,GO:0034033,1,0.669964840995649,0,63,purine nucleoside bisphosphate biosynthetic process,BP,
9111,GO:0034034,1,0.978325524023587,0,5,purine nucleoside bisphosphate catabolic process,BP,
9112,GO:0034035,1,0.895397162713858,0,21,purine ribonucleoside bisphosphate metabolic process,BP,
9113,GO:0034036,1,0.959107162904571,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9114,GO:0034038,1,0.99672663951518,0,1,deoxyhypusine synthase activity,MF,
9115,GO:0034039,1,0.992431004631129,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9117,GO:0034041,1,0.994489197422941,0,1,ATPase-coupled sterol transmembrane transporter activity,MF,
9118,GO:0034045,1,0.879570288330443,0,16,phagophore assembly site membrane,CC,
9119,GO:0034046,1,0.931382041504254,0,8,poly(G) binding,MF,
9120,GO:0034056,1,0.970340920528897,0,4,estrogen response element binding,MF,
9121,GO:0034057,1,0.987707291713367,0,2,RNA strand-exchange activity,MF,
9122,GO:0034058,1,0.931838487813191,0,9,endosomal vesicle fusion,BP,
9123,GO:0034059,1,0.977732482937771,0,2,response to anoxia,BP,
9124,GO:0034061,1,0.797600346456587,0,29,DNA polymerase activity,MF,
9125,GO:0034062,1,0.810680511057727,0,39,5'-3' RNA polymerase activity,MF,
9126,GO:0034063,1,0.818997095008537,0,23,stress granule assembly,BP,
9127,GO:0034066,1,0.991579482169014,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9128,GO:0034067,1,0.778187326275829,0,25,protein localization to Golgi apparatus,BP,
9129,GO:0034080,1,0.875808336928511,0,26,CENP-A containing nucleosome assembly,BP,
9130,GO:0034085,1,0.945438587274552,0,7,establishment of sister chromatid cohesion,BP,
9131,GO:0034086,1,0.910003228320534,0,9,maintenance of sister chromatid cohesion,BP,
9132,GO:0034087,1,0.974641142976601,0,2,establishment of mitotic sister chromatid cohesion,BP,
9133,GO:0034088,1,0.910003228320534,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9134,GO:0034091,1,0.944900359795727,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9135,GO:0034092,1,0.958997890257975,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9136,GO:0034093,1,0.985305822708648,0,2,positive regulation of maintenance of sister chromatid cohesion,BP,
9138,GO:0034098,1,0.94837579001195,0,7,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9139,GO:0034101,1,0.42948630713288,0,121,erythrocyte homeostasis,BP,
9140,GO:0034103,1,0.629451266901401,0,67,regulation of tissue remodeling,BP,
9141,GO:0034104,1,0.887152462156289,0,19,negative regulation of tissue remodeling,BP,
9142,GO:0034105,1,0.826801162884143,0,26,positive regulation of tissue remodeling,BP,
9145,GO:0034111,1,0.90297703589718,0,15,negative regulation of homotypic cell-cell adhesion,BP,
9147,GO:0034113,1,0.669496507948647,0,58,heterotypic cell-cell adhesion,BP,
9148,GO:0034114,1,0.886273548710155,0,22,regulation of heterotypic cell-cell adhesion,BP,
9149,GO:0034115,1,0.946487804353606,0,9,negative regulation of heterotypic cell-cell adhesion,BP,
9150,GO:0034116,1,0.933088536690596,0,14,positive regulation of heterotypic cell-cell adhesion,BP,
9151,GO:0034117,1,0.996884176769897,0,1,erythrocyte aggregation,BP,
9152,GO:0034118,1,0.996884176769897,0,1,regulation of erythrocyte aggregation,BP,
9153,GO:0034120,1,0.996884176769897,0,1,positive regulation of erythrocyte aggregation,BP,
9155,GO:0034122,1,0.768541744542003,0,36,negative regulation of toll-like receptor signaling pathway,BP,
9157,GO:0034124,1,0.982084446612267,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9158,GO:0034125,1,0.992543751753651,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9159,GO:0034127,1,0.95027495084179,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9160,GO:0034128,1,0.954000240060393,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9161,GO:0034130,1,0.994747060254305,0,1,toll-like receptor 1 signaling pathway,BP,
9162,GO:0034134,1,0.91106561676492,0,14,toll-like receptor 2 signaling pathway,BP,
9163,GO:0034135,1,0.939502275424545,0,9,regulation of toll-like receptor 2 signaling pathway,BP,
9164,GO:0034136,1,0.965031899217383,0,4,negative regulation of toll-like receptor 2 signaling pathway,BP,
9165,GO:0034137,1,0.963755390287574,0,6,positive regulation of toll-like receptor 2 signaling pathway,BP,
9166,GO:0034138,1,0.894462637658027,0,20,toll-like receptor 3 signaling pathway,BP,
9167,GO:0034139,1,0.94587445035742,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9168,GO:0034140,1,0.978540480728732,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9169,GO:0034141,1,0.961489939574552,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9172,GO:0034144,1,0.954293764689085,0,7,negative regulation of toll-like receptor 4 signaling pathway,BP,
9174,GO:0034146,1,0.983487426733719,0,2,toll-like receptor 5 signaling pathway,BP,
9175,GO:0034147,1,0.99154430026958,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9176,GO:0034148,1,0.99154430026958,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9177,GO:0034150,1,0.988758442437801,0,1,toll-like receptor 6 signaling pathway,BP,
9178,GO:0034154,1,0.938961234688263,0,10,toll-like receptor 7 signaling pathway,BP,
9179,GO:0034155,1,0.970231346090447,0,5,regulation of toll-like receptor 7 signaling pathway,BP,
9180,GO:0034156,1,0.996379022716881,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9181,GO:0034157,1,0.973758240962186,0,4,positive regulation of toll-like receptor 7 signaling pathway,BP,
9182,GO:0034158,1,0.9817182976443,0,2,toll-like receptor 8 signaling pathway,BP,
9183,GO:0034159,1,0.989645215094909,0,1,regulation of toll-like receptor 8 signaling pathway,BP,
9184,GO:0034161,1,0.989645215094909,0,1,positive regulation of toll-like receptor 8 signaling pathway,BP,
9185,GO:0034162,1,0.855778177102672,0,24,toll-like receptor 9 signaling pathway,BP,
9186,GO:0034163,1,0.941071783766442,0,9,regulation of toll-like receptor 9 signaling pathway,BP,
9187,GO:0034164,1,0.975633541443739,0,3,negative regulation of toll-like receptor 9 signaling pathway,BP,
9188,GO:0034165,1,0.977140506962836,0,4,positive regulation of toll-like receptor 9 signaling pathway,BP,
9189,GO:0034166,1,0.993850171027073,0,1,toll-like receptor 10 signaling pathway,BP,
9190,GO:0034182,1,0.944900359795727,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9191,GO:0034183,1,0.958997890257975,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9192,GO:0034184,1,0.985305822708648,0,2,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9193,GO:0034185,1,0.846959189464527,0,17,apolipoprotein binding,MF,
9194,GO:0034186,1,0.965215257183948,0,5,apolipoprotein A-I binding,MF,
9195,GO:0034188,1,0.967911218376424,0,2,apolipoprotein A-I receptor activity,MF,
9196,GO:0034189,1,0.979742697328677,0,4,very-low-density lipoprotein particle binding,MF,
9197,GO:0034190,1,0.966020436579803,0,5,apolipoprotein receptor binding,MF,
9198,GO:0034191,1,0.972669393821989,0,4,apolipoprotein A-I receptor binding,MF,
9199,GO:0034196,1,0.977134425734532,0,5,acylglycerol transport,BP,
9200,GO:0034197,1,0.977134425734532,0,5,triglyceride transport,BP,
9201,GO:0034198,1,0.777353709979415,0,42,cellular response to amino acid starvation,BP,
9202,GO:0034199,1,0.858719758952829,0,17,activation of protein kinase A activity,BP,
9203,GO:0034201,1,0.964546892948477,0,6,response to oleic acid,BP,
9204,GO:0034203,1,0.990223681556754,0,1,glycolipid translocation,BP,
9205,GO:0034204,1,0.670899615112415,0,42,lipid translocation,BP,
9206,GO:0034205,1,0.7467040822771,0,36,amyloid-beta formation,BP,
9207,GO:0034211,1,0.982701323297205,0,1,GTP-dependent protein kinase activity,MF,
9208,GO:0034212,1,0.642494484920474,0,57,peptide N-acetyltransferase activity,MF,
9209,GO:0034213,1,0.996513744292681,0,1,quinolinate catabolic process,BP,
9210,GO:0034214,1,0.940561531367587,0,7,protein hexamerization,BP,
9211,GO:0034219,1,0.482666058924535,0,98,carbohydrate transmembrane transport,BP,
9213,GO:0034224,1,0.995739117796931,0,1,cellular response to zinc ion starvation,BP,
9214,GO:0034227,1,0.980524242103842,0,5,tRNA thio-modification,BP,
9215,GO:0034230,1,0.985851700671654,0,2,enkephalin processing,BP,
9216,GO:0034231,1,0.99091486762954,0,1,islet amyloid polypeptide processing,BP,
9217,GO:0034235,1,0.970470406839881,0,6,GPI anchor binding,MF,
9218,GO:0034236,1,0.898822426560678,0,13,protein kinase A catalytic subunit binding,MF,
9219,GO:0034237,1,0.778741704915232,0,25,protein kinase A regulatory subunit binding,MF,
9220,GO:0034238,1,0.977744590666429,0,5,macrophage fusion,BP,
9221,GO:0034239,1,0.981131442020046,0,4,regulation of macrophage fusion,BP,
9222,GO:0034241,1,0.981131442020046,0,4,positive regulation of macrophage fusion,BP,
9223,GO:0034242,1,0.98146494512414,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9224,GO:0034243,1,0.831299353215474,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9225,GO:0034244,1,0.9242415365099,0,13,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9226,GO:0034245,1,0.9928061541633,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9227,GO:0034246,1,0.982456687556005,0,2,mitochondrial transcription factor activity,MF,
9228,GO:0034247,1,0.996676509305464,0,1,snoRNA splicing,BP,
9232,GO:0034255,1,0.995877903634853,0,1,regulation of urea metabolic process,BP,
9233,GO:0034260,1,0.702374177942969,0,45,negative regulation of GTPase activity,BP,
9234,GO:0034263,1,0.990582219110237,0,1,positive regulation of autophagy in response to ER overload,BP,
9235,GO:0034271,1,0.980613255225802,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9236,GO:0034272,1,0.980613255225802,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9237,GO:0034274,1,0.976775388245649,0,3,Atg12-Atg5-Atg16 complex,CC,
9238,GO:0034275,1,0.98690713756801,0,2,kynurenic acid metabolic process,BP,
9239,GO:0034276,1,0.98690713756801,0,2,kynurenic acid biosynthetic process,BP,
9241,GO:0034285,1,0.971443342265852,0,4,response to disaccharide,BP,
9242,GO:0034287,1,0.982842687178758,0,4,detection of monosaccharide stimulus,BP,
9243,GO:0034308,1,0.64171846884291,0,82,primary alcohol metabolic process,BP,
9244,GO:0034309,1,0.917766679040435,0,11,primary alcohol biosynthetic process,BP,
9245,GO:0034310,1,0.950834800995812,0,13,primary alcohol catabolic process,BP,
9246,GO:0034311,1,0.879995849531383,0,23,diol metabolic process,BP,
9247,GO:0034312,1,0.891375919057456,0,20,diol biosynthetic process,BP,
9248,GO:0034314,1,0.802781628457584,0,35,Arp2/3 complex-mediated actin nucleation,BP,
9249,GO:0034315,1,0.882308905438478,0,19,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9250,GO:0034316,1,0.965587996768701,0,6,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9253,GO:0034331,1,0.76509697201054,0,30,cell junction maintenance,BP,
9254,GO:0034332,1,0.608004293975959,0,61,adherens junction organization,BP,
9255,GO:0034333,1,0.906487656708028,0,12,adherens junction assembly,BP,
9256,GO:0034334,1,0.95603540051951,0,5,adherens junction maintenance,BP,
9257,GO:0034337,1,0.996232329517488,0,1,RNA folding,BP,
9258,GO:0034338,1,0.96047704241506,0,6,short-chain carboxylesterase activity,MF,
9259,GO:0034340,1,0.621884000013321,0,79,response to type I interferon,BP,
9261,GO:0034342,1,0.994890876864838,0,1,response to type III interferon,BP,
9262,GO:0034343,1,0.979011619134026,0,3,type III interferon production,BP,
9263,GO:0034344,1,0.979011619134026,0,3,regulation of type III interferon production,BP,
9264,GO:0034346,1,0.994386530523869,0,1,positive regulation of type III interferon production,BP,
9265,GO:0034349,1,0.900738932568242,0,15,glial cell apoptotic process,BP,
9266,GO:0034350,1,0.92758515370295,0,10,regulation of glial cell apoptotic process,BP,
9267,GO:0034351,1,0.945451686726035,0,8,negative regulation of glial cell apoptotic process,BP,
9268,GO:0034352,1,0.981113132518706,0,2,positive regulation of glial cell apoptotic process,BP,
9269,GO:0034353,1,0.994890876864838,0,1,RNA pyrophosphohydrolase activity,MF,
9270,GO:0034354,1,0.973475615825748,0,6,'de novo' NAD biosynthetic process from tryptophan,BP,
9271,GO:0034355,1,0.994890876864838,0,1,NAD salvage,BP,
9273,GO:0034358,1,0.842641274997923,0,30,plasma lipoprotein particle,CC,
9274,GO:0034359,1,0.974979532658703,0,1,mature chylomicron,CC,
9275,GO:0034360,1,0.974979532658703,0,1,chylomicron remnant,CC,
9276,GO:0034361,1,0.914135809194721,0,15,very-low-density lipoprotein particle,CC,
9277,GO:0034362,1,0.931209307105983,0,11,low-density lipoprotein particle,CC,
9278,GO:0034363,1,0.965666467917086,0,4,intermediate-density lipoprotein particle,CC,
9279,GO:0034364,1,0.897482769268139,0,22,high-density lipoprotein particle,CC,
9280,GO:0034365,1,0.990443135619365,0,3,discoidal high-density lipoprotein particle,CC,
9281,GO:0034366,1,0.9785264001695,0,6,spherical high-density lipoprotein particle,CC,
9285,GO:0034370,1,0.948783481260311,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9286,GO:0034371,1,0.958847915263834,0,5,chylomicron remodeling,BP,
9287,GO:0034372,1,0.973138405353493,0,7,very-low-density lipoprotein particle remodeling,BP,
9288,GO:0034373,1,0.996467753452859,0,1,intermediate-density lipoprotein particle remodeling,BP,
9290,GO:0034375,1,0.928641522886369,0,15,high-density lipoprotein particle remodeling,BP,
9291,GO:0034377,1,0.845687501458451,0,24,plasma lipoprotein particle assembly,BP,
9292,GO:0034378,1,0.939130615996902,0,8,chylomicron assembly,BP,
9293,GO:0034379,1,0.924685164491019,0,11,very-low-density lipoprotein particle assembly,BP,
9294,GO:0034380,1,0.927560516524843,0,11,high-density lipoprotein particle assembly,BP,
9296,GO:0034382,1,0.947984402639806,0,7,chylomicron remnant clearance,BP,
9298,GO:0034384,1,0.924923693662612,0,11,high-density lipoprotein particle clearance,BP,
9299,GO:0034385,1,0.914135809194721,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9300,GO:0034386,1,0.990584166653363,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9301,GO:0034388,1,0.966544528070738,0,5,Pwp2p-containing subcomplex of 90S preribosome,CC,
9302,GO:0034389,1,0.873261691381218,0,24,lipid droplet organization,BP,
9303,GO:0034390,1,0.87098575180568,0,20,smooth muscle cell apoptotic process,BP,
9304,GO:0034391,1,0.87098575180568,0,20,regulation of smooth muscle cell apoptotic process,BP,
9305,GO:0034392,1,0.947093332099656,0,6,negative regulation of smooth muscle cell apoptotic process,BP,
9306,GO:0034393,1,0.930332415252401,0,12,positive regulation of smooth muscle cell apoptotic process,BP,
9307,GO:0034394,1,0.614209714428579,0,62,protein localization to cell surface,BP,
9308,GO:0034395,1,0.978597627721726,0,3,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9309,GO:0034397,1,0.947507860849811,0,7,telomere localization,BP,
9310,GO:0034398,1,0.989288046336387,0,2,telomere tethering at nuclear periphery,BP,
9312,GO:0034401,1,0.529002181931261,0,80,chromatin organization involved in regulation of transcription,BP,
9313,GO:0034402,1,0.984300895940985,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9314,GO:0034404,1,0.572350612362623,0,100,nucleobase-containing small molecule biosynthetic process,BP,
9315,GO:0034405,1,0.78879663278893,0,32,response to fluid shear stress,BP,
9316,GO:0034414,1,0.988594242318278,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9317,GO:0034416,1,0.994748901495519,0,1,bisphosphoglycerate phosphatase activity,MF,
9318,GO:0034417,1,0.994748901495519,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9319,GO:0034418,1,0.991375826439307,0,2,urate biosynthetic process,BP,
9320,GO:0034421,1,0.980962320339207,0,3,post-translational protein acetylation,BP,
9321,GO:0034423,1,0.99512840842731,0,1,autophagosome lumen,CC,
9322,GO:0034427,1,0.958604193058814,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9323,GO:0034431,1,0.979209716404853,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9324,GO:0034432,1,0.979209716404853,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9325,GO:0034433,1,0.938838634581442,0,12,steroid esterification,BP,
9326,GO:0034434,1,0.938838634581442,0,12,sterol esterification,BP,
9327,GO:0034435,1,0.938838634581442,0,12,cholesterol esterification,BP,
9328,GO:0034436,1,0.979525518678072,0,4,glycoprotein transport,BP,
9329,GO:0034439,1,0.990387349745261,0,2,lipoprotein lipid oxidation,BP,
9330,GO:0034440,1,0.529288238001118,0,107,lipid oxidation,BP,
9331,GO:0034441,1,0.993160079913173,0,2,plasma lipoprotein particle oxidation,BP,
9332,GO:0034442,1,0.990387349745261,0,2,regulation of lipoprotein oxidation,BP,
9333,GO:0034443,1,0.996750665601107,0,1,negative regulation of lipoprotein oxidation,BP,
9334,GO:0034444,1,0.996855757076718,0,1,regulation of plasma lipoprotein oxidation,BP,
9335,GO:0034445,1,0.996855757076718,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9337,GO:0034447,1,0.947979493350667,0,8,very-low-density lipoprotein particle clearance,BP,
9338,GO:0034448,1,0.979592985748045,0,4,EGO complex,CC,
9339,GO:0034450,1,0.902137549772851,0,13,ubiquitin-ubiquitin ligase activity,MF,
9340,GO:0034451,1,0.510509473122284,0,91,centriolar satellite,CC,
9341,GO:0034452,1,0.870310021756422,0,11,dynactin binding,MF,
9342,GO:0034453,1,0.800002296407711,0,21,microtubule anchoring,BP,
9343,GO:0034454,1,0.895888961368462,0,10,microtubule anchoring at centrosome,BP,
9344,GO:0034455,1,0.982459085204497,0,2,t-UTP complex,CC,
9345,GO:0034456,1,0.988764322359233,0,2,UTP-C complex,CC,
9346,GO:0034457,1,0.988895068575691,0,3,Mpp10 complex,CC,
9347,GO:0034458,1,0.974645643795947,0,3,3'-5' RNA helicase activity,MF,
9348,GO:0034462,1,0.965470225700889,0,3,small-subunit processome assembly,BP,
9349,GO:0034463,1,0.996896819794802,0,1,90S preribosome assembly,BP,
9350,GO:0034464,1,0.956174772940731,0,8,BBSome,CC,
9351,GO:0034465,1,0.974660409188341,0,4,response to carbon monoxide,BP,
9352,GO:0034466,1,0.994892675463082,0,1,chromaffin granule lumen,CC,
9353,GO:0034470,1,0.136726779359273,0,348,ncRNA processing,BP,
9354,GO:0034471,1,0.901455252268717,0,20,ncRNA 5'-end processing,BP,
9355,GO:0034472,1,0.896532212501747,0,19,snRNA 3'-end processing,BP,
9356,GO:0034473,1,0.989837748186464,0,3,U1 snRNA 3'-end processing,BP,
9357,GO:0034474,1,0.986655496981306,0,1,U2 snRNA 3'-end processing,BP,
9358,GO:0034475,1,0.972705927562245,0,8,U4 snRNA 3'-end processing,BP,
9359,GO:0034476,1,0.989837748186464,0,3,U5 snRNA 3'-end processing,BP,
9360,GO:0034477,1,0.989697402859107,0,2,U6 snRNA 3'-end processing,BP,
9361,GO:0034478,1,0.994588717865615,0,1,phosphatidylglycerol catabolic process,BP,
9362,GO:0034481,1,0.964211963093986,0,5,chondroitin sulfotransferase activity,MF,
9363,GO:0034483,1,0.898479404775223,0,14,heparan sulfate sulfotransferase activity,MF,
9364,GO:0034485,1,0.989804528646662,0,2,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9365,GO:0034497,1,0.916363810822146,0,12,protein localization to phagophore assembly site,BP,
9366,GO:0034498,1,0.942845910972265,0,8,early endosome to Golgi transport,BP,
9367,GO:0034499,1,0.958020276718241,0,5,late endosome to Golgi transport,BP,
9368,GO:0034501,1,0.926290582965507,0,16,protein localization to kinetochore,BP,
9369,GO:0034502,1,0.61630663484971,0,73,protein localization to chromosome,BP,
9372,GO:0034506,1,0.992366237350058,0,1,chromosome, centromeric core domain,CC,
9373,GO:0034508,1,0.792383793876259,0,37,centromere complex assembly,BP,
9374,GO:0034511,1,0.926899151441532,0,8,U3 snoRNA binding,MF,
9375,GO:0034512,1,0.992540089353925,0,1,box C/D snoRNA binding,MF,
9376,GO:0034513,1,0.978424983264267,0,5,box H/ACA snoRNA binding,MF,
9377,GO:0034514,1,0.995640254826544,0,1,mitochondrial unfolded protein response,BP,
9378,GO:0034515,1,0.988588589409219,0,2,proteasome storage granule,CC,
9379,GO:0034516,1,0.996558105895603,0,1,response to vitamin B6,BP,
9380,GO:0034518,1,0.926152872716453,0,11,RNA cap binding complex,CC,
9381,GO:0034545,1,0.996406004432841,0,1,fumarylpyruvate hydrolase activity,MF,
9382,GO:0034551,1,0.94680254801495,0,10,mitochondrial respiratory chain complex III assembly,BP,
9383,GO:0034552,1,0.993480121494847,0,2,respiratory chain complex II assembly,BP,
9384,GO:0034553,1,0.993480121494847,0,2,mitochondrial respiratory chain complex II assembly,BP,
9385,GO:0034584,1,0.986855216096418,0,2,piRNA binding,MF,
9386,GO:0034587,1,0.917426295262846,0,14,piRNA metabolic process,BP,
9387,GO:0034589,1,0.99180115601632,0,1,hydroxyproline transport,BP,
9388,GO:0034590,1,0.99180115601632,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9389,GO:0034592,1,0.996688574753873,0,1,synaptic vesicle lumen,CC,
9390,GO:0034593,1,0.828405497696586,0,21,phosphatidylinositol bisphosphate phosphatase activity,MF,
9391,GO:0034594,1,0.96047827230331,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9392,GO:0034595,1,0.90581419530725,0,12,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9393,GO:0034596,1,0.948474644610077,0,6,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9394,GO:0034597,1,0.979553559273557,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9396,GO:0034603,1,0.970624397296884,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9397,GO:0034604,1,0.970624397296884,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9399,GO:0034611,1,0.992444782635476,0,1,oligoribonucleotidase activity,MF,
9403,GO:0034616,1,0.914103605746708,0,13,response to laminar fluid shear stress,BP,
9404,GO:0034617,1,0.970266050585376,0,4,tetrahydrobiopterin binding,MF,
9405,GO:0034618,1,0.965896920918968,0,5,arginine binding,MF,
9406,GO:0034620,1,0.439325250994579,0,135,cellular response to unfolded protein,BP,
9408,GO:0034625,1,0.964837379943381,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9409,GO:0034626,1,0.964837379943381,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9410,GO:0034627,1,0.973475615825748,0,6,'de novo' NAD biosynthetic process,BP,
9411,GO:0034629,1,0.877799859822503,0,20,cellular protein-containing complex localization,BP,
9412,GO:0034632,1,0.991581452743848,0,2,retinol transmembrane transporter activity,MF,
9413,GO:0034633,1,0.991581452743848,0,2,retinol transport,BP,
9414,GO:0034634,1,0.974483794336679,0,3,glutathione transmembrane transporter activity,MF,
9415,GO:0034635,1,0.953216386174525,0,5,glutathione transport,BP,
9417,GO:0034638,1,0.931715920350979,0,13,phosphatidylcholine catabolic process,BP,
9418,GO:0034640,1,0.994016986456071,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9420,GO:0034643,1,0.836577791552049,0,22,establishment of mitochondrion localization, microtubule-mediated,BP,
9421,GO:0034644,1,0.580170528602232,0,77,cellular response to UV,BP,
9423,GO:0034647,1,0.945906871444692,0,4,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9424,GO:0034648,1,0.955404541021076,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9425,GO:0034649,1,0.992656374436386,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9426,GO:0034650,1,0.927894435396053,0,9,cortisol metabolic process,BP,
9427,GO:0034651,1,0.931526733244936,0,8,cortisol biosynthetic process,BP,
9428,GO:0034653,1,0.980662707441359,0,4,retinoic acid catabolic process,BP,
9431,GO:0034656,1,0.791286370238157,0,45,nucleobase-containing small molecule catabolic process,BP,
9432,GO:0034657,1,0.97460599024671,0,4,GID complex,CC,
9433,GO:0034660,1,0.0882320172535401,0,417,ncRNA metabolic process,BP,
9434,GO:0034661,1,0.806254711015854,0,31,ncRNA catabolic process,BP,
9435,GO:0034663,1,0.951024484204589,0,9,endoplasmic reticulum chaperone complex,CC,
9436,GO:0034665,1,0.983754553046348,0,2,integrin alpha1-beta1 complex,CC,
9437,GO:0034666,1,0.972563295811924,0,3,integrin alpha2-beta1 complex,CC,
9438,GO:0034667,1,0.983451541100425,0,2,integrin alpha3-beta1 complex,CC,
9439,GO:0034668,1,0.97404027682672,0,3,integrin alpha4-beta1 complex,CC,
9440,GO:0034669,1,0.983274297093685,0,2,integrin alpha4-beta7 complex,CC,
9441,GO:0034670,1,0.981871513233089,0,1,chemotaxis to arachidonic acid,BP,
9442,GO:0034673,1,0.974476548621134,0,3,inhibin-betaglycan-ActRII complex,CC,
9443,GO:0034674,1,0.984834378905918,0,2,integrin alpha5-beta1 complex,CC,
9444,GO:0034676,1,0.988965703632195,0,1,integrin alpha6-beta4 complex,CC,
9445,GO:0034677,1,0.992912328200946,0,1,integrin alpha7-beta1 complex,CC,
9446,GO:0034678,1,0.978196923762011,0,3,integrin alpha8-beta1 complex,CC,
9447,GO:0034679,1,0.99245927102977,0,1,integrin alpha9-beta1 complex,CC,
9448,GO:0034680,1,0.983032605467791,0,2,integrin alpha10-beta1 complex,CC,
9449,GO:0034681,1,0.983354306449535,0,2,integrin alpha11-beta1 complex,CC,
9450,GO:0034683,1,0.97752061149791,0,2,integrin alphav-beta3 complex,CC,
9451,GO:0034684,1,0.980572788121943,0,2,integrin alphav-beta5 complex,CC,
9452,GO:0034685,1,0.982344523276005,0,2,integrin alphav-beta6 complex,CC,
9453,GO:0034686,1,0.970533427085673,0,2,integrin alphav-beta8 complex,CC,
9454,GO:0034687,1,0.984833798088809,0,2,integrin alphaL-beta2 complex,CC,
9455,GO:0034688,1,0.985492811092141,0,2,integrin alphaM-beta2 complex,CC,
9456,GO:0034689,1,0.985674024637161,0,2,integrin alphaX-beta2 complex,CC,
9457,GO:0034693,1,0.99541263095158,0,1,U11/U12 snRNP,CC,
9458,GO:0034694,1,0.80143357628371,0,30,response to prostaglandin,BP,
9459,GO:0034695,1,0.860786109253495,0,22,response to prostaglandin E,BP,
9460,GO:0034696,1,0.991165627503547,0,2,response to prostaglandin F,BP,
9461,GO:0034698,1,0.833138570200651,0,24,response to gonadotropin,BP,
9462,GO:0034699,1,0.977780356166335,0,3,response to luteinizing hormone,BP,
9465,GO:0034704,1,0.543516898123866,0,61,calcium channel complex,CC,
9467,GO:0034706,1,0.742850957400627,0,26,sodium channel complex,CC,
9469,GO:0034708,1,0.492807603225558,0,96,methyltransferase complex,CC,
9470,GO:0034709,1,0.958774113139646,0,12,methylosome,CC,
9471,GO:0034711,1,0.970310843091892,0,5,inhibin binding,MF,
9472,GO:0034713,1,0.937337735443735,0,9,type I transforming growth factor beta receptor binding,MF,
9473,GO:0034714,1,0.980074523880082,0,3,type III transforming growth factor beta receptor binding,MF,
9474,GO:0034715,1,0.980106835572355,0,6,pICln-Sm protein complex,CC,
9475,GO:0034718,1,0.989605272049162,0,1,SMN-Gemin2 complex,CC,
9476,GO:0034719,1,0.9193716323999,0,18,SMN-Sm protein complex,CC,
9477,GO:0034720,1,0.923283879979463,0,7,histone H3-K4 demethylation,BP,
9478,GO:0034721,1,0.935459253167603,0,5,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9479,GO:0034722,1,0.996554283641674,0,1,gamma-glutamyl-peptidase activity,MF,
9480,GO:0034723,1,0.950832281394146,0,8,DNA replication-dependent nucleosome organization,BP,
9481,GO:0034724,1,0.80684283447973,0,35,DNA replication-independent nucleosome organization,BP,
9482,GO:0034727,1,0.941361128284661,0,5,piecemeal microautophagy of the nucleus,BP,
9483,GO:0034728,1,0.510686748805482,0,95,nucleosome organization,BP,
9484,GO:0034729,1,0.974521563807529,0,3,histone H3-K79 methylation,BP,
9485,GO:0034736,1,0.993661144114025,0,1,cholesterol O-acyltransferase activity,MF,
9486,GO:0034739,1,0.984499458601055,0,3,histone deacetylase activity (H4-K16 specific),MF,
9487,GO:0034750,1,0.983693126210049,0,2,Scrib-APC-beta-catenin complex,CC,
9488,GO:0034751,1,0.980150438443315,0,3,aryl hydrocarbon receptor complex,CC,
9489,GO:0034752,1,0.988056133455714,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9491,GO:0034755,1,0.907105886014948,0,16,iron ion transmembrane transport,BP,
9492,GO:0034756,1,0.965853966091041,0,6,regulation of iron ion transport,BP,
9493,GO:0034757,1,0.977771097748606,0,3,negative regulation of iron ion transport,BP,
9494,GO:0034759,1,0.977771097748606,0,3,regulation of iron ion transmembrane transport,BP,
9495,GO:0034760,1,0.977771097748606,0,3,negative regulation of iron ion transmembrane transport,BP,
9497,GO:0034763,1,0.488895514939758,0,110,negative regulation of transmembrane transport,BP,
9500,GO:0034766,1,0.547722039305765,0,90,negative regulation of ion transmembrane transport,BP,
9502,GO:0034769,1,0.988216169182217,0,2,basement membrane disassembly,BP,
9503,GO:0034770,1,0.927302699009609,0,6,histone H4-K20 methylation,BP,
9504,GO:0034773,1,0.961897999461259,0,4,histone H4-K20 trimethylation,BP,
9506,GO:0034775,1,0.95698436985385,0,4,glutathione transmembrane transport,BP,
9508,GO:0034777,1,0.995757728488806,0,1,recycling endosome lumen,CC,
9509,GO:0034875,1,0.996155318283885,0,1,caffeine oxidase activity,MF,
9510,GO:0034899,1,0.995968404693332,0,1,trimethylamine monooxygenase activity,MF,
9511,GO:0034959,1,0.99017356154548,0,1,endothelin maturation,BP,
9512,GO:0034963,1,0.99251557403184,0,2,box C/D snoRNA processing,BP,
9513,GO:0034964,1,0.989609908917226,0,2,box H/ACA snoRNA processing,BP,
9514,GO:0034968,1,0.429735886453344,0,99,histone lysine methylation,BP,
9515,GO:0034969,1,0.952427584959551,0,10,histone arginine methylation,BP,
9516,GO:0034970,1,0.989653278974366,0,2,histone H3-R2 methylation,BP,
9517,GO:0034971,1,0.990403825722078,0,2,histone H3-R17 methylation,BP,
9518,GO:0034975,1,0.947279771920947,0,8,protein folding in endoplasmic reticulum,BP,
9520,GO:0034979,1,0.895221677691906,0,16,NAD-dependent protein deacetylase activity,MF,
9521,GO:0034982,1,0.933739708201794,0,12,mitochondrial protein processing,BP,
9522,GO:0034983,1,0.944027526210387,0,8,peptidyl-lysine deacetylation,BP,
9523,GO:0034986,1,0.98128312890236,0,2,iron chaperone activity,MF,
9524,GO:0034987,1,0.963127080099353,0,6,immunoglobulin receptor binding,MF,
9525,GO:0034988,1,0.979460575589286,0,2,Fc-gamma receptor I complex binding,MF,
9526,GO:0034990,1,0.984946933067063,0,3,nuclear mitotic cohesin complex,CC,
9527,GO:0034991,1,0.969266673830603,0,5,nuclear meiotic cohesin complex,CC,
9528,GO:0034992,1,0.899109275427622,0,8,microtubule organizing center attachment site,CC,
9529,GO:0034993,1,0.899109275427622,0,8,meiotic nuclear membrane microtubule tethering complex,CC,
9530,GO:0034998,1,0.990283385594934,0,2,oligosaccharyltransferase I complex,CC,
9531,GO:0035000,1,0.994805719880305,0,1,oligosaccharyltransferase III complex,CC,
9532,GO:0035004,1,0.892231113388101,0,11,phosphatidylinositol 3-kinase activity,MF,
9533,GO:0035005,1,0.929080733769842,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9535,GO:0035019,1,0.618416438322737,0,70,somatic stem cell population maintenance,BP,
9537,GO:0035021,1,0.959974675064631,0,4,negative regulation of Rac protein signal transduction,BP,
9538,GO:0035022,1,0.966222985338213,0,4,positive regulation of Rac protein signal transduction,BP,
9540,GO:0035024,1,0.8266454119324,0,21,negative regulation of Rho protein signal transduction,BP,
9542,GO:0035026,1,0.985083019471304,0,2,leading edge cell differentiation,BP,
9543,GO:0035032,1,0.966299061740072,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9544,GO:0035033,1,0.977922742264079,0,4,histone deacetylase regulator activity,MF,
9545,GO:0035034,1,0.990100011011114,0,2,histone acetyltransferase regulator activity,MF,
9546,GO:0035035,1,0.800113228119109,0,28,histone acetyltransferase binding,MF,
9547,GO:0035036,1,0.812292290807109,0,43,sperm-egg recognition,BP,
9548,GO:0035037,1,0.991366302946322,0,1,sperm entry,BP,
9549,GO:0035038,1,0.989996591266572,0,2,female pronucleus assembly,BP,
9550,GO:0035039,1,0.995641746303212,0,1,male pronucleus assembly,BP,
9551,GO:0035050,1,0.571682814329306,0,73,embryonic heart tube development,BP,
9552,GO:0035051,1,0.327297471715594,0,128,cardiocyte differentiation,BP,
9553,GO:0035054,1,0.983744294354561,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9554,GO:0035060,1,0.96584361415916,0,3,brahma complex,CC,
9555,GO:0035061,1,0.953630044457456,0,5,interchromatin granule,CC,
9557,GO:0035064,1,0.622377462874687,0,62,methylated histone binding,MF,
9560,GO:0035067,1,0.906084687675702,0,16,negative regulation of histone acetylation,BP,
9561,GO:0035082,1,0.649731016345947,0,56,axoneme assembly,BP,
9562,GO:0035087,1,0.969114466721157,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9563,GO:0035088,1,0.685529035433849,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9564,GO:0035089,1,0.866491540889682,0,19,establishment of apical/basal cell polarity,BP,
9565,GO:0035090,1,0.928910110331293,0,11,maintenance of apical/basal cell polarity,BP,
9567,GO:0035092,1,0.944102332698726,0,6,sperm chromatin condensation,BP,
9568,GO:0035093,1,0.95529749727238,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9569,GO:0035094,1,0.760182689564899,0,41,response to nicotine,BP,
9570,GO:0035095,1,0.942765403324747,0,7,behavioral response to nicotine,BP,
9571,GO:0035097,1,0.557542361146938,0,71,histone methyltransferase complex,CC,
9572,GO:0035098,1,0.894102364179006,0,14,ESC/E(Z) complex,CC,
9573,GO:0035101,1,0.975778739383549,0,4,FACT complex,CC,
9574,GO:0035102,1,0.896903600907524,0,14,PRC1 complex,CC,
9575,GO:0035103,1,0.995658099904583,0,1,sterol regulatory element binding protein cleavage,BP,
9576,GO:0035106,1,0.984518505710993,0,3,operant conditioning,BP,
9577,GO:0035107,1,0.294796982287806,0,142,appendage morphogenesis,BP,
9578,GO:0035108,1,0.294796982287806,0,142,limb morphogenesis,BP,
9579,GO:0035112,1,0.90373846361667,0,13,genitalia morphogenesis,BP,
9580,GO:0035113,1,0.367135061775247,0,120,embryonic appendage morphogenesis,BP,
9581,GO:0035115,1,0.805541680666921,0,32,embryonic forelimb morphogenesis,BP,
9582,GO:0035116,1,0.824384856007674,0,28,embryonic hindlimb morphogenesis,BP,
9583,GO:0035120,1,0.979581872132667,0,1,post-embryonic appendage morphogenesis,BP,
9584,GO:0035127,1,0.979581872132667,0,1,post-embryonic limb morphogenesis,BP,
9585,GO:0035128,1,0.979581872132667,0,1,post-embryonic forelimb morphogenesis,BP,
9586,GO:0035136,1,0.738833805717822,0,40,forelimb morphogenesis,BP,
9587,GO:0035137,1,0.763478334853389,0,36,hindlimb morphogenesis,BP,
9588,GO:0035145,1,0.897013974540291,0,18,exon-exon junction complex,CC,
9591,GO:0035162,1,0.84523327097621,0,22,embryonic hemopoiesis,BP,
9592,GO:0035166,1,0.979509475096679,0,3,post-embryonic hemopoiesis,BP,
9593,GO:0035173,1,0.892764099197841,0,15,histone kinase activity,MF,
9594,GO:0035174,1,0.958988696268889,0,6,histone serine kinase activity,MF,
9595,GO:0035175,1,0.996379022716881,0,1,histone kinase activity (H3-S10 specific),MF,
9597,GO:0035184,1,0.959670925763892,0,5,histone threonine kinase activity,MF,
9598,GO:0035188,1,0.850403525699969,0,26,hatching,BP,
9599,GO:0035189,1,0.985887585914597,0,2,Rb-E2F complex,CC,
9600,GO:0035194,1,0.396479828270734,0,120,post-transcriptional gene silencing by RNA,BP,
9601,GO:0035195,1,0.427274199965939,0,111,gene silencing by miRNA,BP,
9602,GO:0035196,1,0.715829407352539,0,45,production of miRNAs involved in gene silencing by miRNA,BP,
9603,GO:0035197,1,0.917634158293409,0,10,siRNA binding,MF,
9604,GO:0035198,1,0.825656715249057,0,27,miRNA binding,MF,
9605,GO:0035226,1,0.994314833301034,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9606,GO:0035227,1,0.994314833301034,0,1,regulation of glutamate-cysteine ligase activity,BP,
9607,GO:0035229,1,0.994314833301034,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9608,GO:0035234,1,0.937545153167284,0,7,ectopic germ cell programmed cell death,BP,
9610,GO:0035238,1,0.994890876864838,0,1,vitamin A biosynthetic process,BP,
9612,GO:0035240,1,0.963195334514705,0,8,dopamine binding,MF,
9613,GO:0035241,1,0.977910334732679,0,5,protein-arginine omega-N monomethyltransferase activity,MF,
9614,GO:0035242,1,0.977838280930807,0,5,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9615,GO:0035243,1,0.98087495544361,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9616,GO:0035246,1,0.949944843253075,0,11,peptidyl-arginine N-methylation,BP,
9617,GO:0035247,1,0.959132917889922,0,9,peptidyl-arginine omega-N-methylation,BP,
9618,GO:0035248,1,0.994708275338095,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9620,GO:0035250,1,0.881707356770799,0,23,UDP-galactosyltransferase activity,MF,
9621,GO:0035251,1,0.938035832847642,0,9,UDP-glucosyltransferase activity,MF,
9622,GO:0035252,1,0.949100276595635,0,6,UDP-xylosyltransferase activity,MF,
9623,GO:0035253,1,0.910577062990129,0,11,ciliary rootlet,CC,
9626,GO:0035256,1,0.941997165023502,0,11,G protein-coupled glutamate receptor binding,MF,
9627,GO:0035257,1,0.349702046808085,0,137,nuclear hormone receptor binding,MF,
9628,GO:0035258,1,0.548404169922041,0,76,steroid hormone receptor binding,MF,
9629,GO:0035259,1,0.872325955455468,0,15,glucocorticoid receptor binding,MF,
9630,GO:0035261,1,0.962864571229633,0,2,external genitalia morphogenesis,BP,
9631,GO:0035262,1,0.979282935880814,0,2,gonad morphogenesis,BP,
9633,GO:0035265,1,0.284736360379651,0,161,organ growth,BP,
9634,GO:0035267,1,0.888570138733969,0,19,NuA4 histone acetyltransferase complex,CC,
9635,GO:0035268,1,0.852977402776707,0,20,protein mannosylation,BP,
9636,GO:0035269,1,0.896751038484585,0,15,protein O-linked mannosylation,BP,
9638,GO:0035272,1,0.676509274271534,0,49,exocrine system development,BP,
9639,GO:0035276,1,0.985544845457597,0,2,ethanol binding,MF,
9640,GO:0035278,1,0.874153819342272,0,14,miRNA mediated inhibition of translation,BP,
9641,GO:0035279,1,0.988193735626206,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9642,GO:0035280,1,0.945874093934823,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9643,GO:0035281,1,0.986481773050079,0,2,pre-miRNA export from nucleus,BP,
9644,GO:0035282,1,0.510831850546089,0,90,segmentation,BP,
9645,GO:0035283,1,0.984879502358763,0,3,central nervous system segmentation,BP,
9646,GO:0035284,1,0.984879502358763,0,3,brain segmentation,BP,
9647,GO:0035290,1,0.968004815928309,0,4,trunk segmentation,BP,
9650,GO:0035299,1,0.99159047050576,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9654,GO:0035306,1,0.664520826746253,0,54,positive regulation of dephosphorylation,BP,
9655,GO:0035307,1,0.746854822124748,0,41,positive regulation of protein dephosphorylation,BP,
9657,GO:0035312,1,0.955253347052465,0,8,5'-3' exodeoxyribonuclease activity,MF,
9660,GO:0035325,1,0.936239605833817,0,12,Toll-like receptor binding,MF,
9661,GO:0035327,1,0.87186642617231,0,20,transcriptionally active chromatin,CC,
9662,GO:0035329,1,0.670729369949932,0,42,hippo signaling,BP,
9663,GO:0035330,1,0.864181062145714,0,16,regulation of hippo signaling,BP,
9664,GO:0035331,1,0.90168691778689,0,11,negative regulation of hippo signaling,BP,
9665,GO:0035332,1,0.965712998412828,0,3,positive regulation of hippo signaling,BP,
9666,GO:0035333,1,0.956982126661674,0,7,Notch receptor processing, ligand-dependent,BP,
9668,GO:0035336,1,0.873286353574521,0,23,long-chain fatty-acyl-CoA metabolic process,BP,
9669,GO:0035337,1,0.80102460450955,0,37,fatty-acyl-CoA metabolic process,BP,
9670,GO:0035338,1,0.899291291932566,0,18,long-chain fatty-acyl-CoA biosynthetic process,BP,
9671,GO:0035339,1,0.984790783667056,0,4,SPOTS complex,CC,
9672,GO:0035344,1,0.99531845419145,0,1,hypoxanthine transport,BP,
9673,GO:0035349,1,0.989939310949597,0,2,coenzyme A transmembrane transport,BP,
9674,GO:0035350,1,0.990152506168976,0,2,FAD transmembrane transport,BP,
9675,GO:0035351,1,0.994488243633323,0,1,heme transmembrane transport,BP,
9676,GO:0035352,1,0.995715294575166,0,1,NAD transmembrane transport,BP,
9677,GO:0035354,1,0.988451330089972,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9678,GO:0035355,1,0.988758442437801,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9679,GO:0035356,1,0.965323950374903,0,7,cellular triglyceride homeostasis,BP,
9680,GO:0035357,1,0.862163427406441,0,21,peroxisome proliferator activated receptor signaling pathway,BP,
9681,GO:0035358,1,0.918762410473518,0,14,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9682,GO:0035359,1,0.984255156717254,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9683,GO:0035360,1,0.944983577396214,0,9,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9684,GO:0035363,1,0.978771754707166,0,4,histone locus body,CC,
9685,GO:0035364,1,0.99531845419145,0,1,thymine transport,BP,
9686,GO:0035368,1,0.969927824106457,0,5,selenocysteine insertion sequence binding,MF,
9687,GO:0035370,1,0.990929843809484,0,2,UBC13-UEV1A complex,CC,
9688,GO:0035371,1,0.798622025523777,0,22,microtubule plus-end,CC,
9689,GO:0035372,1,0.868220502200364,0,17,protein localization to microtubule,BP,
9690,GO:0035373,1,0.960807180817198,0,3,chondroitin sulfate proteoglycan binding,MF,
9691,GO:0035374,1,0.93758382941627,0,9,chondroitin sulfate binding,MF,
9692,GO:0035375,1,0.985423382777449,0,1,zymogen binding,MF,
9693,GO:0035376,1,0.940190013903315,0,8,sterol import,BP,
9694,GO:0035377,1,0.973956081538789,0,3,transepithelial water transport,BP,
9695,GO:0035378,1,0.994919586867286,0,1,carbon dioxide transmembrane transport,BP,
9696,GO:0035379,1,0.994919586867286,0,1,carbon dioxide transmembrane transporter activity,MF,
9697,GO:0035381,1,0.957888554703062,0,8,ATP-gated ion channel activity,MF,
9698,GO:0035383,1,0.583609938129829,0,93,thioester metabolic process,BP,
9699,GO:0035384,1,0.72427425788142,0,49,thioester biosynthetic process,BP,
9700,GO:0035385,1,0.948716291320033,0,5,Roundabout signaling pathway,BP,
9701,GO:0035397,1,0.994252392499678,0,1,helper T cell enhancement of adaptive immune response,BP,
9702,GO:0035400,1,0.98983972059644,0,1,histone tyrosine kinase activity,MF,
9703,GO:0035401,1,0.98983972059644,0,1,histone kinase activity (H3-Y41 specific),MF,
9704,GO:0035402,1,0.989472280470666,0,2,histone kinase activity (H3-T11 specific),MF,
9705,GO:0035403,1,0.973410350899995,0,2,histone kinase activity (H3-T6 specific),MF,
9706,GO:0035404,1,0.9291911199764,0,12,histone-serine phosphorylation,BP,
9707,GO:0035405,1,0.959670925763892,0,5,histone-threonine phosphorylation,BP,
9708,GO:0035406,1,0.98983972059644,0,1,histone-tyrosine phosphorylation,BP,
9709,GO:0035407,1,0.989472280470666,0,2,histone H3-T11 phosphorylation,BP,
9710,GO:0035408,1,0.973410350899995,0,2,histone H3-T6 phosphorylation,BP,
9711,GO:0035409,1,0.98983972059644,0,1,histone H3-Y41 phosphorylation,BP,
9712,GO:0035410,1,0.993531075420738,0,2,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9714,GO:0035425,1,0.965221808991704,0,7,autocrine signaling,BP,
9715,GO:0035426,1,0.960565028169174,0,5,extracellular matrix-cell signaling,BP,
9716,GO:0035434,1,0.949081469555736,0,6,copper ion transmembrane transport,BP,
9717,GO:0035435,1,0.913138432700699,0,13,phosphate ion transmembrane transport,BP,
9718,GO:0035437,1,0.923102927009284,0,14,maintenance of protein localization in endoplasmic reticulum,BP,
9719,GO:0035441,1,0.966649651981315,0,3,cell migration involved in vasculogenesis,BP,
9720,GO:0035442,1,0.963476541337267,0,4,dipeptide transmembrane transport,BP,
9721,GO:0035443,1,0.95698436985385,0,4,tripeptide transmembrane transport,BP,
9722,GO:0035444,1,0.992068479353006,0,1,nickel cation transmembrane transport,BP,
9723,GO:0035445,1,0.994236721928533,0,1,borate transmembrane transport,BP,
9724,GO:0035455,1,0.878966479442951,0,20,response to interferon-alpha,BP,
9725,GO:0035456,1,0.885952023316158,0,25,response to interferon-beta,BP,
9726,GO:0035457,1,0.925747733885203,0,10,cellular response to interferon-alpha,BP,
9727,GO:0035458,1,0.910209709507843,0,18,cellular response to interferon-beta,BP,
9728,GO:0035459,1,0.857275616013964,0,20,vesicle cargo loading,BP,
9729,GO:0035461,1,0.890478781244324,0,15,vitamin transmembrane transport,BP,
9730,GO:0035469,1,0.962187863067275,0,5,determination of pancreatic left/right asymmetry,BP,
9731,GO:0035470,1,0.983299808100189,0,4,positive regulation of vascular wound healing,BP,
9732,GO:0035473,1,0.958784621669293,0,4,lipase binding,MF,
9733,GO:0035480,1,0.966911646759619,0,4,regulation of Notch signaling pathway involved in heart induction,BP,
9734,GO:0035481,1,0.966911646759619,0,4,positive regulation of Notch signaling pathway involved in heart induction,BP,
9735,GO:0035482,1,0.980255039629499,0,6,gastric motility,BP,
9736,GO:0035483,1,0.983774970378493,0,5,gastric emptying,BP,
9737,GO:0035485,1,0.99624724401736,0,1,adenine/guanine mispair binding,MF,
9740,GO:0035493,1,0.90875965377283,0,17,SNARE complex assembly,BP,
9741,GO:0035494,1,0.983858510644059,0,3,SNARE complex disassembly,BP,
9742,GO:0035497,1,0.905827711014289,0,14,cAMP response element binding,MF,
9743,GO:0035498,1,0.992511059706689,0,1,carnosine metabolic process,BP,
9744,GO:0035499,1,0.992511059706689,0,1,carnosine biosynthetic process,BP,
9745,GO:0035500,1,0.987727665755488,0,2,MH2 domain binding,MF,
9746,GO:0035501,1,0.994782870291466,0,1,MH1 domain binding,MF,
9747,GO:0035502,1,0.971786947434534,0,5,metanephric part of ureteric bud development,BP,
9748,GO:0035504,1,0.996548673676157,0,1,regulation of myosin light chain kinase activity,BP,
9749,GO:0035505,1,0.996548673676157,0,1,positive regulation of myosin light chain kinase activity,BP,
9750,GO:0035507,1,0.934715717070362,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9751,GO:0035508,1,0.989273672274609,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9752,GO:0035509,1,0.95729857448164,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9753,GO:0035510,1,0.802361124410821,0,30,DNA dealkylation,BP,
9754,GO:0035511,1,0.970665738215854,0,6,oxidative DNA demethylation,BP,
9755,GO:0035513,1,0.970677978152624,0,5,oxidative RNA demethylation,BP,
9756,GO:0035514,1,0.976550883634275,0,5,DNA demethylase activity,MF,
9757,GO:0035515,1,0.970677978152624,0,5,oxidative RNA demethylase activity,MF,
9758,GO:0035516,1,0.983120285710727,0,3,oxidative DNA demethylase activity,MF,
9759,GO:0035517,1,0.958098824686171,0,4,PR-DUB complex,CC,
9760,GO:0035518,1,0.888076317557143,0,16,histone H2A monoubiquitination,BP,
9761,GO:0035519,1,0.978099660407515,0,4,protein K29-linked ubiquitination,BP,
9762,GO:0035520,1,0.924477409262565,0,9,monoubiquitinated protein deubiquitination,BP,
9763,GO:0035521,1,0.975472153856295,0,4,monoubiquitinated histone deubiquitination,BP,
9764,GO:0035522,1,0.975472153856295,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9765,GO:0035523,1,0.95583673599087,0,4,protein K29-linked deubiquitination,BP,
9766,GO:0035524,1,0.946549160960377,0,7,proline transmembrane transport,BP,
9767,GO:0035525,1,0.995222801563837,0,1,NF-kappaB p50/p65 complex,CC,
9768,GO:0035526,1,0.982732433092189,0,2,retrograde transport, plasma membrane to Golgi,BP,
9769,GO:0035529,1,0.956503365152887,0,8,NADH pyrophosphatase activity,MF,
9770,GO:0035538,1,0.993953908228704,0,1,carbohydrate response element binding,MF,
9771,GO:0035539,1,0.992921027654906,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9772,GO:0035542,1,0.944053779900707,0,9,regulation of SNARE complex assembly,BP,
9773,GO:0035543,1,0.994133311934308,0,1,positive regulation of SNARE complex assembly,BP,
9774,GO:0035544,1,0.977984254779757,0,3,negative regulation of SNARE complex assembly,BP,
9775,GO:0035545,1,0.967547845650711,0,2,determination of left/right asymmetry in nervous system,BP,
9776,GO:0035552,1,0.988342676813246,0,2,oxidative single-stranded DNA demethylation,BP,
9777,GO:0035553,1,0.982022383960738,0,3,oxidative single-stranded RNA demethylation,BP,
9779,GO:0035561,1,0.869557780265185,0,21,regulation of chromatin binding,BP,
9780,GO:0035562,1,0.943441173364686,0,7,negative regulation of chromatin binding,BP,
9781,GO:0035563,1,0.92765946561569,0,13,positive regulation of chromatin binding,BP,
9782,GO:0035564,1,0.96752706249733,0,3,regulation of kidney size,BP,
9783,GO:0035566,1,0.992193352021718,0,1,regulation of metanephros size,BP,
9785,GO:0035568,1,0.994890876864838,0,1,N-terminal peptidyl-proline methylation,BP,
9786,GO:0035570,1,0.994890876864838,0,1,N-terminal peptidyl-serine methylation,BP,
9787,GO:0035572,1,0.994890876864838,0,1,N-terminal peptidyl-serine dimethylation,BP,
9788,GO:0035573,1,0.994890876864838,0,1,N-terminal peptidyl-serine trimethylation,BP,
9789,GO:0035574,1,0.983338278750502,0,2,histone H4-K20 demethylation,BP,
9790,GO:0035575,1,0.983338278750502,0,2,histone demethylase activity (H4-K20 specific),MF,
9791,GO:0035577,1,0.698136669335084,0,54,azurophil granule membrane,CC,
9795,GO:0035581,1,0.914326567202683,0,10,sequestering of extracellular ligand from receptor,BP,
9796,GO:0035582,1,0.967997942969344,0,4,sequestering of BMP in extracellular matrix,BP,
9797,GO:0035583,1,0.94483219638029,0,4,sequestering of TGFbeta in extracellular matrix,BP,
9798,GO:0035584,1,0.860120677155614,0,20,calcium-mediated signaling using intracellular calcium source,BP,
9799,GO:0035585,1,0.961868596198081,0,4,calcium-mediated signaling using extracellular calcium source,BP,
9800,GO:0035588,1,0.940116377337864,0,11,G protein-coupled purinergic receptor signaling pathway,BP,
9801,GO:0035589,1,0.944074906244745,0,13,G protein-coupled purinergic nucleotide receptor signaling pathway,BP,
9802,GO:0035590,1,0.860217051529206,0,30,purinergic nucleotide receptor signaling pathway,BP,
9805,GO:0035594,1,0.980333862550219,0,4,ganglioside binding,MF,
9806,GO:0035596,1,0.989973151110078,0,2,methylthiotransferase activity,MF,
9807,GO:0035597,1,0.996038580134113,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9808,GO:0035598,1,0.993910689226611,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9809,GO:0035600,1,0.989973151110078,0,2,tRNA methylthiolation,BP,
9810,GO:0035601,1,0.457734496336224,0,102,protein deacylation,BP,
9811,GO:0035602,1,0.992222090970143,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,BP,
9812,GO:0035603,1,0.992222090970143,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9813,GO:0035604,1,0.992222090970143,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9814,GO:0035605,1,0.996664269302455,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9815,GO:0035606,1,0.993556822863946,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9816,GO:0035607,1,0.981503449882063,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9817,GO:0035608,1,0.959767062599476,0,7,protein deglutamylation,BP,
9818,GO:0035609,1,0.977458543692744,0,4,C-terminal protein deglutamylation,BP,
9819,GO:0035610,1,0.973304597593014,0,4,protein side chain deglutamylation,BP,
9820,GO:0035611,1,0.994755341750596,0,1,protein branching point deglutamylation,BP,
9821,GO:0035612,1,0.904399694717856,0,9,AP-2 adaptor complex binding,MF,
9822,GO:0035613,1,0.902578321944254,0,12,RNA stem-loop binding,MF,
9823,GO:0035615,1,0.888889321013677,0,16,clathrin adaptor activity,MF,
9824,GO:0035616,1,0.975057408279114,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9825,GO:0035617,1,0.968743711486179,0,5,stress granule disassembly,BP,
9826,GO:0035621,1,0.989976997407315,0,2,ER to Golgi ceramide transport,BP,
9827,GO:0035622,1,0.971838790777557,0,2,intrahepatic bile duct development,BP,
9828,GO:0035623,1,0.993988988184138,0,1,renal glucose absorption,BP,
9829,GO:0035624,1,0.967409106060629,0,4,receptor transactivation,BP,
9830,GO:0035627,1,0.921033305937801,0,11,ceramide transport,BP,
9832,GO:0035631,1,0.940523429675945,0,11,CD40 receptor complex,CC,
9833,GO:0035632,1,0.992870275629069,0,2,mitochondrial prohibitin complex,CC,
9835,GO:0035634,1,0.97512520677056,0,4,response to stilbenoid,BP,
9836,GO:0035635,1,0.879972568959712,0,14,entry of bacterium into host cell,BP,
9840,GO:0035641,1,0.907029420481628,0,12,locomotory exploration behavior,BP,
9841,GO:0035642,1,0.994503490988661,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9842,GO:0035643,1,0.996389026584328,0,1,L-DOPA receptor activity,MF,
9843,GO:0035644,1,0.994447127299677,0,1,phosphoanandamide dephosphorylation,BP,
9844,GO:0035645,1,0.991840639503319,0,1,enteric smooth muscle cell differentiation,BP,
9845,GO:0035646,1,0.941342523061306,0,10,endosome to melanosome transport,BP,
9846,GO:0035650,1,0.975420841966995,0,5,AP-1 adaptor complex binding,MF,
9847,GO:0035651,1,0.985430582807949,0,3,AP-3 adaptor complex binding,MF,
9848,GO:0035655,1,0.961621591712198,0,8,interleukin-18-mediated signaling pathway,BP,
9849,GO:0035657,1,0.990768694961295,0,1,eRF1 methyltransferase complex,CC,
9850,GO:0035658,1,0.97986648176108,0,4,Mon1-Ccz1 complex,CC,
9851,GO:0035662,1,0.987029193414234,0,4,Toll-like receptor 4 binding,MF,
9852,GO:0035663,1,0.979932380391266,0,3,Toll-like receptor 2 binding,MF,
9853,GO:0035664,1,0.996308337271904,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9854,GO:0035665,1,0.996308337271904,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9855,GO:0035666,1,0.861749585715728,0,28,TRIF-dependent toll-like receptor signaling pathway,BP,
9856,GO:0035668,1,0.972558359669783,0,3,TRAM-dependent toll-like receptor signaling pathway,BP,
9857,GO:0035669,1,0.972558359669783,0,3,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9858,GO:0035671,1,0.987562709262779,0,3,enone reductase activity,MF,
9859,GO:0035672,1,0.932329202661696,0,8,oligopeptide transmembrane transport,BP,
9860,GO:0035673,1,0.957500341835921,0,5,oligopeptide transmembrane transporter activity,MF,
9861,GO:0035674,1,0.990527768656458,0,2,tricarboxylic acid transmembrane transport,BP,
9862,GO:0035675,1,0.986809291662193,0,2,neuromast hair cell development,BP,
9863,GO:0035677,1,0.991662880945026,0,1,posterior lateral line neuromast hair cell development,BP,
9864,GO:0035683,1,0.981055646839172,0,2,memory T cell extravasation,BP,
9865,GO:0035684,1,0.982403544651612,0,3,helper T cell extravasation,BP,
9866,GO:0035685,1,0.985499482244045,0,2,helper T cell diapedesis,BP,
9867,GO:0035686,1,0.973475238703799,0,5,sperm fibrous sheath,CC,
9868,GO:0035690,1,0.660837786761032,0,68,cellular response to drug,BP,
9869,GO:0035691,1,0.984774111077961,0,3,macrophage migration inhibitory factor signaling pathway,BP,
9870,GO:0035692,1,0.987142507619562,0,2,macrophage migration inhibitory factor receptor complex,CC,
9871,GO:0035693,1,0.996664810451459,0,1,NOS2-CD74 complex,CC,
9872,GO:0035694,1,0.974536760536435,0,4,mitochondrial protein catabolic process,BP,
9873,GO:0035695,1,0.991796097928538,0,1,mitophagy by induced vacuole formation,BP,
9874,GO:0035696,1,0.954387117278055,0,6,monocyte extravasation,BP,
9875,GO:0035697,1,0.987799984319449,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9876,GO:0035698,1,0.99241224883448,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9877,GO:0035700,1,0.991681114244101,0,2,astrocyte chemotaxis,BP,
9878,GO:0035701,1,0.94311024340732,0,8,hematopoietic stem cell migration,BP,
9879,GO:0035702,1,0.982861154164536,0,2,monocyte homeostasis,BP,
9880,GO:0035704,1,0.995352825608927,0,1,helper T cell chemotaxis,BP,
9881,GO:0035705,1,0.995352825608927,0,1,T-helper 17 cell chemotaxis,BP,
9882,GO:0035708,1,0.993482673451939,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9883,GO:0035709,1,0.985280020145573,0,3,memory T cell activation,BP,
9885,GO:0035711,1,0.98225154738415,0,4,T-helper 1 cell activation,BP,
9886,GO:0035712,1,0.9874466489712,0,2,T-helper 2 cell activation,BP,
9887,GO:0035713,1,0.993482673451939,0,1,response to nitrogen dioxide,BP,
9888,GO:0035715,1,0.995352825608927,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9889,GO:0035716,1,0.995352825608927,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9890,GO:0035717,1,0.990436461020336,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9891,GO:0035718,1,0.993232552455297,0,2,macrophage migration inhibitory factor binding,MF,
9892,GO:0035720,1,0.984983430932757,0,3,intraciliary anterograde transport,BP,
9893,GO:0035721,1,0.913428809054926,0,9,intraciliary retrograde transport,BP,
9895,GO:0035723,1,0.907177373530067,0,13,interleukin-15-mediated signaling pathway,BP,
9896,GO:0035724,1,0.98706942245828,0,1,CD24 biosynthetic process,BP,
9898,GO:0035726,1,0.954884136767297,0,7,common myeloid progenitor cell proliferation,BP,
9899,GO:0035727,1,0.960698181252622,0,8,lysophosphatidic acid binding,MF,
9900,GO:0035728,1,0.867076262352295,0,19,response to hepatocyte growth factor,BP,
9901,GO:0035729,1,0.884031311637331,0,17,cellular response to hepatocyte growth factor stimulus,BP,
9902,GO:0035730,1,0.996809431736355,0,1,S-nitrosoglutathione binding,MF,
9903,GO:0035731,1,0.996809431736355,0,1,dinitrosyl-iron complex binding,MF,
9904,GO:0035732,1,0.996809431736355,0,1,nitric oxide storage,BP,
9905,GO:0035733,1,0.939930340603629,0,8,hepatic stellate cell activation,BP,
9906,GO:0035735,1,0.746193397095751,0,38,intraciliary transport involved in cilium assembly,BP,
9907,GO:0035739,1,0.952028833985382,0,11,CD4-positive, alpha-beta T cell proliferation,BP,
9908,GO:0035740,1,0.962272806103577,0,7,CD8-positive, alpha-beta T cell proliferation,BP,
9909,GO:0035743,1,0.909570866432617,0,19,CD4-positive, alpha-beta T cell cytokine production,BP,
9910,GO:0035744,1,0.966146486973861,0,7,T-helper 1 cell cytokine production,BP,
9911,GO:0035745,1,0.943340326362307,0,12,T-helper 2 cell cytokine production,BP,
9912,GO:0035746,1,0.996711635262835,0,1,granzyme A production,BP,
9913,GO:0035747,1,0.96287826862743,0,7,natural killer cell chemotaxis,BP,
9914,GO:0035748,1,0.954718775281697,0,6,myelin sheath abaxonal region,CC,
9916,GO:0035750,1,0.989721392178348,0,1,protein localization to myelin sheath abaxonal region,BP,
9917,GO:0035751,1,0.935994094893344,0,13,regulation of lysosomal lumen pH,BP,
9918,GO:0035752,1,0.99618078585442,0,1,lysosomal lumen pH elevation,BP,
9919,GO:0035754,1,0.958790371284535,0,8,B cell chemotaxis,BP,
9920,GO:0035755,1,0.995233725535343,0,1,cardiolipin hydrolase activity,MF,
9921,GO:0035757,1,0.995850691831409,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9922,GO:0035758,1,0.995850691831409,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9923,GO:0035759,1,0.991831943611454,0,2,mesangial cell-matrix adhesion,BP,
9924,GO:0035766,1,0.962882617665958,0,5,cell chemotaxis to fibroblast growth factor,BP,
9925,GO:0035767,1,0.82975865972102,0,24,endothelial cell chemotaxis,BP,
9926,GO:0035768,1,0.962882617665958,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9928,GO:0035771,1,0.95306976865347,0,7,interleukin-4-mediated signaling pathway,BP,
9929,GO:0035772,1,0.996331912092076,0,1,interleukin-13-mediated signaling pathway,BP,
9930,GO:0035773,1,0.671331790839459,0,60,insulin secretion involved in cellular response to glucose stimulus,BP,
9931,GO:0035774,1,0.828013012228748,0,30,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9932,GO:0035780,1,0.994836660783753,0,1,CD80 biosynthetic process,BP,
9933,GO:0035781,1,0.991285669014631,0,2,CD86 biosynthetic process,BP,
9934,GO:0035782,1,0.996711635262835,0,1,mature natural killer cell chemotaxis,BP,
9935,GO:0035783,1,0.986592702200903,0,3,CD4-positive, alpha-beta T cell costimulation,BP,
9936,GO:0035787,1,0.96871779245113,0,4,cell migration involved in kidney development,BP,
9937,GO:0035788,1,0.978746492151941,0,3,cell migration involved in metanephros development,BP,
9938,GO:0035789,1,0.978746492151941,0,3,metanephric mesenchymal cell migration,BP,
9939,GO:0035790,1,0.949817094663184,0,5,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9941,GO:0035793,1,0.978746492151941,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9942,GO:0035794,1,0.733558120037051,0,59,positive regulation of mitochondrial membrane permeability,BP,
9943,GO:0035795,1,0.969708251906239,0,5,negative regulation of mitochondrial membrane permeability,BP,
9944,GO:0035799,1,0.971368871495017,0,4,ureter maturation,BP,
9945,GO:0035800,1,0.989342240639238,0,2,deubiquitinase activator activity,MF,
9946,GO:0035801,1,0.990778433981517,0,2,adrenal cortex development,BP,
9947,GO:0035802,1,0.990778433981517,0,2,adrenal cortex formation,BP,
9948,GO:0035803,1,0.989232881151477,0,3,egg coat formation,BP,
9949,GO:0035804,1,0.993222749591135,0,2,structural constituent of egg coat,MF,
9950,GO:0035805,1,0.988500812706035,0,3,egg coat,CC,
9952,GO:0035810,1,0.923993729576482,0,14,positive regulation of urine volume,BP,
9953,GO:0035811,1,0.975217155362653,0,3,negative regulation of urine volume,BP,
9954,GO:0035812,1,0.907642038011099,0,19,renal sodium excretion,BP,
9955,GO:0035813,1,0.911169491619091,0,18,regulation of renal sodium excretion,BP,
9956,GO:0035814,1,0.981938388187766,0,4,negative regulation of renal sodium excretion,BP,
9957,GO:0035815,1,0.940958985950174,0,12,positive regulation of renal sodium excretion,BP,
9959,GO:0035822,1,0.97050782840086,0,4,gene conversion,BP,
9960,GO:0035825,1,0.722975406129779,0,48,homologous recombination,BP,
9961,GO:0035838,1,0.970180926353186,0,3,growing cell tip,CC,
9962,GO:0035841,1,0.977971393216826,0,2,new growing cell tip,CC,
9963,GO:0035844,1,0.973217796020588,0,4,cloaca development,BP,
9964,GO:0035845,1,0.928054808620355,0,10,photoreceptor cell outer segment organization,BP,
9966,GO:0035851,1,0.990481904784307,0,2,Krueppel-associated box domain binding,MF,
9967,GO:0035853,1,0.991438176665235,0,1,chromosome passenger complex localization to spindle midzone,BP,
9968,GO:0035854,1,0.990303592077614,0,2,eosinophil fate commitment,BP,
9969,GO:0035855,1,0.872308602116649,0,16,megakaryocyte development,BP,
9970,GO:0035859,1,0.930911326373259,0,13,Seh1-associated complex,CC,
9972,GO:0035861,1,0.706583762111831,0,50,site of double-strand break,CC,
9973,GO:0035862,1,0.988475323572307,0,1,dITP metabolic process,BP,
9974,GO:0035863,1,0.988475323572307,0,1,dITP catabolic process,BP,
9975,GO:0035864,1,0.904067904863648,0,12,response to potassium ion,BP,
9976,GO:0035865,1,0.924459815937557,0,9,cellular response to potassium ion,BP,
9977,GO:0035866,1,0.961420705938768,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
9978,GO:0035867,1,0.94418970959448,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9979,GO:0035868,1,0.971280853789505,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
9980,GO:0035869,1,0.649601192702692,0,58,ciliary transition zone,CC,
9981,GO:0035870,1,0.985274458633866,0,2,dITP diphosphatase activity,MF,
9982,GO:0035871,1,0.919475186492955,0,8,protein K11-linked deubiquitination,BP,
9983,GO:0035872,1,0.794935138990906,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9984,GO:0035873,1,0.958270822253617,0,6,lactate transmembrane transport,BP,
9985,GO:0035877,1,0.980199791987712,0,3,death effector domain binding,MF,
9986,GO:0035878,1,0.950111362784788,0,8,nail development,BP,
9987,GO:0035879,1,0.980075251099853,0,3,plasma membrane lactate transport,BP,
9988,GO:0035880,1,0.984930321663696,0,3,embryonic nail plate morphogenesis,BP,
9989,GO:0035881,1,0.960879413319216,0,7,amacrine cell differentiation,BP,
9990,GO:0035883,1,0.833737112268648,0,26,enteroendocrine cell differentiation,BP,
9992,GO:0035887,1,0.996346806019679,0,1,aortic smooth muscle cell differentiation,BP,
9993,GO:0035890,1,0.81693118541948,0,32,exit from host,BP,
9994,GO:0035891,1,0.81693118541948,0,32,exit from host cell,BP,
9995,GO:0035898,1,0.979846145791849,0,3,parathyroid hormone secretion,BP,
9996,GO:0035900,1,0.96496252635644,0,6,response to isolation stress,BP,
9997,GO:0035902,1,0.876395177099259,0,21,response to immobilization stress,BP,
10001,GO:0035907,1,0.94040295108887,0,10,dorsal aorta development,BP,
10003,GO:0035910,1,0.972630505206953,0,4,ascending aorta morphogenesis,BP,
10004,GO:0035912,1,0.952202659806954,0,8,dorsal aorta morphogenesis,BP,
10005,GO:0035914,1,0.643602707257191,0,61,skeletal muscle cell differentiation,BP,
10006,GO:0035915,1,0.981320052859685,0,4,pore formation in membrane of other organism,BP,
10007,GO:0035921,1,0.995948297340211,0,1,desmosome disassembly,BP,
10008,GO:0035922,1,0.996473790744259,0,1,foramen ovale closure,BP,
10010,GO:0035925,1,0.850736870382373,0,25,mRNA 3'-UTR AU-rich region binding,MF,
10011,GO:0035927,1,0.978625425691317,0,4,RNA import into mitochondrion,BP,
10012,GO:0035928,1,0.984828861146241,0,3,rRNA import into mitochondrion,BP,
10013,GO:0035929,1,0.90873913177304,0,18,steroid hormone secretion,BP,
10014,GO:0035930,1,0.937779072861631,0,13,corticosteroid hormone secretion,BP,
10015,GO:0035931,1,0.980238686368631,0,4,mineralocorticoid secretion,BP,
10016,GO:0035932,1,0.980238686368631,0,4,aldosterone secretion,BP,
10017,GO:0035933,1,0.956692887209563,0,9,glucocorticoid secretion,BP,
10018,GO:0035934,1,0.985447273219306,0,4,corticosterone secretion,BP,
10019,GO:0035935,1,0.993916727593001,0,1,androgen secretion,BP,
10020,GO:0035936,1,0.980797107573696,0,2,testosterone secretion,BP,
10021,GO:0035938,1,0.975918872213509,0,3,estradiol secretion,BP,
10022,GO:0035945,1,0.995378806480956,0,1,mitochondrial ncRNA surveillance,BP,
10023,GO:0035946,1,0.995378806480956,0,1,mitochondrial mRNA surveillance,BP,
10024,GO:0035962,1,0.98420610321212,0,3,response to interleukin-13,BP,
10025,GO:0035963,1,0.98420610321212,0,3,cellular response to interleukin-13,BP,
10026,GO:0035964,1,0.962752766939274,0,6,COPI-coated vesicle budding,BP,
10027,GO:0035965,1,0.96245249870647,0,7,cardiolipin acyl-chain remodeling,BP,
10028,GO:0035966,1,0.309169776640436,0,192,response to topologically incorrect protein,BP,
10029,GO:0035967,1,0.37963191647544,0,154,cellular response to topologically incorrect protein,BP,
10030,GO:0035970,1,0.874412300108282,0,22,peptidyl-threonine dephosphorylation,BP,
10031,GO:0035971,1,0.996711635262835,0,1,peptidyl-histidine dephosphorylation,BP,
10032,GO:0035973,1,0.931123584450572,0,9,aggrephagy,BP,
10033,GO:0035976,1,0.982323223186597,0,4,transcription factor AP-1 complex,CC,
10034,GO:0035977,1,0.967053452277299,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10035,GO:0035978,1,0.990405284308423,0,2,histone H2A-S139 phosphorylation,BP,
10036,GO:0035981,1,0.987902081182098,0,2,tongue muscle cell differentiation,BP,
10037,GO:0035983,1,0.975850574308474,0,3,response to trichostatin A,BP,
10038,GO:0035984,1,0.975850574308474,0,3,cellular response to trichostatin A,BP,
10039,GO:0035985,1,0.983976568799951,0,4,senescence-associated heterochromatin focus,CC,
10040,GO:0035986,1,0.98766949697516,0,3,senescence-associated heterochromatin focus assembly,BP,
10044,GO:0035990,1,0.989074395360057,0,3,tendon cell differentiation,BP,
10045,GO:0035992,1,0.989074395360057,0,3,tendon formation,BP,
10046,GO:0035993,1,0.99208327100826,0,2,deltoid tuberosity development,BP,
10047,GO:0035994,1,0.831113721154684,0,18,response to muscle stretch,BP,
10048,GO:0035995,1,0.932708207471087,0,4,detection of muscle stretch,BP,
10049,GO:0035998,1,0.996124675943206,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10050,GO:0035999,1,0.946418811993818,0,10,tetrahydrofolate interconversion,BP,
10052,GO:0036003,1,0.867986090285807,0,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10053,GO:0036004,1,0.996705497758912,0,1,GAF domain binding,MF,
10054,GO:0036005,1,0.928369136298106,0,12,response to macrophage colony-stimulating factor,BP,
10055,GO:0036006,1,0.928369136298106,0,12,cellular response to macrophage colony-stimulating factor stimulus,BP,
10056,GO:0036009,1,0.987533446159032,0,2,protein-glutamine N-methyltransferase activity,MF,
10057,GO:0036010,1,0.826319464186887,0,23,protein localization to endosome,BP,
10058,GO:0036015,1,0.960180762348876,0,5,response to interleukin-3,BP,
10059,GO:0036016,1,0.960180762348876,0,5,cellular response to interleukin-3,BP,
10060,GO:0036017,1,0.970490028244017,0,7,response to erythropoietin,BP,
10061,GO:0036018,1,0.973514263672632,0,6,cellular response to erythropoietin,BP,
10062,GO:0036019,1,0.867657570745422,0,19,endolysosome,CC,
10063,GO:0036020,1,0.892277640711744,0,14,endolysosome membrane,CC,
10064,GO:0036021,1,0.972438607952632,0,5,endolysosome lumen,CC,
10065,GO:0036022,1,0.986136128796239,0,3,limb joint morphogenesis,BP,
10066,GO:0036023,1,0.986136128796239,0,3,embryonic skeletal limb joint morphogenesis,BP,
10067,GO:0036024,1,0.995644726868416,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10068,GO:0036025,1,0.995644726868416,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10069,GO:0036026,1,0.995644726868416,0,1,protein C inhibitor-PLAT complex,CC,
10070,GO:0036027,1,0.995644726868416,0,1,protein C inhibitor-PLAU complex,CC,
10071,GO:0036028,1,0.995644726868416,0,1,protein C inhibitor-thrombin complex,CC,
10072,GO:0036029,1,0.995644726868416,0,1,protein C inhibitor-KLK3 complex,CC,
10073,GO:0036030,1,0.995644726868416,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10074,GO:0036033,1,0.926581062018918,0,5,mediator complex binding,MF,
10075,GO:0036034,1,0.995595143021993,0,1,mediator complex assembly,BP,
10077,GO:0036037,1,0.865975169294614,0,25,CD8-positive, alpha-beta T cell activation,BP,
10078,GO:0036038,1,0.927662133354606,0,13,MKS complex,CC,
10079,GO:0036041,1,0.958776818043024,0,11,long-chain fatty acid binding,MF,
10080,GO:0036042,1,0.976440654338276,0,6,long-chain fatty acyl-CoA binding,MF,
10081,GO:0036046,1,0.994167889758585,0,1,protein demalonylation,BP,
10082,GO:0036047,1,0.994167889758585,0,1,peptidyl-lysine demalonylation,BP,
10083,GO:0036048,1,0.990560505537069,0,2,protein desuccinylation,BP,
10084,GO:0036049,1,0.990560505537069,0,2,peptidyl-lysine desuccinylation,BP,
10085,GO:0036053,1,0.994984533527118,0,1,glomerular endothelium fenestra,CC,
10086,GO:0036054,1,0.994167889758585,0,1,protein-malonyllysine demalonylase activity,MF,
10087,GO:0036055,1,0.990560505537069,0,2,protein-succinyllysine desuccinylase activity,MF,
10088,GO:0036056,1,0.922761598127636,0,8,filtration diaphragm,CC,
10089,GO:0036057,1,0.922761598127636,0,8,slit diaphragm,CC,
10090,GO:0036058,1,0.992361076617887,0,1,filtration diaphragm assembly,BP,
10091,GO:0036060,1,0.992361076617887,0,1,slit diaphragm assembly,BP,
10092,GO:0036064,1,0.385278151328572,0,136,ciliary basal body,CC,
10094,GO:0036066,1,0.977989694121633,0,4,protein O-linked fucosylation,BP,
10095,GO:0036071,1,0.988250392029905,0,2,N-glycan fucosylation,BP,
10098,GO:0036080,1,0.994048910858054,0,1,purine nucleotide-sugar transmembrane transporter activity,MF,
10099,GO:0036085,1,0.994048910858054,0,1,GDP-fucose import into Golgi lumen,BP,
10100,GO:0036088,1,0.996472587785726,0,1,D-serine catabolic process,BP,
10101,GO:0036089,1,0.953401257762379,0,7,cleavage furrow formation,BP,
10102,GO:0036090,1,0.992110930117105,0,2,cleavage furrow ingression,BP,
10103,GO:0036091,1,0.962923650334942,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10104,GO:0036092,1,0.862143436167301,0,14,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10105,GO:0036093,1,0.976186878386897,0,6,germ cell proliferation,BP,
10107,GO:0036100,1,0.984989957940836,0,3,leukotriene catabolic process,BP,
10108,GO:0036101,1,0.984989957940836,0,3,leukotriene B4 catabolic process,BP,
10109,GO:0036102,1,0.984989957940836,0,3,leukotriene B4 metabolic process,BP,
10110,GO:0036105,1,0.993221115062817,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10111,GO:0036109,1,0.927795538315161,0,12,alpha-linolenic acid metabolic process,BP,
10112,GO:0036111,1,0.988175419646386,0,2,very long-chain fatty-acyl-CoA metabolic process,BP,
10113,GO:0036112,1,0.986133938198274,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10114,GO:0036113,1,0.993112079077958,0,1,very long-chain fatty-acyl-CoA catabolic process,BP,
10115,GO:0036114,1,0.996526733188375,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10116,GO:0036115,1,0.989662497223282,0,2,fatty-acyl-CoA catabolic process,BP,
10117,GO:0036116,1,0.996526733188375,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10118,GO:0036117,1,0.991142114508968,0,2,hyaluranon cable,CC,
10119,GO:0036118,1,0.983565069445738,0,3,hyaluranon cable assembly,BP,
10120,GO:0036119,1,0.850802366906775,0,19,response to platelet-derived growth factor,BP,
10121,GO:0036120,1,0.855490725645148,0,18,cellular response to platelet-derived growth factor stimulus,BP,
10123,GO:0036122,1,0.928080794251129,0,12,BMP binding,MF,
10124,GO:0036123,1,0.968994844154097,0,6,histone H3-K9 dimethylation,BP,
10125,GO:0036124,1,0.882392572238932,0,15,histone H3-K9 trimethylation,BP,
10126,GO:0036125,1,0.994363337712221,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10127,GO:0036126,1,0.580019368893173,0,82,sperm flagellum,CC,
10128,GO:0036128,1,0.964422947280163,0,7,CatSper complex,CC,
10129,GO:0036130,1,0.996708818663127,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10130,GO:0036131,1,0.996708818663127,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10131,GO:0036132,1,0.981541265421032,0,3,13-prostaglandin reductase activity,MF,
10132,GO:0036134,1,0.99592665262467,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10133,GO:0036135,1,0.955512447846212,0,3,Schwann cell migration,BP,
10134,GO:0036137,1,0.991222709709928,0,2,kynurenine aminotransferase activity,MF,
10135,GO:0036138,1,0.986842571051012,0,1,peptidyl-histidine hydroxylation,BP,
10136,GO:0036139,1,0.986842571051012,0,1,peptidyl-histidine dioxygenase activity,MF,
10137,GO:0036140,1,0.986842571051012,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10138,GO:0036143,1,0.99683776361,0,1,kringle domain binding,MF,
10139,GO:0036145,1,0.996311318035166,0,1,dendritic cell homeostasis,BP,
10140,GO:0036146,1,0.994890876864838,0,1,cellular response to mycotoxin,BP,
10146,GO:0036153,1,0.994818479149233,0,1,triglyceride acyl-chain remodeling,BP,
10147,GO:0036155,1,0.971162430847442,0,5,acylglycerol acyl-chain remodeling,BP,
10148,GO:0036156,1,0.938291501834572,0,3,inner dynein arm,CC,
10149,GO:0036157,1,0.872853079585264,0,11,outer dynein arm,CC,
10150,GO:0036158,1,0.863061813452013,0,16,outer dynein arm assembly,BP,
10151,GO:0036159,1,0.917200841308155,0,10,inner dynein arm assembly,BP,
10152,GO:0036164,1,0.996762761383773,0,1,cell-abiotic substrate adhesion,BP,
10153,GO:0036166,1,0.956486805174288,0,6,phenotypic switching,BP,
10154,GO:0036179,1,0.994914214762342,0,1,osteoclast maturation,BP,
10155,GO:0036186,1,0.986456455569275,0,2,early phagosome membrane,CC,
10156,GO:0036194,1,0.989572344867295,0,3,muscle cell projection,CC,
10157,GO:0036195,1,0.989572344867295,0,3,muscle cell projection membrane,CC,
10159,GO:0036213,1,0.995834197106905,0,1,contractile ring contraction,BP,
10160,GO:0036215,1,0.974450501414493,0,3,response to stem cell factor,BP,
10161,GO:0036216,1,0.974450501414493,0,3,cellular response to stem cell factor stimulus,BP,
10162,GO:0036218,1,0.973003787365412,0,4,dTTP diphosphatase activity,MF,
10163,GO:0036219,1,0.996863987862682,0,1,GTP diphosphatase activity,MF,
10164,GO:0036228,1,0.987404891233329,0,2,protein localization to nuclear inner membrane,BP,
10166,GO:0036245,1,0.987316580675693,0,2,cellular response to menadione,BP,
10167,GO:0036250,1,0.996154174627011,0,1,peroxisome transport along microtubule,BP,
10168,GO:0036255,1,0.992783258733263,0,1,response to methylamine,BP,
10169,GO:0036257,1,0.851442941005496,0,31,multivesicular body organization,BP,
10170,GO:0036258,1,0.855874437301081,0,30,multivesicular body assembly,BP,
10171,GO:0036260,1,0.839444564015537,0,32,RNA capping,BP,
10172,GO:0036261,1,0.993051773524531,0,1,7-methylguanosine cap hypermethylation,BP,
10173,GO:0036265,1,0.978149278991764,0,4,RNA (guanine-N7)-methylation,BP,
10174,GO:0036266,1,0.995269658514619,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10175,GO:0036268,1,0.98352665937302,0,1,swimming,BP,
10176,GO:0036269,1,0.984611493537286,0,2,swimming behavior,BP,
10177,GO:0036284,1,0.982109355552044,0,2,tubulobulbar complex,CC,
10178,GO:0036289,1,0.935294210886174,0,8,peptidyl-serine autophosphorylation,BP,
10179,GO:0036290,1,0.99237862664342,0,1,protein trans-autophosphorylation,BP,
10180,GO:0036292,1,0.987166277989912,0,2,DNA rewinding,BP,
10182,GO:0036294,1,0.269541146389154,0,196,cellular response to decreased oxygen levels,BP,
10183,GO:0036295,1,0.921399695811514,0,13,cellular response to increased oxygen levels,BP,
10185,GO:0036297,1,0.733678430094193,0,48,interstrand cross-link repair,BP,
10186,GO:0036298,1,0.988468400750634,0,2,recombinational interstrand cross-link repair,BP,
10187,GO:0036301,1,0.974531293718208,0,5,macrophage colony-stimulating factor production,BP,
10188,GO:0036302,1,0.931170650327817,0,7,atrioventricular canal development,BP,
10190,GO:0036304,1,0.990752547628393,0,2,umbilical cord morphogenesis,BP,
10191,GO:0036306,1,0.996473790744259,0,1,embryonic heart tube elongation,BP,
10192,GO:0036309,1,0.94963600719544,0,2,protein localization to M-band,BP,
10193,GO:0036310,1,0.952251095009343,0,7,annealing helicase activity,MF,
10194,GO:0036312,1,0.913354663536513,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10195,GO:0036313,1,0.995460400409346,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10196,GO:0036314,1,0.773360030656609,0,29,response to sterol,BP,
10197,GO:0036315,1,0.834655055232905,0,21,cellular response to sterol,BP,
10198,GO:0036316,1,0.990227913712574,0,2,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10199,GO:0036317,1,0.994890876864838,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10200,GO:0036321,1,0.994890876864838,0,1,ghrelin secretion,BP,
10201,GO:0036323,1,0.990927651029464,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10202,GO:0036324,1,0.966158930219016,0,5,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10203,GO:0036325,1,0.995734083199775,0,1,vascular endothelial growth factor receptor-3 signaling pathway,BP,
10204,GO:0036326,1,0.990927651029464,0,1,VEGF-A-activated receptor activity,MF,
10205,GO:0036327,1,0.990927651029464,0,1,VEGF-B-activated receptor activity,MF,
10206,GO:0036328,1,0.990030295030602,0,1,VEGF-C-activated receptor activity,MF,
10207,GO:0036331,1,0.995755588300367,0,1,avascular cornea development in camera-type eye,BP,
10208,GO:0036332,1,0.990927651029464,0,1,placental growth factor-activated receptor activity,MF,
10209,GO:0036333,1,0.995129267614303,0,1,hepatocyte homeostasis,BP,
10211,GO:0036336,1,0.845484767324426,0,28,dendritic cell migration,BP,
10212,GO:0036337,1,0.963758737713265,0,5,Fas signaling pathway,BP,
10213,GO:0036342,1,0.871620822975902,0,17,post-anal tail morphogenesis,BP,
10214,GO:0036343,1,0.981495432809216,0,4,psychomotor behavior,BP,
10215,GO:0036344,1,0.83912984276735,0,21,platelet morphogenesis,BP,
10216,GO:0036345,1,0.991079976352869,0,2,platelet maturation,BP,
10217,GO:0036351,1,0.995640254826544,0,1,histone H2A-K13 ubiquitination,BP,
10218,GO:0036352,1,0.995640254826544,0,1,histone H2A-K15 ubiquitination,BP,
10219,GO:0036353,1,0.948382948034988,0,7,histone H2A-K119 monoubiquitination,BP,
10220,GO:0036359,1,0.99618078585442,0,1,renal potassium excretion,BP,
10221,GO:0036361,1,0.995385273459009,0,1,racemase activity, acting on amino acids and derivatives,MF,
10222,GO:0036363,1,0.923842193119181,0,9,transforming growth factor beta activation,BP,
10223,GO:0036364,1,0.986962921374708,0,2,transforming growth factor beta1 activation,BP,
10224,GO:0036366,1,0.991898443755878,0,1,transforming growth factor beta3 activation,BP,
10225,GO:0036369,1,0.951444102294106,0,5,transcription factor catabolic process,BP,
10226,GO:0036371,1,0.980669052499577,0,2,protein localization to T-tubule,BP,
10227,GO:0036372,1,0.996804725427978,0,1,opsin transport,BP,
10228,GO:0036373,1,0.994890876864838,0,1,L-fucose mutarotase activity,MF,
10229,GO:0036374,1,0.986085166569851,0,3,glutathione hydrolase activity,MF,
10231,GO:0036378,1,0.98754902529037,0,3,calcitriol biosynthetic process from calciol,BP,
10232,GO:0036379,1,0.862735435765672,0,25,myofilament,CC,
10233,GO:0036387,1,0.987608765942062,0,3,pre-replicative complex,CC,
10234,GO:0036388,1,0.954881290425402,0,8,pre-replicative complex assembly,BP,
10235,GO:0036392,1,0.99301744437563,0,1,chemokine (C-C motif) ligand 20 production,BP,
10236,GO:0036393,1,0.994656215564022,0,1,thiocyanate peroxidase activity,MF,
10237,GO:0036396,1,0.962144357929145,0,6,RNA N6-methyladenosine methyltransferase complex,CC,
10238,GO:0036398,1,0.995452484364715,0,1,TCR signalosome,CC,
10239,GO:0036402,1,0.989660903279253,0,3,proteasome-activating ATPase activity,MF,
10240,GO:0036403,1,0.995140422678749,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10241,GO:0036404,1,0.981019644985119,0,1,conversion of ds siRNA to ss siRNA,BP,
10242,GO:0036409,1,0.986116879988821,0,2,histone H3-K14 acetyltransferase complex,CC,
10243,GO:0036413,1,0.987397667830043,0,2,histone H3-R26 citrullination,BP,
10244,GO:0036414,1,0.974400133486073,0,4,histone citrullination,BP,
10245,GO:0036415,1,0.980710210597217,0,2,regulation of tRNA stability,BP,
10246,GO:0036416,1,0.980710210597217,0,2,tRNA stabilization,BP,
10247,GO:0036435,1,0.979631316521498,0,4,K48-linked polyubiquitin modification-dependent protein binding,MF,
10248,GO:0036438,1,0.975500394691437,0,4,maintenance of lens transparency,BP,
10249,GO:0036440,1,0.994495870857179,0,1,citrate synthase activity,MF,
10250,GO:0036444,1,0.942379311800716,0,10,calcium import into the mitochondrion,BP,
10251,GO:0036446,1,0.966113466096013,0,4,myofibroblast differentiation,BP,
10252,GO:0036449,1,0.917558631562825,0,7,microtubule minus-end,CC,
10253,GO:0036451,1,0.989807596705769,0,2,cap mRNA methylation,BP,
10254,GO:0036452,1,0.877570684376226,0,26,ESCRT complex,CC,
10255,GO:0036454,1,0.962747919401926,0,5,growth factor complex,CC,
10256,GO:0036456,1,0.996560523616724,0,1,L-methionine-(S)-S-oxide reductase activity,MF,
10257,GO:0036457,1,0.977080948219234,0,1,keratohyalin granule,CC,
10259,GO:0036461,1,0.993342268883176,0,2,BLOC-2 complex binding,MF,
10260,GO:0036462,1,0.927660140327877,0,10,TRAIL-activated apoptotic signaling pathway,BP,
10263,GO:0036466,1,0.946827170845616,0,6,synaptic vesicle recycling via endosome,BP,
10264,GO:0036468,1,0.996044143436566,0,1,L-dopa decarboxylase activity,MF,
10265,GO:0036470,1,0.996816752933256,0,1,tyrosine 3-monooxygenase activator activity,MF,
10266,GO:0036471,1,0.996816752933256,0,1,cellular response to glyoxal,BP,
10267,GO:0036473,1,0.596776028939438,0,78,cell death in response to oxidative stress,BP,
10268,GO:0036474,1,0.857599091097275,0,25,cell death in response to hydrogen peroxide,BP,
10269,GO:0036475,1,0.815234571373096,0,26,neuron death in response to oxidative stress,BP,
10270,GO:0036476,1,0.978334678085685,0,4,neuron death in response to hydrogen peroxide,BP,
10272,GO:0036478,1,0.996816752933256,0,1,L-dopa decarboxylase activator activity,MF,
10273,GO:0036479,1,0.982701323297205,0,1,peroxidase inhibitor activity,MF,
10274,GO:0036480,1,0.957474397277865,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10275,GO:0036481,1,0.980262188210495,0,5,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10276,GO:0036482,1,0.991912302106463,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10277,GO:0036483,1,0.991286638937457,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10278,GO:0036484,1,0.968004815928309,0,4,trunk neural crest cell migration,BP,
10279,GO:0036486,1,0.968004815928309,0,4,ventral trunk neural crest cell migration,BP,
10280,GO:0036487,1,0.98344653483578,0,1,nitric-oxide synthase inhibitor activity,MF,
10281,GO:0036488,1,0.99309348289589,0,2,CHOP-C/EBP complex,CC,
10282,GO:0036490,1,0.922909122346894,0,10,regulation of translation in response to endoplasmic reticulum stress,BP,
10283,GO:0036491,1,0.948204091994742,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10284,GO:0036492,1,0.952451071390733,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10285,GO:0036493,1,0.961338068470961,0,5,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10286,GO:0036494,1,0.989302011196474,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10287,GO:0036496,1,0.992126359745183,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10288,GO:0036497,1,0.995543168677913,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10289,GO:0036498,1,0.664118483931254,0,62,IRE1-mediated unfolded protein response,BP,
10290,GO:0036499,1,0.893231731383412,0,20,PERK-mediated unfolded protein response,BP,
10291,GO:0036500,1,0.944718832872875,0,10,ATF6-mediated unfolded protein response,BP,
10292,GO:0036501,1,0.991626653633151,0,1,UFD1-NPL4 complex,CC,
10293,GO:0036502,1,0.994201377378724,0,1,Derlin-1-VIMP complex,CC,
10294,GO:0036503,1,0.553237237072632,0,92,ERAD pathway,BP,
10295,GO:0036505,1,0.990001065721066,0,2,prosaposin receptor activity,MF,
10296,GO:0036506,1,0.975991511590566,0,3,maintenance of unfolded protein,BP,
10297,GO:0036507,1,0.855632820851193,0,19,protein demannosylation,BP,
10298,GO:0036508,1,0.855632820851193,0,19,protein alpha-1,2-demannosylation,BP,
10299,GO:0036509,1,0.991128217121357,0,2,trimming of terminal mannose on B branch,BP,
10300,GO:0036510,1,0.979462151116559,0,3,trimming of terminal mannose on C branch,BP,
10301,GO:0036511,1,0.991128217121357,0,2,trimming of first mannose on A branch,BP,
10302,GO:0036512,1,0.991128217121357,0,2,trimming of second mannose on A branch,BP,
10303,GO:0036513,1,0.953030919745599,0,7,Derlin-1 retrotranslocation complex,CC,
10304,GO:0036514,1,0.945166622944493,0,5,dopaminergic neuron axon guidance,BP,
10305,GO:0036515,1,0.950334181057058,0,4,serotonergic neuron axon guidance,BP,
10306,GO:0036517,1,0.988831518817606,0,1,chemoattraction of serotonergic neuron axon,BP,
10307,GO:0036518,1,0.983456753584044,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10308,GO:0036520,1,0.985385778535856,0,2,astrocyte-dopaminergic neuron signaling,BP,
10309,GO:0036524,1,0.996816752933256,0,1,protein deglycase activity,MF,
10310,GO:0036525,1,0.99342068186381,0,2,protein deglycation,BP,
10311,GO:0036526,1,0.996816752933256,0,1,peptidyl-cysteine deglycation,BP,
10312,GO:0036527,1,0.996816752933256,0,1,peptidyl-arginine deglycation,BP,
10313,GO:0036528,1,0.996816752933256,0,1,peptidyl-lysine deglycation,BP,
10314,GO:0036529,1,0.996816752933256,0,1,protein deglycation, glyoxal removal,BP,
10315,GO:0036530,1,0.996816752933256,0,1,protein deglycation, methylglyoxal removal,BP,
10316,GO:0036531,1,0.996816752933256,0,1,glutathione deglycation,BP,
10317,GO:0038001,1,0.954098599837088,0,4,paracrine signaling,BP,
10318,GO:0038002,1,0.989733782929855,0,1,endocrine signaling,BP,
10319,GO:0038003,1,0.940475717170521,0,12,opioid receptor signaling pathway,BP,
10320,GO:0038007,1,0.8971040754703,0,12,netrin-activated signaling pathway,BP,
10321,GO:0038009,1,0.996632930809694,0,1,regulation of signal transduction by receptor internalization,BP,
10322,GO:0038016,1,0.988612859940566,0,2,insulin receptor internalization,BP,
10323,GO:0038018,1,0.978913547323238,0,2,Wnt receptor catabolic process,BP,
10324,GO:0038020,1,0.979882779840803,0,1,insulin receptor recycling,BP,
10325,GO:0038021,1,0.991885250068072,0,1,leptin receptor activity,MF,
10328,GO:0038025,1,0.985255039343967,0,2,reelin receptor activity,MF,
10329,GO:0038026,1,0.934514207964113,0,7,reelin-mediated signaling pathway,BP,
10330,GO:0038027,1,0.942515156232412,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10331,GO:0038028,1,0.972848155602197,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10332,GO:0038030,1,0.95072207593164,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10333,GO:0038031,1,0.957788605601984,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10334,GO:0038033,1,0.9660821488775,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10335,GO:0038034,1,0.650857479139403,0,69,signal transduction in absence of ligand,BP,
10336,GO:0038036,1,0.959626305773193,0,8,sphingosine-1-phosphate receptor activity,MF,
10337,GO:0038037,1,0.944693670627792,0,7,G protein-coupled receptor dimeric complex,CC,
10338,GO:0038038,1,0.98686622107031,0,1,G protein-coupled receptor homodimeric complex,CC,
10339,GO:0038039,1,0.972851644278321,0,3,G protein-coupled receptor heterodimeric complex,CC,
10340,GO:0038041,1,0.989889285530179,0,2,cross-receptor inhibition within G protein-coupled receptor heterodimer,BP,
10341,GO:0038043,1,0.986789675242692,0,2,interleukin-5-mediated signaling pathway,BP,
10342,GO:0038046,1,0.996320202304473,0,1,enkephalin receptor activity,MF,
10343,GO:0038047,1,0.996224256177234,0,1,morphine receptor activity,MF,
10344,GO:0038048,1,0.990506346822206,0,1,dynorphin receptor activity,MF,
10345,GO:0038060,1,0.99378130158399,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10347,GO:0038062,1,0.982269824706772,0,3,protein tyrosine kinase collagen receptor activity,MF,
10349,GO:0038064,1,0.955046833820964,0,6,collagen receptor activity,MF,
10351,GO:0038066,1,0.752344889321366,0,43,p38MAPK cascade,BP,
10352,GO:0038083,1,0.740335244798508,0,40,peptidyl-tyrosine autophosphorylation,BP,
10353,GO:0038084,1,0.771499606371751,0,34,vascular endothelial growth factor signaling pathway,BP,
10354,GO:0038085,1,0.957435969174779,0,5,vascular endothelial growth factor binding,MF,
10355,GO:0038086,1,0.970172075488939,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10356,GO:0038089,1,0.943036486170686,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10357,GO:0038091,1,0.970172075488939,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10358,GO:0038092,1,0.907990408009769,0,15,nodal signaling pathway,BP,
10359,GO:0038093,1,0.345389893143367,0,171,Fc receptor signaling pathway,BP,
10360,GO:0038094,1,0.593284442463072,0,78,Fc-gamma receptor signaling pathway,BP,
10361,GO:0038095,1,0.531452975848422,0,106,Fc-epsilon receptor signaling pathway,BP,
10362,GO:0038096,1,0.599957710242831,0,75,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10363,GO:0038097,1,0.989827300380563,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10364,GO:0038098,1,0.980360532474393,0,3,sequestering of BMP from receptor via BMP binding,BP,
10365,GO:0038100,1,0.976702963261685,0,3,nodal binding,MF,
10366,GO:0038101,1,0.996361438866745,0,1,sequestering of nodal from receptor via nodal binding,BP,
10367,GO:0038102,1,0.988006208624421,0,2,activin receptor antagonist activity,MF,
10368,GO:0038107,1,0.959035524809359,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10369,GO:0038108,1,0.979104504856481,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10370,GO:0038109,1,0.974450501414493,0,3,Kit signaling pathway,BP,
10371,GO:0038110,1,0.9199921729808,0,11,interleukin-2-mediated signaling pathway,BP,
10372,GO:0038111,1,0.876148091865351,0,16,interleukin-7-mediated signaling pathway,BP,
10373,GO:0038112,1,0.990307725036389,0,2,interleukin-8-mediated signaling pathway,BP,
10374,GO:0038113,1,0.943552190505169,0,7,interleukin-9-mediated signaling pathway,BP,
10375,GO:0038114,1,0.95004693473562,0,7,interleukin-21-mediated signaling pathway,BP,
10376,GO:0038115,1,0.995850691831409,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10377,GO:0038116,1,0.965306980225402,0,4,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10378,GO:0038117,1,0.995850691831409,0,1,C-C motif chemokine 19 receptor activity,MF,
10379,GO:0038118,1,0.996780194014668,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10380,GO:0038121,1,0.995850691831409,0,1,C-C motif chemokine 21 receptor activity,MF,
10381,GO:0038123,1,0.979940587464541,0,4,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10382,GO:0038124,1,0.97510610239375,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10384,GO:0038128,1,0.78764212998323,0,31,ERBB2 signaling pathway,BP,
10385,GO:0038129,1,0.987060378506456,0,3,ERBB3 signaling pathway,BP,
10386,GO:0038131,1,0.990083803524937,0,2,neuregulin receptor activity,MF,
10387,GO:0038132,1,0.950259963320426,0,5,neuregulin binding,MF,
10388,GO:0038133,1,0.99601864458745,0,1,ERBB2-ERBB3 signaling pathway,BP,
10389,GO:0038143,1,0.984873071874998,0,2,ERBB3:ERBB2 complex,CC,
10390,GO:0038145,1,0.968255782113779,0,6,macrophage colony-stimulating factor signaling pathway,BP,
10391,GO:0038146,1,0.977877122008298,0,4,chemokine (C-X-C motif) ligand 12 signaling pathway,BP,
10392,GO:0038147,1,0.996312309476783,0,1,C-X-C motif chemokine 12 receptor activity,MF,
10393,GO:0038154,1,0.982696711158895,0,3,interleukin-11-mediated signaling pathway,BP,
10394,GO:0038155,1,0.955981396592616,0,7,interleukin-23-mediated signaling pathway,BP,
10395,GO:0038156,1,0.978096268447515,0,3,interleukin-3-mediated signaling pathway,BP,
10396,GO:0038158,1,0.9899700490704,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10397,GO:0038159,1,0.996312309476783,0,1,C-X-C chemokine receptor CXCR4 signaling pathway,BP,
10398,GO:0038160,1,0.996312309476783,0,1,CXCL12-activated CXCR4 signaling pathway,BP,
10399,GO:0038161,1,0.973561952093909,0,2,prolactin signaling pathway,BP,
10400,GO:0038162,1,0.983047723939376,0,3,erythropoietin-mediated signaling pathway,BP,
10401,GO:0038163,1,0.96983932064997,0,5,thrombopoietin-mediated signaling pathway,BP,
10402,GO:0038164,1,0.993149485559078,0,1,thrombopoietin receptor activity,MF,
10403,GO:0038165,1,0.937142470103794,0,6,oncostatin-M-mediated signaling pathway,BP,
10405,GO:0038167,1,0.989731876440067,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10406,GO:0038168,1,0.989731876440067,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10407,GO:0038169,1,0.979425588712903,0,4,somatostatin receptor signaling pathway,BP,
10408,GO:0038170,1,0.979425588712903,0,4,somatostatin signaling pathway,BP,
10410,GO:0038172,1,0.98369828579251,0,3,interleukin-33-mediated signaling pathway,BP,
10411,GO:0038177,1,0.996728183092656,0,1,death receptor agonist activity,MF,
10412,GO:0038178,1,0.990520338127412,0,2,complement component C5a signaling pathway,BP,
10413,GO:0038179,1,0.760553032123593,0,37,neurotrophin signaling pathway,BP,
10414,GO:0038180,1,0.909044134643163,0,12,nerve growth factor signaling pathway,BP,
10415,GO:0038181,1,0.983490594025539,0,3,bile acid receptor activity,MF,
10416,GO:0038182,1,0.996554283641674,0,1,G protein-coupled bile acid receptor activity,MF,
10417,GO:0038183,1,0.983490594025539,0,3,bile acid signaling pathway,BP,
10418,GO:0038184,1,0.996554283641674,0,1,cell surface bile acid receptor signaling pathway,BP,
10419,GO:0038185,1,0.995877903634853,0,1,intracellular bile acid receptor signaling pathway,BP,
10420,GO:0038186,1,0.990976863750293,0,1,lithocholic acid receptor activity,MF,
10421,GO:0038187,1,0.879078227401852,0,20,pattern recognition receptor activity,MF,
10422,GO:0038188,1,0.992336824435793,0,2,cholecystokinin signaling pathway,BP,
10423,GO:0038189,1,0.974094953034559,0,4,neuropilin signaling pathway,BP,
10424,GO:0038190,1,0.988827105241573,0,2,VEGF-activated neuropilin signaling pathway,BP,
10425,GO:0038191,1,0.962621100316166,0,4,neuropilin binding,MF,
10426,GO:0038192,1,0.99602864251893,0,1,gastric inhibitory peptide signaling pathway,BP,
10427,GO:0038193,1,0.995708758401878,0,1,thromboxane A2 signaling pathway,BP,
10428,GO:0038194,1,0.989414830352707,0,2,thyroid-stimulating hormone signaling pathway,BP,
10429,GO:0038195,1,0.996589959106216,0,1,urokinase plasminogen activator signaling pathway,BP,
10430,GO:0038201,1,0.869755281927264,0,15,TOR complex,CC,
10431,GO:0038202,1,0.742814136038913,0,39,TORC1 signaling,BP,
10432,GO:0038203,1,0.95106641996256,0,8,TORC2 signaling,BP,
10433,GO:0039003,1,0.984941557444264,0,2,pronephric field specification,BP,
10434,GO:0039007,1,0.98936724836986,0,1,pronephric nephron morphogenesis,BP,
10435,GO:0039008,1,0.98936724836986,0,1,pronephric nephron tubule morphogenesis,BP,
10436,GO:0039017,1,0.984941557444264,0,2,pattern specification involved in pronephros development,BP,
10437,GO:0039019,1,0.982607350793933,0,2,pronephric nephron development,BP,
10438,GO:0039020,1,0.98936724836986,0,1,pronephric nephron tubule development,BP,
10439,GO:0039022,1,0.98936724836986,0,1,pronephric duct development,BP,
10440,GO:0039023,1,0.98936724836986,0,1,pronephric duct morphogenesis,BP,
10441,GO:0039506,1,0.984971511734398,0,2,modulation by virus of host molecular function,BP,
10442,GO:0039507,1,0.984971511734398,0,2,suppression by virus of host molecular function,BP,
10443,GO:0039513,1,0.994905249923337,0,1,suppression by virus of host catalytic activity,BP,
10444,GO:0039514,1,0.990015900056417,0,1,suppression by virus of host JAK-STAT cascade,BP,
10445,GO:0039516,1,0.994905249923337,0,1,modulation by virus of host catalytic activity,BP,
10446,GO:0039519,1,0.976612895330297,0,3,modulation by virus of host autophagy,BP,
10447,GO:0039520,1,0.986009519135288,0,2,induction by virus of host autophagy,BP,
10448,GO:0039521,1,0.990471382129943,0,1,suppression by virus of host autophagy,BP,
10449,GO:0039526,1,0.977842523590998,0,4,modulation by virus of host apoptotic process,BP,
10450,GO:0039528,1,0.833374963901433,0,25,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10451,GO:0039529,1,0.855010972473359,0,20,RIG-I signaling pathway,BP,
10452,GO:0039530,1,0.943197756632649,0,8,MDA-5 signaling pathway,BP,
10453,GO:0039531,1,0.873623658402953,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10454,GO:0039532,1,0.941155171889492,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10455,GO:0039533,1,0.956380668646392,0,5,regulation of MDA-5 signaling pathway,BP,
10456,GO:0039534,1,0.984299428814491,0,3,negative regulation of MDA-5 signaling pathway,BP,
10457,GO:0039535,1,0.883931122409228,0,14,regulation of RIG-I signaling pathway,BP,
10458,GO:0039536,1,0.952251102030974,0,7,negative regulation of RIG-I signaling pathway,BP,
10459,GO:0039552,1,0.974648364248595,0,3,RIG-I binding,MF,
10460,GO:0039562,1,0.990015900056417,0,1,suppression by virus of host STAT activity,BP,
10461,GO:0039563,1,0.990015900056417,0,1,suppression by virus of host STAT1 activity,BP,
10462,GO:0039564,1,0.990015900056417,0,1,suppression by virus of host STAT2 activity,BP,
10463,GO:0039650,1,0.994905249923337,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10464,GO:0039654,1,0.994890876864838,0,1,fusion of virus membrane with host endosome membrane,BP,
10465,GO:0039656,1,0.98538470128493,0,3,modulation by virus of host gene expression,BP,
10466,GO:0039663,1,0.966177275585539,0,7,membrane fusion involved in viral entry into host cell,BP,
10467,GO:0039689,1,0.983629026160077,0,3,negative stranded viral RNA replication,BP,
10468,GO:0039692,1,0.901297083569344,0,18,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10469,GO:0039694,1,0.812192248348062,0,33,viral RNA genome replication,BP,
10470,GO:0039695,1,0.991157614917294,0,1,DNA-templated viral transcription,BP,
10471,GO:0039702,1,0.902295901183505,0,21,viral budding via host ESCRT complex,BP,
10472,GO:0039706,1,0.930447597298318,0,11,co-receptor binding,MF,
10473,GO:0039713,1,0.993584388881114,0,1,viral factory,CC,
10474,GO:0039714,1,0.993584388881114,0,1,cytoplasmic viral factory,CC,
10475,GO:0040001,1,0.766218129832859,0,35,establishment of mitotic spindle localization,BP,
10478,GO:0040009,1,0.939103100421371,0,6,regulation of growth rate,BP,
10479,GO:0040010,1,0.99133122111093,0,2,positive regulation of growth rate,BP,
10485,GO:0040016,1,0.961724475439709,0,5,embryonic cleavage,BP,
10487,GO:0040018,1,0.792969451834392,0,30,positive regulation of multicellular organism growth,BP,
10488,GO:0040019,1,0.782046307571753,0,31,positive regulation of embryonic development,BP,
10490,GO:0040029,1,0.378846424035152,0,129,regulation of gene expression, epigenetic,BP,
10491,GO:0040030,1,0.989757508266244,0,2,regulation of molecular function, epigenetic,BP,
10492,GO:0040031,1,0.968080566511823,0,7,snRNA modification,BP,
10493,GO:0040032,1,0.996194160024034,0,1,post-embryonic body morphogenesis,BP,
10494,GO:0040033,1,0.874153819342272,0,14,negative regulation of translation, ncRNA-mediated,BP,
10495,GO:0040034,1,0.918408401742845,0,13,regulation of development, heterochronic,BP,
10496,GO:0040036,1,0.81999763951166,0,28,regulation of fibroblast growth factor receptor signaling pathway,BP,
10497,GO:0040037,1,0.887946362735801,0,16,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10498,GO:0040038,1,0.971575321337541,0,3,polar body extrusion after meiotic divisions,BP,
10499,GO:0040040,1,0.988394253543796,0,1,thermosensory behavior,BP,
10500,GO:0042000,1,0.995487961521597,0,1,translocation of peptides or proteins into host,BP,
10501,GO:0042007,1,0.990037493868492,0,2,interleukin-18 binding,MF,
10502,GO:0042008,1,0.988507432151851,0,2,interleukin-18 receptor activity,MF,
10503,GO:0042010,1,0.985276255370179,0,3,interleukin-15 receptor activity,MF,
10504,GO:0042011,1,0.994252392499678,0,1,interleukin-16 binding,MF,
10505,GO:0042012,1,0.994252392499678,0,1,interleukin-16 receptor activity,MF,
10506,GO:0042015,1,0.984018080068087,0,3,interleukin-20 binding,MF,
10507,GO:0042019,1,0.990047888983974,0,2,interleukin-23 binding,MF,
10508,GO:0042020,1,0.996085552851057,0,1,interleukin-23 receptor activity,MF,
10509,GO:0042022,1,0.990047888983974,0,2,interleukin-12 receptor complex,CC,
10510,GO:0042023,1,0.96722406787565,0,5,DNA endoreduplication,BP,
10511,GO:0042025,1,0.951233113132574,0,6,host cell nucleus,CC,
10512,GO:0042026,1,0.892914597334592,0,22,protein refolding,BP,
10513,GO:0042030,1,0.957184663500073,0,4,ATPase inhibitor activity,MF,
10514,GO:0042033,1,0.996744158135859,0,1,chemokine biosynthetic process,BP,
10515,GO:0042035,1,0.895631873749342,0,14,regulation of cytokine biosynthetic process,BP,
10516,GO:0042036,1,0.963230568020319,0,5,negative regulation of cytokine biosynthetic process,BP,
10517,GO:0042038,1,0.994890876864838,0,1,peptidyl-histidine methylation, to form tele-methylhistidine,BP,
10518,GO:0042040,1,0.991875105213165,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10519,GO:0042043,1,0.891578770267412,0,14,neurexin family protein binding,MF,
10520,GO:0042044,1,0.860722702937445,0,24,fluid transport,BP,
10521,GO:0042045,1,0.932193890322566,0,8,epithelial fluid transport,BP,
10523,GO:0042053,1,0.900387692624763,0,18,regulation of dopamine metabolic process,BP,
10524,GO:0042054,1,0.666879825828192,0,53,histone methyltransferase activity,MF,
10525,GO:0042056,1,0.891132677024169,0,23,chemoattractant activity,MF,
10530,GO:0042069,1,0.900387692624763,0,18,regulation of catecholamine metabolic process,BP,
10531,GO:0042073,1,0.690123521845537,0,49,intraciliary transport,BP,
10532,GO:0042074,1,0.896521834113939,0,14,cell migration involved in gastrulation,BP,
10533,GO:0042078,1,0.98465475988784,0,3,germ-line stem cell division,BP,
10534,GO:0042083,1,0.996485303877563,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10535,GO:0042084,1,0.98050431534504,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10537,GO:0042089,1,0.877854822748483,0,18,cytokine biosynthetic process,BP,
10541,GO:0042100,1,0.63374406204266,0,74,B cell proliferation,BP,
10542,GO:0042101,1,0.920498469818224,0,17,T cell receptor complex,CC,
10545,GO:0042105,1,0.982328088219151,0,5,alpha-beta T cell receptor complex,CC,
10546,GO:0042107,1,0.874410325682243,0,19,cytokine metabolic process,BP,
10547,GO:0042108,1,0.976601209701713,0,3,positive regulation of cytokine biosynthetic process,BP,
10549,GO:0042113,1,0.229967183160288,0,219,B cell activation,BP,
10550,GO:0042116,1,0.545754342853702,0,87,macrophage activation,BP,
10551,GO:0042117,1,0.943029889115448,0,9,monocyte activation,BP,
10552,GO:0042118,1,0.935467844780804,0,9,endothelial cell activation,BP,
10554,GO:0042126,1,0.991898507720442,0,2,nitrate metabolic process,BP,
10557,GO:0042130,1,0.722876923571289,0,58,negative regulation of T cell proliferation,BP,
10558,GO:0042132,1,0.996519718586635,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10559,GO:0042133,1,0.844328111161492,0,28,neurotransmitter metabolic process,BP,
10560,GO:0042135,1,0.933933869693977,0,11,neurotransmitter catabolic process,BP,
10561,GO:0042136,1,0.906090139319228,0,16,neurotransmitter biosynthetic process,BP,
10563,GO:0042138,1,0.979057499116666,0,3,meiotic DNA double-strand break formation,BP,
10564,GO:0042140,1,0.994890876864838,0,1,late meiotic recombination nodule assembly,BP,
10565,GO:0042144,1,0.978664456667195,0,5,vacuole fusion, non-autophagic,BP,
10566,GO:0042147,1,0.545850450577983,0,79,retrograde transport, endosome to Golgi,BP,
10567,GO:0042148,1,0.969969425552829,0,5,strand invasion,BP,
10568,GO:0042149,1,0.725219531232975,0,47,cellular response to glucose starvation,BP,
10569,GO:0042157,1,0.435834951768799,0,125,lipoprotein metabolic process,BP,
10570,GO:0042158,1,0.56071041674517,0,93,lipoprotein biosynthetic process,BP,
10571,GO:0042159,1,0.89266057998265,0,15,lipoprotein catabolic process,BP,
10572,GO:0042160,1,0.990387349745261,0,2,lipoprotein modification,BP,
10573,GO:0042161,1,0.990387349745261,0,2,lipoprotein oxidation,BP,
10574,GO:0042162,1,0.775539885286244,0,35,telomeric DNA binding,MF,
10575,GO:0042163,1,0.996590607678115,0,1,interleukin-12 beta subunit binding,MF,
10577,GO:0042166,1,0.932109592327542,0,12,acetylcholine binding,MF,
10578,GO:0042167,1,0.986535555165494,0,4,heme catabolic process,BP,
10579,GO:0042168,1,0.85346244622811,0,28,heme metabolic process,BP,
10580,GO:0042169,1,0.724312993912268,0,40,SH2 domain binding,MF,
10581,GO:0042171,1,0.886830802571102,0,16,lysophosphatidic acid acyltransferase activity,MF,
10585,GO:0042178,1,0.947396731948182,0,11,xenobiotic catabolic process,BP,
10588,GO:0042182,1,0.955660704152238,0,10,ketone catabolic process,BP,
10589,GO:0042197,1,0.996413914265722,0,1,halogenated hydrocarbon metabolic process,BP,
10590,GO:0042214,1,0.98586443082052,0,3,terpene metabolic process,BP,
10591,GO:0042218,1,0.99602614868032,0,1,1-aminocyclopropane-1-carboxylate biosynthetic process,BP,
10592,GO:0042219,1,0.867405722216629,0,26,cellular modified amino acid catabolic process,BP,
10593,GO:0042220,1,0.737106927356323,0,44,response to cocaine,BP,
10595,GO:0042245,1,0.987069336780103,0,2,RNA repair,BP,
10597,GO:0042247,1,0.994574578198833,0,1,establishment of planar polarity of follicular epithelium,BP,
10598,GO:0042249,1,0.870602282051608,0,17,establishment of planar polarity of embryonic epithelium,BP,
10599,GO:0042253,1,0.985318964913067,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10600,GO:0042254,1,0.212294519024174,0,277,ribosome biogenesis,BP,
10601,GO:0042255,1,0.739387450148216,0,57,ribosome assembly,BP,
10602,GO:0042256,1,0.971458377267894,0,5,mature ribosome assembly,BP,
10603,GO:0042262,1,0.981802462628913,0,5,DNA protection,BP,
10604,GO:0042264,1,0.980119222251195,0,2,peptidyl-aspartic acid hydroxylation,BP,
10605,GO:0042265,1,0.986842571051012,0,1,peptidyl-asparagine hydroxylation,BP,
10606,GO:0042267,1,0.759877114353105,0,51,natural killer cell mediated cytotoxicity,BP,
10607,GO:0042268,1,0.992080259617092,0,2,regulation of cytolysis,BP,
10608,GO:0042269,1,0.834511489585068,0,35,regulation of natural killer cell mediated cytotoxicity,BP,
10609,GO:0042270,1,0.978210180893258,0,5,protection from natural killer cell mediated cytotoxicity,BP,
10610,GO:0042271,1,0.980945346377737,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
10611,GO:0042272,1,0.996176857639559,0,1,nuclear RNA export factor complex,CC,
10612,GO:0042273,1,0.703572221285125,0,66,ribosomal large subunit biogenesis,BP,
10613,GO:0042274,1,0.689758754248204,0,68,ribosomal small subunit biogenesis,BP,
10614,GO:0042275,1,0.996533661575493,0,1,error-free postreplication DNA repair,BP,
10615,GO:0042276,1,0.871929182833887,0,21,error-prone translesion synthesis,BP,
10617,GO:0042278,1,0.711956047996293,0,56,purine nucleoside metabolic process,BP,
10618,GO:0042281,1,0.993708077669485,0,1,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10619,GO:0042282,1,0.99137827023303,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10620,GO:0042283,1,0.996375352993221,0,1,dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10621,GO:0042284,1,0.992862510152036,0,2,sphingolipid delta-4 desaturase activity,MF,
10622,GO:0042285,1,0.949100276595635,0,6,xylosyltransferase activity,MF,
10623,GO:0042287,1,0.86899947079623,0,28,MHC protein binding,MF,
10624,GO:0042288,1,0.91162353332891,0,18,MHC class I protein binding,MF,
10625,GO:0042289,1,0.970394031696973,0,6,MHC class II protein binding,MF,
10626,GO:0042292,1,0.995427030370975,0,1,URM1 activating enzyme activity,MF,
10627,GO:0042296,1,0.983133126467005,0,4,ISG15 transferase activity,MF,
10629,GO:0042300,1,0.991894383511468,0,1,beta-amyrin synthase activity,MF,
10630,GO:0042301,1,0.941490515171105,0,10,phosphate ion binding,MF,
10631,GO:0042303,1,0.480495145188782,0,97,molting cycle,BP,
10633,GO:0042306,1,0.653844264987433,0,56,regulation of protein import into nucleus,BP,
10634,GO:0042307,1,0.734196349668781,0,39,positive regulation of protein import into nucleus,BP,
10635,GO:0042308,1,0.910537573284156,0,13,negative regulation of protein import into nucleus,BP,
10636,GO:0042309,1,0.994892675463082,0,1,homoiothermy,BP,
10638,GO:0042311,1,0.842123937686096,0,29,vasodilation,BP,
10639,GO:0042313,1,0.995946339837785,0,1,protein kinase C deactivation,BP,
10640,GO:0042316,1,0.990273865801745,0,1,penicillin metabolic process,BP,
10641,GO:0042320,1,0.979631116686026,0,4,regulation of circadian sleep/wake cycle, REM sleep,BP,
10642,GO:0042321,1,0.980077104513116,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10643,GO:0042322,1,0.993558543298224,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10644,GO:0042323,1,0.99130101879712,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10648,GO:0042328,1,0.986780929845544,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10650,GO:0042335,1,0.973103219895223,0,3,cuticle development,BP,
10653,GO:0042350,1,0.996408650453324,0,1,GDP-L-fucose biosynthetic process,BP,
10654,GO:0042351,1,0.996408650453324,0,1,'de novo' GDP-L-fucose biosynthetic process,BP,
10657,GO:0042357,1,0.991887399931333,0,2,thiamine diphosphate metabolic process,BP,
10658,GO:0042359,1,0.876178445973737,0,18,vitamin D metabolic process,BP,
10659,GO:0042360,1,0.987945496258707,0,3,vitamin E metabolic process,BP,
10660,GO:0042361,1,0.984989957940836,0,3,menaquinone catabolic process,BP,
10661,GO:0042362,1,0.937315565266509,0,13,fat-soluble vitamin biosynthetic process,BP,
10662,GO:0042363,1,0.95581141267562,0,9,fat-soluble vitamin catabolic process,BP,
10663,GO:0042364,1,0.963678500473037,0,6,water-soluble vitamin biosynthetic process,BP,
10664,GO:0042365,1,0.992909133032079,0,2,water-soluble vitamin catabolic process,BP,
10665,GO:0042368,1,0.952053225075902,0,10,vitamin D biosynthetic process,BP,
10666,GO:0042369,1,0.989517827633054,0,2,vitamin D catabolic process,BP,
10667,GO:0042371,1,0.993151563060952,0,1,vitamin K biosynthetic process,BP,
10668,GO:0042373,1,0.968744721649009,0,7,vitamin K metabolic process,BP,
10669,GO:0042374,1,0.981797435237115,0,4,phylloquinone metabolic process,BP,
10670,GO:0042376,1,0.981797435237115,0,4,phylloquinone catabolic process,BP,
10671,GO:0042377,1,0.984989957940836,0,3,vitamin K catabolic process,BP,
10672,GO:0042379,1,0.828178169228173,0,44,chemokine receptor binding,MF,
10673,GO:0042382,1,0.959849067787935,0,6,paraspeckles,CC,
10676,GO:0042392,1,0.990603494820594,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10677,GO:0042393,1,0.194188540576887,0,211,histone binding,MF,
10678,GO:0042396,1,0.982399670306247,0,5,phosphagen biosynthetic process,BP,
10679,GO:0042398,1,0.788502551504406,0,45,cellular modified amino acid biosynthetic process,BP,
10680,GO:0042401,1,0.917042604383422,0,20,cellular biogenic amine biosynthetic process,BP,
10681,GO:0042402,1,0.913112695725595,0,19,cellular biogenic amine catabolic process,BP,
10682,GO:0042403,1,0.852420925623038,0,22,thyroid hormone metabolic process,BP,
10683,GO:0042404,1,0.983808430689671,0,2,thyroid hormone catabolic process,BP,
10684,GO:0042405,1,0.879086959901302,0,11,nuclear inclusion body,CC,
10685,GO:0042406,1,0.975404904679354,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10686,GO:0042407,1,0.925792921623145,0,16,cristae formation,BP,
10687,GO:0042412,1,0.991484264303113,0,2,taurine biosynthetic process,BP,
10688,GO:0042413,1,0.995362589543187,0,1,carnitine catabolic process,BP,
10689,GO:0042414,1,0.977056874209822,0,3,epinephrine metabolic process,BP,
10690,GO:0042415,1,0.936716463829594,0,10,norepinephrine metabolic process,BP,
10691,GO:0042416,1,0.941746594340127,0,11,dopamine biosynthetic process,BP,
10692,GO:0042417,1,0.792649302473914,0,36,dopamine metabolic process,BP,
10693,GO:0042418,1,0.992931850836291,0,2,epinephrine biosynthetic process,BP,
10694,GO:0042420,1,0.962111344680845,0,7,dopamine catabolic process,BP,
10695,GO:0042421,1,0.970503227246526,0,6,norepinephrine biosynthetic process,BP,
10696,GO:0042423,1,0.905817758075596,0,19,catecholamine biosynthetic process,BP,
10697,GO:0042424,1,0.956678703112889,0,8,catecholamine catabolic process,BP,
10698,GO:0042426,1,0.961889663743818,0,6,choline catabolic process,BP,
10699,GO:0042427,1,0.987928918468284,0,3,serotonin biosynthetic process,BP,
10700,GO:0042428,1,0.913678625223288,0,10,serotonin metabolic process,BP,
10701,GO:0042430,1,0.876235174168281,0,20,indole-containing compound metabolic process,BP,
10702,GO:0042435,1,0.98453998982005,0,4,indole-containing compound biosynthetic process,BP,
10703,GO:0042436,1,0.965857681052591,0,8,indole-containing compound catabolic process,BP,
10704,GO:0042438,1,0.846323138472614,0,20,melanin biosynthetic process,BP,
10705,GO:0042439,1,0.958980881554955,0,8,ethanolamine-containing compound metabolic process,BP,
10706,GO:0042440,1,0.669555124671688,0,62,pigment metabolic process,BP,
10707,GO:0042441,1,0.99056989974232,0,2,eye pigment metabolic process,BP,
10710,GO:0042447,1,0.932546375173265,0,11,hormone catabolic process,BP,
10712,GO:0042450,1,0.992522769885356,0,2,arginine biosynthetic process via ornithine,BP,
10713,GO:0042451,1,0.913875890718414,0,21,purine nucleoside biosynthetic process,BP,
10714,GO:0042454,1,0.923715755314924,0,18,ribonucleoside catabolic process,BP,
10715,GO:0042455,1,0.913875890718414,0,21,ribonucleoside biosynthetic process,BP,
10716,GO:0042461,1,0.714964706518461,0,42,photoreceptor cell development,BP,
10717,GO:0042462,1,0.791459054917065,0,30,eye photoreceptor cell development,BP,
10719,GO:0042471,1,0.446945204294343,0,113,ear morphogenesis,BP,
10720,GO:0042472,1,0.500461706238807,0,93,inner ear morphogenesis,BP,
10721,GO:0042473,1,0.946957562030775,0,9,outer ear morphogenesis,BP,
10722,GO:0042474,1,0.904390669642743,0,20,middle ear morphogenesis,BP,
10725,GO:0042478,1,0.981843494860828,0,2,regulation of eye photoreceptor cell development,BP,
10726,GO:0042480,1,0.981843494860828,0,2,negative regulation of eye photoreceptor cell development,BP,
10727,GO:0042481,1,0.887796393628227,0,22,regulation of odontogenesis,BP,
10728,GO:0042482,1,0.965015289393963,0,7,positive regulation of odontogenesis,BP,
10729,GO:0042483,1,0.973253011015862,0,4,negative regulation of odontogenesis,BP,
10730,GO:0042487,1,0.938979664429838,0,12,regulation of odontogenesis of dentin-containing tooth,BP,
10731,GO:0042488,1,0.989154279751567,0,2,positive regulation of odontogenesis of dentin-containing tooth,BP,
10732,GO:0042489,1,0.989793900484082,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10734,GO:0042491,1,0.79129669075374,0,30,inner ear auditory receptor cell differentiation,BP,
10735,GO:0042492,1,0.916549231400729,0,11,gamma-delta T cell differentiation,BP,
10737,GO:0042494,1,0.954017121727327,0,5,detection of bacterial lipoprotein,BP,
10738,GO:0042495,1,0.988451330089972,0,2,detection of triacyl bacterial lipopeptide,BP,
10739,GO:0042496,1,0.982500238572063,0,2,detection of diacyl bacterial lipopeptide,BP,
10740,GO:0042497,1,0.993671356664441,0,1,triacyl lipopeptide binding,MF,
10741,GO:0042500,1,0.963436829355911,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10746,GO:0042537,1,0.914479593849144,0,21,benzene-containing compound metabolic process,BP,
10747,GO:0042538,1,0.945789734413555,0,10,hyperosmotic salinity response,BP,
10748,GO:0042539,1,0.980026368013867,0,2,hypotonic salinity response,BP,
10749,GO:0042541,1,0.952634419411464,0,10,hemoglobin biosynthetic process,BP,
10751,GO:0042543,1,0.996885041482208,0,1,protein N-linked glycosylation via arginine,BP,
10752,GO:0042546,1,0.996318235555698,0,1,cell wall biogenesis,BP,
10754,GO:0042552,1,0.351325377468009,0,132,myelination,BP,
10755,GO:0042554,1,0.840489823306828,0,31,superoxide anion generation,BP,
10756,GO:0042555,1,0.934239131912226,0,12,MCM complex,CC,
10757,GO:0042558,1,0.828474831133551,0,32,pteridine-containing compound metabolic process,BP,
10758,GO:0042559,1,0.940980377091941,0,13,pteridine-containing compound biosynthetic process,BP,
10759,GO:0042560,1,0.976888659791669,0,3,pteridine-containing compound catabolic process,BP,
10761,GO:0042564,1,0.991695120367462,0,1,NLS-dependent protein nuclear import complex,CC,
10762,GO:0042565,1,0.986481773050079,0,2,RNA nuclear export complex,CC,
10763,GO:0042567,1,0.96583223320101,0,4,insulin-like growth factor ternary complex,CC,
10764,GO:0042568,1,0.996807685012335,0,1,insulin-like growth factor binary complex,CC,
10765,GO:0042571,1,0.991747198337854,0,2,immunoglobulin complex, circulating,CC,
10766,GO:0042572,1,0.823237792954243,0,39,retinol metabolic process,BP,
10767,GO:0042573,1,0.907374964802133,0,20,retinoic acid metabolic process,BP,
10768,GO:0042574,1,0.920300576392427,0,15,retinal metabolic process,BP,
10769,GO:0042575,1,0.873184877634583,0,21,DNA polymerase complex,CC,
10770,GO:0042577,1,0.980550332960706,0,4,lipid phosphatase activity,MF,
10777,GO:0042585,1,0.995757015301866,0,1,germinal vesicle,CC,
10778,GO:0042586,1,0.99674041724777,0,1,peptide deformylase activity,MF,
10779,GO:0042587,1,0.943394120945327,0,7,glycogen granule,CC,
10780,GO:0042588,1,0.917584068385966,0,14,zymogen granule,CC,
10781,GO:0042589,1,0.936529731520929,0,10,zymogen granule membrane,CC,
10782,GO:0042590,1,0.720391813508453,0,74,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10786,GO:0042595,1,0.989593589921948,0,2,behavioral response to starvation,BP,
10787,GO:0042596,1,0.765613584059367,0,41,fear response,BP,
10788,GO:0042599,1,0.921323802289478,0,14,lamellar body,CC,
10789,GO:0042602,1,0.996836161104017,0,1,riboflavin reductase (NADPH) activity,MF,
10790,GO:0042605,1,0.902191562604253,0,21,peptide antigen binding,MF,
10791,GO:0042608,1,0.959195677419053,0,9,T cell receptor binding,MF,
10792,GO:0042609,1,0.950919389360065,0,9,CD4 receptor binding,MF,
10793,GO:0042610,1,0.984979875350925,0,4,CD8 receptor binding,MF,
10794,GO:0042611,1,0.925391317931083,0,22,MHC protein complex,CC,
10795,GO:0042612,1,0.972933124280615,0,8,MHC class I protein complex,CC,
10796,GO:0042613,1,0.951148735906563,0,14,MHC class II protein complex,CC,
10797,GO:0042622,1,0.900922620653495,0,16,photoreceptor outer segment membrane,CC,
10800,GO:0042627,1,0.943853011873306,0,9,chylomicron,CC,
10801,GO:0042628,1,0.995720366761928,0,1,mating plug formation,BP,
10803,GO:0042631,1,0.98546976414145,0,2,cellular response to water deprivation,BP,
10804,GO:0042632,1,0.628703045254523,0,70,cholesterol homeostasis,BP,
10805,GO:0042633,1,0.480495145188782,0,97,hair cycle,BP,
10806,GO:0042634,1,0.823911294852451,0,26,regulation of hair cycle,BP,
10807,GO:0042635,1,0.930677324366927,0,12,positive regulation of hair cycle,BP,
10808,GO:0042636,1,0.962729709811133,0,5,negative regulation of hair cycle,BP,
10809,GO:0042637,1,0.974759649101701,0,4,catagen,BP,
10810,GO:0042640,1,0.961956849546628,0,5,anagen,BP,
10811,GO:0042641,1,0.523959389926443,0,72,actomyosin,CC,
10812,GO:0042645,1,0.782368641959759,0,40,mitochondrial nucleoid,CC,
10813,GO:0042658,1,0.996664810451459,0,1,MHC class II protein binding, via antigen binding groove,MF,
10814,GO:0042659,1,0.912668433375814,0,13,regulation of cell fate specification,BP,
10815,GO:0042660,1,0.987101373156459,0,1,positive regulation of cell fate specification,BP,
10816,GO:0042661,1,0.971818172064719,0,5,regulation of mesodermal cell fate specification,BP,
10817,GO:0042662,1,0.989151522073451,0,3,negative regulation of mesodermal cell fate specification,BP,
10818,GO:0042663,1,0.993040791090995,0,2,regulation of endodermal cell fate specification,BP,
10819,GO:0042664,1,0.996739578012618,0,1,negative regulation of endodermal cell fate specification,BP,
10820,GO:0042665,1,0.99274163979786,0,1,regulation of ectodermal cell fate specification,BP,
10821,GO:0042666,1,0.99274163979786,0,1,negative regulation of ectodermal cell fate specification,BP,
10822,GO:0042667,1,0.993064254016016,0,1,auditory receptor cell fate specification,BP,
10823,GO:0042669,1,0.993064254016016,0,1,regulation of inner ear auditory receptor cell fate specification,BP,
10824,GO:0042670,1,0.938023534678374,0,9,retinal cone cell differentiation,BP,
10826,GO:0042693,1,0.937445977767284,0,12,muscle cell fate commitment,BP,
10827,GO:0042695,1,0.967105035580763,0,4,thelarche,BP,
10828,GO:0042698,1,0.63069781206673,0,65,ovulation cycle,BP,
10829,GO:0042699,1,0.99200042462731,0,2,follicle-stimulating hormone signaling pathway,BP,
10830,GO:0042700,1,0.99115365325104,0,1,luteinizing hormone signaling pathway,BP,
10831,GO:0042701,1,0.974985483161731,0,4,progesterone secretion,BP,
10832,GO:0042704,1,0.984202503261894,0,2,uterine wall breakdown,BP,
10833,GO:0042706,1,0.995983180678702,0,1,eye photoreceptor cell fate commitment,BP,
10834,GO:0042709,1,0.988053251455694,0,3,succinate-CoA ligase complex,CC,
10836,GO:0042711,1,0.93393366331395,0,10,maternal behavior,BP,
10837,GO:0042713,1,0.965528858564196,0,4,sperm ejaculation,BP,
10838,GO:0042719,1,0.981596463658796,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10839,GO:0042720,1,0.993394063583642,0,2,mitochondrial inner membrane peptidase complex,CC,
10840,GO:0042721,1,0.985953394886216,0,3,TIM22 mitochondrial import inner membrane insertion complex,CC,
10841,GO:0042723,1,0.969890678680079,0,6,thiamine-containing compound metabolic process,BP,
10842,GO:0042726,1,0.951810589871032,0,8,flavin-containing compound metabolic process,BP,
10843,GO:0042727,1,0.991124635266573,0,2,flavin-containing compound biosynthetic process,BP,
10844,GO:0042728,1,0.992691717984483,0,1,flavin-containing compound catabolic process,BP,
10846,GO:0042731,1,0.972942651468222,0,4,PH domain binding,MF,
10847,GO:0042732,1,0.986718336981994,0,3,D-xylose metabolic process,BP,
10848,GO:0042733,1,0.649076846573816,0,56,embryonic digit morphogenesis,BP,
10850,GO:0042737,1,0.916874640398561,0,17,drug catabolic process,BP,
10851,GO:0042738,1,0.924017281538297,0,15,exogenous drug catabolic process,BP,
10853,GO:0042743,1,0.786300544609926,0,49,hydrogen peroxide metabolic process,BP,
10854,GO:0042744,1,0.866782631478859,0,29,hydrogen peroxide catabolic process,BP,
10855,GO:0042745,1,0.869932248189185,0,26,circadian sleep/wake cycle,BP,
10856,GO:0042746,1,0.983618242626192,0,3,circadian sleep/wake cycle, wakefulness,BP,
10857,GO:0042747,1,0.967567416215797,0,7,circadian sleep/wake cycle, REM sleep,BP,
10858,GO:0042748,1,0.944408005275928,0,9,circadian sleep/wake cycle, non-REM sleep,BP,
10859,GO:0042749,1,0.90275393110949,0,20,regulation of circadian sleep/wake cycle,BP,
10860,GO:0042752,1,0.423561084008092,0,115,regulation of circadian rhythm,BP,
10861,GO:0042753,1,0.899659976356824,0,16,positive regulation of circadian rhythm,BP,
10862,GO:0042754,1,0.915746208638963,0,14,negative regulation of circadian rhythm,BP,
10864,GO:0042756,1,0.962040437665498,0,8,drinking behavior,BP,
10865,GO:0042758,1,0.955251748490521,0,9,long-chain fatty acid catabolic process,BP,
10866,GO:0042759,1,0.837319443996329,0,30,long-chain fatty acid biosynthetic process,BP,
10867,GO:0042760,1,0.963526728106596,0,6,very long-chain fatty acid catabolic process,BP,
10868,GO:0042761,1,0.937281070733404,0,12,very long-chain fatty acid biosynthetic process,BP,
10869,GO:0042762,1,0.891617848882414,0,13,regulation of sulfur metabolic process,BP,
10870,GO:0042765,1,0.974090278387228,0,5,GPI-anchor transamidase complex,CC,
10871,GO:0042766,1,0.948987275002801,0,4,nucleosome mobilization,BP,
10872,GO:0042769,1,0.816130294291461,0,37,DNA damage response, detection of DNA damage,BP,
10873,GO:0042770,1,0.416329764982404,0,124,signal transduction in response to DNA damage,BP,
10874,GO:0042771,1,0.753447978501349,0,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10875,GO:0042772,1,0.870741615372336,0,18,DNA damage response, signal transduction resulting in transcription,BP,
10876,GO:0042773,1,0.721987689459282,0,81,ATP synthesis coupled electron transport,BP,
10877,GO:0042774,1,0.994890876864838,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10878,GO:0042775,1,0.725707328239147,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10879,GO:0042776,1,0.985667568623608,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10880,GO:0042779,1,0.985479283567769,0,3,tRNA 3'-trailer cleavage,BP,
10881,GO:0042780,1,0.964130779878522,0,8,tRNA 3'-end processing,BP,
10882,GO:0042781,1,0.988594242318278,0,2,3'-tRNA processing endoribonuclease activity,MF,
10883,GO:0042788,1,0.853494803963715,0,32,polysomal ribosome,CC,
10884,GO:0042789,1,0.907571869764953,0,11,mRNA transcription by RNA polymerase II,BP,
10885,GO:0042790,1,0.918981076934234,0,13,nucleolar large rRNA transcription by RNA polymerase I,BP,
10886,GO:0042791,1,0.959285364696156,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10887,GO:0042795,1,0.666511653696395,0,69,snRNA transcription by RNA polymerase II,BP,
10888,GO:0042796,1,0.9567111236626,0,8,snRNA transcription by RNA polymerase III,BP,
10889,GO:0042797,1,0.956245466295939,0,7,tRNA transcription by RNA polymerase III,BP,
10890,GO:0042799,1,0.977291570306602,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10891,GO:0042800,1,0.878091853599721,0,17,histone methyltransferase activity (H3-K4 specific),MF,
10894,GO:0042805,1,0.722123794706224,0,35,actinin binding,MF,
10895,GO:0042806,1,0.978528866987555,0,5,fucose binding,MF,
10896,GO:0042809,1,0.880252794711475,0,15,vitamin D receptor binding,MF,
10897,GO:0042813,1,0.867587700521598,0,15,Wnt-activated receptor activity,MF,
10898,GO:0042816,1,0.962537874800965,0,5,vitamin B6 metabolic process,BP,
10899,GO:0042819,1,0.975610036954652,0,3,vitamin B6 biosynthetic process,BP,
10900,GO:0042820,1,0.996066812388145,0,1,vitamin B6 catabolic process,BP,
10901,GO:0042822,1,0.975757736334272,0,3,pyridoxal phosphate metabolic process,BP,
10902,GO:0042823,1,0.979611525192922,0,2,pyridoxal phosphate biosynthetic process,BP,
10903,GO:0042824,1,0.958339850949864,0,8,MHC class I peptide loading complex,CC,
10904,GO:0042825,1,0.986950856903997,0,2,TAP complex,CC,
10905,GO:0042826,1,0.45394816679105,0,109,histone deacetylase binding,MF,
10906,GO:0042827,1,0.897830335416829,0,18,platelet dense granule,CC,
10907,GO:0042832,1,0.867514240424047,0,24,defense response to protozoan,BP,
10908,GO:0042834,1,0.949247353335987,0,9,peptidoglycan binding,MF,
10910,GO:0042839,1,0.996566348061452,0,1,D-glucuronate metabolic process,BP,
10911,GO:0042840,1,0.996566348061452,0,1,D-glucuronate catabolic process,BP,
10912,GO:0042843,1,0.996768744797559,0,1,D-xylose catabolic process,BP,
10913,GO:0042851,1,0.985319567763052,0,3,L-alanine metabolic process,BP,
10914,GO:0042853,1,0.985319567763052,0,3,L-alanine catabolic process,BP,
10915,GO:0042866,1,0.972803377309734,0,6,pyruvate biosynthetic process,BP,
10916,GO:0042868,1,0.994858406815001,0,1,antisense RNA metabolic process,BP,
10917,GO:0042883,1,0.983722013373613,0,2,cysteine transport,BP,
10919,GO:0042887,1,0.745761994529837,0,46,amide transmembrane transporter activity,MF,
10920,GO:0042903,1,0.988333028535929,0,2,tubulin deacetylase activity,MF,
10921,GO:0042904,1,0.980901322581215,0,4,9-cis-retinoic acid biosynthetic process,BP,
10922,GO:0042905,1,0.980901322581215,0,4,9-cis-retinoic acid metabolic process,BP,
10925,GO:0042918,1,0.944529798671897,0,6,alkanesulfonate transport,BP,
10926,GO:0042921,1,0.902817797915479,0,13,glucocorticoid receptor signaling pathway,BP,
10927,GO:0042922,1,0.996845389599986,0,1,neuromedin U receptor binding,MF,
10928,GO:0042923,1,0.882418568123617,0,23,neuropeptide binding,MF,
10929,GO:0042924,1,0.989943735924561,0,2,neuromedin U binding,MF,
10930,GO:0042930,1,0.994890876864838,0,1,enterobactin transport,BP,
10931,GO:0042931,1,0.994890876864838,0,1,enterobactin transmembrane transporter activity,MF,
10932,GO:0042937,1,0.974483794336679,0,3,tripeptide transmembrane transporter activity,MF,
10933,GO:0042938,1,0.963476541337267,0,4,dipeptide transport,BP,
10934,GO:0042939,1,0.953216386174525,0,5,tripeptide transport,BP,
10935,GO:0042940,1,0.943600376997442,0,7,D-amino acid transport,BP,
10936,GO:0042941,1,0.996126428951869,0,1,D-alanine transport,BP,
10937,GO:0042942,1,0.985876230083763,0,3,D-serine transport,BP,
10938,GO:0042943,1,0.987492915030107,0,2,D-amino acid transmembrane transporter activity,MF,
10939,GO:0042945,1,0.99446723248971,0,1,D-serine transmembrane transporter activity,MF,
10940,GO:0042946,1,0.981264833505401,0,3,glucoside transport,BP,
10941,GO:0042947,1,0.981264833505401,0,3,glucoside transmembrane transporter activity,MF,
10942,GO:0042953,1,0.875766693502903,0,11,lipoprotein transport,BP,
10943,GO:0042959,1,0.97256769220061,0,3,alkanesulfonate transmembrane transporter activity,MF,
10944,GO:0042969,1,0.994890876864838,0,1,lactone transport,BP,
10945,GO:0042971,1,0.994890876864838,0,1,lactone transmembrane transporter activity,MF,
10946,GO:0042974,1,0.796811421611677,0,27,retinoic acid receptor binding,MF,
10947,GO:0042975,1,0.89204907534162,0,11,peroxisome proliferator activated receptor binding,MF,
10948,GO:0042976,1,0.925542441809896,0,10,activation of Janus kinase activity,BP,
10949,GO:0042978,1,0.986779845952451,0,2,ornithine decarboxylase activator activity,MF,
10950,GO:0042979,1,0.976693783047637,0,5,ornithine decarboxylase regulator activity,MF,
10952,GO:0042982,1,0.644158291927877,0,61,amyloid precursor protein metabolic process,BP,
10953,GO:0042983,1,0.919807621977328,0,13,amyloid precursor protein biosynthetic process,BP,
10954,GO:0042984,1,0.919807621977328,0,13,regulation of amyloid precursor protein biosynthetic process,BP,
10955,GO:0042985,1,0.965682040287527,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10956,GO:0042986,1,0.969219382670923,0,4,positive regulation of amyloid precursor protein biosynthetic process,BP,
10957,GO:0042987,1,0.698281820900064,0,46,amyloid precursor protein catabolic process,BP,
10958,GO:0042988,1,0.990059100057767,0,1,X11-like protein binding,MF,
10959,GO:0042989,1,0.961841247632463,0,10,sequestering of actin monomers,BP,
10960,GO:0042994,1,0.902844175067821,0,16,cytoplasmic sequestering of transcription factor,BP,
10962,GO:0042996,1,0.954905191766275,0,8,regulation of Golgi to plasma membrane protein transport,BP,
10963,GO:0042997,1,0.973683548457816,0,5,negative regulation of Golgi to plasma membrane protein transport,BP,
10964,GO:0042998,1,0.980719203961665,0,3,positive regulation of Golgi to plasma membrane protein transport,BP,
10965,GO:0042999,1,0.991224046158948,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10966,GO:0043000,1,0.971086008745236,0,3,Golgi to plasma membrane CFTR protein transport,BP,
10968,GO:0043002,1,0.991224046158948,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10969,GO:0043004,1,0.991224046158948,0,1,cytoplasmic sequestering of CFTR protein,BP,
10971,GO:0043006,1,0.991260169790398,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10972,GO:0043007,1,0.989074518295631,0,2,maintenance of rDNA,BP,
10973,GO:0043008,1,0.960179617357198,0,8,ATP-dependent protein binding,MF,
10976,GO:0043011,1,0.905287960437819,0,16,myeloid dendritic cell differentiation,BP,
10977,GO:0043012,1,0.995196639998825,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
10978,GO:0043014,1,0.787398098460708,0,34,alpha-tubulin binding,MF,
10979,GO:0043015,1,0.822331233556423,0,27,gamma-tubulin binding,MF,
10980,GO:0043020,1,0.937092190979971,0,11,NADPH oxidase complex,CC,
10981,GO:0043021,1,0.452552079363948,0,120,ribonucleoprotein complex binding,MF,
10982,GO:0043022,1,0.711621450700215,0,50,ribosome binding,MF,
10983,GO:0043023,1,0.92886697461103,0,12,ribosomal large subunit binding,MF,
10984,GO:0043024,1,0.895801878283141,0,17,ribosomal small subunit binding,MF,
10986,GO:0043027,1,0.864054633704622,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
10987,GO:0043028,1,0.775240770477779,0,39,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
10988,GO:0043029,1,0.798969439991767,0,36,T cell homeostasis,BP,
10989,GO:0043030,1,0.707949482148401,0,48,regulation of macrophage activation,BP,
10990,GO:0043031,1,0.919393514327399,0,15,negative regulation of macrophage activation,BP,
10991,GO:0043032,1,0.863363381669125,0,21,positive regulation of macrophage activation,BP,
10992,GO:0043033,1,0.986306424654686,0,1,isoamylase complex,CC,
10993,GO:0043034,1,0.795327783841081,0,19,costamere,CC,
10994,GO:0043035,1,0.96138759954448,0,5,chromatin insulator sequence binding,MF,
10995,GO:0043038,1,0.860876440755538,0,30,amino acid activation,BP,
10996,GO:0043039,1,0.866674481275559,0,29,tRNA aminoacylation,BP,
10997,GO:0043041,1,0.993319556799522,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10999,GO:0043044,1,0.601877296185979,0,69,ATP-dependent chromatin remodeling,BP,
11000,GO:0043045,1,0.949645235430859,0,6,DNA methylation involved in embryo development,BP,
11001,GO:0043046,1,0.900954485256839,0,17,DNA methylation involved in gamete generation,BP,
11002,GO:0043047,1,0.935288825829016,0,11,single-stranded telomeric DNA binding,MF,
11003,GO:0043048,1,0.995809221611913,0,1,dolichyl monophosphate biosynthetic process,BP,
11004,GO:0043049,1,0.994328439527581,0,1,otic placode formation,BP,
11005,GO:0043060,1,0.995402998961019,0,1,meiotic metaphase I plate congression,BP,
11007,GO:0043063,1,0.990629964494459,0,1,intercellular bridge organization,BP,
11013,GO:0043073,1,0.926414579154303,0,12,germ cell nucleus,CC,
11015,GO:0043084,1,0.943166183268365,0,8,penile erection,BP,
11020,GO:0043094,1,0.859537571866011,0,31,cellular metabolic compound salvage,BP,
11021,GO:0043095,1,0.996864307981542,0,1,regulation of GTP cyclohydrolase I activity,BP,
11022,GO:0043096,1,0.990018088578198,0,3,purine nucleobase salvage,BP,
11023,GO:0043097,1,0.956679677503291,0,10,pyrimidine nucleoside salvage,BP,
11024,GO:0043101,1,0.934841829099016,0,14,purine-containing compound salvage,BP,
11025,GO:0043102,1,0.965903793510563,0,7,amino acid salvage,BP,
11026,GO:0043103,1,0.993136919279787,0,2,hypoxanthine salvage,BP,
11027,GO:0043105,1,0.996864307981542,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11028,GO:0043111,1,0.968489804155464,0,4,replication fork arrest,BP,
11033,GO:0043117,1,0.901968824494753,0,17,positive regulation of vascular permeability,BP,
11034,GO:0043120,1,0.967584042128014,0,5,tumor necrosis factor binding,MF,
11035,GO:0043121,1,0.927183841779305,0,9,neurotrophin binding,MF,
11038,GO:0043124,1,0.727431537427432,0,43,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11039,GO:0043125,1,0.966419323429865,0,5,ErbB-3 class receptor binding,MF,
11040,GO:0043126,1,0.996548673676157,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11041,GO:0043128,1,0.996548673676157,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11042,GO:0043129,1,0.947092551675095,0,8,surfactant homeostasis,BP,
11043,GO:0043130,1,0.638948836603086,0,71,ubiquitin binding,MF,
11044,GO:0043131,1,0.990125428856343,0,1,erythrocyte enucleation,BP,
11045,GO:0043132,1,0.98992362876648,0,2,NAD transport,BP,
11046,GO:0043136,1,0.99029272830636,0,2,glycerol-3-phosphatase activity,MF,
11047,GO:0043137,1,0.980614126586386,0,4,DNA replication, removal of RNA primer,BP,
11048,GO:0043138,1,0.872098463540935,0,18,3'-5' DNA helicase activity,MF,
11049,GO:0043139,1,0.962179947990278,0,7,5'-3' DNA helicase activity,MF,
11050,GO:0043144,1,0.95704442346687,0,11,snoRNA processing,BP,
11051,GO:0043149,1,0.448278032150196,0,99,stress fiber assembly,BP,
11052,GO:0043152,1,0.975422103881928,0,4,induction of bacterial agglutination,BP,
11053,GO:0043153,1,0.843831613528059,0,27,entrainment of circadian clock by photoperiod,BP,
11054,GO:0043154,1,0.619822990695128,0,80,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11055,GO:0043159,1,0.986033012592164,0,3,acrosomal matrix,CC,
11056,GO:0043161,1,0.0762912468999075,0,401,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11057,GO:0043162,1,0.879385051203365,0,22,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11058,GO:0043163,1,0.989928950044409,0,2,cell envelope organization,BP,
11063,GO:0043171,1,0.853334766140151,0,24,peptide catabolic process,BP,
11064,GO:0043173,1,0.947460941261493,0,12,nucleotide salvage,BP,
11065,GO:0043174,1,0.934094996269036,0,15,nucleoside salvage,BP,
11066,GO:0043175,1,0.739367099035329,0,44,RNA polymerase core enzyme binding,MF,
11067,GO:0043176,1,0.939893915191511,0,12,amine binding,MF,
11069,GO:0043178,1,0.583346514866932,0,74,alcohol binding,MF,
11070,GO:0043179,1,0.995946339837785,0,1,rhythmic excitation,BP,
11071,GO:0043181,1,0.993244969074651,0,1,vacuolar sequestering,BP,
11072,GO:0043183,1,0.986071972855086,0,3,vascular endothelial growth factor receptor 1 binding,MF,
11073,GO:0043184,1,0.928342151308881,0,9,vascular endothelial growth factor receptor 2 binding,MF,
11074,GO:0043185,1,0.995967759500215,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11075,GO:0043186,1,0.87923768935131,0,17,P granule,CC,
11076,GO:0043189,1,0.888570138733969,0,19,H4/H2A histone acetyltransferase complex,CC,
11077,GO:0043190,1,0.959993370800022,0,5,ATP-binding cassette (ABC) transporter complex,CC,
11078,GO:0043194,1,0.829656462006776,0,16,axon initial segment,CC,
11080,GO:0043196,1,0.941963347361112,0,8,varicosity,CC,
11082,GO:0043198,1,0.745414487147482,0,37,dendritic shaft,CC,
11083,GO:0043199,1,0.970700584765081,0,4,sulfate binding,MF,
11085,GO:0043201,1,0.898605890895649,0,12,response to leucine,BP,
11087,GO:0043203,1,0.953013389163401,0,8,axon hillock,CC,
11090,GO:0043208,1,0.947605875139654,0,8,glycosphingolipid binding,MF,
11092,GO:0043210,1,0.996280053509221,0,1,alkanesulfonate binding,MF,
11093,GO:0043217,1,0.865098848174536,0,16,myelin maintenance,BP,
11095,GO:0043219,1,0.973110462916764,0,4,lateral loop,CC,
11097,GO:0043225,1,0.98970043089499,0,1,ATPase-coupled inorganic anion transmembrane transporter activity,MF,
11107,GO:0043236,1,0.812555393823277,0,27,laminin binding,MF,
11108,GO:0043237,1,0.958668870399626,0,5,laminin-1 binding,MF,
11109,GO:0043240,1,0.944267280119763,0,9,Fanconi anaemia nuclear complex,CC,
11110,GO:0043242,1,0.532457582666489,0,72,negative regulation of protein-containing complex disassembly,BP,
11111,GO:0043243,1,0.762614274606207,0,33,positive regulation of protein-containing complex disassembly,BP,
11112,GO:0043244,1,0.378993465442461,0,112,regulation of protein-containing complex disassembly,BP,
11113,GO:0043247,1,0.911368314911811,0,13,telomere maintenance in response to DNA damage,BP,
11114,GO:0043248,1,0.953798246168466,0,12,proteasome assembly,BP,
11115,GO:0043249,1,0.914888105387384,0,15,erythrocyte maturation,BP,
11116,GO:0043250,1,0.996546554506179,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11117,GO:0043251,1,0.996546554506179,0,1,sodium-dependent organic anion transport,BP,
11119,GO:0043254,1,0.0572304120952336,0,405,regulation of protein-containing complex assembly,BP,
11120,GO:0043255,1,0.513397514422951,0,82,regulation of carbohydrate biosynthetic process,BP,
11121,GO:0043256,1,0.869861936195486,0,12,laminin complex,CC,
11122,GO:0043257,1,0.988760315196418,0,1,laminin-8 complex,CC,
11123,GO:0043259,1,0.953550307843548,0,3,laminin-10 complex,CC,
11124,GO:0043260,1,0.953624426887715,0,3,laminin-11 complex,CC,
11125,GO:0043262,1,0.987742021875782,0,2,adenosine-diphosphatase activity,MF,
11126,GO:0043265,1,0.994187600743563,0,1,ectoplasm,CC,
11128,GO:0043267,1,0.819182859329961,0,30,negative regulation of potassium ion transport,BP,
11132,GO:0043271,1,0.408853258195649,0,133,negative regulation of ion transport,BP,
11133,GO:0043273,1,0.989645215094909,0,1,CTPase activity,MF,
11134,GO:0043274,1,0.905884184461635,0,13,phospholipase binding,MF,
11135,GO:0043276,1,0.797756809937036,0,30,anoikis,BP,
11139,GO:0043280,1,0.462871270497748,0,125,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11140,GO:0043281,1,0.289108528120477,0,201,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11141,GO:0043291,1,0.957019984030902,0,3,RAVE complex,CC,
11142,GO:0043292,1,0.145184698565007,0,223,contractile fiber,CC,
11143,GO:0043293,1,0.982925512523139,0,2,apoptosome,CC,
11144,GO:0043295,1,0.949032903421701,0,12,glutathione binding,MF,
11145,GO:0043296,1,0.34976054878582,0,128,apical junction complex,CC,
11146,GO:0043297,1,0.605356486531951,0,72,apical junction assembly,BP,
11148,GO:0043300,1,0.773140028418921,0,44,regulation of leukocyte degranulation,BP,
11149,GO:0043301,1,0.935689202741839,0,12,negative regulation of leukocyte degranulation,BP,
11150,GO:0043302,1,0.875739619735595,0,23,positive regulation of leukocyte degranulation,BP,
11152,GO:0043304,1,0.853807598688928,0,29,regulation of mast cell degranulation,BP,
11153,GO:0043305,1,0.975202627330553,0,6,negative regulation of mast cell degranulation,BP,
11154,GO:0043306,1,0.927039006439433,0,14,positive regulation of mast cell degranulation,BP,
11155,GO:0043307,1,0.978907754011376,0,5,eosinophil activation,BP,
11156,GO:0043308,1,0.982644390676801,0,4,eosinophil degranulation,BP,
11157,GO:0043309,1,0.986720311197255,0,3,regulation of eosinophil degranulation,BP,
11158,GO:0043310,1,0.995352825608927,0,1,negative regulation of eosinophil degranulation,BP,
11159,GO:0043311,1,0.991327584874602,0,2,positive regulation of eosinophil degranulation,BP,
11161,GO:0043313,1,0.937874008407513,0,8,regulation of neutrophil degranulation,BP,
11162,GO:0043314,1,0.976948373493034,0,2,negative regulation of neutrophil degranulation,BP,
11163,GO:0043315,1,0.97339964662556,0,4,positive regulation of neutrophil degranulation,BP,
11164,GO:0043316,1,0.984890718839661,0,3,cytotoxic T cell degranulation,BP,
11165,GO:0043317,1,0.990009279989385,0,2,regulation of cytotoxic T cell degranulation,BP,
11166,GO:0043318,1,0.990009279989385,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11167,GO:0043320,1,0.962324859979946,0,6,natural killer cell degranulation,BP,
11168,GO:0043321,1,0.979020227437048,0,3,regulation of natural killer cell degranulation,BP,
11169,GO:0043322,1,0.996679631870473,0,1,negative regulation of natural killer cell degranulation,BP,
11170,GO:0043323,1,0.979020227437048,0,3,positive regulation of natural killer cell degranulation,BP,
11171,GO:0043324,1,0.99056989974232,0,2,pigment metabolic process involved in developmental pigmentation,BP,
11173,GO:0043328,1,0.976539194869617,0,5,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11174,GO:0043330,1,0.848030114931291,0,26,response to exogenous dsRNA,BP,
11175,GO:0043331,1,0.81205762851897,0,33,response to dsRNA,BP,
11176,GO:0043333,1,0.996541576909393,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
11177,GO:0043335,1,0.986113396320179,0,3,protein unfolding,BP,
11178,GO:0043337,1,0.992836338383579,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11179,GO:0043353,1,0.937412641093812,0,8,enucleate erythrocyte differentiation,BP,
11180,GO:0043354,1,0.990125428856343,0,1,enucleate erythrocyte maturation,BP,
11181,GO:0043366,1,0.982747329183738,0,3,beta selection,BP,
11183,GO:0043368,1,0.793272603573925,0,33,positive T cell selection,BP,
11184,GO:0043369,1,0.868575192563167,0,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11188,GO:0043373,1,0.892452870105207,0,17,CD4-positive, alpha-beta T cell lineage commitment,BP,
11189,GO:0043374,1,0.912467302998593,0,14,CD8-positive, alpha-beta T cell differentiation,BP,
11190,GO:0043375,1,0.984945315321625,0,2,CD8-positive, alpha-beta T cell lineage commitment,BP,
11191,GO:0043376,1,0.957887521172362,0,6,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11192,GO:0043377,1,0.989963218649731,0,2,negative regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11193,GO:0043378,1,0.96760231791299,0,4,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11194,GO:0043379,1,0.945712215535815,0,8,memory T cell differentiation,BP,
11195,GO:0043380,1,0.961296581805736,0,7,regulation of memory T cell differentiation,BP,
11196,GO:0043381,1,0.991883220809669,0,1,negative regulation of memory T cell differentiation,BP,
11197,GO:0043382,1,0.975614054086354,0,5,positive regulation of memory T cell differentiation,BP,
11198,GO:0043383,1,0.922979966405032,0,12,negative T cell selection,BP,
11199,GO:0043385,1,0.991661789485292,0,2,mycotoxin metabolic process,BP,
11200,GO:0043387,1,0.991661789485292,0,2,mycotoxin catabolic process,BP,
11201,GO:0043388,1,0.696292248522277,0,54,positive regulation of DNA binding,BP,
11202,GO:0043392,1,0.720280595720842,0,50,negative regulation of DNA binding,BP,
11205,GO:0043395,1,0.866656946919923,0,15,heparan sulfate proteoglycan binding,MF,
11206,GO:0043396,1,0.984993658860178,0,2,corticotropin-releasing hormone secretion,BP,
11207,GO:0043397,1,0.984993658860178,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11208,GO:0043398,1,0.97654224566725,0,4,HLH domain binding,MF,
11209,GO:0043400,1,0.97350543960077,0,5,cortisol secretion,BP,
11210,GO:0043401,1,0.373772573078737,0,128,steroid hormone mediated signaling pathway,BP,
11211,GO:0043402,1,0.958959287007978,0,3,glucocorticoid mediated signaling pathway,BP,
11213,GO:0043404,1,0.991653916453966,0,2,corticotropin-releasing hormone receptor activity,MF,
11216,GO:0043407,1,0.652796855219826,0,69,negative regulation of MAP kinase activity,BP,
11222,GO:0043414,1,0.162684915578555,0,261,macromolecule methylation,BP,
11223,GO:0043415,1,0.971710008885886,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11224,GO:0043416,1,0.968327934160765,0,6,regulation of skeletal muscle tissue regeneration,BP,
11225,GO:0043417,1,0.996520461041552,0,1,negative regulation of skeletal muscle tissue regeneration,BP,
11226,GO:0043418,1,0.984620188825778,0,3,homocysteine catabolic process,BP,
11227,GO:0043420,1,0.983690128307878,0,3,anthranilate metabolic process,BP,
11228,GO:0043422,1,0.924077041007254,0,11,protein kinase B binding,MF,
11229,GO:0043423,1,0.991709236237919,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11230,GO:0043425,1,0.823491819265596,0,26,bHLH transcription factor binding,MF,
11231,GO:0043426,1,0.957232339710388,0,5,MRF binding,MF,
11232,GO:0043430,1,0.996541576909393,0,1,2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
11233,GO:0043433,1,0.364700207251102,0,152,negative regulation of DNA-binding transcription factor activity,BP,
11235,GO:0043435,1,0.970394549177215,0,5,response to corticotropin-releasing hormone,BP,
11237,GO:0043438,1,0.994691584553626,0,1,acetoacetic acid metabolic process,BP,
11239,GO:0043455,1,0.907697481723481,0,10,regulation of secondary metabolic process,BP,
11240,GO:0043456,1,0.991593986182221,0,2,regulation of pentose-phosphate shunt,BP,
11241,GO:0043457,1,0.856167509398009,0,25,regulation of cellular respiration,BP,
11242,GO:0043461,1,0.981322058618961,0,4,proton-transporting ATP synthase complex assembly,BP,
11244,GO:0043465,1,0.98764869320882,0,2,regulation of fermentation,BP,
11245,GO:0043467,1,0.354751169628411,0,137,regulation of generation of precursor metabolites and energy,BP,
11246,GO:0043470,1,0.52389485851631,0,80,regulation of carbohydrate catabolic process,BP,
11247,GO:0043471,1,0.942491199779569,0,9,regulation of cellular carbohydrate catabolic process,BP,
11248,GO:0043473,1,0.495088297645284,0,94,pigmentation,BP,
11249,GO:0043474,1,0.99056989974232,0,2,pigment metabolic process involved in pigmentation,BP,
11250,GO:0043476,1,0.909270692295115,0,12,pigment accumulation,BP,
11251,GO:0043482,1,0.909270692295115,0,12,cellular pigment accumulation,BP,
11253,GO:0043485,1,0.941342523061306,0,10,endosome to pigment granule transport,BP,
11254,GO:0043486,1,0.792615106775815,0,38,histone exchange,BP,
11257,GO:0043489,1,0.730824232716406,0,44,RNA stabilization,BP,
11258,GO:0043490,1,0.977523905010534,0,4,malate-aspartate shuttle,BP,
11260,GO:0043495,1,0.876857500025698,0,18,protein-membrane adaptor activity,MF,
11261,GO:0043496,1,0.9883458450248,0,1,regulation of protein homodimerization activity,BP,
11262,GO:0043500,1,0.470981427833676,0,99,muscle adaptation,BP,
11263,GO:0043501,1,0.855786190111917,0,22,skeletal muscle adaptation,BP,
11264,GO:0043502,1,0.530383511985063,0,76,regulation of muscle adaptation,BP,
11265,GO:0043503,1,0.984656657260173,0,4,skeletal muscle fiber adaptation,BP,
11266,GO:0043504,1,0.963198504493411,0,6,mitochondrial DNA repair,BP,
11267,GO:0043506,1,0.545964445660672,0,81,regulation of JUN kinase activity,BP,
11268,GO:0043507,1,0.583966291249621,0,68,positive regulation of JUN kinase activity,BP,
11269,GO:0043508,1,0.928959440052872,0,13,negative regulation of JUN kinase activity,BP,
11270,GO:0043509,1,0.99584795140391,0,1,activin A complex,CC,
11271,GO:0043511,1,0.992464047343705,0,2,inhibin complex,CC,
11272,GO:0043512,1,0.992464047343705,0,2,inhibin A complex,CC,
11273,GO:0043513,1,0.99660212903607,0,1,inhibin B complex,CC,
11274,GO:0043514,1,0.996590607678115,0,1,interleukin-12 complex,CC,
11275,GO:0043515,1,0.95059841370291,0,6,kinetochore binding,MF,
11276,GO:0043516,1,0.817096783067366,0,31,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11277,GO:0043517,1,0.89547600058049,0,15,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11278,GO:0043518,1,0.925700688011721,0,13,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11279,GO:0043519,1,0.995932580157358,0,1,regulation of myosin II filament organization,BP,
11280,GO:0043522,1,0.955985209419353,0,8,leucine zipper domain binding,MF,
11283,GO:0043525,1,0.699419416077159,0,54,positive regulation of neuron apoptotic process,BP,
11284,GO:0043527,1,0.97903452840925,0,5,tRNA methyltransferase complex,CC,
11285,GO:0043531,1,0.775503267875389,0,33,ADP binding,MF,
11286,GO:0043532,1,0.987168978012463,0,1,angiostatin binding,MF,
11287,GO:0043533,1,0.951124270315145,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11291,GO:0043537,1,0.78516291897457,0,32,negative regulation of blood vessel endothelial cell migration,BP,
11292,GO:0043538,1,0.994371075172331,0,1,regulation of actin phosphorylation,BP,
11294,GO:0043540,1,0.996349183774901,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11295,GO:0043541,1,0.989807792934038,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11298,GO:0043544,1,0.993282280062323,0,1,lipoamide binding,MF,
11299,GO:0043545,1,0.966933966056222,0,6,molybdopterin cofactor metabolic process,BP,
11300,GO:0043546,1,0.967378231739752,0,4,molybdopterin cofactor binding,MF,
11302,GO:0043548,1,0.773352236681795,0,28,phosphatidylinositol 3-kinase binding,MF,
11306,GO:0043552,1,0.783817996214081,0,33,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11307,GO:0043553,1,0.98693606303198,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11308,GO:0043555,1,0.866266798085588,0,20,regulation of translation in response to stress,BP,
11309,GO:0043558,1,0.911833754256092,0,14,regulation of translational initiation in response to stress,BP,
11310,GO:0043559,1,0.932651321051638,0,6,insulin binding,MF,
11311,GO:0043560,1,0.903331876900548,0,10,insulin receptor substrate binding,MF,
11312,GO:0043562,1,0.952177816248799,0,11,cellular response to nitrogen levels,BP,
11313,GO:0043564,1,0.989492043850898,0,2,Ku70:Ku80 complex,CC,
11316,GO:0043568,1,0.925596413281963,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11317,GO:0043569,1,0.960014642491948,0,6,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11318,GO:0043570,1,0.959424992677459,0,6,maintenance of DNA repeat elements,BP,
11319,GO:0043574,1,0.672318833691637,0,72,peroxisomal transport,BP,
11321,GO:0043578,1,0.954145572075009,0,3,nuclear matrix organization,BP,
11323,GO:0043584,1,0.878277037334614,0,15,nose development,BP,
11324,GO:0043585,1,0.968632117660244,0,3,nose morphogenesis,BP,
11325,GO:0043586,1,0.841835877055153,0,22,tongue development,BP,
11326,GO:0043587,1,0.934271875491314,0,10,tongue morphogenesis,BP,
11329,GO:0043596,1,0.780124962279046,0,40,nuclear replication fork,CC,
11330,GO:0043601,1,0.876596309722113,0,23,nuclear replisome,CC,
11331,GO:0043602,1,0.995338132508373,0,1,nitrate catabolic process,BP,
11334,GO:0043605,1,0.988835840492286,0,3,cellular amide catabolic process,BP,
11335,GO:0043606,1,0.980112043616179,0,4,formamide metabolic process,BP,
11336,GO:0043610,1,0.983542179762854,0,1,regulation of carbohydrate utilization,BP,
11337,GO:0043614,1,0.981967902031704,0,2,multi-eIF complex,CC,
11338,GO:0043615,1,0.963892351244043,0,7,astrocyte cell migration,BP,
11339,GO:0043616,1,0.729964454631616,0,38,keratinocyte proliferation,BP,
11340,GO:0043618,1,0.558339496880796,0,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11341,GO:0043619,1,0.919124634792587,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11342,GO:0043620,1,0.534408881563154,0,108,regulation of DNA-templated transcription in response to stress,BP,
11343,GO:0043621,1,0.647588750091471,0,53,protein self-association,MF,
11344,GO:0043622,1,0.968340607300447,0,4,cortical microtubule organization,BP,
11346,GO:0043625,1,0.980464153272519,0,4,delta DNA polymerase complex,CC,
11347,GO:0043626,1,0.996651314650244,0,1,PCNA complex,CC,
11349,GO:0043628,1,0.827573484284822,0,36,ncRNA 3'-end processing,BP,
11350,GO:0043631,1,0.74792117093706,0,42,RNA polyadenylation,BP,
11351,GO:0043632,1,0.0156549323955423,0,594,modification-dependent macromolecule catabolic process,BP,
11352,GO:0043633,1,0.96883113576645,0,7,polyadenylation-dependent RNA catabolic process,BP,
11353,GO:0043634,1,0.977429395267936,0,6,polyadenylation-dependent ncRNA catabolic process,BP,
11354,GO:0043647,1,0.622473767662658,0,64,inositol phosphate metabolic process,BP,
11355,GO:0043648,1,0.615830307188655,0,87,dicarboxylic acid metabolic process,BP,
11356,GO:0043649,1,0.917500551565554,0,17,dicarboxylic acid catabolic process,BP,
11357,GO:0043650,1,0.929116838282888,0,13,dicarboxylic acid biosynthetic process,BP,
11358,GO:0043651,1,0.908996234690249,0,18,linoleic acid metabolic process,BP,
11359,GO:0043652,1,0.894955655774663,0,16,engulfment of apoptotic cell,BP,
11360,GO:0043653,1,0.942774784452295,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11361,GO:0043654,1,0.958476752793886,0,6,recognition of apoptotic cell,BP,
11362,GO:0043656,1,0.920574476310375,0,12,host intracellular region,CC,
11363,GO:0043657,1,0.655152135133063,0,60,host cell,CC,
11366,GO:0043682,1,0.97209168825435,0,2,copper transmembrane transporter activity, phosphorylative mechanism,MF,
11367,GO:0043686,1,0.986970665959613,0,3,co-translational protein modification,BP,
11369,GO:0043691,1,0.916715369381245,0,14,reverse cholesterol transport,BP,
11370,GO:0043696,1,0.938415668722903,0,8,dedifferentiation,BP,
11371,GO:0043697,1,0.938415668722903,0,8,cell dedifferentiation,BP,
11372,GO:0043715,1,0.996052145380911,0,1,2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity,MF,
11373,GO:0043716,1,0.996052145380911,0,1,2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity,MF,
11374,GO:0043727,1,0.99378130158399,0,1,5-amino-4-imidazole carboxylate lyase activity,MF,
11375,GO:0043733,1,0.996767636191414,0,1,DNA-3-methylbase glycosylase activity,MF,
11376,GO:0043734,1,0.985193431597125,0,3,DNA-N1-methyladenine dioxygenase activity,MF,
11377,GO:0043739,1,0.993974967007127,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11378,GO:0043754,1,0.980121128446897,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11379,GO:0043783,1,0.995582994103754,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11380,GO:0043795,1,0.996612746461703,0,1,glyceraldehyde oxidoreductase activity,MF,
11381,GO:0043812,1,0.968278806247534,0,4,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11382,GO:0043813,1,0.982836584359064,0,2,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11383,GO:0043843,1,0.995255489379337,0,1,ADP-specific glucokinase activity,MF,
11384,GO:0043849,1,0.994615979273346,0,1,Ras palmitoyltransferase activity,MF,
11385,GO:0043855,1,0.937130453839342,0,9,cyclic nucleotide-gated ion channel activity,MF,
11386,GO:0043865,1,0.994871055428955,0,1,methionine transmembrane transporter activity,MF,
11387,GO:0043874,1,0.996052145380911,0,1,acireductone synthase activity,MF,
11388,GO:0043878,1,0.971824998610618,0,5,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity,MF,
11389,GO:0043890,1,0.995557013166674,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11390,GO:0043891,1,0.996664269302455,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11393,GO:0043902,1,0.787541741038126,0,34,positive regulation of multi-organism process,BP,
11395,GO:0043914,1,0.992577439675333,0,1,NADPH:sulfur oxidoreductase activity,MF,
11396,GO:0043915,1,0.996383585878319,0,1,L-seryl-tRNA(Sec) kinase activity,MF,
11397,GO:0043916,1,0.996767636191414,0,1,DNA-7-methylguanine glycosylase activity,MF,
11398,GO:0043921,1,0.984209481962722,0,2,modulation by host of viral transcription,BP,
11399,GO:0043922,1,0.934673676752672,0,11,negative regulation by host of viral transcription,BP,
11400,GO:0043923,1,0.878840127819922,0,17,positive regulation by host of viral transcription,BP,
11401,GO:0043924,1,0.971687063568824,0,1,suramin binding,MF,
11402,GO:0043928,1,0.826536766691101,0,32,exonucleolytic catabolism of deadenylated mRNA,BP,
11404,GO:0043932,1,0.978856407677311,0,5,ossification involved in bone remodeling,BP,
11406,GO:0043946,1,0.996344898920264,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11407,GO:0043947,1,0.996344898920264,0,1,positive regulation by host of symbiont catalytic activity,BP,
11408,GO:0043949,1,0.719832418721831,0,46,regulation of cAMP-mediated signaling,BP,
11409,GO:0043950,1,0.909792837468527,0,15,positive regulation of cAMP-mediated signaling,BP,
11410,GO:0043951,1,0.829231309831921,0,24,negative regulation of cAMP-mediated signaling,BP,
11411,GO:0043954,1,0.615631406135187,0,55,cellular component maintenance,BP,
11413,GO:0043967,1,0.612831583847506,0,69,histone H4 acetylation,BP,
11414,GO:0043968,1,0.899062050088671,0,16,histone H2A acetylation,BP,
11415,GO:0043969,1,0.972426551389235,0,3,histone H2B acetylation,BP,
11416,GO:0043970,1,0.909832012271586,0,13,histone H3-K9 acetylation,BP,
11417,GO:0043972,1,0.959873108894647,0,5,histone H3-K23 acetylation,BP,
11418,GO:0043973,1,0.99580153474144,0,1,histone H3-K4 acetylation,BP,
11420,GO:0043977,1,0.994530105079586,0,1,histone H2A-K5 acetylation,BP,
11421,GO:0043979,1,0.994154071280641,0,1,histone H2B-K5 acetylation,BP,
11422,GO:0043980,1,0.994530105079586,0,1,histone H2B-K12 acetylation,BP,
11423,GO:0043981,1,0.903773482184582,0,16,histone H4-K5 acetylation,BP,
11424,GO:0043982,1,0.903773482184582,0,16,histone H4-K8 acetylation,BP,
11425,GO:0043983,1,0.966726502651024,0,7,histone H4-K12 acetylation,BP,
11426,GO:0043984,1,0.864420521471357,0,20,histone H4-K16 acetylation,BP,
11427,GO:0043985,1,0.969969525883571,0,6,histone H4-R3 methylation,BP,
11428,GO:0043987,1,0.974786498929295,0,5,histone H3-S10 phosphorylation,BP,
11429,GO:0043988,1,0.985242407251769,0,3,histone H3-S28 phosphorylation,BP,
11430,GO:0043990,1,0.994277806156971,0,1,histone H2A-S1 phosphorylation,BP,
11431,GO:0043994,1,0.959873108894647,0,5,histone acetyltransferase activity (H3-K23 specific),MF,
11432,GO:0043995,1,0.944502825711329,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11433,GO:0043996,1,0.944502825711329,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11434,GO:0043997,1,0.994219064369316,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11435,GO:0043998,1,0.993795504092006,0,1,H2A histone acetyltransferase activity,MF,
11436,GO:0044003,1,0.76227814938098,0,36,modulation by symbiont of host process,BP,
11438,GO:0044020,1,0.982788419077213,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11439,GO:0044026,1,0.985371007437912,0,3,DNA hypermethylation,BP,
11440,GO:0044027,1,0.992453249302441,0,2,hypermethylation of CpG island,BP,
11441,GO:0044028,1,0.98719434334525,0,2,DNA hypomethylation,BP,
11442,GO:0044029,1,0.98719434334525,0,2,hypomethylation of CpG island,BP,
11443,GO:0044030,1,0.880556916625557,0,19,regulation of DNA methylation,BP,
11446,GO:0044036,1,0.993129762539128,0,2,cell wall macromolecule metabolic process,BP,
11447,GO:0044038,1,0.996318235555698,0,1,cell wall macromolecule biosynthetic process,BP,
11448,GO:0044042,1,0.591238442266318,0,65,glucan metabolic process,BP,
11449,GO:0044053,1,0.995487961521597,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11451,GO:0044058,1,0.839259271843872,0,32,regulation of digestive system process,BP,
11452,GO:0044060,1,0.793208708266575,0,40,regulation of endocrine process,BP,
11453,GO:0044062,1,0.892212035540571,0,21,regulation of excretion,BP,
11454,GO:0044065,1,0.901874145727519,0,15,regulation of respiratory system process,BP,
11455,GO:0044068,1,0.842299232406428,0,25,modulation by symbiont of host cellular process,BP,
11456,GO:0044070,1,0.542303226000746,0,90,regulation of anion transport,BP,
11465,GO:0044094,1,0.971493687599215,0,4,host cell nuclear part,CC,
11466,GO:0044105,1,0.99684176521765,0,1,L-xylulose reductase (NAD+) activity,MF,
11467,GO:0044106,1,0.541593324971166,0,120,cellular amine metabolic process,BP,
11468,GO:0044107,1,0.98754902529037,0,3,cellular alcohol metabolic process,BP,
11469,GO:0044108,1,0.98754902529037,0,3,cellular alcohol biosynthetic process,BP,
11470,GO:0044110,1,0.996812011353675,0,1,growth involved in symbiotic interaction,BP,
11473,GO:0044117,1,0.996812011353675,0,1,growth of symbiont in host,BP,
11476,GO:0044154,1,0.908619258578328,0,14,histone H3-K14 acetylation,BP,
11477,GO:0044183,1,0.889931656231229,0,25,protein folding chaperone,MF,
11478,GO:0044190,1,0.996338670751475,0,1,host cell mitochondrial envelope,CC,
11479,GO:0044194,1,0.979018551999195,0,5,cytolytic granule,CC,
11480,GO:0044205,1,0.977633160849535,0,3,'de novo' UMP biosynthetic process,BP,
11481,GO:0044206,1,0.980774437232525,0,5,UMP salvage,BP,
11482,GO:0044207,1,0.992080737099825,0,1,translation initiation ternary complex,CC,
11483,GO:0044208,1,0.99656258692143,0,1,'de novo' AMP biosynthetic process,BP,
11484,GO:0044209,1,0.99287326945198,0,2,AMP salvage,BP,
11485,GO:0044210,1,0.987460446748115,0,2,'de novo' CTP biosynthetic process,BP,
11486,GO:0044211,1,0.988893829890742,0,3,CTP salvage,BP,
11487,GO:0044214,1,0.896958580586154,0,11,spanning component of plasma membrane,CC,
11488,GO:0044216,1,0.984609278154942,0,2,other organism cell,CC,
11489,GO:0044217,1,0.984609278154942,0,2,other organism part,CC,
11490,GO:0044218,1,0.995018911955248,0,1,other organism cell membrane,CC,
11491,GO:0044220,1,0.990736405517665,0,1,host cell perinuclear region of cytoplasm,CC,
11493,GO:0044228,1,0.99093847157835,0,1,host cell surface,CC,
11494,GO:0044232,1,0.848661851700364,0,25,organelle membrane contact site,CC,
11495,GO:0044233,1,0.90263759788744,0,16,mitochondria-associated endoplasmic reticulum membrane,CC,
11498,GO:0044241,1,0.934772505454057,0,12,lipid digestion,BP,
11499,GO:0044242,1,0.281765560479259,0,209,cellular lipid catabolic process,BP,
11500,GO:0044245,1,0.979758359019044,0,3,polysaccharide digestion,BP,
11501,GO:0044247,1,0.827672794934472,0,23,cellular polysaccharide catabolic process,BP,
11506,GO:0044258,1,0.995527713529486,0,1,intestinal lipid catabolic process,BP,
11516,GO:0044275,1,0.753886297908148,0,38,cellular carbohydrate catabolic process,BP,
11517,GO:0044278,1,0.9968460138118,0,1,cell wall disruption in other organism,BP,
11522,GO:0044292,1,0.917141360563883,0,12,dendrite terminus,CC,
11523,GO:0044294,1,0.933386069792283,0,8,dendritic growth cone,CC,
11524,GO:0044295,1,0.774755527272724,0,27,axonal growth cone,CC,
11528,GO:0044301,1,0.988017898268581,0,2,climbing fiber,CC,
11529,GO:0044302,1,0.948551728739031,0,5,dentate gyrus mossy fiber,CC,
11533,GO:0044307,1,0.948497853911117,0,3,dendritic branch,CC,
11534,GO:0044308,1,0.965295510151793,0,3,axonal spine,CC,
11536,GO:0044313,1,0.965890752110596,0,3,protein K6-linked deubiquitination,BP,
11537,GO:0044314,1,0.983915604978545,0,4,protein K27-linked ubiquitination,BP,
11538,GO:0044316,1,0.988272728241187,0,2,cone cell pedicle,CC,
11539,GO:0044317,1,0.996631457948612,0,1,rod spherule,CC,
11541,GO:0044320,1,0.90301624525148,0,17,cellular response to leptin stimulus,BP,
11542,GO:0044321,1,0.858823826301291,0,22,response to leptin,BP,
11543,GO:0044322,1,0.846014791148932,0,22,endoplasmic reticulum quality control compartment,CC,
11544,GO:0044323,1,0.959949232179513,0,6,retinoic acid-responsive element binding,MF,
11545,GO:0044324,1,0.99682342012482,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11547,GO:0044326,1,0.948207773383023,0,7,dendritic spine neck,CC,
11548,GO:0044327,1,0.930613155345669,0,11,dendritic spine head,CC,
11549,GO:0044331,1,0.819025922499659,0,25,cell-cell adhesion mediated by cadherin,BP,
11550,GO:0044332,1,0.99147817964269,0,1,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11551,GO:0044333,1,0.996209031132368,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11552,GO:0044334,1,0.986118990723247,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11553,GO:0044335,1,0.981305227661746,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11554,GO:0044336,1,0.97973096451525,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11555,GO:0044338,1,0.988299080813079,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11556,GO:0044339,1,0.978792683367222,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11557,GO:0044340,1,0.958005626413133,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11558,GO:0044341,1,0.967709160440929,0,6,sodium-dependent phosphate transport,BP,
11559,GO:0044342,1,0.901807834296433,0,19,type B pancreatic cell proliferation,BP,
11560,GO:0044343,1,0.99147817964269,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11562,GO:0044345,1,0.99147817964269,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11563,GO:0044346,1,0.864813499233921,0,20,fibroblast apoptotic process,BP,
11564,GO:0044349,1,0.996363308056365,0,1,DNA excision,BP,
11565,GO:0044351,1,0.936899550561193,0,9,macropinocytosis,BP,
11568,GO:0044355,1,0.996586702756766,0,1,clearance of foreign intracellular DNA,BP,
11569,GO:0044357,1,0.996263518456062,0,1,regulation of rRNA stability,BP,
11572,GO:0044374,1,0.99298102438128,0,1,sequence-specific DNA binding, bending,MF,
11573,GO:0044375,1,0.990015517682615,0,3,regulation of peroxisome size,BP,
11574,GO:0044377,1,0.99298102438128,0,1,RNA polymerase II cis-regulatory region sequence-specific DNA binding, bending,MF,
11575,GO:0044378,1,0.98483823165449,0,2,non-sequence-specific DNA binding, bending,MF,
11576,GO:0044379,1,0.992316731529853,0,1,protein localization to actin cortical patch,BP,
11577,GO:0044380,1,0.612300371633981,0,56,protein localization to cytoskeleton,BP,
11578,GO:0044381,1,0.988225449352806,0,2,glucose import in response to insulin stimulus,BP,
11579,GO:0044387,1,0.947203564842704,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11580,GO:0044388,1,0.980733309103171,0,5,small protein activating enzyme binding,MF,
11581,GO:0044389,1,0.139186392992044,0,300,ubiquitin-like protein ligase binding,MF,
11583,GO:0044391,1,0.513090167998525,0,177,ribosomal subunit,CC,
11584,GO:0044393,1,0.972299056830852,0,4,microspike,CC,
11588,GO:0044409,1,0.413738191600517,0,131,entry into host,BP,
11589,GO:0044417,1,0.95615036546492,0,9,translocation of molecules into host,BP,
11591,GO:0044458,1,0.896663674507708,0,20,motile cilium assembly,BP,
11592,GO:0044466,1,0.993201163620248,0,2,glutaryl-CoA hydrolase activity,MF,
11593,GO:0044467,1,0.970177664671789,0,3,glial cell-derived neurotrophic factor secretion,BP,
11594,GO:0044501,1,0.983988776168783,0,2,modulation of signal transduction in other organism,BP,
11595,GO:0044508,1,0.99420924187086,0,1,glucagon-like peptide 1 receptor activity,MF,
11596,GO:0044524,1,0.996346806019679,0,1,protein sulfhydration,BP,
11597,GO:0044528,1,0.957288362588125,0,7,regulation of mitochondrial mRNA stability,BP,
11598,GO:0044530,1,0.973446321432122,0,3,supraspliceosomal complex,CC,
11599,GO:0044531,1,0.966903895350137,0,6,modulation of programmed cell death in other organism,BP,
11600,GO:0044532,1,0.966903895350137,0,6,modulation of apoptotic process in other organism,BP,
11601,GO:0044533,1,0.996664269302455,0,1,positive regulation of apoptotic process in other organism,BP,
11602,GO:0044539,1,0.893706669069977,0,16,long-chain fatty acid import into cell,BP,
11603,GO:0044540,1,0.996346806019679,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11604,GO:0044545,1,0.959207163981474,0,7,NSL complex,CC,
11605,GO:0044546,1,0.903333581244576,0,14,NLRP3 inflammasome complex assembly,BP,
11606,GO:0044547,1,0.969613515649959,0,5,DNA topoisomerase binding,MF,
11608,GO:0044549,1,0.996864307981542,0,1,GTP cyclohydrolase binding,MF,
11609,GO:0044550,1,0.841750172637648,0,21,secondary metabolite biosynthetic process,BP,
11610,GO:0044557,1,0.954550271019523,0,7,relaxation of smooth muscle,BP,
11611,GO:0044565,1,0.99106877144325,0,2,dendritic cell proliferation,BP,
11612,GO:0044571,1,0.982718769205217,0,5,[2Fe-2S] cluster assembly,BP,
11613,GO:0044594,1,0.995029444403381,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11614,GO:0044595,1,0.996689329953739,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11615,GO:0044596,1,0.996689329953739,0,1,3-demethylubiquinol-10 3-O-methyltransferase activity,MF,
11616,GO:0044597,1,0.966944050393003,0,9,daunorubicin metabolic process,BP,
11617,GO:0044598,1,0.966944050393003,0,9,doxorubicin metabolic process,BP,
11618,GO:0044599,1,0.994890876864838,0,1,AP-5 adaptor complex,CC,
11619,GO:0044601,1,0.996432894868642,0,1,protein denucleotidylation,BP,
11620,GO:0044602,1,0.996432894868642,0,1,protein deadenylylation,BP,
11621,GO:0044603,1,0.996432894868642,0,1,protein adenylylhydrolase activity,MF,
11622,GO:0044609,1,0.990807040781122,0,2,DBIRD complex,CC,
11623,GO:0044610,1,0.995715294575166,0,1,FMN transmembrane transporter activity,MF,
11624,GO:0044611,1,0.969129448130117,0,3,nuclear pore inner ring,CC,
11625,GO:0044613,1,0.96054100415284,0,8,nuclear pore central transport channel,CC,
11626,GO:0044614,1,0.968133994501627,0,3,nuclear pore cytoplasmic filaments,CC,
11627,GO:0044615,1,0.906694246082535,0,12,nuclear pore nuclear basket,CC,
11628,GO:0044620,1,0.996871328163206,0,1,ACP phosphopantetheine attachment site binding,MF,
11629,GO:0044648,1,0.950912344447326,0,6,histone H3-K4 dimethylation,BP,
11630,GO:0044650,1,0.947218755867676,0,9,adhesion of symbiont to host cell,BP,
11631,GO:0044651,1,0.996680149484342,0,1,adhesion of symbiont to host epithelial cell,BP,
11632,GO:0044657,1,0.993789273276728,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11633,GO:0044665,1,0.818349509974681,0,28,MLL1/2 complex,CC,
11634,GO:0044666,1,0.927396347218183,0,11,MLL3/4 complex,CC,
11638,GO:0044715,1,0.996717186250348,0,1,8-oxo-dGDP phosphatase activity,MF,
11639,GO:0044721,1,0.996154174627011,0,1,protein import into peroxisome matrix, substrate release,BP,
11640,GO:0044722,1,0.992681321135424,0,1,renal phosphate excretion,BP,
11641,GO:0044725,1,0.979855282436032,0,1,chromatin reprogramming in the zygote,BP,
11642,GO:0044727,1,0.979855282436032,0,1,DNA demethylation of male pronucleus,BP,
11643,GO:0044728,1,0.550984375535625,0,82,DNA methylation or demethylation,BP,
11644,GO:0044729,1,0.988689959805717,0,2,hemi-methylated DNA-binding,MF,
11646,GO:0044736,1,0.989807596705769,0,2,acid-sensing ion channel activity,MF,
11647,GO:0044743,1,0.84784717908849,0,33,protein transmembrane import into intracellular organelle,BP,
11648,GO:0044752,1,0.983024337108784,0,3,response to human chorionic gonadotropin,BP,
11649,GO:0044753,1,0.977438052260874,0,2,amphisome,CC,
11650,GO:0044754,1,0.946926785561598,0,9,autolysosome,CC,
11651,GO:0044764,1,0.891265014495663,0,16,multi-organism cellular process,BP,
11652,GO:0044766,1,0.639984393171686,0,61,multi-organism transport,BP,
11653,GO:0044769,1,0.902100076272282,0,19,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11655,GO:0044771,1,0.967866789193515,0,6,meiotic cell cycle phase transition,BP,
11657,GO:0044773,1,0.52928950108171,0,94,mitotic DNA damage checkpoint,BP,
11658,GO:0044774,1,0.505798219536591,0,101,mitotic DNA integrity checkpoint,BP,
11659,GO:0044778,1,0.995881955072915,0,1,meiotic DNA integrity checkpoint,BP,
11660,GO:0044779,1,0.994400996008306,0,1,meiotic spindle checkpoint,BP,
11661,GO:0044782,1,0.068456942926325,0,353,cilium organization,BP,
11662,GO:0044783,1,0.652553547269522,0,62,G1 DNA damage checkpoint,BP,
11663,GO:0044784,1,0.669381064020223,0,58,metaphase/anaphase transition of cell cycle,BP,
11664,GO:0044785,1,0.990613493380433,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11665,GO:0044786,1,0.667553307174216,0,63,cell cycle DNA replication,BP,
11667,GO:0044789,1,0.967675173676734,0,4,modulation by host of viral release from host cell,BP,
11668,GO:0044791,1,0.967675173676734,0,4,positive regulation by host of viral release from host cell,BP,
11670,GO:0044794,1,0.89597270172596,0,14,positive regulation by host of viral process,BP,
11671,GO:0044795,1,0.996739997991537,0,1,trans-Golgi network to recycling endosome transport,BP,
11672,GO:0044796,1,0.996651314650244,0,1,DNA polymerase processivity factor complex,CC,
11673,GO:0044800,1,0.966177275585539,0,7,multi-organism membrane fusion,BP,
11674,GO:0044803,1,0.941013571375893,0,10,multi-organism membrane organization,BP,
11675,GO:0044804,1,0.891018640199514,0,14,autophagy of nucleus,BP,
11676,GO:0044805,1,0.943294166743916,0,5,late nucleophagy,BP,
11677,GO:0044806,1,0.943231232129363,0,7,G-quadruplex DNA unwinding,BP,
11678,GO:0044815,1,0.86607342894915,0,18,DNA packaging complex,CC,
11679,GO:0044818,1,0.824021549534566,0,27,mitotic G2/M transition checkpoint,BP,
11680,GO:0044819,1,0.653392886146105,0,62,mitotic G1/S transition checkpoint,BP,
11681,GO:0044821,1,0.989288046336387,0,2,meiotic telomere tethering at nuclear periphery,BP,
11682,GO:0044827,1,0.902327310357191,0,15,modulation by host of viral genome replication,BP,
11683,GO:0044828,1,0.964072379781418,0,5,negative regulation by host of viral genome replication,BP,
11684,GO:0044829,1,0.942891314908563,0,7,positive regulation by host of viral genome replication,BP,
11685,GO:0044830,1,0.982658413129344,0,3,modulation by host of viral RNA genome replication,BP,
11686,GO:0044837,1,0.952583461910416,0,7,actomyosin contractile ring organization,BP,
11687,GO:0044839,1,0.190467585407663,0,255,cell cycle G2/M phase transition,BP,
11689,GO:0044848,1,0.922335719167871,0,11,biological phase,BP,
11690,GO:0044849,1,0.9052539262046,0,15,estrous cycle,BP,
11691,GO:0044851,1,0.937667425061649,0,9,hair cycle phase,BP,
11692,GO:0044853,1,0.447876303191153,0,103,plasma membrane raft,CC,
11693,GO:0044854,1,0.978131226481269,0,5,plasma membrane raft assembly,BP,
11694,GO:0044855,1,0.985341592372821,0,2,plasma membrane raft distribution,BP,
11695,GO:0044856,1,0.985341592372821,0,2,plasma membrane raft localization,BP,
11696,GO:0044857,1,0.957312038680894,0,8,plasma membrane raft organization,BP,
11697,GO:0044858,1,0.99495082173244,0,1,plasma membrane raft polarization,BP,
11698,GO:0044860,1,0.975418637828513,0,4,protein localization to plasma membrane raft,BP,
11699,GO:0044861,1,0.985063252496382,0,2,protein transport into plasma membrane raft,BP,
11700,GO:0044866,1,0.996146141141497,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11701,GO:0044867,1,0.996146141141497,0,1,modulation by host of viral catalytic activity,BP,
11702,GO:0044868,1,0.983876011962798,0,2,modulation by host of viral molecular function,BP,
11703,GO:0044869,1,0.996146141141497,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11704,GO:0044870,1,0.996146141141497,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11705,GO:0044871,1,0.996146141141497,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11706,GO:0044872,1,0.85586016137714,0,12,lipoprotein localization,BP,
11707,GO:0044873,1,0.977299273714976,0,1,lipoprotein localization to membrane,BP,
11709,GO:0044878,1,0.98456839499374,0,4,mitotic cytokinesis checkpoint,BP,
11710,GO:0045002,1,0.969357982767822,0,6,double-strand break repair via single-strand annealing,BP,
11711,GO:0045003,1,0.950492334044216,0,9,double-strand break repair via synthesis-dependent strand annealing,BP,
11712,GO:0045004,1,0.978725679407719,0,2,DNA replication proofreading,BP,
11713,GO:0045005,1,0.742069101067579,0,40,DNA-dependent DNA replication maintenance of fidelity,BP,
11714,GO:0045006,1,0.949657808643023,0,13,DNA deamination,BP,
11715,GO:0045007,1,0.98922286187137,0,3,depurination,BP,
11716,GO:0045008,1,0.967379122836914,0,8,depyrimidination,BP,
11717,GO:0045009,1,0.943738389879405,0,13,chitosome,CC,
11719,GO:0045016,1,0.993775211167078,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11721,GO:0045019,1,0.905224606285261,0,14,negative regulation of nitric oxide biosynthetic process,BP,
11722,GO:0045022,1,0.756800108736539,0,37,early endosome to late endosome transport,BP,
11723,GO:0045023,1,0.73215901773491,0,41,G0 to G1 transition,BP,
11724,GO:0045025,1,0.98662423840855,0,2,mitochondrial degradosome,CC,
11725,GO:0045026,1,0.95615321619862,0,11,plasma membrane fusion,BP,
11726,GO:0045027,1,0.98954478093089,0,2,DNA end binding,MF,
11727,GO:0045028,1,0.944074906244745,0,13,G protein-coupled purinergic nucleotide receptor activity,MF,
11728,GO:0045029,1,0.991569313928163,0,2,G protein-coupled UDP receptor activity,MF,
11729,GO:0045030,1,0.992790983998605,0,2,G protein-coupled UTP receptor activity,MF,
11730,GO:0045031,1,0.990390314497579,0,2,G protein-coupled ATP receptor activity,MF,
11731,GO:0045039,1,0.974811586031992,0,7,protein insertion into mitochondrial inner membrane,BP,
11732,GO:0045040,1,0.976914869740942,0,5,protein insertion into mitochondrial outer membrane,BP,
11733,GO:0045041,1,0.98801705692311,0,3,protein import into mitochondrial intermembrane space,BP,
11734,GO:0045046,1,0.964788963881063,0,6,protein import into peroxisome membrane,BP,
11735,GO:0045047,1,0.653413000248838,0,107,protein targeting to ER,BP,
11736,GO:0045048,1,0.959695357721812,0,7,protein insertion into ER membrane,BP,
11737,GO:0045053,1,0.908239466986024,0,5,protein retention in Golgi apparatus,BP,
11738,GO:0045054,1,0.96221832830908,0,7,constitutive secretory pathway,BP,
11740,GO:0045056,1,0.841546384835168,0,19,transcytosis,BP,
11741,GO:0045058,1,0.724122636804525,0,46,T cell selection,BP,
11742,GO:0045059,1,0.923175057273486,0,13,positive thymic T cell selection,BP,
11743,GO:0045060,1,0.929770244479068,0,11,negative thymic T cell selection,BP,
11744,GO:0045061,1,0.868588982980969,0,21,thymic T cell selection,BP,
11745,GO:0045062,1,0.996379937479829,0,1,extrathymic T cell selection,BP,
11748,GO:0045065,1,0.984455301728755,0,3,cytotoxic T cell differentiation,BP,
11749,GO:0045066,1,0.832936771697904,0,30,regulatory T cell differentiation,BP,
11751,GO:0045070,1,0.764890732003594,0,35,positive regulation of viral genome replication,BP,
11755,GO:0045089,1,0.321801787351794,0,181,positive regulation of innate immune response,BP,
11756,GO:0045091,1,0.904561414482288,0,17,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11757,GO:0045092,1,0.988507432151851,0,2,interleukin-18 receptor complex,CC,
11758,GO:0045095,1,0.89858229443467,0,22,keratin filament,CC,
11759,GO:0045098,1,0.988212860295268,0,3,type III intermediate filament,CC,
11762,GO:0045105,1,0.989362518301575,0,1,intermediate filament polymerization or depolymerization,BP,
11763,GO:0045106,1,0.989362518301575,0,1,intermediate filament depolymerization,BP,
11764,GO:0045108,1,0.989362518301575,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11769,GO:0045113,1,0.977757601467463,0,4,regulation of integrin biosynthetic process,BP,
11770,GO:0045116,1,0.924244005571031,0,14,protein neddylation,BP,
11771,GO:0045117,1,0.938215880168263,0,11,azole transmembrane transport,BP,
11772,GO:0045120,1,0.901366384137539,0,13,pronucleus,CC,
11775,GO:0045124,1,0.762067735126478,0,38,regulation of bone resorption,BP,
11776,GO:0045125,1,0.932023117119461,0,15,bioactive lipid receptor activity,MF,
11777,GO:0045127,1,0.996491566811983,0,1,N-acetylglucosamine kinase activity,MF,
11778,GO:0045130,1,0.99498364907565,0,1,keratan sulfotransferase activity,MF,
11779,GO:0045131,1,0.994493964714736,0,1,pre-mRNA branch point binding,MF,
11780,GO:0045132,1,0.624361128362705,0,71,meiotic chromosome segregation,BP,
11781,GO:0045134,1,0.979203487481075,0,4,uridine-diphosphatase activity,MF,
11782,GO:0045136,1,0.942151433534113,0,8,development of secondary sexual characteristics,BP,
11783,GO:0045137,1,0.244810277140511,0,196,development of primary sexual characteristics,BP,
11784,GO:0045141,1,0.947507860849811,0,7,meiotic telomere clustering,BP,
11785,GO:0045142,1,0.98376301420374,0,2,triplex DNA binding,MF,
11786,GO:0045143,1,0.743754413198421,0,45,homologous chromosome segregation,BP,
11787,GO:0045144,1,0.955554409255495,0,9,meiotic sister chromatid segregation,BP,
11788,GO:0045145,1,0.980899824221054,0,4,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11789,GO:0045153,1,0.996715808738008,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11790,GO:0045155,1,0.986209180896091,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11791,GO:0045159,1,0.897751157010302,0,13,myosin II binding,MF,
11793,GO:0045162,1,0.927570727823036,0,7,clustering of voltage-gated sodium channels,BP,
11796,GO:0045167,1,0.996376272026149,0,1,asymmetric protein localization involved in cell fate determination,BP,
11797,GO:0045168,1,0.99044437061583,0,2,cell-cell signaling involved in cell fate commitment,BP,
11798,GO:0045171,1,0.658295167231925,0,66,intercellular bridge,CC,
11799,GO:0045174,1,0.993414747014903,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11800,GO:0045176,1,0.873866676708842,0,14,apical protein localization,BP,
11802,GO:0045178,1,0.566186647908542,0,66,basal part of cell,CC,
11803,GO:0045179,1,0.951478181204779,0,8,apical cortex,CC,
11804,GO:0045180,1,0.940925522433613,0,5,basal cortex,CC,
11806,GO:0045183,1,0.994890876864838,0,1,translation factor activity, non-nucleic acid binding,MF,
11808,GO:0045185,1,0.497572315432647,0,92,maintenance of protein location,BP,
11809,GO:0045186,1,0.985778334966178,0,1,zonula adherens assembly,BP,
11810,GO:0045187,1,0.919457713721443,0,17,regulation of circadian sleep/wake cycle, sleep,BP,
11811,GO:0045188,1,0.960070760548266,0,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11812,GO:0045190,1,0.757871840133272,0,43,isotype switching,BP,
11813,GO:0045191,1,0.827813731052439,0,29,regulation of isotype switching,BP,
11814,GO:0045196,1,0.975335146053687,0,3,establishment or maintenance of neuroblast polarity,BP,
11815,GO:0045197,1,0.698390282969725,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11816,GO:0045198,1,0.892444457770852,0,15,establishment of epithelial cell apical/basal polarity,BP,
11817,GO:0045199,1,0.928910110331293,0,11,maintenance of epithelial cell apical/basal polarity,BP,
11818,GO:0045200,1,0.975335146053687,0,3,establishment of neuroblast polarity,BP,
11820,GO:0045204,1,0.975158782141694,0,3,MAPK export from nucleus,BP,
11821,GO:0045208,1,0.993321626659884,0,1,MAPK phosphatase export from nucleus,BP,
11822,GO:0045209,1,0.993321626659884,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11823,GO:0045210,1,0.978373181014287,0,2,FasL biosynthetic process,BP,
11825,GO:0045212,1,0.995221118478006,0,1,neurotransmitter receptor biosynthetic process,BP,
11826,GO:0045213,1,0.987287018334708,0,3,neurotransmitter receptor metabolic process,BP,
11827,GO:0045214,1,0.699793203745241,0,42,sarcomere organization,BP,
11828,GO:0045216,1,0.230417346580575,0,188,cell-cell junction organization,BP,
11829,GO:0045217,1,0.918504277165452,0,12,cell-cell junction maintenance,BP,
11830,GO:0045218,1,0.97951224814868,0,3,zonula adherens maintenance,BP,
11831,GO:0045219,1,0.98955966406119,0,1,regulation of FasL production,BP,
11832,GO:0045221,1,0.98955966406119,0,1,negative regulation of FasL production,BP,
11833,GO:0045222,1,0.996739157310398,0,1,CD4 biosynthetic process,BP,
11834,GO:0045223,1,0.996739157310398,0,1,regulation of CD4 production,BP,
11835,GO:0045225,1,0.996739157310398,0,1,negative regulation of CD4 production,BP,
11836,GO:0045226,1,0.984993989335211,0,3,extracellular polysaccharide biosynthetic process,BP,
11837,GO:0045229,1,0.989928950044409,0,2,external encapsulating structure organization,BP,
11838,GO:0045234,1,0.996306344736272,0,1,protein palmitoleylation,BP,
11839,GO:0045236,1,0.932898847932202,0,16,CXCR chemokine receptor binding,MF,
11840,GO:0045237,1,0.993932817609136,0,1,CXCR1 chemokine receptor binding,MF,
11841,GO:0045239,1,0.918786472963068,0,14,tricarboxylic acid cycle enzyme complex,CC,
11842,GO:0045240,1,0.933359338808343,0,10,dihydrolipoyl dehydrogenase complex,CC,
11843,GO:0045244,1,0.995579949107702,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11844,GO:0045252,1,0.964461436589747,0,6,oxoglutarate dehydrogenase complex,CC,
11845,GO:0045254,1,0.95796154995692,0,7,pyruvate dehydrogenase complex,CC,
11846,GO:0045257,1,0.98397300109008,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11847,GO:0045259,1,0.995813403539853,0,1,proton-transporting ATP synthase complex,CC,
11848,GO:0045271,1,0.865193603089621,0,41,respiratory chain complex I,CC,
11849,GO:0045273,1,0.98397300109008,0,4,respiratory chain complex II,CC,
11850,GO:0045275,1,0.960165678163681,0,10,respiratory chain complex III,CC,
11851,GO:0045277,1,0.956333755197456,0,14,respiratory chain complex IV,CC,
11852,GO:0045281,1,0.98397300109008,0,4,succinate dehydrogenase complex,CC,
11853,GO:0045283,1,0.98397300109008,0,4,fumarate reductase complex,CC,
11854,GO:0045292,1,0.835598708512268,0,31,mRNA cis splicing, via spliceosome,BP,
11855,GO:0045293,1,0.962144357929145,0,6,mRNA editing complex,CC,
11859,GO:0045298,1,0.982616449971547,0,2,tubulin complex,CC,
11862,GO:0045322,1,0.941877128059841,0,8,unmethylated CpG binding,MF,
11863,GO:0045324,1,0.893616462446835,0,23,late endosome to vacuole transport,BP,
11864,GO:0045329,1,0.977060980674838,0,5,carnitine biosynthetic process,BP,
11865,GO:0045332,1,0.692049981195255,0,39,phospholipid translocation,BP,
11866,GO:0045333,1,0.452454203447602,0,161,cellular respiration,BP,
11869,GO:0045337,1,0.980507819500929,0,4,farnesyl diphosphate biosynthetic process,BP,
11870,GO:0045338,1,0.97651889667506,0,5,farnesyl diphosphate metabolic process,BP,
11871,GO:0045340,1,0.993170787838579,0,2,mercury ion binding,MF,
11872,GO:0045341,1,0.961352568864453,0,5,MHC class I biosynthetic process,BP,
11873,GO:0045342,1,0.913392505351353,0,14,MHC class II biosynthetic process,BP,
11874,GO:0045343,1,0.961352568864453,0,5,regulation of MHC class I biosynthetic process,BP,
11875,GO:0045344,1,0.995678773209763,0,1,negative regulation of MHC class I biosynthetic process,BP,
11876,GO:0045345,1,0.965526288913794,0,4,positive regulation of MHC class I biosynthetic process,BP,
11877,GO:0045346,1,0.920103307767619,0,13,regulation of MHC class II biosynthetic process,BP,
11878,GO:0045347,1,0.966729676868942,0,6,negative regulation of MHC class II biosynthetic process,BP,
11879,GO:0045348,1,0.948404117422004,0,8,positive regulation of MHC class II biosynthetic process,BP,
11880,GO:0045352,1,0.996310325520138,0,1,interleukin-1 type I receptor antagonist activity,MF,
11881,GO:0045353,1,0.996310325520138,0,1,interleukin-1 type II receptor antagonist activity,MF,
11882,GO:0045423,1,0.985318964913067,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11883,GO:0045425,1,0.985318964913067,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11884,GO:0045428,1,0.698898247129868,0,53,regulation of nitric oxide biosynthetic process,BP,
11885,GO:0045429,1,0.788382111239663,0,36,positive regulation of nitric oxide biosynthetic process,BP,
11886,GO:0045444,1,0.226975224602947,0,212,fat cell differentiation,BP,
11887,GO:0045445,1,0.575893027550697,0,81,myoblast differentiation,BP,
11889,GO:0045448,1,0.978192799141459,0,4,mitotic cell cycle, embryonic,BP,
11890,GO:0045453,1,0.681411162502315,0,58,bone resorption,BP,
11891,GO:0045454,1,0.751832448876695,0,55,cell redox homeostasis,BP,
11893,GO:0045472,1,0.903405748272305,0,13,response to ether,BP,
11894,GO:0045475,1,0.880297435263738,0,13,locomotor rhythm,BP,
11895,GO:0045485,1,0.991566372800231,0,1,omega-6 fatty acid desaturase activity,MF,
11896,GO:0045494,1,0.745854459485555,0,37,photoreceptor cell maintenance,BP,
11897,GO:0045495,1,0.875270261336402,0,18,pole plasm,CC,
11898,GO:0045499,1,0.77555028020282,0,28,chemorepellent activity,MF,
11899,GO:0045503,1,0.947808595194154,0,6,dynein light chain binding,MF,
11900,GO:0045504,1,0.938421712259545,0,10,dynein heavy chain binding,MF,
11901,GO:0045505,1,0.631545517461432,0,28,dynein intermediate chain binding,MF,
11902,GO:0045509,1,0.988051169759251,0,2,interleukin-27 receptor activity,MF,
11903,GO:0045513,1,0.996590607678115,0,1,interleukin-27 binding,MF,
11904,GO:0045515,1,0.996744158135859,0,1,interleukin-18 receptor binding,MF,
11905,GO:0045519,1,0.996783973181345,0,1,interleukin-23 receptor binding,MF,
11906,GO:0045523,1,0.993543964336965,0,2,interleukin-27 receptor binding,MF,
11907,GO:0045540,1,0.733978356023136,0,42,regulation of cholesterol biosynthetic process,BP,
11908,GO:0045541,1,0.975794215004564,0,5,negative regulation of cholesterol biosynthetic process,BP,
11909,GO:0045542,1,0.956001228130475,0,6,positive regulation of cholesterol biosynthetic process,BP,
11910,GO:0045545,1,0.94239011375195,0,7,syndecan binding,MF,
11911,GO:0045547,1,0.984732108340346,0,2,dehydrodolichyl diphosphate synthase activity,MF,
11912,GO:0045550,1,0.993193699032343,0,2,geranylgeranyl reductase activity,MF,
11913,GO:0045569,1,0.975201849362097,0,5,TRAIL binding,MF,
11914,GO:0045575,1,0.986184918929118,0,2,basophil activation,BP,
11916,GO:0045577,1,0.832530527754185,0,28,regulation of B cell differentiation,BP,
11917,GO:0045578,1,0.974175192398644,0,5,negative regulation of B cell differentiation,BP,
11918,GO:0045579,1,0.921949593770623,0,13,positive regulation of B cell differentiation,BP,
11922,GO:0045583,1,0.989669110947361,0,2,regulation of cytotoxic T cell differentiation,BP,
11923,GO:0045585,1,0.989669110947361,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11924,GO:0045586,1,0.928738363605108,0,9,regulation of gamma-delta T cell differentiation,BP,
11925,GO:0045588,1,0.941407567596635,0,7,positive regulation of gamma-delta T cell differentiation,BP,
11926,GO:0045589,1,0.847462554277586,0,27,regulation of regulatory T cell differentiation,BP,
11927,GO:0045590,1,0.976113735090923,0,5,negative regulation of regulatory T cell differentiation,BP,
11928,GO:0045591,1,0.945143995402617,0,11,positive regulation of regulatory T cell differentiation,BP,
11932,GO:0045598,1,0.417823248162783,0,126,regulation of fat cell differentiation,BP,
11933,GO:0045599,1,0.731003806607767,0,43,negative regulation of fat cell differentiation,BP,
11934,GO:0045600,1,0.638881639988574,0,67,positive regulation of fat cell differentiation,BP,
11935,GO:0045601,1,0.768899303845857,0,33,regulation of endothelial cell differentiation,BP,
11936,GO:0045602,1,0.91980503600306,0,9,negative regulation of endothelial cell differentiation,BP,
11937,GO:0045603,1,0.889398220792137,0,16,positive regulation of endothelial cell differentiation,BP,
11938,GO:0045604,1,0.710425871107353,0,50,regulation of epidermal cell differentiation,BP,
11939,GO:0045605,1,0.940954615190565,0,10,negative regulation of epidermal cell differentiation,BP,
11940,GO:0045606,1,0.858286012090635,0,20,positive regulation of epidermal cell differentiation,BP,
11941,GO:0045607,1,0.953590643947514,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
11942,GO:0045608,1,0.969975280709336,0,4,negative regulation of inner ear auditory receptor cell differentiation,BP,
11943,GO:0045616,1,0.784701145325067,0,32,regulation of keratinocyte differentiation,BP,
11944,GO:0045617,1,0.978056325178243,0,4,negative regulation of keratinocyte differentiation,BP,
11945,GO:0045618,1,0.891993058225335,0,14,positive regulation of keratinocyte differentiation,BP,
11953,GO:0045626,1,0.978713733605877,0,3,negative regulation of T-helper 1 cell differentiation,BP,
11957,GO:0045630,1,0.962912935088544,0,7,positive regulation of T-helper 2 cell differentiation,BP,
11958,GO:0045631,1,0.953590643947514,0,7,regulation of mechanoreceptor differentiation,BP,
11959,GO:0045632,1,0.969975280709336,0,4,negative regulation of mechanoreceptor differentiation,BP,
11960,GO:0045634,1,0.938343816266401,0,6,regulation of melanocyte differentiation,BP,
11961,GO:0045636,1,0.941665945443985,0,5,positive regulation of melanocyte differentiation,BP,
11965,GO:0045643,1,0.993197249242058,0,1,regulation of eosinophil differentiation,BP,
11966,GO:0045645,1,0.993197249242058,0,1,positive regulation of eosinophil differentiation,BP,
11968,GO:0045647,1,0.933918364375646,0,10,negative regulation of erythrocyte differentiation,BP,
11969,GO:0045648,1,0.78987242471915,0,31,positive regulation of erythrocyte differentiation,BP,
11971,GO:0045650,1,0.971276916104967,0,6,negative regulation of macrophage differentiation,BP,
11974,GO:0045653,1,0.980489291664042,0,4,negative regulation of megakaryocyte differentiation,BP,
11975,GO:0045654,1,0.958666356931359,0,9,positive regulation of megakaryocyte differentiation,BP,
11976,GO:0045655,1,0.886575414900345,0,19,regulation of monocyte differentiation,BP,
11977,GO:0045656,1,0.948598954641056,0,6,negative regulation of monocyte differentiation,BP,
11978,GO:0045657,1,0.944618888425269,0,11,positive regulation of monocyte differentiation,BP,
11979,GO:0045658,1,0.980114859285843,0,3,regulation of neutrophil differentiation,BP,
11980,GO:0045659,1,0.983973712696613,0,2,negative regulation of neutrophil differentiation,BP,
11981,GO:0045660,1,0.996078929491162,0,1,positive regulation of neutrophil differentiation,BP,
11982,GO:0045661,1,0.722431284805866,0,50,regulation of myoblast differentiation,BP,
11983,GO:0045662,1,0.864952247612792,0,25,negative regulation of myoblast differentiation,BP,
11984,GO:0045663,1,0.868445212749009,0,19,positive regulation of myoblast differentiation,BP,
11989,GO:0045668,1,0.733495702400634,0,41,negative regulation of osteoblast differentiation,BP,
11993,GO:0045672,1,0.869115938382849,0,20,positive regulation of osteoclast differentiation,BP,
11994,GO:0045682,1,0.616615179126632,0,72,regulation of epidermis development,BP,
11995,GO:0045683,1,0.911704522975065,0,14,negative regulation of epidermis development,BP,
11996,GO:0045684,1,0.803887219993668,0,33,positive regulation of epidermis development,BP,
11998,GO:0045686,1,0.864652707180694,0,23,negative regulation of glial cell differentiation,BP,
12000,GO:0045703,1,0.996708818663127,0,1,ketoreductase activity,MF,
12001,GO:0045713,1,0.935264478010979,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12002,GO:0045714,1,0.93880381554525,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12003,GO:0045715,1,0.97752061149791,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12004,GO:0045716,1,0.980100628811865,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12005,GO:0045717,1,0.924213699265394,0,13,negative regulation of fatty acid biosynthetic process,BP,
12006,GO:0045719,1,0.954348074956085,0,5,negative regulation of glycogen biosynthetic process,BP,
12007,GO:0045720,1,0.990680523781097,0,2,negative regulation of integrin biosynthetic process,BP,
12008,GO:0045721,1,0.918260102803735,0,13,negative regulation of gluconeogenesis,BP,
12009,GO:0045722,1,0.904467516052923,0,12,positive regulation of gluconeogenesis,BP,
12011,GO:0045724,1,0.843775854911628,0,19,positive regulation of cilium assembly,BP,
12012,GO:0045725,1,0.863849137136113,0,14,positive regulation of glycogen biosynthetic process,BP,
12013,GO:0045726,1,0.984478908478469,0,2,positive regulation of integrin biosynthetic process,BP,
12015,GO:0045728,1,0.995864341580592,0,1,respiratory burst after phagocytosis,BP,
12016,GO:0045730,1,0.859527388244566,0,27,respiratory burst,BP,
12017,GO:0045732,1,0.222230643078839,0,211,positive regulation of protein catabolic process,BP,
12018,GO:0045736,1,0.819767819684723,0,29,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12019,GO:0045737,1,0.832615984024575,0,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12020,GO:0045738,1,0.798299261469069,0,28,negative regulation of DNA repair,BP,
12021,GO:0045739,1,0.658001982203157,0,58,positive regulation of DNA repair,BP,
12022,GO:0045740,1,0.764785855716563,0,39,positive regulation of DNA replication,BP,
12023,GO:0045741,1,0.930161128327394,0,12,positive regulation of epidermal growth factor-activated receptor activity,BP,
12024,GO:0045742,1,0.789925726393165,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12025,GO:0045743,1,0.958546937501475,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12028,GO:0045746,1,0.802176516197971,0,37,negative regulation of Notch signaling pathway,BP,
12030,GO:0045751,1,0.993992991555906,0,1,negative regulation of Toll signaling pathway,BP,
12031,GO:0045759,1,0.954537398695403,0,8,negative regulation of action potential,BP,
12032,GO:0045760,1,0.923720070054034,0,9,positive regulation of action potential,BP,
12033,GO:0045761,1,0.792964684882095,0,30,regulation of adenylate cyclase activity,BP,
12034,GO:0045762,1,0.907733303638995,0,8,positive regulation of adenylate cyclase activity,BP,
12035,GO:0045763,1,0.973948270704346,0,2,negative regulation of cellular amino acid metabolic process,BP,
12036,GO:0045764,1,0.988447386017806,0,3,positive regulation of cellular amino acid metabolic process,BP,
12039,GO:0045769,1,0.9799750779084,0,1,negative regulation of asymmetric cell division,BP,
12041,GO:0045776,1,0.783180279750327,0,40,negative regulation of blood pressure,BP,
12042,GO:0045777,1,0.844843712867912,0,31,positive regulation of blood pressure,BP,
12044,GO:0045779,1,0.933662380932885,0,12,negative regulation of bone resorption,BP,
12045,GO:0045780,1,0.878753249553134,0,17,positive regulation of bone resorption,BP,
12049,GO:0045792,1,0.92590150435201,0,10,negative regulation of cell size,BP,
12050,GO:0045793,1,0.935452619916009,0,9,positive regulation of cell size,BP,
12051,GO:0045794,1,0.952708480187403,0,5,negative regulation of cell volume,BP,
12052,GO:0045795,1,0.986902622679232,0,1,positive regulation of cell volume,BP,
12053,GO:0045796,1,0.995062653977197,0,1,negative regulation of intestinal cholesterol absorption,BP,
12054,GO:0045797,1,0.995658099904583,0,1,positive regulation of intestinal cholesterol absorption,BP,
12055,GO:0045798,1,0.95581891062066,0,4,negative regulation of chromatin assembly or disassembly,BP,
12056,GO:0045799,1,0.900190023157665,0,12,positive regulation of chromatin assembly or disassembly,BP,
12059,GO:0045813,1,0.9962892356662,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12060,GO:0045814,1,0.667404902036057,0,53,negative regulation of gene expression, epigenetic,BP,
12061,GO:0045815,1,0.721789282235281,0,45,positive regulation of gene expression, epigenetic,BP,
12062,GO:0045819,1,0.992560836031033,0,1,positive regulation of glycogen catabolic process,BP,
12063,GO:0045820,1,0.894679451029767,0,13,negative regulation of glycolytic process,BP,
12064,GO:0045821,1,0.838257530495746,0,20,positive regulation of glycolytic process,BP,
12065,GO:0045822,1,0.85876868440849,0,21,negative regulation of heart contraction,BP,
12067,GO:0045824,1,0.728728450583159,0,53,negative regulation of innate immune response,BP,
12068,GO:0045827,1,0.991273752882936,0,2,negative regulation of isoprenoid metabolic process,BP,
12069,GO:0045828,1,0.993400190095857,0,1,positive regulation of isoprenoid metabolic process,BP,
12070,GO:0045829,1,0.974001335749849,0,5,negative regulation of isotype switching,BP,
12071,GO:0045830,1,0.87437900595602,0,20,positive regulation of isotype switching,BP,
12072,GO:0045833,1,0.614618536817057,0,76,negative regulation of lipid metabolic process,BP,
12075,GO:0045836,1,0.920375515574201,0,13,positive regulation of meiotic nuclear division,BP,
12076,GO:0045837,1,0.939060598780411,0,13,negative regulation of membrane potential,BP,
12077,GO:0045838,1,0.915731372190743,0,13,positive regulation of membrane potential,BP,
12078,GO:0045839,1,0.709875903887844,0,50,negative regulation of mitotic nuclear division,BP,
12079,GO:0045840,1,0.68482401734144,0,51,positive regulation of mitotic nuclear division,BP,
12080,GO:0045841,1,0.782800985302701,0,36,negative regulation of mitotic metaphase/anaphase transition,BP,
12081,GO:0045842,1,0.916117697606013,0,13,positive regulation of mitotic metaphase/anaphase transition,BP,
12082,GO:0045843,1,0.7125575599439,0,50,negative regulation of striated muscle tissue development,BP,
12083,GO:0045844,1,0.627882219431334,0,60,positive regulation of striated muscle tissue development,BP,
12084,GO:0045848,1,0.995877903634853,0,1,positive regulation of nitrogen utilization,BP,
12085,GO:0045851,1,0.73546612182314,0,56,pH reduction,BP,
12086,GO:0045852,1,0.963274043386892,0,5,pH elevation,BP,
12091,GO:0045869,1,0.928585484546124,0,14,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12092,GO:0045870,1,0.97915088282969,0,2,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12093,GO:0045872,1,0.991942611752982,0,2,positive regulation of rhodopsin gene expression,BP,
12094,GO:0045875,1,0.946838880752503,0,4,negative regulation of sister chromatid cohesion,BP,
12095,GO:0045876,1,0.9433354878027,0,7,positive regulation of sister chromatid cohesion,BP,
12096,GO:0045879,1,0.762333285834938,0,32,negative regulation of smoothened signaling pathway,BP,
12097,GO:0045880,1,0.76797401399606,0,35,positive regulation of smoothened signaling pathway,BP,
12098,GO:0045887,1,0.986054403654254,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12101,GO:0045898,1,0.915594547807103,0,13,regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12102,GO:0045899,1,0.934013059677922,0,10,positive regulation of RNA polymerase II transcription preinitiation complex assembly,BP,
12103,GO:0045900,1,0.971262924735181,0,4,negative regulation of translational elongation,BP,
12104,GO:0045901,1,0.970552600730199,0,5,positive regulation of translational elongation,BP,
12105,GO:0045903,1,0.986484432525759,0,3,positive regulation of translational fidelity,BP,
12106,GO:0045905,1,0.974310374931199,0,4,positive regulation of translational termination,BP,
12108,GO:0045907,1,0.857288991336123,0,27,positive regulation of vasoconstriction,BP,
12109,GO:0045910,1,0.812257300620345,0,28,negative regulation of DNA recombination,BP,
12110,GO:0045911,1,0.771715335294122,0,36,positive regulation of DNA recombination,BP,
12111,GO:0045912,1,0.72782797072209,0,42,negative regulation of carbohydrate metabolic process,BP,
12112,GO:0045913,1,0.575013018412178,0,68,positive regulation of carbohydrate metabolic process,BP,
12113,GO:0045914,1,0.981263205812406,0,3,negative regulation of catecholamine metabolic process,BP,
12114,GO:0045915,1,0.968033038008523,0,6,positive regulation of catecholamine metabolic process,BP,
12115,GO:0045916,1,0.939699437502736,0,8,negative regulation of complement activation,BP,
12116,GO:0045917,1,0.97633044912179,0,4,positive regulation of complement activation,BP,
12117,GO:0045918,1,0.995806429378298,0,1,negative regulation of cytolysis,BP,
12118,GO:0045919,1,0.996258296079911,0,1,positive regulation of cytolysis,BP,
12121,GO:0045922,1,0.849690493588814,0,24,negative regulation of fatty acid metabolic process,BP,
12123,GO:0045924,1,0.953137712347812,0,6,regulation of female receptivity,BP,
12124,GO:0045925,1,0.982392427333996,0,2,positive regulation of female receptivity,BP,
12127,GO:0045930,1,0.153039755410809,0,298,negative regulation of mitotic cell cycle,BP,
12129,GO:0045932,1,0.858241059737193,0,21,negative regulation of muscle contraction,BP,
12135,GO:0045938,1,0.975519364765344,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12136,GO:0045939,1,0.892673111239983,0,22,negative regulation of steroid metabolic process,BP,
12138,GO:0045943,1,0.862225163422861,0,20,positive regulation of transcription by RNA polymerase I,BP,
12140,GO:0045945,1,0.915237788981891,0,11,positive regulation of transcription by RNA polymerase III,BP,
12141,GO:0045947,1,0.86766370540962,0,19,negative regulation of translational initiation,BP,
12142,GO:0045948,1,0.820011548448723,0,28,positive regulation of translational initiation,BP,
12143,GO:0045950,1,0.985865759294708,0,3,negative regulation of mitotic recombination,BP,
12144,GO:0045951,1,0.995858892175205,0,1,positive regulation of mitotic recombination,BP,
12145,GO:0045953,1,0.937669044745185,0,15,negative regulation of natural killer cell mediated cytotoxicity,BP,
12146,GO:0045954,1,0.8924814823633,0,20,positive regulation of natural killer cell mediated cytotoxicity,BP,
12147,GO:0045955,1,0.940440645845135,0,8,negative regulation of calcium ion-dependent exocytosis,BP,
12149,GO:0045957,1,0.975111691550678,0,3,negative regulation of complement activation, alternative pathway,BP,
12150,GO:0045959,1,0.974498977806545,0,3,negative regulation of complement activation, classical pathway,BP,
12151,GO:0045963,1,0.981263205812406,0,3,negative regulation of dopamine metabolic process,BP,
12152,GO:0045964,1,0.968033038008523,0,6,positive regulation of dopamine metabolic process,BP,
12153,GO:0045967,1,0.962071463021698,0,2,negative regulation of growth rate,BP,
12154,GO:0045974,1,0.874153819342272,0,14,regulation of translation, ncRNA-mediated,BP,
12155,GO:0045976,1,0.986265290646326,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12156,GO:0045977,1,0.99658144568182,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12157,GO:0045980,1,0.862370770900974,0,20,negative regulation of nucleotide metabolic process,BP,
12158,GO:0045981,1,0.756768179727865,0,37,positive regulation of nucleotide metabolic process,BP,
12159,GO:0045986,1,0.90794174683806,0,13,negative regulation of smooth muscle contraction,BP,
12160,GO:0045987,1,0.843768995536462,0,27,positive regulation of smooth muscle contraction,BP,
12161,GO:0045988,1,0.948352936567083,0,7,negative regulation of striated muscle contraction,BP,
12163,GO:0045990,1,0.967284441705176,0,5,carbon catabolite regulation of transcription,BP,
12164,GO:0045991,1,0.967284441705176,0,5,carbon catabolite activation of transcription,BP,
12166,GO:0045993,1,0.99146517290305,0,1,negative regulation of translational initiation by iron,BP,
12167,GO:0045994,1,0.985871325775958,0,2,positive regulation of translational initiation by iron,BP,
12169,GO:0046005,1,0.996892626853042,0,1,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12171,GO:0046007,1,0.917940700064932,0,13,negative regulation of activated T cell proliferation,BP,
12172,GO:0046010,1,0.983233102500683,0,4,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12173,GO:0046013,1,0.99073832754114,0,2,regulation of T cell homeostatic proliferation,BP,
12174,GO:0046015,1,0.976654596002049,0,5,regulation of transcription by glucose,BP,
12175,GO:0046016,1,0.980172860801738,0,4,positive regulation of transcription by glucose,BP,
12176,GO:0046030,1,0.95136970825564,0,7,inositol trisphosphate phosphatase activity,MF,
12177,GO:0046031,1,0.434097981850141,0,113,ADP metabolic process,BP,
12178,GO:0046032,1,0.996523790210724,0,1,ADP catabolic process,BP,
12179,GO:0046033,1,0.941116393087373,0,12,AMP metabolic process,BP,
12180,GO:0046034,1,0.210366991980797,0,255,ATP metabolic process,BP,
12181,GO:0046036,1,0.949537321198212,0,13,CTP metabolic process,BP,
12182,GO:0046037,1,0.902977535625942,0,14,GMP metabolic process,BP,
12183,GO:0046038,1,0.996604021233342,0,1,GMP catabolic process,BP,
12184,GO:0046039,1,0.874521349410562,0,23,GTP metabolic process,BP,
12185,GO:0046040,1,0.935436453624093,0,10,IMP metabolic process,BP,
12186,GO:0046041,1,0.991892491151907,0,2,ITP metabolic process,BP,
12187,GO:0046048,1,0.989351124063173,0,2,UDP metabolic process,BP,
12188,GO:0046049,1,0.949280860997233,0,10,UMP metabolic process,BP,
12189,GO:0046051,1,0.954507794990761,0,10,UTP metabolic process,BP,
12190,GO:0046053,1,0.991986846858326,0,2,dAMP metabolic process,BP,
12191,GO:0046054,1,0.996800171460964,0,1,dGMP metabolic process,BP,
12192,GO:0046056,1,0.988185486410545,0,2,dADP metabolic process,BP,
12193,GO:0046058,1,0.808343270310573,0,21,cAMP metabolic process,BP,
12194,GO:0046060,1,0.980408305877692,0,5,dATP metabolic process,BP,
12195,GO:0046061,1,0.987505568682385,0,3,dATP catabolic process,BP,
12196,GO:0046065,1,0.996756211178004,0,1,dCTP metabolic process,BP,
12197,GO:0046066,1,0.991707233151492,0,2,dGDP metabolic process,BP,
12198,GO:0046068,1,0.903707581833576,0,13,cGMP metabolic process,BP,
12199,GO:0046069,1,0.95619747178087,0,5,cGMP catabolic process,BP,
12200,GO:0046070,1,0.983868117606453,0,4,dGTP metabolic process,BP,
12201,GO:0046072,1,0.991251928816876,0,2,dTDP metabolic process,BP,
12202,GO:0046073,1,0.987983778297835,0,3,dTMP metabolic process,BP,
12203,GO:0046075,1,0.984469653614238,0,4,dTTP metabolic process,BP,
12204,GO:0046077,1,0.991251928816876,0,2,dUDP metabolic process,BP,
12205,GO:0046078,1,0.985298016789965,0,4,dUMP metabolic process,BP,
12206,GO:0046079,1,0.996484516566367,0,1,dUMP catabolic process,BP,
12207,GO:0046080,1,0.996215580774424,0,1,dUTP metabolic process,BP,
12208,GO:0046081,1,0.996215580774424,0,1,dUTP catabolic process,BP,
12209,GO:0046083,1,0.987088022748364,0,3,adenine metabolic process,BP,
12210,GO:0046084,1,0.987088022748364,0,3,adenine biosynthetic process,BP,
12211,GO:0046085,1,0.960729440271234,0,7,adenosine metabolic process,BP,
12212,GO:0046086,1,0.992302308551469,0,1,adenosine biosynthetic process,BP,
12213,GO:0046087,1,0.959267045663034,0,10,cytidine metabolic process,BP,
12214,GO:0046090,1,0.996521202535912,0,1,deoxyadenosine metabolic process,BP,
12215,GO:0046092,1,0.990323148338782,0,1,deoxycytidine metabolic process,BP,
12216,GO:0046098,1,0.98059657824871,0,3,guanine metabolic process,BP,
12217,GO:0046099,1,0.996604021233342,0,1,guanine biosynthetic process,BP,
12218,GO:0046100,1,0.989032061568201,0,3,hypoxanthine metabolic process,BP,
12219,GO:0046101,1,0.989032061568201,0,3,hypoxanthine biosynthetic process,BP,
12220,GO:0046102,1,0.987301724357359,0,3,inosine metabolic process,BP,
12221,GO:0046103,1,0.991774687230019,0,2,inosine biosynthetic process,BP,
12222,GO:0046104,1,0.977933809887928,0,4,thymidine metabolic process,BP,
12223,GO:0046105,1,0.99674784099044,0,1,thymidine biosynthetic process,BP,
12224,GO:0046108,1,0.991790336331877,0,2,uridine metabolic process,BP,
12225,GO:0046110,1,0.976194041015934,0,3,xanthine metabolic process,BP,
12226,GO:0046111,1,0.996521202535912,0,1,xanthine biosynthetic process,BP,
12227,GO:0046112,1,0.890794872623244,0,18,nucleobase biosynthetic process,BP,
12228,GO:0046113,1,0.955838351884648,0,6,nucleobase catabolic process,BP,
12229,GO:0046120,1,0.99674784099044,0,1,deoxyribonucleoside biosynthetic process,BP,
12230,GO:0046121,1,0.987154802112235,0,3,deoxyribonucleoside catabolic process,BP,
12231,GO:0046122,1,0.993325806519901,0,2,purine deoxyribonucleoside metabolic process,BP,
12232,GO:0046124,1,0.996521202535912,0,1,purine deoxyribonucleoside catabolic process,BP,
12233,GO:0046125,1,0.977933809887928,0,4,pyrimidine deoxyribonucleoside metabolic process,BP,
12234,GO:0046126,1,0.99674784099044,0,1,pyrimidine deoxyribonucleoside biosynthetic process,BP,
12235,GO:0046127,1,0.994217100594094,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12236,GO:0046128,1,0.724471357980452,0,53,purine ribonucleoside metabolic process,BP,
12237,GO:0046129,1,0.913875890718414,0,21,purine ribonucleoside biosynthetic process,BP,
12238,GO:0046130,1,0.970927617330035,0,6,purine ribonucleoside catabolic process,BP,
12239,GO:0046131,1,0.951388511507055,0,12,pyrimidine ribonucleoside metabolic process,BP,
12240,GO:0046133,1,0.951388511507055,0,12,pyrimidine ribonucleoside catabolic process,BP,
12241,GO:0046134,1,0.93222869863161,0,14,pyrimidine nucleoside biosynthetic process,BP,
12242,GO:0046135,1,0.913767041170449,0,21,pyrimidine nucleoside catabolic process,BP,
12243,GO:0046136,1,0.975525360857402,0,4,positive regulation of vitamin metabolic process,BP,
12244,GO:0046137,1,0.971971611569765,0,6,negative regulation of vitamin metabolic process,BP,
12245,GO:0046144,1,0.996472587785726,0,1,D-alanine family amino acid metabolic process,BP,
12246,GO:0046146,1,0.97124018211104,0,7,tetrahydrobiopterin metabolic process,BP,
12247,GO:0046148,1,0.698354135910095,0,54,pigment biosynthetic process,BP,
12248,GO:0046149,1,0.986535555165494,0,4,pigment catabolic process,BP,
12249,GO:0046160,1,0.981091943343443,0,2,heme a metabolic process,BP,
12250,GO:0046164,1,0.762584576837748,0,46,alcohol catabolic process,BP,
12251,GO:0046165,1,0.397334879373243,0,141,alcohol biosynthetic process,BP,
12252,GO:0046166,1,0.992519874363733,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12253,GO:0046167,1,0.974101814469426,0,2,glycerol-3-phosphate biosynthetic process,BP,
12254,GO:0046168,1,0.987336727772998,0,2,glycerol-3-phosphate catabolic process,BP,
12255,GO:0046173,1,0.713144607021985,0,57,polyol biosynthetic process,BP,
12256,GO:0046174,1,0.841436631578439,0,22,polyol catabolic process,BP,
12257,GO:0046176,1,0.991046163562001,0,2,aldonic acid catabolic process,BP,
12258,GO:0046177,1,0.991046163562001,0,2,D-gluconate catabolic process,BP,
12259,GO:0046184,1,0.910465054484988,0,13,aldehyde biosynthetic process,BP,
12260,GO:0046185,1,0.955435885466226,0,11,aldehyde catabolic process,BP,
12261,GO:0046189,1,0.760226560927652,0,41,phenol-containing compound biosynthetic process,BP,
12262,GO:0046203,1,0.99639083166836,0,1,spermidine catabolic process,BP,
12263,GO:0046204,1,0.996807977639106,0,1,nor-spermidine metabolic process,BP,
12264,GO:0046208,1,0.992382617845647,0,2,spermine catabolic process,BP,
12265,GO:0046209,1,0.621298758686006,0,68,nitric oxide metabolic process,BP,
12266,GO:0046210,1,0.995338132508373,0,1,nitric oxide catabolic process,BP,
12267,GO:0046218,1,0.965857681052591,0,8,indolalkylamine catabolic process,BP,
12268,GO:0046219,1,0.98453998982005,0,4,indolalkylamine biosynthetic process,BP,
12269,GO:0046222,1,0.991661789485292,0,2,aflatoxin metabolic process,BP,
12270,GO:0046223,1,0.991661789485292,0,2,aflatoxin catabolic process,BP,
12271,GO:0046226,1,0.993060990943715,0,2,coumarin catabolic process,BP,
12272,GO:0046247,1,0.989646160058766,0,2,terpene catabolic process,BP,
12273,GO:0046271,1,0.993060990943715,0,2,phenylpropanoid catabolic process,BP,
12274,GO:0046272,1,0.995796629651648,0,1,stilbene catabolic process,BP,
12275,GO:0046292,1,0.978943266704915,0,4,formaldehyde metabolic process,BP,
12276,GO:0046293,1,0.990862801058762,0,1,formaldehyde biosynthetic process,BP,
12277,GO:0046294,1,0.987971648866361,0,3,formaldehyde catabolic process,BP,
12278,GO:0046295,1,0.996816752933256,0,1,glycolate biosynthetic process,BP,
12279,GO:0046296,1,0.996342508918834,0,1,glycolate catabolic process,BP,
12280,GO:0046305,1,0.991484264303113,0,2,alkanesulfonate biosynthetic process,BP,
12281,GO:0046314,1,0.982399670306247,0,5,phosphocreatine biosynthetic process,BP,
12282,GO:0046316,1,0.994890876864838,0,1,gluconokinase activity,MF,
12283,GO:0046317,1,0.990210181431007,0,1,regulation of glucosylceramide biosynthetic process,BP,
12284,GO:0046318,1,0.990210181431007,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12285,GO:0046320,1,0.778091040485557,0,31,regulation of fatty acid oxidation,BP,
12286,GO:0046321,1,0.88234623735049,0,14,positive regulation of fatty acid oxidation,BP,
12287,GO:0046322,1,0.929562240944945,0,11,negative regulation of fatty acid oxidation,BP,
12288,GO:0046323,1,0.613588267584442,0,61,glucose import,BP,
12289,GO:0046324,1,0.678444902962732,0,48,regulation of glucose import,BP,
12290,GO:0046325,1,0.937455954359881,0,11,negative regulation of glucose import,BP,
12291,GO:0046326,1,0.747994706395124,0,32,positive regulation of glucose import,BP,
12292,GO:0046327,1,0.991169016876542,0,2,glycerol biosynthetic process from pyruvate,BP,
12293,GO:0046328,1,0.276910155012184,0,171,regulation of JNK cascade,BP,
12294,GO:0046329,1,0.779424652695189,0,34,negative regulation of JNK cascade,BP,
12295,GO:0046330,1,0.389710138029795,0,129,positive regulation of JNK cascade,BP,
12296,GO:0046331,1,0.99044437061583,0,2,lateral inhibition,BP,
12298,GO:0046333,1,0.989296059771533,0,2,octopamine metabolic process,BP,
12300,GO:0046338,1,0.982623468124944,0,3,phosphatidylethanolamine catabolic process,BP,
12301,GO:0046339,1,0.849255057891011,0,20,diacylglycerol metabolic process,BP,
12302,GO:0046340,1,0.981861871943979,0,2,diacylglycerol catabolic process,BP,
12303,GO:0046341,1,0.90900890987138,0,12,CDP-diacylglycerol metabolic process,BP,
12305,GO:0046349,1,0.922792169609883,0,13,amino sugar biosynthetic process,BP,
12306,GO:0046351,1,0.978656984287157,0,4,disaccharide biosynthetic process,BP,
12307,GO:0046356,1,0.992697980865556,0,2,acetyl-CoA catabolic process,BP,
12308,GO:0046359,1,0.996162159258601,0,1,butyrate catabolic process,BP,
12309,GO:0046360,1,0.99592335166314,0,1,2-oxobutyrate biosynthetic process,BP,
12310,GO:0046361,1,0.992356944035146,0,2,2-oxobutyrate metabolic process,BP,
12311,GO:0046364,1,0.599980463034144,0,85,monosaccharide biosynthetic process,BP,
12313,GO:0046368,1,0.990320916108067,0,2,GDP-L-fucose metabolic process,BP,
12314,GO:0046370,1,0.99193376976849,0,2,fructose biosynthetic process,BP,
12315,GO:0046373,1,0.989807596705769,0,2,L-arabinose metabolic process,BP,
12316,GO:0046379,1,0.984993989335211,0,3,extracellular polysaccharide metabolic process,BP,
12317,GO:0046380,1,0.992851952138839,0,1,N-acetylneuraminate biosynthetic process,BP,
12318,GO:0046381,1,0.996702139098049,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12319,GO:0046385,1,0.951189931958597,0,12,deoxyribose phosphate biosynthetic process,BP,
12320,GO:0046386,1,0.918734359411517,0,19,deoxyribose phosphate catabolic process,BP,
12321,GO:0046390,1,0.393458068508521,0,156,ribose phosphate biosynthetic process,BP,
12322,GO:0046391,1,0.977929507382852,0,5,5-phosphoribose 1-diphosphate metabolic process,BP,
12324,GO:0046395,1,0.230330422505352,0,262,carboxylic acid catabolic process,BP,
12325,GO:0046398,1,0.970452612014581,0,4,UDP-glucuronate metabolic process,BP,
12326,GO:0046403,1,0.996363308056365,0,1,polynucleotide 3'-phosphatase activity,MF,
12327,GO:0046404,1,0.979821014841345,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12328,GO:0046415,1,0.958772371890949,0,8,urate metabolic process,BP,
12329,GO:0046416,1,0.98836044795888,0,3,D-amino acid metabolic process,BP,
12333,GO:0046434,1,0.444756900017584,0,132,organophosphate catabolic process,BP,
12334,GO:0046436,1,0.996472587785726,0,1,D-alanine metabolic process,BP,
12335,GO:0046437,1,0.995385273459009,0,1,D-amino acid biosynthetic process,BP,
12336,GO:0046439,1,0.983225372405601,0,4,L-cysteine metabolic process,BP,
12337,GO:0046440,1,0.974957462087632,0,4,L-lysine metabolic process,BP,
12338,GO:0046443,1,0.996102280169004,0,1,FAD metabolic process,BP,
12339,GO:0046444,1,0.995003072987144,0,1,FMN metabolic process,BP,
12340,GO:0046448,1,0.995442960961871,0,1,tropane alkaloid metabolic process,BP,
12341,GO:0046449,1,0.989141618017359,0,1,creatinine metabolic process,BP,
12342,GO:0046452,1,0.988569462527428,0,2,dihydrofolate metabolic process,BP,
12345,GO:0046458,1,0.992907123396694,0,1,hexadecanal metabolic process,BP,
12346,GO:0046459,1,0.924102024898424,0,16,short-chain fatty acid metabolic process,BP,
12347,GO:0046460,1,0.784784177852878,0,37,neutral lipid biosynthetic process,BP,
12348,GO:0046461,1,0.78391486338675,0,37,neutral lipid catabolic process,BP,
12349,GO:0046462,1,0.954729553276038,0,9,monoacylglycerol metabolic process,BP,
12350,GO:0046463,1,0.784784177852878,0,37,acylglycerol biosynthetic process,BP,
12351,GO:0046464,1,0.78391486338675,0,37,acylglycerol catabolic process,BP,
12352,GO:0046465,1,0.964214986133718,0,7,dolichyl diphosphate metabolic process,BP,
12353,GO:0046466,1,0.837757694145318,0,32,membrane lipid catabolic process,BP,
12355,GO:0046469,1,0.952896570330771,0,8,platelet activating factor metabolic process,BP,
12360,GO:0046475,1,0.857258794663111,0,27,glycerophospholipid catabolic process,BP,
12361,GO:0046476,1,0.959154450682506,0,8,glycosylceramide biosynthetic process,BP,
12362,GO:0046477,1,0.959676586081688,0,8,glycosylceramide catabolic process,BP,
12363,GO:0046478,1,0.990781423347301,0,1,lactosylceramide metabolic process,BP,
12364,GO:0046479,1,0.932558587078003,0,14,glycosphingolipid catabolic process,BP,
12366,GO:0046485,1,0.885300277943223,0,17,ether lipid metabolic process,BP,
12368,GO:0046487,1,0.966680811823657,0,8,glyoxylate metabolic process,BP,
12370,GO:0046490,1,0.984925522604704,0,4,isopentenyl diphosphate metabolic process,BP,
12371,GO:0046491,1,0.996833352720764,0,1,L-methylmalonyl-CoA metabolic process,BP,
12372,GO:0046495,1,0.995490313344996,0,1,nicotinamide riboside metabolic process,BP,
12374,GO:0046498,1,0.989286959711383,0,3,S-adenosylhomocysteine metabolic process,BP,
12375,GO:0046499,1,0.993941860303577,0,1,S-adenosylmethioninamine metabolic process,BP,
12376,GO:0046500,1,0.912248899756257,0,16,S-adenosylmethionine metabolic process,BP,
12377,GO:0046501,1,0.934334307364613,0,11,protoporphyrinogen IX metabolic process,BP,
12378,GO:0046502,1,0.992504132693676,0,2,uroporphyrinogen III metabolic process,BP,
12379,GO:0046503,1,0.682532351713925,0,60,glycerolipid catabolic process,BP,
12380,GO:0046504,1,0.925690690159388,0,10,glycerol ether biosynthetic process,BP,
12381,GO:0046511,1,0.98251422248007,0,2,sphinganine biosynthetic process,BP,
12382,GO:0046512,1,0.91779386963716,0,13,sphingosine biosynthetic process,BP,
12384,GO:0046514,1,0.908570099718143,0,19,ceramide catabolic process,BP,
12385,GO:0046519,1,0.897042079823455,0,17,sphingoid metabolic process,BP,
12386,GO:0046520,1,0.91779386963716,0,13,sphingoid biosynthetic process,BP,
12387,GO:0046521,1,0.996224256177234,0,1,sphingoid catabolic process,BP,
12388,GO:0046523,1,0.994255328083851,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12389,GO:0046525,1,0.996364241035216,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12390,GO:0046526,1,0.995305280149271,0,1,D-xylulose reductase activity,MF,
12391,GO:0046527,1,0.890988278806942,0,16,glucosyltransferase activity,MF,
12392,GO:0046530,1,0.63485608183896,0,57,photoreceptor cell differentiation,BP,
12393,GO:0046532,1,0.940409769940347,0,8,regulation of photoreceptor cell differentiation,BP,
12394,GO:0046533,1,0.940409769940347,0,8,negative regulation of photoreceptor cell differentiation,BP,
12395,GO:0046538,1,0.996836621633877,0,1,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12396,GO:0046539,1,0.996824453654078,0,1,histamine N-methyltransferase activity,MF,
12397,GO:0046540,1,0.866844982558542,0,30,U4/U6 x U5 tri-snRNP complex,CC,
12398,GO:0046541,1,0.95336973686663,0,10,saliva secretion,BP,
12399,GO:0046543,1,0.952746747409714,0,6,development of secondary female sexual characteristics,BP,
12400,GO:0046544,1,0.99021789521961,0,1,development of secondary male sexual characteristics,BP,
12401,GO:0046545,1,0.510774801823479,0,93,development of primary female sexual characteristics,BP,
12402,GO:0046546,1,0.407505258329629,0,121,development of primary male sexual characteristics,BP,
12403,GO:0046548,1,0.930794027631342,0,9,retinal rod cell development,BP,
12404,GO:0046549,1,0.938023534678374,0,9,retinal cone cell development,BP,
12405,GO:0046552,1,0.995983180678702,0,1,photoreceptor cell fate commitment,BP,
12406,GO:0046554,1,0.996668040141859,0,1,malate dehydrogenase (NADP+) activity,MF,
12407,GO:0046556,1,0.989807596705769,0,2,alpha-L-arabinofuranosidase activity,MF,
12408,GO:0046570,1,0.996692332975513,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12409,GO:0046573,1,0.989539317836366,0,3,lactonohydrolase activity,MF,
12410,GO:0046577,1,0.992907123396694,0,1,long-chain-alcohol oxidase activity,MF,
12413,GO:0046580,1,0.65793366737843,0,50,negative regulation of Ras protein signal transduction,BP,
12414,GO:0046581,1,0.948775504235596,0,6,intercellular canaliculus,CC,
12415,GO:0046586,1,0.991283746433528,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12416,GO:0046587,1,0.994442333353931,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12417,GO:0046588,1,0.996823938023805,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12418,GO:0046592,1,0.988413150808386,0,3,polyamine oxidase activity,MF,
12419,GO:0046596,1,0.845888628577917,0,32,regulation of viral entry into host cell,BP,
12420,GO:0046597,1,0.92091607427004,0,15,negative regulation of viral entry into host cell,BP,
12421,GO:0046598,1,0.956168724339483,0,10,positive regulation of viral entry into host cell,BP,
12422,GO:0046599,1,0.840520555703759,0,22,regulation of centriole replication,BP,
12423,GO:0046600,1,0.930604178721596,0,9,negative regulation of centriole replication,BP,
12424,GO:0046601,1,0.957103132891119,0,6,positive regulation of centriole replication,BP,
12425,GO:0046602,1,0.940767270289564,0,9,regulation of mitotic centrosome separation,BP,
12426,GO:0046603,1,0.99659222518099,0,1,negative regulation of mitotic centrosome separation,BP,
12427,GO:0046604,1,0.980588324370206,0,3,positive regulation of mitotic centrosome separation,BP,
12428,GO:0046605,1,0.647731041835031,0,58,regulation of centrosome cycle,BP,
12429,GO:0046606,1,0.901807387778588,0,15,negative regulation of centrosome cycle,BP,
12430,GO:0046607,1,0.923103635933857,0,11,positive regulation of centrosome cycle,BP,
12431,GO:0046618,1,0.981180938443945,0,2,drug export,BP,
12432,GO:0046619,1,0.981334487789533,0,2,optic placode formation involved in camera-type eye formation,BP,
12433,GO:0046620,1,0.492961664259167,0,94,regulation of organ growth,BP,
12434,GO:0046621,1,0.778989043921924,0,33,negative regulation of organ growth,BP,
12435,GO:0046622,1,0.697621345199824,0,46,positive regulation of organ growth,BP,
12436,GO:0046623,1,0.956508281623262,0,3,sphingolipid floppase activity,MF,
12437,GO:0046624,1,0.917785317949914,0,11,sphingolipid transporter activity,MF,
12438,GO:0046625,1,0.88528986888472,0,21,sphingolipid binding,MF,
12441,GO:0046628,1,0.841373603305421,0,20,positive regulation of insulin receptor signaling pathway,BP,
12442,GO:0046629,1,0.885079968267085,0,17,gamma-delta T cell activation,BP,
12445,GO:0046633,1,0.831897288768895,0,34,alpha-beta T cell proliferation,BP,
12452,GO:0046640,1,0.851566165247777,0,31,regulation of alpha-beta T cell proliferation,BP,
12453,GO:0046641,1,0.902009074961342,0,20,positive regulation of alpha-beta T cell proliferation,BP,
12454,GO:0046642,1,0.958991206062126,0,10,negative regulation of alpha-beta T cell proliferation,BP,
12455,GO:0046643,1,0.915899886782576,0,11,regulation of gamma-delta T cell activation,BP,
12456,GO:0046645,1,0.928395707596687,0,9,positive regulation of gamma-delta T cell activation,BP,
12459,GO:0046653,1,0.903336857618067,0,17,tetrahydrofolate metabolic process,BP,
12460,GO:0046654,1,0.965469059414894,0,6,tetrahydrofolate biosynthetic process,BP,
12461,GO:0046655,1,0.890495718536732,0,18,folic acid metabolic process,BP,
12462,GO:0046657,1,0.99682997727444,0,1,folic acid catabolic process,BP,
12463,GO:0046658,1,0.720974516793091,0,52,anchored component of plasma membrane,CC,
12464,GO:0046660,1,0.452569590243072,0,106,female sex differentiation,BP,
12465,GO:0046661,1,0.34909650136806,0,143,male sex differentiation,BP,
12466,GO:0046666,1,0.974660058854867,0,5,retinal cell programmed cell death,BP,
12467,GO:0046668,1,0.981441206392445,0,3,regulation of retinal cell programmed cell death,BP,
12468,GO:0046671,1,0.992742680100308,0,1,negative regulation of retinal cell programmed cell death,BP,
12470,GO:0046677,1,0.747690459298562,0,45,response to antibiotic,BP,
12471,GO:0046680,1,0.995954807555892,0,1,response to DDT,BP,
12473,GO:0046684,1,0.979627862269354,0,4,response to pyrethroid,BP,
12474,GO:0046685,1,0.828560681239671,0,33,response to arsenic-containing substance,BP,
12475,GO:0046686,1,0.756813577284104,0,56,response to cadmium ion,BP,
12476,GO:0046687,1,0.996764461891254,0,1,response to chromate,BP,
12477,GO:0046688,1,0.842015473996743,0,33,response to copper ion,BP,
12478,GO:0046689,1,0.955339453062084,0,9,response to mercury ion,BP,
12479,GO:0046690,1,0.993492966633309,0,1,response to tellurium ion,BP,
12480,GO:0046691,1,0.985591533117265,0,2,intracellular canaliculus,CC,
12481,GO:0046695,1,0.988005581511519,0,3,SLIK (SAGA-like) complex,CC,
12482,GO:0046696,1,0.978348445799475,0,4,lipopolysaccharide receptor complex,CC,
12485,GO:0046703,1,0.963544564346058,0,8,natural killer cell lectin-like receptor binding,MF,
12486,GO:0046704,1,0.994732311715085,0,1,CDP metabolic process,BP,
12487,GO:0046705,1,0.994732311715085,0,1,CDP biosynthetic process,BP,
12488,GO:0046707,1,0.985038777783504,0,2,IDP metabolic process,BP,
12489,GO:0046709,1,0.985038777783504,0,2,IDP catabolic process,BP,
12490,GO:0046710,1,0.921325507047677,0,9,GDP metabolic process,BP,
12491,GO:0046711,1,0.996800171460964,0,1,GDP biosynthetic process,BP,
12492,GO:0046713,1,0.994236721928533,0,1,borate transport,BP,
12493,GO:0046715,1,0.994236721928533,0,1,active borate transmembrane transporter activity,MF,
12495,GO:0046717,1,0.784330643230355,0,38,acid secretion,BP,
12496,GO:0046718,1,0.462050406590657,0,119,viral entry into host cell,BP,
12497,GO:0046719,1,0.958633773878428,0,7,regulation by virus of viral protein levels in host cell,BP,
12498,GO:0046724,1,0.991579445244436,0,2,oxalic acid secretion,BP,
12499,GO:0046725,1,0.993313346526276,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12500,GO:0046726,1,0.971783386914009,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12501,GO:0046745,1,0.994890876864838,0,1,viral capsid secondary envelopment,BP,
12502,GO:0046755,1,0.873196995840885,0,26,viral budding,BP,
12504,GO:0046778,1,0.990636551713137,0,2,modification by virus of host mRNA processing,BP,
12505,GO:0046782,1,0.682495428991345,0,61,regulation of viral transcription,BP,
12506,GO:0046784,1,0.960485862376213,0,8,viral mRNA export from host cell nucleus,BP,
12507,GO:0046785,1,0.57118593917834,0,73,microtubule polymerization,BP,
12508,GO:0046786,1,0.990595854135629,0,1,viral replication complex formation and maintenance,BP,
12509,GO:0046789,1,0.994070812197178,0,1,host cell surface receptor binding,MF,
12511,GO:0046794,1,0.645160452906153,0,59,transport of virus,BP,
12512,GO:0046811,1,0.985985621795584,0,2,histone deacetylase inhibitor activity,MF,
12513,GO:0046812,1,0.994070812197178,0,1,host cell surface binding,MF,
12514,GO:0046813,1,0.968368314262458,0,5,receptor-mediated virion attachment to host cell,BP,
12515,GO:0046822,1,0.437394078769136,0,109,regulation of nucleocytoplasmic transport,BP,
12516,GO:0046823,1,0.859120082192183,0,21,negative regulation of nucleocytoplasmic transport,BP,
12517,GO:0046824,1,0.598107139070715,0,65,positive regulation of nucleocytoplasmic transport,BP,
12518,GO:0046825,1,0.734803834862646,0,41,regulation of protein export from nucleus,BP,
12519,GO:0046826,1,0.97160657966545,0,6,negative regulation of protein export from nucleus,BP,
12520,GO:0046827,1,0.84845234452734,0,21,positive regulation of protein export from nucleus,BP,
12521,GO:0046831,1,0.866033679044709,0,16,regulation of RNA export from nucleus,BP,
12522,GO:0046832,1,0.971164615272479,0,2,negative regulation of RNA export from nucleus,BP,
12523,GO:0046833,1,0.940915226174159,0,8,positive regulation of RNA export from nucleus,BP,
12525,GO:0046835,1,0.866961011586227,0,22,carbohydrate phosphorylation,BP,
12526,GO:0046836,1,0.966550040107365,0,7,glycolipid transport,BP,
12527,GO:0046838,1,0.885766171787393,0,16,phosphorylated carbohydrate dephosphorylation,BP,
12528,GO:0046839,1,0.778319094562732,0,31,phospholipid dephosphorylation,BP,
12529,GO:0046847,1,0.636786559224625,0,56,filopodium assembly,BP,
12530,GO:0046848,1,0.996886241566351,0,1,hydroxyapatite binding,MF,
12531,GO:0046849,1,0.564409051592665,0,84,bone remodeling,BP,
12532,GO:0046850,1,0.726262858010098,0,45,regulation of bone remodeling,BP,
12533,GO:0046851,1,0.918432175281314,0,14,negative regulation of bone remodeling,BP,
12534,GO:0046852,1,0.878753249553134,0,17,positive regulation of bone remodeling,BP,
12536,GO:0046855,1,0.89087152987833,0,15,inositol phosphate dephosphorylation,BP,
12537,GO:0046856,1,0.789044372057376,0,28,phosphatidylinositol dephosphorylation,BP,
12538,GO:0046864,1,0.991581452743848,0,2,isoprenoid transport,BP,
12539,GO:0046865,1,0.991581452743848,0,2,terpenoid transport,BP,
12540,GO:0046870,1,0.971058352403811,0,4,cadmium ion binding,MF,
12543,GO:0046874,1,0.977020545681169,0,5,quinolinate metabolic process,BP,
12544,GO:0046875,1,0.818119818690435,0,27,ephrin receptor binding,MF,
12545,GO:0046877,1,0.970968420417756,0,6,regulation of saliva secretion,BP,
12546,GO:0046878,1,0.99168358288545,0,2,positive regulation of saliva secretion,BP,
12548,GO:0046880,1,0.958964191456825,0,6,regulation of follicle-stimulating hormone secretion,BP,
12549,GO:0046881,1,0.958964191456825,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12550,GO:0046882,1,0.986579096613982,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12552,GO:0046884,1,0.950235984888616,0,7,follicle-stimulating hormone secretion,BP,
12555,GO:0046887,1,0.483419319347621,0,116,positive regulation of hormone secretion,BP,
12559,GO:0046898,1,0.968047045137923,0,4,response to cycloheximide,BP,
12560,GO:0046899,1,0.990030227980348,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12561,GO:0046900,1,0.99193754843775,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12562,GO:0046901,1,0.995367462028409,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12565,GO:0046906,1,0.494748871213821,0,116,tetrapyrrole binding,MF,
12567,GO:0046911,1,0.996730590415193,0,1,metal chelating activity,MF,
12568,GO:0046912,1,0.964625545189298,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12570,GO:0046915,1,0.813555284701962,0,34,transition metal ion transmembrane transporter activity,MF,
12573,GO:0046921,1,0.993890543430555,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12574,GO:0046922,1,0.988086945265545,0,2,peptide-O-fucosyltransferase activity,MF,
12577,GO:0046929,1,0.913641088838525,0,10,negative regulation of neurotransmitter secretion,BP,
12578,GO:0046930,1,0.901780519836707,0,19,pore complex,CC,
12579,GO:0046931,1,0.879124320897533,0,19,pore complex assembly,BP,
12580,GO:0046933,1,0.996766148538805,0,1,proton-transporting ATP synthase activity, rotational mechanism,MF,
12581,GO:0046934,1,0.963146517174537,0,5,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12583,GO:0046939,1,0.419171157236109,0,123,nucleotide phosphorylation,BP,
12584,GO:0046940,1,0.928029870983493,0,14,nucleoside monophosphate phosphorylation,BP,
12587,GO:0046946,1,0.986859831028963,0,2,hydroxylysine metabolic process,BP,
12588,GO:0046947,1,0.986859831028963,0,2,hydroxylysine biosynthetic process,BP,
12589,GO:0046949,1,0.839399631652667,0,29,fatty-acyl-CoA biosynthetic process,BP,
12590,GO:0046950,1,0.946213677164456,0,11,cellular ketone body metabolic process,BP,
12591,GO:0046951,1,0.956146710353496,0,9,ketone body biosynthetic process,BP,
12592,GO:0046952,1,0.979317589586297,0,4,ketone body catabolic process,BP,
12595,GO:0046960,1,0.989315074264752,0,2,sensitization,BP,
12596,GO:0046961,1,0.902100076272282,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12597,GO:0046963,1,0.992021399058224,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12598,GO:0046964,1,0.992021399058224,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12599,GO:0046965,1,0.852661329496288,0,18,retinoid X receptor binding,MF,
12600,GO:0046966,1,0.775452046952546,0,29,thyroid hormone receptor binding,MF,
12601,GO:0046967,1,0.96268550274575,0,4,cytosol to endoplasmic reticulum transport,BP,
12602,GO:0046968,1,0.984390464562486,0,2,peptide antigen transport,BP,
12603,GO:0046969,1,0.989216660857588,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12604,GO:0046970,1,0.996132256305386,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12605,GO:0046972,1,0.940373503405737,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12606,GO:0046974,1,0.899196043598839,0,10,histone methyltransferase activity (H3-K9 specific),MF,
12607,GO:0046975,1,0.899533361788285,0,10,histone methyltransferase activity (H3-K36 specific),MF,
12608,GO:0046976,1,0.968015106648426,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12609,GO:0046977,1,0.960650964319747,0,8,TAP binding,MF,
12610,GO:0046978,1,0.970769890276063,0,5,TAP1 binding,MF,
12611,GO:0046979,1,0.984751547561272,0,3,TAP2 binding,MF,
12612,GO:0046980,1,0.992366237350058,0,1,tapasin binding,MF,
12615,GO:0046984,1,0.978622032967131,0,4,regulation of hemoglobin biosynthetic process,BP,
12616,GO:0046985,1,0.987047406533016,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12617,GO:0046986,1,0.99146517290305,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12618,GO:0046997,1,0.988163682986239,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12619,GO:0047006,1,0.993230728755371,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12620,GO:0047012,1,0.996473390007712,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12621,GO:0047015,1,0.996811869309223,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12622,GO:0047016,1,0.99582590295074,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12623,GO:0047017,1,0.996708818663127,0,1,prostaglandin-F synthase activity,MF,
12624,GO:0047020,1,0.993420256449048,0,2,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12625,GO:0047021,1,0.996700688060965,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12626,GO:0047023,1,0.976135778819756,0,7,androsterone dehydrogenase activity,MF,
12627,GO:0047024,1,0.996532936315724,0,1,5alpha-androstane-3beta,17beta-diol dehydrogenase activity,MF,
12628,GO:0047025,1,0.990378398848293,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12629,GO:0047035,1,0.983016174880996,0,5,testosterone dehydrogenase (NAD+) activity,MF,
12630,GO:0047042,1,0.996625512850898,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12631,GO:0047044,1,0.989318623056596,0,3,androstan-3-alpha,17-beta-diol dehydrogenase activity,MF,
12632,GO:0047045,1,0.986672408171707,0,4,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12633,GO:0047057,1,0.993570614299539,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12634,GO:0047058,1,0.996814960071057,0,1,vitamin-K-epoxide reductase (warfarin-insensitive) activity,MF,
12635,GO:0047066,1,0.993609611644913,0,2,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12636,GO:0047086,1,0.986676254002955,0,4,ketosteroid monooxygenase activity,MF,
12637,GO:0047092,1,0.995518404075719,0,1,27-hydroxycholesterol 7-alpha-monooxygenase activity,MF,
12638,GO:0047102,1,0.995415034909321,0,1,aminomuconate-semialdehyde dehydrogenase activity,MF,
12639,GO:0047105,1,0.995343036483078,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12640,GO:0047115,1,0.986721910082655,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12641,GO:0047117,1,0.98403052900273,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12642,GO:0047127,1,0.996630571661885,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12643,GO:0047130,1,0.988735973416558,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12644,GO:0047131,1,0.988735973416558,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12645,GO:0047134,1,0.982894497608559,0,4,protein-disulfide reductase activity,MF,
12646,GO:0047144,1,0.988328935282277,0,2,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12647,GO:0047150,1,0.995349565360505,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12648,GO:0047159,1,0.982262204640631,0,2,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12649,GO:0047166,1,0.996167832557566,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12650,GO:0047173,1,0.990646544203336,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12651,GO:0047179,1,0.990169156444659,0,3,platelet-activating factor acetyltransferase activity,MF,
12652,GO:0047184,1,0.970569459152982,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12653,GO:0047186,1,0.992652217490118,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12654,GO:0047191,1,0.992521425255987,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12655,GO:0047192,1,0.97849733802724,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12656,GO:0047220,1,0.994860215416411,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12657,GO:0047223,1,0.994738768263735,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12658,GO:0047237,1,0.980350725093211,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12659,GO:0047238,1,0.958027959877789,0,6,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12660,GO:0047256,1,0.992178993775289,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12661,GO:0047263,1,0.99464594393384,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12662,GO:0047273,1,0.993838038817279,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12663,GO:0047275,1,0.989254624057931,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12664,GO:0047276,1,0.994890876864838,0,1,N-acetyllactosaminide 3-alpha-galactosyltransferase activity,MF,
12665,GO:0047277,1,0.99612992832177,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12666,GO:0047280,1,0.9912389379141,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12667,GO:0047288,1,0.987879379133636,0,2,monosialoganglioside sialyltransferase activity,MF,
12668,GO:0047290,1,0.99225443467447,0,2,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12669,GO:0047291,1,0.995649191738072,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12670,GO:0047293,1,0.996439673106619,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12671,GO:0047298,1,0.990584166653363,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12672,GO:0047322,1,0.972932873986586,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12673,GO:0047323,1,0.995900756396052,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12674,GO:0047325,1,0.993958925135842,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12675,GO:0047326,1,0.996298331802648,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12676,GO:0047341,1,0.993616147992159,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12677,GO:0047369,1,0.994890876864838,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12678,GO:0047372,1,0.935101147388528,0,11,acylglycerol lipase activity,MF,
12679,GO:0047374,1,0.985430021397426,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12680,GO:0047381,1,0.996333848567032,0,1,dodecanoyl-[acyl-carrier-protein] hydrolase activity,MF,
12681,GO:0047389,1,0.983679734701794,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12682,GO:0047390,1,0.992552536283108,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12683,GO:0047391,1,0.988276525208922,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12684,GO:0047394,1,0.995753446230019,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12685,GO:0047395,1,0.994583065162764,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12686,GO:0047408,1,0.989664512675215,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12687,GO:0047409,1,0.989664512675215,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12688,GO:0047412,1,0.996290757672814,0,1,N-(long-chain-acyl)ethanolamine deacylase activity,MF,
12689,GO:0047419,1,0.996255675077856,0,1,N-acetylgalactosamine-6-phosphate deacetylase activity,MF,
12690,GO:0047429,1,0.943617797463323,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12691,GO:0047444,1,0.996702139098049,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12692,GO:0047451,1,0.98403052900273,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12693,GO:0047464,1,0.990341524740668,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12694,GO:0047484,1,0.915304592373439,0,14,regulation of response to osmotic stress,BP,
12696,GO:0047493,1,0.977874482419559,0,3,ceramide cholinephosphotransferase activity,MF,
12697,GO:0047496,1,0.676559339380566,0,45,vesicle transport along microtubule,BP,
12698,GO:0047497,1,0.836577791552049,0,22,mitochondrion transport along microtubule,BP,
12700,GO:0047499,1,0.961946986508454,0,8,calcium-independent phospholipase A2 activity,MF,
12701,GO:0047522,1,0.981541265421032,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12702,GO:0047536,1,0.995773365534119,0,1,2-aminoadipate transaminase activity,MF,
12703,GO:0047545,1,0.988343983862615,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12704,GO:0047555,1,0.921427710865874,0,10,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12705,GO:0047560,1,0.99003509446927,0,1,3-dehydrosphinganine reductase activity,MF,
12706,GO:0047598,1,0.99509131520587,0,1,7-dehydrocholesterol reductase activity,MF,
12707,GO:0047603,1,0.996739157310398,0,1,acetoacetyl-CoA hydrolase activity,MF,
12708,GO:0047609,1,0.995033826548407,0,1,acetylputrescine deacetylase activity,MF,
12709,GO:0047611,1,0.995033826548407,0,1,acetylspermidine deacetylase activity,MF,
12710,GO:0047617,1,0.921842932508757,0,18,acyl-CoA hydrolase activity,MF,
12711,GO:0047620,1,0.994583065162764,0,1,acylglycerol kinase activity,MF,
12712,GO:0047621,1,0.996406004432841,0,1,acylpyruvate hydrolase activity,MF,
12713,GO:0047623,1,0.984733058752411,0,2,adenosine-phosphate deaminase activity,MF,
12714,GO:0047631,1,0.981855159885635,0,5,ADP-ribose diphosphatase activity,MF,
12715,GO:0047635,1,0.988809489177916,0,2,alanine-oxo-acid transaminase activity,MF,
12716,GO:0047655,1,0.986172912870884,0,4,allyl-alcohol dehydrogenase activity,MF,
12717,GO:0047658,1,0.99639083166836,0,1,alpha-amino-acid esterase activity,MF,
12718,GO:0047661,1,0.995385273459009,0,1,amino-acid racemase activity,MF,
12719,GO:0047676,1,0.933705675074114,0,11,arachidonate-CoA ligase activity,MF,
12720,GO:0047677,1,0.995333222277823,0,1,arachidonate 8(R)-lipoxygenase activity,MF,
12721,GO:0047685,1,0.996544071467709,0,1,amine sulfotransferase activity,MF,
12722,GO:0047693,1,0.996863987862682,0,1,ATP diphosphatase activity,MF,
12723,GO:0047696,1,0.98980575288751,0,2,beta-adrenergic receptor kinase activity,MF,
12724,GO:0047704,1,0.996083749376374,0,1,bile-salt sulfotransferase activity,MF,
12725,GO:0047708,1,0.992738283969636,0,2,biotinidase activity,MF,
12726,GO:0047710,1,0.987850480454335,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12727,GO:0047718,1,0.989841949792122,0,3,indanol dehydrogenase activity,MF,
12728,GO:0047726,1,0.995338132508373,0,1,iron-cytochrome-c reductase activity,MF,
12729,GO:0047730,1,0.992511059706689,0,1,carnosine synthase activity,MF,
12730,GO:0047734,1,0.994890876864838,0,1,CDP-glycerol diphosphatase activity,MF,
12731,GO:0047743,1,0.996722628517053,0,1,chlordecone reductase activity,MF,
12732,GO:0047747,1,0.991219457578752,0,2,cholate-CoA ligase activity,MF,
12733,GO:0047749,1,0.995669932551463,0,1,cholestanetriol 26-monooxygenase activity,MF,
12734,GO:0047750,1,0.993555155102811,0,2,cholestenol delta-isomerase activity,MF,
12735,GO:0047751,1,0.990823992165876,0,2,cholestenone 5-alpha-reductase activity,MF,
12736,GO:0047756,1,0.981437922582166,0,3,chondroitin 4-sulfotransferase activity,MF,
12737,GO:0047757,1,0.975195647481329,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12738,GO:0047760,1,0.966609501865802,0,7,butyrate-CoA ligase activity,MF,
12739,GO:0047777,1,0.988951615016751,0,1,(S)-citramalyl-CoA lyase activity,MF,
12740,GO:0047780,1,0.988287159081284,0,2,citrate dehydratase activity,MF,
12741,GO:0047787,1,0.996708818663127,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12742,GO:0047800,1,0.993008080132176,0,1,cysteamine dioxygenase activity,MF,
12743,GO:0047801,1,0.995903428076893,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12744,GO:0047837,1,0.996768744797559,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12745,GO:0047840,1,0.996756211178004,0,1,dCTP diphosphatase activity,MF,
12746,GO:0047844,1,0.968480804109101,0,8,deoxycytidine deaminase activity,MF,
12747,GO:0047860,1,0.996686298454104,0,1,diiodophenylpyruvate reductase activity,MF,
12748,GO:0047865,1,0.994281710279455,0,1,dimethylglycine dehydrogenase activity,MF,
12749,GO:0047874,1,0.995925992882668,0,1,dolichyldiphosphatase activity,MF,
12750,GO:0047886,1,0.996448886260361,0,1,farnesol dehydrogenase activity,MF,
12751,GO:0047888,1,0.996128762850543,0,1,fatty acid peroxidase activity,MF,
12752,GO:0047894,1,0.989765329233732,0,3,flavonol 3-sulfotransferase activity,MF,
12753,GO:0047915,1,0.996404235180318,0,1,ganglioside galactosyltransferase activity,MF,
12754,GO:0047933,1,0.984004453075106,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12755,GO:0047936,1,0.982965478178739,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12756,GO:0047939,1,0.996566348061452,0,1,L-glucuronate reductase activity,MF,
12757,GO:0047941,1,0.996566348061452,0,1,glucuronolactone reductase activity,MF,
12758,GO:0047946,1,0.995981900648622,0,1,glutamine N-acyltransferase activity,MF,
12759,GO:0047952,1,0.994693441098482,0,1,glycerol-3-phosphate dehydrogenase [NAD(P)+] activity,MF,
12760,GO:0047961,1,0.992623808190698,0,2,glycine N-acyltransferase activity,MF,
12761,GO:0047963,1,0.993615124228356,0,1,glycine N-choloyltransferase activity,MF,
12762,GO:0047975,1,0.994890876864838,0,1,guanosine phosphorylase activity,MF,
12763,GO:0047977,1,0.990624670235744,0,2,hepoxilin-epoxide hydrolase activity,MF,
12764,GO:0047988,1,0.996183584154226,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12765,GO:0047992,1,0.994890876864838,0,1,hydroxylysine kinase activity,MF,
12766,GO:0047994,1,0.996739157310398,0,1,hydroxymethylglutaryl-CoA hydrolase activity,MF,
12768,GO:0048003,1,0.963909760303342,0,6,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12769,GO:0048006,1,0.980342665716165,0,4,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12770,GO:0048007,1,0.963909760303342,0,6,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12773,GO:0048010,1,0.537935104875266,0,89,vascular endothelial growth factor receptor signaling pathway,BP,
12774,GO:0048011,1,0.807353086176645,0,31,neurotrophin TRK receptor signaling pathway,BP,
12775,GO:0048012,1,0.905776366619822,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12777,GO:0048014,1,0.950990898261093,0,4,Tie signaling pathway,BP,
12778,GO:0048015,1,0.26373953660053,0,171,phosphatidylinositol-mediated signaling,BP,
12779,GO:0048016,1,0.656066996523215,0,52,inositol phosphate-mediated signaling,BP,
12780,GO:0048017,1,0.256723348784844,0,175,inositol lipid-mediated signaling,BP,
12782,GO:0048019,1,0.922695274794522,0,15,receptor antagonist activity,MF,
12783,GO:0048020,1,0.904348508065418,0,24,CCR chemokine receptor binding,MF,
12784,GO:0048021,1,0.907697481723481,0,10,regulation of melanin biosynthetic process,BP,
12785,GO:0048022,1,0.970970747288615,0,3,negative regulation of melanin biosynthetic process,BP,
12786,GO:0048023,1,0.951952332215921,0,6,positive regulation of melanin biosynthetic process,BP,
12790,GO:0048027,1,0.841241215052545,0,26,mRNA 5'-UTR binding,MF,
12791,GO:0048029,1,0.700506670576814,0,64,monosaccharide binding,MF,
12792,GO:0048030,1,0.989683534968098,0,3,disaccharide binding,MF,
12793,GO:0048033,1,0.994461493013875,0,1,heme o metabolic process,BP,
12794,GO:0048034,1,0.994461493013875,0,1,heme O biosynthetic process,BP,
12795,GO:0048038,1,0.940164595388492,0,15,quinone binding,MF,
12796,GO:0048039,1,0.977780605443506,0,6,ubiquinone binding,MF,
12797,GO:0048040,1,0.995952206202863,0,1,UDP-glucuronate decarboxylase activity,MF,
12798,GO:0048041,1,0.484198171787776,0,81,focal adhesion assembly,BP,
12799,GO:0048048,1,0.703589713664254,0,37,embryonic eye morphogenesis,BP,
12800,GO:0048050,1,0.960224216291026,0,6,post-embryonic eye morphogenesis,BP,
12801,GO:0048066,1,0.718181980737066,0,43,developmental pigmentation,BP,
12802,GO:0048069,1,0.966498771225825,0,6,eye pigmentation,BP,
12803,GO:0048070,1,0.889744692544837,0,15,regulation of developmental pigmentation,BP,
12804,GO:0048073,1,0.979599251193774,0,3,regulation of eye pigmentation,BP,
12805,GO:0048074,1,0.995983180678702,0,1,negative regulation of eye pigmentation,BP,
12806,GO:0048075,1,0.991788006824109,0,1,positive regulation of eye pigmentation,BP,
12807,GO:0048086,1,0.995983180678702,0,1,negative regulation of developmental pigmentation,BP,
12808,GO:0048087,1,0.921485266497323,0,9,positive regulation of developmental pigmentation,BP,
12809,GO:0048096,1,0.898571601498838,0,13,chromatin-mediated maintenance of transcription,BP,
12810,GO:0048101,1,0.98469190276325,0,3,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12811,GO:0048102,1,0.931307841814788,0,11,autophagic cell death,BP,
12812,GO:0048103,1,0.927625297130053,0,9,somatic stem cell division,BP,
12813,GO:0048104,1,0.953633773284941,0,4,establishment of body hair or bristle planar orientation,BP,
12814,GO:0048105,1,0.953633773284941,0,4,establishment of body hair planar orientation,BP,
12815,GO:0048133,1,0.98465475988784,0,3,male germ-line stem cell asymmetric division,BP,
12816,GO:0048143,1,0.862885284253145,0,22,astrocyte activation,BP,
12820,GO:0048147,1,0.839345097223971,0,27,negative regulation of fibroblast proliferation,BP,
12821,GO:0048148,1,0.93333012827711,0,12,behavioral response to cocaine,BP,
12822,GO:0048149,1,0.939993884135541,0,9,behavioral response to ethanol,BP,
12823,GO:0048156,1,0.714404055794116,0,44,tau protein binding,MF,
12824,GO:0048160,1,0.99115365325104,0,1,primary follicle stage,BP,
12825,GO:0048162,1,0.9881576270748,0,3,multi-layer follicle stage,BP,
12826,GO:0048165,1,0.976822002634892,0,3,fused antrum stage,BP,
12830,GO:0048170,1,0.95838783021307,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12832,GO:0048174,1,0.992232362160368,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12833,GO:0048175,1,0.994070812197178,0,1,hepatocyte growth factor biosynthetic process,BP,
12834,GO:0048176,1,0.994070812197178,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12835,GO:0048178,1,0.994070812197178,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12836,GO:0048179,1,0.933349743528218,0,6,activin receptor complex,CC,
12837,GO:0048180,1,0.99584795140391,0,1,activin complex,CC,
12838,GO:0048185,1,0.890743602769687,0,14,activin binding,MF,
12839,GO:0048188,1,0.913701573777488,0,11,Set1C/COMPASS complex,CC,
12841,GO:0048194,1,0.563462998561508,0,79,Golgi vesicle budding,BP,
12842,GO:0048199,1,0.607286128202363,0,72,vesicle targeting, to, from or within Golgi,BP,
12843,GO:0048200,1,0.962752766939274,0,6,Golgi transport vesicle coating,BP,
12844,GO:0048203,1,0.9908939242975,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12845,GO:0048205,1,0.962752766939274,0,6,COPI coating of Golgi vesicle,BP,
12846,GO:0048207,1,0.638749905799216,0,64,vesicle targeting, rough ER to cis-Golgi,BP,
12847,GO:0048208,1,0.638749905799216,0,64,COPII vesicle coating,BP,
12848,GO:0048209,1,0.964361818257527,0,5,regulation of vesicle targeting, to, from or within Golgi,BP,
12849,GO:0048210,1,0.979676776370183,0,4,Golgi vesicle fusion to target membrane,BP,
12850,GO:0048211,1,0.987631877188266,0,2,Golgi vesicle docking,BP,
12851,GO:0048213,1,0.991125225319321,0,2,Golgi vesicle prefusion complex stabilization,BP,
12852,GO:0048219,1,0.990625089584329,0,1,inter-Golgi cisterna vesicle-mediated transport,BP,
12853,GO:0048227,1,0.950614373233596,0,8,plasma membrane to endosome transport,BP,
12854,GO:0048232,1,0.0544717444147239,0,430,male gamete generation,BP,
12855,GO:0048237,1,0.988889683369532,0,3,rough endoplasmic reticulum lumen,CC,
12856,GO:0048239,1,0.990598730271422,0,2,negative regulation of DNA recombination at telomere,BP,
12857,GO:0048240,1,0.909598304306024,0,17,sperm capacitation,BP,
12858,GO:0048241,1,0.959641575196785,0,8,epinephrine transport,BP,
12859,GO:0048242,1,0.978991137263033,0,5,epinephrine secretion,BP,
12861,GO:0048244,1,0.996419140551554,0,1,phytanoyl-CoA dioxygenase activity,MF,
12862,GO:0048245,1,0.954651146131207,0,11,eosinophil chemotaxis,BP,
12863,GO:0048246,1,0.825002698881287,0,35,macrophage chemotaxis,BP,
12864,GO:0048247,1,0.779725534031956,0,48,lymphocyte chemotaxis,BP,
12865,GO:0048248,1,0.982311289416048,0,5,CXCR3 chemokine receptor binding,MF,
12866,GO:0048250,1,0.99274975258583,0,2,iron import into the mitochondrion,BP,
12868,GO:0048254,1,0.97795137300529,0,4,snoRNA localization,BP,
12869,GO:0048255,1,0.761038883491113,0,38,mRNA stabilization,BP,
12870,GO:0048256,1,0.945700658897472,0,9,flap endonuclease activity,MF,
12871,GO:0048257,1,0.99041178863168,0,2,3'-flap endonuclease activity,MF,
12874,GO:0048261,1,0.865846007027293,0,23,negative regulation of receptor-mediated endocytosis,BP,
12875,GO:0048262,1,0.953565271107933,0,9,determination of dorsal/ventral asymmetry,BP,
12876,GO:0048263,1,0.958894883504092,0,8,determination of dorsal identity,BP,
12877,GO:0048264,1,0.994444251253433,0,1,determination of ventral identity,BP,
12878,GO:0048265,1,0.822629328829486,0,28,response to pain,BP,
12879,GO:0048266,1,0.914898529680971,0,13,behavioral response to pain,BP,
12881,GO:0048269,1,0.990779334419169,0,2,methionine adenosyltransferase complex,CC,
12882,GO:0048270,1,0.995961942448144,0,1,methionine adenosyltransferase regulator activity,MF,
12883,GO:0048273,1,0.971406869936803,0,5,mitogen-activated protein kinase p38 binding,MF,
12885,GO:0048280,1,0.967870137913115,0,6,vesicle fusion with Golgi apparatus,BP,
12889,GO:0048289,1,0.964992189886723,0,6,isotype switching to IgE isotypes,BP,
12890,GO:0048290,1,0.971163271121828,0,6,isotype switching to IgA isotypes,BP,
12891,GO:0048291,1,0.926473728773287,0,12,isotype switching to IgG isotypes,BP,
12892,GO:0048293,1,0.964992189886723,0,6,regulation of isotype switching to IgE isotypes,BP,
12893,GO:0048294,1,0.982365081165586,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12894,GO:0048295,1,0.982318359872834,0,3,positive regulation of isotype switching to IgE isotypes,BP,
12895,GO:0048296,1,0.97724084220296,0,5,regulation of isotype switching to IgA isotypes,BP,
12896,GO:0048297,1,0.995898081151283,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12897,GO:0048298,1,0.981266680550599,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12898,GO:0048302,1,0.930533538001849,0,11,regulation of isotype switching to IgG isotypes,BP,
12899,GO:0048304,1,0.946725666848447,0,8,positive regulation of isotype switching to IgG isotypes,BP,
12900,GO:0048305,1,0.918987650650428,0,19,immunoglobulin secretion,BP,
12902,GO:0048308,1,0.914928782109264,0,15,organelle inheritance,BP,
12903,GO:0048311,1,0.86311821629057,0,16,mitochondrion distribution,BP,
12904,GO:0048312,1,0.925778216330866,0,8,intracellular distribution of mitochondria,BP,
12905,GO:0048313,1,0.914928782109264,0,15,Golgi inheritance,BP,
12906,GO:0048318,1,0.960438341932587,0,7,axial mesoderm development,BP,
12907,GO:0048319,1,0.976138760887796,0,3,axial mesoderm morphogenesis,BP,
12908,GO:0048320,1,0.988504868472548,0,2,axial mesoderm formation,BP,
12909,GO:0048321,1,0.99596388352694,0,1,axial mesodermal cell differentiation,BP,
12910,GO:0048322,1,0.99596388352694,0,1,axial mesodermal cell fate commitment,BP,
12911,GO:0048327,1,0.99596388352694,0,1,axial mesodermal cell fate specification,BP,
12912,GO:0048332,1,0.621671469773654,0,65,mesoderm morphogenesis,BP,
12913,GO:0048333,1,0.815991507735593,0,30,mesodermal cell differentiation,BP,
12914,GO:0048338,1,0.993207627082606,0,1,mesoderm structural organization,BP,
12915,GO:0048339,1,0.875270022813708,0,17,paraxial mesoderm development,BP,
12916,GO:0048340,1,0.927998936529336,0,9,paraxial mesoderm morphogenesis,BP,
12917,GO:0048341,1,0.96361352002815,0,6,paraxial mesoderm formation,BP,
12918,GO:0048342,1,0.996410409235335,0,1,paraxial mesodermal cell differentiation,BP,
12919,GO:0048343,1,0.996410409235335,0,1,paraxial mesodermal cell fate commitment,BP,
12920,GO:0048352,1,0.993207627082606,0,1,paraxial mesoderm structural organization,BP,
12921,GO:0048365,1,0.584515184066612,0,65,Rac GTPase binding,MF,
12922,GO:0048368,1,0.911646434273549,0,15,lateral mesoderm development,BP,
12923,GO:0048369,1,0.974369119312549,0,4,lateral mesoderm morphogenesis,BP,
12924,GO:0048370,1,0.974369119312549,0,4,lateral mesoderm formation,BP,
12925,GO:0048371,1,0.97781788373943,0,3,lateral mesodermal cell differentiation,BP,
12926,GO:0048372,1,0.982478445047449,0,2,lateral mesodermal cell fate commitment,BP,
12927,GO:0048377,1,0.982478445047449,0,2,lateral mesodermal cell fate specification,BP,
12928,GO:0048378,1,0.982478445047449,0,2,regulation of lateral mesodermal cell fate specification,BP,
12929,GO:0048382,1,0.955632097798308,0,7,mesendoderm development,BP,
12930,GO:0048384,1,0.831857165398418,0,32,retinoic acid receptor signaling pathway,BP,
12931,GO:0048385,1,0.910949692173268,0,17,regulation of retinoic acid receptor signaling pathway,BP,
12932,GO:0048386,1,0.973161974454545,0,5,positive regulation of retinoic acid receptor signaling pathway,BP,
12933,GO:0048387,1,0.946070613693369,0,9,negative regulation of retinoic acid receptor signaling pathway,BP,
12934,GO:0048388,1,0.985271079412762,0,3,endosomal lumen acidification,BP,
12935,GO:0048389,1,0.992519052884927,0,2,intermediate mesoderm development,BP,
12936,GO:0048390,1,0.996309331932209,0,1,intermediate mesoderm morphogenesis,BP,
12937,GO:0048391,1,0.996309331932209,0,1,intermediate mesoderm formation,BP,
12938,GO:0048392,1,0.996309331932209,0,1,intermediate mesodermal cell differentiation,BP,
12939,GO:0048403,1,0.969107974547516,0,3,brain-derived neurotrophic factor binding,MF,
12940,GO:0048406,1,0.961853474784898,0,5,nerve growth factor binding,MF,
12942,GO:0048408,1,0.986006626153104,0,3,epidermal growth factor binding,MF,
12946,GO:0048475,1,0.542070619957208,0,89,coated membrane,CC,
12947,GO:0048476,1,0.979628072393765,0,5,Holliday junction resolvase complex,CC,
12948,GO:0048477,1,0.619561131610383,0,73,oogenesis,BP,
12949,GO:0048478,1,0.938289769872766,0,8,replication fork protection,BP,
12950,GO:0048483,1,0.723884063728306,0,42,autonomic nervous system development,BP,
12951,GO:0048484,1,0.919513313123024,0,13,enteric nervous system development,BP,
12952,GO:0048485,1,0.854846582904995,0,20,sympathetic nervous system development,BP,
12953,GO:0048486,1,0.891197751637577,0,16,parasympathetic nervous system development,BP,
12954,GO:0048487,1,0.786429086651731,0,37,beta-tubulin binding,MF,
12957,GO:0048490,1,0.896127425627582,0,18,anterograde synaptic vesicle transport,BP,
12958,GO:0048495,1,0.934953911114978,0,7,Roundabout binding,MF,
12959,GO:0048496,1,0.954757941122833,0,4,maintenance of animal organ identity,BP,
12960,GO:0048499,1,0.979414138196002,0,4,synaptic vesicle membrane organization,BP,
12961,GO:0048500,1,0.959746459215462,0,9,signal recognition particle,CC,
12962,GO:0048505,1,0.921477312981159,0,12,regulation of timing of cell differentiation,BP,
12964,GO:0048512,1,0.73611846600881,0,45,circadian behavior,BP,
12967,GO:0048515,1,0.470096341401381,0,113,spermatid differentiation,BP,
12970,GO:0048520,1,0.856356395446696,0,22,positive regulation of behavior,BP,
12971,GO:0048521,1,0.931962873900871,0,14,negative regulation of behavior,BP,
12974,GO:0048524,1,0.508828276666081,0,104,positive regulation of viral process,BP,
12976,GO:0048531,1,0.955820882420329,0,9,beta-1,3-galactosyltransferase activity,MF,
12977,GO:0048532,1,0.88858210077416,0,16,anatomical structure arrangement,BP,
12980,GO:0048536,1,0.804461090795648,0,32,spleen development,BP,
12981,GO:0048537,1,0.957312468955832,0,7,mucosa-associated lymphoid tissue development,BP,
12982,GO:0048538,1,0.715004498287183,0,44,thymus development,BP,
12983,GO:0048539,1,0.947509448432119,0,9,bone marrow development,BP,
12984,GO:0048541,1,0.957312468955832,0,7,Peyer's patch development,BP,
12986,GO:0048546,1,0.696757643966771,0,45,digestive tract morphogenesis,BP,
12987,GO:0048548,1,0.91881900454159,0,13,regulation of pinocytosis,BP,
12988,GO:0048549,1,0.945376784331758,0,8,positive regulation of pinocytosis,BP,
12989,GO:0048550,1,0.971923287750471,0,5,negative regulation of pinocytosis,BP,
12990,GO:0048557,1,0.88928311308334,0,16,embryonic digestive tract morphogenesis,BP,
12991,GO:0048560,1,0.991629927642098,0,2,establishment of anatomical structure orientation,BP,
12992,GO:0048561,1,0.995778319601854,0,1,establishment of animal organ orientation,BP,
12993,GO:0048562,1,0.126750979100173,0,280,embryonic organ morphogenesis,BP,
12994,GO:0048563,1,0.937849673461683,0,8,post-embryonic animal organ morphogenesis,BP,
12996,GO:0048566,1,0.809063713852046,0,31,embryonic digestive tract development,BP,
12997,GO:0048567,1,0.99525715885182,0,1,ectodermal digestive tract morphogenesis,BP,
12999,GO:0048569,1,0.884398927070876,0,15,post-embryonic animal organ development,BP,
13000,GO:0048570,1,0.931049461258409,0,9,notochord morphogenesis,BP,
13007,GO:0048593,1,0.373108566903975,0,116,camera-type eye morphogenesis,BP,
13008,GO:0048596,1,0.758207499076481,0,28,embryonic camera-type eye morphogenesis,BP,
13009,GO:0048597,1,0.989373283102992,0,3,post-embryonic camera-type eye morphogenesis,BP,
13011,GO:0048599,1,0.764535534545244,0,39,oocyte development,BP,
13014,GO:0048611,1,0.989811059031193,0,2,embryonic ectodermal digestive tract development,BP,
13015,GO:0048613,1,0.99525715885182,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13016,GO:0048617,1,0.914019287055189,0,9,embryonic foregut morphogenesis,BP,
13017,GO:0048619,1,0.983313199498078,0,3,embryonic hindgut morphogenesis,BP,
13018,GO:0048625,1,0.970274451714491,0,5,myoblast fate commitment,BP,
13019,GO:0048627,1,0.976173268581628,0,3,myoblast development,BP,
13020,GO:0048630,1,0.962289240053942,0,6,skeletal muscle tissue growth,BP,
13021,GO:0048631,1,0.969661120954652,0,4,regulation of skeletal muscle tissue growth,BP,
13022,GO:0048632,1,0.981978879336457,0,2,negative regulation of skeletal muscle tissue growth,BP,
13023,GO:0048633,1,0.987458452954786,0,2,positive regulation of skeletal muscle tissue growth,BP,
13025,GO:0048635,1,0.707690845089174,0,51,negative regulation of muscle organ development,BP,
13026,GO:0048636,1,0.627882219431334,0,60,positive regulation of muscle organ development,BP,
13030,GO:0048641,1,0.736585281230772,0,42,regulation of skeletal muscle tissue development,BP,
13031,GO:0048642,1,0.921483792105342,0,11,negative regulation of skeletal muscle tissue development,BP,
13032,GO:0048643,1,0.878539555580739,0,19,positive regulation of skeletal muscle tissue development,BP,
13034,GO:0048645,1,0.650346358094889,0,63,animal organ formation,BP,
13036,GO:0048659,1,0.416933841173053,0,130,smooth muscle cell proliferation,BP,
13037,GO:0048660,1,0.419022218054492,0,129,regulation of smooth muscle cell proliferation,BP,
13038,GO:0048661,1,0.549380987214261,0,84,positive regulation of smooth muscle cell proliferation,BP,
13039,GO:0048662,1,0.779075454359023,0,43,negative regulation of smooth muscle cell proliferation,BP,
13041,GO:0048664,1,0.972362874353372,0,6,neuron fate determination,BP,
13045,GO:0048668,1,0.793975306922159,0,25,collateral sprouting,BP,
13046,GO:0048669,1,0.979999990906386,0,3,collateral sprouting in absence of injury,BP,
13047,GO:0048670,1,0.852487676844655,0,18,regulation of collateral sprouting,BP,
13048,GO:0048671,1,0.923309855302298,0,8,negative regulation of collateral sprouting,BP,
13049,GO:0048672,1,0.923354023992718,0,10,positive regulation of collateral sprouting,BP,
13050,GO:0048673,1,0.996486875533312,0,1,collateral sprouting of intact axon in response to injury,BP,
13051,GO:0048674,1,0.973780452882526,0,1,collateral sprouting of injured axon,BP,
13053,GO:0048677,1,0.935962592834386,0,5,axon extension involved in regeneration,BP,
13054,GO:0048678,1,0.611826429079291,0,72,response to axon injury,BP,
13055,GO:0048679,1,0.821629769748185,0,25,regulation of axon regeneration,BP,
13056,GO:0048680,1,0.94401420122418,0,8,positive regulation of axon regeneration,BP,
13057,GO:0048681,1,0.900385764148972,0,13,negative regulation of axon regeneration,BP,
13058,GO:0048682,1,0.935962592834386,0,5,sprouting of injured axon,BP,
13059,GO:0048683,1,0.996486875533312,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13060,GO:0048685,1,0.996486875533312,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13061,GO:0048686,1,0.946534377988943,0,4,regulation of sprouting of injured axon,BP,
13062,GO:0048687,1,0.968617084462547,0,2,positive regulation of sprouting of injured axon,BP,
13063,GO:0048688,1,0.977208982061966,0,2,negative regulation of sprouting of injured axon,BP,
13064,GO:0048690,1,0.946534377988943,0,4,regulation of axon extension involved in regeneration,BP,
13065,GO:0048691,1,0.968617084462547,0,2,positive regulation of axon extension involved in regeneration,BP,
13066,GO:0048692,1,0.977208982061966,0,2,negative regulation of axon extension involved in regeneration,BP,
13067,GO:0048693,1,0.973780452882526,0,1,regulation of collateral sprouting of injured axon,BP,
13068,GO:0048694,1,0.973780452882526,0,1,positive regulation of collateral sprouting of injured axon,BP,
13069,GO:0048696,1,0.996551486129961,0,1,regulation of collateral sprouting in absence of injury,BP,
13070,GO:0048697,1,0.996551486129961,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13072,GO:0048701,1,0.69781838666599,0,46,embryonic cranial skeleton morphogenesis,BP,
13073,GO:0048702,1,0.926711775598056,0,9,embryonic neurocranium morphogenesis,BP,
13074,GO:0048703,1,0.915616682810132,0,10,embryonic viscerocranium morphogenesis,BP,
13075,GO:0048704,1,0.531340843876268,0,91,embryonic skeletal system morphogenesis,BP,
13082,GO:0048712,1,0.926770587354907,0,11,negative regulation of astrocyte differentiation,BP,
13084,GO:0048714,1,0.874146558800035,0,22,positive regulation of oligodendrocyte differentiation,BP,
13085,GO:0048715,1,0.910934105542149,0,13,negative regulation of oligodendrocyte differentiation,BP,
13087,GO:0048730,1,0.826565621490785,0,28,epidermis morphogenesis,BP,
13090,GO:0048733,1,0.943969736322913,0,6,sebaceous gland development,BP,
13092,GO:0048738,1,0.177447081049056,0,197,cardiac muscle tissue development,BP,
13093,GO:0048739,1,0.866620086797715,0,10,cardiac muscle fiber development,BP,
13094,GO:0048741,1,0.831903355112636,0,26,skeletal muscle fiber development,BP,
13095,GO:0048742,1,0.943847326143961,0,8,regulation of skeletal muscle fiber development,BP,
13096,GO:0048743,1,0.972083454503526,0,5,positive regulation of skeletal muscle fiber development,BP,
13099,GO:0048752,1,0.94185865636637,0,7,semicircular canal morphogenesis,BP,
13100,GO:0048753,1,0.818779107950889,0,28,pigment granule organization,BP,
13102,GO:0048755,1,0.916492924801005,0,10,branching morphogenesis of a nerve,BP,
13103,GO:0048757,1,0.941342523061306,0,10,pigment granule maturation,BP,
13105,GO:0048763,1,0.910838016525567,0,4,calcium-induced calcium release activity,MF,
13106,GO:0048769,1,0.924798095248459,0,3,sarcomerogenesis,BP,
13110,GO:0048787,1,0.788475793763564,0,30,presynaptic active zone membrane,CC,
13112,GO:0048789,1,0.990580271672831,0,1,cytoskeletal matrix organization at active zone,BP,
13113,GO:0048790,1,0.921708555185426,0,5,maintenance of presynaptic active zone structure,BP,
13115,GO:0048792,1,0.993597712816293,0,1,spontaneous exocytosis of neurotransmitter,BP,
13116,GO:0048793,1,0.94955411250143,0,6,pronephros development,BP,
13118,GO:0048806,1,0.694402948683748,0,43,genitalia development,BP,
13119,GO:0048807,1,0.984892269220778,0,3,female genitalia morphogenesis,BP,
13120,GO:0048808,1,0.976933086163236,0,4,male genitalia morphogenesis,BP,
13124,GO:0048817,1,0.982032287150656,0,2,negative regulation of hair follicle maturation,BP,
13125,GO:0048818,1,0.96763365708857,0,5,positive regulation of hair follicle maturation,BP,
13126,GO:0048819,1,0.937667425061649,0,9,regulation of hair follicle maturation,BP,
13127,GO:0048820,1,0.868240661051723,0,16,hair follicle maturation,BP,
13128,GO:0048821,1,0.804273544662231,0,32,erythrocyte development,BP,
13129,GO:0048822,1,0.970900407165256,0,3,enucleate erythrocyte development,BP,
13131,GO:0048840,1,0.959974806425343,0,6,otolith development,BP,
13132,GO:0048841,1,0.741632198692405,0,31,regulation of axon extension involved in axon guidance,BP,
13133,GO:0048842,1,0.911184877470279,0,7,positive regulation of axon extension involved in axon guidance,BP,
13134,GO:0048843,1,0.797931922685131,0,25,negative regulation of axon extension involved in axon guidance,BP,
13136,GO:0048845,1,0.922621230157383,0,9,venous blood vessel morphogenesis,BP,
13137,GO:0048846,1,0.70207261320667,0,36,axon extension involved in axon guidance,BP,
13138,GO:0048850,1,0.988831518817606,0,1,hypophysis morphogenesis,BP,
13139,GO:0048852,1,0.984733501905332,0,2,diencephalon morphogenesis,BP,
13140,GO:0048853,1,0.918799751597767,0,10,forebrain morphogenesis,BP,
13145,GO:0048859,1,0.969812419646901,0,5,formation of anatomical boundary,BP,
13148,GO:0048864,1,0.5321088655826,0,83,stem cell development,BP,
13149,GO:0048865,1,0.961313936208765,0,8,stem cell fate commitment,BP,
13150,GO:0048866,1,0.981416227664179,0,4,stem cell fate specification,BP,
13151,GO:0048867,1,0.987940942489437,0,3,stem cell fate determination,BP,
13156,GO:0048873,1,0.841766243379573,0,27,homeostasis of number of cells within a tissue,BP,
13157,GO:0048874,1,0.990013981104365,0,1,host-mediated regulation of intestinal microbiota composition,BP,
13158,GO:0048875,1,0.935921577412832,0,10,chemical homeostasis within a tissue,BP,
13161,GO:0048881,1,0.991662880945026,0,1,mechanosensory lateral line system development,BP,
13162,GO:0048882,1,0.986809291662193,0,2,lateral line development,BP,
13163,GO:0048884,1,0.986809291662193,0,2,neuromast development,BP,
13164,GO:0048886,1,0.986809291662193,0,2,neuromast hair cell differentiation,BP,
13165,GO:0048915,1,0.991662880945026,0,1,posterior lateral line system development,BP,
13166,GO:0048916,1,0.991662880945026,0,1,posterior lateral line development,BP,
13167,GO:0048919,1,0.991662880945026,0,1,posterior lateral line neuromast development,BP,
13168,GO:0048923,1,0.991662880945026,0,1,posterior lateral line neuromast hair cell differentiation,BP,
13169,GO:0048925,1,0.986809291662193,0,2,lateral line system development,BP,
13170,GO:0048934,1,0.893148453067966,0,13,peripheral nervous system neuron differentiation,BP,
13171,GO:0048935,1,0.893148453067966,0,13,peripheral nervous system neuron development,BP,
13172,GO:0048936,1,0.983717052146227,0,3,peripheral nervous system neuron axonogenesis,BP,
13173,GO:0050000,1,0.62836282187345,0,72,chromosome localization,BP,
13174,GO:0050011,1,0.996480565152294,0,1,itaconyl-CoA hydratase activity,MF,
13175,GO:0050023,1,0.996227492476509,0,1,L-fuconate dehydratase activity,MF,
13176,GO:0050031,1,0.995488745648731,0,1,L-pipecolate oxidase activity,MF,
13177,GO:0050038,1,0.99684176521765,0,1,L-xylulose reductase (NADP+) activity,MF,
13178,GO:0050051,1,0.984989957940836,0,3,leukotriene-B4 20-monooxygenase activity,MF,
13179,GO:0050061,1,0.992907123396694,0,1,long-chain-aldehyde dehydrogenase activity,MF,
13180,GO:0050072,1,0.948423413631582,0,7,m7G(5')pppN diphosphatase activity,MF,
13181,GO:0050080,1,0.995817577748326,0,1,malonyl-CoA decarboxylase activity,MF,
13182,GO:0050104,1,0.996547968223356,0,1,L-gulonate 3-dehydrogenase activity,MF,
13183,GO:0050115,1,0.990646544203336,0,1,myosin-light-chain-phosphatase activity,MF,
13184,GO:0050121,1,0.996565325061949,0,1,N-acylglucosamine 2-epimerase activity,MF,
13185,GO:0050124,1,0.992851952138839,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13186,GO:0050129,1,0.994068822762504,0,1,N-formylglutamate deformylase activity,MF,
13187,GO:0050135,1,0.898281725630931,0,16,NAD(P)+ nucleosidase activity,MF,
13188,GO:0050136,1,0.874333615178542,0,38,NADH dehydrogenase (quinone) activity,MF,
13189,GO:0050145,1,0.862309553968589,0,21,nucleoside monophosphate kinase activity,MF,
13190,GO:0050152,1,0.996684771983133,0,1,omega-amidase activity,MF,
13191,GO:0050155,1,0.996090351479374,0,1,ornithine(lysine) transaminase activity,MF,
13192,GO:0050178,1,0.993767589975629,0,2,phenylpyruvate tautomerase activity,MF,
13193,GO:0050185,1,0.979613256625979,0,1,phosphatidylinositol deacylase activity,MF,
13194,GO:0050196,1,0.980846897712641,0,2,[phosphorylase] phosphatase activity,MF,
13195,GO:0050197,1,0.98846857847335,0,2,phytanate-CoA ligase activity,MF,
13196,GO:0050200,1,0.982262204640631,0,2,plasmalogen synthase activity,MF,
13197,GO:0050211,1,0.98434390293276,0,3,procollagen galactosyltransferase activity,MF,
13198,GO:0050218,1,0.976729550697965,0,4,propionate-CoA ligase activity,MF,
13199,GO:0050220,1,0.988998138183019,0,3,prostaglandin-E synthase activity,MF,
13200,GO:0050221,1,0.996700688060965,0,1,prostaglandin-E2 9-reductase activity,MF,
13201,GO:0050251,1,0.991412717042964,0,2,retinol isomerase activity,MF,
13202,GO:0050252,1,0.988469323204644,0,2,retinol O-fatty-acyltransferase activity,MF,
13203,GO:0050253,1,0.974030179351381,0,4,retinyl-palmitate esterase activity,MF,
13204,GO:0050254,1,0.988107904553207,0,3,rhodopsin kinase activity,MF,
13205,GO:0050255,1,0.995305280149271,0,1,ribitol 2-dehydrogenase activity,MF,
13206,GO:0050262,1,0.989807596705769,0,2,ribosylnicotinamide kinase activity,MF,
13207,GO:0050265,1,0.99478012276385,0,1,RNA uridylyltransferase activity,MF,
13208,GO:0050277,1,0.992756204884581,0,1,sedoheptulokinase activity,MF,
13209,GO:0050290,1,0.990916833988215,0,1,sphingomyelin phosphodiesterase D activity,MF,
13210,GO:0050291,1,0.969730327372821,0,6,sphingosine N-acyltransferase activity,MF,
13211,GO:0050294,1,0.985871321266605,0,4,steroid sulfotransferase activity,MF,
13212,GO:0050295,1,0.988745863770765,0,2,steryl-beta-glucosidase activity,MF,
13213,GO:0050308,1,0.953868125870146,0,8,sugar-phosphatase activity,MF,
13214,GO:0050309,1,0.985210455307856,0,3,sugar-terminal-phosphatase activity,MF,
13215,GO:0050313,1,0.996807977639106,0,1,sulfur dioxygenase activity,MF,
13216,GO:0050321,1,0.829730395863379,0,22,tau-protein kinase activity,MF,
13217,GO:0050333,1,0.996297325380529,0,1,thiamin-triphosphatase activity,MF,
13218,GO:0050337,1,0.996881303882385,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13219,GO:0050346,1,0.994890876864838,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13220,GO:0050347,1,0.98982655545591,0,2,trans-octaprenyltranstransferase activity,MF,
13221,GO:0050353,1,0.994728619431495,0,1,trimethyllysine dioxygenase activity,MF,
13222,GO:0050355,1,0.991460171793269,0,1,triphosphatase activity,MF,
13223,GO:0050405,1,0.972932873986586,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13224,GO:0050421,1,0.995183075943713,0,1,nitrite reductase (NO-forming) activity,MF,
13225,GO:0050427,1,0.895397162713858,0,21,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13226,GO:0050428,1,0.959107162904571,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13227,GO:0050429,1,0.987668134549377,0,1,calcium-dependent phospholipase C activity,MF,
13228,GO:0050431,1,0.835706073828817,0,22,transforming growth factor beta binding,MF,
13231,GO:0050434,1,0.772198358460043,0,41,positive regulation of viral transcription,BP,
13232,GO:0050435,1,0.688322124674995,0,45,amyloid-beta metabolic process,BP,
13233,GO:0050436,1,0.966900224177248,0,3,microfibril binding,MF,
13234,GO:0050444,1,0.993884494377349,0,1,aquacobalamin reductase (NADPH) activity,MF,
13236,GO:0050462,1,0.996702139098049,0,1,N-acetylneuraminate synthase activity,MF,
13237,GO:0050473,1,0.98581019962101,0,3,arachidonate 15-lipoxygenase activity,MF,
13238,GO:0050479,1,0.994890876864838,0,1,glyceryl-ether monooxygenase activity,MF,
13239,GO:0050480,1,0.995891377474433,0,1,imidazolonepropionase activity,MF,
13241,GO:0050486,1,0.993819823211267,0,1,intramolecular transferase activity, transferring hydroxy groups,MF,
13242,GO:0050497,1,0.989973151110078,0,2,transferase activity, transferring alkylthio groups,MF,
13243,GO:0050501,1,0.981137698755081,0,4,hyaluronan synthase activity,MF,
13244,GO:0050508,1,0.979267461548359,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13245,GO:0050509,1,0.986780929845544,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13246,GO:0050510,1,0.972061838824058,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13247,GO:0050512,1,0.995957405259747,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13248,GO:0050528,1,0.995524613400313,0,1,acyloxyacyl hydrolase activity,MF,
13249,GO:0050542,1,0.977944300609887,0,6,icosanoid binding,MF,
13250,GO:0050543,1,0.97836554040009,0,6,icosatetraenoic acid binding,MF,
13251,GO:0050544,1,0.981542507648862,0,5,arachidonic acid binding,MF,
13252,GO:0050560,1,0.993748794652577,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13253,GO:0050561,1,0.992591972216921,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13254,GO:0050567,1,0.984037995549562,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13255,GO:0050571,1,0.996465322757892,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13256,GO:0050610,1,0.993414747014903,0,2,methylarsonate reductase activity,MF,
13257,GO:0050613,1,0.98936339677278,0,2,delta14-sterol reductase activity,MF,
13258,GO:0050614,1,0.99183051038241,0,1,delta24-sterol reductase activity,MF,
13259,GO:0050632,1,0.996601496531062,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13260,GO:0050633,1,0.988720840609473,0,3,acetyl-CoA C-myristoyltransferase activity,MF,
13261,GO:0050646,1,0.996334815176724,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13262,GO:0050647,1,0.996334815176724,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13263,GO:0050648,1,0.996334815176724,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13264,GO:0050649,1,0.992236836937375,0,2,testosterone 6-beta-hydroxylase activity,MF,
13265,GO:0050650,1,0.792558820823646,0,31,chondroitin sulfate proteoglycan biosynthetic process,BP,
13266,GO:0050651,1,0.885464197713599,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13267,GO:0050652,1,0.992997674652912,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13268,GO:0050653,1,0.98556682998181,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13269,GO:0050654,1,0.730595951459217,0,43,chondroitin sulfate proteoglycan metabolic process,BP,
13270,GO:0050655,1,0.881755076326284,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13271,GO:0050656,1,0.957688175513757,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13272,GO:0050657,1,0.270500707793783,0,184,nucleic acid transport,BP,
13273,GO:0050658,1,0.270500707793783,0,184,RNA transport,BP,
13274,GO:0050659,1,0.980144096696763,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13275,GO:0050660,1,0.613208423684992,0,78,flavin adenine dinucleotide binding,MF,
13276,GO:0050661,1,0.742168742017088,0,50,NADP binding,MF,
13277,GO:0050663,1,0.686341421877271,0,62,cytokine secretion,BP,
13278,GO:0050664,1,0.904937938277782,0,16,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13279,GO:0050665,1,0.922072423706494,0,13,hydrogen peroxide biosynthetic process,BP,
13280,GO:0050666,1,0.991078080641456,0,2,regulation of homocysteine metabolic process,BP,
13281,GO:0050667,1,0.930887918019679,0,12,homocysteine metabolic process,BP,
13282,GO:0050668,1,0.995708758401878,0,1,positive regulation of homocysteine metabolic process,BP,
13285,GO:0050672,1,0.659745511137395,0,72,negative regulation of lymphocyte proliferation,BP,
13286,GO:0050673,1,0.0756853668582694,0,355,epithelial cell proliferation,BP,
13287,GO:0050674,1,0.996876452058736,0,1,urothelial cell proliferation,BP,
13288,GO:0050675,1,0.996876452058736,0,1,regulation of urothelial cell proliferation,BP,
13289,GO:0050677,1,0.996876452058736,0,1,positive regulation of urothelial cell proliferation,BP,
13290,GO:0050678,1,0.105321642216962,0,304,regulation of epithelial cell proliferation,BP,
13291,GO:0050679,1,0.2777920588589,0,175,positive regulation of epithelial cell proliferation,BP,
13292,GO:0050680,1,0.418394005171603,0,116,negative regulation of epithelial cell proliferation,BP,
13293,GO:0050681,1,0.817219089761814,0,27,androgen receptor binding,MF,
13294,GO:0050682,1,0.96645365727514,0,3,AF-2 domain binding,MF,
13295,GO:0050683,1,0.992191300386246,0,1,AF-1 domain binding,MF,
13299,GO:0050687,1,0.874916984004254,0,21,negative regulation of defense response to virus,BP,
13300,GO:0050688,1,0.651654175541659,0,63,regulation of defense response to virus,BP,
13301,GO:0050689,1,0.987446042227314,0,3,negative regulation of defense response to virus by host,BP,
13302,GO:0050690,1,0.837526268772568,0,29,regulation of defense response to virus by virus,BP,
13303,GO:0050691,1,0.814939282722671,0,32,regulation of defense response to virus by host,BP,
13304,GO:0050692,1,0.980096142737585,0,3,DNA binding domain binding,MF,
13305,GO:0050693,1,0.958392792579134,0,6,LBD domain binding,MF,
13306,GO:0050694,1,0.982130340359506,0,4,galactose 3-O-sulfotransferase activity,MF,
13307,GO:0050698,1,0.989155163585843,0,2,proteoglycan sulfotransferase activity,MF,
13308,GO:0050699,1,0.83092740549691,0,30,WW domain binding,MF,
13309,GO:0050700,1,0.906874628583318,0,14,CARD domain binding,MF,
13310,GO:0050707,1,0.739354238515644,0,50,regulation of cytokine secretion,BP,
13313,GO:0050710,1,0.916851942464574,0,15,negative regulation of cytokine secretion,BP,
13314,GO:0050714,1,0.361421387684313,0,152,positive regulation of protein secretion,BP,
13315,GO:0050715,1,0.858541515629843,0,27,positive regulation of cytokine secretion,BP,
13322,GO:0050733,1,0.968177026156199,0,5,RS domain binding,MF,
13323,GO:0050746,1,0.910442518791092,0,14,regulation of lipoprotein metabolic process,BP,
13324,GO:0050747,1,0.965923473334351,0,5,positive regulation of lipoprotein metabolic process,BP,
13325,GO:0050748,1,0.967667199023424,0,5,negative regulation of lipoprotein metabolic process,BP,
13327,GO:0050755,1,0.996744158135859,0,1,chemokine metabolic process,BP,
13328,GO:0050757,1,0.991888877620316,0,2,thymidylate synthase biosynthetic process,BP,
13329,GO:0050758,1,0.991888877620316,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13330,GO:0050760,1,0.995118946986568,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13331,GO:0050764,1,0.571725360317233,0,85,regulation of phagocytosis,BP,
13332,GO:0050765,1,0.889746905593509,0,17,negative regulation of phagocytosis,BP,
13333,GO:0050766,1,0.66853791583842,0,62,positive regulation of phagocytosis,BP,
13338,GO:0050771,1,0.570265322012188,0,68,negative regulation of axonogenesis,BP,
13341,GO:0050774,1,0.879294467968361,0,16,negative regulation of dendrite morphogenesis,BP,
13346,GO:0050779,1,0.766807181721955,0,34,RNA destabilization,BP,
13347,GO:0050780,1,0.899992701009313,0,17,dopamine receptor binding,MF,
13348,GO:0050783,1,0.995442960961871,0,1,cocaine metabolic process,BP,
13349,GO:0050785,1,0.996649345953502,0,1,advanced glycation end-product receptor activity,MF,
13350,GO:0050786,1,0.965464904085378,0,10,RAGE receptor binding,MF,
13351,GO:0050787,1,0.987121271097475,0,2,detoxification of mercury ion,BP,
13357,GO:0050795,1,0.639598162327431,0,60,regulation of behavior,BP,
13361,GO:0050802,1,0.893304342888486,0,21,circadian sleep/wake cycle, sleep,BP,
13370,GO:0050812,1,0.934269936199484,0,8,regulation of acyl-CoA biosynthetic process,BP,
13371,GO:0050815,1,0.952184389340814,0,8,phosphoserine residue binding,MF,
13372,GO:0050816,1,0.977694655790321,0,3,phosphothreonine residue binding,MF,
13377,GO:0050821,1,0.316825384128428,0,167,protein stabilization,BP,
13378,GO:0050822,1,0.993453831522747,0,1,peptide stabilization,BP,
13379,GO:0050823,1,0.993453831522747,0,1,peptide antigen stabilization,BP,
13383,GO:0050833,1,0.979605696540701,0,4,pyruvate transmembrane transporter activity,MF,
13386,GO:0050847,1,0.902639113878481,0,9,progesterone receptor signaling pathway,BP,
13388,GO:0050849,1,0.823341861340057,0,29,negative regulation of calcium-mediated signaling,BP,
13389,GO:0050850,1,0.77792013403148,0,38,positive regulation of calcium-mediated signaling,BP,
13390,GO:0050851,1,0.265497489137633,0,232,antigen receptor-mediated signaling pathway,BP,
13391,GO:0050852,1,0.348327534610392,0,187,T cell receptor signaling pathway,BP,
13392,GO:0050853,1,0.692310738335555,0,60,B cell receptor signaling pathway,BP,
13393,GO:0050854,1,0.674299824774522,0,65,regulation of antigen receptor-mediated signaling pathway,BP,
13394,GO:0050855,1,0.854923694269834,0,26,regulation of B cell receptor signaling pathway,BP,
13395,GO:0050856,1,0.781175024323557,0,42,regulation of T cell receptor signaling pathway,BP,
13396,GO:0050857,1,0.870319160145326,0,22,positive regulation of antigen receptor-mediated signaling pathway,BP,
13397,GO:0050858,1,0.858689548926877,0,30,negative regulation of antigen receptor-mediated signaling pathway,BP,
13398,GO:0050859,1,0.966687781481596,0,7,negative regulation of B cell receptor signaling pathway,BP,
13399,GO:0050860,1,0.8883158693174,0,23,negative regulation of T cell receptor signaling pathway,BP,
13400,GO:0050861,1,0.945880184197699,0,8,positive regulation of B cell receptor signaling pathway,BP,
13401,GO:0050862,1,0.925928883090188,0,14,positive regulation of T cell receptor signaling pathway,BP,
13403,GO:0050864,1,0.497287544461707,0,111,regulation of B cell activation,BP,
13408,GO:0050869,1,0.826058904079007,0,32,negative regulation of B cell activation,BP,
13410,GO:0050871,1,0.656605428628188,0,68,positive regulation of B cell activation,BP,
13411,GO:0050872,1,0.91125069446827,0,14,white fat cell differentiation,BP,
13412,GO:0050873,1,0.731470504353903,0,46,brown fat cell differentiation,BP,
13415,GO:0050879,1,0.66652105443824,0,52,multicellular organismal movement,BP,
13416,GO:0050881,1,0.66652105443824,0,52,musculoskeletal movement,BP,
13417,GO:0050882,1,0.904573113511393,0,7,voluntary musculoskeletal movement,BP,
13418,GO:0050883,1,0.991889982582571,0,2,musculoskeletal movement, spinal reflex action,BP,
13419,GO:0050884,1,0.893362117622681,0,15,neuromuscular process controlling posture,BP,
13421,GO:0050886,1,0.650774805679082,0,72,endocrine process,BP,
13423,GO:0050891,1,0.632611995831844,0,60,multicellular organismal water homeostasis,BP,
13424,GO:0050892,1,0.819967036134289,0,30,intestinal absorption,BP,
13428,GO:0050897,1,0.979764056564514,0,3,cobalt ion binding,MF,
13431,GO:0050902,1,0.989264657817017,0,2,leukocyte adhesive activation,BP,
13432,GO:0050904,1,0.962424235335004,0,5,diapedesis,BP,
13434,GO:0050906,1,0.576954106284975,0,95,detection of stimulus involved in sensory perception,BP,
13435,GO:0050907,1,0.842575961144113,0,42,detection of chemical stimulus involved in sensory perception,BP,
13436,GO:0050908,1,0.875427001751009,0,17,detection of light stimulus involved in visual perception,BP,
13437,GO:0050909,1,0.808334359052642,0,44,sensory perception of taste,BP,
13438,GO:0050910,1,0.931320527732753,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13439,GO:0050911,1,0.940981793600197,0,16,detection of chemical stimulus involved in sensory perception of smell,BP,
13440,GO:0050912,1,0.90722280947906,0,24,detection of chemical stimulus involved in sensory perception of taste,BP,
13441,GO:0050913,1,0.892636149504935,0,24,sensory perception of bitter taste,BP,
13442,GO:0050915,1,0.97917748542519,0,4,sensory perception of sour taste,BP,
13443,GO:0050916,1,0.96576766903791,0,5,sensory perception of sweet taste,BP,
13444,GO:0050917,1,0.960287817484492,0,6,sensory perception of umami taste,BP,
13445,GO:0050918,1,0.684363099372103,0,53,positive chemotaxis,BP,
13446,GO:0050919,1,0.653329127319417,0,46,negative chemotaxis,BP,
13449,GO:0050922,1,0.658333527813926,0,54,negative regulation of chemotaxis,BP,
13450,GO:0050923,1,0.959331928531625,0,4,regulation of negative chemotaxis,BP,
13451,GO:0050924,1,0.990459734623842,0,1,positive regulation of negative chemotaxis,BP,
13452,GO:0050925,1,0.974763753025062,0,2,negative regulation of negative chemotaxis,BP,
13453,GO:0050926,1,0.853646343980896,0,25,regulation of positive chemotaxis,BP,
13454,GO:0050927,1,0.862358281941198,0,24,positive regulation of positive chemotaxis,BP,
13455,GO:0050928,1,0.989912402171289,0,1,negative regulation of positive chemotaxis,BP,
13456,GO:0050929,1,0.990459734623842,0,1,induction of negative chemotaxis,BP,
13457,GO:0050930,1,0.938772739109967,0,13,induction of positive chemotaxis,BP,
13458,GO:0050931,1,0.752172486463693,0,34,pigment cell differentiation,BP,
13459,GO:0050932,1,0.928773782409679,0,8,regulation of pigment cell differentiation,BP,
13460,GO:0050942,1,0.932062368571534,0,7,positive regulation of pigment cell differentiation,BP,
13461,GO:0050951,1,0.864812587811155,0,21,sensory perception of temperature stimulus,BP,
13464,GO:0050955,1,0.964533641720561,0,4,thermoception,BP,
13465,GO:0050957,1,0.947353379040781,0,6,equilibrioception,BP,
13466,GO:0050960,1,0.975066945484389,0,3,detection of temperature stimulus involved in thermoception,BP,
13467,GO:0050961,1,0.902373851361536,0,17,detection of temperature stimulus involved in sensory perception,BP,
13468,GO:0050962,1,0.875427001751009,0,17,detection of light stimulus involved in sensory perception,BP,
13469,GO:0050965,1,0.91818742913954,0,15,detection of temperature stimulus involved in sensory perception of pain,BP,
13470,GO:0050966,1,0.911461899847269,0,12,detection of mechanical stimulus involved in sensory perception of pain,BP,
13471,GO:0050968,1,0.98707171280685,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13472,GO:0050974,1,0.83342330500855,0,27,detection of mechanical stimulus involved in sensory perception,BP,
13473,GO:0050975,1,0.969132004762004,0,5,sensory perception of touch,BP,
13474,GO:0050976,1,0.976368443698578,0,3,detection of mechanical stimulus involved in sensory perception of touch,BP,
13475,GO:0050982,1,0.698823180028379,0,40,detection of mechanical stimulus,BP,
13476,GO:0050992,1,0.995898081151283,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13477,GO:0050993,1,0.995898081151283,0,1,dimethylallyl diphosphate metabolic process,BP,
13478,GO:0050994,1,0.694578182414284,0,49,regulation of lipid catabolic process,BP,
13479,GO:0050995,1,0.865492456822757,0,19,negative regulation of lipid catabolic process,BP,
13480,GO:0050996,1,0.862209972216753,0,20,positive regulation of lipid catabolic process,BP,
13481,GO:0050997,1,0.834414684502606,0,23,quaternary ammonium group binding,MF,
13482,GO:0050998,1,0.890633096769032,0,14,nitric-oxide synthase binding,MF,
13483,GO:0050999,1,0.771864614716475,0,43,regulation of nitric-oxide synthase activity,BP,
13484,GO:0051000,1,0.891995884510013,0,19,positive regulation of nitric-oxide synthase activity,BP,
13485,GO:0051001,1,0.954526169275874,0,7,negative regulation of nitric-oxide synthase activity,BP,
13486,GO:0051004,1,0.912252507227952,0,16,regulation of lipoprotein lipase activity,BP,
13487,GO:0051005,1,0.971946626845227,0,4,negative regulation of lipoprotein lipase activity,BP,
13488,GO:0051006,1,0.968223588907797,0,7,positive regulation of lipoprotein lipase activity,BP,
13489,GO:0051008,1,0.996130510687623,0,1,Hsp27 protein binding,MF,
13490,GO:0051010,1,0.812356942402633,0,20,microtubule plus-end binding,MF,
13491,GO:0051011,1,0.897298337616927,0,11,microtubule minus-end binding,MF,
13492,GO:0051012,1,0.979462670453904,0,2,microtubule sliding,BP,
13493,GO:0051013,1,0.927642857525016,0,11,microtubule severing,BP,
13494,GO:0051014,1,0.907317162415779,0,15,actin filament severing,BP,
13495,GO:0051015,1,0.176575400013862,0,191,actin filament binding,MF,
13496,GO:0051016,1,0.878107098477085,0,20,barbed-end actin filament capping,BP,
13499,GO:0051019,1,0.799591470286971,0,33,mitogen-activated protein kinase binding,MF,
13501,GO:0051021,1,0.976377689147835,0,4,GDP-dissociation inhibitor binding,MF,
13502,GO:0051022,1,0.979760545987902,0,3,Rho GDP-dissociation inhibitor binding,MF,
13503,GO:0051023,1,0.934605405969009,0,16,regulation of immunoglobulin secretion,BP,
13504,GO:0051024,1,0.964737054013337,0,9,positive regulation of immunoglobulin secretion,BP,
13505,GO:0051025,1,0.983404324923451,0,3,negative regulation of immunoglobulin secretion,BP,
13506,GO:0051026,1,0.97264113471087,0,5,chiasma assembly,BP,
13507,GO:0051028,1,0.36009877129414,0,140,mRNA transport,BP,
13508,GO:0051029,1,0.965605532476881,0,5,rRNA transport,BP,
13509,GO:0051030,1,0.985536739108951,0,4,snRNA transport,BP,
13510,GO:0051031,1,0.77374713157149,0,33,tRNA transport,BP,
13511,GO:0051032,1,0.983003446209835,0,2,nucleic acid transmembrane transporter activity,MF,
13512,GO:0051033,1,0.983003446209835,0,2,RNA transmembrane transporter activity,MF,
13513,GO:0051036,1,0.97467873108719,0,5,regulation of endosome size,BP,
13514,GO:0051040,1,0.988141621317053,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13515,GO:0051041,1,0.993932817609136,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13516,GO:0051042,1,0.994173806742172,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13518,GO:0051044,1,0.924785360830987,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13526,GO:0051052,1,0.112330803500296,0,314,regulation of DNA metabolic process,BP,
13527,GO:0051053,1,0.482016849394304,0,98,negative regulation of DNA metabolic process,BP,
13528,GO:0051054,1,0.296574781424801,0,179,positive regulation of DNA metabolic process,BP,
13529,GO:0051055,1,0.753900799721515,0,47,negative regulation of lipid biosynthetic process,BP,
13532,GO:0051058,1,0.624416831263571,0,56,negative regulation of small GTPase mediated signal transduction,BP,
13533,GO:0051059,1,0.812768854670433,0,31,NF-kappaB binding,MF,
13534,GO:0051066,1,0.992569557815338,0,2,dihydrobiopterin metabolic process,BP,
13535,GO:0051068,1,0.993282280062323,0,1,dihydrolipoamide metabolic process,BP,
13536,GO:0051081,1,0.89609845301503,0,16,nuclear envelope disassembly,BP,
13537,GO:0051082,1,0.586106357904648,0,102,unfolded protein binding,MF,
13538,GO:0051083,1,0.992180852141045,0,2,'de novo' cotranslational protein folding,BP,
13539,GO:0051084,1,0.838707554042107,0,32,'de novo' posttranslational protein folding,BP,
13540,GO:0051085,1,0.865649174288581,0,28,chaperone cofactor-dependent protein refolding,BP,
13541,GO:0051086,1,0.996111162803166,0,1,chaperone mediated protein folding independent of cofactor,BP,
13543,GO:0051089,1,0.992552536283108,0,1,constitutive protein ectodomain proteolysis,BP,
13549,GO:0051095,1,0.933632219595917,0,12,regulation of helicase activity,BP,
13550,GO:0051096,1,0.957920115705801,0,7,positive regulation of helicase activity,BP,
13551,GO:0051097,1,0.974655947213648,0,5,negative regulation of helicase activity,BP,
13554,GO:0051100,1,0.363895387924347,0,152,negative regulation of binding,BP,
13556,GO:0051102,1,0.992310549326632,0,1,DNA ligation involved in DNA recombination,BP,
13557,GO:0051103,1,0.965717831086933,0,7,DNA ligation involved in DNA repair,BP,
13558,GO:0051105,1,0.968657453148637,0,6,regulation of DNA ligation,BP,
13559,GO:0051106,1,0.973864771414304,0,5,positive regulation of DNA ligation,BP,
13560,GO:0051107,1,0.994654349096504,0,1,negative regulation of DNA ligation,BP,
13561,GO:0051117,1,0.574660367480413,0,82,ATPase binding,MF,
13562,GO:0051119,1,0.863863841552979,0,23,sugar transmembrane transporter activity,MF,
13563,GO:0051120,1,0.988888387605947,0,2,hepoxilin A3 synthase activity,MF,
13564,GO:0051121,1,0.961041049615214,0,9,hepoxilin metabolic process,BP,
13565,GO:0051122,1,0.961041049615214,0,9,hepoxilin biosynthetic process,BP,
13566,GO:0051123,1,0.859867964719007,0,24,RNA polymerase II preinitiation complex assembly,BP,
13568,GO:0051125,1,0.823671775900499,0,28,regulation of actin nucleation,BP,
13569,GO:0051126,1,0.957244189213943,0,8,negative regulation of actin nucleation,BP,
13570,GO:0051127,1,0.88200498842041,0,15,positive regulation of actin nucleation,BP,
13574,GO:0051131,1,0.912532796803029,0,20,chaperone-mediated protein complex assembly,BP,
13575,GO:0051132,1,0.955883351683027,0,9,NK T cell activation,BP,
13576,GO:0051133,1,0.966964520739468,0,7,regulation of NK T cell activation,BP,
13577,GO:0051134,1,0.989449831711162,0,2,negative regulation of NK T cell activation,BP,
13578,GO:0051135,1,0.977277323536547,0,5,positive regulation of NK T cell activation,BP,
13579,GO:0051136,1,0.957629720207735,0,6,regulation of NK T cell differentiation,BP,
13580,GO:0051138,1,0.970201107299329,0,4,positive regulation of NK T cell differentiation,BP,
13581,GO:0051139,1,0.905207065663316,0,13,metal ion:proton antiporter activity,MF,
13582,GO:0051140,1,0.980752582583904,0,4,regulation of NK T cell proliferation,BP,
13583,GO:0051141,1,0.993226301751323,0,1,negative regulation of NK T cell proliferation,BP,
13584,GO:0051142,1,0.987442060992724,0,3,positive regulation of NK T cell proliferation,BP,
13588,GO:0051148,1,0.685071877051052,0,53,negative regulation of muscle cell differentiation,BP,
13590,GO:0051150,1,0.811402195278742,0,30,regulation of smooth muscle cell differentiation,BP,
13591,GO:0051151,1,0.888957757304748,0,16,negative regulation of smooth muscle cell differentiation,BP,
13592,GO:0051152,1,0.938586874748724,0,11,positive regulation of smooth muscle cell differentiation,BP,
13594,GO:0051154,1,0.780624644816839,0,34,negative regulation of striated muscle cell differentiation,BP,
13596,GO:0051156,1,0.869756698241775,0,24,glucose 6-phosphate metabolic process,BP,
13597,GO:0051160,1,0.995305280149271,0,1,L-xylitol catabolic process,BP,
13598,GO:0051164,1,0.995305280149271,0,1,L-xylitol metabolic process,BP,
13599,GO:0051167,1,0.97849578384914,0,5,xylulose 5-phosphate metabolic process,BP,
13600,GO:0051168,1,0.256858718733946,0,193,nuclear export,BP,
13601,GO:0051169,1,0.0891377239898404,0,335,nuclear transport,BP,
13602,GO:0051170,1,0.307629007953286,0,156,import into nucleus,BP,
13607,GO:0051176,1,0.976371282571606,0,3,positive regulation of sulfur metabolic process,BP,
13608,GO:0051177,1,0.955554409255495,0,9,meiotic sister chromatid cohesion,BP,
13610,GO:0051180,1,0.780999069146766,0,37,vitamin transport,BP,
13611,GO:0051189,1,0.966933966056222,0,6,prosthetic group metabolic process,BP,
13612,GO:0051192,1,0.996871328163206,0,1,prosthetic group binding,MF,
13613,GO:0051204,1,0.802235679113274,0,43,protein insertion into mitochondrial membrane,BP,
13614,GO:0051205,1,0.738972711371778,0,59,protein insertion into membrane,BP,
13617,GO:0051213,1,0.543620329335608,0,86,dioxygenase activity,MF,
13620,GO:0051220,1,0.847053728757091,0,23,cytoplasmic sequestering of protein,BP,
13624,GO:0051225,1,0.449793931119036,0,104,spindle assembly,BP,
13625,GO:0051228,1,0.982849458002135,0,2,mitotic spindle disassembly,BP,
13626,GO:0051230,1,0.982849458002135,0,2,spindle disassembly,BP,
13627,GO:0051231,1,0.944578200253414,0,9,spindle elongation,BP,
13628,GO:0051232,1,0.995550867705814,0,1,meiotic spindle elongation,BP,
13629,GO:0051233,1,0.777764282372488,0,35,spindle midzone,CC,
13632,GO:0051236,1,0.259303927119567,0,187,establishment of RNA localization,BP,
13633,GO:0051238,1,0.940649103377099,0,11,sequestering of metal ion,BP,
13646,GO:0051255,1,0.939187603630005,0,11,spindle midzone assembly,BP,
13647,GO:0051256,1,0.9619692124251,0,7,mitotic spindle midzone assembly,BP,
13648,GO:0051257,1,0.987547252854236,0,2,meiotic spindle midzone assembly,BP,
13649,GO:0051258,1,0.144733423956038,0,272,protein polymerization,BP,
13654,GO:0051264,1,0.994818479149233,0,1,mono-olein transacylation activity,MF,
13655,GO:0051265,1,0.994818479149233,0,1,diolein transacylation activity,MF,
13656,GO:0051267,1,0.993980977862161,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13662,GO:0051280,1,0.936457095815813,0,12,negative regulation of release of sequestered calcium ion into cytosol,BP,
13663,GO:0051281,1,0.779624324921235,0,38,positive regulation of release of sequestered calcium ion into cytosol,BP,
13666,GO:0051284,1,0.909926111892148,0,13,positive regulation of sequestering of calcium ion,BP,
13667,GO:0051286,1,0.942811369588793,0,7,cell tip,CC,
13668,GO:0051287,1,0.765556458918357,0,54,NAD binding,MF,
13669,GO:0051289,1,0.685431357016202,0,55,protein homotetramerization,BP,
13672,GO:0051292,1,0.929209639340509,0,9,nuclear pore complex assembly,BP,
13673,GO:0051293,1,0.695162542440614,0,44,establishment of spindle localization,BP,
13674,GO:0051294,1,0.774885385945057,0,35,establishment of spindle orientation,BP,
13675,GO:0051295,1,0.957691407054446,0,4,establishment of meiotic spindle localization,BP,
13676,GO:0051298,1,0.590892021384549,0,65,centrosome duplication,BP,
13677,GO:0051299,1,0.903438779560785,0,15,centrosome separation,BP,
13678,GO:0051301,1,0.0201171880997208,0,543,cell division,BP,
13679,GO:0051302,1,0.338541042497792,0,150,regulation of cell division,BP,
13680,GO:0051303,1,0.62836282187345,0,72,establishment of chromosome localization,BP,
13681,GO:0051304,1,0.548205718475126,0,86,chromosome separation,BP,
13682,GO:0051305,1,0.941874888855594,0,7,chromosome movement towards spindle pole,BP,
13683,GO:0051306,1,0.660011561361344,0,61,mitotic sister chromatid separation,BP,
13684,GO:0051307,1,0.869738752303108,0,20,meiotic chromosome separation,BP,
13685,GO:0051308,1,0.994890876864838,0,1,male meiosis chromosome separation,BP,
13686,GO:0051309,1,0.987769704400654,0,2,female meiosis chromosome separation,BP,
13687,GO:0051310,1,0.691903706391447,0,59,metaphase plate congression,BP,
13688,GO:0051311,1,0.995402998961019,0,1,meiotic metaphase plate congression,BP,
13689,GO:0051315,1,0.9147865348884,0,15,attachment of mitotic spindle microtubules to kinetochore,BP,
13690,GO:0051316,1,0.994890876864838,0,1,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13691,GO:0051318,1,0.983659524878209,0,2,G1 phase,BP,
13693,GO:0051325,1,0.983659524878209,0,2,interphase,BP,
13694,GO:0051329,1,0.983659524878209,0,2,mitotic interphase,BP,
13697,GO:0051339,1,0.729194367101716,0,44,regulation of lyase activity,BP,
13698,GO:0051340,1,0.95995675252393,0,10,regulation of ligase activity,BP,
13699,GO:0051341,1,0.549667676368033,0,96,regulation of oxidoreductase activity,BP,
13700,GO:0051342,1,0.945092879056439,0,9,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13701,GO:0051343,1,0.978873770868511,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13702,GO:0051344,1,0.960081190107305,0,6,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13707,GO:0051349,1,0.853351918548512,0,18,positive regulation of lyase activity,BP,
13708,GO:0051350,1,0.857871264274623,0,24,negative regulation of lyase activity,BP,
13709,GO:0051351,1,0.968844401919611,0,8,positive regulation of ligase activity,BP,
13710,GO:0051352,1,0.990829445845703,0,2,negative regulation of ligase activity,BP,
13711,GO:0051353,1,0.736822165737266,0,48,positive regulation of oxidoreductase activity,BP,
13712,GO:0051354,1,0.842172473607528,0,26,negative regulation of oxidoreductase activity,BP,
13713,GO:0051355,1,0.992820725392346,0,1,proprioception involved in equilibrioception,BP,
13714,GO:0051365,1,0.984368983561156,0,3,cellular response to potassium ion starvation,BP,
13715,GO:0051371,1,0.854485651287424,0,14,muscle alpha-actinin binding,MF,
13716,GO:0051373,1,0.973265095325431,0,5,FATZ binding,MF,
13717,GO:0051377,1,0.97561440470855,0,4,mannose-ethanolamine phosphotransferase activity,MF,
13718,GO:0051378,1,0.939893915191511,0,12,serotonin binding,MF,
13719,GO:0051379,1,0.976465186172993,0,5,epinephrine binding,MF,
13720,GO:0051380,1,0.980615726934227,0,4,norepinephrine binding,MF,
13721,GO:0051382,1,0.894842871478203,0,15,kinetochore assembly,BP,
13722,GO:0051383,1,0.864397347966957,0,20,kinetochore organization,BP,
13724,GO:0051385,1,0.853404590264513,0,27,response to mineralocorticoid,BP,
13725,GO:0051386,1,0.936637439462542,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
13726,GO:0051387,1,0.986709735721699,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13727,GO:0051388,1,0.961451573171104,0,6,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13728,GO:0051389,1,0.970269034355517,0,2,inactivation of MAPKK activity,BP,
13729,GO:0051391,1,0.992516242171655,0,1,tRNA acetylation,BP,
13730,GO:0051393,1,0.764112641124673,0,26,alpha-actinin binding,MF,
13731,GO:0051394,1,0.996632930809694,0,1,regulation of nerve growth factor receptor activity,BP,
13732,GO:0051400,1,0.947839717751108,0,10,BH domain binding,MF,
13734,GO:0051403,1,0.162025995475451,0,259,stress-activated MAPK cascade,BP,
13735,GO:0051409,1,0.937357826581302,0,10,response to nitrosative stress,BP,
13736,GO:0051410,1,0.985693890431422,0,3,detoxification of nitrogen compound,BP,
13737,GO:0051412,1,0.906289027439708,0,16,response to corticosterone,BP,
13738,GO:0051413,1,0.995334859715568,0,1,response to cortisone,BP,
13739,GO:0051414,1,0.954140004872936,0,5,response to cortisol,BP,
13740,GO:0051415,1,0.964805177582043,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13741,GO:0051418,1,0.918096696641794,0,9,microtubule nucleation by microtubule organizing center,BP,
13742,GO:0051424,1,0.991518429058101,0,2,corticotropin-releasing hormone binding,MF,
13743,GO:0051425,1,0.970656040875897,0,3,PTB domain binding,MF,
13744,GO:0051427,1,0.30983229957833,0,161,hormone receptor binding,MF,
13745,GO:0051428,1,0.918476880209999,0,17,peptide hormone receptor binding,MF,
13746,GO:0051429,1,0.977375740565196,0,5,corticotropin-releasing hormone receptor binding,MF,
13747,GO:0051430,1,0.980748985226081,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13748,GO:0051431,1,0.990155628661503,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13749,GO:0051433,1,0.991312507361303,0,1,BH2 domain binding,MF,
13750,GO:0051434,1,0.974382929631723,0,5,BH3 domain binding,MF,
13751,GO:0051438,1,0.722334813643884,0,52,regulation of ubiquitin-protein transferase activity,BP,
13752,GO:0051443,1,0.80870140595932,0,33,positive regulation of ubiquitin-protein transferase activity,BP,
13753,GO:0051444,1,0.912159661123121,0,16,negative regulation of ubiquitin-protein transferase activity,BP,
13755,GO:0051446,1,0.859569758699243,0,21,positive regulation of meiotic cell cycle,BP,
13757,GO:0051450,1,0.884331734648666,0,18,myoblast proliferation,BP,
13759,GO:0051452,1,0.744079295641672,0,53,intracellular pH reduction,BP,
13760,GO:0051453,1,0.592375924299774,0,80,regulation of intracellular pH,BP,
13761,GO:0051454,1,0.972526440049426,0,4,intracellular pH elevation,BP,
13762,GO:0051455,1,0.994890876864838,0,1,monopolar spindle attachment to meiosis I kinetochore,BP,
13763,GO:0051457,1,0.856199430495834,0,22,maintenance of protein location in nucleus,BP,
13764,GO:0051458,1,0.96707815390586,0,7,corticotropin secretion,BP,
13765,GO:0051459,1,0.971696197932729,0,6,regulation of corticotropin secretion,BP,
13766,GO:0051460,1,0.996251994703303,0,1,negative regulation of corticotropin secretion,BP,
13767,GO:0051461,1,0.975352738926397,0,5,positive regulation of corticotropin secretion,BP,
13768,GO:0051462,1,0.97350543960077,0,5,regulation of cortisol secretion,BP,
13769,GO:0051463,1,0.987982052386519,0,1,negative regulation of cortisol secretion,BP,
13770,GO:0051464,1,0.985349052050428,0,4,positive regulation of cortisol secretion,BP,
13771,GO:0051466,1,0.994030963168051,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13773,GO:0051481,1,0.878209884586405,0,12,negative regulation of cytosolic calcium ion concentration,BP,
13774,GO:0051482,1,0.853098858239449,0,31,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,BP,
13775,GO:0051489,1,0.723611746218417,0,42,regulation of filopodium assembly,BP,
13776,GO:0051490,1,0.986181055764222,0,3,negative regulation of filopodium assembly,BP,
13777,GO:0051491,1,0.810274460434491,0,28,positive regulation of filopodium assembly,BP,
13778,GO:0051492,1,0.500058736678116,0,84,regulation of stress fiber assembly,BP,
13781,GO:0051495,1,0.21547178706796,0,212,positive regulation of cytoskeleton organization,BP,
13782,GO:0051496,1,0.682692134790506,0,50,positive regulation of stress fiber assembly,BP,
13783,GO:0051497,1,0.794484155648469,0,26,negative regulation of stress fiber assembly,BP,
13784,GO:0051499,1,0.991542881119672,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13785,GO:0051500,1,0.991542881119672,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13786,GO:0051503,1,0.853301406395915,0,30,adenine nucleotide transport,BP,
13787,GO:0051525,1,0.959678855671567,0,5,NFAT protein binding,MF,
13788,GO:0051536,1,0.693018257073027,0,61,iron-sulfur cluster binding,MF,
13789,GO:0051537,1,0.897087791230514,0,19,2 iron, 2 sulfur cluster binding,MF,
13790,GO:0051538,1,0.98506907251402,0,3,3 iron, 4 sulfur cluster binding,MF,
13791,GO:0051539,1,0.784655969006308,0,40,4 iron, 4 sulfur cluster binding,MF,
13792,GO:0051540,1,0.693018257073027,0,61,metal cluster binding,MF,
13793,GO:0051541,1,0.958055881519659,0,6,elastin metabolic process,BP,
13794,GO:0051542,1,0.979660056599747,0,2,elastin biosynthetic process,BP,
13795,GO:0051543,1,0.995576901013376,0,1,regulation of elastin biosynthetic process,BP,
13796,GO:0051545,1,0.995576901013376,0,1,negative regulation of elastin biosynthetic process,BP,
13797,GO:0051546,1,0.876357238555024,0,17,keratinocyte migration,BP,
13798,GO:0051547,1,0.897326927796866,0,13,regulation of keratinocyte migration,BP,
13799,GO:0051548,1,0.989371978870216,0,1,negative regulation of keratinocyte migration,BP,
13800,GO:0051549,1,0.906975632859391,0,12,positive regulation of keratinocyte migration,BP,
13801,GO:0051552,1,0.987922847387118,0,1,flavone metabolic process,BP,
13802,GO:0051560,1,0.870846526561001,0,24,mitochondrial calcium ion homeostasis,BP,
13803,GO:0051561,1,0.94548298858008,0,11,positive regulation of mitochondrial calcium ion concentration,BP,
13804,GO:0051562,1,0.975930500647527,0,4,negative regulation of mitochondrial calcium ion concentration,BP,
13805,GO:0051563,1,0.981945144841824,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13806,GO:0051567,1,0.713191182942011,0,36,histone H3-K9 methylation,BP,
13807,GO:0051568,1,0.660737139864973,0,50,histone H3-K4 methylation,BP,
13808,GO:0051569,1,0.821604478955618,0,27,regulation of histone H3-K4 methylation,BP,
13809,GO:0051570,1,0.831318377912036,0,21,regulation of histone H3-K9 methylation,BP,
13810,GO:0051571,1,0.875053960727292,0,17,positive regulation of histone H3-K4 methylation,BP,
13811,GO:0051572,1,0.958596876627495,0,5,negative regulation of histone H3-K4 methylation,BP,
13812,GO:0051573,1,0.921426017516887,0,11,negative regulation of histone H3-K9 methylation,BP,
13813,GO:0051574,1,0.918885899960989,0,9,positive regulation of histone H3-K9 methylation,BP,
13814,GO:0051575,1,0.963424448130613,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13815,GO:0051580,1,0.905565576522111,0,16,regulation of neurotransmitter uptake,BP,
13816,GO:0051581,1,0.977065048636764,0,3,negative regulation of neurotransmitter uptake,BP,
13817,GO:0051582,1,0.981281621031757,0,4,positive regulation of neurotransmitter uptake,BP,
13818,GO:0051583,1,0.949662686796977,0,11,dopamine uptake involved in synaptic transmission,BP,
13819,GO:0051584,1,0.965900361792141,0,8,regulation of dopamine uptake involved in synaptic transmission,BP,
13820,GO:0051585,1,0.994133311934308,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13821,GO:0051586,1,0.988287099589435,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13823,GO:0051589,1,0.892668084116083,0,13,negative regulation of neurotransmitter transport,BP,
13827,GO:0051593,1,0.953457921408534,0,9,response to folic acid,BP,
13828,GO:0051594,1,0.982842687178758,0,4,detection of glucose,BP,
13829,GO:0051595,1,0.980765176594458,0,3,response to methylglyoxal,BP,
13830,GO:0051596,1,0.987846067266353,0,3,methylglyoxal catabolic process,BP,
13831,GO:0051597,1,0.946644378493359,0,7,response to methylmercury,BP,
13832,GO:0051598,1,0.987375891211743,0,2,meiotic recombination checkpoint,BP,
13833,GO:0051599,1,0.954586303873733,0,5,response to hydrostatic pressure,BP,
13834,GO:0051601,1,0.962755922526573,0,7,exocyst localization,BP,
13835,GO:0051602,1,0.786718084090728,0,37,response to electrical stimulus,BP,
13836,GO:0051603,1,0.00942826299348984,0,668,proteolysis involved in cellular protein catabolic process,BP,
13839,GO:0051607,1,0.265858372017771,0,213,defense response to virus,BP,
13840,GO:0051608,1,0.937140364508331,0,13,histamine transport,BP,
13841,GO:0051610,1,0.927642223965801,0,11,serotonin uptake,BP,
13842,GO:0051611,1,0.967891607476937,0,4,regulation of serotonin uptake,BP,
13843,GO:0051612,1,0.977065048636764,0,3,negative regulation of serotonin uptake,BP,
13844,GO:0051615,1,0.97934497404021,0,3,histamine uptake,BP,
13845,GO:0051620,1,0.953118244328899,0,8,norepinephrine uptake,BP,
13846,GO:0051621,1,0.990438023831394,0,2,regulation of norepinephrine uptake,BP,
13847,GO:0051622,1,0.994133311934308,0,1,negative regulation of norepinephrine uptake,BP,
13848,GO:0051623,1,0.996283123762659,0,1,positive regulation of norepinephrine uptake,BP,
13849,GO:0051625,1,0.983942394922173,0,2,epinephrine uptake,BP,
13850,GO:0051639,1,0.927711717565376,0,10,actin filament network formation,BP,
13853,GO:0051642,1,0.765924719665659,0,28,centrosome localization,BP,
13854,GO:0051643,1,0.936380055414906,0,7,endoplasmic reticulum localization,BP,
13855,GO:0051645,1,0.905337035296399,0,13,Golgi localization,BP,
13857,GO:0051647,1,0.729468737603474,0,28,nucleus localization,BP,
13862,GO:0051653,1,0.667005005218133,0,48,spindle localization,BP,
13863,GO:0051654,1,0.828088485282104,0,23,establishment of mitochondrion localization,BP,
13865,GO:0051657,1,0.900682972213121,0,10,maintenance of organelle location,BP,
13866,GO:0051659,1,0.989152710802673,0,2,maintenance of mitochondrion location,BP,
13867,GO:0051660,1,0.939935510774066,0,9,establishment of centrosome localization,BP,
13868,GO:0051661,1,0.937225580666839,0,5,maintenance of centrosome location,BP,
13869,GO:0051665,1,0.959245577113142,0,7,membrane raft localization,BP,
13870,GO:0051666,1,0.996241409002472,0,1,actin cortical patch localization,BP,
13874,GO:0051683,1,0.960779377157162,0,7,establishment of Golgi localization,BP,
13875,GO:0051684,1,0.971360961591148,0,3,maintenance of Golgi location,BP,
13876,GO:0051685,1,0.994890876864838,0,1,maintenance of ER location,BP,
13877,GO:0051686,1,0.977892813091763,0,1,establishment of ER localization,BP,
13878,GO:0051691,1,0.996402017712202,0,1,cellular oligosaccharide metabolic process,BP,
13879,GO:0051692,1,0.996402017712202,0,1,cellular oligosaccharide catabolic process,BP,
13880,GO:0051693,1,0.742552023051368,0,35,actin filament capping,BP,
13881,GO:0051694,1,0.950961034239823,0,7,pointed-end actin filament capping,BP,
13882,GO:0051695,1,0.991320471196725,0,1,actin filament uncapping,BP,
13883,GO:0051697,1,0.99467299161771,0,1,protein delipidation,BP,
13884,GO:0051701,1,0.269690553896292,0,194,interaction with host,BP,
13889,GO:0051709,1,0.937291689213121,0,12,regulation of killing of cells of other organism,BP,
13890,GO:0051712,1,0.946161842968857,0,10,positive regulation of killing of cells of other organism,BP,
13891,GO:0051715,1,0.988293779455922,0,3,cytolysis in other organism,BP,
13893,GO:0051717,1,0.984176135730651,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13894,GO:0051721,1,0.803306238324358,0,30,protein phosphatase 2A binding,MF,
13895,GO:0051722,1,0.995415835868773,0,1,protein C-terminal methylesterase activity,MF,
13896,GO:0051723,1,0.995415835868773,0,1,protein methylesterase activity,MF,
13897,GO:0051724,1,0.995715294575166,0,1,NAD transmembrane transporter activity,MF,
13898,GO:0051725,1,0.972867815414328,0,5,protein de-ADP-ribosylation,BP,
13900,GO:0051728,1,0.982454743010368,0,2,cell cycle switching, mitotic to meiotic cell cycle,BP,
13901,GO:0051729,1,0.982454743010368,0,2,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13902,GO:0051731,1,0.967278624140382,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13903,GO:0051732,1,0.996344421464864,0,1,polyribonucleotide kinase activity,MF,
13904,GO:0051733,1,0.979821014841345,0,3,polydeoxyribonucleotide kinase activity,MF,
13905,GO:0051734,1,0.979821014841345,0,3,ATP-dependent polynucleotide kinase activity,MF,
13906,GO:0051736,1,0.996344421464864,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13907,GO:0051747,1,0.993318942040486,0,2,cytosine C-5 DNA demethylase activity,MF,
13908,GO:0051748,1,0.995884651613967,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13909,GO:0051750,1,0.996689329953739,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13910,GO:0051751,1,0.991773852818654,0,1,alpha-1,4-mannosyltransferase activity,MF,
13911,GO:0051754,1,0.97698651776939,0,4,meiotic sister chromatid cohesion, centromeric,BP,
13912,GO:0051758,1,0.987717891971035,0,1,homologous chromosome movement towards spindle pole in meiosis I anaphase,BP,
13913,GO:0051764,1,0.928361762422628,0,11,actin crosslink formation,BP,
13914,GO:0051765,1,0.990279395857818,0,2,inositol tetrakisphosphate kinase activity,MF,
13915,GO:0051766,1,0.968864996136256,0,5,inositol trisphosphate kinase activity,MF,
13916,GO:0051767,1,0.870505775948909,0,18,nitric-oxide synthase biosynthetic process,BP,
13917,GO:0051769,1,0.870505775948909,0,18,regulation of nitric-oxide synthase biosynthetic process,BP,
13918,GO:0051770,1,0.881301843857558,0,15,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13919,GO:0051771,1,0.987765256070184,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13920,GO:0051775,1,0.897416045095647,0,13,response to redox state,BP,
13921,GO:0051780,1,0.992132892685177,0,1,behavioral response to nutrient,BP,
13922,GO:0051781,1,0.615526081612685,0,73,positive regulation of cell division,BP,
13923,GO:0051782,1,0.894080383729483,0,15,negative regulation of cell division,BP,
13926,GO:0051785,1,0.630096900284662,0,64,positive regulation of nuclear division,BP,
13927,GO:0051786,1,0.993838038817279,0,1,all-trans-retinol 13,14-reductase activity,MF,
13928,GO:0051787,1,0.867059291656956,0,26,misfolded protein binding,MF,
13929,GO:0051788,1,0.842955473183675,0,24,response to misfolded protein,BP,
13930,GO:0051790,1,0.978693235979926,0,4,short-chain fatty acid biosynthetic process,BP,
13931,GO:0051791,1,0.938869082405084,0,12,medium-chain fatty acid metabolic process,BP,
13932,GO:0051792,1,0.965792178003605,0,6,medium-chain fatty acid biosynthetic process,BP,
13933,GO:0051793,1,0.96796563935145,0,5,medium-chain fatty acid catabolic process,BP,
13934,GO:0051794,1,0.974759649101701,0,4,regulation of timing of catagen,BP,
13935,GO:0051795,1,0.982783906968579,0,3,positive regulation of timing of catagen,BP,
13936,GO:0051796,1,0.991836587427737,0,1,negative regulation of timing of catagen,BP,
13937,GO:0051797,1,0.87758906819368,0,19,regulation of hair follicle development,BP,
13938,GO:0051798,1,0.937798183158748,0,11,positive regulation of hair follicle development,BP,
13939,GO:0051799,1,0.968933062302886,0,4,negative regulation of hair follicle development,BP,
13940,GO:0051800,1,0.989371978870216,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13941,GO:0051801,1,0.988293779455922,0,3,cytolysis in other organism involved in symbiotic interaction,BP,
13943,GO:0051823,1,0.921426639531576,0,9,regulation of synapse structural plasticity,BP,
13944,GO:0051835,1,0.963321405399667,0,4,positive regulation of synapse structural plasticity,BP,
13945,GO:0051838,1,0.988293779455922,0,3,cytolysis by host of symbiont cells,BP,
13947,GO:0051861,1,0.882973755212266,0,23,glycolipid binding,MF,
13948,GO:0051864,1,0.929236543132553,0,8,histone demethylase activity (H3-K36 specific),MF,
13949,GO:0051865,1,0.613708655517624,0,66,protein autoubiquitination,BP,
13950,GO:0051866,1,0.990106284795055,0,2,general adaptation syndrome,BP,
13951,GO:0051867,1,0.996688574753873,0,1,general adaptation syndrome, behavioral process,BP,
13952,GO:0051870,1,0.986187875172988,0,3,methotrexate binding,MF,
13953,GO:0051873,1,0.948288918038166,0,15,killing by host of symbiont cells,BP,
13954,GO:0051875,1,0.850291517971842,0,26,pigment granule localization,BP,
13955,GO:0051877,1,0.989355334379566,0,2,pigment granule aggregation in cell center,BP,
13956,GO:0051879,1,0.770152999202518,0,38,Hsp90 protein binding,MF,
13957,GO:0051880,1,0.919026864300975,0,10,G-quadruplex DNA binding,MF,
13958,GO:0051881,1,0.705792525637913,0,65,regulation of mitochondrial membrane potential,BP,
13959,GO:0051882,1,0.87346385040764,0,22,mitochondrial depolarization,BP,
13960,GO:0051883,1,0.936312188763986,0,17,killing of cells in other organism involved in symbiotic interaction,BP,
13961,GO:0051884,1,0.961956849546628,0,5,regulation of timing of anagen,BP,
13962,GO:0051885,1,0.984587008910362,0,2,positive regulation of timing of anagen,BP,
13963,GO:0051886,1,0.990115809252812,0,1,negative regulation of timing of anagen,BP,
13964,GO:0051890,1,0.952584259108192,0,7,regulation of cardioblast differentiation,BP,
13965,GO:0051891,1,0.960365898914391,0,6,positive regulation of cardioblast differentiation,BP,
13966,GO:0051892,1,0.991900474094357,0,1,negative regulation of cardioblast differentiation,BP,
13967,GO:0051893,1,0.571124655357462,0,62,regulation of focal adhesion assembly,BP,
13968,GO:0051894,1,0.800875715316352,0,24,positive regulation of focal adhesion assembly,BP,
13969,GO:0051895,1,0.853087513657254,0,18,negative regulation of focal adhesion assembly,BP,
13972,GO:0051898,1,0.733423081871193,0,42,negative regulation of protein kinase B signaling,BP,
13973,GO:0051899,1,0.471781452953166,0,82,membrane depolarization,BP,
13974,GO:0051900,1,0.883006225054525,0,21,regulation of mitochondrial depolarization,BP,
13975,GO:0051901,1,0.953549337917603,0,9,positive regulation of mitochondrial depolarization,BP,
13976,GO:0051902,1,0.964690520754312,0,7,negative regulation of mitochondrial depolarization,BP,
13977,GO:0051903,1,0.99122053413736,0,2,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13978,GO:0051904,1,0.870966620885371,0,23,pigment granule transport,BP,
13979,GO:0051905,1,0.858647354881413,0,24,establishment of pigment granule localization,BP,
13980,GO:0051908,1,0.994068822762504,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13981,GO:0051913,1,0.978268236557371,0,1,regulation of synaptic plasticity by chemical substance,BP,
13982,GO:0051914,1,0.978268236557371,0,1,positive regulation of synaptic plasticity by chemical substance,BP,
13983,GO:0051915,1,0.978268236557371,0,1,induction of synaptic plasticity by chemical substance,BP,
13984,GO:0051916,1,0.990056876853969,0,2,granulocyte colony-stimulating factor binding,MF,
13987,GO:0051919,1,0.987332734158981,0,3,positive regulation of fibrinolysis,BP,
13988,GO:0051920,1,0.977186431495481,0,7,peroxiredoxin activity,MF,
13989,GO:0051923,1,0.918307206701223,0,16,sulfation,BP,
13991,GO:0051926,1,0.732235685517694,0,52,negative regulation of calcium ion transport,BP,
13993,GO:0051930,1,0.83537740527396,0,29,regulation of sensory perception of pain,BP,
13994,GO:0051931,1,0.831195580370114,0,30,regulation of sensory perception,BP,
13996,GO:0051933,1,0.962355042509827,0,4,amino acid neurotransmitter reuptake,BP,
13997,GO:0051934,1,0.949662686796977,0,11,catecholamine uptake involved in synaptic transmission,BP,
13998,GO:0051935,1,0.962355042509827,0,4,glutamate reuptake,BP,
14001,GO:0051939,1,0.971147248001873,0,4,gamma-aminobutyric acid import,BP,
14002,GO:0051940,1,0.965900361792141,0,8,regulation of catecholamine uptake involved in synaptic transmission,BP,
14003,GO:0051941,1,0.970574097765835,0,3,regulation of amino acid uptake involved in synaptic transmission,BP,
14004,GO:0051943,1,0.992912328200946,0,1,positive regulation of amino acid uptake involved in synaptic transmission,BP,
14005,GO:0051944,1,0.988287099589435,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14006,GO:0051945,1,0.994133311934308,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14007,GO:0051946,1,0.970574097765835,0,3,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14008,GO:0051951,1,0.992912328200946,0,1,positive regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14012,GO:0051955,1,0.795644299606153,0,34,regulation of amino acid transport,BP,
14013,GO:0051956,1,0.933555329561888,0,13,negative regulation of amino acid transport,BP,
14014,GO:0051957,1,0.870685444730271,0,19,positive regulation of amino acid transport,BP,
14015,GO:0051958,1,0.982449882728074,0,2,methotrexate transport,BP,
14016,GO:0051959,1,0.637679954061556,0,27,dynein light intermediate chain binding,MF,
14021,GO:0051964,1,0.929476559457788,0,8,negative regulation of synapse assembly,BP,
14024,GO:0051967,1,0.934621569775537,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14026,GO:0051969,1,0.920922331280266,0,14,regulation of transmission of nerve impulse,BP,
14027,GO:0051970,1,0.981162209619574,0,4,negative regulation of transmission of nerve impulse,BP,
14028,GO:0051971,1,0.959921706178546,0,6,positive regulation of transmission of nerve impulse,BP,
14029,GO:0051972,1,0.759285039946678,0,47,regulation of telomerase activity,BP,
14030,GO:0051973,1,0.816209801336798,0,35,positive regulation of telomerase activity,BP,
14031,GO:0051974,1,0.944103599052149,0,11,negative regulation of telomerase activity,BP,
14032,GO:0051977,1,0.995822437882934,0,1,lysophospholipid transport,BP,
14033,GO:0051978,1,0.995822437882934,0,1,lysophospholipid:sodium symporter activity,MF,
14034,GO:0051983,1,0.48518081864328,0,94,regulation of chromosome segregation,BP,
14035,GO:0051984,1,0.79983109567513,0,30,positive regulation of chromosome segregation,BP,
14036,GO:0051985,1,0.738756377144011,0,41,negative regulation of chromosome segregation,BP,
14037,GO:0051987,1,0.964529500636754,0,6,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14038,GO:0051988,1,0.913415896984961,0,13,regulation of attachment of spindle microtubules to kinetochore,BP,
14039,GO:0051990,1,0.99520171579299,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14040,GO:0051996,1,0.995932580157358,0,1,squalene synthase activity,MF,
14041,GO:0051998,1,0.968928033771829,0,5,protein carboxyl O-methyltransferase activity,MF,
14042,GO:0052025,1,0.993789273276728,0,2,modification by symbiont of host cell membrane,BP,
14043,GO:0052026,1,0.994699007718779,0,1,modulation by symbiont of host transcription,BP,
14044,GO:0052027,1,0.983988776168783,0,2,modulation by symbiont of host signal transduction pathway,BP,
14045,GO:0052029,1,0.990015900056417,0,1,suppression by symbiont of host signal transduction pathway,BP,
14046,GO:0052040,1,0.944283289953791,0,9,modulation by symbiont of host programmed cell death,BP,
14047,GO:0052041,1,0.979366379059727,0,4,negative regulation by symbiont of host programmed cell death,BP,
14048,GO:0052042,1,0.984082806793767,0,3,positive regulation by symbiont of host programmed cell death,BP,
14049,GO:0052043,1,0.993789273276728,0,2,modification by symbiont of host cellular component,BP,
14050,GO:0052053,1,0.994905249923337,0,1,negative regulation by symbiont of host catalytic activity,BP,
14051,GO:0052055,1,0.984971511734398,0,2,modulation by symbiont of host molecular function,BP,
14052,GO:0052056,1,0.984971511734398,0,2,negative regulation by symbiont of host molecular function,BP,
14053,GO:0052111,1,0.993789273276728,0,2,modification by symbiont of host structure,BP,
14054,GO:0052126,1,0.363903492064443,0,152,movement in host environment,BP,
14055,GO:0052148,1,0.994905249923337,0,1,modulation by symbiont of host catalytic activity,BP,
14056,GO:0052150,1,0.966903895350137,0,6,modulation by symbiont of host apoptotic process,BP,
14057,GO:0052151,1,0.984082806793767,0,3,positive regulation by symbiont of host apoptotic process,BP,
14058,GO:0052173,1,0.971274201551379,0,3,response to defenses of other organism,BP,
14059,GO:0052185,1,0.993789273276728,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14060,GO:0052188,1,0.993789273276728,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14061,GO:0052199,1,0.991070829434321,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14062,GO:0052200,1,0.971274201551379,0,3,response to host defenses,BP,
14063,GO:0052203,1,0.987448039758197,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14069,GO:0052248,1,0.966903895350137,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14070,GO:0052312,1,0.994699007718779,0,1,modulation of transcription in other organism involved in symbiotic interaction,BP,
14071,GO:0052314,1,0.992238210982547,0,2,phytoalexin metabolic process,BP,
14072,GO:0052330,1,0.984082806793767,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14073,GO:0052332,1,0.993789273276728,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14079,GO:0052372,1,0.808389892623179,0,38,modulation by symbiont of entry into host,BP,
14080,GO:0052381,1,0.995900756396052,0,1,tRNA dimethylallyltransferase activity,MF,
14081,GO:0052403,1,0.996146141141497,0,1,negative regulation by host of symbiont catalytic activity,BP,
14087,GO:0052422,1,0.992504985306036,0,2,modulation by host of symbiont catalytic activity,BP,
14089,GO:0052433,1,0.966903895350137,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14090,GO:0052501,1,0.996664269302455,0,1,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14093,GO:0052590,1,0.98866300112789,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14094,GO:0052591,1,0.98866300112789,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14095,GO:0052593,1,0.987565064598035,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14096,GO:0052594,1,0.987565064598035,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14097,GO:0052595,1,0.987565064598035,0,2,aliphatic-amine oxidase activity,MF,
14098,GO:0052596,1,0.987565064598035,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14099,GO:0052629,1,0.938265521603432,0,7,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14100,GO:0052630,1,0.995617787524824,0,1,UDP-N-acetylgalactosamine diphosphorylase activity,MF,
14101,GO:0052642,1,0.992091141811423,0,2,lysophosphatidic acid phosphatase activity,MF,
14102,GO:0052646,1,0.926680116453497,0,9,alditol phosphate metabolic process,BP,
14103,GO:0052650,1,0.953371552273563,0,12,NADP-retinol dehydrogenase activity,MF,
14104,GO:0052651,1,0.971127126891494,0,6,monoacylglycerol catabolic process,BP,
14105,GO:0052652,1,0.854543946997638,0,18,cyclic purine nucleotide metabolic process,BP,
14106,GO:0052654,1,0.980934409095038,0,2,L-leucine transaminase activity,MF,
14107,GO:0052655,1,0.980934409095038,0,2,L-valine transaminase activity,MF,
14108,GO:0052656,1,0.980934409095038,0,2,L-isoleucine transaminase activity,MF,
14109,GO:0052657,1,0.996604021233342,0,1,guanine phosphoribosyltransferase activity,MF,
14110,GO:0052658,1,0.957390293089751,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14111,GO:0052659,1,0.965637608998559,0,5,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14112,GO:0052666,1,0.99611822932062,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14114,GO:0052692,1,0.99660212903607,0,1,raffinose alpha-galactosidase activity,MF,
14115,GO:0052695,1,0.980615790410896,0,3,cellular glucuronidation,BP,
14116,GO:0052717,1,0.98459149293044,0,2,tRNA-specific adenosine-34 deaminase activity,MF,
14117,GO:0052718,1,0.98459149293044,0,2,tRNA-specific adenosine-34 deaminase complex,CC,
14118,GO:0052723,1,0.966192436645805,0,4,inositol hexakisphosphate 1-kinase activity,MF,
14119,GO:0052724,1,0.966192436645805,0,4,inositol hexakisphosphate 3-kinase activity,MF,
14120,GO:0052725,1,0.993958925135842,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14121,GO:0052726,1,0.993958925135842,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14122,GO:0052731,1,0.995933237643644,0,1,phosphocholine phosphatase activity,MF,
14123,GO:0052732,1,0.995933237643644,0,1,phosphoethanolamine phosphatase activity,MF,
14124,GO:0052735,1,0.971417122823101,0,4,tRNA (cytosine-3-)-methyltransferase activity,MF,
14125,GO:0052739,1,0.969220793313942,0,6,phosphatidylserine 1-acylhydrolase activity,MF,
14126,GO:0052740,1,0.97278722334269,0,5,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14127,GO:0052742,1,0.86840821171359,0,14,phosphatidylinositol kinase activity,MF,
14128,GO:0052743,1,0.950352193065303,0,7,inositol tetrakisphosphate phosphatase activity,MF,
14129,GO:0052744,1,0.85220306368405,0,18,phosphatidylinositol monophosphate phosphatase activity,MF,
14130,GO:0052745,1,0.918024779071657,0,13,inositol phosphate phosphatase activity,MF,
14131,GO:0052746,1,0.98559969410069,0,2,inositol phosphorylation,BP,
14132,GO:0052751,1,0.996791296194508,0,1,GDP-mannose hydrolase activity,MF,
14133,GO:0052794,1,0.986566604142633,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14134,GO:0052795,1,0.986566604142633,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14135,GO:0052796,1,0.986566604142633,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14136,GO:0052798,1,0.995945686882425,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14137,GO:0052803,1,0.935764780706341,0,12,imidazole-containing compound metabolic process,BP,
14138,GO:0052805,1,0.965310895226039,0,7,imidazole-containing compound catabolic process,BP,
14139,GO:0052812,1,0.963146517174537,0,5,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14140,GO:0052813,1,0.963146517174537,0,5,phosphatidylinositol bisphosphate kinase activity,MF,
14141,GO:0052814,1,0.992907123396694,0,1,medium-chain-aldehyde dehydrogenase activity,MF,
14142,GO:0052815,1,0.990374893735534,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14143,GO:0052816,1,0.993615124228356,0,1,long-chain acyl-CoA hydrolase activity,MF,
14144,GO:0052817,1,0.993615124228356,0,1,very long chain acyl-CoA hydrolase activity,MF,
14145,GO:0052821,1,0.996767636191414,0,1,DNA-7-methyladenine glycosylase activity,MF,
14146,GO:0052822,1,0.996767636191414,0,1,DNA-3-methylguanine glycosylase activity,MF,
14147,GO:0052824,1,0.995549329427557,0,1,dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity,MF,
14148,GO:0052826,1,0.994748901495519,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14149,GO:0052827,1,0.994748901495519,0,1,inositol pentakisphosphate phosphatase activity,MF,
14150,GO:0052832,1,0.984469514448657,0,3,inositol monophosphate 3-phosphatase activity,MF,
14151,GO:0052833,1,0.984469514448657,0,3,inositol monophosphate 4-phosphatase activity,MF,
14152,GO:0052834,1,0.984469514448657,0,3,inositol monophosphate phosphatase activity,MF,
14153,GO:0052840,1,0.979209716404853,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14154,GO:0052842,1,0.979209716404853,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14155,GO:0052851,1,0.971572260296097,0,3,ferric-chelate reductase (NADPH) activity,MF,
14156,GO:0052852,1,0.992837001162335,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14157,GO:0052853,1,0.992837001162335,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14158,GO:0052854,1,0.992837001162335,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14159,GO:0052856,1,0.996802009655174,0,1,NADHX epimerase activity,MF,
14160,GO:0052857,1,0.996802009655174,0,1,NADPHX epimerase activity,MF,
14161,GO:0052858,1,0.993305064567667,0,1,peptidyl-lysine acetyltransferase activity,MF,
14162,GO:0052866,1,0.772436053551904,0,30,phosphatidylinositol phosphate phosphatase activity,MF,
14163,GO:0052869,1,0.990912901386442,0,1,arachidonic acid omega-hydroxylase activity,MF,
14164,GO:0052884,1,0.995157531975832,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14165,GO:0052885,1,0.995157531975832,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14166,GO:0052890,1,0.987352385456587,0,2,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14167,GO:0052894,1,0.995977413276461,0,1,norspermine:oxygen oxidoreductase activity,MF,
14168,GO:0052895,1,0.995977413276461,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14169,GO:0052899,1,0.99639083166836,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14170,GO:0052901,1,0.992382617845647,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14171,GO:0052902,1,0.99639083166836,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14172,GO:0052903,1,0.99639083166836,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14173,GO:0052904,1,0.99639083166836,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14174,GO:0052905,1,0.984750030119825,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14175,GO:0052906,1,0.989887523661952,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14176,GO:0052907,1,0.994890876864838,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14177,GO:0052909,1,0.994890876864838,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14178,GO:0052917,1,0.995549329427557,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14179,GO:0052918,1,0.987977425080456,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14180,GO:0052925,1,0.996535470572642,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14181,GO:0052926,1,0.987977425080456,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14182,GO:0052927,1,0.995699287977245,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14183,GO:0052928,1,0.995699287977245,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14184,GO:0052929,1,0.995699287977245,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14187,GO:0055003,1,0.773197731809121,0,18,cardiac myofibril assembly,BP,
14188,GO:0055005,1,0.980136031272285,0,3,ventricular cardiac myofibril assembly,BP,
14189,GO:0055006,1,0.480175376911737,0,73,cardiac cell development,BP,
14190,GO:0055007,1,0.389175521187285,0,102,cardiac muscle cell differentiation,BP,
14191,GO:0055008,1,0.571499962081444,0,59,cardiac muscle tissue morphogenesis,BP,
14192,GO:0055009,1,0.968386433253456,0,5,atrial cardiac muscle tissue morphogenesis,BP,
14193,GO:0055010,1,0.663664778019061,0,45,ventricular cardiac muscle tissue morphogenesis,BP,
14194,GO:0055011,1,0.992564905448738,0,2,atrial cardiac muscle cell differentiation,BP,
14195,GO:0055012,1,0.895616738149202,0,15,ventricular cardiac muscle cell differentiation,BP,
14196,GO:0055013,1,0.506381606390864,0,68,cardiac muscle cell development,BP,
14197,GO:0055014,1,0.992564905448738,0,2,atrial cardiac muscle cell development,BP,
14198,GO:0055015,1,0.93911151855019,0,10,ventricular cardiac muscle cell development,BP,
14199,GO:0055017,1,0.539533743097717,0,80,cardiac muscle tissue growth,BP,
14200,GO:0055018,1,0.996309331932209,0,1,regulation of cardiac muscle fiber development,BP,
14201,GO:0055020,1,0.996309331932209,0,1,positive regulation of cardiac muscle fiber development,BP,
14202,GO:0055021,1,0.64159502979421,0,59,regulation of cardiac muscle tissue growth,BP,
14203,GO:0055022,1,0.852883926841996,0,25,negative regulation of cardiac muscle tissue growth,BP,
14204,GO:0055023,1,0.762023913217716,0,32,positive regulation of cardiac muscle tissue growth,BP,
14205,GO:0055024,1,0.546968072474435,0,79,regulation of cardiac muscle tissue development,BP,
14206,GO:0055025,1,0.706368206413967,0,42,positive regulation of cardiac muscle tissue development,BP,
14207,GO:0055026,1,0.790054650860778,0,34,negative regulation of cardiac muscle tissue development,BP,
14208,GO:0055028,1,0.986317247929674,0,1,cortical microtubule,CC,
14209,GO:0055029,1,0.56001487267425,0,96,nuclear DNA-directed RNA polymerase complex,CC,
14211,GO:0055038,1,0.587132080326733,0,80,recycling endosome membrane,CC,
14212,GO:0055048,1,0.986317247929674,0,1,anastral spindle assembly,BP,
14213,GO:0055056,1,0.95972552486297,0,6,D-glucose transmembrane transporter activity,MF,
14214,GO:0055057,1,0.883140887249158,0,14,neuroblast division,BP,
14215,GO:0055059,1,0.954264719634359,0,6,asymmetric neuroblast division,BP,
14216,GO:0055062,1,0.933870647221348,0,8,phosphate ion homeostasis,BP,
14217,GO:0055064,1,0.897025459150863,0,13,chloride ion homeostasis,BP,
14220,GO:0055069,1,0.838553787551195,0,32,zinc ion homeostasis,BP,
14221,GO:0055070,1,0.892004262155946,0,17,copper ion homeostasis,BP,
14222,GO:0055071,1,0.985078494201861,0,2,manganese ion homeostasis,BP,
14224,GO:0055073,1,0.983680399816013,0,3,cadmium ion homeostasis,BP,
14228,GO:0055077,1,0.98430924976428,0,2,gap junction hemi-channel activity,MF,
14231,GO:0055081,1,0.667317015882411,0,52,anion homeostasis,BP,
14233,GO:0055083,1,0.837643502204067,0,21,monovalent inorganic anion homeostasis,BP,
14236,GO:0055087,1,0.978943758375323,0,3,Ski complex,CC,
14237,GO:0055088,1,0.445307719053772,0,123,lipid homeostasis,BP,
14238,GO:0055089,1,0.906124284531642,0,14,fatty acid homeostasis,BP,
14239,GO:0055090,1,0.856181758068804,0,27,acylglycerol homeostasis,BP,
14240,GO:0055091,1,0.917360706699785,0,12,phospholipid homeostasis,BP,
14241,GO:0055092,1,0.624352518159083,0,71,sterol homeostasis,BP,
14243,GO:0055094,1,0.811737752271896,0,29,response to lipoprotein particle,BP,
14244,GO:0055095,1,0.981798779821436,0,3,lipoprotein particle mediated signaling,BP,
14245,GO:0055096,1,0.981798779821436,0,3,low-density lipoprotein particle mediated signaling,BP,
14246,GO:0055100,1,0.981276605511751,0,3,adiponectin binding,MF,
14248,GO:0055103,1,0.993980977862161,0,1,ligase regulator activity,MF,
14249,GO:0055105,1,0.979446854785454,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14250,GO:0055106,1,0.919567767441865,0,17,ubiquitin-protein transferase regulator activity,MF,
14251,GO:0055108,1,0.996095731408362,0,1,Golgi to transport vesicle transport,BP,
14252,GO:0055111,1,0.989184972662384,0,1,ingression involved in gastrulation with mouth forming second,BP,
14253,GO:0055113,1,0.979827798848468,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14256,GO:0055118,1,0.958403261060211,0,6,negative regulation of cardiac muscle contraction,BP,
14258,GO:0055120,1,0.996781921628756,0,1,striated muscle dense body,CC,
14260,GO:0055129,1,0.977295413585508,0,5,L-proline biosynthetic process,BP,
14261,GO:0055130,1,0.996472587785726,0,1,D-alanine catabolic process,BP,
14262,GO:0055131,1,0.972819743742811,0,6,C3HC4-type RING finger domain binding,MF,
14263,GO:0060001,1,0.983688959975638,0,1,minus-end directed microfilament motor activity,MF,
14264,GO:0060002,1,0.968188057935377,0,2,plus-end directed microfilament motor activity,MF,
14265,GO:0060003,1,0.969067668595288,0,3,copper ion export,BP,
14267,GO:0060005,1,0.970345247701446,0,4,vestibular reflex,BP,
14268,GO:0060007,1,0.992058268663853,0,1,linear vestibuloocular reflex,BP,
14269,GO:0060008,1,0.871371333613414,0,18,Sertoli cell differentiation,BP,
14270,GO:0060009,1,0.889925886117992,0,14,Sertoli cell development,BP,
14271,GO:0060010,1,0.993830957419106,0,1,Sertoli cell fate commitment,BP,
14272,GO:0060011,1,0.980245629882049,0,3,Sertoli cell proliferation,BP,
14273,GO:0060012,1,0.96689631037532,0,6,synaptic transmission, glycinergic,BP,
14275,GO:0060014,1,0.994628167328831,0,1,granulosa cell differentiation,BP,
14276,GO:0060017,1,0.957964044816292,0,6,parathyroid gland development,BP,
14277,GO:0060018,1,0.977542114974951,0,3,astrocyte fate commitment,BP,
14278,GO:0060019,1,0.933059440612775,0,12,radial glial cell differentiation,BP,
14281,GO:0060022,1,0.949799206767656,0,6,hard palate development,BP,
14282,GO:0060023,1,0.953307006720749,0,5,soft palate development,BP,
14283,GO:0060024,1,0.967979804572587,0,4,rhythmic synaptic transmission,BP,
14284,GO:0060025,1,0.974377382291972,0,3,regulation of synaptic activity,BP,
14285,GO:0060026,1,0.897240817677192,0,15,convergent extension,BP,
14286,GO:0060027,1,0.941586926223413,0,8,convergent extension involved in gastrulation,BP,
14287,GO:0060028,1,0.952962782222307,0,7,convergent extension involved in axis elongation,BP,
14288,GO:0060029,1,0.960968550870592,0,6,convergent extension involved in organogenesis,BP,
14289,GO:0060031,1,0.985030479814823,0,2,mediolateral intercalation,BP,
14290,GO:0060032,1,0.980674247876412,0,2,notochord regression,BP,
14291,GO:0060033,1,0.896735495429672,0,16,anatomical structure regression,BP,
14292,GO:0060034,1,0.992511059706689,0,1,notochord cell differentiation,BP,
14293,GO:0060035,1,0.992511059706689,0,1,notochord cell development,BP,
14294,GO:0060037,1,0.830623694534455,0,24,pharyngeal system development,BP,
14295,GO:0060038,1,0.68209791762371,0,50,cardiac muscle cell proliferation,BP,
14296,GO:0060039,1,0.822882072904229,0,19,pericardium development,BP,
14297,GO:0060040,1,0.973458912499256,0,5,retinal bipolar neuron differentiation,BP,
14299,GO:0060042,1,0.628224290282679,0,54,retina morphogenesis in camera-type eye,BP,
14300,GO:0060043,1,0.732171755514062,0,41,regulation of cardiac muscle cell proliferation,BP,
14301,GO:0060044,1,0.907889656147218,0,15,negative regulation of cardiac muscle cell proliferation,BP,
14302,GO:0060045,1,0.816708810957832,0,24,positive regulation of cardiac muscle cell proliferation,BP,
14303,GO:0060046,1,0.918244579242118,0,13,regulation of acrosome reaction,BP,
14306,GO:0060049,1,0.891489365131496,0,14,regulation of protein glycosylation,BP,
14307,GO:0060050,1,0.929528760046672,0,9,positive regulation of protein glycosylation,BP,
14308,GO:0060051,1,0.991147480238145,0,2,negative regulation of protein glycosylation,BP,
14310,GO:0060053,1,0.982486571589505,0,2,neurofilament cytoskeleton,CC,
14311,GO:0060054,1,0.968713550403089,0,6,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14313,GO:0060056,1,0.956853003745269,0,7,mammary gland involution,BP,
14314,GO:0060057,1,0.98785125803367,0,2,apoptotic process involved in mammary gland involution,BP,
14315,GO:0060058,1,0.98785125803367,0,2,positive regulation of apoptotic process involved in mammary gland involution,BP,
14316,GO:0060059,1,0.920143155811382,0,6,embryonic retina morphogenesis in camera-type eye,BP,
14317,GO:0060060,1,0.977110427849937,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14318,GO:0060061,1,0.98030834824791,0,3,Spemann organizer formation,BP,
14319,GO:0060064,1,0.996551486129961,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14320,GO:0060065,1,0.831848156338793,0,20,uterus development,BP,
14321,GO:0060066,1,0.990013282345033,0,2,oviduct development,BP,
14322,GO:0060067,1,0.988831518817606,0,1,cervix development,BP,
14323,GO:0060068,1,0.918279287916758,0,9,vagina development,BP,
14326,GO:0060072,1,0.988018156519459,0,1,large conductance calcium-activated potassium channel activity,MF,
14327,GO:0060073,1,0.951318096720674,0,7,micturition,BP,
14335,GO:0060081,1,0.924417006159196,0,11,membrane hyperpolarization,BP,
14336,GO:0060082,1,0.996514494454413,0,1,eye blink reflex,BP,
14337,GO:0060083,1,0.980252473186401,0,2,smooth muscle contraction involved in micturition,BP,
14338,GO:0060084,1,0.979677001517938,0,3,synaptic transmission involved in micturition,BP,
14339,GO:0060086,1,0.983397085421663,0,3,circadian temperature homeostasis,BP,
14340,GO:0060087,1,0.965701539669084,0,6,relaxation of vascular associated smooth muscle,BP,
14341,GO:0060088,1,0.929903821916032,0,10,auditory receptor cell stereocilium organization,BP,
14344,GO:0060091,1,0.959202913482786,0,7,kinocilium,CC,
14345,GO:0060099,1,0.901875538321369,0,15,regulation of phagocytosis, engulfment,BP,
14346,GO:0060100,1,0.909839662014151,0,13,positive regulation of phagocytosis, engulfment,BP,
14347,GO:0060101,1,0.99619803331882,0,1,negative regulation of phagocytosis, engulfment,BP,
14348,GO:0060112,1,0.993126886857145,0,2,generation of ovulation cycle rhythm,BP,
14350,GO:0060117,1,0.874616224187961,0,17,auditory receptor cell development,BP,
14352,GO:0060120,1,0.962094674507375,0,4,inner ear receptor cell fate commitment,BP,
14353,GO:0060122,1,0.835708764510428,0,24,inner ear receptor cell stereocilium organization,BP,
14354,GO:0060123,1,0.919060260211747,0,11,regulation of growth hormone secretion,BP,
14355,GO:0060124,1,0.959874376097911,0,8,positive regulation of growth hormone secretion,BP,
14356,GO:0060125,1,0.976359998647405,0,2,negative regulation of growth hormone secretion,BP,
14357,GO:0060126,1,0.985085292494888,0,3,somatotropin secreting cell differentiation,BP,
14358,GO:0060127,1,0.99575844146644,0,1,prolactin secreting cell differentiation,BP,
14359,GO:0060128,1,0.990974802305054,0,2,corticotropin hormone secreting cell differentiation,BP,
14360,GO:0060129,1,0.98366590410244,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14361,GO:0060133,1,0.996632047735179,0,1,somatotropin secreting cell development,BP,
14364,GO:0060136,1,0.96268707866207,0,6,embryonic process involved in female pregnancy,BP,
14365,GO:0060137,1,0.951618441569831,0,8,maternal process involved in parturition,BP,
14366,GO:0060139,1,0.987376849107398,0,2,positive regulation of apoptotic process by virus,BP,
14369,GO:0060147,1,0.543383628443,0,84,regulation of posttranscriptional gene silencing,BP,
14370,GO:0060148,1,0.852857172569825,0,24,positive regulation of posttranscriptional gene silencing,BP,
14371,GO:0060149,1,0.858712743392237,0,20,negative regulation of posttranscriptional gene silencing,BP,
14372,GO:0060151,1,0.98306241624037,0,2,peroxisome localization,BP,
14373,GO:0060152,1,0.98306241624037,0,2,microtubule-based peroxisome localization,BP,
14374,GO:0060155,1,0.943623229828297,0,9,platelet dense granule organization,BP,
14375,GO:0060157,1,0.96981256191386,0,4,urinary bladder development,BP,
14376,GO:0060158,1,0.96519130743101,0,8,phospholipase C-activating dopamine receptor signaling pathway,BP,
14377,GO:0060159,1,0.930225278161492,0,11,regulation of dopamine receptor signaling pathway,BP,
14378,GO:0060160,1,0.980568776065351,0,4,negative regulation of dopamine receptor signaling pathway,BP,
14379,GO:0060161,1,0.963064619639608,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14380,GO:0060163,1,0.992126648791525,0,2,subpallium neuron fate commitment,BP,
14381,GO:0060164,1,0.985988848074882,0,3,regulation of timing of neuron differentiation,BP,
14382,GO:0060165,1,0.995394952611099,0,1,regulation of timing of subpallium neuron differentiation,BP,
14383,GO:0060166,1,0.985524304997871,0,3,olfactory pit development,BP,
14384,GO:0060167,1,0.978609907271136,0,3,regulation of adenosine receptor signaling pathway,BP,
14385,GO:0060168,1,0.982026799362328,0,2,positive regulation of adenosine receptor signaling pathway,BP,
14386,GO:0060169,1,0.996521202535912,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14388,GO:0060171,1,0.959883244901151,0,3,stereocilium membrane,CC,
14390,GO:0060174,1,0.907097440494756,0,11,limb bud formation,BP,
14391,GO:0060175,1,0.986470775495684,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14392,GO:0060177,1,0.990197517561422,0,2,regulation of angiotensin metabolic process,BP,
14393,GO:0060178,1,0.995725428858656,0,1,regulation of exocyst localization,BP,
14395,GO:0060180,1,0.948265681883912,0,7,female mating behavior,BP,
14396,GO:0060182,1,0.99464314001561,0,1,apelin receptor activity,MF,
14397,GO:0060183,1,0.988705760212669,0,2,apelin receptor signaling pathway,BP,
14398,GO:0060184,1,0.982454743010368,0,2,cell cycle switching,BP,
14399,GO:0060187,1,0.92479248653672,0,9,cell pole,CC,
14402,GO:0060193,1,0.651943719404954,0,66,positive regulation of lipase activity,BP,
14403,GO:0060197,1,0.983678718604933,0,3,cloacal septation,BP,
14410,GO:0060211,1,0.887257291766083,0,12,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14411,GO:0060212,1,0.996270785710522,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14412,GO:0060213,1,0.887257291766083,0,12,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14413,GO:0060214,1,0.98292870230656,0,4,endocardium formation,BP,
14414,GO:0060215,1,0.94724988839773,0,8,primitive hemopoiesis,BP,
14415,GO:0060216,1,0.853442762718201,0,21,definitive hemopoiesis,BP,
14416,GO:0060217,1,0.990422875038549,0,1,hemangioblast cell differentiation,BP,
14417,GO:0060218,1,0.623593722200829,0,84,hematopoietic stem cell differentiation,BP,
14418,GO:0060219,1,0.829756249301194,0,24,camera-type eye photoreceptor cell differentiation,BP,
14419,GO:0060220,1,0.995983180678702,0,1,camera-type eye photoreceptor cell fate commitment,BP,
14420,GO:0060221,1,0.915477882661042,0,12,retinal rod cell differentiation,BP,
14421,GO:0060228,1,0.990479115926866,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14422,GO:0060229,1,0.936288689328008,0,11,lipase activator activity,MF,
14423,GO:0060230,1,0.993592671485831,0,2,lipoprotein lipase activator activity,MF,
14425,GO:0060232,1,0.971303375167744,0,4,delamination,BP,
14426,GO:0060234,1,0.985964638525744,0,1,neuroblast delamination,BP,
14427,GO:0060235,1,0.952637244761588,0,4,lens induction in camera-type eye,BP,
14428,GO:0060236,1,0.770835452645458,0,34,regulation of mitotic spindle organization,BP,
14429,GO:0060242,1,0.946918589863366,0,8,contact inhibition,BP,
14430,GO:0060243,1,0.991938061438258,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14431,GO:0060244,1,0.984723768558779,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14432,GO:0060245,1,0.946918589863366,0,8,detection of cell density,BP,
14434,GO:0060251,1,0.793542463912902,0,30,regulation of glial cell proliferation,BP,
14435,GO:0060252,1,0.906832085852989,0,15,positive regulation of glial cell proliferation,BP,
14436,GO:0060253,1,0.893206861920916,0,14,negative regulation of glial cell proliferation,BP,
14437,GO:0060254,1,0.996278001386186,0,1,regulation of N-terminal protein palmitoylation,BP,
14439,GO:0060259,1,0.878249760457871,0,18,regulation of feeding behavior,BP,
14440,GO:0060260,1,0.769661257417142,0,35,regulation of transcription initiation from RNA polymerase II promoter,BP,
14441,GO:0060261,1,0.80141441240297,0,29,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14442,GO:0060262,1,0.996278001386186,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14443,GO:0060263,1,0.927607894138228,0,13,regulation of respiratory burst,BP,
14444,GO:0060264,1,0.97854405179775,0,5,regulation of respiratory burst involved in inflammatory response,BP,
14445,GO:0060265,1,0.993107999202969,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14446,GO:0060266,1,0.982219888486393,0,4,negative regulation of respiratory burst involved in inflammatory response,BP,
14447,GO:0060267,1,0.968061747568201,0,5,positive regulation of respiratory burst,BP,
14448,GO:0060268,1,0.969359351522322,0,5,negative regulation of respiratory burst,BP,
14449,GO:0060271,1,0.0773945776048883,0,335,cilium assembly,BP,
14450,GO:0060272,1,0.944128570077436,0,11,embryonic skeletal joint morphogenesis,BP,
14451,GO:0060278,1,0.985619405254856,0,3,regulation of ovulation,BP,
14452,GO:0060279,1,0.98994313640394,0,2,positive regulation of ovulation,BP,
14453,GO:0060280,1,0.995632785523235,0,1,negative regulation of ovulation,BP,
14454,GO:0060281,1,0.926076671215064,0,11,regulation of oocyte development,BP,
14455,GO:0060282,1,0.962743364863049,0,5,positive regulation of oocyte development,BP,
14456,GO:0060283,1,0.971293284787289,0,4,negative regulation of oocyte development,BP,
14458,GO:0060285,1,0.483983863849376,0,96,cilium-dependent cell motility,BP,
14459,GO:0060287,1,0.918203867947399,0,11,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14460,GO:0060290,1,0.953360963368095,0,8,transdifferentiation,BP,
14463,GO:0060293,1,0.87923768935131,0,17,germ plasm,CC,
14464,GO:0060294,1,0.566963791651038,0,85,cilium movement involved in cell motility,BP,
14465,GO:0060295,1,0.927343355795133,0,17,regulation of cilium movement involved in cell motility,BP,
14466,GO:0060296,1,0.970613390948948,0,6,regulation of cilium beat frequency involved in ciliary motility,BP,
14467,GO:0060297,1,0.93748719134401,0,6,regulation of sarcomere organization,BP,
14468,GO:0060298,1,0.975333001741478,0,3,positive regulation of sarcomere organization,BP,
14469,GO:0060299,1,0.996632930809694,0,1,negative regulation of sarcomere organization,BP,
14470,GO:0060300,1,0.980225035690945,0,4,regulation of cytokine activity,BP,
14471,GO:0060301,1,0.995377187964952,0,1,positive regulation of cytokine activity,BP,
14472,GO:0060302,1,0.992662214410102,0,2,negative regulation of cytokine activity,BP,
14473,GO:0060304,1,0.939830142001008,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14474,GO:0060305,1,0.99473415708652,0,1,regulation of cell diameter,BP,
14475,GO:0060306,1,0.77128749637942,0,31,regulation of membrane repolarization,BP,
14476,GO:0060307,1,0.855839855691361,0,20,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14477,GO:0060309,1,0.991760322146836,0,2,elastin catabolic process,BP,
14478,GO:0060310,1,0.996853530369236,0,1,regulation of elastin catabolic process,BP,
14479,GO:0060311,1,0.996853530369236,0,1,negative regulation of elastin catabolic process,BP,
14480,GO:0060312,1,0.949672605607091,0,7,regulation of blood vessel remodeling,BP,
14481,GO:0060313,1,0.973873717815459,0,3,negative regulation of blood vessel remodeling,BP,
14483,GO:0060315,1,0.943864611513951,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14484,GO:0060316,1,0.944566550995548,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14485,GO:0060317,1,0.815395390680149,0,31,cardiac epithelial to mesenchymal transition,BP,
14486,GO:0060318,1,0.960915983127504,0,6,definitive erythrocyte differentiation,BP,
14487,GO:0060319,1,0.977864164873011,0,4,primitive erythrocyte differentiation,BP,
14493,GO:0060327,1,0.983316480169064,0,2,cytoplasmic actin-based contraction involved in cell motility,BP,
14495,GO:0060331,1,0.967475001739925,0,6,negative regulation of response to interferon-gamma,BP,
14496,GO:0060332,1,0.953864272701284,0,6,positive regulation of response to interferon-gamma,BP,
14499,GO:0060335,1,0.953864272701284,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14500,GO:0060336,1,0.967475001739925,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14501,GO:0060337,1,0.638905184286711,0,76,type I interferon signaling pathway,BP,
14502,GO:0060338,1,0.810953653470016,0,31,regulation of type I interferon-mediated signaling pathway,BP,
14503,GO:0060339,1,0.924737944407178,0,12,negative regulation of type I interferon-mediated signaling pathway,BP,
14504,GO:0060340,1,0.913846539327644,0,11,positive regulation of type I interferon-mediated signaling pathway,BP,
14508,GO:0060345,1,0.993756927047099,0,1,spleen trabecula formation,BP,
14510,GO:0060347,1,0.920850510298087,0,13,heart trabecula formation,BP,
14515,GO:0060352,1,0.925827665865462,0,11,cell adhesion molecule production,BP,
14516,GO:0060353,1,0.940508041422369,0,9,regulation of cell adhesion molecule production,BP,
14517,GO:0060354,1,0.961916270738902,0,4,negative regulation of cell adhesion molecule production,BP,
14518,GO:0060355,1,0.982178230863512,0,4,positive regulation of cell adhesion molecule production,BP,
14519,GO:0060357,1,0.989811277794605,0,2,regulation of leucine import,BP,
14520,GO:0060358,1,0.989811277794605,0,2,negative regulation of leucine import,BP,
14521,GO:0060359,1,0.97916496963071,0,3,response to ammonium ion,BP,
14522,GO:0060363,1,0.958058741871547,0,7,cranial suture morphogenesis,BP,
14523,GO:0060364,1,0.974588960570827,0,3,frontal suture morphogenesis,BP,
14524,GO:0060366,1,0.98450707858778,0,1,lambdoid suture morphogenesis,BP,
14525,GO:0060367,1,0.98450707858778,0,1,sagittal suture morphogenesis,BP,
14526,GO:0060368,1,0.920028985062583,0,11,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14527,GO:0060369,1,0.948806071203503,0,7,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14528,GO:0060370,1,0.988982614195446,0,1,susceptibility to T cell mediated cytotoxicity,BP,
14529,GO:0060371,1,0.936134622891558,0,6,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14530,GO:0060372,1,0.935688868829534,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14531,GO:0060373,1,0.957036285161119,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14532,GO:0060374,1,0.959075888843853,0,5,mast cell differentiation,BP,
14533,GO:0060375,1,0.984460926284173,0,2,regulation of mast cell differentiation,BP,
14534,GO:0060377,1,0.993980977862161,0,1,negative regulation of mast cell differentiation,BP,
14535,GO:0060378,1,0.981641426112331,0,2,regulation of brood size,BP,
14536,GO:0060379,1,0.921239730843136,0,10,cardiac muscle cell myoblast differentiation,BP,
14537,GO:0060380,1,0.99599084144268,0,1,regulation of single-stranded telomeric DNA binding,BP,
14538,GO:0060381,1,0.99599084144268,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14539,GO:0060382,1,0.980005906589321,0,2,regulation of DNA strand elongation,BP,
14540,GO:0060383,1,0.992228253223494,0,1,positive regulation of DNA strand elongation,BP,
14542,GO:0060385,1,0.953528735566734,0,6,axonogenesis involved in innervation,BP,
14543,GO:0060386,1,0.989034314340364,0,1,synapse assembly involved in innervation,BP,
14545,GO:0060390,1,0.831811063872435,0,25,regulation of SMAD protein signal transduction,BP,
14546,GO:0060391,1,0.891034496152447,0,15,positive regulation of SMAD protein signal transduction,BP,
14547,GO:0060392,1,0.971276054985592,0,5,negative regulation of SMAD protein signal transduction,BP,
14549,GO:0060394,1,0.940444845338639,0,11,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14552,GO:0060397,1,0.903798528129995,0,11,growth hormone receptor signaling pathway via JAK-STAT,BP,
14554,GO:0060399,1,0.975368383193542,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14558,GO:0060404,1,0.99313701909526,0,1,axonemal microtubule depolymerization,BP,
14559,GO:0060405,1,0.960327463421133,0,6,regulation of penile erection,BP,
14560,GO:0060406,1,0.974524024891267,0,4,positive regulation of penile erection,BP,
14561,GO:0060407,1,0.996521202535912,0,1,negative regulation of penile erection,BP,
14562,GO:0060411,1,0.551165052222735,0,70,cardiac septum morphogenesis,BP,
14563,GO:0060412,1,0.713774102768714,0,40,ventricular septum morphogenesis,BP,
14564,GO:0060413,1,0.894180921534069,0,13,atrial septum morphogenesis,BP,
14568,GO:0060419,1,0.509718035435249,0,88,heart growth,BP,
14569,GO:0060420,1,0.608191681962192,0,66,regulation of heart growth,BP,
14570,GO:0060421,1,0.737630141857551,0,36,positive regulation of heart growth,BP,
14571,GO:0060422,1,0.99567140801192,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14572,GO:0060423,1,0.984147078105701,0,3,foregut regionalization,BP,
14573,GO:0060424,1,0.984147078105701,0,3,lung field specification,BP,
14576,GO:0060428,1,0.79059916320288,0,35,lung epithelium development,BP,
14578,GO:0060430,1,0.941946207293875,0,8,lung saccule development,BP,
14579,GO:0060431,1,0.977650859179665,0,4,primary lung bud formation,BP,
14580,GO:0060432,1,0.996876452058736,0,1,lung pattern specification process,BP,
14581,GO:0060433,1,0.943211379697634,0,10,bronchus development,BP,
14582,GO:0060434,1,0.986374215957119,0,2,bronchus morphogenesis,BP,
14583,GO:0060435,1,0.993542845458152,0,2,bronchiole development,BP,
14584,GO:0060436,1,0.996876452058736,0,1,bronchiole morphogenesis,BP,
14585,GO:0060437,1,0.9650429069429,0,6,lung growth,BP,
14586,GO:0060438,1,0.874846876095711,0,19,trachea development,BP,
14587,GO:0060439,1,0.928961315877139,0,11,trachea morphogenesis,BP,
14588,GO:0060440,1,0.965922405262404,0,6,trachea formation,BP,
14589,GO:0060441,1,0.806170500169415,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14590,GO:0060442,1,0.915658855642402,0,12,branching involved in prostate gland morphogenesis,BP,
14591,GO:0060443,1,0.695893050798939,0,43,mammary gland morphogenesis,BP,
14592,GO:0060444,1,0.813652124312758,0,23,branching involved in mammary gland duct morphogenesis,BP,
14593,GO:0060445,1,0.820981083280514,0,23,branching involved in salivary gland morphogenesis,BP,
14594,GO:0060447,1,0.979045160762157,0,3,bud outgrowth involved in lung branching,BP,
14595,GO:0060448,1,0.965794831393686,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14596,GO:0060449,1,0.960742657312405,0,7,bud elongation involved in lung branching,BP,
14598,GO:0060453,1,0.949557213349748,0,9,regulation of gastric acid secretion,BP,
14599,GO:0060454,1,0.986103146895443,0,2,positive regulation of gastric acid secretion,BP,
14600,GO:0060455,1,0.981607956392058,0,4,negative regulation of gastric acid secretion,BP,
14601,GO:0060456,1,0.95762015111791,0,9,positive regulation of digestive system process,BP,
14602,GO:0060457,1,0.93170702882182,0,13,negative regulation of digestive system process,BP,
14603,GO:0060458,1,0.991767520627501,0,2,right lung development,BP,
14604,GO:0060459,1,0.992471792070204,0,2,left lung development,BP,
14605,GO:0060460,1,0.99596388352694,0,1,left lung morphogenesis,BP,
14606,GO:0060461,1,0.99525715885182,0,1,right lung morphogenesis,BP,
14609,GO:0060465,1,0.977252650467861,0,3,pharynx development,BP,
14610,GO:0060466,1,0.98706942245828,0,1,activation of meiosis involved in egg activation,BP,
14611,GO:0060467,1,0.987305053425867,0,3,negative regulation of fertilization,BP,
14612,GO:0060474,1,0.990693416146742,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14613,GO:0060478,1,0.95218533546262,0,7,acrosomal vesicle exocytosis,BP,
14614,GO:0060479,1,0.871636822276687,0,21,lung cell differentiation,BP,
14615,GO:0060480,1,0.989565200199459,0,3,lung goblet cell differentiation,BP,
14616,GO:0060481,1,0.982252202948115,0,4,lobar bronchus epithelium development,BP,
14617,GO:0060482,1,0.974990672994518,0,5,lobar bronchus development,BP,
14618,GO:0060484,1,0.944073757327032,0,9,lung-associated mesenchyme development,BP,
14620,GO:0060486,1,0.969695536305163,0,4,club cell differentiation,BP,
14621,GO:0060487,1,0.877246146673807,0,20,lung epithelial cell differentiation,BP,
14622,GO:0060488,1,0.969123507273571,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14623,GO:0060489,1,0.969123507273571,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14624,GO:0060490,1,0.969123507273571,0,2,lateral sprouting involved in lung morphogenesis,BP,
14625,GO:0060491,1,0.305280839132572,0,162,regulation of cell projection assembly,BP,
14626,GO:0060492,1,0.984147078105701,0,3,lung induction,BP,
14627,GO:0060495,1,0.996876452058736,0,1,cell-cell signaling involved in lung development,BP,
14628,GO:0060496,1,0.996876452058736,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14629,GO:0060501,1,0.963933910597822,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14630,GO:0060502,1,0.93406609336278,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14631,GO:0060503,1,0.996309331932209,0,1,bud dilation involved in lung branching,BP,
14632,GO:0060509,1,0.945374395576263,0,5,type I pneumocyte differentiation,BP,
14633,GO:0060510,1,0.967769917205292,0,5,type II pneumocyte differentiation,BP,
14634,GO:0060512,1,0.812698167798706,0,27,prostate gland morphogenesis,BP,
14635,GO:0060513,1,0.931013949547969,0,10,prostatic bud formation,BP,
14636,GO:0060514,1,0.994379772030534,0,1,prostate induction,BP,
14637,GO:0060515,1,0.994379772030534,0,1,prostate field specification,BP,
14638,GO:0060516,1,0.989101240975889,0,2,primary prostatic bud elongation,BP,
14639,GO:0060517,1,0.992581591424771,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14640,GO:0060520,1,0.994379772030534,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14641,GO:0060523,1,0.976765709821431,0,3,prostate epithelial cord elongation,BP,
14642,GO:0060525,1,0.905640480469663,0,11,prostate glandular acinus development,BP,
14643,GO:0060526,1,0.949602101282654,0,6,prostate glandular acinus morphogenesis,BP,
14644,GO:0060527,1,0.949602101282654,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14645,GO:0060528,1,0.962264346869194,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14646,GO:0060529,1,0.983423238263378,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14647,GO:0060532,1,0.984413857712069,0,2,bronchus cartilage development,BP,
14648,GO:0060534,1,0.939282428892353,0,8,trachea cartilage development,BP,
14649,GO:0060535,1,0.965132992730551,0,4,trachea cartilage morphogenesis,BP,
14650,GO:0060536,1,0.924795411390094,0,11,cartilage morphogenesis,BP,
14652,GO:0060538,1,0.341413830324447,0,152,skeletal muscle organ development,BP,
14653,GO:0060539,1,0.95654150859639,0,8,diaphragm development,BP,
14655,GO:0060542,1,0.988947858589799,0,1,regulation of strand invasion,BP,
14656,GO:0060544,1,0.891621516291486,0,18,regulation of necroptotic process,BP,
14657,GO:0060545,1,0.984760665358846,0,3,positive regulation of necroptotic process,BP,
14658,GO:0060546,1,0.920752706730665,0,14,negative regulation of necroptotic process,BP,
14659,GO:0060547,1,0.915011118012898,0,16,negative regulation of necrotic cell death,BP,
14661,GO:0060556,1,0.959593419538977,0,8,regulation of vitamin D biosynthetic process,BP,
14662,GO:0060557,1,0.992979183633081,0,2,positive regulation of vitamin D biosynthetic process,BP,
14663,GO:0060558,1,0.966982050349559,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14664,GO:0060559,1,0.992979183633081,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14666,GO:0060561,1,0.844879443709338,0,23,apoptotic process involved in morphogenesis,BP,
14669,GO:0060566,1,0.979771258481234,0,1,positive regulation of DNA-templated transcription, termination,BP,
14670,GO:0060567,1,0.989807596705769,0,2,negative regulation of DNA-templated transcription, termination,BP,
14671,GO:0060571,1,0.854287343799095,0,25,morphogenesis of an epithelial fold,BP,
14672,GO:0060572,1,0.899693449355877,0,16,morphogenesis of an epithelial bud,BP,
14673,GO:0060573,1,0.921968823504032,0,11,cell fate specification involved in pattern specification,BP,
14674,GO:0060574,1,0.981482248920599,0,4,intestinal epithelial cell maturation,BP,
14675,GO:0060575,1,0.887874314910286,0,20,intestinal epithelial cell differentiation,BP,
14676,GO:0060576,1,0.929141143201098,0,13,intestinal epithelial cell development,BP,
14677,GO:0060577,1,0.996473790744259,0,1,pulmonary vein morphogenesis,BP,
14678,GO:0060579,1,0.902576828589899,0,15,ventral spinal cord interneuron fate commitment,BP,
14679,GO:0060580,1,0.995978055021198,0,1,ventral spinal cord interneuron fate determination,BP,
14680,GO:0060581,1,0.902576828589899,0,15,cell fate commitment involved in pattern specification,BP,
14681,GO:0060582,1,0.995978055021198,0,1,cell fate determination involved in pattern specification,BP,
14682,GO:0060584,1,0.979416066860701,0,4,regulation of prostaglandin-endoperoxide synthase activity,BP,
14683,GO:0060585,1,0.979416066860701,0,4,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14684,GO:0060586,1,0.946530273995488,0,8,multicellular organismal iron ion homeostasis,BP,
14685,GO:0060587,1,0.990387349745261,0,2,regulation of lipoprotein lipid oxidation,BP,
14686,GO:0060588,1,0.996750665601107,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14687,GO:0060589,1,0.0751969658772602,0,323,nucleoside-triphosphatase regulator activity,MF,
14688,GO:0060590,1,0.8011350726706,0,39,ATPase regulator activity,MF,
14689,GO:0060591,1,0.976638077807379,0,3,chondroblast differentiation,BP,
14690,GO:0060592,1,0.948690037220315,0,7,mammary gland formation,BP,
14691,GO:0060594,1,0.973796535621439,0,3,mammary gland specification,BP,
14692,GO:0060595,1,0.989122595355514,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14693,GO:0060596,1,0.977834344071846,0,3,mammary placode formation,BP,
14694,GO:0060598,1,0.996704062968524,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14695,GO:0060599,1,0.983273438318768,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14696,GO:0060600,1,0.906179539749328,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14697,GO:0060601,1,0.895222527455974,0,13,lateral sprouting from an epithelium,BP,
14698,GO:0060602,1,0.872532550595079,0,18,branch elongation of an epithelium,BP,
14699,GO:0060603,1,0.757202375163515,0,31,mammary gland duct morphogenesis,BP,
14700,GO:0060605,1,0.964903549258687,0,5,tube lumen cavitation,BP,
14702,GO:0060611,1,0.99546672002597,0,1,mammary gland fat development,BP,
14703,GO:0060612,1,0.740053824691836,0,41,adipose tissue development,BP,
14704,GO:0060613,1,0.944796015692405,0,7,fat pad development,BP,
14705,GO:0060615,1,0.989122595355514,0,2,mammary gland bud formation,BP,
14706,GO:0060620,1,0.968803971998568,0,2,regulation of cholesterol import,BP,
14707,GO:0060623,1,0.989175165943358,0,2,regulation of chromosome condensation,BP,
14709,GO:0060628,1,0.885348946840953,0,16,regulation of ER to Golgi vesicle-mediated transport,BP,
14710,GO:0060631,1,0.962726335810769,0,6,regulation of meiosis I,BP,
14711,GO:0060632,1,0.795497088912843,0,38,regulation of microtubule-based movement,BP,
14712,GO:0060633,1,0.969120832519126,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14713,GO:0060638,1,0.942897307617719,0,8,mesenchymal-epithelial cell signaling,BP,
14714,GO:0060644,1,0.876991403999319,0,16,mammary gland epithelial cell differentiation,BP,
14715,GO:0060648,1,0.98538858107949,0,3,mammary gland bud morphogenesis,BP,
14716,GO:0060661,1,0.992741339303404,0,2,submandibular salivary gland formation,BP,
14717,GO:0060662,1,0.964903549258687,0,5,salivary gland cavitation,BP,
14718,GO:0060664,1,0.976147794908075,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14719,GO:0060665,1,0.974912313004127,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14720,GO:0060666,1,0.945447885773558,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14721,GO:0060667,1,0.989122595355514,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14722,GO:0060668,1,0.993215927816232,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14725,GO:0060671,1,0.990238802695095,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14726,GO:0060672,1,0.990238802695095,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14728,GO:0060675,1,0.619888920441074,0,60,ureteric bud morphogenesis,BP,
14729,GO:0060676,1,0.96327133239739,0,6,ureteric bud formation,BP,
14730,GO:0060677,1,0.923611375113564,0,8,ureteric bud elongation,BP,
14731,GO:0060678,1,0.995719642781064,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14732,GO:0060681,1,0.972550988861296,0,4,branch elongation involved in ureteric bud branching,BP,
14733,GO:0060682,1,0.994944588819646,0,1,primary ureteric bud growth,BP,
14734,GO:0060683,1,0.994885477711322,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14735,GO:0060684,1,0.971628945605968,0,6,epithelial-mesenchymal cell signaling,BP,
14736,GO:0060685,1,0.958263227634409,0,6,regulation of prostatic bud formation,BP,
14737,GO:0060686,1,0.967073126757842,0,4,negative regulation of prostatic bud formation,BP,
14738,GO:0060687,1,0.953947473003279,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
14739,GO:0060688,1,0.708358587264201,0,53,regulation of morphogenesis of a branching structure,BP,
14740,GO:0060689,1,0.975161573099527,0,3,cell differentiation involved in salivary gland development,BP,
14741,GO:0060690,1,0.996285675028102,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14742,GO:0060691,1,0.996285675028102,0,1,epithelial cell maturation involved in salivary gland development,BP,
14743,GO:0060693,1,0.945910515243873,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14744,GO:0060694,1,0.996232329517488,0,1,regulation of cholesterol transporter activity,BP,
14745,GO:0060696,1,0.969532237317405,0,6,regulation of phospholipid catabolic process,BP,
14746,GO:0060697,1,0.991731076578475,0,2,positive regulation of phospholipid catabolic process,BP,
14747,GO:0060698,1,0.986367911848053,0,2,endoribonuclease inhibitor activity,MF,
14748,GO:0060699,1,0.978600415416102,0,4,regulation of endoribonuclease activity,BP,
14749,GO:0060700,1,0.948158946891462,0,9,regulation of ribonuclease activity,BP,
14750,GO:0060701,1,0.986367911848053,0,2,negative regulation of ribonuclease activity,BP,
14751,GO:0060702,1,0.986367911848053,0,2,negative regulation of endoribonuclease activity,BP,
14752,GO:0060703,1,0.99498895358052,0,1,deoxyribonuclease inhibitor activity,MF,
14755,GO:0060710,1,0.96524179337281,0,6,chorio-allantoic fusion,BP,
14757,GO:0060712,1,0.977939428495948,0,3,spongiotrophoblast layer development,BP,
14759,GO:0060715,1,0.978572713551486,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14760,GO:0060716,1,0.891261103917376,0,19,labyrinthine layer blood vessel development,BP,
14761,GO:0060717,1,0.945320333206124,0,7,chorion development,BP,
14762,GO:0060718,1,0.955778360933193,0,5,chorionic trophoblast cell differentiation,BP,
14763,GO:0060720,1,0.981625471629597,0,2,spongiotrophoblast cell proliferation,BP,
14764,GO:0060721,1,0.981625471629597,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14765,GO:0060722,1,0.981625471629597,0,2,cell proliferation involved in embryonic placenta development,BP,
14766,GO:0060723,1,0.981625471629597,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14767,GO:0060729,1,0.967659318461978,0,5,intestinal epithelial structure maintenance,BP,
14768,GO:0060730,1,0.98908010848956,0,2,regulation of intestinal epithelial structure maintenance,BP,
14769,GO:0060731,1,0.993908675883443,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14770,GO:0060732,1,0.944647879135387,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14771,GO:0060733,1,0.982372586078023,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14772,GO:0060734,1,0.991094286844546,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14773,GO:0060735,1,0.996634983836234,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14774,GO:0060736,1,0.900061609741041,0,11,prostate gland growth,BP,
14775,GO:0060737,1,0.969517966952162,0,4,prostate gland morphogenetic growth,BP,
14776,GO:0060738,1,0.990772092070703,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14777,GO:0060739,1,0.985569400959288,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14778,GO:0060740,1,0.815238111973675,0,26,prostate gland epithelium morphogenesis,BP,
14779,GO:0060741,1,0.986807884089225,0,3,prostate gland stromal morphogenesis,BP,
14780,GO:0060742,1,0.920483284402638,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14781,GO:0060743,1,0.984007251053723,0,3,epithelial cell maturation involved in prostate gland development,BP,
14782,GO:0060744,1,0.967105035580763,0,4,mammary gland branching involved in thelarche,BP,
14783,GO:0060745,1,0.929176041812527,0,6,mammary gland branching involved in pregnancy,BP,
14784,GO:0060746,1,0.93393366331395,0,10,parental behavior,BP,
14785,GO:0060748,1,0.963976143560697,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14786,GO:0060749,1,0.875920514338446,0,17,mammary gland alveolus development,BP,
14787,GO:0060750,1,0.958653702920824,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14788,GO:0060751,1,0.958653702920824,0,4,branch elongation involved in mammary gland duct branching,BP,
14789,GO:0060752,1,0.995062653977197,0,1,intestinal phytosterol absorption,BP,
14790,GO:0060753,1,0.970146692017604,0,6,regulation of mast cell chemotaxis,BP,
14791,GO:0060754,1,0.973485910468544,0,5,positive regulation of mast cell chemotaxis,BP,
14793,GO:0060760,1,0.709528718535369,0,53,positive regulation of response to cytokine stimulus,BP,
14794,GO:0060761,1,0.71732067345291,0,53,negative regulation of response to cytokine stimulus,BP,
14795,GO:0060762,1,0.974484156850049,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14796,GO:0060763,1,0.983298493922351,0,2,mammary duct terminal end bud growth,BP,
14797,GO:0060764,1,0.986839112357487,0,2,cell-cell signaling involved in mammary gland development,BP,
14798,GO:0060765,1,0.829067340420662,0,25,regulation of androgen receptor signaling pathway,BP,
14799,GO:0060766,1,0.896074409113449,0,14,negative regulation of androgen receptor signaling pathway,BP,
14800,GO:0060767,1,0.933780352178389,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14801,GO:0060768,1,0.94076356707836,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14802,GO:0060769,1,0.984564857229901,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14803,GO:0060770,1,0.972436217353081,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14804,GO:0060775,1,0.985030479814823,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14805,GO:0060781,1,0.996493899157185,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14806,GO:0060782,1,0.996493899157185,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14807,GO:0060783,1,0.996493899157185,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14808,GO:0060784,1,0.992581591424771,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14809,GO:0060788,1,0.918781606726492,0,11,ectodermal placode formation,BP,
14810,GO:0060789,1,0.973835257856901,0,4,hair follicle placode formation,BP,
14811,GO:0060795,1,0.839919989621497,0,31,cell fate commitment involved in formation of primary germ layer,BP,
14812,GO:0060796,1,0.995595143021993,0,1,regulation of transcription involved in primary germ layer cell fate commitment,BP,
14813,GO:0060800,1,0.979207436562283,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
14814,GO:0060802,1,0.99596388352694,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
14815,GO:0060803,1,0.9965563719936,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
14816,GO:0060804,1,0.994173806742172,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14817,GO:0060806,1,0.996398902221596,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
14818,GO:0060807,1,0.995595143021993,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
14819,GO:0060809,1,0.983839053059939,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
14820,GO:0060816,1,0.974346735186742,0,2,random inactivation of X chromosome,BP,
14821,GO:0060819,1,0.975741965635297,0,2,inactivation of X chromosome by genetic imprinting,BP,
14822,GO:0060820,1,0.983650935311137,0,1,inactivation of X chromosome by heterochromatin assembly,BP,
14823,GO:0060821,1,0.983650935311137,0,1,inactivation of X chromosome by DNA methylation,BP,
14824,GO:0060823,1,0.992273485426941,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14825,GO:0060825,1,0.992633479575778,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14826,GO:0060827,1,0.992273485426941,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14828,GO:0060829,1,0.992273485426941,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14829,GO:0060830,1,0.980764369896375,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14830,GO:0060831,1,0.891757585910545,0,14,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14832,GO:0060837,1,0.941437362423528,0,9,blood vessel endothelial cell differentiation,BP,
14836,GO:0060841,1,0.860422964896152,0,15,venous blood vessel development,BP,
14837,GO:0060842,1,0.959453928617448,0,6,arterial endothelial cell differentiation,BP,
14838,GO:0060843,1,0.982607875776869,0,1,venous endothelial cell differentiation,BP,
14839,GO:0060844,1,0.989445192748936,0,2,arterial endothelial cell fate commitment,BP,
14840,GO:0060846,1,0.984870688361265,0,3,blood vessel endothelial cell fate commitment,BP,
14841,GO:0060847,1,0.984870688361265,0,3,endothelial cell fate specification,BP,
14842,GO:0060849,1,0.986977496766671,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14843,GO:0060850,1,0.89460485128732,0,16,regulation of transcription involved in cell fate commitment,BP,
14844,GO:0060853,1,0.99384208392007,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14845,GO:0060856,1,0.941206244812554,0,11,establishment of blood-brain barrier,BP,
14846,GO:0060857,1,0.995697827924749,0,1,establishment of glial blood-brain barrier,BP,
14847,GO:0060872,1,0.921428690371979,0,9,semicircular canal development,BP,
14848,GO:0060873,1,0.98450707858778,0,1,anterior semicircular canal development,BP,
14849,GO:0060875,1,0.98450707858778,0,1,lateral semicircular canal development,BP,
14850,GO:0060876,1,0.992338254916248,0,2,semicircular canal formation,BP,
14851,GO:0060879,1,0.996876452058736,0,1,semicircular canal fusion,BP,
14852,GO:0060896,1,0.929848964004479,0,8,neural plate pattern specification,BP,
14853,GO:0060897,1,0.955347433867805,0,6,neural plate regionalization,BP,
14854,GO:0060900,1,0.896557279646191,0,12,embryonic camera-type eye formation,BP,
14855,GO:0060901,1,0.991836587427737,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14856,GO:0060903,1,0.96821752880031,0,5,positive regulation of meiosis I,BP,
14857,GO:0060904,1,0.992490336213917,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14858,GO:0060907,1,0.947888599940984,0,9,positive regulation of macrophage cytokine production,BP,
14859,GO:0060911,1,0.951221063303185,0,10,cardiac cell fate commitment,BP,
14860,GO:0060912,1,0.990508300317132,0,2,cardiac cell fate specification,BP,
14861,GO:0060913,1,0.987379356801821,0,3,cardiac cell fate determination,BP,
14862,GO:0060914,1,0.812682383061473,0,29,heart formation,BP,
14863,GO:0060915,1,0.989122595355514,0,2,mesenchymal cell differentiation involved in lung development,BP,
14864,GO:0060916,1,0.960288941837049,0,5,mesenchymal cell proliferation involved in lung development,BP,
14865,GO:0060920,1,0.962903089844477,0,5,cardiac pacemaker cell differentiation,BP,
14866,GO:0060921,1,0.977318761184714,0,3,sinoatrial node cell differentiation,BP,
14867,GO:0060922,1,0.985253131196003,0,2,atrioventricular node cell differentiation,BP,
14868,GO:0060923,1,0.968333032722656,0,6,cardiac muscle cell fate commitment,BP,
14869,GO:0060926,1,0.96605392211771,0,4,cardiac pacemaker cell development,BP,
14870,GO:0060927,1,0.996162159258601,0,1,cardiac pacemaker cell fate commitment,BP,
14871,GO:0060928,1,0.985253131196003,0,2,atrioventricular node cell development,BP,
14872,GO:0060929,1,0.996162159258601,0,1,atrioventricular node cell fate commitment,BP,
14873,GO:0060931,1,0.98051628743803,0,2,sinoatrial node cell development,BP,
14874,GO:0060932,1,0.987098817327399,0,2,His-Purkinje system cell differentiation,BP,
14875,GO:0060935,1,0.976607267228095,0,3,cardiac fibroblast cell differentiation,BP,
14876,GO:0060936,1,0.976607267228095,0,3,cardiac fibroblast cell development,BP,
14877,GO:0060938,1,0.976607267228095,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14878,GO:0060939,1,0.976607267228095,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14879,GO:0060940,1,0.988737832061097,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14880,GO:0060947,1,0.936716830226925,0,8,cardiac vascular smooth muscle cell differentiation,BP,
14881,GO:0060948,1,0.971321986287355,0,3,cardiac vascular smooth muscle cell development,BP,
14882,GO:0060956,1,0.949207391265306,0,6,endocardial cell differentiation,BP,
14883,GO:0060957,1,0.994536744778715,0,1,endocardial cell fate commitment,BP,
14884,GO:0060964,1,0.560343833879083,0,81,regulation of gene silencing by miRNA,BP,
14885,GO:0060965,1,0.876238883892992,0,18,negative regulation of gene silencing by miRNA,BP,
14886,GO:0060966,1,0.543383628443,0,84,regulation of gene silencing by RNA,BP,
14887,GO:0060967,1,0.858712743392237,0,20,negative regulation of gene silencing by RNA,BP,
14888,GO:0060968,1,0.503478235176295,0,94,regulation of gene silencing,BP,
14889,GO:0060969,1,0.829404679833284,0,24,negative regulation of gene silencing,BP,
14890,GO:0060971,1,0.965188991996537,0,4,embryonic heart tube left/right pattern formation,BP,
14891,GO:0060972,1,0.826958360068588,0,22,left/right pattern formation,BP,
14892,GO:0060973,1,0.878315909403159,0,17,cell migration involved in heart development,BP,
14893,GO:0060974,1,0.993531886671322,0,2,cell migration involved in heart formation,BP,
14894,GO:0060975,1,0.996739578012618,0,1,cardioblast migration to the midline involved in heart field formation,BP,
14895,GO:0060976,1,0.642883209742714,0,45,coronary vasculature development,BP,
14896,GO:0060977,1,0.830985182912748,0,16,coronary vasculature morphogenesis,BP,
14897,GO:0060978,1,0.972502951969783,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
14898,GO:0060979,1,0.950619002576039,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
14899,GO:0060980,1,0.993151563060952,0,1,cell migration involved in coronary vasculogenesis,BP,
14900,GO:0060981,1,0.989030552840523,0,1,cell migration involved in coronary angiogenesis,BP,
14901,GO:0060982,1,0.903316340538349,0,9,coronary artery morphogenesis,BP,
14902,GO:0060986,1,0.770683396940911,0,42,endocrine hormone secretion,BP,
14903,GO:0060987,1,0.995632785523235,0,1,lipid tube,CC,
14905,GO:0060992,1,0.953519940762682,0,6,response to fungicide,BP,
14907,GO:0060994,1,0.993035130428669,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14908,GO:0060995,1,0.984315601934035,0,2,cell-cell signaling involved in kidney development,BP,
14913,GO:0061000,1,0.893420695424594,0,12,negative regulation of dendritic spine development,BP,
14915,GO:0061002,1,0.941837075843981,0,7,negative regulation of dendritic spine morphogenesis,BP,
14917,GO:0061004,1,0.962287883876645,0,8,pattern specification involved in kidney development,BP,
14920,GO:0061009,1,0.959910811033162,0,5,common bile duct development,BP,
14921,GO:0061010,1,0.976888615987675,0,2,gall bladder development,BP,
14923,GO:0061014,1,0.667767137066965,0,49,positive regulation of mRNA catabolic process,BP,
14924,GO:0061015,1,0.993172779154378,0,2,snRNA import into nucleus,BP,
14927,GO:0061026,1,0.953920335816454,0,5,cardiac muscle tissue regeneration,BP,
14928,GO:0061027,1,0.990752547628393,0,2,umbilical cord development,BP,
14929,GO:0061028,1,0.712285442433455,0,44,establishment of endothelial barrier,BP,
14930,GO:0061029,1,0.908195987420742,0,13,eyelid development in camera-type eye,BP,
14931,GO:0061030,1,0.984385929573815,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14932,GO:0061031,1,0.992248280882013,0,2,endodermal digestive tract morphogenesis,BP,
14933,GO:0061032,1,0.990045341524952,0,2,visceral serous pericardium development,BP,
14934,GO:0061033,1,0.985475229215773,0,3,secretion by lung epithelial cell involved in lung growth,BP,
14935,GO:0061034,1,0.990046615402367,0,1,olfactory bulb mitral cell layer development,BP,
14936,GO:0061035,1,0.636915497355826,0,60,regulation of cartilage development,BP,
14937,GO:0061036,1,0.804261027823343,0,28,positive regulation of cartilage development,BP,
14938,GO:0061037,1,0.852424056839623,0,25,negative regulation of cartilage development,BP,
14939,GO:0061038,1,0.936799588049052,0,6,uterus morphogenesis,BP,
14940,GO:0061040,1,0.983543904499243,0,1,female gonad morphogenesis,BP,
14946,GO:0061046,1,0.969752229025925,0,6,regulation of branching involved in lung morphogenesis,BP,
14947,GO:0061047,1,0.980514336677667,0,4,positive regulation of branching involved in lung morphogenesis,BP,
14948,GO:0061048,1,0.996418272104253,0,1,negative regulation of branching involved in lung morphogenesis,BP,
14949,GO:0061049,1,0.817177279252084,0,26,cell growth involved in cardiac muscle cell development,BP,
14950,GO:0061050,1,0.876650536383362,0,18,regulation of cell growth involved in cardiac muscle cell development,BP,
14951,GO:0061051,1,0.933173005585283,0,8,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14952,GO:0061052,1,0.939470377722284,0,10,negative regulation of cell growth involved in cardiac muscle cell development,BP,
14953,GO:0061053,1,0.532106979423672,0,78,somite development,BP,
14954,GO:0061054,1,0.988737546884749,0,2,dermatome development,BP,
14955,GO:0061055,1,0.9705350955259,0,4,myotome development,BP,
14956,GO:0061056,1,0.983312381563238,0,4,sclerotome development,BP,
14958,GO:0061072,1,0.921256187031465,0,9,iris morphogenesis,BP,
14959,GO:0061073,1,0.959256258811244,0,4,ciliary body morphogenesis,BP,
14960,GO:0061074,1,0.969441777815258,0,6,regulation of neural retina development,BP,
14961,GO:0061075,1,0.99137811797935,0,2,positive regulation of neural retina development,BP,
14962,GO:0061076,1,0.99419547524527,0,1,negative regulation of neural retina development,BP,
14963,GO:0061077,1,0.752873509605931,0,54,chaperone-mediated protein folding,BP,
14964,GO:0061078,1,0.996883783413978,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14965,GO:0061081,1,0.876901435365813,0,19,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14967,GO:0061083,1,0.976102856888125,0,4,regulation of protein refolding,BP,
14968,GO:0061084,1,0.976102856888125,0,4,negative regulation of protein refolding,BP,
14969,GO:0061085,1,0.944461976557816,0,8,regulation of histone H3-K27 methylation,BP,
14970,GO:0061086,1,0.976940877703678,0,3,negative regulation of histone H3-K27 methylation,BP,
14971,GO:0061087,1,0.960710855267198,0,6,positive regulation of histone H3-K27 methylation,BP,
14972,GO:0061088,1,0.97430197158603,0,4,regulation of sequestering of zinc ion,BP,
14973,GO:0061090,1,0.995509067485572,0,1,positive regulation of sequestering of zinc ion,BP,
14974,GO:0061091,1,0.962562781175566,0,4,regulation of phospholipid translocation,BP,
14975,GO:0061092,1,0.962562781175566,0,4,positive regulation of phospholipid translocation,BP,
14976,GO:0061097,1,0.559610036300401,0,83,regulation of protein tyrosine kinase activity,BP,
14977,GO:0061098,1,0.684582792915166,0,53,positive regulation of protein tyrosine kinase activity,BP,
14978,GO:0061099,1,0.848535086098105,0,25,negative regulation of protein tyrosine kinase activity,BP,
14979,GO:0061100,1,0.995394952611099,0,1,lung neuroendocrine cell differentiation,BP,
14980,GO:0061101,1,0.96367193538901,0,8,neuroendocrine cell differentiation,BP,
14981,GO:0061102,1,0.991991983435621,0,2,stomach neuroendocrine cell differentiation,BP,
14982,GO:0061103,1,0.995394952611099,0,1,carotid body glomus cell differentiation,BP,
14983,GO:0061104,1,0.990213446395411,0,2,adrenal chromaffin cell differentiation,BP,
14984,GO:0061105,1,0.99658144568182,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14985,GO:0061106,1,0.99658144568182,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
14986,GO:0061107,1,0.987023768579654,0,3,seminal vesicle development,BP,
14987,GO:0061108,1,0.995720366761928,0,1,seminal vesicle epithelium development,BP,
14989,GO:0061113,1,0.97792007127861,0,3,pancreas morphogenesis,BP,
14990,GO:0061114,1,0.994328439527581,0,1,branching involved in pancreas morphogenesis,BP,
14991,GO:0061115,1,0.996876452058736,0,1,lung proximal/distal axis specification,BP,
14992,GO:0061117,1,0.852883926841996,0,25,negative regulation of heart growth,BP,
14993,GO:0061133,1,0.970845422849123,0,7,endopeptidase activator activity,MF,
14996,GO:0061136,1,0.307079366733589,0,179,regulation of proteasomal protein catabolic process,BP,
14998,GO:0061140,1,0.953256116569127,0,9,lung secretory cell differentiation,BP,
14999,GO:0061141,1,0.976559584843409,0,3,lung ciliated cell differentiation,BP,
15000,GO:0061143,1,0.994747060254305,0,1,alveolar primary septum development,BP,
15001,GO:0061144,1,0.994258262827234,0,1,alveolar secondary septum development,BP,
15002,GO:0061145,1,0.984413857712069,0,2,lung smooth muscle development,BP,
15003,GO:0061146,1,0.981128803596899,0,3,Peyer's patch morphogenesis,BP,
15004,GO:0061149,1,0.996309331932209,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15005,GO:0061150,1,0.996309331932209,0,1,renal system segmentation,BP,
15006,GO:0061151,1,0.996309331932209,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15007,GO:0061152,1,0.990205273139571,0,2,trachea submucosa development,BP,
15008,GO:0061153,1,0.990205273139571,0,2,trachea gland development,BP,
15009,GO:0061154,1,0.899899257774035,0,18,endothelial tube morphogenesis,BP,
15010,GO:0061155,1,0.996309331932209,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15011,GO:0061156,1,0.93976991833472,0,6,pulmonary artery morphogenesis,BP,
15012,GO:0061157,1,0.784417864435838,0,31,mRNA destabilization,BP,
15013,GO:0061158,1,0.884387231671113,0,17,3'-UTR-mediated mRNA destabilization,BP,
15014,GO:0061159,1,0.990545235812661,0,1,establishment of bipolar cell polarity involved in cell morphogenesis,BP,
15015,GO:0061162,1,0.837245837925619,0,21,establishment of monopolar cell polarity,BP,
15016,GO:0061171,1,0.990545235812661,0,1,establishment of bipolar cell polarity,BP,
15017,GO:0061178,1,0.706471863414241,0,53,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15018,GO:0061179,1,0.963617701998998,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15019,GO:0061180,1,0.576936902494189,0,66,mammary gland epithelium development,BP,
15020,GO:0061181,1,0.982811665365122,0,3,regulation of chondrocyte development,BP,
15021,GO:0061182,1,0.996480961409331,0,1,negative regulation of chondrocyte development,BP,
15022,GO:0061183,1,0.988737546884749,0,2,regulation of dermatome development,BP,
15023,GO:0061184,1,0.992625203655,0,1,positive regulation of dermatome development,BP,
15024,GO:0061185,1,0.996083749376374,0,1,negative regulation of dermatome development,BP,
15025,GO:0061187,1,0.972161230871143,0,3,regulation of ribosomal DNA heterochromatin assembly,BP,
15026,GO:0061188,1,0.978231997566336,0,2,negative regulation of ribosomal DNA heterochromatin assembly,BP,
15027,GO:0061189,1,0.996493899157185,0,1,positive regulation of sclerotome development,BP,
15028,GO:0061190,1,0.996493899157185,0,1,regulation of sclerotome development,BP,
15029,GO:0061193,1,0.98921200886078,0,2,taste bud development,BP,
15030,GO:0061196,1,0.956521303647629,0,6,fungiform papilla development,BP,
15031,GO:0061197,1,0.960646020369467,0,5,fungiform papilla morphogenesis,BP,
15032,GO:0061198,1,0.977032673484235,0,3,fungiform papilla formation,BP,
15035,GO:0061205,1,0.975936665210555,0,3,paramesonephric duct development,BP,
15036,GO:0061209,1,0.980625238843779,0,4,cell proliferation involved in mesonephros development,BP,
15037,GO:0061213,1,0.890213725281442,0,19,positive regulation of mesonephros development,BP,
15038,GO:0061217,1,0.879713912665688,0,22,regulation of mesonephros development,BP,
15039,GO:0061218,1,0.986685514232906,0,3,negative regulation of mesonephros development,BP,
15040,GO:0061227,1,0.992519052884927,0,2,pattern specification involved in mesonephros development,BP,
15041,GO:0061245,1,0.685529035433849,0,45,establishment or maintenance of bipolar cell polarity,BP,
15042,GO:0061289,1,0.984315601934035,0,2,Wnt signaling pathway involved in kidney development,BP,
15043,GO:0061290,1,0.984315601934035,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15046,GO:0061300,1,0.982584739364091,0,2,cerebellum vasculature development,BP,
15047,GO:0061301,1,0.98600232435785,0,1,cerebellum vasculature morphogenesis,BP,
15049,GO:0061303,1,0.942250089074643,0,9,cornea development in camera-type eye,BP,
15051,GO:0061307,1,0.939277475152166,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15052,GO:0061308,1,0.939277475152166,0,11,cardiac neural crest cell development involved in heart development,BP,
15053,GO:0061309,1,0.949474246033789,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15054,GO:0061311,1,0.822820907024218,0,29,cell surface receptor signaling pathway involved in heart development,BP,
15055,GO:0061312,1,0.972517677331181,0,6,BMP signaling pathway involved in heart development,BP,
15056,GO:0061314,1,0.913141169486446,0,11,Notch signaling involved in heart development,BP,
15057,GO:0061316,1,0.985547053755924,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15058,GO:0061317,1,0.991881625940772,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15059,GO:0061318,1,0.864683584998598,0,16,renal filtration cell differentiation,BP,
15060,GO:0061323,1,0.883135889045429,0,16,cell proliferation involved in heart morphogenesis,BP,
15061,GO:0061324,1,0.993614100415638,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15062,GO:0061325,1,0.981376197395587,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15066,GO:0061339,1,0.837245837925619,0,21,establishment or maintenance of monopolar cell polarity,BP,
15067,GO:0061341,1,0.9787005161634,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15068,GO:0061343,1,0.957913998488539,0,5,cell adhesion involved in heart morphogenesis,BP,
15069,GO:0061346,1,0.9787005161634,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15070,GO:0061347,1,0.988831518817606,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15071,GO:0061348,1,0.988831518817606,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15072,GO:0061349,1,0.988831518817606,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15073,GO:0061350,1,0.988831518817606,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15074,GO:0061351,1,0.322547519483699,0,142,neural precursor cell proliferation,BP,
15075,GO:0061354,1,0.988831518817606,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15076,GO:0061355,1,0.972067752165028,0,5,Wnt protein secretion,BP,
15077,GO:0061356,1,0.975672438170129,0,4,regulation of Wnt protein secretion,BP,
15078,GO:0061357,1,0.979371063485151,0,3,positive regulation of Wnt protein secretion,BP,
15079,GO:0061358,1,0.996224256177234,0,1,negative regulation of Wnt protein secretion,BP,
15080,GO:0061360,1,0.992193352021718,0,1,optic chiasma development,BP,
15081,GO:0061364,1,0.969121809299442,0,3,apoptotic process involved in luteolysis,BP,
15082,GO:0061365,1,0.968223588907797,0,7,positive regulation of triglyceride lipase activity,BP,
15083,GO:0061366,1,0.991761934226887,0,2,behavioral response to chemical pain,BP,
15084,GO:0061368,1,0.991761934226887,0,2,behavioral response to formalin induced pain,BP,
15085,GO:0061369,1,0.992625203655,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15086,GO:0061370,1,0.969783937751459,0,6,testosterone biosynthetic process,BP,
15087,GO:0061371,1,0.629574671248294,0,63,determination of heart left/right asymmetry,BP,
15088,GO:0061373,1,0.982859673894937,0,1,mammillary axonal complex development,BP,
15089,GO:0061377,1,0.875920514338446,0,17,mammary gland lobule development,BP,
15091,GO:0061384,1,0.770983313255292,0,32,heart trabecula morphogenesis,BP,
15092,GO:0061386,1,0.971978860207732,0,2,closure of optic fissure,BP,
15094,GO:0061394,1,0.992400068372905,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15095,GO:0061395,1,0.99637212795513,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15096,GO:0061400,1,0.994890876864838,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15097,GO:0061402,1,0.990476854496565,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15098,GO:0061408,1,0.995864341580592,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15099,GO:0061418,1,0.672505137050696,0,72,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15100,GO:0061419,1,0.95496668920214,0,6,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15101,GO:0061428,1,0.974176027686377,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15103,GO:0061433,1,0.996132256305386,0,1,cellular response to caloric restriction,BP,
15104,GO:0061436,1,0.86183501837137,0,22,establishment of skin barrier,BP,
15105,GO:0061437,1,0.821663530278443,0,25,renal system vasculature development,BP,
15106,GO:0061438,1,0.92469414596279,0,7,renal system vasculature morphogenesis,BP,
15107,GO:0061439,1,0.92469414596279,0,7,kidney vasculature morphogenesis,BP,
15108,GO:0061440,1,0.821663530278443,0,25,kidney vasculature development,BP,
15109,GO:0061441,1,0.985720570895164,0,2,renal artery morphogenesis,BP,
15110,GO:0061443,1,0.983110583811326,0,2,endocardial cushion cell differentiation,BP,
15111,GO:0061444,1,0.988511697367671,0,1,endocardial cushion cell development,BP,
15112,GO:0061445,1,0.994536744778715,0,1,endocardial cushion cell fate commitment,BP,
15116,GO:0061459,1,0.952848792540457,0,6,L-arginine transmembrane transporter activity,MF,
15117,GO:0061462,1,0.750742509806335,0,40,protein localization to lysosome,BP,
15118,GO:0061463,1,0.994890876864838,0,1,O-acetyl-ADP-ribose deacetylase activity,MF,
15119,GO:0061469,1,0.941519649658519,0,11,regulation of type B pancreatic cell proliferation,BP,
15120,GO:0061470,1,0.959607602733437,0,5,T follicular helper cell differentiation,BP,
15121,GO:0061474,1,0.995280460917436,0,1,phagolysosome membrane,CC,
15122,GO:0061476,1,0.994278782330307,0,1,response to anticoagulant,BP,
15123,GO:0061481,1,0.996839785721365,0,1,response to TNF agonist,BP,
15124,GO:0061484,1,0.971140784406623,0,4,hematopoietic stem cell homeostasis,BP,
15125,GO:0061485,1,0.985794435632362,0,1,memory T cell proliferation,BP,
15126,GO:0061502,1,0.95276692273304,0,4,early endosome to recycling endosome transport,BP,
15127,GO:0061507,1,0.994763612701618,0,1,cyclic-GMP-AMP binding,MF,
15128,GO:0061508,1,0.994890876864838,0,1,CDP phosphorylation,BP,
15129,GO:0061511,1,0.950423119114599,0,7,centriole elongation,BP,
15130,GO:0061512,1,0.670296186962766,0,56,protein localization to cilium,BP,
15131,GO:0061513,1,0.982338698440941,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15132,GO:0061514,1,0.996314289137698,0,1,interleukin-34-mediated signaling pathway,BP,
15134,GO:0061517,1,0.94675993656641,0,10,macrophage proliferation,BP,
15135,GO:0061518,1,0.965282398371029,0,7,microglial cell proliferation,BP,
15136,GO:0061519,1,0.993267774125088,0,1,macrophage homeostasis,BP,
15137,GO:0061523,1,0.99313701909526,0,1,cilium disassembly,BP,
15138,GO:0061525,1,0.931837771102588,0,8,hindgut development,BP,
15139,GO:0061526,1,0.981036970558034,0,4,acetylcholine secretion,BP,
15140,GO:0061528,1,0.977608895796039,0,2,aspartate secretion,BP,
15141,GO:0061534,1,0.977592864454672,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15142,GO:0061535,1,0.951908199688608,0,4,glutamate secretion, neurotransmission,BP,
15143,GO:0061536,1,0.994030963168051,0,1,glycine secretion,BP,
15144,GO:0061537,1,0.994030963168051,0,1,glycine secretion, neurotransmission,BP,
15145,GO:0061542,1,0.996689329953739,0,1,3-demethylubiquinol-n 3-O-methyltransferase activity,MF,
15146,GO:0061547,1,0.987799733126833,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15147,GO:0061548,1,0.904658017859974,0,15,ganglion development,BP,
15148,GO:0061549,1,0.945357672837622,0,8,sympathetic ganglion development,BP,
15149,GO:0061550,1,0.951971138092194,0,6,cranial ganglion development,BP,
15150,GO:0061551,1,0.958092027275565,0,5,trigeminal ganglion development,BP,
15151,GO:0061552,1,0.985120966502447,0,2,ganglion morphogenesis,BP,
15153,GO:0061565,1,0.994890876864838,0,1,dAMP phosphorylation,BP,
15154,GO:0061566,1,0.994890876864838,0,1,CMP phosphorylation,BP,
15155,GO:0061567,1,0.994890876864838,0,1,dCMP phosphorylation,BP,
15156,GO:0061568,1,0.994890876864838,0,1,GDP phosphorylation,BP,
15157,GO:0061569,1,0.994890876864838,0,1,UDP phosphorylation,BP,
15158,GO:0061570,1,0.994890876864838,0,1,dCDP phosphorylation,BP,
15159,GO:0061571,1,0.994890876864838,0,1,TDP phosphorylation,BP,
15161,GO:0061574,1,0.974397151138993,0,4,ASAP complex,CC,
15162,GO:0061575,1,0.957483904245431,0,9,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15163,GO:0061577,1,0.889477960834974,0,14,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15164,GO:0061578,1,0.913432697292185,0,11,Lys63-specific deubiquitinase activity,MF,
15165,GO:0061580,1,0.992170792413051,0,1,colon epithelial cell migration,BP,
15166,GO:0061582,1,0.980246006048561,0,2,intestinal epithelial cell migration,BP,
15167,GO:0061586,1,0.993773180548496,0,1,positive regulation of transcription by transcription factor localization,BP,
15168,GO:0061588,1,0.962131449373307,0,5,calcium activated phospholipid scrambling,BP,
15169,GO:0061589,1,0.973222436185983,0,4,calcium activated phosphatidylserine scrambling,BP,
15170,GO:0061590,1,0.962131449373307,0,5,calcium activated phosphatidylcholine scrambling,BP,
15171,GO:0061591,1,0.962131449373307,0,5,calcium activated galactosylceramide scrambling,BP,
15172,GO:0061598,1,0.991875105213165,0,1,molybdopterin adenylyltransferase activity,MF,
15173,GO:0061599,1,0.991875105213165,0,1,molybdopterin molybdotransferase activity,MF,
15174,GO:0061604,1,0.995427030370975,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15175,GO:0061605,1,0.995427030370975,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15176,GO:0061608,1,0.854247776060511,0,18,nuclear import signal receptor activity,MF,
15177,GO:0061609,1,0.99546514122548,0,1,fructose-1-phosphate aldolase activity,MF,
15178,GO:0061611,1,0.996318235555698,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15179,GO:0061614,1,0.663611223103831,0,53,pri-miRNA transcription by RNA polymerase II,BP,
15180,GO:0061615,1,0.841163163209629,0,28,glycolytic process through fructose-6-phosphate,BP,
15181,GO:0061617,1,0.969880119337109,0,7,MICOS complex,CC,
15182,GO:0061620,1,0.849253669751549,0,27,glycolytic process through glucose-6-phosphate,BP,
15183,GO:0061621,1,0.852124185754144,0,26,canonical glycolysis,BP,
15184,GO:0061622,1,0.996636735253791,0,1,glycolytic process through glucose-1-phosphate,BP,
15185,GO:0061623,1,0.996636735253791,0,1,glycolytic process from galactose,BP,
15186,GO:0061624,1,0.981017515924691,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15187,GO:0061626,1,0.948273347571766,0,7,pharyngeal arch artery morphogenesis,BP,
15188,GO:0061627,1,0.996076513763949,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15189,GO:0061628,1,0.963518401872582,0,3,H3K27me3 modified histone binding,MF,
15190,GO:0061629,1,0.159607531258296,0,257,RNA polymerase II-specific DNA-binding transcription factor binding,MF,
15191,GO:0061630,1,0.15230170772433,0,254,ubiquitin protein ligase activity,MF,
15192,GO:0061631,1,0.791049492132175,0,38,ubiquitin conjugating enzyme activity,MF,
15193,GO:0061632,1,0.995114640053134,0,1,RNA lariat debranching enzyme activator activity,MF,
15194,GO:0061635,1,0.950238221020719,0,11,regulation of protein complex stability,BP,
15195,GO:0061640,1,0.552119687188477,0,83,cytoskeleton-dependent cytokinesis,BP,
15196,GO:0061641,1,0.875808336928511,0,26,CENP-A containing chromatin organization,BP,
15197,GO:0061642,1,0.95148849695305,0,4,chemoattraction of axon,BP,
15198,GO:0061643,1,0.954250332151362,0,6,chemorepulsion of axon,BP,
15199,GO:0061646,1,0.990531619929249,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15200,GO:0061647,1,0.65984319650328,0,47,histone H3-K9 modification,BP,
15201,GO:0061649,1,0.975314715935341,0,3,ubiquitin modification-dependent histone binding,MF,
15202,GO:0061650,1,0.785883522441001,0,40,ubiquitin-like protein conjugating enzyme activity,MF,
15203,GO:0061654,1,0.996643664473636,0,1,NEDD8 conjugating enzyme activity,MF,
15204,GO:0061656,1,0.996720374049634,0,1,SUMO conjugating enzyme activity,MF,
15205,GO:0061657,1,0.996753851349124,0,1,UFM1 conjugating enzyme activity,MF,
15206,GO:0061659,1,0.14525107645916,0,263,ubiquitin-like protein ligase activity,MF,
15207,GO:0061663,1,0.979489632055817,0,3,NEDD8 ligase activity,MF,
15208,GO:0061665,1,0.959453873608055,0,8,SUMO ligase activity,MF,
15209,GO:0061666,1,0.994890876864838,0,1,UFM1 ligase activity,MF,
15210,GO:0061668,1,0.962822389086699,0,6,mitochondrial ribosome assembly,BP,
15212,GO:0061670,1,0.996547968223356,0,1,evoked neurotransmitter secretion,BP,
15213,GO:0061673,1,0.952772842541233,0,8,mitotic spindle astral microtubule,CC,
15214,GO:0061676,1,0.948615890336136,0,7,importin-alpha family protein binding,MF,
15215,GO:0061682,1,0.995602710770369,0,1,seminal vesicle morphogenesis,BP,
15216,GO:0061684,1,0.907845520856274,0,16,chaperone-mediated autophagy,BP,
15217,GO:0061685,1,0.994890876864838,0,1,diphthine methylesterase activity,MF,
15218,GO:0061687,1,0.940766982278435,0,13,detoxification of inorganic compound,BP,
15219,GO:0061689,1,0.971878435944452,0,4,tricellular tight junction,CC,
15220,GO:0061690,1,0.996734481670248,0,1,lipoamidase activity,MF,
15222,GO:0061697,1,0.990560505537069,0,2,protein-glutaryllysine deglutarylase activity,MF,
15223,GO:0061698,1,0.990560505537069,0,2,protein deglutarylation,BP,
15224,GO:0061699,1,0.990560505537069,0,2,peptidyl-lysine deglutarylation,BP,
15225,GO:0061700,1,0.952984422418915,0,9,GATOR2 complex,CC,
15226,GO:0061702,1,0.913247275048488,0,14,inflammasome complex,CC,
15227,GO:0061709,1,0.931393723391265,0,9,reticulophagy,BP,
15228,GO:0061711,1,0.99216009570662,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15229,GO:0061712,1,0.993910689226611,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15230,GO:0061713,1,0.99200060943813,0,2,anterior neural tube closure,BP,
15231,GO:0061714,1,0.99354650832861,0,2,folic acid receptor activity,MF,
15232,GO:0061715,1,0.993980977862161,0,1,miRNA 2'-O-methylation,BP,
15233,GO:0061718,1,0.852124185754144,0,26,glucose catabolic process to pyruvate,BP,
15234,GO:0061723,1,0.982761233753801,0,2,glycophagy,BP,
15235,GO:0061724,1,0.941410319243356,0,7,lipophagy,BP,
15236,GO:0061726,1,0.568447401075801,0,75,mitochondrion disassembly,BP,
15237,GO:0061727,1,0.987846067266353,0,3,methylglyoxal catabolic process to lactate,BP,
15238,GO:0061731,1,0.978553777052999,0,3,ribonucleoside-diphosphate reductase activity,MF,
15239,GO:0061732,1,0.968768697648865,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15240,GO:0061733,1,0.671620575945176,0,50,peptide-lysine-N-acetyltransferase activity,MF,
15241,GO:0061734,1,0.944706775993057,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15242,GO:0061736,1,0.989067237576379,0,1,engulfment of target by autophagosome,BP,
15243,GO:0061737,1,0.978611518692615,0,5,leukotriene signaling pathway,BP,
15244,GO:0061738,1,0.985632605354814,0,3,late endosomal microautophagy,BP,
15245,GO:0061739,1,0.982037419873203,0,3,protein lipidation involved in autophagosome assembly,BP,
15246,GO:0061740,1,0.983134501957046,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15247,GO:0061741,1,0.99079878334831,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15248,GO:0061743,1,0.977691231763634,0,5,motor learning,BP,
15249,GO:0061744,1,0.944882987545596,0,9,motor behavior,BP,
15250,GO:0061749,1,0.98036527879578,0,2,forked DNA-dependent helicase activity,MF,
15251,GO:0061750,1,0.995625296401021,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15252,GO:0061751,1,0.989902831807601,0,1,neutral sphingomyelin phosphodiesterase activity,MF,
15253,GO:0061752,1,0.990556411264979,0,2,telomeric repeat-containing RNA binding,MF,
15254,GO:0061753,1,0.989067237576379,0,1,substrate localization to autophagosome,BP,
15256,GO:0061757,1,0.98041074382051,0,4,leukocyte adhesion to arterial endothelial cell,BP,
15257,GO:0061760,1,0.984630249995157,0,4,antifungal innate immune response,BP,
15258,GO:0061762,1,0.927869672390523,0,7,CAMKK-AMPK signaling cascade,BP,
15259,GO:0061763,1,0.990054174431989,0,2,multivesicular body-lysosome fusion,BP,
15260,GO:0061767,1,0.98869760626895,0,1,negative regulation of lung blood pressure,BP,
15261,GO:0061768,1,0.99069730703381,0,1,magnesium:sodium antiporter activity,MF,
15262,GO:0061769,1,0.989807596705769,0,2,ribosylnicotinate kinase activity,MF,
15263,GO:0061770,1,0.995864341580592,0,1,translation elongation factor binding,MF,
15264,GO:0061771,1,0.982841820657148,0,3,response to caloric restriction,BP,
15265,GO:0061772,1,0.99363047551008,0,1,xenobiotic transport across blood-nerve barrier,BP,
15266,GO:0061778,1,0.894961901020962,0,16,intracellular chloride channel activity,MF,
15267,GO:0061780,1,0.981211530031672,0,1,mitotic cohesin loading,BP,
15268,GO:0061782,1,0.992232362160368,0,1,vesicle fusion with vesicle,BP,
15269,GO:0061783,1,0.990181826816046,0,3,peptidoglycan muralytic activity,MF,
15270,GO:0061789,1,0.954749569117823,0,3,dense core granule priming,BP,
15271,GO:0061792,1,0.965508831241578,0,4,secretory granule maturation,BP,
15272,GO:0061795,1,0.987193291725031,0,2,Golgi lumen acidification,BP,
15273,GO:0061798,1,0.992086867989554,0,1,GTP 3',8'-cyclase activity,MF,
15274,GO:0061799,1,0.992086867989554,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15275,GO:0061809,1,0.898281725630931,0,16,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15276,GO:0061811,1,0.996560523616724,0,1,ADP-ribosyl cyclase activity,MF,
15277,GO:0061812,1,0.996560523616724,0,1,cyclic ADP-ribose hydrolase,MF,
15278,GO:0061817,1,0.962477319663345,0,5,endoplasmic reticulum-plasma membrane tethering,BP,
15279,GO:0061819,1,0.977032388095396,0,3,telomeric DNA-containing double minutes formation,BP,
15280,GO:0061820,1,0.945600307405262,0,8,telomeric D-loop disassembly,BP,
15281,GO:0061821,1,0.965710498291238,0,4,telomeric D-loop binding,MF,
15282,GO:0061825,1,0.992571212673009,0,1,podosome core,CC,
15283,GO:0061827,1,0.946423534909789,0,10,sperm head,CC,
15284,GO:0061828,1,0.985513268266278,0,1,apical tubulobulbar complex,CC,
15285,GO:0061829,1,0.985513268266278,0,1,basal tubulobulbar complex,CC,
15286,GO:0061830,1,0.988089497073372,0,1,concave side of sperm head,CC,
15287,GO:0061831,1,0.984466785592737,0,1,apical ectoplasmic specialization,CC,
15288,GO:0061832,1,0.985194360814209,0,1,basal ectoplasmic specialization,CC,
15289,GO:0061833,1,0.98753949512559,0,2,protein localization to tricellular tight junction,BP,
15290,GO:0061837,1,0.989141618017359,0,1,neuropeptide processing,BP,
15291,GO:0061842,1,0.762924530922725,0,29,microtubule organizing center localization,BP,
15293,GO:0061845,1,0.993958925135842,0,1,neuron projection branch point,CC,
15294,GO:0061846,1,0.993958925135842,0,1,dendritic spine cytoplasm,CC,
15295,GO:0061847,1,0.989062253176807,0,2,response to cholecystokinin,BP,
15296,GO:0061849,1,0.98036527879578,0,2,telomeric G-quadruplex DNA binding,MF,
15297,GO:0061850,1,0.996829239940352,0,1,growth cone leading edge,CC,
15299,GO:0061857,1,0.987619562480419,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15300,GO:0061860,1,0.978767682198785,0,2,DNA clamp unloader activity,MF,
15301,GO:0061863,1,0.987330967903838,0,1,microtubule plus end polymerase,MF,
15302,GO:0061868,1,0.984319854080239,0,1,hepatic stellate cell migration,BP,
15303,GO:0061869,1,0.984319854080239,0,1,regulation of hepatic stellate cell migration,BP,
15304,GO:0061870,1,0.984319854080239,0,1,positive regulation of hepatic stellate cell migration,BP,
15305,GO:0061880,1,0.996386311008585,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15306,GO:0061881,1,0.996386311008585,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15307,GO:0061884,1,0.989516594943618,0,2,regulation of mini excitatory postsynaptic potential,BP,
15308,GO:0061885,1,0.989516594943618,0,2,positive regulation of mini excitatory postsynaptic potential,BP,
15309,GO:0061888,1,0.968298457334118,0,4,regulation of astrocyte activation,BP,
15310,GO:0061889,1,0.984837168473065,0,2,negative regulation of astrocyte activation,BP,
15311,GO:0061890,1,0.986436425482201,0,1,positive regulation of astrocyte activation,BP,
15313,GO:0061896,1,0.991035029209758,0,1,all-trans retinol 3,4-desaturase activity,MF,
15314,GO:0061897,1,0.991035029209758,0,1,all-trans retinal 3,4-desaturase activity,MF,
15315,GO:0061898,1,0.991035029209758,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15316,GO:0061899,1,0.991035029209758,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15317,GO:0061900,1,0.699675348113296,0,50,glial cell activation,BP,
15318,GO:0061901,1,0.987678377580784,0,2,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15319,GO:0061903,1,0.987678377580784,0,2,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15320,GO:0061909,1,0.988623226562702,0,2,autophagosome-lysosome fusion,BP,
15321,GO:0061912,1,0.639380747287347,0,56,selective autophagy,BP,
15322,GO:0061919,1,0.0307315723382426,0,500,process utilizing autophagic mechanism,BP,
15323,GO:0061920,1,0.98352665937302,0,1,protein propionyltransferase activity,MF,
15324,GO:0061921,1,0.98352665937302,0,1,peptidyl-lysine propionylation,BP,
15325,GO:0061928,1,0.993252074162401,0,2,glutathione specific gamma-glutamylcyclotransferase activity,MF,
15326,GO:0061929,1,0.994890876864838,0,1,gamma-glutamylaminecyclotransferase activity,MF,
15327,GO:0061930,1,0.990125428856343,0,1,regulation of erythrocyte enucleation,BP,
15328,GO:0061931,1,0.990125428856343,0,1,positive regulation of erythrocyte enucleation,BP,
15329,GO:0061944,1,0.991735469479479,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15330,GO:0061945,1,0.981370519439353,0,3,regulation of protein K48-linked ubiquitination,BP,
15331,GO:0061951,1,0.679088212798061,0,53,establishment of protein localization to plasma membrane,BP,
15332,GO:0061952,1,0.920052324217753,0,17,midbody abscission,BP,
15333,GO:0061953,1,0.985205192176506,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15334,GO:0061966,1,0.986574517889606,0,2,establishment of left/right asymmetry,BP,
15335,GO:0061975,1,0.98383565017822,0,3,articular cartilage development,BP,
15336,GO:0061980,1,0.760333573717768,0,36,regulatory RNA binding,MF,
15337,GO:0061981,1,0.996558105895603,0,1,3-hydroxykynureninase activity,MF,
15338,GO:0061982,1,0.53063097087841,0,98,meiosis I cell cycle process,BP,
15339,GO:0061983,1,0.949047093484934,0,10,meiosis II cell cycle process,BP,
15340,GO:0061986,1,0.995491880296837,0,1,negative regulation of transcription by glucose,BP,
15341,GO:0061987,1,0.995491880296837,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15342,GO:0061999,1,0.99519155834605,0,1,regulation of cardiac endothelial to mesenchymal transition,BP,
15343,GO:0062000,1,0.99519155834605,0,1,positive regulation of cardiac endothelial to mesenchymal transition,BP,
15344,GO:0062002,1,0.994547167313796,0,1,regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15345,GO:0062003,1,0.994547167313796,0,1,negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,BP,
15346,GO:0062009,1,0.808576428802945,0,22,secondary palate development,BP,
15349,GO:0062014,1,0.569449688812082,0,85,negative regulation of small molecule metabolic process,BP,
15351,GO:0062025,1,0.990925684034068,0,1,regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
15352,GO:0062026,1,0.990925684034068,0,1,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process,BP,
15353,GO:0062028,1,0.956641840105841,0,5,regulation of stress granule assembly,BP,
15354,GO:0062029,1,0.986612508788482,0,2,positive regulation of stress granule assembly,BP,
15355,GO:0062030,1,0.996602760654371,0,1,negative regulation of stress granule assembly,BP,
15356,GO:0062033,1,0.858595289926534,0,19,positive regulation of mitotic sister chromatid segregation,BP,
15357,GO:0062035,1,0.991031082529829,0,1,sensory perception of cold stimulus,BP,
15358,GO:0062036,1,0.991687057200767,0,1,sensory perception of hot stimulus,BP,
15359,GO:0062037,1,0.965710498291238,0,4,D-loop DNA binding,MF,
15360,GO:0062042,1,0.924038750741053,0,9,regulation of cardiac epithelial to mesenchymal transition,BP,
15361,GO:0062043,1,0.927566955321001,0,8,positive regulation of cardiac epithelial to mesenchymal transition,BP,
15362,GO:0062044,1,0.986280338667815,0,2,negative regulation of cardiac epithelial to mesenchymal transition,BP,
15363,GO:0062050,1,0.994820299748514,0,1,GPI-mannose ethanolamine phosphate phosphodiesterase activity,MF,
15364,GO:0062061,1,0.989987928065217,0,2,TAP complex binding,MF,
15365,GO:0062064,1,0.992540089353925,0,1,box C/D snoRNP complex binding,MF,
15366,GO:0062065,1,0.992540089353925,0,1,box H/ACA snoRNP complex binding,MF,
15367,GO:0062069,1,0.993219040230662,0,1,GARP complex binding,MF,
15368,GO:0062072,1,0.995490313344996,0,1,H3K9me3 modified histone binding,MF,
15369,GO:0062094,1,0.981745733880914,0,3,stomach development,BP,
15370,GO:0062098,1,0.891621516291486,0,18,regulation of programmed necrotic cell death,BP,
15371,GO:0062099,1,0.920752706730665,0,14,negative regulation of programmed necrotic cell death,BP,
15372,GO:0062100,1,0.984760665358846,0,3,positive regulation of programmed necrotic cell death,BP,
15373,GO:0062105,1,0.979369218819932,0,4,RNA 2'-O-methyltransferase activity,MF,
15374,GO:0062111,1,0.992156259067701,0,2,zinc ion import into organelle,BP,
15375,GO:0062125,1,0.862797265553384,0,28,regulation of mitochondrial gene expression,BP,
15376,GO:0062149,1,0.856768124999373,0,22,detection of stimulus involved in sensory perception of pain,BP,
15380,GO:0062232,1,0.986312589793267,0,3,prostanoid catabolic process,BP,
15382,GO:0065001,1,0.969971153881253,0,4,specification of axis polarity,BP,
15383,GO:0065002,1,0.75673675463446,0,49,intracellular protein transmembrane transport,BP,
15385,GO:0065004,1,0.366654978602654,0,157,protein-DNA complex assembly,BP,
15390,GO:0065010,1,0.97804195965947,0,5,extracellular membrane-bounded organelle,CC,
15391,GO:0070001,1,0.907594126923346,0,18,aspartic-type peptidase activity,MF,
15392,GO:0070003,1,0.914696732797209,0,23,threonine-type peptidase activity,MF,
15393,GO:0070004,1,0.981848702224069,0,3,cysteine-type exopeptidase activity,MF,
15394,GO:0070006,1,0.861500858247049,0,22,metalloaminopeptidase activity,MF,
15395,GO:0070008,1,0.944275007444104,0,9,serine-type exopeptidase activity,MF,
15396,GO:0070009,1,0.978223561970497,0,3,serine-type aminopeptidase activity,MF,
15397,GO:0070012,1,0.979530364124413,0,3,oligopeptidase activity,MF,
15399,GO:0070016,1,0.923322983188155,0,10,armadillo repeat domain binding,MF,
15400,GO:0070025,1,0.995183075943713,0,1,carbon monoxide binding,MF,
15401,GO:0070026,1,0.988579491495908,0,3,nitric oxide binding,MF,
15404,GO:0070034,1,0.848993604613902,0,21,telomerase RNA binding,MF,
15405,GO:0070037,1,0.996780540849773,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15406,GO:0070042,1,0.994392319507845,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15407,GO:0070044,1,0.980860797411557,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15409,GO:0070051,1,0.961214002507343,0,5,fibrinogen binding,MF,
15410,GO:0070052,1,0.983088488146448,0,2,collagen V binding,MF,
15411,GO:0070053,1,0.981070089911505,0,3,thrombospondin receptor activity,MF,
15412,GO:0070054,1,0.99237862664342,0,1,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15413,GO:0070059,1,0.707818682227621,0,57,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
15414,GO:0070060,1,0.982931327012999,0,1,'de novo' actin filament nucleation,BP,
15415,GO:0070061,1,0.976015118723771,0,5,fructose binding,MF,
15417,GO:0070063,1,0.655641198600519,0,61,RNA polymerase binding,MF,
15418,GO:0070064,1,0.863744031513891,0,17,proline-rich region binding,MF,
15419,GO:0070069,1,0.907085175650477,0,24,cytochrome complex,CC,
15420,GO:0070070,1,0.972173727846015,0,5,proton-transporting V-type ATPase complex assembly,BP,
15421,GO:0070071,1,0.954010437799041,0,9,proton-transporting two-sector ATPase complex assembly,BP,
15422,GO:0070072,1,0.972173727846015,0,5,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15423,GO:0070075,1,0.996876452058736,0,1,tear secretion,BP,
15424,GO:0070076,1,0.769888431780872,0,26,histone lysine demethylation,BP,
15425,GO:0070077,1,0.993207627082606,0,1,histone arginine demethylation,BP,
15426,GO:0070078,1,0.993207627082606,0,1,histone H3-R2 demethylation,BP,
15427,GO:0070079,1,0.993207627082606,0,1,histone H4-R3 demethylation,BP,
15428,GO:0070080,1,0.988157319571096,0,2,titin Z domain binding,MF,
15431,GO:0070084,1,0.983308645386107,0,3,protein initiator methionine removal,BP,
15433,GO:0070086,1,0.968657896574337,0,5,ubiquitin-dependent endocytosis,BP,
15434,GO:0070087,1,0.934886404195478,0,6,chromo shadow domain binding,MF,
15435,GO:0070089,1,0.988653651459374,0,1,chloride-activated potassium channel activity,MF,
15436,GO:0070091,1,0.954215524118801,0,9,glucagon secretion,BP,
15437,GO:0070092,1,0.954215524118801,0,9,regulation of glucagon secretion,BP,
15438,GO:0070093,1,0.983881626402323,0,4,negative regulation of glucagon secretion,BP,
15439,GO:0070094,1,0.990128624107747,0,2,positive regulation of glucagon secretion,BP,
15440,GO:0070095,1,0.975690625558426,0,5,fructose-6-phosphate binding,MF,
15441,GO:0070096,1,0.993701962387395,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15443,GO:0070098,1,0.694566066322042,0,72,chemokine-mediated signaling pathway,BP,
15444,GO:0070099,1,0.931238727205443,0,9,regulation of chemokine-mediated signaling pathway,BP,
15445,GO:0070100,1,0.945228611626272,0,6,negative regulation of chemokine-mediated signaling pathway,BP,
15446,GO:0070101,1,0.985207743339806,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15448,GO:0070103,1,0.980835508126395,0,4,regulation of interleukin-6-mediated signaling pathway,BP,
15449,GO:0070104,1,0.996384495317719,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15450,GO:0070105,1,0.984395154092762,0,3,positive regulation of interleukin-6-mediated signaling pathway,BP,
15451,GO:0070106,1,0.926696653515482,0,11,interleukin-27-mediated signaling pathway,BP,
15452,GO:0070110,1,0.982410257387871,0,3,ciliary neurotrophic factor receptor complex,CC,
15453,GO:0070119,1,0.992149275397141,0,1,ciliary neurotrophic factor binding,MF,
15454,GO:0070120,1,0.960229539626141,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15455,GO:0070121,1,0.98936724836986,0,1,Kupffer's vesicle development,BP,
15456,GO:0070122,1,0.915775695530688,0,17,isopeptidase activity,MF,
15457,GO:0070123,1,0.987732642165546,0,1,transforming growth factor beta receptor activity, type III,MF,
15458,GO:0070124,1,0.991724196716677,0,2,mitochondrial translational initiation,BP,
15459,GO:0070125,1,0.721885507509521,0,85,mitochondrial translational elongation,BP,
15460,GO:0070126,1,0.717448176260328,0,86,mitochondrial translational termination,BP,
15461,GO:0070127,1,0.960019815620901,0,7,tRNA aminoacylation for mitochondrial protein translation,BP,
15462,GO:0070129,1,0.880164497858037,0,25,regulation of mitochondrial translation,BP,
15463,GO:0070130,1,0.994890876864838,0,1,negative regulation of mitochondrial translation,BP,
15464,GO:0070131,1,0.922005670661262,0,16,positive regulation of mitochondrial translation,BP,
15465,GO:0070137,1,0.972347133564713,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15466,GO:0070138,1,0.97777674908159,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15467,GO:0070139,1,0.972347133564713,0,3,SUMO-specific endopeptidase activity,MF,
15468,GO:0070140,1,0.97777674908159,0,3,SUMO-specific isopeptidase activity,MF,
15469,GO:0070141,1,0.96265714682686,0,6,response to UV-A,BP,
15471,GO:0070143,1,0.990816695850038,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15472,GO:0070145,1,0.993748794652577,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15473,GO:0070158,1,0.995977413276461,0,1,mitochondrial seryl-tRNA aminoacylation,BP,
15474,GO:0070159,1,0.995536995734659,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15475,GO:0070160,1,0.391409577935967,0,116,tight junction,CC,
15477,GO:0070162,1,0.956885215531147,0,6,adiponectin secretion,BP,
15478,GO:0070163,1,0.956885215531147,0,6,regulation of adiponectin secretion,BP,
15479,GO:0070164,1,0.968460807984787,0,4,negative regulation of adiponectin secretion,BP,
15480,GO:0070165,1,0.988051239085927,0,2,positive regulation of adiponectin secretion,BP,
15481,GO:0070166,1,0.913180256171535,0,11,enamel mineralization,BP,
15483,GO:0070168,1,0.84908894837649,0,22,negative regulation of biomineral tissue development,BP,
15485,GO:0070170,1,0.968940929299399,0,5,regulation of tooth mineralization,BP,
15486,GO:0070171,1,0.983290252060802,0,2,negative regulation of tooth mineralization,BP,
15487,GO:0070172,1,0.990279298600549,0,2,positive regulation of tooth mineralization,BP,
15488,GO:0070173,1,0.995082647675306,0,1,regulation of enamel mineralization,BP,
15489,GO:0070176,1,0.996293289035841,0,1,DRM complex,CC,
15490,GO:0070178,1,0.991873976511744,0,2,D-serine metabolic process,BP,
15491,GO:0070179,1,0.995385273459009,0,1,D-serine biosynthetic process,BP,
15492,GO:0070180,1,0.98700796984807,0,4,large ribosomal subunit rRNA binding,MF,
15493,GO:0070181,1,0.957378740250531,0,10,small ribosomal subunit rRNA binding,MF,
15494,GO:0070182,1,0.892353575740369,0,18,DNA polymerase binding,MF,
15495,GO:0070183,1,0.994799330390074,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15496,GO:0070184,1,0.995864341580592,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15497,GO:0070187,1,0.969811850873491,0,6,shelterin complex,CC,
15498,GO:0070189,1,0.96340804943917,0,8,kynurenine metabolic process,BP,
15499,GO:0070191,1,0.994890876864838,0,1,methionine-R-sulfoxide reductase activity,MF,
15500,GO:0070192,1,0.682459174938236,0,55,chromosome organization involved in meiotic cell cycle,BP,
15501,GO:0070193,1,0.897583319063305,0,19,synaptonemal complex organization,BP,
15502,GO:0070194,1,0.990766472321774,0,2,synaptonemal complex disassembly,BP,
15503,GO:0070195,1,0.991681011276179,0,1,growth hormone receptor complex,CC,
15504,GO:0070197,1,0.989288046336387,0,2,meiotic attachment of telomere to nuclear envelope,BP,
15505,GO:0070198,1,0.795000473894588,0,29,protein localization to chromosome, telomeric region,BP,
15506,GO:0070199,1,0.846403816940773,0,23,establishment of protein localization to chromosome,BP,
15507,GO:0070200,1,0.876651632393302,0,18,establishment of protein localization to telomere,BP,
15509,GO:0070202,1,0.946668750060577,0,12,regulation of establishment of protein localization to chromosome,BP,
15510,GO:0070203,1,0.9515326628617,0,11,regulation of establishment of protein localization to telomere,BP,
15511,GO:0070206,1,0.892694441893337,0,17,protein trimerization,BP,
15512,GO:0070207,1,0.905156562280856,0,15,protein homotrimerization,BP,
15513,GO:0070208,1,0.989546369902488,0,1,protein heterotrimerization,BP,
15514,GO:0070209,1,0.98365366162988,0,3,ASTRA complex,CC,
15515,GO:0070212,1,0.930787184962007,0,8,protein poly-ADP-ribosylation,BP,
15516,GO:0070213,1,0.916674871409441,0,11,protein auto-ADP-ribosylation,BP,
15517,GO:0070221,1,0.985576838220196,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15518,GO:0070227,1,0.678186754305618,0,66,lymphocyte apoptotic process,BP,
15519,GO:0070228,1,0.753595001317647,0,49,regulation of lymphocyte apoptotic process,BP,
15520,GO:0070229,1,0.84671991014129,0,27,negative regulation of lymphocyte apoptotic process,BP,
15521,GO:0070230,1,0.930215631480823,0,14,positive regulation of lymphocyte apoptotic process,BP,
15522,GO:0070231,1,0.779514820084163,0,44,T cell apoptotic process,BP,
15523,GO:0070232,1,0.849970230400722,0,29,regulation of T cell apoptotic process,BP,
15524,GO:0070233,1,0.901109569840209,0,17,negative regulation of T cell apoptotic process,BP,
15525,GO:0070234,1,0.953952498878623,0,10,positive regulation of T cell apoptotic process,BP,
15526,GO:0070235,1,0.976523642909873,0,4,regulation of activation-induced cell death of T cells,BP,
15527,GO:0070236,1,0.980291060776751,0,3,negative regulation of activation-induced cell death of T cells,BP,
15528,GO:0070238,1,0.996413039573279,0,1,activated T cell autonomous cell death,BP,
15529,GO:0070239,1,0.996413039573279,0,1,regulation of activated T cell autonomous cell death,BP,
15530,GO:0070241,1,0.996413039573279,0,1,positive regulation of activated T cell autonomous cell death,BP,
15531,GO:0070242,1,0.89465876878138,0,17,thymocyte apoptotic process,BP,
15532,GO:0070243,1,0.928829623928804,0,12,regulation of thymocyte apoptotic process,BP,
15533,GO:0070244,1,0.956349086952222,0,7,negative regulation of thymocyte apoptotic process,BP,
15534,GO:0070245,1,0.971237119577434,0,5,positive regulation of thymocyte apoptotic process,BP,
15535,GO:0070246,1,0.996673884992553,0,1,natural killer cell apoptotic process,BP,
15536,GO:0070247,1,0.996673884992553,0,1,regulation of natural killer cell apoptotic process,BP,
15537,GO:0070251,1,0.995641746303212,0,1,pristanate-CoA ligase activity,MF,
15539,GO:0070253,1,0.98283055967771,0,4,somatostatin secretion,BP,
15540,GO:0070254,1,0.947528470755383,0,10,mucus secretion,BP,
15541,GO:0070255,1,0.950514928005397,0,9,regulation of mucus secretion,BP,
15542,GO:0070256,1,0.99130101879712,0,2,negative regulation of mucus secretion,BP,
15543,GO:0070257,1,0.96363421942203,0,6,positive regulation of mucus secretion,BP,
15544,GO:0070259,1,0.988087415263817,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15545,GO:0070260,1,0.994890876864838,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15547,GO:0070265,1,0.755111944456725,0,49,necrotic cell death,BP,
15548,GO:0070266,1,0.805112854740231,0,36,necroptotic process,BP,
15549,GO:0070267,1,0.993280208098265,0,1,oncosis,BP,
15550,GO:0070268,1,0.680005401753607,0,63,cornification,BP,
15551,GO:0070269,1,0.946677408921186,0,10,pyroptosis,BP,
15552,GO:0070273,1,0.801513969478699,0,26,phosphatidylinositol-4-phosphate binding,MF,
15553,GO:0070274,1,0.996059496082398,0,1,RES complex,CC,
15554,GO:0070278,1,0.938308980213958,0,10,extracellular matrix constituent secretion,BP,
15556,GO:0070280,1,0.992783258733263,0,1,pyridoxal binding,MF,
15557,GO:0070286,1,0.787116344606804,0,26,axonemal dynein complex assembly,BP,
15558,GO:0070287,1,0.993193097521698,0,1,ferritin receptor activity,MF,
15559,GO:0070288,1,0.993552252054026,0,2,ferritin complex,CC,
15560,GO:0070290,1,0.973097531481778,0,3,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15561,GO:0070291,1,0.97420968326482,0,5,N-acylethanolamine metabolic process,BP,
15562,GO:0070292,1,0.985407909657128,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15563,GO:0070293,1,0.913784254422672,0,16,renal absorption,BP,
15564,GO:0070294,1,0.970622897991547,0,4,renal sodium ion absorption,BP,
15565,GO:0070295,1,0.986052637512671,0,3,renal water absorption,BP,
15566,GO:0070296,1,0.728320686923799,0,35,sarcoplasmic reticulum calcium ion transport,BP,
15567,GO:0070300,1,0.866761471738036,0,19,phosphatidic acid binding,MF,
15569,GO:0070302,1,0.214064389702235,0,214,regulation of stress-activated protein kinase signaling cascade,BP,
15570,GO:0070303,1,0.742149255286757,0,42,negative regulation of stress-activated protein kinase signaling cascade,BP,
15571,GO:0070304,1,0.331028939319497,0,155,positive regulation of stress-activated protein kinase signaling cascade,BP,
15572,GO:0070305,1,0.943708751557249,0,6,response to cGMP,BP,
15575,GO:0070309,1,0.962872113190545,0,5,lens fiber cell morphogenesis,BP,
15576,GO:0070314,1,0.949394285830995,0,7,G1 to G0 transition,BP,
15577,GO:0070315,1,0.988134487751616,0,2,G1 to G0 transition involved in cell differentiation,BP,
15579,GO:0070317,1,0.752648735209828,0,37,negative regulation of G0 to G1 transition,BP,
15580,GO:0070318,1,0.976276415790953,0,3,positive regulation of G0 to G1 transition,BP,
15581,GO:0070319,1,0.978316638066906,0,2,Golgi to plasma membrane transport vesicle,CC,
15582,GO:0070320,1,0.995063524952923,0,1,inward rectifier potassium channel inhibitor activity,MF,
15583,GO:0070324,1,0.960326992997881,0,7,thyroid hormone binding,MF,
15585,GO:0070326,1,0.96556029376542,0,4,very-low-density lipoprotein particle receptor binding,MF,
15586,GO:0070327,1,0.944600899963174,0,9,thyroid hormone transport,BP,
15587,GO:0070328,1,0.856181758068804,0,27,triglyceride homeostasis,BP,
15588,GO:0070330,1,0.9316071727335,0,14,aromatase activity,MF,
15589,GO:0070335,1,0.986421967847451,0,1,aspartate binding,MF,
15590,GO:0070336,1,0.977959767704971,0,3,flap-structured DNA binding,MF,
15591,GO:0070337,1,0.988947858589799,0,1,3'-flap-structured DNA binding,MF,
15592,GO:0070339,1,0.966400698461763,0,6,response to bacterial lipopeptide,BP,
15593,GO:0070340,1,0.977338315228321,0,3,detection of bacterial lipopeptide,BP,
15594,GO:0070341,1,0.944044211571692,0,9,fat cell proliferation,BP,
15595,GO:0070343,1,0.985438836988138,0,3,white fat cell proliferation,BP,
15596,GO:0070344,1,0.944044211571692,0,9,regulation of fat cell proliferation,BP,
15597,GO:0070345,1,0.962826342020973,0,5,negative regulation of fat cell proliferation,BP,
15598,GO:0070346,1,0.988587222171752,0,3,positive regulation of fat cell proliferation,BP,
15599,GO:0070350,1,0.985438836988138,0,3,regulation of white fat cell proliferation,BP,
15600,GO:0070352,1,0.993566351198127,0,2,positive regulation of white fat cell proliferation,BP,
15601,GO:0070358,1,0.934342385886947,0,7,actin polymerization-dependent cell motility,BP,
15603,GO:0070366,1,0.992777309046754,0,2,regulation of hepatocyte differentiation,BP,
15604,GO:0070367,1,0.996024900348642,0,1,negative regulation of hepatocyte differentiation,BP,
15605,GO:0070368,1,0.996739578012618,0,1,positive regulation of hepatocyte differentiation,BP,
15606,GO:0070369,1,0.970633687713592,0,3,beta-catenin-TCF7L2 complex,CC,
15607,GO:0070370,1,0.980054899060106,0,5,cellular heat acclimation,BP,
15612,GO:0070375,1,0.985138432584076,0,2,ERK5 cascade,BP,
15613,GO:0070381,1,0.986543515408691,0,2,endosome to plasma membrane transport vesicle,CC,
15615,GO:0070383,1,0.962337800130734,0,9,DNA cytosine deamination,BP,
15616,GO:0070384,1,0.977869835843392,0,4,Harderian gland development,BP,
15617,GO:0070390,1,0.975322826997281,0,5,transcription export complex 2,CC,
15618,GO:0070391,1,0.948080910643284,0,10,response to lipoteichoic acid,BP,
15619,GO:0070392,1,0.996780194014668,0,1,detection of lipoteichoic acid,BP,
15620,GO:0070401,1,0.987971917763199,0,3,NADP+ binding,MF,
15621,GO:0070402,1,0.914156089428934,0,15,NADPH binding,MF,
15622,GO:0070403,1,0.935515168998045,0,14,NAD+ binding,MF,
15623,GO:0070404,1,0.98893624474923,0,3,NADH binding,MF,
15624,GO:0070407,1,0.99422299082915,0,1,oxidation-dependent protein catabolic process,BP,
15625,GO:0070408,1,0.988987312397286,0,1,carbamoyl phosphate metabolic process,BP,
15626,GO:0070409,1,0.988987312397286,0,1,carbamoyl phosphate biosynthetic process,BP,
15627,GO:0070410,1,0.878633407257404,0,12,co-SMAD binding,MF,
15628,GO:0070411,1,0.872931310243451,0,14,I-SMAD binding,MF,
15629,GO:0070412,1,0.80779218737073,0,23,R-SMAD binding,MF,
15630,GO:0070413,1,0.994543378900449,0,1,trehalose metabolism in response to stress,BP,
15631,GO:0070417,1,0.932056562629678,0,9,cellular response to cold,BP,
15632,GO:0070418,1,0.98170432788853,0,2,DNA-dependent protein kinase complex,CC,
15633,GO:0070419,1,0.944173240995695,0,7,nonhomologous end joining complex,CC,
15634,GO:0070421,1,0.993679522910177,0,1,DNA ligase III-XRCC1 complex,CC,
15635,GO:0070423,1,0.79812243048635,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15636,GO:0070424,1,0.932999935455607,0,9,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15637,GO:0070425,1,0.986037914814085,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15638,GO:0070426,1,0.975553473463471,0,4,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15639,GO:0070427,1,0.968178563736363,0,5,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15640,GO:0070428,1,0.976264618688514,0,3,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15641,GO:0070429,1,0.99154430026958,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15642,GO:0070430,1,0.984591313048495,0,2,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15643,GO:0070431,1,0.932663539971791,0,12,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15644,GO:0070432,1,0.966422028906046,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15645,GO:0070433,1,0.986037914814085,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15646,GO:0070434,1,0.980109125670561,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15647,GO:0070435,1,0.989089279733783,0,2,Shc-EGFR complex,CC,
15648,GO:0070436,1,0.9857285331793,0,2,Grb2-EGFR complex,CC,
15649,GO:0070442,1,0.996626111234415,0,1,integrin alphaIIb-beta3 complex,CC,
15650,GO:0070444,1,0.927174306840913,0,8,oligodendrocyte progenitor proliferation,BP,
15651,GO:0070445,1,0.927174306840913,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15652,GO:0070446,1,0.996132256305386,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15653,GO:0070447,1,0.962978343999886,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15654,GO:0070453,1,0.99341672338389,0,2,regulation of heme biosynthetic process,BP,
15655,GO:0070458,1,0.985693890431422,0,3,cellular detoxification of nitrogen compound,BP,
15657,GO:0070460,1,0.979166449654751,0,3,thyroid-stimulating hormone secretion,BP,
15658,GO:0070461,1,0.848547923168205,0,23,SAGA-type complex,CC,
15659,GO:0070462,1,0.99313701909526,0,1,plus-end specific microtubule depolymerization,BP,
15660,GO:0070463,1,0.993513540737981,0,1,tubulin-dependent ATPase activity,MF,
15661,GO:0070469,1,0.738716388112499,0,78,respirasome,CC,
15662,GO:0070471,1,0.951227554821306,0,9,uterine smooth muscle contraction,BP,
15663,GO:0070472,1,0.95579645204524,0,8,regulation of uterine smooth muscle contraction,BP,
15664,GO:0070473,1,0.996126428951869,0,1,negative regulation of uterine smooth muscle contraction,BP,
15665,GO:0070474,1,0.969362101966651,0,5,positive regulation of uterine smooth muscle contraction,BP,
15666,GO:0070475,1,0.968803287023418,0,7,rRNA base methylation,BP,
15667,GO:0070476,1,0.996881943200488,0,1,rRNA (guanine-N7)-methylation,BP,
15668,GO:0070478,1,0.99202765888348,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15669,GO:0070481,1,0.994620669389328,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15671,GO:0070483,1,0.994100614828953,0,1,detection of hypoxia,BP,
15672,GO:0070486,1,0.911805263864605,0,14,leukocyte aggregation,BP,
15673,GO:0070487,1,0.953801695871744,0,6,monocyte aggregation,BP,
15674,GO:0070488,1,0.993787090648107,0,2,neutrophil aggregation,BP,
15675,GO:0070489,1,0.988637387448581,0,2,T cell aggregation,BP,
15676,GO:0070491,1,0.61390332987504,0,71,repressing transcription factor binding,MF,
15677,GO:0070492,1,0.94987653522815,0,11,oligosaccharide binding,MF,
15678,GO:0070493,1,0.921910394659586,0,12,thrombin-activated receptor signaling pathway,BP,
15679,GO:0070494,1,0.978029630740489,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15680,GO:0070495,1,0.978029630740489,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15681,GO:0070498,1,0.594401521157869,0,96,interleukin-1-mediated signaling pathway,BP,
15682,GO:0070506,1,0.990149354355952,0,2,high-density lipoprotein particle receptor activity,MF,
15683,GO:0070507,1,0.229366556643265,0,182,regulation of microtubule cytoskeleton organization,BP,
15684,GO:0070508,1,0.940190013903315,0,8,cholesterol import,BP,
15686,GO:0070510,1,0.986451790308788,0,1,regulation of histone H4-K20 methylation,BP,
15687,GO:0070512,1,0.986451790308788,0,1,positive regulation of histone H4-K20 methylation,BP,
15688,GO:0070513,1,0.953580052182838,0,10,death domain binding,MF,
15689,GO:0070516,1,0.985724166030374,0,4,CAK-ERCC2 complex,CC,
15690,GO:0070522,1,0.972039451843466,0,4,ERCC4-ERCC1 complex,CC,
15691,GO:0070524,1,0.996608093696893,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15692,GO:0070525,1,0.938293077886138,0,14,tRNA threonylcarbamoyladenosine metabolic process,BP,
15694,GO:0070528,1,0.830191208908734,0,29,protein kinase C signaling,BP,
15695,GO:0070530,1,0.884084580736431,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15696,GO:0070531,1,0.963724619200072,0,6,BRCA1-A complex,CC,
15697,GO:0070534,1,0.700953594742056,0,52,protein K63-linked ubiquitination,BP,
15698,GO:0070535,1,0.944561705174831,0,6,histone H2A K63-linked ubiquitination,BP,
15699,GO:0070536,1,0.805121736085942,0,27,protein K63-linked deubiquitination,BP,
15700,GO:0070537,1,0.984419550762618,0,3,histone H2A K63-linked deubiquitination,BP,
15701,GO:0070538,1,0.993376280742941,0,2,oleic acid binding,MF,
15702,GO:0070539,1,0.993429086110433,0,1,linoleic acid binding,MF,
15703,GO:0070541,1,0.977069498630888,0,3,response to platinum ion,BP,
15704,GO:0070542,1,0.563042424613179,0,83,response to fatty acid,BP,
15705,GO:0070543,1,0.995979337819346,0,1,response to linoleic acid,BP,
15706,GO:0070544,1,0.929236543132553,0,8,histone H3-K36 demethylation,BP,
15707,GO:0070545,1,0.991403731339053,0,2,PeBoW complex,CC,
15708,GO:0070547,1,0.994899864244307,0,1,L-tyrosine aminotransferase activity,MF,
15709,GO:0070548,1,0.978256346077414,0,2,L-glutamine aminotransferase activity,MF,
15710,GO:0070550,1,0.981211530031672,0,1,rDNA condensation,BP,
15711,GO:0070551,1,0.994890876864838,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15712,GO:0070552,1,0.985395544222759,0,3,BRISC complex,CC,
15713,GO:0070553,1,0.994890876864838,0,1,nicotinic acid receptor activity,MF,
15716,GO:0070557,1,0.992469556931937,0,2,PCNA-p21 complex,CC,
15717,GO:0070560,1,0.989651669701286,0,2,protein secretion by platelet,BP,
15718,GO:0070561,1,0.93648686346374,0,9,vitamin D receptor signaling pathway,BP,
15719,GO:0070562,1,0.95538739021101,0,6,regulation of vitamin D receptor signaling pathway,BP,
15720,GO:0070563,1,0.986247715532552,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15721,GO:0070564,1,0.991287018648073,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15722,GO:0070566,1,0.871663956722357,0,20,adenylyltransferase activity,MF,
15723,GO:0070567,1,0.95724072241329,0,8,cytidylyltransferase activity,MF,
15724,GO:0070568,1,0.978381262978212,0,4,guanylyltransferase activity,MF,
15725,GO:0070569,1,0.976878308836036,0,5,uridylyltransferase activity,MF,
15726,GO:0070570,1,0.80846974300652,0,28,regulation of neuron projection regeneration,BP,
15727,GO:0070571,1,0.896347768688108,0,14,negative regulation of neuron projection regeneration,BP,
15728,GO:0070572,1,0.940291011214251,0,9,positive regulation of neuron projection regeneration,BP,
15729,GO:0070573,1,0.964484352345007,0,7,metallodipeptidase activity,MF,
15730,GO:0070574,1,0.966308399255347,0,5,cadmium ion transmembrane transport,BP,
15731,GO:0070576,1,0.989322681126616,0,2,vitamin D 24-hydroxylase activity,MF,
15732,GO:0070577,1,0.816443376381081,0,21,lysine-acetylated histone binding,MF,
15733,GO:0070578,1,0.94235665577954,0,9,RISC-loading complex,CC,
15734,GO:0070579,1,0.940888742570058,0,4,methylcytosine dioxygenase activity,MF,
15735,GO:0070584,1,0.880197425969114,0,22,mitochondrion morphogenesis,BP,
15736,GO:0070585,1,0.466978993212983,0,134,protein localization to mitochondrion,BP,
15737,GO:0070586,1,0.941762347563547,0,10,cell-cell adhesion involved in gastrulation,BP,
15738,GO:0070587,1,0.946487804353606,0,9,regulation of cell-cell adhesion involved in gastrulation,BP,
15740,GO:0070589,1,0.996318235555698,0,1,cellular component macromolecule biosynthetic process,BP,
15741,GO:0070593,1,0.873710052719159,0,16,dendrite self-avoidance,BP,
15742,GO:0070601,1,0.943075119349331,0,10,centromeric sister chromatid cohesion,BP,
15743,GO:0070602,1,0.975457580354477,0,4,regulation of centromeric sister chromatid cohesion,BP,
15744,GO:0070603,1,0.569742597180474,0,72,SWI/SNF superfamily-type complex,CC,
15745,GO:0070611,1,0.99512324999916,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15746,GO:0070612,1,0.99512324999916,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15748,GO:0070615,1,0.978391396806137,0,2,nucleosome-dependent ATPase activity,MF,
15749,GO:0070618,1,0.995034702526241,0,1,Grb2-Sos complex,CC,
15750,GO:0070625,1,0.995967759500215,0,1,zymogen granule exocytosis,BP,
15751,GO:0070626,1,0.99656258692143,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15752,GO:0070628,1,0.887586499322175,0,16,proteasome binding,MF,
15753,GO:0070633,1,0.816725762064432,0,24,transepithelial transport,BP,
15754,GO:0070634,1,0.983089617584036,0,2,transepithelial ammonium transport,BP,
15755,GO:0070637,1,0.995490313344996,0,1,pyridine nucleoside metabolic process,BP,
15756,GO:0070638,1,0.995490313344996,0,1,pyridine nucleoside catabolic process,BP,
15757,GO:0070640,1,0.976880362636099,0,4,vitamin D3 metabolic process,BP,
15758,GO:0070643,1,0.986314651231775,0,3,vitamin D 25-hydroxylase activity,MF,
15759,GO:0070644,1,0.972508091257586,0,3,vitamin D response element binding,MF,
15760,GO:0070646,1,0.159588201263789,0,256,protein modification by small protein removal,BP,
15762,GO:0070649,1,0.971575321337541,0,3,formin-nucleated actin cable assembly,BP,
15763,GO:0070651,1,0.994620669389328,0,1,nonfunctional rRNA decay,BP,
15764,GO:0070652,1,0.948696140326443,0,8,HAUS complex,CC,
15765,GO:0070653,1,0.996826493587376,0,1,high-density lipoprotein particle receptor binding,MF,
15767,GO:0070662,1,0.963882664717168,0,5,mast cell proliferation,BP,
15769,GO:0070664,1,0.637796817545267,0,78,negative regulation of leukocyte proliferation,BP,
15771,GO:0070666,1,0.973552945372547,0,4,regulation of mast cell proliferation,BP,
15772,GO:0070667,1,0.983719274275112,0,3,negative regulation of mast cell proliferation,BP,
15773,GO:0070668,1,0.984062212621756,0,2,positive regulation of mast cell proliferation,BP,
15774,GO:0070669,1,0.911964348544878,0,13,response to interleukin-2,BP,
15775,GO:0070670,1,0.82831833890641,0,32,response to interleukin-4,BP,
15777,GO:0070672,1,0.898148737103953,0,14,response to interleukin-15,BP,
15778,GO:0070673,1,0.946262692586772,0,11,response to interleukin-18,BP,
15779,GO:0070676,1,0.988709996071259,0,3,intralumenal vesicle formation,BP,
15780,GO:0070678,1,0.995046950379576,0,1,preprotein binding,MF,
15781,GO:0070679,1,0.867270759187757,0,13,inositol 1,4,5 trisphosphate binding,MF,
15782,GO:0070681,1,0.984037995549562,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15783,GO:0070682,1,0.985897526059151,0,3,proteasome regulatory particle assembly,BP,
15784,GO:0070684,1,0.996748651567075,0,1,seminal clot liquefaction,BP,
15785,GO:0070685,1,0.995927971432791,0,1,macropinocytic cup,CC,
15786,GO:0070694,1,0.994890876864838,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15787,GO:0070695,1,0.948653013951544,0,5,FHF complex,CC,
15789,GO:0070697,1,0.957504751278722,0,8,activin receptor binding,MF,
15790,GO:0070698,1,0.986767135266931,0,3,type I activin receptor binding,MF,
15791,GO:0070699,1,0.977274645286922,0,3,type II activin receptor binding,MF,
15793,GO:0070704,1,0.986499910056994,0,2,sterol desaturase activity,MF,
15794,GO:0070715,1,0.993908675883443,0,1,sodium-dependent organic cation transport,BP,
15795,GO:0070716,1,0.995407818184713,0,1,mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication,BP,
15796,GO:0070717,1,0.80311579636681,0,29,poly-purine tract binding,MF,
15797,GO:0070723,1,0.801535065939618,0,25,response to cholesterol,BP,
15798,GO:0070724,1,0.980848504593658,0,3,BMP receptor complex,CC,
15800,GO:0070728,1,0.949758798919437,0,7,leucine binding,MF,
15801,GO:0070733,1,0.996432894868642,0,1,protein adenylyltransferase activity,MF,
15802,GO:0070734,1,0.882156650947764,0,15,histone H3-K27 methylation,BP,
15803,GO:0070735,1,0.993648882188745,0,1,protein-glycine ligase activity,MF,
15804,GO:0070736,1,0.993648882188745,0,1,protein-glycine ligase activity, initiating,MF,
15805,GO:0070739,1,0.952561602423304,0,8,protein-glutamic acid ligase activity,MF,
15806,GO:0070740,1,0.952561602423304,0,8,tubulin-glutamic acid ligase activity,MF,
15808,GO:0070742,1,0.897664937713097,0,14,C2H2 zinc finger domain binding,MF,
15809,GO:0070743,1,0.996783973181345,0,1,interleukin-23 complex,CC,
15810,GO:0070757,1,0.925614902774389,0,11,interleukin-35-mediated signaling pathway,BP,
15811,GO:0070761,1,0.970883685225079,0,5,pre-snoRNP complex,CC,
15812,GO:0070762,1,0.994890876864838,0,1,nuclear pore transmembrane ring,CC,
15813,GO:0070765,1,0.960746285282288,0,6,gamma-secretase complex,CC,
15814,GO:0070772,1,0.994252392499678,0,1,PAS complex,CC,
15815,GO:0070774,1,0.987205821378785,0,2,phytoceramidase activity,MF,
15816,GO:0070775,1,0.935817440822599,0,9,H3 histone acetyltransferase complex,CC,
15817,GO:0070776,1,0.940626151840788,0,8,MOZ/MORF histone acetyltransferase complex,CC,
15818,GO:0070777,1,0.957124465694699,0,4,D-aspartate transport,BP,
15819,GO:0070778,1,0.923517518586338,0,11,L-aspartate transmembrane transport,BP,
15820,GO:0070779,1,0.957124465694699,0,4,D-aspartate import across plasma membrane,BP,
15821,GO:0070781,1,0.98496860728841,0,2,response to biotin,BP,
15822,GO:0070782,1,0.97052913092578,0,5,phosphatidylserine exposure on apoptotic cell surface,BP,
15823,GO:0070813,1,0.970765587702308,0,5,hydrogen sulfide metabolic process,BP,
15824,GO:0070814,1,0.973875043044759,0,4,hydrogen sulfide biosynthetic process,BP,
15825,GO:0070815,1,0.974694185490972,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15826,GO:0070816,1,0.917038240793265,0,12,phosphorylation of RNA polymerase II C-terminal domain,BP,
15827,GO:0070818,1,0.99634585301425,0,1,protoporphyrinogen oxidase activity,MF,
15830,GO:0070822,1,0.887676771750074,0,15,Sin3-type complex,CC,
15831,GO:0070826,1,0.992068479353006,0,1,paraferritin complex,CC,
15832,GO:0070827,1,0.951478661343641,0,5,chromatin maintenance,BP,
15833,GO:0070828,1,0.672589963061478,0,47,heterochromatin organization,BP,
15834,GO:0070829,1,0.966828264507645,0,3,heterochromatin maintenance,BP,
15835,GO:0070830,1,0.645307044730374,0,64,bicellular tight junction assembly,BP,
15836,GO:0070831,1,0.865849654930976,0,15,basement membrane assembly,BP,
15837,GO:0070836,1,0.981808628747908,0,4,caveola assembly,BP,
15838,GO:0070837,1,0.961967509367872,0,7,dehydroascorbic acid transport,BP,
15841,GO:0070840,1,0.832193888401878,0,20,dynein complex binding,MF,
15842,GO:0070841,1,0.851784762126962,0,22,inclusion body assembly,BP,
15843,GO:0070842,1,0.969522532797202,0,5,aggresome assembly,BP,
15844,GO:0070843,1,0.992170792413051,0,1,misfolded protein transport,BP,
15845,GO:0070844,1,0.992170792413051,0,1,polyubiquitinated protein transport,BP,
15846,GO:0070845,1,0.992170792413051,0,1,polyubiquitinated misfolded protein transport,BP,
15847,GO:0070846,1,0.992170792413051,0,1,Hsp90 deacetylation,BP,
15848,GO:0070847,1,0.957419618838396,0,8,core mediator complex,CC,
15851,GO:0070851,1,0.461683993351908,0,116,growth factor receptor binding,MF,
15852,GO:0070852,1,0.940565456021157,0,7,cell body fiber,CC,
15853,GO:0070853,1,0.971804150792204,0,2,myosin VI binding,MF,
15854,GO:0070856,1,0.988370044877892,0,1,myosin VI light chain binding,MF,
15855,GO:0070857,1,0.954877554617389,0,9,regulation of bile acid biosynthetic process,BP,
15856,GO:0070858,1,0.989248004488137,0,2,negative regulation of bile acid biosynthetic process,BP,
15857,GO:0070859,1,0.985738899377876,0,3,positive regulation of bile acid biosynthetic process,BP,
15858,GO:0070860,1,0.995653649421474,0,1,RNA polymerase I core factor complex,CC,
15859,GO:0070861,1,0.808051551154017,0,27,regulation of protein exit from endoplasmic reticulum,BP,
15860,GO:0070862,1,0.942711413168422,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
15861,GO:0070863,1,0.886637839489951,0,14,positive regulation of protein exit from endoplasmic reticulum,BP,
15862,GO:0070868,1,0.951016254334607,0,4,heterochromatin organization involved in chromatin silencing,BP,
15863,GO:0070873,1,0.764444951013203,0,30,regulation of glycogen metabolic process,BP,
15864,GO:0070874,1,0.954348074956085,0,5,negative regulation of glycogen metabolic process,BP,
15865,GO:0070875,1,0.857413459556675,0,15,positive regulation of glycogen metabolic process,BP,
15866,GO:0070876,1,0.97627027328491,0,4,SOSS complex,CC,
15867,GO:0070877,1,0.986446034872115,0,2,microprocessor complex,CC,
15868,GO:0070878,1,0.945354135614787,0,8,primary miRNA binding,MF,
15869,GO:0070881,1,0.993418769293849,0,1,regulation of proline transport,BP,
15870,GO:0070883,1,0.954341958682152,0,6,pre-miRNA binding,MF,
15871,GO:0070884,1,0.781923051024352,0,31,regulation of calcineurin-NFAT signaling cascade,BP,
15872,GO:0070885,1,0.903470240470398,0,14,negative regulation of calcineurin-NFAT signaling cascade,BP,
15873,GO:0070886,1,0.901377955761248,0,13,positive regulation of calcineurin-NFAT signaling cascade,BP,
15875,GO:0070888,1,0.762651105966747,0,43,E-box binding,MF,
15876,GO:0070889,1,0.990715815085684,0,2,platelet alpha granule organization,BP,
15877,GO:0070890,1,0.982383295646187,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
15878,GO:0070891,1,0.983502497347031,0,4,lipoteichoic acid binding,MF,
15879,GO:0070892,1,0.995979337819346,0,1,lipoteichoic acid immune receptor activity,MF,
15880,GO:0070893,1,0.984568305500321,0,2,transposon integration,BP,
15881,GO:0070894,1,0.984568305500321,0,2,regulation of transposon integration,BP,
15882,GO:0070895,1,0.984568305500321,0,2,negative regulation of transposon integration,BP,
15883,GO:0070897,1,0.783562822609937,0,35,transcription preinitiation complex assembly,BP,
15884,GO:0070898,1,0.972992903336456,0,2,RNA polymerase III preinitiation complex assembly,BP,
15885,GO:0070899,1,0.994451918564084,0,1,mitochondrial tRNA wobble uridine modification,BP,
15886,GO:0070900,1,0.961294129337649,0,8,mitochondrial tRNA modification,BP,
15887,GO:0070901,1,0.978005105393553,0,4,mitochondrial tRNA methylation,BP,
15888,GO:0070902,1,0.996417402617632,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
15889,GO:0070904,1,0.982383295646187,0,2,transepithelial L-ascorbic acid transport,BP,
15890,GO:0070905,1,0.979265140174647,0,4,serine binding,MF,
15891,GO:0070911,1,0.846512413092985,0,26,global genome nucleotide-excision repair,BP,
15892,GO:0070914,1,0.924522481214431,0,12,UV-damage excision repair,BP,
15893,GO:0070915,1,0.97757723144964,0,5,lysophosphatidic acid receptor activity,MF,
15894,GO:0070918,1,0.698787658453035,0,49,production of small RNA involved in gene silencing by RNA,BP,
15895,GO:0070920,1,0.854678638033618,0,23,regulation of production of small RNA involved in gene silencing by RNA,BP,
15896,GO:0070922,1,0.934076344578662,0,9,small RNA loading onto RISC,BP,
15898,GO:0070926,1,0.992700036406464,0,1,regulation of ATP:ADP antiporter activity,BP,
15899,GO:0070931,1,0.989027731870161,0,1,Golgi-associated vesicle lumen,CC,
15900,GO:0070932,1,0.85647215690842,0,20,histone H3 deacetylation,BP,
15901,GO:0070933,1,0.918957976900329,0,11,histone H4 deacetylation,BP,
15902,GO:0070934,1,0.946774179372815,0,5,CRD-mediated mRNA stabilization,BP,
15903,GO:0070935,1,0.886983034227937,0,19,3'-UTR-mediated mRNA stabilization,BP,
15904,GO:0070936,1,0.69211064375724,0,54,protein K48-linked ubiquitination,BP,
15905,GO:0070937,1,0.93934406542871,0,6,CRD-mediated mRNA stability complex,CC,
15906,GO:0070938,1,0.91254098790755,0,10,contractile ring,CC,
15907,GO:0070939,1,0.975422166697204,0,3,Dsl1/NZR complex,CC,
15908,GO:0070940,1,0.968946140007299,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15909,GO:0070942,1,0.965921379473588,0,9,neutrophil mediated cytotoxicity,BP,
15910,GO:0070943,1,0.974837261068322,0,7,neutrophil-mediated killing of symbiont cell,BP,
15911,GO:0070944,1,0.978180674152952,0,6,neutrophil-mediated killing of bacterium,BP,
15912,GO:0070945,1,0.984430976865219,0,4,neutrophil-mediated killing of gram-negative bacterium,BP,
15913,GO:0070946,1,0.996819463064123,0,1,neutrophil-mediated killing of gram-positive bacterium,BP,
15914,GO:0070947,1,0.993413254992495,0,2,neutrophil-mediated killing of fungus,BP,
15915,GO:0070948,1,0.978714556645365,0,5,regulation of neutrophil mediated cytotoxicity,BP,
15916,GO:0070949,1,0.987747325568449,0,3,regulation of neutrophil mediated killing of symbiont cell,BP,
15917,GO:0070950,1,0.99113456735689,0,2,regulation of neutrophil mediated killing of bacterium,BP,
15918,GO:0070951,1,0.99113456735689,0,2,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15919,GO:0070953,1,0.99658276537757,0,1,regulation of neutrophil mediated killing of fungus,BP,
15920,GO:0070960,1,0.991290457998339,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15921,GO:0070961,1,0.991290457998339,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
15922,GO:0070962,1,0.994689727507315,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15923,GO:0070963,1,0.994689727507315,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15924,GO:0070965,1,0.99658276537757,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
15925,GO:0070966,1,0.969786546667369,0,4,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15926,GO:0070971,1,0.800326310130616,0,24,endoplasmic reticulum exit site,CC,
15927,GO:0070972,1,0.500051187806415,0,138,protein localization to endoplasmic reticulum,BP,
15928,GO:0070973,1,0.91857777826309,0,7,protein localization to endoplasmic reticulum exit site,BP,
15929,GO:0070974,1,0.994379772030534,0,1,POU domain binding,MF,
15930,GO:0070975,1,0.986005914656946,0,1,FHA domain binding,MF,
15931,GO:0070976,1,0.994994252787323,0,1,TIR domain binding,MF,
15933,GO:0070979,1,0.874833220078692,0,27,protein K11-linked ubiquitination,BP,
15934,GO:0070981,1,0.995622295217376,0,1,L-asparagine biosynthetic process,BP,
15935,GO:0070982,1,0.992010146088681,0,2,L-asparagine metabolic process,BP,
15936,GO:0070984,1,0.992074607554835,0,1,SET domain binding,MF,
15937,GO:0070985,1,0.989823552505352,0,3,transcription factor TFIIK complex,CC,
15938,GO:0070986,1,0.873318376245636,0,14,left/right axis specification,BP,
15939,GO:0070987,1,0.882113145723934,0,21,error-free translesion synthesis,BP,
15940,GO:0070988,1,0.604715089302898,0,61,demethylation,BP,
15941,GO:0070989,1,0.891954340441294,0,15,oxidative demethylation,BP,
15942,GO:0070990,1,0.975835697322393,0,7,snRNP binding,MF,
15943,GO:0070991,1,0.983777165236701,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15944,GO:0070992,1,0.996896819794802,0,1,translation initiation complex,CC,
15945,GO:0070993,1,0.92258092172041,0,17,translation preinitiation complex,CC,
15946,GO:0070995,1,0.975684484963382,0,4,NADPH oxidation,BP,
15947,GO:0070996,1,0.989365334509652,0,3,type 1 melanocortin receptor binding,MF,
15949,GO:0071000,1,0.991762669156656,0,2,response to magnetism,BP,
15950,GO:0071001,1,0.983511069476346,0,3,U4/U6 snRNP,CC,
15951,GO:0071004,1,0.919725011578032,0,16,U2-type prespliceosome,CC,
15952,GO:0071005,1,0.766578173091823,0,49,U2-type precatalytic spliceosome,CC,
15953,GO:0071006,1,0.938955985488863,0,9,U2-type catalytic step 1 spliceosome,CC,
15954,GO:0071007,1,0.851767611830447,0,30,U2-type catalytic step 2 spliceosome,CC,
15955,GO:0071008,1,0.984047263366302,0,3,U2-type post-mRNA release spliceosomal complex,CC,
15956,GO:0071010,1,0.919725011578032,0,16,prespliceosome,CC,
15957,GO:0071011,1,0.757331445869484,0,51,precatalytic spliceosome,CC,
15958,GO:0071012,1,0.938955985488863,0,9,catalytic step 1 spliceosome,CC,
15959,GO:0071013,1,0.618803610729198,0,83,catalytic step 2 spliceosome,CC,
15960,GO:0071014,1,0.932741108456251,0,13,post-mRNA release spliceosomal complex,CC,
15961,GO:0071020,1,0.992721123274869,0,2,post-spliceosomal complex,CC,
15962,GO:0071021,1,0.996379937479829,0,1,U2-type post-spliceosomal complex,CC,
15963,GO:0071025,1,0.928541910171748,0,15,RNA surveillance,BP,
15964,GO:0071026,1,0.995378806480956,0,1,cytoplasmic RNA surveillance,BP,
15965,GO:0071027,1,0.937904344611175,0,13,nuclear RNA surveillance,BP,
15966,GO:0071028,1,0.937904344611175,0,13,nuclear mRNA surveillance,BP,
15967,GO:0071029,1,0.977429395267936,0,6,nuclear ncRNA surveillance,BP,
15968,GO:0071030,1,0.99125677123176,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15969,GO:0071031,1,0.99256930252777,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15970,GO:0071033,1,0.98032446323067,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15971,GO:0071034,1,0.973228117165232,0,4,CUT catabolic process,BP,
15972,GO:0071035,1,0.977429395267936,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15973,GO:0071036,1,0.994858406815001,0,1,nuclear polyadenylation-dependent snoRNA catabolic process,BP,
15974,GO:0071037,1,0.994858406815001,0,1,nuclear polyadenylation-dependent snRNA catabolic process,BP,
15975,GO:0071038,1,0.977429395267936,0,6,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15976,GO:0071039,1,0.994858406815001,0,1,nuclear polyadenylation-dependent CUT catabolic process,BP,
15977,GO:0071040,1,0.994858406815001,0,1,nuclear polyadenylation-dependent antisense transcript catabolic process,BP,
15978,GO:0071041,1,0.994858406815001,0,1,antisense RNA transcript catabolic process,BP,
15979,GO:0071042,1,0.981131429354264,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15980,GO:0071043,1,0.973228117165232,0,4,CUT metabolic process,BP,
15981,GO:0071044,1,0.911548045696686,0,9,histone mRNA catabolic process,BP,
15982,GO:0071045,1,0.996437138962998,0,1,nuclear histone mRNA catabolic process,BP,
15983,GO:0071046,1,0.977429395267936,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15984,GO:0071047,1,0.981131429354264,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15985,GO:0071048,1,0.99125677123176,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15986,GO:0071049,1,0.99256930252777,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15987,GO:0071051,1,0.972125845593844,0,7,polyadenylation-dependent snoRNA 3'-end processing,BP,
15988,GO:0071062,1,0.979023779576678,0,3,alphav-beta3 integrin-vitronectin complex,CC,
15989,GO:0071065,1,0.988728709480657,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15990,GO:0071071,1,0.900236053990275,0,17,regulation of phospholipid biosynthetic process,BP,
15991,GO:0071072,1,0.960590604138252,0,5,negative regulation of phospholipid biosynthetic process,BP,
15992,GO:0071073,1,0.941324199019435,0,11,positive regulation of phospholipid biosynthetic process,BP,
15993,GO:0071074,1,0.985150869900544,0,2,eukaryotic initiation factor eIF2 binding,MF,
15994,GO:0071077,1,0.978285682828871,0,4,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15996,GO:0071104,1,0.940551324968487,0,8,response to interleukin-9,BP,
15997,GO:0071105,1,0.987697359381954,0,2,response to interleukin-11,BP,
15998,GO:0071106,1,0.989939310949597,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15999,GO:0071107,1,0.930659760521044,0,9,response to parathyroid hormone,BP,
16000,GO:0071108,1,0.757462603510316,0,27,protein K48-linked deubiquitination,BP,
16002,GO:0071110,1,0.988496772383391,0,1,histone biotinylation,BP,
16003,GO:0071133,1,0.994169862436017,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16004,GO:0071139,1,0.983192704545952,0,2,resolution of recombination intermediates,BP,
16005,GO:0071140,1,0.983192704545952,0,2,resolution of mitotic recombination intermediates,BP,
16006,GO:0071141,1,0.910921270054015,0,9,SMAD protein complex,CC,
16007,GO:0071144,1,0.91570280619424,0,8,heteromeric SMAD protein complex,CC,
16008,GO:0071148,1,0.972444644808072,0,2,TEAD-1-YAP complex,CC,
16009,GO:0071149,1,0.98575144301013,0,2,TEAD-2-YAP complex,CC,
16010,GO:0071156,1,0.545556283259247,0,100,regulation of cell cycle arrest,BP,
16011,GO:0071157,1,0.889023998898903,0,20,negative regulation of cell cycle arrest,BP,
16012,GO:0071158,1,0.612801715907,0,77,positive regulation of cell cycle arrest,BP,
16013,GO:0071159,1,0.992077533194687,0,2,NF-kappaB complex,CC,
16014,GO:0071163,1,0.987971639266165,0,3,DNA replication preinitiation complex assembly,BP,
16015,GO:0071164,1,0.993051773524531,0,1,RNA trimethylguanosine synthase activity,MF,
16016,GO:0071166,1,0.432687066560457,0,123,ribonucleoprotein complex localization,BP,
16017,GO:0071168,1,0.868133935455059,0,21,protein localization to chromatin,BP,
16018,GO:0071169,1,0.970500669441437,0,4,establishment of protein localization to chromatin,BP,
16019,GO:0071173,1,0.791685372176502,0,34,spindle assembly checkpoint,BP,
16020,GO:0071174,1,0.791685372176502,0,34,mitotic spindle checkpoint,BP,
16021,GO:0071203,1,0.956962385280068,0,5,WASH complex,CC,
16022,GO:0071204,1,0.963677322218212,0,6,histone pre-mRNA 3'end processing complex,CC,
16024,GO:0071206,1,0.985512377677045,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16025,GO:0071207,1,0.987569603358975,0,2,histone pre-mRNA stem-loop binding,MF,
16026,GO:0071208,1,0.9866605251426,0,4,histone pre-mRNA DCP binding,MF,
16027,GO:0071209,1,0.988757584002274,0,3,U7 snRNA binding,MF,
16028,GO:0071211,1,0.97238430908428,0,4,protein targeting to vacuole involved in autophagy,BP,
16030,GO:0071215,1,0.991699152780688,0,1,cellular response to abscisic acid stimulus,BP,
16032,GO:0071218,1,0.850822283722193,0,22,cellular response to misfolded protein,BP,
16034,GO:0071220,1,0.966400698461763,0,6,cellular response to bacterial lipoprotein,BP,
16035,GO:0071221,1,0.966400698461763,0,6,cellular response to bacterial lipopeptide,BP,
16037,GO:0071223,1,0.948080910643284,0,10,cellular response to lipoteichoic acid,BP,
16038,GO:0071224,1,0.96779082675786,0,6,cellular response to peptidoglycan,BP,
16040,GO:0071226,1,0.976074084177313,0,4,cellular response to molecule of fungal origin,BP,
16041,GO:0071228,1,0.996765400625138,0,1,cellular response to tumor cell,BP,
16044,GO:0071231,1,0.99354650832861,0,2,cellular response to folic acid,BP,
16045,GO:0071233,1,0.919204979447845,0,9,cellular response to leucine,BP,
16046,GO:0071236,1,0.907614312783119,0,13,cellular response to antibiotic,BP,
16048,GO:0071242,1,0.97916496963071,0,3,cellular response to ammonium ion,BP,
16049,GO:0071243,1,0.901182597825825,0,20,cellular response to arsenic-containing substance,BP,
16050,GO:0071245,1,0.993167142034608,0,1,cellular response to carbon monoxide,BP,
16051,GO:0071247,1,0.996764461891254,0,1,cellular response to chromate,BP,
16053,GO:0071250,1,0.987922847387118,0,1,cellular response to nitrite,BP,
16054,GO:0071253,1,0.97152375945332,0,5,connexin binding,MF,
16055,GO:0071256,1,0.975335869300718,0,6,translocon complex,CC,
16056,GO:0071257,1,0.932945353400508,0,10,cellular response to electrical stimulus,BP,
16057,GO:0071258,1,0.992132892685177,0,1,cellular response to gravity,BP,
16058,GO:0071259,1,0.991762669156656,0,2,cellular response to magnetism,BP,
16060,GO:0071261,1,0.996891832776416,0,1,Ssh1 translocon complex,CC,
16061,GO:0071262,1,0.982372586078023,0,2,regulation of translational initiation in response to starvation,BP,
16062,GO:0071264,1,0.982372586078023,0,2,positive regulation of translational initiation in response to starvation,BP,
16063,GO:0071265,1,0.965903793510563,0,7,L-methionine biosynthetic process,BP,
16064,GO:0071267,1,0.965903793510563,0,7,L-methionine salvage,BP,
16065,GO:0071276,1,0.857014432179686,0,33,cellular response to cadmium ion,BP,
16067,GO:0071279,1,0.977175267920863,0,3,cellular response to cobalt ion,BP,
16068,GO:0071280,1,0.896580966078135,0,21,cellular response to copper ion,BP,
16069,GO:0071281,1,0.93112549628235,0,11,cellular response to iron ion,BP,
16070,GO:0071283,1,0.992769320515315,0,2,cellular response to iron(III) ion,BP,
16071,GO:0071284,1,0.963619817857026,0,4,cellular response to lead ion,BP,
16072,GO:0071285,1,0.924840470715836,0,14,cellular response to lithium ion,BP,
16073,GO:0071286,1,0.914199863523786,0,7,cellular response to magnesium ion,BP,
16074,GO:0071287,1,0.913688162850981,0,12,cellular response to manganese ion,BP,
16075,GO:0071288,1,0.990710684037886,0,2,cellular response to mercury ion,BP,
16076,GO:0071294,1,0.900332871305233,0,19,cellular response to zinc ion,BP,
16078,GO:0071298,1,0.993616147992159,0,1,cellular response to L-ascorbic acid,BP,
16080,GO:0071301,1,0.98602027789242,0,1,cellular response to vitamin B1,BP,
16081,GO:0071305,1,0.867496234270146,0,20,cellular response to vitamin D,BP,
16085,GO:0071312,1,0.765887209594624,0,33,cellular response to alkaloid,BP,
16086,GO:0071313,1,0.873430424448799,0,10,cellular response to caffeine,BP,
16087,GO:0071314,1,0.987819462716932,0,3,cellular response to cocaine,BP,
16088,GO:0071315,1,0.968464441164282,0,5,cellular response to morphine,BP,
16089,GO:0071316,1,0.959883800288966,0,9,cellular response to nicotine,BP,
16090,GO:0071317,1,0.968464441164282,0,5,cellular response to isoquinoline alkaloid,BP,
16091,GO:0071318,1,0.885519449123296,0,18,cellular response to ATP,BP,
16092,GO:0071320,1,0.666996481321162,0,49,cellular response to cAMP,BP,
16093,GO:0071321,1,0.943708751557249,0,6,cellular response to cGMP,BP,
16095,GO:0071324,1,0.990417058446513,0,1,cellular response to disaccharide stimulus,BP,
16097,GO:0071329,1,0.990417058446513,0,1,cellular response to sucrose stimulus,BP,
16099,GO:0071332,1,0.970306293070474,0,5,cellular response to fructose stimulus,BP,
16101,GO:0071335,1,0.996876452058736,0,1,hair follicle cell proliferation,BP,
16102,GO:0071336,1,0.996876452058736,0,1,regulation of hair follicle cell proliferation,BP,
16103,GO:0071338,1,0.996876452058736,0,1,positive regulation of hair follicle cell proliferation,BP,
16104,GO:0071339,1,0.818349509974681,0,28,MLL1 complex,CC,
16105,GO:0071340,1,0.931354585328893,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16106,GO:0071344,1,0.993159679997679,0,2,diphosphate metabolic process,BP,
16110,GO:0071348,1,0.990847098635747,0,1,cellular response to interleukin-11,BP,
16112,GO:0071350,1,0.907177373530067,0,13,cellular response to interleukin-15,BP,
16113,GO:0071351,1,0.961621591712198,0,8,cellular response to interleukin-18,BP,
16114,GO:0071352,1,0.914874909038917,0,12,cellular response to interleukin-2,BP,
16115,GO:0071353,1,0.839187847986549,0,30,cellular response to interleukin-4,BP,
16117,GO:0071355,1,0.943552190505169,0,7,cellular response to interleukin-9,BP,
16119,GO:0071357,1,0.638905184286711,0,76,cellular response to type I interferon,BP,
16120,GO:0071359,1,0.88871695985476,0,18,cellular response to dsRNA,BP,
16121,GO:0071360,1,0.917910578100137,0,13,cellular response to exogenous dsRNA,BP,
16122,GO:0071361,1,0.893493702497772,0,13,cellular response to ethanol,BP,
16123,GO:0071362,1,0.945215901909245,0,7,cellular response to ether,BP,
16126,GO:0071371,1,0.890509430863246,0,16,cellular response to gonadotropin stimulus,BP,
16127,GO:0071372,1,0.923630448230312,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16128,GO:0071373,1,0.98992534609275,0,2,cellular response to luteinizing hormone stimulus,BP,
16129,GO:0071374,1,0.947771620037379,0,7,cellular response to parathyroid hormone stimulus,BP,
16131,GO:0071376,1,0.970394549177215,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16132,GO:0071377,1,0.834946114272215,0,23,cellular response to glucagon stimulus,BP,
16134,GO:0071379,1,0.839624504081253,0,21,cellular response to prostaglandin stimulus,BP,
16135,GO:0071380,1,0.893800572848984,0,15,cellular response to prostaglandin E stimulus,BP,
16139,GO:0071386,1,0.967224302095505,0,3,cellular response to corticosterone stimulus,BP,
16140,GO:0071387,1,0.990033174626836,0,1,cellular response to cortisol stimulus,BP,
16141,GO:0071389,1,0.954344562492523,0,6,cellular response to mineralocorticoid stimulus,BP,
16142,GO:0071391,1,0.907839479368238,0,14,cellular response to estrogen stimulus,BP,
16143,GO:0071392,1,0.796648511857537,0,35,cellular response to estradiol stimulus,BP,
16144,GO:0071393,1,0.972876185411968,0,3,cellular response to progesterone stimulus,BP,
16145,GO:0071394,1,0.946077824924111,0,9,cellular response to testosterone stimulus,BP,
16146,GO:0071395,1,0.986676254002955,0,4,cellular response to jasmonic acid stimulus,BP,
16148,GO:0071397,1,0.86503963667216,0,17,cellular response to cholesterol,BP,
16149,GO:0071398,1,0.671111313235004,0,53,cellular response to fatty acid,BP,
16150,GO:0071400,1,0.980785159193335,0,3,cellular response to oleic acid,BP,
16151,GO:0071401,1,0.99567950861844,0,1,cellular response to triglyceride,BP,
16152,GO:0071402,1,0.801857467509864,0,31,cellular response to lipoprotein particle stimulus,BP,
16153,GO:0071403,1,0.987853436297011,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16154,GO:0071404,1,0.875279999214731,0,19,cellular response to low-density lipoprotein particle stimulus,BP,
16156,GO:0071409,1,0.972505632312039,0,3,cellular response to cycloheximide,BP,
16157,GO:0071412,1,0.995690515438286,0,1,cellular response to genistein,BP,
16158,GO:0071413,1,0.995690515438286,0,1,cellular response to hydroxyisoflavone,BP,
16159,GO:0071415,1,0.855440891255713,0,13,cellular response to purine-containing compound,BP,
16161,GO:0071418,1,0.992917142269729,0,2,cellular response to amine stimulus,BP,
16163,GO:0071421,1,0.941968776092523,0,9,manganese ion transmembrane transport,BP,
16164,GO:0071422,1,0.968822506250998,0,6,succinate transmembrane transport,BP,
16165,GO:0071423,1,0.982208989643871,0,4,malate transmembrane transport,BP,
16166,GO:0071424,1,0.994890876864838,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16167,GO:0071425,1,0.863706402870821,0,23,hematopoietic stem cell proliferation,BP,
16168,GO:0071426,1,0.434519004058399,0,122,ribonucleoprotein complex export from nucleus,BP,
16169,GO:0071427,1,0.481189670104648,0,105,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16170,GO:0071428,1,0.9168889770369,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16171,GO:0071431,1,0.781393116364339,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16173,GO:0071438,1,0.967809102325725,0,5,invadopodium membrane,CC,
16174,GO:0071439,1,0.936635119056917,0,8,clathrin complex,CC,
16175,GO:0071440,1,0.966646172701276,0,6,regulation of histone H3-K14 acetylation,BP,
16176,GO:0071441,1,0.992748922115111,0,1,negative regulation of histone H3-K14 acetylation,BP,
16177,GO:0071442,1,0.978709908634791,0,4,positive regulation of histone H3-K14 acetylation,BP,
16178,GO:0071444,1,0.996901385915392,0,1,cellular response to pheromone,BP,
16179,GO:0071447,1,0.947987344563122,0,8,cellular response to hydroperoxide,BP,
16180,GO:0071449,1,0.996821589540215,0,1,cellular response to lipid hydroperoxide,BP,
16181,GO:0071450,1,0.886852805179885,0,24,cellular response to oxygen radical,BP,
16182,GO:0071451,1,0.886852805179885,0,24,cellular response to superoxide,BP,
16183,GO:0071453,1,0.244257457315319,0,212,cellular response to oxygen levels,BP,
16184,GO:0071454,1,0.985921596517854,0,1,cellular response to anoxia,BP,
16185,GO:0071455,1,0.958561995411849,0,6,cellular response to hyperoxia,BP,
16186,GO:0071456,1,0.298435276894544,0,186,cellular response to hypoxia,BP,
16187,GO:0071458,1,0.969540165814273,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16188,GO:0071459,1,0.90474352763229,0,20,protein localization to chromosome, centromeric region,BP,
16189,GO:0071460,1,0.993352957183715,0,2,cellular response to cell-matrix adhesion,BP,
16190,GO:0071461,1,0.981546468102451,0,3,cellular response to redox state,BP,
16191,GO:0071462,1,0.975908313878755,0,3,cellular response to water stimulus,BP,
16192,GO:0071464,1,0.990298982329523,0,1,cellular response to hydrostatic pressure,BP,
16194,GO:0071467,1,0.903707642350934,0,19,cellular response to pH,BP,
16195,GO:0071468,1,0.942019265350563,0,10,cellular response to acidic pH,BP,
16196,GO:0071469,1,0.988399117578077,0,2,cellular response to alkaline pH,BP,
16197,GO:0071470,1,0.740134939410613,0,42,cellular response to osmotic stress,BP,
16198,GO:0071471,1,0.991414200042418,0,1,cellular response to non-ionic osmotic stress,BP,
16199,GO:0071472,1,0.926145699582643,0,12,cellular response to salt stress,BP,
16200,GO:0071474,1,0.916487684787982,0,15,cellular hyperosmotic response,BP,
16201,GO:0071475,1,0.960974124719885,0,7,cellular hyperosmotic salinity response,BP,
16202,GO:0071476,1,0.938374185453623,0,8,cellular hypotonic response,BP,
16203,GO:0071477,1,0.980026368013867,0,2,cellular hypotonic salinity response,BP,
16204,GO:0071478,1,0.316548116064169,0,170,cellular response to radiation,BP,
16205,GO:0071479,1,0.631500424987084,0,66,cellular response to ionizing radiation,BP,
16206,GO:0071480,1,0.818080322427372,0,28,cellular response to gamma radiation,BP,
16207,GO:0071481,1,0.897734592236146,0,12,cellular response to X-ray,BP,
16208,GO:0071482,1,0.468369027781444,0,113,cellular response to light stimulus,BP,
16209,GO:0071483,1,0.986122978262566,0,2,cellular response to blue light,BP,
16210,GO:0071484,1,0.989902831807601,0,1,cellular response to light intensity,BP,
16211,GO:0071486,1,0.989902831807601,0,1,cellular response to high light intensity,BP,
16212,GO:0071492,1,0.980399501316406,0,3,cellular response to UV-A,BP,
16213,GO:0071493,1,0.960709417338222,0,8,cellular response to UV-B,BP,
16214,GO:0071494,1,0.949895346398928,0,7,cellular response to UV-C,BP,
16217,GO:0071498,1,0.889145534628813,0,18,cellular response to fluid shear stress,BP,
16218,GO:0071499,1,0.964768459685361,0,7,cellular response to laminar fluid shear stress,BP,
16219,GO:0071500,1,0.958656488076841,0,6,cellular response to nitrosative stress,BP,
16220,GO:0071501,1,0.908330307146126,0,14,cellular response to sterol depletion,BP,
16221,GO:0071502,1,0.969971582082601,0,5,cellular response to temperature stimulus,BP,
16222,GO:0071503,1,0.969080453172115,0,4,response to heparin,BP,
16223,GO:0071504,1,0.969080453172115,0,4,cellular response to heparin,BP,
16224,GO:0071505,1,0.988924470164777,0,2,response to mycophenolic acid,BP,
16225,GO:0071506,1,0.988924470164777,0,2,cellular response to mycophenolic acid,BP,
16226,GO:0071513,1,0.995781145853149,0,1,phosphopantothenoylcysteine decarboxylase complex,CC,
16227,GO:0071514,1,0.829202492606226,0,24,genetic imprinting,BP,
16228,GO:0071515,1,0.981051855925942,0,1,genetic imprinting at mating-type locus,BP,
16229,GO:0071517,1,0.981051855925942,0,1,maintenance of imprinting at mating-type locus,BP,
16230,GO:0071526,1,0.676141751146084,0,40,semaphorin-plexin signaling pathway,BP,
16231,GO:0071527,1,0.995566208344267,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16232,GO:0071528,1,0.992662610316627,0,1,tRNA re-export from nucleus,BP,
16233,GO:0071529,1,0.995215222495438,0,1,cementum mineralization,BP,
16235,GO:0071535,1,0.97735264476584,0,4,RING-like zinc finger domain binding,MF,
16236,GO:0071539,1,0.750912719456848,0,31,protein localization to centrosome,BP,
16237,GO:0071540,1,0.986380173908686,0,2,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16238,GO:0071541,1,0.967375958723303,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16239,GO:0071542,1,0.81504257656677,0,32,dopaminergic neuron differentiation,BP,
16240,GO:0071543,1,0.979209716404853,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16241,GO:0071544,1,0.996644807500605,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16242,GO:0071545,1,0.88090665182645,0,17,inositol phosphate catabolic process,BP,
16243,GO:0071546,1,0.96082461431783,0,6,pi-body,CC,
16244,GO:0071547,1,0.971575678349882,0,5,piP-body,CC,
16245,GO:0071548,1,0.791538744617444,0,39,response to dexamethasone,BP,
16246,GO:0071549,1,0.840739803390368,0,30,cellular response to dexamethasone stimulus,BP,
16247,GO:0071550,1,0.959753329860851,0,9,death-inducing signaling complex assembly,BP,
16248,GO:0071553,1,0.988043701934421,0,3,G protein-coupled pyrimidinergic nucleotide receptor activity,MF,
16249,GO:0071554,1,0.993129762539128,0,2,cell wall organization or biogenesis,BP,
16250,GO:0071556,1,0.896878168914737,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16251,GO:0071557,1,0.950895477809515,0,5,histone H3-K27 demethylation,BP,
16252,GO:0071558,1,0.950895477809515,0,5,histone demethylase activity (H3-K27 specific),MF,
16255,GO:0071561,1,0.990322181405176,0,1,nucleus-vacuole junction,CC,
16256,GO:0071564,1,0.913506024753335,0,12,npBAF complex,CC,
16257,GO:0071565,1,0.889032099854733,0,15,nBAF complex,CC,
16258,GO:0071566,1,0.994560412292365,0,1,UFM1 activating enzyme activity,MF,
16259,GO:0071567,1,0.995553173689226,0,1,UFM1 hydrolase activity,MF,
16260,GO:0071568,1,0.991661147347362,0,2,UFM1 transferase activity,MF,
16261,GO:0071569,1,0.974550034975546,0,6,protein ufmylation,BP,
16262,GO:0071573,1,0.994585892042755,0,1,shelterin complex assembly,BP,
16263,GO:0071577,1,0.893772258681798,0,20,zinc ion transmembrane transport,BP,
16264,GO:0071578,1,0.957354720759984,0,7,zinc ion import across plasma membrane,BP,
16265,GO:0071579,1,0.990811173069703,0,2,regulation of zinc ion transport,BP,
16266,GO:0071580,1,0.996050916927848,0,1,regulation of zinc ion transmembrane transport,BP,
16267,GO:0071581,1,0.996050916927848,0,1,regulation of zinc ion transmembrane import,BP,
16268,GO:0071582,1,0.996050916927848,0,1,negative regulation of zinc ion transport,BP,
16269,GO:0071583,1,0.996050916927848,0,1,negative regulation of zinc ion transmembrane transport,BP,
16270,GO:0071584,1,0.996050916927848,0,1,negative regulation of zinc ion transmembrane import,BP,
16271,GO:0071585,1,0.996050916927848,0,1,detoxification of cadmium ion,BP,
16272,GO:0071586,1,0.990741982331352,0,2,CAAX-box protein processing,BP,
16273,GO:0071593,1,0.970363581030219,0,5,lymphocyte aggregation,BP,
16274,GO:0071595,1,0.989807596705769,0,2,Nem1-Spo7 phosphatase complex,CC,
16275,GO:0071596,1,0.960556386334264,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16276,GO:0071598,1,0.983195111576119,0,3,neuronal ribonucleoprotein granule,CC,
16277,GO:0071599,1,0.904279648910217,0,15,otic vesicle development,BP,
16278,GO:0071600,1,0.939669965605788,0,10,otic vesicle morphogenesis,BP,
16279,GO:0071602,1,0.991622631109925,0,1,phytosphingosine biosynthetic process,BP,
16280,GO:0071603,1,0.978021333045062,0,3,endothelial cell-cell adhesion,BP,
16281,GO:0071604,1,0.769242262515225,0,36,transforming growth factor beta production,BP,
16282,GO:0071605,1,0.936334038820534,0,13,monocyte chemotactic protein-1 production,BP,
16283,GO:0071606,1,0.996092146970936,0,1,chemokine (C-C motif) ligand 4 production,BP,
16284,GO:0071608,1,0.967476114570191,0,6,macrophage inflammatory protein-1 alpha production,BP,
16285,GO:0071609,1,0.926766716473252,0,11,chemokine (C-C motif) ligand 5 production,BP,
16286,GO:0071610,1,0.995334859715568,0,1,chemokine (C-C motif) ligand 1 production,BP,
16287,GO:0071611,1,0.977506124039987,0,5,granulocyte colony-stimulating factor production,BP,
16288,GO:0071612,1,0.978613170544697,0,1,IP-10 production,BP,
16289,GO:0071613,1,0.986549204010477,0,3,granzyme B production,BP,
16290,GO:0071614,1,0.996229644853621,0,1,linoleic acid epoxygenase activity,MF,
16291,GO:0071616,1,0.72427425788142,0,49,acyl-CoA biosynthetic process,BP,
16292,GO:0071617,1,0.879587724731831,0,18,lysophospholipid acyltransferase activity,MF,
16293,GO:0071619,1,0.995702934536761,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16295,GO:0071622,1,0.783560313841733,0,45,regulation of granulocyte chemotaxis,BP,
16296,GO:0071623,1,0.978097938836329,0,3,negative regulation of granulocyte chemotaxis,BP,
16297,GO:0071624,1,0.884151443946448,0,26,positive regulation of granulocyte chemotaxis,BP,
16299,GO:0071626,1,0.991595950096535,0,2,mastication,BP,
16300,GO:0071629,1,0.996437138962998,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16301,GO:0071630,1,0.970619465967201,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16302,GO:0071633,1,0.982010324851945,0,3,dihydroceramidase activity,MF,
16303,GO:0071634,1,0.780049105963485,0,34,regulation of transforming growth factor beta production,BP,
16304,GO:0071635,1,0.952536285548812,0,8,negative regulation of transforming growth factor beta production,BP,
16305,GO:0071636,1,0.886210707206375,0,19,positive regulation of transforming growth factor beta production,BP,
16306,GO:0071637,1,0.936334038820534,0,13,regulation of monocyte chemotactic protein-1 production,BP,
16307,GO:0071638,1,0.974302020679931,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16308,GO:0071639,1,0.961040546544631,0,8,positive regulation of monocyte chemotactic protein-1 production,BP,
16309,GO:0071640,1,0.967476114570191,0,6,regulation of macrophage inflammatory protein 1 alpha production,BP,
16310,GO:0071641,1,0.981847293742844,0,3,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16311,GO:0071642,1,0.988549090508677,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16312,GO:0071643,1,0.996092146970936,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16313,GO:0071644,1,0.996092146970936,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16314,GO:0071649,1,0.93011195867228,0,10,regulation of chemokine (C-C motif) ligand 5 production,BP,
16315,GO:0071650,1,0.980302764498901,0,4,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16316,GO:0071651,1,0.948810633219752,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16317,GO:0071652,1,0.995334859715568,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16318,GO:0071654,1,0.995334859715568,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16319,GO:0071655,1,0.98107743624441,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16320,GO:0071656,1,0.995631289282231,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16321,GO:0071657,1,0.985382923399348,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16322,GO:0071658,1,0.978613170544697,0,1,regulation of IP-10 production,BP,
16323,GO:0071660,1,0.978613170544697,0,1,positive regulation of IP-10 production,BP,
16324,GO:0071661,1,0.986549204010477,0,3,regulation of granzyme B production,BP,
16325,GO:0071663,1,0.986549204010477,0,3,positive regulation of granzyme B production,BP,
16326,GO:0071664,1,0.964546476887774,0,4,catenin-TCF7L2 complex,CC,
16327,GO:0071665,1,0.993730483236499,0,1,gamma-catenin-TCF7L2 complex,CC,
16328,GO:0071670,1,0.948267251467758,0,9,smooth muscle cell chemotaxis,BP,
16329,GO:0071671,1,0.96434505982701,0,7,regulation of smooth muscle cell chemotaxis,BP,
16330,GO:0071672,1,0.980444478628534,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16331,GO:0071673,1,0.980508299669128,0,4,positive regulation of smooth muscle cell chemotaxis,BP,
16334,GO:0071676,1,0.95242769628974,0,7,negative regulation of mononuclear cell migration,BP,
16336,GO:0071678,1,0.985419825617674,0,1,olfactory bulb axon guidance,BP,
16337,GO:0071679,1,0.899998143539831,0,12,commissural neuron axon guidance,BP,
16338,GO:0071680,1,0.958148633008973,0,5,response to indole-3-methanol,BP,
16339,GO:0071681,1,0.958148633008973,0,5,cellular response to indole-3-methanol,BP,
16341,GO:0071684,1,0.850403525699969,0,26,organism emergence from protective structure,BP,
16342,GO:0071688,1,0.926576022255263,0,3,striated muscle myosin thick filament assembly,BP,
16343,GO:0071691,1,0.937478122176101,0,3,cardiac muscle thin filament assembly,BP,
16345,GO:0071694,1,0.934570753327234,0,7,maintenance of protein location in extracellular region,BP,
16347,GO:0071696,1,0.914530658094058,0,12,ectodermal placode development,BP,
16348,GO:0071697,1,0.918781606726492,0,11,ectodermal placode morphogenesis,BP,
16349,GO:0071698,1,0.97765460139325,0,3,olfactory placode development,BP,
16350,GO:0071699,1,0.97765460139325,0,3,olfactory placode morphogenesis,BP,
16351,GO:0071701,1,0.990707077543793,0,1,regulation of MAPK export from nucleus,BP,
16356,GO:0071707,1,0.996688322624702,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16359,GO:0071712,1,0.925676369840926,0,11,ER-associated misfolded protein catabolic process,BP,
16360,GO:0071714,1,0.991952296627882,0,1,icosanoid transmembrane transporter activity,MF,
16362,GO:0071716,1,0.978159352352871,0,2,leukotriene transport,BP,
16363,GO:0071723,1,0.951176062470477,0,9,lipopeptide binding,MF,
16364,GO:0071724,1,0.97510610239375,0,4,response to diacyl bacterial lipopeptide,BP,
16365,GO:0071725,1,0.984973700800523,0,3,response to triacyl bacterial lipopeptide,BP,
16366,GO:0071726,1,0.97510610239375,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16367,GO:0071727,1,0.984973700800523,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16368,GO:0071731,1,0.892421660157341,0,19,response to nitric oxide,BP,
16369,GO:0071732,1,0.914112574395086,0,15,cellular response to nitric oxide,BP,
16370,GO:0071733,1,0.968598345484195,0,4,transcriptional activation by promoter-enhancer looping,BP,
16371,GO:0071763,1,0.964797569320151,0,6,nuclear membrane organization,BP,
16372,GO:0071765,1,0.991978752370576,0,1,nuclear inner membrane organization,BP,
16376,GO:0071782,1,0.893798496469447,0,20,endoplasmic reticulum tubular network,CC,
16377,GO:0071786,1,0.898928539394118,0,17,endoplasmic reticulum tubular network organization,BP,
16378,GO:0071787,1,0.981186933454074,0,4,endoplasmic reticulum tubular network formation,BP,
16379,GO:0071791,1,0.988484125940202,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16380,GO:0071796,1,0.996676509305464,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16381,GO:0071797,1,0.979655589939921,0,4,LUBAC complex,CC,
16382,GO:0071798,1,0.963570470299361,0,5,response to prostaglandin D,BP,
16383,GO:0071799,1,0.963570470299361,0,5,cellular response to prostaglandin D stimulus,BP,
16384,GO:0071800,1,0.886866534372372,0,17,podosome assembly,BP,
16385,GO:0071801,1,0.914726448166702,0,13,regulation of podosome assembly,BP,
16386,GO:0071802,1,0.992021540927018,0,1,negative regulation of podosome assembly,BP,
16387,GO:0071803,1,0.936504737923382,0,9,positive regulation of podosome assembly,BP,
16389,GO:0071806,1,0.718893621504768,0,57,protein transmembrane transport,BP,
16390,GO:0071812,1,0.994211207093909,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16391,GO:0071813,1,0.834446612428048,0,24,lipoprotein particle binding,MF,
16392,GO:0071814,1,0.834446612428048,0,24,protein-lipid complex binding,MF,
16393,GO:0071816,1,0.982254555422723,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16394,GO:0071817,1,0.9780675171726,0,4,MMXD complex,CC,
16395,GO:0071818,1,0.986565156684242,0,3,BAT3 complex,CC,
16396,GO:0071819,1,0.990139388936431,0,2,DUBm complex,CC,
16397,GO:0071820,1,0.99658144568182,0,1,N-box binding,MF,
16398,GO:0071821,1,0.98328412313223,0,2,FANCM-MHF complex,CC,
16399,GO:0071824,1,0.274758483637236,0,191,protein-DNA complex subunit organization,BP,
16403,GO:0071830,1,0.947984402639806,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16404,GO:0071831,1,0.996730590415193,0,1,intermediate-density lipoprotein particle clearance,BP,
16405,GO:0071837,1,0.890884817642436,0,16,HMG box domain binding,MF,
16406,GO:0071838,1,0.950823400939189,0,7,cell proliferation in bone marrow,BP,
16407,GO:0071839,1,0.968771931099151,0,6,apoptotic process in bone marrow cell,BP,
16409,GO:0071846,1,0.98905901991191,0,2,actin filament debranching,BP,
16410,GO:0071847,1,0.98887202381936,0,2,TNFSF11-mediated signaling pathway,BP,
16411,GO:0071848,1,0.994211207093909,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16412,GO:0071850,1,0.90980956210712,0,16,mitotic cell cycle arrest,BP,
16414,GO:0071863,1,0.956814088951985,0,6,regulation of cell proliferation in bone marrow,BP,
16415,GO:0071864,1,0.956814088951985,0,6,positive regulation of cell proliferation in bone marrow,BP,
16416,GO:0071865,1,0.973233825381933,0,5,regulation of apoptotic process in bone marrow cell,BP,
16417,GO:0071866,1,0.973233825381933,0,5,negative regulation of apoptotic process in bone marrow cell,BP,
16422,GO:0071871,1,0.875516022682162,0,15,response to epinephrine,BP,
16423,GO:0071872,1,0.893055245539875,0,12,cellular response to epinephrine stimulus,BP,
16424,GO:0071873,1,0.97701402697837,0,3,response to norepinephrine,BP,
16425,GO:0071874,1,0.98895915452392,0,2,cellular response to norepinephrine stimulus,BP,
16427,GO:0071877,1,0.996644807500605,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16428,GO:0071878,1,0.971605075016475,0,3,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16429,GO:0071879,1,0.982299518215648,0,2,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16431,GO:0071881,1,0.989369092408461,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16432,GO:0071882,1,0.992700036406464,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16433,GO:0071885,1,0.991722635944497,0,2,N-terminal protein N-methyltransferase activity,MF,
16434,GO:0071886,1,0.9850479254498,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16436,GO:0071888,1,0.946479449086039,0,9,macrophage apoptotic process,BP,
16437,GO:0071889,1,0.783642411735402,0,30,14-3-3 protein binding,MF,
16438,GO:0071890,1,0.99000055092092,0,1,bicarbonate binding,MF,
16439,GO:0071893,1,0.996309331932209,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16440,GO:0071894,1,0.989543522861326,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16442,GO:0071896,1,0.939823466720243,0,6,protein localization to adherens junction,BP,
16444,GO:0071898,1,0.984005111310047,0,3,regulation of estrogen receptor binding,BP,
16445,GO:0071899,1,0.984005111310047,0,3,negative regulation of estrogen receptor binding,BP,
16447,GO:0071901,1,0.438436011453509,0,126,negative regulation of protein serine/threonine kinase activity,BP,
16449,GO:0071907,1,0.939654087790244,0,7,determination of digestive tract left/right asymmetry,BP,
16450,GO:0071908,1,0.989671862765827,0,1,determination of intestine left/right asymmetry,BP,
16451,GO:0071909,1,0.989671862765827,0,1,determination of stomach left/right asymmetry,BP,
16452,GO:0071910,1,0.952850085952761,0,6,determination of liver left/right asymmetry,BP,
16454,GO:0071913,1,0.9964709803441,0,1,citrate secondary active transmembrane transporter activity,MF,
16455,GO:0071914,1,0.985380696353533,0,2,prominosome,CC,
16456,GO:0071916,1,0.989479953529399,0,1,dipeptide transmembrane transporter activity,MF,
16457,GO:0071918,1,0.968393677764165,0,6,urea transmembrane transport,BP,
16458,GO:0071919,1,0.99372946539234,0,1,G-quadruplex DNA formation,BP,
16459,GO:0071920,1,0.991028482645066,0,2,cleavage body,CC,
16460,GO:0071921,1,0.958970876078546,0,5,cohesin loading,BP,
16461,GO:0071922,1,0.963897352789768,0,4,regulation of cohesin loading,BP,
16463,GO:0071929,1,0.989139182611862,0,2,alpha-tubulin acetylation,BP,
16464,GO:0071930,1,0.975039901128695,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16465,GO:0071931,1,0.986019976878755,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16466,GO:0071932,1,0.973085463584759,0,3,replication fork reversal,BP,
16467,GO:0071933,1,0.912287955033188,0,12,Arp2/3 complex binding,MF,
16468,GO:0071934,1,0.982624782176886,0,3,thiamine transmembrane transport,BP,
16469,GO:0071936,1,0.919220866104139,0,9,coreceptor activity involved in Wnt signaling pathway,MF,
16470,GO:0071938,1,0.994747060254305,0,1,vitamin A transport,BP,
16471,GO:0071939,1,0.994747060254305,0,1,vitamin A import,BP,
16472,GO:0071941,1,0.944544976795658,0,12,nitrogen cycle metabolic process,BP,
16473,GO:0071942,1,0.982236175372021,0,3,XPC complex,CC,
16475,GO:0071947,1,0.954734203497233,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16476,GO:0071949,1,0.80547317181971,0,31,FAD binding,MF,
16477,GO:0071951,1,0.994926741713297,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16478,GO:0071953,1,0.980344625823883,0,4,elastic fiber,CC,
16479,GO:0071954,1,0.993482673451939,0,1,chemokine (C-C motif) ligand 11 production,BP,
16480,GO:0071955,1,0.964148732889839,0,3,recycling endosome to Golgi transport,BP,
16481,GO:0071960,1,0.996829239940352,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16482,GO:0071962,1,0.986449048040347,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16483,GO:0071963,1,0.987719083706675,0,2,establishment or maintenance of cell polarity regulating cell shape,BP,
16484,GO:0071971,1,0.960900860103129,0,7,extracellular exosome assembly,BP,
16485,GO:0071976,1,0.993878442898129,0,1,cell gliding,BP,
16486,GO:0071985,1,0.791109981468248,0,38,multivesicular body sorting pathway,BP,
16487,GO:0071986,1,0.970110156010535,0,6,Ragulator complex,CC,
16488,GO:0071987,1,0.966950720011013,0,4,WD40-repeat domain binding,MF,
16489,GO:0071988,1,0.981277339678385,0,2,protein localization to spindle pole body,BP,
16491,GO:0072003,1,0.981566755836497,0,3,kidney rudiment formation,BP,
16492,GO:0072004,1,0.984941557444264,0,2,kidney field specification,BP,
16494,GO:0072007,1,0.956508919520163,0,7,mesangial cell differentiation,BP,
16495,GO:0072008,1,0.960163036635399,0,6,glomerular mesangial cell differentiation,BP,
16497,GO:0072010,1,0.850634451756253,0,19,glomerular epithelium development,BP,
16498,GO:0072011,1,0.991412766329924,0,2,glomerular endothelium development,BP,
16499,GO:0072012,1,0.833588206199427,0,23,glomerulus vasculature development,BP,
16500,GO:0072014,1,0.934190783410628,0,6,proximal tubule development,BP,
16501,GO:0072015,1,0.893443086569875,0,10,glomerular visceral epithelial cell development,BP,
16502,GO:0072016,1,0.995124970104541,0,1,glomerular parietal epithelial cell development,BP,
16503,GO:0072017,1,0.887090593179132,0,11,distal tubule development,BP,
16504,GO:0072019,1,0.995891377474433,0,1,proximal convoluted tubule development,BP,
16505,GO:0072021,1,0.962138145011135,0,3,ascending thin limb development,BP,
16506,GO:0072023,1,0.996550081773305,0,1,thick ascending limb development,BP,
16507,GO:0072024,1,0.996550081773305,0,1,macula densa development,BP,
16508,GO:0072025,1,0.976921169875613,0,4,distal convoluted tubule development,BP,
16509,GO:0072027,1,0.995292062285924,0,1,connecting tubule development,BP,
16511,GO:0072033,1,0.922628429255966,0,8,renal vesicle formation,BP,
16512,GO:0072034,1,0.979716085576869,0,3,renal vesicle induction,BP,
16513,GO:0072036,1,0.992960209320914,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16514,GO:0072038,1,0.970044636678717,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16515,GO:0072039,1,0.977411445150543,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16516,GO:0072040,1,0.977411445150543,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16517,GO:0072044,1,0.877970722109443,0,14,collecting duct development,BP,
16518,GO:0072046,1,0.996574122402086,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16519,GO:0072047,1,0.984839412393651,0,4,proximal/distal pattern formation involved in nephron development,BP,
16520,GO:0072048,1,0.962287883876645,0,8,renal system pattern specification,BP,
16521,GO:0072049,1,0.971585935477885,0,5,comma-shaped body morphogenesis,BP,
16522,GO:0072050,1,0.956820441109578,0,7,S-shaped body morphogenesis,BP,
16523,GO:0072051,1,0.996550081773305,0,1,juxtaglomerular apparatus development,BP,
16524,GO:0072053,1,0.98626941817433,0,2,renal inner medulla development,BP,
16525,GO:0072054,1,0.98626941817433,0,2,renal outer medulla development,BP,
16526,GO:0072055,1,0.990298982329523,0,1,renal cortex development,BP,
16527,GO:0072059,1,0.990298982329523,0,1,cortical collecting duct development,BP,
16528,GO:0072060,1,0.992608585555178,0,1,outer medullary collecting duct development,BP,
16529,GO:0072061,1,0.983881261879885,0,3,inner medullary collecting duct development,BP,
16530,GO:0072069,1,0.981543073654605,0,3,DCT cell differentiation,BP,
16531,GO:0072070,1,0.927528544963214,0,9,loop of Henle development,BP,
16532,GO:0072071,1,0.992790141751136,0,2,kidney interstitial fibroblast differentiation,BP,
16534,GO:0072074,1,0.884938154230558,0,18,kidney mesenchyme development,BP,
16535,GO:0072075,1,0.900345194791249,0,14,metanephric mesenchyme development,BP,
16536,GO:0072076,1,0.971845628223979,0,3,nephrogenic mesenchyme development,BP,
16538,GO:0072078,1,0.576378049310442,0,68,nephron tubule morphogenesis,BP,
16539,GO:0072079,1,0.909874189578208,0,17,nephron tubule formation,BP,
16541,GO:0072081,1,0.984839412393651,0,4,specification of nephron tubule identity,BP,
16542,GO:0072086,1,0.988600658066662,0,3,specification of loop of Henle identity,BP,
16545,GO:0072089,1,0.420974278235977,0,116,stem cell proliferation,BP,
16546,GO:0072091,1,0.623094231108005,0,66,regulation of stem cell proliferation,BP,
16547,GO:0072092,1,0.95452048482754,0,3,ureteric bud invasion,BP,
16548,GO:0072093,1,0.947797749500586,0,4,metanephric renal vesicle formation,BP,
16549,GO:0072095,1,0.979602604745781,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16550,GO:0072096,1,0.996309331932209,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16551,GO:0072097,1,0.996309331932209,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16552,GO:0072098,1,0.992519052884927,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16553,GO:0072099,1,0.996309331932209,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16554,GO:0072100,1,0.996309331932209,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16555,GO:0072101,1,0.996309331932209,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16556,GO:0072102,1,0.912510025621475,0,8,glomerulus morphogenesis,BP,
16557,GO:0072103,1,0.938098137503903,0,5,glomerulus vasculature morphogenesis,BP,
16558,GO:0072104,1,0.938098137503903,0,5,glomerular capillary formation,BP,
16559,GO:0072106,1,0.974596056603212,0,4,regulation of ureteric bud formation,BP,
16560,GO:0072107,1,0.974596056603212,0,4,positive regulation of ureteric bud formation,BP,
16562,GO:0072109,1,0.906753773348356,0,15,glomerular mesangium development,BP,
16563,GO:0072110,1,0.939379779239945,0,10,glomerular mesangial cell proliferation,BP,
16564,GO:0072111,1,0.88970033471284,0,19,cell proliferation involved in kidney development,BP,
16565,GO:0072112,1,0.864683584998598,0,16,glomerular visceral epithelial cell differentiation,BP,
16566,GO:0072114,1,0.98936724836986,0,1,pronephros morphogenesis,BP,
16567,GO:0072124,1,0.949803936443528,0,9,regulation of glomerular mesangial cell proliferation,BP,
16568,GO:0072125,1,0.983210047711152,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16569,GO:0072126,1,0.966029083539488,0,6,positive regulation of glomerular mesangial cell proliferation,BP,
16570,GO:0072127,1,0.995719642781064,0,1,renal capsule development,BP,
16571,GO:0072128,1,0.995719642781064,0,1,renal capsule morphogenesis,BP,
16572,GO:0072129,1,0.995719642781064,0,1,renal capsule formation,BP,
16573,GO:0072130,1,0.995719642781064,0,1,renal capsule specification,BP,
16574,GO:0072131,1,0.968002732673576,0,4,kidney mesenchyme morphogenesis,BP,
16575,GO:0072132,1,0.683277608624488,0,51,mesenchyme morphogenesis,BP,
16576,GO:0072133,1,0.968002732673576,0,4,metanephric mesenchyme morphogenesis,BP,
16577,GO:0072134,1,0.976024373183218,0,2,nephrogenic mesenchyme morphogenesis,BP,
16578,GO:0072135,1,0.982263338686228,0,3,kidney mesenchymal cell proliferation,BP,
16579,GO:0072136,1,0.982263338686228,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16580,GO:0072137,1,0.948983475233236,0,3,condensed mesenchymal cell proliferation,BP,
16581,GO:0072138,1,0.986216527735668,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16582,GO:0072139,1,0.987732038151946,0,2,glomerular parietal epithelial cell differentiation,BP,
16583,GO:0072141,1,0.992790141751136,0,2,renal interstitial fibroblast development,BP,
16584,GO:0072143,1,0.961332348443774,0,6,mesangial cell development,BP,
16585,GO:0072144,1,0.965004706660638,0,5,glomerular mesangial cell development,BP,
16587,GO:0072156,1,0.954612616674162,0,3,distal tubule morphogenesis,BP,
16589,GO:0072161,1,0.962021987134428,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16590,GO:0072162,1,0.974566632777437,0,4,metanephric mesenchymal cell differentiation,BP,
16591,GO:0072163,1,0.479993557779285,0,94,mesonephric epithelium development,BP,
16592,GO:0072164,1,0.479993557779285,0,94,mesonephric tubule development,BP,
16593,GO:0072165,1,0.996195821532018,0,1,anterior mesonephric tubule development,BP,
16594,GO:0072166,1,0.99067149795851,0,2,posterior mesonephric tubule development,BP,
16595,GO:0072167,1,0.996195821532018,0,1,specification of mesonephric tubule identity,BP,
16596,GO:0072168,1,0.996195821532018,0,1,specification of anterior mesonephric tubule identity,BP,
16597,GO:0072169,1,0.996195821532018,0,1,specification of posterior mesonephric tubule identity,BP,
16599,GO:0072171,1,0.617519450517946,0,61,mesonephric tubule morphogenesis,BP,
16600,GO:0072172,1,0.956316655235699,0,8,mesonephric tubule formation,BP,
16601,GO:0072173,1,0.917124542022545,0,11,metanephric tubule morphogenesis,BP,
16602,GO:0072174,1,0.961653072532697,0,6,metanephric tubule formation,BP,
16604,GO:0072176,1,0.883850958073193,0,14,nephric duct development,BP,
16605,GO:0072177,1,0.939627939240347,0,7,mesonephric duct development,BP,
16606,GO:0072178,1,0.929836776172126,0,10,nephric duct morphogenesis,BP,
16607,GO:0072179,1,0.97955896046872,0,4,nephric duct formation,BP,
16608,GO:0072180,1,0.988485182268747,0,3,mesonephric duct morphogenesis,BP,
16609,GO:0072181,1,0.996574122402086,0,1,mesonephric duct formation,BP,
16611,GO:0072183,1,0.989534351679014,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16612,GO:0072184,1,0.996195821532018,0,1,renal vesicle progenitor cell differentiation,BP,
16613,GO:0072185,1,0.991783298120923,0,2,metanephric cap development,BP,
16614,GO:0072186,1,0.991783298120923,0,2,metanephric cap morphogenesis,BP,
16615,GO:0072189,1,0.892836709885067,0,17,ureter development,BP,
16616,GO:0072190,1,0.98515558908279,0,3,ureter urothelium development,BP,
16617,GO:0072191,1,0.980565250203845,0,4,ureter smooth muscle development,BP,
16618,GO:0072192,1,0.996309331932209,0,1,ureter epithelial cell differentiation,BP,
16619,GO:0072193,1,0.980565250203845,0,4,ureter smooth muscle cell differentiation,BP,
16620,GO:0072194,1,0.983071993407993,0,3,kidney smooth muscle tissue development,BP,
16621,GO:0072195,1,0.996493899157185,0,1,kidney smooth muscle cell differentiation,BP,
16622,GO:0072197,1,0.967807167624283,0,6,ureter morphogenesis,BP,
16623,GO:0072198,1,0.987894747767091,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16624,GO:0072199,1,0.987894747767091,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16625,GO:0072200,1,0.996309331932209,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16626,GO:0072201,1,0.945148654092676,0,8,negative regulation of mesenchymal cell proliferation,BP,
16628,GO:0072203,1,0.934421611715674,0,10,cell proliferation involved in metanephros development,BP,
16629,GO:0072204,1,0.984315601934035,0,2,cell-cell signaling involved in metanephros development,BP,
16630,GO:0072205,1,0.911574148203902,0,10,metanephric collecting duct development,BP,
16631,GO:0072206,1,0.996550081773305,0,1,metanephric juxtaglomerular apparatus development,BP,
16633,GO:0072208,1,0.986531341247474,0,2,metanephric smooth muscle tissue development,BP,
16634,GO:0072209,1,0.989701553088754,0,2,metanephric mesangial cell differentiation,BP,
16636,GO:0072213,1,0.995719642781064,0,1,metanephric capsule development,BP,
16637,GO:0072214,1,0.990298982329523,0,1,metanephric cortex development,BP,
16640,GO:0072217,1,0.960081938420783,0,7,negative regulation of metanephros development,BP,
16641,GO:0072218,1,0.962138145011135,0,3,metanephric ascending thin limb development,BP,
16642,GO:0072219,1,0.990298982329523,0,1,metanephric cortical collecting duct development,BP,
16643,GO:0072221,1,0.976921169875613,0,4,metanephric distal convoluted tubule development,BP,
16644,GO:0072223,1,0.967770837818443,0,5,metanephric glomerular mesangium development,BP,
16645,GO:0072224,1,0.915888214910716,0,11,metanephric glomerulus development,BP,
16646,GO:0072227,1,0.996550081773305,0,1,metanephric macula densa development,BP,
16647,GO:0072229,1,0.995891377474433,0,1,metanephric proximal convoluted tubule development,BP,
16648,GO:0072233,1,0.996550081773305,0,1,metanephric thick ascending limb development,BP,
16650,GO:0072235,1,0.943180458666328,0,6,metanephric distal tubule development,BP,
16651,GO:0072236,1,0.955023853330215,0,4,metanephric loop of Henle development,BP,
16652,GO:0072237,1,0.970923670252059,0,2,metanephric proximal tubule development,BP,
16653,GO:0072239,1,0.951967734824442,0,7,metanephric glomerulus vasculature development,BP,
16654,GO:0072240,1,0.981543073654605,0,3,metanephric DCT cell differentiation,BP,
16656,GO:0072244,1,0.988837143382095,0,1,metanephric glomerular epithelium development,BP,
16657,GO:0072248,1,0.988837143382095,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16658,GO:0072249,1,0.988837143382095,0,1,metanephric glomerular visceral epithelial cell development,BP,
16659,GO:0072254,1,0.989701553088754,0,2,metanephric glomerular mesangial cell differentiation,BP,
16660,GO:0072255,1,0.994690656093121,0,1,metanephric glomerular mesangial cell development,BP,
16662,GO:0072258,1,0.996195821532018,0,1,metanephric interstitial fibroblast differentiation,BP,
16663,GO:0072259,1,0.996195821532018,0,1,metanephric interstitial fibroblast development,BP,
16664,GO:0072262,1,0.977843351628348,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16665,GO:0072265,1,0.995719642781064,0,1,metanephric capsule morphogenesis,BP,
16666,GO:0072266,1,0.995719642781064,0,1,metanephric capsule formation,BP,
16667,GO:0072267,1,0.995719642781064,0,1,metanephric capsule specification,BP,
16668,GO:0072268,1,0.9881956047352,0,3,pattern specification involved in metanephros development,BP,
16669,GO:0072272,1,0.996233937215355,0,1,proximal/distal pattern formation involved in metanephric nephron development,BP,
16671,GO:0072274,1,0.988837143382095,0,1,metanephric glomerular basement membrane development,BP,
16672,GO:0072275,1,0.97659981102355,0,2,metanephric glomerulus morphogenesis,BP,
16673,GO:0072276,1,0.97659981102355,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16674,GO:0072277,1,0.97659981102355,0,2,metanephric glomerular capillary formation,BP,
16675,GO:0072278,1,0.978177476234482,0,3,metanephric comma-shaped body morphogenesis,BP,
16676,GO:0072282,1,0.931877631181643,0,8,metanephric nephron tubule morphogenesis,BP,
16678,GO:0072284,1,0.963312808151891,0,5,metanephric S-shaped body morphogenesis,BP,
16679,GO:0072285,1,0.992960209320914,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16680,GO:0072286,1,0.995292062285924,0,1,metanephric connecting tubule development,BP,
16681,GO:0072287,1,0.974930305390663,0,1,metanephric distal tubule morphogenesis,BP,
16682,GO:0072289,1,0.972131376944351,0,4,metanephric nephron tubule formation,BP,
16683,GO:0072298,1,0.9717657657531,0,4,regulation of metanephric glomerulus development,BP,
16684,GO:0072299,1,0.994454792032033,0,1,negative regulation of metanephric glomerulus development,BP,
16685,GO:0072300,1,0.977185711074423,0,3,positive regulation of metanephric glomerulus development,BP,
16686,GO:0072301,1,0.988689959805717,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16687,GO:0072302,1,0.994454792032033,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16688,GO:0072303,1,0.994203344040641,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16689,GO:0072304,1,0.984941557444264,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16690,GO:0072305,1,0.984941557444264,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16692,GO:0072308,1,0.993313346526276,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16693,GO:0072309,1,0.984941557444264,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16694,GO:0072310,1,0.889082627827176,0,11,glomerular epithelial cell development,BP,
16695,GO:0072311,1,0.860462107325811,0,17,glomerular epithelial cell differentiation,BP,
16696,GO:0072312,1,0.988837143382095,0,1,metanephric glomerular epithelial cell differentiation,BP,
16697,GO:0072313,1,0.988837143382095,0,1,metanephric glomerular epithelial cell development,BP,
16700,GO:0072320,1,0.973231099936942,0,4,volume-sensitive chloride channel activity,MF,
16701,GO:0072321,1,0.953305935392153,0,11,chaperone-mediated protein transport,BP,
16702,GO:0072329,1,0.473217637365482,0,129,monocarboxylic acid catabolic process,BP,
16704,GO:0072331,1,0.184383853723104,0,252,signal transduction by p53 class mediator,BP,
16705,GO:0072332,1,0.619618787666015,0,74,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
16706,GO:0072334,1,0.985323726568939,0,4,UDP-galactose transmembrane transport,BP,
16707,GO:0072337,1,0.819053537627057,0,26,modified amino acid transport,BP,
16708,GO:0072338,1,0.975984066990913,0,3,cellular lactam metabolic process,BP,
16709,GO:0072340,1,0.99639083166836,0,1,cellular lactam catabolic process,BP,
16711,GO:0072343,1,0.992926404044367,0,2,pancreatic stellate cell proliferation,BP,
16712,GO:0072344,1,0.978508177404325,0,4,rescue of stalled ribosome,BP,
16713,GO:0072345,1,0.965722761798483,0,5,NAADP-sensitive calcium-release channel activity,MF,
16714,GO:0072348,1,0.727367648282511,0,45,sulfur compound transport,BP,
16715,GO:0072349,1,0.865324933679689,0,19,modified amino acid transmembrane transporter activity,MF,
16716,GO:0072350,1,0.931023687239301,0,13,tricarboxylic acid metabolic process,BP,
16717,GO:0072354,1,0.996379022716881,0,1,histone kinase activity (H3-T3 specific),MF,
16718,GO:0072355,1,0.996379022716881,0,1,histone H3-T3 phosphorylation,BP,
16719,GO:0072356,1,0.992366237350058,0,1,chromosome passenger complex localization to kinetochore,BP,
16720,GO:0072357,1,0.947567427558599,0,7,PTW/PP1 phosphatase complex,CC,
16724,GO:0072379,1,0.971986465676396,0,5,ER membrane insertion complex,CC,
16725,GO:0072380,1,0.985224765309314,0,2,TRC complex,CC,
16726,GO:0072382,1,0.974585672755771,0,1,minus-end-directed vesicle transport along microtubule,BP,
16727,GO:0072383,1,0.928030072287527,0,7,plus-end-directed vesicle transport along microtubule,BP,
16728,GO:0072384,1,0.51937825703678,0,79,organelle transport along microtubule,BP,
16729,GO:0072385,1,0.946338411885216,0,5,minus-end-directed organelle transport along microtubule,BP,
16730,GO:0072386,1,0.917778834292963,0,8,plus-end-directed organelle transport along microtubule,BP,
16731,GO:0072387,1,0.988822200009086,0,2,flavin adenine dinucleotide metabolic process,BP,
16732,GO:0072388,1,0.996102280169004,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16733,GO:0072389,1,0.992691717984483,0,1,flavin adenine dinucleotide catabolic process,BP,
16734,GO:0072393,1,0.880709240830789,0,12,microtubule anchoring at microtubule organizing center,BP,
16735,GO:0072394,1,0.996430763181575,0,1,detection of stimulus involved in cell cycle checkpoint,BP,
16736,GO:0072395,1,0.622754375433127,0,69,signal transduction involved in cell cycle checkpoint,BP,
16737,GO:0072396,1,0.949594579614015,0,6,response to cell cycle checkpoint signaling,BP,
16738,GO:0072401,1,0.633152765889095,0,68,signal transduction involved in DNA integrity checkpoint,BP,
16739,GO:0072402,1,0.949594579614015,0,6,response to DNA integrity checkpoint signaling,BP,
16740,GO:0072413,1,0.684139232586155,0,56,signal transduction involved in mitotic cell cycle checkpoint,BP,
16741,GO:0072414,1,0.986548583267913,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16742,GO:0072421,1,0.996430763181575,0,1,detection of DNA damage stimulus involved in DNA damage checkpoint,BP,
16743,GO:0072422,1,0.633152765889095,0,68,signal transduction involved in DNA damage checkpoint,BP,
16744,GO:0072423,1,0.949594579614015,0,6,response to DNA damage checkpoint signaling,BP,
16745,GO:0072425,1,0.91422807305988,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16746,GO:0072428,1,0.996221010610108,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16747,GO:0072429,1,0.986059982416904,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16748,GO:0072431,1,0.687945195753897,0,55,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16749,GO:0072432,1,0.986548583267913,0,1,response to G1 DNA damage checkpoint signaling,BP,
16750,GO:0072434,1,0.974256007659326,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16751,GO:0072487,1,0.975368512014978,0,4,MSL complex,CC,
16752,GO:0072488,1,0.937932888731178,0,8,ammonium transmembrane transport,BP,
16753,GO:0072492,1,0.996338670751475,0,1,host cell mitochondrial intermembrane space,CC,
16754,GO:0072497,1,0.929841401102746,0,8,mesenchymal stem cell differentiation,BP,
16755,GO:0072498,1,0.92384541144126,0,15,embryonic skeletal joint development,BP,
16756,GO:0072501,1,0.954875890000378,0,5,cellular divalent inorganic anion homeostasis,BP,
16757,GO:0072502,1,0.954875890000378,0,5,cellular trivalent inorganic anion homeostasis,BP,
16759,GO:0072505,1,0.933870647221348,0,8,divalent inorganic anion homeostasis,BP,
16760,GO:0072506,1,0.933870647221348,0,8,trivalent inorganic anion homeostasis,BP,
16764,GO:0072513,1,0.980884366267662,0,3,positive regulation of secondary heart field cardioblast proliferation,BP,
16765,GO:0072517,1,0.993584388881114,0,1,host cell viral assembly compartment,CC,
16766,GO:0072518,1,0.975165907550429,0,2,Rho-dependent protein serine/threonine kinase activity,MF,
16767,GO:0072520,1,0.915554775363716,0,11,seminiferous tubule development,BP,
16768,GO:0072521,1,0.0757394668988511,0,398,purine-containing compound metabolic process,BP,
16769,GO:0072522,1,0.374431590274803,0,165,purine-containing compound biosynthetic process,BP,
16770,GO:0072523,1,0.735441299959631,0,47,purine-containing compound catabolic process,BP,
16773,GO:0072526,1,0.961538162076486,0,7,pyridine-containing compound catabolic process,BP,
16774,GO:0072527,1,0.657252834173103,0,78,pyrimidine-containing compound metabolic process,BP,
16775,GO:0072528,1,0.828037913155389,0,37,pyrimidine-containing compound biosynthetic process,BP,
16776,GO:0072529,1,0.821810137854723,0,36,pyrimidine-containing compound catabolic process,BP,
16777,GO:0072530,1,0.959795835188212,0,9,purine-containing compound transmembrane transport,BP,
16778,GO:0072531,1,0.943898133635605,0,11,pyrimidine-containing compound transmembrane transport,BP,
16779,GO:0072534,1,0.974753142897501,0,2,perineuronal net,CC,
16781,GO:0072536,1,0.990047888983974,0,2,interleukin-23 receptor complex,CC,
16782,GO:0072537,1,0.924613910409135,0,11,fibroblast activation,BP,
16783,GO:0072538,1,0.840915509340817,0,25,T-helper 17 type immune response,BP,
16784,GO:0072539,1,0.854429439044422,0,22,T-helper 17 cell differentiation,BP,
16785,GO:0072540,1,0.948454362805193,0,10,T-helper 17 cell lineage commitment,BP,
16786,GO:0072542,1,0.931111377583091,0,12,protein phosphatase activator activity,MF,
16787,GO:0072544,1,0.996389026584328,0,1,L-DOPA binding,MF,
16788,GO:0072545,1,0.992268152497136,0,2,tyrosine binding,MF,
16789,GO:0072546,1,0.948400566520021,0,10,ER membrane protein complex,CC,
16790,GO:0072553,1,0.965419844272058,0,5,terminal button organization,BP,
16791,GO:0072554,1,0.989293502083023,0,2,blood vessel lumenization,BP,
16792,GO:0072557,1,0.975469026127435,0,4,IPAF inflammasome complex,CC,
16793,GO:0072558,1,0.979925374426708,0,4,NLRP1 inflammasome complex,CC,
16794,GO:0072559,1,0.951047744438146,0,8,NLRP3 inflammasome complex,CC,
16795,GO:0072560,1,0.990990701571002,0,2,type B pancreatic cell maturation,BP,
16797,GO:0072563,1,0.990685311052358,0,2,endothelial microparticle,CC,
16798,GO:0072564,1,0.992411866714491,0,2,blood microparticle formation,BP,
16799,GO:0072566,1,0.984173212460535,0,3,chemokine (C-X-C motif) ligand 1 production,BP,
16800,GO:0072567,1,0.932435493370319,0,13,chemokine (C-X-C motif) ligand 2 production,BP,
16801,GO:0072570,1,0.982763100845486,0,2,ADP-D-ribose binding,MF,
16802,GO:0072571,1,0.988707897735905,0,1,mono-ADP-D-ribose binding,MF,
16803,GO:0072572,1,0.995890034074941,0,1,poly-ADP-D-ribose binding,MF,
16804,GO:0072573,1,0.99154430026958,0,1,tolerance induction to lipopolysaccharide,BP,
16805,GO:0072574,1,0.882506940982579,0,19,hepatocyte proliferation,BP,
16806,GO:0072575,1,0.882506940982579,0,19,epithelial cell proliferation involved in liver morphogenesis,BP,
16807,GO:0072576,1,0.871072590056622,0,20,liver morphogenesis,BP,
16810,GO:0072579,1,0.991875105213165,0,1,glycine receptor clustering,BP,
16812,GO:0072584,1,0.923018959339701,0,12,caveolin-mediated endocytosis,BP,
16813,GO:0072586,1,0.991392237945291,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity,MF,
16814,GO:0072587,1,0.991392237945291,0,1,DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity,MF,
16815,GO:0072588,1,0.978424983264267,0,5,box H/ACA RNP complex,CC,
16816,GO:0072589,1,0.985779864699864,0,4,box H/ACA scaRNP complex,CC,
16817,GO:0072590,1,0.96958652467914,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16818,GO:0072591,1,0.988840893356306,0,1,citrate-L-glutamate ligase activity,MF,
16819,GO:0072592,1,0.975734930068889,0,5,oxygen metabolic process,BP,
16822,GO:0072595,1,0.763616895863128,0,41,maintenance of protein localization in organelle,BP,
16823,GO:0072599,1,0.615536290152857,0,111,establishment of protein localization to endoplasmic reticulum,BP,
16824,GO:0072655,1,0.473426927546143,0,132,establishment of protein localization to mitochondrion,BP,
16825,GO:0072656,1,0.96636126199512,0,5,maintenance of protein location in mitochondrion,BP,
16827,GO:0072658,1,0.963692390795354,0,2,maintenance of protein location in membrane,BP,
16829,GO:0072660,1,0.963692390795354,0,2,maintenance of protein location in plasma membrane,BP,
16830,GO:0072662,1,0.691007368302155,0,68,protein localization to peroxisome,BP,
16831,GO:0072663,1,0.691007368302155,0,68,establishment of protein localization to peroxisome,BP,
16832,GO:0072665,1,0.612073068067344,0,64,protein localization to vacuole,BP,
16833,GO:0072666,1,0.674119657345597,0,49,establishment of protein localization to vacuole,BP,
16834,GO:0072669,1,0.972154502207048,0,7,tRNA-splicing ligase complex,CC,
16835,GO:0072671,1,0.995269658514619,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16836,GO:0072672,1,0.943701131277182,0,9,neutrophil extravasation,BP,
16838,GO:0072674,1,0.935899742353954,0,7,multinuclear osteoclast differentiation,BP,
16839,GO:0072675,1,0.941352318485855,0,6,osteoclast fusion,BP,
16840,GO:0072676,1,0.57933449464609,0,95,lymphocyte migration,BP,
16841,GO:0072677,1,0.939458572803699,0,14,eosinophil migration,BP,
16842,GO:0072678,1,0.704133796933586,0,58,T cell migration,BP,
16843,GO:0072679,1,0.973080392753988,0,6,thymocyte migration,BP,
16844,GO:0072680,1,0.994169862436017,0,1,extracellular matrix-dependent thymocyte migration,BP,
16845,GO:0072681,1,0.994169862436017,0,1,fibronectin-dependent thymocyte migration,BP,
16846,GO:0072682,1,0.993642748452914,0,1,eosinophil extravasation,BP,
16847,GO:0072683,1,0.934471669203615,0,11,T cell extravasation,BP,
16848,GO:0072684,1,0.992799909664326,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
16849,GO:0072686,1,0.394251362413062,0,121,mitotic spindle,CC,
16850,GO:0072687,1,0.943768709757778,0,9,meiotic spindle,CC,
16851,GO:0072695,1,0.990598730271422,0,2,regulation of DNA recombination at telomere,BP,
16852,GO:0072697,1,0.928153181541717,0,11,protein localization to cell cortex,BP,
16853,GO:0072698,1,0.632951894438036,0,52,protein localization to microtubule cytoskeleton,BP,
16854,GO:0072702,1,0.989217982384045,0,1,response to methyl methanesulfonate,BP,
16855,GO:0072703,1,0.989217982384045,0,1,cellular response to methyl methanesulfonate,BP,
16856,GO:0072706,1,0.995237919618884,0,1,response to sodium dodecyl sulfate,BP,
16857,GO:0072707,1,0.995237919618884,0,1,cellular response to sodium dodecyl sulfate,BP,
16858,GO:0072708,1,0.97553945774967,0,5,response to sorbitol,BP,
16859,GO:0072709,1,0.985428341065365,0,3,cellular response to sorbitol,BP,
16860,GO:0072710,1,0.925955755865823,0,10,response to hydroxyurea,BP,
16861,GO:0072711,1,0.930714297663154,0,9,cellular response to hydroxyurea,BP,
16862,GO:0072714,1,0.996351081089854,0,1,response to selenite ion,BP,
16863,GO:0072715,1,0.996351081089854,0,1,cellular response to selenite ion,BP,
16864,GO:0072716,1,0.973232437433501,0,4,response to actinomycin D,BP,
16865,GO:0072717,1,0.978231440197101,0,3,cellular response to actinomycin D,BP,
16866,GO:0072718,1,0.938114062150337,0,9,response to cisplatin,BP,
16867,GO:0072719,1,0.961281340364471,0,6,cellular response to cisplatin,BP,
16868,GO:0072720,1,0.989807596705769,0,2,response to dithiothreitol,BP,
16869,GO:0072721,1,0.994890876864838,0,1,cellular response to dithiothreitol,BP,
16870,GO:0072733,1,0.986929427906562,0,3,response to staurosporine,BP,
16871,GO:0072734,1,0.986929427906562,0,3,cellular response to staurosporine,BP,
16872,GO:0072737,1,0.991101672170748,0,2,response to diamide,BP,
16873,GO:0072738,1,0.991101672170748,0,2,cellular response to diamide,BP,
16874,GO:0072739,1,0.991102631821732,0,2,response to anisomycin,BP,
16875,GO:0072740,1,0.996192496231238,0,1,cellular response to anisomycin,BP,
16876,GO:0072749,1,0.996283123762659,0,1,cellular response to cytochalasin B,BP,
16877,GO:0072750,1,0.996679631870473,0,1,cellular response to leptomycin B,BP,
16878,GO:0072752,1,0.982529770065698,0,2,cellular response to rapamycin,BP,
16879,GO:0072755,1,0.992918573909992,0,1,cellular response to benomyl,BP,
16880,GO:0072757,1,0.975240794591884,0,4,cellular response to camptothecin,BP,
16881,GO:0075044,1,0.945596387135857,0,7,positive regulation by symbiont of host autophagy,BP,
16882,GO:0075071,1,0.945596387135857,0,7,modulation by symbiont of host autophagy,BP,
16883,GO:0075136,1,0.971274201551379,0,3,response to host,BP,
16884,GO:0075294,1,0.956168724339483,0,10,positive regulation by symbiont of entry into host,BP,
16885,GO:0075341,1,0.995670670382441,0,1,host cell PML body,CC,
16886,GO:0075506,1,0.982143903430845,0,2,entry of viral genome into host nucleus through nuclear pore complex via importin,BP,
16887,GO:0075509,1,0.942322463770947,0,7,endocytosis involved in viral entry into host cell,BP,
16888,GO:0075512,1,0.987170806150054,0,1,clathrin-dependent endocytosis of virus by host cell,BP,
16889,GO:0075519,1,0.996866805152442,0,1,microtubule-dependent intracellular transport of viral material,BP,
16890,GO:0075521,1,0.996866805152442,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
16891,GO:0075522,1,0.934652337091563,0,10,IRES-dependent viral translational initiation,BP,
16892,GO:0075525,1,0.97342106763942,0,5,viral translational termination-reinitiation,BP,
16893,GO:0075606,1,0.996866805152442,0,1,transport of viral material towards nucleus,BP,
16894,GO:0075713,1,0.961118186632469,0,8,establishment of integrated proviral latency,BP,
16895,GO:0075732,1,0.963096851793694,0,4,viral penetration into host nucleus,BP,
16896,GO:0075733,1,0.684803526477946,0,52,intracellular transport of virus,BP,
16897,GO:0080008,1,0.807469174156071,0,31,Cul4-RING E3 ubiquitin ligase complex,CC,
16898,GO:0080009,1,0.911182867000203,0,15,mRNA methylation,BP,
16899,GO:0080019,1,0.985868013585868,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
16901,GO:0080030,1,0.976377943467718,0,4,methyl indole-3-acetate esterase activity,MF,
16902,GO:0080033,1,0.987922847387118,0,1,response to nitrite,BP,
16903,GO:0080048,1,0.994890876864838,0,1,GDP-D-glucose phosphorylase activity,MF,
16904,GO:0080058,1,0.996638479009536,0,1,protein deglutathionylation,BP,
16905,GO:0080084,1,0.967500334816149,0,3,5S rDNA binding,MF,
16907,GO:0080101,1,0.996799244009751,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
16908,GO:0080111,1,0.829215295376588,0,24,DNA demethylation,BP,
16909,GO:0080120,1,0.990741982331352,0,2,CAAX-box protein maturation,BP,
16910,GO:0080121,1,0.989939310949597,0,2,AMP transport,BP,
16911,GO:0080122,1,0.989939310949597,0,2,AMP transmembrane transporter activity,MF,
16912,GO:0080129,1,0.996765400625138,0,1,proteasome core complex assembly,BP,
16913,GO:0080132,1,0.995469875416489,0,1,fatty acid alpha-hydroxylase activity,MF,
16916,GO:0080144,1,0.961224269873842,0,4,amino acid homeostasis,BP,
16917,GO:0080146,1,0.996346806019679,0,1,L-cysteine desulfhydrase activity,MF,
16918,GO:0080154,1,0.882474410487342,0,20,regulation of fertilization,BP,
16919,GO:0080163,1,0.995522286319054,0,1,regulation of protein serine/threonine phosphatase activity,BP,
16920,GO:0080170,1,0.996588659266292,0,1,hydrogen peroxide transmembrane transport,BP,
16921,GO:0080171,1,0.645621963270419,0,62,lytic vacuole organization,BP,
16922,GO:0080182,1,0.842706276274134,0,18,histone H3-K4 trimethylation,BP,
16923,GO:0080184,1,0.977952970599537,0,5,response to phenylpropanoid,BP,
16924,GO:0085017,1,0.986784392616845,0,1,entry into host cell by a symbiont-containing vacuole,BP,
16925,GO:0085018,1,0.994919586867286,0,1,maintenance of symbiont-containing vacuole by host,BP,
16926,GO:0085020,1,0.957607267728504,0,8,protein K6-linked ubiquitination,BP,
16928,GO:0085032,1,0.993912702292961,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
16930,GO:0086002,1,0.640473369096124,0,49,cardiac muscle cell action potential involved in contraction,BP,
16931,GO:0086003,1,0.542382365312077,0,67,cardiac muscle cell contraction,BP,
16932,GO:0086004,1,0.692383401552418,0,37,regulation of cardiac muscle cell contraction,BP,
16933,GO:0086005,1,0.751161831847037,0,32,ventricular cardiac muscle cell action potential,BP,
16934,GO:0086006,1,0.952476478631039,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
16935,GO:0086007,1,0.933300992744018,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
16938,GO:0086010,1,0.660020123861474,0,35,membrane depolarization during action potential,BP,
16940,GO:0086012,1,0.796537432749902,0,21,membrane depolarization during cardiac muscle cell action potential,BP,
16942,GO:0086014,1,0.822704592589986,0,18,atrial cardiac muscle cell action potential,BP,
16943,GO:0086015,1,0.886965519963673,0,8,SA node cell action potential,BP,
16944,GO:0086016,1,0.883348152363735,0,9,AV node cell action potential,BP,
16945,GO:0086017,1,0.973182900416736,0,3,Purkinje myocyte action potential,BP,
16946,GO:0086018,1,0.886965519963673,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
16947,GO:0086019,1,0.748214386790183,0,29,cell-cell signaling involved in cardiac conduction,BP,
16948,GO:0086020,1,0.985537318969718,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16949,GO:0086021,1,0.985537318969718,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16951,GO:0086024,1,0.984668516336492,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16952,GO:0086026,1,0.822704592589986,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
16953,GO:0086027,1,0.883348152363735,0,9,AV node cell to bundle of His cell signaling,BP,
16954,GO:0086028,1,0.950311748036651,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
16955,GO:0086029,1,0.940897371400913,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16957,GO:0086036,1,0.948968456342826,0,7,regulation of cardiac muscle cell membrane potential,BP,
16958,GO:0086038,1,0.994890876864838,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16959,GO:0086039,1,0.984466785592737,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16960,GO:0086040,1,0.99125284323368,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16961,GO:0086041,1,0.986270360362717,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
16962,GO:0086042,1,0.93895034886518,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16963,GO:0086043,1,0.950311748036651,0,6,bundle of His cell action potential,BP,
16964,GO:0086045,1,0.931634632311444,0,5,membrane depolarization during AV node cell action potential,BP,
16965,GO:0086046,1,0.928105800541285,0,5,membrane depolarization during SA node cell action potential,BP,
16966,GO:0086047,1,0.973182900416736,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
16967,GO:0086048,1,0.969315538974988,0,3,membrane depolarization during bundle of His cell action potential,BP,
16968,GO:0086050,1,0.99472492509736,0,1,membrane repolarization during bundle of His cell action potential,BP,
16969,GO:0086052,1,0.99472492509736,0,1,membrane repolarization during SA node cell action potential,BP,
16970,GO:0086053,1,0.985537318969718,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
16971,GO:0086056,1,0.954141072490706,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16972,GO:0086057,1,0.992722916082396,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16973,GO:0086059,1,0.971196073699496,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
16974,GO:0086060,1,0.984027051562746,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
16975,GO:0086061,1,0.984027051562746,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
16976,GO:0086062,1,0.980762238345942,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
16977,GO:0086063,1,0.984027051562746,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
16980,GO:0086066,1,0.822704592589986,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
16981,GO:0086067,1,0.870556882616608,0,10,AV node cell to bundle of His cell communication,BP,
16982,GO:0086068,1,0.940897371400913,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16983,GO:0086069,1,0.891154058740601,0,13,bundle of His cell to Purkinje myocyte communication,BP,
16984,GO:0086070,1,0.8741223902996,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
16985,GO:0086072,1,0.995398173294519,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16986,GO:0086073,1,0.943293752952087,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16987,GO:0086075,1,0.979837228976655,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16988,GO:0086077,1,0.985537318969718,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16989,GO:0086080,1,0.883670244171463,0,13,protein binding involved in heterotypic cell-cell adhesion,MF,
16990,GO:0086082,1,0.995398173294519,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16991,GO:0086083,1,0.948968719698011,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16992,GO:0086087,1,0.99472492509736,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
16993,GO:0086089,1,0.978423360831293,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16994,GO:0086090,1,0.99472492509736,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
16995,GO:0086091,1,0.717574467473084,0,37,regulation of heart rate by cardiac conduction,BP,
16996,GO:0086092,1,0.987663223873138,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
16997,GO:0086096,1,0.996644807500605,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
16998,GO:0086097,1,0.986983360435019,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
16999,GO:0086098,1,0.987410630457413,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17000,GO:0086100,1,0.951179293756086,0,7,endothelin receptor signaling pathway,BP,
17002,GO:0089700,1,0.969462121170642,0,4,protein kinase D signaling,BP,
17003,GO:0089701,1,0.984500530549821,0,4,U2AF complex,CC,
17004,GO:0089709,1,0.963350045126474,0,6,L-histidine transmembrane transport,BP,
17005,GO:0089717,1,0.84462912109017,0,17,spanning component of membrane,CC,
17006,GO:0089718,1,0.742556145272876,0,38,amino acid import across plasma membrane,BP,
17007,GO:0089720,1,0.956337626289421,0,10,caspase binding,MF,
17008,GO:0090009,1,0.940575268012311,0,8,primitive streak formation,BP,
17009,GO:0090010,1,0.99596388352694,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17010,GO:0090022,1,0.855194712818727,0,31,regulation of neutrophil chemotaxis,BP,
17011,GO:0090023,1,0.887007213462303,0,25,positive regulation of neutrophil chemotaxis,BP,
17012,GO:0090024,1,0.978097938836329,0,3,negative regulation of neutrophil chemotaxis,BP,
17015,GO:0090027,1,0.968931943299915,0,5,negative regulation of monocyte chemotaxis,BP,
17016,GO:0090030,1,0.924060381362193,0,11,regulation of steroid hormone biosynthetic process,BP,
17017,GO:0090031,1,0.982321936474805,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17018,GO:0090032,1,0.9713391183348,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17019,GO:0090034,1,0.9964709803441,0,1,regulation of chaperone-mediated protein complex assembly,BP,
17020,GO:0090035,1,0.9964709803441,0,1,positive regulation of chaperone-mediated protein complex assembly,BP,
17021,GO:0090036,1,0.876751134994142,0,17,regulation of protein kinase C signaling,BP,
17022,GO:0090037,1,0.945072343641919,0,9,positive regulation of protein kinase C signaling,BP,
17023,GO:0090038,1,0.964323636083447,0,4,negative regulation of protein kinase C signaling,BP,
17024,GO:0090042,1,0.877654133986844,0,13,tubulin deacetylation,BP,
17025,GO:0090043,1,0.90252586125701,0,10,regulation of tubulin deacetylation,BP,
17026,GO:0090044,1,0.9964709803441,0,1,positive regulation of tubulin deacetylation,BP,
17027,GO:0090045,1,0.939960643676569,0,8,positive regulation of deacetylase activity,BP,
17030,GO:0090051,1,0.890904741601015,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17031,GO:0090063,1,0.95915832049906,0,5,positive regulation of microtubule nucleation,BP,
17032,GO:0090065,1,0.989020779805561,0,2,regulation of production of siRNA involved in RNA interference,BP,
17034,GO:0090067,1,0.991326445411605,0,1,regulation of thalamus size,BP,
17036,GO:0090069,1,0.899940675974873,0,15,regulation of ribosome biogenesis,BP,
17037,GO:0090070,1,0.948080657213223,0,9,positive regulation of ribosome biogenesis,BP,
17038,GO:0090071,1,0.958892155169153,0,5,negative regulation of ribosome biogenesis,BP,
17039,GO:0090074,1,0.9883458450248,0,1,negative regulation of protein homodimerization activity,BP,
17041,GO:0090076,1,0.98315524267223,0,2,relaxation of skeletal muscle,BP,
17044,GO:0090080,1,0.976609207110336,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17045,GO:0090081,1,0.97817441408122,0,4,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17046,GO:0090082,1,0.97817441408122,0,4,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17047,GO:0090083,1,0.893091106816598,0,15,regulation of inclusion body assembly,BP,
17048,GO:0090084,1,0.918530965422973,0,10,negative regulation of inclusion body assembly,BP,
17049,GO:0090085,1,0.929172921871048,0,11,regulation of protein deubiquitination,BP,
17050,GO:0090086,1,0.989679228975582,0,3,negative regulation of protein deubiquitination,BP,
17052,GO:0090088,1,0.991525261609797,0,2,regulation of oligopeptide transport,BP,
17053,GO:0090089,1,0.991525261609797,0,2,regulation of dipeptide transport,BP,
17057,GO:0090094,1,0.991783298120923,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17058,GO:0090095,1,0.9955707955465,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17059,GO:0090096,1,0.9955707955465,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17061,GO:0090101,1,0.390555060500348,0,117,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17063,GO:0090103,1,0.855587008625668,0,23,cochlea morphogenesis,BP,
17064,GO:0090107,1,0.973493392791899,0,3,regulation of high-density lipoprotein particle assembly,BP,
17065,GO:0090108,1,0.976774790515873,0,2,positive regulation of high-density lipoprotein particle assembly,BP,
17066,GO:0090109,1,0.571124655357462,0,62,regulation of cell-substrate junction assembly,BP,
17067,GO:0090110,1,0.88767973124948,0,15,COPII-coated vesicle cargo loading,BP,
17068,GO:0090113,1,0.974101094811901,0,4,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17069,GO:0090114,1,0.598930140507367,0,71,COPII-coated vesicle budding,BP,
17070,GO:0090116,1,0.974213734181369,0,3,C-5 methylation of cytosine,BP,
17072,GO:0090119,1,0.98742592979431,0,2,vesicle-mediated cholesterol transport,BP,
17073,GO:0090122,1,0.996049687522993,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17074,GO:0090128,1,0.892610206729925,0,13,regulation of synapse maturation,BP,
17075,GO:0090129,1,0.927870408781868,0,8,positive regulation of synapse maturation,BP,
17077,GO:0090131,1,0.978196844908487,0,5,mesenchyme migration,BP,
17079,GO:0090133,1,0.996782436719845,0,1,mesendoderm migration,BP,
17080,GO:0090134,1,0.996782436719845,0,1,cell migration involved in mesendoderm migration,BP,
17081,GO:0090135,1,0.981330744265188,0,3,actin filament branching,BP,
17082,GO:0090136,1,0.884569453229259,0,15,epithelial cell-cell adhesion,BP,
17083,GO:0090138,1,0.993112079077958,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17084,GO:0090140,1,0.826162362139658,0,23,regulation of mitochondrial fission,BP,
17085,GO:0090141,1,0.897536992826626,0,15,positive regulation of mitochondrial fission,BP,
17086,GO:0090143,1,0.996869044864044,0,1,nucleoid organization,BP,
17087,GO:0090144,1,0.996869044864044,0,1,mitochondrial nucleoid organization,BP,
17089,GO:0090149,1,0.986973943802226,0,2,mitochondrial membrane fission,BP,
17091,GO:0090151,1,0.787065723330652,0,47,establishment of protein localization to mitochondrial membrane,BP,
17092,GO:0090152,1,0.992409621033618,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17093,GO:0090153,1,0.910104226679999,0,16,regulation of sphingolipid biosynthetic process,BP,
17094,GO:0090154,1,0.951240798678659,0,9,positive regulation of sphingolipid biosynthetic process,BP,
17095,GO:0090155,1,0.96009296518394,0,6,negative regulation of sphingolipid biosynthetic process,BP,
17096,GO:0090156,1,0.968828906684446,0,5,cellular sphingolipid homeostasis,BP,
17097,GO:0090158,1,0.973038185490866,0,5,endoplasmic reticulum membrane organization,BP,
17098,GO:0090160,1,0.941104667861513,0,9,Golgi to lysosome transport,BP,
17099,GO:0090161,1,0.872541761808776,0,14,Golgi ribbon formation,BP,
17100,GO:0090162,1,0.777658105240012,0,30,establishment of epithelial cell polarity,BP,
17101,GO:0090164,1,0.980740036445362,0,2,asymmetric Golgi ribbon formation,BP,
17102,GO:0090166,1,0.959758702162618,0,7,Golgi disassembly,BP,
17103,GO:0090168,1,0.971842445665326,0,4,Golgi reassembly,BP,
17104,GO:0090169,1,0.838439964225621,0,24,regulation of spindle assembly,BP,
17105,GO:0090170,1,0.980935150516858,0,4,regulation of Golgi inheritance,BP,
17106,GO:0090171,1,0.99277493391596,0,1,chondrocyte morphogenesis,BP,
17109,GO:0090176,1,0.977122110040821,0,3,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17110,GO:0090177,1,0.883771209160445,0,15,establishment of planar polarity involved in neural tube closure,BP,
17111,GO:0090178,1,0.88668923688335,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17112,GO:0090179,1,0.894581612211548,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17113,GO:0090181,1,0.682034524840114,0,56,regulation of cholesterol metabolic process,BP,
17114,GO:0090182,1,0.992499194951802,0,2,regulation of secretion of lysosomal enzymes,BP,
17117,GO:0090185,1,0.927836931021637,0,14,negative regulation of kidney development,BP,
17118,GO:0090186,1,0.964367543456866,0,5,regulation of pancreatic juice secretion,BP,
17119,GO:0090187,1,0.995980619695328,0,1,positive regulation of pancreatic juice secretion,BP,
17120,GO:0090188,1,0.968260605737772,0,4,negative regulation of pancreatic juice secretion,BP,
17121,GO:0090189,1,0.892976575435618,0,19,regulation of branching involved in ureteric bud morphogenesis,BP,
17122,GO:0090190,1,0.90363307533649,0,16,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17123,GO:0090191,1,0.992311009555807,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17124,GO:0090192,1,0.929988223027984,0,12,regulation of glomerulus development,BP,
17125,GO:0090193,1,0.945878244551287,0,9,positive regulation of glomerulus development,BP,
17126,GO:0090194,1,0.983210047711152,0,3,negative regulation of glomerulus development,BP,
17127,GO:0090199,1,0.785722178681186,0,46,regulation of release of cytochrome c from mitochondria,BP,
17128,GO:0090200,1,0.876567511763042,0,27,positive regulation of release of cytochrome c from mitochondria,BP,
17129,GO:0090201,1,0.896015232115638,0,19,negative regulation of release of cytochrome c from mitochondria,BP,
17130,GO:0090202,1,0.968598345484195,0,4,gene looping,BP,
17131,GO:0090204,1,0.979770211968193,0,3,protein localization to nuclear pore,BP,
17132,GO:0090205,1,0.947060579270295,0,8,positive regulation of cholesterol metabolic process,BP,
17133,GO:0090206,1,0.975794215004564,0,5,negative regulation of cholesterol metabolic process,BP,
17134,GO:0090207,1,0.824529388640275,0,31,regulation of triglyceride metabolic process,BP,
17135,GO:0090208,1,0.905220374737979,0,19,positive regulation of triglyceride metabolic process,BP,
17136,GO:0090209,1,0.942731640269864,0,7,negative regulation of triglyceride metabolic process,BP,
17137,GO:0090210,1,0.978971245352371,0,3,regulation of establishment of blood-brain barrier,BP,
17138,GO:0090212,1,0.987310805127623,0,2,negative regulation of establishment of blood-brain barrier,BP,
17139,GO:0090214,1,0.981625471629597,0,2,spongiotrophoblast layer developmental growth,BP,
17140,GO:0090215,1,0.993219040230662,0,1,regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17141,GO:0090216,1,0.993219040230662,0,1,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity,BP,
17142,GO:0090218,1,0.772875645532304,0,36,positive regulation of lipid kinase activity,BP,
17143,GO:0090219,1,0.981210500966997,0,3,negative regulation of lipid kinase activity,BP,
17144,GO:0090220,1,0.947507860849811,0,7,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17145,GO:0090222,1,0.972346489391331,0,2,centrosome-templated microtubule nucleation,BP,
17146,GO:0090224,1,0.748546992369634,0,38,regulation of spindle organization,BP,
17147,GO:0090226,1,0.996842415658143,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17148,GO:0090230,1,0.967978875935124,0,4,regulation of centromere complex assembly,BP,
17149,GO:0090231,1,0.913279169067806,0,14,regulation of spindle checkpoint,BP,
17150,GO:0090232,1,0.950182179641878,0,7,positive regulation of spindle checkpoint,BP,
17151,GO:0090233,1,0.995050444321846,0,1,negative regulation of spindle checkpoint,BP,
17152,GO:0090234,1,0.976939071888337,0,3,regulation of kinetochore assembly,BP,
17153,GO:0090235,1,0.921027633340588,0,8,regulation of metaphase plate congression,BP,
17154,GO:0090237,1,0.961215651374708,0,6,regulation of arachidonic acid secretion,BP,
17155,GO:0090238,1,0.970576757132631,0,5,positive regulation of arachidonic acid secretion,BP,
17156,GO:0090239,1,0.921715251690634,0,14,regulation of histone H4 acetylation,BP,
17157,GO:0090240,1,0.956437787450193,0,7,positive regulation of histone H4 acetylation,BP,
17158,GO:0090241,1,0.971577354421338,0,6,negative regulation of histone H4 acetylation,BP,
17159,GO:0090242,1,0.993920751779109,0,1,retinoic acid receptor signaling pathway involved in somitogenesis,BP,
17160,GO:0090244,1,0.965532488998998,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17161,GO:0090245,1,0.955362012053263,0,4,axis elongation involved in somitogenesis,BP,
17162,GO:0090246,1,0.99147817964269,0,1,convergent extension involved in somitogenesis,BP,
17163,GO:0090247,1,0.99520171579299,0,1,cell motility involved in somitogenic axis elongation,BP,
17164,GO:0090249,1,0.99520171579299,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17165,GO:0090251,1,0.979156360895677,0,1,protein localization involved in establishment of planar polarity,BP,
17167,GO:0090258,1,0.969082579931004,0,4,negative regulation of mitochondrial fission,BP,
17168,GO:0090259,1,0.966266248513912,0,5,regulation of retinal ganglion cell axon guidance,BP,
17169,GO:0090260,1,0.982892967123707,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17170,GO:0090261,1,0.98395480477651,0,4,positive regulation of inclusion body assembly,BP,
17172,GO:0090264,1,0.988062399489242,0,3,regulation of immune complex clearance by monocytes and macrophages,BP,
17173,GO:0090265,1,0.991563943492232,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17174,GO:0090266,1,0.913279169067806,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17175,GO:0090267,1,0.950182179641878,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17176,GO:0090269,1,0.935805672259127,0,8,fibroblast growth factor production,BP,
17177,GO:0090270,1,0.935805672259127,0,8,regulation of fibroblast growth factor production,BP,
17178,GO:0090271,1,0.954561414285155,0,5,positive regulation of fibroblast growth factor production,BP,
17179,GO:0090272,1,0.980360492443536,0,3,negative regulation of fibroblast growth factor production,BP,
17180,GO:0090273,1,0.989049925566875,0,2,regulation of somatostatin secretion,BP,
17181,GO:0090274,1,0.994129353515148,0,1,positive regulation of somatostatin secretion,BP,
17182,GO:0090275,1,0.994890876864838,0,1,negative regulation of somatostatin secretion,BP,
17184,GO:0090277,1,0.596151899541207,0,85,positive regulation of peptide hormone secretion,BP,
17186,GO:0090279,1,0.80165716619026,0,34,regulation of calcium ion import,BP,
17187,GO:0090280,1,0.888925680594445,0,18,positive regulation of calcium ion import,BP,
17188,GO:0090281,1,0.980848069224492,0,5,negative regulation of calcium ion import,BP,
17189,GO:0090282,1,0.994426974810579,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17190,GO:0090283,1,0.977509597004195,0,3,regulation of protein glycosylation in Golgi,BP,
17191,GO:0090284,1,0.98624152364818,0,1,positive regulation of protein glycosylation in Golgi,BP,
17192,GO:0090285,1,0.991147480238145,0,2,negative regulation of protein glycosylation in Golgi,BP,
17194,GO:0090288,1,0.316165419930104,0,144,negative regulation of cellular response to growth factor stimulus,BP,
17195,GO:0090289,1,0.980600383230738,0,3,regulation of osteoclast proliferation,BP,
17196,GO:0090290,1,0.996784312826241,0,1,positive regulation of osteoclast proliferation,BP,
17197,GO:0090291,1,0.983764380130422,0,2,negative regulation of osteoclast proliferation,BP,
17198,GO:0090292,1,0.954145572075009,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17199,GO:0090293,1,0.995877903634853,0,1,nitrogen catabolite regulation of transcription,BP,
17200,GO:0090294,1,0.995877903634853,0,1,nitrogen catabolite activation of transcription,BP,
17201,GO:0090296,1,0.974171332713835,0,4,regulation of mitochondrial DNA replication,BP,
17202,GO:0090297,1,0.996683238342371,0,1,positive regulation of mitochondrial DNA replication,BP,
17203,GO:0090298,1,0.984210533489861,0,2,negative regulation of mitochondrial DNA replication,BP,
17204,GO:0090299,1,0.996420874330746,0,1,regulation of neural crest formation,BP,
17205,GO:0090301,1,0.996420874330746,0,1,negative regulation of neural crest formation,BP,
17208,GO:0090305,1,0.164319890129437,0,280,nucleic acid phosphodiester bond hydrolysis,BP,
17209,GO:0090306,1,0.963842214507981,0,4,spindle assembly involved in meiosis,BP,
17210,GO:0090307,1,0.654074998331536,0,59,mitotic spindle assembly,BP,
17211,GO:0090308,1,0.907694129660777,0,11,regulation of DNA methylation-dependent heterochromatin assembly,BP,
17212,GO:0090309,1,0.92898983965243,0,9,positive regulation of DNA methylation-dependent heterochromatin assembly,BP,
17213,GO:0090310,1,0.977093139037223,0,2,negative regulation of DNA methylation-dependent heterochromatin assembly,BP,
17214,GO:0090311,1,0.709168255564051,0,42,regulation of protein deacetylation,BP,
17215,GO:0090312,1,0.860536459433125,0,20,positive regulation of protein deacetylation,BP,
17218,GO:0090315,1,0.974771161987326,0,5,negative regulation of protein targeting to membrane,BP,
17221,GO:0090322,1,0.849796743487443,0,32,regulation of superoxide metabolic process,BP,
17222,GO:0090323,1,0.996883783413978,0,1,prostaglandin secretion involved in immune response,BP,
17223,GO:0090324,1,0.967820993383794,0,6,negative regulation of oxidative phosphorylation,BP,
17224,GO:0090325,1,0.977716605010622,0,4,regulation of locomotion involved in locomotory behavior,BP,
17225,GO:0090326,1,0.993880460326495,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17226,GO:0090327,1,0.992086867989554,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17227,GO:0090329,1,0.720539259882309,0,50,regulation of DNA-dependent DNA replication,BP,
17229,GO:0090331,1,0.919305959491956,0,12,negative regulation of platelet aggregation,BP,
17230,GO:0090335,1,0.833682329924838,0,23,regulation of brown fat cell differentiation,BP,
17231,GO:0090336,1,0.87969590535229,0,16,positive regulation of brown fat cell differentiation,BP,
17232,GO:0090340,1,0.995980619695328,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17233,GO:0090341,1,0.996504666815365,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17234,GO:0090342,1,0.733454992249982,0,46,regulation of cell aging,BP,
17235,GO:0090343,1,0.936904523641818,0,14,positive regulation of cell aging,BP,
17236,GO:0090344,1,0.838871521841773,0,23,negative regulation of cell aging,BP,
17237,GO:0090345,1,0.991839657594544,0,2,cellular organohalogen metabolic process,BP,
17238,GO:0090346,1,0.991839657594544,0,2,cellular organofluorine metabolic process,BP,
17239,GO:0090347,1,0.996485303877563,0,1,regulation of cellular organohalogen metabolic process,BP,
17240,GO:0090348,1,0.996485303877563,0,1,regulation of cellular organofluorine metabolic process,BP,
17241,GO:0090349,1,0.996485303877563,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17242,GO:0090350,1,0.996485303877563,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17243,GO:0090357,1,0.996695800687134,0,1,regulation of tryptophan metabolic process,BP,
17244,GO:0090360,1,0.983420452487383,0,3,platelet-derived growth factor production,BP,
17245,GO:0090361,1,0.983420452487383,0,3,regulation of platelet-derived growth factor production,BP,
17246,GO:0090362,1,0.987383309847714,0,2,positive regulation of platelet-derived growth factor production,BP,
17247,GO:0090370,1,0.963903808480748,0,4,negative regulation of cholesterol efflux,BP,
17248,GO:0090381,1,0.948896638423344,0,7,regulation of heart induction,BP,
17249,GO:0090382,1,0.76070108334941,0,46,phagosome maturation,BP,
17250,GO:0090383,1,0.872561092701435,0,27,phagosome acidification,BP,
17251,GO:0090384,1,0.99618078585442,0,1,phagosome-lysosome docking,BP,
17252,GO:0090385,1,0.950448610945275,0,9,phagosome-lysosome fusion,BP,
17253,GO:0090386,1,0.977313386358011,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17254,GO:0090387,1,0.977313386358011,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17255,GO:0090389,1,0.985515049482797,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17257,GO:0090398,1,0.655727329798409,0,64,cellular senescence,BP,
17259,GO:0090400,1,0.952185410465406,0,8,stress-induced premature senescence,BP,
17260,GO:0090402,1,0.990900547113925,0,2,oncogene-induced cell senescence,BP,
17261,GO:0090403,1,0.975072097864503,0,4,oxidative stress-induced premature senescence,BP,
17263,GO:0090409,1,0.995680243824821,0,1,malonyl-CoA synthetase activity,MF,
17264,GO:0090410,1,0.995680243824821,0,1,malonate catabolic process,BP,
17265,GO:0090416,1,0.995245458510889,0,1,nicotinate transmembrane transporter activity,MF,
17266,GO:0090420,1,0.996612746461703,0,1,naphthalene-containing compound metabolic process,BP,
17267,GO:0090422,1,0.991560415731157,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17268,GO:0090425,1,0.994328439527581,0,1,acinar cell differentiation,BP,
17269,GO:0090427,1,0.979140081052537,0,3,activation of meiosis,BP,
17270,GO:0090429,1,0.996430763181575,0,1,detection of endogenous biotic stimulus,BP,
17271,GO:0090435,1,0.951529489958938,0,8,protein localization to nuclear envelope,BP,
17272,GO:0090443,1,0.979866470620975,0,3,FAR/SIN/STRIPAK complex,CC,
17273,GO:0090461,1,0.961224269873842,0,4,glutamate homeostasis,BP,
17274,GO:0090472,1,0.99203173826053,0,1,dibasic protein processing,BP,
17275,GO:0090480,1,0.994048910858054,0,1,purine nucleotide-sugar transmembrane transport,BP,
17276,GO:0090481,1,0.93900576857795,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17277,GO:0090482,1,0.846727081130843,0,27,vitamin transmembrane transporter activity,MF,
17278,GO:0090486,1,0.994890876864838,0,1,small RNA 2'-O-methyltransferase,MF,
17279,GO:0090493,1,0.919570245386098,0,17,catecholamine uptake,BP,
17280,GO:0090494,1,0.923003689910155,0,16,dopamine uptake,BP,
17281,GO:0090498,1,0.971659646166142,0,4,extrinsic component of Golgi membrane,CC,
17282,GO:0090500,1,0.982055027990665,0,4,endocardial cushion to mesenchymal transition,BP,
17283,GO:0090501,1,0.396826287106557,0,144,RNA phosphodiester bond hydrolysis,BP,
17284,GO:0090502,1,0.615249386808888,0,75,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17285,GO:0090503,1,0.753112638605048,0,42,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17288,GO:0090520,1,0.936563721699963,0,11,sphingolipid mediated signaling pathway,BP,
17289,GO:0090521,1,0.96652675255249,0,4,glomerular visceral epithelial cell migration,BP,
17290,GO:0090522,1,0.994640335001841,0,1,vesicle tethering involved in exocytosis,BP,
17291,GO:0090527,1,0.938663529038845,0,10,actin filament reorganization,BP,
17292,GO:0090529,1,0.996241409002472,0,1,cell septum assembly,BP,
17294,GO:0090534,1,0.996379022716881,0,1,calcium ion-transporting ATPase complex,CC,
17295,GO:0090537,1,0.981515760146553,0,2,CERF complex,CC,
17296,GO:0090541,1,0.986575900076673,0,2,MIT domain binding,MF,
17297,GO:0090543,1,0.798404819593249,0,30,Flemming body,CC,
17298,GO:0090545,1,0.870206512192857,0,15,CHD-type complex,CC,
17299,GO:0090554,1,0.946342233465172,0,5,phosphatidylcholine floppase activity,MF,
17300,GO:0090555,1,0.976778836090539,0,2,phosphatidylethanolamine flippase activity,MF,
17301,GO:0090556,1,0.967911218376424,0,2,phosphatidylserine floppase activity,MF,
17302,GO:0090557,1,0.906060775249371,0,10,establishment of endothelial intestinal barrier,BP,
17304,GO:0090560,1,0.995867740335858,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17305,GO:0090571,1,0.97078406079951,0,6,RNA polymerase II transcription repressor complex,CC,
17306,GO:0090575,1,0.356515441215841,0,152,RNA polymerase II transcription regulator complex,CC,
17307,GO:0090576,1,0.929723957417344,0,9,RNA polymerase III transcription regulator complex,CC,
17308,GO:0090579,1,0.968598345484195,0,4,dsDNA loop formation,BP,
17311,GO:0090598,1,0.976933086163236,0,4,male anatomical structure morphogenesis,BP,
17312,GO:0090599,1,0.951850086711787,0,5,alpha-glucosidase activity,MF,
17313,GO:0090600,1,0.99261897132761,0,1,alpha-1,3-glucosidase activity,MF,
17314,GO:0090601,1,0.990125428856343,0,1,enucleation,BP,
17315,GO:0090611,1,0.971762208600586,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17316,GO:0090615,1,0.987401896541981,0,2,mitochondrial mRNA processing,BP,
17317,GO:0090616,1,0.991205193332263,0,1,mitochondrial mRNA 3'-end processing,BP,
17318,GO:0090618,1,0.978767682198785,0,2,DNA clamp unloading,BP,
17319,GO:0090624,1,0.989807596705769,0,2,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17320,GO:0090625,1,0.994890876864838,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17322,GO:0090634,1,0.984372002929602,0,3,microglial cell mediated cytotoxicity,BP,
17323,GO:0090646,1,0.940573215321426,0,12,mitochondrial tRNA processing,BP,
17324,GO:0090647,1,0.945749646504311,0,8,modulation of age-related behavioral decline,BP,
17325,GO:0090648,1,0.988074666718824,0,1,response to environmental enrichment,BP,
17326,GO:0090649,1,0.924915268566941,0,10,response to oxygen-glucose deprivation,BP,
17327,GO:0090650,1,0.931231759740834,0,8,cellular response to oxygen-glucose deprivation,BP,
17328,GO:0090651,1,0.978975794229691,0,3,apical cytoplasm,CC,
17329,GO:0090656,1,0.908098356603238,0,14,t-circle formation,BP,
17330,GO:0090657,1,0.93279914019301,0,10,telomeric loop disassembly,BP,
17331,GO:0090659,1,0.779303621239326,0,29,walking behavior,BP,
17332,GO:0090660,1,0.975573250553151,0,4,cerebrospinal fluid circulation,BP,
17333,GO:0090661,1,0.985779864699864,0,4,box H/ACA telomerase RNP complex,CC,
17334,GO:0090663,1,0.993425977183072,0,2,galanin-activated signaling pathway,BP,
17335,GO:0090665,1,0.856983670706874,0,19,glycoprotein complex,CC,
17336,GO:0090666,1,0.978834759242458,0,5,scaRNA localization to Cajal body,BP,
17337,GO:0090667,1,0.985127942610219,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17338,GO:0090668,1,0.985127942610219,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17339,GO:0090669,1,0.979298600136012,0,4,telomerase RNA stabilization,BP,
17340,GO:0090670,1,0.909942984005513,0,19,RNA localization to Cajal body,BP,
17341,GO:0090671,1,0.909942984005513,0,19,telomerase RNA localization to Cajal body,BP,
17342,GO:0090672,1,0.909942984005513,0,19,telomerase RNA localization,BP,
17343,GO:0090673,1,0.962374620588663,0,5,endothelial cell-matrix adhesion,BP,
17344,GO:0090674,1,0.975979752153169,0,4,endothelial cell-matrix adhesion via fibronectin,BP,
17345,GO:0090675,1,0.991938061438258,0,1,intermicrovillar adhesion,BP,
17346,GO:0090677,1,0.969064612271277,0,5,reversible differentiation,BP,
17347,GO:0090678,1,0.990939049153259,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17348,GO:0090679,1,0.977927536606342,0,3,cell differentiation involved in phenotypic switching,BP,
17349,GO:0090685,1,0.909942984005513,0,19,RNA localization to nucleus,BP,
17350,GO:0090694,1,0.976197452148476,0,2,Scc2-Scc4 cohesin loading complex,CC,
17351,GO:0090713,1,0.935750107114699,0,11,immunological memory process,BP,
17352,GO:0090715,1,0.945712215535815,0,8,immunological memory formation process,BP,
17353,GO:0090716,1,0.989471887443851,0,3,adaptive immune memory response,BP,
17354,GO:0090720,1,0.982878431766141,0,1,primary adaptive immune response,BP,
17355,GO:0090721,1,0.982878431766141,0,1,primary adaptive immune response involving T cells and B cells,BP,
17356,GO:0090722,1,0.970082738587309,0,4,receptor-receptor interaction,MF,
17357,GO:0090724,1,0.976270332484996,0,4,central region of growth cone,CC,
17358,GO:0090725,1,0.996829239940352,0,1,peripheral region of growth cone,CC,
17359,GO:0090730,1,0.995441371174048,0,1,Las1 complex,CC,
17360,GO:0090731,1,0.996730590415193,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17361,GO:0090734,1,0.612612443539224,0,68,site of DNA damage,CC,
17362,GO:0090735,1,0.973388881565455,0,6,DNA repair complex assembly,BP,
17363,GO:0090737,1,0.908098356603238,0,14,telomere maintenance via telomere trimming,BP,
17364,GO:0090741,1,0.943738389879405,0,13,pigment granule membrane,CC,
17365,GO:0095500,1,0.863362568529618,0,25,acetylcholine receptor signaling pathway,BP,
17366,GO:0097001,1,0.933680019112094,0,13,ceramide binding,MF,
17367,GO:0097003,1,0.988422970004704,0,2,adipokinetic hormone receptor activity,MF,
17369,GO:0097009,1,0.764770699971199,0,35,energy homeostasis,BP,
17370,GO:0097010,1,0.97780302787733,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17371,GO:0097011,1,0.956058593777385,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17372,GO:0097012,1,0.956058593777385,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17374,GO:0097014,1,0.396723797461905,0,105,ciliary plasm,CC,
17375,GO:0097016,1,0.974890278363435,0,4,L27 domain binding,MF,
17376,GO:0097017,1,0.990315511740164,0,2,renal protein absorption,BP,
17377,GO:0097018,1,0.995341402520803,0,1,renal albumin absorption,BP,
17378,GO:0097020,1,0.993736589106426,0,1,COPII adaptor activity,MF,
17379,GO:0097021,1,0.955398948050215,0,6,lymphocyte migration into lymphoid organs,BP,
17380,GO:0097022,1,0.976839055521896,0,2,lymphocyte migration into lymph node,BP,
17381,GO:0097025,1,0.965139448229208,0,5,MPP7-DLG1-LIN7 complex,CC,
17382,GO:0097026,1,0.974432644237932,0,4,dendritic cell dendrite assembly,BP,
17383,GO:0097027,1,0.95613683872959,0,8,ubiquitin-protein transferase activator activity,MF,
17384,GO:0097028,1,0.801020863317317,0,41,dendritic cell differentiation,BP,
17385,GO:0097029,1,0.984296898021523,0,4,mature conventional dendritic cell differentiation,BP,
17386,GO:0097035,1,0.650123746166485,0,48,regulation of membrane lipid distribution,BP,
17387,GO:0097036,1,0.996590607678115,0,1,regulation of plasma membrane sterol distribution,BP,
17388,GO:0097037,1,0.983672340775597,0,3,heme export,BP,
17389,GO:0097038,1,0.858618143066779,0,20,perinuclear endoplasmic reticulum,CC,
17390,GO:0097039,1,0.969098780961883,0,4,protein linear polyubiquitination,BP,
17391,GO:0097045,1,0.990842193120657,0,1,phosphatidylserine exposure on blood platelet,BP,
17392,GO:0097048,1,0.941196872944501,0,11,dendritic cell apoptotic process,BP,
17394,GO:0097050,1,0.92201184477464,0,10,type B pancreatic cell apoptotic process,BP,
17395,GO:0097051,1,0.969735912517437,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17396,GO:0097052,1,0.973818670592489,0,5,L-kynurenine metabolic process,BP,
17397,GO:0097053,1,0.991988763927262,0,2,L-kynurenine catabolic process,BP,
17398,GO:0097055,1,0.990722683767864,0,2,agmatine biosynthetic process,BP,
17399,GO:0097056,1,0.981640144524058,0,3,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17400,GO:0097057,1,0.992513559212437,0,2,TRAF2-GSTP1 complex,CC,
17401,GO:0097058,1,0.992594611798728,0,2,CRLF-CLCF1 complex,CC,
17402,GO:0097059,1,0.992394117444522,0,2,CNTFR-CLCF1 complex,CC,
17405,GO:0097062,1,0.861374510757447,0,18,dendritic spine maintenance,BP,
17406,GO:0097064,1,0.760200314271984,0,35,ncRNA export from nucleus,BP,
17407,GO:0097065,1,0.959154780830411,0,6,anterior head development,BP,
17409,GO:0097067,1,0.882635740576424,0,16,cellular response to thyroid hormone stimulus,BP,
17410,GO:0097068,1,0.974662341966917,0,4,response to thyroxine,BP,
17411,GO:0097069,1,0.987345713161486,0,2,cellular response to thyroxine stimulus,BP,
17412,GO:0097070,1,0.961464910601775,0,5,ductus arteriosus closure,BP,
17413,GO:0097079,1,0.994001994752578,0,1,selenite:proton symporter activity,MF,
17414,GO:0097080,1,0.994001994752578,0,1,plasma membrane selenite transport,BP,
17416,GO:0097086,1,0.99312870677681,0,1,amniotic stem cell differentiation,BP,
17417,GO:0097089,1,0.988128699134413,0,3,methyl-branched fatty acid metabolic process,BP,
17418,GO:0097090,1,0.893523866240271,0,11,presynaptic membrane organization,BP,
17420,GO:0097094,1,0.886542426189512,0,15,craniofacial suture morphogenesis,BP,
17421,GO:0097100,1,0.973947595378306,0,5,supercoiled DNA binding,MF,
17422,GO:0097101,1,0.984870688361265,0,3,blood vessel endothelial cell fate specification,BP,
17423,GO:0097102,1,0.989247455206729,0,2,endothelial tip cell fate specification,BP,
17424,GO:0097104,1,0.88026201587185,0,12,postsynaptic membrane assembly,BP,
17425,GO:0097105,1,0.906672136009935,0,10,presynaptic membrane assembly,BP,
17428,GO:0097108,1,0.971148472048533,0,3,hedgehog family protein binding,MF,
17429,GO:0097109,1,0.950857072974232,0,5,neuroligin family protein binding,MF,
17431,GO:0097111,1,0.974773165900662,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17434,GO:0097114,1,0.953278049883843,0,4,NMDA glutamate receptor clustering,BP,
17435,GO:0097115,1,0.990580271672831,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17436,GO:0097116,1,0.961904327501731,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17437,GO:0097117,1,0.986391256249277,0,1,guanylate kinase-associated protein clustering,BP,
17438,GO:0097118,1,0.949783425102299,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17439,GO:0097119,1,0.906881010982236,0,9,postsynaptic density protein 95 clustering,BP,
17441,GO:0097123,1,0.991942913738532,0,2,cyclin A1-CDK2 complex,CC,
17442,GO:0097124,1,0.983460412093747,0,4,cyclin A2-CDK2 complex,CC,
17443,GO:0097125,1,0.992313868572542,0,2,cyclin B1-CDK1 complex,CC,
17444,GO:0097129,1,0.993285964308843,0,2,cyclin D2-CDK4 complex,CC,
17445,GO:0097132,1,0.978764294482056,0,1,cyclin D2-CDK6 complex,CC,
17446,GO:0097134,1,0.986982549345827,0,3,cyclin E1-CDK2 complex,CC,
17447,GO:0097135,1,0.99072954190656,0,2,cyclin E2-CDK2 complex,CC,
17448,GO:0097136,1,0.965188729463446,0,6,Bcl-2 family protein complex,CC,
17449,GO:0097144,1,0.996846220865447,0,1,BAX complex,CC,
17450,GO:0097145,1,0.99267685694229,0,2,BAK complex,CC,
17451,GO:0097149,1,0.980030163480325,0,3,centralspindlin complex,CC,
17452,GO:0097150,1,0.792885402438128,0,23,neuronal stem cell population maintenance,BP,
17454,GO:0097152,1,0.930142160521381,0,12,mesenchymal cell apoptotic process,BP,
17455,GO:0097153,1,0.941001425800304,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17456,GO:0097154,1,0.929971567696539,0,13,GABAergic neuron differentiation,BP,
17457,GO:0097155,1,0.960093871923948,0,3,fasciculation of sensory neuron axon,BP,
17458,GO:0097156,1,0.979863849990884,0,2,fasciculation of motor neuron axon,BP,
17459,GO:0097157,1,0.919457436397712,0,12,pre-mRNA intronic binding,MF,
17460,GO:0097158,1,0.9925769089346,0,2,pre-mRNA intronic pyrimidine-rich binding,MF,
17462,GO:0097161,1,0.987860000336312,0,1,DH domain binding,MF,
17463,GO:0097162,1,0.993916727593001,0,1,MADS box domain binding,MF,
17464,GO:0097163,1,0.996514119494283,0,1,sulfur carrier activity,MF,
17465,GO:0097164,1,0.84021856912896,0,24,ammonium ion metabolic process,BP,
17466,GO:0097165,1,0.962202085106765,0,6,nuclear stress granule,CC,
17467,GO:0097166,1,0.979812212012902,0,2,lens epithelial cell proliferation,BP,
17468,GO:0097167,1,0.971407316308723,0,4,circadian regulation of translation,BP,
17469,GO:0097168,1,0.976343615252609,0,5,mesenchymal stem cell proliferation,BP,
17470,GO:0097169,1,0.98687776261284,0,4,AIM2 inflammasome complex,CC,
17471,GO:0097176,1,0.979428846225434,0,5,epoxide metabolic process,BP,
17472,GO:0097177,1,0.984622968440249,0,4,mitochondrial ribosome binding,MF,
17473,GO:0097178,1,0.786055645093906,0,39,ruffle assembly,BP,
17474,GO:0097179,1,0.985789602867282,0,4,protease inhibitor complex,CC,
17475,GO:0097180,1,0.992094695439026,0,2,serine protease inhibitor complex,CC,
17476,GO:0097181,1,0.995644726868416,0,1,protein C inhibitor-coagulation factor V complex,CC,
17477,GO:0097182,1,0.995644726868416,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17478,GO:0097183,1,0.995644726868416,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17479,GO:0097186,1,0.88067352114245,0,17,amelogenesis,BP,
17481,GO:0097188,1,0.995216065271688,0,1,dentin mineralization,BP,
17484,GO:0097192,1,0.650857479139403,0,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,
17485,GO:0097193,1,0.188356610274164,0,267,intrinsic apoptotic signaling pathway,BP,
17486,GO:0097194,1,0.628526925868924,0,76,execution phase of apoptosis,BP,
17487,GO:0097195,1,0.983115960676547,0,3,pilomotor reflex,BP,
17488,GO:0097196,1,0.991050197139331,0,2,Shu complex,CC,
17490,GO:0097198,1,0.950135260239416,0,5,histone H3-K36 trimethylation,BP,
17491,GO:0097199,1,0.954900490017013,0,9,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17492,GO:0097200,1,0.956364241367415,0,8,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17493,GO:0097201,1,0.935289906214565,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17494,GO:0097202,1,0.903517059503681,0,15,activation of cysteine-type endopeptidase activity,BP,
17495,GO:0097205,1,0.874974596082773,0,19,renal filtration,BP,
17496,GO:0097208,1,0.966807782642092,0,6,alveolar lamellar body,CC,
17497,GO:0097209,1,0.969943443549451,0,4,epidermal lamellar body,CC,
17498,GO:0097210,1,0.969608758566892,0,5,response to gonadotropin-releasing hormone,BP,
17499,GO:0097211,1,0.969608758566892,0,5,cellular response to gonadotropin-releasing hormone,BP,
17500,GO:0097212,1,0.988771725300467,0,3,lysosomal membrane organization,BP,
17501,GO:0097213,1,0.992647574818667,0,2,regulation of lysosomal membrane permeability,BP,
17502,GO:0097214,1,0.996881731550697,0,1,positive regulation of lysosomal membrane permeability,BP,
17503,GO:0097222,1,0.991205193332263,0,1,mitochondrial mRNA polyadenylation,BP,
17504,GO:0097224,1,0.964244276533141,0,7,sperm connecting piece,CC,
17505,GO:0097225,1,0.882889516730086,0,22,sperm midpiece,CC,
17506,GO:0097227,1,0.988089497073372,0,1,sperm annulus,CC,
17507,GO:0097228,1,0.884924014085006,0,20,sperm principal piece,CC,
17508,GO:0097229,1,0.991563292366203,0,2,sperm end piece,CC,
17509,GO:0097232,1,0.981188091099898,0,2,lamellar body membrane,CC,
17510,GO:0097233,1,0.981188091099898,0,2,alveolar lamellar body membrane,CC,
17511,GO:0097237,1,0.581914931306719,0,105,cellular response to toxic substance,BP,
17512,GO:0097238,1,0.993440173708315,0,2,cellular response to methylglyoxal,BP,
17513,GO:0097240,1,0.989288046336387,0,2,chromosome attachment to the nuclear envelope,BP,
17514,GO:0097241,1,0.980660365585861,0,4,hematopoietic stem cell migration to bone marrow,BP,
17515,GO:0097242,1,0.735436296343346,0,33,amyloid-beta clearance,BP,
17516,GO:0097243,1,0.992964147185342,0,2,flavonoid binding,MF,
17517,GO:0097250,1,0.979267105105185,0,6,mitochondrial respirasome assembly,BP,
17518,GO:0097252,1,0.968388156150775,0,4,oligodendrocyte apoptotic process,BP,
17519,GO:0097254,1,0.99592401230561,0,1,renal tubular secretion,BP,
17520,GO:0097255,1,0.97969291522944,0,5,R2TP complex,CC,
17521,GO:0097264,1,0.965466632857152,0,6,self proteolysis,BP,
17522,GO:0097267,1,0.972641343246658,0,4,omega-hydroxylase P450 pathway,BP,
17523,GO:0097268,1,0.979254694782302,0,3,cytoophidium,CC,
17524,GO:0097272,1,0.985425586065305,0,2,ammonium homeostasis,BP,
17525,GO:0097273,1,0.988955371669458,0,1,creatinine homeostasis,BP,
17526,GO:0097274,1,0.98256017618421,0,2,urea homeostasis,BP,
17527,GO:0097275,1,0.988955371669458,0,1,cellular ammonium homeostasis,BP,
17528,GO:0097276,1,0.988955371669458,0,1,cellular creatinine homeostasis,BP,
17529,GO:0097277,1,0.988955371669458,0,1,cellular urea homeostasis,BP,
17530,GO:0097278,1,0.948550022676295,0,8,complement-dependent cytotoxicity,BP,
17531,GO:0097281,1,0.996430763181575,0,1,immune complex formation,BP,
17532,GO:0097283,1,0.97680245081664,0,5,keratinocyte apoptotic process,BP,
17533,GO:0097284,1,0.926015549916129,0,12,hepatocyte apoptotic process,BP,
17534,GO:0097291,1,0.996064377448237,0,1,renal phosphate ion absorption,BP,
17535,GO:0097296,1,0.970592432138949,0,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17536,GO:0097298,1,0.992571212673009,0,1,regulation of nucleus size,BP,
17537,GO:0097300,1,0.785727333693449,0,41,programmed necrotic cell death,BP,
17539,GO:0097306,1,0.505370905218405,0,82,cellular response to alcohol,BP,
17540,GO:0097309,1,0.989807596705769,0,2,cap1 mRNA methylation,BP,
17541,GO:0097310,1,0.994890876864838,0,1,cap2 mRNA methylation,BP,
17543,GO:0097322,1,0.948224971737285,0,8,7SK snRNA binding,MF,
17544,GO:0097323,1,0.988864047999266,0,2,B cell adhesion,BP,
17545,GO:0097324,1,0.973097876013581,0,2,melanocyte migration,BP,
17546,GO:0097325,1,0.978673636691978,0,3,melanocyte proliferation,BP,
17547,GO:0097326,1,0.990069666968894,0,1,melanocyte adhesion,BP,
17548,GO:0097327,1,0.965557531630695,0,6,response to antineoplastic agent,BP,
17549,GO:0097332,1,0.98994832983966,0,2,response to antipsychotic drug,BP,
17550,GO:0097338,1,0.977046629764312,0,3,response to clozapine,BP,
17551,GO:0097340,1,0.936302216199351,0,10,inhibition of cysteine-type endopeptidase activity,BP,
17552,GO:0097341,1,0.936302216199351,0,10,zymogen inhibition,BP,
17553,GO:0097342,1,0.9644307364,0,6,ripoptosome,CC,
17554,GO:0097343,1,0.969785113409488,0,3,ripoptosome assembly,BP,
17555,GO:0097344,1,0.990848979437758,0,2,Rix1 complex,CC,
17556,GO:0097345,1,0.756354438039644,0,53,mitochondrial outer membrane permeabilization,BP,
17557,GO:0097346,1,0.843658212032744,0,25,INO80-type complex,CC,
17559,GO:0097352,1,0.790952998375716,0,37,autophagosome maturation,BP,
17560,GO:0097354,1,0.931119692940331,0,10,prenylation,BP,
17561,GO:0097355,1,0.996442198035923,0,1,protein localization to heterochromatin,BP,
17562,GO:0097356,1,0.976718397350621,0,2,perinucleolar compartment,CC,
17563,GO:0097359,1,0.97069687329084,0,2,UDP-glucosylation,BP,
17564,GO:0097360,1,0.962788730795128,0,4,chorionic trophoblast cell proliferation,BP,
17565,GO:0097361,1,0.985441648717282,0,2,CIA complex,CC,
17566,GO:0097362,1,0.988468400750634,0,2,MCM8-MCM9 complex,CC,
17567,GO:0097363,1,0.979410611570135,0,3,protein O-GlcNAc transferase activity,MF,
17569,GO:0097368,1,0.953341960528826,0,5,establishment of Sertoli cell barrier,BP,
17570,GO:0097370,1,0.994890876864838,0,1,protein O-GlcNAcylation via threonine,BP,
17571,GO:0097371,1,0.944701518967695,0,7,MDM2/MDM4 family protein binding,MF,
17572,GO:0097372,1,0.996371666164808,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17573,GO:0097374,1,0.981831159059937,0,3,sensory neuron axon guidance,BP,
17574,GO:0097376,1,0.992285156065025,0,2,interneuron axon guidance,BP,
17575,GO:0097377,1,0.995668456285264,0,1,spinal cord interneuron axon guidance,BP,
17576,GO:0097378,1,0.995668456285264,0,1,dorsal spinal cord interneuron axon guidance,BP,
17577,GO:0097380,1,0.995668456285264,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17578,GO:0097381,1,0.898107884552185,0,16,photoreceptor disc membrane,CC,
17579,GO:0097384,1,0.925690690159388,0,10,cellular lipid biosynthetic process,BP,
17580,GO:0097386,1,0.760582606394152,0,33,glial cell projection,CC,
17581,GO:0097393,1,0.979581872132667,0,1,telomeric repeat-containing RNA transcription,BP,
17582,GO:0097394,1,0.979581872132667,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17583,GO:0097396,1,0.968573978093628,0,6,response to interleukin-17,BP,
17584,GO:0097398,1,0.968573978093628,0,6,cellular response to interleukin-17,BP,
17585,GO:0097400,1,0.968573978093628,0,6,interleukin-17-mediated signaling pathway,BP,
17587,GO:0097402,1,0.981178414047033,0,2,neuroblast migration,BP,
17588,GO:0097403,1,0.994425053082633,0,1,cellular response to raffinose,BP,
17589,GO:0097409,1,0.996118816604654,0,1,glial cytoplasmic inclusion,CC,
17590,GO:0097411,1,0.958957022522476,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17591,GO:0097413,1,0.965274001343572,0,7,Lewy body,CC,
17592,GO:0097414,1,0.996118816604654,0,1,classical Lewy body,CC,
17594,GO:0097421,1,0.836229028229025,0,31,liver regeneration,BP,
17595,GO:0097422,1,0.971118871142192,0,5,tubular endosome,CC,
17596,GO:0097427,1,0.953572081335646,0,6,microtubule bundle,CC,
17597,GO:0097428,1,0.959221445922742,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17598,GO:0097431,1,0.784972860073808,0,29,mitotic spindle pole,CC,
17599,GO:0097433,1,0.973784861727339,0,5,dense body,CC,
17601,GO:0097440,1,0.844664239690575,0,18,apical dendrite,CC,
17603,GO:0097442,1,0.969141286360257,0,3,CA3 pyramidal cell dendrite,CC,
17604,GO:0097443,1,0.951774744467684,0,6,sorting endosome,CC,
17605,GO:0097444,1,0.973020226556777,0,4,spine apparatus,CC,
17607,GO:0097449,1,0.858295041942688,0,18,astrocyte projection,CC,
17608,GO:0097450,1,0.94626465787,0,7,astrocyte end-foot,CC,
17609,GO:0097451,1,0.984742125390701,0,2,glial limiting end-foot,CC,
17610,GO:0097452,1,0.980594037115277,0,3,GAIT complex,CC,
17611,GO:0097453,1,0.995498140649407,0,1,mesaxon,CC,
17612,GO:0097454,1,0.972373590383073,0,3,Schwann cell microvillus,CC,
17613,GO:0097457,1,0.953940535300939,0,4,hippocampal mossy fiber,CC,
17614,GO:0097462,1,0.996118816604654,0,1,Lewy neurite,CC,
17615,GO:0097466,1,0.967053452277299,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17616,GO:0097468,1,0.936426829319573,0,11,programmed cell death in response to reactive oxygen species,BP,
17618,GO:0097472,1,0.83804823593162,0,28,cyclin-dependent protein kinase activity,MF,
17619,GO:0097473,1,0.989902831807601,0,1,retinal rod cell apoptotic process,BP,
17620,GO:0097474,1,0.981843494860828,0,2,retinal cone cell apoptotic process,BP,
17621,GO:0097475,1,0.963241701286136,0,4,motor neuron migration,BP,
17622,GO:0097476,1,0.974128369314452,0,2,spinal cord motor neuron migration,BP,
17623,GO:0097477,1,0.974128369314452,0,2,lateral motor column neuron migration,BP,
17627,GO:0097486,1,0.983351187277453,0,5,multivesicular body lumen,CC,
17628,GO:0097487,1,0.970753177208006,0,4,multivesicular body, internal vesicle,CC,
17629,GO:0097489,1,0.995250476949181,0,1,multivesicular body, internal vesicle lumen,CC,
17630,GO:0097490,1,0.968004815928309,0,4,sympathetic neuron projection extension,BP,
17631,GO:0097491,1,0.968004815928309,0,4,sympathetic neuron projection guidance,BP,
17632,GO:0097493,1,0.837662605020497,0,11,structural molecule activity conferring elasticity,MF,
17633,GO:0097494,1,0.944992856652127,0,9,regulation of vesicle size,BP,
17634,GO:0097497,1,0.994155058877539,0,1,blood vessel endothelial cell delamination,BP,
17635,GO:0097498,1,0.984974892212457,0,2,endothelial tube lumen extension,BP,
17636,GO:0097499,1,0.918270222468676,0,11,protein localization to non-motile cilium,BP,
17637,GO:0097500,1,0.968786676193028,0,4,receptor localization to non-motile cilium,BP,
17638,GO:0097501,1,0.942873724138547,0,13,stress response to metal ion,BP,
17639,GO:0097502,1,0.795613878111102,0,33,mannosylation,BP,
17641,GO:0097504,1,0.932094790369967,0,12,Gemini of coiled bodies,CC,
17642,GO:0097505,1,0.989004228907584,0,1,Rad6-Rad18 complex,CC,
17643,GO:0097506,1,0.983137551182562,0,4,deaminated base DNA N-glycosylase activity,MF,
17644,GO:0097510,1,0.996005431213626,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17645,GO:0097512,1,0.978293722254441,0,5,cardiac myofibril,CC,
17646,GO:0097513,1,0.95875930047717,0,3,myosin II filament,CC,
17647,GO:0097517,1,0.591782291515053,0,62,contractile actin filament bundle,CC,
17648,GO:0097519,1,0.987462136410912,0,1,DNA recombinase complex,CC,
17649,GO:0097524,1,0.957411099138506,0,6,sperm plasma membrane,CC,
17650,GO:0097525,1,0.761421791946128,0,55,spliceosomal snRNP complex,CC,
17651,GO:0097526,1,0.866844982558542,0,30,spliceosomal tri-snRNP complex,CC,
17652,GO:0097527,1,0.963741795096795,0,8,necroptotic signaling pathway,BP,
17653,GO:0097528,1,0.991984849796122,0,2,execution phase of necroptosis,BP,
17657,GO:0097532,1,0.989879309312658,0,2,stress response to acid chemical,BP,
17658,GO:0097533,1,0.989879309312658,0,2,cellular stress response to acid chemical,BP,
17659,GO:0097534,1,0.985419825617674,0,1,lymphoid lineage cell migration,BP,
17660,GO:0097535,1,0.985419825617674,0,1,lymphoid lineage cell migration into thymus,BP,
17661,GO:0097536,1,0.99592401230561,0,1,thymus epithelium morphogenesis,BP,
17662,GO:0097539,1,0.912192976165295,0,10,ciliary transition fiber,CC,
17663,GO:0097541,1,0.994890876864838,0,1,axonemal basal plate,CC,
17664,GO:0097542,1,0.731048418010304,0,42,ciliary tip,CC,
17665,GO:0097543,1,0.987927061598455,0,2,ciliary inversin compartment,CC,
17666,GO:0097546,1,0.844186876035585,0,27,ciliary base,CC,
17667,GO:0097549,1,0.589048526845458,0,67,chromatin organization involved in negative regulation of transcription,BP,
17668,GO:0097550,1,0.956473906382396,0,9,transcription preinitiation complex,CC,
17670,GO:0097573,1,0.996638479009536,0,1,glutathione oxidoreductase activity,MF,
17671,GO:0097574,1,0.980774112139906,0,2,lateral part of cell,CC,
17672,GO:0097575,1,0.980774112139906,0,2,lateral cell cortex,CC,
17673,GO:0097576,1,0.978664456667195,0,5,vacuole fusion,BP,
17674,GO:0097577,1,0.986517398576992,0,4,sequestering of iron ion,BP,
17676,GO:0097598,1,0.984596044575562,0,2,sperm cytoplasmic droplet,CC,
17677,GO:0097602,1,0.857602997288223,0,23,cullin family protein binding,MF,
17678,GO:0097603,1,0.988451096391856,0,2,temperature-gated ion channel activity,MF,
17679,GO:0097604,1,0.996281077985028,0,1,temperature-gated cation channel activity,MF,
17681,GO:0097621,1,0.9956655013377,0,1,monoamine oxidase activity,MF,
17683,GO:0097629,1,0.978414432726529,0,3,extrinsic component of omegasome membrane,CC,
17684,GO:0097630,1,0.994890876864838,0,1,intrinsic component of omegasome membrane,CC,
17685,GO:0097631,1,0.994890876864838,0,1,integral component of omegasome membrane,CC,
17686,GO:0097632,1,0.984896228437616,0,2,extrinsic component of phagophore assembly site membrane,CC,
17687,GO:0097635,1,0.981139359184356,0,2,extrinsic component of autophagosome membrane,CC,
17688,GO:0097636,1,0.986897281576692,0,2,intrinsic component of autophagosome membrane,CC,
17689,GO:0097637,1,0.986897281576692,0,2,integral component of autophagosome membrane,CC,
17690,GO:0097638,1,0.95279276147676,0,6,L-arginine import across plasma membrane,BP,
17691,GO:0097639,1,0.990991936578078,0,2,L-lysine import across plasma membrane,BP,
17692,GO:0097640,1,0.99574987193547,0,1,L-ornithine import across plasma membrane,BP,
17693,GO:0097642,1,0.96935166367249,0,6,calcitonin family receptor activity,MF,
17694,GO:0097643,1,0.983638397998218,0,4,amylin receptor activity,MF,
17695,GO:0097644,1,0.97748722020954,0,4,calcitonin family binding,MF,
17698,GO:0097648,1,0.935301425340834,0,9,G protein-coupled receptor complex,CC,
17699,GO:0097651,1,0.963537856431292,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17700,GO:0097655,1,0.994890876864838,0,1,serpin family protein binding,MF,
17702,GO:0097676,1,0.952370603573818,0,4,histone H3-K36 dimethylation,BP,
17704,GO:0097680,1,0.953366370516572,0,6,double-strand break repair via classical nonhomologous end joining,BP,
17705,GO:0097681,1,0.948820747237683,0,4,double-strand break repair via alternative nonhomologous end joining,BP,
17706,GO:0097682,1,0.995935208746673,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17708,GO:0097692,1,0.934747598094799,0,8,histone H3-K4 monomethylation,BP,
17709,GO:0097694,1,0.959132820368147,0,3,establishment of RNA localization to telomere,BP,
17710,GO:0097695,1,0.959132820368147,0,3,establishment of protein-containing complex localization to telomere,BP,
17712,GO:0097698,1,0.996554980689551,0,1,telomere maintenance via base-excision repair,BP,
17713,GO:0097699,1,0.991484184634299,0,1,vascular endothelial cell response to fluid shear stress,BP,
17714,GO:0097707,1,0.990816775836405,0,2,ferroptosis,BP,
17717,GO:0097711,1,0.486477305881391,0,94,ciliary basal body-plasma membrane docking,BP,
17718,GO:0097712,1,0.994890876864838,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17719,GO:0097718,1,0.776953761647475,0,30,disordered domain specific binding,MF,
17721,GO:0097722,1,0.598167220107258,0,73,sperm motility,BP,
17722,GO:0097726,1,0.996754443668797,0,1,LEM domain binding,MF,
17723,GO:0097728,1,0.974803430322933,0,1,9+0 motile cilium,CC,
17724,GO:0097729,1,0.537129480658226,0,87,9+2 motile cilium,CC,
17727,GO:0097732,1,0.959202913482786,0,7,9+2 non-motile cilium,CC,
17729,GO:0097734,1,0.907171131592402,0,18,extracellular exosome biogenesis,BP,
17730,GO:0097742,1,0.969599311986802,0,4,de novo centriole assembly,BP,
17731,GO:0097744,1,0.991526252988644,0,1,urate salt excretion,BP,
17732,GO:0097745,1,0.991718871826852,0,2,mitochondrial tRNA 5'-end processing,BP,
17734,GO:0097747,1,0.810680511057727,0,39,RNA polymerase activity,MF,
17736,GO:0097750,1,0.982105431168651,0,2,endosome membrane tubulation,BP,
17737,GO:0097752,1,0.991237476150886,0,2,regulation of DNA stability,BP,
17741,GO:0098038,1,0.993571057032178,0,1,non-replicative transposition, DNA-mediated,BP,
17742,GO:0098502,1,0.993254597724336,0,2,DNA dephosphorylation,BP,
17743,GO:0098505,1,0.945882689035736,0,10,G-rich strand telomeric DNA binding,MF,
17744,GO:0098506,1,0.996363308056365,0,1,polynucleotide 3' dephosphorylation,BP,
17745,GO:0098507,1,0.987929110133272,0,2,polynucleotide 5' dephosphorylation,BP,
17746,GO:0098508,1,0.990924538852246,0,2,endothelial to hematopoietic transition,BP,
17747,GO:0098518,1,0.984335879533268,0,3,polynucleotide phosphatase activity,MF,
17748,GO:0098519,1,0.974240351303218,0,4,nucleotide phosphatase activity, acting on free nucleotides,MF,
17749,GO:0098528,1,0.961614728942974,0,6,skeletal muscle fiber differentiation,BP,
17750,GO:0098530,1,0.988947858589799,0,1,positive regulation of strand invasion,BP,
17751,GO:0098531,1,0.671692056237698,0,49,ligand-activated transcription factor activity,MF,
17752,GO:0098532,1,0.956686289635511,0,4,histone H3-K27 trimethylation,BP,
17754,GO:0098534,1,0.749577391449138,0,37,centriole assembly,BP,
17755,GO:0098535,1,0.969599311986802,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17756,GO:0098536,1,0.972343722233336,0,4,deuterosome,CC,
17758,GO:0098543,1,0.88812308325454,0,16,detection of other organism,BP,
17759,GO:0098547,1,0.995736961356784,0,1,lumenal side of Golgi membrane,CC,
17761,GO:0098553,1,0.896878168914737,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17762,GO:0098554,1,0.920397036748459,0,14,cytoplasmic side of endoplasmic reticulum membrane,CC,
17763,GO:0098556,1,0.984024069565296,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17764,GO:0098559,1,0.985789097716065,0,3,cytoplasmic side of early endosome membrane,CC,
17765,GO:0098560,1,0.99018942630793,0,2,cytoplasmic side of late endosome membrane,CC,
17768,GO:0098573,1,0.681047422928989,0,73,intrinsic component of mitochondrial membrane,CC,
17769,GO:0098574,1,0.979993708841948,0,4,cytoplasmic side of lysosomal membrane,CC,
17770,GO:0098575,1,0.991783987030725,0,2,lumenal side of lysosomal membrane,CC,
17771,GO:0098576,1,0.877105657905788,0,30,lumenal side of membrane,CC,
17772,GO:0098577,1,0.987001921477036,0,1,inactive sex chromosome,CC,
17773,GO:0098581,1,0.865660241738257,0,21,detection of external biotic stimulus,BP,
17774,GO:0098582,1,0.993161949499453,0,1,innate vocalization behavior,BP,
17775,GO:0098583,1,0.991595950096535,0,2,learned vocalization behavior,BP,
17776,GO:0098586,1,0.725936893366656,0,47,cellular response to virus,BP,
17780,GO:0098591,1,0.950247751560925,0,5,external side of apical plasma membrane,CC,
17781,GO:0098592,1,0.981653151709119,0,3,cytoplasmic side of apical plasma membrane,CC,
17782,GO:0098594,1,0.996859661772592,0,1,mucin granule,CC,
17783,GO:0098595,1,0.995741272368597,0,1,perivitelline space,CC,
17787,GO:0098599,1,0.943525043059792,0,12,palmitoyl hydrolase activity,MF,
17789,GO:0098629,1,0.994890876864838,0,1,trans-Golgi network membrane organization,BP,
17793,GO:0098633,1,0.989529001133358,0,2,collagen fibril binding,MF,
17794,GO:0098634,1,0.939929037891527,0,7,cell-matrix adhesion mediator activity,MF,
17795,GO:0098636,1,0.747385152662625,0,36,protein complex involved in cell adhesion,CC,
17796,GO:0098637,1,0.992562911187317,0,1,protein complex involved in cell-matrix adhesion,CC,
17797,GO:0098639,1,0.950196976206735,0,5,collagen binding involved in cell-matrix adhesion,MF,
17798,GO:0098640,1,0.989199370948154,0,2,integrin binding involved in cell-matrix adhesion,MF,
17804,GO:0098646,1,0.995141279653256,0,1,collagen sheet,CC,
17805,GO:0098647,1,0.972179160441286,0,3,collagen beaded filament,CC,
17806,GO:0098648,1,0.9826775225133,0,1,collagen anchoring fibril,CC,
17808,GO:0098652,1,0.9826775225133,0,1,collagen type VII anchoring fibril,CC,
17812,GO:0098658,1,0.978414368020284,0,2,inorganic anion import across plasma membrane,BP,
17817,GO:0098664,1,0.89752580343295,0,22,G protein-coupled serotonin receptor signaling pathway,BP,
17818,GO:0098674,1,0.983404361895909,0,1,extrinsic component of neuronal dense core vesicle membrane,CC,
17819,GO:0098675,1,0.988523580774637,0,2,intrinsic component of neuronal dense core vesicle membrane,CC,
17820,GO:0098680,1,0.992411688368383,0,1,template-free RNA nucleotidyltransferase,MF,
17821,GO:0098683,1,0.985339843103599,0,1,cochlear hair cell ribbon synapse,CC,
17825,GO:0098687,1,0.117148157545429,0,301,chromosomal region,CC,
17826,GO:0098688,1,0.884106233666814,0,16,parallel fiber to Purkinje cell synapse,CC,
17828,GO:0098691,1,0.932147415509145,0,12,dopaminergic synapse,CC,
17830,GO:0098694,1,0.994161969635545,0,1,regulation of synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
17831,GO:0098695,1,0.981220644231937,0,1,inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels,MF,
17832,GO:0098696,1,0.941482341772608,0,8,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
17836,GO:0098704,1,0.960148289404353,0,6,carbohydrate import across plasma membrane,BP,
17837,GO:0098705,1,0.990859856299393,0,1,copper ion import across plasma membrane,BP,
17838,GO:0098708,1,0.964361389624239,0,5,glucose import across plasma membrane,BP,
17839,GO:0098711,1,0.986943265864835,0,3,iron ion import across plasma membrane,BP,
17840,GO:0098712,1,0.883285293751544,0,13,L-glutamate import across plasma membrane,BP,
17841,GO:0098713,1,0.970269540676847,0,5,leucine import across plasma membrane,BP,
17842,GO:0098718,1,0.99180115601632,0,1,serine import across plasma membrane,BP,
17843,GO:0098719,1,0.869528118223287,0,17,sodium ion import across plasma membrane,BP,
17844,GO:0098722,1,0.939614491825613,0,9,asymmetric stem cell division,BP,
17845,GO:0098725,1,0.994890876864838,0,1,symmetric cell division,BP,
17847,GO:0098728,1,0.98465475988784,0,3,germline stem cell asymmetric division,BP,
17848,GO:0098732,1,0.452105405086741,0,105,macromolecule deacylation,BP,
17849,GO:0098734,1,0.943525043059792,0,12,macromolecule depalmitoylation,BP,
17850,GO:0098735,1,0.939122344792797,0,4,positive regulation of the force of heart contraction,BP,
17851,GO:0098736,1,0.98344653483578,0,1,negative regulation of the force of heart contraction,BP,
17852,GO:0098737,1,0.996823679358212,0,1,protein insertion into plasma membrane,BP,
17856,GO:0098745,1,0.996349183774901,0,1,Dcp1-Dcp2 complex,CC,
17858,GO:0098749,1,0.976789908582506,0,3,cerebellar neuron development,BP,
17860,GO:0098753,1,0.995596658133279,0,1,anchored component of the cytoplasmic side of the plasma membrane,CC,
17861,GO:0098754,1,0.563792173286831,0,116,detoxification,BP,
17862,GO:0098756,1,0.95004693473562,0,7,response to interleukin-21,BP,
17863,GO:0098757,1,0.95004693473562,0,7,cellular response to interleukin-21,BP,
17864,GO:0098758,1,0.984566693525534,0,3,response to interleukin-8,BP,
17865,GO:0098759,1,0.984566693525534,0,3,cellular response to interleukin-8,BP,
17866,GO:0098760,1,0.827178700324481,0,27,response to interleukin-7,BP,
17867,GO:0098761,1,0.827178700324481,0,27,cellular response to interleukin-7,BP,
17868,GO:0098763,1,0.983659524878209,0,2,mitotic cell cycle phase,BP,
17869,GO:0098770,1,0.971876604087704,0,2,FBXO family protein binding,MF,
17872,GO:0098773,1,0.534540626083329,0,82,skin epidermis development,BP,
17873,GO:0098779,1,0.909463625651098,0,9,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
17874,GO:0098780,1,0.856532644153765,0,19,response to mitochondrial depolarisation,BP,
17875,GO:0098781,1,0.551081043431347,0,98,ncRNA transcription,BP,
17876,GO:0098782,1,0.996281077985028,0,1,mechanosensitived potassium channel activity,MF,
17877,GO:0098787,1,0.910475738963076,0,13,mRNA cleavage involved in mRNA processing,BP,
17878,GO:0098789,1,0.917474149745381,0,12,pre-mRNA cleavage required for polyadenylation,BP,
17880,GO:0098792,1,0.946214265799239,0,9,xenophagy,BP,
17883,GO:0098795,1,0.988193735626206,0,2,mRNA cleavage involved in gene silencing,BP,
17886,GO:0098798,1,0.404762137180659,0,217,mitochondrial protein complex,CC,
17887,GO:0098799,1,0.907098515940293,0,20,outer mitochondrial membrane protein complex,CC,
17888,GO:0098800,1,0.684360505011705,0,97,inner mitochondrial membrane protein complex,CC,
17889,GO:0098801,1,0.846321158462302,0,30,regulation of renal system process,BP,
17891,GO:0098803,1,0.789500042783431,0,66,respiratory chain complex,CC,
17893,GO:0098808,1,0.991029908970977,0,2,mRNA cap binding,MF,
17894,GO:0098809,1,0.995183075943713,0,1,nitrite reductase activity,MF,
17895,GO:0098810,1,0.812162048086907,0,31,neurotransmitter reuptake,BP,
17896,GO:0098813,1,0.193403375732346,0,233,nuclear chromosome segregation,BP,
17899,GO:0098816,1,0.989516594943618,0,2,mini excitatory postsynaptic potential,BP,
17900,GO:0098821,1,0.950417413397087,0,5,BMP receptor activity,MF,
17901,GO:0098822,1,0.995427030370975,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
17902,GO:0098826,1,0.981053062673613,0,4,endoplasmic reticulum tubular network membrane,CC,
17903,GO:0098827,1,0.85995701907993,0,24,endoplasmic reticulum subcompartment,CC,
17905,GO:0098829,1,0.987622096533685,0,1,intestinal folate absorption,BP,
17906,GO:0098830,1,0.990761843163033,0,1,presynaptic endosome,CC,
17910,GO:0098837,1,0.951075870745826,0,8,postsynaptic recycling endosome,CC,
17911,GO:0098838,1,0.944045583533725,0,6,folate transmembrane transport,BP,
17913,GO:0098840,1,0.600531558921259,0,64,protein transport along microtubule,BP,
17914,GO:0098842,1,0.985461116350291,0,3,postsynaptic early endosome,CC,
17915,GO:0098843,1,0.931700958452276,0,10,postsynaptic endocytic zone,CC,
17916,GO:0098844,1,0.96182067399509,0,5,postsynaptic endocytic zone membrane,CC,
17917,GO:0098845,1,0.917571910002553,0,14,postsynaptic endosome,CC,
17918,GO:0098847,1,0.928013573723471,0,13,sequence-specific single stranded DNA binding,MF,
17919,GO:0098850,1,0.981941262300992,0,4,extrinsic component of synaptic vesicle membrane,CC,
17921,GO:0098855,1,0.969921126265906,0,3,HCN channel complex,CC,
17922,GO:0098856,1,0.940603916301877,0,11,intestinal lipid absorption,BP,
17926,GO:0098867,1,0.995121529265153,0,1,intramembranous bone growth,BP,
17927,GO:0098868,1,0.807887080032733,0,31,bone growth,BP,
17928,GO:0098869,1,0.644822121357639,0,87,cellular oxidant detoxification,BP,
17929,GO:0098870,1,0.932776693209265,0,8,action potential propagation,BP,
17930,GO:0098871,1,0.951978777515377,0,5,postsynaptic actin cytoskeleton,CC,
17931,GO:0098872,1,0.98686622107031,0,1,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
17933,GO:0098875,1,0.990930601739981,0,1,epididymosome,CC,
17937,GO:0098879,1,0.966943402501474,0,3,structural constituent of postsynaptic specialization,MF,
17938,GO:0098880,1,0.935113209105677,0,6,maintenance of postsynaptic specialization structure,BP,
17939,GO:0098882,1,0.924903843545351,0,4,structural constituent of presynaptic active zone,MF,
17940,GO:0098883,1,0.938742129589255,0,11,synapse pruning,BP,
17941,GO:0098884,1,0.854671415916863,0,20,postsynaptic neurotransmitter receptor internalization,BP,
17942,GO:0098885,1,0.913126396600676,0,11,modification of postsynaptic actin cytoskeleton,BP,
17943,GO:0098886,1,0.98510168792824,0,2,modification of dendritic spine,BP,
17944,GO:0098887,1,0.949315282957784,0,8,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
17946,GO:0098889,1,0.53395365890456,0,82,intrinsic component of presynaptic membrane,CC,
17947,GO:0098890,1,0.903696851440942,0,9,extrinsic component of postsynaptic membrane,CC,
17948,GO:0098891,1,0.990799055056303,0,1,extrinsic component of presynaptic active zone membrane,CC,
17949,GO:0098892,1,0.932731578259592,0,6,extrinsic component of postsynaptic specialization membrane,CC,
17951,GO:0098895,1,0.976177226278556,0,4,postsynaptic endosome membrane,CC,
17952,GO:0098896,1,0.994160982644207,0,1,postsynaptic early endosome membrane,CC,
17953,GO:0098897,1,0.990059100057767,0,1,spine apparatus membrane,CC,
17954,GO:0098898,1,0.977035455272309,0,2,dense core granule lumen,CC,
17956,GO:0098901,1,0.744680664557452,0,27,regulation of cardiac muscle cell action potential,BP,
17957,GO:0098902,1,0.954732530581589,0,5,regulation of membrane depolarization during action potential,BP,
17958,GO:0098903,1,0.937138803654433,0,8,regulation of membrane repolarization during action potential,BP,
17959,GO:0098904,1,0.967214248038872,0,2,regulation of AV node cell action potential,BP,
17960,GO:0098905,1,0.996842415658143,0,1,regulation of bundle of His cell action potential,BP,
17961,GO:0098907,1,0.956799094967932,0,2,regulation of SA node cell action potential,BP,
17962,GO:0098908,1,0.973963265257698,0,5,regulation of neuronal action potential,BP,
17963,GO:0098909,1,0.926894887568494,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
17964,GO:0098910,1,0.927123322985302,0,5,regulation of atrial cardiac muscle cell action potential,BP,
17965,GO:0098911,1,0.851957171613163,0,15,regulation of ventricular cardiac muscle cell action potential,BP,
17966,GO:0098912,1,0.952571535577454,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
17967,GO:0098914,1,0.958947189202515,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17968,GO:0098915,1,0.920213545545746,0,14,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
17970,GO:0098917,1,0.911136260203952,0,10,retrograde trans-synaptic signaling,BP,
17972,GO:0098919,1,0.966943402501474,0,3,structural constituent of postsynaptic density,MF,
17973,GO:0098920,1,0.957452022259588,0,5,retrograde trans-synaptic signaling by lipid,BP,
17974,GO:0098921,1,0.957452022259588,0,5,retrograde trans-synaptic signaling by endocannabinoid,BP,
17975,GO:0098922,1,0.983404361895909,0,1,extrinsic component of dense core granule membrane,CC,
17976,GO:0098923,1,0.986414740258483,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
17977,GO:0098924,1,0.986414740258483,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
17978,GO:0098926,1,0.81054276032501,0,33,postsynaptic signal transduction,BP,
17979,GO:0098927,1,0.731514453167017,0,40,vesicle-mediated transport between endosomal compartments,BP,
17980,GO:0098928,1,0.941957453446889,0,2,presynaptic signal transduction,BP,
17981,GO:0098930,1,0.613628843249586,0,57,axonal transport,BP,
17982,GO:0098935,1,0.91748179368974,0,10,dendritic transport,BP,
17984,GO:0098937,1,0.944856382993949,0,6,anterograde dendritic transport,BP,
17985,GO:0098939,1,0.981863996004275,0,2,dendritic transport of mitochondrion,BP,
17986,GO:0098942,1,0.979770919168081,0,2,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
17987,GO:0098943,1,0.966383663940766,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
17988,GO:0098944,1,0.989807596705769,0,2,postsynaptic recycling endosome membrane,CC,
17989,GO:0098945,1,0.864106810141214,0,18,intrinsic component of presynaptic active zone membrane,CC,
17991,GO:0098949,1,0.989807596705769,0,2,intrinsic component of postsynaptic endosome membrane,CC,
17992,GO:0098951,1,0.989807596705769,0,2,intrinsic component of postsynaptic recycling endosome membrane,CC,
17993,GO:0098952,1,0.990059100057767,0,1,intrinsic component of spine apparatus membrane,CC,
17994,GO:0098953,1,0.946935319321618,0,9,receptor diffusion trapping,BP,
17995,GO:0098956,1,0.988523580774637,0,2,intrinsic component of dense core granule membrane,CC,
17996,GO:0098957,1,0.962266314973454,0,5,anterograde axonal transport of mitochondrion,BP,
17997,GO:0098958,1,0.989930409726073,0,2,retrograde axonal transport of mitochondrion,BP,
17999,GO:0098961,1,0.976650069738477,0,3,dendritic transport of ribonucleoprotein complex,BP,
18001,GO:0098963,1,0.976650069738477,0,3,dendritic transport of messenger ribonucleoprotein complex,BP,
18002,GO:0098966,1,0.944988249201141,0,4,perisynaptic extracellular matrix,CC,
18004,GO:0098968,1,0.990015900056417,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18006,GO:0098970,1,0.946935319321618,0,9,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18007,GO:0098971,1,0.961481662925735,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18008,GO:0098972,1,0.987531955883625,0,1,anterograde dendritic transport of mitochondrion,BP,
18012,GO:0098977,1,0.989870308492092,0,1,inhibitory chemical synaptic transmission,BP,
18014,GO:0098981,1,0.943864095836191,0,9,cholinergic synapse,CC,
18016,GO:0098983,1,0.963301452173981,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18019,GO:0098988,1,0.937565692009808,0,7,G protein-coupled glutamate receptor activity,MF,
18020,GO:0098989,1,0.982875783420776,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18023,GO:0098998,1,0.994160982644207,0,1,extrinsic component of postsynaptic early endosome membrane,CC,
18024,GO:0098999,1,0.986230674751547,0,2,extrinsic component of postsynaptic endosome membrane,CC,
18026,GO:0099004,1,0.924976698378297,0,8,calmodulin dependent kinase signaling pathway,BP,
18027,GO:0099010,1,0.880566515169778,0,17,modification of postsynaptic structure,BP,
18028,GO:0099011,1,0.932466995374585,0,6,neuronal dense core vesicle exocytosis,BP,
18029,GO:0099012,1,0.962080960305442,0,4,neuronal dense core vesicle membrane,CC,
18030,GO:0099013,1,0.977035455272309,0,2,neuronal dense core vesicle lumen,CC,
18031,GO:0099020,1,0.994750742217943,0,1,perinuclear endoplasmic reticulum lumen,CC,
18032,GO:0099022,1,0.941966434794531,0,8,vesicle tethering,BP,
18033,GO:0099023,1,0.637102040130105,0,64,vesicle tethering complex,CC,
18034,GO:0099024,1,0.675062521523867,0,60,plasma membrane invagination,BP,
18035,GO:0099025,1,0.962256776711071,0,5,anchored component of postsynaptic membrane,CC,
18036,GO:0099026,1,0.945976253217091,0,9,anchored component of presynaptic membrane,CC,
18037,GO:0099029,1,0.979737522790112,0,4,anchored component of presynaptic active zone membrane,CC,
18038,GO:0099030,1,0.982688406670775,0,3,anchored component of postsynaptic specialization membrane,CC,
18039,GO:0099031,1,0.982688406670775,0,3,anchored component of postsynaptic density membrane,CC,
18040,GO:0099033,1,0.989807596705769,0,2,anchored component of postsynaptic recycling endosome membrane,CC,
18041,GO:0099034,1,0.989807596705769,0,2,anchored component of postsynaptic endosome membrane,CC,
18042,GO:0099038,1,0.975319585153689,0,2,ceramide floppase activity,MF,
18043,GO:0099039,1,0.944802818124639,0,4,sphingolipid translocation,BP,
18044,GO:0099040,1,0.975319585153689,0,2,ceramide translocation,BP,
18045,GO:0099041,1,0.955427968017377,0,5,vesicle tethering to Golgi,BP,
18046,GO:0099044,1,0.991229975750274,0,2,vesicle tethering to endoplasmic reticulum,BP,
18047,GO:0099046,1,0.996586702756766,0,1,clearance of foreign intracellular nucleic acids,BP,
18049,GO:0099053,1,0.980366741173881,0,3,activating signal cointegrator 1 complex,CC,
18052,GO:0099056,1,0.564626921985297,0,73,integral component of presynaptic membrane,CC,
18053,GO:0099059,1,0.882000553098099,0,14,integral component of presynaptic active zone membrane,CC,
18056,GO:0099065,1,0.990059100057767,0,1,integral component of spine apparatus membrane,CC,
18057,GO:0099066,1,0.988523580774637,0,2,integral component of neuronal dense core vesicle membrane,CC,
18060,GO:0099073,1,0.98524560373704,0,2,mitochondrion-derived vesicle,CC,
18061,GO:0099074,1,0.988990312799058,0,2,mitochondrion to lysosome transport,BP,
18062,GO:0099075,1,0.988990312799058,0,2,mitochondrion-derived vesicle mediated transport,BP,
18063,GO:0099077,1,0.9889619463563,0,1,histone-dependent DNA binding,MF,
18064,GO:0099078,1,0.984726640892884,0,4,BORC complex,CC,
18067,GO:0099082,1,0.984679850698482,0,2,retrograde trans-synaptic signaling by neuropeptide,BP,
18068,GO:0099083,1,0.99238895479945,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18070,GO:0099086,1,0.8150376299786,0,32,synaptonemal structure,CC,
18071,GO:0099087,1,0.994652482138736,0,1,anterograde axonal transport of messenger ribonucleoprotein complex,BP,
18072,GO:0099088,1,0.994652482138736,0,1,axonal transport of messenger ribonucleoprotein complex,BP,
18073,GO:0099089,1,0.977892813091763,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18074,GO:0099091,1,0.856650278397928,0,21,postsynaptic specialization, intracellular component,CC,
18075,GO:0099092,1,0.87899747427566,0,17,postsynaptic density, intracellular component,CC,
18076,GO:0099093,1,0.984469348068564,0,2,calcium export from the mitochondrion,BP,
18079,GO:0099098,1,0.994016986456071,0,1,microtubule polymerization based movement,BP,
18080,GO:0099103,1,0.978181543192089,0,4,channel activator activity,MF,
18081,GO:0099104,1,0.978181543192089,0,4,potassium channel activator activity,MF,
18083,GO:0099111,1,0.235933439745063,0,178,microtubule-based transport,BP,
18084,GO:0099115,1,0.976095995721069,0,2,chromosome, subtelomeric region,CC,
18085,GO:0099116,1,0.935238589460977,0,15,tRNA 5'-end processing,BP,
18086,GO:0099118,1,0.600531558921259,0,64,microtubule-based protein transport,BP,
18087,GO:0099122,1,0.941848158410276,0,8,RNA polymerase II C-terminal domain binding,MF,
18088,GO:0099142,1,0.988245416847562,0,1,intracellularly ATP-gated ion channel activity,MF,
18089,GO:0099144,1,0.922755114321912,0,12,anchored component of synaptic membrane,CC,
18091,GO:0099147,1,0.936397776110208,0,5,extrinsic component of postsynaptic density membrane,CC,
18092,GO:0099149,1,0.909796212541135,0,12,regulation of postsynaptic neurotransmitter receptor internalization,BP,
18093,GO:0099150,1,0.901598017157542,0,13,regulation of postsynaptic specialization assembly,BP,
18094,GO:0099151,1,0.905058076500248,0,12,regulation of postsynaptic density assembly,BP,
18095,GO:0099152,1,0.989081394697526,0,2,regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18096,GO:0099154,1,0.988088968504922,0,2,serotonergic synapse,CC,
18097,GO:0099156,1,0.993773180548496,0,1,cell-cell signaling via exosome,BP,
18098,GO:0099158,1,0.994160982644207,0,1,regulation of recycling endosome localization within postsynapse,BP,
18099,GO:0099159,1,0.940474101293327,0,8,regulation of modification of postsynaptic structure,BP,
18100,GO:0099160,1,0.993014323036889,0,1,postsynaptic intermediate filament cytoskeleton,CC,
18101,GO:0099161,1,0.992232362160368,0,1,regulation of presynaptic dense core granule exocytosis,BP,
18102,GO:0099163,1,0.986414740258483,0,1,synaptic signaling by nitric oxide,BP,
18103,GO:0099170,1,0.876053764764291,0,14,postsynaptic modulation of chemical synaptic transmission,BP,
18110,GO:0099178,1,0.983981486766036,0,2,regulation of retrograde trans-synaptic signaling by endocanabinoid,BP,
18111,GO:0099179,1,0.963596505022107,0,4,regulation of synaptic membrane adhesion,BP,
18112,GO:0099180,1,0.992156259067701,0,2,zinc ion import into synaptic vesicle,BP,
18113,GO:0099181,1,0.99225908525967,0,1,structural constituent of presynapse,MF,
18114,GO:0099183,1,0.968843610948495,0,4,trans-synaptic signaling by BDNF, modulating synaptic transmission,BP,
18119,GO:0099189,1,0.985077512304228,0,1,postsynaptic spectrin-associated cytoskeleton,CC,
18120,GO:0099191,1,0.968843610948495,0,4,trans-synaptic signaling by BDNF,BP,
18123,GO:0099400,1,0.982701323297205,0,1,caveola neck,CC,
18124,GO:0099403,1,0.962049498410563,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18125,GO:0099404,1,0.962049498410563,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18131,GO:0099505,1,0.938710473708775,0,6,regulation of presynaptic membrane potential,BP,
18132,GO:0099507,1,0.968239561043313,0,3,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,
18133,GO:0099508,1,0.969511959956886,0,3,voltage-gated ion channel activity involved in regulation of presynaptic membrane potential,MF,
18134,GO:0099509,1,0.883398981789175,0,16,regulation of presynaptic cytosolic calcium ion concentration,BP,
18135,GO:0099510,1,0.991908768300451,0,2,calcium ion binding involved in regulation of cytosolic calcium ion concentration,MF,
18136,GO:0099511,1,0.951239533139902,0,6,voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels,MF,
18139,GO:0099514,1,0.896127425627582,0,18,synaptic vesicle cytoskeletal transport,BP,
18140,GO:0099515,1,0.787045716167474,0,20,actin filament-based transport,BP,
18141,GO:0099517,1,0.896127425627582,0,18,synaptic vesicle transport along microtubule,BP,
18142,GO:0099518,1,0.525394616025749,0,67,vesicle cytoskeletal trafficking,BP,
18143,GO:0099519,1,0.880714233509205,0,11,dense core granule cytoskeletal transport,BP,
18147,GO:0099524,1,0.855568850781241,0,18,postsynaptic cytosol,CC,
18148,GO:0099525,1,0.932466995374585,0,6,presynaptic dense core vesicle exocytosis,BP,
18149,GO:0099526,1,0.941957453446889,0,2,presynapse to nucleus signaling pathway,BP,
18150,GO:0099527,1,0.938907853404493,0,8,postsynapse to nucleus signaling pathway,BP,
18151,GO:0099528,1,0.945688454503366,0,9,G protein-coupled neurotransmitter receptor activity,MF,
18153,GO:0099530,1,0.958969205127066,0,4,G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18154,GO:0099532,1,0.920605483191719,0,9,synaptic vesicle endosomal processing,BP,
18155,GO:0099533,1,0.963452227461771,0,4,positive regulation of presynaptic cytosolic calcium concentration,BP,
18156,GO:0099534,1,0.991908768300451,0,2,calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18157,GO:0099535,1,0.944988249201141,0,4,synapse-associated extracellular matrix,CC,
18160,GO:0099538,1,0.968138349707875,0,4,synaptic signaling via neuropeptide,BP,
18161,GO:0099540,1,0.971355857336181,0,3,trans-synaptic signaling by neuropeptide,BP,
18162,GO:0099541,1,0.920030938898598,0,8,trans-synaptic signaling by lipid,BP,
18163,GO:0099542,1,0.920030938898598,0,8,trans-synaptic signaling by endocannabinoid,BP,
18164,GO:0099543,1,0.986414740258483,0,1,trans-synaptic signaling by soluble gas,BP,
18165,GO:0099544,1,0.938357569955925,0,5,perisynaptic space,CC,
18166,GO:0099545,1,0.934250161707241,0,8,trans-synaptic signaling by trans-synaptic complex,BP,
18167,GO:0099546,1,0.989086059081135,0,1,protein catabolic process, modulating synaptic transmission,BP,
18168,GO:0099547,1,0.97104407348621,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18169,GO:0099548,1,0.986414740258483,0,1,trans-synaptic signaling by nitric oxide,BP,
18170,GO:0099550,1,0.907958167217669,0,12,trans-synaptic signaling, modulating synaptic transmission,BP,
18171,GO:0099551,1,0.978961685105862,0,2,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18172,GO:0099552,1,0.967136142988239,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18173,GO:0099553,1,0.967136142988239,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18174,GO:0099557,1,0.980518686829357,0,3,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18175,GO:0099558,1,0.841251859303388,0,16,maintenance of synapse structure,BP,
18177,GO:0099562,1,0.959745739572055,0,4,maintenance of postsynaptic density structure,BP,
18178,GO:0099563,1,0.840590857230095,0,23,modification of synaptic structure,BP,
18179,GO:0099564,1,0.993958925135842,0,1,modification of synaptic structure, modulating synaptic transmission,BP,
18182,GO:0099567,1,0.995292062285924,0,1,calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18185,GO:0099571,1,0.9312108453953,0,7,postsynaptic cytoskeleton,CC,
18187,GO:0099575,1,0.982979873493866,0,3,regulation of protein catabolic process at presynapse, modulating synaptic transmission,BP,
18188,GO:0099576,1,0.95873087041359,0,4,regulation of protein catabolic process at postsynapse, modulating synaptic transmission,BP,
18189,GO:0099578,1,0.987294851526748,0,2,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18190,GO:0099579,1,0.986450696389531,0,2,G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18191,GO:0099580,1,0.978503303897639,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18192,GO:0099582,1,0.994761775626439,0,1,neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
18193,GO:0099583,1,0.961461444265999,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18195,GO:0099588,1,0.990161041460086,0,1,positive regulation of postsynaptic cytosolic calcium concentration,BP,
18196,GO:0099589,1,0.89752580343295,0,22,serotonin receptor activity,MF,
18199,GO:0099602,1,0.961159831638698,0,9,neurotransmitter receptor regulator activity,MF,
18201,GO:0099606,1,0.983751234152721,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18202,GO:0099607,1,0.980506902504653,0,2,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18204,GO:0099609,1,0.977784003933191,0,2,microtubule lateral binding,MF,
18206,GO:0099617,1,0.9903027597147,0,2,matrix side of mitochondrial inner membrane,CC,
18208,GO:0099623,1,0.822717513263109,0,24,regulation of cardiac muscle cell membrane repolarization,BP,
18209,GO:0099624,1,0.922100523502465,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18210,GO:0099625,1,0.838781538866024,0,24,ventricular cardiac muscle cell membrane repolarization,BP,
18211,GO:0099626,1,0.951239533139902,0,6,voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,MF,
18212,GO:0099628,1,0.946935319321618,0,9,neurotransmitter receptor diffusion trapping,BP,
18214,GO:0099631,1,0.99348905081332,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18215,GO:0099633,1,0.861186607613812,0,21,protein localization to postsynaptic specialization membrane,BP,
18217,GO:0099635,1,0.963452227461771,0,4,voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels,MF,
18219,GO:0099638,1,0.930423101285075,0,10,endosome to plasma membrane protein transport,BP,
18220,GO:0099639,1,0.949315282957784,0,8,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18221,GO:0099640,1,0.887766557526884,0,13,axo-dendritic protein transport,BP,
18222,GO:0099641,1,0.915543889077525,0,9,anterograde axonal protein transport,BP,
18223,GO:0099642,1,0.967212452411302,0,2,retrograde axonal protein transport,BP,
18225,GO:0099645,1,0.861186607613812,0,21,neurotransmitter receptor localization to postsynaptic specialization membrane,BP,
18227,GO:0099703,1,0.963452227461771,0,4,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,BP,
18229,GO:0100001,1,0.975052307516817,0,2,regulation of skeletal muscle contraction by action potential,BP,
18230,GO:0100002,1,0.994715680320183,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18231,GO:0100012,1,0.97817441408122,0,4,regulation of heart induction by canonical Wnt signaling pathway,BP,
18232,GO:0100026,1,0.992354884900885,0,1,positive regulation of DNA repair by transcription from RNA polymerase II promoter,BP,
18233,GO:0101002,1,0.516822288738066,0,123,ficolin-1-rich granule,CC,
18234,GO:0101003,1,0.668282086700843,0,56,ficolin-1-rich granule membrane,CC,
18235,GO:0101005,1,0.501393540932466,0,80,ubiquitinyl hydrolase activity,MF,
18236,GO:0101006,1,0.987948597232984,0,3,protein histidine phosphatase activity,MF,
18237,GO:0101020,1,0.973941104099659,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18238,GO:0101021,1,0.995171173429256,0,1,estrogen 2-hydroxylase activity,MF,
18239,GO:0101023,1,0.843511462094801,0,20,vascular endothelial cell proliferation,BP,
18240,GO:0101030,1,0.992067671673105,0,2,tRNA-guanine transglycosylation,BP,
18241,GO:0101031,1,0.898488125797614,0,23,chaperone complex,CC,
18242,GO:0102007,1,0.989539317836366,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18243,GO:0102008,1,0.990397676349947,0,1,cytosolic dipeptidase activity,MF,
18244,GO:0102009,1,0.996191385767568,0,1,proline dipeptidase activity,MF,
18245,GO:0102076,1,0.994728619431495,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18246,GO:0102077,1,0.992002100694347,0,2,oleamide hydrolase activity,MF,
18247,GO:0102084,1,0.990088332151663,0,2,L-dopa O-methyltransferase activity,MF,
18248,GO:0102092,1,0.979146608111783,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18249,GO:0102102,1,0.992511059706689,0,1,homocarnosine synthase activity,MF,
18250,GO:0102113,1,0.986842571051012,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18251,GO:0102121,1,0.977348680951886,0,4,ceramidase activity,MF,
18252,GO:0102131,1,0.98403052900273,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18253,GO:0102132,1,0.98403052900273,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18254,GO:0102140,1,0.973614051509347,0,2,heparan sulfate N-deacetylase activity,MF,
18255,GO:0102148,1,0.991635482913462,0,2,N-acetyl-beta-D-galactosaminidase activity,MF,
18256,GO:0102158,1,0.979718048345423,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18257,GO:0102193,1,0.992874492029534,0,2,protein-ribulosamine 3-kinase activity,MF,
18258,GO:0102194,1,0.996593192993099,0,1,protein-fructosamine 3-kinase activity,MF,
18259,GO:0102200,1,0.990013981104365,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity,MF,
18260,GO:0102250,1,0.980537927783794,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18261,GO:0102258,1,0.992818643730494,0,1,1,3-diacylglycerol acylhydrolase activity,MF,
18262,GO:0102259,1,0.992818643730494,0,1,1,2-diacylglycerol acylhydrolase activity,MF,
18263,GO:0102264,1,0.994890876864838,0,1,tRNA-dihydrouridine20 synthase activity,MF,
18264,GO:0102279,1,0.990646544203336,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18265,GO:0102336,1,0.964837379943381,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18266,GO:0102337,1,0.964837379943381,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18267,GO:0102338,1,0.964837379943381,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18268,GO:0102339,1,0.995283778986517,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18269,GO:0102340,1,0.995283778986517,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18270,GO:0102341,1,0.995283778986517,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18271,GO:0102342,1,0.995283778986517,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18272,GO:0102343,1,0.979718048345423,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18273,GO:0102344,1,0.979718048345423,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18274,GO:0102345,1,0.979718048345423,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18275,GO:0102389,1,0.995083515122915,0,1,polyprenol reductase activity,MF,
18276,GO:0102390,1,0.995114640053134,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18277,GO:0102391,1,0.945419640096943,0,9,decanoate-CoA ligase activity,MF,
18278,GO:0102420,1,0.98263145838392,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18279,GO:0102483,1,0.996402017712202,0,1,scopolin beta-glucosidase activity,MF,
18280,GO:0102485,1,0.968233916151881,0,3,dATP phosphohydrolase activity,MF,
18281,GO:0102486,1,0.968233916151881,0,3,dCTP phosphohydrolase activity,MF,
18282,GO:0102487,1,0.968233916151881,0,3,dUTP phosphohydrolase activity,MF,
18283,GO:0102488,1,0.968233916151881,0,3,dTTP phosphohydrolase activity,MF,
18284,GO:0102489,1,0.968233916151881,0,3,GTP phosphohydrolase activity,MF,
18285,GO:0102490,1,0.968233916151881,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18286,GO:0102491,1,0.968233916151881,0,3,dGTP phosphohydrolase activity,MF,
18287,GO:0102499,1,0.980537927783794,0,3,SHG alpha-glucan phosphorylase activity,MF,
18288,GO:0102500,1,0.986306424654686,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18289,GO:0102521,1,0.993791447449259,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18290,GO:0102522,1,0.995789604292063,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18291,GO:0102524,1,0.994890876864838,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18292,GO:0102545,1,0.939104110009341,0,10,phosphatidyl phospholipase B activity,MF,
18293,GO:0102552,1,0.99640996993186,0,1,lipoyl synthase activity (acting on glycine-cleavage complex H protein,MF,
18294,GO:0102553,1,0.99640996993186,0,1,lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein),MF,
18295,GO:0102555,1,0.996810296987815,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18296,GO:0102559,1,0.988779045661262,0,1,protein-(glutamine-N5) methyltransferase activity,MF,
18299,GO:0102704,1,0.994639399754126,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18300,GO:0102707,1,0.995258827654657,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18301,GO:0102732,1,0.996298331802648,0,1,myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity,MF,
18302,GO:0102751,1,0.990067078012985,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18303,GO:0102752,1,0.994248477082807,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18304,GO:0102756,1,0.964837379943381,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18305,GO:0102758,1,0.996734052239921,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18306,GO:0102769,1,0.996446385820686,0,1,dihydroceramide glucosyltransferase activity,MF,
18307,GO:0102773,1,0.986132839198993,0,2,dihydroceramide kinase activity,MF,
18308,GO:0102797,1,0.9905005170546,0,1,geranial:oxygen oxidoreductase activity,MF,
18309,GO:0102798,1,0.9905005170546,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18310,GO:0102867,1,0.994949931748947,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18311,GO:0102938,1,0.990088332151663,0,2,orcinol O-methyltransferase activity,MF,
18312,GO:0102953,1,0.986085166569851,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18313,GO:0102965,1,0.985868013585868,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18314,GO:0102991,1,0.958356726165846,0,10,myristoyl-CoA hydrolase activity,MF,
18315,GO:0103025,1,0.992293599957951,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18316,GO:0103045,1,0.995978055021198,0,1,methione N-acyltransferase activity,MF,
18317,GO:0103046,1,0.990397676349947,0,1,alanylglutamate dipeptidase activity,MF,
18318,GO:0103053,1,0.992039254609569,0,2,1-ethyladenine demethylase activity,MF,
18319,GO:0103066,1,0.996473390007712,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18320,GO:0103067,1,0.996473390007712,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18321,GO:0103068,1,0.986085166569851,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18322,GO:0103073,1,0.992002100694347,0,2,anandamide amidohydrolase activity,MF,
18324,GO:0106001,1,0.962469080140083,0,6,intestinal hexose absorption,BP,
18325,GO:0106003,1,0.987280588783161,0,1,amyloid-beta complex,CC,
18326,GO:0106004,1,0.992991134291699,0,2,tRNA (guanine-N7)-methylation,BP,
18327,GO:0106005,1,0.988135863387112,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18328,GO:0106006,1,0.974753323994966,0,3,cytoskeletal protein-membrane anchor activity,MF,
18329,GO:0106014,1,0.979070474352943,0,5,regulation of inflammatory response to wounding,BP,
18330,GO:0106015,1,0.988042310971245,0,3,negative regulation of inflammatory response to wounding,BP,
18331,GO:0106016,1,0.992484903561583,0,2,positive regulation of inflammatory response to wounding,BP,
18332,GO:0106017,1,0.969140709033775,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18333,GO:0106018,1,0.92215152068368,0,9,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18334,GO:0106019,1,0.90807813753564,0,11,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18335,GO:0106020,1,0.988349785783223,0,2,regulation of vesicle docking,BP,
18336,GO:0106022,1,0.992593010405681,0,1,positive regulation of vesicle docking,BP,
18338,GO:0106028,1,0.990663131689003,0,1,neuron projection retraction,BP,
18339,GO:0106029,1,0.98552645168562,0,3,tRNA pseudouridine synthase activity,MF,
18340,GO:0106030,1,0.806788765762744,0,23,neuron projection fasciculation,BP,
18341,GO:0106035,1,0.996777042841678,0,1,protein maturation by [4Fe-4S] cluster transfer,BP,
18343,GO:0106044,1,0.996816752933256,0,1,guanine deglycation,BP,
18344,GO:0106045,1,0.996816752933256,0,1,guanine deglycation, methylglyoxal removal,BP,
18345,GO:0106046,1,0.996816752933256,0,1,guanine deglycation, glyoxal removal,BP,
18346,GO:0106047,1,0.995033826548407,0,1,polyamine deacetylation,BP,
18347,GO:0106048,1,0.995033826548407,0,1,spermidine deacetylation,BP,
18348,GO:0106049,1,0.936089049533555,0,11,regulation of cellular response to osmotic stress,BP,
18349,GO:0106050,1,0.991028740588493,0,2,tRNA 2'-O-methyltransferase activity,MF,
18351,GO:0106057,1,0.903470240470398,0,14,negative regulation of calcineurin-mediated signaling,BP,
18352,GO:0106058,1,0.901377955761248,0,13,positive regulation of calcineurin-mediated signaling,BP,
18353,GO:0106064,1,0.988951615016751,0,1,regulation of cobalamin metabolic process,BP,
18354,GO:0106068,1,0.962655643283524,0,7,SUMO ligase complex,CC,
18355,GO:0106070,1,0.915337118085118,0,12,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18356,GO:0106071,1,0.959021314902536,0,5,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18357,GO:0106072,1,0.947452223547804,0,9,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,BP,
18358,GO:0106073,1,0.975681379024326,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18359,GO:0106074,1,0.9535196718914,0,8,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18360,GO:0106075,1,0.994219064369316,0,1,peptide N-succinyltransferase activity,MF,
18361,GO:0106077,1,0.974283891070571,0,4,histone succinylation,BP,
18362,GO:0106078,1,0.994219064369316,0,1,histone succinyltransferase activity,MF,
18363,GO:0106083,1,0.899109275427622,0,8,nuclear membrane protein complex,CC,
18364,GO:0106088,1,0.986917189081627,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18365,GO:0106089,1,0.986917189081627,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18366,GO:0106091,1,0.992706539153926,0,2,glial cell projection elongation,BP,
18367,GO:0106094,1,0.899109275427622,0,8,nuclear membrane microtubule tethering complex,CC,
18368,GO:0106096,1,0.989030552840523,0,1,response to ceramide,BP,
18369,GO:0106101,1,0.996245125832489,0,1,ER-dependent peroxisome localization,BP,
18371,GO:0106105,1,0.994890876864838,0,1,Ala-tRNA(Thr) hydrolase activity,MF,
18373,GO:0106118,1,0.733978356023136,0,42,regulation of sterol biosynthetic process,BP,
18374,GO:0106119,1,0.975794215004564,0,5,negative regulation of sterol biosynthetic process,BP,
18375,GO:0106120,1,0.956001228130475,0,6,positive regulation of sterol biosynthetic process,BP,
18376,GO:0106121,1,0.988951615016751,0,1,positive regulation of cobalamin metabolic process,BP,
18377,GO:0106130,1,0.993474412079687,0,2,purine phosphoribosyltransferase activity,MF,
18378,GO:0106134,1,0.969952681588031,0,4,positive regulation of cardiac muscle cell contraction,BP,
18379,GO:0106135,1,0.989991547156144,0,2,negative regulation of cardiac muscle cell contraction,BP,
18380,GO:0106137,1,0.99333404336054,0,1,IkappaB kinase complex binding,MF,
18381,GO:0106138,1,0.988245416847562,0,1,Sec61 translocon complex binding,MF,
18382,GO:0106140,1,0.979587557149789,0,3,P-TEFb complex binding,MF,
18383,GO:0106153,1,0.996740626605071,0,1,phosphorylated histone binding,MF,
18384,GO:0110008,1,0.99436043449338,0,1,ncRNA deadenylation,BP,
18385,GO:0110009,1,0.971575321337541,0,3,formin-nucleated actin cable organization,BP,
18386,GO:0110011,1,0.939775170013206,0,5,regulation of basement membrane organization,BP,
18387,GO:0110017,1,0.993285302449125,0,2,cap-independent translational initiation of linear mRNA,BP,
18388,GO:0110020,1,0.457369600140409,0,92,regulation of actomyosin structure organization,BP,
18389,GO:0110021,1,0.982746195200146,0,3,cardiac muscle myoblast proliferation,BP,
18390,GO:0110022,1,0.982746195200146,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18391,GO:0110024,1,0.982746195200146,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18392,GO:0110025,1,0.988455688067667,0,2,DNA strand resection involved in replication fork processing,BP,
18393,GO:0110026,1,0.994351719392244,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18394,GO:0110028,1,0.986317247929674,0,1,positive regulation of mitotic spindle organization,BP,
18395,GO:0110030,1,0.982463462020401,0,3,regulation of G2/MI transition of meiotic cell cycle,BP,
18396,GO:0110032,1,0.982463462020401,0,3,positive regulation of G2/MI transition of meiotic cell cycle,BP,
18398,GO:0110057,1,0.989491332811943,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18399,GO:0110059,1,0.989491332811943,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18400,GO:0110061,1,0.975165907550429,0,2,regulation of angiotensin-activated signaling pathway,BP,
18401,GO:0110070,1,0.996146141141497,0,1,cellularization cleavage furrow,CC,
18402,GO:0110075,1,0.990816775836405,0,2,regulation of ferroptosis,BP,
18403,GO:0110076,1,0.990816775836405,0,2,negative regulation of ferroptosis,BP,
18404,GO:0110077,1,0.994573634618804,0,1,vesicle-mediated intercellular transport,BP,
18405,GO:0110088,1,0.976015693250089,0,4,hippocampal neuron apoptotic process,BP,
18406,GO:0110089,1,0.976015693250089,0,4,regulation of hippocampal neuron apoptotic process,BP,
18407,GO:0110090,1,0.987792880045105,0,2,positive regulation of hippocampal neuron apoptotic process,BP,
18408,GO:0110091,1,0.988078727317355,0,2,negative regulation of hippocampal neuron apoptotic process,BP,
18409,GO:0110095,1,0.969636888539527,0,8,cellular detoxification of aldehyde,BP,
18410,GO:0110096,1,0.962284067505576,0,10,cellular response to aldehyde,BP,
18411,GO:0110097,1,0.995657358658021,0,1,regulation of calcium import into the mitochondrion,BP,
18412,GO:0110104,1,0.97243965865748,0,3,mRNA alternative polyadenylation,BP,
18414,GO:0110111,1,0.782127358527423,0,32,negative regulation of animal organ morphogenesis,BP,
18415,GO:0110112,1,0.991103603875434,0,2,regulation of lipid transporter activity,BP,
18416,GO:0110113,1,0.994852072375899,0,1,positive regulation of lipid transporter activity,BP,
18419,GO:0110150,1,0.84908894837649,0,22,negative regulation of biomineralization,BP,
18421,GO:0110154,1,0.923845759991035,0,12,RNA decapping,BP,
18422,GO:0110156,1,0.923845759991035,0,12,methylguanosine-cap decapping,BP,
18424,GO:0120001,1,0.992841626521597,0,2,apical plasma membrane urothelial plaque,CC,
18425,GO:0120003,1,0.996823679358212,0,1,hinge region between urothelial plaques of apical plasma membrane,CC,
18426,GO:0120009,1,0.790891291803332,0,36,intermembrane lipid transfer,BP,
18427,GO:0120013,1,0.80755986828856,0,34,lipid transfer activity,MF,
18428,GO:0120014,1,0.908811380630995,0,17,phospholipid transfer activity,MF,
18429,GO:0120015,1,0.883151593458984,0,18,sterol transfer activity,MF,
18430,GO:0120016,1,0.970933832405074,0,6,sphingolipid transfer activity,MF,
18431,GO:0120017,1,0.970933832405074,0,6,ceramide transfer activity,MF,
18432,GO:0120019,1,0.996408210104187,0,1,phosphatidylcholine transfer activity,MF,
18433,GO:0120020,1,0.891859950991233,0,17,cholesterol transfer activity,MF,
18436,GO:0120032,1,0.310023906763523,0,160,regulation of plasma membrane bounded cell projection assembly,BP,
18437,GO:0120033,1,0.864203636808129,0,24,negative regulation of plasma membrane bounded cell projection assembly,BP,
18438,GO:0120034,1,0.502680488225512,0,91,positive regulation of plasma membrane bounded cell projection assembly,BP,
18442,GO:0120040,1,0.965041458433824,0,6,regulation of macrophage proliferation,BP,
18443,GO:0120041,1,0.969787363592115,0,5,positive regulation of macrophage proliferation,BP,
18444,GO:0120042,1,0.995107740824499,0,1,negative regulation of macrophage proliferation,BP,
18445,GO:0120043,1,0.991400222344403,0,1,stereocilium shaft,CC,
18446,GO:0120044,1,0.981430841248832,0,2,stereocilium base,CC,
18447,GO:0120045,1,0.995371517590328,0,1,stereocilium maintenance,BP,
18448,GO:0120048,1,0.994890876864838,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18449,GO:0120049,1,0.988021249706999,0,2,snRNA (adenine-N6)-methylation,BP,
18450,GO:0120054,1,0.996863987862682,0,1,intestinal motility,BP,
18451,GO:0120055,1,0.996863987862682,0,1,small intestinal transit,BP,
18452,GO:0120057,1,0.996863987862682,0,1,regulation of small intestinal transit,BP,
18453,GO:0120058,1,0.996863987862682,0,1,positive regulation of small intestinal transit,BP,
18454,GO:0120060,1,0.99345938848324,0,2,regulation of gastric emptying,BP,
18455,GO:0120061,1,0.99345938848324,0,2,negative regulation of gastric emptying,BP,
18456,GO:0120063,1,0.986946070956399,0,2,stomach smooth muscle contraction,BP,
18457,GO:0120064,1,0.990069666968894,0,1,stomach pylorus smooth muscle contraction,BP,
18458,GO:0120065,1,0.990069666968894,0,1,pyloric antrum smooth muscle contraction,BP,
18459,GO:0120068,1,0.996845389599986,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18460,GO:0120069,1,0.996845389599986,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18461,GO:0120071,1,0.990069666968894,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18462,GO:0120072,1,0.990069666968894,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18463,GO:0120077,1,0.986917189081627,0,1,angiogenic sprout fusion,BP,
18464,GO:0120078,1,0.986917189081627,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18465,GO:0120092,1,0.993738623939467,0,1,crotonyl-CoA hydratase activity,MF,
18466,GO:0120093,1,0.993738623939467,0,1,regulation of peptidyl-lysine crotonylation,BP,
18467,GO:0120094,1,0.993738623939467,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18468,GO:0120103,1,0.931241189459584,0,9,centriolar subdistal appendage,CC,
18469,GO:0120111,1,0.49716179767515,0,86,neuron projection cytoplasm,CC,
18470,GO:0120114,1,0.686691391772439,0,73,Sm-like protein family complex,CC,
18471,GO:0120115,1,0.974952522455392,0,7,Lsm2-8 complex,CC,
18472,GO:0120117,1,0.993878442898129,0,1,T cell meandering migration,BP,
18473,GO:0120127,1,0.995739117796931,0,1,response to zinc ion starvation,BP,
18474,GO:0120134,1,0.974803430322933,0,1,proximal portion of axoneme,CC,
18475,GO:0120135,1,0.98405052816237,0,1,distal portion of axoneme,CC,
18476,GO:0120146,1,0.977902541669948,0,5,sulfatide binding,MF,
18477,GO:0120147,1,0.995937833717985,0,1,Formylglycine-generating oxidase activity,MF,
18478,GO:0120153,1,0.996648216378589,0,1,calcium-dependent carbohydrate binding,MF,
18479,GO:0120160,1,0.983292345493415,0,2,intraciliary transport particle A binding,MF,
18482,GO:0120163,1,0.729261265962634,0,44,negative regulation of cold-induced thermogenesis,BP,
18483,GO:0120168,1,0.991687057200767,0,1,detection of hot stimulus involved in thermoception,BP,
18484,GO:0120169,1,0.991031082529829,0,1,detection of cold stimulus involved in thermoception,BP,
18485,GO:0120170,1,0.965432674197375,0,5,intraciliary transport particle B binding,MF,
18487,GO:0120180,1,0.954345728501468,0,5,cell-substrate junction disassembly,BP,
18488,GO:0120181,1,0.954345728501468,0,5,focal adhesion disassembly,BP,
18489,GO:0120182,1,0.954345728501468,0,5,regulation of focal adhesion disassembly,BP,
18490,GO:0120183,1,0.954345728501468,0,5,positive regulation of focal adhesion disassembly,BP,
18491,GO:0120187,1,0.981211530031672,0,1,positive regulation of protein localization to chromatin,BP,
18492,GO:0120188,1,0.98690425246211,0,2,regulation of bile acid secretion,BP,
18493,GO:0120189,1,0.990818656500853,0,1,positive regulation of bile acid secretion,BP,
18494,GO:0120191,1,0.989807596705769,0,2,negative regulation of termination of RNA polymerase II transcription,BP,
18495,GO:0120192,1,0.640092700541487,0,66,tight junction assembly,BP,
18496,GO:0120193,1,0.614419085633122,0,69,tight junction organization,BP,
18497,GO:0120222,1,0.986213600553903,0,1,regulation of blastocyst development,BP,
18498,GO:0120227,1,0.900313585456729,0,22,acyl-CoA binding,MF,
18500,GO:0120253,1,0.985485877557504,0,3,hydrocarbon catabolic process,BP,
18503,GO:0120256,1,0.995796629651648,0,1,olefinic compound catabolic process,BP,
18504,GO:0140007,1,0.982156392873102,0,4,KICSTOR complex,CC,
18505,GO:0140009,1,0.974328165446646,0,4,L-aspartate import across plasma membrane,BP,
18506,GO:0140010,1,0.992987268436278,0,1,D-aspartate transmembrane transporter activity,MF,
18508,GO:0140014,1,0.143650050791368,0,266,mitotic nuclear division,BP,
18510,GO:0140030,1,0.360886490035844,0,134,modification-dependent protein binding,MF,
18511,GO:0140031,1,0.97174246980356,0,4,phosphorylation-dependent protein binding,MF,
18512,GO:0140033,1,0.816443376381081,0,21,acetylation-dependent protein binding,MF,
18513,GO:0140034,1,0.622377462874687,0,62,methylation-dependent protein binding,MF,
18514,GO:0140035,1,0.929930085878691,0,11,ubiquitination-like modification-dependent protein binding,MF,
18515,GO:0140036,1,0.939483323532275,0,9,ubiquitin-dependent protein binding,MF,
18516,GO:0140037,1,0.989837710084468,0,2,sumo-dependent protein binding,MF,
18517,GO:0140039,1,0.982936251142132,0,2,cell-cell adhesion in response to extracellular stimulus,BP,
18518,GO:0140041,1,0.996816752933256,0,1,cellular detoxification of methylglyoxal,BP,
18519,GO:0140042,1,0.955875277881084,0,9,lipid droplet formation,BP,
18520,GO:0140049,1,0.996422603960133,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18521,GO:0140051,1,0.996422603960133,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18522,GO:0140052,1,0.92679697337931,0,10,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18523,GO:0140053,1,0.483836043025465,0,156,mitochondrial gene expression,BP,
18525,GO:0140058,1,0.772597060228181,0,26,neuron projection arborization,BP,
18526,GO:0140059,1,0.958700380081638,0,7,dendrite arborization,BP,
18527,GO:0140064,1,0.98352665937302,0,1,peptide crotonyltransferase activity,MF,
18528,GO:0140065,1,0.98352665937302,0,1,peptide butyryltransferase activity,MF,
18529,GO:0140066,1,0.977367411146041,0,2,peptidyl-lysine crotonylation,BP,
18530,GO:0140067,1,0.98352665937302,0,1,peptidyl-lysine butyrylation,BP,
18531,GO:0140068,1,0.98352665937302,0,1,histone crotonyltransferase activity,MF,
18532,GO:0140069,1,0.98352665937302,0,1,histone butyryltransferase activity,MF,
18533,GO:0140074,1,0.985304676197924,0,2,cardiac endothelial to mesenchymal transition,BP,
18534,GO:0140078,1,0.972903470638968,0,7,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18535,GO:0140081,1,0.992210686205853,0,2,glycosylated region protein binding,MF,
18536,GO:0140090,1,0.986914157754903,0,3,membrane curvature sensor activity,MF,
18539,GO:0140098,1,0.131249518863218,0,333,catalytic activity, acting on RNA,MF,
18540,GO:0140101,1,0.602760450423106,0,96,catalytic activity, acting on a tRNA,MF,
18541,GO:0140102,1,0.923481164951225,0,17,catalytic activity, acting on a rRNA,MF,
18542,GO:0140103,1,0.891768938325555,0,19,catalytic activity, acting on a glycoprotein,MF,
18543,GO:0140104,1,0.938583512057116,0,10,molecular carrier activity,MF,
18545,GO:0140112,1,0.896984660970493,0,20,extracellular vesicle biogenesis,BP,
18547,GO:0140131,1,0.900570144559181,0,17,positive regulation of lymphocyte chemotaxis,BP,
18548,GO:0140135,1,0.975768573234629,0,4,mechanosensitive cation channel activity,MF,
18549,GO:0140142,1,0.777204067296831,0,28,nucleocytoplasmic carrier activity,MF,
18550,GO:0140157,1,0.96699012232129,0,3,ammonium import across plasma membrane,BP,
18551,GO:0140161,1,0.956762930104935,0,9,monocarboxylate:sodium symporter activity,MF,
18552,GO:0140192,1,0.966048898706614,0,3,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18553,GO:0140193,1,0.996644807500605,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18554,GO:0140194,1,0.996644807500605,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18555,GO:0140196,1,0.986414740258483,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18556,GO:0140199,1,0.979356459473682,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18557,GO:0140200,1,0.984668516336492,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18558,GO:0140205,1,0.971713915776406,0,2,oligopeptide import across plasma membrane,BP,
18559,GO:0140206,1,0.971713915776406,0,2,dipeptide import across plasma membrane,BP,
18560,GO:0140212,1,0.951657582234613,0,6,regulation of long-chain fatty acid import into cell,BP,
18561,GO:0140213,1,0.960774673562873,0,4,negative regulation of long-chain fatty acid import into cell,BP,
18562,GO:0140214,1,0.990514466028782,0,2,positive regulation of long-chain fatty acid import into cell,BP,
18563,GO:0140223,1,0.805131317575029,0,40,general transcription initiation factor activity,MF,
18565,GO:0140239,1,0.854671415916863,0,20,postsynaptic endocytosis,BP,
18566,GO:0140243,1,0.97104407348621,0,3,regulation of translation at synapse,BP,
18567,GO:0140245,1,0.987294851526748,0,2,regulation of translation at postsynapse,BP,
18568,GO:0140246,1,0.989086059081135,0,1,protein catabolic process at synapse,BP,
18570,GO:0140261,1,0.987835063001304,0,1,BCOR complex,CC,
18571,GO:0140271,1,0.960148289404353,0,6,hexose import across plasma membrane,BP,
18572,GO:0140272,1,0.640483811199394,0,65,exogenous protein binding,MF,
18573,GO:0140296,1,0.731185764488566,0,44,general transcription initiation factor binding,MF,
18574,GO:0140297,1,0.0925043096952792,0,329,DNA-binding transcription factor binding,MF,
18576,GO:0140303,1,0.838867400615414,0,19,intramembrane lipid transporter activity,MF,
18577,GO:0140312,1,0.88331530265134,0,17,cargo adaptor activity,MF,
18578,GO:0140318,1,0.905881042710971,0,17,protein transporter activity,MF,
18579,GO:0140321,1,0.990471382129943,0,1,negative regulation by symbiont of host autophagy,BP,
18580,GO:0140323,1,0.828020224525259,0,25,solute:anion antiporter activity,MF,
18581,GO:0140326,1,0.884359491052638,0,11,ATPase-coupled intramembrane lipid transporter activity,MF,
18582,GO:0140327,1,0.940309804858171,0,6,flippase activity,MF,
18583,GO:0140328,1,0.931712464543498,0,6,floppase activity,MF,
18584,GO:0140333,1,0.976778836090539,0,2,glycerophospholipid flippase activity,MF,
18586,GO:0140353,1,0.824733775930023,0,33,lipid export from cell,BP,
18587,GO:0140354,1,0.893706669069977,0,16,lipid import into cell,BP,
18588,GO:0140375,1,0.513443469083358,0,118,immune receptor activity,MF,
18589,GO:0140410,1,0.93736781711846,0,6,solute:bicarbonate symporter activity,MF,
18590,GO:0140414,1,0.996871328163206,0,1,phosphopantetheine-dependent carrier activity,MF,
18591,GO:0140445,1,0.942621836702609,0,11,chromosome, telomeric repeat region,CC,
18592,GO:0140448,1,0.850617061290108,0,26,signaling receptor ligand precursor processing,BP,
18593,GO:0140455,1,0.996437138962998,0,1,cytoplasm protein quality control,BP,
18594,GO:0140457,1,0.77208017706002,0,25,protein demethylase activity,MF,
18595,GO:0140461,1,0.996442198035923,0,1,subtelomeric heterochromatin organization,BP,
18596,GO:0140462,1,0.990994336083943,0,2,pericentric heterochromatin organization,BP,
18597,GO:0140467,1,0.893231731383412,0,20,integrated stress response signaling,BP,
18598,GO:0140507,1,0.974588020076421,0,5,granzyme-mediated programmed cell death signaling pathway,BP,
18599,GO:0150001,1,0.970370712209984,0,2,primary dendrite,CC,
18600,GO:0150002,1,0.982215507999994,0,2,distal dendrite,CC,
18601,GO:0150003,1,0.943860650902091,0,6,regulation of spontaneous synaptic transmission,BP,
18602,GO:0150005,1,0.98426759484552,0,4,enzyme activator complex,CC,
18603,GO:0150007,1,0.977120064032316,0,2,clathrin-dependent synaptic vesicle endocytosis,BP,
18604,GO:0150011,1,0.86871654685635,0,14,regulation of neuron projection arborization,BP,
18605,GO:0150012,1,0.932423367976885,0,8,positive regulation of neuron projection arborization,BP,
18606,GO:0150014,1,0.989152924721618,0,1,apical distal dendrite,CC,
18607,GO:0150018,1,0.975576194978949,0,3,basal dendrite development,BP,
18608,GO:0150019,1,0.975576194978949,0,3,basal dendrite morphogenesis,BP,
18609,GO:0150020,1,0.975576194978949,0,3,basal dendrite arborization,BP,
18610,GO:0150024,1,0.995979337819346,0,1,oxidised low-density lipoprotein particle clearance,BP,
18611,GO:0150025,1,0.995979337819346,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18612,GO:0150031,1,0.983795327661379,0,2,regulation of protein localization to lysosome,BP,
18613,GO:0150032,1,0.996016135711337,0,1,positive regulation of protein localization to lysosome,BP,
18614,GO:0150033,1,0.987730798209826,0,1,negative regulation of protein localization to lysosome,BP,
18616,GO:0150051,1,0.92961709642491,0,5,postsynaptic Golgi apparatus,CC,
18617,GO:0150052,1,0.901598017157542,0,13,regulation of postsynapse assembly,BP,
18618,GO:0150056,1,0.990063522184625,0,2,amylin receptor complex 1,CC,
18619,GO:0150057,1,0.990090955228854,0,2,amylin receptor complex 2,CC,
18620,GO:0150058,1,0.989889285530179,0,2,amylin receptor complex 3,CC,
18621,GO:0150062,1,0.974806501131637,0,4,complement-mediated synapse pruning,BP,
18623,GO:0150064,1,0.977956032686002,0,3,vertebrate eye-specific patterning,BP,
18624,GO:0150065,1,0.90887707418352,0,11,regulation of deacetylase activity,BP,
18625,GO:0150066,1,0.974618473212284,0,2,negative regulation of deacetylase activity,BP,
18626,GO:0150070,1,0.995734083199775,0,1,regulation of arginase activity,BP,
18627,GO:0150072,1,0.995734083199775,0,1,positive regulation of arginase activity,BP,
18628,GO:0150073,1,0.995734083199775,0,1,regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18629,GO:0150074,1,0.995734083199775,0,1,positive regulation of protein-glutamine gamma-glutamyltransferase activity,BP,
18630,GO:0150076,1,0.636915804054113,0,62,neuroinflammatory response,BP,
18631,GO:0150077,1,0.813330474065381,0,29,regulation of neuroinflammatory response,BP,
18632,GO:0150078,1,0.92601186325909,0,12,positive regulation of neuroinflammatory response,BP,
18633,GO:0150079,1,0.92553344036178,0,11,negative regulation of neuroinflammatory response,BP,
18634,GO:0150089,1,0.994110532640637,0,1,multiple spine synapse organization,BP,
18635,GO:0150090,1,0.994110532640637,0,1,multiple spine synapse organization, single dendrite,BP,
18636,GO:0150093,1,0.935838044609974,0,7,amyloid-beta clearance by transcytosis,BP,
18637,GO:0150094,1,0.913837043795241,0,7,amyloid-beta clearance by cellular catabolic process,BP,
18638,GO:0150098,1,0.985385778535856,0,2,glial cell-neuron signaling,BP,
18639,GO:0150100,1,0.993366376897158,0,2,RNA binding involved in posttranscriptional gene silencing,MF,
18640,GO:0150104,1,0.939006239258989,0,11,transport across blood-brain barrier,BP,
18641,GO:0150105,1,0.887571934080262,0,13,protein localization to cell-cell junction,BP,
18642,GO:0150106,1,0.989659488731851,0,1,regulation of protein localization to cell-cell junction,BP,
18643,GO:0150115,1,0.382582793748662,0,100,cell-substrate junction organization,BP,
18644,GO:0150116,1,0.556847804992786,0,65,regulation of cell-substrate junction organization,BP,
18645,GO:0150117,1,0.774799587235215,0,28,positive regulation of cell-substrate junction organization,BP,
18646,GO:0150118,1,0.853087513657254,0,18,negative regulation of cell-substrate junction organization,BP,
18647,GO:0150146,1,0.876172671912159,0,19,cell junction disassembly,BP,
18648,GO:0150147,1,0.978050074832259,0,3,cell-cell junction disassembly,BP,
18649,GO:0150172,1,0.954100196199931,0,8,regulation of phosphatidylcholine metabolic process,BP,
18650,GO:0150173,1,0.982170433978337,0,3,positive regulation of phosphatidylcholine metabolic process,BP,
18651,GO:0150200,1,0.996730590415193,0,1,regulation of transport across blood-brain barrier,BP,
18652,GO:0150201,1,0.996730590415193,0,1,positive regulation of transport across blood-brain barrier,BP,
18654,GO:1900003,1,0.969766364605627,0,4,regulation of serine-type endopeptidase activity,BP,
18655,GO:1900004,1,0.969766364605627,0,4,negative regulation of serine-type endopeptidase activity,BP,
18656,GO:1900005,1,0.982599387937213,0,1,positive regulation of serine-type endopeptidase activity,BP,
18658,GO:1900010,1,0.996251994703303,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18659,GO:1900011,1,0.996251994703303,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18660,GO:1900015,1,0.765205877024187,0,40,regulation of cytokine production involved in inflammatory response,BP,
18661,GO:1900016,1,0.911041325938441,0,14,negative regulation of cytokine production involved in inflammatory response,BP,
18662,GO:1900017,1,0.884563399850603,0,18,positive regulation of cytokine production involved in inflammatory response,BP,
18663,GO:1900019,1,0.971494687100866,0,4,regulation of protein kinase C activity,BP,
18664,GO:1900020,1,0.971494687100866,0,4,positive regulation of protein kinase C activity,BP,
18665,GO:1900022,1,0.993435274461892,0,1,regulation of D-erythro-sphingosine kinase activity,BP,
18668,GO:1900026,1,0.791569144441451,0,35,positive regulation of substrate adhesion-dependent cell spreading,BP,
18669,GO:1900027,1,0.858993093593297,0,26,regulation of ruffle assembly,BP,
18670,GO:1900028,1,0.966724472290545,0,6,negative regulation of ruffle assembly,BP,
18671,GO:1900029,1,0.931062726311599,0,12,positive regulation of ruffle assembly,BP,
18673,GO:1900035,1,0.994984533527118,0,1,negative regulation of cellular response to heat,BP,
18674,GO:1900036,1,0.995610258959623,0,1,positive regulation of cellular response to heat,BP,
18675,GO:1900037,1,0.925072611498696,0,13,regulation of cellular response to hypoxia,BP,
18676,GO:1900038,1,0.961616723969177,0,7,negative regulation of cellular response to hypoxia,BP,
18677,GO:1900039,1,0.990421260339645,0,2,positive regulation of cellular response to hypoxia,BP,
18678,GO:1900044,1,0.897760294281073,0,12,regulation of protein K63-linked ubiquitination,BP,
18679,GO:1900045,1,0.940406378673862,0,7,negative regulation of protein K63-linked ubiquitination,BP,
18683,GO:1900052,1,0.990130513116852,0,2,regulation of retinoic acid biosynthetic process,BP,
18684,GO:1900053,1,0.996708818663127,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18685,GO:1900054,1,0.993400190095857,0,1,positive regulation of retinoic acid biosynthetic process,BP,
18686,GO:1900060,1,0.975163830725262,0,5,negative regulation of ceramide biosynthetic process,BP,
18687,GO:1900062,1,0.993014323036889,0,1,regulation of replicative cell aging,BP,
18688,GO:1900063,1,0.966277446847896,0,3,regulation of peroxisome organization,BP,
18689,GO:1900069,1,0.974483915820571,0,4,regulation of cellular hyperosmotic salinity response,BP,
18690,GO:1900073,1,0.996491177227124,0,1,regulation of neuromuscular synaptic transmission,BP,
18691,GO:1900075,1,0.996491177227124,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18694,GO:1900078,1,0.827198583155452,0,23,positive regulation of cellular response to insulin stimulus,BP,
18695,GO:1900079,1,0.99618078585442,0,1,regulation of arginine biosynthetic process,BP,
18696,GO:1900081,1,0.98344653483578,0,1,regulation of arginine catabolic process,BP,
18697,GO:1900082,1,0.98344653483578,0,1,negative regulation of arginine catabolic process,BP,
18698,GO:1900084,1,0.96121256144728,0,5,regulation of peptidyl-tyrosine autophosphorylation,BP,
18699,GO:1900085,1,0.995063524952923,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18700,GO:1900086,1,0.965982758194382,0,4,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18702,GO:1900094,1,0.959035524809359,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18703,GO:1900095,1,0.980487137556955,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18704,GO:1900098,1,0.996285675028102,0,1,regulation of plasma cell differentiation,BP,
18705,GO:1900100,1,0.996285675028102,0,1,positive regulation of plasma cell differentiation,BP,
18706,GO:1900101,1,0.861000037277866,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18707,GO:1900102,1,0.935406163707727,0,12,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18708,GO:1900103,1,0.921277294822725,0,12,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18709,GO:1900104,1,0.983565069445738,0,3,regulation of hyaluranon cable assembly,BP,
18710,GO:1900106,1,0.983565069445738,0,3,positive regulation of hyaluranon cable assembly,BP,
18711,GO:1900107,1,0.957318481635224,0,7,regulation of nodal signaling pathway,BP,
18712,GO:1900108,1,0.987708559957347,0,3,negative regulation of nodal signaling pathway,BP,
18713,GO:1900109,1,0.988501417082567,0,3,regulation of histone H3-K9 dimethylation,BP,
18714,GO:1900110,1,0.993103940118218,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18715,GO:1900111,1,0.99536583857042,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18716,GO:1900112,1,0.923795017531549,0,10,regulation of histone H3-K9 trimethylation,BP,
18717,GO:1900113,1,0.97260301582173,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18718,GO:1900114,1,0.974571695508574,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18719,GO:1900115,1,0.907240098594391,0,12,extracellular regulation of signal transduction,BP,
18720,GO:1900116,1,0.907240098594391,0,12,extracellular negative regulation of signal transduction,BP,
18722,GO:1900118,1,0.93564978713149,0,11,negative regulation of execution phase of apoptosis,BP,
18723,GO:1900119,1,0.924371631084583,0,15,positive regulation of execution phase of apoptosis,BP,
18725,GO:1900121,1,0.915893779794641,0,13,negative regulation of receptor binding,BP,
18727,GO:1900125,1,0.936290403300399,0,8,regulation of hyaluronan biosynthetic process,BP,
18728,GO:1900126,1,0.963516270532563,0,4,negative regulation of hyaluronan biosynthetic process,BP,
18729,GO:1900127,1,0.971753558764854,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18730,GO:1900130,1,0.993221115062817,0,1,regulation of lipid binding,BP,
18731,GO:1900131,1,0.993221115062817,0,1,negative regulation of lipid binding,BP,
18732,GO:1900133,1,0.982485098181366,0,3,regulation of renin secretion into blood stream,BP,
18733,GO:1900134,1,0.992826970482153,0,1,negative regulation of renin secretion into blood stream,BP,
18734,GO:1900135,1,0.989584155511738,0,2,positive regulation of renin secretion into blood stream,BP,
18736,GO:1900139,1,0.990345394588493,0,1,negative regulation of arachidonic acid secretion,BP,
18737,GO:1900141,1,0.97973358143964,0,2,regulation of oligodendrocyte apoptotic process,BP,
18738,GO:1900142,1,0.995341402520803,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18739,GO:1900143,1,0.984319854080239,0,1,positive regulation of oligodendrocyte apoptotic process,BP,
18740,GO:1900145,1,0.966620713770019,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18741,GO:1900146,1,0.993094077199985,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18742,GO:1900147,1,0.955512447846212,0,3,regulation of Schwann cell migration,BP,
18743,GO:1900148,1,0.994890876864838,0,1,negative regulation of Schwann cell migration,BP,
18744,GO:1900149,1,0.960421333056009,0,2,positive regulation of Schwann cell migration,BP,
18745,GO:1900150,1,0.987425940956031,0,3,regulation of defense response to fungus,BP,
18746,GO:1900151,1,0.856788725941779,0,18,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18747,GO:1900152,1,0.996270785710522,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18748,GO:1900153,1,0.856788725941779,0,18,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18749,GO:1900154,1,0.988576832154231,0,2,regulation of bone trabecula formation,BP,
18750,GO:1900155,1,0.988576832154231,0,2,negative regulation of bone trabecula formation,BP,
18752,GO:1900158,1,0.992154396979955,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18754,GO:1900161,1,0.994852072375899,0,1,regulation of phospholipid scramblase activity,BP,
18755,GO:1900163,1,0.994852072375899,0,1,positive regulation of phospholipid scramblase activity,BP,
18756,GO:1900164,1,0.959035524809359,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18757,GO:1900166,1,0.970177664671789,0,3,regulation of glial cell-derived neurotrophic factor secretion,BP,
18758,GO:1900168,1,0.970177664671789,0,3,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18759,GO:1900169,1,0.971214651674268,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18760,GO:1900170,1,0.994890876864838,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18761,GO:1900175,1,0.966620713770019,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18762,GO:1900176,1,0.993094077199985,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18764,GO:1900181,1,0.812417833393868,0,27,negative regulation of protein localization to nucleus,BP,
18766,GO:1900186,1,0.97670976489742,0,4,negative regulation of clathrin-dependent endocytosis,BP,
18769,GO:1900193,1,0.95895086551115,0,8,regulation of oocyte maturation,BP,
18770,GO:1900194,1,0.984873193945591,0,3,negative regulation of oocyte maturation,BP,
18771,GO:1900195,1,0.983161520299547,0,3,positive regulation of oocyte maturation,BP,
18772,GO:1900200,1,0.984941557444264,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18773,GO:1900204,1,0.984941557444264,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18774,GO:1900205,1,0.984941557444264,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18775,GO:1900208,1,0.986178187959843,0,4,regulation of cardiolipin metabolic process,BP,
18776,GO:1900210,1,0.992920968545938,0,2,positive regulation of cardiolipin metabolic process,BP,
18777,GO:1900211,1,0.984941557444264,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18778,GO:1900212,1,0.984941557444264,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18779,GO:1900214,1,0.984941557444264,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18780,GO:1900215,1,0.984941557444264,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18781,GO:1900217,1,0.984941557444264,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18782,GO:1900218,1,0.984941557444264,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18783,GO:1900220,1,0.977686579976499,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18784,GO:1900221,1,0.891122260282703,0,14,regulation of amyloid-beta clearance,BP,
18785,GO:1900222,1,0.954198146675575,0,7,negative regulation of amyloid-beta clearance,BP,
18786,GO:1900223,1,0.939378059708187,0,6,positive regulation of amyloid-beta clearance,BP,
18787,GO:1900224,1,0.976769826622122,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18788,GO:1900225,1,0.913923046677702,0,12,regulation of NLRP3 inflammasome complex assembly,BP,
18789,GO:1900226,1,0.972503889714243,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18790,GO:1900227,1,0.944504783291055,0,7,positive regulation of NLRP3 inflammasome complex assembly,BP,
18793,GO:1900234,1,0.989641409529715,0,1,regulation of Kit signaling pathway,BP,
18794,GO:1900235,1,0.989641409529715,0,1,negative regulation of Kit signaling pathway,BP,
18795,GO:1900238,1,0.978746492151941,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18796,GO:1900239,1,0.956486805174288,0,6,regulation of phenotypic switching,BP,
18797,GO:1900240,1,0.98107773265087,0,2,negative regulation of phenotypic switching,BP,
18798,GO:1900241,1,0.99149718966467,0,2,positive regulation of phenotypic switching,BP,
18800,GO:1900243,1,0.989946873263755,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18801,GO:1900244,1,0.946923281138086,0,7,positive regulation of synaptic vesicle endocytosis,BP,
18802,GO:1900245,1,0.966918877530706,0,3,positive regulation of MDA-5 signaling pathway,BP,
18803,GO:1900246,1,0.937338788890145,0,6,positive regulation of RIG-I signaling pathway,BP,
18804,GO:1900247,1,0.94410327619797,0,9,regulation of cytoplasmic translational elongation,BP,
18805,GO:1900248,1,0.978236059472358,0,2,negative regulation of cytoplasmic translational elongation,BP,
18806,GO:1900259,1,0.996192496231238,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18807,GO:1900260,1,0.996192496231238,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18808,GO:1900262,1,0.963359678487077,0,9,regulation of DNA-directed DNA polymerase activity,BP,
18809,GO:1900264,1,0.963359678487077,0,9,positive regulation of DNA-directed DNA polymerase activity,BP,
18811,GO:1900272,1,0.919142775269384,0,12,negative regulation of long-term synaptic potentiation,BP,
18813,GO:1900274,1,0.726032703518515,0,46,regulation of phospholipase C activity,BP,
18814,GO:1900275,1,0.982859611594429,0,2,negative regulation of phospholipase C activity,BP,
18815,GO:1900276,1,0.993584388881114,0,1,regulation of proteinase activated receptor activity,BP,
18816,GO:1900279,1,0.990009893199438,0,2,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18817,GO:1900280,1,0.996504666815365,0,1,negative regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18818,GO:1900281,1,0.993482673451939,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18819,GO:1900363,1,0.894179753048681,0,16,regulation of mRNA polyadenylation,BP,
18820,GO:1900364,1,0.94839161913252,0,8,negative regulation of mRNA polyadenylation,BP,
18821,GO:1900365,1,0.97077231903877,0,4,positive regulation of mRNA polyadenylation,BP,
18822,GO:1900368,1,0.966589662665367,0,4,regulation of RNA interference,BP,
18823,GO:1900369,1,0.980024550423494,0,2,negative regulation of RNA interference,BP,
18824,GO:1900370,1,0.989675670826443,0,1,positive regulation of RNA interference,BP,
18825,GO:1900371,1,0.807299797824122,0,33,regulation of purine nucleotide biosynthetic process,BP,
18826,GO:1900372,1,0.967012944316679,0,6,negative regulation of purine nucleotide biosynthetic process,BP,
18827,GO:1900373,1,0.90294996605211,0,17,positive regulation of purine nucleotide biosynthetic process,BP,
18828,GO:1900376,1,0.907697481723481,0,10,regulation of secondary metabolite biosynthetic process,BP,
18829,GO:1900377,1,0.970970747288615,0,3,negative regulation of secondary metabolite biosynthetic process,BP,
18830,GO:1900378,1,0.951952332215921,0,6,positive regulation of secondary metabolite biosynthetic process,BP,
18831,GO:1900383,1,0.993942864691503,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18832,GO:1900407,1,0.626483465790987,0,72,regulation of cellular response to oxidative stress,BP,
18833,GO:1900408,1,0.761936393022144,0,41,negative regulation of cellular response to oxidative stress,BP,
18834,GO:1900409,1,0.897308849627443,0,17,positive regulation of cellular response to oxidative stress,BP,
18835,GO:1900424,1,0.914568782176737,0,15,regulation of defense response to bacterium,BP,
18836,GO:1900425,1,0.967567388988302,0,5,negative regulation of defense response to bacterium,BP,
18837,GO:1900426,1,0.960494299196206,0,8,positive regulation of defense response to bacterium,BP,
18839,GO:1900450,1,0.978773705546063,0,3,negative regulation of glutamate receptor signaling pathway,BP,
18840,GO:1900451,1,0.890723977887921,0,15,positive regulation of glutamate receptor signaling pathway,BP,
18842,GO:1900453,1,0.983158137647271,0,3,negative regulation of long-term synaptic depression,BP,
18844,GO:1900477,1,0.995971627216071,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18845,GO:1900480,1,0.994969477934209,0,1,regulation of diacylglycerol biosynthetic process,BP,
18846,GO:1900533,1,0.996526733188375,0,1,palmitic acid metabolic process,BP,
18847,GO:1900535,1,0.996526733188375,0,1,palmitic acid biosynthetic process,BP,
18848,GO:1900542,1,0.457730651469742,0,103,regulation of purine nucleotide metabolic process,BP,
18849,GO:1900543,1,0.865134298143838,0,19,negative regulation of purine nucleotide metabolic process,BP,
18850,GO:1900544,1,0.756768179727865,0,37,positive regulation of purine nucleotide metabolic process,BP,
18851,GO:1900619,1,0.980307917998036,0,4,acetate ester metabolic process,BP,
18852,GO:1900620,1,0.990532885958926,0,2,acetate ester biosynthetic process,BP,
18853,GO:1900623,1,0.974410563917014,0,3,regulation of monocyte aggregation,BP,
18854,GO:1900625,1,0.974410563917014,0,3,positive regulation of monocyte aggregation,BP,
18857,GO:1900737,1,0.993584388881114,0,1,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,BP,
18859,GO:1900739,1,0.871986507228093,0,26,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18860,GO:1900740,1,0.871986507228093,0,26,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18861,GO:1900744,1,0.776483489405465,0,37,regulation of p38MAPK cascade,BP,
18862,GO:1900745,1,0.850867132749244,0,25,positive regulation of p38MAPK cascade,BP,
18863,GO:1900746,1,0.888744915445065,0,16,regulation of vascular endothelial growth factor signaling pathway,BP,
18864,GO:1900747,1,0.953177551715638,0,7,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18865,GO:1900748,1,0.948891858369703,0,5,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18866,GO:1900749,1,0.993908675883443,0,1,(R)-carnitine transport,BP,
18867,GO:1900750,1,0.944460703310723,0,13,oligopeptide binding,MF,
18868,GO:1900753,1,0.991693104368419,0,1,doxorubicin transport,BP,
18869,GO:1900756,1,0.980736214111727,0,2,protein processing in phagocytic vesicle,BP,
18870,GO:1900825,1,0.966905671818938,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18871,GO:1900826,1,0.996632930809694,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18872,GO:1900827,1,0.981556402177454,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18873,GO:1900864,1,0.961294129337649,0,8,mitochondrial RNA modification,BP,
18874,GO:1900923,1,0.990711499687685,0,2,regulation of glycine import across plasma membrane,BP,
18875,GO:1900924,1,0.990711499687685,0,2,negative regulation of glycine import across plasma membrane,BP,
18876,GO:1901000,1,0.974483915820571,0,4,regulation of response to salt stress,BP,
18877,GO:1901003,1,0.98764869320882,0,2,negative regulation of fermentation,BP,
18878,GO:1901004,1,0.996685790426054,0,1,ubiquinone-6 metabolic process,BP,
18879,GO:1901006,1,0.996685790426054,0,1,ubiquinone-6 biosynthetic process,BP,
18881,GO:1901017,1,0.875705589178798,0,19,negative regulation of potassium ion transmembrane transporter activity,BP,
18884,GO:1901020,1,0.832546068308246,0,32,negative regulation of calcium ion transmembrane transporter activity,BP,
18885,GO:1901021,1,0.758556183059272,0,37,positive regulation of calcium ion transmembrane transporter activity,BP,
18886,GO:1901026,1,0.969785113409488,0,3,ripoptosome assembly involved in necroptotic process,BP,
18887,GO:1901028,1,0.796806044342696,0,44,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18888,GO:1901029,1,0.960153307040612,0,9,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18889,GO:1901030,1,0.832989919492943,0,34,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18890,GO:1901031,1,0.820399162178943,0,33,regulation of response to reactive oxygen species,BP,
18891,GO:1901032,1,0.909292812048391,0,15,negative regulation of response to reactive oxygen species,BP,
18892,GO:1901033,1,0.949138538447274,0,9,positive regulation of response to reactive oxygen species,BP,
18893,GO:1901052,1,0.990640985260671,0,2,sarcosine metabolic process,BP,
18894,GO:1901053,1,0.993847138847661,0,1,sarcosine catabolic process,BP,
18895,GO:1901068,1,0.793596801125977,0,36,guanosine-containing compound metabolic process,BP,
18896,GO:1901069,1,0.996604021233342,0,1,guanosine-containing compound catabolic process,BP,
18897,GO:1901070,1,0.953616854653054,0,13,guanosine-containing compound biosynthetic process,BP,
18900,GO:1901073,1,0.982769272933706,0,2,glucosamine-containing compound biosynthetic process,BP,
18901,GO:1901074,1,0.97888427829964,0,3,regulation of engulfment of apoptotic cell,BP,
18902,GO:1901076,1,0.983766322462026,0,2,positive regulation of engulfment of apoptotic cell,BP,
18904,GO:1901078,1,0.968448157764308,0,4,negative regulation of relaxation of muscle,BP,
18906,GO:1901086,1,0.990273865801745,0,1,benzylpenicillin metabolic process,BP,
18907,GO:1901096,1,0.908545040277875,0,12,regulation of autophagosome maturation,BP,
18908,GO:1901097,1,0.971143227932176,0,4,negative regulation of autophagosome maturation,BP,
18909,GO:1901098,1,0.933510842786653,0,7,positive regulation of autophagosome maturation,BP,
18910,GO:1901099,1,0.836689349329275,0,33,negative regulation of signal transduction in absence of ligand,BP,
18914,GO:1901142,1,0.962857470117743,0,5,insulin metabolic process,BP,
18915,GO:1901143,1,0.983614796502633,0,2,insulin catabolic process,BP,
18916,GO:1901145,1,0.977411445150543,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18917,GO:1901147,1,0.984941557444264,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18918,GO:1901159,1,0.97849578384914,0,5,xylulose 5-phosphate biosynthetic process,BP,
18919,GO:1901160,1,0.895801112843001,0,14,primary amino compound metabolic process,BP,
18920,GO:1901162,1,0.978762477868538,0,5,primary amino compound biosynthetic process,BP,
18923,GO:1901165,1,0.968398119362026,0,6,positive regulation of trophoblast cell migration,BP,
18924,GO:1901166,1,0.952706548770836,0,5,neural crest cell migration involved in autonomic nervous system development,BP,
18927,GO:1901186,1,0.782831845245254,0,34,positive regulation of ERBB signaling pathway,BP,
18928,GO:1901187,1,0.983472758758376,0,2,regulation of ephrin receptor signaling pathway,BP,
18929,GO:1901189,1,0.995576138506172,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18930,GO:1901193,1,0.996751865538371,0,1,regulation of formation of translation preinitiation complex,BP,
18931,GO:1901194,1,0.996751865538371,0,1,negative regulation of formation of translation preinitiation complex,BP,
18932,GO:1901201,1,0.877539239984181,0,14,regulation of extracellular matrix assembly,BP,
18933,GO:1901202,1,0.995586035997366,0,1,negative regulation of extracellular matrix assembly,BP,
18934,GO:1901203,1,0.906881108833059,0,10,positive regulation of extracellular matrix assembly,BP,
18935,GO:1901207,1,0.986228727040953,0,2,regulation of heart looping,BP,
18936,GO:1901208,1,0.993708077669485,0,1,negative regulation of heart looping,BP,
18937,GO:1901210,1,0.993708077669485,0,1,regulation of cardiac chamber formation,BP,
18938,GO:1901211,1,0.993708077669485,0,1,negative regulation of cardiac chamber formation,BP,
18939,GO:1901213,1,0.939576966298547,0,7,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18942,GO:1901216,1,0.529739678637591,0,91,positive regulation of neuron death,BP,
18943,GO:1901219,1,0.993708077669485,0,1,regulation of cardiac chamber morphogenesis,BP,
18944,GO:1901220,1,0.993708077669485,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18946,GO:1901223,1,0.853412524652084,0,20,negative regulation of NIK/NF-kappaB signaling,BP,
18948,GO:1901228,1,0.966549133048238,0,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18949,GO:1901229,1,0.99520171579299,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18950,GO:1901231,1,0.99520171579299,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18951,GO:1901232,1,0.99520171579299,0,1,regulation of convergent extension involved in axis elongation,BP,
18952,GO:1901233,1,0.99520171579299,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18953,GO:1901235,1,0.993908675883443,0,1,(R)-carnitine transmembrane transporter activity,MF,
18954,GO:1901246,1,0.991822682662711,0,2,regulation of lung ciliated cell differentiation,BP,
18955,GO:1901247,1,0.996681697515034,0,1,negative regulation of lung ciliated cell differentiation,BP,
18956,GO:1901248,1,0.995124970104541,0,1,positive regulation of lung ciliated cell differentiation,BP,
18957,GO:1901249,1,0.996681697515034,0,1,regulation of lung goblet cell differentiation,BP,
18958,GO:1901251,1,0.996681697515034,0,1,positive regulation of lung goblet cell differentiation,BP,
18959,GO:1901252,1,0.98850052810653,0,2,regulation of intracellular transport of viral material,BP,
18960,GO:1901253,1,0.996815376007367,0,1,negative regulation of intracellular transport of viral material,BP,
18961,GO:1901254,1,0.991658853495653,0,1,positive regulation of intracellular transport of viral material,BP,
18962,GO:1901255,1,0.983640661515256,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18963,GO:1901256,1,0.974531293718208,0,5,regulation of macrophage colony-stimulating factor production,BP,
18964,GO:1901257,1,0.995631289282231,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18965,GO:1901258,1,0.985382923399348,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18966,GO:1901264,1,0.635898124285014,0,86,carbohydrate derivative transport,BP,
18968,GO:1901291,1,0.99616952965934,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18969,GO:1901292,1,0.657037754113588,0,70,nucleoside phosphate catabolic process,BP,
18971,GO:1901295,1,0.991881625940772,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18972,GO:1901296,1,0.9962892356662,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18973,GO:1901297,1,0.995576138506172,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18974,GO:1901298,1,0.943439046135203,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18975,GO:1901299,1,0.971209762463557,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18976,GO:1901300,1,0.971414290136983,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18977,GO:1901301,1,0.986220018679923,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18978,GO:1901303,1,0.99498895358052,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18979,GO:1901304,1,0.99639083166836,0,1,regulation of spermidine biosynthetic process,BP,
18980,GO:1901307,1,0.99639083166836,0,1,positive regulation of spermidine biosynthetic process,BP,
18981,GO:1901308,1,0.995658099904583,0,1,regulation of sterol regulatory element binding protein cleavage,BP,
18982,GO:1901310,1,0.995658099904583,0,1,positive regulation of sterol regulatory element binding protein cleavage,BP,
18983,GO:1901314,1,0.958858672241074,0,4,regulation of histone H2A K63-linked ubiquitination,BP,
18984,GO:1901315,1,0.958858672241074,0,4,negative regulation of histone H2A K63-linked ubiquitination,BP,
18985,GO:1901317,1,0.955432941090051,0,11,regulation of flagellated sperm motility,BP,
18986,GO:1901318,1,0.996154746580108,0,1,negative regulation of flagellated sperm motility,BP,
18987,GO:1901321,1,0.948896638423344,0,7,positive regulation of heart induction,BP,
18988,GO:1901328,1,0.996283123762659,0,1,response to cytochalasin B,BP,
18991,GO:1901337,1,0.988229121611841,0,2,thioester transport,BP,
18992,GO:1901338,1,0.939937199199177,0,13,catecholamine binding,MF,
18993,GO:1901339,1,0.95256679084259,0,7,regulation of store-operated calcium channel activity,BP,
18994,GO:1901340,1,0.99215542141012,0,1,negative regulation of store-operated calcium channel activity,BP,
18995,GO:1901341,1,0.965740464260685,0,5,positive regulation of store-operated calcium channel activity,BP,
18998,GO:1901344,1,0.996679631870473,0,1,response to leptomycin B,BP,
18999,GO:1901346,1,0.995755588300367,0,1,negative regulation of vasculature development involved in avascular cornea development in camera-type eye,BP,
19000,GO:1901355,1,0.97846698371426,0,3,response to rapamycin,BP,
19005,GO:1901373,1,0.996601496531062,0,1,lipid hydroperoxide transport,BP,
19006,GO:1901374,1,0.972934701511678,0,6,acetate ester transport,BP,
19007,GO:1901375,1,0.991742696778015,0,2,acetate ester transmembrane transporter activity,MF,
19008,GO:1901376,1,0.991661789485292,0,2,organic heteropentacyclic compound metabolic process,BP,
19009,GO:1901377,1,0.991661789485292,0,2,organic heteropentacyclic compound catabolic process,BP,
19011,GO:1901380,1,0.857451012787263,0,23,negative regulation of potassium ion transmembrane transport,BP,
19013,GO:1901382,1,0.962788730795128,0,4,regulation of chorionic trophoblast cell proliferation,BP,
19014,GO:1901383,1,0.979702528789821,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
19015,GO:1901385,1,0.809571782808672,0,34,regulation of voltage-gated calcium channel activity,BP,
19016,GO:1901386,1,0.932613225427933,0,13,negative regulation of voltage-gated calcium channel activity,BP,
19017,GO:1901387,1,0.938795560845259,0,12,positive regulation of voltage-gated calcium channel activity,BP,
19018,GO:1901388,1,0.936797059468115,0,7,regulation of transforming growth factor beta activation,BP,
19019,GO:1901389,1,0.995278800867257,0,1,negative regulation of transforming growth factor beta activation,BP,
19020,GO:1901390,1,0.99203173826053,0,1,positive regulation of transforming growth factor beta activation,BP,
19021,GO:1901392,1,0.99203173826053,0,1,regulation of transforming growth factor beta1 activation,BP,
19022,GO:1901394,1,0.99203173826053,0,1,positive regulation of transforming growth factor beta1 activation,BP,
19023,GO:1901398,1,0.991898443755878,0,1,regulation of transforming growth factor beta3 activation,BP,
19024,GO:1901401,1,0.982440350692676,0,3,regulation of tetrapyrrole metabolic process,BP,
19025,GO:1901403,1,0.988951615016751,0,1,positive regulation of tetrapyrrole metabolic process,BP,
19026,GO:1901407,1,0.981767421616818,0,3,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19027,GO:1901409,1,0.995702934536761,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
19028,GO:1901419,1,0.991699152780688,0,1,regulation of response to alcohol,BP,
19029,GO:1901421,1,0.991699152780688,0,1,positive regulation of response to alcohol,BP,
19030,GO:1901423,1,0.996764461891254,0,1,response to benzene,BP,
19031,GO:1901463,1,0.99341672338389,0,2,regulation of tetrapyrrole biosynthetic process,BP,
19032,GO:1901474,1,0.94239964982145,0,10,azole transmembrane transporter activity,MF,
19033,GO:1901475,1,0.979605696540701,0,4,pyruvate transmembrane transport,BP,
19034,GO:1901480,1,0.995822437882934,0,1,oleate transmembrane transporter activity,MF,
19035,GO:1901483,1,0.979196495178036,0,3,regulation of transcription factor catabolic process,BP,
19036,GO:1901485,1,0.979196495178036,0,3,positive regulation of transcription factor catabolic process,BP,
19037,GO:1901490,1,0.959211193111017,0,5,regulation of lymphangiogenesis,BP,
19038,GO:1901491,1,0.974763157669628,0,3,negative regulation of lymphangiogenesis,BP,
19039,GO:1901492,1,0.984049431186936,0,2,positive regulation of lymphangiogenesis,BP,
19040,GO:1901494,1,0.982046951199635,0,1,regulation of cysteine metabolic process,BP,
19041,GO:1901503,1,0.92129535396539,0,11,ether biosynthetic process,BP,
19042,GO:1901505,1,0.745202336550156,0,55,carbohydrate derivative transmembrane transporter activity,MF,
19043,GO:1901506,1,0.995658099904583,0,1,regulation of acylglycerol transport,BP,
19044,GO:1901508,1,0.995658099904583,0,1,positive regulation of acylglycerol transport,BP,
19045,GO:1901509,1,0.960610437227331,0,6,regulation of endothelial tube morphogenesis,BP,
19046,GO:1901522,1,0.82617200843708,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
19047,GO:1901523,1,0.971505966458003,0,6,icosanoid catabolic process,BP,
19048,GO:1901524,1,0.843621635049877,0,16,regulation of mitophagy,BP,
19049,GO:1901525,1,0.95456174169285,0,6,negative regulation of mitophagy,BP,
19050,GO:1901526,1,0.883829708017933,0,10,positive regulation of mitophagy,BP,
19051,GO:1901529,1,0.966314342089247,0,4,positive regulation of anion channel activity,BP,
19052,GO:1901532,1,0.611368588360727,0,83,regulation of hematopoietic progenitor cell differentiation,BP,
19053,GO:1901533,1,0.953834702977083,0,8,negative regulation of hematopoietic progenitor cell differentiation,BP,
19054,GO:1901534,1,0.961158174674953,0,5,positive regulation of hematopoietic progenitor cell differentiation,BP,
19055,GO:1901535,1,0.936345968147463,0,6,regulation of DNA demethylation,BP,
19056,GO:1901536,1,0.988878934525878,0,2,negative regulation of DNA demethylation,BP,
19057,GO:1901537,1,0.946882015765944,0,4,positive regulation of DNA demethylation,BP,
19058,GO:1901538,1,0.949645235430859,0,6,changes to DNA methylation involved in embryo development,BP,
19059,GO:1901545,1,0.994425053082633,0,1,response to raffinose,BP,
19060,GO:1901550,1,0.897519510850884,0,15,regulation of endothelial cell development,BP,
19061,GO:1901551,1,0.985481168805535,0,2,negative regulation of endothelial cell development,BP,
19062,GO:1901552,1,0.961572683778395,0,6,positive regulation of endothelial cell development,BP,
19063,GO:1901555,1,0.986780758211359,0,1,response to paclitaxel,BP,
19064,GO:1901557,1,0.992444782635476,0,1,response to fenofibrate,BP,
19065,GO:1901558,1,0.984200227806788,0,2,response to metformin,BP,
19066,GO:1901561,1,0.992918573909992,0,1,response to benomyl,BP,
19067,GO:1901563,1,0.965690984165066,0,5,response to camptothecin,BP,
19071,GO:1901567,1,0.890434254502408,0,26,fatty acid derivative binding,MF,
19073,GO:1901569,1,0.941567063064303,0,12,fatty acid derivative catabolic process,BP,
19078,GO:1901580,1,0.979581872132667,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19079,GO:1901581,1,0.979581872132667,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19080,GO:1901582,1,0.979581872132667,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19081,GO:1901585,1,0.994791105723256,0,1,regulation of acid-sensing ion channel activity,BP,
19082,GO:1901588,1,0.96834861822108,0,3,dendritic microtubule,CC,
19083,GO:1901594,1,0.992141082832073,0,1,response to capsazepine,BP,
19084,GO:1901605,1,0.368739066393499,0,180,alpha-amino acid metabolic process,BP,
19085,GO:1901606,1,0.614646273690236,0,96,alpha-amino acid catabolic process,BP,
19086,GO:1901607,1,0.698499490519571,0,61,alpha-amino acid biosynthetic process,BP,
19087,GO:1901608,1,0.974129891741055,0,4,regulation of vesicle transport along microtubule,BP,
19088,GO:1901609,1,0.996654943668624,0,1,negative regulation of vesicle transport along microtubule,BP,
19089,GO:1901610,1,0.977400098259719,0,3,positive regulation of vesicle transport along microtubule,BP,
19090,GO:1901611,1,0.925604232534464,0,13,phosphatidylglycerol binding,MF,
19091,GO:1901612,1,0.942378060289072,0,9,cardiolipin binding,MF,
19092,GO:1901615,1,0.0415383468710818,0,486,organic hydroxy compound metabolic process,BP,
19093,GO:1901616,1,0.693854249859137,0,63,organic hydroxy compound catabolic process,BP,
19094,GO:1901617,1,0.233333184504607,0,227,organic hydroxy compound biosynthetic process,BP,
19096,GO:1901620,1,0.951578067186126,0,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19097,GO:1901621,1,0.960475520060161,0,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19098,GO:1901622,1,0.995215222495438,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
19099,GO:1901623,1,0.879693509210558,0,22,regulation of lymphocyte chemotaxis,BP,
19100,GO:1901624,1,0.985078351229799,0,3,negative regulation of lymphocyte chemotaxis,BP,
19102,GO:1901627,1,0.995608750889622,0,1,negative regulation of postsynaptic membrane organization,BP,
19103,GO:1901628,1,0.969526414527585,0,4,positive regulation of postsynaptic membrane organization,BP,
19104,GO:1901629,1,0.984876201123599,0,1,regulation of presynaptic membrane organization,BP,
19105,GO:1901631,1,0.984876201123599,0,1,positive regulation of presynaptic membrane organization,BP,
19106,GO:1901639,1,0.988475323572307,0,1,XDP catabolic process,BP,
19107,GO:1901640,1,0.988475323572307,0,1,XTP binding,MF,
19108,GO:1901641,1,0.988475323572307,0,1,ITP binding,MF,
19109,GO:1901642,1,0.973460063891481,0,6,nucleoside transmembrane transport,BP,
19110,GO:1901645,1,0.996418272104253,0,1,regulation of synoviocyte proliferation,BP,
19111,GO:1901647,1,0.996418272104253,0,1,positive regulation of synoviocyte proliferation,BP,
19114,GO:1901654,1,0.287157657723255,0,185,response to ketone,BP,
19115,GO:1901655,1,0.521868983523289,0,91,cellular response to ketone,BP,
19116,GO:1901656,1,0.973112034442165,0,4,glycoside transport,BP,
19117,GO:1901657,1,0.541866473184654,0,116,glycosyl compound metabolic process,BP,
19118,GO:1901658,1,0.846895733464993,0,37,glycosyl compound catabolic process,BP,
19119,GO:1901659,1,0.837725073254562,0,38,glycosyl compound biosynthetic process,BP,
19121,GO:1901661,1,0.87046037411655,0,32,quinone metabolic process,BP,
19122,GO:1901662,1,0.981797435237115,0,4,quinone catabolic process,BP,
19123,GO:1901663,1,0.937594594802198,0,15,quinone biosynthetic process,BP,
19124,GO:1901664,1,0.981541199182559,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19125,GO:1901666,1,0.981541199182559,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19126,GO:1901668,1,0.979232021554,0,5,regulation of superoxide dismutase activity,BP,
19127,GO:1901671,1,0.984261533038242,0,4,positive regulation of superoxide dismutase activity,BP,
19128,GO:1901673,1,0.903302540744258,0,17,regulation of mitotic spindle assembly,BP,
19130,GO:1901675,1,0.987242143737642,0,1,negative regulation of histone H3-K27 acetylation,BP,
19133,GO:1901679,1,0.96453115700124,0,7,nucleotide transmembrane transport,BP,
19134,GO:1901680,1,0.982046951199635,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19136,GO:1901682,1,0.767935822515815,0,38,sulfur compound transmembrane transporter activity,MF,
19137,GO:1901685,1,0.9348717377692,0,19,glutathione derivative metabolic process,BP,
19138,GO:1901687,1,0.9348717377692,0,19,glutathione derivative biosynthetic process,BP,
19139,GO:1901696,1,0.995140422678749,0,1,cannabinoid biosynthetic process,BP,
19144,GO:1901702,1,0.984213912791727,0,3,salt transmembrane transporter activity,MF,
19145,GO:1901706,1,0.995205096394078,0,1,mesenchymal cell differentiation involved in bone development,BP,
19146,GO:1901707,1,0.996679631870473,0,1,leptomycin B binding,MF,
19147,GO:1901722,1,0.93551055490584,0,12,regulation of cell proliferation involved in kidney development,BP,
19148,GO:1901723,1,0.972728632840583,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19149,GO:1901724,1,0.96174886458925,0,7,positive regulation of cell proliferation involved in kidney development,BP,
19150,GO:1901725,1,0.915211088615547,0,9,regulation of histone deacetylase activity,BP,
19151,GO:1901726,1,0.974618473212284,0,2,negative regulation of histone deacetylase activity,BP,
19152,GO:1901727,1,0.94650906790578,0,6,positive regulation of histone deacetylase activity,BP,
19155,GO:1901740,1,0.992862802968245,0,2,negative regulation of myoblast fusion,BP,
19157,GO:1901748,1,0.986085166569851,0,3,leukotriene D4 metabolic process,BP,
19158,GO:1901750,1,0.986085166569851,0,3,leukotriene D4 biosynthetic process,BP,
19159,GO:1901751,1,0.990841000510086,0,2,leukotriene A4 metabolic process,BP,
19160,GO:1901753,1,0.995255489379337,0,1,leukotriene A4 biosynthetic process,BP,
19161,GO:1901796,1,0.315562870800077,0,168,regulation of signal transduction by p53 class mediator,BP,
19162,GO:1901797,1,0.85213674573793,0,27,negative regulation of signal transduction by p53 class mediator,BP,
19163,GO:1901798,1,0.857091091005486,0,22,positive regulation of signal transduction by p53 class mediator,BP,
19164,GO:1901799,1,0.710768861764688,0,51,negative regulation of proteasomal protein catabolic process,BP,
19165,GO:1901800,1,0.512020537819902,0,104,positive regulation of proteasomal protein catabolic process,BP,
19166,GO:1901804,1,0.991923974809618,0,2,beta-glucoside metabolic process,BP,
19167,GO:1901805,1,0.991923974809618,0,2,beta-glucoside catabolic process,BP,
19168,GO:1901810,1,0.994890876864838,0,1,beta-carotene metabolic process,BP,
19169,GO:1901825,1,0.995157531975832,0,1,zeaxanthin metabolic process,BP,
19170,GO:1901827,1,0.995157531975832,0,1,zeaxanthin biosynthetic process,BP,
19171,GO:1901834,1,0.996349183774901,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19172,GO:1901835,1,0.996349183774901,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19173,GO:1901836,1,0.935355010772492,0,10,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19174,GO:1901838,1,0.938763311642127,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19175,GO:1901841,1,0.925084157384605,0,13,regulation of high voltage-gated calcium channel activity,BP,
19176,GO:1901842,1,0.976034235731701,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19177,GO:1901843,1,0.974861389869643,0,4,positive regulation of high voltage-gated calcium channel activity,BP,
19178,GO:1901844,1,0.940724976662528,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19179,GO:1901846,1,0.991386251006644,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19180,GO:1901856,1,0.979800137231218,0,4,negative regulation of cellular respiration,BP,
19181,GO:1901857,1,0.966065479043849,0,7,positive regulation of cellular respiration,BP,
19182,GO:1901858,1,0.974176752766852,0,4,regulation of mitochondrial DNA metabolic process,BP,
19183,GO:1901859,1,0.994981879732436,0,1,negative regulation of mitochondrial DNA metabolic process,BP,
19184,GO:1901860,1,0.987922847387118,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19186,GO:1901862,1,0.698029275356287,0,53,negative regulation of muscle tissue development,BP,
19187,GO:1901863,1,0.62026410025701,0,61,positive regulation of muscle tissue development,BP,
19188,GO:1901873,1,0.962241596930576,0,4,regulation of post-translational protein modification,BP,
19189,GO:1901874,1,0.977345845281623,0,3,negative regulation of post-translational protein modification,BP,
19190,GO:1901876,1,0.993253284529502,0,2,regulation of calcium ion binding,BP,
19191,GO:1901877,1,0.993253284529502,0,2,negative regulation of calcium ion binding,BP,
19192,GO:1901879,1,0.497336732178939,0,80,regulation of protein depolymerization,BP,
19193,GO:1901880,1,0.566675633853322,0,63,negative regulation of protein depolymerization,BP,
19194,GO:1901881,1,0.899422470110231,0,16,positive regulation of protein depolymerization,BP,
19196,GO:1901889,1,0.757151133288527,0,32,negative regulation of cell junction assembly,BP,
19198,GO:1901894,1,0.928798370447887,0,9,regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19199,GO:1901895,1,0.977296131075956,0,3,negative regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19200,GO:1901896,1,0.953378832678391,0,5,positive regulation of ATPase-coupled calcium transmembrane transporter activity,BP,
19202,GO:1901898,1,0.97665797141767,0,2,negative regulation of relaxation of cardiac muscle,BP,
19204,GO:1901906,1,0.979209716404853,0,4,diadenosine pentaphosphate metabolic process,BP,
19205,GO:1901907,1,0.979209716404853,0,4,diadenosine pentaphosphate catabolic process,BP,
19206,GO:1901908,1,0.979209716404853,0,4,diadenosine hexaphosphate metabolic process,BP,
19207,GO:1901909,1,0.979209716404853,0,4,diadenosine hexaphosphate catabolic process,BP,
19208,GO:1901910,1,0.979209716404853,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19209,GO:1901911,1,0.979209716404853,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19210,GO:1901917,1,0.994926741713297,0,1,regulation of exoribonuclease activity,BP,
19211,GO:1901919,1,0.994926741713297,0,1,positive regulation of exoribonuclease activity,BP,
19212,GO:1901950,1,0.880714233509205,0,11,dense core granule transport,BP,
19213,GO:1901951,1,0.983391252905501,0,2,regulation of anterograde dense core granule transport,BP,
19214,GO:1901953,1,0.983391252905501,0,2,positive regulation of anterograde dense core granule transport,BP,
19215,GO:1901962,1,0.995768401140782,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19216,GO:1901963,1,0.989946765491605,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19217,GO:1901964,1,0.996309331932209,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19218,GO:1901970,1,0.916117697606013,0,13,positive regulation of mitotic sister chromatid separation,BP,
19219,GO:1901976,1,0.830662325380942,0,31,regulation of cell cycle checkpoint,BP,
19220,GO:1901977,1,0.969038575292899,0,6,negative regulation of cell cycle checkpoint,BP,
19221,GO:1901978,1,0.939960629358886,0,9,positive regulation of cell cycle checkpoint,BP,
19222,GO:1901979,1,0.963413692424716,0,5,regulation of inward rectifier potassium channel activity,BP,
19223,GO:1901980,1,0.978191362590488,0,2,positive regulation of inward rectifier potassium channel activity,BP,
19226,GO:1901984,1,0.869722481712658,0,22,negative regulation of protein acetylation,BP,
19228,GO:1901986,1,0.996612128946267,0,1,response to ketamine,BP,
19230,GO:1901988,1,0.249435145756924,0,226,negative regulation of cell cycle phase transition,BP,
19233,GO:1901991,1,0.266864499356658,0,215,negative regulation of mitotic cell cycle phase transition,BP,
19235,GO:1901993,1,0.967866789193515,0,6,regulation of meiotic cell cycle phase transition,BP,
19236,GO:1901994,1,0.988912200790346,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19237,GO:1901995,1,0.97872097515747,0,4,positive regulation of meiotic cell cycle phase transition,BP,
19238,GO:1901998,1,0.788497993930024,0,39,toxin transport,BP,
19239,GO:1901999,1,0.996578795406472,0,1,homogentisate metabolic process,BP,
19240,GO:1902000,1,0.996578795406472,0,1,homogentisate catabolic process,BP,
19241,GO:1902001,1,0.844388902618171,0,21,fatty acid transmembrane transport,BP,
19242,GO:1902003,1,0.778647480813864,0,30,regulation of amyloid-beta formation,BP,
19243,GO:1902004,1,0.871394741044362,0,18,positive regulation of amyloid-beta formation,BP,
19244,GO:1902010,1,0.993484732409896,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19245,GO:1902017,1,0.694948413566202,0,48,regulation of cilium assembly,BP,
19246,GO:1902018,1,0.935245420935127,0,11,negative regulation of cilium assembly,BP,
19247,GO:1902019,1,0.927343355795133,0,17,regulation of cilium-dependent cell motility,BP,
19248,GO:1902020,1,0.996154746580108,0,1,negative regulation of cilium-dependent cell motility,BP,
19249,GO:1902022,1,0.958880286941142,0,5,L-lysine transport,BP,
19250,GO:1902023,1,0.933995520275817,0,10,L-arginine transport,BP,
19251,GO:1902031,1,0.976828828278365,0,4,regulation of NADP metabolic process,BP,
19252,GO:1902033,1,0.949280470166463,0,9,regulation of hematopoietic stem cell proliferation,BP,
19253,GO:1902035,1,0.96489086206288,0,6,positive regulation of hematopoietic stem cell proliferation,BP,
19254,GO:1902036,1,0.677462755176479,0,70,regulation of hematopoietic stem cell differentiation,BP,
19255,GO:1902037,1,0.984822603525157,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19256,GO:1902038,1,0.993579262175081,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19259,GO:1902043,1,0.887665117656323,0,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19260,GO:1902044,1,0.980968806759818,0,3,regulation of Fas signaling pathway,BP,
19261,GO:1902045,1,0.995579949107702,0,1,negative regulation of Fas signaling pathway,BP,
19262,GO:1902047,1,0.969282603285474,0,6,polyamine transmembrane transport,BP,
19263,GO:1902064,1,0.993236673419317,0,1,regulation of transcription from RNA polymerase II promoter involved in spermatogenesis,BP,
19264,GO:1902065,1,0.92814184963351,0,11,response to L-glutamate,BP,
19265,GO:1902071,1,0.996731460277086,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19266,GO:1902073,1,0.996731460277086,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19267,GO:1902074,1,0.946360301507226,0,12,response to salt,BP,
19268,GO:1902075,1,0.970720902546984,0,7,cellular response to salt,BP,
19269,GO:1902076,1,0.978827720414942,0,1,regulation of lateral motor column neuron migration,BP,
19270,GO:1902078,1,0.978827720414942,0,1,positive regulation of lateral motor column neuron migration,BP,
19271,GO:1902080,1,0.989797727839971,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19272,GO:1902081,1,0.996379022716881,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19273,GO:1902082,1,0.993395027214379,0,1,positive regulation of calcium ion import into sarcoplasmic reticulum,BP,
19274,GO:1902083,1,0.947086655522318,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19275,GO:1902093,1,0.962155029984683,0,9,positive regulation of flagellated sperm motility,BP,
19276,GO:1902098,1,0.990976863750293,0,1,calcitriol binding,MF,
19277,GO:1902099,1,0.681148640761211,0,56,regulation of metaphase/anaphase transition of cell cycle,BP,
19278,GO:1902100,1,0.782800985302701,0,36,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19279,GO:1902101,1,0.912625499687036,0,14,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19280,GO:1902102,1,0.990613493380433,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19281,GO:1902103,1,0.994400996008306,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19282,GO:1902104,1,0.996191385767568,0,1,positive regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19287,GO:1902109,1,0.992679380551687,0,2,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19288,GO:1902110,1,0.749400003688908,0,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19289,GO:1902115,1,0.252096636631227,0,176,regulation of organelle assembly,BP,
19290,GO:1902116,1,0.782495361797193,0,36,negative regulation of organelle assembly,BP,
19291,GO:1902117,1,0.592171755420542,0,61,positive regulation of organelle assembly,BP,
19292,GO:1902121,1,0.990976863750293,0,1,lithocholic acid binding,MF,
19293,GO:1902122,1,0.995877903634853,0,1,chenodeoxycholic acid binding,MF,
19294,GO:1902159,1,0.985130359331784,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19295,GO:1902161,1,0.988245416847562,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19296,GO:1902162,1,0.988590175054016,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19297,GO:1902164,1,0.988590175054016,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19298,GO:1902165,1,0.91945989245032,0,16,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19299,GO:1902166,1,0.927397514114323,0,14,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19300,GO:1902167,1,0.996881518446326,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19301,GO:1902170,1,0.887259498899342,0,18,cellular response to reactive nitrogen species,BP,
19302,GO:1902172,1,0.97680245081664,0,5,regulation of keratinocyte apoptotic process,BP,
19303,GO:1902174,1,0.985879363036673,0,3,positive regulation of keratinocyte apoptotic process,BP,
19304,GO:1902175,1,0.878225626573753,0,24,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19305,GO:1902176,1,0.917382408345186,0,17,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19306,GO:1902177,1,0.973863779635108,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19307,GO:1902178,1,0.991810262802073,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19308,GO:1902186,1,0.831324937086616,0,28,regulation of viral release from host cell,BP,
19309,GO:1902187,1,0.903288427579931,0,14,negative regulation of viral release from host cell,BP,
19310,GO:1902188,1,0.922389973847602,0,14,positive regulation of viral release from host cell,BP,
19311,GO:1902202,1,0.976939158896039,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19312,GO:1902203,1,0.990477207264964,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19313,GO:1902204,1,0.996056437463706,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19314,GO:1902205,1,0.996384495317719,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19315,GO:1902206,1,0.996384495317719,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19316,GO:1902211,1,0.994890876864838,0,1,regulation of prolactin signaling pathway,BP,
19317,GO:1902213,1,0.994890876864838,0,1,positive regulation of prolactin signaling pathway,BP,
19318,GO:1902214,1,0.978229602280192,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19319,GO:1902215,1,0.996384495317719,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19320,GO:1902216,1,0.98177988471072,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19321,GO:1902217,1,0.996656606741891,0,1,erythrocyte apoptotic process,BP,
19322,GO:1902218,1,0.964293965892635,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19323,GO:1902219,1,0.967425145244818,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19324,GO:1902220,1,0.996764461891254,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19325,GO:1902221,1,0.961187842314145,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19326,GO:1902222,1,0.961187842314145,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19327,GO:1902224,1,0.941188006785564,0,12,ketone body metabolic process,BP,
19328,GO:1902225,1,0.994890876864838,0,1,negative regulation of acrosome reaction,BP,
19329,GO:1902226,1,0.988432594708311,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19330,GO:1902227,1,0.992934163038874,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19331,GO:1902228,1,0.99546672002597,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19332,GO:1902229,1,0.833386356398423,0,36,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19333,GO:1902230,1,0.858671567686464,0,29,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19334,GO:1902231,1,0.975918357325206,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19335,GO:1902232,1,0.988558810753121,0,2,regulation of positive thymic T cell selection,BP,
19336,GO:1902233,1,0.996384495317719,0,1,negative regulation of positive thymic T cell selection,BP,
19337,GO:1902235,1,0.845447271520428,0,30,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19338,GO:1902236,1,0.897964349954904,0,18,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19339,GO:1902237,1,0.953270412754605,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19340,GO:1902238,1,0.992023580098037,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19341,GO:1902239,1,0.992023580098037,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19342,GO:1902250,1,0.996656606741891,0,1,regulation of erythrocyte apoptotic process,BP,
19343,GO:1902251,1,0.996656606741891,0,1,negative regulation of erythrocyte apoptotic process,BP,
19344,GO:1902253,1,0.861333263879735,0,27,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19345,GO:1902254,1,0.887701822841213,0,19,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19346,GO:1902255,1,0.983684313898217,0,5,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19347,GO:1902256,1,0.980154678070441,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19348,GO:1902257,1,0.99001248929069,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19349,GO:1902259,1,0.88377468120293,0,18,regulation of delayed rectifier potassium channel activity,BP,
19350,GO:1902260,1,0.93997473780889,0,10,negative regulation of delayed rectifier potassium channel activity,BP,
19351,GO:1902261,1,0.962074099483278,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19352,GO:1902262,1,0.973154980219092,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19353,GO:1902263,1,0.970281711340169,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19354,GO:1902267,1,0.976693783047637,0,5,regulation of polyamine transmembrane transport,BP,
19355,GO:1902268,1,0.989780168509741,0,3,negative regulation of polyamine transmembrane transport,BP,
19356,GO:1902269,1,0.986779845952451,0,2,positive regulation of polyamine transmembrane transport,BP,
19357,GO:1902270,1,0.993908675883443,0,1,(R)-carnitine transmembrane transport,BP,
19358,GO:1902271,1,0.987468918004846,0,2,D3 vitamins binding,MF,
19360,GO:1902282,1,0.944264466935217,0,11,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19361,GO:1902283,1,0.99237862664342,0,1,negative regulation of primary amine oxidase activity,BP,
19362,GO:1902284,1,0.70207261320667,0,36,neuron projection extension involved in neuron projection guidance,BP,
19363,GO:1902285,1,0.859123273161082,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19364,GO:1902287,1,0.86807999480607,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19365,GO:1902292,1,0.966166498703944,0,5,cell cycle DNA replication initiation,BP,
19366,GO:1902296,1,0.993888527349977,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19367,GO:1902298,1,0.97501213615957,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19368,GO:1902299,1,0.954881290425402,0,8,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19369,GO:1902305,1,0.605072543363206,0,63,regulation of sodium ion transmembrane transport,BP,
19370,GO:1902306,1,0.894722304920135,0,13,negative regulation of sodium ion transmembrane transport,BP,
19371,GO:1902307,1,0.837003512951133,0,21,positive regulation of sodium ion transmembrane transport,BP,
19372,GO:1902308,1,0.967511105151522,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19373,GO:1902309,1,0.975318652918261,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19374,GO:1902310,1,0.99199686990714,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19375,GO:1902311,1,0.996320202304473,0,1,regulation of copper ion transmembrane transport,BP,
19376,GO:1902315,1,0.966166498703944,0,5,nuclear cell cycle DNA replication initiation,BP,
19377,GO:1902319,1,0.993888527349977,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19378,GO:1902336,1,0.988827105241573,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19379,GO:1902337,1,0.919584314811816,0,11,regulation of apoptotic process involved in morphogenesis,BP,
19380,GO:1902338,1,0.967647317241925,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19381,GO:1902339,1,0.959906925983846,0,5,positive regulation of apoptotic process involved in morphogenesis,BP,
19382,GO:1902356,1,0.982208989643871,0,4,oxaloacetate(2-) transmembrane transport,BP,
19383,GO:1902358,1,0.912159196093296,0,14,sulfate transmembrane transport,BP,
19384,GO:1902359,1,0.991032200506582,0,2,Notch signaling pathway involved in somitogenesis,BP,
19385,GO:1902362,1,0.994834845062344,0,1,melanocyte apoptotic process,BP,
19386,GO:1902363,1,0.986317247929674,0,1,regulation of protein localization to spindle pole body,BP,
19387,GO:1902365,1,0.986317247929674,0,1,positive regulation of protein localization to spindle pole body,BP,
19388,GO:1902366,1,0.991032200506582,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19389,GO:1902367,1,0.991032200506582,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19390,GO:1902369,1,0.674667869542239,0,54,negative regulation of RNA catabolic process,BP,
19391,GO:1902370,1,0.980710210597217,0,2,regulation of tRNA catabolic process,BP,
19392,GO:1902371,1,0.980710210597217,0,2,negative regulation of tRNA catabolic process,BP,
19393,GO:1902373,1,0.718989332644973,0,45,negative regulation of mRNA catabolic process,BP,
19394,GO:1902374,1,0.996263518456062,0,1,regulation of rRNA catabolic process,BP,
19395,GO:1902378,1,0.995377187964952,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19396,GO:1902379,1,0.985735471872869,0,2,chemoattractant activity involved in axon guidance,MF,
19397,GO:1902380,1,0.99547617734118,0,1,positive regulation of endoribonuclease activity,BP,
19398,GO:1902387,1,0.976769435205061,0,5,ceramide 1-phosphate binding,MF,
19399,GO:1902388,1,0.974434705153424,0,5,ceramide 1-phosphate transfer activity,MF,
19400,GO:1902389,1,0.974434705153424,0,5,ceramide 1-phosphate transport,BP,
19401,GO:1902396,1,0.943508139065446,0,6,protein localization to bicellular tight junction,BP,
19402,GO:1902400,1,0.687945195753897,0,55,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19403,GO:1902402,1,0.684139232586155,0,56,signal transduction involved in mitotic DNA damage checkpoint,BP,
19404,GO:1902403,1,0.684139232586155,0,56,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19405,GO:1902410,1,0.886546258555437,0,23,mitotic cytokinetic process,BP,
19406,GO:1902412,1,0.953180235702426,0,6,regulation of mitotic cytokinesis,BP,
19408,GO:1902415,1,0.948755142101085,0,10,regulation of mRNA binding,BP,
19409,GO:1902416,1,0.957496632652609,0,8,positive regulation of mRNA binding,BP,
19410,GO:1902423,1,0.979689882224126,0,3,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19411,GO:1902425,1,0.979689882224126,0,3,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19412,GO:1902426,1,0.995050444321846,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19413,GO:1902430,1,0.892356905977476,0,13,negative regulation of amyloid-beta formation,BP,
19414,GO:1902435,1,0.97069440249204,0,2,regulation of male mating behavior,BP,
19415,GO:1902437,1,0.97069440249204,0,2,positive regulation of male mating behavior,BP,
19416,GO:1902440,1,0.994890876864838,0,1,protein localization to mitotic spindle pole body,BP,
19417,GO:1902442,1,0.992964372506676,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19418,GO:1902443,1,0.992964372506676,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19419,GO:1902444,1,0.996726860582086,0,1,riboflavin binding,MF,
19420,GO:1902445,1,0.989455139036596,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19421,GO:1902455,1,0.962151386065289,0,6,negative regulation of stem cell population maintenance,BP,
19422,GO:1902459,1,0.934675358980549,0,8,positive regulation of stem cell population maintenance,BP,
19423,GO:1902460,1,0.980386992112275,0,4,regulation of mesenchymal stem cell proliferation,BP,
19424,GO:1902462,1,0.980386992112275,0,4,positive regulation of mesenchymal stem cell proliferation,BP,
19425,GO:1902463,1,0.980527175341347,0,3,protein localization to cell leading edge,BP,
19426,GO:1902464,1,0.991584444256424,0,1,regulation of histone H3-K27 trimethylation,BP,
19427,GO:1902466,1,0.991584444256424,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19428,GO:1902473,1,0.826041836159971,0,25,regulation of protein localization to synapse,BP,
19429,GO:1902474,1,0.907311090900238,0,11,positive regulation of protein localization to synapse,BP,
19432,GO:1902480,1,0.995471452005485,0,1,protein localization to mitotic spindle,BP,
19433,GO:1902488,1,0.983542179762854,0,1,cholangiocyte apoptotic process,BP,
19434,GO:1902490,1,0.996092146970936,0,1,regulation of sperm capacitation,BP,
19435,GO:1902493,1,0.557225170438462,0,85,acetyltransferase complex,CC,
19438,GO:1902498,1,0.946267049369417,0,5,regulation of protein autoubiquitination,BP,
19439,GO:1902499,1,0.974496850718679,0,3,positive regulation of protein autoubiquitination,BP,
19440,GO:1902504,1,0.994488243633323,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19441,GO:1902510,1,0.946173785347442,0,11,regulation of apoptotic DNA fragmentation,BP,
19442,GO:1902511,1,0.982857427433714,0,3,negative regulation of apoptotic DNA fragmentation,BP,
19443,GO:1902512,1,0.9831435943292,0,5,positive regulation of apoptotic DNA fragmentation,BP,
19444,GO:1902513,1,0.937176769276503,0,10,regulation of organelle transport along microtubule,BP,
19445,GO:1902514,1,0.916114863947185,0,12,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19446,GO:1902523,1,0.968841651669077,0,4,positive regulation of protein K63-linked ubiquitination,BP,
19447,GO:1902524,1,0.989549537532539,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19448,GO:1902525,1,0.962988130263302,0,6,regulation of protein monoubiquitination,BP,
19449,GO:1902527,1,0.969738244776856,0,5,positive regulation of protein monoubiquitination,BP,
19450,GO:1902528,1,0.984171533399329,0,1,regulation of protein linear polyubiquitination,BP,
19451,GO:1902530,1,0.984171533399329,0,1,positive regulation of protein linear polyubiquitination,BP,
19455,GO:1902544,1,0.990833602894861,0,2,regulation of DNA N-glycosylase activity,BP,
19456,GO:1902546,1,0.996839785721365,0,1,positive regulation of DNA N-glycosylase activity,BP,
19457,GO:1902547,1,0.865681712185115,0,18,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19458,GO:1902548,1,0.928459347402258,0,9,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19459,GO:1902551,1,0.99478012276385,0,1,regulation of catalase activity,BP,
19460,GO:1902553,1,0.99478012276385,0,1,positive regulation of catalase activity,BP,
19461,GO:1902554,1,0.552686912374211,0,84,serine/threonine protein kinase complex,CC,
19462,GO:1902555,1,0.855401939655973,0,29,endoribonuclease complex,CC,
19463,GO:1902559,1,0.992021399058224,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19464,GO:1902560,1,0.99275530522785,0,2,GMP reductase complex,CC,
19465,GO:1902562,1,0.761671021254607,0,42,H4 histone acetyltransferase complex,CC,
19467,GO:1902564,1,0.96557071078658,0,5,negative regulation of neutrophil activation,BP,
19468,GO:1902565,1,0.97339964662556,0,4,positive regulation of neutrophil activation,BP,
19469,GO:1902566,1,0.982968330955974,0,4,regulation of eosinophil activation,BP,
19470,GO:1902567,1,0.991568350758952,0,2,negative regulation of eosinophil activation,BP,
19471,GO:1902568,1,0.991327584874602,0,2,positive regulation of eosinophil activation,BP,
19472,GO:1902569,1,0.99619803331882,0,1,negative regulation of activation of Janus kinase activity,BP,
19473,GO:1902570,1,0.923430618680722,0,13,protein localization to nucleolus,BP,
19474,GO:1902571,1,0.969766364605627,0,4,regulation of serine-type peptidase activity,BP,
19475,GO:1902572,1,0.969766364605627,0,4,negative regulation of serine-type peptidase activity,BP,
19476,GO:1902573,1,0.982599387937213,0,1,positive regulation of serine-type peptidase activity,BP,
19477,GO:1902576,1,0.979014816781869,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19478,GO:1902579,1,0.639984393171686,0,61,multi-organism localization,BP,
19479,GO:1902586,1,0.995761291282718,0,1,multi-organism intercellular transport,BP,
19480,GO:1902595,1,0.99166953753726,0,2,regulation of DNA replication origin binding,BP,
19482,GO:1902603,1,0.98588996175365,0,3,carnitine transmembrane transport,BP,
19483,GO:1902605,1,0.994939240709015,0,1,heterotrimeric G-protein complex assembly,BP,
19484,GO:1902606,1,0.99353735552533,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19485,GO:1902608,1,0.99353735552533,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19486,GO:1902612,1,0.994930315715295,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19487,GO:1902613,1,0.994930315715295,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19488,GO:1902616,1,0.981845076379952,0,4,acyl carnitine transmembrane transport,BP,
19491,GO:1902622,1,0.821840973160339,0,38,regulation of neutrophil migration,BP,
19492,GO:1902623,1,0.972103212026532,0,4,negative regulation of neutrophil migration,BP,
19493,GO:1902624,1,0.86787782820642,0,28,positive regulation of neutrophil migration,BP,
19494,GO:1902626,1,0.990255280234824,0,3,assembly of large subunit precursor of preribosome,BP,
19495,GO:1902629,1,0.996634983836234,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19496,GO:1902630,1,0.970813965971413,0,3,regulation of membrane hyperpolarization,BP,
19497,GO:1902631,1,0.986728990252428,0,1,negative regulation of membrane hyperpolarization,BP,
19498,GO:1902636,1,0.987317675709138,0,3,kinociliary basal body,CC,
19499,GO:1902644,1,0.897199382687492,0,18,tertiary alcohol metabolic process,BP,
19500,GO:1902645,1,0.931526733244936,0,8,tertiary alcohol biosynthetic process,BP,
19501,GO:1902652,1,0.417092209153795,0,136,secondary alcohol metabolic process,BP,
19502,GO:1902653,1,0.646356357083369,0,63,secondary alcohol biosynthetic process,BP,
19504,GO:1902659,1,0.982927702676028,0,3,regulation of glucose mediated signaling pathway,BP,
19505,GO:1902661,1,0.982927702676028,0,3,positive regulation of glucose mediated signaling pathway,BP,
19506,GO:1902667,1,0.667392894222595,0,43,regulation of axon guidance,BP,
19507,GO:1902668,1,0.784251142228489,0,27,negative regulation of axon guidance,BP,
19508,GO:1902669,1,0.907580946085029,0,8,positive regulation of axon guidance,BP,
19511,GO:1902683,1,0.887971447791798,0,16,regulation of receptor localization to synapse,BP,
19512,GO:1902684,1,0.996654943668624,0,1,negative regulation of receptor localization to synapse,BP,
19513,GO:1902685,1,0.960950581557806,0,4,positive regulation of receptor localization to synapse,BP,
19514,GO:1902686,1,0.742522168234002,0,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19515,GO:1902688,1,0.98764869320882,0,2,regulation of NAD metabolic process,BP,
19516,GO:1902689,1,0.98764869320882,0,2,negative regulation of NAD metabolic process,BP,
19517,GO:1902691,1,0.994258262827234,0,1,respiratory basal cell differentiation,BP,
19518,GO:1902692,1,0.780038672287302,0,31,regulation of neuroblast proliferation,BP,
19521,GO:1902722,1,0.982768413246914,0,3,positive regulation of prolactin secretion,BP,
19522,GO:1902723,1,0.974983516356631,0,4,negative regulation of skeletal muscle satellite cell proliferation,BP,
19523,GO:1902724,1,0.980424261896851,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19524,GO:1902725,1,0.969406693783293,0,4,negative regulation of satellite cell differentiation,BP,
19525,GO:1902728,1,0.980424261896851,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19526,GO:1902729,1,0.991946194959028,0,1,negative regulation of proteoglycan biosynthetic process,BP,
19527,GO:1902730,1,0.973177154127372,0,4,positive regulation of proteoglycan biosynthetic process,BP,
19528,GO:1902731,1,0.962181493248004,0,3,negative regulation of chondrocyte proliferation,BP,
19530,GO:1902737,1,0.970486191195773,0,4,dendritic filopodium,CC,
19531,GO:1902742,1,0.775297798109319,0,34,apoptotic process involved in development,BP,
19533,GO:1902744,1,0.963873437707108,0,4,negative regulation of lamellipodium organization,BP,
19534,GO:1902745,1,0.799802019682952,0,29,positive regulation of lamellipodium organization,BP,
19535,GO:1902746,1,0.930046406027902,0,9,regulation of lens fiber cell differentiation,BP,
19536,GO:1902747,1,0.962984986573629,0,6,negative regulation of lens fiber cell differentiation,BP,
19537,GO:1902748,1,0.97017996364044,0,2,positive regulation of lens fiber cell differentiation,BP,
19538,GO:1902749,1,0.27239818397077,0,201,regulation of cell cycle G2/M phase transition,BP,
19539,GO:1902750,1,0.60553411548847,0,94,negative regulation of cell cycle G2/M phase transition,BP,
19540,GO:1902751,1,0.832682403508592,0,29,positive regulation of cell cycle G2/M phase transition,BP,
19541,GO:1902761,1,0.994297311475596,0,1,positive regulation of chondrocyte development,BP,
19542,GO:1902766,1,0.99283373368385,0,2,skeletal muscle satellite cell migration,BP,
19543,GO:1902767,1,0.989023990762747,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19544,GO:1902769,1,0.979882779840803,0,1,regulation of choline O-acetyltransferase activity,BP,
19545,GO:1902771,1,0.979882779840803,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19546,GO:1902773,1,0.994387495612072,0,1,GTPase activator complex,CC,
19547,GO:1902774,1,0.947265830160747,0,7,late endosome to lysosome transport,BP,
19548,GO:1902775,1,0.974397211543789,0,3,mitochondrial large ribosomal subunit assembly,BP,
19549,GO:1902803,1,0.958389662052714,0,5,regulation of synaptic vesicle transport,BP,
19550,GO:1902804,1,0.996654943668624,0,1,negative regulation of synaptic vesicle transport,BP,
19551,GO:1902805,1,0.989152924721618,0,1,positive regulation of synaptic vesicle transport,BP,
19553,GO:1902807,1,0.501101162575466,0,102,negative regulation of cell cycle G1/S phase transition,BP,
19555,GO:1902809,1,0.97816775871611,0,4,regulation of skeletal muscle fiber differentiation,BP,
19556,GO:1902811,1,0.983398054463512,0,3,positive regulation of skeletal muscle fiber differentiation,BP,
19557,GO:1902816,1,0.955624663438872,0,5,regulation of protein localization to microtubule,BP,
19558,GO:1902817,1,0.955624663438872,0,5,negative regulation of protein localization to microtubule,BP,
19559,GO:1902822,1,0.969745109079127,0,4,regulation of late endosome to lysosome transport,BP,
19560,GO:1902823,1,0.97668659917278,0,2,negative regulation of late endosome to lysosome transport,BP,
19561,GO:1902824,1,0.992894489774538,0,2,positive regulation of late endosome to lysosome transport,BP,
19562,GO:1902834,1,0.993418769293849,0,1,regulation of proline import across plasma membrane,BP,
19563,GO:1902836,1,0.993418769293849,0,1,positive regulation of proline import across plasma membrane,BP,
19564,GO:1902838,1,0.990125428856343,0,1,regulation of nuclear migration along microtubule,BP,
19565,GO:1902841,1,0.961174790818008,0,4,regulation of netrin-activated signaling pathway,BP,
19566,GO:1902842,1,0.961174790818008,0,4,negative regulation of netrin-activated signaling pathway,BP,
19567,GO:1902846,1,0.986317247929674,0,1,positive regulation of mitotic spindle elongation,BP,
19568,GO:1902847,1,0.994750742217943,0,1,regulation of neuronal signal transduction,BP,
19569,GO:1902850,1,0.359232626453891,0,135,microtubule cytoskeleton organization involved in mitosis,BP,
19570,GO:1902855,1,0.930980978434339,0,9,regulation of non-motile cilium assembly,BP,
19571,GO:1902856,1,0.976231584256938,0,3,negative regulation of non-motile cilium assembly,BP,
19572,GO:1902857,1,0.958116108827467,0,5,positive regulation of non-motile cilium assembly,BP,
19573,GO:1902858,1,0.995891377474433,0,1,propionyl-CoA metabolic process,BP,
19574,GO:1902860,1,0.995891377474433,0,1,propionyl-CoA biosynthetic process,BP,
19576,GO:1902867,1,0.99419547524527,0,1,negative regulation of retina development in camera-type eye,BP,
19577,GO:1902868,1,0.99137811797935,0,2,positive regulation of retina development in camera-type eye,BP,
19578,GO:1902869,1,0.985623141275735,0,3,regulation of amacrine cell differentiation,BP,
19579,GO:1902870,1,0.99419547524527,0,1,negative regulation of amacrine cell differentiation,BP,
19580,GO:1902871,1,0.99137811797935,0,2,positive regulation of amacrine cell differentiation,BP,
19581,GO:1902882,1,0.603154946016978,0,79,regulation of response to oxidative stress,BP,
19582,GO:1902883,1,0.752785458844692,0,43,negative regulation of response to oxidative stress,BP,
19583,GO:1902884,1,0.893389891056557,0,18,positive regulation of response to oxidative stress,BP,
19584,GO:1902889,1,0.987001921477036,0,1,protein localization to spindle microtubule,BP,
19585,GO:1902893,1,0.679596576271284,0,51,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19586,GO:1902894,1,0.889275863157878,0,14,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19587,GO:1902895,1,0.750498573061362,0,40,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19588,GO:1902896,1,0.982203512005441,0,3,terminal web assembly,BP,
19589,GO:1902897,1,0.979195513701146,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19590,GO:1902902,1,0.926788887187577,0,12,negative regulation of autophagosome assembly,BP,
19593,GO:1902905,1,0.250497478493418,0,190,positive regulation of supramolecular fiber organization,BP,
19594,GO:1902908,1,0.98825479825941,0,2,regulation of melanosome transport,BP,
19595,GO:1902910,1,0.991836587427737,0,1,positive regulation of melanosome transport,BP,
19596,GO:1902911,1,0.486123686786062,0,98,protein kinase complex,CC,
19597,GO:1902912,1,0.994890876864838,0,1,pyruvate kinase complex,CC,
19599,GO:1902914,1,0.837344102428298,0,22,regulation of protein polyubiquitination,BP,
19600,GO:1902915,1,0.920443555112687,0,9,negative regulation of protein polyubiquitination,BP,
19601,GO:1902916,1,0.927160799481257,0,11,positive regulation of protein polyubiquitination,BP,
19602,GO:1902930,1,0.61802078629941,0,69,regulation of alcohol biosynthetic process,BP,
19603,GO:1902931,1,0.933098624914136,0,13,negative regulation of alcohol biosynthetic process,BP,
19604,GO:1902932,1,0.884976043399901,0,20,positive regulation of alcohol biosynthetic process,BP,
19606,GO:1902937,1,0.981528143763327,0,3,inward rectifier potassium channel complex,CC,
19607,GO:1902938,1,0.974886587070054,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19608,GO:1902939,1,0.994663676520301,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19609,GO:1902941,1,0.980469870187546,0,2,regulation of voltage-gated chloride channel activity,BP,
19610,GO:1902943,1,0.980469870187546,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19611,GO:1902945,1,0.992552536283108,0,1,metalloendopeptidase activity involved in amyloid precursor protein catabolic process,MF,
19612,GO:1902946,1,0.905234615587845,0,10,protein localization to early endosome,BP,
19613,GO:1902947,1,0.933064019863438,0,10,regulation of tau-protein kinase activity,BP,
19614,GO:1902948,1,0.970895856855411,0,2,negative regulation of tau-protein kinase activity,BP,
19615,GO:1902949,1,0.969108298614007,0,6,positive regulation of tau-protein kinase activity,BP,
19616,GO:1902950,1,0.937564077891205,0,10,regulation of dendritic spine maintenance,BP,
19617,GO:1902951,1,0.979675642658262,0,3,negative regulation of dendritic spine maintenance,BP,
19618,GO:1902952,1,0.979151152274675,0,3,positive regulation of dendritic spine maintenance,BP,
19619,GO:1902953,1,0.963745896812297,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19620,GO:1902954,1,0.965781591221253,0,2,regulation of early endosome to recycling endosome transport,BP,
19621,GO:1902955,1,0.979882779840803,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19622,GO:1902956,1,0.977857355452478,0,5,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19623,GO:1902957,1,0.989043123380638,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19624,GO:1902958,1,0.988691555770316,0,3,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19625,GO:1902959,1,0.92990768618134,0,9,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19626,GO:1902960,1,0.975602554245982,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19627,GO:1902961,1,0.953173690499929,0,7,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19628,GO:1902962,1,0.972864873605286,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19629,GO:1902963,1,0.972864873605286,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19630,GO:1902965,1,0.918622128699258,0,8,regulation of protein localization to early endosome,BP,
19631,GO:1902966,1,0.918622128699258,0,8,positive regulation of protein localization to early endosome,BP,
19632,GO:1902969,1,0.896063929136464,0,15,mitotic DNA replication,BP,
19633,GO:1902975,1,0.966166498703944,0,5,mitotic DNA replication initiation,BP,
19634,GO:1902977,1,0.996159882930779,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19635,GO:1902983,1,0.993888527349977,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19636,GO:1902988,1,0.963976139907204,0,3,neurofibrillary tangle assembly,BP,
19637,GO:1902990,1,0.979579482088698,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19638,GO:1902991,1,0.748474416679089,0,36,regulation of amyloid precursor protein catabolic process,BP,
19639,GO:1902992,1,0.881634073920479,0,15,negative regulation of amyloid precursor protein catabolic process,BP,
19640,GO:1902993,1,0.860362011430426,0,21,positive regulation of amyloid precursor protein catabolic process,BP,
19641,GO:1902994,1,0.980595013608093,0,3,regulation of phospholipid efflux,BP,
19642,GO:1902995,1,0.980595013608093,0,3,positive regulation of phospholipid efflux,BP,
19643,GO:1902996,1,0.974738081322925,0,2,regulation of neurofibrillary tangle assembly,BP,
19644,GO:1902997,1,0.979882779840803,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19645,GO:1902998,1,0.994750742217943,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19646,GO:1903000,1,0.996730590415193,0,1,regulation of lipid transport across blood-brain barrier,BP,
19647,GO:1903002,1,0.996730590415193,0,1,positive regulation of lipid transport across blood-brain barrier,BP,
19648,GO:1903003,1,0.963455402376391,0,6,positive regulation of protein deubiquitination,BP,
19649,GO:1903004,1,0.992691717984483,0,1,regulation of protein K63-linked deubiquitination,BP,
19650,GO:1903006,1,0.992691717984483,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19651,GO:1903007,1,0.992691717984483,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19652,GO:1903008,1,0.477494527817145,0,104,organelle disassembly,BP,
19656,GO:1903015,1,0.992561886157128,0,2,regulation of exo-alpha-sialidase activity,BP,
19657,GO:1903016,1,0.996146141141497,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19658,GO:1903017,1,0.996402017712202,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19659,GO:1903018,1,0.746563121333091,0,44,regulation of glycoprotein metabolic process,BP,
19660,GO:1903019,1,0.925771206788956,0,14,negative regulation of glycoprotein metabolic process,BP,
19661,GO:1903020,1,0.837274644688195,0,24,positive regulation of glycoprotein metabolic process,BP,
19663,GO:1903026,1,0.969310756959252,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19664,GO:1903027,1,0.977686236997421,0,3,regulation of opsonization,BP,
19665,GO:1903028,1,0.981860030854322,0,2,positive regulation of opsonization,BP,
19666,GO:1903031,1,0.991381495163078,0,2,regulation of microtubule plus-end binding,BP,
19667,GO:1903033,1,0.991381495163078,0,2,positive regulation of microtubule plus-end binding,BP,
19674,GO:1903041,1,0.994297311475596,0,1,regulation of chondrocyte hypertrophy,BP,
19675,GO:1903043,1,0.994297311475596,0,1,positive regulation of chondrocyte hypertrophy,BP,
19676,GO:1903044,1,0.958558468027968,0,8,protein localization to membrane raft,BP,
19677,GO:1903045,1,0.989154809391079,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19680,GO:1903050,1,0.244330852703028,0,209,regulation of proteolysis involved in cellular protein catabolic process,BP,
19681,GO:1903051,1,0.632941236980779,0,65,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19682,GO:1903052,1,0.454320565401048,0,120,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19684,GO:1903054,1,0.932018125442088,0,11,negative regulation of extracellular matrix organization,BP,
19686,GO:1903056,1,0.9793099808421,0,2,regulation of melanosome organization,BP,
19687,GO:1903059,1,0.955323646126563,0,7,regulation of protein lipidation,BP,
19688,GO:1903060,1,0.993149576814927,0,2,negative regulation of protein lipidation,BP,
19689,GO:1903061,1,0.969026066502132,0,4,positive regulation of protein lipidation,BP,
19690,GO:1903069,1,0.953580386250678,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19691,GO:1903070,1,0.984518038588819,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19692,GO:1903071,1,0.964347873125889,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19693,GO:1903072,1,0.996816752933256,0,1,regulation of death-inducing signaling complex assembly,BP,
19694,GO:1903073,1,0.996816752933256,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19696,GO:1903077,1,0.86619275319233,0,23,negative regulation of protein localization to plasma membrane,BP,
19698,GO:1903080,1,0.996780194014668,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19699,GO:1903082,1,0.996780194014668,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19700,GO:1903093,1,0.980131640953089,0,3,regulation of protein K48-linked deubiquitination,BP,
19701,GO:1903094,1,0.9935037355992,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19702,GO:1903095,1,0.986446034872115,0,2,ribonuclease III complex,CC,
19703,GO:1903096,1,0.994400996008306,0,1,protein localization to meiotic spindle midzone,BP,
19704,GO:1903108,1,0.98029314153911,0,3,regulation of mitochondrial transcription,BP,
19705,GO:1903109,1,0.98710957250397,0,2,positive regulation of mitochondrial transcription,BP,
19707,GO:1903116,1,0.969952681588031,0,4,positive regulation of actin filament-based movement,BP,
19708,GO:1903119,1,0.992316731529853,0,1,protein localization to actin cytoskeleton,BP,
19709,GO:1903121,1,0.971969560575036,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19710,GO:1903122,1,0.996816752933256,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19711,GO:1903123,1,0.982701323297205,0,1,regulation of thioredoxin peroxidase activity,BP,
19712,GO:1903124,1,0.982701323297205,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19713,GO:1903125,1,0.982701323297205,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19714,GO:1903126,1,0.995899419218899,0,1,negative regulation of centriole-centriole cohesion,BP,
19715,GO:1903131,1,0.786983611644137,0,34,mononuclear cell differentiation,BP,
19716,GO:1903135,1,0.980267983661994,0,4,cupric ion binding,MF,
19717,GO:1903136,1,0.960890107176113,0,7,cuprous ion binding,MF,
19718,GO:1903140,1,0.897519510850884,0,15,regulation of establishment of endothelial barrier,BP,
19719,GO:1903141,1,0.985481168805535,0,2,negative regulation of establishment of endothelial barrier,BP,
19720,GO:1903142,1,0.961572683778395,0,6,positive regulation of establishment of endothelial barrier,BP,
19721,GO:1903143,1,0.983989664163563,0,3,adrenomedullin receptor complex,CC,
19722,GO:1903146,1,0.708983577778441,0,40,regulation of autophagy of mitochondrion,BP,
19723,GO:1903147,1,0.946875539396658,0,8,negative regulation of autophagy of mitochondrion,BP,
19724,GO:1903165,1,0.995023303095778,0,1,response to polycyclic arene,BP,
19725,GO:1903167,1,0.996816752933256,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19726,GO:1903168,1,0.996816752933256,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19728,GO:1903170,1,0.806495893611683,0,35,negative regulation of calcium ion transmembrane transport,BP,
19729,GO:1903173,1,0.989144947372498,0,2,fatty alcohol metabolic process,BP,
19730,GO:1903176,1,0.996816752933256,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19731,GO:1903178,1,0.996816752933256,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19732,GO:1903179,1,0.990716498676566,0,2,regulation of dopamine biosynthetic process,BP,
19733,GO:1903181,1,0.990716498676566,0,2,positive regulation of dopamine biosynthetic process,BP,
19734,GO:1903182,1,0.996720374049634,0,1,regulation of SUMO transferase activity,BP,
19735,GO:1903184,1,0.996816752933256,0,1,L-dopa metabolic process,BP,
19736,GO:1903185,1,0.996816752933256,0,1,L-dopa biosynthetic process,BP,
19737,GO:1903189,1,0.996816752933256,0,1,glyoxal metabolic process,BP,
19738,GO:1903190,1,0.996816752933256,0,1,glyoxal catabolic process,BP,
19739,GO:1903195,1,0.996816752933256,0,1,regulation of L-dopa biosynthetic process,BP,
19740,GO:1903197,1,0.996816752933256,0,1,positive regulation of L-dopa biosynthetic process,BP,
19741,GO:1903198,1,0.996816752933256,0,1,regulation of L-dopa decarboxylase activity,BP,
19742,GO:1903200,1,0.996816752933256,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19743,GO:1903201,1,0.675774706820913,0,58,regulation of oxidative stress-induced cell death,BP,
19744,GO:1903202,1,0.761936393022144,0,41,negative regulation of oxidative stress-induced cell death,BP,
19745,GO:1903203,1,0.830555780786707,0,23,regulation of oxidative stress-induced neuron death,BP,
19746,GO:1903204,1,0.875695747543887,0,17,negative regulation of oxidative stress-induced neuron death,BP,
19747,GO:1903205,1,0.872334144007498,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19748,GO:1903206,1,0.909292812048391,0,15,negative regulation of hydrogen peroxide-induced cell death,BP,
19749,GO:1903207,1,0.978334678085685,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19750,GO:1903208,1,0.978334678085685,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19751,GO:1903209,1,0.90876557672166,0,14,positive regulation of oxidative stress-induced cell death,BP,
19752,GO:1903210,1,0.978383691616258,0,2,glomerular visceral epithelial cell apoptotic process,BP,
19753,GO:1903214,1,0.74358915880815,0,43,regulation of protein targeting to mitochondrion,BP,
19754,GO:1903215,1,0.951436209047253,0,7,negative regulation of protein targeting to mitochondrion,BP,
19755,GO:1903216,1,0.979491734340624,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19756,GO:1903217,1,0.979491734340624,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19757,GO:1903223,1,0.957459009719625,0,5,positive regulation of oxidative stress-induced neuron death,BP,
19760,GO:1903231,1,0.993366376897158,0,2,mRNA binding involved in posttranscriptional gene silencing,MF,
19761,GO:1903232,1,0.9772241484756,0,5,melanosome assembly,BP,
19765,GO:1903237,1,0.986722936969813,0,4,negative regulation of leukocyte tethering or rolling,BP,
19766,GO:1903238,1,0.944706306560592,0,8,positive regulation of leukocyte tethering or rolling,BP,
19767,GO:1903241,1,0.981646530132429,0,3,U2-type prespliceosome assembly,BP,
19768,GO:1903242,1,0.931225704493668,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19769,GO:1903243,1,0.945671319864217,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19770,GO:1903244,1,0.984732939504158,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19771,GO:1903248,1,0.98344653483578,0,1,regulation of citrulline biosynthetic process,BP,
19772,GO:1903249,1,0.98344653483578,0,1,negative regulation of citrulline biosynthetic process,BP,
19773,GO:1903251,1,0.957453415739371,0,7,multi-ciliated epithelial cell differentiation,BP,
19774,GO:1903265,1,0.946441121386031,0,10,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19775,GO:1903276,1,0.983234042824344,0,4,regulation of sodium ion export across plasma membrane,BP,
19776,GO:1903278,1,0.983234042824344,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19777,GO:1903279,1,0.977141849535574,0,3,regulation of calcium:sodium antiporter activity,BP,
19778,GO:1903280,1,0.989517894699812,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19779,GO:1903281,1,0.987494161816133,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19780,GO:1903282,1,0.994133311934308,0,1,regulation of glutathione peroxidase activity,BP,
19781,GO:1903284,1,0.994133311934308,0,1,positive regulation of glutathione peroxidase activity,BP,
19782,GO:1903285,1,0.985242003163114,0,2,positive regulation of hydrogen peroxide catabolic process,BP,
19783,GO:1903286,1,0.924483618806525,0,8,regulation of potassium ion import,BP,
19784,GO:1903288,1,0.933465858857915,0,7,positive regulation of potassium ion import across plasma membrane,BP,
19785,GO:1903292,1,0.987936268754042,0,2,protein localization to Golgi membrane,BP,
19787,GO:1903294,1,0.973732480935114,0,3,regulation of glutamate secretion, neurotransmission,BP,
19788,GO:1903296,1,0.973732480935114,0,3,positive regulation of glutamate secretion, neurotransmission,BP,
19789,GO:1903297,1,0.973850434771675,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19790,GO:1903298,1,0.973850434771675,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19791,GO:1903299,1,0.940673272589306,0,9,regulation of hexokinase activity,BP,
19792,GO:1903300,1,0.981041485671057,0,4,negative regulation of hexokinase activity,BP,
19793,GO:1903301,1,0.958859391795059,0,5,positive regulation of hexokinase activity,BP,
19794,GO:1903302,1,0.996012365369154,0,1,regulation of pyruvate kinase activity,BP,
19796,GO:1903306,1,0.86927946985738,0,22,negative regulation of regulated secretory pathway,BP,
19801,GO:1903314,1,0.995877903634853,0,1,regulation of nitrogen cycle metabolic process,BP,
19804,GO:1903319,1,0.871929744121551,0,21,positive regulation of protein maturation,BP,
19805,GO:1903320,1,0.230046388559566,0,219,regulation of protein modification by small protein conjugation or removal,BP,
19806,GO:1903321,1,0.595278421482,0,81,negative regulation of protein modification by small protein conjugation or removal,BP,
19807,GO:1903322,1,0.427397814991665,0,128,positive regulation of protein modification by small protein conjugation or removal,BP,
19808,GO:1903326,1,0.980710210597217,0,2,regulation of tRNA metabolic process,BP,
19809,GO:1903327,1,0.980710210597217,0,2,negative regulation of tRNA metabolic process,BP,
19810,GO:1903332,1,0.934444104045885,0,12,regulation of protein folding,BP,
19811,GO:1903333,1,0.969917799153683,0,6,negative regulation of protein folding,BP,
19812,GO:1903334,1,0.975349637327835,0,4,positive regulation of protein folding,BP,
19813,GO:1903335,1,0.969745109079127,0,4,regulation of vacuolar transport,BP,
19814,GO:1903336,1,0.97668659917278,0,2,negative regulation of vacuolar transport,BP,
19815,GO:1903337,1,0.992894489774538,0,2,positive regulation of vacuolar transport,BP,
19816,GO:1903341,1,0.988424060925948,0,1,regulation of meiotic DNA double-strand break formation,BP,
19817,GO:1903343,1,0.988424060925948,0,1,positive regulation of meiotic DNA double-strand break formation,BP,
19818,GO:1903347,1,0.964443771669697,0,4,negative regulation of bicellular tight junction assembly,BP,
19819,GO:1903348,1,0.964826231251157,0,6,positive regulation of bicellular tight junction assembly,BP,
19820,GO:1903349,1,0.973414504132837,0,4,omegasome membrane,CC,
19823,GO:1903352,1,0.952894279713524,0,6,L-ornithine transmembrane transport,BP,
19824,GO:1903353,1,0.99066996409886,0,1,regulation of nucleus organization,BP,
19825,GO:1903358,1,0.900232997286233,0,15,regulation of Golgi organization,BP,
19826,GO:1903361,1,0.962260246029344,0,8,protein localization to basolateral plasma membrane,BP,
19829,GO:1903364,1,0.375568675307192,0,142,positive regulation of cellular protein catabolic process,BP,
19830,GO:1903365,1,0.946987066410002,0,9,regulation of fear response,BP,
19831,GO:1903366,1,0.996755819621341,0,1,negative regulation of fear response,BP,
19832,GO:1903367,1,0.962162997820708,0,7,positive regulation of fear response,BP,
19833,GO:1903371,1,0.954200902281153,0,5,regulation of endoplasmic reticulum tubular network organization,BP,
19834,GO:1903373,1,0.972516305670817,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19835,GO:1903375,1,0.974435551502788,0,3,facioacoustic ganglion development,BP,
19836,GO:1903376,1,0.957474397277865,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19837,GO:1903377,1,0.978781857825096,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19838,GO:1903378,1,0.985708031138034,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19839,GO:1903381,1,0.991286638937457,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19840,GO:1903382,1,0.991286638937457,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19841,GO:1903383,1,0.991912302106463,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19842,GO:1903384,1,0.991912302106463,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19843,GO:1903385,1,0.978437010613553,0,3,regulation of homophilic cell adhesion,BP,
19844,GO:1903387,1,0.989879871628774,0,1,positive regulation of homophilic cell adhesion,BP,
19845,GO:1903391,1,0.961948336504652,0,5,regulation of adherens junction organization,BP,
19846,GO:1903392,1,0.979232172338323,0,3,negative regulation of adherens junction organization,BP,
19847,GO:1903393,1,0.982353271055233,0,2,positive regulation of adherens junction organization,BP,
19848,GO:1903394,1,0.995586035997366,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19849,GO:1903400,1,0.944084174788917,0,8,L-arginine transmembrane transport,BP,
19850,GO:1903401,1,0.958880286941142,0,5,L-lysine transmembrane transport,BP,
19851,GO:1903402,1,0.992681321135424,0,1,regulation of renal phosphate excretion,BP,
19852,GO:1903403,1,0.992681321135424,0,1,negative regulation of renal phosphate excretion,BP,
19853,GO:1903405,1,0.94783448528554,0,12,protein localization to nuclear body,BP,
19854,GO:1903406,1,0.993167142034608,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19855,GO:1903408,1,0.993167142034608,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19857,GO:1903412,1,0.978487506764607,0,5,response to bile acid,BP,
19858,GO:1903413,1,0.978487506764607,0,5,cellular response to bile acid,BP,
19860,GO:1903420,1,0.987763997343936,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19862,GO:1903422,1,0.981343882705485,0,2,negative regulation of synaptic vesicle recycling,BP,
19863,GO:1903423,1,0.924325240860222,0,9,positive regulation of synaptic vesicle recycling,BP,
19865,GO:1903427,1,0.842294879836799,0,27,negative regulation of reactive oxygen species biosynthetic process,BP,
19867,GO:1903429,1,0.846436004849286,0,22,regulation of cell maturation,BP,
19868,GO:1903430,1,0.965921125165338,0,6,negative regulation of cell maturation,BP,
19869,GO:1903431,1,0.919691074125853,0,10,positive regulation of cell maturation,BP,
19870,GO:1903432,1,0.817917208091294,0,31,regulation of TORC1 signaling,BP,
19871,GO:1903433,1,0.987584257190911,0,2,regulation of constitutive secretory pathway,BP,
19872,GO:1903434,1,0.99271667561336,0,1,negative regulation of constitutive secretory pathway,BP,
19873,GO:1903435,1,0.994830303379715,0,1,positive regulation of constitutive secretory pathway,BP,
19874,GO:1903436,1,0.981805681264455,0,2,regulation of mitotic cytokinetic process,BP,
19875,GO:1903438,1,0.981805681264455,0,2,positive regulation of mitotic cytokinetic process,BP,
19876,GO:1903439,1,0.974210699700763,0,5,calcitonin family receptor complex,CC,
19877,GO:1903440,1,0.983638397998218,0,4,amylin receptor complex,CC,
19878,GO:1903441,1,0.923186191852843,0,11,protein localization to ciliary membrane,BP,
19879,GO:1903442,1,0.992783258733263,0,1,response to lipoic acid,BP,
19880,GO:1903444,1,0.98916597711967,0,2,negative regulation of brown fat cell differentiation,BP,
19881,GO:1903445,1,0.988409506361066,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19882,GO:1903450,1,0.983787590579588,0,1,regulation of G1 to G0 transition,BP,
19883,GO:1903452,1,0.983787590579588,0,1,positive regulation of G1 to G0 transition,BP,
19884,GO:1903457,1,0.996023026087141,0,1,lactate catabolic process,BP,
19885,GO:1903461,1,0.994256306425152,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19886,GO:1903463,1,0.973222595008663,0,4,regulation of mitotic cell cycle DNA replication,BP,
19887,GO:1903464,1,0.989637662522949,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19888,GO:1903465,1,0.989198174197412,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19889,GO:1903487,1,0.986439419817739,0,3,regulation of lactation,BP,
19890,GO:1903489,1,0.993022360418032,0,2,positive regulation of lactation,BP,
19891,GO:1903490,1,0.981805681264455,0,2,positive regulation of mitotic cytokinesis,BP,
19892,GO:1903492,1,0.9968460138118,0,1,response to acetylsalicylate,BP,
19893,GO:1903494,1,0.996803825683795,0,1,response to dehydroepiandrosterone,BP,
19894,GO:1903496,1,0.996803825683795,0,1,response to 11-deoxycorticosterone,BP,
19895,GO:1903504,1,0.913279169067806,0,14,regulation of mitotic spindle checkpoint,BP,
19901,GO:1903512,1,0.99602114971042,0,1,phytanic acid metabolic process,BP,
19902,GO:1903513,1,0.849760120410062,0,26,endoplasmic reticulum to cytosol transport,BP,
19903,GO:1903514,1,0.751191226754241,0,31,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19904,GO:1903515,1,0.975417001809552,0,2,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19905,GO:1903516,1,0.983089244097899,0,3,regulation of single strand break repair,BP,
19906,GO:1903517,1,0.994652482138736,0,1,negative regulation of single strand break repair,BP,
19907,GO:1903518,1,0.988375215272128,0,2,positive regulation of single strand break repair,BP,
19908,GO:1903519,1,0.98785125803367,0,2,regulation of mammary gland involution,BP,
19909,GO:1903521,1,0.98785125803367,0,2,positive regulation of mammary gland involution,BP,
19914,GO:1903526,1,0.984784588575031,0,2,negative regulation of membrane tubulation,BP,
19920,GO:1903537,1,0.990361274574264,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19921,GO:1903538,1,0.990361274574264,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19924,GO:1903541,1,0.923797556019601,0,14,regulation of exosomal secretion,BP,
19925,GO:1903542,1,0.989491713265687,0,2,negative regulation of exosomal secretion,BP,
19926,GO:1903543,1,0.923797556019601,0,14,positive regulation of exosomal secretion,BP,
19927,GO:1903544,1,0.99363047551008,0,1,response to butyrate,BP,
19928,GO:1903545,1,0.99363047551008,0,1,cellular response to butyrate,BP,
19929,GO:1903546,1,0.953454668591589,0,5,protein localization to photoreceptor outer segment,BP,
19930,GO:1903547,1,0.993466051415015,0,2,regulation of growth hormone activity,BP,
19931,GO:1903551,1,0.965746214430554,0,6,regulation of extracellular exosome assembly,BP,
19932,GO:1903553,1,0.974469919554218,0,4,positive regulation of extracellular exosome assembly,BP,
19935,GO:1903557,1,0.732048931868064,0,47,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19937,GO:1903564,1,0.941639542337545,0,7,regulation of protein localization to cilium,BP,
19938,GO:1903565,1,0.987414783885436,0,2,negative regulation of protein localization to cilium,BP,
19939,GO:1903566,1,0.959200083450179,0,4,positive regulation of protein localization to cilium,BP,
19940,GO:1903567,1,0.98924908904156,0,2,regulation of protein localization to ciliary membrane,BP,
19941,GO:1903568,1,0.993661144114025,0,1,negative regulation of protein localization to ciliary membrane,BP,
19942,GO:1903569,1,0.995560081298519,0,1,positive regulation of protein localization to ciliary membrane,BP,
19943,GO:1903570,1,0.993419801136921,0,1,regulation of protein kinase D signaling,BP,
19944,GO:1903572,1,0.993419801136921,0,1,positive regulation of protein kinase D signaling,BP,
19945,GO:1903573,1,0.758181000776962,0,48,negative regulation of response to endoplasmic reticulum stress,BP,
19946,GO:1903575,1,0.978270743698945,0,5,cornified envelope assembly,BP,
19947,GO:1903576,1,0.995983180678702,0,1,response to L-arginine,BP,
19948,GO:1903578,1,0.4595146797722,0,107,regulation of ATP metabolic process,BP,
19949,GO:1903579,1,0.837506200032862,0,25,negative regulation of ATP metabolic process,BP,
19950,GO:1903580,1,0.75923700923323,0,38,positive regulation of ATP metabolic process,BP,
19951,GO:1903584,1,0.991640736763234,0,1,regulation of histone deubiquitination,BP,
19952,GO:1903586,1,0.991640736763234,0,1,positive regulation of histone deubiquitination,BP,
19953,GO:1903587,1,0.921574336046312,0,12,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19954,GO:1903588,1,0.969853143965205,0,5,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19955,GO:1903589,1,0.962656990607081,0,6,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19956,GO:1903593,1,0.984315450902846,0,4,regulation of histamine secretion by mast cell,BP,
19957,GO:1903595,1,0.984315450902846,0,4,positive regulation of histamine secretion by mast cell,BP,
19958,GO:1903596,1,0.974257972243401,0,5,regulation of gap junction assembly,BP,
19959,GO:1903597,1,0.990311733361749,0,2,negative regulation of gap junction assembly,BP,
19960,GO:1903598,1,0.983790752253288,0,3,positive regulation of gap junction assembly,BP,
19961,GO:1903599,1,0.819267402077093,0,19,positive regulation of autophagy of mitochondrion,BP,
19962,GO:1903608,1,0.960484189720328,0,6,protein localization to cytoplasmic stress granule,BP,
19963,GO:1903609,1,0.995063524952923,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19964,GO:1903610,1,0.996154746580108,0,1,regulation of calcium-dependent ATPase activity,BP,
19965,GO:1903611,1,0.996154746580108,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19966,GO:1903613,1,0.965177523942472,0,6,regulation of protein tyrosine phosphatase activity,BP,
19967,GO:1903614,1,0.987962442587108,0,3,negative regulation of protein tyrosine phosphatase activity,BP,
19968,GO:1903615,1,0.976940229470554,0,3,positive regulation of protein tyrosine phosphatase activity,BP,
19969,GO:1903618,1,0.992411688368383,0,1,regulation of transdifferentiation,BP,
19970,GO:1903620,1,0.992411688368383,0,1,positive regulation of transdifferentiation,BP,
19971,GO:1903621,1,0.996133999702073,0,1,protein localization to photoreceptor connecting cilium,BP,
19972,GO:1903624,1,0.923348066187208,0,13,regulation of DNA catabolic process,BP,
19973,GO:1903625,1,0.979077437526893,0,4,negative regulation of DNA catabolic process,BP,
19974,GO:1903626,1,0.963139882163223,0,6,positive regulation of DNA catabolic process,BP,
19975,GO:1903627,1,0.996154746580108,0,1,regulation of dUTP diphosphatase activity,BP,
19976,GO:1903629,1,0.996154746580108,0,1,positive regulation of dUTP diphosphatase activity,BP,
19977,GO:1903630,1,0.992880292440115,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19978,GO:1903631,1,0.996154746580108,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19979,GO:1903632,1,0.996713033261032,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19980,GO:1903633,1,0.996154746580108,0,1,regulation of leucine-tRNA ligase activity,BP,
19981,GO:1903634,1,0.996154746580108,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19982,GO:1903636,1,0.996883783413978,0,1,regulation of protein insertion into mitochondrial outer membrane,BP,
19983,GO:1903638,1,0.996883783413978,0,1,positive regulation of protein insertion into mitochondrial outer membrane,BP,
19984,GO:1903644,1,0.974344876294569,0,5,regulation of chaperone-mediated protein folding,BP,
19985,GO:1903645,1,0.993665051613105,0,2,negative regulation of chaperone-mediated protein folding,BP,
19986,GO:1903646,1,0.985224765309314,0,2,positive regulation of chaperone-mediated protein folding,BP,
19987,GO:1903649,1,0.835724020641435,0,23,regulation of cytoplasmic transport,BP,
19988,GO:1903650,1,0.987997828730464,0,3,negative regulation of cytoplasmic transport,BP,
19989,GO:1903651,1,0.906540901549665,0,11,positive regulation of cytoplasmic transport,BP,
19990,GO:1903659,1,0.962958716418053,0,6,regulation of complement-dependent cytotoxicity,BP,
19991,GO:1903660,1,0.991976008039554,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19992,GO:1903661,1,0.995757015301866,0,1,positive regulation of complement-dependent cytotoxicity,BP,
19994,GO:1903671,1,0.816255473164565,0,26,negative regulation of sprouting angiogenesis,BP,
19996,GO:1903673,1,0.9961644315838,0,1,mitotic cleavage furrow formation,BP,
19997,GO:1903674,1,0.996172353141243,0,1,regulation of cap-dependent translational initiation,BP,
19998,GO:1903676,1,0.996172353141243,0,1,positive regulation of cap-dependent translational initiation,BP,
19999,GO:1903677,1,0.987131283248884,0,3,regulation of cap-independent translational initiation,BP,
20000,GO:1903679,1,0.987131283248884,0,3,positive regulation of cap-independent translational initiation,BP,
20001,GO:1903689,1,0.919364037836928,0,6,regulation of wound healing, spreading of epidermal cells,BP,
20002,GO:1903690,1,0.950038411532696,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
20003,GO:1903691,1,0.967728710597493,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
20004,GO:1903697,1,0.993763023883575,0,1,negative regulation of microvillus assembly,BP,
20005,GO:1903699,1,0.978557892522232,0,1,tarsal gland development,BP,
20006,GO:1903701,1,0.990043734866832,0,1,substantia propria of cornea development,BP,
20007,GO:1903704,1,0.992411688368383,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
20011,GO:1903709,1,0.978557892522232,0,1,uterine gland development,BP,
20012,GO:1903710,1,0.99241375583027,0,1,spermine transmembrane transport,BP,
20013,GO:1903712,1,0.992987268436278,0,1,cysteine transmembrane transport,BP,
20014,GO:1903713,1,0.996069243493824,0,1,asparagine transmembrane transport,BP,
20015,GO:1903714,1,0.989692810991723,0,1,isoleucine transmembrane transport,BP,
20016,GO:1903715,1,0.960171096141089,0,6,regulation of aerobic respiration,BP,
20017,GO:1903719,1,0.964304839983505,0,7,regulation of I-kappaB phosphorylation,BP,
20018,GO:1903720,1,0.992195403809805,0,1,negative regulation of I-kappaB phosphorylation,BP,
20019,GO:1903721,1,0.971892222216388,0,6,positive regulation of I-kappaB phosphorylation,BP,
20020,GO:1903722,1,0.962015733287626,0,6,regulation of centriole elongation,BP,
20021,GO:1903723,1,0.991731392514529,0,2,negative regulation of centriole elongation,BP,
20022,GO:1903724,1,0.970039038881284,0,4,positive regulation of centriole elongation,BP,
20024,GO:1903726,1,0.945088395549707,0,8,negative regulation of phospholipid metabolic process,BP,
20025,GO:1903727,1,0.727962560202611,0,48,positive regulation of phospholipid metabolic process,BP,
20027,GO:1903742,1,0.985843791555488,0,2,regulation of anterograde synaptic vesicle transport,BP,
20028,GO:1903743,1,0.996654943668624,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
20029,GO:1903744,1,0.989152924721618,0,1,positive regulation of anterograde synaptic vesicle transport,BP,
20030,GO:1903747,1,0.638709255309045,0,71,regulation of establishment of protein localization to mitochondrion,BP,
20031,GO:1903748,1,0.937650918493731,0,9,negative regulation of establishment of protein localization to mitochondrion,BP,
20032,GO:1903749,1,0.697065604749376,0,58,positive regulation of establishment of protein localization to mitochondrion,BP,
20033,GO:1903750,1,0.98759927970729,0,3,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20034,GO:1903751,1,0.98759927970729,0,3,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
20035,GO:1903753,1,0.955442338758922,0,6,negative regulation of p38MAPK cascade,BP,
20036,GO:1903755,1,0.996720374049634,0,1,positive regulation of SUMO transferase activity,BP,
20037,GO:1903760,1,0.974543882357303,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20038,GO:1903762,1,0.98400750123832,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
20039,GO:1903763,1,0.967527550848267,0,5,gap junction channel activity involved in cell communication by electrical coupling,MF,
20041,GO:1903765,1,0.983401465209156,0,3,negative regulation of potassium ion export across plasma membrane,BP,
20043,GO:1903767,1,0.995255489379337,0,1,sweet taste receptor complex,CC,
20044,GO:1903768,1,0.995255489379337,0,1,taste receptor complex,CC,
20045,GO:1903770,1,0.994652482138736,0,1,negative regulation of beta-galactosidase activity,BP,
20046,GO:1903772,1,0.984100000490571,0,4,regulation of viral budding via host ESCRT complex,BP,
20047,GO:1903774,1,0.98734440970437,0,3,positive regulation of viral budding via host ESCRT complex,BP,
20048,GO:1903775,1,0.989645215188387,0,2,regulation of DNA double-strand break processing,BP,
20049,GO:1903778,1,0.987828599309928,0,1,protein localization to vacuolar membrane,BP,
20051,GO:1903781,1,0.976320672106669,0,3,positive regulation of cardiac conduction,BP,
20052,GO:1903786,1,0.977081403860438,0,2,regulation of glutathione biosynthetic process,BP,
20053,GO:1903788,1,0.994944588819646,0,1,positive regulation of glutathione biosynthetic process,BP,
20054,GO:1903789,1,0.922231199674739,0,12,regulation of amino acid transmembrane transport,BP,
20055,GO:1903792,1,0.833595088533911,0,27,negative regulation of anion transport,BP,
20056,GO:1903793,1,0.730936542197709,0,48,positive regulation of anion transport,BP,
20057,GO:1903795,1,0.94010403235869,0,6,regulation of inorganic anion transmembrane transport,BP,
20058,GO:1903796,1,0.978292812885886,0,2,negative regulation of inorganic anion transmembrane transport,BP,
20059,GO:1903797,1,0.980469870187546,0,2,positive regulation of inorganic anion transmembrane transport,BP,
20060,GO:1903798,1,0.861223599415144,0,22,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20061,GO:1903799,1,0.896065603392604,0,14,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20062,GO:1903800,1,0.952673948022054,0,10,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
20063,GO:1903801,1,0.970269540676847,0,5,L-leucine import across plasma membrane,BP,
20064,GO:1903803,1,0.996155318283885,0,1,L-glutamine import across plasma membrane,BP,
20065,GO:1903804,1,0.97957980574399,0,4,glycine import across plasma membrane,BP,
20066,GO:1903806,1,0.989692810991723,0,1,L-isoleucine import across plasma membrane,BP,
20067,GO:1903810,1,0.986054403654254,0,1,L-histidine import across plasma membrane,BP,
20068,GO:1903812,1,0.99180115601632,0,1,L-serine import across plasma membrane,BP,
20069,GO:1903814,1,0.996837536280683,0,1,regulation of collecting lymphatic vessel constriction,BP,
20070,GO:1903815,1,0.996837536280683,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
20071,GO:1903817,1,0.935331706362559,0,11,negative regulation of voltage-gated potassium channel activity,BP,
20073,GO:1903823,1,0.994652482138736,0,1,telomere single strand break repair,BP,
20074,GO:1903824,1,0.994652482138736,0,1,negative regulation of telomere single strand break repair,BP,
20076,GO:1903826,1,0.944084174788917,0,8,arginine transmembrane transport,BP,
20078,GO:1903828,1,0.4805436164479,0,108,negative regulation of cellular protein localization,BP,
20080,GO:1903830,1,0.899428870498693,0,15,magnesium ion transmembrane transport,BP,
20081,GO:1903837,1,0.995394952611099,0,1,regulation of mRNA 3'-UTR binding,BP,
20082,GO:1903839,1,0.995394952611099,0,1,positive regulation of mRNA 3'-UTR binding,BP,
20083,GO:1903840,1,0.990630939556817,0,1,response to arsenite(3-),BP,
20084,GO:1903841,1,0.990630939556817,0,1,cellular response to arsenite(3-),BP,
20085,GO:1903842,1,0.972704580229982,0,4,response to arsenite ion,BP,
20086,GO:1903843,1,0.972704580229982,0,4,cellular response to arsenite ion,BP,
20088,GO:1903845,1,0.53387701808857,0,79,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
20089,GO:1903846,1,0.786051924566058,0,29,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
20090,GO:1903847,1,0.974525376832209,0,2,regulation of aorta morphogenesis,BP,
20091,GO:1903849,1,0.974525376832209,0,2,positive regulation of aorta morphogenesis,BP,
20092,GO:1903850,1,0.984109968380381,0,4,regulation of cristae formation,BP,
20093,GO:1903852,1,0.987891730783066,0,3,positive regulation of cristae formation,BP,
20095,GO:1903860,1,0.989431753064891,0,2,negative regulation of dendrite extension,BP,
20097,GO:1903862,1,0.96290468004248,0,9,positive regulation of oxidative phosphorylation,BP,
20098,GO:1903867,1,0.934193983904391,0,9,extraembryonic membrane development,BP,
20099,GO:1903881,1,0.99301744437563,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
20100,GO:1903883,1,0.99301744437563,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
20101,GO:1903884,1,0.99301744437563,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
20102,GO:1903886,1,0.99301744437563,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
20103,GO:1903891,1,0.976373959515766,0,4,regulation of ATF6-mediated unfolded protein response,BP,
20104,GO:1903892,1,0.988353261129378,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
20105,GO:1903893,1,0.995356083058287,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
20106,GO:1903894,1,0.923651404697619,0,13,regulation of IRE1-mediated unfolded protein response,BP,
20107,GO:1903895,1,0.974276889116649,0,5,negative regulation of IRE1-mediated unfolded protein response,BP,
20108,GO:1903896,1,0.954735963728758,0,6,positive regulation of IRE1-mediated unfolded protein response,BP,
20109,GO:1903897,1,0.942052818723403,0,9,regulation of PERK-mediated unfolded protein response,BP,
20110,GO:1903898,1,0.971430459628381,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
20111,GO:1903899,1,0.977106433209912,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
20114,GO:1903902,1,0.67523803357087,0,59,positive regulation of viral life cycle,BP,
20115,GO:1903903,1,0.976032153834344,0,3,regulation of establishment of T cell polarity,BP,
20116,GO:1903905,1,0.980986276876958,0,2,positive regulation of establishment of T cell polarity,BP,
20117,GO:1903906,1,0.99495082173244,0,1,regulation of plasma membrane raft polarization,BP,
20119,GO:1903910,1,0.995608750889622,0,1,negative regulation of receptor clustering,BP,
20120,GO:1903911,1,0.966179226141343,0,5,positive regulation of receptor clustering,BP,
20121,GO:1903912,1,0.971331925322491,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
20122,GO:1903916,1,0.995543168677913,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20123,GO:1903917,1,0.995543168677913,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
20124,GO:1903918,1,0.985713973491769,0,1,regulation of actin filament severing,BP,
20125,GO:1903919,1,0.985713973491769,0,1,negative regulation of actin filament severing,BP,
20126,GO:1903921,1,0.980736214111727,0,2,regulation of protein processing in phagocytic vesicle,BP,
20127,GO:1903923,1,0.980736214111727,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
20128,GO:1903924,1,0.995774073890781,0,1,estradiol binding,MF,
20129,GO:1903925,1,0.996221010610108,0,1,response to bisphenol A,BP,
20130,GO:1903926,1,0.996221010610108,0,1,cellular response to bisphenol A,BP,
20131,GO:1903929,1,0.98973118171587,0,2,primary palate development,BP,
20132,GO:1903935,1,0.978683206272399,0,5,response to sodium arsenite,BP,
20133,GO:1903936,1,0.978683206272399,0,5,cellular response to sodium arsenite,BP,
20134,GO:1903939,1,0.982221259311834,0,2,regulation of TORC2 signaling,BP,
20135,GO:1903943,1,0.996117054016947,0,1,regulation of hepatocyte apoptotic process,BP,
20136,GO:1903944,1,0.996117054016947,0,1,negative regulation of hepatocyte apoptotic process,BP,
20137,GO:1903946,1,0.989991547156144,0,2,negative regulation of ventricular cardiac muscle cell action potential,BP,
20138,GO:1903947,1,0.98400750123832,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
20139,GO:1903949,1,0.984804825451627,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
20140,GO:1903952,1,0.992473765027611,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20141,GO:1903954,1,0.992473765027611,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20142,GO:1903955,1,0.799644979318865,0,32,positive regulation of protein targeting to mitochondrion,BP,
20143,GO:1903959,1,0.79058887272875,0,30,regulation of anion transmembrane transport,BP,
20144,GO:1903960,1,0.896239481707829,0,15,negative regulation of anion transmembrane transport,BP,
20145,GO:1903961,1,0.927664827634725,0,10,positive regulation of anion transmembrane transport,BP,
20147,GO:1903964,1,0.98145899073248,0,3,monounsaturated fatty acid metabolic process,BP,
20148,GO:1903965,1,0.996628496149833,0,1,monounsaturated fatty acid catabolic process,BP,
20149,GO:1903966,1,0.984779688931458,0,2,monounsaturated fatty acid biosynthetic process,BP,
20150,GO:1903969,1,0.971555969653932,0,5,regulation of response to macrophage colony-stimulating factor,BP,
20151,GO:1903970,1,0.992934163038874,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20152,GO:1903971,1,0.978471190681149,0,3,positive regulation of response to macrophage colony-stimulating factor,BP,
20153,GO:1903972,1,0.971555969653932,0,5,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20154,GO:1903973,1,0.992934163038874,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20155,GO:1903974,1,0.978471190681149,0,3,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20156,GO:1903975,1,0.900614940044375,0,15,regulation of glial cell migration,BP,
20157,GO:1903976,1,0.981708591662886,0,4,negative regulation of glial cell migration,BP,
20158,GO:1903977,1,0.920809387945654,0,10,positive regulation of glial cell migration,BP,
20159,GO:1903978,1,0.876696125934495,0,16,regulation of microglial cell activation,BP,
20160,GO:1903979,1,0.952434766641213,0,7,negative regulation of microglial cell activation,BP,
20161,GO:1903980,1,0.94630381872041,0,6,positive regulation of microglial cell activation,BP,
20162,GO:1903981,1,0.992586380389762,0,2,enterobactin binding,MF,
20163,GO:1903984,1,0.975074247203598,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20164,GO:1903988,1,0.993756927047099,0,1,iron ion export across plasma membrane,BP,
20165,GO:1903995,1,0.941048099761602,0,8,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20166,GO:1903996,1,0.996561212309943,0,1,negative regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20167,GO:1903997,1,0.944297199935851,0,7,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20168,GO:1903998,1,0.95537504088644,0,6,regulation of eating behavior,BP,
20169,GO:1903999,1,0.97442280625788,0,4,negative regulation of eating behavior,BP,
20170,GO:1904000,1,0.980457267690053,0,2,positive regulation of eating behavior,BP,
20171,GO:1904008,1,0.996612128946267,0,1,response to monosodium glutamate,BP,
20172,GO:1904009,1,0.996612128946267,0,1,cellular response to monosodium glutamate,BP,
20173,GO:1904010,1,0.996612128946267,0,1,response to Aroclor 1254,BP,
20174,GO:1904016,1,0.963957382325512,0,4,response to Thyroglobulin triiodothyronine,BP,
20175,GO:1904017,1,0.975207906903149,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20178,GO:1904020,1,0.984215976739812,0,3,regulation of G protein-coupled receptor internalization,BP,
20179,GO:1904021,1,0.990126664738233,0,2,negative regulation of G protein-coupled receptor internalization,BP,
20180,GO:1904022,1,0.994030963168051,0,1,positive regulation of G protein-coupled receptor internalization,BP,
20181,GO:1904023,1,0.98764869320882,0,2,regulation of glucose catabolic process to lactate via pyruvate,BP,
20182,GO:1904024,1,0.98764869320882,0,2,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
20183,GO:1904026,1,0.966262058419233,0,5,regulation of collagen fibril organization,BP,
20184,GO:1904027,1,0.987896204202378,0,2,negative regulation of collagen fibril organization,BP,
20185,GO:1904028,1,0.985767683002206,0,2,positive regulation of collagen fibril organization,BP,
20186,GO:1904029,1,0.557672912046341,0,98,regulation of cyclin-dependent protein kinase activity,BP,
20187,GO:1904030,1,0.816148437098644,0,30,negative regulation of cyclin-dependent protein kinase activity,BP,
20188,GO:1904031,1,0.809289259179574,0,33,positive regulation of cyclin-dependent protein kinase activity,BP,
20191,GO:1904037,1,0.804705067430668,0,32,positive regulation of epithelial cell apoptotic process,BP,
20192,GO:1904041,1,0.993884494377349,0,1,regulation of cystathionine beta-synthase activity,BP,
20193,GO:1904042,1,0.993884494377349,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20194,GO:1904044,1,0.973988155626311,0,5,response to aldosterone,BP,
20195,GO:1904045,1,0.995792416986189,0,1,cellular response to aldosterone,BP,
20196,GO:1904046,1,0.996829239940352,0,1,negative regulation of vascular endothelial growth factor production,BP,
20197,GO:1904047,1,0.937592700023018,0,13,S-adenosyl-L-methionine binding,MF,
20198,GO:1904048,1,0.972774949141558,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20199,GO:1904049,1,0.981303567949174,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20200,GO:1904050,1,0.991310516720702,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20201,GO:1904054,1,0.980152610399006,0,2,regulation of cholangiocyte proliferation,BP,
20202,GO:1904056,1,0.980152610399006,0,2,positive regulation of cholangiocyte proliferation,BP,
20203,GO:1904057,1,0.996449717705429,0,1,negative regulation of sensory perception of pain,BP,
20204,GO:1904058,1,0.96042796135671,0,6,positive regulation of sensory perception of pain,BP,
20205,GO:1904059,1,0.95269446290207,0,3,regulation of locomotor rhythm,BP,
20207,GO:1904063,1,0.598974236595679,0,79,negative regulation of cation transmembrane transport,BP,
20209,GO:1904071,1,0.918964425122943,0,4,presynaptic active zone assembly,BP,
20210,GO:1904073,1,0.986213600553903,0,1,regulation of trophectodermal cell proliferation,BP,
20211,GO:1904075,1,0.986213600553903,0,1,positive regulation of trophectodermal cell proliferation,BP,
20212,GO:1904090,1,0.985789602867282,0,4,peptidase inhibitor complex,CC,
20213,GO:1904092,1,0.973467646222786,0,4,regulation of autophagic cell death,BP,
20214,GO:1904093,1,0.996780194014668,0,1,negative regulation of autophagic cell death,BP,
20215,GO:1904098,1,0.981405318291925,0,3,regulation of protein O-linked glycosylation,BP,
20216,GO:1904100,1,0.981405318291925,0,3,positive regulation of protein O-linked glycosylation,BP,
20217,GO:1904106,1,0.994907940859255,0,1,protein localization to microvillus,BP,
20218,GO:1904108,1,0.993177525693269,0,1,protein localization to ciliary inversin compartment,BP,
20219,GO:1904109,1,0.973780452882526,0,1,positive regulation of cholesterol import,BP,
20220,GO:1904115,1,0.616561054850881,0,56,axon cytoplasm,CC,
20221,GO:1904116,1,0.976997357019795,0,3,response to vasopressin,BP,
20222,GO:1904117,1,0.976997357019795,0,3,cellular response to vasopressin,BP,
20223,GO:1904118,1,0.994248477082807,0,1,regulation of otic vesicle morphogenesis,BP,
20224,GO:1904120,1,0.994248477082807,0,1,positive regulation of otic vesicle morphogenesis,BP,
20225,GO:1904121,1,0.996408210104187,0,1,phosphatidylethanolamine transfer activity,MF,
20226,GO:1904124,1,0.96980499490368,0,7,microglial cell migration,BP,
20227,GO:1904139,1,0.96980499490368,0,7,regulation of microglial cell migration,BP,
20228,GO:1904140,1,0.996537273645794,0,1,negative regulation of microglial cell migration,BP,
20229,GO:1904141,1,0.973175754935117,0,6,positive regulation of microglial cell migration,BP,
20230,GO:1904149,1,0.984372002929602,0,3,regulation of microglial cell mediated cytotoxicity,BP,
20231,GO:1904151,1,0.984372002929602,0,3,positive regulation of microglial cell mediated cytotoxicity,BP,
20232,GO:1904152,1,0.9233588892407,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20233,GO:1904153,1,0.947461747741639,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20234,GO:1904154,1,0.981019557754491,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20235,GO:1904155,1,0.984184260732947,0,2,DN2 thymocyte differentiation,BP,
20236,GO:1904156,1,0.993782316442918,0,1,DN3 thymocyte differentiation,BP,
20237,GO:1904158,1,0.964893406973305,0,3,axonemal central apparatus assembly,BP,
20238,GO:1904161,1,0.990044972495357,0,2,DNA synthesis involved in UV-damage excision repair,BP,
20239,GO:1904170,1,0.985076640284947,0,2,regulation of bleb assembly,BP,
20240,GO:1904172,1,0.985076640284947,0,2,positive regulation of bleb assembly,BP,
20241,GO:1904177,1,0.935326279330834,0,8,regulation of adipose tissue development,BP,
20242,GO:1904178,1,0.99065811845026,0,2,negative regulation of adipose tissue development,BP,
20243,GO:1904179,1,0.944151478439642,0,6,positive regulation of adipose tissue development,BP,
20244,GO:1904180,1,0.96144117061474,0,8,negative regulation of membrane depolarization,BP,
20245,GO:1904181,1,0.928717747806519,0,11,positive regulation of membrane depolarization,BP,
20246,GO:1904182,1,0.944814375779006,0,8,regulation of pyruvate dehydrogenase activity,BP,
20247,GO:1904183,1,0.962554506777132,0,5,negative regulation of pyruvate dehydrogenase activity,BP,
20248,GO:1904184,1,0.984793057711522,0,2,positive regulation of pyruvate dehydrogenase activity,BP,
20249,GO:1904192,1,0.983542179762854,0,1,regulation of cholangiocyte apoptotic process,BP,
20250,GO:1904193,1,0.983542179762854,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20251,GO:1904195,1,0.983542179762854,0,1,regulation of granulosa cell proliferation,BP,
20252,GO:1904197,1,0.983542179762854,0,1,positive regulation of granulosa cell proliferation,BP,
20253,GO:1904199,1,0.992273485426941,0,1,positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization,BP,
20254,GO:1904200,1,0.976938004314528,0,2,iodide transmembrane transport,BP,
20255,GO:1904201,1,0.983542179762854,0,1,regulation of iodide transport,BP,
20256,GO:1904202,1,0.983542179762854,0,1,negative regulation of iodide transport,BP,
20257,GO:1904204,1,0.971822124255794,0,2,regulation of skeletal muscle hypertrophy,BP,
20258,GO:1904205,1,0.988085789172707,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20259,GO:1904206,1,0.983542179762854,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20260,GO:1904210,1,0.99662311067945,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20261,GO:1904211,1,0.986760534881639,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20262,GO:1904212,1,0.983542179762854,0,1,regulation of iodide transmembrane transport,BP,
20263,GO:1904213,1,0.983542179762854,0,1,negative regulation of iodide transmembrane transport,BP,
20264,GO:1904217,1,0.986469107041504,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20265,GO:1904219,1,0.986469107041504,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20266,GO:1904220,1,0.981428428433381,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20267,GO:1904222,1,0.986469107041504,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20268,GO:1904226,1,0.995828671124588,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20269,GO:1904227,1,0.995828671124588,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20270,GO:1904229,1,0.980628750856612,0,2,regulation of succinate dehydrogenase activity,BP,
20271,GO:1904231,1,0.986382226240667,0,1,positive regulation of succinate dehydrogenase activity,BP,
20272,GO:1904232,1,0.983179257991858,0,2,regulation of aconitate hydratase activity,BP,
20273,GO:1904234,1,0.983179257991858,0,2,positive regulation of aconitate hydratase activity,BP,
20274,GO:1904235,1,0.972296564113023,0,2,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20275,GO:1904237,1,0.972296564113023,0,2,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20276,GO:1904238,1,0.949342508434918,0,8,pericyte cell differentiation,BP,
20277,GO:1904239,1,0.99662311067945,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20278,GO:1904240,1,0.99662311067945,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20279,GO:1904245,1,0.990682627084528,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20280,GO:1904246,1,0.996349183774901,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20281,GO:1904247,1,0.994312887987001,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20282,GO:1904251,1,0.933264323285241,0,12,regulation of bile acid metabolic process,BP,
20283,GO:1904252,1,0.989248004488137,0,2,negative regulation of bile acid metabolic process,BP,
20284,GO:1904253,1,0.985738899377876,0,3,positive regulation of bile acid metabolic process,BP,
20285,GO:1904259,1,0.939775170013206,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20286,GO:1904261,1,0.939775170013206,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20287,GO:1904262,1,0.929053355682384,0,11,negative regulation of TORC1 signaling,BP,
20288,GO:1904263,1,0.913737903691763,0,15,positive regulation of TORC1 signaling,BP,
20289,GO:1904266,1,0.986284783625989,0,1,regulation of Schwann cell chemotaxis,BP,
20290,GO:1904268,1,0.986284783625989,0,1,positive regulation of Schwann cell chemotaxis,BP,
20291,GO:1904270,1,0.996559143452224,0,1,pyroptosome complex assembly,BP,
20292,GO:1904271,1,0.978658303250995,0,3,L-proline import across plasma membrane,BP,
20293,GO:1904273,1,0.98074039592789,0,3,L-alanine import across plasma membrane,BP,
20294,GO:1904274,1,0.995775489971659,0,1,tricellular tight junction assembly,BP,
20295,GO:1904282,1,0.996133418816741,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20296,GO:1904283,1,0.996133418816741,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20297,GO:1904288,1,0.966946737100782,0,4,BAT3 complex binding,MF,
20298,GO:1904289,1,0.985877870860057,0,2,regulation of mitotic DNA damage checkpoint,BP,
20299,GO:1904290,1,0.991342382272193,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20300,GO:1904292,1,0.824222397489496,0,30,regulation of ERAD pathway,BP,
20301,GO:1904293,1,0.920766309130953,0,14,negative regulation of ERAD pathway,BP,
20302,GO:1904294,1,0.904855520727466,0,15,positive regulation of ERAD pathway,BP,
20303,GO:1904298,1,0.966117595870605,0,2,regulation of transcytosis,BP,
20304,GO:1904300,1,0.966117595870605,0,2,positive regulation of transcytosis,BP,
20305,GO:1904301,1,0.992132892685177,0,1,regulation of maternal process involved in parturition,BP,
20306,GO:1904303,1,0.992132892685177,0,1,positive regulation of maternal process involved in parturition,BP,
20307,GO:1904304,1,0.971121008184882,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20308,GO:1904306,1,0.971121008184882,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20309,GO:1904313,1,0.992490336213917,0,1,response to methamphetamine hydrochloride,BP,
20311,GO:1904316,1,0.992132892685177,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20312,GO:1904317,1,0.992132892685177,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20313,GO:1904321,1,0.889270193966137,0,11,response to forskolin,BP,
20314,GO:1904322,1,0.889270193966137,0,11,cellular response to forskolin,BP,
20315,GO:1904323,1,0.99464314001561,0,1,regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20316,GO:1904325,1,0.99464314001561,0,1,positive regulation of inhibitory G protein-coupled receptor phosphorylation,BP,
20317,GO:1904327,1,0.982159328564372,0,2,protein localization to cytosolic proteasome complex,BP,
20319,GO:1904338,1,0.942388721808444,0,9,regulation of dopaminergic neuron differentiation,BP,
20320,GO:1904339,1,0.983040478833501,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20321,GO:1904340,1,0.984199593519813,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20322,GO:1904341,1,0.990069666968894,0,1,regulation of colon smooth muscle contraction,BP,
20323,GO:1904343,1,0.990069666968894,0,1,positive regulation of colon smooth muscle contraction,BP,
20324,GO:1904344,1,0.992274843108485,0,2,regulation of gastric mucosal blood circulation,BP,
20325,GO:1904346,1,0.992274843108485,0,2,positive regulation of gastric mucosal blood circulation,BP,
20326,GO:1904347,1,0.986964486356191,0,2,regulation of small intestine smooth muscle contraction,BP,
20327,GO:1904349,1,0.986964486356191,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20328,GO:1904350,1,0.892219738955289,0,11,regulation of protein catabolic process in the vacuole,BP,
20329,GO:1904351,1,0.972700610290335,0,4,negative regulation of protein catabolic process in the vacuole,BP,
20330,GO:1904352,1,0.929515027793396,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20331,GO:1904353,1,0.815288262523878,0,26,regulation of telomere capping,BP,
20332,GO:1904354,1,0.922032420027421,0,8,negative regulation of telomere capping,BP,
20333,GO:1904355,1,0.893635910991656,0,17,positive regulation of telomere capping,BP,
20334,GO:1904356,1,0.66052998497739,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20335,GO:1904357,1,0.820168104132284,0,24,negative regulation of telomere maintenance via telomere lengthening,BP,
20336,GO:1904358,1,0.785686422769886,0,37,positive regulation of telomere maintenance via telomere lengthening,BP,
20337,GO:1904370,1,0.992316731529853,0,1,regulation of protein localization to actin cortical patch,BP,
20338,GO:1904372,1,0.992316731529853,0,1,positive regulation of protein localization to actin cortical patch,BP,
20339,GO:1904373,1,0.988859225169665,0,2,response to kainic acid,BP,
20341,GO:1904376,1,0.856290228070853,0,25,negative regulation of protein localization to cell periphery,BP,
20343,GO:1904378,1,0.975991511590566,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20344,GO:1904379,1,0.982159328564372,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20345,GO:1904380,1,0.88790276780307,0,15,endoplasmic reticulum mannose trimming,BP,
20346,GO:1904381,1,0.97606440275126,0,3,Golgi apparatus mannose trimming,BP,
20347,GO:1904382,1,0.967053452277299,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20348,GO:1904383,1,0.99058271126054,0,2,response to sodium phosphate,BP,
20350,GO:1904386,1,0.967171835593728,0,5,response to L-phenylalanine derivative,BP,
20351,GO:1904387,1,0.987345713161486,0,2,cellular response to L-phenylalanine derivative,BP,
20352,GO:1904389,1,0.996515991881927,0,1,rod bipolar cell differentiation,BP,
20353,GO:1904391,1,0.996515991881927,0,1,response to ciliary neurotrophic factor,BP,
20354,GO:1904393,1,0.967168082011086,0,4,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20355,GO:1904394,1,0.995608750889622,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20356,GO:1904395,1,0.981444361906265,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20357,GO:1904396,1,0.920480150883917,0,10,regulation of neuromuscular junction development,BP,
20358,GO:1904397,1,0.992139888865239,0,2,negative regulation of neuromuscular junction development,BP,
20359,GO:1904398,1,0.959803251156685,0,4,positive regulation of neuromuscular junction development,BP,
20360,GO:1904399,1,0.979601419742395,0,3,heparan sulfate binding,MF,
20361,GO:1904400,1,0.994278782330307,0,1,response to Thyroid stimulating hormone,BP,
20362,GO:1904404,1,0.98602027789242,0,1,response to formaldehyde,BP,
20363,GO:1904406,1,0.905224606285261,0,14,negative regulation of nitric oxide metabolic process,BP,
20364,GO:1904407,1,0.784301753743736,0,37,positive regulation of nitric oxide metabolic process,BP,
20365,GO:1904408,1,0.996746211301798,0,1,melatonin binding,MF,
20366,GO:1904412,1,0.993207627082606,0,1,regulation of cardiac ventricle development,BP,
20367,GO:1904414,1,0.993207627082606,0,1,positive regulation of cardiac ventricle development,BP,
20368,GO:1904415,1,0.965298941694424,0,6,regulation of xenophagy,BP,
20369,GO:1904417,1,0.965298941694424,0,6,positive regulation of xenophagy,BP,
20370,GO:1904423,1,0.984732108340346,0,2,dehydrodolichyl diphosphate synthase complex,CC,
20371,GO:1904424,1,0.911391854230567,0,12,regulation of GTP binding,BP,
20372,GO:1904425,1,0.988209752995748,0,2,negative regulation of GTP binding,BP,
20373,GO:1904426,1,0.982760516380827,0,2,positive regulation of GTP binding,BP,
20374,GO:1904427,1,0.645155408503892,0,66,positive regulation of calcium ion transmembrane transport,BP,
20375,GO:1904428,1,0.92920216319411,0,6,negative regulation of tubulin deacetylation,BP,
20376,GO:1904429,1,0.963657761508231,0,6,regulation of t-circle formation,BP,
20377,GO:1904430,1,0.979617202531919,0,3,negative regulation of t-circle formation,BP,
20378,GO:1904431,1,0.983711821384831,0,3,positive regulation of t-circle formation,BP,
20379,GO:1904432,1,0.992947366206177,0,2,regulation of ferrous iron binding,BP,
20380,GO:1904434,1,0.992947366206177,0,2,positive regulation of ferrous iron binding,BP,
20381,GO:1904435,1,0.992947366206177,0,2,regulation of transferrin receptor binding,BP,
20382,GO:1904437,1,0.992947366206177,0,2,positive regulation of transferrin receptor binding,BP,
20383,GO:1904438,1,0.996753257450972,0,1,regulation of iron ion import across plasma membrane,BP,
20384,GO:1904439,1,0.996753257450972,0,1,negative regulation of iron ion import across plasma membrane,BP,
20385,GO:1904447,1,0.949351872367382,0,5,folate import across plasma membrane,BP,
20386,GO:1904448,1,0.977608895796039,0,2,regulation of aspartate secretion,BP,
20387,GO:1904450,1,0.977608895796039,0,2,positive regulation of aspartate secretion,BP,
20388,GO:1904456,1,0.996217755789144,0,1,negative regulation of neuronal action potential,BP,
20389,GO:1904457,1,0.995505949277943,0,1,positive regulation of neuronal action potential,BP,
20390,GO:1904464,1,0.962391258937868,0,5,regulation of matrix metallopeptidase secretion,BP,
20391,GO:1904465,1,0.992105278928909,0,2,negative regulation of matrix metallopeptidase secretion,BP,
20392,GO:1904466,1,0.982927843882631,0,2,positive regulation of matrix metallopeptidase secretion,BP,
20393,GO:1904470,1,0.996649345953502,0,1,regulation of endothelin production,BP,
20394,GO:1904472,1,0.996649345953502,0,1,positive regulation of endothelin production,BP,
20395,GO:1904475,1,0.969489561587709,0,3,regulation of Ras GTPase binding,BP,
20396,GO:1904477,1,0.987860000336312,0,1,positive regulation of Ras GTPase binding,BP,
20397,GO:1904478,1,0.967363763723031,0,6,regulation of intestinal absorption,BP,
20398,GO:1904479,1,0.991972157255029,0,2,negative regulation of intestinal absorption,BP,
20399,GO:1904480,1,0.995658099904583,0,1,positive regulation of intestinal absorption,BP,
20400,GO:1904481,1,0.991188185081593,0,2,response to tetrahydrofolate,BP,
20401,GO:1904482,1,0.991188185081593,0,2,cellular response to tetrahydrofolate,BP,
20402,GO:1904491,1,0.966596988576739,0,7,protein localization to ciliary transition zone,BP,
20403,GO:1904492,1,0.995184773719864,0,1,Ac-Asp-Glu binding,MF,
20404,GO:1904493,1,0.995184773719864,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20405,GO:1904499,1,0.993614100415638,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20406,GO:1904501,1,0.993614100415638,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20407,GO:1904502,1,0.948774530739215,0,5,regulation of lipophagy,BP,
20408,GO:1904504,1,0.948774530739215,0,5,positive regulation of lipophagy,BP,
20409,GO:1904505,1,0.968483187078022,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20410,GO:1904506,1,0.968483187078022,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20411,GO:1904508,1,0.996514494454413,0,1,regulation of protein localization to basolateral plasma membrane,BP,
20412,GO:1904510,1,0.996514494454413,0,1,positive regulation of protein localization to basolateral plasma membrane,BP,
20413,GO:1904515,1,0.982221259311834,0,2,positive regulation of TORC2 signaling,BP,
20414,GO:1904526,1,0.933483091670208,0,10,regulation of microtubule binding,BP,
20415,GO:1904527,1,0.978480173859919,0,2,negative regulation of microtubule binding,BP,
20416,GO:1904528,1,0.96816009208643,0,6,positive regulation of microtubule binding,BP,
20417,GO:1904529,1,0.9835369223514,0,2,regulation of actin filament binding,BP,
20418,GO:1904530,1,0.994269016329043,0,1,negative regulation of actin filament binding,BP,
20419,GO:1904531,1,0.98920666255267,0,1,positive regulation of actin filament binding,BP,
20420,GO:1904533,1,0.980611851502531,0,3,regulation of telomeric loop disassembly,BP,
20421,GO:1904534,1,0.989267037860324,0,2,negative regulation of telomeric loop disassembly,BP,
20422,GO:1904535,1,0.991251849792857,0,1,positive regulation of telomeric loop disassembly,BP,
20423,GO:1904538,1,0.990488860306746,0,1,regulation of glycolytic process through fructose-6-phosphate,BP,
20424,GO:1904539,1,0.990488860306746,0,1,negative regulation of glycolytic process through fructose-6-phosphate,BP,
20425,GO:1904542,1,0.995080044408047,0,1,regulation of free ubiquitin chain polymerization,BP,
20426,GO:1904544,1,0.995080044408047,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20427,GO:1904550,1,0.995984459785051,0,1,response to arachidonic acid,BP,
20428,GO:1904555,1,0.978658303250995,0,3,L-proline transmembrane transport,BP,
20429,GO:1904556,1,0.986757027503365,0,2,L-tryptophan transmembrane transport,BP,
20430,GO:1904557,1,0.97688459433116,0,4,L-alanine transmembrane transport,BP,
20431,GO:1904562,1,0.972031859154383,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20432,GO:1904565,1,0.994216118570401,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20433,GO:1904566,1,0.994216118570401,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20434,GO:1904567,1,0.994442333353931,0,1,response to wortmannin,BP,
20435,GO:1904568,1,0.994442333353931,0,1,cellular response to wortmannin,BP,
20436,GO:1904569,1,0.993251036761767,0,2,regulation of selenocysteine incorporation,BP,
20437,GO:1904570,1,0.996351081089854,0,1,negative regulation of selenocysteine incorporation,BP,
20438,GO:1904571,1,0.996888716680078,0,1,positive regulation of selenocysteine incorporation,BP,
20439,GO:1904572,1,0.996351081089854,0,1,negative regulation of mRNA binding,BP,
20440,GO:1904573,1,0.996351081089854,0,1,regulation of selenocysteine insertion sequence binding,BP,
20441,GO:1904574,1,0.996351081089854,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20442,GO:1904576,1,0.991198778629755,0,2,response to tunicamycin,BP,
20443,GO:1904577,1,0.991198778629755,0,2,cellular response to tunicamycin,BP,
20444,GO:1904578,1,0.983011590787978,0,3,response to thapsigargin,BP,
20445,GO:1904579,1,0.983011590787978,0,3,cellular response to thapsigargin,BP,
20446,GO:1904580,1,0.984092702326279,0,3,regulation of intracellular mRNA localization,BP,
20447,GO:1904582,1,0.984092702326279,0,3,positive regulation of intracellular mRNA localization,BP,
20448,GO:1904585,1,0.995865701740864,0,1,response to putrescine,BP,
20449,GO:1904586,1,0.995865701740864,0,1,cellular response to putrescine,BP,
20450,GO:1904587,1,0.958343881447476,0,6,response to glycoprotein,BP,
20451,GO:1904588,1,0.996699230033063,0,1,cellular response to glycoprotein,BP,
20452,GO:1904589,1,0.642333718432594,0,59,regulation of protein import,BP,
20453,GO:1904590,1,0.910537573284156,0,13,negative regulation of protein import,BP,
20454,GO:1904591,1,0.724172240180496,0,41,positive regulation of protein import,BP,
20455,GO:1904594,1,0.969783006687837,0,3,regulation of termination of RNA polymerase II transcription,BP,
20456,GO:1904595,1,0.979771258481234,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20457,GO:1904596,1,0.996649345953502,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20458,GO:1904597,1,0.996649345953502,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20459,GO:1904602,1,0.992040227687856,0,2,serotonin-activated cation-selective channel complex,CC,
20460,GO:1904606,1,0.989848594746614,0,2,fat cell apoptotic process,BP,
20461,GO:1904612,1,0.967500114809028,0,4,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20462,GO:1904613,1,0.980153897535561,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20463,GO:1904616,1,0.9835369223514,0,2,regulation of actin binding,BP,
20464,GO:1904617,1,0.994269016329043,0,1,negative regulation of actin binding,BP,
20465,GO:1904618,1,0.98920666255267,0,1,positive regulation of actin binding,BP,
20466,GO:1904627,1,0.980798155425056,0,4,response to phorbol 13-acetate 12-myristate,BP,
20467,GO:1904628,1,0.980798155425056,0,4,cellular response to phorbol 13-acetate 12-myristate,BP,
20468,GO:1904631,1,0.995750587211804,0,1,response to glucoside,BP,
20469,GO:1904633,1,0.978383691616258,0,2,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20470,GO:1904635,1,0.978383691616258,0,2,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20471,GO:1904636,1,0.96965997349641,0,4,response to ionomycin,BP,
20472,GO:1904637,1,0.96965997349641,0,4,cellular response to ionomycin,BP,
20473,GO:1904638,1,0.982267147817447,0,2,response to resveratrol,BP,
20474,GO:1904639,1,0.987922847387118,0,1,cellular response to resveratrol,BP,
20475,GO:1904640,1,0.979906857760386,0,3,response to methionine,BP,
20476,GO:1904643,1,0.987821213012257,0,1,response to curcumin,BP,
20479,GO:1904647,1,0.982903167181667,0,1,response to rotenone,BP,
20480,GO:1904649,1,0.989848594746614,0,2,regulation of fat cell apoptotic process,BP,
20481,GO:1904651,1,0.993616147992159,0,1,positive regulation of fat cell apoptotic process,BP,
20482,GO:1904659,1,0.503315000731549,0,92,glucose transmembrane transport,BP,
20483,GO:1904666,1,0.881634803409411,0,23,regulation of ubiquitin protein ligase activity,BP,
20484,GO:1904667,1,0.966772339319391,0,9,negative regulation of ubiquitin protein ligase activity,BP,
20485,GO:1904668,1,0.919963610007753,0,13,positive regulation of ubiquitin protein ligase activity,BP,
20486,GO:1904672,1,0.948934342652651,0,8,regulation of somatic stem cell population maintenance,BP,
20487,GO:1904673,1,0.977411445150543,0,3,negative regulation of somatic stem cell population maintenance,BP,
20488,GO:1904674,1,0.985763483586953,0,2,positive regulation of somatic stem cell population maintenance,BP,
20489,GO:1904675,1,0.994583065162764,0,1,regulation of somatic stem cell division,BP,
20490,GO:1904677,1,0.994583065162764,0,1,positive regulation of somatic stem cell division,BP,
20491,GO:1904679,1,0.978912670820903,0,1,myo-inositol import across plasma membrane,BP,
20492,GO:1904680,1,0.837082978449229,0,27,peptide transmembrane transporter activity,MF,
20493,GO:1904681,1,0.995023303095778,0,1,response to 3-methylcholanthrene,BP,
20494,GO:1904683,1,0.941375961981304,0,6,regulation of metalloendopeptidase activity,BP,
20495,GO:1904684,1,0.95450902856833,0,4,negative regulation of metalloendopeptidase activity,BP,
20496,GO:1904685,1,0.986247374639012,0,2,positive regulation of metalloendopeptidase activity,BP,
20497,GO:1904688,1,0.967728675387758,0,5,regulation of cytoplasmic translational initiation,BP,
20498,GO:1904689,1,0.996751865538371,0,1,negative regulation of cytoplasmic translational initiation,BP,
20499,GO:1904690,1,0.970883167590178,0,4,positive regulation of cytoplasmic translational initiation,BP,
20500,GO:1904691,1,0.992747347585137,0,2,negative regulation of type B pancreatic cell proliferation,BP,
20501,GO:1904692,1,0.990023102940075,0,2,positive regulation of type B pancreatic cell proliferation,BP,
20502,GO:1904693,1,0.970097859137307,0,3,midbrain morphogenesis,BP,
20503,GO:1904694,1,0.965099571051924,0,3,negative regulation of vascular associated smooth muscle contraction,BP,
20504,GO:1904695,1,0.991121112241945,0,2,positive regulation of vascular associated smooth muscle contraction,BP,
20505,GO:1904697,1,0.9968460138118,0,1,regulation of acinar cell proliferation,BP,
20506,GO:1904699,1,0.9968460138118,0,1,positive regulation of acinar cell proliferation,BP,
20507,GO:1904700,1,0.991968042343177,0,2,granulosa cell apoptotic process,BP,
20508,GO:1904701,1,0.9962892356662,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20509,GO:1904702,1,0.989659488731851,0,1,regulation of protein localization to adherens junction,BP,
20510,GO:1904705,1,0.703829840244731,0,50,regulation of vascular associated smooth muscle cell proliferation,BP,
20511,GO:1904706,1,0.904706490790377,0,17,negative regulation of vascular associated smooth muscle cell proliferation,BP,
20512,GO:1904707,1,0.77539096691465,0,34,positive regulation of vascular associated smooth muscle cell proliferation,BP,
20513,GO:1904708,1,0.991968042343177,0,2,regulation of granulosa cell apoptotic process,BP,
20514,GO:1904710,1,0.996764461891254,0,1,positive regulation of granulosa cell apoptotic process,BP,
20515,GO:1904711,1,0.9962892356662,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20516,GO:1904713,1,0.977679708254048,0,2,beta-catenin destruction complex binding,MF,
20517,GO:1904714,1,0.959824901602727,0,8,regulation of chaperone-mediated autophagy,BP,
20518,GO:1904715,1,0.986091662758547,0,3,negative regulation of chaperone-mediated autophagy,BP,
20519,GO:1904716,1,0.995563146359098,0,1,positive regulation of chaperone-mediated autophagy,BP,
20521,GO:1904719,1,0.987858985187703,0,2,positive regulation of AMPA glutamate receptor clustering,BP,
20522,GO:1904723,1,0.9962892356662,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20524,GO:1904729,1,0.981292095525437,0,4,regulation of intestinal lipid absorption,BP,
20525,GO:1904730,1,0.995062653977197,0,1,negative regulation of intestinal lipid absorption,BP,
20526,GO:1904731,1,0.995658099904583,0,1,positive regulation of intestinal lipid absorption,BP,
20527,GO:1904732,1,0.968931319006779,0,5,regulation of electron transfer activity,BP,
20528,GO:1904734,1,0.996894379530465,0,1,positive regulation of electron transfer activity,BP,
20529,GO:1904738,1,0.798828056942396,0,21,vascular associated smooth muscle cell migration,BP,
20530,GO:1904742,1,0.96244753034015,0,4,regulation of telomeric DNA binding,BP,
20531,GO:1904743,1,0.969444718490622,0,2,negative regulation of telomeric DNA binding,BP,
20532,GO:1904744,1,0.992784505129573,0,2,positive regulation of telomeric DNA binding,BP,
20533,GO:1904746,1,0.967647317241925,0,5,negative regulation of apoptotic process involved in development,BP,
20534,GO:1904747,1,0.959906925983846,0,5,positive regulation of apoptotic process involved in development,BP,
20535,GO:1904748,1,0.919584314811816,0,11,regulation of apoptotic process involved in development,BP,
20536,GO:1904749,1,0.951141834448352,0,8,regulation of protein localization to nucleolus,BP,
20537,GO:1904750,1,0.98729890394661,0,1,negative regulation of protein localization to nucleolus,BP,
20538,GO:1904751,1,0.980510745552758,0,4,positive regulation of protein localization to nucleolus,BP,
20539,GO:1904752,1,0.798828056942396,0,21,regulation of vascular associated smooth muscle cell migration,BP,
20540,GO:1904753,1,0.959661667251561,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20541,GO:1904754,1,0.832468711622904,0,16,positive regulation of vascular associated smooth muscle cell migration,BP,
20542,GO:1904760,1,0.966113466096013,0,4,regulation of myofibroblast differentiation,BP,
20543,GO:1904761,1,0.973494567268584,0,3,negative regulation of myofibroblast differentiation,BP,
20544,GO:1904762,1,0.992419958973094,0,1,positive regulation of myofibroblast differentiation,BP,
20545,GO:1904764,1,0.996027396070592,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20546,GO:1904766,1,0.986855304597426,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20547,GO:1904768,1,0.987889438920234,0,2,all-trans-retinol binding,MF,
20548,GO:1904772,1,0.995129267614303,0,1,response to tetrachloromethane,BP,
20549,GO:1904776,1,0.936670615739385,0,9,regulation of protein localization to cell cortex,BP,
20550,GO:1904777,1,0.994890876864838,0,1,negative regulation of protein localization to cell cortex,BP,
20551,GO:1904778,1,0.95027270469965,0,6,positive regulation of protein localization to cell cortex,BP,
20552,GO:1904779,1,0.90848344492106,0,10,regulation of protein localization to centrosome,BP,
20553,GO:1904780,1,0.983707939188372,0,2,negative regulation of protein localization to centrosome,BP,
20554,GO:1904781,1,0.927735912130343,0,7,positive regulation of protein localization to centrosome,BP,
20555,GO:1904782,1,0.98474927426213,0,2,negative regulation of NMDA glutamate receptor activity,BP,
20556,GO:1904783,1,0.973534474266517,0,5,positive regulation of NMDA glutamate receptor activity,BP,
20557,GO:1904784,1,0.989483746332724,0,1,NLRP1 inflammasome complex assembly,BP,
20558,GO:1904790,1,0.994585892042755,0,1,regulation of shelterin complex assembly,BP,
20559,GO:1904792,1,0.994585892042755,0,1,positive regulation of shelterin complex assembly,BP,
20560,GO:1904793,1,0.993614100415638,0,1,regulation of euchromatin binding,BP,
20561,GO:1904796,1,0.951096810596705,0,7,regulation of core promoter binding,BP,
20562,GO:1904797,1,0.985036096498734,0,2,negative regulation of core promoter binding,BP,
20563,GO:1904798,1,0.965550236151386,0,5,positive regulation of core promoter binding,BP,
20564,GO:1904799,1,0.992513132617793,0,1,regulation of neuron remodeling,BP,
20565,GO:1904800,1,0.992513132617793,0,1,negative regulation of neuron remodeling,BP,
20566,GO:1904803,1,0.996881518446326,0,1,regulation of translation involved in cellular response to UV,BP,
20567,GO:1904806,1,0.989807596705769,0,2,regulation of protein oxidation,BP,
20568,GO:1904808,1,0.989807596705769,0,2,positive regulation of protein oxidation,BP,
20569,GO:1904809,1,0.983391252905501,0,2,regulation of dense core granule transport,BP,
20570,GO:1904811,1,0.983391252905501,0,2,positive regulation of dense core granule transport,BP,
20571,GO:1904812,1,0.992516242171655,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20572,GO:1904813,1,0.516822288738066,0,123,ficolin-1-rich granule lumen,CC,
20573,GO:1904814,1,0.935388198685502,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20574,GO:1904815,1,0.994585892042755,0,1,negative regulation of protein localization to chromosome, telomeric region,BP,
20575,GO:1904816,1,0.940483198009928,0,12,positive regulation of protein localization to chromosome, telomeric region,BP,
20576,GO:1904823,1,0.986273454655044,0,3,purine nucleobase transmembrane transport,BP,
20577,GO:1904825,1,0.980934638374706,0,4,protein localization to microtubule plus-end,BP,
20578,GO:1904826,1,0.985563161506897,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20579,GO:1904828,1,0.985563161506897,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20580,GO:1904829,1,0.996346806019679,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20581,GO:1904831,1,0.996346806019679,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20582,GO:1904833,1,0.984261533038242,0,4,positive regulation of removal of superoxide radicals,BP,
20583,GO:1904835,1,0.985120966502447,0,2,dorsal root ganglion morphogenesis,BP,
20584,GO:1904837,1,0.78399607894434,0,30,beta-catenin-TCF complex assembly,BP,
20585,GO:1904841,1,0.991902107535601,0,2,TORC2 complex binding,MF,
20586,GO:1904842,1,0.992267252067847,0,2,response to nitroglycerin,BP,
20587,GO:1904843,1,0.995864341580592,0,1,cellular response to nitroglycerin,BP,
20588,GO:1904844,1,0.984561916237172,0,3,response to L-glutamine,BP,
20589,GO:1904845,1,0.984561916237172,0,3,cellular response to L-glutamine,BP,
20590,GO:1904847,1,0.962882617665958,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20591,GO:1904848,1,0.996720374049634,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20592,GO:1904849,1,0.973056965879841,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20593,GO:1904850,1,0.994585892042755,0,1,negative regulation of establishment of protein localization to telomere,BP,
20594,GO:1904851,1,0.956714710921066,0,10,positive regulation of establishment of protein localization to telomere,BP,
20595,GO:1904854,1,0.994092674639147,0,1,proteasome core complex binding,MF,
20596,GO:1904855,1,0.996676509305464,0,1,proteasome regulatory particle binding,MF,
20599,GO:1904863,1,0.992834256602159,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20600,GO:1904864,1,0.992834256602159,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20601,GO:1904867,1,0.94783448528554,0,12,protein localization to Cajal body,BP,
20602,GO:1904868,1,0.964355834534092,0,2,telomerase catalytic core complex assembly,BP,
20603,GO:1904869,1,0.951420914668049,0,11,regulation of protein localization to Cajal body,BP,
20604,GO:1904871,1,0.951420914668049,0,11,positive regulation of protein localization to Cajal body,BP,
20605,GO:1904872,1,0.913387450428533,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20606,GO:1904874,1,0.939070926153728,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20607,GO:1904875,1,0.990600589696153,0,2,regulation of DNA ligase activity,BP,
20608,GO:1904876,1,0.994654349096504,0,1,negative regulation of DNA ligase activity,BP,
20609,GO:1904877,1,0.995924672723072,0,1,positive regulation of DNA ligase activity,BP,
20610,GO:1904878,1,0.976427056482365,0,2,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20611,GO:1904879,1,0.987659736009998,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20612,GO:1904880,1,0.978963860915613,0,3,response to hydrogen sulfide,BP,
20613,GO:1904881,1,0.983516005508699,0,2,cellular response to hydrogen sulfide,BP,
20614,GO:1904882,1,0.964355834534092,0,2,regulation of telomerase catalytic core complex assembly,BP,
20615,GO:1904884,1,0.964355834534092,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20616,GO:1904885,1,0.950301433683647,0,5,beta-catenin destruction complex assembly,BP,
20617,GO:1904886,1,0.869849925903149,0,17,beta-catenin destruction complex disassembly,BP,
20618,GO:1904887,1,0.982701323297205,0,1,Wnt signalosome assembly,BP,
20619,GO:1904888,1,0.603914314638835,0,63,cranial skeletal system development,BP,
20620,GO:1904889,1,0.891767984639088,0,15,regulation of excitatory synapse assembly,BP,
20621,GO:1904891,1,0.985330297141857,0,3,positive regulation of excitatory synapse assembly,BP,
20625,GO:1904895,1,0.996418272104253,0,1,ESCRT complex assembly,BP,
20626,GO:1904896,1,0.951568860778989,0,10,ESCRT complex disassembly,BP,
20627,GO:1904897,1,0.993828933588208,0,1,regulation of hepatic stellate cell proliferation,BP,
20628,GO:1904899,1,0.993828933588208,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20629,GO:1904902,1,0.996418272104253,0,1,ESCRT III complex assembly,BP,
20630,GO:1904903,1,0.951568860778989,0,10,ESCRT III complex disassembly,BP,
20631,GO:1904904,1,0.975979752153169,0,4,regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20632,GO:1904906,1,0.975979752153169,0,4,positive regulation of endothelial cell-matrix adhesion via fibronectin,BP,
20633,GO:1904907,1,0.962049498410563,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20634,GO:1904908,1,0.962049498410563,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20635,GO:1904910,1,0.994585892042755,0,1,regulation of establishment of RNA localization to telomere,BP,
20636,GO:1904911,1,0.994585892042755,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20637,GO:1904913,1,0.994585892042755,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20638,GO:1904914,1,0.994585892042755,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20639,GO:1904923,1,0.885050330642596,0,13,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20640,GO:1904924,1,0.995502047302218,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20641,GO:1904925,1,0.88905394977864,0,12,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20642,GO:1904928,1,0.963429525551028,0,3,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20643,GO:1904929,1,0.954129903518292,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20644,GO:1904933,1,0.988831518817606,0,1,regulation of cell proliferation in midbrain,BP,
20645,GO:1904934,1,0.988831518817606,0,1,negative regulation of cell proliferation in midbrain,BP,
20646,GO:1904936,1,0.959501829740658,0,6,interneuron migration,BP,
20647,GO:1904938,1,0.945166622944493,0,5,planar cell polarity pathway involved in axon guidance,BP,
20648,GO:1904947,1,0.994413513860184,0,1,folate import into mitochondrion,BP,
20649,GO:1904948,1,0.904802132094041,0,15,midbrain dopaminergic neuron differentiation,BP,
20650,GO:1904949,1,0.551586134537399,0,76,ATPase complex,CC,
20653,GO:1904953,1,0.931006320544298,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20654,GO:1904954,1,0.984941568280142,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20655,GO:1904955,1,0.988831518817606,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20656,GO:1904956,1,0.975117017758924,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20657,GO:1904958,1,0.987366883681868,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20658,GO:1904959,1,0.968931319006779,0,5,regulation of cytochrome-c oxidase activity,BP,
20659,GO:1904960,1,0.996894379530465,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20660,GO:1904970,1,0.974184343115852,0,3,brush border assembly,BP,
20661,GO:1904971,1,0.991157614917294,0,1,regulation of viral translation,BP,
20662,GO:1904973,1,0.991157614917294,0,1,positive regulation of viral translation,BP,
20663,GO:1904975,1,0.982725085107259,0,2,response to bleomycin,BP,
20664,GO:1904976,1,0.982725085107259,0,2,cellular response to bleomycin,BP,
20665,GO:1904977,1,0.991059991820471,0,2,lymphatic endothelial cell migration,BP,
20666,GO:1904978,1,0.973396076951373,0,3,regulation of endosome organization,BP,
20667,GO:1904979,1,0.995761291282718,0,1,negative regulation of endosome organization,BP,
20668,GO:1904980,1,0.986516001046473,0,1,positive regulation of endosome organization,BP,
20669,GO:1904983,1,0.995908760730147,0,1,glycine import into mitochondrion,BP,
20670,GO:1904984,1,0.996695800687134,0,1,regulation of quinolinate biosynthetic process,BP,
20671,GO:1904985,1,0.996695800687134,0,1,negative regulation of quinolinate biosynthetic process,BP,
20672,GO:1904990,1,0.995450105980023,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20673,GO:1904992,1,0.995450105980023,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20675,GO:1904995,1,0.981386502946481,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20676,GO:1904996,1,0.870740766980694,0,20,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20677,GO:1904997,1,0.986327555054423,0,3,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20678,GO:1904998,1,0.994592483981713,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20679,GO:1904999,1,0.991690585150843,0,2,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20680,GO:1905000,1,0.983951466687874,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20681,GO:1905003,1,0.996695800687134,0,1,picolinic acid metabolic process,BP,
20682,GO:1905004,1,0.996695800687134,0,1,picolinic acid biosynthetic process,BP,
20683,GO:1905005,1,0.954756126793133,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20684,GO:1905006,1,0.986280338667815,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20685,GO:1905007,1,0.958400422404712,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20686,GO:1905008,1,0.995221960103272,0,1,regulation of L-lysine import across plasma membrane,BP,
20687,GO:1905010,1,0.995221960103272,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20688,GO:1905012,1,0.996695800687134,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20689,GO:1905024,1,0.969020955336303,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20690,GO:1905025,1,0.994334264859106,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20691,GO:1905026,1,0.98400750123832,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20692,GO:1905030,1,0.974870998872837,0,2,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20693,GO:1905031,1,0.953464746753444,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20694,GO:1905032,1,0.994334264859106,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20695,GO:1905033,1,0.98400750123832,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20696,GO:1905034,1,0.990812091667816,0,2,regulation of antifungal innate immune response,BP,
20697,GO:1905035,1,0.994598129615994,0,1,negative regulation of antifungal innate immune response,BP,
20698,GO:1905036,1,0.996193605680214,0,1,positive regulation of antifungal innate immune response,BP,
20699,GO:1905037,1,0.526524166007406,0,91,autophagosome organization,BP,
20700,GO:1905038,1,0.910104226679999,0,16,regulation of membrane lipid metabolic process,BP,
20702,GO:1905040,1,0.995377187964952,0,1,otic placode development,BP,
20703,GO:1905041,1,0.995748440757121,0,1,regulation of epithelium regeneration,BP,
20704,GO:1905042,1,0.995748440757121,0,1,negative regulation of epithelium regeneration,BP,
20705,GO:1905044,1,0.994890876864838,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20706,GO:1905045,1,0.994890876864838,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20709,GO:1905050,1,0.960118313489359,0,8,positive regulation of metallopeptidase activity,BP,
20710,GO:1905051,1,0.993173456696446,0,2,regulation of base-excision repair,BP,
20711,GO:1905053,1,0.993173456696446,0,2,positive regulation of base-excision repair,BP,
20712,GO:1905056,1,0.958393349411653,0,3,calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration,MF,
20713,GO:1905059,1,0.983313232605474,0,1,calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
20715,GO:1905062,1,0.994999546682056,0,1,positive regulation of cardioblast proliferation,BP,
20716,GO:1905063,1,0.906012538500457,0,14,regulation of vascular associated smooth muscle cell differentiation,BP,
20717,GO:1905064,1,0.943825756280925,0,8,negative regulation of vascular associated smooth muscle cell differentiation,BP,
20718,GO:1905065,1,0.95995891020734,0,6,positive regulation of vascular associated smooth muscle cell differentiation,BP,
20719,GO:1905066,1,0.991881625940772,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20720,GO:1905067,1,0.9962892356662,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20721,GO:1905068,1,0.995576138506172,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20722,GO:1905069,1,0.988236651099282,0,2,allantois development,BP,
20723,GO:1905071,1,0.982029688013734,0,2,tight junction disassembly,BP,
20724,GO:1905073,1,0.982029688013734,0,2,regulation of tight junction disassembly,BP,
20725,GO:1905075,1,0.982029688013734,0,2,positive regulation of tight junction disassembly,BP,
20726,GO:1905089,1,0.977793933364076,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20727,GO:1905090,1,0.977793933364076,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20728,GO:1905097,1,0.942163721154721,0,7,regulation of guanyl-nucleotide exchange factor activity,BP,
20729,GO:1905098,1,0.971822794920027,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20730,GO:1905099,1,0.987860000336312,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20731,GO:1905103,1,0.978592141961914,0,3,integral component of lysosomal membrane,CC,
20733,GO:1905115,1,0.996702621226445,0,1,regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20734,GO:1905116,1,0.996702621226445,0,1,positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore,BP,
20735,GO:1905123,1,0.983385155791713,0,2,regulation of glucosylceramidase activity,BP,
20736,GO:1905132,1,0.990613493380433,0,2,regulation of meiotic chromosome separation,BP,
20737,GO:1905133,1,0.994400996008306,0,1,negative regulation of meiotic chromosome separation,BP,
20738,GO:1905134,1,0.996191385767568,0,1,positive regulation of meiotic chromosome separation,BP,
20739,GO:1905135,1,0.987252289418821,0,2,biotin import across plasma membrane,BP,
20740,GO:1905143,1,0.996509223011586,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20741,GO:1905144,1,0.838616021139427,0,27,response to acetylcholine,BP,
20742,GO:1905145,1,0.838616021139427,0,27,cellular response to acetylcholine,BP,
20743,GO:1905146,1,0.861337850743966,0,15,lysosomal protein catabolic process,BP,
20744,GO:1905150,1,0.957222711702769,0,7,regulation of voltage-gated sodium channel activity,BP,
20745,GO:1905152,1,0.988698541791471,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20746,GO:1905153,1,0.892799559578416,0,16,regulation of membrane invagination,BP,
20747,GO:1905154,1,0.98618274821282,0,2,negative regulation of membrane invagination,BP,
20748,GO:1905155,1,0.909839662014151,0,13,positive regulation of membrane invagination,BP,
20749,GO:1905161,1,0.989946873263755,0,1,protein localization to phagocytic vesicle,BP,
20750,GO:1905162,1,0.982411413957597,0,3,regulation of phagosome maturation,BP,
20751,GO:1905164,1,0.996193605680214,0,1,positive regulation of phagosome maturation,BP,
20752,GO:1905165,1,0.899898717978812,0,9,regulation of lysosomal protein catabolic process,BP,
20753,GO:1905166,1,0.972700610290335,0,4,negative regulation of lysosomal protein catabolic process,BP,
20754,GO:1905167,1,0.937511698190204,0,3,positive regulation of lysosomal protein catabolic process,BP,
20755,GO:1905168,1,0.919071908060355,0,10,positive regulation of double-strand break repair via homologous recombination,BP,
20756,GO:1905169,1,0.989946873263755,0,1,regulation of protein localization to phagocytic vesicle,BP,
20757,GO:1905171,1,0.989946873263755,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20758,GO:1905172,1,0.97445662649148,0,3,RISC complex binding,MF,
20759,GO:1905174,1,0.990939049153259,0,2,regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20760,GO:1905176,1,0.994690656093121,0,1,positive regulation of vascular associated smooth muscle cell dedifferentiation,BP,
20761,GO:1905178,1,0.991318057553814,0,2,regulation of cardiac muscle tissue regeneration,BP,
20762,GO:1905179,1,0.991318057553814,0,2,negative regulation of cardiac muscle tissue regeneration,BP,
20763,GO:1905184,1,0.994407738581775,0,1,positive regulation of protein serine/threonine phosphatase activity,BP,
20764,GO:1905186,1,0.996191385767568,0,1,regulation of metaphase/anaphase transition of meiosis I,BP,
20765,GO:1905188,1,0.996191385767568,0,1,positive regulation of metaphase/anaphase transition of meiosis I,BP,
20766,GO:1905198,1,0.984790660304438,0,2,manchette assembly,BP,
20767,GO:1905199,1,0.995378806480956,0,1,manchette disassembly,BP,
20768,GO:1905202,1,0.988390804671299,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20769,GO:1905203,1,0.963247437790084,0,4,regulation of connective tissue replacement,BP,
20770,GO:1905204,1,0.996649345953502,0,1,negative regulation of connective tissue replacement,BP,
20771,GO:1905205,1,0.966486905098594,0,3,positive regulation of connective tissue replacement,BP,
20772,GO:1905206,1,0.964320953114539,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20773,GO:1905207,1,0.701147409921377,0,48,regulation of cardiocyte differentiation,BP,
20774,GO:1905208,1,0.860681869686588,0,20,negative regulation of cardiocyte differentiation,BP,
20775,GO:1905209,1,0.818504870999628,0,27,positive regulation of cardiocyte differentiation,BP,
20776,GO:1905214,1,0.927371586154433,0,12,regulation of RNA binding,BP,
20777,GO:1905215,1,0.996351081089854,0,1,negative regulation of RNA binding,BP,
20778,GO:1905216,1,0.947595909731068,0,9,positive regulation of RNA binding,BP,
20779,GO:1905217,1,0.994278782330307,0,1,response to astaxanthin,BP,
20780,GO:1905219,1,0.969187455110537,0,2,regulation of platelet formation,BP,
20781,GO:1905221,1,0.969187455110537,0,2,positive regulation of platelet formation,BP,
20782,GO:1905222,1,0.994196459157495,0,1,atrioventricular canal morphogenesis,BP,
20783,GO:1905223,1,0.974158363528907,0,2,epicardium morphogenesis,BP,
20784,GO:1905224,1,0.974307788436418,0,3,clathrin-coated pit assembly,BP,
20785,GO:1905225,1,0.99099670811914,0,2,response to thyrotropin-releasing hormone,BP,
20786,GO:1905226,1,0.996680149484342,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20787,GO:1905229,1,0.996699230033063,0,1,cellular response to thyrotropin-releasing hormone,BP,
20788,GO:1905232,1,0.966115283695258,0,5,cellular response to L-glutamate,BP,
20789,GO:1905239,1,0.99038217789177,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20790,GO:1905240,1,0.99038217789177,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20791,GO:1905242,1,0.988776322149443,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20792,GO:1905243,1,0.995043454014117,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20793,GO:1905244,1,0.910151698841551,0,12,regulation of modification of synaptic structure,BP,
20794,GO:1905245,1,0.925854743561977,0,10,regulation of aspartic-type peptidase activity,BP,
20795,GO:1905246,1,0.975602554245982,0,2,negative regulation of aspartic-type peptidase activity,BP,
20796,GO:1905247,1,0.949020368833471,0,8,positive regulation of aspartic-type peptidase activity,BP,
20797,GO:1905255,1,0.987682873551452,0,1,regulation of RNA binding transcription factor activity,BP,
20798,GO:1905258,1,0.99334595591195,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20799,GO:1905259,1,0.99334595591195,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20800,GO:1905267,1,0.985368969301531,0,3,endonucleolytic cleavage involved in tRNA processing,BP,
20801,GO:1905268,1,0.683344759933298,0,48,negative regulation of chromatin organization,BP,
20803,GO:1905271,1,0.996876328287932,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20804,GO:1905273,1,0.996876328287932,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20805,GO:1905274,1,0.954360005824809,0,5,regulation of modification of postsynaptic actin cytoskeleton,BP,
20806,GO:1905276,1,0.864137092213365,0,18,regulation of epithelial tube formation,BP,
20807,GO:1905277,1,0.994331352638263,0,1,negative regulation of epithelial tube formation,BP,
20808,GO:1905278,1,0.974596056603212,0,4,positive regulation of epithelial tube formation,BP,
20809,GO:1905279,1,0.972272956500159,0,3,regulation of retrograde transport, endosome to Golgi,BP,
20810,GO:1905280,1,0.994471056633423,0,1,negative regulation of retrograde transport, endosome to Golgi,BP,
20811,GO:1905285,1,0.993207627082606,0,1,fibrous ring of heart morphogenesis,BP,
20812,GO:1905286,1,0.985436889724184,0,3,serine-type peptidase complex,CC,
20813,GO:1905288,1,0.930131324863794,0,9,vascular associated smooth muscle cell apoptotic process,BP,
20814,GO:1905289,1,0.955907201264336,0,3,regulation of CAMKK-AMPK signaling cascade,BP,
20815,GO:1905291,1,0.996780194014668,0,1,positive regulation of CAMKK-AMPK signaling cascade,BP,
20816,GO:1905292,1,0.978870216780587,0,3,regulation of neural crest cell differentiation,BP,
20817,GO:1905294,1,0.978870216780587,0,3,positive regulation of neural crest cell differentiation,BP,
20818,GO:1905301,1,0.973896652865751,0,3,regulation of macropinocytosis,BP,
20819,GO:1905302,1,0.991310516720702,0,1,negative regulation of macropinocytosis,BP,
20820,GO:1905303,1,0.982435009365589,0,2,positive regulation of macropinocytosis,BP,
20821,GO:1905304,1,0.983543904499243,0,1,regulation of cardiac myofibril assembly,BP,
20822,GO:1905305,1,0.983543904499243,0,1,negative regulation of cardiac myofibril assembly,BP,
20823,GO:1905309,1,0.981211530031672,0,1,positive regulation of cohesin loading,BP,
20824,GO:1905310,1,0.978870216780587,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20825,GO:1905312,1,0.978870216780587,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20826,GO:1905313,1,0.995806429378298,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20827,GO:1905314,1,0.748629916246182,0,36,semi-lunar valve development,BP,
20828,GO:1905317,1,0.99107847423784,0,1,inferior endocardial cushion morphogenesis,BP,
20829,GO:1905319,1,0.987105874399181,0,3,mesenchymal stem cell migration,BP,
20830,GO:1905320,1,0.987105874399181,0,3,regulation of mesenchymal stem cell migration,BP,
20831,GO:1905322,1,0.987105874399181,0,3,positive regulation of mesenchymal stem cell migration,BP,
20832,GO:1905323,1,0.946115232512722,0,6,telomerase holoenzyme complex assembly,BP,
20833,GO:1905327,1,0.996493899157185,0,1,tracheoesophageal septum formation,BP,
20835,GO:1905331,1,0.882049068086698,0,16,negative regulation of morphogenesis of an epithelium,BP,
20837,GO:1905333,1,0.986800485536135,0,4,regulation of gastric motility,BP,
20838,GO:1905335,1,0.967421536776357,0,3,regulation of aggrephagy,BP,
20839,GO:1905337,1,0.967421536776357,0,3,positive regulation of aggrephagy,BP,
20840,GO:1905340,1,0.982248881016093,0,4,regulation of protein localization to kinetochore,BP,
20841,GO:1905341,1,0.995050444321846,0,1,negative regulation of protein localization to kinetochore,BP,
20842,GO:1905342,1,0.982248881016093,0,4,positive regulation of protein localization to kinetochore,BP,
20843,GO:1905344,1,0.986312589793267,0,3,prostaglandin catabolic process,BP,
20844,GO:1905347,1,0.967343115957188,0,6,endodeoxyribonuclease complex,CC,
20845,GO:1905348,1,0.827424175321414,0,35,endonuclease complex,CC,
20846,GO:1905349,1,0.994812102807441,0,1,ciliary transition zone assembly,BP,
20847,GO:1905354,1,0.875947351106322,0,24,exoribonuclease complex,CC,
20848,GO:1905355,1,0.990161041460086,0,1,spine apparatus assembly,BP,
20849,GO:1905359,1,0.994400996008306,0,1,protein localization to meiotic spindle,BP,
20851,GO:1905364,1,0.996224256177234,0,1,regulation of endosomal vesicle fusion,BP,
20852,GO:1905365,1,0.995761291282718,0,1,regulation of intralumenal vesicle formation,BP,
20853,GO:1905366,1,0.995761291282718,0,1,negative regulation of intralumenal vesicle formation,BP,
20854,GO:1905368,1,0.658309995142218,0,83,peptidase complex,CC,
20855,GO:1905369,1,0.73490134057672,0,65,endopeptidase complex,CC,
20856,GO:1905370,1,0.995502047302218,0,1,serine-type endopeptidase complex,CC,
20857,GO:1905371,1,0.984841422477652,0,2,ceramide phosphoethanolamine metabolic process,BP,
20858,GO:1905373,1,0.984841422477652,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20859,GO:1905377,1,0.9912389379141,0,1,response to D-galactose,BP,
20860,GO:1905380,1,0.981658784809784,0,4,regulation of snRNA transcription by RNA polymerase II,BP,
20861,GO:1905382,1,0.981658784809784,0,4,positive regulation of snRNA transcription by RNA polymerase II,BP,
20862,GO:1905383,1,0.907282458227145,0,11,protein localization to presynapse,BP,
20863,GO:1905384,1,0.990984403070015,0,2,regulation of protein localization to presynapse,BP,
20864,GO:1905386,1,0.990984403070015,0,2,positive regulation of protein localization to presynapse,BP,
20865,GO:1905394,1,0.949097174891005,0,5,retromer complex binding,MF,
20866,GO:1905395,1,0.984892168180338,0,3,response to flavonoid,BP,
20867,GO:1905396,1,0.996653552058813,0,1,cellular response to flavonoid,BP,
20868,GO:1905397,1,0.992625329812322,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20869,GO:1905402,1,0.992625329812322,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20870,GO:1905403,1,0.996092146970936,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20871,GO:1905404,1,0.996519718586635,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20872,GO:1905405,1,0.981211530031672,0,1,regulation of mitotic cohesin loading,BP,
20873,GO:1905406,1,0.981211530031672,0,1,positive regulation of mitotic cohesin loading,BP,
20874,GO:1905407,1,0.990117405819891,0,2,regulation of creatine transmembrane transporter activity,BP,
20875,GO:1905408,1,0.990117405819891,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20876,GO:1905413,1,0.991304545561792,0,1,regulation of dense core granule exocytosis,BP,
20877,GO:1905414,1,0.992232362160368,0,1,negative regulation of dense core granule exocytosis,BP,
20878,GO:1905415,1,0.992232362160368,0,1,positive regulation of dense core granule exocytosis,BP,
20879,GO:1905420,1,0.977927536606342,0,3,vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
20880,GO:1905424,1,0.991044748683808,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20881,GO:1905426,1,0.991044748683808,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20883,GO:1905430,1,0.989335595613596,0,2,cellular response to glycine,BP,
20884,GO:1905432,1,0.992232362160368,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20885,GO:1905433,1,0.992232362160368,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20886,GO:1905435,1,0.987984005511289,0,2,regulation of histone H3-K4 trimethylation,BP,
20887,GO:1905437,1,0.987984005511289,0,2,positive regulation of histone H3-K4 trimethylation,BP,
20888,GO:1905438,1,0.985443522637786,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20889,GO:1905443,1,0.991408208820327,0,1,regulation of clathrin coat assembly,BP,
20890,GO:1905445,1,0.991408208820327,0,1,positive regulation of clathrin coat assembly,BP,
20891,GO:1905446,1,0.970339732446986,0,7,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20892,GO:1905447,1,0.989043123380638,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20893,GO:1905448,1,0.98109147763946,0,5,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20894,GO:1905449,1,0.938090040358141,0,7,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20895,GO:1905450,1,0.978316914220411,0,2,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20896,GO:1905451,1,0.958890360229358,0,5,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20897,GO:1905453,1,0.995490313344996,0,1,regulation of myeloid progenitor cell differentiation,BP,
20898,GO:1905454,1,0.995490313344996,0,1,negative regulation of myeloid progenitor cell differentiation,BP,
20899,GO:1905456,1,0.928855470848351,0,8,regulation of lymphoid progenitor cell differentiation,BP,
20900,GO:1905457,1,0.975986781265397,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20901,GO:1905458,1,0.984130948271302,0,2,positive regulation of lymphoid progenitor cell differentiation,BP,
20902,GO:1905459,1,0.930131324863794,0,9,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20903,GO:1905460,1,0.975991719286472,0,2,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20904,GO:1905461,1,0.953022621330048,0,7,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20905,GO:1905462,1,0.96497073160794,0,6,regulation of DNA duplex unwinding,BP,
20906,GO:1905463,1,0.979383412477665,0,3,negative regulation of DNA duplex unwinding,BP,
20907,GO:1905464,1,0.985286969265943,0,3,positive regulation of DNA duplex unwinding,BP,
20908,GO:1905468,1,0.989946873263755,0,1,regulation of clathrin-coated pit assembly,BP,
20909,GO:1905469,1,0.989946873263755,0,1,negative regulation of clathrin-coated pit assembly,BP,
20910,GO:1905474,1,0.996551486129961,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20912,GO:1905476,1,0.835257175804437,0,30,negative regulation of protein localization to membrane,BP,
20914,GO:1905483,1,0.978827720414942,0,1,regulation of motor neuron migration,BP,
20915,GO:1905485,1,0.978827720414942,0,1,positive regulation of motor neuron migration,BP,
20916,GO:1905492,1,0.99333404336054,0,1,positive regulation of branching morphogenesis of a nerve,BP,
20917,GO:1905502,1,0.988784271988052,0,2,acetyl-CoA binding,MF,
20918,GO:1905503,1,0.996312309476783,0,1,regulation of motile cilium assembly,BP,
20919,GO:1905505,1,0.996312309476783,0,1,positive regulation of motile cilium assembly,BP,
20920,GO:1905508,1,0.736813758749454,0,33,protein localization to microtubule organizing center,BP,
20921,GO:1905512,1,0.995245458510889,0,1,regulation of short-term synaptic potentiation,BP,
20922,GO:1905513,1,0.995245458510889,0,1,negative regulation of short-term synaptic potentiation,BP,
20923,GO:1905515,1,0.692793144135963,0,50,non-motile cilium assembly,BP,
20924,GO:1905516,1,0.919986188479182,0,12,positive regulation of fertilization,BP,
20925,GO:1905517,1,0.774241713805031,0,48,macrophage migration,BP,
20926,GO:1905518,1,0.990580271672831,0,1,regulation of presynaptic active zone assembly,BP,
20927,GO:1905520,1,0.990580271672831,0,1,positive regulation of presynaptic active zone assembly,BP,
20928,GO:1905521,1,0.816722914562027,0,36,regulation of macrophage migration,BP,
20929,GO:1905522,1,0.950940120293879,0,9,negative regulation of macrophage migration,BP,
20930,GO:1905523,1,0.88257195341907,0,22,positive regulation of macrophage migration,BP,
20931,GO:1905524,1,0.985442061192431,0,1,negative regulation of protein autoubiquitination,BP,
20932,GO:1905526,1,0.987193291725031,0,2,regulation of Golgi lumen acidification,BP,
20933,GO:1905528,1,0.991366302946322,0,1,positive regulation of Golgi lumen acidification,BP,
20934,GO:1905532,1,0.989811277794605,0,2,regulation of leucine import across plasma membrane,BP,
20935,GO:1905533,1,0.989811277794605,0,2,negative regulation of leucine import across plasma membrane,BP,
20936,GO:1905535,1,0.989973703516647,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20937,GO:1905537,1,0.989973703516647,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20938,GO:1905538,1,0.964540072986309,0,5,polysome binding,MF,
20939,GO:1905541,1,0.995221960103272,0,1,regulation of L-arginine import across plasma membrane,BP,
20940,GO:1905546,1,0.995690515438286,0,1,cellular response to phenylpropanoid,BP,
20941,GO:1905547,1,0.996442198035923,0,1,regulation of subtelomeric heterochromatin assembly,BP,
20942,GO:1905549,1,0.996442198035923,0,1,positive regulation of subtelomeric heterochromatin assembly,BP,
20943,GO:1905550,1,0.992155742246073,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20944,GO:1905552,1,0.992155742246073,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20945,GO:1905553,1,0.979267209567549,0,4,regulation of blood vessel branching,BP,
20946,GO:1905555,1,0.98255834405516,0,3,positive regulation blood vessel branching,BP,
20947,GO:1905562,1,0.843511462094801,0,20,regulation of vascular endothelial cell proliferation,BP,
20948,GO:1905563,1,0.957869593223245,0,5,negative regulation of vascular endothelial cell proliferation,BP,
20949,GO:1905564,1,0.880660143287727,0,15,positive regulation of vascular endothelial cell proliferation,BP,
20950,GO:1905572,1,0.994769120785294,0,1,ganglioside GM1 transport to membrane,BP,
20951,GO:1905573,1,0.990959049374181,0,2,ganglioside GM1 binding,MF,
20952,GO:1905574,1,0.994769120785294,0,1,ganglioside GM2 binding,MF,
20953,GO:1905575,1,0.994769120785294,0,1,ganglioside GM3 binding,MF,
20954,GO:1905576,1,0.986497485692459,0,3,ganglioside GT1b binding,MF,
20955,GO:1905577,1,0.994769120785294,0,1,ganglioside GP1c binding,MF,
20956,GO:1905578,1,0.995444550020843,0,1,regulation of ERBB3 signaling pathway,BP,
20957,GO:1905580,1,0.995444550020843,0,1,positive regulation of ERBB3 signaling pathway,BP,
20959,GO:1905589,1,0.995221960103272,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20960,GO:1905590,1,0.99420924187086,0,1,fibronectin fibril organization,BP,
20961,GO:1905594,1,0.996746211301798,0,1,resveratrol binding,MF,
20963,GO:1905596,1,0.993166103564716,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20965,GO:1905598,1,0.977819802737988,0,2,negative regulation of low-density lipoprotein receptor activity,BP,
20968,GO:1905601,1,0.977819802737988,0,2,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20972,GO:1905605,1,0.960149115178366,0,5,positive regulation of blood-brain barrier permeability,BP,
20974,GO:1905607,1,0.9962892356662,0,1,negative regulation of presynapse assembly,BP,
20975,GO:1905608,1,0.990580271672831,0,1,positive regulation of presynapse assembly,BP,
20976,GO:1905610,1,0.989973703516647,0,1,regulation of mRNA cap binding,BP,
20977,GO:1905612,1,0.989973703516647,0,1,positive regulation of mRNA cap binding,BP,
20978,GO:1905616,1,0.97554621557859,0,3,regulation of miRNA mediated inhibition of translation,BP,
20979,GO:1905618,1,0.97554621557859,0,3,positive regulation of miRNA mediated inhibition of translation,BP,
20980,GO:1905634,1,0.948579354238526,0,5,regulation of protein localization to chromatin,BP,
20981,GO:1905636,1,0.975267485827533,0,3,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20982,GO:1905642,1,0.994890876864838,0,1,negative regulation of DNA methylation,BP,
20983,GO:1905643,1,0.97875334344757,0,3,positive regulation of DNA methylation,BP,
20984,GO:1905647,1,0.978658303250995,0,3,proline import across plasma membrane,BP,
20985,GO:1905651,1,0.971431915983097,0,3,regulation of artery morphogenesis,BP,
20986,GO:1905653,1,0.971431915983097,0,3,positive regulation of artery morphogenesis,BP,
20987,GO:1905661,1,0.984583470780692,0,3,regulation of telomerase RNA reverse transcriptase activity,BP,
20988,GO:1905662,1,0.995571559405562,0,1,negative regulation of telomerase RNA reverse transcriptase activity,BP,
20989,GO:1905663,1,0.988963522987442,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20990,GO:1905664,1,0.980931698931015,0,4,regulation of calcium ion import across plasma membrane,BP,
20991,GO:1905665,1,0.989889285530179,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20992,GO:1905666,1,0.894350416293159,0,13,regulation of protein localization to endosome,BP,
20993,GO:1905667,1,0.992598201642733,0,1,negative regulation of protein localization to endosome,BP,
20994,GO:1905668,1,0.901026553565211,0,12,positive regulation of protein localization to endosome,BP,
20995,GO:1905671,1,0.978889131171168,0,4,regulation of lysosome organization,BP,
20996,GO:1905673,1,0.995644726868416,0,1,positive regulation of lysosome organization,BP,
20997,GO:1905674,1,0.989471887443851,0,3,regulation of adaptive immune memory response,BP,
20998,GO:1905675,1,0.992898950870044,0,2,negative regulation of adaptive immune memory response,BP,
20999,GO:1905676,1,0.996548673676157,0,1,positive regulation of adaptive immune memory response,BP,
21000,GO:1905684,1,0.975130488898294,0,3,regulation of plasma membrane repair,BP,
21001,GO:1905687,1,0.9889619463563,0,1,regulation of diacylglycerol kinase activity,BP,
21002,GO:1905689,1,0.9889619463563,0,1,positive regulation of diacylglycerol kinase activity,BP,
21003,GO:1905693,1,0.995877903634853,0,1,regulation of phosphatidic acid biosynthetic process,BP,
21004,GO:1905695,1,0.995877903634853,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
21005,GO:1905696,1,0.981219098286683,0,2,regulation of polysome binding,BP,
21006,GO:1905698,1,0.991157614917294,0,1,positive regulation of polysome binding,BP,
21007,GO:1905702,1,0.972327335930815,0,4,regulation of inhibitory synapse assembly,BP,
21008,GO:1905703,1,0.996041055082296,0,1,negative regulation of inhibitory synapse assembly,BP,
21009,GO:1905704,1,0.985395778953917,0,2,positive regulation of inhibitory synapse assembly,BP,
21010,GO:1905705,1,0.986780758211359,0,1,cellular response to paclitaxel,BP,
21011,GO:1905706,1,0.995303630307367,0,1,regulation of mitochondrial ATP synthesis coupled proton transport,BP,
21012,GO:1905709,1,0.947234982305573,0,7,negative regulation of membrane permeability,BP,
21013,GO:1905710,1,0.731263570961312,0,60,positive regulation of membrane permeability,BP,
21014,GO:1905711,1,0.992836338383579,0,1,response to phosphatidylethanolamine,BP,
21015,GO:1905719,1,0.989541460932069,0,2,protein localization to perinuclear region of cytoplasm,BP,
21016,GO:1905720,1,0.986317247929674,0,1,cytoplasmic microtubule bundle,CC,
21017,GO:1905721,1,0.986315966604685,0,3,mitotic spindle astral microtubule end,CC,
21018,GO:1905725,1,0.980934638374706,0,4,protein localization to microtubule end,BP,
21019,GO:1905735,1,0.993418769293849,0,1,regulation of L-proline import across plasma membrane,BP,
21020,GO:1905737,1,0.993418769293849,0,1,positive regulation of L-proline import across plasma membrane,BP,
21021,GO:1905747,1,0.991595950096535,0,2,negative regulation of saliva secretion,BP,
21022,GO:1905748,1,0.991595950096535,0,2,hard palate morphogenesis,BP,
21023,GO:1905749,1,0.969405818856572,0,4,regulation of endosome to plasma membrane protein transport,BP,
21024,GO:1905751,1,0.980109383813574,0,2,positive regulation of endosome to plasma membrane protein transport,BP,
21025,GO:1905764,1,0.977032388095396,0,3,regulation of protection from non-homologous end joining at telomere,BP,
21026,GO:1905765,1,0.977032388095396,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
21027,GO:1905767,1,0.987110504825161,0,1,regulation of double-stranded telomeric DNA binding,BP,
21028,GO:1905768,1,0.987110504825161,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
21029,GO:1905770,1,0.966196641824275,0,6,regulation of mesodermal cell differentiation,BP,
21030,GO:1905771,1,0.989151522073451,0,3,negative regulation of mesodermal cell differentiation,BP,
21031,GO:1905772,1,0.994217100594094,0,1,positive regulation of mesodermal cell differentiation,BP,
21032,GO:1905773,1,0.972744625363302,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
21033,GO:1905774,1,0.975664844192556,0,5,regulation of DNA helicase activity,BP,
21034,GO:1905775,1,0.990235633650133,0,2,negative regulation of DNA helicase activity,BP,
21035,GO:1905776,1,0.985286969265943,0,3,positive regulation of DNA helicase activity,BP,
21036,GO:1905777,1,0.98424768957228,0,3,regulation of exonuclease activity,BP,
21037,GO:1905778,1,0.989267037860324,0,2,negative regulation of exonuclease activity,BP,
21038,GO:1905779,1,0.994926741713297,0,1,positive regulation of exonuclease activity,BP,
21039,GO:1905784,1,0.989987375413901,0,2,regulation of anaphase-promoting complex-dependent catabolic process,BP,
21040,GO:1905786,1,0.989987375413901,0,2,positive regulation of anaphase-promoting complex-dependent catabolic process,BP,
21041,GO:1905787,1,0.995003072987144,0,1,regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21042,GO:1905788,1,0.995003072987144,0,1,negative regulation of detection of mechanical stimulus involved in sensory perception of touch,BP,
21043,GO:1905793,1,0.970286151169544,0,2,protein localization to pericentriolar material,BP,
21044,GO:1905794,1,0.981291951321174,0,1,response to puromycin,BP,
21045,GO:1905795,1,0.981291951321174,0,1,cellular response to puromycin,BP,
21046,GO:1905799,1,0.990582219110237,0,1,regulation of intraciliary retrograde transport,BP,
21047,GO:1905802,1,0.994739690112676,0,1,regulation of cellular response to manganese ion,BP,
21048,GO:1905809,1,0.826277359028885,0,24,negative regulation of synapse organization,BP,
21049,GO:1905818,1,0.652427524277165,0,62,regulation of chromosome separation,BP,
21050,GO:1905819,1,0.780340208316361,0,37,negative regulation of chromosome separation,BP,
21051,GO:1905820,1,0.900126946142776,0,15,positive regulation of chromosome separation,BP,
21052,GO:1905828,1,0.994908837555436,0,1,regulation of prostaglandin catabolic process,BP,
21053,GO:1905832,1,0.945330379761522,0,5,positive regulation of spindle assembly,BP,
21054,GO:1905834,1,0.996333364855147,0,1,response to pyrimidine ribonucleotide,BP,
21055,GO:1905835,1,0.996333364855147,0,1,cellular response to pyrimidine ribonucleotide,BP,
21056,GO:1905838,1,0.989267037860324,0,2,regulation of telomeric D-loop disassembly,BP,
21057,GO:1905839,1,0.989267037860324,0,2,negative regulation of telomeric D-loop disassembly,BP,
21058,GO:1905843,1,0.979656742011984,0,1,regulation of cellular response to gamma radiation,BP,
21059,GO:1905853,1,0.996730590415193,0,1,regulation of heparan sulfate binding,BP,
21060,GO:1905855,1,0.996730590415193,0,1,positive regulation of heparan sulfate binding,BP,
21061,GO:1905856,1,0.995205096394078,0,1,negative regulation of pentose-phosphate shunt,BP,
21062,GO:1905858,1,0.996730590415193,0,1,regulation of heparan sulfate proteoglycan binding,BP,
21063,GO:1905860,1,0.996730590415193,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
21065,GO:1905867,1,0.978880153676428,0,5,epididymis development,BP,
21066,GO:1905868,1,0.986517565105268,0,3,regulation of 3'-UTR-mediated mRNA stabilization,BP,
21067,GO:1905869,1,0.994890876864838,0,1,negative regulation of 3'-UTR-mediated mRNA stabilization,BP,
21068,GO:1905870,1,0.991584118677969,0,2,positive regulation of 3'-UTR-mediated mRNA stabilization,BP,
21069,GO:1905874,1,0.881411419356303,0,16,regulation of postsynaptic density organization,BP,
21070,GO:1905875,1,0.99459154262944,0,1,negative regulation of postsynaptic density organization,BP,
21071,GO:1905878,1,0.981820409500764,0,1,invadopodium disassembly,BP,
21072,GO:1905879,1,0.926076671215064,0,11,regulation of oogenesis,BP,
21073,GO:1905880,1,0.971293284787289,0,4,negative regulation of oogenesis,BP,
21074,GO:1905881,1,0.962743364863049,0,5,positive regulation of oogenesis,BP,
21075,GO:1905883,1,0.995658099904583,0,1,regulation of triglyceride transport,BP,
21076,GO:1905885,1,0.995658099904583,0,1,positive regulation of triglyceride transport,BP,
21077,GO:1905890,1,0.996730590415193,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
21078,GO:1905891,1,0.994750742217943,0,1,regulation of cellular response to thapsigargin,BP,
21079,GO:1905892,1,0.994750742217943,0,1,negative regulation of cellular response to thapsigargin,BP,
21080,GO:1905894,1,0.994750742217943,0,1,regulation of cellular response to tunicamycin,BP,
21081,GO:1905895,1,0.994750742217943,0,1,negative regulation of cellular response to tunicamycin,BP,
21082,GO:1905897,1,0.596504177565264,0,86,regulation of response to endoplasmic reticulum stress,BP,
21083,GO:1905898,1,0.802458964299533,0,36,positive regulation of response to endoplasmic reticulum stress,BP,
21084,GO:1905899,1,0.996493899157185,0,1,regulation of smooth muscle tissue development,BP,
21085,GO:1905900,1,0.996493899157185,0,1,negative regulation of smooth muscle tissue development,BP,
21086,GO:1905901,1,0.996493899157185,0,1,positive regulation of smooth muscle tissue development,BP,
21087,GO:1905902,1,0.966196641824275,0,6,regulation of mesoderm formation,BP,
21088,GO:1905903,1,0.989151522073451,0,3,negative regulation of mesoderm formation,BP,
21089,GO:1905904,1,0.994217100594094,0,1,positive regulation of mesoderm formation,BP,
21090,GO:1905906,1,0.956758777928038,0,7,regulation of amyloid fibril formation,BP,
21091,GO:1905907,1,0.978403707620709,0,4,negative regulation of amyloid fibril formation,BP,
21092,GO:1905908,1,0.973595448516449,0,4,positive regulation of amyloid fibril formation,BP,
21093,GO:1905912,1,0.991573778047096,0,2,regulation of calcium ion export across plasma membrane,BP,
21094,GO:1905913,1,0.996247772913155,0,1,negative regulation of calcium ion export across plasma membrane,BP,
21095,GO:1905915,1,0.977927536606342,0,3,regulation of cell differentiation involved in phenotypic switching,BP,
21096,GO:1905916,1,0.98107773265087,0,2,negative regulation of cell differentiation involved in phenotypic switching,BP,
21097,GO:1905917,1,0.99678965917787,0,1,positive regulation of cell differentiation involved in phenotypic switching,BP,
21098,GO:1905918,1,0.992735846171972,0,2,regulation of CoA-transferase activity,BP,
21099,GO:1905920,1,0.992735846171972,0,2,positive regulation of CoA-transferase activity,BP,
21100,GO:1905927,1,0.981820409500764,0,1,regulation of invadopodium disassembly,BP,
21101,GO:1905929,1,0.981820409500764,0,1,positive regulation of invadopodium disassembly,BP,
21102,GO:1905930,1,0.977927536606342,0,3,regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21103,GO:1905931,1,0.98107773265087,0,2,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21104,GO:1905932,1,0.99678965917787,0,1,positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,BP,
21105,GO:1905933,1,0.99658144568182,0,1,regulation of cell fate determination,BP,
21106,GO:1905934,1,0.99658144568182,0,1,negative regulation of cell fate determination,BP,
21107,GO:1905936,1,0.985057232503982,0,4,regulation of germ cell proliferation,BP,
21108,GO:1905937,1,0.988216119339884,0,3,negative regulation of germ cell proliferation,BP,
21109,GO:1905938,1,0.996803825683795,0,1,positive regulation of germ cell proliferation,BP,
21110,GO:1905939,1,0.887328230066789,0,19,regulation of gonad development,BP,
21111,GO:1905940,1,0.971041941942716,0,5,negative regulation of gonad development,BP,
21112,GO:1905941,1,0.935549189466906,0,11,positive regulation of gonad development,BP,
21114,GO:1905953,1,0.754635756518655,0,36,negative regulation of lipid localization,BP,
21116,GO:1905956,1,0.986666593001468,0,2,positive regulation of endothelial tube morphogenesis,BP,
21117,GO:1905957,1,0.991699152780688,0,1,regulation of cellular response to alcohol,BP,
21118,GO:1905959,1,0.991699152780688,0,1,positive regulation of cellular response to alcohol,BP,
21119,GO:1905961,1,0.954359087597342,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
21120,GO:1905962,1,0.973458912499256,0,5,glutamatergic neuron differentiation,BP,
21121,GO:1990000,1,0.901808954164468,0,17,amyloid fibril formation,BP,
21122,GO:1990001,1,0.959819110388579,0,6,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
21123,GO:1990005,1,0.991286391313463,0,2,granular vesicle,CC,
21124,GO:1990008,1,0.996377189990659,0,1,neurosecretory vesicle,CC,
21125,GO:1990009,1,0.965176807803738,0,4,retinal cell apoptotic process,BP,
21126,GO:1990015,1,0.995498140649407,0,1,ensheathing process,CC,
21127,GO:1990023,1,0.889239264208966,0,13,mitotic spindle midzone,CC,
21128,GO:1990026,1,0.983840101108033,0,2,hippocampal mossy fiber expansion,CC,
21129,GO:1990030,1,0.988043246212772,0,2,pericellular basket,CC,
21130,GO:1990031,1,0.994149132004111,0,1,pinceau fiber,CC,
21131,GO:1990032,1,0.991437177263627,0,1,parallel fiber,CC,
21133,GO:1990036,1,0.968723555100947,0,4,calcium ion import into sarcoplasmic reticulum,BP,
21134,GO:1990037,1,0.988376829506268,0,3,Lewy body core,CC,
21135,GO:1990038,1,0.996118816604654,0,1,Lewy body corona,CC,
21136,GO:1990044,1,0.996466133993314,0,1,protein localization to lipid droplet,BP,
21137,GO:1990046,1,0.996683238342371,0,1,stress-induced mitochondrial fusion,BP,
21138,GO:1990047,1,0.995693442875574,0,1,spindle matrix,CC,
21139,GO:1990048,1,0.920956046197306,0,7,anterograde neuronal dense core vesicle transport,BP,
21140,GO:1990049,1,0.934351336289402,0,5,retrograde neuronal dense core vesicle transport,BP,
21141,GO:1990050,1,0.985825084549448,0,4,phosphatidic acid transfer activity,MF,
21142,GO:1990051,1,0.970988110659283,0,5,activation of protein kinase C activity,BP,
21143,GO:1990070,1,0.996854652375195,0,1,TRAPPI protein complex,CC,
21144,GO:1990071,1,0.983609586376635,0,2,TRAPPII protein complex,CC,
21145,GO:1990072,1,0.991761438477193,0,2,TRAPPIII protein complex,CC,
21146,GO:1990074,1,0.993427023035375,0,1,polyuridylation-dependent mRNA catabolic process,BP,
21147,GO:1990075,1,0.957914801361568,0,4,periciliary membrane compartment,CC,
21148,GO:1990079,1,0.975892115108895,0,3,cartilage homeostasis,BP,
21149,GO:1990086,1,0.971752885841844,0,4,lens fiber cell apoptotic process,BP,
21152,GO:1990092,1,0.993980977862161,0,1,calcium-dependent self proteolysis,BP,
21153,GO:1990108,1,0.971207214884549,0,3,protein linear deubiquitination,BP,
21154,GO:1990111,1,0.976830375569472,0,4,spermatoproteasome complex,CC,
21155,GO:1990112,1,0.989807596705769,0,2,RQC complex,CC,
21156,GO:1990114,1,0.996435444406599,0,1,RNA polymerase II core complex assembly,BP,
21157,GO:1990116,1,0.989807596705769,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
21158,GO:1990117,1,0.996846220865447,0,1,B cell receptor apoptotic signaling pathway,BP,
21159,GO:1990120,1,0.97243965865748,0,3,messenger ribonucleoprotein complex assembly,BP,
21160,GO:1990124,1,0.922712510913795,0,10,messenger ribonucleoprotein complex,CC,
21161,GO:1990126,1,0.847961345233114,0,22,retrograde transport, endosome to plasma membrane,BP,
21162,GO:1990127,1,0.992023580098037,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
21163,GO:1990130,1,0.971856950675921,0,5,GATOR1 complex,CC,
21164,GO:1990131,1,0.979592985748045,0,4,Gtr1-Gtr2 GTPase complex,CC,
21165,GO:1990134,1,0.99034829723333,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
21166,GO:1990136,1,0.995333222277823,0,1,linoleate 9S-lipoxygenase activity,MF,
21168,GO:1990144,1,0.965809192558723,0,7,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
21169,GO:1990145,1,0.9877959269155,0,2,maintenance of translational fidelity,BP,
21170,GO:1990147,1,0.993854213022379,0,1,talin binding,MF,
21171,GO:1990164,1,0.978979858676773,0,4,histone H2A phosphorylation,BP,
21172,GO:1990165,1,0.996043526239926,0,1,single-strand break-containing DNA binding,MF,
21173,GO:1990166,1,0.995571559405562,0,1,protein localization to site of double-strand break,BP,
21174,GO:1990167,1,0.975769953526574,0,2,protein K27-linked deubiquitination,BP,
21175,GO:1990168,1,0.970405983621296,0,3,protein K33-linked deubiquitination,BP,
21176,GO:1990169,1,0.953779984916475,0,11,stress response to copper ion,BP,
21177,GO:1990170,1,0.996050916927848,0,1,stress response to cadmium ion,BP,
21178,GO:1990172,1,0.988758442437801,0,1,G protein-coupled receptor catabolic process,BP,
21179,GO:1990173,1,0.938577846939985,0,13,protein localization to nucleoplasm,BP,
21180,GO:1990174,1,0.981281276307931,0,2,phosphodiesterase decapping endonuclease activity,MF,
21181,GO:1990175,1,0.992567061759164,0,1,EH domain binding,MF,
21182,GO:1990180,1,0.987453419399103,0,3,mitochondrial tRNA 3'-end processing,BP,
21183,GO:1990182,1,0.911748197149755,0,17,exosomal secretion,BP,
21184,GO:1990183,1,0.996837536280683,0,1,lymphatic vascular process in circulatory system,BP,
21185,GO:1990184,1,0.987068075205843,0,2,amino acid transport complex,CC,
21186,GO:1990186,1,0.996837536280683,0,1,regulation of lymphatic vessel size,BP,
21187,GO:1990188,1,0.995142993126639,0,1,euchromatin binding,MF,
21188,GO:1990189,1,0.987216413440519,0,3,peptide-serine-N-acetyltransferase activity,MF,
21189,GO:1990190,1,0.993380246549876,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
21190,GO:1990192,1,0.996837536280683,0,1,collecting lymphatic vessel constriction,BP,
21191,GO:1990204,1,0.641821466781861,0,94,oxidoreductase complex,CC,
21192,GO:1990221,1,0.982989122909457,0,2,L-cysteine desulfurase complex,CC,
21193,GO:1990226,1,0.963239086819175,0,7,histone methyltransferase binding,MF,
21195,GO:1990238,1,0.987462136410912,0,1,double-stranded DNA endodeoxyribonuclease activity,MF,
21197,GO:1990246,1,0.97471152325918,0,5,uniplex complex,CC,
21198,GO:1990247,1,0.943372541660887,0,7,N6-methyladenosine-containing RNA binding,MF,
21199,GO:1990248,1,0.995205096394078,0,1,regulation of transcription from RNA polymerase II promoter in response to DNA damage,BP,
21200,GO:1990253,1,0.938375199479002,0,8,cellular response to leucine starvation,BP,
21202,GO:1990256,1,0.978510557302048,0,1,signal clustering,BP,
21203,GO:1990258,1,0.974446335023918,0,3,histone glutamine methylation,BP,
21204,GO:1990259,1,0.996734910369831,0,1,histone-glutamine methyltransferase activity,MF,
21205,GO:1990261,1,0.994890876864838,0,1,pre-mRNA catabolic process,BP,
21206,GO:1990262,1,0.994930315715295,0,1,anti-Mullerian hormone signaling pathway,BP,
21208,GO:1990266,1,0.598623757108589,0,98,neutrophil migration,BP,
21209,GO:1990267,1,0.989954624387469,0,2,response to transition metal nanoparticle,BP,
21210,GO:1990268,1,0.994026971364893,0,1,response to gold nanoparticle,BP,
21211,GO:1990269,1,0.976220212640925,0,4,RNA polymerase II C-terminal domain phosphoserine binding,MF,
21212,GO:1990275,1,0.994677644522158,0,1,preribosome binding,MF,
21213,GO:1990276,1,0.994933887431066,0,1,RNA 5'-methyltransferase activity,MF,
21214,GO:1990280,1,0.987001921477036,0,1,RNA localization to chromatin,BP,
21215,GO:1990298,1,0.99587181159592,0,1,bub1-bub3 complex,CC,
21216,GO:1990314,1,0.932250835665086,0,7,cellular response to insulin-like growth factor stimulus,BP,
21217,GO:1990316,1,0.929994144832947,0,8,Atg1/ULK1 kinase complex,CC,
21218,GO:1990332,1,0.99237862664342,0,1,Ire1 complex,CC,
21219,GO:1990349,1,0.977905588812722,0,4,gap junction-mediated intercellular transport,BP,
21221,GO:1990356,1,0.996720374049634,0,1,sumoylated E2 ligase complex,CC,
21222,GO:1990357,1,0.975709636882452,0,4,terminal web,CC,
21223,GO:1990379,1,0.973589967341691,0,6,lipid transport across blood-brain barrier,BP,
21224,GO:1990380,1,0.889428872423092,0,10,Lys48-specific deubiquitinase activity,MF,
21225,GO:1990381,1,0.899024891441135,0,17,ubiquitin-specific protease binding,MF,
21226,GO:1990384,1,0.960193248790525,0,7,hyaloid vascular plexus regression,BP,
21227,GO:1990385,1,0.992108336716213,0,1,meiotic spindle midzone,CC,
21228,GO:1990386,1,0.996095731408362,0,1,mitotic cleavage furrow ingression,BP,
21229,GO:1990390,1,0.993525877168439,0,1,protein K33-linked ubiquitination,BP,
21230,GO:1990391,1,0.773366816539718,0,33,DNA repair complex,CC,
21231,GO:1990393,1,0.959668288155634,0,5,3M complex,CC,
21232,GO:1990399,1,0.995748440757121,0,1,epithelium regeneration,BP,
21233,GO:1990401,1,0.990306952409103,0,2,embryonic lung development,BP,
21234,GO:1990402,1,0.992503947434499,0,2,embryonic liver development,BP,
21235,GO:1990403,1,0.923504376955876,0,12,embryonic brain development,BP,
21236,GO:1990404,1,0.881134739015077,0,16,protein ADP-ribosylase activity,MF,
21237,GO:1990405,1,0.941558805936193,0,7,protein antigen binding,MF,
21238,GO:1990406,1,0.987271384998396,0,2,CGRP receptor complex,CC,
21239,GO:1990407,1,0.996824196122221,0,1,calcitonin gene-related peptide binding,MF,
21240,GO:1990408,1,0.987271384998396,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
21241,GO:1990409,1,0.987298741444684,0,2,adrenomedullin binding,MF,
21243,GO:1990414,1,0.946558089819909,0,8,replication-born double-strand break repair via sister chromatid exchange,BP,
21244,GO:1990415,1,0.982678882663037,0,3,Pex17p-Pex14p docking complex,CC,
21246,GO:1990418,1,0.985763242245131,0,3,response to insulin-like growth factor stimulus,BP,
21247,GO:1990422,1,0.996816752933256,0,1,glyoxalase (glycolic acid-forming) activity,MF,
21248,GO:1990423,1,0.97548554724463,0,3,RZZ complex,CC,
21249,GO:1990425,1,0.95665079651739,0,3,ryanodine receptor complex,CC,
21250,GO:1990426,1,0.97501213615957,0,2,mitotic recombination-dependent replication fork processing,BP,
21251,GO:1990427,1,0.985995144371306,0,1,stereocilia tip-link density,CC,
21252,GO:1990428,1,0.980778870947196,0,3,miRNA transport,BP,
21253,GO:1990429,1,0.982678882663037,0,3,peroxisomal importomer complex,CC,
21254,GO:1990430,1,0.958077296171007,0,5,extracellular matrix protein binding,MF,
21255,GO:1990435,1,0.985995144371306,0,1,upper tip-link density,CC,
21256,GO:1990437,1,0.995766980849258,0,1,snRNA 2'-O-methylation,BP,
21257,GO:1990438,1,0.995766980849258,0,1,U6 2'-O-snRNA methylation,BP,
21258,GO:1990439,1,0.994561357497746,0,1,MAP kinase serine/threonine phosphatase activity,MF,
21259,GO:1990440,1,0.946592860520587,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21260,GO:1990441,1,0.980134032163227,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21261,GO:1990442,1,0.99019030144698,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21263,GO:1990444,1,0.986547606953665,0,2,F-box domain binding,MF,
21264,GO:1990446,1,0.983173283445652,0,5,U1 snRNP binding,MF,
21265,GO:1990447,1,0.996769112977544,0,1,U2 snRNP binding,MF,
21266,GO:1990448,1,0.987379552000506,0,1,exon-exon junction complex binding,MF,
21267,GO:1990452,1,0.987027002037383,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21268,GO:1990454,1,0.90457470833208,0,12,L-type voltage-gated calcium channel complex,CC,
21269,GO:1990456,1,0.976475320596994,0,3,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21270,GO:1990459,1,0.945027714506902,0,9,transferrin receptor binding,MF,
21271,GO:1990460,1,0.969940878310146,0,4,leptin receptor binding,MF,
21272,GO:1990462,1,0.987124271348334,0,2,omegasome,CC,
21273,GO:1990467,1,0.995876551390518,0,1,NuA3a histone acetyltransferase complex,CC,
21274,GO:1990468,1,0.995876551390518,0,1,NuA3b histone acetyltransferase complex,CC,
21275,GO:1990478,1,0.99247824242257,0,2,response to ultrasound,BP,
21276,GO:1990481,1,0.975249611134358,0,5,mRNA pseudouridine synthesis,BP,
21277,GO:1990498,1,0.966091922802794,0,3,mitotic spindle microtubule,CC,
21278,GO:1990502,1,0.973069334225089,0,3,dense core granule maturation,BP,
21279,GO:1990504,1,0.904167562717444,0,9,dense core granule exocytosis,BP,
21280,GO:1990505,1,0.97501213615957,0,2,mitotic DNA replication maintenance of fidelity,BP,
21281,GO:1990511,1,0.973145162850006,0,4,piRNA biosynthetic process,BP,
21282,GO:1990513,1,0.981332008050654,0,2,CLOCK-BMAL transcription complex,CC,
21283,GO:1990518,1,0.978942112304451,0,3,single-stranded 3'-5' DNA helicase activity,MF,
21284,GO:1990519,1,0.987692384182257,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21286,GO:1990529,1,0.991773852818654,0,1,glycosylphosphatidylinositol-mannosyltransferase I complex,CC,
21288,GO:1990539,1,0.995632785523235,0,1,fructose import across plasma membrane,BP,
21289,GO:1990540,1,0.994001994752578,0,1,mitochondrial manganese ion transmembrane transport,BP,
21290,GO:1990542,1,0.671085304207957,0,73,mitochondrial transmembrane transport,BP,
21291,GO:1990546,1,0.9964709803441,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21292,GO:1990548,1,0.994413513860184,0,1,mitochondrial FAD transmembrane transport,BP,
21293,GO:1990564,1,0.978273464563793,0,5,protein polyufmylation,BP,
21294,GO:1990565,1,0.991706861577481,0,2,HSP90-CDC37 chaperone complex,CC,
21295,GO:1990569,1,0.963088773335378,0,5,UDP-N-acetylglucosamine transmembrane transport,BP,
21296,GO:1990572,1,0.992411688368383,0,1,TERT-RMRP complex,CC,
21298,GO:1990575,1,0.984622800587175,0,3,mitochondrial L-ornithine transmembrane transport,BP,
21299,GO:1990578,1,0.984357945174428,0,2,perinuclear endoplasmic reticulum membrane,CC,
21300,GO:1990579,1,0.99237862664342,0,1,peptidyl-serine trans-autophosphorylation,BP,
21301,GO:1990583,1,0.996095731408362,0,1,phospholipase D activator activity,MF,
21302,GO:1990584,1,0.99048386994292,0,3,cardiac Troponin complex,CC,
21303,GO:1990589,1,0.978308758143097,0,2,ATF4-CREB1 transcription factor complex,CC,
21304,GO:1990590,1,0.99183778501652,0,2,ATF1-ATF4 transcription factor complex,CC,
21305,GO:1990592,1,0.978273464563793,0,5,protein K69-linked ufmylation,BP,
21306,GO:1990597,1,0.983880417819839,0,2,AIP1-IRE1 complex,CC,
21307,GO:1990599,1,0.977032388095396,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21308,GO:1990604,1,0.97822190704144,0,3,IRE1-TRAF2-ASK1 complex,CC,
21309,GO:1990613,1,0.993412577489935,0,1,mitochondrial membrane fusion,BP,
21310,GO:1990617,1,0.993206956772591,0,2,CHOP-ATF4 complex,CC,
21311,GO:1990619,1,0.989216660857588,0,2,histone H3-K9 deacetylation,BP,
21312,GO:1990622,1,0.99284957939431,0,2,CHOP-ATF3 complex,CC,
21313,GO:1990630,1,0.99237862664342,0,1,IRE1-RACK1-PP2A complex,CC,
21314,GO:1990635,1,0.952676253313691,0,6,proximal dendrite,CC,
21315,GO:1990637,1,0.976888744724376,0,3,response to prolactin,BP,
21316,GO:1990641,1,0.984563617494188,0,3,response to iron ion starvation,BP,
21317,GO:1990646,1,0.994442333353931,0,1,cellular response to prolactin,BP,
21318,GO:1990654,1,0.99058319286858,0,1,sebum secreting cell proliferation,BP,
21320,GO:1990666,1,0.983129652076619,0,2,PCSK9-LDLR complex,CC,
21322,GO:1990668,1,0.973430187460848,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21323,GO:1990678,1,0.991921801369169,0,1,histone H4-K16 deacetylation,BP,
21324,GO:1990682,1,0.9879145242678,0,2,CSF1-CSF1R complex,CC,
21325,GO:1990696,1,0.973368928634252,0,2,USH2 complex,CC,
21326,GO:1990697,1,0.995776905208867,0,1,protein depalmitoleylation,BP,
21327,GO:1990698,1,0.988847888403212,0,2,palmitoleoyltransferase activity,MF,
21328,GO:1990699,1,0.995776905208867,0,1,palmitoleyl hydrolase activity,MF,
21329,GO:1990700,1,0.992540089353925,0,1,nucleolar chromatin organization,BP,
21330,GO:1990705,1,0.959667003803789,0,3,cholangiocyte proliferation,BP,
21331,GO:1990707,1,0.979581872132667,0,1,nuclear subtelomeric heterochromatin,CC,
21332,GO:1990708,1,0.99391471508194,0,1,conditioned place preference,BP,
21333,GO:1990709,1,0.891691220810405,0,8,presynaptic active zone organization,BP,
21334,GO:1990712,1,0.955904347153476,0,7,HFE-transferrin receptor complex,CC,
21335,GO:1990715,1,0.983887173632094,0,3,mRNA CDS binding,MF,
21336,GO:1990716,1,0.965050648214769,0,3,axonemal central apparatus,CC,
21337,GO:1990718,1,0.981940281685655,0,1,axonemal central pair projection,CC,
21338,GO:1990723,1,0.97317612118202,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21339,GO:1990726,1,0.983132746382745,0,5,Lsm1-7-Pat1 complex,CC,
21340,GO:1990729,1,0.996117054016947,0,1,primary miRNA modification,BP,
21341,GO:1990730,1,0.986094529649058,0,2,VCP-NSFL1C complex,CC,
21342,GO:1990731,1,0.993218002781279,0,1,UV-damage excision repair, DNA incision,BP,
21343,GO:1990736,1,0.992273485426941,0,1,regulation of vascular associated smooth muscle cell membrane depolarization,BP,
21344,GO:1990737,1,0.979677162958571,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21345,GO:1990739,1,0.983542179762854,0,1,granulosa cell proliferation,BP,
21346,GO:1990742,1,0.980176277958446,0,3,microvesicle,CC,
21348,GO:1990744,1,0.996117054016947,0,1,primary miRNA methylation,BP,
21349,GO:1990745,1,0.977169054914219,0,3,EARP complex,CC,
21350,GO:1990748,1,0.611867691086657,0,98,cellular detoxification,BP,
21351,GO:1990751,1,0.986284783625989,0,1,Schwann cell chemotaxis,BP,
21352,GO:1990752,1,0.71865327003721,0,32,microtubule end,CC,
21353,GO:1990755,1,0.994890876864838,0,1,mitotic spindle microtubule depolymerization,BP,
21354,GO:1990756,1,0.933281752909953,0,14,ubiquitin ligase-substrate adaptor activity,MF,
21355,GO:1990757,1,0.978490229940145,0,3,ubiquitin ligase activator activity,MF,
21356,GO:1990758,1,0.996257248463426,0,1,mitotic sister chromatid biorientation,BP,
21357,GO:1990760,1,0.975316740285312,0,3,osmolarity-sensing cation channel activity,MF,
21358,GO:1990761,1,0.970175253861461,0,3,growth cone lamellipodium,CC,
21359,GO:1990763,1,0.941810416053637,0,9,arrestin family protein binding,MF,
21361,GO:1990765,1,0.990069666968894,0,1,colon smooth muscle contraction,BP,
21362,GO:1990768,1,0.992274843108485,0,2,gastric mucosal blood circulation,BP,
21363,GO:1990769,1,0.975554623503456,0,4,proximal neuron projection,CC,
21364,GO:1990770,1,0.986964486356191,0,2,small intestine smooth muscle contraction,BP,
21365,GO:1990771,1,0.9883458450248,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21366,GO:1990773,1,0.962391258937868,0,5,matrix metallopeptidase secretion,BP,
21367,GO:1990774,1,0.983079931968493,0,3,tumor necrosis factor secretion,BP,
21368,GO:1990775,1,0.996649345953502,0,1,endothelin production,BP,
21370,GO:1990777,1,0.842641274997923,0,30,lipoprotein particle,CC,
21372,GO:1990780,1,0.992316731529853,0,1,cytoplasmic side of dendritic spine plasma membrane,CC,
21373,GO:1990782,1,0.512259577778056,0,93,protein tyrosine kinase binding,MF,
21374,GO:1990784,1,0.98727314258481,0,2,response to dsDNA,BP,
21375,GO:1990785,1,0.963370080657712,0,4,response to water-immersion restraint stress,BP,
21376,GO:1990786,1,0.98727314258481,0,2,cellular response to dsDNA,BP,
21377,GO:1990787,1,0.985857088508849,0,1,negative regulation of hh target transcription factor activity,BP,
21378,GO:1990791,1,0.9572302831713,0,7,dorsal root ganglion development,BP,
21379,GO:1990798,1,0.9968460138118,0,1,pancreas regeneration,BP,
21380,GO:1990809,1,0.981051633594666,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21381,GO:1990811,1,0.994890876864838,0,1,MWP complex,CC,
21382,GO:1990812,1,0.971071399154418,0,4,growth cone filopodium,CC,
21384,GO:1990817,1,0.995699287977245,0,1,RNA adenylyltransferase activity,MF,
21385,GO:1990822,1,0.924649396016448,0,11,basic amino acid transmembrane transport,BP,
21387,GO:1990825,1,0.944686894823191,0,10,sequence-specific mRNA binding,MF,
21388,GO:1990828,1,0.995865701740864,0,1,hepatocyte dedifferentiation,BP,
21389,GO:1990829,1,0.990282735447318,0,2,C-rich single-stranded DNA binding,MF,
21391,GO:1990832,1,0.996027396070592,0,1,slow axonal transport,BP,
21392,GO:1990833,1,0.996027396070592,0,1,clathrin-uncoating ATPase activity,MF,
21393,GO:1990834,1,0.978853253336093,0,4,response to odorant,BP,
21394,GO:1990836,1,0.992265255831832,0,1,lysosomal matrix,CC,
21396,GO:1990838,1,0.994890876864838,0,1,poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends,MF,
21397,GO:1990839,1,0.987527926503745,0,2,response to endothelin,BP,
21398,GO:1990841,1,0.6512631824449,0,55,promoter-specific chromatin binding,MF,
21399,GO:1990843,1,0.987922847387118,0,1,subsarcolemmal mitochondrion,CC,
21400,GO:1990844,1,0.987922847387118,0,1,interfibrillar mitochondrion,CC,
21402,GO:1990851,1,0.965910079327931,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21403,GO:1990859,1,0.995652164326348,0,1,cellular response to endothelin,BP,
21404,GO:1990863,1,0.9968460138118,0,1,acinar cell proliferation,BP,
21405,GO:1990864,1,0.9968460138118,0,1,response to growth hormone-releasing hormone,BP,
21406,GO:1990867,1,0.9968460138118,0,1,response to gastrin,BP,
21409,GO:1990874,1,0.703829840244731,0,50,vascular associated smooth muscle cell proliferation,BP,
21410,GO:1990876,1,0.987359380614091,0,1,cytoplasmic side of nuclear pore,CC,
21411,GO:1990878,1,0.9968460138118,0,1,cellular response to gastrin,BP,
21412,GO:1990879,1,0.989807596705769,0,2,CST complex,CC,
21413,GO:1990882,1,0.992516242171655,0,1,rRNA acetylation,BP,
21414,GO:1990883,1,0.992516242171655,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21415,GO:1990884,1,0.992516242171655,0,1,RNA acetylation,BP,
21416,GO:1990889,1,0.989996537470348,0,2,H4K20me3 modified histone binding,MF,
21417,GO:1990890,1,0.982865875178136,0,2,netrin receptor binding,MF,
21419,GO:1990907,1,0.905852889407843,0,11,beta-catenin-TCF complex,CC,
21420,GO:1990909,1,0.889233715307774,0,11,Wnt signalosome,CC,
21421,GO:1990910,1,0.978827612751494,0,4,response to hypobaric hypoxia,BP,
21422,GO:1990911,1,0.980427175497419,0,4,response to psychosocial stress,BP,
21423,GO:1990913,1,0.979810492062823,0,4,sperm head plasma membrane,CC,
21424,GO:1990917,1,0.995278800867257,0,1,ooplasm,CC,
21425,GO:1990918,1,0.969600542560808,0,4,double-strand break repair involved in meiotic recombination,BP,
21426,GO:1990922,1,0.993828933588208,0,1,hepatic stellate cell proliferation,BP,
21427,GO:1990923,1,0.983885771348633,0,3,PET complex,CC,
21428,GO:1990926,1,0.981264751107208,0,3,short-term synaptic potentiation,BP,
21429,GO:1990927,1,0.981375431054691,0,2,calcium ion regulated lysosome exocytosis,BP,
21430,GO:1990928,1,0.759476001129178,0,45,response to amino acid starvation,BP,
21431,GO:1990930,1,0.996493899157185,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21432,GO:1990931,1,0.985478075274793,0,2,RNA N6-methyladenosine dioxygenase activity,MF,
21433,GO:1990935,1,0.988826446807995,0,3,splicing factor binding,MF,
21434,GO:1990936,1,0.990939049153259,0,2,vascular associated smooth muscle cell dedifferentiation,BP,
21435,GO:1990938,1,0.99241375583027,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21436,GO:1990939,1,0.591944419222709,0,34,ATP-dependent microtubule motor activity,MF,
21437,GO:1990948,1,0.983366347213744,0,5,ubiquitin ligase inhibitor activity,MF,
21438,GO:1990949,1,0.996191385767568,0,1,metaphase/anaphase transition of meiosis I,BP,
21439,GO:1990955,1,0.992228253223494,0,1,G-rich single-stranded DNA binding,MF,
21440,GO:1990959,1,0.993149485559078,0,1,eosinophil homeostasis,BP,
21441,GO:1990960,1,0.993149485559078,0,1,basophil homeostasis,BP,
21442,GO:1990961,1,0.951932945608343,0,8,xenobiotic detoxification by transmembrane export across the plasma membrane,BP,
21443,GO:1990962,1,0.964487486233485,0,5,xenobiotic transport across blood-brain barrier,BP,
21444,GO:1990963,1,0.996063768114654,0,1,establishment of blood-retinal barrier,BP,
21445,GO:1990966,1,0.974146193888208,0,4,ATP generation from poly-ADP-D-ribose,BP,
21446,GO:1990968,1,0.987682873551452,0,1,modulation by host of RNA binding by virus,BP,
21447,GO:1990969,1,0.987682873551452,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21448,GO:1990971,1,0.992562911187317,0,1,EMILIN complex,CC,
21449,GO:1990983,1,0.995210162392753,0,1,tRNA demethylation,BP,
21450,GO:1990984,1,0.987069336780103,0,2,tRNA demethylase activity,MF,
21451,GO:2000001,1,0.914809529074597,0,16,regulation of DNA damage checkpoint,BP,
21452,GO:2000002,1,0.973860025718148,0,5,negative regulation of DNA damage checkpoint,BP,
21453,GO:2000003,1,0.994890876864838,0,1,positive regulation of DNA damage checkpoint,BP,
21454,GO:2000004,1,0.996309331932209,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21455,GO:2000005,1,0.996309331932209,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21456,GO:2000006,1,0.996309331932209,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21457,GO:2000007,1,0.996309331932209,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21458,GO:2000008,1,0.74426197520009,0,39,regulation of protein localization to cell surface,BP,
21459,GO:2000009,1,0.914580152307227,0,13,negative regulation of protein localization to cell surface,BP,
21460,GO:2000010,1,0.87393093878676,0,17,positive regulation of protein localization to cell surface,BP,
21461,GO:2000011,1,0.995802234615765,0,1,regulation of adaxial/abaxial pattern formation,BP,
21462,GO:2000015,1,0.981327183642185,0,4,regulation of determination of dorsal identity,BP,
21463,GO:2000016,1,0.993060626448904,0,2,negative regulation of determination of dorsal identity,BP,
21464,GO:2000017,1,0.988185385934877,0,2,positive regulation of determination of dorsal identity,BP,
21465,GO:2000018,1,0.941953300086786,0,9,regulation of male gonad development,BP,
21466,GO:2000019,1,0.992625203655,0,1,negative regulation of male gonad development,BP,
21467,GO:2000020,1,0.948955304935664,0,8,positive regulation of male gonad development,BP,
21470,GO:2000035,1,0.937973295518519,0,10,regulation of stem cell division,BP,
21471,GO:2000036,1,0.797269245515322,0,31,regulation of stem cell population maintenance,BP,
21472,GO:2000040,1,0.987594970476753,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21473,GO:2000041,1,0.987594970476753,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21474,GO:2000042,1,0.890833913513068,0,13,negative regulation of double-strand break repair via homologous recombination,BP,
21475,GO:2000043,1,0.995595143021993,0,1,regulation of cardiac cell fate specification,BP,
21477,GO:2000047,1,0.868653393142571,0,18,regulation of cell-cell adhesion mediated by cadherin,BP,
21478,GO:2000048,1,0.933047223166705,0,9,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21479,GO:2000049,1,0.931031543546112,0,9,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21481,GO:2000051,1,0.940940886225178,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21483,GO:2000053,1,0.99147817964269,0,1,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21484,GO:2000054,1,0.99147817964269,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21485,GO:2000056,1,0.996209031132368,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21486,GO:2000057,1,0.996209031132368,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21487,GO:2000058,1,0.363351664945219,0,151,regulation of ubiquitin-dependent protein catabolic process,BP,
21488,GO:2000059,1,0.724058808013175,0,45,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21489,GO:2000060,1,0.529520528921055,0,97,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21490,GO:2000061,1,0.996493899157185,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21491,GO:2000062,1,0.996493899157185,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21492,GO:2000063,1,0.996493899157185,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21493,GO:2000064,1,0.94600087092529,0,7,regulation of cortisol biosynthetic process,BP,
21494,GO:2000065,1,0.978257912298077,0,4,negative regulation of cortisol biosynthetic process,BP,
21495,GO:2000066,1,0.992625203655,0,1,positive regulation of cortisol biosynthetic process,BP,
21496,GO:2000074,1,0.95075345756031,0,8,regulation of type B pancreatic cell development,BP,
21497,GO:2000077,1,0.982384143139647,0,2,negative regulation of type B pancreatic cell development,BP,
21498,GO:2000078,1,0.987784022311643,0,3,positive regulation of type B pancreatic cell development,BP,
21499,GO:2000079,1,0.99147817964269,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21500,GO:2000080,1,0.99147817964269,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21505,GO:2000101,1,0.994583065162764,0,1,regulation of mammary stem cell proliferation,BP,
21506,GO:2000103,1,0.994583065162764,0,1,positive regulation of mammary stem cell proliferation,BP,
21507,GO:2000104,1,0.88066326009092,0,18,negative regulation of DNA-dependent DNA replication,BP,
21508,GO:2000105,1,0.90414825994029,0,12,positive regulation of DNA-dependent DNA replication,BP,
21510,GO:2000107,1,0.770711453289876,0,43,negative regulation of leukocyte apoptotic process,BP,
21512,GO:2000109,1,0.954723269236208,0,7,regulation of macrophage apoptotic process,BP,
21513,GO:2000110,1,0.981026587941563,0,3,negative regulation of macrophage apoptotic process,BP,
21514,GO:2000111,1,0.977605021323492,0,3,positive regulation of macrophage apoptotic process,BP,
21517,GO:2000114,1,0.848099578022798,0,18,regulation of establishment of cell polarity,BP,
21520,GO:2000118,1,0.979431469414233,0,4,regulation of sodium-dependent phosphate transport,BP,
21521,GO:2000119,1,0.99451300612482,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21522,GO:2000120,1,0.992643862544632,0,2,positive regulation of sodium-dependent phosphate transport,BP,
21523,GO:2000121,1,0.947455510972441,0,11,regulation of removal of superoxide radicals,BP,
21525,GO:2000134,1,0.506713673187271,0,100,negative regulation of G1/S transition of mitotic cell cycle,BP,
21526,GO:2000136,1,0.886902250053378,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21527,GO:2000137,1,0.957552433877412,0,3,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21528,GO:2000138,1,0.963494790012812,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21529,GO:2000142,1,0.712537530263177,0,44,regulation of DNA-templated transcription, initiation,BP,
21530,GO:2000143,1,0.962203454784215,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21531,GO:2000144,1,0.752642051021285,0,36,positive regulation of DNA-templated transcription, initiation,BP,
21535,GO:2000152,1,0.975456611355403,0,5,regulation of ubiquitin-specific protease activity,BP,
21536,GO:2000155,1,0.962155029984683,0,9,positive regulation of cilium-dependent cell motility,BP,
21537,GO:2000156,1,0.987435469346,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21538,GO:2000157,1,0.9935037355992,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21539,GO:2000158,1,0.989342240639238,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21540,GO:2000167,1,0.989671862765827,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21541,GO:2000169,1,0.930218004864412,0,8,regulation of peptidyl-cysteine S-nitrosylation,BP,
21542,GO:2000170,1,0.982198489534614,0,3,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21543,GO:2000171,1,0.787915492601016,0,27,negative regulation of dendrite development,BP,
21544,GO:2000172,1,0.958799832832303,0,5,regulation of branching morphogenesis of a nerve,BP,
21545,GO:2000173,1,0.992513132617793,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21546,GO:2000174,1,0.992475836045063,0,1,regulation of pro-T cell differentiation,BP,
21547,GO:2000176,1,0.992475836045063,0,1,positive regulation of pro-T cell differentiation,BP,
21548,GO:2000177,1,0.536063428303208,0,81,regulation of neural precursor cell proliferation,BP,
21549,GO:2000178,1,0.850249101075656,0,22,negative regulation of neural precursor cell proliferation,BP,
21550,GO:2000179,1,0.696836842800567,0,47,positive regulation of neural precursor cell proliferation,BP,
21551,GO:2000180,1,0.992625203655,0,1,negative regulation of androgen biosynthetic process,BP,
21555,GO:2000191,1,0.890406964732063,0,18,regulation of fatty acid transport,BP,
21556,GO:2000192,1,0.951495086538997,0,5,negative regulation of fatty acid transport,BP,
21557,GO:2000193,1,0.935816730673535,0,13,positive regulation of fatty acid transport,BP,
21558,GO:2000194,1,0.928796889887015,0,12,regulation of female gonad development,BP,
21559,GO:2000195,1,0.978257975854309,0,4,negative regulation of female gonad development,BP,
21560,GO:2000196,1,0.985880120631434,0,3,positive regulation of female gonad development,BP,
21561,GO:2000197,1,0.942373633430496,0,7,regulation of ribonucleoprotein complex localization,BP,
21562,GO:2000199,1,0.994269993355115,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21563,GO:2000200,1,0.994269993355115,0,1,regulation of ribosomal subunit export from nucleus,BP,
21564,GO:2000202,1,0.994269993355115,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21565,GO:2000206,1,0.994269993355115,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21566,GO:2000208,1,0.994269993355115,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21567,GO:2000209,1,0.85335385742718,0,21,regulation of anoikis,BP,
21568,GO:2000210,1,0.972651872829106,0,5,positive regulation of anoikis,BP,
21569,GO:2000211,1,0.968551962620616,0,3,regulation of glutamate metabolic process,BP,
21570,GO:2000212,1,0.990343459615274,0,1,negative regulation of glutamate metabolic process,BP,
21571,GO:2000213,1,0.995877903634853,0,1,positive regulation of glutamate metabolic process,BP,
21572,GO:2000224,1,0.98617957019388,0,3,regulation of testosterone biosynthetic process,BP,
21573,GO:2000225,1,0.989436331195682,0,2,negative regulation of testosterone biosynthetic process,BP,
21574,GO:2000226,1,0.99658144568182,0,1,regulation of pancreatic A cell differentiation,BP,
21575,GO:2000227,1,0.99658144568182,0,1,negative regulation of pancreatic A cell differentiation,BP,
21576,GO:2000229,1,0.992926404044367,0,2,regulation of pancreatic stellate cell proliferation,BP,
21577,GO:2000230,1,0.996232329517488,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21578,GO:2000231,1,0.996681697515034,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21579,GO:2000232,1,0.914292621720577,0,13,regulation of rRNA processing,BP,
21580,GO:2000233,1,0.974174467796549,0,3,negative regulation of rRNA processing,BP,
21581,GO:2000234,1,0.948080657213223,0,9,positive regulation of rRNA processing,BP,
21584,GO:2000243,1,0.62446687170802,0,72,positive regulation of reproductive process,BP,
21585,GO:2000249,1,0.760773671353858,0,39,regulation of actin cytoskeleton reorganization,BP,
21586,GO:2000250,1,0.986569408379345,0,1,negative regulation of actin cytoskeleton reorganization,BP,
21587,GO:2000251,1,0.910276712261414,0,19,positive regulation of actin cytoskeleton reorganization,BP,
21588,GO:2000252,1,0.958505349693954,0,8,negative regulation of feeding behavior,BP,
21589,GO:2000253,1,0.956815117162356,0,5,positive regulation of feeding behavior,BP,
21590,GO:2000254,1,0.985057232503982,0,4,regulation of male germ cell proliferation,BP,
21591,GO:2000255,1,0.988216119339884,0,3,negative regulation of male germ cell proliferation,BP,
21592,GO:2000256,1,0.996803825683795,0,1,positive regulation of male germ cell proliferation,BP,
21593,GO:2000269,1,0.883770362472687,0,17,regulation of fibroblast apoptotic process,BP,
21594,GO:2000270,1,0.945457312375565,0,7,negative regulation of fibroblast apoptotic process,BP,
21595,GO:2000271,1,0.939825670411073,0,8,positive regulation of fibroblast apoptotic process,BP,
21597,GO:2000273,1,0.785431700715704,0,34,positive regulation of signaling receptor activity,BP,
21598,GO:2000275,1,0.984957501838495,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21599,GO:2000276,1,0.992250834761703,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21600,GO:2000277,1,0.996816752933256,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21601,GO:2000278,1,0.517428225507369,0,102,regulation of DNA biosynthetic process,BP,
21602,GO:2000279,1,0.797675136342477,0,33,negative regulation of DNA biosynthetic process,BP,
21603,GO:2000282,1,0.976570680512432,0,3,regulation of cellular amino acid biosynthetic process,BP,
21604,GO:2000283,1,0.98344653483578,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21605,GO:2000284,1,0.996816752933256,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21606,GO:2000286,1,0.983271657624451,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21607,GO:2000287,1,0.995745575899501,0,1,positive regulation of myotome development,BP,
21608,GO:2000288,1,0.944799996324123,0,9,positive regulation of myoblast proliferation,BP,
21609,GO:2000290,1,0.995745575899501,0,1,regulation of myotome development,BP,
21610,GO:2000291,1,0.913416807617776,0,14,regulation of myoblast proliferation,BP,
21611,GO:2000295,1,0.97887529264911,0,4,regulation of hydrogen peroxide catabolic process,BP,
21612,GO:2000296,1,0.993538882515264,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21613,GO:2000297,1,0.976492382100848,0,3,negative regulation of synapse maturation,BP,
21614,GO:2000298,1,0.966369814672269,0,4,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21615,GO:2000299,1,0.970719971490236,0,3,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21617,GO:2000301,1,0.976254813788597,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21619,GO:2000303,1,0.924398095172787,0,15,regulation of ceramide biosynthetic process,BP,
21620,GO:2000304,1,0.951240798678659,0,9,positive regulation of ceramide biosynthetic process,BP,
21623,GO:2000309,1,0.994169862436017,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21626,GO:2000312,1,0.975026746760017,0,3,regulation of kainate selective glutamate receptor activity,BP,
21627,GO:2000313,1,0.992633479575778,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21628,GO:2000314,1,0.996420874330746,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21629,GO:2000316,1,0.897293155590388,0,16,regulation of T-helper 17 type immune response,BP,
21630,GO:2000317,1,0.935959021993559,0,9,negative regulation of T-helper 17 type immune response,BP,
21631,GO:2000318,1,0.958715268068073,0,7,positive regulation of T-helper 17 type immune response,BP,
21632,GO:2000319,1,0.908293954627942,0,14,regulation of T-helper 17 cell differentiation,BP,
21633,GO:2000320,1,0.941670048818276,0,8,negative regulation of T-helper 17 cell differentiation,BP,
21634,GO:2000321,1,0.964577401426032,0,6,positive regulation of T-helper 17 cell differentiation,BP,
21635,GO:2000322,1,0.947464228155486,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21636,GO:2000323,1,0.957723543647601,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21637,GO:2000324,1,0.989292414449512,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21638,GO:2000325,1,0.970286084258138,0,3,regulation of nuclear receptor transcription coactivator activity,BP,
21639,GO:2000327,1,0.973690363462562,0,2,positive regulation of nuclear receptor transcription coactivator activity,BP,
21640,GO:2000328,1,0.982424829339478,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21641,GO:2000329,1,0.989468623593686,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21642,GO:2000330,1,0.992881988876081,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21643,GO:2000331,1,0.986504934825576,0,2,regulation of terminal button organization,BP,
21644,GO:2000332,1,0.992411866714491,0,2,regulation of blood microparticle formation,BP,
21645,GO:2000334,1,0.992411866714491,0,2,positive regulation of blood microparticle formation,BP,
21646,GO:2000338,1,0.984173212460535,0,3,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21647,GO:2000340,1,0.984173212460535,0,3,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21648,GO:2000341,1,0.932435493370319,0,13,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21649,GO:2000342,1,0.990183189944512,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21650,GO:2000343,1,0.953076590628514,0,9,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21651,GO:2000344,1,0.940270352671827,0,9,positive regulation of acrosome reaction,BP,
21652,GO:2000345,1,0.921401702526703,0,13,regulation of hepatocyte proliferation,BP,
21653,GO:2000346,1,0.982494451302396,0,3,negative regulation of hepatocyte proliferation,BP,
21654,GO:2000347,1,0.95166103611485,0,8,positive regulation of hepatocyte proliferation,BP,
21655,GO:2000348,1,0.964529127455231,0,6,regulation of CD40 signaling pathway,BP,
21656,GO:2000349,1,0.987644039529379,0,2,negative regulation of CD40 signaling pathway,BP,
21657,GO:2000350,1,0.996780194014668,0,1,positive regulation of CD40 signaling pathway,BP,
21660,GO:2000353,1,0.881158705731703,0,19,positive regulation of endothelial cell apoptotic process,BP,
21661,GO:2000354,1,0.968157452642378,0,6,regulation of ovarian follicle development,BP,
21662,GO:2000355,1,0.992201550546874,0,2,negative regulation of ovarian follicle development,BP,
21663,GO:2000356,1,0.996493899157185,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21664,GO:2000357,1,0.996493899157185,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21665,GO:2000358,1,0.996493899157185,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21666,GO:2000359,1,0.99237561091108,0,2,regulation of binding of sperm to zona pellucida,BP,
21667,GO:2000360,1,0.99237561091108,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21668,GO:2000361,1,0.977040181558801,0,3,regulation of prostaglandin-E synthase activity,BP,
21669,GO:2000363,1,0.977040181558801,0,3,positive regulation of prostaglandin-E synthase activity,BP,
21670,GO:2000367,1,0.985418237289823,0,3,regulation of acrosomal vesicle exocytosis,BP,
21671,GO:2000368,1,0.99277222344447,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21673,GO:2000370,1,0.957453299037966,0,5,positive regulation of clathrin-dependent endocytosis,BP,
21674,GO:2000371,1,0.961776488211823,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21675,GO:2000373,1,0.961776488211823,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21676,GO:2000374,1,0.989742226766065,0,3,regulation of oxygen metabolic process,BP,
21677,GO:2000376,1,0.993701875059186,0,2,positive regulation of oxygen metabolic process,BP,
21679,GO:2000378,1,0.731489967355452,0,50,negative regulation of reactive oxygen species metabolic process,BP,
21681,GO:2000380,1,0.899398694994897,0,16,regulation of mesoderm development,BP,
21682,GO:2000381,1,0.958519824805396,0,7,negative regulation of mesoderm development,BP,
21683,GO:2000382,1,0.964741564686542,0,5,positive regulation of mesoderm development,BP,
21684,GO:2000383,1,0.99274163979786,0,1,regulation of ectoderm development,BP,
21685,GO:2000384,1,0.99274163979786,0,1,negative regulation of ectoderm development,BP,
21686,GO:2000386,1,0.988955341581045,0,2,positive regulation of ovarian follicle development,BP,
21687,GO:2000387,1,0.996620088484601,0,1,regulation of antral ovarian follicle growth,BP,
21688,GO:2000388,1,0.996620088484601,0,1,positive regulation of antral ovarian follicle growth,BP,
21689,GO:2000389,1,0.970958498367626,0,5,regulation of neutrophil extravasation,BP,
21690,GO:2000391,1,0.975353550360546,0,4,positive regulation of neutrophil extravasation,BP,
21692,GO:2000393,1,0.985059555582763,0,2,negative regulation of lamellipodium morphogenesis,BP,
21693,GO:2000394,1,0.945124848132644,0,7,positive regulation of lamellipodium morphogenesis,BP,
21694,GO:2000395,1,0.993327661754263,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21695,GO:2000397,1,0.993327661754263,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21696,GO:2000401,1,0.710015702363187,0,56,regulation of lymphocyte migration,BP,
21697,GO:2000402,1,0.92101478009476,0,13,negative regulation of lymphocyte migration,BP,
21698,GO:2000403,1,0.820563897052944,0,33,positive regulation of lymphocyte migration,BP,
21699,GO:2000404,1,0.789909462388588,0,39,regulation of T cell migration,BP,
21700,GO:2000405,1,0.972657789471882,0,5,negative regulation of T cell migration,BP,
21701,GO:2000406,1,0.839182931755536,0,28,positive regulation of T cell migration,BP,
21702,GO:2000407,1,0.975470649334454,0,5,regulation of T cell extravasation,BP,
21703,GO:2000408,1,0.993938846711865,0,1,negative regulation of T cell extravasation,BP,
21704,GO:2000409,1,0.985206421810539,0,3,positive regulation of T cell extravasation,BP,
21705,GO:2000410,1,0.982274486923221,0,4,regulation of thymocyte migration,BP,
21706,GO:2000412,1,0.986295169373257,0,3,positive regulation of thymocyte migration,BP,
21707,GO:2000413,1,0.994169862436017,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21708,GO:2000415,1,0.994169862436017,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21709,GO:2000416,1,0.979298208557298,0,4,regulation of eosinophil migration,BP,
21710,GO:2000417,1,0.989864710781509,0,2,negative regulation of eosinophil migration,BP,
21711,GO:2000418,1,0.989326389991538,0,2,positive regulation of eosinophil migration,BP,
21712,GO:2000419,1,0.993642748452914,0,1,regulation of eosinophil extravasation,BP,
21713,GO:2000420,1,0.993642748452914,0,1,negative regulation of eosinophil extravasation,BP,
21714,GO:2000422,1,0.99512840842731,0,1,regulation of eosinophil chemotaxis,BP,
21715,GO:2000424,1,0.99512840842731,0,1,positive regulation of eosinophil chemotaxis,BP,
21716,GO:2000425,1,0.932004453743994,0,10,regulation of apoptotic cell clearance,BP,
21717,GO:2000426,1,0.989973282969701,0,2,negative regulation of apoptotic cell clearance,BP,
21718,GO:2000427,1,0.942674485157376,0,8,positive regulation of apoptotic cell clearance,BP,
21719,GO:2000431,1,0.992571212673009,0,1,regulation of cytokinesis, actomyosin contractile ring assembly,BP,
21720,GO:2000434,1,0.987873292636434,0,3,regulation of protein neddylation,BP,
21721,GO:2000435,1,0.993674764502582,0,2,negative regulation of protein neddylation,BP,
21722,GO:2000436,1,0.994161969635545,0,1,positive regulation of protein neddylation,BP,
21723,GO:2000437,1,0.971799803312281,0,4,regulation of monocyte extravasation,BP,
21724,GO:2000438,1,0.98706942245828,0,1,negative regulation of monocyte extravasation,BP,
21725,GO:2000439,1,0.984532345484476,0,3,positive regulation of monocyte extravasation,BP,
21726,GO:2000446,1,0.984774111077961,0,3,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21727,GO:2000448,1,0.992989295836978,0,2,positive regulation of macrophage migration inhibitory factor signaling pathway,BP,
21728,GO:2000449,1,0.987799984319449,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21729,GO:2000451,1,0.991610467476639,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21730,GO:2000452,1,0.99241224883448,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21731,GO:2000454,1,0.996240344714381,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21732,GO:2000458,1,0.991681114244101,0,2,regulation of astrocyte chemotaxis,BP,
21734,GO:2000464,1,0.995352825608927,0,1,positive regulation of astrocyte chemotaxis,BP,
21735,GO:2000465,1,0.944644133525833,0,7,regulation of glycogen (starch) synthase activity,BP,
21736,GO:2000466,1,0.976519217420863,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21737,GO:2000467,1,0.968585288994291,0,4,positive regulation of glycogen (starch) synthase activity,BP,
21738,GO:2000468,1,0.971834452001784,0,3,regulation of peroxidase activity,BP,
21739,GO:2000469,1,0.982701323297205,0,1,negative regulation of peroxidase activity,BP,
21740,GO:2000470,1,0.988943753194007,0,2,positive regulation of peroxidase activity,BP,
21741,GO:2000471,1,0.985739752179985,0,2,regulation of hematopoietic stem cell migration,BP,
21742,GO:2000473,1,0.985739752179985,0,2,positive regulation of hematopoietic stem cell migration,BP,
21743,GO:2000474,1,0.987808523771054,0,2,regulation of opioid receptor signaling pathway,BP,
21744,GO:2000479,1,0.875872066888144,0,19,regulation of cAMP-dependent protein kinase activity,BP,
21745,GO:2000480,1,0.953812136497564,0,9,negative regulation of cAMP-dependent protein kinase activity,BP,
21746,GO:2000481,1,0.954863760742847,0,5,positive regulation of cAMP-dependent protein kinase activity,BP,
21747,GO:2000485,1,0.989057772364295,0,2,regulation of glutamine transport,BP,
21748,GO:2000486,1,0.993616147992159,0,1,negative regulation of glutamine transport,BP,
21749,GO:2000487,1,0.99541263095158,0,1,positive regulation of glutamine transport,BP,
21750,GO:2000489,1,0.960372396203368,0,6,regulation of hepatic stellate cell activation,BP,
21751,GO:2000490,1,0.989147055309919,0,2,negative regulation of hepatic stellate cell activation,BP,
21752,GO:2000491,1,0.970912753506985,0,4,positive regulation of hepatic stellate cell activation,BP,
21753,GO:2000492,1,0.994488243633323,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21754,GO:2000494,1,0.994488243633323,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21755,GO:2000501,1,0.983128169002885,0,5,regulation of natural killer cell chemotaxis,BP,
21756,GO:2000502,1,0.99336066810053,0,2,negative regulation of natural killer cell chemotaxis,BP,
21757,GO:2000503,1,0.989699796574063,0,3,positive regulation of natural killer cell chemotaxis,BP,
21758,GO:2000504,1,0.995579949107702,0,1,positive regulation of blood vessel remodeling,BP,
21759,GO:2000508,1,0.962225330643286,0,9,regulation of dendritic cell chemotaxis,BP,
21760,GO:2000509,1,0.993872389007951,0,1,negative regulation of dendritic cell chemotaxis,BP,
21761,GO:2000510,1,0.968159755246085,0,8,positive regulation of dendritic cell chemotaxis,BP,
21762,GO:2000511,1,0.996711635262835,0,1,regulation of granzyme A production,BP,
21763,GO:2000513,1,0.996711635262835,0,1,positive regulation of granzyme A production,BP,
21767,GO:2000517,1,0.996711635262835,0,1,regulation of T-helper 1 cell activation,BP,
21768,GO:2000518,1,0.996711635262835,0,1,negative regulation of T-helper 1 cell activation,BP,
21769,GO:2000520,1,0.988139338370046,0,3,regulation of immunological synapse formation,BP,
21770,GO:2000521,1,0.992256838444447,0,2,negative regulation of immunological synapse formation,BP,
21771,GO:2000522,1,0.995850691831409,0,1,positive regulation of immunological synapse formation,BP,
21772,GO:2000523,1,0.985901624305512,0,3,regulation of T cell costimulation,BP,
21773,GO:2000524,1,0.996504666815365,0,1,negative regulation of T cell costimulation,BP,
21774,GO:2000525,1,0.989360138198798,0,2,positive regulation of T cell costimulation,BP,
21775,GO:2000526,1,0.995850691831409,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21776,GO:2000527,1,0.996831678420969,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21777,GO:2000529,1,0.996831678420969,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21778,GO:2000532,1,0.995341402520803,0,1,regulation of renal albumin absorption,BP,
21779,GO:2000533,1,0.995341402520803,0,1,negative regulation of renal albumin absorption,BP,
21780,GO:2000535,1,0.955741926670996,0,6,regulation of entry of bacterium into host cell,BP,
21781,GO:2000536,1,0.986784392616845,0,1,negative regulation of entry of bacterium into host cell,BP,
21782,GO:2000537,1,0.988447862828682,0,2,regulation of B cell chemotaxis,BP,
21783,GO:2000538,1,0.988447862828682,0,2,positive regulation of B cell chemotaxis,BP,
21784,GO:2000539,1,0.995346302317168,0,1,regulation of protein geranylgeranylation,BP,
21785,GO:2000541,1,0.995346302317168,0,1,positive regulation of protein geranylgeranylation,BP,
21787,GO:2000543,1,0.976912549666493,0,5,positive regulation of gastrulation,BP,
21788,GO:2000544,1,0.962882617665958,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21789,GO:2000545,1,0.996720374049634,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21790,GO:2000546,1,0.973056965879841,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21791,GO:2000547,1,0.989586926088651,0,3,regulation of dendritic cell dendrite assembly,BP,
21792,GO:2000548,1,0.996831678420969,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21793,GO:2000549,1,0.99686889855885,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21794,GO:2000551,1,0.958102577904944,0,9,regulation of T-helper 2 cell cytokine production,BP,
21795,GO:2000552,1,0.991830942403474,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21796,GO:2000553,1,0.965996586964889,0,7,positive regulation of T-helper 2 cell cytokine production,BP,
21797,GO:2000554,1,0.974264292899037,0,5,regulation of T-helper 1 cell cytokine production,BP,
21798,GO:2000556,1,0.974264292899037,0,5,positive regulation of T-helper 1 cell cytokine production,BP,
21799,GO:2000557,1,0.996711635262835,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21800,GO:2000558,1,0.996711635262835,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21801,GO:2000559,1,0.98706942245828,0,1,regulation of CD24 production,BP,
21802,GO:2000560,1,0.98706942245828,0,1,positive regulation of CD24 production,BP,
21803,GO:2000561,1,0.952028833985382,0,11,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21804,GO:2000562,1,0.969041056871132,0,8,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21805,GO:2000563,1,0.975705372267106,0,5,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21806,GO:2000564,1,0.962272806103577,0,7,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21807,GO:2000566,1,0.984169375902299,0,4,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21808,GO:2000567,1,0.996511488008149,0,1,regulation of memory T cell activation,BP,
21809,GO:2000568,1,0.996511488008149,0,1,positive regulation of memory T cell activation,BP,
21810,GO:2000569,1,0.9939247748468,0,1,regulation of T-helper 2 cell activation,BP,
21811,GO:2000570,1,0.9939247748468,0,1,positive regulation of T-helper 2 cell activation,BP,
21812,GO:2000571,1,0.993482673451939,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21813,GO:2000572,1,0.993482673451939,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21814,GO:2000573,1,0.661382947105463,0,68,positive regulation of DNA biosynthetic process,BP,
21815,GO:2000574,1,0.944743585668323,0,9,regulation of microtubule motor activity,BP,
21816,GO:2000575,1,0.989152924721618,0,1,negative regulation of microtubule motor activity,BP,
21817,GO:2000576,1,0.984928972309157,0,4,positive regulation of microtubule motor activity,BP,
21818,GO:2000580,1,0.989987449791552,0,3,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21819,GO:2000582,1,0.989987449791552,0,3,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21820,GO:2000583,1,0.961910305110306,0,4,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21821,GO:2000584,1,0.992745801065245,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21823,GO:2000587,1,0.952136478581927,0,4,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21824,GO:2000588,1,0.970211921344367,0,3,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21825,GO:2000589,1,0.978746492151941,0,3,regulation of metanephric mesenchymal cell migration,BP,
21826,GO:2000591,1,0.978746492151941,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21827,GO:2000592,1,0.984941557444264,0,2,regulation of metanephric DCT cell differentiation,BP,
21828,GO:2000594,1,0.984941557444264,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21829,GO:2000595,1,0.992193352021718,0,1,regulation of optic nerve formation,BP,
21830,GO:2000597,1,0.992193352021718,0,1,positive regulation of optic nerve formation,BP,
21831,GO:2000601,1,0.93182690169763,0,9,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21832,GO:2000606,1,0.994331352638263,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21833,GO:2000607,1,0.994331352638263,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21834,GO:2000609,1,0.973360591304798,0,5,regulation of thyroid hormone generation,BP,
21835,GO:2000611,1,0.977069779728933,0,4,positive regulation of thyroid hormone generation,BP,
21836,GO:2000612,1,0.992691717984483,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21837,GO:2000615,1,0.922770164663987,0,11,regulation of histone H3-K9 acetylation,BP,
21838,GO:2000616,1,0.990080236614488,0,1,negative regulation of histone H3-K9 acetylation,BP,
21839,GO:2000617,1,0.941484091833248,0,8,positive regulation of histone H3-K9 acetylation,BP,
21840,GO:2000618,1,0.953538550947239,0,6,regulation of histone H4-K16 acetylation,BP,
21841,GO:2000619,1,0.983513636124327,0,3,negative regulation of histone H4-K16 acetylation,BP,
21842,GO:2000620,1,0.975229985898296,0,2,positive regulation of histone H4-K16 acetylation,BP,
21843,GO:2000622,1,0.96635158859626,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21844,GO:2000623,1,0.96635158859626,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21845,GO:2000625,1,0.975840649549539,0,3,regulation of miRNA catabolic process,BP,
21846,GO:2000627,1,0.975840649549539,0,3,positive regulation of miRNA catabolic process,BP,
21847,GO:2000628,1,0.923944002852897,0,10,regulation of miRNA metabolic process,BP,
21848,GO:2000630,1,0.960474275276916,0,6,positive regulation of miRNA metabolic process,BP,
21849,GO:2000631,1,0.983504777712374,0,2,regulation of pre-miRNA processing,BP,
21850,GO:2000632,1,0.983504777712374,0,2,negative regulation of pre-miRNA processing,BP,
21851,GO:2000634,1,0.97684255994085,0,3,regulation of primary miRNA processing,BP,
21852,GO:2000635,1,0.97684255994085,0,3,negative regulation of primary miRNA processing,BP,
21853,GO:2000637,1,0.861767506584839,0,23,positive regulation of gene silencing by miRNA,BP,
21854,GO:2000638,1,0.965793536288917,0,6,regulation of SREBP signaling pathway,BP,
21855,GO:2000639,1,0.983260356632182,0,3,negative regulation of SREBP signaling pathway,BP,
21856,GO:2000640,1,0.988913519462075,0,2,positive regulation of SREBP signaling pathway,BP,
21857,GO:2000641,1,0.892097907260061,0,17,regulation of early endosome to late endosome transport,BP,
21858,GO:2000642,1,0.993491144070589,0,2,negative regulation of early endosome to late endosome transport,BP,
21859,GO:2000643,1,0.940801977408485,0,8,positive regulation of early endosome to late endosome transport,BP,
21862,GO:2000646,1,0.94621388283322,0,6,positive regulation of receptor catabolic process,BP,
21863,GO:2000647,1,0.923501733004541,0,11,negative regulation of stem cell proliferation,BP,
21864,GO:2000648,1,0.73300396590369,0,43,positive regulation of stem cell proliferation,BP,
21865,GO:2000649,1,0.654119833497365,0,54,regulation of sodium ion transmembrane transporter activity,BP,
21866,GO:2000650,1,0.897539616527665,0,12,negative regulation of sodium ion transmembrane transporter activity,BP,
21867,GO:2000651,1,0.863138765936851,0,16,positive regulation of sodium ion transmembrane transporter activity,BP,
21868,GO:2000653,1,0.960844096107706,0,4,regulation of genetic imprinting,BP,
21869,GO:2000654,1,0.992748922115111,0,1,regulation of cellular response to testosterone stimulus,BP,
21870,GO:2000655,1,0.992748922115111,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21871,GO:2000656,1,0.996209031132368,0,1,regulation of apolipoprotein binding,BP,
21872,GO:2000657,1,0.996209031132368,0,1,negative regulation of apolipoprotein binding,BP,
21873,GO:2000659,1,0.955345859979936,0,8,regulation of interleukin-1-mediated signaling pathway,BP,
21874,GO:2000660,1,0.972244465704441,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21875,GO:2000661,1,0.990595854135629,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21876,GO:2000668,1,0.941196872944501,0,11,regulation of dendritic cell apoptotic process,BP,
21877,GO:2000669,1,0.967155204057039,0,7,negative regulation of dendritic cell apoptotic process,BP,
21878,GO:2000670,1,0.973168969537021,0,4,positive regulation of dendritic cell apoptotic process,BP,
21880,GO:2000672,1,0.978023546044894,0,4,negative regulation of motor neuron apoptotic process,BP,
21881,GO:2000674,1,0.948891621731659,0,9,regulation of type B pancreatic cell apoptotic process,BP,
21882,GO:2000675,1,0.963120511291851,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21883,GO:2000676,1,0.985231778469111,0,3,positive regulation of type B pancreatic cell apoptotic process,BP,
21885,GO:2000678,1,0.882862951633722,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21886,GO:2000679,1,0.868683704295902,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21887,GO:2000683,1,0.989143502483262,0,2,regulation of cellular response to X-ray,BP,
21888,GO:2000685,1,0.994782870291466,0,1,positive regulation of cellular response to X-ray,BP,
21889,GO:2000690,1,0.991900474094357,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21890,GO:2000691,1,0.991900474094357,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21892,GO:2000697,1,0.975775335247439,0,5,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21894,GO:2000699,1,0.994331352638263,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21895,GO:2000701,1,0.994331352638263,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21896,GO:2000702,1,0.994331352638263,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21897,GO:2000703,1,0.994331352638263,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21899,GO:2000706,1,0.99312870677681,0,1,negative regulation of dense core granule biogenesis,BP,
21901,GO:2000718,1,0.996829239940352,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21902,GO:2000719,1,0.996829239940352,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21903,GO:2000721,1,0.972395710098412,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21904,GO:2000722,1,0.977133680669601,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21905,GO:2000723,1,0.995064395775955,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21906,GO:2000724,1,0.981981230666681,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21907,GO:2000725,1,0.763911293657663,0,35,regulation of cardiac muscle cell differentiation,BP,
21908,GO:2000726,1,0.876196809615817,0,17,negative regulation of cardiac muscle cell differentiation,BP,
21909,GO:2000727,1,0.872006863036419,0,18,positive regulation of cardiac muscle cell differentiation,BP,
21910,GO:2000729,1,0.991554557620479,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21911,GO:2000730,1,0.994154071280641,0,1,regulation of termination of RNA polymerase I transcription,BP,
21912,GO:2000733,1,0.994331352638263,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21913,GO:2000734,1,0.994331352638263,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21914,GO:2000736,1,0.493312494116568,0,112,regulation of stem cell differentiation,BP,
21915,GO:2000737,1,0.854415989445891,0,19,negative regulation of stem cell differentiation,BP,
21916,GO:2000738,1,0.866302791455222,0,21,positive regulation of stem cell differentiation,BP,
21917,GO:2000739,1,0.940856961402263,0,6,regulation of mesenchymal stem cell differentiation,BP,
21918,GO:2000740,1,0.99312870677681,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21919,GO:2000741,1,0.959432489453451,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21920,GO:2000742,1,0.995961294964222,0,1,regulation of anterior head development,BP,
21921,GO:2000744,1,0.995961294964222,0,1,positive regulation of anterior head development,BP,
21922,GO:2000752,1,0.994852072375899,0,1,regulation of glucosylceramide catabolic process,BP,
21923,GO:2000753,1,0.994852072375899,0,1,positive regulation of glucosylceramide catabolic process,BP,
21924,GO:2000754,1,0.994852072375899,0,1,regulation of sphingomyelin catabolic process,BP,
21925,GO:2000755,1,0.994852072375899,0,1,positive regulation of sphingomyelin catabolic process,BP,
21927,GO:2000757,1,0.887600516292782,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21929,GO:2000759,1,0.990673868928724,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21930,GO:2000761,1,0.990673868928724,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21931,GO:2000763,1,0.995566208344267,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21932,GO:2000764,1,0.995566208344267,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21933,GO:2000765,1,0.84008807133277,0,26,regulation of cytoplasmic translation,BP,
21934,GO:2000766,1,0.935581909877497,0,8,negative regulation of cytoplasmic translation,BP,
21935,GO:2000767,1,0.934587429085285,0,10,positive regulation of cytoplasmic translation,BP,
21936,GO:2000768,1,0.992571212673009,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21937,GO:2000772,1,0.757899765683961,0,41,regulation of cellular senescence,BP,
21938,GO:2000773,1,0.861746175184733,0,19,negative regulation of cellular senescence,BP,
21939,GO:2000774,1,0.946928197347268,0,12,positive regulation of cellular senescence,BP,
21940,GO:2000775,1,0.995954807555892,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21941,GO:2000777,1,0.991712391747998,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21942,GO:2000779,1,0.581490434462922,0,70,regulation of double-strand break repair,BP,
21943,GO:2000780,1,0.80515058112323,0,26,negative regulation of double-strand break repair,BP,
21944,GO:2000781,1,0.784636369111445,0,28,positive regulation of double-strand break repair,BP,
21945,GO:2000785,1,0.784475797551153,0,34,regulation of autophagosome assembly,BP,
21946,GO:2000786,1,0.933231310757258,0,8,positive regulation of autophagosome assembly,BP,
21947,GO:2000790,1,0.977468640926437,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21948,GO:2000791,1,0.977468640926437,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21949,GO:2000793,1,0.94189523792239,0,4,cell proliferation involved in heart valve development,BP,
21950,GO:2000794,1,0.942051357963239,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21951,GO:2000795,1,0.984612315822251,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21952,GO:2000797,1,0.99312870677681,0,1,regulation of amniotic stem cell differentiation,BP,
21953,GO:2000798,1,0.99312870677681,0,1,negative regulation of amniotic stem cell differentiation,BP,
21954,GO:2000800,1,0.996422603960133,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21955,GO:2000802,1,0.996422603960133,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21956,GO:2000804,1,0.969783006687837,0,3,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21957,GO:2000805,1,0.989807596705769,0,2,negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21958,GO:2000806,1,0.979771258481234,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21959,GO:2000807,1,0.917870959257865,0,9,regulation of synaptic vesicle clustering,BP,
21960,GO:2000808,1,0.989371978870216,0,1,negative regulation of synaptic vesicle clustering,BP,
21961,GO:2000809,1,0.953674493377661,0,5,positive regulation of synaptic vesicle clustering,BP,
21962,GO:2000810,1,0.84608477844604,0,23,regulation of bicellular tight junction assembly,BP,
21963,GO:2000811,1,0.8842280411152,0,16,negative regulation of anoikis,BP,
21964,GO:2000812,1,0.992670925660515,0,1,regulation of barbed-end actin filament capping,BP,
21965,GO:2000815,1,0.985061342544546,0,2,regulation of mRNA stability involved in response to oxidative stress,BP,
21966,GO:2000816,1,0.780340208316361,0,37,negative regulation of mitotic sister chromatid separation,BP,
21967,GO:2000818,1,0.991114037780543,0,2,negative regulation of myoblast proliferation,BP,
21968,GO:2000819,1,0.982937062924543,0,3,regulation of nucleotide-excision repair,BP,
21969,GO:2000820,1,0.97944804967886,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21970,GO:2000821,1,0.960364103504958,0,5,regulation of grooming behavior,BP,
21971,GO:2000822,1,0.946987066410002,0,9,regulation of behavioral fear response,BP,
21972,GO:2000825,1,0.97594125464153,0,4,positive regulation of androgen receptor activity,BP,
21973,GO:2000826,1,0.74923697163251,0,38,regulation of heart morphogenesis,BP,
21974,GO:2000827,1,0.995378806480956,0,1,mitochondrial RNA surveillance,BP,
21975,GO:2000828,1,0.985433035716692,0,2,regulation of parathyroid hormone secretion,BP,
21976,GO:2000830,1,0.989198174197412,0,1,positive regulation of parathyroid hormone secretion,BP,
21977,GO:2000831,1,0.925496232099661,0,16,regulation of steroid hormone secretion,BP,
21978,GO:2000832,1,0.981995005954382,0,2,negative regulation of steroid hormone secretion,BP,
21979,GO:2000833,1,0.962691393595238,0,9,positive regulation of steroid hormone secretion,BP,
21980,GO:2000834,1,0.993916727593001,0,1,regulation of androgen secretion,BP,
21981,GO:2000836,1,0.993916727593001,0,1,positive regulation of androgen secretion,BP,
21982,GO:2000843,1,0.980797107573696,0,2,regulation of testosterone secretion,BP,
21983,GO:2000845,1,0.980797107573696,0,2,positive regulation of testosterone secretion,BP,
21984,GO:2000846,1,0.937779072861631,0,13,regulation of corticosteroid hormone secretion,BP,
21985,GO:2000847,1,0.981995005954382,0,2,negative regulation of corticosteroid hormone secretion,BP,
21986,GO:2000848,1,0.971607255404894,0,7,positive regulation of corticosteroid hormone secretion,BP,
21987,GO:2000849,1,0.956692887209563,0,9,regulation of glucocorticoid secretion,BP,
21988,GO:2000850,1,0.981995005954382,0,2,negative regulation of glucocorticoid secretion,BP,
21989,GO:2000851,1,0.982143865195531,0,5,positive regulation of glucocorticoid secretion,BP,
21990,GO:2000852,1,0.985447273219306,0,4,regulation of corticosterone secretion,BP,
21991,GO:2000854,1,0.993442575285031,0,2,positive regulation of corticosterone secretion,BP,
21992,GO:2000855,1,0.980238686368631,0,4,regulation of mineralocorticoid secretion,BP,
21993,GO:2000857,1,0.989273755242352,0,2,positive regulation of mineralocorticoid secretion,BP,
21994,GO:2000858,1,0.980238686368631,0,4,regulation of aldosterone secretion,BP,
21995,GO:2000860,1,0.989273755242352,0,2,positive regulation of aldosterone secretion,BP,
21996,GO:2000864,1,0.975918872213509,0,3,regulation of estradiol secretion,BP,
21997,GO:2000866,1,0.987996689780407,0,2,positive regulation of estradiol secretion,BP,
21998,GO:2000870,1,0.992951401430131,0,2,regulation of progesterone secretion,BP,
21999,GO:2000872,1,0.99689078116753,0,1,positive regulation of progesterone secretion,BP,
22000,GO:2000878,1,0.991525261609797,0,2,positive regulation of oligopeptide transport,BP,
22001,GO:2000880,1,0.991525261609797,0,2,positive regulation of dipeptide transport,BP,
22002,GO:2000896,1,0.994161969635545,0,1,amylopectin metabolic process,BP,
22003,GO:2000909,1,0.968803971998568,0,2,regulation of sterol import,BP,
22004,GO:2000911,1,0.973780452882526,0,1,positive regulation of sterol import,BP,
22005,GO:2000969,1,0.935357115685321,0,8,positive regulation of AMPA receptor activity,BP,
22006,GO:2000970,1,0.995491880296837,0,1,regulation of detection of glucose,BP,
22007,GO:2000971,1,0.995491880296837,0,1,negative regulation of detection of glucose,BP,
22008,GO:2000973,1,0.93590199312798,0,7,regulation of pro-B cell differentiation,BP,
22009,GO:2000974,1,0.975986781265397,0,3,negative regulation of pro-B cell differentiation,BP,
22010,GO:2000975,1,0.991592479526111,0,1,positive regulation of pro-B cell differentiation,BP,
22011,GO:2000977,1,0.978284889192188,0,5,regulation of forebrain neuron differentiation,BP,
22012,GO:2000978,1,0.99008592799608,0,3,negative regulation of forebrain neuron differentiation,BP,
22013,GO:2000979,1,0.994328439527581,0,1,positive regulation of forebrain neuron differentiation,BP,
22014,GO:2000980,1,0.953590643947514,0,7,regulation of inner ear receptor cell differentiation,BP,
22015,GO:2000981,1,0.969975280709336,0,4,negative regulation of inner ear receptor cell differentiation,BP,
22016,GO:2000983,1,0.996711635262835,0,1,regulation of ATP citrate synthase activity,BP,
22017,GO:2000984,1,0.996711635262835,0,1,negative regulation of ATP citrate synthase activity,BP,
22018,GO:2000986,1,0.996755819621341,0,1,negative regulation of behavioral fear response,BP,
22019,GO:2000987,1,0.962162997820708,0,7,positive regulation of behavioral fear response,BP,
22020,GO:2001012,1,0.962021987134428,0,7,mesenchymal cell differentiation involved in renal system development,BP,
22021,GO:2001013,1,0.963453704877034,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
22022,GO:2001014,1,0.874478361401134,0,19,regulation of skeletal muscle cell differentiation,BP,
22023,GO:2001015,1,0.953712922236085,0,6,negative regulation of skeletal muscle cell differentiation,BP,
22024,GO:2001016,1,0.959830302427997,0,6,positive regulation of skeletal muscle cell differentiation,BP,
22025,GO:2001020,1,0.256782657075233,0,200,regulation of response to DNA damage stimulus,BP,
22026,GO:2001021,1,0.620059788467672,0,72,negative regulation of response to DNA damage stimulus,BP,
22027,GO:2001022,1,0.532672425755225,0,91,positive regulation of response to DNA damage stimulus,BP,
22028,GO:2001023,1,0.951885850405451,0,5,regulation of response to drug,BP,
22029,GO:2001025,1,0.994890876864838,0,1,positive regulation of response to drug,BP,
22030,GO:2001026,1,0.858443970027832,0,18,regulation of endothelial cell chemotaxis,BP,
22031,GO:2001027,1,0.968501180848902,0,3,negative regulation of endothelial cell chemotaxis,BP,
22032,GO:2001028,1,0.892830469638335,0,14,positive regulation of endothelial cell chemotaxis,BP,
22033,GO:2001029,1,0.989411732254915,0,1,regulation of cellular glucuronidation,BP,
22034,GO:2001031,1,0.989411732254915,0,1,positive regulation of cellular glucuronidation,BP,
22035,GO:2001032,1,0.851655966549362,0,21,regulation of double-strand break repair via nonhomologous end joining,BP,
22036,GO:2001033,1,0.964018874120336,0,6,negative regulation of double-strand break repair via nonhomologous end joining,BP,
22037,GO:2001034,1,0.905950461492004,0,11,positive regulation of double-strand break repair via nonhomologous end joining,BP,
22038,GO:2001035,1,0.987902081182098,0,2,regulation of tongue muscle cell differentiation,BP,
22039,GO:2001037,1,0.987902081182098,0,2,positive regulation of tongue muscle cell differentiation,BP,
22040,GO:2001038,1,0.976687691899164,0,3,regulation of cellular response to drug,BP,
22041,GO:2001040,1,0.994890876864838,0,1,positive regulation of cellular response to drug,BP,
22043,GO:2001045,1,0.973211782325499,0,3,negative regulation of integrin-mediated signaling pathway,BP,
22044,GO:2001046,1,0.95324758882738,0,7,positive regulation of integrin-mediated signaling pathway,BP,
22045,GO:2001049,1,0.996080135909399,0,1,regulation of tendon cell differentiation,BP,
22046,GO:2001051,1,0.996080135909399,0,1,positive regulation of tendon cell differentiation,BP,
22047,GO:2001053,1,0.940907166881431,0,11,regulation of mesenchymal cell apoptotic process,BP,
22048,GO:2001054,1,0.948529944545835,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
22049,GO:2001055,1,0.991967826141465,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
22051,GO:2001057,1,0.619141563609355,0,69,reactive nitrogen species metabolic process,BP,
22052,GO:2001065,1,0.996648216378589,0,1,mannan binding,MF,
22053,GO:2001069,1,0.956721758569177,0,7,glycogen binding,MF,
22054,GO:2001070,1,0.985000275204747,0,2,starch binding,MF,
22055,GO:2001074,1,0.990781414361412,0,2,regulation of metanephric ureteric bud development,BP,
22056,GO:2001076,1,0.990781414361412,0,2,positive regulation of metanephric ureteric bud development,BP,
22057,GO:2001106,1,0.969489561587709,0,3,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22058,GO:2001108,1,0.987860000336312,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
22059,GO:2001109,1,0.979812212012902,0,2,regulation of lens epithelial cell proliferation,BP,
22060,GO:2001111,1,0.979812212012902,0,2,positive regulation of lens epithelial cell proliferation,BP,
22061,GO:2001112,1,0.990477207264964,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
22062,GO:2001113,1,0.990477207264964,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
22063,GO:2001135,1,0.923490844952901,0,10,regulation of endocytic recycling,BP,
22064,GO:2001136,1,0.993769118595252,0,1,negative regulation of endocytic recycling,BP,
22065,GO:2001137,1,0.958629846196508,0,4,positive regulation of endocytic recycling,BP,
22066,GO:2001138,1,0.931357930948613,0,11,regulation of phospholipid transport,BP,
22067,GO:2001140,1,0.931357930948613,0,11,positive regulation of phospholipid transport,BP,
22069,GO:2001142,1,0.995245458510889,0,1,nicotinate transport,BP,
22070,GO:2001144,1,0.995832816908303,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22071,GO:2001145,1,0.995832816908303,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
22072,GO:2001148,1,0.991525261609797,0,2,regulation of dipeptide transmembrane transport,BP,
22073,GO:2001150,1,0.991525261609797,0,2,positive regulation of dipeptide transmembrane transport,BP,
22074,GO:2001151,1,0.994030963168051,0,1,regulation of renal water transport,BP,
22075,GO:2001153,1,0.994030963168051,0,1,positive regulation of renal water transport,BP,
22076,GO:2001160,1,0.988499892665677,0,2,regulation of histone H3-K79 methylation,BP,
22077,GO:2001162,1,0.988499892665677,0,2,positive regulation of histone H3-K79 methylation,BP,
22078,GO:2001163,1,0.995702934536761,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22079,GO:2001165,1,0.995702934536761,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
22080,GO:2001166,1,0.967893455277024,0,5,regulation of histone H2B ubiquitination,BP,
22081,GO:2001168,1,0.971879863555269,0,4,positive regulation of histone H2B ubiquitination,BP,
22082,GO:2001169,1,0.915321944569937,0,15,regulation of ATP biosynthetic process,BP,
22083,GO:2001170,1,0.982490768335477,0,3,negative regulation of ATP biosynthetic process,BP,
22084,GO:2001171,1,0.94128891707716,0,10,positive regulation of ATP biosynthetic process,BP,
22085,GO:2001173,1,0.995899419218899,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
22086,GO:2001176,1,0.995595143021993,0,1,regulation of mediator complex assembly,BP,
22087,GO:2001178,1,0.995595143021993,0,1,positive regulation of mediator complex assembly,BP,
22088,GO:2001185,1,0.906007169499755,0,17,regulation of CD8-positive, alpha-beta T cell activation,BP,
22089,GO:2001186,1,0.977510548994958,0,5,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
22090,GO:2001187,1,0.95227955670296,0,8,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
22091,GO:2001188,1,0.976785073492892,0,6,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22092,GO:2001189,1,0.987014864183281,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22093,GO:2001190,1,0.989636980029037,0,3,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
22094,GO:2001191,1,0.994717530295309,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
22095,GO:2001193,1,0.994717530295309,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
22096,GO:2001197,1,0.939775170013206,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
22097,GO:2001198,1,0.948065900532993,0,12,regulation of dendritic cell differentiation,BP,
22098,GO:2001199,1,0.973082845356846,0,6,negative regulation of dendritic cell differentiation,BP,
22099,GO:2001200,1,0.978502643414355,0,4,positive regulation of dendritic cell differentiation,BP,
22102,GO:2001206,1,0.982641220641293,0,4,positive regulation of osteoclast development,BP,
22103,GO:2001207,1,0.992820725392346,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
22104,GO:2001208,1,0.992820725392346,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
22106,GO:2001213,1,0.988998589550453,0,1,negative regulation of vasculogenesis,BP,
22110,GO:2001224,1,0.849304773199206,0,14,positive regulation of neuron migration,BP,
22111,GO:2001225,1,0.928830603050024,0,10,regulation of chloride transport,BP,
22112,GO:2001226,1,0.982710471387904,0,3,negative regulation of chloride transport,BP,
22113,GO:2001228,1,0.956017078541067,0,2,regulation of response to gamma radiation,BP,
22114,GO:2001229,1,0.975874319394553,0,1,negative regulation of response to gamma radiation,BP,
22121,GO:2001239,1,0.77391162142228,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22122,GO:2001240,1,0.836689349329275,0,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22123,GO:2001241,1,0.9285577351549,0,11,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
22124,GO:2001242,1,0.441842962394644,0,150,regulation of intrinsic apoptotic signaling pathway,BP,
22125,GO:2001243,1,0.596767138976341,0,91,negative regulation of intrinsic apoptotic signaling pathway,BP,
22126,GO:2001244,1,0.774879857945979,0,53,positive regulation of intrinsic apoptotic signaling pathway,BP,
22127,GO:2001245,1,0.971668445785764,0,5,regulation of phosphatidylcholine biosynthetic process,BP,
22128,GO:2001246,1,0.992521425255987,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
22129,GO:2001247,1,0.982170433978337,0,3,positive regulation of phosphatidylcholine biosynthetic process,BP,
22130,GO:2001248,1,0.995877903634853,0,1,regulation of ammonia assimilation cycle,BP,
22131,GO:2001250,1,0.995877903634853,0,1,positive regulation of ammonia assimilation cycle,BP,
22132,GO:2001251,1,0.385419989163191,0,124,negative regulation of chromosome organization,BP,
22134,GO:2001253,1,0.978225388804765,0,3,regulation of histone H3-K36 trimethylation,BP,
22135,GO:2001255,1,0.983691427336854,0,2,positive regulation of histone H3-K36 trimethylation,BP,
22136,GO:2001256,1,0.92733675291237,0,13,regulation of store-operated calcium entry,BP,
22138,GO:2001258,1,0.793164604410665,0,41,negative regulation of cation channel activity,BP,
22140,GO:2001260,1,0.981158074737433,0,3,regulation of semaphorin-plexin signaling pathway,BP,
22141,GO:2001262,1,0.995566208344267,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
22142,GO:2001267,1,0.912194957386382,0,17,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22143,GO:2001268,1,0.975937665794403,0,6,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22144,GO:2001269,1,0.934701089978152,0,11,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
22145,GO:2001270,1,0.970158675034022,0,5,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22146,GO:2001271,1,0.976601030016224,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22147,GO:2001272,1,0.99340484935104,0,2,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
22150,GO:2001286,1,0.948277897323166,0,7,regulation of caveolin-mediated endocytosis,BP,
22151,GO:2001287,1,0.989317596337323,0,2,negative regulation of caveolin-mediated endocytosis,BP,
22152,GO:2001288,1,0.965952728114004,0,4,positive regulation of caveolin-mediated endocytosis,BP,
22153,GO:2001293,1,0.978546525060652,0,2,malonyl-CoA metabolic process,BP,
22154,GO:2001294,1,0.995817577748326,0,1,malonyl-CoA catabolic process,BP,
22155,GO:2001295,1,0.982657129529842,0,1,malonyl-CoA biosynthetic process,BP,
22156,GO:2001300,1,0.969997855725912,0,7,lipoxin metabolic process,BP,
22157,GO:2001301,1,0.969997855725912,0,7,lipoxin biosynthetic process,BP,
22158,GO:2001302,1,0.98581019962101,0,3,lipoxin A4 metabolic process,BP,
22159,GO:2001303,1,0.98581019962101,0,3,lipoxin A4 biosynthetic process,BP,
22160,GO:2001304,1,0.995564677736363,0,1,lipoxin B4 metabolic process,BP,
22161,GO:2001306,1,0.995564677736363,0,1,lipoxin B4 biosynthetic process,BP,
22162,GO:2001311,1,0.991815488964744,0,2,lysobisphosphatidic acid metabolic process,BP,
7665,GO:0031116,1,0.768483283011078,0,29,positive regulation of microtubule polymerization,BP,
11718,GO:0045010,1,0.736083954332282,0,47,actin nucleation,BP,
12029,GO:0045747,1,0.660057192728874,0,49,positive regulation of Notch signaling pathway,BP,
11967,GO:0045646,1,0.709441087893735,0,47,regulation of erythrocyte differentiation,BP,
18721,GO:1900117,1,0.849597084988588,0,28,regulation of execution phase of apoptosis,BP,
21596,GO:2000272,1.00000000000001,0.776194181218641,0,42,negative regulation of signaling receptor activity,BP,
